peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names,,,,,,,,,,,
LLYEEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.-.- (33%);4.3.1.19 (33%);7.1.1.1 (33%),Glycosyltransferases (33%);Threonine ammonia-lyase (33%);Proton-translocating NAD(P)(+) transhydrogenase (33%),GO:0016021 (40%),integral component of membrane (40%),GO:0003677 (29%);GO:0003700 (26%);GO:0005524 (11%),DNA binding (29%);DNA-binding transcription factor activity (26%);ATP binding (11%),GO:0005975 (3%);GO:1902600 (3%),carbohydrate metabolic process (3%);proton transmembrane transport (3%),IPR000524 (19%);IPR036388 (19%);IPR036390 (19%),Transcription regulator HTH, GntR (19%);Winged helix-like DNA-binding domain superfamily (19%);Winged helix DNA-binding domain superfamily (19%),,,,,,,,,,
FEDTNLAALHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.182 (9%);3.4.14.- (6%);4.3.2.2 (5%),Lipid-A-disaccharide synthase (9%);Dipeptidyl-peptidases and tripeptidyl-peptidases (6%);Adenylosuccinate lyase (5%),GO:0016021 (17%);GO:0042613 (8%);GO:0005737 (4%),integral component of membrane (17%);MHC class II protein complex (8%);cytoplasm (4%),GO:0005524 (15%);GO:0003677 (11%);GO:0005198 (7%),ATP binding (15%);DNA binding (11%);structural molecule activity (7%),GO:0006955 (7%);GO:0019882 (7%);GO:0071973 (7%),immune response (7%);antigen processing and presentation (7%);bacterial-type flagellum-dependent cell motility (7%),IPR027417 (8%);IPR000353 (7%);IPR011162 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);MHC class II, beta chain, N-terminal (7%);MHC classes I/II-like antigen recognition protein (7%),,,,,,,,,
LLEWLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (50%);2.1.1.198 (17%);2.7.7.48 (8%),Methyltransferases (50%);16S rRNA (cytidine(1402)-2'-O)-methyltransferase (17%);RNA-directed RNA polymerase (8%),GO:0016021 (13%);GO:0005737 (11%);GO:0016020 (4%),integral component of membrane (13%);cytoplasm (11%);membrane (4%),GO:0003677 (29%);GO:0008170 (21%);GO:0005524 (14%),DNA binding (29%);N-methyltransferase activity (21%);ATP binding (14%),GO:0006306 (21%);GO:0000453 (6%);GO:0009143 (5%),DNA methylation (21%);enzyme-directed rRNA 2'-O-methylation (6%);nucleoside triphosphate catabolic process (5%),IPR029063 (21%);IPR002941 (19%);IPR002052 (19%),S-adenosyl-L-methionine-dependent methyltransferase (21%);DNA methylase N-4/N-6 (19%);DNA methylase, N-6 adenine-specific, conserved site (19%),,,,,,,,,
EEDLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.99.1.1 (79%);2.4.1.227 (3%);3.6.4.12 (2%),Protoporphyrin ferrochelatase (79%);Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (3%);DNA helicase (2%),GO:0005737 (42%);GO:0016021 (8%);GO:0032300 (3%),cytoplasm (42%);integral component of membrane (8%);mismatch repair complex (3%),GO:0046872 (46%);GO:0004325 (38%);GO:0005524 (13%),metal ion binding (46%);ferrochelatase activity (38%);ATP binding (13%),GO:0006783 (38%);GO:0009231 (8%);GO:0006298 (3%),heme biosynthetic process (38%);riboflavin biosynthetic process (8%);mismatch repair (3%),IPR001015 (34%);IPR033644 (34%);IPR033659 (34%),Ferrochelatase (34%);Ferrochelatase, C-terminal (34%);Ferrochelatase, N-terminal (34%),,,,,,,,,
FFNEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (58%);2.1.2.2 (8%);3.1.4.- (8%),DNA-directed DNA polymerase (58%);Phosphoribosylglycinamide formyltransferase (8%);Phosphoric diester hydrolases (8%),GO:0005737 (84%);GO:0016021 (8%);GO:0005886 (0%),cytoplasm (84%);integral component of membrane (8%);plasma membrane (0%),GO:0003676 (63%);GO:0003677 (15%);GO:0005524 (3%),nucleic acid binding (63%);DNA binding (15%);ATP binding (3%),GO:0006260 (2%);GO:0006189 (0%);GO:0009113 (0%),DNA replication (2%);'de novo' IMP biosynthetic process (0%);purine nucleobase biosynthetic process (0%),IPR002059 (81%);IPR012340 (81%);IPR012156 (80%),Cold-shock protein, DNA-binding (81%);Nucleic acid-binding, OB-fold (81%);Cold shock, CspA (80%),,,,,,,,
TEAPLNPK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR004000 (100%);IPR004001 (1%),Actin family (100%);Actin, conserved site (1%),,,,,,,,,,
LLELEEELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.11 (100%),Phosphopyruvate hydratase (100%),GO:0005737 (28%);GO:0005576 (24%);GO:0009986 (24%),cytoplasm (28%);extracellular region (24%);cell surface (24%),GO:0004634 (31%);GO:0000287 (28%);GO:0016149 (17%),phosphopyruvate hydratase activity (31%);magnesium ion binding (28%);translation release factor activity, codon specific (17%),GO:0006096 (28%);GO:0006777 (3%);GO:0006937 (3%),glycolytic process (28%);Mo-molybdopterin cofactor biosynthetic process (3%);regulation of muscle contraction (3%),IPR000533 (63%);IPR000941 (12%);IPR020809 (12%),Tropomyosin (63%);Enolase (12%);Enolase, conserved site (12%),,,,,,,,,
WLSLYLPK,Aureitalea marina,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Aureitalea,,,,Aureitalea marina,,,,,,,,,,,,,,,,,,,,,,,,
ALEQEEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%);GO:0005737 (20%),integral component of membrane (60%);cytoplasm (20%),GO:0003743 (20%);GO:0003924 (20%);GO:0005525 (20%),translation initiation factor activity (20%);GTPase activity (20%);GTP binding (20%),GO:0006797 (20%);GO:0007165 (20%),polyphosphate metabolic process (20%);signal transduction (20%),IPR011990 (50%);IPR013026 (33%);IPR027417 (33%),Tetratricopeptide-like helical domain superfamily (50%);Tetratricopeptide repeat-containing domain (33%);P-loop containing nucleoside triphosphate hydrolase (33%),,,,,,,,,,,
EATGALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (22%);GO:0009279 (20%);GO:0005887 (5%),integral component of membrane (22%);cell outer membrane (20%);integral component of plasma membrane (5%),GO:0070006 (40%);GO:0005509 (20%);GO:0004177 (15%),metalloaminopeptidase activity (40%);calcium ion binding (20%);aminopeptidase activity (15%),GO:0007155 (20%);GO:0009306 (5%);GO:0006606 (2%),cell adhesion (20%);protein secretion (5%);protein import into nucleus (2%),IPR036005 (54%);IPR000994 (52%);IPR000587 (51%),Creatinase/aminopeptidase-like (54%);Peptidase M24 (52%);Creatinase, N-terminal (51%),,,,,,,,,,
FLFDDVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (50%),cytoplasm (50%),GO:0005524 (100%),ATP binding (100%),GO:0019538 (100%);GO:0009408 (50%);GO:0042026 (50%),protein metabolic process (100%);response to heat (50%);protein refolding (50%),IPR012910 (75%);IPR037066 (75%);IPR027417 (19%),TonB-dependent receptor, plug domain (75%);TonB-dependent receptor, plug domain superfamily (75%);P-loop containing nucleoside triphosphate hydrolase (19%),,,,,,,,,
LENVVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.16 (100%),Cysteine--tRNA ligase (100%),GO:0016021 (67%);GO:0005737 (33%),integral component of membrane (67%);cytoplasm (33%),GO:0005524 (50%);GO:0004817 (33%);GO:0008270 (33%),ATP binding (50%);cysteine-tRNA ligase activity (33%);zinc ion binding (33%),GO:0006423 (33%),cysteinyl-tRNA aminoacylation (33%),IPR011022 (36%);IPR014752 (36%);IPR014756 (36%),Arrestin C-terminal-like domain (36%);Arrestin, C-terminal (36%);Immunoglobulin E-set (36%),,,,,,,,,,
GCLWPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (99%);6.1.1.15 (1%),Metalloendopeptidases (99%);Proline--tRNA ligase (1%),GO:0016021 (11%);GO:0001750 (1%);GO:0005737 (1%),integral component of membrane (11%);photoreceptor outer segment (1%);cytoplasm (1%),GO:0004222 (94%);GO:0008270 (93%);GO:0043531 (3%),metalloendopeptidase activity (94%);zinc ion binding (93%);ADP binding (3%),GO:0042742 (9%);GO:0007601 (3%);GO:0007602 (3%),defense response to bacterium (9%);visual perception (3%);phototransduction (3%),IPR001506 (93%);IPR024079 (93%);IPR006026 (92%),Peptidase M12A (93%);Metallopeptidase, catalytic domain superfamily (93%);Peptidase, metallopeptidase (92%),,,,,,,,,
VLEGNEQFLNAAK,Catarrhini,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (17%);GO:0005576 (4%);GO:1904724 (4%),extracellular space (17%);extracellular region (4%);tertiary granule lumen (4%),GO:0004252 (100%);GO:0005509 (17%);GO:0008236 (4%),serine-type endopeptidase activity (100%);calcium ion binding (17%);serine-type peptidase activity (4%),GO:0031638 (17%);GO:0043542 (17%);GO:0006508 (13%),zymogen activation (17%);endothelial cell migration (17%);proteolysis (13%),IPR001254 (100%);IPR009003 (100%);IPR001314 (96%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1A, chymotrypsin family (96%),,,,,,,,
APLLDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.8 (30%);6.3.5.3 (12%);3.4.21.- (11%),Polyribonucleotide nucleotidyltransferase (30%);Phosphoribosylformylglycinamidine synthase (12%);Serine endopeptidases (11%),GO:0016021 (31%);GO:0005737 (11%);GO:0008091 (4%),integral component of membrane (31%);cytoplasm (11%);spectrin (4%),GO:0005524 (17%);GO:0000287 (11%);GO:0003723 (8%),ATP binding (17%);magnesium ion binding (11%);RNA binding (8%),GO:0006396 (8%);GO:0006402 (7%);GO:0006529 (4%),RNA processing (8%);mRNA catabolic process (7%);asparagine biosynthetic process (4%),IPR027417 (10%);IPR020568 (9%);IPR036890 (7%),P-loop containing nucleoside triphosphate hydrolase (10%);Ribosomal protein S5 domain 2-type fold (9%);Histidine kinase/HSP90-like ATPase superfamily (7%),,,,,,,,,,,
SSPATLNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAEVNEQWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGQLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (18%);2.7.1.25 (9%);2.7.7.4 (8%),Endopeptidase La (18%);Adenylyl-sulfate kinase (9%);Sulfate adenylyltransferase (8%),GO:0016021 (29%);GO:0019031 (12%);GO:0020002 (12%),integral component of membrane (29%);viral envelope (12%);host cell plasma membrane (12%),GO:0005524 (23%);GO:0046789 (12%);GO:0003677 (11%),ATP binding (23%);host cell surface receptor binding (12%);DNA binding (11%),GO:0019062 (12%);GO:0039654 (12%);GO:0075512 (12%),virion attachment to host cell (12%);fusion of virus membrane with host endosome membrane (12%);clathrin-dependent endocytosis of virus by host cell (12%),IPR027417 (17%);IPR001364 (10%);IPR008980 (10%),P-loop containing nucleoside triphosphate hydrolase (17%);Haemagglutinin, influenzavirus A/B (10%);Viral capsid/haemagglutinin protein (10%),,,,,,,,,,
WMAEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016787 (50%);GO:0003677 (13%),hydrolase activity (50%);DNA binding (13%),GO:0006310 (13%);GO:0015074 (13%);GO:0016042 (13%),DNA recombination (13%);DNA integration (13%);lipid catabolic process (13%),IPR029058 (33%);IPR000073 (22%);IPR002068 (11%),Alpha/Beta hydrolase fold (33%);Alpha/beta hydrolase fold-1 (22%);Alpha crystallin/Hsp20 domain (11%),,,,,,,,,,,
LAVEAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.49 (33%);4.2.1.19 (5%);2.1.1.10 (4%),Urocanate hydratase (33%);Imidazoleglycerol-phosphate dehydratase (5%);Homocysteine S-methyltransferase (4%),GO:0016021 (18%);GO:0005737 (16%);GO:0005886 (2%),integral component of membrane (18%);cytoplasm (16%);plasma membrane (2%),GO:0003677 (12%);GO:0005524 (9%);GO:0016153 (7%),DNA binding (12%);ATP binding (9%);urocanate hydratase activity (7%),GO:0032259 (9%);GO:0019556 (7%);GO:0019557 (7%),methylation (9%);histidine catabolic process to glutamate and formamide (7%);histidine catabolic process to glutamate and formate (7%),IPR036388 (12%);IPR036589 (8%);IPR003726 (8%),Winged helix-like DNA-binding domain superfamily (12%);Homocysteine-binding domain superfamily (8%);Homocysteine-binding domain (8%),,,,,,,,,,,
FFNETK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.2.29 (40%);2.7.13.3 (20%);2.7.7.6 (20%),5-dehydro-2-deoxyphosphogluconate aldolase (40%);Histidine kinase (20%);DNA-directed RNA polymerase (20%),GO:0005737 (96%);GO:0016021 (2%);GO:0005739 (0%),cytoplasm (96%);integral component of membrane (2%);mitochondrion (0%),GO:0003676 (71%);GO:0003677 (18%);GO:0005524 (1%),nucleic acid binding (71%);DNA binding (18%);ATP binding (1%),GO:0006418 (0%);GO:0005975 (0%);GO:0006355 (0%),tRNA aminoacylation for protein translation (0%);carbohydrate metabolic process (0%);regulation of transcription, DNA-templated (0%),IPR002059 (96%);IPR012340 (96%);IPR011129 (95%),Cold-shock protein, DNA-binding (96%);Nucleic acid-binding, OB-fold (96%);Cold shock domain (95%),,,,,,,,
ENLGFLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (100%),Leucine--tRNA ligase (100%),GO:0005737 (29%),cytoplasm (29%),GO:0004823 (29%);GO:0005524 (29%);GO:0002161 (14%),leucine-tRNA ligase activity (29%);ATP binding (29%);aminoacyl-tRNA editing activity (14%),GO:0006355 (29%);GO:0006429 (29%);GO:0006777 (14%),regulation of transcription, DNA-templated (29%);leucyl-tRNA aminoacylation (29%);Mo-molybdopterin cofactor biosynthetic process (14%),IPR002300 (25%);IPR004330 (25%);IPR004493 (25%),Aminoacyl-tRNA synthetase, class Ia (25%);FAR1 DNA binding domain (25%);Leucyl-tRNA synthetase, class Ia, archaeal/eukaryotic cytosolic (25%),,,,,,,
SGPSLVHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR007016 (100%);IPR021797 (100%);IPR031726 (100%),O-antigen ligase-related (100%);Virulence factor membrane-bound polymerase, C-terminal (100%);Protein glycosylation ligase domain (100%),,,,,,,,,,
LDNAPEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (57%),cytoplasm (57%),GO:0003924 (100%);GO:0005525 (100%);GO:0003746 (91%),GTPase activity (100%);GTP binding (100%);translation elongation factor activity (91%),,,IPR000795 (100%);IPR027417 (100%);IPR031157 (100%),Transcription factor, GTP-binding domain (100%);P-loop containing nucleoside triphosphate hydrolase (100%);Tr-type G domain, conserved site (100%),,,,,,,,,
DLALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.2 (8%);6.1.1.21 (5%);3.6.4.12 (4%),Tryptophan--tRNA ligase (8%);Histidine--tRNA ligase (5%);DNA helicase (4%),GO:0016021 (20%);GO:0005737 (15%);GO:0005886 (4%),integral component of membrane (20%);cytoplasm (15%);plasma membrane (4%),GO:0005524 (21%);GO:0003677 (12%);GO:0046872 (6%),ATP binding (21%);DNA binding (12%);metal ion binding (6%),GO:0006355 (3%);GO:0006457 (2%);GO:0006436 (2%),regulation of transcription, DNA-templated (3%);protein folding (2%);tryptophanyl-tRNA aminoacylation (2%),IPR027417 (9%);IPR036388 (5%);IPR036291 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);Winged helix-like DNA-binding domain superfamily (5%);NAD(P)-binding domain superfamily (4%),,,,,,,,,,
LLYFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.49 (36%);1.-.-.- (9%);1.4.1.13 (9%),RNA-directed DNA polymerase (36%);Oxidoreductases (9%);Glutamate synthase (NADPH) (9%),GO:0016021 (29%);GO:0005634 (5%);GO:0000781 (4%),integral component of membrane (29%);nucleus (5%);chromosome, telomeric region (4%),GO:0030170 (25%);GO:0003677 (16%);GO:0003824 (15%),pyridoxal phosphate binding (25%);DNA binding (16%);catalytic activity (15%),GO:0009058 (24%);GO:0006537 (4%);GO:0051301 (3%),biosynthetic process (24%);glutamate biosynthetic process (4%);cell division (3%),IPR015421 (24%);IPR015422 (24%);IPR015424 (24%),Pyridoxal phosphate-dependent transferase, major domain (24%);Pyridoxal phosphate-dependent transferase domain 1 (24%);Pyridoxal phosphate-dependent transferase (24%),,,,,,,,,
EGDDEEVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEEETVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.3.36 (63%);6.1.1.17 (25%);4.4.1.8 (13%),1,4-dihydroxy-2-naphthoyl-CoA synthase (63%);Glutamate--tRNA ligase (25%);Cystathionine beta-lyase (13%),GO:0005737 (17%);GO:0005813 (7%);GO:0005874 (7%),cytoplasm (17%);centrosome (7%);microtubule (7%),GO:0008935 (17%);GO:0005524 (14%);GO:0003677 (10%),1,4-dihydroxy-2-naphthoyl-CoA synthase activity (17%);ATP binding (14%);DNA binding (10%),GO:0009234 (17%);GO:0006207 (10%);GO:0009116 (10%),menaquinone biosynthetic process (17%);'de novo' pyrimidine nucleobase biosynthetic process (10%);nucleoside metabolic process (10%),IPR001753 (17%);IPR014748 (17%);IPR029045 (17%),Enoyl-CoA hydratase/isomerase (17%);Enoyl-CoA hydratase, C-terminal (17%);ClpP/crotonase-like domain superfamily (17%),,,,,,,,
VGNLQLER,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%);GO:0003700 (100%),DNA binding (100%);DNA-binding transcription factor activity (100%),,,IPR000847 (100%);IPR005119 (100%);IPR036388 (100%),Transcription regulator HTH, LysR (100%);LysR, substrate-binding (100%);Winged helix-like DNA-binding domain superfamily (100%),,,,,,,,,
YLVVDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.3 (33%);4.3.1.17 (17%);2.4.1.83 (8%),Ureidoglycolate lyase (33%);L-serine ammonia-lyase (17%);Dolichyl-phosphate beta-D-mannosyltransferase (8%),GO:0016021 (33%);GO:0016459 (23%);GO:0005886 (11%),integral component of membrane (33%);myosin complex (23%);plasma membrane (11%),GO:0005524 (23%);GO:0003774 (23%);GO:0051015 (22%),ATP binding (23%);motor activity (23%);actin filament binding (22%),GO:0015031 (10%);GO:0005975 (7%);GO:0000256 (5%),protein transport (10%);carbohydrate metabolic process (7%);allantoin catabolic process (5%),IPR027417 (22%);IPR001609 (17%);IPR004009 (17%),P-loop containing nucleoside triphosphate hydrolase (22%);Myosin head, motor domain (17%);Myosin, N-terminal, SH3-like (17%),,,,,,,,
LNQLLELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.21 (67%);6.3.5.- (33%),Starch synthase (67%);Carbon--nitrogen ligases with glutamine as amido-N-donor (33%),GO:0005737 (18%);GO:0016021 (18%),cytoplasm (18%);integral component of membrane (18%),GO:0005509 (18%);GO:0005525 (18%);GO:0009011 (18%),calcium ion binding (18%);GTP binding (18%);starch synthase activity (18%),GO:0005978 (18%);GO:0006412 (9%),glycogen biosynthetic process (18%);translation (9%),IPR036465 (25%);IPR000152 (17%);IPR000742 (17%),von Willebrand factor A-like domain superfamily (25%);EGF-type aspartate/asparagine hydroxylation site (17%);EGF-like domain (17%),,,,,,,,,,,
YFELPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.108 (29%);4.2.1.59 (29%);6.1.1.3 (29%),UDP-3-O-acyl-N-acetylglucosamine deacetylase (29%);3-hydroxyacyl-[acyl-carrier-protein] dehydratase (29%);Threonine--tRNA ligase (29%),GO:0016021 (35%);GO:0005737 (13%);GO:0033179 (5%),integral component of membrane (35%);cytoplasm (13%);proton-transporting V-type ATPase, V0 domain (5%),GO:0005524 (18%);GO:0046872 (10%);GO:0004252 (8%),ATP binding (18%);metal ion binding (10%);serine-type endopeptidase activity (8%),GO:0006435 (5%);GO:0006633 (5%);GO:0009245 (5%),threonyl-tRNA aminoacylation (5%);fatty acid biosynthetic process (5%);lipid A biosynthetic process (5%),IPR027417 (13%);IPR036291 (9%);IPR002068 (7%),P-loop containing nucleoside triphosphate hydrolase (13%);NAD(P)-binding domain superfamily (9%);Alpha crystallin/Hsp20 domain (7%),,,,,,,,,,
EAGASVELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CEDEVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYEETR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.198 (29%);6.3.2.8 (11%);2.7.13.3 (7%),16S rRNA (cytidine(1402)-2'-O)-methyltransferase (29%);UDP-N-acetylmuramate--L-alanine ligase (11%);Histidine kinase (7%),GO:0016021 (27%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (27%);cytoplasm (5%);nucleus (2%),GO:0000155 (13%);GO:0000166 (11%);GO:0003968 (11%),phosphorelay sensor kinase activity (13%);nucleotide binding (11%);RNA-directed 5'-3' RNA polymerase activity (11%),GO:0006351 (34%);GO:0039694 (11%);GO:0007165 (5%),transcription, DNA-templated (34%);viral RNA genome replication (11%);signal transduction (5%),IPR036388 (23%);IPR013225 (23%);IPR011965 (23%),Winged helix-like DNA-binding domain superfamily (23%);PaaX-like, C-terminal (23%);Phenylacetic acid degradation operon negative regulatory protein PaaX (23%),,,,,,,,,
LEEDLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (20%);4.3.2.2 (12%);5.6.2.2 (12%),Leucine--tRNA ligase (20%);Adenylosuccinate lyase (12%);DNA topoisomerase (ATP-hydrolyzing) (12%),GO:0016021 (25%);GO:0005737 (11%);GO:0005694 (3%),integral component of membrane (25%);cytoplasm (11%);chromosome (3%),GO:0005524 (26%);GO:0046872 (16%);GO:0003677 (13%),ATP binding (26%);metal ion binding (16%);DNA binding (13%),GO:0001680 (6%);GO:0007165 (6%);GO:0042245 (6%),tRNA 3'-terminal CCA addition (6%);signal transduction (6%);RNA repair (6%),IPR027417 (14%);IPR021736 (11%);IPR012926 (6%),P-loop containing nucleoside triphosphate hydrolase (14%);Protein of unknown function DUF3305 (11%);TMPIT-like (6%),,,,,,,,,,,
FGDLELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (86%);2.4.1.1 (10%);2.1.2.9 (5%),Peptidylprolyl isomerase (86%);Glycogen phosphorylase (10%);Methionyl-tRNA formyltransferase (5%),GO:0016021 (13%);GO:0019867 (7%);GO:0005737 (5%),integral component of membrane (13%);outer membrane (7%);cytoplasm (5%),GO:0003755 (38%);GO:0005524 (13%);GO:0003677 (11%),peptidyl-prolyl cis-trans isomerase activity (38%);ATP binding (13%);DNA binding (11%),GO:0006457 (25%);GO:0005975 (5%);GO:0006355 (2%),protein folding (25%);carbohydrate metabolic process (5%);regulation of transcription, DNA-templated (2%),IPR002130 (34%);IPR029000 (34%);IPR020892 (26%),Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain (34%);Cyclophilin-like domain superfamily (34%);Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site (26%),,,,,,,,,
CVDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.2 (14%);2.7.11.1 (13%);1.1.5.3 (12%),Deoxyribonuclease IV (14%);Non-specific serine/threonine protein kinase (13%);Glycerol-3-phosphate dehydrogenase (12%),GO:0016021 (29%);GO:0033644 (12%);GO:0044165 (11%),integral component of membrane (29%);host cell membrane (12%);host cell endoplasmic reticulum (11%),GO:0005524 (26%);GO:0003677 (20%);GO:0008270 (15%),ATP binding (26%);DNA binding (20%);zinc ion binding (15%),GO:0006261 (13%);GO:0006351 (13%);GO:0032259 (12%),DNA-dependent DNA replication (13%);transcription, DNA-templated (13%);methylation (12%),IPR027417 (14%);IPR001098 (11%);IPR002298 (11%),P-loop containing nucleoside triphosphate hydrolase (14%);DNA-directed DNA polymerase, family A, palm domain (11%);DNA polymerase A (11%),,,,,,,,
FFEEGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.13 (80%);2.3.1.28 (10%);5.1.3.- (5%),dTDP-4-dehydrorhamnose 3,5-epimerase (80%);Chloramphenicol O-acetyltransferase (10%);Acting on carbohydrates and derivatives (5%),GO:0016021 (13%);GO:0009279 (2%);GO:0000778 (1%),integral component of membrane (13%);cell outer membrane (2%);condensed nuclear chromosome kinetochore (1%),GO:0003677 (37%);GO:0008830 (21%);GO:0016787 (12%),DNA binding (37%);dTDP-4-dehydrorhamnose 3,5-epimerase activity (21%);hydrolase activity (12%),GO:0046677 (2%);GO:0005975 (1%);GO:0006044 (1%),response to antibiotic (2%);carbohydrate metabolic process (1%);N-acetylglucosamine metabolic process (1%),IPR003115 (30%);IPR036086 (30%);IPR004437 (29%),ParB/Sulfiredoxin (30%);ParB/Sulfiredoxin superfamily (30%);ParB/RepB/Spo0J partition protein (29%),,,,,,,,,
AGTEVVEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.37 (100%),Malate dehydrogenase (100%),GO:0005737 (50%);GO:0005739 (50%),cytoplasm (50%);mitochondrion (50%),GO:0030060 (100%),L-malate dehydrogenase activity (100%),GO:0005975 (100%);GO:0006099 (100%);GO:0006108 (100%),carbohydrate metabolic process (100%);tricarboxylic acid cycle (100%);malate metabolic process (100%),IPR001236 (100%);IPR001252 (100%);IPR001557 (100%),Lactate/malate dehydrogenase, N-terminal (100%);Malate dehydrogenase, active site (100%);L-lactate/malate dehydrogenase (100%),,,,,,,,,
TYLLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (24%);1.8.-.- (10%);2.7.7.12 (8%),Exoribonuclease II (24%);Acting on a sulfur group of donors (10%);UDP-glucose--hexose-1-phosphate uridylyltransferase (8%),GO:0016459 (71%);GO:0016021 (5%);GO:0005737 (5%),myosin complex (71%);integral component of membrane (5%);cytoplasm (5%),GO:0005524 (78%);GO:0003774 (71%);GO:0051015 (47%),ATP binding (78%);motor activity (71%);actin filament binding (47%),GO:0006892 (2%);GO:0030050 (2%);GO:0032869 (2%),post-Golgi vesicle-mediated transport (2%);vesicle transport along actin filament (2%);cellular response to insulin stimulus (2%),IPR027417 (74%);IPR001609 (71%);IPR036961 (70%),P-loop containing nucleoside triphosphate hydrolase (74%);Myosin head, motor domain (71%);Kinesin motor domain superfamily (70%),,,,,,,,,,
LVQSAQPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEDESNLVAQLQK,Platynereis dumerilii,Eukaryota,Metazoa,,,Annelida,,,Polychaeta,Palpata,Aciculata,,Phyllodocida,,,,,Nereididae,,,,Platynereis,,,,Platynereis dumerilii,,,,,,GO:0016459 (100%),myosin complex (100%),GO:0003774 (100%);GO:0005524 (100%);GO:0051015 (100%),motor activity (100%);ATP binding (100%);actin filament binding (100%),,,IPR000048 (100%);IPR001609 (100%);IPR002912 (100%),IQ motif, EF-hand binding site (100%);Myosin head, motor domain (100%);ACT domain (100%),,,,,,,,,
TDLLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.13 (30%);2.1.1.297 (16%);4.3.2.10 (13%),Glutamate synthase (NADPH) (30%);Peptide chain release factor N(5)-glutamine methyltransferase (16%);Imidazole glycerol-phosphate synthase (13%),GO:0016021 (18%);GO:0005737 (7%);GO:0005887 (4%),integral component of membrane (18%);cytoplasm (7%);integral component of plasma membrane (4%),GO:0004355 (10%);GO:0005524 (8%);GO:0046872 (7%),glutamate synthase (NADPH) activity (10%);ATP binding (8%);metal ion binding (7%),GO:0006537 (18%);GO:0018364 (6%);GO:0000105 (5%),glutamate biosynthetic process (18%);peptidyl-glutamine methylation (6%);histidine biosynthetic process (5%),IPR013785 (22%);IPR029055 (17%);IPR002489 (17%),Aldolase-type TIM barrel (22%);Nucleophile aminohydrolases, N-terminal (17%);Glutamate synthase, alpha subunit, C-terminal (17%),,,,,,,,
AGDYLNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAAYNDWVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WQYQVR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042597 (50%);GO:0016021 (25%),periplasmic space (50%);integral component of membrane (25%),GO:0016829 (50%);GO:0003677 (25%);GO:0003678 (25%),lyase activity (50%);DNA binding (25%);DNA helicase activity (25%),GO:0006281 (25%),DNA repair (25%),IPR008397 (40%);IPR008929 (40%);IPR013320 (40%),Alginate lyase domain (40%);Chondroitin AC/alginate lyase (40%);Concanavalin A-like lectin/glucanase domain superfamily (40%),,,,,,,,,,,
FAEEEDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016491 (100%);GO:0046872 (100%),oxidoreductase activity (100%);metal ion binding (100%),,,IPR000914 (71%);IPR025370 (71%);IPR039424 (71%),Solute-binding protein family 5 domain (71%);Transcriptional regulator SgrR, N-terminal HTH domain (71%);Solute-binding protein family 5 (71%),,,,,,,,,,
NPGNEVEDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FELEWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (26%);GO:0005615 (19%);GO:0005886 (11%),integral component of membrane (26%);extracellular space (19%);plasma membrane (11%),GO:0016491 (15%);GO:0004896 (11%);GO:0004902 (11%),oxidoreductase activity (15%);cytokine receptor activity (11%);granulocyte colony-stimulating factor receptor activity (11%),GO:0006355 (11%);GO:0045471 (11%);GO:0097011 (11%),regulation of transcription, DNA-templated (11%);response to ethanol (11%);cellular response to granulocyte macrophage colony-stimulating factor stimulus (11%),IPR000215 (16%);IPR000531 (16%);IPR023796 (16%),Serpin family (16%);TonB-dependent receptor-like, beta-barrel (16%);Serpin domain (16%),,,,,,,,,
LQEENLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (60%);2.8.1.4 (10%);3.1.3.5 (10%),DNA-directed DNA polymerase (60%);tRNA uracil 4-sulfurtransferase (10%);5'-nucleotidase (10%),GO:0016021 (30%);GO:0098536 (12%);GO:0005737 (5%),integral component of membrane (30%);deuterosome (12%);cytoplasm (5%),GO:0046872 (20%);GO:0003677 (9%);GO:0003887 (7%),metal ion binding (20%);DNA binding (9%);DNA-directed DNA polymerase activity (7%),GO:0098535 (12%);GO:0006281 (11%);GO:0006261 (7%),de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (12%);DNA repair (11%);DNA-dependent DNA replication (7%),IPR005235 (9%);IPR029052 (9%);IPR029611 (9%),Metallophosphoesterase, YmdB-like (9%);Metallo-dependent phosphatase-like (9%);Deuterosome assembly protein 1 (9%),,,,,,,,,,
VALNFEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.4 (88%);6.5.1.- (13%),Dihydrolipoyl dehydrogenase (88%);Forming phosphoric ester bonds (13%),GO:0005623 (50%);GO:0016021 (29%),cell (50%);integral component of membrane (29%),GO:0004148 (50%);GO:0009055 (50%);GO:0050660 (50%),dihydrolipoyl dehydrogenase activity (50%);electron transfer activity (50%);flavin adenine dinucleotide binding (50%),GO:0045454 (50%);GO:0006396 (7%);GO:0007018 (7%),cell redox homeostasis (50%);RNA processing (7%);microtubule-based movement (7%),IPR012999 (62%);IPR023753 (62%);IPR036188 (62%),Pyridine nucleotide-disulphide oxidoreductase, class I, active site (62%);FAD/NAD(P)-binding domain (62%);FAD/NAD(P)-binding domain superfamily (62%),,,,,,,,,
SFTQNENR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSVDDEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.- (50%);6.3.5.- (50%),Interconverting aldoses and ketoses (50%);Carbon--nitrogen ligases with glutamine as amido-N-donor (50%),GO:0016021 (27%);GO:0005576 (9%);GO:0005623 (9%),integral component of membrane (27%);extracellular region (9%);cell (9%),GO:0000155 (18%);GO:0003677 (18%);GO:0005524 (18%),phosphorelay sensor kinase activity (18%);DNA binding (18%);ATP binding (18%),GO:0006260 (9%);GO:0006281 (9%);GO:0006351 (9%),DNA replication (9%);DNA repair (9%);transcription, DNA-templated (9%),IPR000014 (15%);IPR000700 (15%);IPR003594 (15%),PAS domain (15%);PAS-associated, C-terminal (15%);Histidine kinase/HSP90-like ATPase (15%),,,,,,,,,
LYEESR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (27%);3.4.16.4 (17%);1.2.1.41 (7%),Histidine kinase (27%);Serine-type D-Ala-D-Ala carboxypeptidase (17%);Glutamate-5-semialdehyde dehydrogenase (7%),GO:0016021 (61%);GO:0042600 (6%);GO:0005737 (2%),integral component of membrane (61%);egg chorion (6%);cytoplasm (2%),GO:0000155 (55%);GO:0046983 (53%);GO:0005524 (7%),phosphorelay sensor kinase activity (55%);protein dimerization activity (53%);ATP binding (7%),GO:0006979 (6%);GO:0006351 (2%);GO:0009252 (2%),response to oxidative stress (6%);transcription, DNA-templated (2%);peptidoglycan biosynthetic process (2%),IPR029016 (55%);IPR003018 (55%);IPR036890 (51%),GAF-like domain superfamily (55%);GAF domain (55%);Histidine kinase/HSP90-like ATPase superfamily (51%),,,,,,,,,,
FGLSLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.37 (99%);4.1.1.31 (1%);3.2.1.26 (0%),Malate dehydrogenase (99%);Phosphoenolpyruvate carboxylase (1%);Beta-fructofuranosidase (0%),GO:0016021 (0%);GO:0005886 (0%);GO:0005737 (0%),integral component of membrane (0%);plasma membrane (0%);cytoplasm (0%),GO:0030060 (94%);GO:0008964 (3%);GO:0004553 (2%),L-malate dehydrogenase activity (94%);phosphoenolpyruvate carboxylase activity (3%);hydrolase activity, hydrolyzing O-glycosyl compounds (2%),GO:0006099 (97%);GO:0005975 (92%);GO:0006108 (85%),tricarboxylic acid cycle (97%);carbohydrate metabolic process (92%);malate metabolic process (85%),IPR015955 (94%);IPR022383 (94%);IPR023958 (94%),Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal (94%);Lactate/malate dehydrogenase, C-terminal (94%);Malate dehydrogenase, type 1, bacterial (94%),,,,,
LVLDLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.4 (20%);3.2.2.9 (11%);1.1.5.3 (9%),Sulfate adenylyltransferase (20%);Adenosylhomocysteine nucleosidase (11%);Glycerol-3-phosphate dehydrogenase (9%),GO:0015934 (71%);GO:0005840 (3%);GO:0016021 (2%),large ribosomal subunit (71%);ribosome (3%);integral component of membrane (2%),GO:0019843 (73%);GO:0003735 (71%);GO:0005524 (5%),rRNA binding (73%);structural constituent of ribosome (71%);ATP binding (5%),GO:0006412 (73%);GO:0009058 (3%);GO:0019516 (2%),translation (73%);biosynthetic process (3%);lactate oxidation (2%),IPR001063 (71%);IPR036394 (71%);IPR005727 (71%),Ribosomal protein L22/L17 (71%);Ribosomal protein L22/L17 superfamily (71%);Ribosomal protein L22, bacterial/chloroplast-type (71%),,,,,,,,,,
WYLFDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.89 (83%);3.4.-.- (8%);3.4.22.- (8%),Arabinogalactan endo-beta-1,4-galactanase (83%);Acting on peptide bonds (peptidases) (8%);Cysteine endopeptidases (8%),GO:0016021 (9%);GO:0005886 (1%),integral component of membrane (9%);plasma membrane (1%),GO:0003796 (54%);GO:0015926 (13%);GO:0031218 (13%),lysozyme activity (54%);glucosidase activity (13%);arabinogalactan endo-1,4-beta-galactosidase activity (13%),GO:0009253 (64%);GO:0016998 (54%);GO:0008152 (13%),peptidoglycan catabolic process (64%);cell wall macromolecule catabolic process (54%);metabolic process (13%),IPR018337 (89%);IPR017853 (53%);IPR002053 (41%),Cell wall/choline-binding repeat (89%);Glycoside hydrolase superfamily (53%);Glycoside hydrolase, family 25 (41%),,,,,,,,
LLRPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (18%);2.7.1.26 (10%);2.7.7.2 (10%),Non-specific serine/threonine protein kinase (18%);Riboflavin kinase (10%);FAD synthase (10%),GO:0016021 (10%);GO:0030286 (6%);GO:0005886 (1%),integral component of membrane (10%);dynein complex (6%);plasma membrane (1%),GO:0005524 (54%);GO:0004674 (31%);GO:0004672 (16%),ATP binding (54%);protein serine/threonine kinase activity (31%);protein kinase activity (16%),GO:0007018 (6%);GO:0006355 (2%);GO:0055085 (1%),microtubule-based movement (6%);regulation of transcription, DNA-templated (2%);transmembrane transport (1%),IPR000719 (42%);IPR011009 (42%);IPR008271 (42%),Protein kinase domain (42%);Protein kinase-like domain superfamily (42%);Serine/threonine-protein kinase, active site (42%),,,,,,,,,
TGCLWPK,candidate division WWE3,Bacteria,,,,candidate division WWE3,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0016757 (100%),transferase activity, transferring glycosyl groups (100%),,,IPR025993 (100%);IPR029044 (100%),Ceramide glucosyltransferase (100%);Nucleotide-diphospho-sugar transferases (100%),,,,,,,,,,
VNQVFTK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%);GO:0009279 (33%),integral component of membrane (100%);cell outer membrane (33%),,,GO:0007165 (67%),signal transduction (67%),IPR008769 (67%);IPR000014 (22%);IPR000160 (22%),Poly granule associated (67%);PAS domain (22%);GGDEF domain (22%),,,,,,,,,,,
MDAPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.29 (38%);1.14.-.- (21%);1.14.15.12 (7%),Aminoacyl-tRNA hydrolase (38%);Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2) (21%);Transferred entry: 1.14.14.46 (7%),GO:0005737 (39%);GO:0016021 (6%);GO:0005681 (3%),cytoplasm (39%);integral component of membrane (6%);spliceosomal complex (3%),GO:0005524 (41%);GO:0003697 (36%);GO:0008094 (36%),ATP binding (41%);single-stranded DNA binding (36%);DNA-dependent ATPase activity (36%),GO:0006310 (37%);GO:0006281 (37%);GO:0009432 (36%),DNA recombination (37%);DNA repair (37%);SOS response (36%),IPR027417 (40%);IPR003593 (38%);IPR013765 (36%),P-loop containing nucleoside triphosphate hydrolase (40%);AAA+ ATPase domain (38%);DNA recombination and repair protein RecA (36%),,,,,,,,,,
LQAVLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000786 (50%);GO:0005634 (25%);GO:0016021 (25%),nucleosome (50%);nucleus (25%);integral component of membrane (25%),GO:0046982 (75%);GO:0003677 (50%);GO:0004866 (25%),protein heterodimerization activity (75%);DNA binding (50%);endopeptidase inhibitor activity (25%),,,IPR032454 (80%);IPR009072 (60%);IPR002119 (40%),Histone H2A, C-terminal domain (80%);Histone-fold (60%);Histone H2A (40%),,,,,,,,,,
NANLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (21%);3.5.1.2 (9%);6.3.5.3 (9%),DNA-directed RNA polymerase (21%);Glutaminase (9%);Phosphoribosylformylglycinamidine synthase (9%),GO:0016021 (21%);GO:0043190 (8%);GO:0005737 (7%),integral component of membrane (21%);ATP-binding cassette (ABC) transporter complex (8%);cytoplasm (7%),GO:0005524 (17%);GO:0003677 (14%);GO:0046983 (6%),ATP binding (17%);DNA binding (14%);protein dimerization activity (6%),GO:0055085 (10%);GO:0006351 (6%);GO:0006260 (3%),transmembrane transport (10%);transcription, DNA-templated (6%);DNA replication (3%),IPR001646 (9%);IPR027417 (8%);IPR000914 (6%),Pentapeptide repeat (9%);P-loop containing nucleoside triphosphate hydrolase (8%);Solute-binding protein family 5 domain (6%),,,,,,,,,,
ALLEWLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.3 (71%);2.1.1.- (7%);2.3.1.29 (7%),Aconitate hydratase (71%);Methyltransferases (7%);Glycine C-acetyltransferase (7%),GO:0016021 (25%);GO:0009358 (2%);GO:0009360 (2%),integral component of membrane (25%);polyphosphate kinase complex (2%);DNA polymerase III complex (2%),GO:0046872 (20%);GO:0051539 (18%);GO:0003994 (17%),metal ion binding (20%);4 iron, 4 sulfur cluster binding (18%);aconitate hydratase activity (17%),GO:0009058 (3%);GO:0005975 (2%);GO:0006260 (2%),biosynthetic process (3%);carbohydrate metabolic process (2%);DNA replication (2%),IPR000573 (18%);IPR001030 (18%);IPR006249 (18%),Aconitase A/isopropylmalate dehydratase small subunit, swivel domain (18%);Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha domain (18%);Aconitase/Iron-responsive element-binding protein 2 (18%),,,,,,,,
ELGGLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.3.1 (100%);2.3.2.31 (0%);3.1.13.1 (0%),Isocitrate lyase (100%);RBR-type E3 ubiquitin transferase (0%);Exoribonuclease II (0%),GO:0016021 (1%);GO:0005730 (0%);GO:0005737 (0%),integral component of membrane (1%);nucleolus (0%);cytoplasm (0%),GO:0004451 (94%);GO:0046872 (90%);GO:0003677 (4%),isocitrate lyase activity (94%);metal ion binding (90%);DNA binding (4%),GO:0019752 (89%);GO:0001889 (0%);GO:0006289 (0%),carboxylic acid metabolic process (89%);liver development (0%);nucleotide-excision repair (0%),IPR006254 (93%);IPR015813 (93%);IPR039556 (89%),Isocitrate lyase (93%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (93%);ICL/PEPM domain (89%),,,,,,,,,,,
ASNLVLDAK,Amylibacter kogurei,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhodobacterales,,,,,Rhodobacteraceae,,,,Amylibacter,,,,Amylibacter kogurei,,,,3.6.4.12 (100%),DNA helicase (100%),,,GO:0003677 (100%);GO:0003678 (100%);GO:0005524 (100%),DNA binding (100%);DNA helicase activity (100%);ATP binding (100%),,,IPR000212 (100%);IPR013986 (100%);IPR014016 (100%),DNA helicase, UvrD/REP type (100%);DExx box DNA helicase domain superfamily (100%);UvrD-like helicase, ATP-binding domain (100%),,,,,,,,,
LELELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.3.27 (72%);5.6.2.2 (7%);2.3.1.37 (2%),Anthranilate synthase (72%);DNA topoisomerase (ATP-hydrolyzing) (7%);5-aminolevulinate synthase (2%),GO:0016021 (19%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (19%);cytoplasm (5%);plasma membrane (4%),GO:0004049 (28%);GO:0046872 (28%);GO:0005524 (13%),anthranilate synthase activity (28%);metal ion binding (28%);ATP binding (13%),GO:0000162 (26%);GO:0006397 (6%);GO:0006814 (4%),tryptophan biosynthetic process (26%);mRNA processing (6%);sodium ion transport (4%),IPR005801 (24%);IPR015890 (24%);IPR019999 (24%),ADC synthase (24%);Chorismate-utilising enzyme, C-terminal (24%);Anthranilate synthase component I-like (24%),,,,,,,,,,
FNLEDYATTYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNLWYFTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNTLQGFR,Dysgonomonas capnocytophagoides,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Dysgonamonadaceae,,,,Dysgonomonas,,,,Dysgonomonas capnocytophagoides,,,,,,,,,,,,,,,,,,,,,,,,
LSEQEASQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDNLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.2 (13%);5.2.1.8 (11%);2.6.1.16 (10%),Fumarate hydratase (13%);Peptidylprolyl isomerase (11%);Glutamine--fructose-6-phosphate transaminase (isomerizing) (10%),GO:0016021 (39%);GO:0005737 (8%);GO:0005634 (4%),integral component of membrane (39%);cytoplasm (8%);nucleus (4%),GO:0005524 (12%);GO:0003677 (11%);GO:0003700 (5%),ATP binding (12%);DNA binding (11%);DNA-binding transcription factor activity (5%),GO:0000160 (3%);GO:0006310 (2%);GO:0006099 (2%),phosphorelay signal transduction system (3%);DNA recombination (2%);tricarboxylic acid cycle (2%),IPR004244 (13%);IPR042497 (13%);IPR035301 (13%),Transposase, L1 (13%);Transposase, L1 superfamily (13%);L1 transposable element, trimerization domain (13%),,,,,,,,
EQEDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.- (46%);3.1.-.- (3%);6.3.1.1 (3%),Exoribonucleases producing 5'-phosphomonoesters (46%);Acting on ester bonds (3%);Aspartate--ammonia ligase (3%),GO:0016021 (24%);GO:0005634 (8%);GO:0005886 (5%),integral component of membrane (24%);nucleus (8%);plasma membrane (5%),GO:0008270 (15%);GO:0005524 (11%);GO:0003676 (9%),zinc ion binding (15%);ATP binding (11%);nucleic acid binding (9%),GO:0030041 (11%);GO:0006397 (5%);GO:0006629 (2%),actin filament polymerization (11%);mRNA processing (5%);lipid metabolic process (2%),IPR027417 (12%);IPR001452 (9%);IPR036028 (9%),P-loop containing nucleoside triphosphate hydrolase (12%);SH3 domain (9%);SH3-like domain superfamily (9%),,,,,,,,,,,
LVLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (23%);2.5.1.16 (8%);2.7.7.6 (5%),DNA-directed DNA polymerase (23%);Spermidine synthase (8%);DNA-directed RNA polymerase (5%),GO:0016021 (30%);GO:0005737 (7%);GO:0005840 (7%),integral component of membrane (30%);cytoplasm (7%);ribosome (7%),GO:0005524 (14%);GO:0003677 (12%);GO:0046872 (9%),ATP binding (14%);DNA binding (12%);metal ion binding (9%),GO:0006412 (7%);GO:0006260 (3%);GO:0000917 (3%),translation (7%);DNA replication (3%);division septum assembly (3%),IPR027417 (14%);IPR025838 (7%);IPR025840 (7%),P-loop containing nucleoside triphosphate hydrolase (14%);Inactive transglutaminase fused to 7 transmembrane helices (7%);7 transmembrane helices usually fused to an inactive transglutaminase (7%),,,,,,,,,,,
LFEVSPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDEEWDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AANELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.14.5 (54%);1.17.7.3 (8%);1.1.1.18 (5%),Alkanesulfonate monooxygenase (54%);(E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (8%);Inositol 2-dehydrogenase (5%),GO:0016021 (14%);GO:0005737 (4%);GO:0005634 (1%),integral component of membrane (14%);cytoplasm (4%);nucleus (1%),GO:0008726 (14%);GO:0046872 (7%);GO:0016491 (5%),alkanesulfonate monooxygenase activity (14%);metal ion binding (7%);oxidoreductase activity (5%),GO:0009228 (18%);GO:0006886 (5%);GO:0055114 (5%),thiamine biosynthetic process (18%);intracellular protein transport (5%);oxidation-reduction process (5%),IPR015168 (19%);IPR027939 (19%);IPR036291 (12%),SsuA/THI5-like (19%);NMT1/THI5 family (19%);NAD(P)-binding domain superfamily (12%),,,,,,,,,,,
NFENTNLAALHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAQLVQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.7 (100%),Alanine--tRNA ligase (100%),GO:0016021 (70%);GO:0005737 (13%),integral component of membrane (70%);cytoplasm (13%),GO:0005524 (23%);GO:0004813 (13%);GO:0000049 (10%),ATP binding (23%);alanine-tRNA ligase activity (13%);tRNA binding (10%),GO:0006419 (13%);GO:0006979 (3%),alanyl-tRNA aminoacylation (13%);response to oxidative stress (3%),IPR039562 (63%);IPR002318 (13%);IPR003156 (13%),Membrane fusion protein, biotin-lipoyl like domain (63%);Alanine-tRNA ligase, class IIc (13%);DHHA1 domain (13%),,,,,,,,,
LSGQLYEESR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLENVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),GO:0005623 (76%);GO:0016021 (76%);GO:0030141 (71%),cell (76%);integral component of membrane (76%);secretory granule (71%),GO:0004725 (33%);GO:0003677 (5%);GO:0003899 (5%),protein tyrosine phosphatase activity (33%);DNA binding (5%);DNA-directed 5'-3' RNA polymerase activity (5%),GO:0035773 (71%);GO:0006351 (5%);GO:0045454 (5%),insulin secretion involved in cellular response to glucose stimulus (71%);transcription, DNA-templated (5%);cell redox homeostasis (5%),IPR021613 (68%);IPR029403 (68%);IPR033522 (68%),Protein-tyrosine phosphatase receptor IA-2 ectodomain (68%);RESP18 domain (68%);Receptor-type tyrosine-protein phosphatase-like N/N2 (68%),,,,,,,,,,
AGDYLNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQGNANQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APVDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (34%);6.3.2.4 (11%);2.2.1.9 (6%),Glycine--tRNA ligase (34%);D-alanine--D-alanine ligase (11%);2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylic-acisynthase (6%),GO:0016021 (29%);GO:0005737 (16%);GO:0005886 (4%),integral component of membrane (29%);cytoplasm (16%);plasma membrane (4%),GO:0005524 (20%);GO:0046872 (9%);GO:0003677 (8%),ATP binding (20%);metal ion binding (9%);DNA binding (8%),GO:0006426 (8%);GO:0006420 (7%);GO:0000724 (3%),glycyl-tRNA aminoacylation (8%);arginyl-tRNA aminoacylation (7%);double-strand break repair via homologous recombination (3%),IPR027417 (7%);IPR006194 (6%);IPR015944 (6%),P-loop containing nucleoside triphosphate hydrolase (7%);Glycine-tRNA synthetase, heterodimeric (6%);Glycine-tRNA ligase, beta subunit (6%),,,,,,,,,
LLVDGFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.22 (75%);1.2.1.- (25%),Alpha-galactosidase (75%);With NAD(+) or NADP(+) as acceptor (25%),GO:0016021 (32%);GO:0005634 (16%);GO:0005737 (4%),integral component of membrane (32%);nucleus (16%);cytoplasm (4%),GO:0005524 (32%);GO:0016887 (28%);GO:0051082 (24%),ATP binding (32%);ATPase activity (28%);unfolded protein binding (24%),GO:0006457 (24%);GO:0016226 (24%);GO:0005975 (12%),protein folding (24%);iron-sulfur cluster assembly (24%);carbohydrate metabolic process (12%),IPR010236 (17%);IPR013126 (17%);IPR018181 (17%),ISC system FeS cluster assembly, HscA chaperone (17%);Heat shock protein 70 family (17%);Heat shock protein 70, conserved site (17%),,,,,,,,,
EEGLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (46%);3.4.21.88 (25%);5.2.1.8 (11%),Carboxylic ester hydrolases (46%);Repressor LexA (25%);Peptidylprolyl isomerase (11%),GO:0005737 (50%);GO:0016021 (4%);GO:0005829 (4%),cytoplasm (50%);integral component of membrane (4%);cytosol (4%),GO:0005096 (75%);GO:0008080 (3%);GO:0048365 (2%),GTPase activator activity (75%);N-acetyltransferase activity (3%);Rac GTPase binding (2%),GO:0007165 (82%);GO:0032956 (2%);GO:0035020 (2%),signal transduction (82%);regulation of actin cytoskeleton organization (2%);regulation of Rac protein signal transduction (2%),IPR000198 (85%);IPR008936 (85%);IPR027267 (54%),Rho GTPase-activating protein domain (85%);Rho GTPase activation protein (85%);AH/BAR domain superfamily (54%),,,,,,,,,,,
SGQLEELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (100%),Acting on ATP; involved in cellular and subcellular movement (100%),,,GO:0003676 (67%);GO:0004386 (67%);GO:0005524 (67%),nucleic acid binding (67%);helicase activity (67%);ATP binding (67%),,,IPR001650 (67%);IPR011545 (67%);IPR013701 (67%),Helicase, C-terminal (67%);DEAD/DEAH box helicase domain (67%);DEAD/H associated (67%),,,,,,,,,,
VTNLAVAELR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEEELEMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNGSLNWEFENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLEQLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),GO:0032865 (32%);GO:0005789 (23%);GO:0016021 (19%),ERMES complex (32%);endoplasmic reticulum membrane (23%);integral component of membrane (19%),GO:0008289 (32%);GO:0003677 (13%);GO:0005524 (13%),lipid binding (32%);DNA binding (13%);ATP binding (13%),GO:0006869 (32%);GO:0045040 (32%);GO:0000002 (16%),lipid transport (32%);protein insertion into mitochondrial outer membrane (32%);mitochondrial genome maintenance (16%),IPR027532 (24%);IPR031468 (24%);IPR008862 (12%),Mitochondrial distribution and morphology protein 12 (24%);Synaptotagmin-like mitochondrial-lipid-binding domain (24%);T-complex 11 (12%),,,,,,,,,,,
YDLCFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005874 (80%);GO:0016021 (10%),microtubule (80%);integral component of membrane (10%),GO:0005200 (80%);GO:0005525 (80%);GO:0016491 (10%),structural constituent of cytoskeleton (80%);GTP binding (80%);oxidoreductase activity (10%),GO:0007017 (80%),microtubule-based process (80%),IPR000217 (62%);IPR002453 (62%);IPR008280 (62%),Tubulin (62%);Beta tubulin (62%);Tubulin/FtsZ, C-terminal (62%),,,,,,,,,,
AGDYLDEK,Firmicutes bacterium,Bacteria,,,,Firmicutes,,,,,,,,,,,,,,,,,,,,Firmicutes bacterium,,,,,,GO:0032300 (100%),mismatch repair complex (100%),GO:0005524 (100%);GO:0016887 (100%);GO:0030983 (100%),ATP binding (100%);ATPase activity (100%);mismatched DNA binding (100%),GO:0006298 (100%),mismatch repair (100%),IPR013507 (100%);IPR014721 (100%);IPR014790 (100%),DNA mismatch repair protein,  S5 domain 2-like (100%);Ribosomal protein S5 domain 2-type fold, subgroup (100%);MutL, C-terminal, dimerisation (100%),,,,,,,
QQYAYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.49 (100%),RNA-directed DNA polymerase (100%),GO:0016021 (13%);GO:0005634 (3%);GO:0005737 (3%),integral component of membrane (13%);nucleus (3%);cytoplasm (3%),GO:0003676 (34%);GO:0008168 (22%);GO:0004386 (16%),nucleic acid binding (34%);methyltransferase activity (22%);helicase activity (16%),GO:0032259 (22%);GO:0006355 (3%);GO:0009913 (3%),methylation (22%);regulation of transcription, DNA-templated (3%);epidermal cell differentiation (3%),IPR013087 (32%);IPR027756 (32%);IPR036236 (32%),Zinc finger C2H2-type (32%);Ovo-like (32%);Zinc finger C2H2 superfamily (32%),,,,,,,,,,
NSFEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.4 (50%);3.4.-.- (30%);3.6.4.12 (10%),Tripeptide aminopeptidase (50%);Acting on peptide bonds (peptidases) (30%);DNA helicase (10%),GO:0005815 (45%);GO:0000242 (13%);GO:0005794 (13%),microtubule organizing center (45%);pericentriolar material (13%);Golgi apparatus (13%),GO:0005516 (13%);GO:0044212 (13%);GO:0019901 (12%),calmodulin binding (13%);transcription regulatory region DNA binding (13%);protein kinase binding (12%),GO:0000226 (51%);GO:0001578 (13%);GO:0007059 (13%),microtubule cytoskeleton organization (51%);microtubule bundle formation (13%);chromosome segregation (13%),IPR042791 (54%);IPR012943 (52%);IPR022233 (11%),CDK5 regulatory subunit-associated protein 2 (54%);Centrosomin, N-terminal motif 1 (52%);TRAPP II complex, TRAPPC10 (11%),,,,,,,,,
AWLFTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.207 (100%),tRNA (cytidine(34)-2'-O)-methyltransferase (100%),GO:0016021 (91%);GO:0005737 (2%);GO:0016020 (2%),integral component of membrane (91%);cytoplasm (2%);membrane (2%),GO:0003677 (2%);GO:0003723 (2%);GO:0005524 (2%),DNA binding (2%);RNA binding (2%);ATP binding (2%),GO:0006355 (2%);GO:0009058 (2%),regulation of transcription, DNA-templated (2%);biosynthetic process (2%),IPR003838 (84%);IPR004291 (4%);IPR027417 (4%),ABC transporter permease protein domain (84%);Transposase, IS66 (4%);P-loop containing nucleoside triphosphate hydrolase (4%),,,,,,,,,
LATVSLPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),GO:0016042 (100%),lipid catabolic process (100%),IPR000014 (50%);IPR000780 (50%);IPR013767 (50%),PAS domain (50%);MCP methyltransferase, CheR-type (50%);PAS fold (50%),,,,,,,,,,
AEPLNPK,Coriobacteriaceae,Bacteria,,,,Actinobacteria,,,Coriobacteriia,,,,Coriobacteriales,,,,,Coriobacteriaceae,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR041030 (100%),SHIRT domain (100%),,,,,,,,,,,
FLSLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.129 (17%);2.3.2.- (11%);1.1.1.42 (8%),Peptidoglycan glycosyltransferase (17%);Aminoacyltransferases (11%);Isocitrate dehydrogenase (NADP(+)) (8%),GO:0016021 (58%);GO:0005739 (9%);GO:0005634 (5%),integral component of membrane (58%);mitochondrion (9%);nucleus (5%),GO:0008658 (28%);GO:0016740 (26%);GO:0003676 (7%),penicillin binding (28%);transferase activity (26%);nucleic acid binding (7%),GO:0000956 (6%);GO:0055085 (4%);GO:0006886 (4%),nuclear-transcribed mRNA catabolic process (6%);transmembrane transport (4%);intracellular protein transport (4%),IPR036950 (28%);IPR001264 (28%);IPR023346 (28%),Penicillin binding protein transglycosylase domain (28%);Glycosyl transferase, family 51 (28%);Lysozyme-like domain superfamily (28%),,,,,,,,,,
FPSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (22%);1.1.1.267 (10%);2.1.1.182 (5%),Phenylalanine--tRNA ligase (22%);1-deoxy-D-xylulose-5-phosphate reductoisomerase (10%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (5%),GO:0016021 (20%);GO:0005737 (7%);GO:0016020 (4%),integral component of membrane (20%);cytoplasm (7%);membrane (4%),GO:0005524 (10%);GO:0046872 (6%);GO:0003677 (5%),ATP binding (10%);metal ion binding (6%);DNA binding (5%),GO:0006432 (4%);GO:0016114 (3%);GO:0019288 (3%),phenylalanyl-tRNA aminoacylation (4%);terpenoid biosynthetic process (3%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (3%),IPR032675 (7%);IPR027417 (7%);IPR036188 (6%),Leucine-rich repeat domain superfamily (7%);P-loop containing nucleoside triphosphate hydrolase (7%);FAD/NAD(P)-binding domain superfamily (6%),,,,,,,,,,
CFQDDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003676 (100%),nucleic acid binding (100%),,,IPR032698 (91%);IPR013087 (9%);IPR036236 (9%),Protein SirB1, N-terminal (91%);Zinc finger C2H2-type (9%);Zinc finger C2H2 superfamily (9%),,,,,,,,,,
VNNLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.- (55%);2.7.1.48 (25%);3.6.4.- (10%),Sulfurtransferases (55%);Uridine kinase (25%);Acting on ATP; involved in cellular and subcellular movement (10%),GO:0016021 (32%);GO:0005737 (17%);GO:0005576 (3%),integral component of membrane (32%);cytoplasm (17%);extracellular region (3%),GO:0005524 (36%);GO:0000049 (17%);GO:0000287 (17%),ATP binding (36%);tRNA binding (17%);magnesium ion binding (17%),GO:0034227 (17%);GO:0009116 (11%);GO:0044206 (8%),tRNA thio-modification (17%);nucleoside metabolic process (11%);UMP salvage (8%),IPR027417 (19%);IPR014729 (18%);IPR011063 (16%),P-loop containing nucleoside triphosphate hydrolase (19%);Rossmann-like alpha/beta/alpha sandwich fold (18%);tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal (16%),,,,,,,,,,
LEVCLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.- (32%);1.14.13.81 (9%);3.1.-.- (9%),With NAD(+) or NADP(+) as acceptor (32%);Magnesium-protoporphyrin IX monomethyl ester (oxidative) cyclase (9%);Acting on ester bonds (9%),GO:0016021 (19%);GO:0005737 (2%);GO:0005634 (1%),integral component of membrane (19%);cytoplasm (2%);nucleus (1%),GO:0005524 (16%);GO:0050660 (14%);GO:0046872 (13%),ATP binding (16%);flavin adenine dinucleotide binding (14%);metal ion binding (13%),GO:0000160 (9%);GO:0009405 (6%);GO:0006265 (3%),phosphorelay signal transduction system (9%);pathogenesis (6%);DNA topological change (3%),IPR000058 (12%);IPR035896 (12%);IPR001269 (8%),Zinc finger, AN1-type (12%);AN1-like Zinc finger (12%);tRNA-dihydrouridine synthase (8%),,,,,,,,,,
FLENVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.- (50%);6.1.1.7 (50%),Transferases for other substituted phosphate groups (50%);Alanine--tRNA ligase (50%),GO:0005634 (38%);GO:0005737 (36%);GO:0016021 (17%),nucleus (38%);cytoplasm (36%);integral component of membrane (17%),GO:0061608 (34%);GO:0005525 (19%);GO:0008270 (11%),nuclear import signal receptor activity (34%);GTP binding (19%);zinc ion binding (11%),GO:0006606 (32%);GO:0042254 (19%);GO:0035773 (6%),protein import into nucleus (32%);ribosome biogenesis (19%);insulin secretion involved in cellular response to glucose stimulus (6%),IPR000225 (36%);IPR011989 (36%);IPR016024 (36%),Armadillo (36%);Armadillo-like helical (36%);Armadillo-type fold (36%),,,,,,,,,,,
VSLVTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (11%);3.6.4.12 (11%);1.1.1.262 (5%),Beta-galactosidase (11%);DNA helicase (11%);4-hydroxythreonine-4-phosphate dehydrogenase (5%),GO:0016021 (25%);GO:0030126 (11%);GO:0000139 (10%),integral component of membrane (25%);COPI vesicle coat (11%);Golgi membrane (10%),GO:0005524 (14%);GO:0005198 (11%);GO:0046872 (7%),ATP binding (14%);structural molecule activity (11%);metal ion binding (7%),GO:0006886 (11%);GO:0016192 (10%);GO:0006457 (4%),intracellular protein transport (11%);vesicle-mediated transport (10%);protein folding (4%),IPR027417 (13%);IPR011989 (10%);IPR016024 (10%),P-loop containing nucleoside triphosphate hydrolase (13%);Armadillo-like helical (10%);Armadillo-type fold (10%),,,,,,,,,,,
YEVLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.54 (59%);3.1.4.58 (14%);4.2.2.- (7%),3-deoxy-7-phosphoheptulonate synthase (59%);RNA 2',3'-cyclic 3'-phosphodiesterase (14%);Acting on polysaccharides (7%),GO:0016021 (24%);GO:0005737 (4%);GO:0005886 (4%),integral component of membrane (24%);cytoplasm (4%);plasma membrane (4%),GO:0003849 (24%);GO:0005524 (8%);GO:0004113 (7%),3-deoxy-7-phosphoheptulonate synthase activity (24%);ATP binding (8%);2',3'-cyclic-nucleotide 3'-phosphodiesterase activity (7%),GO:0009073 (24%);GO:0009423 (24%);GO:0015031 (4%),aromatic amino acid family biosynthetic process (24%);chorismate biosynthetic process (24%);protein transport (4%),IPR002480 (21%);IPR001633 (6%);IPR004175 (6%),DAHP synthetase, class II (21%);EAL domain (6%);RNA 2',3'-cyclic phosphodiesterase (6%),,,,,,,
ALALELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (35%);6.3.5.5 (17%);2.4.1.227 (12%),DNA (cytosine-5-)-methyltransferase (35%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (17%);Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (12%),GO:0005737 (21%);GO:0016021 (10%);GO:0005886 (3%),cytoplasm (21%);integral component of membrane (10%);plasma membrane (3%),GO:0008168 (19%);GO:0005524 (12%);GO:0003886 (7%),methyltransferase activity (19%);ATP binding (12%);DNA (cytosine-5-)-methyltransferase activity (7%),GO:0032259 (19%);GO:0006417 (18%);GO:0044238 (15%),methylation (19%);regulation of translation (18%);primary metabolic process (15%),IPR029063 (25%);IPR001525 (24%);IPR031303 (23%),S-adenosyl-L-methionine-dependent methyltransferase (25%);C-5 cytosine methyltransferase (24%);DNA methylase, C-5 cytosine-specific,  conserved site (23%),,,,,,,,,
SVFPSPK,Actinidia chinensis var. chinensis,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Ericales,,,,,Actinidiaceae,,,,Actinidia,,,,Actinidia chinensis,,Actinidia chinensis var. chinensis,,,,,,,,GO:0051513 (100%),regulation of monopolar cell growth (100%),IPR025486 (100%);IPR032795 (100%);IPR033334 (100%),Domain of unknown function DUF4378 (100%);DUF3741-associated sequence motif (100%);Protein LONGIFOLIA 1/2 (100%),,,,,,,,,,,
FSVFSPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPATLNSR,Dipodomys ordii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Rodentia,Castorimorpha,,,,Heteromyidae,Dipodomyinae,,,Dipodomys,,,,Dipodomys ordii,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%),,,,,,,,
EELEAER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.14.1 (26%);3.6.5.- (20%);6.1.1.17 (14%),Protein arginine kinase (26%);Acting on GTP; involved in cellular and subcellular movement (20%);Glutamate--tRNA ligase (14%),GO:0016021 (26%);GO:0005737 (18%);GO:0016459 (6%),integral component of membrane (26%);cytoplasm (18%);myosin complex (6%),GO:0005524 (32%);GO:0003677 (10%);GO:0000287 (8%),ATP binding (32%);DNA binding (10%);magnesium ion binding (8%),GO:0046314 (8%);GO:0055085 (8%);GO:0042254 (7%),phosphocreatine biosynthetic process (8%);transmembrane transport (8%);ribosome biogenesis (7%),IPR027417 (22%);IPR014275 (12%);IPR028987 (10%),P-loop containing nucleoside triphosphate hydrolase (22%);ATPase, A1A0, subunit H (12%);F-type ATP synthase subunit B-like, membrane domain superfamily (10%),,,,,,,,
VTNLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (43%);6.3.1.20 (7%);6.5.1.4 (3%),Acting on polysaccharides (43%);Lipoate--protein ligase (7%);RNA 3'-terminal-phosphate cyclase (ATP) (3%),GO:0016021 (17%);GO:0005737 (3%);GO:0005886 (3%),integral component of membrane (17%);cytoplasm (3%);plasma membrane (3%),GO:0005524 (28%);GO:0003676 (22%);GO:0016829 (10%),ATP binding (28%);nucleic acid binding (22%);lyase activity (10%),GO:0071555 (10%);GO:0000270 (9%);GO:0009166 (6%),cell wall organization (10%);peptidoglycan metabolic process (9%);nucleotide catabolic process (6%),IPR027417 (23%);IPR014001 (18%);IPR001650 (18%),P-loop containing nucleoside triphosphate hydrolase (23%);Helicase superfamily 1/2, ATP-binding domain (18%);Helicase, C-terminal (18%),,,,,,,,,
FTEATNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR000648 (50%);IPR018494 (50%);IPR019236 (50%),Oxysterol-binding protein (50%);Oxysterol-binding protein, conserved site (50%);Domain of unknown function DUF2183 (50%),,,,,,,,,,
ATVSSDALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPDFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (12%);GO:0005634 (1%);GO:0005737 (1%),integral component of membrane (12%);nucleus (1%);cytoplasm (1%),GO:0008236 (58%);GO:0005524 (12%);GO:0004386 (8%),serine-type peptidase activity (58%);ATP binding (12%);helicase activity (8%),GO:0046777 (3%);GO:0000727 (1%);GO:0006355 (1%),protein autophosphorylation (3%);double-strand break repair via break-induced replication (1%);regulation of transcription, DNA-templated (1%),IPR029058 (60%);IPR001375 (59%);IPR038554 (59%),Alpha/Beta hydrolase fold (60%);Peptidase S9, prolyl oligopeptidase, catalytic domain (59%);Dipeptidylpeptidase IV, N-terminal domain superfamily (59%),,,,,,,
LESLETK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.2.6 (52%);3.6.4.12 (13%);2.5.1.9 (9%),P-type K(+) transporter (52%);DNA helicase (13%);Riboflavin synthase (9%),GO:0071203 (21%);GO:0016021 (17%);GO:0005887 (10%),WASH complex (21%);integral component of membrane (17%);integral component of plasma membrane (10%),GO:0005524 (24%);GO:0003779 (21%);GO:0017048 (21%),ATP binding (24%);actin binding (21%);Rho GTPase binding (21%),GO:0030036 (21%);GO:0000398 (5%);GO:0006260 (4%),actin cytoskeleton organization (21%);mRNA splicing, via spliceosome (5%);DNA replication (4%),IPR016024 (18%);IPR011989 (17%);IPR010472 (16%),Armadillo-type fold (18%);Armadillo-like helical (17%);Formin, FH3 domain (16%),,,,,,,,,
FVNNCDNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFLLNVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VCEVAQAGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLCAQDSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVDLLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (62%);5.3.1.6 (15%);2.7.7.8 (4%),Endopeptidase La (62%);Ribose-5-phosphate isomerase (15%);Polyribonucleotide nucleotidyltransferase (4%),GO:0005737 (27%);GO:0016021 (23%);GO:0005886 (10%),cytoplasm (27%);integral component of membrane (23%);plasma membrane (10%),GO:0005524 (28%);GO:0004176 (22%);GO:0004252 (22%),ATP binding (28%);ATP-dependent peptidase activity (22%);serine-type endopeptidase activity (22%),GO:0006515 (21%);GO:0034605 (21%);GO:0009052 (5%),protein quality control for misfolded or incompletely synthesized proteins (21%);cellular response to heat (21%);pentose-phosphate shunt, non-oxidative branch (5%),IPR027417 (26%);IPR020568 (21%);IPR014721 (20%),P-loop containing nucleoside triphosphate hydrolase (26%);Ribosomal protein S5 domain 2-type fold (21%);Ribosomal protein S5 domain 2-type fold, subgroup (20%),,,,,,,,,
YTLGQVLWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFNEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.5 (50%);3.1.21.- (50%),Pyridoxal 5'-phosphate synthase (50%);Endodeoxyribonucleases producing 5'-phosphomonoesters (50%),GO:0005737 (95%);GO:0005758 (1%);GO:0016021 (1%),cytoplasm (95%);mitochondrial intermembrane space (1%);integral component of membrane (1%),GO:0003676 (75%);GO:0003677 (14%);GO:0004733 (2%),nucleic acid binding (75%);DNA binding (14%);pyridoxamine-phosphate oxidase activity (2%),GO:0008615 (2%);GO:0006351 (1%);GO:0006306 (0%),pyridoxine biosynthetic process (2%);transcription, DNA-templated (1%);DNA methylation (0%),IPR002059 (96%);IPR012340 (96%);IPR012156 (96%),Cold-shock protein, DNA-binding (96%);Nucleic acid-binding, OB-fold (96%);Cold shock, CspA (96%),,,,,,,
VAAVDNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YADLLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.13 (64%);2.6.1.9 (9%);3.4.24.- (9%),tRNA-uridine 2-sulfurtransferase (64%);Histidinol-phosphate transaminase (9%);Metalloendopeptidases (9%),GO:0016021 (13%);GO:0005737 (6%);GO:0005840 (6%),integral component of membrane (13%);cytoplasm (6%);ribosome (6%),GO:0003700 (32%);GO:0043565 (31%);GO:0003824 (8%),DNA-binding transcription factor activity (32%);sequence-specific DNA binding (31%);catalytic activity (8%),GO:0006400 (6%);GO:0006412 (5%);GO:0007165 (3%),tRNA modification (6%);translation (5%);signal transduction (3%),IPR002818 (30%);IPR009057 (30%);IPR018060 (30%),DJ-1/PfpI (30%);Homeobox-like domain superfamily (30%);DNA binding HTH domain, AraC-type (30%),,,,,,,,,,
LVVDCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.75 (28%);2.7.7.38 (17%);1.-.-.- (6%),Uroporphyrinogen-III synthase (28%);3-deoxy-manno-octulosonate cytidylyltransferase (17%);Oxidoreductases (6%),GO:0016021 (10%);GO:0005737 (2%);GO:0005576 (1%),integral component of membrane (10%);cytoplasm (2%);extracellular region (1%),GO:0016740 (34%);GO:0016757 (12%);GO:0004725 (8%),transferase activity (34%);transferase activity, transferring glycosyl groups (12%);protein tyrosine phosphatase activity (8%),GO:1902751 (8%);GO:0006780 (3%);GO:0006782 (3%),positive regulation of cell cycle G2/M phase transition (8%);uroporphyrinogen III biosynthetic process (3%);protoporphyrinogen IX biosynthetic process (3%),IPR028098 (36%);IPR001296 (30%);IPR005583 (9%),Glycosyltransferase subfamily 4-like, N-terminal domain (36%);Glycosyl transferase, family 1 (30%);Peroxide stress protein YaaA (9%),,,,,,,,
WMTEAAK,Cystobacter fuscus,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Myxococcales,Cystobacterineae,,,,Archangiaceae,,,,Cystobacter,,,,Cystobacter fuscus,,,,,,GO:0005615 (100%),extracellular space (100%),GO:0004866 (100%),endopeptidase inhibitor activity (100%),,,IPR001599 (100%);IPR002890 (100%);IPR008930 (100%),Alpha-2-macroglobulin (100%);Macroglobulin domain (100%);Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid (100%),,,,,,,,,,,
LLNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.13 (6%);1.1.1.3 (5%);3.4.11.- (4%),Methionine synthase (6%);Homoserine dehydrogenase (5%);Aminopeptidases (4%),GO:0016021 (19%);GO:0005737 (11%);GO:0005886 (3%),integral component of membrane (19%);cytoplasm (11%);plasma membrane (3%),GO:0005524 (19%);GO:0003677 (8%);GO:0046872 (7%),ATP binding (19%);DNA binding (8%);metal ion binding (7%),GO:0005975 (4%);GO:0006435 (3%);GO:0032259 (2%),carbohydrate metabolic process (4%);threonyl-tRNA aminoacylation (3%);methylation (2%),IPR027417 (11%);IPR036291 (3%);IPR006195 (3%),P-loop containing nucleoside triphosphate hydrolase (11%);NAD(P)-binding domain superfamily (3%);Aminoacyl-tRNA synthetase, class II (3%),,,,,,,,,,
MLYLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.13.11.24 (38%);3.4.24.- (3%);7.2.2.6 (3%),Quercetin 2,3-dioxygenase (38%);Metalloendopeptidases (3%);P-type K(+) transporter (3%),GO:0009279 (29%);GO:0016021 (28%);GO:0005886 (2%),cell outer membrane (29%);integral component of membrane (28%);plasma membrane (2%),GO:0005524 (11%);GO:0016746 (5%);GO:0051213 (5%),ATP binding (11%);transferase activity, transferring acyl groups (5%);dioxygenase activity (5%),GO:0043165 (28%);GO:0051205 (28%);GO:0005975 (1%),Gram-negative-bacterium-type cell outer membrane assembly (28%);protein insertion into membrane (28%);carbohydrate metabolic process (1%),IPR011990 (23%);IPR017689 (22%);IPR039565 (22%),Tetratricopeptide-like helical domain superfamily (23%);Outer membrane protein assembly factor BamD (22%);Outer membrane lipoprotein BamD-like (22%),,,,,,,,,
NPSLAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.- (33%);2.7.13.3 (33%);3.6.4.13 (33%),With NAD(+) or NADP(+) as acceptor (33%);Histidine kinase (33%);RNA helicase (33%),GO:0005737 (11%);GO:0005741 (6%);GO:0016021 (6%),cytoplasm (11%);mitochondrial outer membrane (6%);integral component of membrane (6%),GO:0003677 (11%);GO:0005524 (11%);GO:0016491 (11%),DNA binding (11%);ATP binding (11%);oxidoreductase activity (11%),GO:0000746 (11%);GO:0006108 (6%);GO:0006355 (6%),conjugation (11%);malate metabolic process (6%);regulation of transcription, DNA-templated (6%),IPR027417 (13%);IPR036291 (13%);IPR001482 (9%),P-loop containing nucleoside triphosphate hydrolase (13%);NAD(P)-binding domain superfamily (13%);Type II/IV secretion system protein (9%),,,,,,,,,,
NSATLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.5.4 (50%);5.4.2.11 (50%),Fumarate reductase (quinol) (50%);Phosphoglycerate mutase (2,3-diphosphoglycerate-dependent) (50%),GO:0016021 (38%);GO:0005737 (5%),integral component of membrane (38%);cytoplasm (5%),GO:0005524 (29%);GO:0016787 (14%);GO:0016887 (14%),ATP binding (29%);hydrolase activity (14%);ATPase activity (14%),GO:0000160 (5%);GO:0001514 (5%);GO:0005975 (5%),phosphorelay signal transduction system (5%);selenocysteine incorporation (5%);carbohydrate metabolic process (5%),IPR027417 (24%);IPR003593 (20%);IPR003439 (16%),P-loop containing nucleoside triphosphate hydrolase (24%);AAA+ ATPase domain (20%);ABC transporter-like (16%),,,,,,,,,,
VNLPDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (100%),Endopeptidase La (100%),GO:0005737 (8%);GO:0009426 (8%);GO:0016021 (8%),cytoplasm (8%);bacterial-type flagellum basal body, distal rod (8%);integral component of membrane (8%),GO:0042302 (30%);GO:0016788 (22%);GO:0031177 (22%),structural constituent of cuticle (30%);hydrolase activity, acting on ester bonds (22%);phosphopantetheine binding (22%),GO:0009058 (22%);GO:0030163 (11%);GO:0071973 (8%),biosynthetic process (22%);protein catabolic process (11%);bacterial-type flagellum-dependent cell motility (8%),IPR000618 (23%);IPR001031 (19%);IPR009081 (19%),Insect cuticle protein (23%);Thioesterase (19%);Phosphopantetheine binding ACP domain (19%),,,,,,,,,
FALLVDEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSVDYGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.10.3.2 (100%),Laccase (100%),GO:0005874 (99%);GO:0005737 (69%);GO:0005881 (1%),microtubule (99%);cytoplasm (69%);cytoplasmic microtubule (1%),GO:0005525 (99%);GO:0003924 (99%);GO:0005200 (96%),GTP binding (99%);GTPase activity (99%);structural constituent of cytoskeleton (96%),GO:0007017 (96%);GO:0000226 (6%);GO:0000278 (6%),microtubule-based process (96%);microtubule cytoskeleton organization (6%);mitotic cell cycle (6%),IPR000217 (100%);IPR036525 (100%);IPR003008 (99%),Tubulin (100%);Tubulin/FtsZ, GTPase domain superfamily (100%);Tubulin/FtsZ, GTPase domain (99%),,,,,,,,,
ANSAENSLSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLNNFTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0005634 (83%);GO:0016021 (8%),nucleus (83%);integral component of membrane (8%),GO:0003677 (83%);GO:0030337 (83%);GO:0003755 (8%),DNA binding (83%);DNA polymerase processivity factor activity (83%);peptidyl-prolyl cis-trans isomerase activity (8%),GO:0006260 (83%);GO:0006275 (83%);GO:0006457 (8%),DNA replication (83%);regulation of DNA replication (83%);protein folding (8%),IPR000730 (77%);IPR022648 (77%);IPR022649 (77%),Proliferating cell nuclear antigen, PCNA (77%);Proliferating cell nuclear antigen, PCNA, N-terminal (77%);Proliferating cell nuclear antigen, PCNA, C-terminal (77%),,,,,,
FVKPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.4 (50%);1.5.-.- (25%);2.3.1.129 (25%),Type II site-specific deoxyribonuclease (50%);Acting on the CH-NH group of donors (25%);Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (25%),GO:0016021 (21%);GO:0043564 (17%);GO:0005739 (13%),integral component of membrane (21%);Ku70:Ku80 complex (17%);mitochondrion (13%),GO:0003684 (17%);GO:0042162 (17%);GO:0003677 (13%),damaged DNA binding (17%);telomeric DNA binding (17%);DNA binding (13%),GO:0000723 (17%);GO:0006303 (17%);GO:0006310 (17%),telomere maintenance (17%);double-strand break repair via nonhomologous end joining (17%);DNA recombination (17%),IPR005161 (12%);IPR006164 (12%);IPR016194 (12%),Ku70/Ku80, N-terminal alpha/beta (12%);Ku70/Ku80 beta-barrel domain (12%);SPOC-like, C-terminal domain superfamily (12%),,,,,,,,,
SALEEWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (31%);GO:0016021 (23%);GO:0005774 (8%),cytoplasm (31%);integral component of membrane (23%);vacuolar membrane (8%),GO:0004842 (31%);GO:0016810 (31%);GO:0004672 (8%),ubiquitin-protein transferase activity (31%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (31%);protein kinase activity (8%),GO:0000045 (8%);GO:0000422 (8%);GO:0001934 (8%),autophagosome assembly (8%);autophagy of mitochondrion (8%);positive regulation of protein phosphorylation (8%),IPR003613 (27%);IPR006680 (27%);IPR011059 (27%),U box domain (27%);Amidohydrolase-related (27%);Metal-dependent hydrolase, composite domain superfamily (27%),,,,,,,,,
LWLEPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (30%);2.4.1.187 (20%);2.7.13.3 (20%),Acting on ester bonds (30%);N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-Dmannosaminyltransferase (20%);Histidine kinase (20%),GO:0016021 (31%);GO:0005737 (5%);GO:0005840 (1%),integral component of membrane (31%);cytoplasm (5%);ribosome (1%),GO:0016757 (48%);GO:0005524 (15%);GO:0000155 (12%),transferase activity, transferring glycosyl groups (48%);ATP binding (15%);phosphorelay sensor kinase activity (12%),GO:0009058 (43%);GO:0006355 (6%);GO:0008360 (3%),biosynthetic process (43%);regulation of transcription, DNA-templated (6%);regulation of cell shape (3%),IPR004629 (49%);IPR036890 (12%);IPR003594 (12%),Glycosyl transferase WecB/TagA/CpsF (49%);Histidine kinase/HSP90-like ATPase superfamily (12%);Histidine kinase/HSP90-like ATPase (12%),,,,,,,,,
DFWDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6.1.2 (88%);2.1.1.- (13%),Guanylate cyclase (88%);Methyltransferases (13%),GO:0016021 (38%);GO:0005634 (4%),integral component of membrane (38%);nucleus (4%),GO:0005524 (69%);GO:0004812 (42%);GO:0004383 (27%),ATP binding (69%);aminoacyl-tRNA ligase activity (42%);guanylate cyclase activity (27%),GO:0006418 (35%);GO:0035556 (27%);GO:0006412 (8%),tRNA aminoacylation for protein translation (35%);intracellular signal transduction (27%);translation (8%),IPR011051 (38%);IPR014710 (38%);IPR014729 (38%),RmlC-like cupin domain superfamily (38%);RmlC-like jelly roll fold (38%);Rossmann-like alpha/beta/alpha sandwich fold (38%),,,,,,,,,,,
ETEMVLLR,Actinobacteria,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,,,,,,,,,,,,,,,,,,,,,,GO:0051920 (100%),peroxiredoxin activity (100%),,,IPR003779 (100%);IPR029032 (100%),Carboxymuconolactone decarboxylase-like (100%);AhpD-like (100%),,,,,,,,,,,
LLEEFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.228 (8%);1.6.5.11 (7%);3.6.4.12 (5%),tRNA (guanine(37)-N(1))-methyltransferase (8%);NADH dehydrogenase (quinone) (7%);DNA helicase (5%),GO:0016021 (15%);GO:0005737 (8%);GO:0005634 (5%),integral component of membrane (15%);cytoplasm (8%);nucleus (5%),GO:0005524 (22%);GO:0003677 (13%);GO:0003824 (12%),ATP binding (22%);DNA binding (13%);catalytic activity (12%),GO:0055085 (3%);GO:0015074 (3%);GO:0006412 (2%),transmembrane transport (3%);DNA integration (3%);translation (2%),IPR008912 (20%);IPR027417 (12%);IPR013785 (7%),Uncharacterised protein family CoxE-like (20%);P-loop containing nucleoside triphosphate hydrolase (12%);Aldolase-type TIM barrel (7%),,,,,,,,,,,
WCADER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (50%);6.3.5.7 (50%),RNA-directed RNA polymerase (50%);Glutaminyl-tRNA synthase (glutamine-hydrolyzing) (50%),GO:0030956 (17%),glutamyl-tRNA(Gln) amidotransferase complex (17%),GO:0003723 (17%);GO:0003968 (17%);GO:0004040 (17%),RNA binding (17%);RNA-directed 5'-3' RNA polymerase activity (17%);amidase activity (17%),GO:0007165 (67%);GO:0006412 (17%),signal transduction (67%);translation (17%),IPR000157 (63%);IPR015032 (63%);IPR035897 (63%),Toll/interleukin-1 receptor homology (TIR) domain (63%);MTH538 TIR-like domain (63%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (63%),,,,,,,,,,,
LDVVYALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNLFER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (79%);3.-.-.- (6%);3.1.3.- (6%),DNA-directed RNA polymerase (79%);Hydrolases (6%);Phosphoric monoester hydrolases (6%),GO:0009507 (41%);GO:0016021 (12%);GO:0005737 (4%),chloroplast (41%);integral component of membrane (12%);cytoplasm (4%),GO:0003677 (45%);GO:0008270 (41%);GO:0003899 (41%),DNA binding (45%);zinc ion binding (41%);DNA-directed 5'-3' RNA polymerase activity (41%),GO:0006351 (41%);GO:0000083 (3%);GO:0006189 (2%),transcription, DNA-templated (41%);regulation of transcription involved in G1/S transition of mitotic cell cycle (3%);'de novo' IMP biosynthetic process (2%),IPR007081 (39%);IPR007083 (39%);IPR012756 (39%),RNA polymerase Rpb1, domain 5 (39%);RNA polymerase Rpb1, domain 4 (39%);DNA-directed RNA polymerase, subunit beta'' (39%),,,,,,,
NDADVVK,Clostridiales,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005328 (100%),neurotransmitter:sodium symporter activity (100%),,,IPR000175 (100%);IPR037272 (100%),Sodium:neurotransmitter symporter (100%);Sodium:neurotransmitter symporter superfamily (100%),,,,,,,,,,,
LPQVEGTGGNVQPSQDLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALDDETR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6.1.1 (44%);2.1.2.1 (11%);2.4.1.25 (11%),Adenylate cyclase (44%);Glycine hydroxymethyltransferase (11%);4-alpha-glucanotransferase (11%),GO:0005737 (24%);GO:0016021 (15%);GO:0031226 (15%),cytoplasm (24%);integral component of membrane (15%);intrinsic component of plasma membrane (15%),GO:0003700 (32%);GO:0005524 (17%);GO:0005525 (17%),DNA-binding transcription factor activity (32%);ATP binding (17%);GTP binding (17%),GO:0006614 (15%);GO:0046034 (7%);GO:0006171 (6%),SRP-dependent cotranslational protein targeting to membrane (15%);ATP metabolic process (7%);cAMP biosynthetic process (6%),IPR036390 (33%);IPR001845 (29%);IPR011991 (29%),Winged helix DNA-binding domain superfamily (33%);HTH ArsR-type DNA-binding domain (29%);ArsR-like helix-turn-helix domain (29%),,,,,,,,,,,
VTFELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (28%);1.11.1.6 (17%);5.4.4.2 (17%),Peptidylprolyl isomerase (28%);Catalase (17%);Isochorismate synthase (17%),GO:0016021 (17%);GO:0043190 (16%);GO:0005737 (3%),integral component of membrane (17%);ATP-binding cassette (ABC) transporter complex (16%);cytoplasm (3%),GO:0005524 (13%);GO:0008168 (11%);GO:0003677 (8%),ATP binding (13%);methyltransferase activity (11%);DNA binding (8%),GO:0008610 (20%);GO:0055085 (16%);GO:0032259 (12%),lipid biosynthetic process (20%);transmembrane transport (16%);methylation (12%),IPR009925 (19%);IPR029063 (14%);IPR003333 (13%),Protein of unknown function DUF1463 (19%);S-adenosyl-L-methionine-dependent methyltransferase (14%);Mycolic acid cyclopropane synthase (13%),,,,,,,,,,,
TFELTSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.42 (50%);2.7.13.3 (50%),Isocitrate dehydrogenase (NADP(+)) (50%);Histidine kinase (50%),GO:0016021 (39%),integral component of membrane (39%),GO:0016849 (22%);GO:0003677 (17%);GO:0004476 (17%),phosphorus-oxygen lyase activity (22%);DNA binding (17%);mannose-6-phosphate isomerase activity (17%),GO:0009190 (22%);GO:0035556 (22%);GO:0000160 (17%),cyclic nucleotide biosynthetic process (22%);intracellular signal transduction (22%);phosphorelay signal transduction system (17%),IPR001054 (20%);IPR011051 (20%);IPR014710 (20%),Adenylyl cyclase class-3/4/guanylyl cyclase (20%);RmlC-like cupin domain superfamily (20%);RmlC-like jelly roll fold (20%),,,,,,,,,,,
FLNNDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.26 (40%);3.4.-.- (11%);3.4.21.- (9%),Prolyl oligopeptidase (40%);Acting on peptide bonds (peptidases) (11%);Serine endopeptidases (9%),GO:0016021 (36%);GO:0005682 (3%);GO:0005737 (3%),integral component of membrane (36%);U5 snRNP (3%);cytoplasm (3%),GO:0004252 (20%);GO:0070008 (18%);GO:0005216 (16%),serine-type endopeptidase activity (20%);serine-type exopeptidase activity (18%);ion channel activity (16%),GO:0006313 (11%);GO:0006412 (2%);GO:0006096 (1%),transposition, DNA-mediated (11%);translation (2%);glycolytic process (1%),IPR029058 (18%);IPR001375 (17%);IPR002470 (17%),Alpha/Beta hydrolase fold (18%);Peptidase S9, prolyl oligopeptidase, catalytic domain (17%);Peptidase S9A, prolyl oligopeptidase (17%),,,,,,,
NLEFEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.2 (24%);6.3.2.4 (11%);2.7.1.23 (7%),Oxoglutarate dehydrogenase (succinyl-transferring) (24%);D-alanine--D-alanine ligase (11%);NAD(+) kinase (7%),GO:0005737 (86%);GO:0009380 (77%);GO:0016021 (2%),cytoplasm (86%);excinuclease repair complex (77%);integral component of membrane (2%),GO:0003677 (87%);GO:0005524 (84%);GO:0009381 (80%),DNA binding (87%);ATP binding (84%);excinuclease ABC activity (80%),GO:0009432 (86%);GO:0006289 (85%);GO:0006281 (2%),SOS response (86%);nucleotide-excision repair (85%);DNA repair (2%),IPR036876 (84%);IPR001943 (83%);IPR027417 (80%),UVR domain superfamily (84%);UVR domain (83%);P-loop containing nucleoside triphosphate hydrolase (80%),,,,,,,,,,,
TSELLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (47%);3.1.3.45 (16%);6.3.4.15 (16%),Exoribonuclease II (47%);3-deoxy-manno-octulosonate-8-phosphatase (16%);Biotin--[biotin carboxyl-carrier protein] ligase (16%),GO:0005737 (51%);GO:0016021 (18%);GO:0005634 (2%),cytoplasm (51%);integral component of membrane (18%);nucleus (2%),GO:0005525 (45%);GO:0004499 (10%);GO:0050660 (10%),GTP binding (45%);N,N-dimethylaniline monooxygenase activity (10%);flavin adenine dinucleotide binding (10%),GO:0006355 (4%);GO:0007165 (3%);GO:0006418 (2%),regulation of transcription, DNA-templated (4%);signal transduction (3%);tRNA aminoacylation for protein translation (2%),IPR027417 (45%);IPR006073 (43%);IPR016478 (43%),P-loop containing nucleoside triphosphate hydrolase (45%);GTP binding domain (43%);GTPase, MTG1 (43%),,,,,,,,
LLDEVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.47 (29%);2.7.7.6 (24%);6.1.1.6 (17%),Cysteine synthase (29%);DNA-directed RNA polymerase (24%);Lysine--tRNA ligase (17%),GO:0016021 (23%);GO:0009279 (14%);GO:0005737 (13%),integral component of membrane (23%);cell outer membrane (14%);cytoplasm (13%),GO:0000287 (17%);GO:0003677 (17%);GO:0005524 (16%),magnesium ion binding (17%);DNA binding (17%);ATP binding (16%),GO:0006535 (13%);GO:0006006 (11%);GO:0006351 (10%),cysteine biosynthetic process from serine (13%);glucose metabolic process (11%);transcription, DNA-templated (10%),IPR000531 (13%);IPR008969 (13%);IPR012910 (13%),TonB-dependent receptor-like, beta-barrel (13%);Carboxypeptidase-like, regulatory domain superfamily (13%);TonB-dependent receptor, plug domain (13%),,,,,,,
NGPNVQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FTVDELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.130 (25%);2.7.13.3 (25%);3.6.5.3 (25%),Tetraacyldisaccharide 4'-kinase (25%);Histidine kinase (25%);Protein-synthesizing GTPase (25%),GO:0005623 (12%);GO:0005794 (12%);GO:0016021 (6%),cell (12%);Golgi apparatus (12%);integral component of membrane (6%),GO:0003924 (36%);GO:0005525 (36%);GO:0003746 (24%),GTPase activity (36%);GTP binding (36%);translation elongation factor activity (24%),GO:0015031 (12%);GO:0045053 (12%);GO:0045324 (12%),protein transport (12%);protein retention in Golgi apparatus (12%);late endosome to vacuole transport (12%),IPR027417 (32%);IPR000795 (30%);IPR005225 (30%),P-loop containing nucleoside triphosphate hydrolase (32%);Transcription factor, GTP-binding domain (30%);Small GTP-binding protein domain (30%),,,,,,,,,,
TFELFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6.1.2 (46%);2.7.7.7 (7%);1.18.1.6 (4%),Guanylate cyclase (46%);DNA-directed DNA polymerase (7%);Adrenodoxin-NADP(+) reductase (4%),GO:0016021 (44%);GO:0005886 (6%);GO:0005789 (4%),integral component of membrane (44%);plasma membrane (6%);endoplasmic reticulum membrane (4%),GO:0005524 (18%);GO:0003824 (15%);GO:0005525 (11%),ATP binding (18%);catalytic activity (15%);GTP binding (11%),GO:0035556 (9%);GO:0055072 (5%);GO:0006260 (3%),intracellular signal transduction (9%);iron ion homeostasis (5%);DNA replication (3%),IPR027417 (16%);IPR001736 (12%);IPR011990 (11%),P-loop containing nucleoside triphosphate hydrolase (16%);Phospholipase D/Transphosphatidylase (12%);Tetratricopeptide-like helical domain superfamily (11%),,,,,,,,,,,
NFGNWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.99.5 (100%),Dissimilatory sulfite reductase (100%),GO:0005887 (9%);GO:0009279 (9%);GO:0016021 (9%),integral component of plasma membrane (9%);cell outer membrane (9%);integral component of membrane (9%),GO:0046872 (55%);GO:0051539 (55%);GO:0009055 (45%),metal ion binding (55%);4 iron, 4 sulfur cluster binding (55%);electron transfer activity (45%),GO:0006790 (45%);GO:0000398 (9%);GO:0009306 (9%),sulfur compound metabolic process (45%);mRNA splicing, via spliceosome (9%);protein secretion (9%),IPR005117 (46%);IPR006067 (46%);IPR011808 (46%),Nitrite/Sulfite reductase ferredoxin-like domain (46%);Nitrite/sulphite reductase 4Fe-4S domain (46%);Sulphite reductase, dissimilatory-type beta subunit (46%),,,,,,,,
EFLELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (28%);6.5.1.2 (6%);3.4.21.89 (6%),DNA helicase (28%);DNA ligase (NAD(+)) (6%);Signal peptidase I (6%),GO:0016021 (19%);GO:0005737 (13%);GO:0005887 (1%),integral component of membrane (19%);cytoplasm (13%);integral component of plasma membrane (1%),GO:0005524 (33%);GO:0003676 (12%);GO:0000155 (11%),ATP binding (33%);nucleic acid binding (12%);phosphorelay sensor kinase activity (11%),GO:0006281 (12%);GO:0006260 (12%);GO:0006310 (10%),DNA repair (12%);DNA replication (12%);DNA recombination (10%),IPR027417 (25%);IPR036388 (10%);IPR036249 (10%),P-loop containing nucleoside triphosphate hydrolase (25%);Winged helix-like DNA-binding domain superfamily (10%);Thioredoxin-like superfamily (10%),,,,,,,,,,,
LQEDYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (33%);2.7.3.9 (33%);3.1.21.3 (33%),Histidine kinase (33%);Phosphoenolpyruvate--protein phosphotransferase (33%);Type I site-specific deoxyribonuclease (33%),GO:0016021 (27%);GO:0005737 (23%);GO:0000502 (5%),integral component of membrane (27%);cytoplasm (23%);proteasome complex (5%),GO:0005524 (27%);GO:0008168 (14%);GO:0036402 (14%),ATP binding (27%);methyltransferase activity (14%);proteasome-activating ATPase activity (14%),GO:0030163 (14%);GO:0000160 (5%);GO:0000226 (5%),protein catabolic process (14%);phosphorelay signal transduction system (5%);microtubule cytoskeleton organization (5%),IPR027417 (24%);IPR029063 (16%);IPR003593 (12%),P-loop containing nucleoside triphosphate hydrolase (24%);S-adenosyl-L-methionine-dependent methyltransferase (16%);AAA+ ATPase domain (12%),,,,,,,,,,,
EEELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (15%);6.3.4.14 (8%);6.4.1.2 (8%),Acting on ester bonds (15%);Biotin carboxylase (8%);Acetyl-CoA carboxylase (8%),GO:0016021 (14%);GO:0005737 (7%);GO:0005634 (4%),integral component of membrane (14%);cytoplasm (7%);nucleus (4%),GO:0003677 (23%);GO:0005524 (16%);GO:0003700 (5%),DNA binding (23%);ATP binding (16%);DNA-binding transcription factor activity (5%),GO:0006355 (11%);GO:0000160 (10%);GO:0009966 (4%),regulation of transcription, DNA-templated (11%);phosphorelay signal transduction system (10%);regulation of signal transduction (4%),IPR027417 (10%);IPR001789 (9%);IPR011006 (9%),P-loop containing nucleoside triphosphate hydrolase (10%);Signal transduction response regulator, receiver domain (9%);CheY-like superfamily (9%),,,,,,,,,
YANNSETPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLLPDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.26 (15%);2.7.7.2 (15%);6.3.4.15 (10%),Riboflavin kinase (15%);FAD synthase (15%);Biotin--[biotin carboxyl-carrier protein] ligase (10%),GO:0016021 (15%);GO:0031012 (6%);GO:0016020 (1%),integral component of membrane (15%);extracellular matrix (6%);membrane (1%),GO:0042302 (47%);GO:0005524 (10%);GO:0004077 (7%),structural constituent of cuticle (47%);ATP binding (10%);biotin-[acetyl-CoA-carboxylase] ligase activity (7%),GO:0006464 (7%);GO:0006355 (3%);GO:0005975 (2%),cellular protein modification process (7%);regulation of transcription, DNA-templated (3%);carbohydrate metabolic process (2%),IPR000618 (40%);IPR031311 (29%);IPR004143 (6%),Insect cuticle protein (40%);Chitin-binding type R&R consensus (29%);Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain (6%),,,,,,,,,
YTEYSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (33%);2.4.1.54 (17%);4.6.1.1 (17%),Acting on ester bonds (33%);Undecaprenyl-phosphate mannosyltransferase (17%);Adenylate cyclase (17%),GO:0016021 (42%);GO:0005737 (6%);GO:0016020 (6%),integral component of membrane (42%);cytoplasm (6%);membrane (6%),GO:0016787 (26%);GO:0046872 (10%);GO:0008137 (6%),hydrolase activity (26%);metal ion binding (10%);NADH dehydrogenase (ubiquinone) activity (6%),GO:0042773 (6%);GO:0006355 (4%);GO:0006171 (2%),ATP synthesis coupled electron transport (6%);regulation of transcription, DNA-templated (4%);cAMP biosynthetic process (2%),IPR008930 (42%);IPR003343 (38%);IPR008964 (38%),Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid (42%);Bacterial Ig-like, group 2 (38%);Invasin/intimin cell-adhesion fragments (38%),,,,,,,,,
LYNDQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.25 (20%);2.4.1.182 (10%);2.4.1.21 (10%),tRNA pseudouridine(55) synthase (20%);Lipid-A-disaccharide synthase (10%);Starch synthase (10%),GO:0016021 (25%);GO:0005886 (1%);GO:0009279 (1%),integral component of membrane (25%);plasma membrane (1%);cell outer membrane (1%),GO:0043531 (56%);GO:0046872 (5%);GO:0005524 (4%),ADP binding (56%);metal ion binding (5%);ATP binding (4%),GO:0009405 (1%);GO:0015986 (1%);GO:0031119 (1%),pathogenesis (1%);ATP synthesis coupled proton transport (1%);tRNA pseudouridine synthesis (1%),IPR027417 (67%);IPR002182 (62%);IPR041118 (52%),P-loop containing nucleoside triphosphate hydrolase (67%);NB-ARC (62%);Rx, N-terminal (52%),,,,,,,,,,
QAVAVVTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VETADR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.99.- (33%);2.4.99.17 (10%);6.3.4.19 (10%),With other acceptors (33%);S-adenosylmethionine:tRNA ribosyltransferase-isomerase (10%);tRNA(Ile)-lysidine synthetase (10%),GO:0016021 (18%);GO:0005737 (6%);GO:0005886 (2%),integral component of membrane (18%);cytoplasm (6%);plasma membrane (2%),GO:0003677 (35%);GO:0005524 (10%);GO:0016740 (10%),DNA binding (35%);ATP binding (10%);transferase activity (10%),GO:0000160 (27%);GO:0006355 (25%);GO:0019478 (5%),phosphorelay signal transduction system (27%);regulation of transcription, DNA-templated (25%);D-amino acid catabolic process (5%),IPR001789 (24%);IPR011006 (24%);IPR036388 (24%),Signal transduction response regulator, receiver domain (24%);CheY-like superfamily (24%);Winged helix-like DNA-binding domain superfamily (24%),,,,,,,,,
FQDYDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (80%);1.3.8.- (20%),Protein-serine/threonine phosphatase (80%);With a flavin as acceptor (20%),GO:0016021 (56%);GO:0009279 (4%);GO:0005634 (2%),integral component of membrane (56%);cell outer membrane (4%);nucleus (2%),GO:0003924 (47%);GO:0005525 (47%);GO:0050660 (18%),GTPase activity (47%);GTP binding (47%);flavin adenine dinucleotide binding (18%),GO:0032259 (4%);GO:0006260 (2%);GO:0006351 (2%),methylation (4%);DNA replication (2%);transcription, DNA-templated (2%),IPR027417 (45%);IPR015894 (43%);IPR006091 (16%),P-loop containing nucleoside triphosphate hydrolase (45%);Guanylate-binding protein, N-terminal (43%);Acyl-CoA oxidase/dehydrogenase, central domain (16%),,,,,,,,
LEDELLAEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (10%);GO:0005884 (10%),nucleus (10%);actin filament (10%),GO:0042803 (40%);GO:0003824 (20%);GO:0050662 (20%),protein homodimerization activity (40%);catalytic activity (20%);coenzyme binding (20%),GO:0006937 (40%);GO:0006936 (10%);GO:0007015 (10%),regulation of muscle contraction (40%);muscle contraction (10%);actin filament organization (10%),IPR000533 (94%);IPR001509 (3%);IPR036291 (3%),Tropomyosin (94%);NAD-dependent epimerase/dehydratase (3%);NAD(P)-binding domain superfamily (3%),,,,,,,,,,,
YDSTELALQADEK,Moritella viscosa,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Alteromonadales,,,,,Moritellaceae,,,,Moritella,,,,Moritella viscosa,,,,4.1.3.1 (100%),Isocitrate lyase (100%),,,GO:0004451 (100%);GO:0046872 (100%),isocitrate lyase activity (100%);metal ion binding (100%),GO:0019752 (100%),carboxylic acid metabolic process (100%),IPR006254 (100%);IPR015813 (100%);IPR039556 (100%),Isocitrate lyase (100%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (100%);ICL/PEPM domain (100%),,,,,,,,,,,
KPFGQLTER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EALEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.0 (19%);1.1.1.23 (4%);1.16.1.1 (3%), (19%);Histidinol dehydrogenase (4%);Mercury(II) reductase (3%),GO:0016021 (12%);GO:0005737 (10%);GO:0019012 (8%),integral component of membrane (12%);cytoplasm (10%);virion (8%),GO:0005524 (14%);GO:0005198 (13%);GO:0008270 (9%),ATP binding (14%);structural molecule activity (13%);zinc ion binding (9%),GO:0016032 (9%);GO:0045727 (5%);GO:0039702 (3%),viral process (9%);positive regulation of translation (5%);viral budding via host ESCRT complex (3%),IPR027417 (15%);IPR010999 (11%);IPR012344 (11%),P-loop containing nucleoside triphosphate hydrolase (15%);Retroviral matrix protein (11%);Matrix protein, lentiviral and alpha-retroviral, N-terminal (11%),,,,,,,,,
YVALDFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDLWENK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%);GO:0004518 (100%),DNA binding (100%);nuclease activity (100%),,,IPR006166 (67%);IPR011335 (67%);IPR027421 (67%),ERCC4 domain (67%);Restriction endonuclease  type II-like (67%);DNA polymerase lambda lyase domain superfamily (67%),,,,,,,,,,,
LYDLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.169 (12%);1.-.-.- (9%);6.3.2.13 (5%),2-dehydropantoate 2-reductase (12%);Oxidoreductases (9%);UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (5%),GO:0016021 (19%);GO:0005737 (8%);GO:0005886 (4%),integral component of membrane (19%);cytoplasm (8%);plasma membrane (4%),GO:0016787 (19%);GO:0005524 (15%);GO:0003677 (7%),hydrolase activity (19%);ATP binding (15%);DNA binding (7%),GO:0006351 (2%);GO:0015940 (2%);GO:0071973 (2%),transcription, DNA-templated (2%);pantothenate biosynthetic process (2%);bacterial-type flagellum-dependent cell motility (2%),IPR004843 (12%);IPR025142 (12%);IPR027417 (11%),Calcineurin-like phosphoesterase domain, ApaH type (12%);Domain of unknown function DUF4073 (12%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,
LVPASR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.13 (42%);1.15.1.1 (6%);1.17.1.8 (6%),2-isopropylmalate synthase (42%);Superoxide dismutase (6%);4-hydroxy-tetrahydrodipicolinate reductase (6%),GO:0016021 (37%);GO:0005886 (5%);GO:0005737 (3%),integral component of membrane (37%);plasma membrane (5%);cytoplasm (3%),GO:0005524 (9%);GO:0003677 (7%);GO:0046872 (7%),ATP binding (9%);DNA binding (7%);metal ion binding (7%),GO:0055085 (7%);GO:0009098 (4%);GO:0043335 (4%),transmembrane transport (7%);leucine biosynthetic process (4%);protein unfolding (4%),IPR040420 (18%);IPR002549 (7%);IPR027417 (6%),Uncharacterized protein At1g76660-like (18%);Transmembrane protein TqsA-like (7%);P-loop containing nucleoside triphosphate hydrolase (6%),,,,,,,,,,,
FYCNEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLNLVLDR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016874 (100%),ligase activity (100%),,,IPR003329 (50%);IPR007235 (50%);IPR011763 (50%),Acylneuraminate cytidylyltransferase (50%);Glycosyl transferase, family 28, C-terminal (50%);Acetyl-coenzyme A carboxyltransferase, C-terminal (50%),,,,,,,,
DELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (4%);4.1.99.22 (4%);2.7.7.7 (3%),DNA topoisomerase (ATP-hydrolyzing) (4%);GTP 3',8-cyclase (4%);DNA-directed DNA polymerase (3%),GO:0016021 (18%);GO:0005737 (11%);GO:0005886 (3%),integral component of membrane (18%);cytoplasm (11%);plasma membrane (3%),GO:0005524 (21%);GO:0003677 (12%);GO:0046872 (9%),ATP binding (21%);DNA binding (12%);metal ion binding (9%),GO:0006355 (2%);GO:0009058 (2%);GO:0006281 (1%),regulation of transcription, DNA-templated (2%);biosynthetic process (2%);DNA repair (1%),IPR027417 (12%);IPR014001 (4%);IPR001650 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);Helicase superfamily 1/2, ATP-binding domain (4%);Helicase, C-terminal (4%),,,,,,,
EAADLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (67%);1.17.4.1 (17%);2.7.7.12 (8%),Acting on ester bonds (67%);Ribonucleoside-diphosphate reductase (17%);UDP-glucose--hexose-1-phosphate uridylyltransferase (8%),GO:0048500 (31%);GO:0005737 (10%);GO:0016021 (9%),signal recognition particle (31%);cytoplasm (10%);integral component of membrane (9%),GO:0003924 (53%);GO:0005525 (53%);GO:0008312 (31%),GTPase activity (53%);GTP binding (53%);7S RNA binding (31%),GO:0006614 (31%);GO:0006364 (7%);GO:0006412 (3%),SRP-dependent cotranslational protein targeting to membrane (31%);rRNA processing (7%);translation (3%),IPR027417 (51%);IPR000897 (30%);IPR003593 (30%),P-loop containing nucleoside triphosphate hydrolase (51%);Signal recognition particle, SRP54 subunit, GTPase domain (30%);AAA+ ATPase domain (30%),,,,,,,,,
VEQLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.6 (22%);2.7.7.7 (15%);2.3.2.27 (7%),Phosphoribosylaminoimidazolesuccinocarboxamide synthase (22%);DNA-directed DNA polymerase (15%);RING-type E3 ubiquitin transferase (7%),GO:0016021 (24%);GO:0005737 (19%);GO:0005694 (11%),integral component of membrane (24%);cytoplasm (19%);chromosome (11%),GO:0005524 (32%);GO:0003677 (22%);GO:0046872 (8%),ATP binding (32%);DNA binding (22%);metal ion binding (8%),GO:0006260 (16%);GO:0007062 (11%);GO:0030261 (11%),DNA replication (16%);sister chromatid cohesion (11%);chromosome condensation (11%),IPR027417 (21%);IPR003395 (10%);IPR024704 (10%),P-loop containing nucleoside triphosphate hydrolase (21%);RecF/RecN/SMC, N-terminal (10%);Structural maintenance of chromosomes protein (10%),,,,,,,,,,
EAYAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.21 (19%);2.7.8.7 (18%);4.2.1.20 (5%),Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (19%);Holo-[acyl-carrier-protein] synthase (18%);Tryptophan synthase (5%),GO:0016021 (15%);GO:0005737 (11%);GO:0019028 (9%),integral component of membrane (15%);cytoplasm (11%);viral capsid (9%),GO:0005524 (28%);GO:0003723 (10%);GO:0004386 (9%),ATP binding (28%);RNA binding (10%);helicase activity (9%),GO:0006351 (11%);GO:0039694 (9%);GO:0018144 (9%),transcription, DNA-templated (11%);viral RNA genome replication (9%);RNA-protein covalent cross-linking (9%),IPR027417 (19%);IPR001650 (9%);IPR014001 (8%),P-loop containing nucleoside triphosphate hydrolase (19%);Helicase, C-terminal (9%);Helicase superfamily 1/2, ATP-binding domain (8%),,,,,,,,
ENLAALEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.3 (91%);1.1.1.69 (4%);3.1.3.- (4%),Formate--tetrahydrofolate ligase (91%);Gluconate 5-dehydrogenase (4%);Phosphoric monoester hydrolases (4%),GO:0005874 (39%);GO:0005737 (33%);GO:0016021 (4%),microtubule (39%);cytoplasm (33%);integral component of membrane (4%),GO:0005524 (47%);GO:0004329 (43%);GO:0005200 (39%),ATP binding (47%);formate-tetrahydrofolate ligase activity (43%);structural constituent of cytoskeleton (39%),GO:0035999 (43%);GO:0007017 (39%);GO:0006438 (3%),tetrahydrofolate interconversion (43%);microtubule-based process (39%);valyl-tRNA aminoacylation (3%),IPR027417 (35%);IPR000559 (34%);IPR000217 (33%),P-loop containing nucleoside triphosphate hydrolase (35%);Formate-tetrahydrofolate ligase, FTHFS (34%);Tubulin (33%),,,,,,,,,,
FNDPQCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EENLEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (40%);2.7.7.12 (20%);3.1.-.- (10%),Protein-serine/threonine phosphatase (40%);UDP-glucose--hexose-1-phosphate uridylyltransferase (20%);Acting on ester bonds (10%),GO:0005737 (15%);GO:0005886 (8%);GO:0016021 (8%),cytoplasm (15%);plasma membrane (8%);integral component of membrane (8%),GO:0005524 (19%);GO:0004721 (15%);GO:0016757 (15%),ATP binding (19%);phosphoprotein phosphatase activity (15%);transferase activity, transferring glycosyl groups (15%),GO:0006012 (4%);GO:0006261 (4%);GO:0006265 (4%),galactose metabolic process (4%);DNA-dependent DNA replication (4%);DNA topological change (4%),IPR002495 (23%);IPR029044 (23%);IPR004843 (17%),Glycosyl transferase, family 8 (23%);Nucleotide-diphospho-sugar transferases (23%);Calcineurin-like phosphoesterase domain, ApaH type (17%),,,,,,,,
SWLLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (25%);3.4.24.- (10%);3.6.4.- (10%),Acting on GTP; involved in cellular and subcellular movement (25%);Metalloendopeptidases (10%);Acting on ATP; involved in cellular and subcellular movement (10%),GO:0042597 (52%);GO:0016021 (29%);GO:0005737 (1%),periplasmic space (52%);integral component of membrane (29%);cytoplasm (1%),GO:0005524 (10%);GO:0016887 (8%);GO:0042626 (8%),ATP binding (10%);ATPase activity (8%);ATPase-coupled transmembrane transporter activity (8%),GO:0015734 (52%);GO:0005975 (2%);GO:0035278 (1%),taurine transport (52%);carbohydrate metabolic process (2%);miRNA mediated inhibition of translation (1%),IPR015168 (51%);IPR010068 (46%);IPR027417 (10%),SsuA/THI5-like (51%);Taurine ABC transporter, substrate-binding protein TauA (46%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,,,
AETATTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (14%);GO:0005634 (14%);GO:0016021 (14%),extracellular space (14%);nucleus (14%);integral component of membrane (14%),GO:0003677 (29%);GO:0004519 (29%),DNA binding (29%);endonuclease activity (29%),GO:0006289 (29%);GO:0009411 (29%);GO:0006355 (14%),nucleotide-excision repair (29%);response to UV (29%);regulation of transcription, DNA-templated (14%),IPR004601 (25%);IPR036237 (25%);IPR000215 (13%),UV-endonuclease UvdE (25%);Xylose isomerase-like superfamily (25%);Serpin family (13%),,,,,,,,,,
VLDQLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.45 (48%);5.1.3.2 (38%);1.1.1.95 (2%),Thymidylate synthase (48%);UDP-glucose 4-epimerase (38%);Phosphoglycerate dehydrogenase (2%),GO:0005737 (24%);GO:0016021 (13%);GO:0005634 (3%),cytoplasm (24%);integral component of membrane (13%);nucleus (3%),GO:0004799 (20%);GO:0003978 (16%);GO:0005524 (9%),thymidylate synthase activity (20%);UDP-glucose 4-epimerase activity (16%);ATP binding (9%),GO:0032259 (22%);GO:0006231 (18%);GO:0006235 (17%),methylation (22%);dTMP biosynthetic process (18%);dTTP biosynthetic process (17%),IPR036291 (22%);IPR000398 (17%);IPR023451 (17%),NAD(P)-binding domain superfamily (22%);Thymidylate synthase (17%);Thymidylate synthase/dCMP hydroxymethylase domain (17%),,,,,,,,,,,
FLELEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.4 (8%);2.7.1.25 (6%);1.5.1.3 (5%),Sulfate adenylyltransferase (8%);Adenylyl-sulfate kinase (6%);Dihydrofolate reductase (5%),GO:0016021 (14%);GO:0005737 (8%);GO:0009507 (3%),integral component of membrane (14%);cytoplasm (8%);chloroplast (3%),GO:0005524 (17%);GO:0003677 (10%);GO:0004325 (5%),ATP binding (17%);DNA binding (10%);ferrochelatase activity (5%),GO:0019354 (5%);GO:0006336 (5%);GO:0006306 (3%),siroheme biosynthetic process (5%);DNA replication-independent nucleosome assembly (5%);DNA methylation (3%),IPR027417 (11%);IPR011990 (9%);IPR013026 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);Tetratricopeptide-like helical domain superfamily (9%);Tetratricopeptide repeat-containing domain (7%),,,,,,,,,,,
WWQPM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVELYSK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.15 (100%),Acetyl-CoA carboxytransferase (100%),GO:0015935 (96%);GO:0005840 (4%);GO:0005737 (0%),small ribosomal subunit (96%);ribosome (4%);cytoplasm (0%),GO:0019843 (99%);GO:0003735 (96%);GO:0003723 (1%),rRNA binding (99%);structural constituent of ribosome (96%);RNA binding (1%),GO:0006412 (99%);GO:0006633 (0%);GO:0045903 (0%),translation (99%);fatty acid biosynthetic process (0%);positive regulation of translational fidelity (0%),IPR036986 (100%);IPR002942 (99%);IPR005709 (99%),RNA-binding S4 domain superfamily (100%);RNA-binding S4 domain (99%);Ribosomal protein S4, bacterial-type (99%),,,,,,,,,,
VQEFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (42%);6.1.1.10 (21%);2.7.13.3 (11%),DNA-directed DNA polymerase (42%);Methionine--tRNA ligase (21%);Histidine kinase (11%),GO:0000813 (8%);GO:0005737 (5%);GO:0016021 (4%),ESCRT I complex (8%);cytoplasm (5%);integral component of membrane (4%),GO:0005524 (28%);GO:0015419 (25%);GO:1901681 (25%),ATP binding (28%);ATPase-coupled sulfate transmembrane transporter activity (25%);sulfur compound binding (25%),GO:0006457 (11%);GO:0043162 (8%);GO:0006865 (7%),protein folding (11%);ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (8%);amino acid transport (7%),IPR005669 (22%);IPR034408 (22%);IPR013126 (16%),Thiosulphate/Sulfate-binding protein (22%);Sulphate/thiosulphate-binding site (22%);Heat shock protein 70 family (16%),,,,,,,,,,,
FNLDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.4 (64%);3.1.4.46 (5%);2.7.1.48 (4%),Adenylosuccinate synthase (64%);Glycerophosphodiester phosphodiesterase (5%);Uridine kinase (4%),GO:0005737 (30%);GO:0016021 (12%);GO:0009380 (3%),cytoplasm (30%);integral component of membrane (12%);excinuclease repair complex (3%),GO:0008081 (28%);GO:0000287 (22%);GO:0005525 (21%),phosphoric diester hydrolase activity (28%);magnesium ion binding (22%);GTP binding (21%),GO:0006629 (30%);GO:0044208 (21%);GO:0006289 (3%),lipid metabolic process (30%);'de novo' AMP biosynthetic process (21%);nucleotide-excision repair (3%),IPR017946 (28%);IPR030395 (28%);IPR027417 (24%),PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily (28%);Glycerophosphodiester phosphodiesterase domain (28%);P-loop containing nucleoside triphosphate hydrolase (24%),,,,,,,,,,
MPFLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.129 (29%);1.14.99.60 (12%);1.8.4.11 (12%),Peptidoglycan glycosyltransferase (29%);3-demethoxyubiquinol 3-hydroxylase (12%);Peptide-methionine (S)-S-oxide reductase (12%),GO:0016021 (21%);GO:0016020 (12%);GO:0005886 (8%),integral component of membrane (21%);membrane (12%);plasma membrane (8%),GO:0016874 (12%);GO:0005524 (10%);GO:0000155 (7%),ligase activity (12%);ATP binding (10%);phosphorelay sensor kinase activity (7%),GO:0006605 (4%);GO:0015031 (4%);GO:0017038 (4%),protein targeting (4%);protein transport (4%);protein import (4%),IPR042099 (18%);IPR000873 (17%);IPR020845 (16%),AMP-dependent synthetase-like superfamily (18%);AMP-dependent synthetase/ligase (17%);AMP-binding, conserved site (16%),,,,,,,,,,
FHVYDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000159 (31%);GO:0016021 (23%),protein phosphatase type 2A complex (31%);integral component of membrane (23%),GO:0016757 (38%);GO:0019888 (31%);GO:0009055 (23%),transferase activity, transferring glycosyl groups (38%);protein phosphatase regulator activity (31%);electron transfer activity (23%),GO:0007165 (31%),signal transduction (31%),IPR002201 (38%);IPR002554 (31%);IPR011989 (31%),Glycosyl transferase, family 9 (38%);Protein phosphatase 2A, regulatory B subunit, B56 (31%);Armadillo-like helical (31%),,,,,,,
TVVQAQSVAER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNVDLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.20 (33%);2.3.1.- (17%);3.4.21.- (17%),Diacylglycerol O-acyltransferase (33%);Transferring groups other than amino-acyl groups (17%);Serine endopeptidases (17%),GO:0005737 (21%);GO:0009279 (7%);GO:0016021 (7%),cytoplasm (21%);cell outer membrane (7%);integral component of membrane (7%),GO:0016746 (21%);GO:0004144 (14%);GO:0046872 (14%),transferase activity, transferring acyl groups (21%);diacylglycerol O-acyltransferase activity (14%);metal ion binding (14%),GO:0006071 (14%);GO:0019432 (14%);GO:0006431 (7%),glycerol metabolic process (14%);triglyceride biosynthetic process (14%);methionyl-tRNA aminoacylation (7%),IPR004167 (17%);IPR009051 (17%);IPR023753 (17%),Peripheral subunit-binding domain (17%);Alpha-helical ferredoxin (17%);FAD/NAD(P)-binding domain (17%),,,,,,,,,,
ALQCLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.6 (39%);3.2.1.14 (15%);2.4.2.18 (12%),Acetolactate synthase (39%);Chitinase (15%);Anthranilate phosphoribosyltransferase (12%),GO:0016021 (16%);GO:0005737 (6%);GO:0031235 (5%),integral component of membrane (16%);cytoplasm (6%);intrinsic component of the cytoplasmic side of the plasma membrane (5%),GO:0003677 (13%);GO:0046872 (13%);GO:0008061 (10%),DNA binding (13%);metal ion binding (13%);chitin binding (10%),GO:0006355 (11%);GO:0005975 (10%);GO:0009097 (7%),regulation of transcription, DNA-templated (11%);carbohydrate metabolic process (10%);isoleucine biosynthetic process (7%),IPR011990 (14%);IPR019734 (11%);IPR013026 (10%),Tetratricopeptide-like helical domain superfamily (14%);Tetratricopeptide repeat (11%);Tetratricopeptide repeat-containing domain (10%),,,,,,,,,,
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%),,,,,,,,
LSWNEDEDWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNLVLDAR,Candidatus Methanoliparum thermophilum,Archaea,,,,Euryarchaeota,,,Candidatus Methanoliparia,,,,Candidatus Methanoliparales,,,,,Candidatus Methanoliparaceae,,,,Candidatus Methanoliparum,,,,Candidatus Methanoliparum thermophilum,,,,,,,,,,,,IPR002938 (100%);IPR036188 (100%),FAD-binding domain (100%);FAD/NAD(P)-binding domain superfamily (100%),,,,,,,,,,,
YAVNDLFER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVLVFYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WAAYDDDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QSVEPVLENALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EELLPQLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (100%),Polyphosphate kinase (100%),GO:0016021 (2%);GO:0009358 (1%),integral component of membrane (2%);polyphosphate kinase complex (1%),GO:0036459 (92%);GO:0004197 (2%);GO:0004843 (2%),thiol-dependent ubiquitinyl hydrolase activity (92%);cysteine-type endopeptidase activity (2%);thiol-dependent ubiquitin-specific protease activity (2%),GO:0006511 (94%);GO:0016579 (94%);GO:0006799 (1%),ubiquitin-dependent protein catabolic process (94%);protein deubiquitination (94%);polyphosphate biosynthetic process (1%),IPR001394 (92%);IPR018200 (92%);IPR028889 (92%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (92%);Ubiquitin specific protease, conserved site (92%);Ubiquitin specific protease domain (92%),,,,,,,,,
LDWPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.52 (17%);2.1.1.- (17%);6.1.1.4 (9%),Phosphoserine transaminase (17%);Methyltransferases (17%);Leucine--tRNA ligase (9%),GO:0016021 (42%);GO:0005737 (10%);GO:0005886 (2%),integral component of membrane (42%);cytoplasm (10%);plasma membrane (2%),GO:0005524 (16%);GO:0016740 (13%);GO:0004648 (5%),ATP binding (16%);transferase activity (13%);O-phospho-L-serine:2-oxoglutarate aminotransferase activity (5%),GO:0006564 (5%);GO:0032259 (4%);GO:0005975 (2%),L-serine biosynthetic process (5%);methylation (4%);carbohydrate metabolic process (2%),IPR029044 (13%);IPR001173 (11%);IPR003458 (8%),Nucleotide-diphospho-sugar transferases (13%);Glycosyltransferase 2-like (11%);Bacteriophage T4, Gp38, tail fibre assembly (8%),,,,,,,,,
WVVLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.5 (81%);2.3.1.30 (6%);2.7.11.1 (6%),Apyrase (81%);Serine O-acetyltransferase (6%);Non-specific serine/threonine protein kinase (6%),GO:0016021 (79%);GO:0005886 (10%);GO:0005737 (3%),integral component of membrane (79%);plasma membrane (10%);cytoplasm (3%),GO:0005509 (32%);GO:0017110 (32%);GO:0102485 (21%),calcium ion binding (32%);nucleoside-diphosphatase activity (32%);dATP phosphohydrolase activity (21%),GO:0055085 (10%);GO:0000160 (2%);GO:0006355 (2%),transmembrane transport (10%);phosphorelay signal transduction system (2%);regulation of transcription, DNA-templated (2%),IPR009283 (23%);IPR036258 (23%);IPR001036 (15%),Apyrase (23%);Apyrase superfamily (23%);Acriflavin resistance protein (15%),,,,,,,,,,
NWDTLYFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LENVVTGR,Steinernema carpocapsae,Eukaryota,Metazoa,,,Nematoda,,,Chromadorea,,,,Rhabditida,Tylenchina,Panagrolaimomorpha,,Strongyloidoidea,Steinernematidae,,,,Steinernema,,,,Steinernema carpocapsae,,,,,,,,GO:0003676 (100%),nucleic acid binding (100%),GO:0031047 (100%),gene silencing by RNA (100%),IPR003100 (100%);IPR003165 (100%);IPR012337 (100%),PAZ domain (100%);Piwi domain (100%);Ribonuclease H-like superfamily (100%),,,,,,,,,,,
VEDEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.4 (47%);1.18.6.1 (6%);2.7.13.3 (6%),Asparagine synthase (glutamine-hydrolyzing) (47%);Nitrogenase (6%);Histidine kinase (6%),GO:0016021 (31%);GO:0016593 (11%);GO:0005576 (6%),integral component of membrane (31%);Cdc73/Paf1 complex (11%);extracellular region (6%),GO:0005524 (17%);GO:0004066 (10%);GO:0003723 (7%),ATP binding (17%);asparagine synthase (glutamine-hydrolyzing) activity (10%);RNA binding (7%),GO:0006368 (11%);GO:0016570 (11%);GO:0006529 (9%),transcription elongation from RNA polymerase II promoter (11%);histone modification (11%);asparagine biosynthetic process (9%),IPR032041 (11%);IPR007852 (10%);IPR014729 (10%),Paf1 complex subunit Cdc73, N-terminal domain (11%);Cdc73/Parafibromin (10%);Rossmann-like alpha/beta/alpha sandwich fold (10%),,,,,,,,,,
LANESAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (24%),integral component of membrane (24%),GO:0046556 (33%);GO:0016491 (19%);GO:0016747 (14%),alpha-L-arabinofuranosidase activity (33%);oxidoreductase activity (19%);transferase activity, transferring acyl groups other than amino-acyl groups (14%),GO:0046373 (33%);GO:0006013 (5%);GO:0006281 (5%),L-arabinose metabolic process (33%);mannose metabolic process (5%);DNA repair (5%),IPR010720 (26%);IPR013780 (26%);IPR017853 (26%),Alpha-L-arabinofuranosidase, C-terminal (26%);Glycosyl hydrolase, all-beta (26%);Glycoside hydrolase superfamily (26%),,,,,,,,
EALMMVNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELVVPEFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTQNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.18 (38%);3.1.21.3 (20%);3.4.11.- (8%),5-(carboxyamino)imidazole ribonucleotide synthase (38%);Type I site-specific deoxyribonuclease (20%);Aminopeptidases (8%),GO:0016021 (21%);GO:0019028 (16%);GO:0042025 (15%),integral component of membrane (21%);viral capsid (16%);host cell nucleus (15%),GO:0005524 (27%);GO:0003677 (26%);GO:0008270 (19%),ATP binding (27%);DNA binding (26%);zinc ion binding (19%),GO:0006351 (16%);GO:0006268 (15%);GO:0039687 (15%),transcription, DNA-templated (16%);DNA unwinding involved in DNA replication (15%);viral DNA strand displacement replication (15%),IPR027417 (24%);IPR003176 (11%);IPR005376 (11%),P-loop containing nucleoside triphosphate hydrolase (24%);Adenovirus DNA-binding, all-alpha domain (11%);Adenovirus DNA-binding, zinc-binding domain (11%),,,,,,,,
YNVGTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.45 (50%);2.7.1.92 (50%),2-dehydro-3-deoxygluconokinase (50%);5-dehydro-2-deoxygluconokinase (50%),GO:0016021 (5%);GO:0043190 (4%);GO:0000127 (1%),integral component of membrane (5%);ATP-binding cassette (ABC) transporter complex (4%);transcription factor TFIIIC complex (1%),GO:0016301 (76%);GO:0008673 (4%);GO:0022857 (4%),kinase activity (76%);2-dehydro-3-deoxygluconokinase activity (4%);transmembrane transporter activity (4%),GO:0071705 (4%);GO:0000271 (1%);GO:0005975 (1%),nitrogen compound transport (4%);polysaccharide biosynthetic process (1%);carbohydrate metabolic process (1%),IPR011611 (69%);IPR029056 (69%);IPR001638 (5%),Carbohydrate kinase PfkB (69%);Ribokinase-like (69%);Solute-binding protein  family 3/N-terminal domain of MltF (5%),,,,,,,,,,,
LLDVALLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (29%);GO:0005634 (14%),integral component of membrane (29%);nucleus (14%),GO:0003824 (29%);GO:0031177 (29%);GO:0003677 (14%),catalytic activity (29%);phosphopantetheine binding (29%);DNA binding (14%),GO:0006351 (14%);GO:0009966 (14%),transcription, DNA-templated (14%);regulation of signal transduction (14%),IPR000873 (22%);IPR009081 (22%);IPR013120 (22%),AMP-dependent synthetase/ligase (22%);Phosphopantetheine binding ACP domain (22%);Male sterility, NAD-binding (22%),,,,,,,,,
VTVLEGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008080 (100%),N-acetyltransferase activity (100%),,,IPR008964 (67%);IPR000182 (17%);IPR016181 (17%),Invasin/intimin cell-adhesion fragments (67%);GNAT domain (17%);Acyl-CoA N-acyltransferase (17%),,,,,,,,,,,
LLPGELAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000786 (43%);GO:0005634 (43%),nucleosome (43%);nucleus (43%),GO:0003677 (43%);GO:0046982 (43%);GO:0003824 (29%),DNA binding (43%);protein heterodimerization activity (43%);catalytic activity (29%),,,IPR028081 (83%);IPR028082 (83%);IPR000558 (6%),Leucine-binding protein domain (83%);Periplasmic binding protein-like I (83%);Histone H2B (6%),,,,,,,,,,,
EETLYQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
LDSYLNPEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEELLAWNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLALAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (28%);3.5.2.3 (12%);6.1.1.19 (9%),3-methyl-2-oxobutanoate hydroxymethyltransferase (28%);Dihydroorotase (12%);Arginine--tRNA ligase (9%),GO:0016021 (23%);GO:0005737 (20%);GO:0005634 (2%),integral component of membrane (23%);cytoplasm (20%);nucleus (2%),GO:0046872 (17%);GO:0005524 (13%);GO:0008168 (10%),metal ion binding (17%);ATP binding (13%);methyltransferase activity (10%),GO:0032259 (12%);GO:0015940 (10%);GO:0044205 (4%),methylation (12%);pantothenate biosynthetic process (10%);'de novo' UMP biosynthetic process (4%),IPR015813 (9%);IPR040442 (9%);IPR003700 (8%),Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (9%);Pyruvate kinase-like domain superfamily (9%);Ketopantoate hydroxymethyltransferase (8%),,,,,,,,,,,
CAMAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.74 (20%);2.5.1.72 (20%);3.1.3.15 (20%),Methylenetetrahydrofolate--tRNA-(uracil(54)-C(5))-methyltransferas(NAD(P)H-oxidizing) (20%);Quinolinate synthase (20%);Histidinol-phosphatase (20%),GO:0016021 (37%);GO:0005634 (19%);GO:0005737 (7%),integral component of membrane (37%);nucleus (19%);cytoplasm (7%),GO:0003677 (19%);GO:0008270 (15%);GO:0051539 (15%),DNA binding (19%);zinc ion binding (15%);4 iron, 4 sulfur cluster binding (15%),GO:0006351 (15%);GO:0009435 (11%);GO:0000105 (4%),transcription, DNA-templated (15%);NAD biosynthetic process (11%);histidine biosynthetic process (4%),IPR002687 (22%);IPR012976 (22%);IPR029012 (22%),Nop domain (22%);NOSIC (22%);Helix hairpin bin domain superfamily (22%),,,,,,,,,
WNQQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLYNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.4.12 (16%);5.6.2.2 (14%);2.7.7.7 (11%),Peptide-methionine (R)-S-oxide reductase (16%);DNA topoisomerase (ATP-hydrolyzing) (14%);DNA-directed DNA polymerase (11%),GO:0016021 (33%);GO:0005886 (7%);GO:0005737 (5%),integral component of membrane (33%);plasma membrane (7%);cytoplasm (5%),GO:0005524 (16%);GO:0016887 (7%);GO:0003677 (6%),ATP binding (16%);ATPase activity (7%);DNA binding (6%),GO:0055085 (7%);GO:0005975 (4%);GO:0001510 (2%),transmembrane transport (7%);carbohydrate metabolic process (4%);RNA methylation (2%),IPR027417 (13%);IPR000515 (6%);IPR035906 (6%),P-loop containing nucleoside triphosphate hydrolase (13%);ABC transporter type 1, transmembrane domain MetI-like (6%);MetI-like superfamily (6%),,,,,,,,,,
YNQATNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENELLAEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.11 (100%),Cellobiose epimerase (100%),GO:0016021 (33%);GO:0005737 (17%);GO:0030915 (17%),integral component of membrane (33%);cytoplasm (17%);Smc5-Smc6 complex (17%),GO:0047736 (33%);GO:0000155 (17%),cellobiose epimerase activity (33%);phosphorelay sensor kinase activity (17%),GO:0000724 (17%);GO:0000917 (17%);GO:0007062 (17%),double-strand break repair via homologous recombination (17%);division septum assembly (17%);sister chromatid cohesion (17%),IPR008928 (33%);IPR011990 (33%);IPR012341 (33%),Six-hairpin glycosidase superfamily (33%);Tetratricopeptide-like helical domain superfamily (33%);Six-hairpin glycosidase-like superfamily (33%),,,,,,,,,,,
NNFFFGK,Rosa chinensis,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Rosales,,,,,Rosaceae,Rosoideae,,,Rosa,,,,Rosa chinensis,,,,2.7.11.1 (100%),Non-specific serine/threonine protein kinase (100%),GO:0016021 (100%),integral component of membrane (100%),GO:0004674 (100%),protein serine/threonine kinase activity (100%),,,IPR001611 (100%);IPR003591 (100%);IPR013210 (100%),Leucine-rich repeat (100%);Leucine-rich repeat, typical subtype (100%);Leucine-rich repeat-containing N-terminal, plant-type (100%),,,,,,,,,
CLHVDER,Anaerobacillus isosaccharinicus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Bacillaceae,,,,Anaerobacillus,,,,Anaerobacillus isosaccharinicus,,,,,,,,,,GO:0006281 (100%);GO:0006310 (100%),DNA repair (100%);DNA recombination (100%),IPR003717 (100%);IPR012340 (100%);IPR022572 (100%),Recombination protein O, RecO (100%);Nucleic acid-binding, OB-fold (100%);DNA replication/recombination mediator RecO, N-terminal (100%),,,,,,,,
ECQSTELR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPFGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.9 (31%);4.3.2.2 (11%);6.1.1.4 (9%),Nucleotide diphosphatase (31%);Adenylosuccinate lyase (11%);Leucine--tRNA ligase (9%),GO:0016021 (25%);GO:0005737 (12%);GO:0005634 (11%),integral component of membrane (25%);cytoplasm (12%);nucleus (11%),GO:0005524 (9%);GO:0047429 (9%);GO:0035529 (8%),ATP binding (9%);nucleoside-triphosphate diphosphatase activity (9%);NADH pyrophosphatase activity (8%),GO:0009117 (9%);GO:0051301 (3%);GO:0006310 (3%),nucleotide metabolic process (9%);cell division (3%);DNA recombination (3%),IPR026306 (8%);IPR011944 (7%);IPR027843 (7%),RSBN1/Dpy-21 (8%);Steroid delta5-4-isomerase (7%);Domain of unknown function DUF4440 (7%),,,,,,,,,,,
WGNVLVFWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTEDELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.33 (19%);4.1.2.19 (18%);5.2.1.8 (9%),Pantothenate kinase (19%);Rhamnulose-1-phosphate aldolase (18%);Peptidylprolyl isomerase (9%),GO:0016021 (17%);GO:0005737 (12%);GO:0005886 (2%),integral component of membrane (17%);cytoplasm (12%);plasma membrane (2%),GO:0050660 (16%);GO:0005506 (15%);GO:0010181 (15%),flavin adenine dinucleotide binding (16%);iron ion binding (15%);FMN binding (15%),GO:0006537 (15%);GO:0015937 (4%);GO:0019301 (3%),glutamate biosynthetic process (15%);coenzyme A biosynthetic process (4%);rhamnose catabolic process (3%),IPR036188 (13%);IPR013785 (13%);IPR002489 (13%),FAD/NAD(P)-binding domain superfamily (13%);Aldolase-type TIM barrel (13%);Glutamate synthase, alpha subunit, C-terminal (13%),,,,,,,,,
LGNFELPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTNLEETR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (100%);IPR012910 (100%);IPR023996 (100%),TonB-dependent receptor-like, beta-barrel (100%);TonB-dependent receptor, plug domain (100%);TonB-dependent outer membrane protein, SusC/RagA (100%),,,,,,,,
FNHMTVSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDEGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.3 (29%);5.4.99.- (7%);1.3.99.- (7%),Protein-synthesizing GTPase (29%);Transferring other groups (7%);With other acceptors (7%),GO:0005737 (34%);GO:0016021 (4%);GO:0043190 (1%),cytoplasm (34%);integral component of membrane (4%);ATP-binding cassette (ABC) transporter complex (1%),GO:0003746 (56%);GO:0005525 (51%);GO:0003924 (43%),translation elongation factor activity (56%);GTP binding (51%);GTPase activity (43%),GO:0009058 (2%);GO:0006355 (1%);GO:0055085 (1%),biosynthetic process (2%);regulation of transcription, DNA-templated (1%);transmembrane transport (1%),IPR009000 (53%);IPR004161 (51%);IPR033720 (50%),Translation protein, beta-barrel domain superfamily (53%);Translation elongation factor EFTu-like, domain 2 (51%);Elongation factor Tu, domain 2 (50%),,,,,,,
MLEEYSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPATLSNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.6 (8%);3.1.4.- (8%);2.7.1.90 (7%),Acetolactate synthase (8%);Phosphoric diester hydrolases (8%);Diphosphate--fructose-6-phosphate 1-phosphotransferase (7%),GO:0016021 (26%);GO:0005737 (4%);GO:0005637 (3%),integral component of membrane (26%);cytoplasm (4%);nuclear inner membrane (3%),GO:0003677 (22%);GO:0046872 (14%);GO:0005524 (11%),DNA binding (22%);metal ion binding (14%);ATP binding (11%),GO:0006284 (8%);GO:0006310 (4%);GO:0015074 (4%),base-excision repair (8%);DNA recombination (4%);DNA integration (4%),IPR027417 (10%);IPR036388 (8%);IPR011257 (7%),P-loop containing nucleoside triphosphate hydrolase (10%);Winged helix-like DNA-binding domain superfamily (8%);DNA glycosylase (7%),,,,,,,,,,,
TVEDETR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (60%);3.1.-.- (20%);6.1.1.1 (20%),DNA-directed DNA polymerase (60%);Acting on ester bonds (20%);Tyrosine--tRNA ligase (20%),GO:0005737 (57%);GO:0005886 (14%),cytoplasm (57%);plasma membrane (14%),GO:0003676 (43%);GO:0003887 (43%);GO:0008408 (43%),nucleic acid binding (43%);DNA-directed DNA polymerase activity (43%);3'-5' exonuclease activity (43%),GO:0006260 (43%);GO:0006402 (14%);GO:0006437 (14%),DNA replication (43%);mRNA catabolic process (14%);tyrosyl-tRNA aminoacylation (14%),IPR003141 (43%);IPR004013 (43%);IPR004365 (43%),Polymerase/histidinol phosphatase, N-terminal (43%);PHP domain (43%);OB-fold nucleic acid binding domain, AA-tRNA synthetase-type (43%),,,,,,,,,
VYVYPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (67%);6.3.5.3 (25%);3.6.4.12 (8%),Exoribonuclease II (67%);Phosphoribosylformylglycinamidine synthase (25%);DNA helicase (8%),GO:0005737 (50%);GO:0016021 (18%),cytoplasm (50%);integral component of membrane (18%),GO:0003723 (36%);GO:0008859 (36%);GO:0005524 (18%),RNA binding (36%);exoribonuclease II activity (36%);ATP binding (18%),GO:0006189 (14%);GO:0006383 (9%),'de novo' IMP biosynthetic process (14%);transcription by RNA polymerase III (9%),IPR001900 (29%);IPR003029 (29%);IPR011805 (29%),Ribonuclease II/R (29%);S1 domain (29%);Ribonuclease R (29%),,,,,,,,,,,
AWDLEGK,Chloroflexi bacterium,Bacteria,,,,Chloroflexi,,,,,,,,,,,,,,,,,,,,Chloroflexi bacterium,,,,,,,,GO:0016740 (100%),transferase activity (100%),,,IPR001296 (100%);IPR024004 (100%);IPR028098 (100%),Glycosyl transferase, family 1 (100%);Glycosyltransferase family 1, Daro2409 family (100%);Glycosyltransferase subfamily 4-like, N-terminal domain (100%),,,,,,,,
YYLAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (50%);2.1.2.10 (17%);3.1.11.- (17%),DNA-directed RNA polymerase (50%);Aminomethyltransferase (17%);Exodeoxyribonucleases producing 5'-phosphomonoesters (17%),GO:0005634 (84%);GO:0043626 (11%);GO:0000785 (9%),nucleus (84%);PCNA complex (11%);chromatin (9%),GO:0030337 (92%);GO:0003677 (89%);GO:0003682 (9%),DNA polymerase processivity factor activity (92%);DNA binding (89%);chromatin binding (9%),GO:0006275 (85%);GO:0006260 (81%);GO:0019985 (11%),regulation of DNA replication (85%);DNA replication (81%);translesion synthesis (11%),IPR000730 (96%);IPR022649 (96%);IPR022648 (91%),Proliferating cell nuclear antigen, PCNA (96%);Proliferating cell nuclear antigen, PCNA, C-terminal (96%);Proliferating cell nuclear antigen, PCNA, N-terminal (91%),,,,,,
VLFWDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.6 (100%),Lysine--tRNA ligase (100%),GO:0005737 (40%);GO:0016021 (40%);GO:0005634 (20%),cytoplasm (40%);integral component of membrane (40%);nucleus (20%),GO:0000287 (40%);GO:0003676 (40%);GO:0004824 (40%),magnesium ion binding (40%);nucleic acid binding (40%);lysine-tRNA ligase activity (40%),GO:0006430 (40%),lysyl-tRNA aminoacylation (40%),IPR001680 (50%);IPR002313 (50%);IPR004364 (50%),WD40 repeat (50%);Lysine-tRNA ligase, class II (50%);Aminoacyl-tRNA synthetase, class II (D/K/N) (50%),,,,,,,,,
VAYSEHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLNQLLELR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (40%),integral component of membrane (40%),GO:0000155 (100%);GO:0003700 (90%);GO:0043565 (90%),phosphorelay sensor kinase activity (100%);DNA-binding transcription factor activity (90%);sequence-specific DNA binding (90%),,,IPR003594 (100%);IPR003661 (100%);IPR005467 (100%),Histidine kinase/HSP90-like ATPase (100%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (100%);Histidine kinase domain (100%),,,,,,,,,,
YLAEDDAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAPVDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (21%);1.3.99.- (8%);1.8.98.1 (8%),3-isopropylmalate dehydratase (21%);With other acceptors (8%);Dihydromethanophenazine:CoB--CoM heterodisulfide reductase (8%),GO:0016021 (21%);GO:0009316 (5%);GO:0005737 (4%),integral component of membrane (21%);3-isopropylmalate dehydratase complex (5%);cytoplasm (4%),GO:0046872 (17%);GO:0003677 (10%);GO:0016491 (8%),metal ion binding (17%);DNA binding (10%);oxidoreductase activity (8%),GO:0006355 (7%);GO:0000160 (6%);GO:0009098 (5%),regulation of transcription, DNA-templated (7%);phosphorelay signal transduction system (6%);leucine biosynthetic process (5%),IPR006311 (12%);IPR027417 (7%);IPR029058 (7%),Twin-arginine translocation pathway, signal sequence (12%);P-loop containing nucleoside triphosphate hydrolase (7%);Alpha/Beta hydrolase fold (7%),,,,,,,,,
VLWAYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (50%);2.4.1.- (50%),Transferring groups other than amino-acyl groups (50%);Hexosyltransferases (50%),GO:0016021 (45%);GO:0005730 (3%);GO:0005886 (3%),integral component of membrane (45%);nucleolus (3%);plasma membrane (3%),GO:0003980 (27%);GO:0008108 (12%);GO:0008270 (12%),UDP-glucose:glycoprotein glucosyltransferase activity (27%);UDP-glucose:hexose-1-phosphate uridylyltransferase activity (12%);zinc ion binding (12%),GO:0006486 (27%);GO:0033499 (12%);GO:0000154 (3%),protein glycosylation (27%);galactose catabolic process via UDP-galactose (12%);rRNA modification (3%),IPR009448 (37%);IPR029044 (37%);IPR040497 (37%),UDP-glucose:Glycoprotein Glucosyltransferase (37%);Nucleotide-diphospho-sugar transferases (37%);Glucosyltransferase 24, catalytic domain (37%),,,,,,,,,,
FLNLFWK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR007387 (50%);IPR011990 (50%);IPR013026 (50%),TRAP transporter, small membrane protein DctQ (50%);Tetratricopeptide-like helical domain superfamily (50%);Tetratricopeptide repeat-containing domain (50%),,,,,,,,,,
LFLPGTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.-.-.- (100%),Lyases (100%),GO:0016021 (25%);GO:0016020 (13%),integral component of membrane (25%);membrane (13%),GO:0003676 (13%);GO:0008270 (13%);GO:0016787 (13%),nucleic acid binding (13%);zinc ion binding (13%);hydrolase activity (13%),GO:0008616 (13%);GO:0015074 (13%),queuosine biosynthetic process (13%);DNA integration (13%),IPR026875 (22%);IPR000433 (11%);IPR001584 (11%),Phosphohydrolase-associated domain (22%);Zinc finger, ZZ-type (11%);Integrase, catalytic core (11%),,,,,,,,,
MPLVMYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASNLVDLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEMPLLAEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNEAYEGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDLEPTVVDEVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENAFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (50%);3.6.5.0 (50%),Molybdopterin molybdotransferase (50%); (50%),GO:0016021 (29%);GO:0005694 (5%);GO:0005737 (5%),integral component of membrane (29%);chromosome (5%);cytoplasm (5%),GO:0003676 (14%);GO:0005524 (14%);GO:0046872 (14%),nucleic acid binding (14%);ATP binding (14%);metal ion binding (14%),GO:0006355 (10%);GO:0006260 (5%);GO:0006310 (5%),regulation of transcription, DNA-templated (10%);DNA replication (5%);DNA recombination (5%),IPR011990 (28%);IPR027417 (19%);IPR013026 (17%),Tetratricopeptide-like helical domain superfamily (28%);P-loop containing nucleoside triphosphate hydrolase (19%);Tetratricopeptide repeat-containing domain (17%),,,,,,,,,,
EVSETTFGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAVQTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (43%);GO:0005743 (14%),integral component of membrane (43%);mitochondrial inner membrane (14%),GO:0016301 (29%);GO:0004129 (14%),kinase activity (29%);cytochrome-c oxidase activity (14%),GO:0051301 (43%);GO:0051988 (43%),cell division (43%);regulation of attachment of spindle microtubules to kinetochore (43%),IPR004147 (30%);IPR011009 (30%);IPR028728 (30%),UbiB domain (30%);Protein kinase-like domain superfamily (30%);Sperm-associated antigen 5 (30%),,,,,,,,,,,
VEPVLLGEFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVEPTEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.166 (100%),3-deoxy-D-manno-octulosonic acid kinase (100%),GO:0005737 (25%);GO:0016021 (25%);GO:0005615 (8%),cytoplasm (25%);integral component of membrane (25%);extracellular space (8%),GO:0003676 (25%);GO:0003924 (25%);GO:0005525 (25%),nucleic acid binding (25%);GTPase activity (25%);GTP binding (25%),GO:0006449 (25%);GO:0015074 (17%);GO:0000463 (8%),regulation of translational termination (25%);DNA integration (17%);maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (8%),IPR027417 (22%);IPR000477 (17%);IPR000795 (17%),P-loop containing nucleoside triphosphate hydrolase (22%);Reverse transcriptase domain (17%);Transcription factor, GTP-binding domain (17%),,,,,,,,
TATGTHENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAAANRPR,Rachicladosporium antarcticum,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Dothideomycetes,Dothideomycetidae,,,Capnodiales,,,,,Cladosporiaceae,,,,Rachicladosporium,,,,Rachicladosporium antarcticum,,,,,,,,GO:0003677 (100%),DNA binding (100%),,,IPR009057 (100%),Homeobox-like domain superfamily (100%),,,,,,,,,,,
SSDLDDAEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVDELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.9 (22%);3.4.25.1 (20%);1.1.1.22 (15%),N-acylglucosamine-6-phosphate 2-epimerase (22%);Proteasome endopeptidase complex (20%);UDP-glucose 6-dehydrogenase (15%),GO:0016021 (31%);GO:0005643 (21%);GO:0009507 (8%),integral component of membrane (31%);nuclear pore (21%);chloroplast (8%),GO:0005524 (10%);GO:0005509 (10%);GO:0051287 (6%),ATP binding (10%);calcium ion binding (10%);NAD binding (6%),GO:0009658 (12%);GO:0010239 (12%);GO:0048366 (7%),chloroplast organization (12%);chloroplast mRNA processing (12%);leaf development (7%),IPR021827 (20%);IPR034563 (11%);IPR011992 (9%),Nucleoporin Nup186/Nup192/Nup205 (20%);Protein PALE CRESS (11%);EF-hand domain pair (9%),,,,,,,,,,,
LMNDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.144 (38%);2.7.13.3 (8%);3.6.3.- (6%),Tagatose-6-phosphate kinase (38%);Histidine kinase (8%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (6%),GO:0016021 (29%);GO:0005737 (4%);GO:0005886 (2%),integral component of membrane (29%);cytoplasm (4%);plasma membrane (2%),GO:0005524 (31%);GO:0016887 (16%);GO:0016787 (14%),ATP binding (31%);ATPase activity (16%);hydrolase activity (14%),GO:0015833 (14%);GO:0005988 (6%);GO:2001059 (6%),peptide transport (14%);lactose metabolic process (6%);D-tagatose 6-phosphate catabolic process (6%),IPR027417 (23%);IPR003593 (17%);IPR003439 (17%),P-loop containing nucleoside triphosphate hydrolase (23%);AAA+ ATPase domain (17%);ABC transporter-like (17%),,,,,,,,,,,
QSNYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (40%);3.2.1.- (20%);3.4.24.- (20%),RNA helicase (40%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (20%);Metalloendopeptidases (20%),GO:0016021 (14%);GO:0005737 (6%);GO:0000786 (3%),integral component of membrane (14%);cytoplasm (6%);nucleosome (3%),GO:0005524 (31%);GO:0003924 (26%);GO:0005525 (26%),ATP binding (31%);GTPase activity (26%);GTP binding (26%),GO:0007249 (20%);GO:0006401 (6%);GO:0007165 (6%),I-kappaB kinase/NF-kappaB signaling (20%);RNA catabolic process (6%);signal transduction (6%),IPR027417 (30%);IPR001806 (23%);IPR040976 (18%),P-loop containing nucleoside triphosphate hydrolase (30%);Small GTPase (23%);Fungal-type protein kinase (18%),,,,,,,,,,
LGNFVYM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVPVVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0062023 (100%),collagen-containing extracellular matrix (100%),,,GO:0007601 (100%);GO:0030199 (100%);GO:0048596 (80%),visual perception (100%);collagen fibril organization (100%);embryonic camera-type eye morphogenesis (80%),IPR008962 (55%);IPR013783 (55%);IPR000372 (45%),PapD-like superfamily (55%);Immunoglobulin-like fold (55%);Leucine-rich repeat N-terminal domain (45%),,,,,,,,,,,
EAALVLTK,Geminocystis,Bacteria,,,,Cyanobacteria,,,,Oscillatoriophycideae,,,Chroococcales,,,,,Chroococcaceae,,,,Geminocystis,,,,,,,,,,,,,,,,IPR011990 (100%);IPR039904 (100%),Tetratricopeptide-like helical domain superfamily (100%);TPR and ankyrin repeat-containing protein 1 (100%),,,,,,,,,,,
LANAVEVTGPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEVEEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.2 (100%),GMP synthase (glutamine-hydrolyzing) (100%),GO:0016021 (17%);GO:0000938 (13%);GO:0005829 (13%),integral component of membrane (17%);GARP complex (13%);cytosol (13%),GO:0005524 (30%);GO:0003922 (22%);GO:0016462 (22%),ATP binding (30%);GMP synthase (glutamine-hydrolyzing) activity (22%);pyrophosphatase activity (22%),GO:0006541 (22%);GO:0042147 (13%);GO:0006313 (9%),glutamine metabolic process (22%);retrograde transport, endosome to Golgi (13%);transposition, DNA-mediated (9%),IPR001674 (22%);IPR004739 (22%);IPR014729 (22%),GMP synthase, C-terminal (22%);GMP synthase, glutamine amidotransferase (22%);Rossmann-like alpha/beta/alpha sandwich fold (22%),,,,,,,
FESLVER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.297 (25%);2.6.99.2 (25%);2.7.13.3 (25%),Peptide chain release factor N(5)-glutamine methyltransferase (25%);Pyridoxine 5'-phosphate synthase (25%);Histidine kinase (25%),GO:0016021 (50%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (50%);cytoplasm (6%);plasma membrane (3%),GO:0022857 (26%);GO:0003824 (18%);GO:0016787 (6%),transmembrane transporter activity (26%);catalytic activity (18%);hydrolase activity (6%),GO:0000105 (3%);GO:0006400 (3%);GO:0006468 (3%),histidine biosynthetic process (3%);tRNA modification (3%);protein phosphorylation (3%),IPR001036 (26%);IPR027463 (26%);IPR000873 (11%),Acriflavin resistance protein (26%);Multidrug efflux transporter AcrB TolC docking domain, DN/DC subdomains (26%);AMP-dependent synthetase/ligase (11%),,,,,,,,,,
ENATYNR,Pseudomonas phage PaBG,Viruses,,,,,,,,,,,Caudovirales,,,,,Myoviridae,,,,,,,,Pseudomonas phage PaBG,,,,,,,,,,,,,,,,,,,,,,,,
LENLTDYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVFLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.113 (27%);3.1.3.6 (23%);3.1.4.16 (21%),o-succinylbenzoate synthase (27%);3'-nucleotidase (23%);2',3'-cyclic-nucleotide 2'-phosphodiesterase (21%),GO:0016021 (44%);GO:0005886 (7%);GO:0005737 (2%),integral component of membrane (44%);plasma membrane (7%);cytoplasm (2%),GO:0005524 (26%);GO:0004672 (15%);GO:0046872 (8%),ATP binding (26%);protein kinase activity (15%);metal ion binding (8%),GO:0009166 (7%);GO:0055085 (6%);GO:0009234 (5%),nucleotide catabolic process (7%);transmembrane transport (6%);menaquinone biosynthetic process (5%),IPR002549 (17%);IPR000719 (17%);IPR011009 (17%),Transmembrane protein TqsA-like (17%);Protein kinase domain (17%);Protein kinase-like domain superfamily (17%),,,,,,,,,,
STVDVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR021484 (60%);IPR011990 (20%);IPR013026 (20%),Protein of unknown function DUF3137 (60%);Tetratricopeptide-like helical domain superfamily (20%);Tetratricopeptide repeat-containing domain (20%),,,,,,,,,,,
VLDQWVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005763 (25%),integral component of membrane (50%);mitochondrial small ribosomal subunit (25%),GO:0000155 (50%);GO:0003735 (25%);GO:0004222 (25%),phosphorelay sensor kinase activity (50%);structural constituent of ribosome (25%);metalloendopeptidase activity (25%),,,IPR001789 (50%);IPR003594 (50%);IPR003661 (50%),Signal transduction response regulator, receiver domain (50%);Histidine kinase/HSP90-like ATPase (50%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (50%),,,,,,,,,
MKPVPTK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016788 (100%),hydrolase activity, acting on ester bonds (100%),,,IPR012908 (33%);IPR018392 (33%);IPR021953 (33%),GPI inositol-deacylase PGAP1-like (33%);LysM domain (33%);Protein of unknown function DUF3570 (33%),,,,,,,,,,
VSLVTVSK,Acipenser ruthenus,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Chondrostei,,,Acipenseriformes,Acipenseroidei,,,,Acipenseridae,Acipenserinae,Acipenserini,,Acipenser,,,,Acipenser ruthenus,,,,,,,,,,,,IPR023412 (100%);IPR036816 (100%),Ribonuclease A-domain (100%);Ribonuclease A-like domain superfamily (100%),,,,,,,,,,,
LELDVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.25 (28%);2.7.7.6 (24%);3.1.6.1 (6%),Inositol-phosphate phosphatase (28%);DNA-directed RNA polymerase (24%);Arylsulfatase (type I) (6%),GO:0016021 (15%);GO:0005737 (4%);GO:0009507 (4%),integral component of membrane (15%);cytoplasm (4%);chloroplast (4%),GO:0003677 (15%);GO:0046872 (9%);GO:0005524 (8%),DNA binding (15%);metal ion binding (9%);ATP binding (8%),GO:0046854 (6%);GO:0010468 (6%);GO:0046855 (5%),phosphatidylinositol phosphorylation (6%);regulation of gene expression (6%);inositol phosphate dephosphorylation (5%),IPR000917 (7%);IPR009003 (7%);IPR017850 (7%),Sulfatase, N-terminal (7%);Peptidase S1, PA clan (7%);Alkaline-phosphatase-like, core domain superfamily (7%),,,,,,,,
VDLFLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.65 (100%),Phosphatidylserine decarboxylase (100%),GO:0005615 (27%);GO:0005886 (27%);GO:0016021 (27%),extracellular space (27%);plasma membrane (27%);integral component of membrane (27%),GO:0004609 (27%);GO:0000155 (18%);GO:0005509 (9%),phosphatidylserine decarboxylase activity (27%);phosphorelay sensor kinase activity (18%);calcium ion binding (9%),GO:0006646 (27%);GO:0006281 (9%);GO:0006310 (9%),phosphatidylethanolamine biosynthetic process (27%);DNA repair (9%);DNA recombination (9%),IPR000215 (27%);IPR003817 (27%);IPR023795 (27%),Serpin family (27%);Phosphatidylserine decarboxylase-related (27%);Serpin, conserved site (27%),,,,,,,,,,
TTDESLETSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAATATYTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLFVSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (17%);2.7.13.3 (17%);2.7.7.7 (17%),Methyltransferases (17%);Histidine kinase (17%);DNA-directed DNA polymerase (17%),GO:0016021 (25%);GO:0005737 (8%);GO:0005634 (2%),integral component of membrane (25%);cytoplasm (8%);nucleus (2%),GO:0003677 (9%);GO:0003723 (8%);GO:0003824 (8%),DNA binding (9%);RNA binding (8%);catalytic activity (8%),GO:0032259 (4%);GO:0006352 (3%);GO:0006013 (2%),methylation (4%);DNA-templated transcription, initiation (3%);mannose metabolic process (2%),IPR008928 (5%);IPR011009 (5%);IPR027414 (5%),Six-hairpin glycosidase superfamily (5%);Protein kinase-like domain superfamily (5%);Glycosyl hydrolase family 95, N-terminal domain (5%),,,,,,,,,
TPLVNVLQQEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSLQFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (27%);5.1.3.3 (18%);6.3.4.19 (18%),Transferring groups other than amino-acyl groups (27%);Aldose 1-epimerase (18%);tRNA(Ile)-lysidine synthetase (18%),GO:0016021 (18%);GO:0009279 (5%);GO:0005737 (2%),integral component of membrane (18%);cell outer membrane (5%);cytoplasm (2%),GO:0051082 (34%);GO:0005524 (14%);GO:0030246 (12%),unfolded protein binding (34%);ATP binding (14%);carbohydrate binding (12%),GO:0006400 (2%);GO:0016051 (2%);GO:0031047 (2%),tRNA modification (2%);carbohydrate biosynthetic process (2%);gene silencing by RNA (2%),IPR005632 (34%);IPR024930 (34%);IPR001079 (10%),Chaperone protein Skp (34%);Skp domain superfamily (34%);Galectin, carbohydrate recognition domain (10%),,,,,,,,,,
ALQQQLENPLAQQLLSWLVPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLTDMVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WADSDDER,Archaea,Archaea,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (100%),Acting on ester bonds (100%),,,GO:0003677 (100%);GO:0004520 (100%);GO:0046872 (100%),DNA binding (100%);endodeoxyribonuclease activity (100%);metal ion binding (100%),GO:0043571 (100%);GO:0051607 (100%),maintenance of CRISPR repeat elements (100%);defense response to virus (100%),IPR002729 (100%);IPR019856 (100%);IPR042206 (100%),CRISPR-associated protein Cas1 (100%);CRISPR-associated protein Cas1, DVULG subtype (100%);CRISPR-associated endonuclease Cas1, C-terminal domain (100%),,,,,,,,,
MMAMVHQCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVMLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.17 (43%);2.1.1.185 (29%);2.7.7.48 (14%),Xylulokinase (43%);23S rRNA (guanosine(2251)-2'-O)-methyltransferase (29%);RNA-directed RNA polymerase (14%),GO:0016021 (29%);GO:0005737 (10%);GO:0032039 (3%),integral component of membrane (29%);cytoplasm (10%);integrator complex (3%),GO:0046872 (16%);GO:0016829 (13%);GO:0003723 (10%),metal ion binding (16%);lyase activity (13%);RNA binding (10%),GO:0006623 (19%);GO:0005997 (10%);GO:0042732 (10%),protein targeting to vacuole (19%);xylulose metabolic process (10%);D-xylose metabolic process (10%),IPR004353 (18%);IPR005000 (12%);IPR011206 (12%),Vacuolar fusion protein Mon1 (18%);HpcH/HpaI aldolase/citrate lyase domain (12%);Citrate lyase beta subunit-like (12%),,,,,,,,,,,
VMVGWAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLNLEDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.3.15 (17%);2.7.11.1 (17%);2.7.2.8 (17%),(S)-2-hydroxy-acid oxidase (17%);Non-specific serine/threonine protein kinase (17%);Acetylglutamate kinase (17%),GO:0016021 (20%);GO:0005737 (7%);GO:0009318 (3%),integral component of membrane (20%);cytoplasm (7%);exodeoxyribonuclease VII complex (3%),GO:0005524 (30%);GO:0003677 (17%);GO:0016887 (17%),ATP binding (30%);DNA binding (17%);ATPase activity (17%),GO:0005975 (7%);GO:0006355 (7%);GO:0008033 (7%),carbohydrate metabolic process (7%);regulation of transcription, DNA-templated (7%);tRNA processing (7%),IPR027417 (27%);IPR003439 (11%);IPR003593 (11%),P-loop containing nucleoside triphosphate hydrolase (27%);ABC transporter-like (11%);AAA+ ATPase domain (11%),,,,,,,,,,
EEELENER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000124 (100%);GO:0046695 (100%),SAGA complex (100%);SLIK (SAGA-like) complex (100%),GO:0016740 (100%);GO:0046982 (100%),transferase activity (100%);protein heterodimerization activity (100%),,,IPR001487 (50%);IPR006565 (50%);IPR009072 (50%),Bromodomain (50%);Bromodomain associated domain (50%);Histone-fold (50%),,,,,,,,,,,
TSLVVVDEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGLYEEDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYEESDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.99.2 (80%);7.5.2.7 (20%),Aminopyrimidine aminohydrolase (80%);ABC-type D-ribose transporter (20%),GO:0016021 (27%);GO:0005886 (5%),integral component of membrane (27%);plasma membrane (5%),GO:0050334 (18%);GO:0003677 (14%);GO:0005524 (14%),thiaminase activity (18%);DNA binding (14%);ATP binding (14%),GO:0005975 (23%);GO:0009228 (18%);GO:0009229 (18%),carbohydrate metabolic process (23%);thiamine biosynthetic process (18%);thiamine diphosphate biosynthetic process (18%),IPR001223 (27%);IPR017853 (27%);IPR004305 (18%),Glycoside hydrolase family 18, catalytic domain (27%);Glycoside hydrolase superfamily (27%);Thiaminase-2/PQQC (18%),,,,,,,,,,
WNFLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFAGVWR,Knoellia subterranea,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Micrococcales,,,,,Intrasporangiaceae,,,,Knoellia,,,,Knoellia subterranea,,,,,,,,GO:0003677 (100%),DNA binding (100%),GO:0000160 (100%);GO:0006355 (100%),phosphorelay signal transduction system (100%);regulation of transcription, DNA-templated (100%),IPR001867 (100%);IPR005158 (100%);IPR011990 (100%),OmpR/PhoB-type DNA-binding domain (100%);Bacterial transcriptional activator domain (100%);Tetratricopeptide-like helical domain superfamily (100%),,,,,,,,,,
YFDENGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.- (100%),Acting on acid anhydrides; catalyzing transmembrane movement of substances (100%),GO:0016021 (29%),integral component of membrane (29%),GO:0005524 (69%);GO:0016887 (63%);GO:0004672 (2%),ATP binding (69%);ATPase activity (63%);protein kinase activity (2%),GO:0015833 (63%),peptide transport (63%),IPR003439 (67%);IPR003593 (67%);IPR013563 (67%),ABC transporter-like (67%);AAA+ ATPase domain (67%);Oligopeptide/dipeptide ABC transporter, C-terminal (67%),,,,,,,,,,
FFNNWLEDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFDLAEAR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016787 (100%),ATP binding (100%);hydrolase activity (100%),,,IPR000407 (50%);IPR010683 (50%),Nucleoside phosphatase GDA1/CD39 (50%);Protein of unknown function DUF1262 (50%),,,,,,,,,,,
LMSTVER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.- (100%),Exoribonucleases producing 5'-phosphomonoesters (100%),GO:0005634 (50%),nucleus (50%),GO:0000150 (50%);GO:0003676 (50%);GO:0003677 (50%),recombinase activity (50%);nucleic acid binding (50%);DNA binding (50%),GO:0006397 (50%),mRNA processing (50%),IPR004859 (50%);IPR006119 (50%);IPR011109 (50%),Putative 5-3 exonuclease (50%);Resolvase, N-terminal catalytic domain (50%);DNA-binding recombinase domain (50%),,,,,,,,,,
VATVSVPR,Neognathae,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Aves,,Neognathae,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR015425 (100%);IPR042201 (100%),Formin, FH2 domain (100%);Formin, FH2 domain superfamily (100%),,,,,,,,,
LFVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (17%);3.2.1.26 (5%);4.2.1.2 (5%),Signal peptidase I (17%);Beta-fructofuranosidase (5%);Fumarate hydratase (5%),GO:0016021 (22%);GO:0005737 (6%);GO:0000276 (3%),integral component of membrane (22%);cytoplasm (6%);mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) (3%),GO:0003677 (21%);GO:0005524 (9%);GO:0008270 (8%),DNA binding (21%);ATP binding (9%);zinc ion binding (8%),GO:0045892 (11%);GO:0005975 (4%);GO:0015986 (2%),negative regulation of transcription, DNA-templated (11%);carbohydrate metabolic process (4%);ATP synthesis coupled proton transport (2%),IPR036388 (12%);IPR036390 (10%);IPR029016 (10%),Winged helix-like DNA-binding domain superfamily (12%);Winged helix DNA-binding domain superfamily (10%);GAF-like domain superfamily (10%),,,,,,,,,
VSVVTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (32%);2.7.2.4 (16%);1.1.1.41 (5%),L-aspartate oxidase (32%);Aspartate kinase (16%);Isocitrate dehydrogenase (NAD(+)) (5%),GO:0016021 (29%);GO:0005737 (8%);GO:0005886 (2%),integral component of membrane (29%);cytoplasm (8%);plasma membrane (2%),GO:0030246 (15%);GO:0003824 (13%);GO:0004559 (13%),carbohydrate binding (15%);catalytic activity (13%);alpha-mannosidase activity (13%),GO:0006013 (13%);GO:0009435 (5%);GO:0000160 (2%),mannose metabolic process (13%);NAD biosynthetic process (5%);phosphorelay signal transduction system (2%),IPR000602 (12%);IPR011013 (12%);IPR011330 (12%),Glycoside hydrolase family 38, N-terminal domain (12%);Galactose mutarotase-like domain superfamily (12%);Glycoside hydrolase/deacetylase, beta/alpha-barrel (12%),,,,,,,,,
VVQSVQPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVDELTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (29%);1.2.4.1 (14%);2.2.1.1 (14%),Acting on ATP; involved in cellular and subcellular movement (29%);Pyruvate dehydrogenase (acetyl-transferring) (14%);Transketolase (14%),GO:0016021 (22%);GO:0005737 (13%);GO:0030117 (6%),integral component of membrane (22%);cytoplasm (13%);membrane coat (6%),GO:0003677 (19%);GO:0005524 (19%);GO:0016810 (9%),DNA binding (19%);ATP binding (19%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (9%),GO:0006268 (6%);GO:0006269 (6%);GO:0006886 (6%),DNA unwinding involved in DNA replication (6%);DNA replication, synthesis of RNA primer (6%);intracellular protein transport (6%),IPR027417 (11%);IPR029068 (11%);IPR037523 (11%),P-loop containing nucleoside triphosphate hydrolase (11%);Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase (11%);Vicinal oxygen chelate (VOC) domain (11%),,,,,,,,,
LVLPWLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETNMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.71 (90%);2.3.1.234 (5%);3.1.1.- (5%),Shikimate kinase (90%);N(6)-L-threonylcarbamoyladenine synthase (5%);Carboxylic ester hydrolases (5%),GO:0005737 (26%);GO:0016021 (26%);GO:0016592 (4%),cytoplasm (26%);integral component of membrane (26%);mediator complex (4%),GO:0005524 (41%);GO:0000287 (26%);GO:0004765 (26%),ATP binding (41%);magnesium ion binding (26%);shikimate kinase activity (26%),GO:0009073 (26%);GO:0009423 (26%);GO:0006357 (4%),aromatic amino acid family biosynthetic process (26%);chorismate biosynthetic process (26%);regulation of transcription by RNA polymerase II (4%),IPR027417 (26%);IPR000623 (22%);IPR023000 (22%),P-loop containing nucleoside triphosphate hydrolase (26%);Shikimate kinase/Threonine synthase-like 1 (22%);Shikimate kinase, conserved site (22%),,,,,,,,,,
NNLLPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.18 (100%),Methionyl aminopeptidase (100%),GO:0016021 (28%);GO:0005634 (6%);GO:0043190 (6%),integral component of membrane (28%);nucleus (6%);ATP-binding cassette (ABC) transporter complex (6%),GO:0003824 (11%);GO:0005524 (11%);GO:0016887 (11%),catalytic activity (11%);ATP binding (11%);ATPase activity (11%),GO:0070084 (11%);GO:0007049 (6%);GO:0010468 (6%),protein initiator methionine removal (11%);cell cycle (6%);regulation of gene expression (6%),IPR000994 (9%);IPR001119 (9%);IPR001714 (9%),Peptidase M24 (9%);S-layer homology domain (9%);Peptidase M24, methionine aminopeptidase (9%),,,,,,,,,,
LADAFSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.197 (25%);2.3.1.31 (25%);3.5.4.16 (25%),Malonyl-[acyl-carrier protein] O-methyltransferase (25%);Homoserine O-acetyltransferase (25%);GTP cyclohydrolase I (25%),GO:0016021 (17%);GO:0005615 (6%);GO:0005737 (4%),integral component of membrane (17%);extracellular space (6%);cytoplasm (4%),GO:0005524 (32%);GO:0004326 (13%);GO:0003677 (11%),ATP binding (32%);tetrahydrofolylpolyglutamate synthase activity (13%);DNA binding (11%),GO:0030638 (4%);GO:0006396 (2%);GO:0006429 (2%),polyketide metabolic process (4%);RNA processing (2%);leucyl-tRNA aminoacylation (2%),IPR001645 (17%);IPR013221 (17%);IPR018109 (17%),Folylpolyglutamate synthetase (17%);Mur ligase, central (17%);Folylpolyglutamate synthetase, conserved site (17%),,,,,,,,,
LLLLDAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.5 (66%);1.8.2.3 (8%);1.8.2.- (6%),Succinate--CoA ligase (ADP-forming) (66%);Sulfide-cytochrome-c reductase (flavocytochrome c) (8%);With a cytochrome as acceptor (6%),GO:0016021 (14%);GO:0009331 (3%);GO:0005737 (2%),integral component of membrane (14%);glycerol-3-phosphate dehydrogenase complex (3%);cytoplasm (2%),GO:0016491 (47%);GO:0050660 (46%);GO:0005524 (23%),oxidoreductase activity (47%);flavin adenine dinucleotide binding (46%);ATP binding (23%),GO:0006099 (15%);GO:0006072 (3%);GO:0009307 (3%),tricarboxylic acid cycle (15%);glycerol-3-phosphate metabolic process (3%);DNA restriction-modification system (3%),IPR036188 (48%);IPR016156 (42%);IPR023753 (42%),FAD/NAD(P)-binding domain superfamily (48%);FAD/NAD-linked reductase, dimerisation domain superfamily (42%);FAD/NAD(P)-binding domain (42%),,,,,,,,,,
APLLDQLLEVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VENPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.18 (53%);5.3.1.9 (13%);2.3.1.274 (3%),Glutamine--tRNA ligase (53%);Glucose-6-phosphate isomerase (13%);Phosphate acyltransferase (3%),GO:0005737 (26%);GO:0016021 (14%);GO:0005840 (5%),cytoplasm (26%);integral component of membrane (14%);ribosome (5%),GO:0005524 (27%);GO:0004819 (18%);GO:0008410 (11%),ATP binding (27%);glutamine-tRNA ligase activity (18%);CoA-transferase activity (11%),GO:0006425 (17%);GO:0006094 (4%);GO:0006096 (4%),glutaminyl-tRNA aminoacylation (17%);gluconeogenesis (4%);glycolytic process (4%),IPR014729 (15%);IPR011035 (15%);IPR020056 (15%),Rossmann-like alpha/beta/alpha sandwich fold (15%);Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain superfamily (15%);Ribosomal protein L25/Gln-tRNA synthetase, N-terminal (15%),,,,,,,,,
TAWLDGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0005654 (15%);GO:0048471 (15%);GO:0034663 (14%),nucleoplasm (15%);perinuclear region of cytoplasm (15%);endoplasmic reticulum chaperone complex (14%),GO:0003755 (97%);GO:0016018 (21%);GO:0070063 (15%),peptidyl-prolyl cis-trans isomerase activity (97%);cyclosporin A binding (21%);RNA polymerase binding (15%),GO:0006457 (66%);GO:0061077 (19%);GO:0040018 (15%),protein folding (66%);chaperone-mediated protein folding (19%);positive regulation of multicellular organism growth (15%),IPR002130 (90%);IPR029000 (90%);IPR020892 (85%),Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain (90%);Cyclophilin-like domain superfamily (90%);Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site (85%),,,,,,,,,,
FNVDYER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.8 (17%);5.6.2.2 (15%);3.1.13.- (7%),Mannonate dehydratase (17%);DNA topoisomerase (ATP-hydrolyzing) (15%);Exoribonucleases producing 5'-phosphomonoesters (7%),GO:0016021 (27%);GO:0036064 (15%);GO:0005814 (3%),integral component of membrane (27%);ciliary basal body (15%);centriole (3%),GO:0005085 (19%);GO:0016787 (8%);GO:0005524 (6%),guanyl-nucleotide exchange factor activity (19%);hydrolase activity (8%);ATP binding (6%),GO:0007264 (21%);GO:0035023 (21%);GO:0060271 (15%),small GTPase mediated signal transduction (21%);regulation of Rho protein signal transduction (21%);cilium assembly (15%),IPR000651 (20%);IPR008937 (20%);IPR023578 (20%),Ras-like guanine nucleotide exchange factor, N-terminal (20%);Ras-like guanine nucleotide exchange factor (20%);Ras guanine nucleotide exchange factor domain superfamily (20%),,,,,,,,,,
FLQDNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0005840 (33%);GO:0016021 (33%),ribosome (33%);integral component of membrane (33%),GO:0003735 (33%);GO:0003755 (33%),structural constituent of ribosome (33%);peptidyl-prolyl cis-trans isomerase activity (33%),GO:0006412 (33%);GO:0006457 (33%);GO:0055085 (33%),translation (33%);protein folding (33%);transmembrane transport (33%),IPR012854 (43%);IPR018711 (43%);IPR036582 (43%),Copper amine oxidase-like, N-terminal (43%);Phosphodiester glycosidase (43%);Copper amine oxidase-like, N-terminal domain superfamily (43%),,,,,,,,,
VLVFWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (78%);GO:0016020 (4%),integral component of membrane (78%);membrane (4%),GO:0003677 (9%);GO:0005262 (4%);GO:0005524 (4%),DNA binding (9%);calcium channel activity (4%);ATP binding (4%),GO:0030638 (9%);GO:0006281 (4%);GO:0006310 (4%),polyketide metabolic process (9%);DNA repair (4%);DNA recombination (4%),IPR032675 (27%);IPR001810 (20%);IPR009959 (13%),Leucine-rich repeat domain superfamily (27%);F-box domain (20%);Polyketide cyclase SnoaL-like (13%),,,,,,,,,,,
EALLEWLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%);GO:0003887 (33%);GO:0016787 (33%),DNA binding (100%);DNA-directed DNA polymerase activity (33%);hydrolase activity (33%),GO:0006310 (67%);GO:0015074 (67%);GO:0006281 (33%),DNA recombination (67%);DNA integration (67%);DNA repair (33%),IPR002104 (33%);IPR011010 (33%);IPR013762 (33%),Integrase, catalytic domain (33%);DNA breaking-rejoining enzyme, catalytic core (33%);Integrase-like, catalytic domain superfamily (33%),,,,,,,,
WFSEAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.2 (50%);6.2.1.1 (50%),Phosphoribosylglycinamide formyltransferase (50%);Acetate--CoA ligase (50%),GO:0043240 (59%);GO:0005737 (3%);GO:0016021 (3%),Fanconi anaemia nuclear complex (59%);cytoplasm (3%);integral component of membrane (3%),GO:0004560 (8%);GO:0003723 (5%);GO:0003824 (5%),alpha-L-fucosidase activity (8%);RNA binding (5%);catalytic activity (5%),GO:0036297 (59%);GO:0006004 (8%);GO:0006351 (5%),interstrand cross-link repair (59%);fucose metabolic process (8%);transcription, DNA-templated (5%),IPR003516 (43%);IPR031729 (41%);IPR011990 (17%),Fanconi anaemia group A protein (43%);Fanconi anaemia group A protein, N-terminal domain (41%);Tetratricopeptide-like helical domain superfamily (17%),,,,,,,,,
NNNFVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.3 (100%),Homoserine dehydrogenase (100%),GO:0016021 (43%);GO:0005886 (14%);GO:0016020 (14%),integral component of membrane (43%);plasma membrane (14%);membrane (14%),GO:0004412 (14%);GO:0005509 (14%);GO:0008375 (14%),homoserine dehydrogenase activity (14%);calcium ion binding (14%);acetylglucosaminyltransferase activity (14%),GO:0007156 (14%);GO:0009086 (14%);GO:0009088 (14%),homophilic cell adhesion via plasma membrane adhesion molecules (14%);methionine biosynthetic process (14%);threonine biosynthetic process (14%),IPR001498 (22%);IPR020568 (22%);IPR023582 (22%),Impact, N-terminal (22%);Ribosomal protein S5 domain 2-type fold (22%);Impact family (22%),,,,,,,,,,
VEEEAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (20%);GO:0005783 (20%);GO:0016021 (20%),nucleus (20%);endoplasmic reticulum (20%);integral component of membrane (20%),GO:0003677 (60%);GO:0003746 (20%);GO:0019902 (20%),DNA binding (60%);translation elongation factor activity (20%);phosphatase binding (20%),GO:0009788 (20%);GO:0010922 (20%);GO:0032784 (20%),negative regulation of abscisic acid-activated signaling pathway (20%);positive regulation of phosphatase activity (20%);regulation of DNA-templated transcription, elongation (20%),IPR000944 (40%);IPR036388 (40%);IPR036390 (40%),Transcription regulator Rrf2-type (40%);Winged helix-like DNA-binding domain superfamily (40%);Winged helix DNA-binding domain superfamily (40%),,,,,,,,,,
ASWMSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (75%),integral component of membrane (75%),GO:0004129 (25%);GO:0016787 (25%);GO:0020037 (25%),cytochrome-c oxidase activity (25%);hydrolase activity (25%);heme binding (25%),GO:0009060 (25%),aerobic respiration (25%),IPR012495 (50%);IPR000883 (25%);IPR011105 (25%),TadE-like (50%);Cytochrome c oxidase subunit I (25%);Cell wall hydrolase, SleB (25%),,,,,,,,,,
LDLVGLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.- (19%);6.3.1.2 (19%);3.6.3.- (13%),Hydro-lyases (19%);Glutamine synthetase (19%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (13%),GO:0016021 (39%);GO:0005739 (3%);GO:0005783 (3%),integral component of membrane (39%);mitochondrion (3%);endoplasmic reticulum (3%),GO:0004356 (19%);GO:0005524 (11%);GO:0016887 (8%),glutamate-ammonia ligase activity (19%);ATP binding (11%);ATPase activity (8%),GO:0006542 (19%);GO:0055085 (5%);GO:0006099 (4%),glutamine biosynthetic process (19%);transmembrane transport (5%);tricarboxylic acid cycle (4%),IPR013481 (20%);IPR011990 (12%);IPR019734 (12%),Conserved hypothetical protein CHP02664, nitrate reductase-associated (20%);Tetratricopeptide-like helical domain superfamily (12%);Tetratricopeptide repeat (12%),,,,,,,,,,
VLSLYENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.10 (80%);2.7.1.148 (20%),Formyltetrahydrofolate deformylase (80%);4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase (20%),,,GO:0008864 (80%);GO:0016742 (60%);GO:0005524 (20%),formyltetrahydrofolate deformylase activity (80%);hydroxymethyl-, formyl- and related transferase activity (60%);ATP binding (20%),GO:0006189 (80%);GO:0006730 (80%);GO:0016114 (20%),'de novo' IMP biosynthetic process (80%);one-carbon metabolic process (80%);terpenoid biosynthetic process (20%),IPR002376 (80%);IPR002912 (80%);IPR004810 (80%),Formyl transferase, N-terminal (80%);ACT domain (80%);Formyltetrahydrofolate deformylase (80%),,,,,,,,,
LSGLLYEEEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEELVEAK,Penicillium digitatum,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Eurotiomycetidae,,,Eurotiales,,,,,Aspergillaceae,,,,Penicillium,,,,Penicillium digitatum,,,,,,,,GO:0004553 (100%);GO:0008061 (100%),hydrolase activity, hydrolyzing O-glycosyl compounds (100%);chitin binding (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR001002 (100%);IPR001223 (100%);IPR001579 (100%),Chitin-binding, type 1 (100%);Glycoside hydrolase family 18, catalytic domain (100%);Glycoside hydrolase, chitinase active site (100%),,,,,,,
MMASLNNAGMNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEQEGTVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEEELYHK,Tilletia indica,Eukaryota,Fungi,Dikarya,,Basidiomycota,Ustilaginomycotina,,Exobasidiomycetes,,,,Tilletiales,,,,,Tilletiaceae,,,,Tilletia,,,,Tilletia indica,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0004672 (100%);GO:0005524 (100%),protein kinase activity (100%);ATP binding (100%),,,IPR000719 (100%);IPR011009 (100%),Protein kinase domain (100%);Protein kinase-like domain superfamily (100%),,,,,,,,,,,
AAETDFR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6.1.1 (50%);5.4.99.- (50%),Adenylate cyclase (50%);Transferring other groups (50%),GO:0016021 (25%),integral component of membrane (25%),GO:0003677 (25%);GO:0003723 (25%);GO:0004016 (25%),DNA binding (25%);RNA binding (25%);adenylate cyclase activity (25%),GO:0001522 (25%),pseudouridine synthesis (25%),IPR036388 (75%);IPR000944 (50%);IPR036390 (50%),Winged helix-like DNA-binding domain superfamily (75%);Transcription regulator Rrf2-type (50%);Winged helix DNA-binding domain superfamily (50%),,,,,,,,,,,
TASLEECR,Bacillus aryabhattai,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Bacillaceae,,,,Bacillus,,,,Bacillus aryabhattai,,,,,,,,,,,,IPR038726 (100%),PD-(D/E)XK endonuclease-like domain, AddAB-type (100%),,,,,,,,,,
QVYLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.1 (50%);1.3.5.1 (25%);5.4.99.- (25%),Alanine racemase (50%);Succinate dehydrogenase (quinone) (25%);Transferring other groups (25%),GO:0016021 (24%);GO:0008305 (6%);GO:0005634 (3%),integral component of membrane (24%);integrin complex (6%);nucleus (3%),GO:0008233 (21%);GO:0003824 (6%);GO:0004089 (6%),peptidase activity (21%);catalytic activity (6%);carbonate dehydratase activity (6%),GO:0007155 (9%);GO:0007229 (9%);GO:0055085 (9%),cell adhesion (9%);integrin-mediated signaling pathway (9%);transmembrane transport (9%),IPR008866 (17%);IPR003709 (13%);IPR009045 (13%),Bacteriophage lambda, GpA (17%);Peptidase M15B (13%);Hedgehog signalling/DD-peptidase zinc-binding domain superfamily (13%),,,,,,,,,,
TVLLWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.48 (100%),Histone acetyltransferase (100%),GO:0033588 (36%);GO:0016021 (21%);GO:0000139 (11%),Elongator holoenzyme complex (36%);integral component of membrane (21%);Golgi membrane (11%),GO:0005198 (11%);GO:0004930 (8%);GO:0004842 (7%),structural molecule activity (11%);G protein-coupled receptor activity (8%);ubiquitin-protein transferase activity (7%),GO:0002098 (36%);GO:0015031 (11%);GO:0090114 (11%),tRNA wobble uridine modification (36%);protein transport (11%);COPII-coated vesicle budding (11%),IPR015943 (70%);IPR001680 (70%);IPR017986 (70%),WD40/YVTN repeat-like-containing domain superfamily (70%);WD40 repeat (70%);WD40-repeat-containing domain (70%),,,,,,,,,,,
SYVGDEAQSK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR004000 (100%);IPR004001 (50%);IPR020902 (50%),Actin family (100%);Actin, conserved site (50%);Actin/actin-like conserved site (50%),,,,,,,,,,
SNFNECK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TALMAGATPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVFLLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.11 (100%),Cellobiose epimerase (100%),GO:0005886 (3%);GO:0016021 (3%);GO:0045263 (3%),plasma membrane (3%);integral component of membrane (3%);proton-transporting ATP synthase complex, coupling factor F(o) (3%),GO:0003677 (34%);GO:0003700 (34%);GO:0016987 (34%),DNA binding (34%);DNA-binding transcription factor activity (34%);sigma factor activity (34%),GO:0006352 (34%);GO:0006355 (24%);GO:0015074 (3%),DNA-templated transcription, initiation (34%);regulation of transcription, DNA-templated (24%);DNA integration (3%),IPR036388 (29%);IPR014710 (27%);IPR007627 (24%),Winged helix-like DNA-binding domain superfamily (29%);RmlC-like jelly roll fold (27%);RNA polymerase sigma-70 region 2 (24%),,,,,,,,
DLVFAPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (50%),integral component of membrane (50%),GO:0000155 (50%);GO:0005524 (50%);GO:0016853 (50%),phosphorelay sensor kinase activity (50%);ATP binding (50%);isomerase activity (50%),GO:0005975 (50%),carbohydrate metabolic process (50%),IPR003594 (50%);IPR003660 (50%);IPR008183 (50%),Histidine kinase/HSP90-like ATPase (50%);HAMP domain (50%);Aldose 1-/Glucose-6-phosphate 1-epimerase (50%),,,,,,,,,,,
TQAPVDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016491 (100%),oxidoreductase activity (100%),,,IPR002937 (50%);IPR029058 (50%);IPR036188 (50%),Amine oxidase (50%);Alpha/Beta hydrolase fold (50%);FAD/NAD(P)-binding domain superfamily (50%),,,,,,,,,,,
NAEYAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVEAVDVWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFYNELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043190 (50%);GO:0005737 (25%);GO:0005856 (25%),ATP-binding cassette (ABC) transporter complex (50%);cytoplasm (25%);cytoskeleton (25%),GO:0003677 (25%);GO:0005524 (25%),DNA binding (25%);ATP binding (25%),GO:0055085 (50%),transmembrane transport (50%),IPR004000 (95%);IPR020902 (93%);IPR000914 (2%),Actin family (95%);Actin/actin-like conserved site (93%);Solute-binding protein family 5 domain (2%),,,,,,,,,,,
ADTFELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008773 (50%);GO:0016301 (50%);GO:0016740 (50%),[protein-PII] uridylyltransferase activity (50%);kinase activity (50%);transferase activity (50%),,,IPR000182 (25%);IPR000644 (25%);IPR005105 (25%),GNAT domain (25%);CBS domain (25%);Protein-PII uridylyltransferase, N-terminal (25%),,,,,,,,,,
DTNLVHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.42 (100%);2.7.7.89 (100%),[Glutamine synthetase] adenylyltransferase (100%);[Glutamine synthetase]-adenylyl-L-tyrosine phosphorylase (100%),GO:0009507 (33%);GO:0016021 (33%),chloroplast (33%);integral component of membrane (33%),GO:0000287 (33%);GO:0004494 (33%);GO:0005524 (33%),magnesium ion binding (33%);methylmalonyl-CoA mutase activity (33%);ATP binding (33%),GO:0000820 (33%);GO:0008152 (33%),regulation of glutamine family amino acid metabolic process (33%);metabolic process (33%),IPR003359 (33%);IPR005190 (33%);IPR006098 (33%),Photosystem I Ycf4, assembly (33%);Glutamate-ammonia ligase adenylyltransferase, repeated domain (33%);Methylmalonyl-CoA mutase, alpha chain, catalytic (33%),,,,,,,
FNFPFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (43%);GO:0016021 (35%);GO:0005886 (26%),ribosome (43%);integral component of membrane (35%);plasma membrane (26%),GO:0003735 (43%);GO:0000049 (39%);GO:0019843 (39%),structural constituent of ribosome (43%);tRNA binding (39%);rRNA binding (39%),GO:0006412 (43%);GO:0055085 (9%),translation (43%);transmembrane transport (9%),IPR002132 (38%);IPR020930 (38%);IPR022803 (38%),Ribosomal protein L5 (38%);Ribosomal protein L5, bacterial-type (38%);Ribosomal protein L5 domain superfamily (38%),,,,,,,,,,
NVVYALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003677 (50%),DNA binding (50%),GO:0006310 (50%);GO:0015074 (50%),DNA recombination (50%);DNA integration (50%),IPR000160 (33%);IPR001680 (33%);IPR011010 (33%),GGDEF domain (33%);WD40 repeat (33%);DNA breaking-rejoining enzyme, catalytic core (33%),,,,,,,,,,
SPAHFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.3 (37%);2.7.11.1 (5%);2.7.7.7 (4%),Ornithine carbamoyltransferase (37%);Non-specific serine/threonine protein kinase (5%);DNA-directed DNA polymerase (4%),GO:0016021 (20%);GO:0005737 (13%);GO:0005840 (4%),integral component of membrane (20%);cytoplasm (13%);ribosome (4%),GO:0003677 (8%);GO:0004585 (8%);GO:0005524 (8%),DNA binding (8%);ornithine carbamoyltransferase activity (8%);ATP binding (8%),GO:0005975 (5%);GO:0006633 (4%);GO:0006412 (4%),carbohydrate metabolic process (5%);fatty acid biosynthetic process (4%);translation (4%),IPR006130 (7%);IPR036901 (7%);IPR006131 (7%),Aspartate/ornithine carbamoyltransferase (7%);Aspartate/ornithine carbamoyltransferase superfamily (7%);Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain (7%),,,,,,,,,,
YYMDEYK,Flavobacterium frigidimaris,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Flavobacterium,,,,Flavobacterium frigidimaris,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0004222 (100%);GO:0008270 (100%),metalloendopeptidase activity (100%);zinc ion binding (100%),,,IPR001506 (100%);IPR006026 (100%);IPR024079 (100%),Peptidase M12A (100%);Peptidase, metallopeptidase (100%);Metallopeptidase, catalytic domain superfamily (100%),,,,,,,,,
TVADDER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.266 (100%),[Ribosomal protein S18]-alanine N-acetyltransferase (100%),GO:0005737 (17%);GO:0016021 (17%),cytoplasm (17%);integral component of membrane (17%),GO:0005524 (17%);GO:0008080 (17%);GO:0008484 (17%),ATP binding (17%);N-acetyltransferase activity (17%);sulfuric ester hydrolase activity (17%),GO:0006281 (17%);GO:0006310 (17%);GO:0006474 (17%),DNA repair (17%);DNA recombination (17%);N-terminal protein amino acid acetylation (17%),IPR000182 (14%);IPR000873 (14%);IPR000917 (14%),GNAT domain (14%);AMP-dependent synthetase/ligase (14%);Sulfatase, N-terminal (14%),,,,,,,,,,
LAAELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.179 (14%);2.1.3.3 (4%);5.1.1.- (4%),Beta-ketoacyl-[acyl-carrier-protein] synthase II (14%);Ornithine carbamoyltransferase (4%);Acting on amino acids and derivatives (4%),GO:0005737 (9%);GO:0016021 (9%);GO:0005840 (2%),cytoplasm (9%);integral component of membrane (9%);ribosome (2%),GO:0003743 (19%);GO:0005524 (15%);GO:0003677 (8%),translation initiation factor activity (19%);ATP binding (15%);DNA binding (8%),GO:0006633 (4%);GO:0006412 (2%);GO:0006281 (2%),fatty acid biosynthetic process (4%);translation (2%);DNA repair (2%),IPR036877 (19%);IPR001950 (19%);IPR005872 (19%),SUI1 domain superfamily (19%);SUI1 domain (19%);Archaeal/bacterial translation initiation factor SUI1 (19%),,,,,,,,,,,
DLSLLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (59%);6.3.2.13 (9%);2.7.4.9 (4%),DNA helicase (59%);UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (9%);dTMP kinase (4%),GO:0016021 (19%);GO:0005623 (4%);GO:0034993 (4%),integral component of membrane (19%);cell (4%);meiotic nuclear membrane microtubule tethering complex (4%),GO:0005524 (44%);GO:0003677 (40%);GO:0004386 (32%),ATP binding (44%);DNA binding (40%);helicase activity (32%),GO:0001878 (7%);GO:0090286 (4%);GO:0006412 (2%),response to yeast (7%);cytoskeletal anchoring at nuclear membrane (4%);translation (2%),IPR027417 (38%);IPR001650 (33%);IPR014001 (33%),P-loop containing nucleoside triphosphate hydrolase (38%);Helicase, C-terminal (33%);Helicase superfamily 1/2, ATP-binding domain (33%),,,,,,,,
LNADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.1 (5%);1.5.1.5 (5%);3.5.4.9 (5%),Amino-acid N-acetyltransferase (5%);Methylenetetrahydrofolate dehydrogenase (NADP(+)) (5%);Methenyltetrahydrofolate cyclohydrolase (5%),GO:0016021 (19%);GO:0042597 (14%);GO:0005737 (10%),integral component of membrane (19%);periplasmic space (14%);cytoplasm (10%),GO:0001530 (13%);GO:0005524 (13%);GO:0003677 (8%),lipopolysaccharide binding (13%);ATP binding (13%);DNA binding (8%),GO:0015920 (15%);GO:0043165 (15%);GO:0009086 (3%),lipopolysaccharide transport (15%);Gram-negative-bacterium-type cell outer membrane assembly (15%);methionine biosynthetic process (3%),IPR005653 (14%);IPR014340 (13%);IPR027417 (7%),Organic solvent tolerance-like, N-terminal (14%);Lipopolysaccharide export system protein LptA (13%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,
DEATR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (9%);2.1.1.181 (8%);6.5.1.2 (6%),Transaminases (9%);23S rRNA (adenine(1618)-N(6))-methyltransferase (8%);DNA ligase (NAD(+)) (6%),GO:0016021 (27%);GO:0005886 (12%);GO:0009425 (10%),integral component of membrane (27%);plasma membrane (12%);bacterial-type flagellum basal body (10%),GO:0005524 (12%);GO:0046872 (9%);GO:0003677 (8%),ATP binding (12%);metal ion binding (9%);DNA binding (8%),GO:0006935 (10%);GO:0071973 (10%);GO:0006281 (3%),chemotaxis (10%);bacterial-type flagellum-dependent cell motility (10%);DNA repair (3%),IPR005503 (10%);IPR013609 (8%);IPR037053 (7%),Flagellar basal body-associated protein FliL (10%);Bacteriophage 933W, L0121, tail fibre, N-terminal (8%);Phage tail collar domain superfamily (7%),,,,,,,,
ADEFVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.4.1 (100%),Protein disulfide-isomerase (100%),GO:0005623 (74%);GO:0005783 (74%);GO:0016021 (15%),cell (74%);endoplasmic reticulum (74%);integral component of membrane (15%),GO:0016853 (71%);GO:0004045 (9%);GO:0005525 (6%),isomerase activity (71%);aminoacyl-tRNA hydrolase activity (9%);GTP binding (6%),GO:0045454 (74%);GO:0006886 (3%);GO:0009553 (3%),cell redox homeostasis (74%);intracellular protein transport (3%);embryo sac development (3%),IPR005788 (72%);IPR011679 (72%);IPR013766 (72%),Disulphide isomerase (72%);Endoplasmic reticulum resident protein 29, C-terminal (72%);Thioredoxin domain (72%),,,,,,,,,,
LEDEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.13 (35%);2.7.11.1 (23%);1.11.1.6 (9%),Glutamate synthase (NADPH) (35%);Non-specific serine/threonine protein kinase (23%);Catalase (9%),GO:0016021 (30%);GO:0005737 (8%);GO:0005856 (8%),integral component of membrane (30%);cytoplasm (8%);cytoskeleton (8%),GO:0005524 (25%);GO:0046872 (20%);GO:0004674 (15%),ATP binding (25%);metal ion binding (20%);protein serine/threonine kinase activity (15%),GO:0006537 (12%);GO:0035556 (9%);GO:0030036 (8%),glutamate biosynthetic process (12%);intracellular signal transduction (9%);actin cytoskeleton organization (8%),IPR011009 (13%);IPR000719 (13%);IPR015008 (13%),Protein kinase-like domain superfamily (13%);Protein kinase domain (13%);Rho binding domain (13%),,,,,,,,,,,
SGAGNMVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNEEPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (15%);3.5.4.16 (15%);1.12.1.3 (10%),DNA-directed DNA polymerase (15%);GTP cyclohydrolase I (15%);Hydrogen dehydrogenase (NADP(+)) (10%),GO:0005737 (23%);GO:0009380 (13%);GO:0016021 (11%),cytoplasm (23%);excinuclease repair complex (13%);integral component of membrane (11%),GO:0046872 (29%);GO:0051539 (25%);GO:0009055 (23%),metal ion binding (29%);4 iron, 4 sulfur cluster binding (25%);electron transfer activity (23%),GO:0006289 (15%);GO:0009432 (15%);GO:0006631 (5%),nucleotide-excision repair (15%);SOS response (15%);fatty acid metabolic process (5%),IPR001041 (18%);IPR006963 (18%);IPR017896 (18%),2Fe-2S ferredoxin-type iron-sulfur binding domain (18%);Molybdopterin oxidoreductase, 4Fe-4S domain (18%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (18%),,,,,,,,
MPNGQVVYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSVVFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0016740 (33%),transferase activity (33%),,,IPR000326 (50%);IPR001173 (50%);IPR029044 (50%),Phosphatidic acid phosphatase type 2/haloperoxidase (50%);Glycosyltransferase 2-like (50%);Nucleotide-diphospho-sugar transferases (50%),,,,,,,,,,,
TEQLSENR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0003677 (100%),DNA binding (100%),GO:0006355 (100%),regulation of transcription, DNA-templated (100%),IPR027417 (75%);IPR041685 (75%);IPR011990 (25%),P-loop containing nucleoside triphosphate hydrolase (75%);AAA domain, group 15 (75%);Tetratricopeptide-like helical domain superfamily (25%),,,,,,,,,
WAASDCAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDNFLEEAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLLDVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (36%);2.7.13.3 (10%);2.1.1.72 (5%),Transaminases (36%);Histidine kinase (10%);Site-specific DNA-methyltransferase (adenine-specific) (5%),GO:0016021 (36%);GO:0005737 (3%);GO:0005840 (2%),integral component of membrane (36%);cytoplasm (3%);ribosome (2%),GO:0000155 (30%);GO:0046983 (27%);GO:0005524 (21%),phosphorelay sensor kinase activity (30%);protein dimerization activity (27%);ATP binding (21%),GO:0009058 (9%);GO:0006520 (8%);GO:0015833 (3%),biosynthetic process (9%);cellular amino acid metabolic process (8%);peptide transport (3%),IPR036890 (30%);IPR011712 (27%);IPR003594 (25%),Histidine kinase/HSP90-like ATPase superfamily (30%);Signal transduction histidine kinase, subgroup 3, dimerisation and phosphoacceptor domain (27%);Histidine kinase/HSP90-like ATPase (25%),,,,,,,,,
VLDELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.3 (10%);5.6.2.1 (7%);2.1.2.3 (4%),Adenosinetriphosphatase (10%);DNA topoisomerase (7%);Phosphoribosylaminoimidazolecarboxamide formyltransferase (4%),GO:0016021 (15%);GO:0005886 (11%);GO:0005737 (10%),integral component of membrane (15%);plasma membrane (11%);cytoplasm (10%),GO:0005524 (24%);GO:0003677 (11%);GO:0015079 (10%),ATP binding (24%);DNA binding (11%);potassium ion transmembrane transporter activity (10%),GO:0033567 (2%);GO:0030435 (2%);GO:0006265 (2%),DNA replication, Okazaki fragment processing (2%);sporulation resulting in formation of a cellular spore (2%);DNA topological change (2%),IPR027417 (17%);IPR036291 (16%);IPR006037 (13%),P-loop containing nucleoside triphosphate hydrolase (17%);NAD(P)-binding domain superfamily (16%);Regulator of K+ conductance, C-terminal (13%),,,,,,,,,
DVLEDPVELLDNER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYEEEVSR,Euryarchaeota archaeon,Archaea,,,,Euryarchaeota,,,,,,,,,,,,,,,,,,,,Euryarchaeota archaeon,,,,,,,,GO:0016868 (100%),intramolecular transferase activity, phosphotransferases (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR005841 (100%);IPR005844 (100%);IPR016055 (100%),Alpha-D-phosphohexomutase superfamily (100%);Alpha-D-phosphohexomutase, alpha/beta/alpha domain I (100%);Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III (100%),,,,,,,,
FNAVDLR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (100%);IPR010104 (100%);IPR012910 (100%),TonB-dependent receptor-like, beta-barrel (100%);Bacterial TonB-dependent receptor (100%);TonB-dependent receptor, plug domain (100%),,,,,,,,,
EFLENWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (33%);GO:0005886 (22%);GO:0016021 (22%),cytoplasm (33%);plasma membrane (22%);integral component of membrane (22%),GO:0005524 (44%);GO:0051082 (33%);GO:0004888 (22%),ATP binding (44%);unfolded protein binding (33%);transmembrane signaling receptor activity (22%),GO:0006457 (33%);GO:0007268 (22%);GO:0005980 (11%),protein folding (33%);chemical synaptic transmission (22%);glycogen catabolic process (11%),IPR001404 (30%);IPR019805 (30%);IPR020568 (30%),Heat shock protein Hsp90 family (30%);Heat shock protein Hsp90, conserved site (30%);Ribosomal protein S5 domain 2-type fold (30%),,,,,,,,,,
YVGDEAQSK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR004000 (100%);IPR004001 (94%);IPR020902 (88%),Actin family (100%);Actin, conserved site (94%);Actin/actin-like conserved site (88%),,,,,,,,,,
TEEELDQK,Cellulophaga algicola,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Cellulophaga,,,,Cellulophaga algicola,,,,,,,,,,,,IPR027417 (100%),P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,,,
AEELEEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR011009 (60%);IPR007139 (40%),Protein kinase-like domain superfamily (60%);Protein of unknown function DUF349 (40%),,,,,,,,,,,
TTLLLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (80%);1.3.98.3 (20%),DNA helicase (80%);Coproporphyrinogen dehydrogenase (20%),GO:0016021 (14%);GO:0005886 (5%),integral component of membrane (14%);plasma membrane (5%),GO:0005524 (29%);GO:0004386 (24%);GO:0004803 (24%),ATP binding (29%);helicase activity (24%);transposase activity (24%),GO:0006313 (24%);GO:0008360 (5%);GO:0051301 (5%),transposition, DNA-mediated (24%);regulation of cell shape (5%);cell division (5%),IPR027417 (52%);IPR014016 (26%);IPR041677 (26%),P-loop containing nucleoside triphosphate hydrolase (52%);UvrD-like helicase, ATP-binding domain (26%);DNA2/NAM7 helicase, AAA domain (26%),,,,,,,,
LAVVLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.11 (57%);6.3.5.2 (14%);2.7.7.60 (10%),Exopolyphosphatase (57%);GMP synthase (glutamine-hydrolyzing) (14%);2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (10%),GO:0016021 (3%);GO:0005737 (1%);GO:0030288 (1%),integral component of membrane (3%);cytoplasm (1%);outer membrane-bounded periplasmic space (1%),GO:0004309 (37%);GO:0003677 (28%);GO:0004803 (27%),exopolyphosphatase activity (37%);DNA binding (28%);transposase activity (27%),GO:0006793 (28%);GO:0006313 (27%);GO:0006541 (14%),phosphorus metabolic process (28%);transposition, DNA-mediated (27%);glutamine metabolic process (14%),IPR003695 (44%);IPR030673 (43%);IPR003346 (29%),Ppx/GppA phosphatase (44%);Pyrophosphatase, GppA/Ppx-type (43%);Transposase, IS116/IS110/IS902 (29%),,,,,,,,
LMDSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (9%);2.7.1.24 (8%);2.7.7.7 (6%),Acting on ester bonds (9%);Dephospho-CoA kinase (8%);DNA-directed DNA polymerase (6%),GO:0016021 (29%);GO:0005737 (8%);GO:0005634 (3%),integral component of membrane (29%);cytoplasm (8%);nucleus (3%),GO:0005524 (15%);GO:0003677 (8%);GO:0016491 (7%),ATP binding (15%);DNA binding (8%);oxidoreductase activity (7%),GO:0006355 (3%);GO:0046952 (3%);GO:0055085 (3%),regulation of transcription, DNA-templated (3%);ketone body catabolic process (3%);transmembrane transport (3%),IPR027417 (8%);IPR036291 (8%);IPR011009 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);NAD(P)-binding domain superfamily (8%);Protein kinase-like domain superfamily (5%),,,,,,,,,,
SNNLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (24%);2.1.1.- (19%);2.1.1.45 (4%),Acting on ATP; involved in cellular and subcellular movement (24%);Methyltransferases (19%);Thymidylate synthase (4%),GO:0016021 (20%);GO:0009507 (12%);GO:0005737 (8%),integral component of membrane (20%);chloroplast (12%);cytoplasm (8%),GO:0003677 (16%);GO:0003723 (13%);GO:0005524 (12%),DNA binding (16%);RNA binding (13%);ATP binding (12%),GO:0008033 (13%);GO:0006397 (12%);GO:0008380 (8%),tRNA processing (13%);mRNA processing (12%);RNA splicing (8%),IPR002866 (10%);IPR024942 (10%);IPR024937 (8%),Maturase MatK (10%);Maturase MatK, N-terminal domain (10%);Domain X (8%),,,,,,,,,,
NSEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (15%);7.6.2.1 (10%);3.4.16.4 (9%),Histidine kinase (15%);P-type phospholipid transporter (10%);Serine-type D-Ala-D-Ala carboxypeptidase (9%),GO:0016021 (31%);GO:0030127 (5%);GO:0005634 (5%),integral component of membrane (31%);COPII vesicle coat (5%);nucleus (5%),GO:0005524 (18%);GO:0000155 (9%);GO:0008270 (8%),ATP binding (18%);phosphorelay sensor kinase activity (9%);zinc ion binding (8%),GO:0006886 (6%);GO:0006355 (6%);GO:0006888 (5%),intracellular protein transport (6%);regulation of transcription, DNA-templated (6%);endoplasmic reticulum to Golgi vesicle-mediated transport (5%),IPR035965 (14%);IPR000014 (14%);IPR000700 (13%),PAS domain superfamily (14%);PAS domain (14%);PAS-associated, C-terminal (13%),,,,,,,,,
AEVPAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (63%);7.-.-.- (15%);6.3.2.2 (6%),DNA-directed DNA polymerase (63%);Translocases (15%);Glutamate--cysteine ligase (6%),GO:0005737 (24%);GO:0016021 (20%);GO:0030130 (10%),cytoplasm (24%);integral component of membrane (20%);clathrin coat of trans-Golgi network vesicle (10%),GO:0003887 (23%);GO:0008408 (22%);GO:0005198 (10%),DNA-directed DNA polymerase activity (23%);3'-5' exonuclease activity (22%);structural molecule activity (10%),GO:0006260 (23%);GO:0006886 (10%);GO:0016192 (10%),DNA replication (23%);intracellular protein transport (10%);vesicle-mediated transport (10%),IPR004805 (23%);IPR029460 (23%);IPR011708 (22%),DNA polymerase III, alpha subunit (23%);DNA polymerase, helix-hairpin-helix motif (23%);Bacterial DNA polymerase III, alpha subunit, NTPase domain (22%),,,,,,,
GPDVMVQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LENLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (40%);2.5.1.- (9%);6.1.1.19 (8%),Proline--tRNA ligase (40%);Transferring alkyl or aryl groups, other than methyl groups (9%);Arginine--tRNA ligase (8%),GO:0005737 (32%);GO:0016021 (15%);GO:0005886 (11%),cytoplasm (32%);integral component of membrane (15%);plasma membrane (11%),GO:0005524 (45%);GO:0004827 (15%);GO:0046872 (15%),ATP binding (45%);proline-tRNA ligase activity (15%);metal ion binding (15%),GO:0006433 (15%);GO:0006605 (11%);GO:0065002 (11%),prolyl-tRNA aminoacylation (15%);protein targeting (11%);intracellular protein transmembrane transport (11%),IPR027417 (21%);IPR006195 (14%);IPR002316 (13%),P-loop containing nucleoside triphosphate hydrolase (21%);Aminoacyl-tRNA synthetase, class II (14%);Proline-tRNA ligase, class IIa (13%),,,,,,,,
SESNNAHHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YETEQGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEEALGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.11 (49%);6.1.1.7 (6%);2.5.1.6 (5%),Phosphopyruvate hydratase (49%);Alanine--tRNA ligase (6%);Methionine adenosyltransferase (5%),GO:0005576 (20%);GO:0009986 (20%);GO:0000015 (19%),extracellular region (20%);cell surface (20%);phosphopyruvate hydratase complex (19%),GO:0000287 (22%);GO:0004634 (20%);GO:0005524 (14%),magnesium ion binding (22%);phosphopyruvate hydratase activity (20%);ATP binding (14%),GO:0006096 (21%);GO:0009236 (6%);GO:0009058 (3%),glycolytic process (21%);cobalamin biosynthetic process (6%);biosynthetic process (3%),IPR000941 (14%);IPR020810 (14%);IPR020811 (14%),Enolase (14%);Enolase, C-terminal TIM barrel domain (14%);Enolase, N-terminal (14%),,,,,,,,,
TDHTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.9.1 (9%);2.3.1.54 (7%);2.4.1.18 (7%),Pyruvate, phosphate dikinase (9%);Formate C-acetyltransferase (7%);1,4-alpha-glucan branching enzyme (7%),GO:0016021 (38%);GO:0005737 (8%);GO:0005634 (3%),integral component of membrane (38%);cytoplasm (8%);nucleus (3%),GO:0005524 (20%);GO:0004674 (7%);GO:0046872 (6%),ATP binding (20%);protein serine/threonine kinase activity (7%);metal ion binding (6%),GO:0055085 (12%);GO:0005975 (5%);GO:0006807 (3%),transmembrane transport (12%);carbohydrate metabolic process (5%);nitrogen compound metabolic process (3%),IPR020846 (13%);IPR036259 (13%);IPR001411 (11%),Major facilitator superfamily domain (13%);MFS transporter superfamily (13%);Tetracycline resistance protein/drug resistance transporter (11%),,,,,,,,,
VTVDEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (50%);1.8.1.9 (50%),Oxidoreductases (50%);Thioredoxin-disulfide reductase (50%),GO:0016020 (3%);GO:0016021 (3%);GO:0005737 (1%),membrane (3%);integral component of membrane (3%);cytoplasm (1%),GO:0030246 (80%);GO:0004553 (79%);GO:0005506 (5%),carbohydrate binding (80%);hydrolase activity, hydrolyzing O-glycosyl compounds (79%);iron ion binding (5%),GO:0005975 (79%);GO:0000160 (1%);GO:0000272 (1%),carbohydrate metabolic process (79%);phosphorelay signal transduction system (1%);polysaccharide catabolic process (1%),IPR000322 (77%);IPR011013 (77%);IPR017853 (77%),Glycoside hydrolase family 31 (77%);Galactose mutarotase-like domain superfamily (77%);Glycoside hydrolase superfamily (77%),,,,,,,,,,
SVDLAFEK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR006143 (100%);IPR039562 (100%);IPR032317 (33%),RND efflux pump, membrane fusion protein (100%);Membrane fusion protein, biotin-lipoyl like domain (100%);RND efflux pump, membrane fusion protein, barrel-sandwich domain (33%),,,,,,,
DSEAM,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.88 (100%),Repressor LexA (100%),,,GO:0003677 (100%);GO:0004252 (100%),DNA binding (100%);serine-type endopeptidase activity (100%),GO:0006260 (100%);GO:0006281 (100%);GO:0009432 (100%),DNA replication (100%);DNA repair (100%);SOS response (100%),IPR001202 (50%);IPR002013 (50%);IPR006197 (50%),WW domain (50%);SAC domain (50%);Peptidase S24, LexA-like (50%),,,,,,,,,,
EEGDDEEVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPDDSTLNNVQLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMLDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (42%);2.7.13.3 (25%);1.17.7.3 (8%),DNA topoisomerase (ATP-hydrolyzing) (42%);Histidine kinase (25%);(E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (8%),GO:0016021 (17%);GO:0005886 (4%);GO:0017122 (4%),integral component of membrane (17%);plasma membrane (4%);protein N-acetylglucosaminyltransferase complex (4%),GO:0003677 (25%);GO:0005524 (23%);GO:0003700 (10%),DNA binding (25%);ATP binding (23%);DNA-binding transcription factor activity (10%),GO:0006265 (13%);GO:0019752 (8%);GO:0006097 (4%),DNA topological change (13%);carboxylic acid metabolic process (8%);glyoxylate cycle (4%),IPR036890 (15%);IPR006171 (10%);IPR036388 (10%),Histidine kinase/HSP90-like ATPase superfamily (15%);TOPRIM  domain (10%);Winged helix-like DNA-binding domain superfamily (10%),,,,,,,,,,,
DSLVTPPK,Proteus,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Enterobacterales,,,,,Morganellaceae,,,,Proteus,,,,,,,,3.4.21.83 (67%);3.4.-.- (33%),Oligopeptidase B (67%);Acting on peptide bonds (peptidases) (33%),,,GO:0004252 (100%);GO:0070008 (100%),serine-type endopeptidase activity (100%);serine-type exopeptidase activity (100%),,,IPR001375 (100%);IPR002470 (100%);IPR002471 (100%),Peptidase S9, prolyl oligopeptidase, catalytic domain (100%);Peptidase S9A, prolyl oligopeptidase (100%);Peptidase S9, serine active site (100%),,,,,,,
NQAEDGYSVWVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMELGQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVSAGPMLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVLFFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVNSLLEAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEFAEEDAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
METSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (13%);2.8.2.- (11%);1.3.1.98 (9%),Peptidylprolyl isomerase (13%);Sulfotransferases (11%);UDP-N-acetylmuramate dehydrogenase (9%),GO:0016021 (41%);GO:0005737 (6%);GO:0005634 (4%),integral component of membrane (41%);cytoplasm (6%);nucleus (4%),GO:0005524 (10%);GO:0003677 (10%);GO:0046872 (5%),ATP binding (10%);DNA binding (10%);metal ion binding (5%),GO:0051301 (2%);GO:0055085 (2%);GO:0006355 (2%),cell division (2%);transmembrane transport (2%);regulation of transcription, DNA-templated (2%),IPR019029 (14%);IPR013387 (14%);IPR027417 (8%),Type III secretion system, PrgH/EprH-like (14%);Type III secretion system, PrgH/EprH (14%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,
MYLFNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.- (50%);4.1.99.22 (50%),Other oxidoreductases (50%);GTP 3',8-cyclase (50%),GO:0016021 (53%);GO:0019008 (3%);GO:0030015 (2%),integral component of membrane (53%);molybdopterin synthase complex (3%);CCR4-NOT core complex (2%),GO:0005524 (7%);GO:0008184 (7%);GO:0030170 (7%),ATP binding (7%);glycogen phosphorylase activity (7%);pyridoxal phosphate binding (7%),GO:0005975 (10%);GO:0006777 (3%);GO:0000271 (2%),carbohydrate metabolic process (10%);Mo-molybdopterin cofactor biosynthetic process (3%);polysaccharide biosynthetic process (2%),IPR011089 (8%);IPR013785 (8%);IPR036388 (8%),Domain of unknown function DUF1524 (8%);Aldolase-type TIM barrel (8%);Winged helix-like DNA-binding domain superfamily (8%),,,,,,,,,,
NLWQVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (56%);GO:0005887 (19%);GO:0019867 (6%),integral component of membrane (56%);integral component of plasma membrane (19%);outer membrane (6%),GO:0003983 (13%);GO:0030246 (13%);GO:0004499 (6%),UTP:glucose-1-phosphate uridylyltransferase activity (13%);carbohydrate binding (13%);N,N-dimethylaniline monooxygenase activity (6%),GO:0009306 (19%);GO:0006011 (13%);GO:0009058 (13%),protein secretion (19%);UDP-glucose metabolic process (13%);biosynthetic process (13%),IPR007168 (26%);IPR021255 (26%);IPR007452 (16%),Phage shock protein, PspC, N-terminal (26%);Putative auto-transporter adhesin, head GIN domain (26%);Translocation and assembly module TamB (16%),,,,,,,
LFLLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.84 (39%);3.1.1.61 (25%);2.7.7.85 (8%),Alcohol-forming fatty acyl-CoA reductase (39%);Protein-glutamate methylesterase (25%);Diadenylate cyclase (8%),GO:0016021 (43%);GO:0005737 (7%);GO:0005886 (6%),integral component of membrane (43%);cytoplasm (7%);plasma membrane (6%),GO:0005524 (10%);GO:0102965 (9%);GO:0080019 (8%),ATP binding (10%);alcohol-forming fatty acyl-CoA reductase activity (9%);fatty-acyl-CoA reductase (alcohol-forming) activity (8%),GO:0006629 (9%);GO:0006935 (6%);GO:0006366 (5%),lipid metabolic process (9%);chemotaxis (6%);transcription by RNA polymerase II (5%),IPR036291 (9%);IPR013120 (8%);IPR026055 (8%),NAD(P)-binding domain superfamily (9%);Male sterility, NAD-binding (8%);Fatty acyl-CoA reductase (8%),,,,,,,,,,
VESGDLEANGEDFLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLDEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.23 (77%);1.16.3.2 (6%);1.5.1.2 (5%),Histidinol dehydrogenase (77%);Bacterial non-heme ferritin (6%);Pyrroline-5-carboxylate reductase (5%),GO:0016021 (13%);GO:0005737 (6%);GO:0005623 (3%),integral component of membrane (13%);cytoplasm (6%);cell (3%),GO:0008270 (39%);GO:0004399 (38%);GO:0051287 (37%),zinc ion binding (39%);histidinol dehydrogenase activity (38%);NAD binding (37%),GO:0000105 (38%);GO:0006355 (4%);GO:0006879 (3%),histidine biosynthetic process (38%);regulation of transcription, DNA-templated (4%);cellular iron ion homeostasis (3%),IPR001692 (31%);IPR012131 (31%);IPR016161 (31%),Histidinol dehydrogenase, conserved site (31%);Histidinol dehydrogenase (31%);Aldehyde/histidinol dehydrogenase (31%),,,,,,,,,
NAALTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (26%);GO:0009279 (7%);GO:0019867 (4%),integral component of membrane (26%);cell outer membrane (7%);outer membrane (4%),GO:0003677 (48%);GO:0043565 (7%);GO:0003676 (4%),DNA binding (48%);sequence-specific DNA binding (7%);nucleic acid binding (4%),GO:0015074 (48%);GO:0032196 (48%);GO:0000160 (7%),DNA integration (48%);transposition (48%);phosphorelay signal transduction system (7%),IPR001584 (47%);IPR012337 (47%);IPR024967 (47%),Integrase, catalytic core (47%);Ribonuclease H-like superfamily (47%);DNA-binding domain, IS481-type (47%),,,,,,,,,
NQFGADSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NALEDEDK,Methanoregulaceae,Archaea,,,,Euryarchaeota,,,Methanomicrobia,,,,Methanomicrobiales,,,,,Methanoregulaceae,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0016829 (100%),lyase activity (100%),,,IPR004155 (100%);IPR011989 (100%);IPR016024 (100%),PBS lyase HEAT-like repeat (100%);Armadillo-like helical (100%);Armadillo-type fold (100%),,,,,,,,,,,
DLDSAAYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESFDVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.22 (25%);2.4.99.16 (17%);2.1.2.11 (8%),UMP kinase (25%);Starch synthase (maltosyl-transferring) (17%);3-methyl-2-oxobutanoate hydroxymethyltransferase (8%),GO:0016021 (15%);GO:0005737 (9%);GO:0043190 (4%),integral component of membrane (15%);cytoplasm (9%);ATP-binding cassette (ABC) transporter complex (4%),GO:0005524 (17%);GO:0003677 (11%);GO:0008483 (7%),ATP binding (17%);DNA binding (11%);transaminase activity (7%),GO:0044210 (7%);GO:0009190 (4%);GO:0030979 (4%),'de novo' CTP biosynthetic process (7%);cyclic nucleotide biosynthetic process (4%);alpha-glucan biosynthetic process (4%),IPR027417 (10%);IPR003593 (9%);IPR032710 (7%),P-loop containing nucleoside triphosphate hydrolase (10%);AAA+ ATPase domain (9%);NTF2-like domain superfamily (7%),,,,,,,,,,,
NWAEVVFAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YGGNTALSAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLENVVNK,Candidatus Roizmanbacteria,Bacteria,,,,Candidatus Roizmanbacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%),ATP binding (100%),GO:0009058 (100%),biosynthetic process (100%),IPR013221 (100%);IPR013564 (100%);IPR036565 (100%),Mur ligase, central (100%);Domain of unknown function DUF1727 (100%);Mur-like, catalytic domain superfamily (100%),,,,,,,,,
VALALALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (92%);2.7.-.- (8%),Non-specific serine/threonine protein kinase (92%);Transferring phosphorus-containing groups (8%),GO:0016021 (64%);GO:0016020 (17%);GO:0042597 (17%),integral component of membrane (64%);membrane (17%);periplasmic space (17%),GO:0004674 (31%);GO:0004553 (17%);GO:0008933 (17%),protein serine/threonine kinase activity (31%);hydrolase activity, hydrolyzing O-glycosyl compounds (17%);lytic transglycosylase activity (17%),GO:0000270 (17%);GO:0006635 (6%),peptidoglycan metabolic process (17%);fatty acid beta-oxidation (6%),IPR001611 (61%);IPR032675 (61%);IPR003591 (55%),Leucine-rich repeat (61%);Leucine-rich repeat domain superfamily (61%);Leucine-rich repeat, typical subtype (55%),,,,,,,,,
DELEELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.17 (28%);5.6.2.2 (21%);2.3.1.29 (13%),Glutamate--tRNA ligase (28%);DNA topoisomerase (ATP-hydrolyzing) (21%);Glycine C-acetyltransferase (13%),GO:0005615 (16%);GO:0016459 (12%);GO:0016021 (11%),extracellular space (16%);myosin complex (12%);integral component of membrane (11%),GO:0005524 (49%);GO:0016887 (26%);GO:0051015 (15%),ATP binding (49%);ATPase activity (26%);actin filament binding (15%),GO:0010506 (16%);GO:0090286 (5%);GO:0051017 (4%),regulation of autophagy (16%);cytoskeletal anchoring at nuclear membrane (5%);actin filament bundle assembly (4%),IPR027417 (42%);IPR003593 (23%);IPR003439 (22%),P-loop containing nucleoside triphosphate hydrolase (42%);AAA+ ATPase domain (23%);ABC transporter-like (22%),,,,,,,,,,,
NFEFVTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFPSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.16.- (25%);3.4.11.4 (23%);3.1.26.4 (10%),Serine-type carboxypeptidases (25%);Tripeptide aminopeptidase (23%);Ribonuclease H (10%),GO:0016021 (15%);GO:0005737 (8%);GO:0005874 (2%),integral component of membrane (15%);cytoplasm (8%);microtubule (2%),GO:0016787 (22%);GO:0016491 (9%);GO:0004185 (8%),hydrolase activity (22%);oxidoreductase activity (9%);serine-type carboxypeptidase activity (8%),GO:0006507 (11%);GO:0009952 (11%);GO:0021532 (11%),GPI anchor release (11%);anterior/posterior pattern specification (11%);neural tube patterning (11%),IPR004963 (17%);IPR036188 (11%);IPR006076 (10%),Pectinacetylesterase/NOTUM (17%);FAD/NAD(P)-binding domain superfamily (11%);FAD dependent oxidoreductase (10%),,,,,,,,,,,
EELDNQVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLPVLLGFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFVLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (78%);3.1.21.- (11%);3.1.3.16 (11%),Methyltransferases (78%);Endodeoxyribonucleases producing 5'-phosphomonoesters (11%);Protein-serine/threonine phosphatase (11%),GO:0016021 (37%);GO:0005634 (6%);GO:0005623 (2%),integral component of membrane (37%);nucleus (6%);cell (2%),GO:0003723 (22%);GO:0008168 (12%);GO:0003677 (8%),RNA binding (22%);methyltransferase activity (12%);DNA binding (8%),GO:0006364 (12%);GO:0032259 (12%);GO:0006355 (4%),rRNA processing (12%);methylation (12%);regulation of transcription, DNA-templated (4%),IPR001313 (22%);IPR016024 (22%);IPR040059 (22%),Pumilio RNA-binding repeat (22%);Armadillo-type fold (22%);Pumilio homologue 3 (22%),,,,,,,,,,
VFSSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.6 (13%);3.4.21.92 (8%);5.6.2.2 (8%),Lysine--tRNA ligase (13%);Endopeptidase Clp (8%);DNA topoisomerase (ATP-hydrolyzing) (8%),GO:0016021 (31%);GO:0005737 (6%);GO:0009279 (3%),integral component of membrane (31%);cytoplasm (6%);cell outer membrane (3%),GO:0003677 (18%);GO:0005524 (14%);GO:0003700 (9%),DNA binding (18%);ATP binding (14%);DNA-binding transcription factor activity (9%),GO:0042373 (9%);GO:0006352 (8%);GO:0006397 (4%),vitamin K metabolic process (9%);DNA-templated transcription, initiation (8%);mRNA processing (4%),IPR036388 (9%);IPR007627 (7%);IPR013325 (7%),Winged helix-like DNA-binding domain superfamily (9%);RNA polymerase sigma-70 region 2 (7%);RNA polymerase sigma factor, region 2 (7%),,,,,,,,,
MAPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (16%);3.2.2.0 (8%);2.7.11.1 (5%),Acting on ester bonds (16%); (8%);Non-specific serine/threonine protein kinase (5%),GO:0016021 (16%);GO:0005737 (6%);GO:0008180 (4%),integral component of membrane (16%);cytoplasm (6%);COP9 signalosome (4%),GO:0005524 (14%);GO:0003723 (13%);GO:0016887 (8%),ATP binding (14%);RNA binding (13%);ATPase activity (8%),GO:0006364 (2%);GO:0006281 (2%);GO:0031388 (2%),rRNA processing (2%);DNA repair (2%);organic acid phosphorylation (2%),IPR027417 (10%);IPR035979 (9%);IPR000504 (9%),P-loop containing nucleoside triphosphate hydrolase (10%);RNA-binding domain superfamily (9%);RNA recognition motif domain (9%),,,,,,,,,,,
WNNQNQWDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAQLSEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.9 (88%);3.1.-.- (13%),Glucose-6-phosphate isomerase (88%);Acting on ester bonds (13%),GO:0005737 (54%);GO:0016021 (23%);GO:0005886 (15%),cytoplasm (54%);integral component of membrane (23%);plasma membrane (15%),GO:0004347 (54%);GO:0003723 (8%);GO:0004521 (8%),glucose-6-phosphate isomerase activity (54%);RNA binding (8%);endoribonuclease activity (8%),GO:0006094 (54%);GO:0006096 (54%);GO:0000160 (15%),gluconeogenesis (54%);glycolytic process (54%);phosphorelay signal transduction system (15%),IPR001672 (44%);IPR018189 (44%);IPR035476 (44%),Phosphoglucose isomerase (PGI) (44%);Phosphoglucose isomerase, conserved site (44%);Phosphoglucose isomerase, SIS domain 1 (44%),,,,,,,,,
EAGWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.11 (27%);4.1.1.32 (7%);2.1.1.33 (5%),Aspartate-semialdehyde dehydrogenase (27%);Phosphoenolpyruvate carboxykinase (GTP) (7%);tRNA (guanine(46)-N(7))-methyltransferase (5%),GO:0016021 (20%);GO:0005737 (4%);GO:0043190 (4%),integral component of membrane (20%);cytoplasm (4%);ATP-binding cassette (ABC) transporter complex (4%),GO:0005524 (8%);GO:0003677 (8%);GO:0004073 (7%),ATP binding (8%);DNA binding (8%);aspartate-semialdehyde dehydrogenase activity (7%),GO:0009089 (7%);GO:0009088 (7%);GO:0009097 (7%),lysine biosynthetic process via diaminopimelate (7%);threonine biosynthetic process (7%);isoleucine biosynthetic process (7%),IPR036291 (8%);IPR029044 (8%);IPR027417 (6%),NAD(P)-binding domain superfamily (8%);Nucleotide-diphospho-sugar transferases (8%);P-loop containing nucleoside triphosphate hydrolase (6%),,,,,,,,,,,
FELDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (36%);2.7.7.6 (16%);3.1.11.5 (4%),Glycine--tRNA ligase (36%);DNA-directed RNA polymerase (16%);Exodeoxyribonuclease V (4%),GO:0016021 (30%);GO:0005737 (14%);GO:0005886 (2%),integral component of membrane (30%);cytoplasm (14%);plasma membrane (2%),GO:0005524 (22%);GO:0004820 (10%);GO:0003677 (9%),ATP binding (22%);glycine-tRNA ligase activity (10%);DNA binding (9%),GO:0006426 (10%);GO:0006420 (7%);GO:0006351 (5%),glycyl-tRNA aminoacylation (10%);arginyl-tRNA aminoacylation (7%);transcription, DNA-templated (5%),IPR027417 (10%);IPR015944 (8%);IPR006194 (8%),P-loop containing nucleoside triphosphate hydrolase (10%);Glycine-tRNA ligase, beta subunit (8%);Glycine-tRNA synthetase, heterodimeric (8%),,,,,,,,
ELVVNTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003951 (75%);GO:0004519 (25%),NAD+ kinase activity (75%);endonuclease activity (25%),GO:0006741 (75%);GO:0019674 (75%),NADP biosynthetic process (75%);NAD metabolic process (75%),IPR002504 (50%);IPR016064 (50%);IPR017437 (50%),NAD kinase (50%);NAD kinase/diacylglycerol kinase-like domain superfamily (50%);ATP-NAD kinase, PpnK-type, C-terminal (50%),,,,,,,,,
EHFEVNYLVPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSEQTEK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0003677 (67%),DNA binding (67%),GO:0000160 (67%);GO:0006355 (67%),phosphorelay signal transduction system (67%);regulation of transcription, DNA-templated (67%),IPR001789 (100%);IPR001867 (100%);IPR011006 (100%),Signal transduction response regulator, receiver domain (100%);OmpR/PhoB-type DNA-binding domain (100%);CheY-like superfamily (100%),,,,,,,,,
YNLSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.3 (16%);4.2.1.75 (14%);2.3.1.81 (11%),Adenylate kinase (16%);Uroporphyrinogen-III synthase (14%);Aminoglycoside N(3)-acetyltransferase (11%),GO:0016021 (24%);GO:0005737 (9%);GO:0035658 (3%),integral component of membrane (24%);cytoplasm (9%);Mon1-Ccz1 complex (3%),GO:0005524 (26%);GO:0003676 (16%);GO:0004386 (12%),ATP binding (26%);nucleic acid binding (16%);helicase activity (12%),GO:0044209 (3%);GO:0006423 (3%);GO:0006780 (3%),AMP salvage (3%);cysteinyl-tRNA aminoacylation (3%);uroporphyrinogen III biosynthetic process (3%),IPR027417 (18%);IPR023210 (11%);IPR036812 (11%),P-loop containing nucleoside triphosphate hydrolase (18%);NADP-dependent oxidoreductase domain (11%);NADP-dependent oxidoreductase domain superfamily (11%),,,,,,,,,,,
DEAANNYAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EALADLFAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR018445 (75%);IPR038078 (75%);IPR023214 (25%),Putative phosphate transport regulator (75%);PhoU-like domain superfamily (75%);HAD superfamily (25%),,,,,,,,,,,
NEAFATR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0003755 (33%);GO:0016787 (33%);GO:0016831 (33%),peptidyl-prolyl cis-trans isomerase activity (33%);hydrolase activity (33%);carboxy-lyase activity (33%),,,IPR000297 (33%);IPR006680 (33%);IPR010897 (33%),Peptidyl-prolyl cis-trans isomerase, PpiC-type (33%);Amidohydrolase-related (33%);Sporulation stage II, protein P (33%),,,,,,,,,
ESAEWMNVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGLLNEAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNVEAMDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAEVFVPTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MCQLLSPYSTAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLAPPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (50%);2.1.1.- (7%);3.1.2.15 (7%),DNA helicase (50%);Methyltransferases (7%);Deleted entry (7%),GO:0005856 (85%);GO:0005737 (85%);GO:0005884 (7%),cytoskeleton (85%);cytoplasm (85%);actin filament (7%),GO:0005524 (97%);GO:0042802 (6%);GO:0005200 (5%),ATP binding (97%);identical protein binding (6%);structural constituent of cytoskeleton (5%),GO:0010628 (6%);GO:0090131 (5%);GO:0006897 (4%),positive regulation of gene expression (6%);mesenchyme migration (5%);endocytosis (4%),IPR004000 (99%);IPR020902 (77%);IPR004001 (73%),Actin family (99%);Actin/actin-like conserved site (77%);Actin, conserved site (73%),,,,,,,,,,
SNFNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.3.3 (40%);2.7.7.6 (14%);3.4.24.- (6%),Coproporphyrinogen oxidase (40%);DNA-directed RNA polymerase (14%);Metalloendopeptidases (6%),GO:0016021 (21%);GO:0005737 (10%);GO:0005840 (4%),integral component of membrane (21%);cytoplasm (10%);ribosome (4%),GO:0046872 (30%);GO:0003676 (18%);GO:0005524 (9%),metal ion binding (30%);nucleic acid binding (18%);ATP binding (9%),GO:0006355 (14%);GO:0006782 (7%);GO:0006412 (4%),regulation of transcription, DNA-templated (14%);protoporphyrinogen IX biosynthetic process (7%);translation (4%),IPR013087 (18%);IPR036236 (17%);IPR001909 (14%),Zinc finger C2H2-type (18%);Zinc finger C2H2 superfamily (17%);Krueppel-associated box (14%),,,,,,,,,,
SSESSVTEDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALAPEYEK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.4.1 (100%),Protein disulfide-isomerase (100%),GO:0005623 (97%);GO:0005783 (4%);GO:0005788 (4%),cell (97%);endoplasmic reticulum (4%);endoplasmic reticulum lumen (4%),GO:0003756 (90%);GO:0016853 (8%);GO:0051213 (1%),protein disulfide isomerase activity (90%);isomerase activity (8%);dioxygenase activity (1%),GO:0045454 (97%);GO:0006457 (4%);GO:0034976 (4%),cell redox homeostasis (97%);protein folding (4%);response to endoplasmic reticulum stress (4%),IPR013766 (100%);IPR017937 (100%);IPR036249 (100%),Thioredoxin domain (100%);Thioredoxin, conserved site (100%);Thioredoxin-like superfamily (100%),,,,,,,,,,
VLQNEAVNAVSTKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YSFWEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.- (50%);4.1.2.48 (50%),Phosphoric diester hydrolases (50%);Low-specificity L-threonine aldolase (50%),GO:0016021 (23%);GO:0005654 (15%);GO:0005794 (15%),integral component of membrane (23%);nucleoplasm (15%);Golgi apparatus (15%),GO:0016829 (31%);GO:0000014 (15%);GO:0003684 (8%),lyase activity (31%);single-stranded DNA endodeoxyribonuclease activity (15%);damaged DNA binding (8%),GO:0006520 (31%);GO:0010212 (15%);GO:0030183 (15%),cellular amino acid metabolic process (31%);response to ionizing radiation (15%);B cell differentiation (15%),IPR001597 (29%);IPR011084 (29%);IPR015421 (29%),Aromatic amino acid beta-eliminating lyase/threonine aldolase (29%);DNA repair metallo-beta-lactamase (29%);Pyridoxal phosphate-dependent transferase, major domain (29%),,,,,,,,,,
LATGFAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.94 (20%);3.4.21.62 (20%);4.2.1.17 (20%),Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (20%);Subtilisin (20%);Enoyl-CoA hydratase (20%),GO:0016021 (27%);GO:0009279 (9%);GO:0005737 (5%),integral component of membrane (27%);cell outer membrane (9%);cytoplasm (5%),GO:0008168 (18%);GO:0004252 (14%);GO:0005337 (9%),methyltransferase activity (18%);serine-type endopeptidase activity (14%);nucleoside transmembrane transporter activity (9%),GO:0032259 (18%);GO:0007165 (9%);GO:0005975 (5%),methylation (18%);signal transduction (9%);carbohydrate metabolic process (5%),IPR029063 (16%);IPR000209 (12%);IPR023828 (12%),S-adenosyl-L-methionine-dependent methyltransferase (16%);Peptidase S8/S53 domain (12%);Peptidase S8, subtilisin, Ser-active site (12%),,,,,,,,,
SALEQWNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTVNGAETPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNALNQSLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFVPLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.37 (100%),5-aminolevulinate synthase (100%),GO:0016021 (10%),integral component of membrane (10%),GO:0003824 (30%);GO:0008270 (30%);GO:0050662 (20%),catalytic activity (30%);zinc ion binding (30%);coenzyme binding (20%),GO:0007165 (10%);GO:0033014 (10%),signal transduction (10%);tetrapyrrole biosynthetic process (10%),IPR011990 (20%);IPR024983 (20%);IPR036291 (20%),Tetratricopeptide-like helical domain superfamily (20%);CHAT domain (20%);NAD(P)-binding domain superfamily (20%),,,,,,,,,,,
VLGNLLVTNPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEQQLAEDVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEDLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.- (8%);2.8.4.4 (7%);2.7.1.40 (6%),Other oxidoreductases (8%);[Ribosomal protein S12] (aspartate(89)-C(3))-methylthiotransferase (7%);Pyruvate kinase (6%),GO:0016021 (35%);GO:0005737 (9%);GO:0005884 (8%),integral component of membrane (35%);cytoplasm (9%);actin filament (8%),GO:0005524 (12%);GO:0008270 (10%);GO:0016491 (9%),ATP binding (12%);zinc ion binding (10%);oxidoreductase activity (9%),GO:0045010 (8%);GO:0006412 (4%);GO:0071973 (2%),actin nucleation (8%);translation (4%);bacterial-type flagellum-dependent cell motility (2%),IPR032710 (22%);IPR007430 (22%);IPR036291 (9%),NTF2-like domain superfamily (22%);Bacterial virulence protein VirB8 (22%);NAD(P)-binding domain superfamily (9%),,,,,,,,,,,
LLEQEEYK,Myzostoma alatum,Eukaryota,Metazoa,,,Annelida,,,,,,,Myzostomida,,,,,Myzostomatidae,,,,Myzostoma,,,,Myzostoma alatum,,,,,,GO:0016459 (100%),myosin complex (100%),GO:0003774 (100%);GO:0003779 (100%);GO:0005524 (100%),motor activity (100%);actin binding (100%);ATP binding (100%),,,IPR001609 (100%);IPR027417 (100%),Myosin head, motor domain (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,,
QWLLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.31 (50%);6.5.1.1 (50%),Phosphoribosyl-ATP diphosphatase (50%);DNA ligase (ATP) (50%),GO:0016021 (44%);GO:0005886 (8%);GO:0005737 (5%),integral component of membrane (44%);plasma membrane (8%);cytoplasm (5%),GO:0016874 (13%);GO:0003676 (5%);GO:0003910 (5%),ligase activity (13%);nucleic acid binding (5%);DNA ligase (ATP) activity (5%),GO:0000105 (5%);GO:0006865 (5%);GO:0055114 (5%),histidine biosynthetic process (5%);amino acid transport (5%);oxidation-reduction process (5%),IPR014144 (17%);IPR022266 (13%);IPR001841 (9%),DNA ligase D, 3'-phosphoesterase domain (17%);Integrating conjugative element protein, PFL4697-type (13%);Zinc finger, RING-type (9%),,,,,,,,
MSFEVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008168 (100%),methyltransferase activity (100%),GO:0032259 (100%),methylation (100%),IPR010736 (50%);IPR001525 (25%);IPR012925 (25%),Sperm-tail PG-rich repeat (50%);C-5 cytosine methyltransferase (25%);TipAS antibiotic-recognition domain (25%),,,,,,,,,,,
FLFNDDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLVFVNVLGNAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNGNEQTHAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPGMHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNQQFLNAAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYLSQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.- (32%);2.7.4.- (32%);2.6.1.16 (7%),Protein-serine/threonine kinases (32%);Phosphotransferases with a phosphate group as acceptor (32%);Glutamine--fructose-6-phosphate transaminase (isomerizing) (7%),GO:0016021 (24%);GO:0005623 (6%);GO:0005737 (5%),integral component of membrane (24%);cell (6%);cytoplasm (5%),GO:0005524 (14%);GO:0003677 (13%);GO:0003676 (10%),ATP binding (14%);DNA binding (13%);nucleic acid binding (10%),GO:0006351 (9%);GO:0030420 (9%);GO:0005975 (7%),transcription, DNA-templated (9%);establishment of competence for transformation (9%);carbohydrate metabolic process (7%),IPR027417 (8%);IPR012340 (7%);IPR016940 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);Nucleic acid-binding, OB-fold (7%);ComG operon protein C (7%),,,,,,,,,
TGAENSELTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNDLELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.-.- (20%);2.5.1.6 (20%);3.1.11.6 (20%),Acting on the CH-CH group of donors (20%);Methionine adenosyltransferase (20%);Exodeoxyribonuclease VII (20%),GO:0016021 (49%);GO:0005737 (13%);GO:0009279 (9%),integral component of membrane (49%);cytoplasm (13%);cell outer membrane (9%),GO:0005524 (17%);GO:0022857 (15%);GO:0016887 (6%),ATP binding (17%);transmembrane transporter activity (15%);ATPase activity (6%),GO:0006355 (6%);GO:0009584 (5%);GO:0018298 (5%),regulation of transcription, DNA-templated (6%);detection of visible light (5%);protein-chromophore linkage (5%),IPR006143 (13%);IPR032317 (13%);IPR027417 (12%),RND efflux pump, membrane fusion protein (13%);RND efflux pump, membrane fusion protein, barrel-sandwich domain (13%);P-loop containing nucleoside triphosphate hydrolase (12%),,,,,,,
VSEETTTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNGPVNQAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTNVLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.4.2 (25%);3.4.-.- (25%);3.5.4.19 (25%),Glycine dehydrogenase (aminomethyl-transferring) (25%);Acting on peptide bonds (peptidases) (25%);Phosphoribosyl-AMP cyclohydrolase (25%),GO:0000145 (10%);GO:0016021 (10%);GO:0009279 (4%),exocyst (10%);integral component of membrane (10%);cell outer membrane (4%),GO:0003700 (65%);GO:0043565 (65%);GO:0005524 (3%),DNA-binding transcription factor activity (65%);sequence-specific DNA binding (65%);ATP binding (3%),GO:0006887 (10%);GO:0015031 (10%);GO:0000105 (1%),exocytosis (10%);protein transport (10%);histidine biosynthetic process (1%),IPR009057 (63%);IPR018060 (63%);IPR018062 (63%),Homeobox-like domain superfamily (63%);DNA binding HTH domain, AraC-type (63%);HTH domain AraC-type, conserved site (63%),,,,,,,,,
VVAELPEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLSLSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (61%);7.6.2.11 (10%);2.-.-.- (3%),DNA-directed DNA polymerase (61%);ABC-type polyamine transporter (10%);Transferases (3%),GO:0005840 (36%);GO:0016021 (28%);GO:0005886 (8%),ribosome (36%);integral component of membrane (28%);plasma membrane (8%),GO:0003735 (36%);GO:0003723 (34%);GO:0003677 (8%),structural constituent of ribosome (36%);RNA binding (34%);DNA binding (8%),GO:0006412 (36%);GO:0006281 (6%);GO:0006260 (5%),translation (36%);DNA repair (6%);DNA replication (5%),IPR012340 (31%);IPR003029 (30%);IPR022967 (29%),Nucleic acid-binding, OB-fold (31%);S1 domain (30%);RNA-binding domain, S1 (29%),,,,,,,,,
AVVENPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (80%);2.7.2.3 (20%),Non-specific serine/threonine protein kinase (80%);Phosphoglycerate kinase (20%),GO:0016020 (50%);GO:0005634 (8%);GO:0005737 (8%),membrane (50%);nucleus (8%);cytoplasm (8%),GO:0022857 (50%);GO:0005524 (42%);GO:0004674 (33%),transmembrane transporter activity (50%);ATP binding (42%);protein serine/threonine kinase activity (33%),GO:0006096 (8%);GO:0006468 (8%);GO:0006478 (8%),glycolytic process (8%);protein phosphorylation (8%);peptidyl-tyrosine sulfation (8%),IPR006143 (46%);IPR032317 (46%);IPR000719 (31%),RND efflux pump, membrane fusion protein (46%);RND efflux pump, membrane fusion protein, barrel-sandwich domain (46%);Protein kinase domain (31%),,,,,,,,
FTANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (20%);2.3.1.61 (9%);2.7.7.7 (5%),DNA topoisomerase (ATP-hydrolyzing) (20%);Dihydrolipoyllysine-residue succinyltransferase (9%);DNA-directed DNA polymerase (5%),GO:0016021 (67%);GO:0033644 (50%);GO:0044220 (50%),integral component of membrane (67%);host cell membrane (50%);host cell perinuclear region of cytoplasm (50%),GO:0003723 (51%);GO:0008270 (50%);GO:0003968 (50%),RNA binding (51%);zinc ion binding (50%);RNA-directed 5'-3' RNA polymerase activity (50%),GO:0019082 (50%);GO:0039520 (50%);GO:0006351 (26%),viral protein processing (50%);induction by virus of host autophagy (50%);transcription, DNA-templated (26%),IPR009003 (44%);IPR008740 (44%);IPR032505 (44%),Peptidase S1, PA clan (44%);Peptidase C30, Coronavirus endopeptidase (44%);Coronavirus nonstructural protein 4, C-terminal (44%),,,,,,,
WEEEGDDEEVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSDGGADAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YAVGENK,Hungatella hathewayi,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Clostridiaceae,,,,Hungatella,,,,Hungatella hathewayi,,,,,,,,,,,,IPR001279 (100%);IPR036866 (100%);IPR041712 (100%),Metallo-beta-lactamase (100%);Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (100%);Methanocaldococcus jannaschii dihydropteroate synthase-like, MBL-fold metallo hydrolase domain (100%),,,,,,,,,,
WEFVVDAEGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALEHMER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (14%),integral component of membrane (14%),GO:0003924 (36%);GO:0005525 (36%);GO:0008484 (29%),GTPase activity (36%);GTP binding (36%);sulfuric ester hydrolase activity (29%),GO:0044238 (14%),primary metabolic process (14%),IPR005129 (31%);IPR027417 (31%);IPR000917 (25%),SIMIBI class G3E GTPase, ArgK/MeaB (31%);P-loop containing nucleoside triphosphate hydrolase (31%);Sulfatase, N-terminal (25%),,,,,,,,,
TVDAELAEVLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLNAPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.7 (100%),Imidazolonepropionase (100%),GO:0016021 (38%);GO:0005737 (8%),integral component of membrane (38%);cytoplasm (8%),GO:0003700 (23%);GO:0003677 (15%);GO:0016987 (15%),DNA-binding transcription factor activity (23%);DNA binding (15%);sigma factor activity (15%),GO:0007165 (15%);GO:0006352 (8%);GO:0008643 (8%),signal transduction (15%);DNA-templated transcription, initiation (8%);carbohydrate transport (8%),IPR002725 (24%);IPR000943 (12%);IPR003660 (12%),Protein of unknown function DUF45 (24%);RNA polymerase sigma-70 (12%);HAMP domain (12%),,,,,,,,,,
YSQNYNK,Sparassis crispa,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Agaricomycetes,,,,Polyporales,,,,,Sparassidaceae,,,,Sparassis,,,,Sparassis crispa,,,,,,,,,,GO:0000902 (100%),cell morphogenesis (100%),IPR016024 (100%);IPR025481 (100%);IPR025614 (100%),Armadillo-type fold (100%);Cell morphogenesis protein C-terminal (100%);Cell morphogenesis protein N-terminal (100%),,,,,,,,,,,
MLVVVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.76 (50%);3.2.1.89 (50%),(S,S)-butanediol dehydrogenase (50%);Arabinogalactan endo-beta-1,4-galactanase (50%),,,GO:0043531 (33%);GO:0003723 (17%);GO:0005096 (17%),ADP binding (33%);RNA binding (17%);GTPase activator activity (17%),GO:0008152 (17%);GO:0051056 (17%),metabolic process (17%);regulation of small GTPase mediated signal transduction (17%),IPR002182 (25%);IPR006936 (25%);IPR011713 (25%),NB-ARC (25%);ALOG domain (25%);Leucine-rich repeat 3 (25%),,,,,,,,,
SVGEDWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSMELMSLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNSGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (10%);2.4.2.29 (7%);3.4.21.22 (7%),Methyltransferases (10%);tRNA-guanine(34) transglycosylase (7%);Coagulation factor IXa (7%),GO:0016021 (18%);GO:0005576 (9%);GO:0016020 (9%),integral component of membrane (18%);extracellular region (9%);membrane (9%),GO:0005509 (15%);GO:0004252 (15%);GO:0005524 (8%),calcium ion binding (15%);serine-type endopeptidase activity (15%);ATP binding (8%),GO:0007596 (15%);GO:0031638 (6%);GO:0032543 (5%),blood coagulation (15%);zymogen activation (6%);mitochondrial translation (5%),IPR000294 (13%);IPR017857 (13%);IPR035694 (13%),Gamma-carboxyglutamic acid-rich (GLA) domain (13%);Coagulation factor-like, Gla domain superfamily (13%);Coagulation factor IX (13%),,,,,,,,,,
GNDLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.13 (53%);2.3.1.274 (38%);2.7.13.3 (1%),Methionine synthase (53%);Phosphate acyltransferase (38%);Histidine kinase (1%),GO:0005737 (37%);GO:0016021 (7%);GO:0005886 (2%),cytoplasm (37%);integral component of membrane (7%);plasma membrane (2%),GO:0008270 (31%);GO:0031419 (31%);GO:0008705 (30%),zinc ion binding (31%);cobalamin binding (31%);methionine synthase activity (30%),GO:0032259 (31%);GO:0042558 (24%);GO:0006633 (21%),methylation (31%);pteridine-containing compound metabolic process (24%);fatty acid biosynthetic process (21%),IPR000489 (30%);IPR011005 (30%);IPR003759 (29%),Pterin-binding domain (30%);Dihydropteroate synthase-like (30%);Cobalamin (vitamin B12)-binding module, cap domain (29%),,,,,,,,,,
FVLDQLAK,Actinobacteria,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003847 (100%),1-alkyl-2-acetylglycerophosphocholine esterase activity (100%),GO:0016042 (100%),lipid catabolic process (100%),IPR005065 (100%);IPR029058 (100%);IPR006311 (8%),Platelet-activating factor acetylhydrolase-like (100%);Alpha/Beta hydrolase fold (100%);Twin-arginine translocation pathway, signal sequence (8%),,,,,,,,,,
YQMWVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVLLFNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.4 (75%);1.1.1.22 (25%),Aspartate kinase (75%);UDP-glucose 6-dehydrogenase (25%),GO:0016021 (29%),integral component of membrane (29%),GO:0005524 (36%);GO:0004072 (21%);GO:0003979 (7%),ATP binding (36%);aspartate kinase activity (21%);UDP-glucose 6-dehydrogenase activity (7%),GO:0009088 (21%);GO:0009089 (21%);GO:0000271 (7%),threonine biosynthetic process (21%);lysine biosynthetic process via diaminopimelate (21%);polysaccharide biosynthetic process (7%),IPR001048 (23%);IPR001341 (23%);IPR002912 (23%),Aspartate/glutamate/uridylate kinase (23%);Aspartate kinase (23%);ACT domain (23%),,,,,,,,,,,
MGGLVEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNNWTMHMVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAPEHPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.-.- (67%);4.6.1.1 (33%),Glycosyltransferases (67%);Adenylate cyclase (33%),GO:0016021 (11%),integral component of membrane (11%),GO:0016849 (68%);GO:0016740 (9%);GO:0005524 (5%),phosphorus-oxygen lyase activity (68%);transferase activity (9%);ATP binding (5%),GO:0009190 (70%);GO:0035556 (70%);GO:0006438 (2%),cyclic nucleotide biosynthetic process (70%);intracellular signal transduction (70%);valyl-tRNA aminoacylation (2%),IPR011990 (76%);IPR013026 (75%);IPR019734 (75%),Tetratricopeptide-like helical domain superfamily (76%);Tetratricopeptide repeat-containing domain (75%);Tetratricopeptide repeat (75%),,,,,,,,,,,
VSFPSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (50%);GO:0016787 (50%);GO:0016887 (50%),ATP binding (50%);hydrolase activity (50%);ATPase activity (50%),,,IPR002925 (50%);IPR003439 (50%);IPR003593 (50%),Dienelactone hydrolase (50%);ABC transporter-like (50%);AAA+ ATPase domain (50%),,,,,,,,,,,
MPNLEVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.61 (50%);2.7.7.6 (50%),Dihydrolipoyllysine-residue succinyltransferase (50%);DNA-directed RNA polymerase (50%),GO:0016021 (25%);GO:0045252 (25%),integral component of membrane (25%);oxoglutarate dehydrogenase complex (25%),GO:0003677 (25%);GO:0003824 (25%);GO:0003899 (25%),DNA binding (25%);catalytic activity (25%);DNA-directed 5'-3' RNA polymerase activity (25%),GO:0006099 (25%);GO:0006351 (25%);GO:0033512 (25%),tricarboxylic acid cycle (25%);transcription, DNA-templated (25%);L-lysine catabolic process to acetyl-CoA via saccharopine (25%),IPR021866 (20%);IPR036513 (20%);IPR038396 (20%),SpoIIAA-like (20%);STAS domain superfamily (20%);SpoIIAA-like superfamily (20%),,,,,,,,,,
LLLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.2.11 (18%);2.7.7.- (7%);2.4.2.17 (6%),Phosphoglycerate mutase (2,3-diphosphoglycerate-dependent) (18%);Nucleotidyltransferases (7%);ATP phosphoribosyltransferase (6%),GO:0016021 (29%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (29%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (18%);GO:0003677 (12%);GO:0016887 (5%),ATP binding (18%);DNA binding (12%);ATPase activity (5%),GO:0006355 (4%);GO:0006352 (3%);GO:0007018 (3%),regulation of transcription, DNA-templated (4%);DNA-templated transcription, initiation (3%);microtubule-based movement (3%),IPR027417 (13%);IPR029033 (8%);IPR013078 (8%),P-loop containing nucleoside triphosphate hydrolase (13%);Histidine phosphatase superfamily (8%);Histidine phosphatase superfamily, clade-1 (8%),,,,,,,
LSLESLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (31%);2.3.2.27 (13%);6.5.1.2 (13%),Acting on ATP; involved in cellular and subcellular movement (31%);RING-type E3 ubiquitin transferase (13%);DNA ligase (NAD(+)) (13%),GO:0016021 (23%);GO:0005737 (14%);GO:0005634 (3%),integral component of membrane (23%);cytoplasm (14%);nucleus (3%),GO:0005524 (21%);GO:0003677 (11%);GO:0016787 (10%),ATP binding (21%);DNA binding (11%);hydrolase activity (10%),GO:0006355 (8%);GO:0000716 (7%);GO:0006526 (3%),regulation of transcription, DNA-templated (8%);transcription-coupled nucleotide-excision repair, DNA damage recognition (7%);arginine biosynthetic process (3%),IPR027417 (18%);IPR014001 (6%);IPR001650 (6%),P-loop containing nucleoside triphosphate hydrolase (18%);Helicase superfamily 1/2, ATP-binding domain (6%);Helicase, C-terminal (6%),,,,,,,
ASAESGEVTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YYGDDVSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFELFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.6 (21%);3.6.4.12 (10%);1.5.1.5 (8%),Beta-lactamase (21%);DNA helicase (10%);Methylenetetrahydrofolate dehydrogenase (NADP(+)) (8%),GO:0016021 (23%);GO:0005737 (4%);GO:0005886 (3%),integral component of membrane (23%);cytoplasm (4%);plasma membrane (3%),GO:0003677 (21%);GO:0005524 (18%);GO:0051287 (7%),DNA binding (21%);ATP binding (18%);NAD binding (7%),GO:0000160 (5%);GO:0005975 (2%);GO:0055072 (2%),phosphorelay signal transduction system (5%);carbohydrate metabolic process (2%);iron ion homeostasis (2%),IPR009057 (12%);IPR009403 (12%);IPR011990 (11%),Homeobox-like domain superfamily (12%);Protein of unknown function UPF0637 (12%);Tetratricopeptide-like helical domain superfamily (11%),,,,,,,,,,,
THSTELLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTNLTTGR,Meiothermus ruber,Bacteria,,,,Deinococcus-Thermus,,,Deinococci,,,,Thermales,,,,,Thermaceae,,,,Meiothermus,,,,Meiothermus ruber,,,,,,,,,,,,IPR009003 (100%),Peptidase S1, PA clan (100%),,,,,,,,,,
FELDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.- (16%);3.4.21.- (13%);4.1.1.48 (9%),With NADH or NADPH as one donor, and incorporation of one atom of oxygen (16%);Serine endopeptidases (13%);Indole-3-glycerol-phosphate synthase (9%),GO:0016021 (27%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (27%);cytoplasm (5%);plasma membrane (4%),GO:0005524 (29%);GO:0016301 (16%);GO:0004672 (13%),ATP binding (29%);kinase activity (16%);protein kinase activity (13%),GO:0006744 (13%);GO:0006351 (5%);GO:0039694 (5%),ubiquinone biosynthetic process (13%);transcription, DNA-templated (5%);viral RNA genome replication (5%),IPR011009 (12%);IPR000719 (11%);IPR027417 (11%),Protein kinase-like domain superfamily (12%);Protein kinase domain (11%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,,
ASFNFLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VADAGTHAHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNLEFLAK,Nitrosopumilus adriaticus,Archaea,,,,Thaumarchaeota,,,,,,,Nitrosopumilales,,,,,Nitrosopumilaceae,,,,Nitrosopumilus,,,,Nitrosopumilus adriaticus,,,,,,,,GO:0003824 (100%),catalytic activity (100%),,,IPR000653 (100%);IPR015421 (100%);IPR015422 (100%),DegT/DnrJ/EryC1/StrS aminotransferase (100%);Pyridoxal phosphate-dependent transferase, major domain (100%);Pyridoxal phosphate-dependent transferase domain 1 (100%),,,,,,,,,,
SFLAVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%);GO:0005634 (20%);GO:0005761 (20%),integral component of membrane (60%);nucleus (20%);mitochondrial ribosome (20%),GO:0005524 (40%);GO:0003723 (20%);GO:0003735 (20%),ATP binding (40%);RNA binding (20%);structural constituent of ribosome (20%),GO:0006412 (20%);GO:0006468 (20%),translation (20%);protein phosphorylation (20%),IPR000719 (33%);IPR008271 (33%);IPR010729 (33%),Protein kinase domain (33%);Serine/threonine-protein kinase, active site (33%);Ribosomal protein L47, mitochondrial (33%),,,,,,,,,
VNFFFTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMVHDLYSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGNFNYDALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLTDNAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.99.33 (100%),Urocanate reductase (100%),GO:0000145 (6%);GO:0016020 (6%),exocyst (6%);membrane (6%),GO:0003676 (44%);GO:0003677 (28%);GO:0000104 (6%),nucleic acid binding (44%);DNA binding (28%);succinate dehydrogenase activity (6%),GO:0015074 (72%);GO:0032196 (72%);GO:0006887 (6%),DNA integration (72%);transposition (72%);exocytosis (6%),IPR001584 (70%);IPR012337 (70%);IPR036397 (70%),Integrase, catalytic core (70%);Ribonuclease H-like superfamily (70%);Ribonuclease H superfamily (70%),,,,,,,,,,
KPSPDHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.29 (100%),Aminoacyl-tRNA hydrolase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004045 (100%),aminoacyl-tRNA hydrolase activity (100%),GO:0006412 (100%),translation (100%),IPR001328 (90%);IPR018171 (90%);IPR036416 (90%),Peptidyl-tRNA hydrolase (90%);Peptidyl-tRNA hydrolase, conserved site (90%);Peptidyl-tRNA hydrolase superfamily (90%),,,,,,,,,,
LSEQDSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004252 (100%);GO:0070008 (100%),serine-type endopeptidase activity (100%);serine-type exopeptidase activity (100%),,,IPR001375 (50%);IPR002470 (50%);IPR006600 (50%),Peptidase S9, prolyl oligopeptidase, catalytic domain (50%);Peptidase S9A, prolyl oligopeptidase (50%);HTH CenpB-type DNA-binding domain (50%),,,,,,,,
FLNFTSK,Rhizophagus irregularis,Eukaryota,Fungi,,,Mucoromycota,Glomeromycotina,,Glomeromycetes,,,,Glomerales,,,,,Glomeraceae,,,,Rhizophagus,,,,Rhizophagus irregularis,,,,,,,,GO:0005524 (100%);GO:0016787 (100%),ATP binding (100%);hydrolase activity (100%),,,IPR003959 (100%);IPR027417 (100%),ATPase, AAA-type, core (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,
SSMYEAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFVPELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (100%),Acting on ATP; involved in cellular and subcellular movement (100%),GO:0016021 (7%);GO:0005634 (5%);GO:0005623 (2%),integral component of membrane (7%);nucleus (5%);cell (2%),GO:0046872 (31%);GO:0047617 (24%);GO:0003723 (21%),metal ion binding (31%);acyl-CoA hydrolase activity (24%);RNA binding (21%),GO:0006637 (24%);GO:0009166 (7%);GO:0045944 (7%),acyl-CoA metabolic process (24%);nucleotide catabolic process (7%);positive regulation of transcription by RNA polymerase II (7%),IPR027417 (27%);IPR001900 (23%);IPR012340 (23%),P-loop containing nucleoside triphosphate hydrolase (27%);Ribonuclease II/R (23%);Nucleic acid-binding, OB-fold (23%),,,,,,,,,,
TQPVLLWFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQTHPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.49 (100%),RNA-directed DNA polymerase (100%),GO:0016021 (43%);GO:0005737 (24%);GO:0005829 (5%),integral component of membrane (43%);cytoplasm (24%);cytosol (5%),GO:0005524 (29%);GO:0004817 (24%);GO:0003964 (19%),ATP binding (29%);cysteine-tRNA ligase activity (24%);RNA-directed DNA polymerase activity (19%),GO:0006423 (24%);GO:0006412 (5%);GO:0006535 (5%),cysteinyl-tRNA aminoacylation (24%);translation (5%);cysteine biosynthetic process from serine (5%),IPR009080 (36%);IPR015273 (36%);IPR024909 (36%),Aminoacyl-tRNA synthetase, class Ia, anticodon-binding (36%);Cysteinyl-tRNA synthetase, class Ia, DALR (36%);Cysteinyl-tRNA synthetase/mycothiol ligase (36%),,,,,,,
NLALAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.4.1 (12%);2.1.1.222 (10%);2.1.1.64 (10%),Protein disulfide-isomerase (12%);2-polyprenyl-6-hydroxyphenol methylase (10%);3-demethylubiquinol 3-O-methyltransferase (10%),GO:0016021 (26%);GO:0005737 (6%);GO:0042613 (4%),integral component of membrane (26%);cytoplasm (6%);MHC class II protein complex (4%),GO:0008237 (10%);GO:0005524 (10%);GO:0046872 (6%),metallopeptidase activity (10%);ATP binding (10%);metal ion binding (6%),GO:0045454 (3%);GO:0006955 (3%);GO:0019882 (3%),cell redox homeostasis (3%);immune response (3%);antigen processing and presentation (3%),IPR002510 (8%);IPR035068 (8%);IPR036059 (8%),Metalloprotease TldD/PmbA (8%);Metalloprotease TldD/PmbA, N-terminal (8%);Metalloprotease TldD/PmbA superfamily (8%),,,,,,,,,,
LGGNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.4.3 (17%);2.1.1.14 (7%);4.3.2.2 (6%),tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (17%);5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (7%);Adenylosuccinate lyase (6%),GO:0016021 (24%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (24%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (17%);GO:0003677 (9%);GO:0008168 (9%),ATP binding (17%);DNA binding (9%);methyltransferase activity (9%),GO:0032259 (10%);GO:0006355 (7%);GO:0000160 (4%),methylation (10%);regulation of transcription, DNA-templated (7%);phosphorelay signal transduction system (4%),IPR027417 (11%);IPR023370 (8%);IPR036413 (8%),P-loop containing nucleoside triphosphate hydrolase (11%);TrmO-like, N-terminal domain (8%);YaeB-like superfamily (8%),,,,,,,,,
DYLLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (69%);3.1.26.- (3%);5.3.1.26 (3%),Transaminases (69%);Endoribonucleases producing 5'-phosphomonoesters (3%);Galactose-6-phosphate isomerase (3%),GO:0016021 (16%);GO:0005737 (5%);GO:0005886 (1%),integral component of membrane (16%);cytoplasm (5%);plasma membrane (1%),GO:0008483 (34%);GO:0030170 (34%);GO:0003677 (10%),transaminase activity (34%);pyridoxal phosphate binding (34%);DNA binding (10%),GO:0009058 (33%);GO:0000160 (3%);GO:0006355 (3%),biosynthetic process (33%);phosphorelay signal transduction system (3%);regulation of transcription, DNA-templated (3%),IPR015422 (31%);IPR015424 (31%);IPR015421 (31%),Pyridoxal phosphate-dependent transferase domain 1 (31%);Pyridoxal phosphate-dependent transferase (31%);Pyridoxal phosphate-dependent transferase, major domain (31%),,,,,,,,,
WLTNTMDVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQDLMLLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (37%);6.1.1.5 (4%);1.-.-.- (4%),Histidine kinase (37%);Isoleucine--tRNA ligase (4%);Oxidoreductases (4%),GO:0016021 (29%);GO:0005737 (10%);GO:0005886 (2%),integral component of membrane (29%);cytoplasm (10%);plasma membrane (2%),GO:0005524 (24%);GO:0000155 (9%);GO:0016491 (9%),ATP binding (24%);phosphorelay sensor kinase activity (9%);oxidoreductase activity (9%),GO:0006260 (2%);GO:0006457 (1%);GO:0007018 (1%),DNA replication (2%);protein folding (1%);microtubule-based movement (1%),IPR027417 (10%);IPR036890 (8%);IPR003594 (8%),P-loop containing nucleoside triphosphate hydrolase (10%);Histidine kinase/HSP90-like ATPase superfamily (8%);Histidine kinase/HSP90-like ATPase (8%),,,,,,,,,,,
MGGFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (9%);2.1.1.176 (5%);2.7.7.6 (4%),3-methyl-2-oxobutanoate hydroxymethyltransferase (9%);16S rRNA (cytosine(967)-C(5))-methyltransferase (5%);DNA-directed RNA polymerase (4%),GO:0016021 (41%);GO:0009279 (3%);GO:0005737 (3%),integral component of membrane (41%);cell outer membrane (3%);cytoplasm (3%),GO:0022857 (13%);GO:0003677 (11%);GO:0005524 (6%),transmembrane transporter activity (13%);DNA binding (11%);ATP binding (6%),GO:0032259 (4%);GO:0006355 (3%);GO:0006352 (3%),methylation (4%);regulation of transcription, DNA-templated (3%);DNA-templated transcription, initiation (3%),IPR023393 (18%);IPR005031 (18%);IPR012893 (8%),START-like domain superfamily (18%);Coenzyme Q-binding protein COQ10, START domain (18%);HipA-like, C-terminal (8%),,,,,,,
EFWNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.25 (50%);2.5.1.75 (50%),4-alpha-glucanotransferase (50%);tRNA dimethylallyltransferase (50%),GO:0016021 (3%),integral component of membrane (3%),GO:0004134 (67%);GO:0004135 (67%);GO:0008168 (15%),4-alpha-glucanotransferase activity (67%);amylo-alpha-1,6-glucosidase activity (67%);methyltransferase activity (15%),GO:0005980 (67%);GO:0032259 (15%);GO:0008033 (3%),glycogen catabolic process (67%);methylation (15%);tRNA processing (3%),IPR008928 (60%);IPR010401 (60%);IPR012341 (60%),Six-hairpin glycosidase superfamily (60%);Glycogen debranching enzyme (60%);Six-hairpin glycosidase-like superfamily (60%),,,,,,,,,,
LFNLVQQWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVALLMGR,Thermococcus celericrescens,Archaea,,,,Euryarchaeota,,,Thermococci,,,,Thermococcales,,,,,Thermococcaceae,,,,Thermococcus,,,,Thermococcus celericrescens,,,,4.3.99.3 (100%),7-carboxy-7-deazaguanine synthase (100%),,,GO:0000287 (100%);GO:0016840 (100%);GO:0051539 (100%),magnesium ion binding (100%);carbon-nitrogen lyase activity (100%);4 iron, 4 sulfur cluster binding (100%),,,IPR007197 (100%);IPR013785 (100%);IPR024924 (100%),Radical SAM (100%);Aldolase-type TIM barrel (100%);7-carboxy-7-deazaguanine synthase-like (100%),,,,,,,,,,
NLEALEWEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFLMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.56 (100%);2.7.7.48 (100%);2.7.7.88 (100%),mRNA (guanine-N(7)-)-methyltransferase (100%);RNA-directed RNA polymerase (100%);GDP polyribonucleotidyltransferase (100%),GO:0019012 (96%);GO:0030430 (96%);GO:0005840 (1%),virion (96%);host cell cytoplasm (96%);ribosome (1%),GO:0005524 (97%);GO:0003968 (97%);GO:0004482 (96%),ATP binding (97%);RNA-directed 5'-3' RNA polymerase activity (97%);mRNA (guanine-N7-)-methyltransferase activity (96%),GO:0006412 (1%);GO:0006313 (0%);GO:0006351 (0%),translation (1%);transposition, DNA-mediated (0%);transcription, DNA-templated (0%),IPR025786 (96%);IPR014023 (96%);IPR039736 (96%),Mononegavirus L protein 2-O-ribose methyltransferase (96%);Mononegavirales RNA-directed RNA polymerase catalytic domain (96%);RNA-directed RNA polymerase L, C-terminal (96%),,,,,,,,
GLASEHTLMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLAAPQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.12 (29%);1.17.7.4 (14%);1.7.99.4 (14%),tRNA pseudouridine(38-40) synthase (29%);4-hydroxy-3-methylbut-2-enyl diphosphate reductase (14%);Nitrate reductase (14%),GO:0016021 (18%);GO:0032420 (9%);GO:0000145 (3%),integral component of membrane (18%);stereocilium (9%);exocyst (3%),GO:0046872 (18%);GO:0016491 (15%);GO:0051539 (15%),metal ion binding (18%);oxidoreductase activity (15%);4 iron, 4 sulfur cluster binding (15%),GO:0042128 (12%);GO:0007605 (9%);GO:0048839 (9%),nitrate assimilation (12%);sensory perception of sound (9%);inner ear development (9%),IPR036388 (15%);IPR001867 (10%);IPR006655 (10%),Winged helix-like DNA-binding domain superfamily (15%);OmpR/PhoB-type DNA-binding domain (10%);Molybdopterin oxidoreductase, prokaryotic, conserved site (10%),,,,,,,,
TLLDYAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.25.1 (96%);2.4.1.1 (4%),Proteasome endopeptidase complex (96%);Glycogen phosphorylase (4%),GO:0005737 (65%);GO:0019773 (65%);GO:0005634 (47%),cytoplasm (65%);proteasome core complex, alpha-subunit complex (65%);nucleus (47%),GO:0004298 (65%);GO:0005524 (8%);GO:0003677 (7%),threonine-type endopeptidase activity (65%);ATP binding (8%);DNA binding (7%),GO:0043161 (46%);GO:0051603 (16%);GO:0000160 (3%),proteasome-mediated ubiquitin-dependent protein catabolic process (46%);proteolysis involved in cellular protein catabolic process (16%);phosphorelay signal transduction system (3%),IPR001353 (56%);IPR023332 (56%);IPR029055 (56%),Proteasome, subunit alpha/beta (56%);Proteasome alpha-type subunit (56%);Nucleophile aminohydrolases, N-terminal (56%),,,,,,,,
EYNESGPSLVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGNGTEWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPTQCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.99.- (50%);2.4.1.- (50%),With other acceptors (50%);Hexosyltransferases (50%),GO:0005886 (18%);GO:0016021 (18%);GO:0005634 (9%),plasma membrane (18%);integral component of membrane (18%);nucleus (9%),GO:0046872 (36%);GO:0003677 (27%);GO:0003700 (18%),metal ion binding (36%);DNA binding (27%);DNA-binding transcription factor activity (18%),GO:0006352 (18%);GO:0009250 (18%);GO:0006606 (9%),DNA-templated transcription, initiation (18%);glucan biosynthetic process (18%);protein import into nucleus (9%),IPR013785 (21%);IPR023885 (21%);IPR001173 (14%),Aldolase-type TIM barrel (21%);4Fe4S-binding SPASM domain (21%);Glycosyltransferase 2-like (14%),,,,,,,,,,
VVVVGCPK,Anaerovirgula multivorans,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,,,,,Anaerovirgula,,,,Anaerovirgula multivorans,,,,,,,,,,,,IPR017896 (100%),4Fe-4S ferredoxin-type, iron-sulphur binding domain (100%),,,,,,,,,,
MLYLMLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEMYPSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPTLMSDSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGYPLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (87%);2.7.7.7 (12%);3.6.1.- (1%),Glycine--tRNA ligase (87%);DNA-directed DNA polymerase (12%);In phosphorus-containing anhydrides (1%),GO:0005737 (63%);GO:0008305 (6%);GO:0016021 (2%),cytoplasm (63%);integrin complex (6%);integral component of membrane (2%),GO:0004820 (63%);GO:0005524 (63%);GO:0016614 (16%),glycine-tRNA ligase activity (63%);ATP binding (63%);oxidoreductase activity, acting on CH-OH group of donors (16%),GO:0006426 (63%);GO:0006261 (9%);GO:0006281 (9%),glycyl-tRNA aminoacylation (63%);DNA-dependent DNA replication (9%);DNA repair (9%),IPR002310 (61%);IPR006194 (61%);IPR036188 (16%),Glycine-tRNA ligase, alpha subunit (61%);Glycine-tRNA synthetase, heterodimeric (61%);FAD/NAD(P)-binding domain superfamily (16%),,,,,,,,
DGNEEVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDVVVPGR,Kibdelosporangium aridum,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Pseudonocardiales,,,,,Pseudonocardiaceae,,,,Kibdelosporangium,,,,Kibdelosporangium aridum,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0000155 (100%);GO:0046983 (100%),phosphorelay sensor kinase activity (100%);protein dimerization activity (100%),,,IPR011712 (100%);IPR036890 (100%),Signal transduction histidine kinase, subgroup 3, dimerisation and phosphoacceptor domain (100%);Histidine kinase/HSP90-like ATPase superfamily (100%),,,,,,,,,
SNLQLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (50%);6.3.3.1 (50%),Histidine kinase (50%);Phosphoribosylformylglycinamidine cyclo-ligase (50%),GO:0016021 (40%);GO:0005737 (10%),integral component of membrane (40%);cytoplasm (10%),GO:0000155 (40%);GO:0005524 (40%);GO:0004641 (10%),phosphorelay sensor kinase activity (40%);ATP binding (40%);phosphoribosylformylglycinamidine cyclo-ligase activity (10%),GO:0006189 (10%);GO:0032259 (10%),'de novo' IMP biosynthetic process (10%);methylation (10%),IPR027417 (35%);IPR001789 (29%);IPR003594 (29%),P-loop containing nucleoside triphosphate hydrolase (35%);Signal transduction response regulator, receiver domain (29%);Histidine kinase/HSP90-like ATPase (29%),,,,,,,,,,
FAGDDAPR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR004000 (100%);IPR004001 (13%);IPR020902 (12%),Actin family (100%);Actin, conserved site (13%);Actin/actin-like conserved site (12%),,,,,,,,,,
FVQLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.6 (68%);2.1.1.- (10%);2.7.1.26 (6%),Beta-lactamase (68%);Methyltransferases (10%);Riboflavin kinase (6%),GO:0008091 (27%);GO:0016021 (9%);GO:0005737 (3%),spectrin (27%);integral component of membrane (9%);cytoplasm (3%),GO:0005543 (30%);GO:0003779 (27%);GO:0005200 (27%),phospholipid binding (30%);actin binding (27%);structural constituent of cytoskeleton (27%),GO:0051693 (26%);GO:0046677 (19%);GO:0030655 (16%),actin filament capping (26%);response to antibiotic (19%);beta-lactam antibiotic catabolic process (16%),IPR002017 (27%);IPR018159 (27%);IPR001605 (27%),Spectrin repeat (27%);Spectrin/alpha-actinin (27%);Pleckstrin homology domain, spectrin-type (27%),,,,,,,,,,
SPDDDDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000159 (7%);GO:0016021 (2%),protein phosphatase type 2A complex (7%);integral component of membrane (2%),GO:0005086 (84%);GO:0019888 (7%);GO:0003677 (5%),ARF guanyl-nucleotide exchange factor activity (84%);protein phosphatase regulator activity (7%);DNA binding (5%),GO:0032012 (84%);GO:0006355 (5%);GO:0032259 (2%),regulation of ARF protein signal transduction (84%);regulation of transcription, DNA-templated (5%);methylation (2%),IPR000904 (82%);IPR011993 (82%);IPR023394 (82%),Sec7 domain (82%);PH-like domain superfamily (82%);Sec7, C-terminal domain superfamily (82%),,,,,,,,,
VFLEAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.47 (33%);2.3.1.180 (17%);2.3.2.27 (17%),1-alkyl-2-acetylglycerophosphocholine esterase (33%);Beta-ketoacyl-[acyl-carrier-protein] synthase III (17%);RING-type E3 ubiquitin transferase (17%),GO:0005737 (15%);GO:0016021 (12%);GO:0019867 (4%),cytoplasm (15%);integral component of membrane (12%);outer membrane (4%),GO:0008168 (15%);GO:0016491 (15%);GO:0003677 (8%),methyltransferase activity (15%);oxidoreductase activity (15%);DNA binding (8%),GO:0032259 (15%);GO:0016042 (8%);GO:0000162 (4%),methylation (15%);lipid catabolic process (8%);tryptophan biosynthetic process (4%),IPR001214 (26%);IPR003616 (18%);IPR000683 (10%),SET domain (26%);Post-SET domain (18%);Oxidoreductase, N-terminal (10%),,,,,,,,,,
SYELPNGQVLTLGNER,Cebus capucinus imitator,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Platyrrhini,,Cebidae,Cebinae,,,Cebus,,,,Cebus capucinus,Cebus capucinus imitator,,,,,,,,,,,IPR004000 (100%);IPR004001 (100%),Actin family (100%);Actin, conserved site (100%),,,,,,,,,,
NNPVSDSYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MALYFANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMTLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (85%);1.1.1.42 (5%);2.7.13.3 (3%),Cytochrome-c oxidase (85%);Isocitrate dehydrogenase (NADP(+)) (5%);Histidine kinase (3%),GO:0016021 (58%);GO:0005743 (32%);GO:0070469 (32%),integral component of membrane (58%);mitochondrial inner membrane (32%);respirasome (32%),GO:0020037 (34%);GO:0046872 (33%);GO:0004129 (32%),heme binding (34%);metal ion binding (33%);cytochrome-c oxidase activity (32%),GO:0006119 (32%);GO:0009060 (32%);GO:0017004 (11%),oxidative phosphorylation (32%);aerobic respiration (32%);cytochrome complex assembly (11%),IPR000883 (26%);IPR023616 (26%);IPR036927 (26%),Cytochrome c oxidase subunit I (26%);Cytochrome c oxidase-like, subunit I domain (26%);Cytochrome c oxidase-like, subunit I  superfamily (26%),,,,,,,,,
WVEWVPR,Acremonium chrysogenum,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Hypocreales,,,,,,,,,Acremonium,,,,Acremonium chrysogenum,,,,,,,,,,,,IPR000210 (100%);IPR011333 (100%),BTB/POZ domain (100%);SKP1/BTB/POZ domain superfamily (100%),,,,,,,,,,,
LAENGDQLSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVLLWQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008622 (67%),epsilon DNA polymerase complex (67%),GO:0003677 (100%);GO:0003887 (67%);GO:0003700 (33%),DNA binding (100%);DNA-directed DNA polymerase activity (67%);DNA-binding transcription factor activity (33%),GO:0006261 (67%),DNA-dependent DNA replication (67%),IPR007185 (67%);IPR016266 (67%);IPR024639 (67%),DNA polymerase alpha/delta/epsilon, subunit B (67%);DNA polymerase epsilon, subunit B (67%);DNA polymerase epsilon subunit B, N-terminal (67%),,,,,,,,
FTTTAER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (67%);GO:0005856 (50%);GO:0015629 (17%),cytoplasm (67%);cytoskeleton (50%);actin cytoskeleton (17%),GO:0005524 (67%);GO:0005525 (17%);GO:0008483 (17%),ATP binding (67%);GTP binding (17%);transaminase activity (17%),,,IPR004000 (73%);IPR004001 (45%);IPR020902 (45%),Actin family (73%);Actin, conserved site (45%);Actin/actin-like conserved site (45%),,,,,,,,,,
DLNDELAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),GO:0005634 (33%);GO:0016021 (33%),nucleus (33%);integral component of membrane (33%),GO:0003677 (33%);GO:0003899 (33%);GO:0008270 (33%),DNA binding (33%);DNA-directed 5'-3' RNA polymerase activity (33%);zinc ion binding (33%),GO:0006351 (67%),transcription, DNA-templated (67%),IPR000722 (33%);IPR004113 (33%);IPR006094 (33%),RNA polymerase, alpha subunit (33%);FAD-linked oxidase, C-terminal (33%);FAD linked oxidase, N-terminal (33%),,,,,,,
FGSESPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.9 (100%),Nucleotide diphosphatase (100%),GO:0005737 (67%);GO:0005813 (33%);GO:0005874 (33%),cytoplasm (67%);centrosome (33%);microtubule (33%),GO:0016491 (33%);GO:0035529 (33%);GO:0047429 (33%),oxidoreductase activity (33%);NADH pyrophosphatase activity (33%);nucleoside-triphosphate diphosphatase activity (33%),GO:0000281 (33%);GO:0009117 (33%);GO:0016055 (33%),mitotic cytokinesis (33%);nucleotide metabolic process (33%);Wnt signaling pathway (33%),IPR000683 (33%);IPR003697 (33%);IPR004104 (33%),Oxidoreductase, N-terminal (33%);Nucleoside triphosphate pyrophosphatase Maf-like protein (33%);Oxidoreductase, C-terminal (33%),,,,,,,,,
SETFVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.0 (31%);1.-.-.- (23%);1.2.1.- (23%), (31%);Oxidoreductases (23%);With NAD(+) or NADP(+) as acceptor (23%),GO:0016021 (25%);GO:0005680 (5%);GO:0005886 (5%),integral component of membrane (25%);anaphase-promoting complex (5%);plasma membrane (5%),GO:0016491 (19%);GO:0016787 (7%);GO:0005509 (5%),oxidoreductase activity (19%);hydrolase activity (7%);calcium ion binding (5%),GO:0007165 (7%);GO:0016042 (5%);GO:0006511 (4%),signal transduction (7%);lipid catabolic process (5%);ubiquitin-dependent protein catabolic process (4%),IPR036291 (52%);IPR002347 (50%);IPR008969 (21%),NAD(P)-binding domain superfamily (52%);Short-chain dehydrogenase/reductase SDR (50%);Carboxypeptidase-like, regulatory domain superfamily (21%),,,,,,,,,,
QLQFPVGR,Zea mays,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,Petrosaviidae,,,Poales,,,,,Poaceae,Panicoideae,Andropogoneae,Tripsacinae,Zea,,,,Zea mays,,,,,,,,,,GO:0045892 (100%),negative regulation of transcription, DNA-templated (100%),IPR006458 (100%);IPR038933 (100%),Ovate  protein family, C-terminal (100%);Ovate protein family (100%),,,,,,,,,
LFTTDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.3 (33%);2.3.2.27 (11%);2.4.1.12 (11%),Phosphoribosylformylglycinamidine synthase (33%);RING-type E3 ubiquitin transferase (11%);Cellulose synthase (UDP-forming) (11%),GO:0070772 (24%);GO:0016021 (21%);GO:0005737 (11%),PAS complex (24%);integral component of membrane (21%);cytoplasm (11%),GO:0016740 (12%);GO:0005524 (11%);GO:0003677 (7%),transferase activity (12%);ATP binding (11%);DNA binding (7%),GO:0006661 (24%);GO:0055085 (6%);GO:0006541 (5%),phosphatidylinositol biosynthetic process (24%);transmembrane transport (6%);glutamine metabolic process (5%),IPR016024 (20%);IPR021841 (20%);IPR026825 (20%),Armadillo-type fold (20%);Vacuolar protein 14 C-terminal Fig4-binding domain (20%);Vacuole morphology and inheritance protein 14 (20%),,,,,,,,,,,
LTLLSEDK,Spiroplasma sp. WSS,Bacteria,,,,Tenericutes,,,Mollicutes,,,,Entomoplasmatales,,,,,Spiroplasmataceae,,,,Spiroplasma,,,,Spiroplasma sp. WSS,,,,,,,,GO:0003677 (33%);GO:0003899 (33%);GO:0004177 (33%),DNA binding (33%);DNA-directed 5'-3' RNA polymerase activity (33%);aminopeptidase activity (33%),GO:0006351 (33%);GO:0006797 (33%),transcription, DNA-templated (33%);polyphosphate metabolic process (33%),IPR000819 (33%);IPR011260 (33%);IPR011262 (33%),Peptidase M17, leucyl aminopeptidase, C-terminal (33%);RNA polymerase, alpha subunit, C-terminal (33%);DNA-directed RNA polymerase, insert domain (33%),,,,,
NNQFQDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLNLLEAK,Helobdella robusta,Eukaryota,Metazoa,,,Annelida,,,Clitellata,Hirudinea,,,Hirudinida,Glossiphoniiformes,,,,Glossiphoniidae,,,,Helobdella,,,,Helobdella robusta,,,,,,,,,,,,IPR036691 (100%),Endonuclease/exonuclease/phosphatase superfamily (100%),,,,,,,,,,,
LNYEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.17 (29%);1.1.1.47 (14%);1.2.7.1 (14%),Tetrahydrofolate synthase (29%);Glucose 1-dehydrogenase (NAD(P)(+)) (14%);Pyruvate synthase (14%),GO:0016021 (41%);GO:0005694 (5%);GO:0005634 (2%),integral component of membrane (41%);chromosome (5%);nucleus (2%),GO:0005524 (27%);GO:0004326 (7%);GO:0008236 (7%),ATP binding (27%);tetrahydrofolylpolyglutamate synthase activity (7%);serine-type peptidase activity (7%),GO:0006730 (5%);GO:0009072 (5%);GO:0051276 (5%),one-carbon metabolic process (5%);aromatic amino acid family metabolic process (5%);chromosome organization (5%),IPR027417 (15%);IPR024735 (11%);IPR035628 (11%),P-loop containing nucleoside triphosphate hydrolase (15%);Conjugative transposon protein TcpC (11%);TcpC, C-terminal (11%),,,,,,,,,,
FPNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (22%);2.3.1.174 (18%);2.3.1.16 (7%),Acting on ATP; involved in cellular and subcellular movement (22%);3-oxoadipyl-CoA thiolase (18%);Acetyl-CoA C-acyltransferase (7%),GO:0016021 (16%);GO:0016020 (7%);GO:0005886 (6%),integral component of membrane (16%);membrane (7%);plasma membrane (6%),GO:0004553 (24%);GO:0030246 (23%);GO:0016747 (16%),hydrolase activity, hydrolyzing O-glycosyl compounds (24%);carbohydrate binding (23%);transferase activity, transferring acyl groups other than amino-acyl groups (16%),GO:0005975 (25%);GO:0006353 (3%);GO:0006412 (2%),carbohydrate metabolic process (25%);DNA-templated transcription, termination (3%);translation (2%),IPR017853 (24%);IPR000322 (24%);IPR013780 (23%),Glycoside hydrolase superfamily (24%);Glycoside hydrolase family 31 (24%);Glycosyl hydrolase, all-beta (23%),,,,,,,
QALEEAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (23%);2.8.1.7 (16%);3.6.-.- (12%),Methyltransferases (23%);Cysteine desulfurase (16%);Acting on acid anhydrides (12%),GO:0016021 (21%);GO:0005737 (12%);GO:0016020 (3%),integral component of membrane (21%);cytoplasm (12%);membrane (3%),GO:0005524 (18%);GO:0046872 (12%);GO:0000155 (9%),ATP binding (18%);metal ion binding (12%);phosphorelay sensor kinase activity (9%),GO:0032259 (7%);GO:0019752 (5%);GO:0044571 (4%),methylation (7%);carboxylic acid metabolic process (5%);[2Fe-2S] cluster assembly (4%),IPR027417 (23%);IPR011990 (7%);IPR015421 (7%),P-loop containing nucleoside triphosphate hydrolase (23%);Tetratricopeptide-like helical domain superfamily (7%);Pyridoxal phosphate-dependent transferase, major domain (7%),,,,,,,,,,
NNQLQNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNNGNDENHAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFLLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.84 (64%);3.4.11.1 (6%);3.4.11.10 (6%),Alcohol-forming fatty acyl-CoA reductase (64%);Leucyl aminopeptidase (6%);Bacterial leucyl aminopeptidase (6%),GO:0016021 (45%);GO:0005737 (8%);GO:0005886 (8%),integral component of membrane (45%);cytoplasm (8%);plasma membrane (8%),GO:0080019 (17%);GO:0102965 (16%);GO:0005524 (16%),fatty-acyl-CoA reductase (alcohol-forming) activity (17%);alcohol-forming fatty acyl-CoA reductase activity (16%);ATP binding (16%),GO:0006629 (16%);GO:0007018 (6%);GO:0050770 (3%),lipid metabolic process (16%);microtubule-based movement (6%);regulation of axonogenesis (3%),IPR036291 (17%);IPR013120 (16%);IPR026055 (15%),NAD(P)-binding domain superfamily (17%);Male sterility, NAD-binding (16%);Fatty acyl-CoA reductase (15%),,,,,,,,,,
EPSTALLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYDQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.21 (12%);6.3.4.5 (5%);3.2.1.52 (4%),Starch synthase (12%);Argininosuccinate synthase (5%);Beta-N-acetylhexosaminidase (4%),GO:0016021 (41%);GO:0005737 (6%);GO:0005886 (4%),integral component of membrane (41%);cytoplasm (6%);plasma membrane (4%),GO:0005524 (18%);GO:0003677 (7%);GO:0016887 (6%),ATP binding (18%);DNA binding (7%);ATPase activity (6%),GO:0055085 (5%);GO:0006869 (3%);GO:0061817 (3%),transmembrane transport (5%);lipid transport (3%);endoplasmic reticulum-plasma membrane tethering (3%),IPR027417 (9%);IPR029787 (7%);IPR000160 (7%),P-loop containing nucleoside triphosphate hydrolase (9%);Nucleotide cyclase (7%);GGDEF domain (7%),,,,,,,,,,,
SGLEGGFSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CELFLPMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELVDLCDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLVLDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.14.11 (40%);1.2.1.11 (20%);2.6.1.9 (20%),Xaa-Pro dipeptidyl-peptidase (40%);Aspartate-semialdehyde dehydrogenase (20%);Histidinol-phosphate transaminase (20%),GO:0016021 (21%);GO:0005737 (3%);GO:0043190 (3%),integral component of membrane (21%);cytoplasm (3%);ATP-binding cassette (ABC) transporter complex (3%),GO:0003677 (18%);GO:0016491 (18%);GO:0003700 (10%),DNA binding (18%);oxidoreductase activity (18%);DNA-binding transcription factor activity (10%),GO:0006351 (5%);GO:0006629 (5%);GO:0000105 (3%),transcription, DNA-templated (5%);lipid metabolic process (5%);histidine biosynthetic process (3%),IPR013783 (13%);IPR008962 (12%);IPR029058 (9%),Immunoglobulin-like fold (13%);PapD-like superfamily (12%);Alpha/Beta hydrolase fold (9%),,,,,,,,,,
TSVSCLR,Teleostei,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,,,,,,,,,,,,,,,,,,,,,GO:0005737 (100%);GO:0005813 (100%),cytoplasm (100%);centrosome (100%),,,GO:0071539 (100%),protein localization to centrosome (100%),IPR001680 (100%);IPR015943 (100%);IPR017986 (100%),WD40 repeat (100%);WD40/YVTN repeat-like-containing domain superfamily (100%);WD40-repeat-containing domain (100%),,,,,,,,,,,
VYLMGSGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVTVSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.4.2.11 (50%);2.7.7.6 (25%);5.1.1.7 (25%),ABC-type methionine transporter (50%);DNA-directed RNA polymerase (25%);Diaminopimelate epimerase (25%),GO:0016021 (17%);GO:0005737 (10%);GO:0005886 (7%),integral component of membrane (17%);cytoplasm (10%);plasma membrane (7%),GO:0046872 (17%);GO:0051539 (17%);GO:0003677 (15%),metal ion binding (17%);4 iron, 4 sulfur cluster binding (17%);DNA binding (15%),GO:0002949 (10%);GO:0006351 (10%);GO:0006749 (7%),tRNA threonylcarbamoyladenosine modification (10%);transcription, DNA-templated (10%);glutathione metabolic process (7%),IPR027417 (15%);IPR005117 (13%);IPR006067 (13%),P-loop containing nucleoside triphosphate hydrolase (15%);Nitrite/Sulfite reductase ferredoxin-like domain (13%);Nitrite/sulphite reductase 4Fe-4S domain (13%),,,,,,,,,
TTLLSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.12 (45%);3.5.1.44 (36%);2.1.2.11 (9%),UDP-glucose--hexose-1-phosphate uridylyltransferase (45%);Protein-glutamine glutaminase (36%);3-methyl-2-oxobutanoate hydroxymethyltransferase (9%),GO:0016021 (53%);GO:0005737 (9%);GO:0031972 (4%),integral component of membrane (53%);cytoplasm (9%);chloroplast intermembrane space (4%),GO:0005524 (31%);GO:0000155 (10%);GO:0008108 (8%),ATP binding (31%);phosphorelay sensor kinase activity (10%);UDP-glucose:hexose-1-phosphate uridylyltransferase activity (8%),GO:0006935 (10%);GO:0006012 (8%);GO:0007165 (5%),chemotaxis (10%);galactose metabolic process (8%);signal transduction (5%),IPR003660 (11%);IPR027417 (11%);IPR003594 (9%),HAMP domain (11%);P-loop containing nucleoside triphosphate hydrolase (11%);Histidine kinase/HSP90-like ATPase (9%),,,,,,,,,,,
AATTGLCHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPEAELEAEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDEENANAADR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNLLLEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.4 (100%),3-dehydroquinate synthase (100%),GO:0005737 (20%),cytoplasm (20%),GO:0003677 (40%);GO:0003918 (40%);GO:0005524 (40%),DNA binding (40%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (40%);ATP binding (40%),GO:0006265 (40%);GO:0006629 (20%);GO:0009073 (20%),DNA topological change (40%);lipid metabolic process (20%);aromatic amino acid family biosynthetic process (20%),IPR002205 (33%);IPR006691 (33%);IPR013757 (33%),DNA topoisomerase, type IIA, subunit A/C-terminal (33%);DNA gyrase/topoisomerase IV, subunit A, C-terminal repeat (33%);Type IIA DNA topoisomerase subunit A, alpha-helical domain superfamily (33%),,,,,
AVELVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.8 (11%);4.2.1.9 (9%);4.1.1.36 (7%),Phosphate acetyltransferase (11%);Dihydroxy-acid dehydratase (9%);Phosphopantothenoylcysteine decarboxylase (7%),GO:0016021 (13%);GO:0005737 (10%);GO:0005886 (2%),integral component of membrane (13%);cytoplasm (10%);plasma membrane (2%),GO:0005524 (13%);GO:0016491 (10%);GO:0046872 (9%),ATP binding (13%);oxidoreductase activity (10%);metal ion binding (9%),GO:0032259 (4%);GO:0006355 (2%);GO:0000160 (2%),methylation (4%);regulation of transcription, DNA-templated (2%);phosphorelay signal transduction system (2%),IPR002505 (10%);IPR036291 (8%);IPR027417 (8%),Phosphate acetyl/butaryl transferase (10%);NAD(P)-binding domain superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
QTVAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.5 (44%);2.7.7.87 (17%);1.1.5.- (8%),Urease (44%);L-threonylcarbamoyladenylate synthase (17%);With a quinone or similar compound as acceptor (8%),GO:0016021 (27%);GO:0005737 (15%);GO:0005887 (1%),integral component of membrane (27%);cytoplasm (15%);integral component of plasma membrane (1%),GO:0003824 (40%);GO:0005524 (11%);GO:0009039 (9%),catalytic activity (40%);ATP binding (11%);urease activity (9%),GO:0043419 (9%);GO:0002949 (3%);GO:0032259 (1%),urea catabolic process (9%);tRNA threonylcarbamoyladenosine modification (3%);methylation (1%),IPR011042 (42%);IPR012938 (42%);IPR011041 (38%),Six-bladed beta-propeller, TolB-like (42%);Glucose/Sorbosone dehydrogenase (42%);Soluble quinoprotein glucose/sorbosone dehydrogenase (38%),,,,,,,,,,
SGLDDCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005576 (50%),extracellular region (50%),GO:0003677 (50%);GO:0030248 (50%),DNA binding (50%);cellulose binding (50%),GO:0005975 (50%);GO:0006355 (50%),carbohydrate metabolic process (50%);regulation of transcription, DNA-templated (50%),IPR000254 (50%);IPR000792 (50%);IPR011990 (50%),Cellulose-binding domain, fungal (50%);Transcription regulator LuxR, C-terminal (50%);Tetratricopeptide-like helical domain superfamily (50%),,,,,,,,
VLVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (50%);1.1.1.22 (21%);3.4.25.1 (4%),Signal peptidase I (50%);UDP-glucose 6-dehydrogenase (21%);Proteasome endopeptidase complex (4%),GO:0016021 (39%);GO:0005737 (9%);GO:0005634 (3%),integral component of membrane (39%);cytoplasm (9%);nucleus (3%),GO:0008236 (24%);GO:0005524 (12%);GO:0003979 (11%),serine-type peptidase activity (24%);ATP binding (12%);UDP-glucose 6-dehydrogenase activity (11%),GO:0000271 (10%);GO:0000226 (2%);GO:0006511 (2%),polysaccharide biosynthetic process (10%);microtubule cytoskeleton organization (2%);ubiquitin-dependent protein catabolic process (2%),IPR036286 (23%);IPR000223 (23%);IPR015927 (23%),LexA/Signal peptidase-like superfamily (23%);Peptidase S26A, signal peptidase I (23%);Peptidase S24/S26A/S26B/S26C (23%),,,,,,,,,,
TSLDEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (78%);GO:0005737 (11%),integral component of membrane (78%);cytoplasm (11%),GO:0004553 (22%);GO:0008757 (11%);GO:0016740 (11%),hydrolase activity, hydrolyzing O-glycosyl compounds (22%);S-adenosylmethionine-dependent methyltransferase activity (11%);transferase activity (11%),GO:0006890 (56%);GO:0005975 (22%);GO:0031591 (11%),retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (56%);carbohydrate metabolic process (22%);wybutosine biosynthetic process (11%),IPR013861 (56%);IPR035952 (56%);IPR000322 (22%),TMEM115/Pdh1/Rbl19 (56%);Rhomboid-like superfamily (56%);Glycoside hydrolase family 31 (22%),,,,,,,,,
NPGTVEFGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVFLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.19.12 (69%);6.1.1.18 (11%);1.2.4.1 (3%),Ubiquitinyl hydrolase 1 (69%);Glutamine--tRNA ligase (11%);Pyruvate dehydrogenase (acetyl-transferring) (3%),GO:0016021 (15%);GO:0005737 (9%);GO:0019867 (1%),integral component of membrane (15%);cytoplasm (9%);outer membrane (1%),GO:0008270 (29%);GO:0004843 (27%);GO:0003677 (15%),zinc ion binding (29%);thiol-dependent ubiquitin-specific protease activity (27%);DNA binding (15%),GO:0016579 (28%);GO:0006511 (28%);GO:0006425 (4%),protein deubiquitination (28%);ubiquitin-dependent protein catabolic process (28%);glutaminyl-tRNA aminoacylation (4%),IPR013083 (24%);IPR001394 (24%);IPR038765 (24%),Zinc finger, RING/FYVE/PHD-type (24%);Peptidase C19, ubiquitin carboxyl-terminal hydrolase (24%);Papain-like cysteine peptidase superfamily (24%),,,,,,,,,
QSGELNVLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNLGGDYLALDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAVELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.6 (20%);5.4.99.18 (12%);2.7.7.87 (9%),Catalase (20%);5-(carboxyamino)imidazole ribonucleotide mutase (12%);L-threonylcarbamoyladenylate synthase (9%),GO:0005737 (9%);GO:0016021 (7%);GO:0005840 (4%),cytoplasm (9%);integral component of membrane (7%);ribosome (4%),GO:0005524 (19%);GO:0003677 (7%);GO:0003700 (6%),ATP binding (19%);DNA binding (7%);DNA-binding transcription factor activity (6%),GO:0006412 (6%);GO:0000160 (5%);GO:0006189 (4%),translation (6%);phosphorelay signal transduction system (5%);'de novo' IMP biosynthetic process (4%),IPR009078 (61%);IPR007760 (60%);IPR039377 (58%),Ferritin-like superfamily (61%);Manganese catalase (60%);Manganese catalase, ferritin-like di-iron-binding domain (58%),,,,,,,,,,
FMLFNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.3 (33%);1.9.3.1 (33%);2.7.1.30 (33%),Dihydrofolate reductase (33%);Cytochrome-c oxidase (33%);Glycerol kinase (33%),GO:0016021 (25%);GO:0005623 (10%);GO:0005743 (5%),integral component of membrane (25%);cell (10%);mitochondrial inner membrane (5%),GO:0005543 (25%);GO:0003779 (15%);GO:0016787 (15%),phospholipid binding (25%);actin binding (15%);hydrolase activity (15%),GO:0045454 (10%);GO:0005975 (5%);GO:0006072 (5%),cell redox homeostasis (10%);carbohydrate metabolic process (5%);glycerol-3-phosphate metabolic process (5%),IPR011993 (30%);IPR002017 (26%);IPR018159 (26%),PH-like domain superfamily (30%);Spectrin repeat (26%);Spectrin/alpha-actinin (26%),,,,,,,,,,,
EQELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.4 (15%);1.3.1.- (9%);5.4.99.5 (9%),Aspartate kinase (15%);With NAD(+) or NADP(+) as acceptor (9%);Chorismate mutase (9%),GO:0032300 (15%);GO:0016021 (12%);GO:0005737 (5%),mismatch repair complex (15%);integral component of membrane (12%);cytoplasm (5%),GO:0005524 (32%);GO:0016887 (20%);GO:0030983 (16%),ATP binding (32%);ATPase activity (20%);mismatched DNA binding (16%),GO:0006298 (16%);GO:0046417 (9%);GO:0006355 (4%),mismatch repair (16%);chorismate metabolic process (9%);regulation of transcription, DNA-templated (4%),IPR036890 (15%);IPR027417 (15%);IPR014721 (14%),Histidine kinase/HSP90-like ATPase superfamily (15%);P-loop containing nucleoside triphosphate hydrolase (15%);Ribosomal protein S5 domain 2-type fold, subgroup (14%),,,,,,,,,
QNLYWWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLGQNEAVDAVSNALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (94%);GO:0005829 (0%);GO:0016020 (0%),cytoplasm (94%);cytosol (0%);membrane (0%),GO:0005524 (100%);GO:0008233 (6%);GO:0016787 (1%),ATP binding (100%);peptidase activity (6%);hydrolase activity (1%),GO:0009408 (94%);GO:0042026 (94%);GO:0019538 (90%),response to heat (94%);protein refolding (94%);protein metabolic process (90%),IPR027417 (100%);IPR003959 (99%);IPR001270 (99%),P-loop containing nucleoside triphosphate hydrolase (100%);ATPase, AAA-type, core (99%);ClpA/B family (99%),,,,,,,,,
ALTVLFEK,Acyrthosiphon pisum,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Hemiptera,Sternorrhyncha,Aphidomorpha,,Aphidoidea,Aphididae,Aphidinae,Macrosiphini,,Acyrthosiphon,,,,Acyrthosiphon pisum,,,,,,,,GO:0046983 (100%),protein dimerization activity (100%),,,IPR012337 (100%);IPR025398 (100%);IPR008906 (50%),Ribonuclease H-like superfamily (100%);Domain of unknown function DUF4371 (100%);HAT, C-terminal dimerisation domain (50%),,,,,,,,,,
LLNEAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.227 (16%);3.6.4.- (16%);1.1.1.86 (11%),Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (16%);Acting on ATP; involved in cellular and subcellular movement (16%);Ketol-acid reductoisomerase (NADP(+)) (11%),GO:0016021 (10%);GO:0005737 (3%);GO:0005886 (2%),integral component of membrane (10%);cytoplasm (3%);plasma membrane (2%),GO:0047661 (55%);GO:0005524 (7%);GO:0016779 (3%),amino-acid racemase activity (55%);ATP binding (7%);nucleotidyltransferase activity (3%),GO:0006807 (56%);GO:0006355 (4%);GO:0007049 (3%),nitrogen compound metabolic process (56%);regulation of transcription, DNA-templated (4%);cell cycle (3%),IPR001920 (52%);IPR015942 (52%);IPR004380 (51%),Asp/Glu racemase (52%);Asp/Glu/hydantoin racemase (52%);Aspartate racemase (51%),,,,,,,,,,
LNAALLTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEFNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.70 (43%);2.7.7.7 (21%);6.3.2.13 (14%),Glutamyl-tRNA reductase (43%);DNA-directed DNA polymerase (21%);UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (14%),GO:0016021 (28%);GO:0005634 (3%);GO:0005737 (3%),integral component of membrane (28%);nucleus (3%);cytoplasm (3%),GO:0005086 (12%);GO:0005524 (12%);GO:0003677 (9%),ARF guanyl-nucleotide exchange factor activity (12%);ATP binding (12%);DNA binding (9%),GO:0032012 (12%);GO:0006782 (9%);GO:0033567 (6%),regulation of ARF protein signal transduction (12%);protoporphyrinogen IX biosynthetic process (9%);DNA replication, Okazaki fragment processing (6%),IPR000904 (8%);IPR001849 (8%);IPR011993 (8%),Sec7 domain (8%);Pleckstrin homology domain (8%);PH-like domain superfamily (8%),,,,,,,,,
MCDEGAVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SEADFAK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.- (33%);1.9.3.1 (33%);3.2.1.4 (33%),With NAD(+) or NADP(+) as acceptor (33%);Cytochrome-c oxidase (33%);Cellulase (33%),GO:0016021 (38%);GO:0005886 (6%);GO:0019867 (6%),integral component of membrane (38%);plasma membrane (6%);outer membrane (6%),GO:0016811 (19%);GO:0046872 (19%);GO:0016491 (13%),hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (19%);metal ion binding (19%);oxidoreductase activity (13%),GO:0017000 (19%);GO:0008152 (6%),antibiotic biosynthetic process (19%);metabolic process (6%),IPR023210 (45%);IPR036812 (45%);IPR001763 (14%),NADP-dependent oxidoreductase domain (45%);NADP-dependent oxidoreductase domain superfamily (45%);Rhodanese-like domain (14%),,,,,,,,,
DCLATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.24 (25%);1.2.1.16 (25%);2.7.4.7 (25%),3-hydroxybenzoate 6-monooxygenase (25%);Succinate-semialdehyde dehydrogenase (NAD(P)(+)) (25%);Phosphooxymethylpyrimidine kinase (25%),GO:0016021 (42%);GO:0015935 (3%),integral component of membrane (42%);small ribosomal subunit (3%),GO:0005509 (17%);GO:0005272 (11%);GO:0005524 (11%),calcium ion binding (17%);sodium channel activity (11%);ATP binding (11%),GO:0009228 (11%);GO:0006986 (6%);GO:0000105 (3%),thiamine biosynthetic process (11%);response to unfolded protein (6%);histidine biosynthetic process (3%),IPR000152 (12%);IPR000742 (12%);IPR001881 (12%),EGF-type aspartate/asparagine hydroxylation site (12%);EGF-like domain (12%);EGF-like calcium-binding domain (12%),,,,,,,,,,,
DLVFVSMMGPEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VETLMMVPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPQADQVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMDEYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.113 (50%);4.3.1.17 (50%),Site-specific DNA-methyltransferase (cytosine-N(4)-specific) (50%);L-serine ammonia-lyase (50%),GO:0016021 (43%),integral component of membrane (43%),GO:0004553 (29%);GO:0016746 (29%);GO:0003677 (14%),hydrolase activity, hydrolyzing O-glycosyl compounds (29%);transferase activity, transferring acyl groups (29%);DNA binding (14%),GO:0005975 (29%);GO:0000160 (7%);GO:0006094 (7%),carbohydrate metabolic process (29%);phosphorelay signal transduction system (7%);gluconeogenesis (7%),IPR003323 (19%);IPR038765 (19%);IPR000514 (15%),OTU domain (19%);Papain-like cysteine peptidase superfamily (19%);Glycoside hydrolase, family 39 (15%),,,,,,,,
QFLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.3.7 (27%);3.4.21.53 (6%);3.2.1.89 (5%),4-hydroxy-tetrahydrodipicolinate synthase (27%);Endopeptidase La (6%);Arabinogalactan endo-beta-1,4-galactanase (5%),GO:0016021 (18%);GO:0005737 (7%);GO:0033650 (3%),integral component of membrane (18%);cytoplasm (7%);host cell mitochondrion (3%),GO:0003677 (16%);GO:0009055 (9%);GO:0004803 (9%),DNA binding (16%);electron transfer activity (9%);transposase activity (9%),GO:0015074 (12%);GO:0006313 (9%);GO:0009089 (4%),DNA integration (12%);transposition, DNA-mediated (9%);lysine biosynthetic process via diaminopimelate (4%),IPR012337 (11%);IPR001584 (10%);IPR001598 (8%),Ribonuclease H-like superfamily (11%);Integrase, catalytic core (10%);Transposase, IS30, conserved site (8%),,,,,,
FGDLDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.44 (30%);2.7.1.158 (20%);1.1.1.5 (10%),Transferred entry: 7.6.2.2 (30%);Inositol-pentakisphosphate 2-kinase (20%);Transferred entry: 1.1.1.303 and 1.1.1.304 (10%),GO:0016021 (42%);GO:0005623 (31%);GO:0019867 (17%),integral component of membrane (42%);cell (31%);outer membrane (17%),GO:0005524 (38%);GO:0016887 (31%);GO:0042626 (31%),ATP binding (38%);ATPase activity (31%);ATPase-coupled transmembrane transporter activity (31%),GO:0045454 (31%);GO:0006434 (2%);GO:0016260 (2%),cell redox homeostasis (31%);seryl-tRNA aminoacylation (2%);selenocysteine biosynthetic process (2%),IPR000866 (27%);IPR003439 (27%);IPR003593 (27%),Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant (27%);ABC transporter-like (27%);AAA+ ATPase domain (27%),,,,,,,,,,,
SAPEYNETALPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNLFWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.75 (67%);1.1.99.1 (33%);1.2.1.8 (33%),Uroporphyrinogen-III synthase (67%);Choline dehydrogenase (33%);Betaine-aldehyde dehydrogenase (33%),GO:0016021 (77%);GO:1990112 (3%);GO:0005634 (1%),integral component of membrane (77%);RQC complex (3%);nucleus (1%),GO:0000155 (29%);GO:0005524 (27%);GO:0022857 (5%),phosphorelay sensor kinase activity (29%);ATP binding (27%);transmembrane transporter activity (5%),GO:0033014 (4%);GO:0006353 (3%);GO:0007165 (3%),tetrapyrrole biosynthetic process (4%);DNA-templated transcription, termination (3%);signal transduction (3%),IPR003660 (29%);IPR003661 (29%);IPR035965 (29%),HAMP domain (29%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (29%);PAS domain superfamily (29%),,,,,,,,,
YELQSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (33%);GO:0016021 (33%),membrane (33%);integral component of membrane (33%),GO:0005524 (67%);GO:0022857 (33%);GO:0046872 (33%),ATP binding (67%);transmembrane transporter activity (33%);metal ion binding (33%),,,IPR000330 (67%);IPR001650 (67%);IPR001841 (67%),SNF2-related, N-terminal domain (67%);Helicase, C-terminal (67%);Zinc finger, RING-type (67%),,,,,,,,
TDPEEDVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLAVGVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAMFYHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPMFYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR001959 (40%);IPR010095 (40%);IPR026847 (40%),Probable transposase, IS891/IS1136/IS1341 (40%);Transposase IS605, OrfB, C-terminal (40%);Vacuolar protein sorting-associated protein 13 (40%),,,,,,,,
ALDDSSWVTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVEDLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.7 (21%);6.1.1.20 (14%);7.1.1.1 (14%),Alanine--tRNA ligase (21%);Phenylalanine--tRNA ligase (14%);Proton-translocating NAD(P)(+) transhydrogenase (14%),GO:0016021 (34%);GO:0005737 (6%);GO:0005886 (2%),integral component of membrane (34%);cytoplasm (6%);plasma membrane (2%),GO:0005524 (54%);GO:0003677 (33%);GO:0051082 (13%),ATP binding (54%);DNA binding (33%);unfolded protein binding (13%),GO:0051301 (22%);GO:0006457 (13%);GO:0009058 (6%),cell division (22%);protein folding (13%);biosynthetic process (6%),IPR027417 (38%);IPR002543 (28%);IPR013126 (11%),P-loop containing nucleoside triphosphate hydrolase (38%);FtsK domain (28%);Heat shock protein 70 family (11%),,,,,,,,,,,
LNNGVLLGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEGCTVELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FWEVMYMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGGALNNK,Archaea,Archaea,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR029471 (100%),HNH endonuclease 5 (100%),,,,,,,,,,,
LEELQNSGLEMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVPVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.15 (68%);4.1.3.27 (12%);1.2.1.38 (3%),Dihydropteroate synthase (68%);Anthranilate synthase (12%);N-acetyl-gamma-glutamyl-phosphate reductase (3%),GO:0016021 (13%);GO:0005737 (3%);GO:0005623 (1%),integral component of membrane (13%);cytoplasm (3%);cell (1%),GO:0004156 (44%);GO:0046872 (35%);GO:0004049 (6%),dihydropteroate synthase activity (44%);metal ion binding (35%);anthranilate synthase activity (6%),GO:0046654 (28%);GO:0046656 (28%);GO:0009396 (15%),tetrahydrofolate biosynthetic process (28%);folic acid biosynthetic process (28%);folic acid-containing compound biosynthetic process (15%),IPR000489 (42%);IPR011005 (42%);IPR006390 (41%),Pterin-binding domain (42%);Dihydropteroate synthase-like (42%);Dihydropteroate synthase (41%),,,,,,,,,,,
MELMAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.22.- (25%);2.6.1.- (17%);5.6.2.2 (17%),Cysteine endopeptidases (25%);Transaminases (17%);DNA topoisomerase (ATP-hydrolyzing) (17%),GO:0016021 (28%);GO:0031965 (4%);GO:0005634 (3%),integral component of membrane (28%);nuclear membrane (4%);nucleus (3%),GO:0005524 (17%);GO:0003676 (15%);GO:0003700 (12%),ATP binding (17%);nucleic acid binding (15%);DNA-binding transcription factor activity (12%),GO:0015074 (7%);GO:0055085 (5%);GO:0006998 (4%),DNA integration (7%);transmembrane transport (5%);nuclear envelope organization (4%),IPR007157 (73%);IPR027417 (3%);IPR013783 (3%),PspA/IM30 (73%);P-loop containing nucleoside triphosphate hydrolase (3%);Immunoglobulin-like fold (3%),,,,,,,,,,,
TAVATPEQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLEQLEK,[Clostridium] ultunense,Bacteria,,,,Firmicutes,,,Tissierellia,,,,Tissierellales,,,,,Tissierellaceae,,,,,,,,[Clostridium] ultunense,,,,2.7.4.8 (100%),Guanylate kinase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004385 (100%);GO:0005524 (100%),guanylate kinase activity (100%);ATP binding (100%),,,IPR008144 (100%);IPR008145 (100%);IPR017665 (100%),Guanylate kinase-like domain (100%);Guanylate kinase/L-type calcium channel beta subunit (100%);Guanylate kinase (100%),,,,,,,,,,,
VACDVAEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNEEFNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (33%);GO:0008134 (33%);GO:0016740 (33%),ATP binding (33%);transcription factor binding (33%);transferase activity (33%),GO:0006355 (33%),regulation of transcription, DNA-templated (33%),IPR000014 (33%);IPR000700 (33%);IPR001296 (33%),PAS domain (33%);PAS-associated, C-terminal (33%);Glycosyl transferase, family 1 (33%),,,,,,,,
TLNLLQMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETNETFGLVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVLPNAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.33 (50%);6.3.2.13 (50%),Pantothenate kinase (50%);UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (50%),GO:0005737 (40%);GO:0016021 (20%),cytoplasm (40%);integral component of membrane (20%),GO:0005524 (40%);GO:0004594 (20%);GO:0008765 (20%),ATP binding (40%);pantothenate kinase activity (20%);UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase activity (20%),GO:0007049 (20%);GO:0008360 (20%);GO:0009252 (20%),cell cycle (20%);regulation of cell shape (20%);peptidoglycan biosynthetic process (20%),IPR000246 (25%);IPR003423 (25%);IPR004101 (25%),Peptidase T2, asparaginase 2 (25%);Outer membrane efflux protein (25%);Mur ligase, C-terminal (25%),,,,,,,
TDDTPTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPQGSPGPR,Bacillus megaterium,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Bacillaceae,,,,Bacillus,,,,Bacillus megaterium,,,,,,,,,,,,IPR008160 (100%);IPR025237 (100%),Collagen triple helix repeat (100%);Domain of unknown function DUF4183 (100%),,,,,,,,,,,
TENFQEFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTDYFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.33 (14%);2.2.1.2 (14%);2.7.1.11 (14%),tRNA (guanine(46)-N(7))-methyltransferase (14%);Transaldolase (14%);6-phosphofructokinase (14%),GO:0016021 (28%);GO:0005737 (6%);GO:0005840 (6%),integral component of membrane (28%);cytoplasm (6%);ribosome (6%),GO:0004134 (11%);GO:2001070 (11%);GO:0005524 (9%),4-alpha-glucanotransferase activity (11%);starch binding (11%);ATP binding (9%),GO:0006412 (7%);GO:0009401 (5%);GO:0005975 (3%),translation (7%);phosphoenolpyruvate-dependent sugar phosphotransferase system (5%);carbohydrate metabolic process (3%),IPR017853 (14%);IPR013783 (13%);IPR003385 (10%),Glycoside hydrolase superfamily (14%);Immunoglobulin-like fold (13%);Glycoside hydrolase, family 77 (10%),,,,,,,,,,
SSVAAATGPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSVGVMPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTLSNDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),GO:0016021 (29%),integral component of membrane (29%),GO:0003677 (57%);GO:0005524 (43%);GO:0003678 (29%),DNA binding (57%);ATP binding (43%);DNA helicase activity (29%),GO:0006139 (29%);GO:0006351 (14%);GO:0009116 (14%),nucleobase-containing compound metabolic process (29%);transcription, DNA-templated (14%);nucleoside metabolic process (14%),IPR014001 (43%);IPR027417 (43%);IPR001650 (29%),Helicase superfamily 1/2, ATP-binding domain (43%);P-loop containing nucleoside triphosphate hydrolase (43%);Helicase, C-terminal (29%),,,,,,,,
LGPAGQQMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAEEFAEEDAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDAGVTTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDLEDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.17 (21%);3.1.-.- (15%);1.4.4.2 (10%),Glutamate--tRNA ligase (21%);Acting on ester bonds (15%);Glycine dehydrogenase (aminomethyl-transferring) (10%),GO:0016021 (15%);GO:0005737 (13%);GO:0000124 (5%),integral component of membrane (15%);cytoplasm (13%);SAGA complex (5%),GO:0005524 (22%);GO:0030170 (8%);GO:0008483 (8%),ATP binding (22%);pyridoxal phosphate binding (8%);transaminase activity (8%),GO:0009058 (10%);GO:0006355 (6%);GO:0006424 (4%),biosynthetic process (10%);regulation of transcription, DNA-templated (6%);glutamyl-tRNA aminoacylation (4%),IPR027417 (13%);IPR015421 (12%);IPR015424 (12%),P-loop containing nucleoside triphosphate hydrolase (13%);Pyridoxal phosphate-dependent transferase, major domain (12%);Pyridoxal phosphate-dependent transferase (12%),,,,,,,,,
TLVYAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.47 (27%);3.4.11.18 (18%);3.6.3.3 (18%),8-amino-7-oxononanoate synthase (27%);Methionyl aminopeptidase (18%);Transferred entry: 7.2.2.21 (18%),GO:0016021 (32%);GO:0043190 (25%);GO:0005886 (4%),integral component of membrane (32%);ATP-binding cassette (ABC) transporter complex (25%);plasma membrane (4%),GO:0005524 (42%);GO:0016887 (26%);GO:0022857 (24%),ATP binding (42%);ATPase activity (26%);transmembrane transporter activity (24%),GO:0006537 (4%);GO:0006355 (2%);GO:0055085 (2%),glutamate biosynthetic process (4%);regulation of transcription, DNA-templated (2%);transmembrane transport (2%),IPR027417 (30%);IPR008995 (28%);IPR013611 (28%),P-loop containing nucleoside triphosphate hydrolase (30%);Molybdate/tungstate binding, C-terminal (28%);Transport-associated OB, type 2 (28%),,,,,,,,
SNTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.12 (16%);1.1.1.22 (5%);2.1.1.- (4%),3,4-dihydroxy-2-butanone-4-phosphate synthase (16%);UDP-glucose 6-dehydrogenase (5%);Methyltransferases (4%),GO:0016021 (31%);GO:0005737 (4%);GO:0005634 (3%),integral component of membrane (31%);cytoplasm (4%);nucleus (3%),GO:0005524 (9%);GO:0003677 (8%);GO:0003700 (8%),ATP binding (9%);DNA binding (8%);DNA-binding transcription factor activity (8%),GO:0009253 (4%);GO:0005975 (3%);GO:0006355 (2%),peptidoglycan catabolic process (4%);carbohydrate metabolic process (3%);regulation of transcription, DNA-templated (2%),IPR013783 (8%);IPR011009 (7%);IPR036890 (6%),Immunoglobulin-like fold (8%);Protein kinase-like domain superfamily (7%);Histidine kinase/HSP90-like ATPase superfamily (6%),,,,,,,,,
WALDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.1 (33%);2.1.1.150 (17%);1.1.1.25 (8%),Acetate--CoA ligase (33%);Isoflavone 7-O-methyltransferase (17%);Shikimate dehydrogenase (8%),GO:0016021 (38%);GO:0030915 (3%);GO:0005681 (1%),integral component of membrane (38%);Smc5-Smc6 complex (3%);spliceosomal complex (1%),GO:0005524 (9%);GO:0000155 (6%);GO:0046983 (6%),ATP binding (9%);phosphorelay sensor kinase activity (6%);protein dimerization activity (6%),GO:0032259 (6%);GO:0000724 (3%);GO:0007062 (3%),methylation (6%);double-strand break repair via homologous recombination (3%);sister chromatid cohesion (3%),IPR029058 (31%);IPR000073 (10%);IPR027417 (8%),Alpha/Beta hydrolase fold (31%);Alpha/beta hydrolase fold-1 (10%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
NEMPLANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSVAAASHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTDSAFTEVLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEMDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (62%);2.7.7.7 (4%);6.3.1.2 (4%),Proline--tRNA ligase (62%);DNA-directed DNA polymerase (4%);Glutamine synthetase (4%),GO:0005737 (37%);GO:0016021 (14%);GO:0005634 (2%),cytoplasm (37%);integral component of membrane (14%);nucleus (2%),GO:0005524 (47%);GO:0004827 (31%);GO:0002161 (25%),ATP binding (47%);proline-tRNA ligase activity (31%);aminoacyl-tRNA editing activity (25%),GO:0006433 (30%);GO:0015031 (7%);GO:0006464 (7%),prolyl-tRNA aminoacylation (30%);protein transport (7%);cellular protein modification process (7%),IPR006195 (27%);IPR002314 (27%);IPR002316 (27%),Aminoacyl-tRNA synthetase, class II (27%);Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) (27%);Proline-tRNA ligase, class IIa (27%),,,,,,,,
AGSCLFFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVEFLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (100%),Acting on ester bonds (100%),GO:0005737 (14%);GO:0016021 (14%);GO:0043190 (14%),cytoplasm (14%);integral component of membrane (14%);ATP-binding cassette (ABC) transporter complex (14%),GO:0005524 (43%);GO:0016887 (29%);GO:0000155 (14%),ATP binding (43%);ATPase activity (29%);phosphorelay sensor kinase activity (14%),GO:0006304 (14%);GO:0071705 (14%),DNA modification (14%);nitrogen compound transport (14%),IPR027417 (25%);IPR003439 (17%);IPR003593 (17%),P-loop containing nucleoside triphosphate hydrolase (25%);ABC transporter-like (17%);AAA+ ATPase domain (17%),,,,,,,,,,,
QANQVNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.16 (100%),Cysteine--tRNA ligase (100%),GO:0005737 (50%);GO:0016021 (50%),cytoplasm (50%);integral component of membrane (50%),GO:0004817 (50%);GO:0005524 (50%);GO:0008270 (50%),cysteine-tRNA ligase activity (50%);ATP binding (50%);zinc ion binding (50%),GO:0006423 (50%),cysteinyl-tRNA aminoacylation (50%),IPR006143 (50%);IPR009080 (50%);IPR014729 (50%),RND efflux pump, membrane fusion protein (50%);Aminoacyl-tRNA synthetase, class Ia, anticodon-binding (50%);Rossmann-like alpha/beta/alpha sandwich fold (50%),,,,,,,,
DYLYDQSLGSSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLDTWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVVHLSSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLYDDLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.77 (100%),Molybdenum cofactor guanylyltransferase (100%),GO:0005737 (33%),cytoplasm (33%),GO:0004553 (67%);GO:0008061 (67%);GO:0005525 (33%),hydrolase activity, hydrolyzing O-glycosyl compounds (67%);chitin binding (67%);GTP binding (33%),GO:0005975 (67%);GO:0006777 (33%),carbohydrate metabolic process (67%);Mo-molybdopterin cofactor biosynthetic process (33%),IPR001223 (67%);IPR001579 (67%);IPR011583 (67%),Glycoside hydrolase family 18, catalytic domain (67%);Glycoside hydrolase, chitinase active site (67%);Chitinase II (67%),,,,,,,,
WLDLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.34 (10%);2.4.1.292 (9%);2.2.1.6 (7%),tRNA (guanosine(18)-2'-O)-methyltransferase (10%);GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-diNAcBac-PP-undecaprenol alpha1,4-N-acetyl-D-galactosaminyltransferase (9%);Acetolactate synthase (7%),GO:0016021 (33%);GO:0009279 (12%);GO:0005737 (5%),integral component of membrane (33%);cell outer membrane (12%);cytoplasm (5%),GO:0005524 (7%);GO:0016740 (7%);GO:0003676 (6%),ATP binding (7%);transferase activity (7%);nucleic acid binding (6%),GO:0005978 (5%);GO:0015074 (5%);GO:0055085 (4%),glycogen biosynthetic process (5%);DNA integration (5%);transmembrane transport (4%),IPR023996 (11%);IPR012910 (11%);IPR037066 (11%),TonB-dependent outer membrane protein, SusC/RagA (11%);TonB-dependent receptor, plug domain (11%);TonB-dependent receptor, plug domain superfamily (11%),,,,,,,
WEEALCMTLTVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNQLSENR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (55%);5.2.1.8 (3%);7.5.2.6 (3%),DNA helicase (55%);Peptidylprolyl isomerase (3%);ABC-type lipid A-core oligosaccharide transporter (3%),GO:0016021 (19%);GO:0005737 (15%);GO:0009379 (12%),integral component of membrane (19%);cytoplasm (15%);Holliday junction helicase complex (12%),GO:0005524 (30%);GO:0003677 (26%);GO:0009378 (14%),ATP binding (30%);DNA binding (26%);four-way junction helicase activity (14%),GO:0006310 (15%);GO:0006281 (14%);GO:0009432 (13%),DNA recombination (15%);DNA repair (14%);SOS response (13%),IPR027417 (17%);IPR012340 (13%);IPR000085 (12%),P-loop containing nucleoside triphosphate hydrolase (17%);Nucleic acid-binding, OB-fold (13%);Bacterial DNA recombination protein RuvA (12%),,,,,,,,,,
LEEVDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (16%);1.1.1.261 (11%);6.1.1.5 (10%),Exoribonuclease II (16%);sn-glycerol-1-phosphate dehydrogenase (11%);Isoleucine--tRNA ligase (10%),GO:0016021 (14%);GO:0005856 (12%);GO:0005737 (9%),integral component of membrane (14%);cytoskeleton (12%);cytoplasm (9%),GO:0003677 (15%);GO:0003779 (10%);GO:0005524 (10%),DNA binding (15%);actin binding (10%);ATP binding (10%),GO:0030036 (14%);GO:0007507 (10%);GO:0006355 (8%),actin cytoskeleton organization (14%);heart development (10%);regulation of transcription, DNA-templated (8%),IPR012510 (12%);IPR030072 (12%);IPR030107 (12%),Actin-binding, Xin repeat (12%);Xin actin-binding repeat-containing protein 1/2 (12%);Xin actin-binding repeat-containing protein 2 (12%),,,,,,,,,
GFDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (10%);3.2.1.- (8%);3.6.4.12 (8%),Nucleotidyltransferases (10%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (8%);DNA helicase (8%),GO:0016021 (37%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (37%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (16%);GO:0008484 (9%);GO:0046872 (7%),ATP binding (16%);sulfuric ester hydrolase activity (9%);metal ion binding (7%),GO:0005975 (4%);GO:0006412 (2%);GO:0055085 (2%),carbohydrate metabolic process (4%);translation (2%);transmembrane transport (2%),IPR027417 (9%);IPR017850 (8%);IPR000917 (8%),P-loop containing nucleoside triphosphate hydrolase (9%);Alkaline-phosphatase-like, core domain superfamily (8%);Sulfatase, N-terminal (8%),,,,,,,,
NSGVETR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.71 (50%);4.2.3.4 (50%);6.1.1.7 (50%),Shikimate kinase (50%);3-dehydroquinate synthase (50%);Alanine--tRNA ligase (50%),GO:0005737 (50%),cytoplasm (50%),GO:0005524 (50%);GO:0000049 (25%);GO:0000287 (25%),ATP binding (50%);tRNA binding (25%);magnesium ion binding (25%),GO:0006166 (25%);GO:0006419 (25%);GO:0006633 (25%),purine ribonucleoside salvage (25%);alanyl-tRNA aminoacylation (25%);fatty acid biosynthetic process (25%),IPR002347 (38%);IPR036291 (38%);IPR000623 (13%),Short-chain dehydrogenase/reductase SDR (38%);NAD(P)-binding domain superfamily (38%);Shikimate kinase/Threonine synthase-like 1 (13%),,,,,,,,,,,
LALLNDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.1 (36%);1.1.1.22 (33%);1.1.1.25 (6%),Alanine dehydrogenase (36%);UDP-glucose 6-dehydrogenase (33%);Shikimate dehydrogenase (6%),GO:0016021 (13%);GO:0005576 (3%);GO:0016020 (3%),integral component of membrane (13%);extracellular region (3%);membrane (3%),GO:0000286 (9%);GO:0000166 (8%);GO:0003979 (8%),alanine dehydrogenase activity (9%);nucleotide binding (8%);UDP-glucose 6-dehydrogenase activity (8%),GO:0006865 (39%);GO:0042853 (9%);GO:0000271 (6%),amino acid transport (39%);L-alanine catabolic process (9%);polysaccharide biosynthetic process (6%),IPR000709 (37%);IPR028081 (37%);IPR028082 (37%),Leu/Ile/Val-binding protein (37%);Leucine-binding protein domain (37%);Periplasmic binding protein-like I (37%),,,,,,,,,,,
LLNYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.5.3 (4%);2.2.1.1 (4%);3.1.21.3 (4%),Protoporphyrinogen IX dehydrogenase (menaquinone) (4%);Transketolase (4%);Type I site-specific deoxyribonuclease (4%),GO:0016021 (24%);GO:0005840 (18%);GO:0005737 (5%),integral component of membrane (24%);ribosome (18%);cytoplasm (5%),GO:0019843 (18%);GO:0003735 (17%);GO:0003677 (12%),rRNA binding (18%);structural constituent of ribosome (17%);DNA binding (12%),GO:0006412 (18%);GO:0005975 (3%);GO:0006355 (2%),translation (18%);carbohydrate metabolic process (3%);regulation of transcription, DNA-templated (2%),IPR009068 (16%);IPR000589 (16%);IPR005290 (16%),S15/NS1, RNA-binding (16%);Ribosomal protein S15 (16%);Ribosomal protein S15, bacterial-type (16%),,,,,,,,
EVLLEFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (29%);1.7.1.7 (14%);2.7.13.3 (14%),DNA-directed DNA polymerase (29%);GMP reductase (14%);Histidine kinase (14%),GO:0016021 (30%);GO:0005737 (5%);GO:0005634 (3%),integral component of membrane (30%);cytoplasm (5%);nucleus (3%),GO:0008270 (30%);GO:0005524 (19%);GO:0016887 (11%),zinc ion binding (30%);ATP binding (19%);ATPase activity (11%),GO:0006260 (5%);GO:0000160 (3%);GO:0006434 (3%),DNA replication (5%);phosphorelay signal transduction system (3%);seryl-tRNA aminoacylation (3%),IPR001870 (42%);IPR003879 (42%);IPR006574 (42%),B30.2/SPRY domain (42%);Butyrophylin-like, SPRY domain (42%);SPRY-associated (42%),,,,,,,,,,
AAAGYDDWPWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAPCFNK,Campylobacter jejuni,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Epsilonproteobacteria,,,,Campylobacterales,,,,,Campylobacteraceae,,,,Campylobacter,,,,Campylobacter jejuni,,,,,,,,,,,,,,,,,,,,,,,,
NETELDDFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGGLGTVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPAESR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.92 (22%);4.2.2.- (10%);3.5.1.88 (8%),Endopeptidase Clp (22%);Acting on polysaccharides (10%);Peptide deformylase (8%),GO:0016021 (32%);GO:0005737 (6%);GO:0016020 (2%),integral component of membrane (32%);cytoplasm (6%);membrane (2%),GO:0005524 (11%);GO:0046872 (7%);GO:0003677 (7%),ATP binding (11%);metal ion binding (7%);DNA binding (7%),GO:0006355 (4%);GO:0032259 (3%);GO:0055085 (2%),regulation of transcription, DNA-templated (4%);methylation (3%);transmembrane transport (2%),IPR008258 (10%);IPR023346 (10%);IPR007730 (7%),Transglycosylase SLT domain 1 (10%);Lysozyme-like domain superfamily (10%);Sporulation-like domain (7%),,,,,,,,,,
TVVDEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (14%);GO:0005829 (10%);GO:0005623 (5%),integral component of membrane (14%);cytosol (10%);cell (5%),GO:0004497 (19%);GO:0005506 (19%);GO:0016705 (19%),monooxygenase activity (19%);iron ion binding (19%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (19%),GO:0008299 (10%);GO:0009166 (10%);GO:0019287 (10%),isoprenoid biosynthetic process (10%);nucleotide catabolic process (10%);isopentenyl diphosphate biosynthetic process, mevalonate pathway (10%),IPR008557 (44%);IPR006311 (13%);IPR001128 (9%),Protein of unknown function DUF839 (44%);Twin-arginine translocation pathway, signal sequence (13%);Cytochrome P450 (9%),,,,,,,
DQPALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.99.1.1 (42%);2.7.7.7 (23%);3.1.4.58 (11%),Protoporphyrin ferrochelatase (42%);DNA-directed DNA polymerase (23%);RNA 2',3'-cyclic 3'-phosphodiesterase (11%),GO:0016021 (26%);GO:0005737 (18%);GO:0005576 (3%),integral component of membrane (26%);cytoplasm (18%);extracellular region (3%),GO:0005524 (13%);GO:0046872 (12%);GO:0004325 (11%),ATP binding (13%);metal ion binding (12%);ferrochelatase activity (11%),GO:0006783 (11%);GO:0006281 (7%);GO:0005975 (3%),heme biosynthetic process (11%);DNA repair (7%);carbohydrate metabolic process (3%),IPR001015 (10%);IPR019772 (10%);IPR033644 (10%),Ferrochelatase (10%);Ferrochelatase, active site (10%);Ferrochelatase, C-terminal (10%),,,,,,,,
YDETLEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVEDQSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DAALELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.30 (29%);1.1.1.94 (14%);1.2.4.1 (14%),Glycerol kinase (29%);Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (14%);Pyruvate dehydrogenase (acetyl-transferring) (14%),GO:0016021 (39%);GO:0005886 (20%);GO:0030870 (7%),integral component of membrane (39%);plasma membrane (20%);Mre11 complex (7%),GO:0022857 (26%);GO:0016788 (11%);GO:0016887 (7%),transmembrane transporter activity (26%);hydrolase activity, acting on ester bonds (11%);ATPase activity (7%),GO:0071705 (20%);GO:0000723 (7%);GO:0006281 (7%),nitrogen compound transport (20%);telomere maintenance (7%);DNA repair (7%),IPR011990 (17%);IPR019734 (16%);IPR027417 (14%),Tetratricopeptide-like helical domain superfamily (17%);Tetratricopeptide repeat (16%);P-loop containing nucleoside triphosphate hydrolase (14%),,,,,,,,,,
VADAMGMAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLLVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.99.1.1 (67%);3.1.3.- (33%),Protoporphyrin ferrochelatase (67%);Phosphoric monoester hydrolases (33%),GO:0016021 (38%);GO:0005634 (25%);GO:0005737 (5%),integral component of membrane (38%);nucleus (25%);cytoplasm (5%),GO:0005096 (25%);GO:0008168 (23%);GO:0003676 (22%),GTPase activator activity (25%);methyltransferase activity (23%);nucleic acid binding (22%),GO:0051056 (25%);GO:0032259 (20%);GO:0006351 (4%),regulation of small GTPase mediated signal transduction (25%);methylation (20%);transcription, DNA-templated (4%),IPR029063 (22%);IPR000331 (21%);IPR016024 (21%),S-adenosyl-L-methionine-dependent methyltransferase (22%);Rap GTPase activating protein domain (21%);Armadillo-type fold (21%),,,,,,,,,,
LSGWNSVK,Methanosaeta harundinacea,Archaea,,,,Euryarchaeota,,,Methanomicrobia,,,,Methanosarcinales,,,,,Methanotrichaceae,,,,Methanothrix,,,,Methanosaeta harundinacea,,,,,,,,GO:0003743 (100%);GO:0003924 (100%);GO:0005525 (100%),translation initiation factor activity (100%);GTPase activity (100%);GTP binding (100%),,,IPR000795 (100%);IPR004161 (100%);IPR004544 (100%),Transcription factor, GTP-binding domain (100%);Translation elongation factor EFTu-like, domain 2 (100%);Translation initiation factor aIF-2, archaea (100%),,,,,,,,
MPPVLLWFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGPQEFGHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NANLGVSSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSEVEGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.6 (55%);6.3.5.7 (21%);3.4.-.- (7%),Exodeoxyribonuclease VII (55%);Glutaminyl-tRNA synthase (glutamine-hydrolyzing) (21%);Acting on peptide bonds (peptidases) (7%),GO:0001401 (34%);GO:0005737 (23%);GO:0009318 (19%),SAM complex (34%);cytoplasm (23%);exodeoxyribonuclease VII complex (19%),GO:0008855 (19%);GO:0005524 (16%);GO:0003677 (9%),exodeoxyribonuclease VII activity (19%);ATP binding (16%);DNA binding (9%),GO:0006308 (19%);GO:0006281 (8%);GO:0006355 (7%),DNA catabolic process (19%);DNA repair (8%);regulation of transcription, DNA-templated (7%),IPR019564 (31%);IPR033468 (31%);IPR036282 (31%),Mitochondrial outer membrane transport complex Sam37/metaxin, N-terminal domain (31%);Metaxin, glutathione S-transferase domain (31%);Glutathione S-transferase, C-terminal domain superfamily (31%),,,,,,,
TQNLLGMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSADLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.61 (30%);1.1.1.3 (20%);3.5.1.44 (20%),Protein-glutamate methylesterase (30%);Homoserine dehydrogenase (20%);Protein-glutamine glutaminase (20%),GO:0000151 (25%);GO:0016021 (25%);GO:0005737 (8%),ubiquitin ligase complex (25%);integral component of membrane (25%);cytoplasm (8%),GO:0046872 (26%);GO:0034450 (25%);GO:0005524 (8%),metal ion binding (26%);ubiquitin-ubiquitin ligase activity (25%);ATP binding (8%),GO:0006511 (25%);GO:0051603 (6%);GO:0009615 (6%),ubiquitin-dependent protein catabolic process (25%);proteolysis involved in cellular protein catabolic process (6%);response to virus (6%),IPR009663 (57%);IPR001870 (16%);IPR003877 (16%),Pilin accessory predicted (57%);B30.2/SPRY domain (16%);SPRY domain (16%),,,,,,,,,,,
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (14%);GO:0016021 (3%),extracellular space (14%);integral component of membrane (3%),GO:0004252 (100%);GO:0046872 (5%),serine-type endopeptidase activity (100%);metal ion binding (5%),GO:0006508 (14%);GO:0007586 (5%),proteolysis (14%);digestion (5%),IPR001254 (100%);IPR009003 (100%);IPR001314 (97%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1A, chymotrypsin family (97%),,,,,,,,
SQEAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.11 (33%);5.6.2.1 (8%);3.1.-.- (6%),Serine--tRNA ligase (33%);DNA topoisomerase (8%);Acting on ester bonds (6%),GO:0016021 (35%);GO:0005737 (12%);GO:0005634 (5%),integral component of membrane (35%);cytoplasm (12%);nucleus (5%),GO:0005524 (21%);GO:0003677 (17%);GO:0004828 (6%),ATP binding (21%);DNA binding (17%);serine-tRNA ligase activity (6%),GO:0006434 (6%);GO:0016260 (6%);GO:0097056 (6%),seryl-tRNA aminoacylation (6%);selenocysteine biosynthetic process (6%);selenocysteinyl-tRNA(Sec) biosynthetic process (6%),IPR027417 (9%);IPR000436 (9%);IPR035976 (9%),P-loop containing nucleoside triphosphate hydrolase (9%);Sushi/SCR/CCP domain (9%);Sushi/SCR/CCP superfamily (9%),,,,,,,,,,,
FTPMEANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMAGDDAPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEELNMLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAVVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.7 (21%);2.3.1.234 (5%);3.1.26.5 (5%),UDP-N-acetylglucosamine 1-carboxyvinyltransferase (21%);N(6)-L-threonylcarbamoyladenine synthase (5%);Ribonuclease P (5%),GO:0016021 (21%);GO:0005737 (11%);GO:0009507 (7%),integral component of membrane (21%);cytoplasm (11%);chloroplast (7%),GO:0005524 (13%);GO:0003723 (8%);GO:0046872 (7%),ATP binding (13%);RNA binding (8%);metal ion binding (7%),GO:0008033 (7%);GO:0006397 (7%);GO:0071555 (5%),tRNA processing (7%);mRNA processing (7%);cell wall organization (5%),IPR027417 (9%);IPR002866 (5%);IPR024942 (5%),P-loop containing nucleoside triphosphate hydrolase (9%);Maturase MatK (5%);Maturase MatK, N-terminal domain (5%),,,,,,,,,,
VAQFRPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016301 (50%);GO:0019104 (50%),kinase activity (50%);DNA N-glycosylase activity (50%),GO:0006281 (50%),DNA repair (50%),IPR001453 (50%);IPR005122 (50%);IPR015637 (50%),MoaB/Mog domain (50%);Uracil-DNA glycosylase-like (50%);G/U mismatch-specific DNA glycosylase (50%),,,,,,,,,,,
LLGTLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.52 (40%);2.7.4.3 (16%);2.7.11.- (12%),Beta-N-acetylhexosaminidase (40%);Adenylate kinase (16%);Protein-serine/threonine kinases (12%),GO:0016021 (35%);GO:0005737 (8%);GO:0005759 (3%),integral component of membrane (35%);cytoplasm (8%);mitochondrial matrix (3%),GO:0005524 (19%);GO:0004563 (10%);GO:0102148 (10%),ATP binding (19%);beta-N-acetylhexosaminidase activity (10%);N-acetyl-beta-D-galactosaminidase activity (10%),GO:0005975 (19%);GO:0055085 (6%);GO:0044209 (4%),carbohydrate metabolic process (19%);transmembrane transport (6%);AMP salvage (4%),IPR001764 (11%);IPR017853 (11%);IPR036962 (11%),Glycoside hydrolase, family 3, N-terminal (11%);Glycoside hydrolase superfamily (11%);Glycoside hydrolase, family 3, N-terminal domain superfamily (11%),,,,,,,
ALDLLDEAASSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (100%),Serine endopeptidases (100%),GO:0005737 (94%);GO:0016020 (0%);GO:0005759 (0%),cytoplasm (94%);membrane (0%);mitochondrial matrix (0%),GO:0005524 (100%);GO:0008233 (8%);GO:0016787 (1%),ATP binding (100%);peptidase activity (8%);hydrolase activity (1%),GO:0042026 (94%);GO:0009408 (94%);GO:0019538 (88%),protein refolding (94%);response to heat (94%);protein metabolic process (88%),IPR027417 (100%);IPR041546 (100%);IPR003959 (99%),P-loop containing nucleoside triphosphate hydrolase (100%);ClpA/ClpB, AAA lid domain (100%);ATPase, AAA-type, core (99%),,,,,,,,
NPQFNLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.- (100%),Carbon--nitrogen ligases with glutamine as amido-N-donor (100%),,,GO:0004067 (100%);GO:0005524 (100%);GO:0016740 (100%),asparaginase activity (100%);ATP binding (100%);transferase activity (100%),GO:0006412 (100%),translation (100%),IPR006033 (100%);IPR006034 (100%);IPR011878 (100%),Type I L-asparaginase family (100%);Asparaginase/glutaminase-like (100%);Glutamyl-tRNA(Gln) amidotransferase subunit  D (100%),,,,,,,,,,,
VTVNGADPSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGQALDDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPSHNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.16 (43%);2.4.1.227 (14%);2.4.2.17 (14%),Glutamine--fructose-6-phosphate transaminase (isomerizing) (43%);Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (14%);ATP phosphoribosyltransferase (14%),GO:0016021 (50%);GO:0005737 (7%);GO:0005886 (5%),integral component of membrane (50%);cytoplasm (7%);plasma membrane (5%),GO:0005524 (16%);GO:0003677 (9%);GO:0050660 (7%),ATP binding (16%);DNA binding (9%);flavin adenine dinucleotide binding (7%),GO:0005975 (9%);GO:0055085 (7%);GO:1901137 (5%),carbohydrate metabolic process (9%);transmembrane transport (7%);carbohydrate derivative biosynthetic process (5%),IPR000160 (7%);IPR000644 (7%);IPR002550 (7%),GGDEF domain (7%);CBS domain (7%);CNNM, transmembrane domain (7%),,,,,,,,,,
QDYELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.30 (38%);2.7.7.7 (34%);3.2.1.23 (7%),dCTP deaminase (dUMP-forming) (38%);DNA-directed DNA polymerase (34%);Beta-galactosidase (7%),GO:0016021 (19%);GO:0005737 (13%);GO:0005929 (2%),integral component of membrane (19%);cytoplasm (13%);cilium (2%),GO:0004674 (15%);GO:0005524 (15%);GO:0003677 (13%),protein serine/threonine kinase activity (15%);ATP binding (15%);DNA binding (13%),GO:0006226 (11%);GO:0006229 (11%);GO:0006260 (10%),dUMP biosynthetic process (11%);dUTP biosynthetic process (11%);DNA replication (10%),IPR022165 (16%);IPR000719 (13%);IPR008920 (13%),Polo kinase kinase (16%);Protein kinase domain (13%);Transcription regulator FadR/GntR, C-terminal (13%),,,,,,,,,,
MTELER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (23%);6.1.1.4 (20%);3.6.4.12 (8%),DNA ligase (NAD(+)) (23%);Leucine--tRNA ligase (20%);DNA helicase (8%),GO:0016021 (17%);GO:0005737 (12%);GO:0005886 (4%),integral component of membrane (17%);cytoplasm (12%);plasma membrane (4%),GO:0003677 (25%);GO:0005524 (16%);GO:0016491 (14%),DNA binding (25%);ATP binding (16%);oxidoreductase activity (14%),GO:0006281 (8%);GO:0006260 (7%);GO:0006429 (5%),DNA repair (8%);DNA replication (7%);leucyl-tRNA aminoacylation (5%),IPR036188 (10%);IPR003953 (8%);IPR027477 (8%),FAD/NAD(P)-binding domain superfamily (10%);FAD-dependent oxidoreductase 2, FAD binding domain (8%);Succinate dehydrogenase/fumarate reductase flavoprotein, catalytic domain superfamily (8%),,,,,,,,,
EVPLLQSK,Brassica rapa,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Brassicales,,,,,Brassicaceae,,Brassiceae,,Brassica,,,,Brassica rapa,,,,,,,,,,,,,,,,,,,,,,,,
EENLPQLK,Oxytricha trifallax,Eukaryota,,,,Ciliophora,Intramacronucleata,,Spirotrichea,Stichotrichia,,,Sporadotrichida,,,,,Oxytrichidae,Oxytrichinae,,,Oxytricha,,,,Oxytricha trifallax,,,,,,,,,,,,,,,,,,,,,,,,
YADLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.21 (42%);3.6.4.12 (13%);3.2.1.8 (8%),Starch synthase (42%);DNA helicase (13%);Endo-1,4-beta-xylanase (8%),GO:0016021 (24%);GO:0016020 (6%);GO:0005737 (4%),integral component of membrane (24%);membrane (6%);cytoplasm (4%),GO:0005524 (16%);GO:0009011 (11%);GO:0033201 (11%),ATP binding (16%);starch synthase activity (11%);alpha-1,4-glucan synthase activity (11%),GO:0005978 (11%);GO:0009291 (6%);GO:0007165 (4%),glycogen biosynthetic process (11%);unidirectional conjugation (6%);signal transduction (4%),IPR011990 (34%);IPR013026 (33%);IPR019734 (32%),Tetratricopeptide-like helical domain superfamily (34%);Tetratricopeptide repeat-containing domain (33%);Tetratricopeptide repeat (32%),,,,,,,,,
DCETK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.3 (22%);3.5.1.10 (17%);2.7.7.6 (11%),Adenylate kinase (22%);Formyltetrahydrofolate deformylase (17%);DNA-directed RNA polymerase (11%),GO:0016021 (34%);GO:0005737 (5%);GO:0005623 (3%),integral component of membrane (34%);cytoplasm (5%);cell (3%),GO:0005524 (15%);GO:0046872 (12%);GO:0003677 (4%),ATP binding (15%);metal ion binding (12%);DNA binding (4%),GO:0042981 (3%);GO:0006438 (2%);GO:0007051 (2%),regulation of apoptotic process (3%);valyl-tRNA aminoacylation (2%);spindle organization (2%),IPR027417 (14%);IPR003598 (7%);IPR003599 (7%),P-loop containing nucleoside triphosphate hydrolase (14%);Immunoglobulin subtype 2 (7%);Immunoglobulin subtype (7%),,,,,,,,,,,
DNQGQLDTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNLLTCHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVTVTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (67%);2.8.4.3 (33%),Acting on ester bonds (67%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (33%),GO:0005840 (35%);GO:0005737 (8%);GO:0005634 (5%),ribosome (35%);cytoplasm (8%);nucleus (5%),GO:0003735 (38%);GO:0003729 (33%);GO:0005524 (33%),structural constituent of ribosome (38%);mRNA binding (33%);ATP binding (33%),GO:0006412 (33%);GO:0006457 (30%);GO:0060271 (30%),translation (33%);protein folding (30%);cilium assembly (30%),IPR001351 (28%);IPR004044 (28%);IPR004087 (28%),Ribosomal protein S3, C-terminal (28%);K Homology domain, type 2 (28%);K Homology domain (28%),,,,,,,,,
WNALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.4 (15%);4.2.1.3 (12%);5.2.1.8 (5%),Phospholipase D (15%);Aconitate hydratase (12%);Peptidylprolyl isomerase (5%),GO:0016021 (22%);GO:0005779 (4%);GO:0016020 (4%),integral component of membrane (22%);integral component of peroxisomal membrane (4%);membrane (4%),GO:0005524 (11%);GO:0005509 (6%);GO:0051539 (4%),ATP binding (11%);calcium ion binding (6%);4 iron, 4 sulfur cluster binding (4%),GO:0005975 (6%);GO:0016559 (4%);GO:0006629 (4%),carbohydrate metabolic process (6%);peroxisome fission (4%);lipid metabolic process (4%),IPR027417 (8%);IPR002017 (6%);IPR018159 (6%),P-loop containing nucleoside triphosphate hydrolase (8%);Spectrin repeat (6%);Spectrin/alpha-actinin (6%),,,,,,,,,,
NNQTSMHTVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGTLDHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LANLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (8%);3.6.4.12 (5%);1.1.1.22 (4%),Phenylalanine--tRNA ligase (8%);DNA helicase (5%);UDP-glucose 6-dehydrogenase (4%),GO:0016021 (24%);GO:0005737 (10%);GO:0005634 (3%),integral component of membrane (24%);cytoplasm (10%);nucleus (3%),GO:0005524 (18%);GO:0003677 (9%);GO:0008270 (4%),ATP binding (18%);DNA binding (9%);zinc ion binding (4%),GO:0005975 (2%);GO:0055085 (2%);GO:0007165 (2%),carbohydrate metabolic process (2%);transmembrane transport (2%);signal transduction (2%),IPR027417 (11%);IPR036388 (3%);IPR032675 (3%),P-loop containing nucleoside triphosphate hydrolase (11%);Winged helix-like DNA-binding domain superfamily (3%);Leucine-rich repeat domain superfamily (3%),,,,,,,,,,,
DLFTVENGGTPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YEYYLNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAASC,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.59 (100%),3-hydroxyacyl-[acyl-carrier-protein] dehydratase (100%),GO:0005737 (33%);GO:0016021 (33%),cytoplasm (33%);integral component of membrane (33%),GO:0004317 (33%);GO:0008659 (33%);GO:0008693 (33%),3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity (33%);(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity (33%);3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity (33%),GO:0006633 (33%);GO:0009245 (33%);GO:0055085 (33%),fatty acid biosynthetic process (33%);lipid A biosynthetic process (33%);transmembrane transport (33%),IPR004776 (25%);IPR006597 (25%);IPR010084 (25%),Membrane transport protein (25%);Sel1-like repeat (25%);Beta-hydroxyacyl-(acyl-carrier-protein) dehydratase FabZ (25%),,,,,,,,,,,
VPNEEPNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VASQLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.3.9 (67%);1.1.5.3 (17%);2.8.1.- (17%),Phosphoenolpyruvate--protein phosphotransferase (67%);Glycerol-3-phosphate dehydrogenase (17%);Sulfurtransferases (17%),GO:0016021 (32%);GO:0005737 (20%);GO:0005886 (8%),integral component of membrane (32%);cytoplasm (20%);plasma membrane (8%),GO:0003824 (16%);GO:0005524 (16%);GO:0008965 (16%),catalytic activity (16%);ATP binding (16%);phosphoenolpyruvate-protein phosphotransferase activity (16%),GO:0009401 (16%);GO:0006614 (8%);GO:0006072 (4%),phosphoenolpyruvate-dependent sugar phosphotransferase system (16%);SRP-dependent cotranslational protein targeting to membrane (8%);glycerol-3-phosphate metabolic process (4%),IPR027417 (30%);IPR000121 (15%);IPR001753 (15%),P-loop containing nucleoside triphosphate hydrolase (30%);PEP-utilising enzyme, C-terminal (15%);Enoyl-CoA hydratase/isomerase (15%),,,,,,,,,,
LLTPDHNGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMELEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (56%);4.2.1.33 (9%);3.1.-.- (5%),DNA topoisomerase (56%);3-isopropylmalate dehydratase (9%);Acting on ester bonds (5%),GO:0016021 (18%);GO:0005694 (11%);GO:0005737 (4%),integral component of membrane (18%);chromosome (11%);cytoplasm (4%),GO:0003723 (32%);GO:0046872 (17%);GO:0003677 (16%),RNA binding (32%);metal ion binding (17%);DNA binding (16%),GO:0006265 (12%);GO:0007624 (3%);GO:0006355 (2%),DNA topological change (12%);ultradian rhythm (3%);regulation of transcription, DNA-templated (2%),IPR012677 (27%);IPR000504 (27%);IPR035979 (27%),Nucleotide-binding alpha-beta plait domain superfamily (27%);RNA recognition motif domain (27%);RNA-binding domain superfamily (27%),,,,,,,,,,
LGNSSDTTTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLAGMYK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.17 (100%),Transferred entry: 7.5.2.8 (100%),GO:0016021 (50%),integral component of membrane (50%),GO:0005524 (50%);GO:0015407 (50%);GO:0016887 (50%),ATP binding (50%);ATPase-coupled monosaccharide transmembrane transporter activity (50%);ATPase activity (50%),,,IPR003439 (100%);IPR003593 (100%);IPR017871 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);ABC transporter, conserved site (100%),,,,,,,,,,
NPTTLTMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMQLSYNK,Glossina brevipalpis,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Diptera,Brachycera,Muscomorpha,,Hippoboscoidea,Glossinidae,,,,Glossina,Austenina,,,Glossina brevipalpis,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0008270 (100%);GO:0008745 (100%),zinc ion binding (100%);N-acetylmuramoyl-L-alanine amidase activity (100%),GO:0009253 (100%),peptidoglycan catabolic process (100%),IPR002502 (100%);IPR006619 (100%);IPR015510 (100%),N-acetylmuramoyl-L-alanine amidase domain (100%);Peptidoglycan recognition protein family domain, metazoa/bacteria (100%);Peptidoglycan recognition protein (100%),,,,,,,,,,
GFDENLVDGVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNFWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.11 (25%);2.7.1.30 (25%);3.1.1.- (25%),Acetylornithine transaminase (25%);Glycerol kinase (25%);Carboxylic ester hydrolases (25%),GO:0016021 (47%);GO:0005886 (11%);GO:0009279 (2%),integral component of membrane (47%);plasma membrane (11%);cell outer membrane (2%),GO:0005506 (28%);GO:0016705 (28%);GO:0020037 (28%),iron ion binding (28%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (28%);heme binding (28%),GO:0046677 (10%);GO:0005975 (4%);GO:0019062 (2%),response to antibiotic (10%);carbohydrate metabolic process (4%);virion attachment to host cell (2%),IPR001128 (22%);IPR002401 (22%);IPR036396 (22%),Cytochrome P450 (22%);Cytochrome P450, E-class, group I (22%);Cytochrome P450 superfamily (22%),,,,,,,
TENTSKPK,Cyclobacterium marinum,Bacteria,,,,Bacteroidetes,,,Cytophagia,,,,Cytophagales,,,,,Cyclobacteriaceae,,,,Cyclobacterium,,,,Cyclobacterium marinum,,,,,,,,,,,,IPR023485 (100%);IPR036196 (100%),Phosphotyrosine protein phosphatase I (100%);Phosphotyrosine protein phosphatase I superfamily (100%),,,,,,,,,,,
LGLNQVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (60%);2.1.1.297 (20%);5.4.99.- (20%),DNA-directed DNA polymerase (60%);Peptide chain release factor N(5)-glutamine methyltransferase (20%);Transferring other groups (20%),GO:0005737 (25%),cytoplasm (25%),GO:0003887 (25%);GO:0008408 (25%);GO:0003676 (17%),DNA-directed DNA polymerase activity (25%);3'-5' exonuclease activity (25%);nucleic acid binding (17%),GO:0006260 (25%);GO:0006281 (25%);GO:0006310 (17%),DNA replication (25%);DNA repair (25%);DNA recombination (17%),IPR003141 (19%);IPR004013 (19%);IPR004805 (19%),Polymerase/histidinol phosphatase, N-terminal (19%);PHP domain (19%);DNA polymerase III, alpha subunit (19%),,,,,,,,,
TSMAEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.72 (35%);6.3.5.3 (12%);2.7.7.6 (8%),Quinolinate synthase (35%);Phosphoribosylformylglycinamidine synthase (12%);DNA-directed RNA polymerase (8%),GO:0016021 (18%);GO:0005737 (14%);GO:0005886 (2%),integral component of membrane (18%);cytoplasm (14%);plasma membrane (2%),GO:0005524 (18%);GO:0046872 (17%);GO:0000287 (12%),ATP binding (18%);metal ion binding (17%);magnesium ion binding (12%),GO:0042759 (11%);GO:0009435 (10%);GO:0009058 (3%),long-chain fatty acid biosynthetic process (11%);NAD biosynthetic process (10%);biosynthetic process (3%),IPR005064 (13%);IPR042100 (13%);IPR036291 (9%),Bordetella uptake gene (13%);Bordetella uptake gene, domain 1 (13%);NAD(P)-binding domain superfamily (9%),,,,,,,,,,
AAAEAEDDTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLQSDVPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLNLGNLTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CDVASVDK,Chlorobaculum limnaeum,Bacteria,,,,Chlorobi,,,Chlorobia,,,,Chlorobiales,,,,,Chlorobiaceae,,,,Chlorobaculum,,,,Chlorobaculum limnaeum,,,,,,GO:0005737 (100%);GO:0009360 (100%),cytoplasm (100%);DNA polymerase III complex (100%),GO:0003677 (100%);GO:0003887 (100%);GO:0008408 (100%),DNA binding (100%);DNA-directed DNA polymerase activity (100%);3'-5' exonuclease activity (100%),GO:0006260 (100%),DNA replication (100%),IPR001001 (100%);IPR022634 (100%);IPR022635 (100%),DNA polymerase III, beta sliding clamp (100%);DNA polymerase III, beta sliding clamp, N-terminal (100%);DNA polymerase III, beta sliding clamp, C-terminal (100%),,,,,,
LDPTSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.88 (50%);6.3.5.5 (50%),Peptide deformylase (50%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (50%),GO:0016021 (12%);GO:0005643 (2%);GO:0005886 (2%),integral component of membrane (12%);nuclear pore (2%);plasma membrane (2%),GO:0003677 (35%);GO:0003700 (33%);GO:0005524 (30%),DNA binding (35%);DNA-binding transcription factor activity (33%);ATP binding (30%),GO:0005975 (4%);GO:0006541 (4%);GO:1901135 (4%),carbohydrate metabolic process (4%);glutamine metabolic process (4%);carbohydrate derivative metabolic process (4%),IPR000847 (33%);IPR005119 (33%);IPR036388 (33%),Transcription regulator HTH, LysR (33%);LysR, substrate-binding (33%);Winged helix-like DNA-binding domain superfamily (33%),,,,,,,,,
LSGSVGNTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MELGQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.7 (47%);1.11.1.15 (9%);2.4.1.17 (9%),Peroxidase (47%);Peroxiredoxin (9%);Glucuronosyltransferase (9%),GO:0016021 (25%);GO:0005576 (8%);GO:0005623 (7%),integral component of membrane (25%);extracellular region (8%);cell (7%),GO:0003677 (27%);GO:0016491 (19%);GO:0004601 (11%),DNA binding (27%);oxidoreductase activity (19%);peroxidase activity (11%),GO:0006979 (9%);GO:0042744 (9%);GO:0045454 (7%),response to oxidative stress (9%);hydrogen peroxide catabolic process (9%);cell redox homeostasis (7%),IPR001387 (18%);IPR010982 (18%);IPR036188 (17%),Cro/C1-type helix-turn-helix domain (18%);Lambda repressor-like, DNA-binding domain superfamily (18%);FAD/NAD(P)-binding domain superfamily (17%),,,,,,,,,,
LVAPPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.2 (33%);3.2.2.- (33%);5.4.99.- (33%),Phosphoribosylglycinamide formyltransferase (33%);Hydrolyzing N-glycosyl compounds (33%);Transferring other groups (33%),GO:0005737 (94%);GO:0005856 (92%);GO:0015629 (2%),cytoplasm (94%);cytoskeleton (92%);actin cytoskeleton (2%),GO:0005524 (95%);GO:0016740 (1%);GO:0003677 (1%),ATP binding (95%);transferase activity (1%);DNA binding (1%),GO:0000281 (2%);GO:0006897 (1%);GO:0043486 (1%),mitotic cytokinesis (2%);endocytosis (1%);histone exchange (1%),IPR004000 (98%);IPR020902 (84%);IPR004001 (58%),Actin family (98%);Actin/actin-like conserved site (84%);Actin, conserved site (58%),,,,,,,,,,
VVVTDSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.39 (100%),[Acyl-carrier-protein] S-malonyltransferase (100%),GO:0005840 (96%);GO:0015935 (0%),ribosome (96%);small ribosomal subunit (0%),GO:0003735 (95%);GO:0004177 (1%);GO:0031177 (1%),structural constituent of ribosome (95%);aminopeptidase activity (1%);phosphopantetheine binding (1%),GO:0006412 (97%);GO:0006886 (0%);GO:0016192 (0%),translation (97%);intracellular protein transport (0%);vesicle-mediated transport (0%),IPR000307 (95%);IPR023803 (95%);IPR020592 (80%),Ribosomal protein S16 (95%);Ribosomal protein S16 domain superfamily (95%);Ribosomal protein S16, conserved site (80%),,,,,,,,,,
WASAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.6.1 (16%);3.4.16.4 (16%);4.2.1.3 (12%),Ribose-phosphate diphosphokinase (16%);Serine-type D-Ala-D-Ala carboxypeptidase (16%);Aconitate hydratase (12%),GO:0016021 (20%);GO:0005737 (7%);GO:0005829 (4%),integral component of membrane (20%);cytoplasm (7%);cytosol (4%),GO:0008270 (18%);GO:0003676 (17%);GO:0005524 (11%),zinc ion binding (18%);nucleic acid binding (17%);ATP binding (11%),GO:0009116 (3%);GO:0009156 (3%);GO:0009165 (3%),nucleoside metabolic process (3%);ribonucleoside monophosphate biosynthetic process (3%);nucleotide biosynthetic process (3%),IPR032567 (15%);IPR001878 (14%);IPR036875 (14%),LDOC1-related (15%);Zinc finger, CCHC-type (14%);Zinc finger, CCHC-type superfamily (14%),,,,,,,,,
WFTTNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (95%),integral component of membrane (95%),GO:0022857 (5%);GO:0003676 (2%);GO:0016740 (2%),transmembrane transporter activity (5%);nucleic acid binding (2%);transferase activity (2%),GO:0055085 (83%),transmembrane transport (83%),IPR011701 (89%);IPR020846 (89%);IPR036259 (89%),Major facilitator superfamily (89%);Major facilitator superfamily domain (89%);MFS transporter superfamily (89%),,,,,,,,,,,
NGLEQLGR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0001216 (33%);GO:0003677 (33%);GO:0004673 (33%),DNA-binding transcription activator activity (33%);DNA binding (33%);protein histidine kinase activity (33%),GO:0006352 (33%),DNA-templated transcription, initiation (33%),IPR000394 (25%);IPR000587 (25%);IPR000994 (25%),RNA polymerase sigma factor 54 (25%);Creatinase, N-terminal (25%);Peptidase M24 (25%),,,,,,,,,
NPVLLADPVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALNLLDEFPNAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FTVSHMK,Collinsella aerofaciens,Bacteria,,,,Actinobacteria,,,Coriobacteriia,,,,Coriobacteriales,,,,,Coriobacteriaceae,,,,Collinsella,,,,Collinsella aerofaciens,,,,3.1.3.16 (100%),Protein-serine/threonine phosphatase (100%),,,GO:0004721 (100%),phosphoprotein phosphatase activity (100%),,,IPR004843 (100%);IPR006186 (100%);IPR029052 (100%),Calcineurin-like phosphoesterase domain, ApaH type (100%);Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase (100%);Metallo-dependent phosphatase-like (100%),,,,,,,,,,
VDNSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (33%);2.7.13.3 (33%);2.7.7.6 (33%),Non-specific serine/threonine protein kinase (33%);Histidine kinase (33%);DNA-directed RNA polymerase (33%),GO:0016021 (21%);GO:0005576 (7%);GO:0009507 (7%),integral component of membrane (21%);extracellular region (7%);chloroplast (7%),GO:0003677 (14%);GO:0005524 (14%);GO:0008236 (14%),DNA binding (14%);ATP binding (14%);serine-type peptidase activity (14%),GO:0006310 (7%);GO:0006351 (7%);GO:0006355 (7%),DNA recombination (7%);transcription, DNA-templated (7%);regulation of transcription, DNA-templated (7%),IPR042841 (18%);IPR000719 (12%);IPR001478 (12%),Splicing factor, arginine/serine-rich 19 (18%);Protein kinase domain (12%);PDZ domain (12%),,,,,,,,
MLDRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.16 (21%);7.6.2.11 (14%);1.1.1.18 (7%),GTP cyclohydrolase I (21%);ABC-type polyamine transporter (14%);Inositol 2-dehydrogenase (7%),GO:0016021 (16%);GO:0005634 (7%);GO:0005737 (3%),integral component of membrane (16%);nucleus (7%);cytoplasm (3%),GO:0005524 (39%);GO:0016887 (19%);GO:0003677 (12%),ATP binding (39%);ATPase activity (19%);DNA binding (12%),GO:0006529 (8%);GO:0006541 (8%);GO:0006730 (4%),asparagine biosynthetic process (8%);glutamine metabolic process (8%);one-carbon metabolic process (4%),IPR027417 (20%);IPR003593 (16%);IPR003439 (13%),P-loop containing nucleoside triphosphate hydrolase (20%);AAA+ ATPase domain (16%);ABC transporter-like (13%),,,,,,,,,,,
FGAGDDAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTPDENR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.22 (100%),Alpha-galactosidase (100%),GO:0016021 (17%),integral component of membrane (17%),GO:0016853 (33%);GO:0004450 (17%);GO:0022857 (17%),isomerase activity (33%);isocitrate dehydrogenase (NADP+) activity (17%);transmembrane transporter activity (17%),GO:0005975 (17%);GO:0006102 (17%);GO:0006869 (17%),carbohydrate metabolic process (17%);isocitrate metabolic process (17%);lipid transport (17%),IPR001680 (25%);IPR015943 (25%);IPR017986 (25%),WD40 repeat (25%);WD40/YVTN repeat-like-containing domain superfamily (25%);WD40-repeat-containing domain (25%),,,,,,,,,,,
QVLMWPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGESDLAQPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDLDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (35%);3.1.4.4 (8%);6.1.1.3 (7%),DNA topoisomerase (ATP-hydrolyzing) (35%);Phospholipase D (8%);Threonine--tRNA ligase (7%),GO:0016021 (35%);GO:0005737 (9%);GO:0005694 (5%),integral component of membrane (35%);cytoplasm (9%);chromosome (5%),GO:0005524 (19%);GO:0003677 (14%);GO:0005242 (8%),ATP binding (19%);DNA binding (14%);inward rectifier potassium channel activity (8%),GO:0034765 (8%);GO:0006265 (6%);GO:0006261 (6%),regulation of ion transmembrane transport (8%);DNA topological change (6%);DNA-dependent DNA replication (6%),IPR004000 (43%);IPR020902 (42%);IPR021795 (12%),Actin family (43%);Actin/actin-like conserved site (42%);Protein of unknown function DUF3363 (12%),,,,,,,,,,,
FELWMSPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DKPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.1 (25%);4.1.2.13 (11%);2.1.1.113 (6%),Receptor protein-tyrosine kinase (25%);Fructose-bisphosphate aldolase (11%);Site-specific DNA-methyltransferase (cytosine-N(4)-specific) (6%),GO:0016021 (28%);GO:0005737 (3%);GO:0000124 (2%),integral component of membrane (28%);cytoplasm (3%);SAGA complex (2%),GO:0005524 (17%);GO:0046872 (12%);GO:0051539 (11%),ATP binding (17%);metal ion binding (12%);4 iron, 4 sulfur cluster binding (11%),GO:0008284 (9%);GO:0005975 (6%);GO:0006260 (2%),positive regulation of cell population proliferation (9%);carbohydrate metabolic process (6%);DNA replication (2%),IPR013783 (10%);IPR017896 (9%);IPR017900 (9%),Immunoglobulin-like fold (10%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (9%);4Fe-4S ferredoxin, iron-sulphur binding, conserved site (9%),,,,,,,
LTCWSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (83%);GO:0000139 (17%);GO:0005789 (17%),integral component of membrane (83%);Golgi membrane (17%);endoplasmic reticulum membrane (17%),GO:0016747 (17%);GO:0032934 (17%);GO:0046912 (17%),transferase activity, transferring acyl groups other than amino-acyl groups (17%);sterol binding (17%);transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer (17%),GO:0019752 (17%);GO:0032933 (17%);GO:0051188 (17%),carboxylic acid metabolic process (17%);SREBP signaling pathway (17%);cofactor biosynthetic process (17%),IPR000731 (40%);IPR036322 (40%);IPR000891 (20%),Sterol-sensing domain (40%);WD40-repeat-containing domain superfamily (40%);Pyruvate carboxyltransferase (20%),,,,,,,,
TAAATLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.169 (100%),2-dehydropantoate 2-reductase (100%),GO:0005737 (25%),cytoplasm (25%),GO:0003700 (50%);GO:0008677 (50%);GO:0003723 (25%),DNA-binding transcription factor activity (50%);2-dehydropantoate 2-reductase activity (50%);RNA binding (25%),GO:0006353 (50%);GO:0015940 (50%);GO:0031564 (50%),DNA-templated transcription, termination (50%);pantothenate biosynthetic process (50%);transcription antitermination (50%),IPR003710 (40%);IPR008927 (40%);IPR012340 (40%),Ketopantoate reductase ApbA/PanE (40%);6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily (40%);Nucleic acid-binding, OB-fold (40%),,,,,,,,
QVLTLWGGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (13%);2.7.7.7 (10%);2.1.1.- (8%),Endopeptidase La (13%);DNA-directed DNA polymerase (10%);Methyltransferases (8%),GO:0016021 (48%);GO:0005886 (4%);GO:0000145 (3%),integral component of membrane (48%);plasma membrane (4%);exocyst (3%),GO:0005524 (9%);GO:0003677 (5%);GO:0003723 (5%),ATP binding (9%);DNA binding (5%);RNA binding (5%),GO:0007165 (6%);GO:0006904 (3%);GO:0006935 (3%),signal transduction (6%);vesicle docking involved in exocytosis (3%);chemotaxis (3%),IPR009387 (11%);IPR027417 (10%);IPR004089 (5%),Toxin HigB-2 (11%);P-loop containing nucleoside triphosphate hydrolase (10%);Methyl-accepting chemotaxis protein (MCP) signalling domain (5%),,,,,,,,,,,
LLSLSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (99%);GO:0016021 (0%);GO:0022625 (0%),ribosome (99%);integral component of membrane (0%);cytosolic large ribosomal subunit (0%),GO:0000049 (98%);GO:0019843 (98%);GO:0003735 (94%),tRNA binding (98%);rRNA binding (98%);structural constituent of ribosome (94%),GO:0006412 (99%);GO:0016042 (0%);GO:0000027 (0%),translation (99%);lipid catabolic process (0%);ribosomal large subunit assembly (0%),IPR002132 (99%);IPR022803 (99%);IPR031309 (99%),Ribosomal protein L5 (99%);Ribosomal protein L5 domain superfamily (99%);Ribosomal protein L5, C-terminal (99%),,,,,,,,,,
NFLNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.6 (11%);3.6.4.12 (9%);6.3.5.7 (9%),Lysine--tRNA ligase (11%);DNA helicase (9%);Glutaminyl-tRNA synthase (glutamine-hydrolyzing) (9%),GO:0016021 (48%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (48%);cytoplasm (5%);plasma membrane (4%),GO:0005524 (12%);GO:0003723 (9%);GO:0046872 (9%),ATP binding (12%);RNA binding (9%);metal ion binding (9%),GO:0007186 (10%);GO:0019236 (10%);GO:0009401 (3%),G protein-coupled receptor signaling pathway (10%);response to pheromone (10%);phosphoenolpyruvate-dependent sugar phosphotransferase system (3%),IPR027417 (12%);IPR019336 (9%);IPR000504 (8%),P-loop containing nucleoside triphosphate hydrolase (12%);Intimal thickness related receptor, IRP (9%);RNA recognition motif domain (8%),,,,,,,,,,
FVETVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.115 (100%),UDP-N-acetylglucosamine 4,6-dehydratase (inverting) (100%),GO:0016021 (47%);GO:0005623 (7%);GO:0019028 (7%),integral component of membrane (47%);cell (7%);viral capsid (7%),GO:0046872 (40%);GO:0005524 (13%);GO:0016829 (13%),metal ion binding (40%);ATP binding (13%);lyase activity (13%),GO:0007165 (33%);GO:0006351 (7%);GO:0039694 (7%),signal transduction (33%);transcription, DNA-templated (7%);viral RNA genome replication (7%),IPR003660 (33%);IPR012312 (33%);IPR012827 (33%),HAMP domain (33%);Haemerythrin-like (33%);Hemerythrin, metal-binding domain (33%),,,,,,,,
AALLPEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (71%);5.2.1.8 (17%);2.7.9.1 (4%),Acting on polysaccharides (71%);Peptidylprolyl isomerase (17%);Pyruvate, phosphate dikinase (4%),GO:0043190 (61%);GO:0005887 (18%);GO:0015935 (1%),ATP-binding cassette (ABC) transporter complex (61%);integral component of plasma membrane (18%);small ribosomal subunit (1%),GO:0008932 (18%);GO:0016829 (18%);GO:0003755 (4%),lytic endotransglycosylase activity (18%);lyase activity (18%);peptidyl-prolyl cis-trans isomerase activity (4%),GO:0055085 (61%);GO:0009252 (18%);GO:0071555 (18%),transmembrane transport (61%);peptidoglycan biosynthetic process (18%);cell wall organization (18%),IPR000914 (58%);IPR030678 (58%);IPR039424 (58%),Solute-binding protein family 5 domain (58%);Peptide/nickel binding protein, MppA-type (58%);Solute-binding protein family 5 (58%),,,,,,,,,
LNLAMFNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMLLLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (67%);2.7.7.7 (33%),RING-type E3 ubiquitin transferase (67%);DNA-directed DNA polymerase (33%),,,GO:0016787 (50%);GO:0008270 (33%);GO:0061630 (33%),hydrolase activity (50%);zinc ion binding (33%);ubiquitin protein ligase activity (33%),GO:0071596 (33%);GO:0006261 (17%);GO:0006281 (17%),ubiquitin-dependent protein catabolic process via the N-end rule pathway (33%);DNA-dependent DNA replication (17%);DNA repair (17%),IPR001466 (33%);IPR003126 (33%);IPR012338 (33%),Beta-lactamase-related (33%);Zinc finger, UBR-type (33%);Beta-lactamase/transpeptidase-like (33%),,,,,,,,,,
EFELVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (33%);3.1.-.- (30%);2.7.7.8 (13%),DNA helicase (33%);Acting on ester bonds (30%);Polyribonucleotide nucleotidyltransferase (13%),GO:0016021 (22%);GO:0009507 (8%);GO:0005737 (4%),integral component of membrane (22%);chloroplast (8%);cytoplasm (4%),GO:0003677 (25%);GO:0005524 (14%);GO:0003723 (11%),DNA binding (25%);ATP binding (14%);RNA binding (11%),GO:0000160 (11%);GO:0006355 (10%);GO:0008033 (9%),phosphorelay signal transduction system (11%);regulation of transcription, DNA-templated (10%);tRNA processing (9%),IPR036388 (13%);IPR027417 (9%);IPR001867 (9%),Winged helix-like DNA-binding domain superfamily (13%);P-loop containing nucleoside triphosphate hydrolase (9%);OmpR/PhoB-type DNA-binding domain (9%),,,,,,,,,,
MPSFYHLVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEDTVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (90%);6.3.2.10 (10%),DNA (cytosine-5-)-methyltransferase (90%);UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (10%),GO:0005634 (56%);GO:0016021 (6%);GO:0070877 (6%),nucleus (56%);integral component of membrane (6%);microprocessor complex (6%),GO:0003682 (63%);GO:0003886 (38%);GO:0008168 (28%),chromatin binding (63%);DNA (cytosine-5-)-methyltransferase activity (38%);methyltransferase activity (28%),GO:0032259 (28%);GO:0031053 (6%);GO:0005980 (3%),methylation (28%);primary miRNA processing (6%);glycogen catabolic process (3%),IPR001025 (67%);IPR029063 (64%);IPR001525 (61%),Bromo adjacent homology (BAH) domain (67%);S-adenosyl-L-methionine-dependent methyltransferase (64%);C-5 cytosine methyltransferase (61%),,,,,,,,,,,
LYLYPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.21 (22%);2.7.11.1 (11%);2.7.8.- (11%),Beta-glucosidase (22%);Non-specific serine/threonine protein kinase (11%);Transferases for other substituted phosphate groups (11%),GO:0005634 (27%);GO:0016021 (17%);GO:0016020 (5%),nucleus (27%);integral component of membrane (17%);membrane (5%),GO:0003677 (31%);GO:0003723 (12%);GO:0009982 (11%),DNA binding (31%);RNA binding (12%);pseudouridine synthase activity (11%),GO:0009734 (27%);GO:0006355 (25%);GO:0001522 (11%),auxin-activated signaling pathway (27%);regulation of transcription, DNA-templated (25%);pseudouridine synthesis (11%),IPR000270 (24%);IPR010525 (24%);IPR033389 (24%),PB1 domain (24%);Auxin response factor (24%);AUX/IAA domain (24%),,,,,,,,,,
TMLMVFVK,Candidatus Liptonbacteria,Bacteria,,,,Candidatus Liptonbacteria,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),GO:0015450 (100%),P-P-bond-hydrolysis-driven protein transmembrane transporter activity (100%),GO:0006605 (100%);GO:0043952 (100%);GO:0065002 (100%),protein targeting (100%);protein transport by the Sec complex (100%);intracellular protein transmembrane transport (100%),IPR001036 (100%);IPR005791 (100%);IPR022645 (100%),Acriflavin resistance protein (100%);Protein translocase subunit SecD (100%);Protein-export membrane protein SecD/SecF, bacterial (100%),,,,,,,,,,
TFQWGTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLNEAAMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAVMLNMAPLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAVSVDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDSVLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.18.6.1 (36%);3.1.-.- (14%);2.2.1.2 (9%),Nitrogenase (36%);Acting on ester bonds (14%);Transaldolase (9%),GO:0005737 (15%);GO:0016021 (13%);GO:0005623 (2%),cytoplasm (15%);integral component of membrane (13%);cell (2%),GO:0005524 (29%);GO:0046872 (16%);GO:0016887 (15%),ATP binding (29%);metal ion binding (16%);ATPase activity (15%),GO:0009399 (13%);GO:0006298 (5%);GO:0045910 (5%),nitrogen fixation (13%);mismatch repair (5%);negative regulation of DNA recombination (5%),IPR027417 (17%);IPR000318 (10%);IPR000510 (10%),P-loop containing nucleoside triphosphate hydrolase (17%);Nitrogenase component 1, conserved site (10%);Nitrogenase/oxidoreductase, component 1 (10%),,,,,,,,,
FMYELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%);GO:0005737 (25%),integral component of membrane (33%);cytoplasm (25%),GO:0003677 (33%);GO:0003743 (33%);GO:0003824 (17%),DNA binding (33%);translation initiation factor activity (33%);catalytic activity (17%),GO:0006310 (25%);GO:0015074 (25%);GO:0006306 (8%),DNA recombination (25%);DNA integration (25%);DNA methylation (8%),IPR013783 (31%);IPR001288 (25%);IPR019814 (25%),Immunoglobulin-like fold (31%);Translation initiation factor 3 (25%);Translation initiation factor 3, N-terminal (25%),,,,,,,,,,
VASNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.97 (18%);6.3.5.3 (17%);1.17.1.4 (11%),Glycylpeptide N-tetradecanoyltransferase (18%);Phosphoribosylformylglycinamidine synthase (17%);Xanthine dehydrogenase (11%),GO:0016021 (20%);GO:0005576 (7%);GO:0016459 (4%),integral component of membrane (20%);extracellular region (7%);myosin complex (4%),GO:0005524 (17%);GO:0003677 (13%);GO:0046872 (8%),ATP binding (17%);DNA binding (13%);metal ion binding (8%),GO:0000272 (6%);GO:0006353 (5%);GO:0031564 (5%),polysaccharide catabolic process (6%);DNA-templated transcription, termination (5%);transcription antitermination (5%),IPR027417 (12%);IPR015943 (7%);IPR001680 (7%),P-loop containing nucleoside triphosphate hydrolase (12%);WD40/YVTN repeat-like-containing domain superfamily (7%);WD40 repeat (7%),,,,,,,,,,
MMMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.40 (24%);3.4.13.22 (11%);7.1.1.2 (8%),Pyruvate kinase (24%);D-Ala-D-Ala dipeptidase (11%);NADH:ubiquinone reductase (H(+)-translocating) (8%),GO:0016021 (25%);GO:0005730 (23%);GO:0005634 (6%),integral component of membrane (25%);nucleolus (23%);nucleus (6%),GO:0005524 (10%);GO:0003677 (5%);GO:0000287 (5%),ATP binding (10%);DNA binding (5%);magnesium ion binding (5%),GO:0000055 (23%);GO:0030036 (23%);GO:0042273 (23%),ribosomal large subunit export from nucleus (23%);actin cytoskeleton organization (23%);ribosomal large subunit biogenesis (23%),IPR027312 (19%);IPR007949 (17%);IPR016024 (16%),Sda1 (19%);SDA1 domain (17%);Armadillo-type fold (16%),,,,,,,,,,,
DMSDVMNGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYLQPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.297 (92%);5.6.2.1 (8%),Peptide chain release factor N(5)-glutamine methyltransferase (92%);DNA topoisomerase (8%),GO:0008076 (46%);GO:0016021 (9%);GO:0005829 (2%),voltage-gated potassium channel complex (46%);integral component of membrane (9%);cytosol (2%),GO:0005249 (46%);GO:0030955 (22%);GO:0003676 (10%),voltage-gated potassium channel activity (46%);potassium ion binding (22%);nucleic acid binding (10%),GO:0034765 (45%);GO:0051260 (45%);GO:0018364 (9%),regulation of ion transmembrane transport (45%);protein homooligomerization (45%);peptidyl-glutamine methylation (9%),IPR005821 (45%);IPR027359 (45%);IPR028325 (45%),Ion transport domain (45%);Voltage-dependent channel domain superfamily (45%);Voltage-gated potassium channel (45%),,,,,,,,,,,
ALDLLDEAASLSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGDVVDLSQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAGYQEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDAGVDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HEVTTMWLDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEEQVEATGPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SANFNECK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGQNLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.- (58%);2.10.1.1 (37%);4.2.3.1 (2%),Exoribonucleases producing 5'-phosphomonoesters (58%);Molybdopterin molybdotransferase (37%);Threonine synthase (2%),GO:0019013 (36%);GO:0005737 (35%);GO:0019029 (12%),viral nucleocapsid (36%);cytoplasm (35%);helical viral capsid (12%),GO:0003723 (43%);GO:0003700 (32%);GO:0000166 (31%),RNA binding (43%);DNA-binding transcription factor activity (32%);nucleotide binding (31%),GO:0006353 (34%);GO:0031564 (34%);GO:0039689 (12%),DNA-templated transcription, termination (34%);transcription antitermination (34%);negative stranded viral RNA replication (12%),IPR035084 (35%);IPR038115 (35%);IPR015946 (34%),Nucleocapsid, C-terminal, Arenaviridae (35%);Nucleocapsid, C-terminal superfamily (35%);K homology domain-like, alpha/beta (34%),,,,,,
LTEVDLER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSYETEQGPK,Photobacterium,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Vibrionales,,,,,Vibrionaceae,,,,Photobacterium,,,,,,,,,,GO:0005737 (100%),cytoplasm (100%),GO:0003676 (96%);GO:0003677 (4%),nucleic acid binding (96%);DNA binding (4%),,,IPR002059 (100%);IPR011129 (100%);IPR012156 (100%),Cold-shock protein, DNA-binding (100%);Cold shock domain (100%);Cold shock, CspA (100%),,,,,,,,,
FNVFAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVDQEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
CDNLNLQAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSAVVWK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR000210 (50%);IPR001060 (50%);IPR006652 (50%),BTB/POZ domain (50%);FCH domain (50%);Kelch repeat type 1 (50%),,,,,,,,,,,
EVEQSPR,Micrococcales,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Micrococcales,,,,,,,,,,,,,,,,,,,,,GO:0016740 (100%),transferase activity (100%),,,IPR000600 (50%);IPR001173 (50%);IPR029044 (50%),ROK family (50%);Glycosyltransferase 2-like (50%);Nucleotide-diphospho-sugar transferases (50%),,,,,,,,,,,
WYVGDEAGASK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALNNGDLTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HVAQMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.63 (25%);2.7.7.6 (25%);3.5.2.7 (25%),Methylated-DNA--[protein]-cysteine S-methyltransferase (25%);DNA-directed RNA polymerase (25%);Imidazolonepropionase (25%),GO:0016021 (18%);GO:0005737 (9%),integral component of membrane (18%);cytoplasm (9%),GO:0046872 (36%);GO:0003677 (24%);GO:0004673 (9%),metal ion binding (36%);DNA binding (24%);protein histidine kinase activity (9%),GO:0006829 (30%);GO:0009058 (6%);GO:0006260 (3%),zinc ion transport (30%);biosynthetic process (6%);DNA replication (3%),IPR001737 (25%);IPR006127 (25%);IPR023165 (25%),Ribosomal RNA adenine methyltransferase KsgA/Erm (25%);Periplasmic solute binding protein, ZnuA-like (25%);rRNA adenine dimethylase-like (25%),,,,,,,,,,
WLMDER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.4 (100%),Cellulase (100%),GO:0016021 (27%);GO:0005615 (9%),integral component of membrane (27%);extracellular space (9%),GO:0008484 (18%);GO:0003951 (9%);GO:0004866 (9%),sulfuric ester hydrolase activity (18%);NAD+ kinase activity (9%);endopeptidase inhibitor activity (9%),GO:0043123 (36%);GO:0006741 (9%);GO:0007030 (9%),positive regulation of I-kappaB kinase/NF-kappaB signaling (36%);NADP biosynthetic process (9%);Golgi organization (9%),IPR003495 (19%);IPR011629 (19%);IPR011990 (19%),CobW/HypB/UreG, nucleotide-binding domain (19%);Cobalamin (vitamin B12) biosynthesis CobW-like, C-terminal (19%);Tetratricopeptide-like helical domain superfamily (19%),,,,,,,,,
VLDETVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.28 (27%);1.1.1.86 (18%);1.1.1.49 (9%),2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (27%);Ketol-acid reductoisomerase (NADP(+)) (18%);Glucose-6-phosphate dehydrogenase (NADP(+)) (9%),GO:0016021 (21%);GO:0005634 (4%);GO:0005737 (4%),integral component of membrane (21%);nucleus (4%);cytoplasm (4%),GO:0005524 (26%);GO:0003677 (13%);GO:0005506 (13%),ATP binding (26%);DNA binding (13%);iron ion binding (13%),GO:0006355 (11%);GO:0007165 (6%);GO:0019290 (6%),regulation of transcription, DNA-templated (11%);signal transduction (6%);siderophore biosynthetic process (6%),IPR000014 (18%);IPR035965 (18%);IPR000700 (13%),PAS domain (18%);PAS domain superfamily (18%);PAS-associated, C-terminal (13%),,,,,,,
VMLHPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.234 (50%);4.3.3.7 (50%),N(6)-L-threonylcarbamoyladenine synthase (50%);4-hydroxy-tetrahydrodipicolinate synthase (50%),GO:0016021 (19%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (19%);cytoplasm (6%);plasma membrane (3%),GO:0003725 (39%);GO:0016740 (17%);GO:0003677 (6%),double-stranded RNA binding (39%);transferase activity (17%);DNA binding (6%),GO:0000184 (3%);GO:0002949 (3%);GO:0005975 (3%),nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (3%);tRNA threonylcarbamoyladenosine modification (3%);carbohydrate metabolic process (3%),IPR036280 (43%);IPR006070 (20%);IPR017945 (20%),Multiheme cytochrome superfamily (43%);YrdC-like domain (20%);DHBP synthase RibB-like alpha/beta domain superfamily (20%),,,,,,,,,,
FQTNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (44%);GO:0005634 (11%);GO:0033644 (11%),integral component of membrane (44%);nucleus (11%);host cell membrane (11%),GO:0004197 (50%);GO:0005524 (50%);GO:0004672 (33%),cysteine-type endopeptidase activity (50%);ATP binding (50%);protein kinase activity (33%),GO:0006351 (11%);GO:0019082 (11%);GO:0032259 (11%),transcription, DNA-templated (11%);viral protein processing (11%);methylation (11%),IPR000719 (26%);IPR001309 (26%);IPR002110 (26%),Protein kinase domain (26%);Peptidase C14,  p20 domain (26%);Ankyrin repeat (26%),,,,,,,,,
LNNQDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.6 (50%);3.4.24.- (25%);3.5.1.108 (25%),Urea carboxylase (50%);Metalloendopeptidases (25%);UDP-3-O-acyl-N-acetylglucosamine deacetylase (25%),GO:0016021 (13%);GO:0005886 (3%),integral component of membrane (13%);plasma membrane (3%),GO:0003677 (20%);GO:0005524 (17%);GO:0016787 (17%),DNA binding (20%);ATP binding (17%);hydrolase activity (17%),GO:0006270 (7%);GO:0005975 (3%);GO:0009245 (3%),DNA replication initiation (7%);carbohydrate metabolic process (3%);lipid A biosynthetic process (3%),IPR003778 (61%);IPR029000 (61%);IPR027417 (7%),Carboxyltransferase domain, subdomain A and B (61%);Cyclophilin-like domain superfamily (61%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,
QNEEELQQTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVLDAYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.4 (100%),3-dehydroquinate synthase (100%),GO:0005737 (50%);GO:0005623 (31%);GO:0005886 (6%),cytoplasm (50%);cell (31%);plasma membrane (6%),GO:0003746 (25%);GO:0003924 (22%);GO:0005525 (22%),translation elongation factor activity (25%);GTPase activity (22%);GTP binding (22%),GO:0030643 (31%);GO:0045936 (31%);GO:0006817 (28%),cellular phosphate ion homeostasis (31%);negative regulation of phosphate metabolic process (31%);phosphate ion transport (28%),IPR026022 (24%);IPR027417 (24%);IPR028366 (24%),PhoU domain (24%);P-loop containing nucleoside triphosphate hydrolase (24%);Phosphate transport system protein PhoU (24%),,,,,,,,,,,
LEGFQNYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FENSER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.206 (63%);6.3.2.10 (25%);2.4.1.182 (13%),tRNA (cytidine(56)-2'-O)-methyltransferase (63%);UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (25%);Lipid-A-disaccharide synthase (13%),GO:0016021 (34%);GO:0005737 (28%);GO:0005886 (6%),integral component of membrane (34%);cytoplasm (28%);plasma membrane (6%),GO:0008175 (22%);GO:0005524 (9%);GO:0022857 (9%),tRNA methyltransferase activity (22%);ATP binding (9%);transmembrane transporter activity (9%),GO:0002128 (22%);GO:0003341 (6%);GO:0007049 (6%),tRNA nucleoside ribose methylation (22%);cilium movement (6%);cell cycle (6%),IPR002845 (14%);IPR029026 (14%);IPR029028 (14%),tRNA ribose 2'-O-methyltransferase, aTrm56 (14%);tRNA (guanine-N1-)-methyltransferase, N-terminal (14%);Alpha/beta knot methyltransferases (14%),,,,,,,,,
EFENTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.- (17%);2.1.1.182 (17%);3.1.-.- (17%),With NAD(+) or NADP(+) as acceptor (17%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (17%);Acting on ester bonds (17%),GO:0016021 (52%);GO:0005634 (2%);GO:0005737 (2%),integral component of membrane (52%);nucleus (2%);cytoplasm (2%),GO:0000340 (5%);GO:0003677 (5%);GO:0003729 (5%),RNA 7-methylguanosine cap binding (5%);DNA binding (5%);mRNA binding (5%),GO:0006355 (18%);GO:0000160 (1%);GO:0006352 (1%),regulation of transcription, DNA-templated (18%);phosphorelay signal transduction system (1%);DNA-templated transcription, initiation (1%),IPR006214 (35%);IPR001387 (20%);IPR010985 (19%),Bax inhibitor 1-related (35%);Cro/C1-type helix-turn-helix domain (20%);Ribbon-helix-helix (19%),,,,,,,,,
LTEAPLNPK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (100%),cytoplasm (100%),,,,,IPR004000 (100%);IPR004001 (8%),Actin family (100%);Actin, conserved site (8%),,,,,,,,,,
QENLGALLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MQLLHNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.36 (100%);6.3.2.5 (100%),Phosphopantothenoylcysteine decarboxylase (100%);Phosphopantothenate--cysteine ligase (CTP) (100%),,,GO:0003676 (33%);GO:0004632 (33%);GO:0004633 (33%),nucleic acid binding (33%);phosphopantothenate--cysteine ligase activity (33%);phosphopantothenoylcysteine decarboxylase activity (33%),GO:0015937 (33%);GO:0015941 (33%);GO:0015074 (17%),coenzyme A biosynthetic process (33%);pantothenate catabolic process (33%);DNA integration (17%),IPR003382 (33%);IPR005252 (33%);IPR007085 (33%),Flavoprotein (33%);Coenzyme A biosynthesis bifunctional protein CoaBC (33%);DNA/pantothenate metabolism flavoprotein, C-terminal (33%),,,,,,,,,,
QGDAAAYDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEGTAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.10 (53%);3.6.4.13 (12%);6.1.1.5 (9%),Aminomethyltransferase (53%);RNA helicase (12%);Isoleucine--tRNA ligase (9%),GO:0016021 (18%);GO:0005737 (8%);GO:0005886 (7%),integral component of membrane (18%);cytoplasm (8%);plasma membrane (7%),GO:0005524 (18%);GO:0004047 (17%);GO:0008483 (17%),ATP binding (18%);aminomethyltransferase activity (17%);transaminase activity (17%),GO:0019464 (17%);GO:0032259 (16%);GO:0006260 (6%),glycine decarboxylation via glycine cleavage system (17%);methylation (16%);DNA replication (6%),IPR006222 (14%);IPR006223 (14%);IPR013977 (14%),Aminomethyltransferase, folate-binding domain (14%);Glycine cleavage system T protein (14%);Glycine cleavage T-protein, C-terminal barrel domain (14%),,,,,,,,,
MLLWFYK,Fomitiporia mediterranea,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Agaricomycetes,,,,Hymenochaetales,,,,,Hymenochaetaceae,,,,Fomitiporia,,,,Fomitiporia mediterranea,,,,,,GO:0016021 (67%);GO:0005739 (33%),integral component of membrane (67%);mitochondrion (33%),GO:0008484 (33%),sulfuric ester hydrolase activity (33%),,,IPR000917 (50%);IPR004868 (50%);IPR012337 (50%),Sulfatase, N-terminal (50%);DNA-directed DNA polymerase, family B, mitochondria/virus (50%);Ribonuclease H-like superfamily (50%),,,,,,,,
NEDAEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR024559 (100%),Protein of unknown function DUF3846 (100%),,,,,,,,,,,
FAGDDPAR,Leucosporidium creatinivorum,Eukaryota,Fungi,Dikarya,,Basidiomycota,Pucciniomycotina,,Microbotryomycetes,,,,Leucosporidiales,,,,,Leucosporidiaceae,,,,Leucosporidium,,,,Leucosporidium creatinivorum,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0016491 (100%),oxidoreductase activity (100%),,,IPR013112 (100%);IPR013121 (100%);IPR013130 (100%),FAD-binding 8 (100%);Ferric reductase, NAD binding domain (100%);Ferric reductase transmembrane component-like domain (100%),,,,,,,,,,
EVLQSDFAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CFSHVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.19.12 (100%),Ubiquitinyl hydrolase 1 (100%),GO:0016021 (100%),integral component of membrane (100%),GO:0036459 (100%),thiol-dependent ubiquitinyl hydrolase activity (100%),GO:0006511 (100%);GO:0016579 (100%),ubiquitin-dependent protein catabolic process (100%);protein deubiquitination (100%),IPR000408 (25%);IPR001394 (25%);IPR003749 (25%),Regulator of chromosome condensation, RCC1 (25%);Peptidase C19, ubiquitin carboxyl-terminal hydrolase (25%);Sulfur carrier ThiS/MoaD-like (25%),,,,,,,,,
ELWVNLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EANTCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (67%);GO:0051536 (67%),catalytic activity (67%);iron-sulfur cluster binding (67%),GO:0006886 (33%),intracellular protein transport (33%),IPR006638 (29%);IPR007197 (29%);IPR023404 (29%),Elp3/MiaB/NifB (29%);Radical SAM (29%);Radical SAM, alpha/beta horseshoe (29%),,,,,,,,,,
QGLEDESR,Brochothrix thermosphacta,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Listeriaceae,,,,Brochothrix,,,,Brochothrix thermosphacta,,,,,,,,GO:0008982 (100%),protein-N(PI)-phosphohistidine-sugar phosphotransferase activity (100%),GO:0006355 (100%);GO:0009401 (100%),regulation of transcription, DNA-templated (100%);phosphoenolpyruvate-dependent sugar phosphotransferase system (100%),IPR007737 (100%);IPR011608 (100%);IPR013011 (100%),Mga helix-turn-helix domain (100%);PRD domain (100%);Phosphotransferase system, EIIB component, type 2 (100%),,,,,,,,
LLTALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.61 (33%);3.5.1.44 (33%);1.2.4.1 (17%),Protein-glutamate methylesterase (33%);Protein-glutamine glutaminase (33%);Pyruvate dehydrogenase (acetyl-transferring) (17%),GO:0016021 (51%);GO:0019028 (29%);GO:0033644 (29%),integral component of membrane (51%);viral capsid (29%);host cell membrane (29%),GO:0005524 (42%);GO:0003723 (31%);GO:0004252 (30%),ATP binding (42%);RNA binding (31%);serine-type endopeptidase activity (30%),GO:0019062 (29%);GO:0019087 (29%);GO:0039503 (29%),virion attachment to host cell (29%);transformation of host cell by virus (29%);suppression by virus of host innate immune response (29%),IPR027417 (33%);IPR000745 (25%);IPR001490 (25%),P-loop containing nucleoside triphosphate hydrolase (33%);Hepatitis C virus non-structural protein NS4a (25%);Hepatitis C virus non-structural protein NS4b (25%),,,,,,,,,,,
LAVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.85 (28%);3.1.3.2 (8%);2.7.11.1 (7%),Aminodeoxychorismate synthase (28%);Acid phosphatase (8%);Non-specific serine/threonine protein kinase (7%),GO:0016021 (28%);GO:0005737 (4%);GO:0005840 (3%),integral component of membrane (28%);cytoplasm (4%);ribosome (3%),GO:0005524 (11%);GO:0050660 (8%);GO:0046872 (6%),ATP binding (11%);flavin adenine dinucleotide binding (8%);metal ion binding (6%),GO:0009396 (9%);GO:0006915 (4%);GO:0055085 (3%),folic acid-containing compound biosynthetic process (9%);apoptotic process (4%);transmembrane transport (3%),IPR005801 (8%);IPR015890 (8%);IPR019999 (8%),ADC synthase (8%);Chorismate-utilising enzyme, C-terminal (8%);Anthranilate synthase component I-like (8%),,,,,,,,,,
DAFVELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (73%);GO:0005737 (8%);GO:0016020 (3%),integral component of membrane (73%);cytoplasm (8%);membrane (3%),GO:0046872 (8%);GO:0003723 (3%);GO:0004222 (3%),metal ion binding (8%);RNA binding (3%);metalloendopeptidase activity (3%),GO:0002949 (3%);GO:0070929 (3%);GO:0071973 (3%),tRNA threonylcarbamoyladenosine modification (3%);trans-translation (3%);bacterial-type flagellum-dependent cell motility (3%),IPR008756 (48%);IPR027417 (12%);IPR002893 (8%),Peptidase M56 (48%);P-loop containing nucleoside triphosphate hydrolase (12%);Zinc finger, MYND-type (8%),,,,,,,,,,
EVLEALEWEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (24%);4.1.1.48 (7%);2.1.-.- (6%),Transaminases (24%);Indole-3-glycerol-phosphate synthase (7%);Transferring one-carbon groups (6%),GO:0016021 (37%);GO:0005886 (5%);GO:0005737 (3%),integral component of membrane (37%);plasma membrane (5%);cytoplasm (3%),GO:0005524 (9%);GO:0016491 (7%);GO:0003677 (6%),ATP binding (9%);oxidoreductase activity (7%);DNA binding (6%),GO:0009058 (5%);GO:0006520 (4%);GO:0006355 (2%),biosynthetic process (5%);cellular amino acid metabolic process (4%);regulation of transcription, DNA-templated (2%),IPR027417 (7%);IPR036188 (6%);IPR015424 (4%),P-loop containing nucleoside triphosphate hydrolase (7%);FAD/NAD(P)-binding domain superfamily (6%);Pyridoxal phosphate-dependent transferase (4%),,,,,,,,,,
VGSEEAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYTYTVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FQLNAAK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR010512 (50%);IPR036846 (50%);IPR041664 (50%),Protein of unknown function DUF1091 (50%);GM2-AP, lipid-recognition domain superfamily (50%);Orc1-like, AAA ATPase domain (50%),,,,,,,,,
NALTLTGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAPVVEAQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YQYSSEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANLESDVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVVHMGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVNVDAGWNPVVTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQPYALK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.3.1 (100%),H(+)-exporting diphosphatase (100%),GO:0005887 (50%),integral component of plasma membrane (50%),GO:0000287 (50%);GO:0003824 (50%);GO:0004427 (50%),magnesium ion binding (50%);catalytic activity (50%);inorganic diphosphatase activity (50%),,,IPR004131 (50%);IPR006638 (50%);IPR007197 (50%),Pyrophosphate-energised proton pump (50%);Elp3/MiaB/NifB (50%);Radical SAM (50%),,,,,,,,,,,
DVSMWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (100%),Ribonucleoside-diphosphate reductase (100%),GO:0009279 (29%);GO:0000127 (14%),cell outer membrane (29%);transcription factor TFIIIC complex (14%),GO:0001004 (29%);GO:0004748 (14%);GO:0005524 (14%),obsolete RNA polymerase III transcription regulator recruiting activity (29%);ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor (14%);ATP binding (14%),GO:0005975 (14%);GO:0006260 (14%);GO:0006383 (14%),carbohydrate metabolic process (14%);DNA replication (14%);transcription by RNA polymerase III (14%),IPR000531 (20%);IPR000626 (20%);IPR010105 (20%),TonB-dependent receptor-like, beta-barrel (20%);Ubiquitin-like domain (20%);TonB-dependent siderophore receptor (20%),,,,,,,,,
LLDLVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.11 (42%);1.3.1.9 (12%);1.1.1.35 (8%),Fructose-bisphosphatase (42%);Enoyl-[acyl-carrier-protein] reductase (NADH) (12%);3-hydroxyacyl-CoA dehydrogenase (8%),GO:0005737 (16%);GO:0005829 (10%);GO:0016021 (10%),cytoplasm (16%);cytosol (10%);integral component of membrane (10%),GO:0042132 (35%);GO:0000287 (12%);GO:0005524 (10%),fructose 1,6-bisphosphate 1-phosphatase activity (35%);magnesium ion binding (12%);ATP binding (10%),GO:0005975 (14%);GO:0006094 (11%);GO:0016051 (11%),carbohydrate metabolic process (14%);gluconeogenesis (11%);carbohydrate biosynthetic process (11%),IPR000146 (30%);IPR028343 (30%);IPR033391 (30%),Fructose-1,6-bisphosphatase class 1 (30%);Fructose-1,6-bisphosphatase (30%);Fructose-1-6-bisphosphatase class I, N-terminal (30%),,,,,,,
LMWAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (17%);GO:0016021 (17%),plasma membrane (17%);integral component of membrane (17%),GO:0005524 (67%);GO:0004527 (50%);GO:0003678 (17%),ATP binding (67%);exonuclease activity (50%);DNA helicase activity (17%),GO:0006281 (50%);GO:0006260 (17%);GO:0032259 (17%),DNA repair (50%);DNA replication (17%);methylation (17%),IPR005635 (36%);IPR027417 (29%);IPR014153 (21%),Inner centromere protein, ARK-binding domain (36%);P-loop containing nucleoside triphosphate hydrolase (29%);Double-strand break repair protein AddB (21%),,,,,,,,,,
TYQFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.228 (100%),tRNA (guanine(37)-N(1))-methyltransferase (100%),GO:0016021 (17%);GO:0005623 (8%);GO:0033588 (4%),integral component of membrane (17%);cell (8%);Elongator holoenzyme complex (4%),GO:0008237 (33%);GO:0008168 (15%);GO:0050660 (10%),metallopeptidase activity (33%);methyltransferase activity (15%);flavin adenine dinucleotide binding (10%),GO:0032259 (15%);GO:0045454 (8%);GO:0015689 (6%),methylation (15%);cell redox homeostasis (8%);molybdate ion transport (6%),IPR024079 (33%);IPR036322 (18%);IPR029063 (16%),Metallopeptidase, catalytic domain superfamily (33%);WD40-repeat-containing domain superfamily (18%);S-adenosyl-L-methionine-dependent methyltransferase (16%),,,,,,,,,,
NVPSDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.15 (33%);3.2.-.- (33%);3.4.13.- (33%),Glycerol-3-phosphate 1-O-acyltransferase (33%);Glycosylases (33%);Dipeptidases (33%),GO:0016021 (43%);GO:0005840 (3%);GO:0009279 (3%),integral component of membrane (43%);ribosome (3%);cell outer membrane (3%),GO:0003677 (11%);GO:0004725 (11%);GO:0046872 (10%),DNA binding (11%);protein tyrosine phosphatase activity (11%);metal ion binding (10%),GO:0006355 (6%);GO:0005975 (3%);GO:0006351 (3%),regulation of transcription, DNA-templated (6%);carbohydrate metabolic process (3%);transcription, DNA-templated (3%),IPR007557 (10%);IPR029021 (9%);IPR000242 (8%),PSP1, C-terminal (10%);Protein-tyrosine phosphatase-like (9%);PTP type protein phosphatase (8%),,,,,,,,
DYLSLESLK,Vertebrata australis,Eukaryota,,,,Rhodophyta,,,Florideophyceae,Rhodymeniophycidae,,,Ceramiales,,,,,Rhodomelaceae,Polysiphonioideae,,,Vertebrata,,,,Vertebrata australis,,,,6.1.1.21 (100%),Histidine--tRNA ligase (100%),GO:0009507 (100%),chloroplast (100%),GO:0004821 (100%);GO:0005524 (100%),histidine-tRNA ligase activity (100%);ATP binding (100%),GO:0006427 (100%),histidyl-tRNA aminoacylation (100%),IPR004154 (100%);IPR004516 (100%);IPR006195 (100%),Anticodon-binding (100%);Histidine-tRNA ligase/ATP phosphoribosyltransferase regulatory subunit (100%);Aminoacyl-tRNA synthetase, class II (100%),,,,,,,,,,
FTLAM,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (86%),integral component of membrane (86%),GO:0000155 (14%);GO:0005524 (14%);GO:0016740 (14%),phosphorelay sensor kinase activity (14%);ATP binding (14%);transferase activity (14%),,,IPR000195 (50%);IPR035969 (50%);IPR003344 (25%),Rab-GTPase-TBC domain (50%);Rab-GTPase-TBC domain superfamily (50%);Big-1 (bacterial Ig-like domain 1) domain (25%),,,,,,,,,,,
NNSLLWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0003677 (33%);GO:0004519 (33%);GO:0008375 (33%),DNA binding (33%);endonuclease activity (33%);acetylglucosaminyltransferase activity (33%),GO:0006486 (33%);GO:0009307 (33%),protein glycosylation (33%);DNA restriction-modification system (33%),IPR004139 (50%);IPR007560 (50%);IPR011335 (50%),Glycosyl transferase, family 13 (50%);Restriction endonuclease type IV,  Mrr (50%);Restriction endonuclease  type II-like (50%),,,,,,,,,
ANVLTVEQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALELLTFSNK,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,GO:0015934 (85%);GO:0005840 (15%),large ribosomal subunit (85%);ribosome (15%),GO:0019843 (100%);GO:0003735 (85%),rRNA binding (100%);structural constituent of ribosome (85%),GO:0006412 (100%),translation (100%),IPR001063 (100%);IPR005727 (100%);IPR018260 (100%),Ribosomal protein L22/L17 (100%);Ribosomal protein L22, bacterial/chloroplast-type (100%);Ribosomal protein L22/L17, conserved site (100%),,,,,,,,,
LTGESGAGQTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESTVN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.2 (98%);2.1.1.74 (1%);2.5.1.3 (1%),Phosphoribosylglycinamide formyltransferase (98%);Methylenetetrahydrofolate--tRNA-(uracil(54)-C(5))-methyltransferas(NAD(P)H-oxidizing) (1%);Thiamine phosphate synthase (1%),GO:0005737 (2%);GO:0005829 (1%);GO:0016021 (1%),cytoplasm (2%);cytosol (1%);integral component of membrane (1%),GO:0004644 (95%);GO:0000287 (1%);GO:0003677 (1%),phosphoribosylglycinamide formyltransferase activity (95%);magnesium ion binding (1%);DNA binding (1%),GO:0006189 (95%);GO:0006355 (1%);GO:0008643 (1%),'de novo' IMP biosynthetic process (95%);regulation of transcription, DNA-templated (1%);carbohydrate transport (1%),IPR001555 (93%);IPR002376 (93%);IPR004607 (93%),Phosphoribosylglycinamide formyltransferase, active site (93%);Formyl transferase, N-terminal (93%);Phosphoribosylglycinamide formyltransferase (93%),,,,,,,,
WAALNYATAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (10%);3.1.-.- (9%);2.5.1.49 (9%),DNA helicase (10%);Acting on ester bonds (9%);O-acetylhomoserine aminocarboxypropyltransferase (9%),GO:0016021 (23%);GO:0005737 (11%);GO:0005634 (2%),integral component of membrane (23%);cytoplasm (11%);nucleus (2%),GO:0005524 (10%);GO:0003677 (8%);GO:0046872 (6%),ATP binding (10%);DNA binding (8%);metal ion binding (6%),GO:0019346 (4%);GO:0005975 (4%);GO:0006355 (2%),transsulfuration (4%);carbohydrate metabolic process (4%);regulation of transcription, DNA-templated (2%),IPR027417 (7%);IPR013785 (4%);IPR015421 (4%),P-loop containing nucleoside triphosphate hydrolase (7%);Aldolase-type TIM barrel (4%);Pyridoxal phosphate-dependent transferase, major domain (4%),,,,,,,,,
NMHEHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVQVPVAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTAWDVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNAAAYDDER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYTLLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (60%);3.4.21.83 (40%),DNA helicase (60%);Oligopeptidase B (40%),GO:0016021 (40%);GO:0000127 (11%);GO:0005694 (6%),integral component of membrane (40%);transcription factor TFIIIC complex (11%);chromosome (6%),GO:0003677 (17%);GO:0004252 (11%);GO:0070008 (11%),DNA binding (17%);serine-type endopeptidase activity (11%);serine-type exopeptidase activity (11%),GO:0006384 (11%);GO:0006265 (9%);GO:0032981 (6%),transcription initiation from RNA polymerase III promoter (11%);DNA topological change (9%);mitochondrial respiratory chain complex I assembly (6%),IPR000380 (13%);IPR001375 (13%);IPR002470 (13%),DNA topoisomerase, type IA (13%);Peptidase S9, prolyl oligopeptidase, catalytic domain (13%);Peptidase S9A, prolyl oligopeptidase (13%),,,,,,,
TCLVLPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPVLLWVPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WTDTVEDLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANELANR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.7.5 (33%);2.7.7.- (33%);6.1.1.20 (33%),Aldehyde ferredoxin oxidoreductase (33%);Nucleotidyltransferases (33%);Phenylalanine--tRNA ligase (33%),GO:0016021 (43%);GO:0005886 (11%);GO:0005737 (9%),integral component of membrane (43%);plasma membrane (11%);cytoplasm (9%),GO:0005524 (17%);GO:0004830 (13%);GO:0015079 (7%),ATP binding (17%);tryptophan-tRNA ligase activity (13%);potassium ion transmembrane transporter activity (7%),GO:0006436 (13%);GO:0000917 (4%);GO:0044780 (4%),tryptophanyl-tRNA aminoacylation (13%);division septum assembly (4%);bacterial-type flagellum assembly (4%),IPR002305 (15%);IPR002306 (15%);IPR014729 (15%),Aminoacyl-tRNA synthetase, class Ic (15%);Tryptophan-tRNA ligase (15%);Rossmann-like alpha/beta/alpha sandwich fold (15%),,,,,,,,,,
VVFDLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.13 (44%);2.1.2.9 (22%);5.2.1.8 (22%),2-isopropylmalate synthase (44%);Methionyl-tRNA formyltransferase (22%);Peptidylprolyl isomerase (22%),GO:0016021 (20%);GO:0005737 (13%);GO:0005739 (7%),integral component of membrane (20%);cytoplasm (13%);mitochondrion (7%),GO:0003852 (27%);GO:0050662 (27%);GO:0003824 (20%),2-isopropylmalate synthase activity (27%);coenzyme binding (27%);catalytic activity (20%),GO:0009098 (27%);GO:0006457 (13%);GO:0007049 (13%),leucine biosynthetic process (27%);protein folding (13%);cell cycle (13%),IPR022235 (25%);IPR000891 (20%);IPR001509 (20%),Protein of unknown function DUF3760 (25%);Pyruvate carboxyltransferase (20%);NAD-dependent epimerase/dehydratase (20%),,,,,,,,,,,
LGTWSFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005886 (17%);GO:0005887 (17%),integral component of membrane (50%);plasma membrane (17%);integral component of plasma membrane (17%),GO:0003700 (33%);GO:0004930 (33%);GO:0003677 (17%),DNA-binding transcription factor activity (33%);G protein-coupled receptor activity (33%);DNA binding (17%),GO:0007216 (17%);GO:0051966 (17%),G protein-coupled glutamate receptor signaling pathway (17%);regulation of synaptic transmission, glutamatergic (17%),IPR000014 (25%);IPR000068 (25%);IPR000160 (25%),PAS domain (25%);GPCR, family 3, extracellular calcium-sensing receptor-related (25%);GGDEF domain (25%),,,,,,,,
LLYANR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (56%);1.14.15.30 (12%);3.5.2.7 (7%),Histidine kinase (56%);3-ketosteroid 9-alpha-monooxygenase (12%);Imidazolonepropionase (7%),GO:0016021 (34%);GO:0005737 (2%);GO:0015935 (1%),integral component of membrane (34%);cytoplasm (2%);small ribosomal subunit (1%),GO:0000155 (25%);GO:0046872 (23%);GO:0005524 (21%),phosphorelay sensor kinase activity (25%);metal ion binding (23%);ATP binding (21%),GO:0006355 (17%);GO:0006284 (2%);GO:0006289 (2%),regulation of transcription, DNA-templated (17%);base-excision repair (2%);nucleotide-excision repair (2%),IPR035965 (43%);IPR000014 (39%);IPR036890 (28%),PAS domain superfamily (43%);PAS domain (39%);Histidine kinase/HSP90-like ATPase superfamily (28%),,,,,,,,,,
SSLLVDGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVMNSEAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNEFLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (67%);3.6.1.- (33%),DNA helicase (67%);In phosphorus-containing anhydrides (33%),GO:0016021 (35%);GO:0005737 (15%);GO:0005886 (15%),integral component of membrane (35%);cytoplasm (15%);plasma membrane (15%),GO:0003677 (38%);GO:0003678 (38%);GO:0005524 (38%),DNA binding (38%);DNA helicase activity (38%);ATP binding (38%),GO:0006281 (31%);GO:0042274 (15%);GO:0006412 (4%),DNA repair (31%);ribosomal small subunit biogenesis (15%);translation (4%),IPR027417 (45%);IPR000212 (32%);IPR013986 (32%),P-loop containing nucleoside triphosphate hydrolase (45%);DNA helicase, UvrD/REP type (32%);DExx box DNA helicase domain superfamily (32%),,,,,,,,,,
LNDAMLSWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EASTVMPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTAVELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.-.-.- (60%);2.5.1.47 (20%);2.7.7.6 (20%),Translocases (60%);Cysteine synthase (20%);DNA-directed RNA polymerase (20%),GO:0016021 (30%);GO:0005886 (20%),integral component of membrane (30%);plasma membrane (20%),GO:0008270 (40%);GO:0004089 (35%);GO:0003677 (15%),zinc ion binding (40%);carbonate dehydratase activity (35%);DNA binding (15%),GO:0022900 (15%);GO:0055085 (15%);GO:0005992 (10%),electron transport chain (15%);transmembrane transport (15%);trehalose biosynthetic process (10%),IPR001148 (28%);IPR023561 (28%);IPR036398 (28%),Alpha carbonic anhydrase domain (28%);Carbonic anhydrase, alpha-class (28%);Alpha carbonic anhydrase domain superfamily (28%),,,,,,,,,,
MVMYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (33%);1.1.1.47 (11%);2.5.1.- (11%),Cytochrome-c oxidase (33%);Glucose 1-dehydrogenase (NAD(P)(+)) (11%);Transferring alkyl or aryl groups, other than methyl groups (11%),GO:0016021 (35%);GO:0005886 (6%);GO:0005737 (4%),integral component of membrane (35%);plasma membrane (6%);cytoplasm (4%),GO:0003746 (18%);GO:0005525 (16%);GO:0003924 (15%),translation elongation factor activity (18%);GTP binding (16%);GTPase activity (15%),GO:0008299 (5%);GO:0006119 (3%);GO:0009060 (3%),isoprenoid biosynthetic process (5%);oxidative phosphorylation (3%);aerobic respiration (3%),IPR027417 (16%);IPR009000 (15%);IPR005225 (14%),P-loop containing nucleoside triphosphate hydrolase (16%);Translation protein, beta-barrel domain superfamily (15%);Small GTP-binding protein domain (14%),,,,,,,,,
EFTWC,Vitis vinifera,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Vitales,,,,,Vitaceae,,Viteae,,Vitis,,,,Vitis vinifera,,,,,,,,,,,,IPR000477 (100%);IPR036691 (100%),Reverse transcriptase domain (100%);Endonuclease/exonuclease/phosphatase superfamily (100%),,,,,,,,,,,
LVLVTSNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYVGDEAQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSAEVSPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAVCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.1 (16%);3.4.24.- (12%);2.7.8.7 (11%),Acetate kinase (16%);Metalloendopeptidases (12%);Holo-[acyl-carrier-protein] synthase (11%),GO:0016021 (21%);GO:0005737 (8%);GO:0005886 (7%),integral component of membrane (21%);cytoplasm (8%);plasma membrane (7%),GO:0051087 (14%);GO:0005509 (13%);GO:0005112 (11%),chaperone binding (14%);calcium ion binding (13%);Notch binding (11%),GO:0007219 (12%);GO:0007275 (9%);GO:0071356 (5%),Notch signaling pathway (12%);multicellular organism development (9%);cellular response to tumor necrosis factor (5%),IPR003103 (12%);IPR036533 (12%);IPR039773 (12%),BAG domain (12%);BAG domain superfamily (12%);Molecular chaperone regulator BAG (12%),,,,,,,,,,,
ALDLEHEAASAER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGDSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.20 (93%);2.3.1.- (4%);6.1.1.14 (1%),Methylenetetrahydrofolate reductase (NAD(P)H) (93%);Transferring groups other than amino-acyl groups (4%);Glycine--tRNA ligase (1%),GO:0016021 (5%);GO:0005829 (4%);GO:0005737 (1%),integral component of membrane (5%);cytosol (4%);cytoplasm (1%),GO:0004489 (55%);GO:0016301 (15%);GO:0008270 (8%),methylenetetrahydrofolate reductase (NAD(P)H) activity (55%);kinase activity (15%);zinc ion binding (8%),GO:0035999 (55%);GO:0006555 (46%);GO:0009086 (7%),tetrahydrofolate interconversion (55%);methionine metabolic process (46%);methionine biosynthetic process (7%),IPR003171 (54%);IPR029041 (53%);IPR004621 (52%),Methylenetetrahydrofolate reductase (54%);FAD-linked oxidoreductase-like (53%);Eukaryotic-type methylenetetrahydrofolate reductase (52%),,,,,,,,,,,
FMLNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (92%);3.4.19.- (8%),DNA-directed RNA polymerase (92%);Omega peptidases (8%),GO:0016021 (28%);GO:0019867 (5%);GO:0005737 (4%),integral component of membrane (28%);outer membrane (5%);cytoplasm (4%),GO:0003677 (23%);GO:0003899 (20%);GO:0032549 (20%),DNA binding (23%);DNA-directed 5'-3' RNA polymerase activity (20%);ribonucleoside binding (20%),GO:0006351 (20%);GO:0001522 (4%);GO:0005975 (1%),transcription, DNA-templated (20%);pseudouridine synthesis (4%);carbohydrate metabolic process (1%),IPR029033 (37%);IPR000560 (28%);IPR027417 (19%),Histidine phosphatase superfamily (37%);Histidine phosphatase superfamily, clade-2 (28%);P-loop containing nucleoside triphosphate hydrolase (19%),,,,,,,,,
LLAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.9 (23%);2.7.11.- (7%);2.7.4.- (7%),UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (23%);Protein-serine/threonine kinases (7%);Phosphotransferases with a phosphate group as acceptor (7%),GO:0016021 (24%);GO:0005737 (7%);GO:0005886 (5%),integral component of membrane (24%);cytoplasm (7%);plasma membrane (5%),GO:0005524 (18%);GO:0003677 (7%);GO:0016620 (6%),ATP binding (18%);DNA binding (7%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (6%),GO:0009405 (7%);GO:0051301 (4%);GO:0071555 (4%),pathogenesis (7%);cell division (4%);cell wall organization (4%),IPR027417 (8%);IPR036291 (6%);IPR003298 (6%),P-loop containing nucleoside triphosphate hydrolase (8%);NAD(P)-binding domain superfamily (6%);Apical membrane antigen 1 (6%),,,,,,,,,
MHPGWGLEDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEVLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.31 (15%);3.4.24.14 (10%);2.7.1.121 (7%),Phosphoenolpyruvate carboxylase (15%);Procollagen N-endopeptidase (10%);Phosphoenolpyruvate--glycerone phosphotransferase (7%),GO:0062023 (33%);GO:0016021 (17%);GO:0005737 (2%),collagen-containing extracellular matrix (33%);integral component of membrane (17%);cytoplasm (2%),GO:0004222 (39%);GO:0008270 (35%);GO:0005524 (10%),metalloendopeptidase activity (39%);zinc ion binding (35%);ATP binding (10%),GO:0007229 (16%);GO:0007283 (9%);GO:0016485 (9%),integrin-mediated signaling pathway (16%);spermatogenesis (9%);protein processing (9%),IPR010909 (38%);IPR000884 (37%);IPR036383 (37%),PLAC (38%);Thrombospondin type-1 (TSP1) repeat (37%);Thrombospondin type-1 (TSP1) repeat superfamily (37%),,,,,,,,,,,
VEPVYLDPEVANR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLQVMAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WQGALEVSER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVHDHEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLSPSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.6 (25%);1.2.7.8 (25%);2.7.1.68 (25%),Glycerol dehydrogenase (25%);Indolepyruvate ferredoxin oxidoreductase (25%);1-phosphatidylinositol-4-phosphate 5-kinase (25%),GO:0016021 (47%);GO:0031514 (3%);GO:0005576 (1%),integral component of membrane (47%);motile cilium (3%);extracellular region (1%),GO:0003677 (9%);GO:0005524 (8%);GO:0016614 (8%),DNA binding (9%);ATP binding (8%);oxidoreductase activity, acting on CH-OH group of donors (8%),GO:0009231 (3%);GO:0048015 (3%);GO:0000422 (1%),riboflavin biosynthetic process (3%);phosphatidylinositol-mediated signaling (3%);autophagy of mitochondrion (1%),IPR003115 (17%);IPR036086 (17%);IPR013935 (8%),ParB/Sulfiredoxin (17%);ParB/Sulfiredoxin superfamily (17%);TRAPP II complex, Trs120 (8%),,,,,,,,,
TAVTYYK,Clostridiales,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,,,,,,,,,,,,,5.4.99.- (100%),Transferring other groups (100%),,,GO:0003723 (100%);GO:0009982 (100%),RNA binding (100%);pseudouridine synthase activity (100%),GO:0001522 (100%),pseudouridine synthesis (100%),IPR002942 (100%);IPR006145 (100%);IPR006224 (100%),RNA-binding S4 domain (100%);Pseudouridine synthase, RsuA/RluA (100%);Pseudouridine synthase, RluC/RluD, conserved site (100%),,,,,,,,
LDDGNDENHAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DAQDAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.1 (15%);2.7.1.26 (15%);2.7.7.2 (15%),Transketolase (15%);Riboflavin kinase (15%);FAD synthase (15%),GO:0016021 (20%);GO:0005737 (16%);GO:0005886 (2%),integral component of membrane (20%);cytoplasm (16%);plasma membrane (2%),GO:0000774 (12%);GO:0042803 (12%);GO:0051087 (12%),adenyl-nucleotide exchange factor activity (12%);protein homodimerization activity (12%);chaperone binding (12%),GO:0006457 (12%);GO:0007165 (7%);GO:0009058 (4%),protein folding (12%);signal transduction (7%);biosynthetic process (4%),IPR012347 (49%);IPR001680 (14%);IPR015943 (14%),Ferritin-like (49%);WD40 repeat (14%);WD40/YVTN repeat-like-containing domain superfamily (14%),,,,,,,,,,,
LTEQTCLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWDSTTPQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.48 (12%);6.3.2.2 (9%);2.3.1.157 (8%),Histone acetyltransferase (12%);Glutamate--cysteine ligase (9%);Glucosamine-1-phosphate N-acetyltransferase (8%),GO:0016021 (33%);GO:0005634 (8%);GO:0005737 (5%),integral component of membrane (33%);nucleus (8%);cytoplasm (5%),GO:0005524 (13%);GO:0008233 (13%);GO:0003677 (6%),ATP binding (13%);peptidase activity (13%);DNA binding (6%),GO:0032012 (3%);GO:0043335 (3%);GO:0006355 (3%),regulation of ARF protein signal transduction (3%);protein unfolding (3%);regulation of transcription, DNA-templated (3%),IPR036013 (17%);IPR001107 (17%);IPR027417 (7%),Band 7/SPFH domain superfamily (17%);Band 7 domain (17%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,
LAGQEVEK,Porphyromonas macacae,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Porphyromonadaceae,,,,Porphyromonas,,,,Porphyromonas macacae,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (100%);IPR008969 (100%);IPR012910 (100%),TonB-dependent receptor-like, beta-barrel (100%);Carboxypeptidase-like, regulatory domain superfamily (100%);TonB-dependent receptor, plug domain (100%),,,,,,,,
LGTADTEWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPAVHPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (50%);GO:0016021 (50%),plasma membrane (50%);integral component of membrane (50%),GO:0015035 (50%);GO:0022857 (50%),protein disulfide oxidoreductase activity (50%);transmembrane transporter activity (50%),,,IPR001173 (33%);IPR001851 (33%);IPR001853 (33%),Glycosyltransferase 2-like (33%);ABC transporter, permease (33%);DSBA-like thioredoxin domain (33%),,,,,,,,,,
QNLNNLLQNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVGNLAALDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDLQYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.61 (33%);3.5.1.- (33%);6.3.5.- (33%),tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase (33%);In linear amides (33%);Carbon--nitrogen ligases with glutamine as amido-N-donor (33%),GO:0016021 (29%);GO:0000178 (8%);GO:0005886 (8%),integral component of membrane (29%);exosome (RNase complex) (8%);plasma membrane (8%),GO:0005524 (18%);GO:0008080 (13%);GO:0016491 (11%),ATP binding (18%);N-acetyltransferase activity (13%);oxidoreductase activity (11%),GO:0006396 (11%);GO:0006401 (8%);GO:0009253 (5%),RNA processing (11%);RNA catabolic process (8%);peptidoglycan catabolic process (5%),IPR000182 (12%);IPR016181 (12%);IPR011990 (10%),GNAT domain (12%);Acyl-CoA N-acyltransferase (12%);Tetratricopeptide-like helical domain superfamily (10%),,,,,,,,,,,
NELLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.4 (24%);3.6.4.12 (14%);2.1.2.2 (9%),Tripeptide aminopeptidase (24%);DNA helicase (14%);Phosphoribosylglycinamide formyltransferase (9%),GO:0016021 (17%);GO:0005737 (14%);GO:0005886 (5%),integral component of membrane (17%);cytoplasm (14%);plasma membrane (5%),GO:0005524 (23%);GO:0003677 (13%);GO:0008270 (8%),ATP binding (23%);DNA binding (13%);zinc ion binding (8%),GO:0043171 (6%);GO:0006355 (4%);GO:0006281 (3%),peptide catabolic process (6%);regulation of transcription, DNA-templated (4%);DNA repair (3%),IPR027417 (17%);IPR003593 (6%);IPR002933 (5%),P-loop containing nucleoside triphosphate hydrolase (17%);AAA+ ATPase domain (6%);Peptidase M20 (5%),,,,,,,,,,
AEVSLQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (83%);3.2.1.- (17%),Histidine kinase (83%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (17%),GO:0016021 (56%);GO:0005886 (17%);GO:0045261 (11%),integral component of membrane (56%);plasma membrane (17%);proton-transporting ATP synthase complex, catalytic core F(1) (11%),GO:0000155 (39%);GO:0005524 (17%);GO:0008880 (17%),phosphorelay sensor kinase activity (39%);ATP binding (17%);glucuronate isomerase activity (17%),GO:0019310 (17%);GO:0006355 (11%);GO:0015986 (11%),inositol catabolic process (17%);regulation of transcription, DNA-templated (11%);ATP synthesis coupled proton transport (11%),IPR003661 (35%);IPR036097 (35%);IPR036890 (35%),Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (35%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain superfamily (35%);Histidine kinase/HSP90-like ATPase superfamily (35%),,,,,,
YEEPFVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLTGNFGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPVLLWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DEPWHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (8%);GO:0030018 (8%);GO:0001725 (5%),nucleus (8%);Z disc (8%);stress fiber (5%),GO:0046872 (100%);GO:0003712 (5%);GO:0003779 (5%),metal ion binding (100%);transcription coregulator activity (5%);actin binding (5%),GO:0030036 (5%);GO:0007015 (1%);GO:0045944 (1%),actin cytoskeleton organization (5%);actin filament organization (1%);positive regulation of transcription by RNA polymerase II (1%),IPR001781 (100%);IPR037987 (100%),Zinc finger, LIM-type (100%);Four and a half LIM domains protein 2/3/5 (100%),,,,,,,,,,
LPNAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.27.- (30%);2.3.3.13 (20%);3.1.13.- (20%),Endoribonucleases producing other than 5'-phosphomonoesters (30%);2-isopropylmalate synthase (20%);Exoribonucleases producing 5'-phosphomonoesters (20%),GO:0016021 (11%);GO:0005576 (6%);GO:0005634 (6%),integral component of membrane (11%);extracellular region (6%);nucleus (6%),GO:0051116 (19%);GO:0003723 (17%);GO:0003676 (11%),cobaltochelatase activity (19%);RNA binding (17%);nucleic acid binding (11%),GO:0009236 (19%);GO:0000160 (6%);GO:0006397 (6%),cobalamin biosynthetic process (19%);phosphorelay signal transduction system (6%);mRNA processing (6%),IPR015943 (17%);IPR001680 (15%);IPR003672 (15%),WD40/YVTN repeat-like-containing domain superfamily (17%);WD40 repeat (15%);CobN/magnesium chelatase (15%),,,,,,,,,,,
FLNDVCK,Candidatus Riesia pediculischaeffi,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Enterobacterales,,,,,Enterobacteriaceae,,,,Candidatus Riesia,,,,Candidatus Riesia pediculischaeffi,,,,,,GO:0009360 (100%),DNA polymerase III complex (100%),GO:0003677 (100%);GO:0003887 (100%),DNA binding (100%);DNA-directed DNA polymerase activity (100%),GO:0006260 (100%),DNA replication (100%),IPR008921 (100%);IPR010372 (100%);IPR027417 (100%),DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal (100%);DNA polymerase III delta, N-terminal (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,
DATQLTEPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYNAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (17%);6.1.1.16 (8%);3.6.5.- (6%),Ribonucleoside-diphosphate reductase (17%);Cysteine--tRNA ligase (8%);Acting on GTP; involved in cellular and subcellular movement (6%),GO:0016021 (37%);GO:0005886 (19%);GO:0005737 (7%),integral component of membrane (37%);plasma membrane (19%);cytoplasm (7%),GO:0005524 (27%);GO:0046872 (25%);GO:0019829 (14%),ATP binding (27%);metal ion binding (25%);ATPase-coupled cation transmembrane transporter activity (14%),GO:0030001 (15%);GO:0006260 (3%);GO:0009263 (3%),metal ion transport (15%);DNA replication (3%);deoxyribonucleotide biosynthetic process (3%),IPR036412 (13%);IPR023214 (13%);IPR008250 (13%),HAD-like superfamily (13%);HAD superfamily (13%);P-type ATPase, A domain superfamily (13%),,,,,,,,,,
TVLVLSPLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QENGPDVMAQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNEEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (38%);3.1.-.- (8%);4.1.2.- (6%),DNA helicase (38%);Acting on ester bonds (8%);Aldehyde-lyases (6%),GO:0005737 (16%);GO:0016021 (15%);GO:0005634 (8%),cytoplasm (16%);integral component of membrane (15%);nucleus (8%),GO:0005524 (20%);GO:0003700 (16%);GO:0003677 (15%),ATP binding (20%);DNA-binding transcription factor activity (16%);DNA binding (15%),GO:0006353 (13%);GO:0031564 (13%);GO:1905775 (7%),DNA-templated transcription, termination (13%);transcription antitermination (13%);negative regulation of DNA helicase activity (7%),IPR012340 (16%);IPR027417 (15%);IPR009019 (10%),Nucleic acid-binding, OB-fold (16%);P-loop containing nucleoside triphosphate hydrolase (15%);K homology domain superfamily, prokaryotic type (10%),,,,,,,,
MFPLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (30%);3.6.4.12 (20%);4.3.3.7 (20%),Acting on ester bonds (30%);DNA helicase (20%);4-hydroxy-tetrahydrodipicolinate synthase (20%),GO:0030288 (25%);GO:0005746 (25%);GO:0016021 (13%),outer membrane-bounded periplasmic space (25%);mitochondrial respirasome (25%);integral component of membrane (13%),GO:0004129 (25%);GO:0016491 (16%);GO:0046872 (13%),cytochrome-c oxidase activity (25%);oxidoreductase activity (16%);metal ion binding (13%),GO:0043711 (25%);GO:0061077 (25%);GO:0071555 (25%),pilus organization (25%);chaperone-mediated protein folding (25%);cell wall organization (25%),IPR001829 (25%);IPR008962 (25%);IPR013783 (25%),Pili assembly chaperone, bacterial (25%);PapD-like superfamily (25%);Immunoglobulin-like fold (25%),,,,,,,,,,
VLSNPALAK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016740 (50%),transferase activity (50%),,,IPR001296 (50%);IPR011050 (50%);IPR028098 (50%),Glycosyl transferase, family 1 (50%);Pectin lyase fold/virulence factor (50%);Glycosyltransferase subfamily 4-like, N-terminal domain (50%),,,,,,,,,
EFTDQSPK,Daucus carota subsp. sativus,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Apiales,Apiineae,,,,Apiaceae,Apioideae,Scandiceae,Daucinae,Daucus,,,,Daucus carota,Daucus carota subsp. sativus,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR040411 (100%),Uncharacterized protein At5g23160-like (100%),,,,,,,,,,,
DVLEPTVANLWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSLSMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.0 (100%), (100%),GO:0016021 (15%),integral component of membrane (15%),GO:0003676 (54%);GO:0000166 (4%);GO:0000287 (4%),nucleic acid binding (54%);nucleotide binding (4%);magnesium ion binding (4%),GO:0006139 (54%);GO:0006355 (19%),nucleobase-containing compound metabolic process (54%);regulation of transcription, DNA-templated (19%),IPR003029 (44%);IPR006641 (44%);IPR010994 (44%),S1 domain (44%);YqgF/RNase H-like domain (44%);RuvA domain 2-like (44%),,,,,,,,,,
NNDSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (18%);2.1.1.- (18%);1.1.3.21 (12%),Transferring other groups (18%);Methyltransferases (18%);Glycerol-3-phosphate oxidase (12%),GO:0016021 (16%);GO:0005737 (9%);GO:0043190 (6%),integral component of membrane (16%);cytoplasm (9%);ATP-binding cassette (ABC) transporter complex (6%),GO:0003723 (9%);GO:0005524 (8%);GO:0031625 (7%),RNA binding (9%);ATP binding (8%);ubiquitin protein ligase binding (7%),GO:0006511 (7%);GO:0055085 (6%);GO:0006072 (5%),ubiquitin-dependent protein catabolic process (7%);transmembrane transport (6%);glycerol-3-phosphate metabolic process (5%),IPR027417 (9%);IPR036388 (7%);IPR036390 (6%),P-loop containing nucleoside triphosphate hydrolase (9%);Winged helix-like DNA-binding domain superfamily (7%);Winged helix DNA-binding domain superfamily (6%),,,,,,,,,,,
LENVLNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.130 (60%);5.4.99.12 (13%);2.7.1.180 (7%),Tetraacyldisaccharide 4'-kinase (60%);tRNA pseudouridine(38-40) synthase (13%);FAD:protein FMN transferase (7%),GO:0000145 (87%);GO:0016021 (6%);GO:0005886 (2%),exocyst (87%);integral component of membrane (6%);plasma membrane (2%),GO:0017160 (22%);GO:0019901 (22%);GO:0047485 (20%),Ral GTPase binding (22%);protein kinase binding (22%);protein N-terminus binding (20%),GO:0006887 (87%);GO:0006893 (87%);GO:0015031 (87%),exocytosis (87%);Golgi to plasma membrane transport (87%);protein transport (87%),IPR029175 (80%);IPR039481 (80%);IPR013783 (75%),Exocyst complex component EXOC2/Sec5 (80%);Exocyst complex component EXOC2/Sec5, N-terminal domain (80%);Immunoglobulin-like fold (75%),,,,,,,,,,
MVFVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.39 (8%);1.17.1.9 (5%);2.1.1.- (5%),[Acyl-carrier-protein] S-malonyltransferase (8%);Formate dehydrogenase (5%);Methyltransferases (5%),GO:0016021 (27%);GO:0005737 (8%);GO:0005634 (7%),integral component of membrane (27%);cytoplasm (8%);nucleus (7%),GO:0003677 (8%);GO:0016740 (8%);GO:0005524 (8%),DNA binding (8%);transferase activity (8%);ATP binding (8%),GO:0006355 (6%);GO:0006313 (4%);GO:0055085 (2%),regulation of transcription, DNA-templated (6%);transposition, DNA-mediated (4%);transmembrane transport (2%),IPR027417 (31%);IPR031314 (28%);IPR016035 (6%),P-loop containing nucleoside triphosphate hydrolase (31%);Deoxynucleoside kinase domain (28%);Acyl transferase/acyl hydrolase/lysophospholipase (6%),,,,,,,,,
APFEDCVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VALGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.1 (24%);6.3.5.5 (13%);3.6.3.17 (8%),Threonine synthase (24%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (13%);Transferred entry: 7.5.2.8 (8%),GO:0016021 (21%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (21%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (30%);GO:0016887 (16%);GO:0046872 (9%),ATP binding (30%);ATPase activity (16%);metal ion binding (9%),GO:0009088 (5%);GO:0006526 (3%);GO:0044205 (3%),threonine biosynthetic process (5%);arginine biosynthetic process (3%);'de novo' UMP biosynthetic process (3%),IPR027417 (18%);IPR003593 (15%);IPR003439 (14%),P-loop containing nucleoside triphosphate hydrolase (18%);AAA+ ATPase domain (15%);ABC transporter-like (14%),,,,,,,,,,,
MNEPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (31%);2.7.1.48 (23%);2.7.7.18 (15%),Peptidylprolyl isomerase (31%);Uridine kinase (23%);Nicotinate-nucleotide adenylyltransferase (15%),GO:0016021 (43%);GO:0005737 (9%);GO:0005886 (5%),integral component of membrane (43%);cytoplasm (9%);plasma membrane (5%),GO:0005524 (16%);GO:0003677 (9%);GO:0003755 (9%),ATP binding (16%);DNA binding (9%);peptidyl-prolyl cis-trans isomerase activity (9%),GO:0006355 (9%);GO:0006811 (5%);GO:0009435 (5%),regulation of transcription, DNA-templated (9%);ion transport (5%);NAD biosynthetic process (5%),IPR001179 (8%);IPR001440 (8%);IPR011990 (8%),FKBP-type peptidyl-prolyl cis-trans isomerase domain (8%);Tetratricopeptide repeat 1 (8%);Tetratricopeptide-like helical domain superfamily (8%),,,,,,,,,,
FLFNNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0016021 (83%);GO:0005576 (4%),integral component of membrane (83%);extracellular region (4%),GO:0003700 (13%);GO:0043565 (13%);GO:0003755 (4%),DNA-binding transcription factor activity (13%);sequence-specific DNA binding (13%);peptidyl-prolyl cis-trans isomerase activity (4%),GO:0006030 (4%),chitin metabolic process (4%),IPR009057 (50%);IPR018060 (50%);IPR018062 (50%),Homeobox-like domain superfamily (50%);DNA binding HTH domain, AraC-type (50%);HTH domain AraC-type, conserved site (50%),,,,,,,,,
NQADVEQDDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LWLFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.1 (44%);2.4.2.28 (33%);2.1.1.182 (11%),Alanine racemase (44%);S-methyl-5'-thioadenosine phosphorylase (33%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (11%),GO:0016021 (62%);GO:0030286 (11%);GO:0005886 (5%),integral component of membrane (62%);dynein complex (11%);plasma membrane (5%),GO:0015297 (35%);GO:0042910 (35%);GO:0003777 (12%),antiporter activity (35%);xenobiotic transmembrane transporter activity (35%);microtubule motor activity (12%),GO:0007018 (12%);GO:0007165 (7%);GO:0055085 (5%),microtubule-based movement (12%);signal transduction (7%);transmembrane transport (5%),IPR002528 (31%);IPR027417 (15%);IPR003593 (11%),Multi antimicrobial extrusion protein (31%);P-loop containing nucleoside triphosphate hydrolase (15%);AAA+ ATPase domain (11%),,,,,,,,,,,
TNPTHTMQAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLYYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.187 (33%);2.7.13.3 (33%);7.6.2.1 (33%),N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-Dmannosaminyltransferase (33%);Histidine kinase (33%);P-type phospholipid transporter (33%),GO:0016020 (36%);GO:0016021 (26%);GO:0043190 (5%),membrane (36%);integral component of membrane (26%);ATP-binding cassette (ABC) transporter complex (5%),GO:0010181 (21%);GO:0047355 (15%);GO:0005524 (8%),FMN binding (21%);CDP-glycerol glycerophosphotransferase activity (15%);ATP binding (8%),GO:0006006 (8%);GO:0055085 (8%);GO:0005975 (5%),glucose metabolic process (8%);transmembrane transport (8%);carbohydrate metabolic process (5%),IPR007329 (18%);IPR035965 (18%);IPR007554 (12%),FMN-binding (18%);PAS domain superfamily (18%);CDP-glycerol glycerophosphotransferase (12%),,,,,,,,,,,
MDVVSVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016779 (100%),nucleotidyltransferase activity (100%),,,IPR002934 (100%),Polymerase, nucleotidyl transferase domain (100%),,,,,,,,,,
VAAAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.2 (20%);2.5.1.145 (13%);2.7.1.23 (13%),Oxoglutarate dehydrogenase (succinyl-transferring) (20%);Phosphatidylglycerol--prolipoprotein diacylglyceryl transferase (13%);NAD(+) kinase (13%),GO:0016021 (48%);GO:0005737 (3%);GO:0005634 (2%),integral component of membrane (48%);cytoplasm (3%);nucleus (2%),GO:0016491 (40%);GO:0005506 (39%);GO:0003677 (14%),oxidoreductase activity (40%);iron ion binding (39%);DNA binding (14%),GO:0008610 (39%);GO:0006099 (3%);GO:0005975 (2%),lipid biosynthetic process (39%);tricarboxylic acid cycle (3%);carbohydrate metabolic process (2%),IPR006694 (35%);IPR009057 (10%);IPR001647 (9%),Fatty acid hydroxylase (35%);Homeobox-like domain superfamily (10%);DNA-binding HTH domain, TetR-type (9%),,,,,,,,,,
TACDLPR,Rhizobium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Rhizobiaceae,,,,Rhizobium,,,,,,,,,,,,GO:0016740 (100%),transferase activity (100%),,,IPR001173 (100%);IPR029044 (100%),Glycosyltransferase 2-like (100%);Nucleotide-diphospho-sugar transferases (100%),,,,,,,,,,,
DSSNGTVPER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YSDEVVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.16 (50%);3.5.1.108 (50%),Glutamine--fructose-6-phosphate transaminase (isomerizing) (50%);UDP-3-O-acyl-N-acetylglucosamine deacetylase (50%),GO:0005840 (97%);GO:0005737 (1%);GO:0009570 (0%),ribosome (97%);cytoplasm (1%);chloroplast stroma (0%),GO:0019843 (97%);GO:0003735 (90%);GO:0004360 (1%),rRNA binding (97%);structural constituent of ribosome (90%);glutamine-fructose-6-phosphate transaminase (isomerizing) activity (1%),GO:0006412 (97%);GO:0005975 (1%);GO:0009245 (1%),translation (97%);carbohydrate metabolic process (1%);lipid A biosynthetic process (1%),IPR000702 (97%);IPR019906 (97%);IPR020040 (97%),Ribosomal protein L6 (97%);Ribosomal protein L6, bacterial-type (97%);Ribosomal protein L6, alpha-beta domain (97%),,,,,,,,,
TQALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.4 (20%);2.7.7.8 (11%);2.7.13.3 (4%),Sulfate adenylyltransferase (20%);Polyribonucleotide nucleotidyltransferase (11%);Histidine kinase (4%),GO:0016021 (24%);GO:0031932 (7%);GO:0005737 (6%),integral component of membrane (24%);TORC2 complex (7%);cytoplasm (6%),GO:0005524 (20%);GO:0003677 (8%);GO:0000155 (5%),ATP binding (20%);DNA binding (8%);phosphorelay sensor kinase activity (5%),GO:0006826 (8%);GO:0031929 (7%);GO:0006355 (4%),iron ion transport (8%);TOR signaling (7%);regulation of transcription, DNA-templated (4%),IPR027417 (12%);IPR016024 (9%);IPR007845 (8%),P-loop containing nucleoside triphosphate hydrolase (12%);Armadillo-type fold (9%);Haemin-degrading HemS/ChuX domain (8%),,,,,,,,,,
LDENLNESDNGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTLPPC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SEVSNSQLK,Pseudoalteromonas,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Alteromonadales,,,,,Pseudoalteromonadaceae,,,,Pseudoalteromonas,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNVTTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (100%),RNA-directed RNA polymerase (100%),GO:0005737 (6%);GO:0016021 (6%),cytoplasm (6%);integral component of membrane (6%),GO:0003676 (38%);GO:0003677 (19%);GO:0003723 (19%),nucleic acid binding (38%);DNA binding (19%);RNA binding (19%),GO:0006417 (6%);GO:0044238 (6%),regulation of translation (6%);primary metabolic process (6%),IPR035979 (27%);IPR000504 (23%);IPR012677 (23%),RNA-binding domain superfamily (27%);RNA recognition motif domain (23%);Nucleotide-binding alpha-beta plait domain superfamily (23%),,,,,,,,,,,
YAVMTSMHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVAGSTFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VETADC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAVVTDVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVEQTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.2 (50%);3.1.21.3 (27%);1.17.4.1 (5%),CTP synthase (glutamine hydrolyzing) (50%);Type I site-specific deoxyribonuclease (27%);Ribonucleoside-diphosphate reductase (5%),GO:0016021 (20%);GO:0005840 (4%);GO:0005623 (1%),integral component of membrane (20%);ribosome (4%);cell (1%),GO:0005524 (38%);GO:0046872 (17%);GO:0003883 (16%),ATP binding (38%);metal ion binding (17%);CTP synthase activity (16%),GO:0006541 (16%);GO:0044210 (16%);GO:0009307 (9%),glutamine metabolic process (16%);'de novo' CTP biosynthetic process (16%);DNA restriction-modification system (9%),IPR000160 (31%);IPR029016 (31%);IPR029787 (31%),GGDEF domain (31%);GAF-like domain superfamily (31%);Nucleotide cyclase (31%),,,,,,,,,,,
WYQNELAQAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNMVVVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNNAELGR,Deferribacteraceae bacterium,Bacteria,,,,Deferribacteres,,,Deferribacteres,,,,Deferribacterales,,,,,Deferribacteraceae,,,,,,,,Deferribacteraceae bacterium,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR000014 (100%);IPR000160 (100%);IPR000700 (100%),PAS domain (100%);GGDEF domain (100%);PAS-associated, C-terminal (100%),,,,,,,,,,
NGDVQNESPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENYWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (42%);2.7.7.27 (12%);5.6.2.2 (9%),Serine endopeptidases (42%);Glucose-1-phosphate adenylyltransferase (12%);DNA topoisomerase (ATP-hydrolyzing) (9%),GO:0016021 (25%);GO:0005737 (12%);GO:0005634 (3%),integral component of membrane (25%);cytoplasm (12%);nucleus (3%),GO:0008236 (13%);GO:0005524 (12%);GO:0004573 (10%),serine-type peptidase activity (13%);ATP binding (12%);mannosyl-oligosaccharide glucosidase activity (10%),GO:0009311 (10%);GO:0005978 (3%);GO:0006289 (3%),oligosaccharide metabolic process (10%);glycogen biosynthetic process (3%);nucleotide-excision repair (3%),IPR015943 (16%);IPR029045 (10%);IPR005151 (10%),WD40/YVTN repeat-like-containing domain superfamily (16%);ClpP/crotonase-like domain superfamily (10%);Tail specific protease (10%),,,,,,,,,,,
GNPAWYDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVVLDPSK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005737 (17%),integral component of membrane (50%);cytoplasm (17%),GO:0003677 (50%);GO:0005524 (33%);GO:0003700 (17%),DNA binding (50%);ATP binding (33%);DNA-binding transcription factor activity (17%),,,IPR001650 (67%);IPR006935 (67%);IPR014001 (67%),Helicase, C-terminal (67%);Helicase/UvrB, N-terminal (67%);Helicase superfamily 1/2, ATP-binding domain (67%),,,,,,,,
FGNTVLGNPMHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNNLFFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (25%);GO:0016887 (25%);GO:0042626 (25%),ATP binding (25%);ATPase activity (25%);ATPase-coupled transmembrane transporter activity (25%),,,IPR003004 (50%);IPR003439 (50%);IPR003593 (50%),GspF/PilC family (50%);ABC transporter-like (50%);AAA+ ATPase domain (50%),,,,,,,,,,,
LVSSDMMANPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DWNWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.2 (63%);2.4.1.- (27%);3.4.16.4 (4%),Pectate lyase (63%);Hexosyltransferases (27%);Serine-type D-Ala-D-Ala carboxypeptidase (4%),GO:0016021 (29%);GO:0005794 (6%);GO:0009279 (2%),integral component of membrane (29%);Golgi apparatus (6%);cell outer membrane (2%),GO:0005524 (39%);GO:0004672 (33%);GO:0046872 (23%),ATP binding (39%);protein kinase activity (33%);metal ion binding (23%),GO:0045490 (22%);GO:0009834 (6%);GO:0045492 (6%),pectin catabolic process (22%);plant-type secondary cell wall biogenesis (6%);xylan biosynthetic process (6%),IPR009045 (68%);IPR013230 (68%);IPR010275 (38%),Hedgehog signalling/DD-peptidase zinc-binding domain superfamily (68%);Peptidase M15A, C-terminal (68%);Protein of unknown function DUF882 (38%),,,,,,,,,,
AADESTSALGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLTMFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016459 (38%);GO:0005886 (13%),myosin complex (38%);plasma membrane (13%),GO:0015631 (63%);GO:0031625 (63%);GO:0044548 (63%),tubulin binding (63%);ubiquitin protein ligase binding (63%);S100 protein binding (63%),,,IPR007052 (45%);IPR007699 (45%);IPR008978 (45%),CS domain (45%);SGS domain (45%);HSP20-like chaperone (45%),,,,,,,,,,,
MLVTYPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016597 (100%);GO:0016743 (100%),amino acid binding (100%);carboxyl- or carbamoyltransferase activity (100%),GO:0006520 (100%),cellular amino acid metabolic process (100%),IPR006130 (67%);IPR006131 (67%);IPR036901 (67%),Aspartate/ornithine carbamoyltransferase (67%);Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain (67%);Aspartate/ornithine carbamoyltransferase superfamily (67%),,,,,,,,,,
TTQLDEVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLEVVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.22 (16%);2.5.1.61 (8%);3.1.21.3 (8%),GTP 3',8-cyclase (16%);Hydroxymethylbilane synthase (8%);Type I site-specific deoxyribonuclease (8%),GO:0016021 (13%);GO:0005840 (8%);GO:0005886 (2%),integral component of membrane (13%);ribosome (8%);plasma membrane (2%),GO:0003677 (20%);GO:0005524 (10%);GO:0003735 (8%),DNA binding (20%);ATP binding (10%);structural constituent of ribosome (8%),GO:0000160 (15%);GO:0006412 (8%);GO:0006486 (5%),phosphorelay signal transduction system (15%);translation (8%);protein glycosylation (5%),IPR001789 (14%);IPR011006 (14%);IPR009057 (8%),Signal transduction response regulator, receiver domain (14%);CheY-like superfamily (14%);Homeobox-like domain superfamily (8%),,,,,,,,,
EDWWEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGDDNFR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%);GO:0005886 (33%),integral component of membrane (67%);plasma membrane (33%),GO:0003677 (33%);GO:0005524 (33%);GO:0008168 (33%),DNA binding (33%);ATP binding (33%);methyltransferase activity (33%),GO:0007049 (33%);GO:0007059 (33%);GO:0032259 (33%),cell cycle (33%);chromosome segregation (33%);methylation (33%),IPR006222 (50%);IPR013977 (50%);IPR018959 (50%),Aminomethyltransferase, folate-binding domain (50%);Glycine cleavage T-protein, C-terminal barrel domain (50%);Domain of unknown function DUF1989 (50%),,,,,,,,,
LAGEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.59 (9%);2.7.13.3 (7%);1.1.1.103 (4%),3-hydroxyacyl-[acyl-carrier-protein] dehydratase (9%);Histidine kinase (7%);L-threonine 3-dehydrogenase (4%),GO:0016021 (60%);GO:0000786 (15%);GO:0005737 (8%),integral component of membrane (60%);nucleosome (15%);cytoplasm (8%),GO:0019534 (46%);GO:0003677 (18%);GO:0005524 (12%),toxin transmembrane transporter activity (46%);DNA binding (18%);ATP binding (12%),GO:0043213 (46%);GO:0006334 (15%);GO:0051301 (9%),bacteriocin transport (46%);nucleosome assembly (15%);cell division (9%),IPR014161 (43%);IPR006260 (42%);IPR005819 (15%),Tol-Pal system, TolA (43%);TonB/TolA, C-terminal (42%);Histone H5 (15%),,,,,,,,,
FATDPLSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNDFNVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMPSNDGSHPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALLPFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.- (57%);5.6.2.2 (4%);6.3.4.19 (4%),Other oxidoreductases (57%);DNA topoisomerase (ATP-hydrolyzing) (4%);tRNA(Ile)-lysidine synthetase (4%),GO:0005737 (20%);GO:0016021 (13%);GO:0005623 (4%),cytoplasm (20%);integral component of membrane (13%);cell (4%),GO:0051539 (20%);GO:0043365 (19%);GO:0005524 (17%),4 iron, 4 sulfur cluster binding (20%);[formate-C-acetyltransferase]-activating enzyme activity (19%);ATP binding (17%),GO:0006935 (11%);GO:0007049 (6%);GO:0000271 (5%),chemotaxis (11%);cell cycle (6%);polysaccharide biosynthetic process (5%),IPR013785 (18%);IPR034457 (16%);IPR001989 (16%),Aldolase-type TIM barrel (18%);Organic radical-activating enzymes (16%);Radical-activating enzyme, conserved site (16%),,,,,,,,,
MNVWELENVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEEEPMGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNHQAER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLPMVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNGFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.8 (100%),Polyribonucleotide nucleotidyltransferase (100%),GO:0009507 (52%);GO:0016021 (6%),chloroplast (52%);integral component of membrane (6%),GO:0003723 (55%);GO:0004519 (27%);GO:0004527 (27%),RNA binding (55%);endonuclease activity (27%);exonuclease activity (27%),GO:0006397 (52%);GO:0008033 (52%);GO:0008380 (27%),mRNA processing (52%);tRNA processing (52%);RNA splicing (27%),IPR002866 (40%);IPR024942 (40%);IPR005135 (36%),Maturase MatK (40%);Maturase MatK, N-terminal domain (40%);Endonuclease/exonuclease/phosphatase (36%),,,,,,,,,,
VFPSLVGR,Actinobacteria bacterium,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,,,,,,,,,,,,,,Actinobacteria bacterium,,,,,,,,,,,,IPR006098 (100%);IPR006099 (100%);IPR006158 (100%),Methylmalonyl-CoA mutase, alpha chain, catalytic (100%);Methylmalonyl-CoA mutase, alpha/beta chain, catalytic (100%);Cobalamin (vitamin B12)-binding domain (100%),,,,,,,
QENGPDVM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWMNHAYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTLEVNVSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LANNDAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003677 (50%);GO:0003678 (50%);GO:0004527 (50%),DNA binding (50%);DNA helicase activity (50%);exonuclease activity (50%),GO:0006281 (50%),DNA repair (50%),IPR000212 (50%);IPR014016 (50%);IPR014017 (50%),DNA helicase, UvrD/REP type (50%);UvrD-like helicase, ATP-binding domain (50%);UvrD-like DNA helicase, C-terminal (50%),,,,,,,,
NNPATHK,Gammaproteobacteria bacterium,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,Gammaproteobacteria bacterium,,,,2.1.1.197 (100%),Malonyl-[acyl-carrier protein] O-methyltransferase (100%),,,GO:0010340 (100%);GO:0102130 (100%),carboxyl-O-methyltransferase activity (100%);malonyl-CoA methyltransferase activity (100%),GO:0009102 (100%);GO:0032259 (100%),biotin biosynthetic process (100%);methylation (100%),IPR011814 (100%);IPR013216 (100%);IPR029063 (100%),Malonyl-[acyl-carrier protein] O-methyltransferase BioC (100%);Methyltransferase type 11 (100%);S-adenosyl-L-methionine-dependent methyltransferase (100%),,,,,,,,,,,
QNTLSNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPVLLER,Terriglobus albidus,Bacteria,,,,Acidobacteria,,,Acidobacteriia,,,,Acidobacteriales,,,,,Acidobacteriaceae,,,,Terriglobus,,,,Terriglobus albidus,,,,,,,,,,,,IPR024654 (100%);IPR029052 (100%),Calcineurin-like phosphoesterase domain, lpxH-type (100%);Metallo-dependent phosphatase-like (100%),,,,,,,,,,
GPQAER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.10.3.- (74%);3.1.-.- (9%);2.7.13.3 (6%),With oxygen as acceptor (74%);Acting on ester bonds (9%);Histidine kinase (6%),GO:0005737 (53%);GO:0016021 (27%);GO:0005886 (10%),cytoplasm (53%);integral component of membrane (27%);plasma membrane (10%),GO:0003676 (29%);GO:0003677 (25%);GO:0004129 (12%),nucleic acid binding (29%);DNA binding (25%);cytochrome-c oxidase activity (12%),GO:0000967 (1%);GO:0017000 (1%);GO:0000270 (0%),rRNA 5'-end processing (1%);antibiotic biosynthetic process (1%);peptidoglycan metabolic process (0%),IPR002059 (51%);IPR011129 (51%);IPR012340 (51%),Cold-shock protein, DNA-binding (51%);Cold shock domain (51%);Nucleic acid-binding, OB-fold (51%),,,,,,,,,
ETSTLNDVMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DECEDDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMTLMNK,Pseudomonas,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Pseudomonadales,,,,,Pseudomonadaceae,,,,Pseudomonas,,,,,,,,,,,,GO:0010181 (100%);GO:0016491 (100%);GO:0043546 (100%),FMN binding (100%);oxidoreductase activity (100%);molybdopterin cofactor binding (100%),GO:0042128 (100%),nitrate assimilation (100%),IPR001094 (100%);IPR001433 (100%);IPR001709 (100%),Flavodoxin-like (100%);Oxidoreductase FAD/NAD(P)-binding (100%);Flavoprotein pyridine nucleotide cytochrome reductase (100%),,,,,,,,,,,
LLAPDPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.65 (67%);3.6.4.12 (33%),Phosphatidylserine decarboxylase (67%);DNA helicase (33%),GO:0015935 (22%);GO:0016021 (14%);GO:0005886 (4%),small ribosomal subunit (22%);integral component of membrane (14%);plasma membrane (4%),GO:0016787 (36%);GO:0000049 (22%);GO:0003735 (22%),hydrolase activity (36%);tRNA binding (22%);structural constituent of ribosome (22%),GO:0006281 (36%);GO:0009432 (36%);GO:0006412 (22%),DNA repair (36%);SOS response (36%);translation (22%),IPR036286 (35%);IPR039418 (35%);IPR000235 (22%),LexA/Signal peptidase-like superfamily (35%);LexA-like (35%);Ribosomal protein S5/S7 (22%),,,,,,,,,,,
LQFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.225 (35%);3.2.1.45 (17%);3.1.3.16 (9%),Protein S-acyltransferase (35%);Glucosylceramidase (17%);Protein-serine/threonine phosphatase (9%),GO:0016021 (52%);GO:0019867 (5%);GO:0016020 (3%),integral component of membrane (52%);outer membrane (5%);membrane (3%),GO:0005524 (9%);GO:0016491 (7%);GO:0019706 (5%),ATP binding (9%);oxidoreductase activity (7%);protein-cysteine S-palmitoyltransferase activity (5%),GO:0006680 (2%);GO:0055085 (2%);GO:0006000 (2%),glucosylceramide catabolic process (2%);transmembrane transport (2%);fructose metabolic process (2%),IPR002549 (21%);IPR014227 (21%);IPR032710 (12%),Transmembrane protein TqsA-like (21%);Putative transport protein YtvI-like (21%);NTF2-like domain superfamily (12%),,,,,,,,,,,
VWEVEVVTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FTLQESK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),GO:0016021 (75%),integral component of membrane (75%),GO:0000155 (50%);GO:0003677 (25%);GO:0003678 (25%),phosphorelay sensor kinase activity (50%);DNA binding (25%);DNA helicase activity (25%),,,IPR010559 (50%);IPR036890 (50%);IPR000212 (25%),Signal transduction histidine kinase, internal region (50%);Histidine kinase/HSP90-like ATPase superfamily (50%);DNA helicase, UvrD/REP type (25%),,,,,,,,,
ELNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (6%);4.2.-.- (2%);7.2.1.1 (2%),DNA-directed DNA polymerase (6%);Carbon-oxygen lyases (2%);NADH:ubiquinone reductase (Na(+)-transporting) (2%),GO:0016021 (26%);GO:0005737 (11%);GO:0005886 (4%),integral component of membrane (26%);cytoplasm (11%);plasma membrane (4%),GO:0005524 (19%);GO:0046872 (8%);GO:0003677 (7%),ATP binding (19%);metal ion binding (8%);DNA binding (7%),GO:0006260 (2%);GO:0006412 (2%);GO:0006355 (2%),DNA replication (2%);translation (2%);regulation of transcription, DNA-templated (2%),IPR027417 (11%);IPR003593 (4%);IPR003439 (3%),P-loop containing nucleoside triphosphate hydrolase (11%);AAA+ ATPase domain (4%);ABC transporter-like (3%),,,,,,,,,,
EDLHHLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAVNVEEAR,Blastopirellula marina,Bacteria,,,,Planctomycetes,,,Planctomycetia,,,,Pirellulales,,,,,Pirellulaceae,,,,Blastopirellula,,,,Blastopirellula marina,,,,,,,,,,,,,,,,,,,,,,,,
AAGTTEFGWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EESFLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.14 (33%);2.4.99.16 (33%);3.6.4.12 (33%),Amidophosphoribosyltransferase (33%);Starch synthase (maltosyl-transferring) (33%);DNA helicase (33%),GO:0016021 (11%);GO:0005737 (4%);GO:0005925 (4%),integral component of membrane (11%);cytoplasm (4%);focal adhesion (4%),GO:0031419 (50%);GO:0016866 (46%);GO:0046872 (25%),cobalamin binding (50%);intramolecular transferase activity (46%);metal ion binding (25%),GO:0031532 (7%);GO:0005975 (4%);GO:0006189 (4%),actin cytoskeleton reorganization (7%);carbohydrate metabolic process (4%);'de novo' IMP biosynthetic process (4%),IPR006099 (52%);IPR016176 (52%);IPR036724 (28%),Methylmalonyl-CoA mutase, alpha/beta chain, catalytic (52%);Cobalamin (vitamin B12)-dependent enzyme, catalytic (52%);Cobalamin-binding domain superfamily (28%),,,,,,,,
FEYVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.79 (54%);4.3.1.19 (25%);2.7.13.3 (4%),tRNA(His) guanylyltransferase (54%);Threonine ammonia-lyase (25%);Histidine kinase (4%),GO:0016021 (21%);GO:0009279 (1%);GO:0005634 (1%),integral component of membrane (21%);cell outer membrane (1%);nucleus (1%),GO:0000287 (25%);GO:0008193 (24%);GO:0005525 (19%),magnesium ion binding (25%);tRNA guanylyltransferase activity (24%);GTP binding (19%),GO:0006400 (25%);GO:0009097 (8%);GO:0009058 (6%),tRNA modification (25%);isoleucine biosynthetic process (8%);biosynthetic process (6%),IPR024956 (22%);IPR007537 (22%);IPR038469 (22%),tRNAHis guanylyltransferase catalytic domain (22%);tRNAHis guanylyltransferase Thg1 (22%);tRNAHis guanylyltransferase Thg1 superfamily (22%),,,,,,,,,,,
WAVFMAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYVSHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (60%);3.1.-.- (20%);5.6.2.2 (20%),DNA topoisomerase (60%);Acting on ester bonds (20%);DNA topoisomerase (ATP-hydrolyzing) (20%),GO:0016021 (37%);GO:0005846 (29%);GO:0005694 (8%),integral component of membrane (37%);nuclear cap binding complex (29%);chromosome (8%),GO:0000339 (29%);GO:0003677 (10%);GO:0005524 (10%),RNA cap binding (29%);DNA binding (10%);ATP binding (10%),GO:0045292 (29%);GO:0051028 (29%);GO:0009847 (23%),mRNA cis splicing, via spliceosome (29%);mRNA transport (29%);spore germination (23%),IPR015172 (24%);IPR015174 (24%);IPR016021 (24%),MIF4G-like, type 1 (24%);MIF4G-like, type 2 (24%);MIF4G-like domain superfamily (24%),,,,,,,,
MGQNPHYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YYATTSFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YADVACPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLAQAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.193 (50%);3.5.4.26 (50%);4.2.1.96 (50%),5-amino-6-(5-phosphoribosylamino)uracil reductase (50%);Diaminohydroxyphosphoribosylaminopyrimidine deaminase (50%);4a-hydroxytetrahydrobiopterin dehydratase (50%),,,GO:0003677 (78%);GO:0003700 (75%);GO:0008080 (3%),DNA binding (78%);DNA-binding transcription factor activity (75%);N-acetyltransferase activity (3%),GO:0006729 (3%);GO:0006807 (3%);GO:0009231 (3%),tetrahydrobiopterin biosynthetic process (3%);nitrogen compound metabolic process (3%);riboflavin biosynthetic process (3%),IPR000524 (76%);IPR008920 (76%);IPR011711 (76%),Transcription regulator HTH, GntR (76%);Transcription regulator FadR/GntR, C-terminal (76%);GntR, C-terminal (76%),,,,,,,,
EVADVMFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPVLLWM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEQPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.6 (45%);6.2.1.26 (7%);2.1.1.79 (4%),Acetolactate synthase (45%);o-succinylbenzoate--CoA ligase (7%);Cyclopropane-fatty-acyl-phospholipid synthase (4%),GO:0009279 (35%);GO:0046930 (31%);GO:0016021 (19%),cell outer membrane (35%);pore complex (31%);integral component of membrane (19%),GO:0046872 (32%);GO:0015288 (31%);GO:0015420 (30%),metal ion binding (32%);porin activity (31%);ATPase-coupled vitamin B12 transmembrane transporter activity (30%),GO:0006811 (31%);GO:0009097 (4%);GO:0009099 (4%),ion transport (31%);isoleucine biosynthetic process (4%);valine biosynthetic process (4%),IPR012910 (32%);IPR037066 (32%);IPR039426 (32%),TonB-dependent receptor, plug domain (32%);TonB-dependent receptor, plug domain superfamily (32%);Vitamin B12 transporter BtuB-like (32%),,,,,,,,,
NLVGDFSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLSLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (34%);3.6.1.66 (14%);5.4.99.- (12%),DNA helicase (34%);XTP/dITP diphosphatase (14%);Transferring other groups (12%),GO:0016021 (11%);GO:0005737 (9%);GO:0005886 (6%),integral component of membrane (11%);cytoplasm (9%);plasma membrane (6%),GO:0003677 (25%);GO:0005524 (24%);GO:0003678 (16%),DNA binding (25%);ATP binding (24%);DNA helicase activity (16%),GO:0006412 (6%);GO:0009117 (5%);GO:0009146 (5%),translation (6%);nucleotide metabolic process (5%);purine nucleoside triphosphate catabolic process (5%),IPR027417 (21%);IPR000212 (12%);IPR014016 (10%),P-loop containing nucleoside triphosphate hydrolase (21%);DNA helicase, UvrD/REP type (12%);UvrD-like helicase, ATP-binding domain (10%),,,,,,,,,
LLEFDPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (87%);2.7.11.24 (6%);1.1.1.133 (3%),DNA helicase (87%);Mitogen-activated protein kinase (6%);dTDP-4-dehydrorhamnose reductase (3%),GO:0016021 (10%);GO:0005765 (4%);GO:0030897 (4%),integral component of membrane (10%);lysosomal membrane (4%);HOPS complex (4%),GO:0005524 (67%);GO:0003677 (54%);GO:0043139 (54%),ATP binding (67%);DNA binding (54%);5'-3' DNA helicase activity (54%),GO:0006281 (10%);GO:0006886 (4%);GO:0007033 (4%),DNA repair (10%);intracellular protein transport (4%);vacuole organization (4%),IPR027417 (48%);IPR010994 (44%);IPR027785 (44%),P-loop containing nucleoside triphosphate hydrolase (48%);RuvA domain 2-like (44%);UvrD-like helicase C-terminal domain (44%),,,,,,,,,,,
QAEAEAEMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAVEANR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.29 (50%);4.1.1.11 (50%);4.1.1.25 (50%),Aminoacyl-tRNA hydrolase (50%);Aspartate 1-decarboxylase (50%);Tyrosine decarboxylase (50%),GO:0016021 (44%);GO:0042597 (16%);GO:0005737 (3%),integral component of membrane (44%);periplasmic space (16%);cytoplasm (3%),GO:0030976 (19%);GO:0004553 (16%);GO:0005506 (16%),thiamine pyrophosphate binding (19%);hydrolase activity, hydrolyzing O-glycosyl compounds (16%);iron ion binding (16%),GO:0022900 (16%);GO:0006412 (3%);GO:0009294 (3%),electron transport chain (16%);translation (3%);DNA mediated transformation (3%),IPR008258 (19%);IPR008939 (19%);IPR011766 (19%),Transglycosylase SLT domain 1 (19%);Lytic transglycosylase, superhelical U-shaped (19%);Thiamine pyrophosphate enzyme, C-terminal TPP-binding (19%),,,,,,,,
LEDYDNTER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGGVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (20%);1.3.1.98 (4%);3.2.1.23 (3%),Hydron translocation or charge separation linked to oxidoreductase reactions (20%);UDP-N-acetylmuramate dehydrogenase (4%);Beta-galactosidase (3%),GO:0016021 (31%);GO:0005886 (10%);GO:0005737 (4%),integral component of membrane (31%);plasma membrane (10%);cytoplasm (4%),GO:0005524 (12%);GO:0016810 (8%);GO:0051287 (6%),ATP binding (12%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (8%);NAD binding (6%),GO:0055085 (8%);GO:0006869 (3%);GO:0019068 (3%),transmembrane transport (8%);lipid transport (3%);virion assembly (3%),IPR027417 (8%);IPR032466 (8%);IPR011059 (8%),P-loop containing nucleoside triphosphate hydrolase (8%);Metal-dependent hydrolase (8%);Metal-dependent hydrolase, composite domain superfamily (8%),,,,,,,,,
WNSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.30 (27%);1.3.5.1 (9%);1.5.-.- (9%),Receptor protein serine/threonine kinase (27%);Succinate dehydrogenase (quinone) (9%);Acting on the CH-NH group of donors (9%),GO:0016021 (24%);GO:0009279 (8%);GO:0005737 (5%),integral component of membrane (24%);cell outer membrane (8%);cytoplasm (5%),GO:0005524 (45%);GO:0004363 (24%);GO:0046872 (12%),ATP binding (45%);glutathione synthase activity (24%);metal ion binding (12%),GO:0006419 (3%);GO:0005975 (2%);GO:0006468 (2%),alanyl-tRNA aminoacylation (3%);carbohydrate metabolic process (2%);protein phosphorylation (2%),IPR004218 (20%);IPR013815 (18%);IPR011761 (11%),Prokaryotic glutathione synthetase, ATP-binding (20%);ATP-grasp fold, subdomain 1 (18%);ATP-grasp fold (11%),,,,,,,,,
WFGAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.8 (9%);4.3.99.3 (9%);2.1.1.13 (7%),Mannonate dehydratase (9%);7-carboxy-7-deazaguanine synthase (9%);Methionine synthase (7%),GO:0016021 (49%);GO:0005886 (3%);GO:0005737 (2%),integral component of membrane (49%);plasma membrane (3%);cytoplasm (2%),GO:0005524 (8%);GO:0016740 (8%);GO:0046872 (4%),ATP binding (8%);transferase activity (8%);metal ion binding (4%),GO:0055085 (6%);GO:0032259 (3%);GO:0000398 (2%),transmembrane transport (6%);methylation (3%);mRNA splicing, via spliceosome (2%),IPR002718 (50%);IPR009683 (5%);IPR027417 (4%),Outer membrane protein, Helicobacter (50%);Extensin-like, C-terminal (5%);P-loop containing nucleoside triphosphate hydrolase (4%),,,,,,,,
MLAVMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0016887 (100%),ATP binding (100%);ATPase activity (100%),,,IPR003439 (100%);IPR003593 (100%);IPR027417 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,,,
DVLVM,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEQTYFMK,Shewanella,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Alteromonadales,,,,,Shewanellaceae,,,,Shewanella,,,,,,,,,,,,GO:0004553 (100%);GO:0030246 (100%),hydrolase activity, hydrolyzing O-glycosyl compounds (100%);carbohydrate binding (100%),GO:0016052 (100%),carbohydrate catabolic process (100%),IPR010502 (100%),Carbohydrate-binding domain, family 9 (100%),,,,,,,,,
QCEAVEMLAEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEFHVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0004672 (50%);GO:0005524 (50%),protein kinase activity (50%);ATP binding (50%),,,IPR000719 (50%);IPR011009 (50%);IPR011467 (50%),Protein kinase domain (50%);Protein kinase-like domain superfamily (50%);Protein of unknown function DUF1573 (50%),,,,,,,,,,,
LLECWAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TALVRPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNCLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.192 (37%);2.3.1.- (34%);1.3.1.98 (10%),23S rRNA (adenine(2503)-C(2))-methyltransferase (37%);Transferring groups other than amino-acyl groups (34%);UDP-N-acetylmuramate dehydrogenase (10%),GO:0016021 (25%);GO:0005737 (19%);GO:0016020 (6%),integral component of membrane (25%);cytoplasm (19%);membrane (6%),GO:0000049 (14%);GO:0002935 (14%);GO:0016747 (14%),tRNA binding (14%);tRNA (adenine-C2-)-methyltransferase activity (14%);transferase activity, transferring acyl groups other than amino-acyl groups (14%),GO:0006633 (14%);GO:0070475 (14%);GO:0007165 (9%),fatty acid biosynthetic process (14%);rRNA base methylation (14%);signal transduction (9%),IPR003123 (38%);IPR037191 (38%);IPR041545 (31%),VPS9 domain (38%);VPS9 domain superfamily (38%);RABX5, catalytic core helical domain (31%),,,,,,,,,
QGNDEWFNVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNVNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.17 (40%);4.2.1.9 (13%);2.7.7.6 (3%),Mannitol-1-phosphate 5-dehydrogenase (40%);Dihydroxy-acid dehydratase (13%);DNA-directed RNA polymerase (3%),GO:0016021 (34%);GO:0005634 (6%);GO:0005886 (6%),integral component of membrane (34%);nucleus (6%);plasma membrane (6%),GO:0030215 (9%);GO:0005524 (9%);GO:0050662 (7%),semaphorin receptor binding (9%);ATP binding (9%);coenzyme binding (7%),GO:0019594 (7%);GO:0016042 (5%);GO:0006865 (5%),mannitol metabolic process (7%);lipid catabolic process (5%);amino acid transport (5%),IPR027231 (8%);IPR036291 (8%);IPR015943 (7%),Semaphorin (8%);NAD(P)-binding domain superfamily (8%);WD40/YVTN repeat-like-containing domain superfamily (7%),,,,,,,,,,,
LLELFTSHR,Brenneria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Enterobacterales,,,,,Pectobacteriaceae,,,,Brenneria,,,,,,,,,,,,,,,,IPR000415 (100%);IPR016446 (100%);IPR029479 (100%),Nitroreductase-like (100%);Flavin oxidoreductase Frp family (100%);Nitroreductase (100%),,,,,,,,,,,
VNVGEGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.3 (50%);6.1.1.19 (50%),Phosphoglycerate kinase (50%);Arginine--tRNA ligase (50%),GO:0005737 (25%);GO:0016021 (13%),cytoplasm (25%);integral component of membrane (13%),GO:0003676 (38%);GO:0004518 (38%);GO:0005524 (25%),nucleic acid binding (38%);nuclease activity (38%);ATP binding (25%),GO:0006096 (13%);GO:0006420 (13%);GO:0006508 (13%),glycolytic process (13%);arginyl-tRNA aminoacylation (13%);proteolysis (13%),IPR011856 (38%);IPR014883 (38%);IPR000160 (13%),tRNA endonuclease-like domain superfamily (38%);VRR-NUC domain (38%);GGDEF domain (13%),,,,,,,,,,,
ANVNLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.15 (100%),Peroxiredoxin (100%),GO:0005623 (71%);GO:0005737 (71%);GO:0016021 (14%),cell (71%);cytoplasm (71%);integral component of membrane (14%),GO:0004601 (71%);GO:0051920 (71%);GO:0003677 (14%),peroxidase activity (71%);peroxiredoxin activity (71%);DNA binding (14%),GO:0006979 (71%);GO:0045454 (71%);GO:0006310 (14%),response to oxidative stress (71%);cell redox homeostasis (71%);DNA recombination (14%),IPR000866 (71%);IPR013766 (71%);IPR017559 (71%),Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant (71%);Thioredoxin domain (71%);Alkyl hydroperoxide reductase subunit C (71%),,,,,,,,,,,
ALWMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.16.-.- (60%);1.16.3.1 (20%);2.7.13.3 (10%),Oxidizing metal ions (60%);Ferroxidase (20%);Histidine kinase (10%),GO:0005623 (72%);GO:0016021 (3%);GO:0005886 (2%),cell (72%);integral component of membrane (3%);plasma membrane (2%),GO:0008199 (72%);GO:0016722 (66%);GO:0003677 (17%),ferric iron binding (72%);oxidoreductase activity, oxidizing metal ions (66%);DNA binding (17%),GO:0006879 (72%);GO:0009116 (7%);GO:0009252 (2%),cellular iron ion homeostasis (72%);nucleoside metabolic process (7%);peptidoglycan biosynthetic process (2%),IPR002177 (61%);IPR008331 (61%);IPR009078 (61%),DNA-binding protein Dps (61%);Ferritin/DPS protein domain (61%);Ferritin-like superfamily (61%),,,,,,,,,,
LADYQHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEYEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.28 (18%);1.4.99.5 (12%);2.5.1.19 (12%),Alpha,alpha-trehalase (18%);Glycine dehydrogenase (cyanide-forming) (12%);3-phosphoshikimate 1-carboxyvinyltransferase (12%),GO:0016021 (23%);GO:0005737 (3%);GO:0016459 (2%),integral component of membrane (23%);cytoplasm (3%);myosin complex (2%),GO:0008408 (39%);GO:0016491 (6%);GO:0046983 (6%),3'-5' exonuclease activity (39%);oxidoreductase activity (6%);protein dimerization activity (6%),GO:0006260 (39%);GO:0006310 (1%);GO:0015074 (1%),DNA replication (39%);DNA recombination (1%);DNA integration (1%),IPR003141 (34%);IPR004013 (34%);IPR004805 (34%),Polymerase/histidinol phosphatase, N-terminal (34%);PHP domain (34%);DNA polymerase III, alpha subunit (34%),,,,,,,,
GLSVQPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (33%);2.7.3.9 (33%);2.7.7.6 (33%),DNA (cytosine-5-)-methyltransferase (33%);Phosphoenolpyruvate--protein phosphotransferase (33%);DNA-directed RNA polymerase (33%),GO:0009507 (38%);GO:0005737 (13%);GO:0009536 (13%),chloroplast (38%);cytoplasm (13%);plastid (13%),GO:0003677 (50%);GO:0003899 (50%);GO:0003824 (25%),DNA binding (50%);DNA-directed 5'-3' RNA polymerase activity (50%);catalytic activity (25%),GO:0006351 (50%);GO:0009116 (25%);GO:0009401 (13%),transcription, DNA-templated (50%);nucleoside metabolic process (25%);phosphoenolpyruvate-dependent sugar phosphotransferase system (13%),IPR007081 (36%);IPR007083 (36%);IPR012756 (36%),RNA polymerase Rpb1, domain 5 (36%);RNA polymerase Rpb1, domain 4 (36%);DNA-directed RNA polymerase, subunit beta'' (36%),,,,,,,
APLNGQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDYFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (32%);3.1.-.- (12%);5.4.2.2 (11%),DNA helicase (32%);Acting on ester bonds (12%);Phosphoglucomutase (alpha-D-glucose-1,6-bisphosphate-dependent) (11%),GO:0016021 (41%);GO:0009279 (8%);GO:0005737 (4%),integral component of membrane (41%);cell outer membrane (8%);cytoplasm (4%),GO:0005524 (15%);GO:0003677 (6%);GO:0004555 (6%),ATP binding (15%);DNA binding (6%);alpha,alpha-trehalase activity (6%),GO:0005991 (6%);GO:0005975 (6%);GO:0006605 (2%),trehalose metabolic process (6%);carbohydrate metabolic process (6%);protein targeting (2%),IPR027417 (12%);IPR000477 (6%);IPR012910 (6%),P-loop containing nucleoside triphosphate hydrolase (12%);Reverse transcriptase domain (6%);TonB-dependent receptor, plug domain (6%),,,,,,,,
ELFDSMNANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVDLSER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.131 (33%);3.1.4.1 (33%);6.3.2.3 (33%),Precorrin-3B C(17)-methyltransferase (33%);Phosphodiesterase I (33%);Glutathione synthase (33%),GO:0005737 (27%);GO:0009380 (27%);GO:0016021 (14%),cytoplasm (27%);excinuclease repair complex (27%);integral component of membrane (14%),GO:0003677 (32%);GO:0009381 (27%);GO:0005524 (14%),DNA binding (32%);excinuclease ABC activity (27%);ATP binding (14%),GO:0006289 (27%);GO:0009432 (27%);GO:0007165 (11%),nucleotide-excision repair (27%);SOS response (27%);signal transduction (11%),IPR000305 (21%);IPR001162 (21%);IPR004791 (21%),GIY-YIG endonuclease (21%);UvrC family homology region (21%);UvrABC system, subunit C (21%),,,,,,,,,,
LATELEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.49 (33%);2.7.4.25 (33%);3.6.4.12 (33%),Glucose-6-phosphate dehydrogenase (NADP(+)) (33%);(d)CMP kinase (33%);DNA helicase (33%),GO:0005737 (8%);GO:0030288 (8%);GO:1990077 (8%),cytoplasm (8%);outer membrane-bounded periplasmic space (8%);primosome complex (8%),GO:0008483 (42%);GO:0030170 (25%);GO:0005524 (17%),transaminase activity (42%);pyridoxal phosphate binding (25%);ATP binding (17%),GO:0006006 (8%);GO:0006098 (8%);GO:0006220 (8%),glucose metabolic process (8%);pentose-phosphate shunt (8%);pyrimidine nucleotide metabolic process (8%),IPR005814 (36%);IPR015421 (36%);IPR015422 (36%),Aminotransferase class-III (36%);Pyridoxal phosphate-dependent transferase, major domain (36%);Pyridoxal phosphate-dependent transferase domain 1 (36%),,,,,,,,,,
LVMNMHPEANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESDSMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (33%);2.7.7.12 (33%);3.1.-.- (33%),Histidine kinase (33%);UDP-glucose--hexose-1-phosphate uridylyltransferase (33%);Acting on ester bonds (33%),GO:0016021 (35%);GO:0005737 (19%);GO:0005634 (8%),integral component of membrane (35%);cytoplasm (19%);nucleus (8%),GO:0005524 (42%);GO:0016887 (23%);GO:0003677 (12%),ATP binding (42%);ATPase activity (23%);DNA binding (12%),GO:0006364 (8%);GO:0006426 (8%);GO:0000967 (4%),rRNA processing (8%);glycyl-tRNA aminoacylation (8%);rRNA 5'-end processing (4%),IPR027417 (24%);IPR016300 (21%);IPR025723 (21%),P-loop containing nucleoside triphosphate hydrolase (24%);Arsenical pump ATPase, ArsA/GET3 (21%);Anion-transporting ATPase-like domain (21%),,,,,,,,,,
VVNDLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.9 (50%);7.1.1.2 (50%),Dihydroxy-acid dehydratase (50%);NADH:ubiquinone reductase (H(+)-translocating) (50%),GO:0016021 (83%);GO:0005743 (4%);GO:0070469 (4%),integral component of membrane (83%);mitochondrial inner membrane (4%);respirasome (4%),GO:0003824 (4%);GO:0004160 (4%);GO:0004352 (4%),catalytic activity (4%);dihydroxy-acid dehydratase activity (4%);glutamate dehydrogenase (NAD+) activity (4%),GO:0019551 (4%);GO:0042773 (4%),glutamate catabolic process to 2-oxoglutarate (4%);ATP synthesis coupled electron transport (4%),IPR029045 (68%);IPR036915 (7%);IPR042099 (7%),ClpP/crotonase-like domain superfamily (68%);Cyclin-like superfamily (7%);AMP-dependent synthetase-like superfamily (7%),,,,,,,,,,,
LDEFHGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0046872 (50%);GO:0004497 (25%);GO:0005524 (25%),metal ion binding (50%);monooxygenase activity (25%);ATP binding (25%),GO:0007131 (50%),reciprocal meiotic recombination (50%),IPR010776 (33%);IPR036388 (33%);IPR040461 (33%),Homologous-pairing protein 2, winged helix domain (33%);Winged helix-like DNA-binding domain superfamily (33%);Homologous-pairing protein 2 (33%),,,,,,,,,,
NNRPSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (67%);3.1.13.- (33%),Beta-galactosidase (67%);Exoribonucleases producing 5'-phosphomonoesters (33%),GO:0016021 (21%);GO:0009341 (14%);GO:0000932 (7%),integral component of membrane (21%);beta-galactosidase complex (14%);P-body (7%),GO:0000287 (14%);GO:0004565 (14%);GO:0016740 (14%),magnesium ion binding (14%);beta-galactosidase activity (14%);transferase activity (14%),GO:0005975 (14%);GO:0006412 (7%);GO:0034427 (7%),carbohydrate metabolic process (14%);translation (7%);nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (7%),IPR013783 (11%);IPR004199 (9%);IPR006101 (9%),Immunoglobulin-like fold (11%);Beta galactosidase small chain/ domain 5 (9%);Glycoside hydrolase, family 2 (9%),,,,,,,,
FDQLTAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADFLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.76 (11%);2.4.2.29 (8%);2.6.1.9 (8%),Diaminobutyrate--2-oxoglutarate transaminase (11%);tRNA-guanine(34) transglycosylase (8%);Histidinol-phosphate transaminase (8%),GO:0016021 (31%);GO:0005737 (3%);GO:0005886 (2%),integral component of membrane (31%);cytoplasm (3%);plasma membrane (2%),GO:0016491 (17%);GO:0008168 (8%);GO:0005524 (8%),oxidoreductase activity (17%);methyltransferase activity (8%);ATP binding (8%),GO:0016117 (16%);GO:0032259 (8%);GO:0006260 (2%),carotenoid biosynthetic process (16%);methylation (8%);DNA replication (2%),IPR002937 (13%);IPR014105 (13%);IPR036188 (13%),Amine oxidase (13%);Carotenoid/retinoid oxidoreductase (13%);FAD/NAD(P)-binding domain superfamily (13%),,,,,,,,,,,
MLAPLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (30%);3.4.21.83 (30%);2.4.1.227 (10%),Electron-transferring-flavoprotein dehydrogenase (30%);Oligopeptidase B (30%);Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (10%),GO:0016021 (19%);GO:0031305 (4%);GO:0005737 (2%),integral component of membrane (19%);integral component of mitochondrial inner membrane (4%);cytoplasm (2%),GO:0004553 (43%);GO:0004252 (13%);GO:0070008 (13%),hydrolase activity, hydrolyzing O-glycosyl compounds (43%);serine-type endopeptidase activity (13%);serine-type exopeptidase activity (13%),GO:0005975 (47%);GO:0006013 (4%);GO:0006979 (4%),carbohydrate metabolic process (47%);mannose metabolic process (4%);response to oxidative stress (4%),IPR001764 (44%);IPR002772 (44%);IPR013783 (44%),Glycoside hydrolase, family 3, N-terminal (44%);Glycoside hydrolase family 3 C-terminal domain (44%);Immunoglobulin-like fold (44%),,,,,,,,
ENELNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016459 (40%),myosin complex (40%),GO:0003774 (40%);GO:0005524 (40%),motor activity (40%);ATP binding (40%),GO:0007040 (20%),lysosome organization (20%),IPR003593 (29%);IPR003959 (29%);IPR010926 (29%),AAA+ ATPase domain (29%);ATPase, AAA-type, core (29%);Class I myosin tail homology domain (29%),,,,,,,,,
QLLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (12%);6.1.1.20 (6%);3.1.-.- (4%),DNA helicase (12%);Phenylalanine--tRNA ligase (6%);Acting on ester bonds (4%),GO:0016021 (28%);GO:0005737 (7%);GO:0005886 (5%),integral component of membrane (28%);cytoplasm (7%);plasma membrane (5%),GO:0005524 (18%);GO:0003677 (12%);GO:0046872 (6%),ATP binding (18%);DNA binding (12%);metal ion binding (6%),GO:0006777 (3%);GO:0006355 (3%);GO:0007018 (2%),Mo-molybdopterin cofactor biosynthetic process (3%);regulation of transcription, DNA-templated (3%);microtubule-based movement (2%),IPR027417 (13%);IPR036388 (5%);IPR003593 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);Winged helix-like DNA-binding domain superfamily (5%);AAA+ ATPase domain (4%),,,,,,,,,,
SNGDLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (78%);GO:0030054 (48%);GO:0045211 (48%),integral component of membrane (78%);cell junction (48%);postsynaptic membrane (48%),GO:0004970 (48%);GO:0047710 (9%);GO:0003676 (4%),ionotropic glutamate receptor activity (48%);bis(5'-adenosyl)-triphosphatase activity (9%);nucleic acid binding (4%),GO:0030194 (9%);GO:0006260 (4%);GO:0006355 (4%),positive regulation of blood coagulation (9%);DNA replication (4%);regulation of transcription, DNA-templated (4%),IPR001320 (43%);IPR001508 (43%);IPR019594 (43%),Ionotropic glutamate receptor (43%);Ionotropic glutamate receptor, metazoa (43%);Ionotropic glutamate receptor, L-glutamate and glycine-binding domain (43%),,,,,,,,
WNLQMPK,Streptophytina,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0009734 (100%);GO:0055085 (100%),auxin-activated signaling pathway (100%);transmembrane transport (100%),IPR004776 (100%);IPR014024 (100%),Membrane transport protein (100%);Auxin efflux carrier, plant type (100%),,,,,,,,,,
LLGDFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (30%);3.1.21.7 (6%);2.8.1.8 (5%),3-isopropylmalate dehydratase (30%);Deoxyribonuclease V (6%);Lipoyl synthase (5%),GO:0016021 (15%);GO:0005737 (5%);GO:0005623 (4%),integral component of membrane (15%);cytoplasm (5%);cell (4%),GO:0005524 (20%);GO:0043565 (11%);GO:0003677 (11%),ATP binding (20%);sequence-specific DNA binding (11%);DNA binding (11%),GO:0006351 (12%);GO:0009098 (5%);GO:0045454 (3%),transcription, DNA-templated (12%);leucine biosynthetic process (5%);cell redox homeostasis (3%),IPR027417 (14%);IPR025422 (8%);IPR003593 (7%),P-loop containing nucleoside triphosphate hydrolase (14%);Transcription factor TGA like domain (8%);AAA+ ATPase domain (7%),,,,,,,,,,
TECSYAMGYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNNTLVTLSER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDSGVGSVSNCVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNLGQDEEEAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDVLNDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (100%),Serine endopeptidases (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0002161 (25%);GO:0004252 (25%);GO:0004832 (25%),aminoacyl-tRNA editing activity (25%);serine-type endopeptidase activity (25%);valine-tRNA ligase activity (25%),GO:0006438 (25%);GO:0006777 (25%),valyl-tRNA aminoacylation (25%);Mo-molybdopterin cofactor biosynthetic process (25%),IPR006499 (64%);IPR000209 (9%);IPR001412 (9%),Reticulocyte binding protein (64%);Peptidase S8/S53 domain (9%);Aminoacyl-tRNA synthetase, class I, conserved site (9%),,,,,,,,,
NPQPELK,Lactobacillus ceti,Bacteria,,,,Firmicutes,,,Bacilli,,,,Lactobacillales,,,,,Lactobacillaceae,,,,Lactobacillus,,,,Lactobacillus ceti,,,,,,,,GO:0003677 (100%);GO:0003700 (100%);GO:0003824 (100%),DNA binding (100%);DNA-binding transcription factor activity (100%);catalytic activity (100%),GO:0009058 (100%),biosynthetic process (100%),IPR000524 (100%);IPR004839 (100%);IPR015421 (100%),Transcription regulator HTH, GntR (100%);Aminotransferase, class I/classII (100%);Pyridoxal phosphate-dependent transferase, major domain (100%),,,,,,,,
NGATAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.61 (100%);3.5.1.44 (100%),Protein-glutamate methylesterase (100%);Protein-glutamine glutaminase (100%),GO:0005737 (20%),cytoplasm (20%),GO:0046872 (40%);GO:0000156 (20%);GO:0004252 (20%),metal ion binding (40%);phosphorelay response regulator activity (20%);serine-type endopeptidase activity (20%),GO:0006482 (20%);GO:0006935 (20%);GO:0009116 (20%),protein demethylation (20%);chemotaxis (20%);nucleoside metabolic process (20%),IPR007922 (29%);IPR000032 (14%);IPR001789 (14%),Protein of unknown function DUF721/UPF0232 (29%);Phosphocarrier protein HPr-like (14%);Signal transduction response regulator, receiver domain (14%),,,,,,,,,,
QGNQGTLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.6 (12%);2.2.1.2 (6%);3.6.4.12 (5%),Methionine adenosyltransferase (12%);Transaldolase (6%);DNA helicase (5%),GO:0016021 (21%);GO:0005737 (15%);GO:0005634 (3%),integral component of membrane (21%);cytoplasm (15%);nucleus (3%),GO:0005524 (26%);GO:0046872 (8%);GO:0003677 (7%),ATP binding (26%);metal ion binding (8%);DNA binding (7%),GO:0005975 (4%);GO:0055085 (3%);GO:0006556 (3%),carbohydrate metabolic process (4%);transmembrane transport (3%);S-adenosylmethionine biosynthetic process (3%),IPR027417 (12%);IPR003593 (6%);IPR016024 (5%),P-loop containing nucleoside triphosphate hydrolase (12%);AAA+ ATPase domain (6%);Armadillo-type fold (5%),,,,,,,,,,,
HMFAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR007051 (100%);IPR007052 (100%);IPR008978 (100%),CHORD domain (100%);CS domain (100%);HSP20-like chaperone (100%),,,,,,,,,,,
TEDGDLHDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNPCVTTFHMTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGLLLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.186 (22%);2.3.2.27 (22%);2.1.1.14 (11%),23S rRNA (cytidine(2498)-2'-O)-methyltransferase (22%);RING-type E3 ubiquitin transferase (22%);5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (11%),GO:0016021 (27%);GO:0000502 (23%);GO:0005634 (4%),integral component of membrane (27%);proteasome complex (23%);nucleus (4%),GO:0005524 (26%);GO:0016887 (26%);GO:0008658 (10%),ATP binding (26%);ATPase activity (26%);penicillin binding (10%),GO:0010498 (23%);GO:0019941 (23%);GO:0000045 (4%),proteasomal protein catabolic process (23%);modification-dependent protein catabolic process (23%);autophagosome assembly (4%),IPR027417 (23%);IPR003593 (16%);IPR032501 (16%),P-loop containing nucleoside triphosphate hydrolase (23%);AAA+ ATPase domain (16%);Proteasomal ATPase OB C-terminal domain (16%),,,,,,,,,,,
FLLFMMMMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLLGAGVK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (50%);GO:0016021 (50%),cell outer membrane (50%);integral component of membrane (50%),GO:0003677 (50%);GO:0003700 (50%),DNA binding (50%);DNA-binding transcription factor activity (50%),,,IPR000847 (50%);IPR005119 (50%);IPR006664 (50%),Transcription regulator HTH, LysR (50%);LysR, substrate-binding (50%);Outer membrane protein, bacterial (50%),,,,,,,,
VVNSSLDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPSLLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (45%);2.3.3.9 (18%);2.7.2.4 (9%),Carboxylic ester hydrolases (45%);Malate synthase (18%);Aspartate kinase (9%),GO:0005737 (18%);GO:0016021 (18%);GO:0005615 (14%),cytoplasm (18%);integral component of membrane (18%);extracellular space (14%),GO:0004620 (23%);GO:0046872 (14%);GO:0004474 (9%),phospholipase activity (23%);metal ion binding (14%);malate synthase activity (9%),GO:0016042 (23%);GO:0008152 (14%);GO:0006081 (9%),lipid catabolic process (23%);metabolic process (14%);cellular aldehyde metabolic process (9%),IPR007000 (16%);IPR017853 (16%);IPR032320 (16%),Phospholipase B-like (16%);Glycoside hydrolase superfamily (16%);Protein of unknown function DUF4849, putative glycoside hydrolase family 18 (16%),,,,,,,,,,
FVDLPDQAPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLDEDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.21 (28%);2.3.2.27 (18%);6.1.1.23 (10%),D-amino-acid transaminase (28%);RING-type E3 ubiquitin transferase (18%);Aspartate--tRNA(Asn) ligase (10%),GO:0016021 (12%);GO:0005737 (11%);GO:0005634 (5%),integral component of membrane (12%);cytoplasm (11%);nucleus (5%),GO:0008168 (10%);GO:0005524 (9%);GO:0016787 (7%),methyltransferase activity (10%);ATP binding (9%);hydrolase activity (7%),GO:0016226 (14%);GO:0008610 (13%);GO:0032259 (10%),iron-sulfur cluster assembly (14%);lipid biosynthetic process (13%);methylation (10%),IPR000825 (13%);IPR011542 (13%);IPR037284 (13%),SUF system FeS cluster assembly, SufBD (13%);SUF system FeS cluster assembly, SufD (13%);SUF system FeS cluster assembly, SufBD superfamily (13%),,,,,,,,
VFGPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.67 (33%);3.4.21.53 (33%);6.1.1.14 (33%),1-phosphatidylinositol 4-kinase (33%);Endopeptidase La (33%);Glycine--tRNA ligase (33%),GO:0005737 (13%);GO:0016021 (8%);GO:0000151 (4%),cytoplasm (13%);integral component of membrane (8%);ubiquitin ligase complex (4%),GO:0005524 (29%);GO:0052861 (29%);GO:0003676 (13%),ATP binding (29%);glucan endo-1,3-beta-glucanase activity, C-3 substituted reducing group (29%);nucleic acid binding (13%),GO:0048015 (8%);GO:0000209 (4%);GO:0000398 (4%),phosphatidylinositol-mediated signaling (8%);protein polyubiquitination (4%);mRNA splicing, via spliceosome (4%),IPR005200 (22%);IPR019622 (22%);IPR040451 (22%),Endo-1,3(4)-beta-glucanase (22%);Rrn9 domain (22%);Glycosyl hydrolase family 81, N-terminal (22%),,,,,,
MLLSGWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (33%);2.4.1.266 (33%);2.7.1.30 (33%),Hexosyltransferases (33%);Glucosyl-3-phosphoglycerate synthase (33%);Glycerol kinase (33%),GO:0016021 (5%),integral component of membrane (5%),GO:0016740 (63%);GO:0016757 (16%);GO:0003824 (5%),transferase activity (63%);transferase activity, transferring glycosyl groups (16%);catalytic activity (5%),GO:0006072 (5%);GO:0019563 (5%),glycerol-3-phosphate metabolic process (5%);glycerol catabolic process (5%),IPR029044 (67%);IPR001173 (50%);IPR028992 (8%),Nucleotide-diphospho-sugar transferases (67%);Glycosyltransferase 2-like (50%);Hedgehog/Intein (Hint) domain (8%),,,,,,,,,,
NGSEFENEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSALPEFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.47 (100%),Cysteine synthase (100%),,,GO:0003677 (25%);GO:0003917 (25%);GO:0004124 (25%),DNA binding (25%);DNA topoisomerase type I (single strand cut, ATP-independent) activity (25%);cysteine synthase activity (25%),GO:0007165 (50%);GO:0006265 (25%);GO:0006535 (25%),signal transduction (50%);DNA topological change (25%);cysteine biosynthetic process from serine (25%),IPR000157 (50%);IPR035897 (50%);IPR000380 (25%),Toll/interleukin-1 receptor homology (TIR) domain (50%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (50%);DNA topoisomerase, type IA (25%),,,,,,,,,
QVFNGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVNNAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.4.2 (33%);2.1.1.72 (33%);2.4.99.17 (33%),Glycine dehydrogenase (aminomethyl-transferring) (33%);Site-specific DNA-methyltransferase (adenine-specific) (33%);S-adenosylmethionine:tRNA ribosyltransferase-isomerase (33%),GO:0016021 (16%);GO:0016586 (16%);GO:0000784 (1%),integral component of membrane (16%);RSC-type complex (16%);nuclear chromosome, telomeric region (1%),GO:0004867 (43%);GO:0032977 (6%);GO:0003677 (4%),serine-type endopeptidase inhibitor activity (43%);membrane insertase activity (6%);DNA binding (4%),GO:0030212 (43%);GO:0006338 (16%);GO:0006281 (4%),hyaluronan metabolic process (43%);chromatin remodeling (16%);DNA repair (4%),IPR002035 (39%);IPR013694 (39%);IPR036465 (39%),von Willebrand factor, type A (39%);VIT domain (39%);von Willebrand factor A-like domain superfamily (39%),,,,,,,,,
TQLNSMRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLHLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (79%);2.7.10.1 (4%);3.5.1.18 (4%),Glycine--tRNA ligase (79%);Receptor protein-tyrosine kinase (4%);Succinyl-diaminopimelate desuccinylase (4%),GO:0016021 (21%);GO:0005737 (12%);GO:0005576 (6%),integral component of membrane (21%);cytoplasm (12%);extracellular region (6%),GO:0005524 (37%);GO:0004820 (10%);GO:0016887 (10%),ATP binding (37%);glycine-tRNA ligase activity (10%);ATPase activity (10%),GO:0006426 (10%);GO:0006030 (6%);GO:0048010 (4%),glycyl-tRNA aminoacylation (10%);chitin metabolic process (6%);vascular endothelial growth factor receptor signaling pathway (4%),IPR027417 (17%);IPR026136 (13%);IPR031780 (13%),P-loop containing nucleoside triphosphate hydrolase (17%);RIPOR family member 3 (13%);FAM65, N-terminal (13%),,,,,,,,,,
EWVELVSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFLDAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.4 (31%);3.6.4.12 (8%);5.1.1.1 (8%),Adenylosuccinate synthase (31%);DNA helicase (8%);Alanine racemase (8%),GO:0016021 (31%);GO:0005737 (10%);GO:0005886 (5%),integral component of membrane (31%);cytoplasm (10%);plasma membrane (5%),GO:0005524 (9%);GO:0000287 (8%);GO:0004019 (7%),ATP binding (9%);magnesium ion binding (8%);adenylosuccinate synthase activity (7%),GO:0044208 (7%);GO:0006352 (2%);GO:0006355 (2%),'de novo' AMP biosynthetic process (7%);DNA-templated transcription, initiation (2%);regulation of transcription, DNA-templated (2%),IPR027417 (14%);IPR001114 (6%);IPR042109 (6%),P-loop containing nucleoside triphosphate hydrolase (14%);Adenylosuccinate synthetase (6%);Adenylosuccinate synthetase, domain 1 (6%),,,,,,,,
LALLWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.-.-.- (19%);2.7.7.48 (18%);1.1.1.44 (14%),Transferases (19%);RNA-directed RNA polymerase (18%);Phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (14%),GO:0016021 (52%);GO:0005886 (6%);GO:0005634 (3%),integral component of membrane (52%);plasma membrane (6%);nucleus (3%),GO:0005524 (21%);GO:0042626 (13%);GO:0003677 (9%),ATP binding (21%);ATPase-coupled transmembrane transporter activity (13%);DNA binding (9%),GO:0055085 (4%);GO:0008610 (4%);GO:0000027 (3%),transmembrane transport (4%);lipid biosynthetic process (4%);ribosomal large subunit assembly (3%),IPR027417 (17%);IPR011527 (13%);IPR036640 (13%),P-loop containing nucleoside triphosphate hydrolase (17%);ABC transporter type 1, transmembrane domain (13%);ABC transporter type 1, transmembrane domain superfamily (13%),,,,,,,,
CMLSVYWLAAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVWNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (100%),Glycogen phosphorylase (100%),GO:0016021 (67%);GO:0005623 (8%),integral component of membrane (67%);cell (8%),GO:0004177 (8%);GO:0005524 (8%);GO:0008237 (8%),aminopeptidase activity (8%);ATP binding (8%);metallopeptidase activity (8%),GO:0055085 (38%);GO:0005975 (8%);GO:0045454 (8%),transmembrane transport (38%);carbohydrate metabolic process (8%);cell redox homeostasis (8%),IPR004776 (35%);IPR010994 (12%);IPR032812 (12%),Membrane transport protein (35%);RuvA domain 2-like (12%);SbsA, Ig-like domain (12%),,,,,,,,,,
LEVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.3.12 (29%);2.7.7.7 (14%);2.4.2.7 (6%),Agmatine deiminase (29%);DNA-directed DNA polymerase (14%);Adenine phosphoribosyltransferase (6%),GO:0016021 (15%);GO:0005737 (14%);GO:0005694 (4%),integral component of membrane (15%);cytoplasm (14%);chromosome (4%),GO:0036459 (21%);GO:0003677 (13%);GO:0005524 (10%),thiol-dependent ubiquitinyl hydrolase activity (21%);DNA binding (13%);ATP binding (10%),GO:0006511 (25%);GO:0016579 (23%);GO:0006260 (5%),ubiquitin-dependent protein catabolic process (25%);protein deubiquitination (23%);DNA replication (5%),IPR038765 (23%);IPR018200 (22%);IPR028889 (22%),Papain-like cysteine peptidase superfamily (23%);Ubiquitin specific protease, conserved site (22%);Ubiquitin specific protease domain (22%),,,,,,,,,,
QVPVEPVR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003824 (50%);GO:0046872 (50%);GO:0051536 (50%),catalytic activity (50%);metal ion binding (50%);iron-sulfur cluster binding (50%),,,IPR007197 (100%);IPR013785 (100%);IPR016431 (100%),Radical SAM (100%);Aldolase-type TIM barrel (100%);Pyruvate-formate lyase-activating enzyme, predicted (100%),,,,,,,,,,
VEVEATEYPYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FTELSMDGQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFETMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.198 (100%),16S rRNA (cytidine(1402)-2'-O)-methyltransferase (100%),GO:0016021 (13%);GO:0005737 (1%),integral component of membrane (13%);cytoplasm (1%),GO:0003677 (50%);GO:0005524 (22%);GO:0051082 (17%),DNA binding (50%);ATP binding (22%);unfolded protein binding (17%),GO:0006310 (50%);GO:0015074 (49%);GO:0006457 (17%),DNA recombination (50%);DNA integration (49%);protein folding (17%),IPR002104 (46%);IPR010998 (46%);IPR011010 (46%),Integrase, catalytic domain (46%);Integrase/recombinase, N-terminal (46%);DNA breaking-rejoining enzyme, catalytic core (46%),,,,,,,,
LAPTVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (40%),integral component of membrane (40%),GO:0004497 (60%);GO:0005506 (60%);GO:0016705 (60%),monooxygenase activity (60%);iron ion binding (60%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (60%),GO:0006351 (20%);GO:0006355 (20%),transcription, DNA-templated (20%);regulation of transcription, DNA-templated (20%),IPR001128 (60%);IPR002403 (60%);IPR036396 (60%),Cytochrome P450 (60%);Cytochrome P450, E-class, group IV (60%);Cytochrome P450 superfamily (60%),,,,,
MGEFYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (100%),Molybdopterin molybdotransferase (100%),GO:0016021 (43%);GO:0005886 (7%),integral component of membrane (43%);plasma membrane (7%),GO:0003677 (43%);GO:0046872 (21%);GO:0020037 (14%),DNA binding (43%);metal ion binding (21%);heme binding (14%),GO:0006777 (14%);GO:0032324 (14%);GO:0006935 (7%),Mo-molybdopterin cofactor biosynthetic process (14%);molybdopterin cofactor biosynthetic process (14%);chemotaxis (7%),IPR001387 (33%);IPR010982 (33%);IPR001453 (11%),Cro/C1-type helix-turn-helix domain (33%);Lambda repressor-like, DNA-binding domain superfamily (33%);MoaB/Mog domain (11%),,,,,,,,,,
AELELMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.18 (75%);3.4.11.9 (13%);3.4.21.53 (4%),Methionyl aminopeptidase (75%);Xaa-Pro aminopeptidase (13%);Endopeptidase La (4%),GO:0016021 (71%);GO:0005737 (2%);GO:0005623 (1%),integral component of membrane (71%);cytoplasm (2%);cell (1%),GO:0046872 (10%);GO:0070006 (10%);GO:0004177 (6%),metal ion binding (10%);metalloaminopeptidase activity (10%);aminopeptidase activity (6%),GO:0070084 (10%);GO:0006878 (1%);GO:0009072 (1%),protein initiator methionine removal (10%);cellular copper ion homeostasis (1%);aromatic amino acid family metabolic process (1%),IPR010406 (63%);IPR000994 (15%);IPR036005 (15%),Protein of unknown function DUF1003 (63%);Peptidase M24 (15%);Creatinase/aminopeptidase-like (15%),,,,,,,,,,,
LFAER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.40 (27%);6.1.1.18 (6%);4.2.1.2 (5%),Guanosine-5'-triphosphate,3'-diphosphate diphosphatase (27%);Glutamine--tRNA ligase (6%);Fumarate hydratase (5%),GO:0016021 (11%);GO:0005737 (5%);GO:0005886 (1%),integral component of membrane (11%);cytoplasm (5%);plasma membrane (1%),GO:0003677 (27%);GO:0005524 (19%);GO:0046872 (8%),DNA binding (27%);ATP binding (19%);metal ion binding (8%),GO:0015974 (5%);GO:0015970 (5%);GO:0006541 (3%),guanosine pentaphosphate catabolic process (5%);guanosine tetraphosphate biosynthetic process (5%);glutamine metabolic process (3%),IPR009057 (19%);IPR001647 (18%);IPR036271 (12%),Homeobox-like domain superfamily (19%);DNA-binding HTH domain, TetR-type (18%);Tetracyclin repressor-like, C-terminal domain superfamily (12%),,,,,,,,
DSLWLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.9 (38%);3.2.1.8 (38%);2.7.7.7 (13%),Riboflavin synthase (38%);Endo-1,4-beta-xylanase (38%);DNA-directed DNA polymerase (13%),GO:0016021 (42%);GO:0016020 (12%);GO:0005634 (8%),integral component of membrane (42%);membrane (12%);nucleus (8%),GO:0008933 (12%);GO:0003677 (5%);GO:0004635 (5%),lytic transglycosylase activity (12%);DNA binding (5%);phosphoribosyl-AMP cyclohydrolase activity (5%),GO:0000270 (12%);GO:0000105 (5%);GO:0008360 (3%),peptidoglycan metabolic process (12%);histidine biosynthetic process (5%);regulation of cell shape (3%),IPR000189 (12%);IPR008258 (12%);IPR018392 (12%),Prokaryotic transglycosylase, active site (12%);Transglycosylase SLT domain 1 (12%);LysM domain (12%),,,,,,,,,
TSNLLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.10 (100%),Methionine--tRNA ligase (100%),GO:0016021 (40%);GO:0043231 (40%);GO:0005737 (20%),integral component of membrane (40%);intracellular membrane-bounded organelle (40%);cytoplasm (20%),GO:0008194 (40%);GO:0016758 (40%);GO:0004825 (20%),UDP-glycosyltransferase activity (40%);transferase activity, transferring hexosyl groups (40%);methionine-tRNA ligase activity (20%),GO:0006431 (20%);GO:0031167 (20%),methionyl-tRNA aminoacylation (20%);rRNA methylation (20%),IPR002213 (33%);IPR001412 (17%);IPR002110 (17%),UDP-glucuronosyl/UDP-glucosyltransferase (33%);Aminoacyl-tRNA synthetase, class I, conserved site (17%);Ankyrin repeat (17%),,,,,,,,
LLTFPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005763 (50%),mitochondrial small ribosomal subunit (50%),GO:0003735 (50%);GO:0008233 (50%),structural constituent of ribosome (50%);peptidase activity (50%),GO:0007229 (50%),integrin-mediated signaling pathway (50%),IPR000884 (33%);IPR010909 (33%);IPR013219 (33%),Thrombospondin type-1 (TSP1) repeat (33%);PLAC (33%);Ribosomal protein S27/S33, mitochondrial (33%),,,,,,,,,,
TCLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.- (17%);2.1.1.- (13%);2.3.2.27 (13%),Transferring alkyl or aryl groups, other than methyl groups (17%);Methyltransferases (13%);RING-type E3 ubiquitin transferase (13%),GO:0016021 (11%);GO:0032040 (5%);GO:0034388 (4%),integral component of membrane (11%);small-subunit processome (5%);Pwp2p-containing subcomplex of 90S preribosome (4%),GO:0046872 (39%);GO:0003729 (27%);GO:0004842 (27%),metal ion binding (39%);mRNA binding (27%);ubiquitin-protein transferase activity (27%),GO:0010608 (27%);GO:0045493 (6%);GO:0006629 (2%),posttranscriptional regulation of gene expression (27%);xylan catabolic process (6%);lipid metabolic process (2%),IPR013083 (27%);IPR001841 (26%);IPR017907 (26%),Zinc finger, RING/FYVE/PHD-type (27%);Zinc finger, RING-type (26%);Zinc finger, RING-type, conserved site (26%),,,,,,
NFVVPSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.23 (100%),Aspartate--tRNA(Asn) ligase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0003676 (100%);GO:0004815 (100%);GO:0005524 (100%),nucleic acid binding (100%);aspartate-tRNA ligase activity (100%);ATP binding (100%),GO:0006422 (100%),aspartyl-tRNA aminoacylation (100%),IPR002312 (100%);IPR004115 (100%);IPR004364 (100%),Aspartyl/Asparaginyl-tRNA synthetase, class IIb (100%);GAD-like domain superfamily (100%);Aminoacyl-tRNA synthetase, class II (D/K/N) (100%),,,,,,,,,
DFATSER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.70 (100%),Pseudouridylate synthase (100%),,,GO:0046872 (44%);GO:0004386 (33%);GO:0004730 (22%),metal ion binding (44%);helicase activity (33%);pseudouridylate synthase activity (22%),GO:0046113 (22%),nucleobase catabolic process (22%),IPR006935 (33%);IPR014001 (33%);IPR027417 (33%),Helicase/UvrB, N-terminal (33%);Helicase superfamily 1/2, ATP-binding domain (33%);P-loop containing nucleoside triphosphate hydrolase (33%),,,,,,,,,
FQYLDAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVSVDNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003677 (50%);GO:0005524 (50%);GO:0036459 (50%),DNA binding (50%);ATP binding (50%);thiol-dependent ubiquitinyl hydrolase activity (50%),GO:0006511 (50%);GO:0016579 (50%),ubiquitin-dependent protein catabolic process (50%);protein deubiquitination (50%),IPR001394 (33%);IPR002543 (33%);IPR018200 (33%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (33%);FtsK domain (33%);Ubiquitin specific protease, conserved site (33%),,,,,,,,,
LEMPELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.-.- (40%);2.7.4.1 (20%);2.7.7.6 (20%),Acting on acid anhydrides (40%);Polyphosphate kinase (20%);DNA-directed RNA polymerase (20%),GO:0005737 (38%);GO:0016021 (25%);GO:0005665 (13%),cytoplasm (38%);integral component of membrane (25%);RNA polymerase II, core complex (13%),GO:0005524 (38%);GO:0003924 (25%);GO:0005525 (25%),ATP binding (38%);GTPase activity (25%);GTP binding (25%),GO:0006400 (25%);GO:0006366 (13%);GO:0006515 (13%),tRNA modification (25%);transcription by RNA polymerase II (13%);protein quality control for misfolded or incompletely synthesized proteins (13%),IPR027417 (38%);IPR004520 (25%);IPR005225 (25%),P-loop containing nucleoside triphosphate hydrolase (38%);tRNA modification GTPase MnmE (25%);Small GTP-binding protein domain (25%),,,,,,,,,,
TTMMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.42 (20%);3.6.3.28 (18%);3.6.3.- (17%),Isocitrate dehydrogenase (NADP(+)) (20%);Transferred entry: 7.3.2.2 (18%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (17%),GO:0016021 (8%);GO:0005634 (1%);GO:0005737 (1%),integral component of membrane (8%);nucleus (1%);cytoplasm (1%),GO:0005524 (74%);GO:0016887 (47%);GO:0009055 (5%),ATP binding (74%);ATPase activity (47%);electron transfer activity (5%),GO:0006355 (3%);GO:0000160 (2%);GO:0006099 (2%),regulation of transcription, DNA-templated (3%);phosphorelay signal transduction system (2%);tricarboxylic acid cycle (2%),IPR027417 (79%);IPR005053 (38%);IPR014136 (38%),P-loop containing nucleoside triphosphate hydrolase (79%);MobA/MobL protein (38%);Ti-type conjugative transfer relaxase TraA (38%),,,,,,,,,,
NSVYVFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLLQNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.4 (100%),Malate dehydrogenase (quinone) (100%),GO:0016021 (92%);GO:0005886 (84%);GO:0005737 (2%),integral component of membrane (92%);plasma membrane (84%);cytoplasm (2%),GO:0005524 (3%);GO:0048037 (3%);GO:0003677 (2%),ATP binding (3%);cofactor binding (3%);DNA binding (2%),GO:0006865 (81%);GO:0007165 (3%);GO:0006099 (2%),amino acid transport (81%);signal transduction (3%);tricarboxylic acid cycle (2%),IPR001123 (70%);IPR009081 (9%);IPR036736 (9%),Amino acid exporter protein, LeuE-type (70%);Phosphopantetheine binding ACP domain (9%);ACP-like superfamily (9%),,,,,,,,,,
LPAYYQHCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGLLDEASK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEAAEDAPK,Brevundimonas,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Caulobacterales,,,,,Caulobacteraceae,,,,Brevundimonas,,,,,,,,,,GO:0005840 (100%),ribosome (100%),GO:0019843 (100%),rRNA binding (100%),GO:0006412 (100%),translation (100%),IPR001787 (100%);IPR028909 (100%);IPR036164 (100%),Ribosomal protein L21 (100%);Ribosomal protein L21-like (100%);L21-like superfamily (100%),,,,,,,,,,,
LLTMDDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.5 (100%),Succinate--CoA ligase (ADP-forming) (100%),GO:0005615 (14%);GO:0016021 (14%),extracellular space (14%);integral component of membrane (14%),GO:0000287 (29%);GO:0004775 (29%);GO:0005524 (29%),magnesium ion binding (29%);succinate-CoA ligase (ADP-forming) activity (29%);ATP binding (29%),GO:0006099 (29%),tricarboxylic acid cycle (29%),IPR005809 (20%);IPR005811 (20%);IPR011059 (20%),Succinate--CoA synthetase, beta subunit (20%);ATP-citrate lyase/succinyl-CoA ligase (20%);Metal-dependent hydrolase, composite domain superfamily (20%),,,,,,,,,
EVTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.19 (13%);5.2.1.8 (11%);2.3.1.- (10%),Arginine decarboxylase (13%);Peptidylprolyl isomerase (11%);Transferring groups other than amino-acyl groups (10%),GO:0016021 (22%);GO:0005737 (9%);GO:0005856 (4%),integral component of membrane (22%);cytoplasm (9%);cytoskeleton (4%),GO:0005524 (17%);GO:0046872 (8%);GO:0003677 (8%),ATP binding (17%);metal ion binding (8%);DNA binding (8%),GO:0018095 (4%);GO:0019878 (3%);GO:0008295 (3%),protein polyglutamylation (4%);lysine biosynthetic process via aminoadipic acid (3%);spermidine biosynthetic process (3%),IPR027417 (8%);IPR015943 (7%);IPR001680 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);WD40/YVTN repeat-like-containing domain superfamily (7%);WD40 repeat (7%),,,,,,,,,,,
FAGQEM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLTLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.52 (39%);4.2.1.134 (15%);2.7.13.3 (6%),Beta-N-acetylhexosaminidase (39%);Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (15%);Histidine kinase (6%),GO:0016021 (35%);GO:0005886 (7%);GO:0005737 (5%),integral component of membrane (35%);plasma membrane (7%);cytoplasm (5%),GO:0003677 (26%);GO:0005524 (8%);GO:0016787 (6%),DNA binding (26%);ATP binding (8%);hydrolase activity (6%),GO:0006974 (19%);GO:0046856 (6%);GO:0006865 (5%),cellular response to DNA damage stimulus (19%);phosphatidylinositol dephosphorylation (6%);amino acid transport (5%),IPR001680 (20%);IPR036322 (20%);IPR019775 (19%),WD40 repeat (20%);WD40-repeat-containing domain superfamily (20%);WD40 repeat, conserved site (19%),,,,,,,,,,
ANNAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.286 (40%);6.1.1.5 (40%);1.11.1.6 (20%),Protein acetyllysine N-acetyltransferase (40%);Isoleucine--tRNA ligase (40%);Catalase (20%),GO:0016021 (60%);GO:0005737 (16%);GO:0000407 (4%),integral component of membrane (60%);cytoplasm (16%);phagophore assembly site (4%),GO:0008270 (24%);GO:0005524 (12%);GO:0000049 (8%),zinc ion binding (24%);ATP binding (12%);tRNA binding (8%),GO:0006428 (8%);GO:0006979 (8%);GO:0042744 (8%),isoleucyl-tRNA aminoacylation (8%);response to oxidative stress (8%);hydrogen peroxide catabolic process (8%),IPR013525 (35%);IPR001680 (13%);IPR015943 (13%),ABC-2 type transporter (35%);WD40 repeat (13%);WD40/YVTN repeat-like-containing domain superfamily (13%),,,,,,,,,,,
AAQWNPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSVSVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (18%);2.7.7.6 (10%);3.2.1.21 (10%),Histidine kinase (18%);DNA-directed RNA polymerase (10%);Beta-glucosidase (10%),GO:0016021 (33%);GO:0005634 (7%);GO:0005737 (3%),integral component of membrane (33%);nucleus (7%);cytoplasm (3%),GO:0003677 (14%);GO:0005524 (10%);GO:0008289 (9%),DNA binding (14%);ATP binding (10%);lipid binding (9%),GO:0006869 (9%);GO:0061817 (9%);GO:0005975 (7%),lipid transport (9%);endoplasmic reticulum-plasma membrane tethering (9%);carbohydrate metabolic process (7%),IPR000008 (9%);IPR035892 (9%);IPR037733 (8%),C2 domain (9%);C2 domain superfamily (9%);Extended synaptotagmin, C2A domain (8%),,,,,,,,,,
LLTWSQATDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNNPGNEVEDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADSFELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (33%);GO:0016021 (33%);GO:0031514 (33%),plasma membrane (33%);integral component of membrane (33%);motile cilium (33%),GO:0004014 (33%);GO:0005524 (33%);GO:0016887 (33%),adenosylmethionine decarboxylase activity (33%);ATP binding (33%);ATPase activity (33%),GO:0008295 (33%);GO:0046677 (33%),spermidine biosynthetic process (33%);response to antibiotic (33%),IPR021136 (63%);IPR038610 (63%);IPR003439 (13%),Flagellar hook-length control protein-like, C-terminal (63%);FliK-like, C-terminal domain superfamily (63%);ABC transporter-like (13%),,,,,,,,,
WWQCMTLTVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DEVDEDVPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHNFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (47%);3.1.3.2 (10%);2.1.1.37 (9%),Metalloendopeptidases (47%);Acid phosphatase (10%);DNA (cytosine-5-)-methyltransferase (9%),GO:0016021 (50%);GO:0009279 (4%);GO:0016020 (3%),integral component of membrane (50%);cell outer membrane (4%);membrane (3%),GO:0005524 (11%);GO:0016746 (8%);GO:0004222 (8%),ATP binding (11%);transferase activity, transferring acyl groups (8%);metalloendopeptidase activity (8%),GO:0007018 (3%);GO:0005975 (1%);GO:0006310 (1%),microtubule-based movement (3%);carbohydrate metabolic process (1%);DNA recombination (1%),IPR021822 (35%);IPR016181 (8%);IPR002123 (7%),Protein of unknown function DUF3405 (35%);Acyl-CoA N-acyltransferase (8%);Phospholipid/glycerol acyltransferase (7%),,,,,,,,,,
DFHDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.- (18%);1.1.1.205 (16%);6.3.5.5 (16%),With NAD(+) or NADP(+) as acceptor (18%);IMP dehydrogenase (16%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (16%),GO:0016021 (32%);GO:0043190 (7%);GO:0005737 (5%),integral component of membrane (32%);ATP-binding cassette (ABC) transporter complex (7%);cytoplasm (5%),GO:0005524 (13%);GO:0046872 (9%);GO:0022857 (7%),ATP binding (13%);metal ion binding (9%);transmembrane transporter activity (7%),GO:0044205 (3%);GO:0006177 (3%);GO:0009228 (3%),'de novo' UMP biosynthetic process (3%);GMP biosynthetic process (3%);thiamine biosynthetic process (3%),IPR000731 (8%);IPR032190 (8%);IPR003392 (8%),Sterol-sensing domain (8%);Niemann-Pick C1, N-terminal (8%);Protein patched/dispatched (8%),,,,,,,,,,
VSYEHSDDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYELNENHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.11 (20%);2.2.1.7 (5%);1.2.1.88 (4%),Phosphopyruvate hydratase (20%);1-deoxy-D-xylulose-5-phosphate synthase (5%);L-glutamate gamma-semialdehyde dehydrogenase (4%),GO:0005737 (22%);GO:0005856 (16%);GO:0016021 (16%),cytoplasm (22%);cytoskeleton (16%);integral component of membrane (16%),GO:0005524 (29%);GO:0003677 (9%);GO:0046872 (9%),ATP binding (29%);DNA binding (9%);metal ion binding (9%),GO:0006096 (5%);GO:0006355 (2%);GO:0005975 (2%),glycolytic process (5%);regulation of transcription, DNA-templated (2%);carbohydrate metabolic process (2%),IPR004000 (26%);IPR020902 (20%);IPR004001 (18%),Actin family (26%);Actin/actin-like conserved site (20%);Actin, conserved site (18%),,,,,,,,,
FMLNPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0033644 (50%);GO:0055036 (50%),integral component of membrane (50%);host cell membrane (50%);virion membrane (50%),GO:0003676 (50%);GO:0003723 (50%);GO:0003724 (50%),nucleic acid binding (50%);RNA binding (50%);RNA helicase activity (50%),GO:0019062 (50%);GO:0019082 (50%);GO:0039503 (50%),virion attachment to host cell (50%);viral protein processing (50%);suppression by virus of host innate immune response (50%),IPR000280 (50%);IPR001650 (50%);IPR002166 (50%),Pestivirus NS3, peptidase S31 (50%);Helicase, C-terminal (50%);RNA dependent RNA polymerase, hepatitis C virus (50%),,,,,,,,
NSTYHSLLSPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDCEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.- (100%);4.2.99.18 (100%),Hydrolyzing N-glycosyl compounds (100%);DNA-(apurinic or apyrimidinic site) lyase (100%),GO:0016021 (44%);GO:0005634 (13%);GO:0005739 (13%),integral component of membrane (44%);nucleus (13%);mitochondrion (13%),GO:0003676 (19%);GO:0008270 (19%);GO:0000703 (13%),nucleic acid binding (19%);zinc ion binding (19%);oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity (13%),GO:0006285 (13%);GO:0006397 (13%),base-excision repair, AP site formation (13%);mRNA processing (13%),IPR042505 (28%);IPR015943 (26%);IPR036322 (26%),WD repeat-containing protein 60 (28%);WD40/YVTN repeat-like-containing domain superfamily (26%);WD40-repeat-containing domain superfamily (26%),,,,,,,,,,
AYLVPNK,Asaccharospora irregularis,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Peptostreptococcaceae,,,,Asaccharospora,,,,Asaccharospora irregularis,,,,,,,,,,,,,,,,,,,,,,,,
VVEPLLTALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALVAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (6%);2.1.3.15 (5%);2.9.1.1 (5%),Histidine kinase (6%);Acetyl-CoA carboxytransferase (5%);L-seryl-tRNA(Sec) selenium transferase (5%),GO:0016021 (29%);GO:0005886 (3%);GO:0005737 (3%),integral component of membrane (29%);plasma membrane (3%);cytoplasm (3%),GO:0010181 (18%);GO:0005524 (11%);GO:0046872 (8%),FMN binding (18%);ATP binding (11%);metal ion binding (8%),GO:0055085 (3%);GO:0006633 (1%);GO:0008643 (1%),transmembrane transport (3%);fatty acid biosynthetic process (1%);carbohydrate transport (1%),IPR002563 (18%);IPR012349 (18%);IPR029058 (7%),Flavin reductase like domain (18%);FMN-binding split barrel (18%);Alpha/Beta hydrolase fold (7%),,,,,,,,,,,
TDSSLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTPLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.23 (31%);2.1.1.354 (20%);2.7.7.27 (9%),Histidinol dehydrogenase (31%);[Histone H3]-lysine(4) N-trimethyltransferase (20%);Glucose-1-phosphate adenylyltransferase (9%),GO:0005737 (57%);GO:0016021 (15%);GO:0005886 (4%),cytoplasm (57%);integral component of membrane (15%);plasma membrane (4%),GO:0003746 (56%);GO:0005525 (56%);GO:0003924 (52%),translation elongation factor activity (56%);GTP binding (56%);GTPase activity (52%),GO:0042128 (4%);GO:0006355 (3%);GO:0000105 (2%),nitrate assimilation (4%);regulation of transcription, DNA-templated (3%);histidine biosynthetic process (2%),IPR027417 (51%);IPR000795 (50%);IPR005225 (50%),P-loop containing nucleoside triphosphate hydrolase (51%);Transcription factor, GTP-binding domain (50%);Small GTP-binding protein domain (50%),,,,,,,,,
APLLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.85 (21%);3.5.1.2 (12%);4.3.3.6 (12%),Diadenylate cyclase (21%);Glutaminase (12%);Pyridoxal 5'-phosphate synthase (glutamine hydrolyzing) (12%),GO:0016021 (21%);GO:0008091 (7%);GO:0005887 (5%),integral component of membrane (21%);spectrin (7%);integral component of plasma membrane (5%),GO:0005524 (19%);GO:0003779 (7%);GO:0005086 (7%),ATP binding (19%);actin binding (7%);ARF guanyl-nucleotide exchange factor activity (7%),GO:0032012 (7%);GO:0055085 (7%);GO:0051693 (6%),regulation of ARF protein signal transduction (7%);transmembrane transport (7%);actin filament capping (6%),IPR011993 (7%);IPR002017 (7%);IPR018159 (7%),PH-like domain superfamily (7%);Spectrin repeat (7%);Spectrin/alpha-actinin (7%),,,,,,,,,,,
LDPVLLEGFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSHEFAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDNVEM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTDWELK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (50%);1.1.5.4 (25%);6.3.1.2 (25%),Transferring other groups (50%);Malate dehydrogenase (quinone) (25%);Glutamine synthetase (25%),,,GO:0004356 (53%);GO:0003723 (27%);GO:0016853 (27%),glutamate-ammonia ligase activity (53%);RNA binding (27%);isomerase activity (27%),GO:0006542 (53%);GO:0006099 (13%);GO:0005975 (7%),glutamine biosynthetic process (53%);tricarboxylic acid cycle (13%);carbohydrate metabolic process (7%),IPR008146 (56%);IPR014746 (56%);IPR036651 (56%),Glutamine synthetase, catalytic domain (56%);Glutamine synthetase/guanido kinase, catalytic domain (56%);Glutamine synthetase, N-terminal domain superfamily (56%),,,,,,,,
SWAENWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLCTVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0016021 (38%);GO:0042025 (8%);GO:0005737 (4%),integral component of membrane (38%);host cell nucleus (8%);cytoplasm (4%),GO:0005524 (27%);GO:0003755 (19%);GO:0004672 (19%),ATP binding (27%);peptidyl-prolyl cis-trans isomerase activity (19%);protein kinase activity (19%),GO:0006457 (19%);GO:0055085 (12%);GO:0006260 (8%),protein folding (19%);transmembrane transport (12%);DNA replication (8%),IPR000719 (24%);IPR008271 (24%);IPR011009 (24%),Protein kinase domain (24%);Serine/threonine-protein kinase, active site (24%);Protein kinase-like domain superfamily (24%),,,,,,,,,,
LPVAFHHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSLEQEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (50%);5.3.1.6 (50%),Methyltransferases (50%);Ribose-5-phosphate isomerase (50%),GO:0005634 (29%);GO:0005623 (7%);GO:0005737 (7%),nucleus (29%);cell (7%);cytoplasm (7%),GO:0003677 (29%);GO:0003824 (14%);GO:0005524 (14%),DNA binding (29%);catalytic activity (14%);ATP binding (14%),GO:0006306 (7%);GO:0006438 (7%);GO:0030643 (7%),DNA methylation (7%);valyl-tRNA aminoacylation (7%);cellular phosphate ion homeostasis (7%),IPR036209 (30%);IPR001680 (21%);IPR012952 (21%),YwmB-like superfamily (30%);WD40 repeat (21%);BING4, C-terminal domain (21%),,,,,,,,,,
AENVLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (33%);2.1.1.171 (33%);7.3.2.1 (33%),Methyltransferases (33%);16S rRNA (guanine(966)-N(2))-methyltransferase (33%);ABC-type phosphate transporter (33%),GO:0016021 (13%);GO:0005886 (6%),integral component of membrane (13%);plasma membrane (6%),GO:0008173 (38%);GO:0005524 (25%);GO:0003676 (13%),RNA methyltransferase activity (38%);ATP binding (25%);nucleic acid binding (13%),GO:0006396 (38%);GO:0006457 (6%),RNA processing (38%);protein folding (6%),IPR012340 (33%);IPR029063 (33%);IPR002792 (29%),Nucleic acid-binding, OB-fold (33%);S-adenosyl-L-methionine-dependent methyltransferase (33%);TRAM domain (29%),,,,,,,,,,
TPESAAVR,Pestalotiopsis fici,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Xylariomycetidae,,,Xylariales,,,,,Sporocadaceae,,,,Pestalotiopsis,,,,Pestalotiopsis fici,,,,,,,,GO:0008374 (100%),O-acyltransferase activity (100%),GO:0044255 (100%),cellular lipid metabolic process (100%),IPR002123 (100%);IPR022284 (100%);IPR041728 (100%),Phospholipid/glycerol acyltransferase (100%);Glycerol-3-phosphate O-acyltransferase/Dihydroxyacetone phosphate acyltransferase (100%);GPAT/DHAPAT, acyltransferase domain (100%),,,,,,,,,,
WSALNNLLQNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPDLPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (75%),integral component of membrane (75%),GO:0022857 (75%);GO:0043531 (25%),transmembrane transporter activity (75%);ADP binding (25%),GO:0006865 (75%);GO:0007165 (25%),amino acid transport (75%);signal transduction (25%),IPR002293 (55%);IPR004840 (55%);IPR004841 (55%),Amino acid/polyamine transporter I (55%);Amino acid permease, conserved site (55%);Amino acid permease/ SLC12A domain (55%),,,,,,,,,,
MKPETDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.9 (100%),Kynurenine 3-monooxygenase (100%),GO:0005759 (25%);GO:0009507 (25%),mitochondrial matrix (25%);chloroplast (25%),GO:0000774 (25%);GO:0003676 (25%);GO:0004386 (25%),adenyl-nucleotide exchange factor activity (25%);nucleic acid binding (25%);helicase activity (25%),GO:0006355 (25%);GO:0006457 (25%);GO:0006569 (25%),regulation of transcription, DNA-templated (25%);protein folding (25%);tryptophan catabolic process (25%),IPR036188 (40%);IPR000629 (20%);IPR000740 (20%),FAD/NAD(P)-binding domain superfamily (40%);ATP-dependent RNA helicase DEAD-box, conserved site (20%);GrpE nucleotide exchange factor (20%),,,,,,,,,
WDLLQHDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVDSQEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (50%),nucleus (50%),GO:0004252 (50%);GO:0005524 (50%);GO:0016887 (50%),serine-type endopeptidase activity (50%);ATP binding (50%);ATPase activity (50%),GO:0000027 (50%),ribosomal large subunit assembly (50%),IPR000209 (33%);IPR002035 (33%);IPR003593 (33%),Peptidase S8/S53 domain (33%);von Willebrand factor, type A (33%);AAA+ ATPase domain (33%),,,,,,,,,,
TVTNFSAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALNLLDEAASVTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLAAQPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.31 (74%);1.3.1.28 (7%);3.6.4.12 (5%),Phosphoenolpyruvate carboxylase (74%);2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (7%);DNA helicase (5%),GO:0016021 (6%);GO:0005851 (2%);GO:0005886 (2%),integral component of membrane (6%);eukaryotic translation initiation factor 2B complex (2%);plasma membrane (2%),GO:0000287 (25%);GO:0008964 (25%);GO:0003743 (23%),magnesium ion binding (25%);phosphoenolpyruvate carboxylase activity (25%);translation initiation factor activity (23%),GO:0006107 (25%);GO:0015977 (25%);GO:0006099 (24%),oxaloacetate metabolic process (25%);carbon fixation (25%);tricarboxylic acid cycle (24%),IPR000649 (37%);IPR037171 (37%);IPR042529 (34%),Initiation factor 2B-related (37%);NagB/RpiA transferase-like (37%);Initiation factor 2B-like, C-terminal (34%),,,,,,,,
FAGTEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (97%);GO:0016021 (2%);GO:0009279 (1%),cytoplasm (97%);integral component of membrane (2%);cell outer membrane (1%),GO:0005524 (86%);GO:0003824 (1%);GO:0004930 (1%),ATP binding (86%);catalytic activity (1%);G protein-coupled receptor activity (1%),GO:0006457 (97%),protein folding (97%),IPR011032 (95%);IPR020818 (95%);IPR037124 (95%),GroES-like superfamily (95%);GroES chaperonin family (95%);GroES chaperonin superfamily (95%),,,,,,,,,,,
YELPNGQVLTLGNER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLSEATFGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPLYLQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENSGLAAR,Eumeta japonica,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,Amphiesmenoptera,Lepidoptera,Glossata,Neolepidoptera,Heteroneura,Tineoidea,Psychidae,Oiketicinae,,,Eumeta,,,,Eumeta japonica,,,,,,,,,,,,,,,,,,,,,,,,
MVALLGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DANDLCPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCAWALSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVMGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.29 (58%);2.7.7.8 (15%);3.4.24.- (7%),Glycine C-acetyltransferase (58%);Polyribonucleotide nucleotidyltransferase (15%);Metalloendopeptidases (7%),GO:0016021 (19%);GO:0005737 (10%);GO:0005576 (4%),integral component of membrane (19%);cytoplasm (10%);extracellular region (4%),GO:0008890 (28%);GO:0030170 (28%);GO:0016874 (13%),glycine C-acetyltransferase activity (28%);pyridoxal phosphate binding (28%);ligase activity (13%),GO:0019518 (26%);GO:0009058 (25%);GO:0006402 (7%),L-threonine catabolic process to glycine (26%);biosynthetic process (25%);mRNA catabolic process (7%),IPR004839 (24%);IPR015421 (24%);IPR015422 (24%),Aminotransferase, class I/classII (24%);Pyridoxal phosphate-dependent transferase, major domain (24%);Pyridoxal phosphate-dependent transferase domain 1 (24%),,,,,,,,,
APANVAYPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPYLGNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSALPEFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADQSTTGLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDNLFFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.98 (50%);3.1.1.- (50%),UDP-N-acetylmuramate dehydrogenase (50%);Carboxylic ester hydrolases (50%),GO:0031514 (50%);GO:0005737 (25%);GO:0005929 (13%),motile cilium (50%);cytoplasm (25%);cilium (13%),GO:0003677 (13%);GO:0003700 (13%);GO:0004104 (13%),DNA binding (13%);DNA-binding transcription factor activity (13%);cholinesterase activity (13%),GO:0007049 (13%);GO:0008360 (13%);GO:0009252 (13%),cell cycle (13%);regulation of cell shape (13%);peptidoglycan biosynthetic process (13%),IPR025697 (89%);IPR011990 (25%);IPR033646 (18%),CLU domain (89%);Tetratricopeptide-like helical domain superfamily (25%);CLU central domain (18%),,,,,,,,,,,
TCQQLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR004291 (78%);IPR024474 (44%);IPR007816 (11%),Transposase, IS66 (78%);Zinc-finger binding domain of transposase IS66 (44%);ResB-like domain (11%),,,,,,,,,,
GYSFTTGFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVSDMLMTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DALPPNMAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQAFWNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFLDAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (100%),Hexosyltransferases (100%),GO:0016021 (75%);GO:0000139 (13%);GO:0005634 (13%),integral component of membrane (75%);Golgi membrane (13%);nucleus (13%),GO:0016868 (25%);GO:0000026 (13%),intramolecular transferase activity, phosphotransferases (25%);alpha-1,2-mannosyltransferase activity (13%),GO:0005975 (25%);GO:0000032 (13%);GO:0006487 (13%),carbohydrate metabolic process (25%);cell wall mannoprotein biosynthetic process (13%);protein N-linked glycosylation (13%),IPR005843 (67%);IPR005845 (67%);IPR005846 (67%),Alpha-D-phosphohexomutase, C-terminal (67%);Alpha-D-phosphohexomutase, alpha/beta/alpha domain II (67%);Alpha-D-phosphohexomutase, alpha/beta/alpha domain III (67%),,,,,,
FNLEAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.40 (52%);2.6.1.52 (10%);1.1.1.25 (5%),Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP(+)) (52%);Phosphoserine transaminase (10%);Shikimate dehydrogenase (5%),GO:0005737 (25%);GO:0016021 (4%);GO:0005623 (3%),cytoplasm (25%);integral component of membrane (4%);cell (3%),GO:0005524 (68%);GO:0003677 (41%);GO:0003700 (33%),ATP binding (68%);DNA binding (41%);DNA-binding transcription factor activity (33%),GO:0042026 (23%);GO:0006108 (7%);GO:0000160 (3%),protein refolding (23%);malate metabolic process (7%);phosphorelay signal transduction system (3%),IPR027417 (35%);IPR002078 (32%);IPR003593 (32%),P-loop containing nucleoside triphosphate hydrolase (35%);RNA polymerase sigma factor 54 interaction domain (32%);AAA+ ATPase domain (32%),,,,,,,,,,,
VSNTGTGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMENPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.3 (100%),Ribonuclease III (100%),GO:0005737 (50%),cytoplasm (50%),GO:0004525 (50%);GO:0016740 (50%);GO:0019843 (50%),ribonuclease III activity (50%);transferase activity (50%);rRNA binding (50%),GO:0006364 (50%);GO:0006397 (50%);GO:0008033 (50%),rRNA processing (50%);mRNA processing (50%);tRNA processing (50%),IPR000999 (14%);IPR001173 (14%);IPR005135 (14%),Ribonuclease III domain (14%);Glycosyltransferase 2-like (14%);Endonuclease/exonuclease/phosphatase (14%),,,,,,,,,,,
NLNDLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.8 (29%);2.7.1.6 (29%);1.1.1.205 (14%),Hypoxanthine phosphoribosyltransferase (29%);Galactokinase (29%);IMP dehydrogenase (14%),GO:0016021 (57%);GO:0005737 (15%);GO:0005886 (5%),integral component of membrane (57%);cytoplasm (15%);plasma membrane (5%),GO:0046872 (10%);GO:0000166 (8%);GO:0005524 (8%),metal ion binding (10%);nucleotide binding (8%);ATP binding (8%),GO:0006012 (5%);GO:0006166 (5%);GO:0006813 (5%),galactose metabolic process (5%);purine ribonucleoside salvage (5%);potassium ion transport (5%),IPR011049 (23%);IPR000705 (6%);IPR000836 (6%),Serralysin-like metalloprotease, C-terminal (23%);Galactokinase (6%);Phosphoribosyltransferase domain (6%),,,,,,,,,,
LNLAER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (42%);2.8.1.6 (6%);2.3.3.13 (5%),Endopeptidase La (42%);Biotin synthase (6%);2-isopropylmalate synthase (5%),GO:0005737 (42%);GO:0015627 (41%);GO:0016021 (12%),cytoplasm (42%);type II protein secretion system complex (41%);integral component of membrane (12%),GO:0005524 (54%);GO:0016887 (10%);GO:0004315 (6%),ATP binding (54%);ATPase activity (10%);3-oxoacyl-[acyl-carrier-protein] synthase activity (6%),GO:0015628 (41%);GO:0006633 (6%);GO:0009297 (6%),protein secretion by the type II secretion system (41%);fatty acid biosynthetic process (6%);pilus assembly (6%),IPR027417 (63%);IPR001482 (52%);IPR003593 (51%),P-loop containing nucleoside triphosphate hydrolase (63%);Type II/IV secretion system protein (52%);AAA+ ATPase domain (51%),,,,,,,,,,,
DNVQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (42%);2.7.13.3 (4%);3.1.2.- (4%),DNA topoisomerase (ATP-hydrolyzing) (42%);Histidine kinase (4%);Thiolester hydrolases (4%),GO:0005737 (28%);GO:0016021 (22%);GO:0005694 (7%),cytoplasm (28%);integral component of membrane (22%);chromosome (7%),GO:0003677 (34%);GO:0005524 (15%);GO:0046872 (10%),DNA binding (34%);ATP binding (15%);metal ion binding (10%),GO:0006355 (25%);GO:0006265 (7%);GO:0006261 (2%),regulation of transcription, DNA-templated (25%);DNA topological change (7%);DNA-dependent DNA replication (2%),IPR002876 (22%);IPR026564 (22%);IPR029072 (22%),Transcriptional regulator TACO1-like (22%);Transcriptional regulator TACO1-like, domain 3 (22%);YebC-like (22%),,,,,,,,,
VLAPDPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0015935 (39%);GO:0005840 (11%);GO:0016021 (6%),small ribosomal subunit (39%);ribosome (11%);integral component of membrane (6%),GO:0000049 (50%);GO:0019843 (50%);GO:0003735 (39%),tRNA binding (50%);rRNA binding (50%);structural constituent of ribosome (39%),GO:0006412 (50%);GO:0000160 (6%);GO:0009166 (6%),translation (50%);phosphorelay signal transduction system (6%);nucleotide catabolic process (6%),IPR000235 (45%);IPR005717 (45%);IPR020606 (45%),Ribosomal protein S5/S7 (45%);Ribosomal protein S7, bacterial/organellar-type (45%);Ribosomal protein S7, conserved site (45%),,,,,,,,,
QNPTVLEELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPKPTWNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.30 (22%);3.1.-.- (14%);3.6.4.12 (10%),Glycerol kinase (22%);Acting on ester bonds (14%);DNA helicase (10%),GO:0016021 (46%);GO:0005737 (3%);GO:0005634 (2%),integral component of membrane (46%);cytoplasm (3%);nucleus (2%),GO:0005524 (12%);GO:0004252 (12%);GO:0004197 (11%),ATP binding (12%);serine-type endopeptidase activity (12%);cysteine-type endopeptidase activity (11%),GO:0019082 (28%);GO:0006355 (5%);GO:0006072 (2%),viral protein processing (28%);regulation of transcription, DNA-templated (5%);glycerol-3-phosphate metabolic process (2%),IPR032855 (33%);IPR032785 (25%);IPR008743 (21%),Arterivirus polyprotein, nsp2, immunogenic region (33%);Replicase polyprotein 1ab, peptidase C33-associated domain (25%);Arterivirus Nsp2, peptidase C33 (21%),,,,,,
MFVNKPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQSYVNQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QYLLDEDR,Amaricoccus,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhodobacterales,,,,,Rhodobacteraceae,,,,Amaricoccus,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
EELNNSSTAMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLSFYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (31%);2.7.11.1 (23%);2.6.1.85 (8%),Hexosyltransferases (31%);Non-specific serine/threonine protein kinase (23%);Aminodeoxychorismate synthase (8%),GO:0005813 (20%);GO:0016021 (11%);GO:0005634 (1%),centrosome (20%);integral component of membrane (11%);nucleus (1%),GO:0005524 (74%);GO:0004672 (66%);GO:0019901 (21%),ATP binding (74%);protein kinase activity (66%);protein kinase binding (21%),GO:0006281 (4%);GO:0005975 (2%);GO:0006188 (2%),DNA repair (4%);carbohydrate metabolic process (2%);IMP biosynthetic process (2%),IPR000408 (69%);IPR009091 (69%);IPR000719 (69%),Regulator of chromosome condensation, RCC1 (69%);Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II (69%);Protein kinase domain (69%),,,,,,,,,,
LASGWPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0004252 (33%);GO:0016829 (33%);GO:0046872 (33%),serine-type endopeptidase activity (33%);lyase activity (33%);metal ion binding (33%),GO:0015689 (33%),molybdate ion transport (33%),IPR013783 (75%);IPR003961 (50%);IPR036116 (50%),Immunoglobulin-like fold (75%);Fibronectin type III (50%);Fibronectin type III superfamily (50%),,,,,,,,,,,
WSVLPLGR,Candidatus Sumerlaeota,Bacteria,,,,Candidatus Sumerlaeota,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR011990 (100%);IPR013026 (100%);IPR019734 (100%),Tetratricopeptide-like helical domain superfamily (100%);Tetratricopeptide repeat-containing domain (100%);Tetratricopeptide repeat (100%),,,,,,,,,,,
NQEAER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (25%);5.99.1.2 (25%);1.2.1.3 (13%),Acting on ester bonds (25%);Transferred entry: 5.6.2.1 (25%);Aldehyde dehydrogenase (NAD(+)) (13%),GO:0016021 (34%);GO:0009376 (19%);GO:0005737 (4%),integral component of membrane (34%);HslUV protease complex (19%);cytoplasm (4%),GO:0005524 (36%);GO:0016887 (21%);GO:0070011 (19%),ATP binding (36%);ATPase activity (21%);peptidase activity, acting on L-amino acid peptides (19%),GO:0000160 (3%);GO:0006281 (3%);GO:0006355 (3%),phosphorelay signal transduction system (3%);DNA repair (3%);regulation of transcription, DNA-templated (3%),IPR005094 (22%);IPR011990 (21%);IPR027417 (21%),Endonuclease relaxase, MobA/VirD2 (22%);Tetratricopeptide-like helical domain superfamily (21%);P-loop containing nucleoside triphosphate hydrolase (21%),,,,,,,,
EPTWWQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNAFTPDEEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLYEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (83%);GO:0016020 (17%),integral component of membrane (83%);membrane (17%),GO:0047355 (17%),CDP-glycerol glycerophosphotransferase activity (17%),,,IPR000163 (38%);IPR001107 (38%);IPR036013 (38%),Prohibitin (38%);Band 7 domain (38%);Band 7/SPFH domain superfamily (38%),,,,,,,,,,,
ALMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.13 (43%);2.1.3.3 (7%);2.6.99.2 (6%),Methionine synthase (43%);Ornithine carbamoyltransferase (7%);Pyridoxine 5'-phosphate synthase (6%),GO:0016021 (28%);GO:0005886 (11%);GO:0005737 (9%),integral component of membrane (28%);plasma membrane (11%);cytoplasm (9%),GO:0008270 (13%);GO:0008705 (12%);GO:0031419 (12%),zinc ion binding (13%);methionine synthase activity (12%);cobalamin binding (12%),GO:0032259 (13%);GO:0042558 (9%);GO:0006813 (6%),methylation (13%);pteridine-containing compound metabolic process (9%);potassium ion transport (6%),IPR011055 (11%);IPR016047 (11%);IPR018392 (10%),Duplicated hybrid motif (11%);Peptidase M23 (11%);LysM domain (10%),,,,,,,,,,,
QNDVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (20%);2.2.1.6 (8%);6.3.4.16 (6%),RNA helicase (20%);Acetolactate synthase (8%);Carbamoyl-phosphate synthase (ammonia) (6%),GO:0016021 (28%);GO:0005737 (7%);GO:0016580 (7%),integral component of membrane (28%);cytoplasm (7%);Sin3 complex (7%),GO:0005524 (15%);GO:0003714 (7%);GO:0046872 (6%),ATP binding (15%);transcription corepressor activity (7%);metal ion binding (6%),GO:0005975 (10%);GO:0006355 (9%);GO:0000027 (4%),carbohydrate metabolic process (10%);regulation of transcription, DNA-templated (9%);ribosomal large subunit assembly (4%),IPR027417 (8%);IPR031693 (6%);IPR039774 (6%),P-loop containing nucleoside triphosphate hydrolase (8%);Sin3, C-terminal (6%);Transcriptional regulatory protein Sin3-like (6%),,,,,,,,,
LTTGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.47 (56%);1.17.4.1 (11%);2.5.1.7 (7%),8-amino-7-oxononanoate synthase (56%);Ribonucleoside-diphosphate reductase (11%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (7%),GO:0016021 (46%);GO:0005794 (36%);GO:0016020 (8%),integral component of membrane (46%);Golgi apparatus (36%);membrane (8%),GO:0030170 (11%);GO:0046872 (10%);GO:0022857 (8%),pyridoxal phosphate binding (11%);metal ion binding (10%);transmembrane transporter activity (8%),GO:0009102 (6%);GO:0009058 (5%);GO:1905793 (4%),biotin biosynthetic process (6%);biosynthetic process (5%);protein localization to pericentriolar material (4%),IPR026202 (38%);IPR004839 (9%);IPR015421 (9%),Golgin subfamily B member 1 (38%);Aminotransferase, class I/classII (9%);Pyridoxal phosphate-dependent transferase, major domain (9%),,,,,,,,,
FDVNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.109 (33%);2.7.1.71 (17%);2.7.6.5 (17%),Methylthioribulose 1-phosphate dehydratase (33%);Shikimate kinase (17%);GTP diphosphokinase (17%),GO:0016021 (20%);GO:0005737 (10%);GO:0005886 (10%),integral component of membrane (20%);cytoplasm (10%);plasma membrane (10%),GO:0016491 (23%);GO:0003677 (17%);GO:0004519 (13%),oxidoreductase activity (23%);DNA binding (17%);endonuclease activity (13%),GO:0019284 (7%);GO:0019509 (7%);GO:0000723 (3%),L-methionine salvage from S-adenosylmethionine (7%);L-methionine salvage from methylthioadenosine (7%);telomere maintenance (3%),IPR005123 (14%);IPR011335 (14%);IPR011337 (14%),Oxoglutarate/iron-dependent dioxygenase (14%);Restriction endonuclease  type II-like (14%);DNA mismatch repair MutH/Restriction endonuclease, type II (14%),,,,,,,,,,
LSCPTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.208 (50%);3.1.-.- (50%);3.6.4.12 (50%),Diglucosyl diacylglycerol synthase (1,2-linking) (50%);Acting on ester bonds (50%);DNA helicase (50%),GO:0005737 (33%);GO:0016021 (7%),cytoplasm (33%);integral component of membrane (7%),GO:0005524 (33%);GO:0003991 (27%);GO:0003677 (13%),ATP binding (33%);acetylglutamate kinase activity (27%);DNA binding (13%),GO:0006526 (27%);GO:0006013 (7%);GO:0006281 (7%),arginine biosynthetic process (27%);mannose metabolic process (7%);DNA repair (7%),IPR001048 (27%);IPR001057 (27%);IPR004662 (27%),Aspartate/glutamate/uridylate kinase (27%);Glutamate/acetylglutamate kinase (27%);Acetylglutamate kinase family (27%),,,,,,,,,,
LQVVSEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNVVEGR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR021246 (100%),Protein of unknown function DUF2797 (100%),,,,,,,,,,,
EVWVNANNMHGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVFDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.1 (78%);5.3.3.2 (5%);1.2.7.12 (3%),Phosphoribosylformylglycinamidine cyclo-ligase (78%);Isopentenyl-diphosphate Delta-isomerase (5%);Formylmethanofuran dehydrogenase (3%),GO:0005737 (21%);GO:0032300 (20%);GO:0031011 (16%),cytoplasm (21%);mismatch repair complex (20%);Ino80 complex (16%),GO:0005524 (40%);GO:0016887 (20%);GO:0030983 (20%),ATP binding (40%);ATPase activity (20%);mismatched DNA binding (20%),GO:0006298 (21%);GO:0006189 (19%);GO:0006338 (16%),mismatch repair (21%);'de novo' IMP biosynthetic process (19%);chromatin remodeling (16%),IPR036890 (18%);IPR038973 (18%);IPR014762 (18%),Histidine kinase/HSP90-like ATPase superfamily (18%);DNA mismatch repair protein MutL/Mlh/Pms (18%);DNA mismatch repair, conserved site (18%),,,,,,,,,,
AMMVQVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVFEDTNLTYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESAAPVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.47 (100%),Arabinofuranan 3-O-arabinosyltransferase (100%),GO:0016021 (42%);GO:0005886 (11%);GO:0005737 (3%),integral component of membrane (42%);plasma membrane (11%);cytoplasm (3%),GO:0003700 (19%);GO:0046872 (14%);GO:0005506 (11%),DNA-binding transcription factor activity (19%);metal ion binding (14%);iron ion binding (11%),GO:0042128 (11%);GO:0009399 (8%);GO:0015689 (8%),nitrate assimilation (11%);nitrogen fixation (8%);molybdate ion transport (8%),IPR007419 (16%);IPR036388 (16%);IPR036390 (16%),BFD-like [2Fe-2S]-binding domain (16%);Winged helix-like DNA-binding domain superfamily (16%);Winged helix DNA-binding domain superfamily (16%),,,,,,,,,,,
MLMPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.4.1.2 (44%);6.3.4.14 (17%);3.6.3.3 (11%),Acetyl-CoA carboxylase (44%);Biotin carboxylase (17%);Transferred entry: 7.2.2.21 (11%),GO:0016021 (22%);GO:0005886 (10%);GO:0005856 (6%),integral component of membrane (22%);plasma membrane (10%);cytoskeleton (6%),GO:0005524 (44%);GO:0046872 (34%);GO:0003989 (24%),ATP binding (44%);metal ion binding (34%);acetyl-CoA carboxylase activity (24%),GO:0006633 (22%);GO:0006807 (4%);GO:0000160 (1%),fatty acid biosynthetic process (22%);nitrogen compound metabolic process (4%);phosphorelay signal transduction system (1%),IPR000089 (19%);IPR001882 (19%);IPR005479 (19%),Biotin/lipoyl attachment (19%);Biotin-binding site (19%);Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain (19%),,,,,,,,,,
NQCWDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEEVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.198 (53%);6.3.4.4 (7%);5.3.1.1 (6%),16S rRNA (cytidine(1402)-2'-O)-methyltransferase (53%);Adenylosuccinate synthase (7%);Triose-phosphate isomerase (6%),GO:0005737 (32%);GO:0016021 (11%);GO:0048500 (2%),cytoplasm (32%);integral component of membrane (11%);signal recognition particle (2%),GO:0070677 (22%);GO:0005524 (10%);GO:0003677 (6%),rRNA (cytosine-2'-O-)-methyltransferase activity (22%);ATP binding (10%);DNA binding (6%),GO:0000453 (22%);GO:0015031 (6%);GO:0006094 (4%),enzyme-directed rRNA 2'-O-methylation (22%);protein transport (6%);gluconeogenesis (4%),IPR014776 (18%);IPR035996 (18%);IPR008189 (18%),Tetrapyrrole methylase, subdomain 2 (18%);Tetrapyrrole methylase superfamily (18%);rRNA small subunit methyltransferase I (18%),,,,,,,,,,
VLAVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (23%);3.4.23.36 (9%);4.1.1.20 (7%),Acting on ester bonds (23%);Signal peptidase II (9%);Diaminopimelate decarboxylase (7%),GO:0016021 (28%);GO:0005737 (9%);GO:0016020 (7%),integral component of membrane (28%);cytoplasm (9%);membrane (7%),GO:0005524 (33%);GO:0004672 (13%);GO:0016887 (7%),ATP binding (33%);protein kinase activity (13%);ATPase activity (7%),GO:0006298 (5%);GO:0045910 (5%);GO:0009253 (3%),mismatch repair (5%);negative regulation of DNA recombination (5%);peptidoglycan catabolic process (3%),IPR011009 (17%);IPR000719 (15%);IPR027417 (14%),Protein kinase-like domain superfamily (17%);Protein kinase domain (15%);P-loop containing nucleoside triphosphate hydrolase (14%),,,,,,,,,,,
LPLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.11 (13%);4.1.1.98 (10%);2.7.1.71 (6%),Phosphopyruvate hydratase (13%);4-hydroxy-3-polyprenylbenzoate decarboxylase (10%);Shikimate kinase (6%),GO:0016021 (28%);GO:0000015 (9%);GO:0005737 (7%),integral component of membrane (28%);phosphopyruvate hydratase complex (9%);cytoplasm (7%),GO:0005524 (15%);GO:0000287 (10%);GO:0004634 (9%),ATP binding (15%);magnesium ion binding (10%);phosphopyruvate hydratase activity (9%),GO:0006096 (9%);GO:0000270 (5%);GO:0006744 (2%),glycolytic process (9%);peptidoglycan metabolic process (5%);ubiquinone biosynthetic process (2%),IPR029017 (8%);IPR036849 (8%);IPR027417 (7%),Enolase-like, N-terminal (8%);Enolase-like, C-terminal domain superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,
FQSNLSVEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGAVAWETK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLELENELNQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVNFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.10 (35%);6.1.1.4 (13%);1.17.4.1 (12%),Imidazole glycerol-phosphate synthase (35%);Leucine--tRNA ligase (13%);Ribonucleoside-diphosphate reductase (12%),GO:0005737 (35%);GO:0016021 (17%);GO:0005886 (1%),cytoplasm (35%);integral component of membrane (17%);plasma membrane (1%),GO:0005524 (56%);GO:0008233 (14%);GO:0005261 (10%),ATP binding (56%);peptidase activity (14%);cation channel activity (10%),GO:0019538 (29%);GO:0009408 (25%);GO:0042026 (25%),protein metabolic process (29%);response to heat (25%);protein refolding (25%),IPR027417 (48%);IPR003959 (45%);IPR003593 (45%),P-loop containing nucleoside triphosphate hydrolase (48%);ATPase, AAA-type, core (45%);AAA+ ATPase domain (45%),,,,,,,,,
QTYFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.50 (80%);1.14.13.106 (20%),Hydroxyethylthiazole kinase (80%);Epi-isozizaene 5-monooxygenase (20%),GO:0016021 (18%);GO:0005634 (9%);GO:0032221 (9%),integral component of membrane (18%);nucleus (9%);Rpd3S complex (9%),GO:0000287 (36%);GO:0004417 (36%);GO:0005524 (36%),magnesium ion binding (36%);hydroxyethylthiazole kinase activity (36%);ATP binding (36%),GO:0009228 (36%);GO:0009229 (36%);GO:0006281 (9%),thiamine biosynthetic process (36%);thiamine diphosphate biosynthetic process (36%);DNA repair (9%),IPR000417 (27%);IPR029056 (27%);IPR001810 (20%),Hydroxyethylthiazole kinase (27%);Ribokinase-like (27%);F-box domain (20%),,,,,,,,,,,
AYVSYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (17%);GO:0016020 (17%);GO:0016021 (13%),ribosome (17%);membrane (17%);integral component of membrane (13%),GO:0016491 (22%);GO:0015473 (17%);GO:0004497 (9%),oxidoreductase activity (22%);fimbrial usher porin activity (17%);monooxygenase activity (9%),GO:0009297 (17%);GO:0006260 (4%);GO:0006270 (4%),pilus assembly (17%);DNA replication (4%);DNA replication initiation (4%),IPR002347 (17%);IPR020904 (17%);IPR036291 (17%),Short-chain dehydrogenase/reductase SDR (17%);Short-chain dehydrogenase/reductase, conserved site (17%);NAD(P)-binding domain superfamily (17%),,,,,,,,,,
NSAAFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.9 (66%);6.1.1.10 (26%);3.1.-.- (3%),Malate synthase (66%);Methionine--tRNA ligase (26%);Acting on ester bonds (3%),GO:0005737 (66%);GO:0016021 (10%);GO:0015935 (3%),cytoplasm (66%);integral component of membrane (10%);small ribosomal subunit (3%),GO:0004474 (49%);GO:0046872 (48%);GO:0005524 (24%),malate synthase activity (49%);metal ion binding (48%);ATP binding (24%),GO:0006097 (49%);GO:0006099 (47%);GO:0006431 (19%),glyoxylate cycle (49%);tricarboxylic acid cycle (47%);methionyl-tRNA aminoacylation (19%),IPR001465 (38%);IPR006253 (38%);IPR011076 (38%),Malate synthase (38%);Malate synthase G (38%);Malate synthase-like superfamily (38%),,,,,,,,,,,
VLEDPVELLDWGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWAENDQHFTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLNNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.13 (18%);1.10.3.2 (12%);6.6.1.2 (12%),Ornithine aminotransferase (18%);Laccase (12%);Cobaltochelatase (12%),GO:0016021 (21%);GO:0005737 (12%);GO:0042597 (6%),integral component of membrane (21%);cytoplasm (12%);periplasmic space (6%),GO:0005524 (29%);GO:0003677 (12%);GO:0016887 (11%),ATP binding (29%);DNA binding (12%);ATPase activity (11%),GO:0000184 (4%);GO:0005975 (4%);GO:0055129 (4%),nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (4%);carbohydrate metabolic process (4%);L-proline biosynthetic process (4%),IPR027417 (19%);IPR000719 (9%);IPR001245 (9%),P-loop containing nucleoside triphosphate hydrolase (19%);Protein kinase domain (9%);Serine-threonine/tyrosine-protein kinase, catalytic domain (9%),,,,,,,,,
LLDPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.7.8 (40%);2.7.10.2 (13%);6.1.1.2 (10%),Indolepyruvate ferredoxin oxidoreductase (40%);Non-specific protein-tyrosine kinase (13%);Tryptophan--tRNA ligase (10%),GO:0016021 (27%);GO:0005737 (4%);GO:0030288 (3%),integral component of membrane (27%);cytoplasm (4%);outer membrane-bounded periplasmic space (3%),GO:0016903 (12%);GO:0051536 (11%);GO:0016491 (10%),oxidoreductase activity, acting on the aldehyde or oxo group of donors (12%);iron-sulfur cluster binding (11%);oxidoreductase activity (10%),GO:0009103 (3%);GO:0015888 (3%);GO:0031047 (3%),lipopolysaccharide biosynthetic process (3%);thiamine transport (3%);gene silencing by RNA (3%),IPR002869 (14%);IPR009014 (14%);IPR019752 (14%),Pyruvate-flavodoxin oxidoreductase, central domain (14%);Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II (14%);Pyruvate/ketoisovalerate oxidoreductase, catalytic domain (14%),,,,,,,,
ALWQEDR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.28 (100%);3.5.4.31 (100%),S-adenosylhomocysteine deaminase (100%);S-methyl-5'-thioadenosine deaminase (100%),,,GO:0016301 (50%);GO:0016773 (50%);GO:0046872 (50%),kinase activity (50%);phosphotransferase activity, alcohol group as acceptor (50%);metal ion binding (50%),GO:0005975 (50%),carbohydrate metabolic process (50%),IPR006680 (25%);IPR007569 (25%);IPR011059 (25%),Amidohydrolase-related (25%);Domain of unknown function DUF559 (25%);Metal-dependent hydrolase, composite domain superfamily (25%),,,,,,,,,
GDLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.4 (34%);3.4.21.107 (8%);2.10.1.1 (7%),Asparagine synthase (glutamine-hydrolyzing) (34%);Peptidase Do (8%);Molybdopterin molybdotransferase (7%),GO:0016021 (29%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (29%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (26%);GO:0004066 (19%);GO:0046872 (9%),ATP binding (26%);asparagine synthase (glutamine-hydrolyzing) activity (19%);metal ion binding (9%),GO:0006529 (18%);GO:0006541 (17%);GO:0006457 (9%),asparagine biosynthetic process (18%);glutamine metabolic process (17%);protein folding (9%),IPR014020 (16%);IPR029021 (16%);IPR029023 (16%),Tensin phosphatase, C2 domain (16%);Protein-tyrosine phosphatase-like (16%);Tensin-type phosphatase domain (16%),,,,,,,,,,
LLVDLVFGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNLYTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.3 (32%);2.5.1.- (26%);2.5.1.47 (16%),Dihydroorotase (32%);Transferring alkyl or aryl groups, other than methyl groups (26%);Cysteine synthase (16%),GO:0016021 (44%);GO:0005737 (3%);GO:0005886 (2%),integral component of membrane (44%);cytoplasm (3%);plasma membrane (2%),GO:0046872 (8%);GO:0000287 (7%);GO:0005524 (7%),metal ion binding (8%);magnesium ion binding (7%);ATP binding (7%),GO:0005975 (4%);GO:0006535 (3%);GO:0006270 (2%),carbohydrate metabolic process (4%);cysteine biosynthetic process from serine (3%);DNA replication initiation (2%),IPR018946 (17%);IPR038607 (17%);IPR013783 (6%),Alkaline phosphatase D-related (17%);PhoD-like superfamily (17%);Immunoglobulin-like fold (6%),,,,,,,,,,
DVMVQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (50%);3.2.1.45 (50%),Histidine kinase (50%);Glucosylceramidase (50%),GO:0016021 (72%);GO:0005886 (2%);GO:0005737 (1%),integral component of membrane (72%);plasma membrane (2%);cytoplasm (1%),GO:0050660 (67%);GO:0005524 (14%);GO:0010181 (9%),flavin adenine dinucleotide binding (67%);ATP binding (14%);FMN binding (9%),GO:0006665 (2%);GO:0015833 (2%);GO:0016539 (2%),sphingolipid metabolic process (2%);peptide transport (2%);intein-mediated protein splicing (2%),IPR000644 (55%);IPR005170 (55%);IPR016169 (55%),CBS domain (55%);Transporter-associated domain (55%);FAD-binding, type PCMH, subdomain 2 (55%),,,,,,,,,
DLLNDENVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNAVVFLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNECAAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLVEQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (27%);6.1.1.1 (18%);3.2.2.31 (14%),Acting on GTP; involved in cellular and subcellular movement (27%);Tyrosine--tRNA ligase (18%);Adenine glycosylase (14%),GO:0016021 (5%);GO:0005737 (4%);GO:0005829 (3%),integral component of membrane (5%);cytoplasm (4%);cytosol (3%),GO:0003677 (49%);GO:0001671 (10%);GO:0051087 (10%),DNA binding (49%);ATPase activator activity (10%);chaperone binding (10%),GO:0006310 (45%);GO:0015074 (45%);GO:0019441 (4%),DNA recombination (45%);DNA integration (45%);tryptophan catabolic process to kynurenine (4%),IPR011010 (43%);IPR013762 (43%);IPR010998 (42%),DNA breaking-rejoining enzyme, catalytic core (43%);Integrase-like, catalytic domain superfamily (43%);Integrase/recombinase, N-terminal (42%),,,,,,,,
TGELQQMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPSNVEPFLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLMDLPR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (100%);GO:0005694 (100%),nucleus (100%);chromosome (100%),GO:0008270 (100%);GO:0018024 (100%),zinc ion binding (100%);histone-lysine N-methyltransferase activity (100%),,,IPR001214 (100%);IPR007728 (100%);IPR017896 (100%),SET domain (100%);Pre-SET domain (100%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (100%),,,,,,,,,,
DQDLWGR,Cellvibrionaceae bacterium,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Cellvibrionales,,,,,Cellvibrionaceae,,,,,,,,Cellvibrionaceae bacterium,,,,4.1.3.40 (100%),Chorismate lyase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0008813 (100%),chorismate lyase activity (100%),GO:0006744 (100%);GO:0042866 (100%),ubiquinone biosynthetic process (100%);pyruvate biosynthetic process (100%),IPR007440 (100%);IPR028978 (100%),Chorismate--pyruvate lyase (100%);Chorismate pyruvate-lyase/UbiC transcription regulator-associated domain superfamily (100%),,,,,,,,,,,
MLSNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.1 (20%);2.7.7.18 (15%);3.5.2.9 (10%),Proton-translocating NAD(P)(+) transhydrogenase (20%);Nicotinate-nucleotide adenylyltransferase (15%);5-oxoprolinase (ATP-hydrolyzing) (10%),GO:0005840 (83%);GO:0009507 (59%);GO:0009536 (24%),ribosome (83%);chloroplast (59%);plastid (24%),GO:0003735 (68%);GO:0019843 (68%);GO:0005524 (3%),structural constituent of ribosome (68%);rRNA binding (68%);ATP binding (3%),GO:0006412 (77%);GO:0005975 (1%);GO:0003391 (1%),translation (77%);carbohydrate metabolic process (1%);amphid sensory organ dendrite retrograde extension (1%),IPR000114 (80%);IPR016180 (80%);IPR036920 (80%),Ribosomal protein L16 (80%);Ribosomal protein L10e/L16 (80%);Ribosomal protein L10e/L16 superfamily (80%),,,,,,,,,,,
FVVLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.51 (100%),Prephenate dehydratase (100%),GO:0016021 (28%);GO:0005886 (4%);GO:0005737 (2%),integral component of membrane (28%);plasma membrane (4%);cytoplasm (2%),GO:0005524 (35%);GO:0016887 (22%);GO:0003677 (11%),ATP binding (35%);ATPase activity (22%);DNA binding (11%),GO:0006306 (4%);GO:0006355 (4%);GO:0009094 (4%),DNA methylation (4%);regulation of transcription, DNA-templated (4%);L-phenylalanine biosynthetic process (4%),IPR027417 (31%);IPR003593 (21%);IPR003439 (17%),P-loop containing nucleoside triphosphate hydrolase (31%);AAA+ ATPase domain (21%);ABC transporter-like (17%),,,,,,,,,,
DFLWYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016740 (50%);GO:0016742 (50%),transferase activity (50%);hydroxymethyl-, formyl- and related transferase activity (50%),GO:0005975 (50%);GO:0009058 (50%),carbohydrate metabolic process (50%);biosynthetic process (50%),IPR001173 (25%);IPR002376 (25%);IPR005793 (25%),Glycosyltransferase 2-like (25%);Formyl transferase, N-terminal (25%);Formyl transferase, C-terminal (25%),,,,,,,,
NEVESGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (27%);GO:0000176 (9%);GO:0000177 (9%),integral component of membrane (27%);nuclear exosome (RNase complex) (9%);cytoplasmic exosome (RNase complex) (9%),GO:0000287 (18%);GO:0003723 (18%);GO:0016616 (18%),magnesium ion binding (18%);RNA binding (18%);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (18%),GO:0000447 (9%);GO:0007265 (9%);GO:0016075 (9%),endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (9%);Ras protein signal transduction (9%);rRNA catabolic process (9%),IPR001900 (47%);IPR002716 (47%);IPR012340 (47%),Ribonuclease II/R (47%);PIN domain (47%);Nucleic acid-binding, OB-fold (47%),,,,,,
LYVTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (50%);5.6.2.1 (50%),Peptidylprolyl isomerase (50%);DNA topoisomerase (50%),GO:0016021 (48%);GO:0005886 (20%);GO:0005747 (2%),integral component of membrane (48%);plasma membrane (20%);mitochondrial respiratory chain complex I (2%),GO:0003677 (24%);GO:0003700 (21%);GO:0005509 (20%),DNA binding (24%);DNA-binding transcription factor activity (21%);calcium ion binding (20%),GO:0007156 (20%);GO:0006120 (2%);GO:0006265 (2%),homophilic cell adhesion via plasma membrane adhesion molecules (20%);mitochondrial electron transport, NADH to ubiquinone (2%);DNA topological change (2%),IPR036388 (25%);IPR036390 (23%);IPR000835 (20%),Winged helix-like DNA-binding domain superfamily (25%);Winged helix DNA-binding domain superfamily (23%);MarR-type HTH domain (20%),,,,,,,,,,
EAKPQLFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.29 (21%);2.7.1.107 (8%);4.2.1.3 (8%),tRNA-guanine(34) transglycosylase (21%);Diacylglycerol kinase (ATP) (8%);Aconitate hydratase (8%),GO:0016021 (43%);GO:0055036 (24%);GO:0019031 (24%),integral component of membrane (43%);virion membrane (24%);viral envelope (24%),GO:0005524 (15%);GO:0005198 (13%);GO:0016887 (7%),ATP binding (15%);structural molecule activity (13%);ATPase activity (7%),GO:0019062 (24%);GO:0039663 (13%);GO:0019064 (11%),virion attachment to host cell (24%);membrane fusion involved in viral entry into host cell (13%);fusion of virus membrane with host plasma membrane (11%),IPR000777 (19%);IPR036377 (19%);IPR000328 (10%),Human immunodeficiency virus 1, envelope glycoprotein Gp120 (19%);Gp120 core superfamily (19%);Retroviral envelope protein GP41-like (10%),,,,,,,,,,
ENWGWSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.21 (26%);2.5.1.72 (17%);6.1.1.20 (12%),Starch synthase (26%);Quinolinate synthase (17%);Phenylalanine--tRNA ligase (12%),GO:0016021 (16%);GO:0005737 (6%);GO:0005615 (4%),integral component of membrane (16%);cytoplasm (6%);extracellular space (4%),GO:0005524 (22%);GO:0003677 (15%);GO:0003723 (15%),ATP binding (22%);DNA binding (15%);RNA binding (15%),GO:0006401 (14%);GO:0005978 (5%);GO:0006520 (4%),RNA catabolic process (14%);glycogen biosynthetic process (5%);cellular amino acid metabolic process (4%),IPR027417 (18%);IPR014001 (15%);IPR001650 (14%),P-loop containing nucleoside triphosphate hydrolase (18%);Helicase superfamily 1/2, ATP-binding domain (15%);Helicase, C-terminal (14%),,,,,,,,,
LNAFGEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.5.3 (33%);2.7.8.12 (33%);6.1.1.6 (33%),Transferred entry: 7.1.1.2 (33%);Teichoic acid poly(glycerol phosphate) polymerase (33%);Lysine--tRNA ligase (33%),GO:0016021 (56%);GO:0005737 (11%);GO:0016020 (11%),integral component of membrane (56%);cytoplasm (11%);membrane (11%),GO:0016810 (22%);GO:0000287 (11%);GO:0003676 (11%),hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (22%);magnesium ion binding (11%);nucleic acid binding (11%),GO:0006430 (11%);GO:0042773 (11%),lysyl-tRNA aminoacylation (11%);ATP synthesis coupled electron transport (11%),IPR006680 (20%);IPR008910 (20%);IPR011042 (20%),Amidohydrolase-related (20%);Conserved TM helix (20%);Six-bladed beta-propeller, TolB-like (20%),,,,,,,,,
LYMQGNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (83%);GO:0005886 (11%),integral component of membrane (83%);plasma membrane (11%),GO:0005524 (93%);GO:0004674 (72%);GO:0004672 (20%),ATP binding (93%);protein serine/threonine kinase activity (72%);protein kinase activity (20%),GO:0009755 (11%),hormone-mediated signaling pathway (11%),IPR001611 (97%);IPR032675 (97%);IPR003591 (77%),Leucine-rich repeat (97%);Leucine-rich repeat domain superfamily (97%);Leucine-rich repeat, typical subtype (77%),,,,,,,,,,
SYWNLAEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLVWEPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.2.4 (100%),Nitrous-oxide reductase (100%),GO:0016021 (6%),integral component of membrane (6%),GO:0005507 (88%);GO:0050304 (38%),copper ion binding (88%);nitrous-oxide reductase activity (38%),,,IPR008972 (94%);IPR011045 (94%);IPR015943 (94%),Cupredoxin (94%);Nitrous oxide reductase, N-terminal (94%);WD40/YVTN repeat-like-containing domain superfamily (94%),,,,,,,,,,
LFVEFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.72 (33%);3.6.4.12 (33%);2.7.7.- (17%),CCA tRNA nucleotidyltransferase (33%);DNA helicase (33%);Nucleotidyltransferases (17%),GO:0016021 (5%);GO:0005634 (0%);GO:0005887 (0%),integral component of membrane (5%);nucleus (0%);integral component of plasma membrane (0%),GO:0003723 (77%);GO:0005524 (5%);GO:0003676 (4%),RNA binding (77%);ATP binding (5%);nucleic acid binding (4%),GO:0043484 (72%);GO:0007165 (2%);GO:0000380 (1%),regulation of RNA splicing (72%);signal transduction (2%);alternative mRNA splicing, via spliceosome (1%),IPR012677 (65%);IPR003954 (64%);IPR035979 (63%),Nucleotide-binding alpha-beta plait domain superfamily (65%);RNA recognition motif domain, eukaryote (64%);RNA-binding domain superfamily (63%),,,,,,,,,
LLEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.9 (35%);7.1.1.- (19%);4.1.2.- (7%),UDP-galactopyranose mutase (35%);Hydron translocation or charge separation linked to oxidoreductase reactions (19%);Aldehyde-lyases (7%),GO:0016021 (10%);GO:0005886 (8%);GO:0005737 (8%),integral component of membrane (10%);plasma membrane (8%);cytoplasm (8%),GO:0008767 (27%);GO:0005524 (13%);GO:0048038 (8%),UDP-galactopyranose mutase activity (27%);ATP binding (13%);quinone binding (8%),GO:0005975 (4%);GO:0030433 (4%);GO:0051301 (2%),carbohydrate metabolic process (4%);ubiquitin-dependent ERAD pathway (4%);cell division (2%),IPR015899 (23%);IPR004379 (22%);IPR027417 (11%),UDP-galactopyranose mutase, C-terminal (23%);UDP-galactopyranose mutase (22%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,,,
MAAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (9%);2.1.1.201 (5%);2.2.1.7 (3%),Pyruvate dehydrogenase (acetyl-transferring) (9%);2-methoxy-6-polyprenyl-1,4-benzoquinol methylase (5%);1-deoxy-D-xylulose-5-phosphate synthase (3%),GO:0016021 (27%);GO:0005737 (8%);GO:0005886 (5%),integral component of membrane (27%);cytoplasm (8%);plasma membrane (5%),GO:0003677 (10%);GO:0005524 (8%);GO:0046872 (5%),DNA binding (10%);ATP binding (8%);metal ion binding (5%),GO:0006313 (3%);GO:0055085 (2%);GO:0006310 (2%),transposition, DNA-mediated (3%);transmembrane transport (2%);DNA recombination (2%),IPR027417 (5%);IPR036388 (4%);IPR009057 (4%),P-loop containing nucleoside triphosphate hydrolase (5%);Winged helix-like DNA-binding domain superfamily (4%);Homeobox-like domain superfamily (4%),,,,,,,,,
VLELAPTDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMPELNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (50%);GO:0016021 (50%),cell outer membrane (50%);integral component of membrane (50%),GO:0003676 (50%),nucleic acid binding (50%),,,IPR000531 (50%);IPR008969 (50%);IPR011662 (50%),TonB-dependent receptor-like, beta-barrel (50%);Carboxypeptidase-like, regulatory domain superfamily (50%);Secretin/TonB, short N-terminal domain (50%),,,,,,,,
SSTEEEGPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVALLNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNWLLVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008080 (100%),N-acetyltransferase activity (100%),,,IPR000182 (67%);IPR016181 (67%);IPR011519 (33%),GNAT domain (67%);Acyl-CoA N-acyltransferase (67%);ASPIC/UnbV (33%),,,,,,,,,,,
LAPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.52 (25%);1.5.3.1 (16%);2.7.7.7 (6%),Cyclic-guanylate-specific phosphodiesterase (25%);Sarcosine oxidase (16%);DNA-directed DNA polymerase (6%),GO:0016021 (20%);GO:0005737 (11%);GO:0005886 (2%),integral component of membrane (20%);cytoplasm (11%);plasma membrane (2%),GO:0005524 (11%);GO:0003676 (6%);GO:0071111 (6%),ATP binding (11%);nucleic acid binding (6%);cyclic-guanylate-specific phosphodiesterase activity (6%),GO:0046653 (4%);GO:0007165 (3%);GO:0120009 (2%),tetrahydrofolate metabolic process (4%);signal transduction (3%);intermembrane lipid transfer (2%),IPR027417 (11%);IPR036188 (7%);IPR035919 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);FAD/NAD(P)-binding domain superfamily (7%);EAL domain superfamily (7%),,,,,,,,,,,
TMGMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.42 (34%);1.9.3.1 (22%);4.2.3.4 (10%),Branched-chain-amino-acid transaminase (34%);Cytochrome-c oxidase (22%);3-dehydroquinate synthase (10%),GO:0016021 (41%);GO:0005886 (8%);GO:0005743 (6%),integral component of membrane (41%);plasma membrane (8%);mitochondrial inner membrane (6%),GO:0005524 (26%);GO:0016887 (20%);GO:0005315 (14%),ATP binding (26%);ATPase activity (20%);inorganic phosphate transmembrane transporter activity (14%),GO:0006817 (14%);GO:0009082 (8%);GO:0006119 (6%),phosphate ion transport (14%);branched-chain amino acid biosynthetic process (8%);oxidative phosphorylation (6%),IPR027417 (21%);IPR003593 (19%);IPR003439 (19%),P-loop containing nucleoside triphosphate hydrolase (21%);AAA+ ATPase domain (19%);ABC transporter-like (19%),,,,,,,,,,,
MMVAWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
LQVYEDAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSGNHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (50%);2.8.3.16 (25%);3.6.5.5 (13%),Phenylalanine--tRNA ligase (50%);Formyl-CoA transferase (25%);Dynamin GTPase (13%),GO:0016021 (49%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (49%);cytoplasm (5%);nucleus (2%),GO:0005524 (9%);GO:0000049 (5%);GO:0000287 (5%),ATP binding (9%);tRNA binding (5%);magnesium ion binding (5%),GO:0006432 (5%);GO:0005975 (4%);GO:0007165 (4%),phenylalanyl-tRNA aminoacylation (5%);carbohydrate metabolic process (4%);signal transduction (4%),IPR018702 (18%);IPR027417 (12%);IPR003593 (7%),Protein of unknown function DUF2207, membrane (18%);P-loop containing nucleoside triphosphate hydrolase (12%);AAA+ ATPase domain (7%),,,,,,,,,,
NVEWWLGTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSELENNVEMGPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEAEEADLQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLWLEAVDAVYNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPEAPMR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR005122 (100%);IPR005273 (100%);IPR023875 (100%),Uracil-DNA glycosylase-like (100%);Uracil-DNA glycosylase family 4 (100%);DNA metabolism protein, putative (100%),,,,,,,,,,
EEGTSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.13 (100%),Methionine synthase (100%),,,GO:0008270 (100%);GO:0008705 (100%);GO:0031419 (100%),zinc ion binding (100%);methionine synthase activity (100%);cobalamin binding (100%),GO:0032259 (100%),methylation (100%),IPR000489 (100%);IPR003726 (100%);IPR003759 (100%),Pterin-binding domain (100%);Homocysteine-binding domain (100%);Cobalamin (vitamin B12)-binding module, cap domain (100%),,,,,,,,,,
EVTFMSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (14%);4.1.1.32 (12%);6.5.1.2 (12%),Type I site-specific deoxyribonuclease (14%);Phosphoenolpyruvate carboxykinase (GTP) (12%);DNA ligase (NAD(+)) (12%),GO:0016021 (21%);GO:0005737 (13%);GO:0005886 (2%),integral component of membrane (21%);cytoplasm (13%);plasma membrane (2%),GO:0005524 (22%);GO:0003677 (14%);GO:0046872 (8%),ATP binding (22%);DNA binding (14%);metal ion binding (8%),GO:0006260 (5%);GO:0009307 (4%);GO:0006281 (4%),DNA replication (5%);DNA restriction-modification system (4%);DNA repair (4%),IPR027417 (13%);IPR014001 (4%);IPR039424 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);Helicase superfamily 1/2, ATP-binding domain (4%);Solute-binding protein family 5 (4%),,,,,,,,,,
VFPSLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.85 (67%);2.3.1.51 (33%),3-isopropylmalate dehydrogenase (67%);1-acylglycerol-3-phosphate O-acyltransferase (33%),GO:0016021 (13%);GO:0000178 (7%);GO:0005634 (7%),integral component of membrane (13%);exosome (RNase complex) (7%);nucleus (7%),GO:0000287 (13%);GO:0003676 (13%);GO:0003862 (13%),magnesium ion binding (13%);nucleic acid binding (13%);3-isopropylmalate dehydrogenase activity (13%),GO:0009098 (13%);GO:0019752 (13%);GO:0006260 (7%),leucine biosynthetic process (13%);carboxylic acid metabolic process (13%);DNA replication (7%),IPR005301 (51%);IPR036703 (51%);IPR002129 (5%),MOB kinase activator family (51%);MOB kinase activator superfamily (51%);Pyridoxal phosphate-dependent decarboxylase (5%),,,,,,,,,,,
FEDLQTSMTHVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGGQTAVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QWLNSHMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLHFTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (31%);GO:0005886 (8%),integral component of membrane (31%);plasma membrane (8%),GO:0000155 (46%);GO:0003700 (46%);GO:0043565 (46%),phosphorelay sensor kinase activity (46%);DNA-binding transcription factor activity (46%);sequence-specific DNA binding (46%),GO:0006491 (8%);GO:0055085 (8%),N-glycan processing (8%);transmembrane transport (8%),IPR015943 (54%);IPR001789 (46%);IPR003594 (46%),WD40/YVTN repeat-like-containing domain superfamily (54%);Signal transduction response regulator, receiver domain (46%);Histidine kinase/HSP90-like ATPase (46%),,,,,,,,,,
MAQDSFDEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEPNGQVLTLEGNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLVHSMPAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAGNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.3 (50%);2.3.1.97 (25%);3.6.5.5 (25%),Glycerol-3-phosphate dehydrogenase (50%);Glycylpeptide N-tetradecanoyltransferase (25%);Dynamin GTPase (25%),GO:0005741 (13%);GO:0005777 (13%);GO:0005829 (13%),mitochondrial outer membrane (13%);peroxisome (13%);cytosol (13%),GO:0005525 (76%);GO:0003924 (75%);GO:0042803 (13%),GTP binding (76%);GTPase activity (75%);protein homodimerization activity (13%),GO:0016559 (16%);GO:0000001 (13%);GO:0001300 (13%),peroxisome fission (16%);mitochondrion inheritance (13%);chronological cell aging (13%),IPR027417 (69%);IPR001401 (67%);IPR019762 (67%),P-loop containing nucleoside triphosphate hydrolase (69%);Dynamin, GTPase domain (67%);Dynamin, GTPase region, conserved site (67%),,,,,,,,
VHDESFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (50%),nucleus (50%),GO:0005524 (100%);GO:0000981 (50%);GO:0004066 (50%),ATP binding (100%);DNA-binding transcription factor activity, RNA polymerase II-specific (50%);asparagine synthase (glutamine-hydrolyzing) activity (50%),GO:0006529 (50%);GO:0006541 (50%),asparagine biosynthetic process (50%);glutamine metabolic process (50%),IPR000330 (50%);IPR001138 (50%);IPR001525 (50%),SNF2-related, N-terminal domain (50%);Zn(2)-C6 fungal-type DNA-binding domain (50%);C-5 cytosine methyltransferase (50%),,,,,,,,,
WLNEVVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWTAWFGPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVNADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.6 (40%);3.1.-.- (20%);4.2.1.9 (20%),Catalase (40%);Acting on ester bonds (20%);Dihydroxy-acid dehydratase (20%),GO:0016021 (42%);GO:0005886 (31%);GO:1990904 (18%),integral component of membrane (42%);plasma membrane (31%);ribonucleoprotein complex (18%),GO:0003723 (26%);GO:0016746 (8%);GO:0046872 (6%),RNA binding (26%);transferase activity, transferring acyl groups (8%);metal ion binding (6%),GO:0042121 (15%);GO:0042953 (10%);GO:0005975 (5%),alginic acid biosynthetic process (15%);lipoprotein transport (10%);carbohydrate metabolic process (5%),IPR000504 (20%);IPR003954 (20%);IPR012677 (20%),RNA recognition motif domain (20%);RNA recognition motif domain, eukaryote (20%);Nucleotide-binding alpha-beta plait domain superfamily (20%),,,,,,,,,
QVSLNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (100%),Non-specific serine/threonine protein kinase (100%),GO:0016021 (67%),integral component of membrane (67%),GO:0003677 (33%);GO:0004519 (33%);GO:0016301 (33%),DNA binding (33%);endonuclease activity (33%);kinase activity (33%),GO:0006304 (33%),DNA modification (33%),IPR000055 (14%);IPR000719 (14%);IPR001680 (14%),Restriction endonuclease, type I, HsdS (14%);Protein kinase domain (14%);WD40 repeat (14%),,,,,,,,,
VLYSLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.21 (50%);6.1.1.23 (50%),Starch synthase (50%);Aspartate--tRNA(Asn) ligase (50%),GO:0016021 (15%);GO:0005634 (2%);GO:0005737 (2%),integral component of membrane (15%);nucleus (2%);cytoplasm (2%),GO:0005524 (68%);GO:0003777 (61%);GO:0008017 (61%),ATP binding (68%);microtubule motor activity (61%);microtubule binding (61%),GO:0007018 (61%);GO:0007155 (5%);GO:0009253 (5%),microtubule-based movement (61%);cell adhesion (5%);peptidoglycan catabolic process (5%),IPR027417 (57%);IPR001752 (54%);IPR019821 (54%),P-loop containing nucleoside triphosphate hydrolase (57%);Kinesin motor domain (54%);Kinesin motor domain, conserved site (54%),,,,,,,,,,
TMAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.5 (77%);1.-.-.- (3%);1.17.7.4 (2%),Lysophospholipase (77%);Oxidoreductases (3%);4-hydroxy-3-methylbut-2-enyl diphosphate reductase (2%),GO:0016021 (45%);GO:0005789 (38%);GO:0005634 (4%),integral component of membrane (45%);endoplasmic reticulum membrane (38%);nucleus (4%),GO:0004622 (38%);GO:0016491 (15%);GO:0005524 (9%),lysophospholipase activity (38%);oxidoreductase activity (15%);ATP binding (9%),GO:0016042 (38%);GO:0046470 (16%);GO:0006355 (2%),lipid catabolic process (38%);phosphatidylcholine metabolic process (16%);regulation of transcription, DNA-templated (2%),IPR016035 (36%);IPR000595 (35%);IPR002641 (35%),Acyl transferase/acyl hydrolase/lysophospholipase (36%);Cyclic nucleotide-binding domain (35%);Patatin-like phospholipase domain (35%),,,,,,,,,,
VEHMNSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVNLAQLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (50%);GO:0005737 (50%);GO:0016021 (50%),cell (50%);cytoplasm (50%);integral component of membrane (50%),,,GO:0006817 (50%);GO:0030643 (50%);GO:0045936 (50%),phosphate ion transport (50%);cellular phosphate ion homeostasis (50%);negative regulation of phosphate metabolic process (50%),IPR001119 (50%);IPR026022 (50%);IPR028366 (50%),S-layer homology domain (50%);PhoU domain (50%);Phosphate transport system protein PhoU (50%),,,,,,,,,,,
NLFHMVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLDEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (21%);2.5.1.15 (12%);1.2.1.41 (11%),DNA-directed RNA polymerase (21%);Dihydropteroate synthase (12%);Glutamate-5-semialdehyde dehydrogenase (11%),GO:0016021 (33%);GO:0005576 (11%);GO:0005618 (11%),integral component of membrane (33%);extracellular region (11%);cell wall (11%),GO:0003677 (12%);GO:0046872 (9%);GO:0005524 (7%),DNA binding (12%);metal ion binding (9%);ATP binding (7%),GO:0006351 (5%);GO:0015986 (4%);GO:0032259 (4%),transcription, DNA-templated (5%);ATP synthesis coupled proton transport (4%);methylation (4%),IPR006860 (13%);IPR012373 (13%);IPR019931 (8%),FecR protein (13%);Fe(2+)-dicitrate sensor, transmembrane component (13%);LPXTG cell wall anchor domain (8%),,,,,,,,,
QVVVWDK,Ramazzottius varieornatus,Eukaryota,Metazoa,,,Tardigrada,,,Eutardigrada,,,,Parachela,,,,Hypsibioidea,Ramazzottiidae,,,,Ramazzottius,,,,Ramazzottius varieornatus,,,,,,,,GO:0016651 (100%),oxidoreductase activity, acting on NAD(P)H (100%),,,IPR002937 (100%);IPR036188 (100%);IPR040174 (100%),Amine oxidase (100%);FAD/NAD(P)-binding domain superfamily (100%);Renalase (100%),,,,,,,,,,
TEGAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (33%);2.7.10.2 (15%);6.3.5.3 (6%),Phenylalanine--tRNA ligase (33%);Non-specific protein-tyrosine kinase (15%);Phosphoribosylformylglycinamidine synthase (6%),GO:0016021 (29%);GO:0005737 (21%);GO:0005886 (3%),integral component of membrane (29%);cytoplasm (21%);plasma membrane (3%),GO:0005524 (29%);GO:0000287 (12%);GO:0004826 (10%),ATP binding (29%);magnesium ion binding (12%);phenylalanine-tRNA ligase activity (10%),GO:0006432 (10%);GO:0006541 (4%);GO:0042128 (3%),phenylalanyl-tRNA aminoacylation (10%);glutamine metabolic process (4%);nitrate assimilation (3%),IPR006195 (9%);IPR002319 (9%);IPR004188 (9%),Aminoacyl-tRNA synthetase, class II (9%);Phenylalanyl-tRNA synthetase (9%);Phenylalanine-tRNA ligase, class II, N-terminal (9%),,,,,,,,
MGELVDTPDSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFNVTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.13 (88%);2.4.1.- (6%);2.3.3.3 (4%),2-isopropylmalate synthase (88%);Hexosyltransferases (6%);Citrate (Re)-synthase (4%),GO:0016021 (3%);GO:0000015 (0%);GO:0005737 (0%),integral component of membrane (3%);phosphopyruvate hydratase complex (0%);cytoplasm (0%),GO:0003824 (75%);GO:0003852 (16%);GO:0016740 (2%),catalytic activity (75%);2-isopropylmalate synthase activity (16%);transferase activity (2%),GO:0005975 (1%);GO:0055085 (1%);GO:0001123 (0%),carbohydrate metabolic process (1%);transmembrane transport (1%);transcription initiation from bacterial-type RNA polymerase promoter (0%),IPR013785 (90%);IPR000891 (89%);IPR027417 (2%),Aldolase-type TIM barrel (90%);Pyruvate carboxyltransferase (89%);P-loop containing nucleoside triphosphate hydrolase (2%),,,,,,,,,,,
QLNHLFSK,Armadillidium,Eukaryota,Metazoa,,,Arthropoda,Crustacea,Multicrustacea,Malacostraca,Eumalacostraca,,Peracarida,Isopoda,Oniscidea,,,,Armadillidiidae,,,,Armadillidium,,,,,,,,,,,,GO:0003723 (100%),RNA binding (100%),,,IPR000504 (100%);IPR012677 (100%);IPR035979 (100%),RNA recognition motif domain (100%);Nucleotide-binding alpha-beta plait domain superfamily (100%);RNA-binding domain superfamily (100%),,,,,,,,,,,
EYVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (17%);6.1.1.12 (7%);6.1.1.23 (3%),DNA topoisomerase (17%);Aspartate--tRNA ligase (7%);Aspartate--tRNA(Asn) ligase (3%),GO:0016021 (21%);GO:0005737 (9%);GO:0005634 (6%),integral component of membrane (21%);cytoplasm (9%);nucleus (6%),GO:0005524 (25%);GO:0003677 (14%);GO:0046872 (10%),ATP binding (25%);DNA binding (14%);metal ion binding (10%),GO:0032968 (5%);GO:0006265 (4%);GO:0006139 (4%),positive regulation of transcription elongation from RNA polymerase II promoter (5%);DNA topological change (4%);nucleobase-containing compound metabolic process (4%),IPR027417 (16%);IPR014710 (7%);IPR011051 (7%),P-loop containing nucleoside triphosphate hydrolase (16%);RmlC-like jelly roll fold (7%);RmlC-like cupin domain superfamily (7%),,,,,,,,,,,
APLLNLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.20 (100%),7-cyano-7-deazaguanine synthase (100%),,,GO:0005524 (100%);GO:0008270 (100%);GO:0016879 (100%),ATP binding (100%);zinc ion binding (100%);ligase activity, forming carbon-nitrogen bonds (100%),GO:0008616 (50%),queuosine biosynthetic process (50%),IPR014729 (100%);IPR018317 (100%),Rossmann-like alpha/beta/alpha sandwich fold (100%);Queuosine biosynthesis protein QueC (100%),,,,,,,,,,
QHMFGDTYTQHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNASMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQTGLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.5.11 (25%);1.6.5.- (13%);1.6.5.3 (13%),NADH dehydrogenase (quinone) (25%);With a quinone or similar compound as acceptor (13%);Transferred entry: 7.1.1.2 (13%),GO:0016021 (67%);GO:0005634 (6%);GO:0005737 (6%),integral component of membrane (67%);nucleus (6%);cytoplasm (6%),GO:0008137 (25%);GO:0005524 (17%);GO:0042578 (17%),NADH dehydrogenase (ubiquinone) activity (25%);ATP binding (17%);phosphoric ester hydrolase activity (17%),GO:0042773 (23%);GO:0006468 (6%);GO:0019915 (4%),ATP synthesis coupled electron transport (23%);protein phosphorylation (6%);lipid storage (4%),IPR001750 (42%);IPR003945 (42%);IPR001516 (40%),NADH:quinone oxidoreductase/Mrp antiporter, membrane subunit (42%);NADH-plastoquinone oxidoreductase, chain 5 (42%);NADH-Ubiquinone oxidoreductase (complex I), chain 5 N-terminal (40%),,,,,,,,
LANKPPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTQLVFEMVCPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNAGPEK,Oceanobacillus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Bacillaceae,,,,Oceanobacillus,,,,,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),,,IPR003607 (100%),HD/PDEase domain (100%),,,,,,,,,,,
FVFMMVFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DTEVQEEYSANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MANLNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (45%);2.1.3.3 (9%);2.3.1.222 (9%),Acting on ester bonds (45%);Ornithine carbamoyltransferase (9%);Phosphate propanoyltransferase (9%),GO:0015934 (28%);GO:0016021 (21%);GO:0005634 (11%),large ribosomal subunit (28%);integral component of membrane (21%);nucleus (11%),GO:0003735 (29%);GO:0003677 (13%);GO:0016614 (11%),structural constituent of ribosome (29%);DNA binding (13%);oxidoreductase activity, acting on CH-OH group of donors (11%),GO:0006412 (29%);GO:0034976 (3%);GO:0035269 (3%),translation (29%);response to endoplasmic reticulum stress (3%);protein O-linked mannosylation (3%),IPR005996 (27%);IPR016082 (27%);IPR036919 (27%),Ribosomal protein L30, bacterial-type (27%);Ribosomal protein L30, ferredoxin-like fold domain (27%);Ribosomal protein L30, ferredoxin-like fold domain superfamily (27%),,,,,,,
LWDTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.6 (52%);7.1.2.2 (9%);6.3.5.- (5%),Phosphoribosylaminoimidazolesuccinocarboxamide synthase (52%);H(+)-transporting two-sector ATPase (9%);Carbon--nitrogen ligases with glutamine as amido-N-donor (5%),GO:0016021 (15%);GO:0005730 (4%);GO:0045278 (3%),integral component of membrane (15%);nucleolus (4%);plasma membrane respiratory chain complex IV (3%),GO:0003677 (38%);GO:0005524 (14%);GO:0004639 (8%),DNA binding (38%);ATP binding (14%);phosphoribosylaminoimidazolesuccinocarboxamide synthase activity (8%),GO:0006310 (36%);GO:0015074 (35%);GO:0006189 (8%),DNA recombination (36%);DNA integration (35%);'de novo' IMP biosynthetic process (8%),IPR015943 (37%);IPR001680 (36%);IPR017986 (35%),WD40/YVTN repeat-like-containing domain superfamily (37%);WD40 repeat (36%);WD40-repeat-containing domain (35%),,,,,,,,,,,
ALTLWAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDPLDAMTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLLVTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.4 (27%);3.5.1.115 (17%);3.1.26.4 (13%),Phospholipase D (27%);Mycothiol S-conjugate amidase (17%);Ribonuclease H (13%),GO:0016021 (54%);GO:0005794 (34%);GO:0005887 (13%),integral component of membrane (54%);Golgi apparatus (34%);integral component of plasma membrane (13%),GO:0008373 (30%);GO:0038023 (13%);GO:0003677 (9%),sialyltransferase activity (30%);signaling receptor activity (13%);DNA binding (9%),GO:0006486 (31%);GO:0007411 (13%);GO:0030513 (13%),protein glycosylation (31%);axon guidance (13%);positive regulation of BMP signaling pathway (13%),IPR001675 (27%);IPR038578 (27%);IPR012163 (26%),Glycosyl transferase family 29 (27%);GT29-like superfamiliy (27%);Sialyltransferase (26%),,,,,,,,,,,
LAMAALPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGNFEGK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.199 (92%);1.7.2.4 (8%),16S rRNA (cytosine(1402)-N(4))-methyltransferase (92%);Nitrous-oxide reductase (8%),GO:0005737 (52%);GO:0030257 (4%),cytoplasm (52%);type III protein secretion system complex (4%),GO:0071424 (48%);GO:0003824 (39%);GO:0005524 (4%),rRNA (cytosine-N4-)-methyltransferase activity (48%);catalytic activity (39%);ATP binding (4%),GO:0070475 (48%);GO:0009058 (4%);GO:0030254 (4%),rRNA base methylation (48%);biosynthetic process (4%);protein secretion by the type III secretion system (4%),IPR029063 (50%);IPR002903 (46%);IPR023397 (46%),S-adenosyl-L-methionine-dependent methyltransferase (50%);Ribosomal RNA small subunit methyltransferase H (46%);S-adenosyl-L-methionine-dependent methyltransferase, MraW, recognition domain superfamily (46%),,,,,,,,,
QMSDQGAQLYDDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAQEEDNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QFVLLTVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (86%);GO:0005840 (86%);GO:0016021 (14%),cytoplasm (86%);ribosome (86%);integral component of membrane (14%),GO:0043022 (86%);GO:0005216 (14%),ribosome binding (86%);ion channel activity (14%),GO:0006364 (86%);GO:0042274 (86%),rRNA processing (86%);ribosomal small subunit biogenesis (86%),IPR002676 (75%);IPR009000 (75%);IPR011033 (75%),RimM, N-terminal (75%);Translation protein, beta-barrel domain superfamily (75%);PRC-barrel-like superfamily (75%),,,,,,,,,
TMLLLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GCPEAFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFYHEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (67%);5.2.1.8 (33%),Transferring other groups (67%);Peptidylprolyl isomerase (33%),GO:0005634 (14%);GO:0016021 (14%);GO:0005737 (7%),nucleus (14%);integral component of membrane (14%);cytoplasm (7%),GO:0003723 (29%);GO:0003824 (21%);GO:0009982 (14%),RNA binding (29%);catalytic activity (21%);pseudouridine synthase activity (14%),GO:0001522 (14%);GO:0006457 (7%);GO:0006508 (7%),pseudouridine synthesis (14%);protein folding (7%);proteolysis (7%),IPR002942 (14%);IPR004087 (14%);IPR004088 (14%),RNA-binding S4 domain (14%);K Homology domain (14%);K Homology domain, type 1 (14%),,,,,,,,,,
YMPGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0070469 (36%);GO:0016021 (29%);GO:0005739 (21%),respirasome (36%);integral component of membrane (29%);mitochondrion (21%),GO:0009055 (57%);GO:0020037 (57%);GO:0046872 (43%),electron transfer activity (57%);heme binding (57%);metal ion binding (43%),GO:0010336 (14%);GO:0006122 (7%);GO:0006123 (7%),gibberellic acid homeostasis (14%);mitochondrial electron transport, ubiquinol to cytochrome c (7%);mitochondrial electron transport, cytochrome c to oxygen (7%),IPR009056 (62%);IPR036909 (62%);IPR002327 (46%),Cytochrome c-like domain (62%);Cytochrome c-like domain superfamily (62%);Cytochrome c, class IA/ IB (46%),,,,,,,,
APTWVDLMELPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNLALLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.96 (28%);2.4.2.29 (12%);2.1.1.228 (8%),Carboxynorspermidine decarboxylase (28%);tRNA-guanine(34) transglycosylase (12%);tRNA (guanine(37)-N(1))-methyltransferase (8%),GO:0016021 (36%);GO:0032300 (8%);GO:0005737 (4%),integral component of membrane (36%);mismatch repair complex (8%);cytoplasm (4%),GO:0005524 (16%);GO:0004252 (13%);GO:0016831 (10%),ATP binding (16%);serine-type endopeptidase activity (13%);carboxy-lyase activity (10%),GO:0006298 (10%);GO:0045312 (10%);GO:0007018 (2%),mismatch repair (10%);nor-spermidine biosynthetic process (10%);microtubule-based movement (2%),IPR009003 (22%);IPR036890 (15%);IPR039562 (14%),Peptidase S1, PA clan (22%);Histidine kinase/HSP90-like ATPase superfamily (15%);Membrane fusion protein, biotin-lipoyl like domain (14%),,,,,,,,,
SPTNAVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (90%);GO:0098793 (80%),integral component of membrane (90%);presynapse (80%),GO:0005509 (80%);GO:0000166 (10%);GO:0016639 (10%),calcium ion binding (80%);nucleotide binding (10%);oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor (10%),GO:0016079 (80%);GO:0006520 (10%),synaptic vesicle exocytosis (80%);cellular amino acid metabolic process (10%),IPR000008 (80%);IPR012561 (80%);IPR012968 (80%),C2 domain (80%);Ferlin B-domain (80%);FerIin domain (80%),,,,,,,,,
DLAPHFEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.39 (10%);1.1.1.267 (9%);1.1.5.4 (6%),Homoserine kinase (10%);1-deoxy-D-xylulose-5-phosphate reductoisomerase (9%);Malate dehydrogenase (quinone) (6%),GO:0016021 (20%);GO:0005737 (6%);GO:0043190 (4%),integral component of membrane (20%);cytoplasm (6%);ATP-binding cassette (ABC) transporter complex (4%),GO:0005524 (13%);GO:0003677 (8%);GO:0046872 (8%),ATP binding (13%);DNA binding (8%);metal ion binding (8%),GO:0006355 (5%);GO:0006260 (4%);GO:0018142 (4%),regulation of transcription, DNA-templated (5%);DNA replication (4%);protein-DNA covalent cross-linking (4%),IPR027417 (7%);IPR036291 (5%);IPR002678 (4%),P-loop containing nucleoside triphosphate hydrolase (7%);NAD(P)-binding domain superfamily (5%);GTP cyclohydrolase 1 type 2/Nif3 (4%),,,,,,,,,,
LVAPGLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.39 (65%);2.6.1.57 (7%);2.6.1.- (5%),2-aminoadipate transaminase (65%);Aromatic-amino-acid transaminase (7%);Transaminases (5%),GO:0016021 (5%);GO:0005634 (2%);GO:0005759 (2%),integral component of membrane (5%);nucleus (2%);mitochondrial matrix (2%),GO:0030170 (80%);GO:0008483 (62%);GO:0003824 (17%),pyridoxal phosphate binding (80%);transaminase activity (62%);catalytic activity (17%),GO:0009058 (80%);GO:0016226 (2%);GO:0006289 (2%),biosynthetic process (80%);iron-sulfur cluster assembly (2%);nucleotide-excision repair (2%),IPR004839 (84%);IPR015421 (84%);IPR015424 (84%),Aminotransferase, class I/classII (84%);Pyridoxal phosphate-dependent transferase, major domain (84%);Pyridoxal phosphate-dependent transferase (84%),,,,,,,,,
FFWLFVSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVELMPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVDADEAWEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQLEENR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (67%);6.1.1.7 (33%),Peptidylprolyl isomerase (67%);Alanine--tRNA ligase (33%),GO:0005813 (69%);GO:0016021 (17%);GO:0005643 (5%),centrosome (69%);integral component of membrane (17%);nuclear pore (5%),GO:0008017 (69%);GO:0003755 (3%);GO:0000049 (2%),microtubule binding (69%);peptidyl-prolyl cis-trans isomerase activity (3%);tRNA binding (2%),GO:0034453 (69%);GO:0016973 (5%);GO:0006457 (3%),microtubule anchoring (69%);poly(A)+ mRNA export from nucleus (5%);protein folding (3%),IPR000938 (63%);IPR028750 (63%);IPR036859 (63%),CAP Gly-rich domain (63%);Centrosome-associated protein 350 (63%);CAP Gly-rich domain superfamily (63%),,,,,,,,,,,
FVEEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.13 (11%);2.7.7.7 (11%);3.6.4.13 (9%),Methionine synthase (11%);DNA-directed DNA polymerase (11%);RNA helicase (9%),GO:0016021 (11%);GO:0005886 (9%);GO:0005737 (5%),integral component of membrane (11%);plasma membrane (9%);cytoplasm (5%),GO:0030676 (24%);GO:0046872 (16%);GO:0031419 (11%),Rac guanyl-nucleotide exchange factor activity (24%);metal ion binding (16%);cobalamin binding (11%),GO:0035556 (20%);GO:0007186 (9%);GO:0008344 (8%),intracellular signal transduction (20%);G protein-coupled receptor signaling pathway (9%);adult locomotory behavior (8%),IPR001478 (27%);IPR036034 (27%);IPR036388 (27%),PDZ domain (27%);PDZ superfamily (27%);Winged helix-like DNA-binding domain superfamily (27%),,,,,,,,,,,
NADER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.16.4 (9%);2.7.13.3 (7%);2.1.3.15 (7%),Serine-type D-Ala-D-Ala carboxypeptidase (9%);Histidine kinase (7%);Acetyl-CoA carboxytransferase (7%),GO:0016021 (19%);GO:0005737 (18%);GO:0005886 (3%),integral component of membrane (19%);cytoplasm (18%);plasma membrane (3%),GO:0005524 (37%);GO:0003677 (16%);GO:0016787 (10%),ATP binding (37%);DNA binding (16%);hydrolase activity (10%),GO:0030163 (13%);GO:0006887 (2%);GO:0006366 (2%),protein catabolic process (13%);exocytosis (2%);transcription by RNA polymerase II (2%),IPR027417 (29%);IPR003593 (13%);IPR003959 (11%),P-loop containing nucleoside triphosphate hydrolase (29%);AAA+ ATPase domain (13%);ATPase, AAA-type, core (11%),,,,,,,,,
LLAHWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.33 (31%);2.7.1.35 (13%);2.7.4.25 (10%),Pantothenate kinase (31%);Pyridoxal kinase (13%);(d)CMP kinase (10%),GO:0016021 (14%);GO:0005737 (5%);GO:0043190 (1%),integral component of membrane (14%);cytoplasm (5%);ATP-binding cassette (ABC) transporter complex (1%),GO:0003677 (31%);GO:0003824 (13%);GO:0005524 (13%),DNA binding (31%);catalytic activity (13%);ATP binding (13%),GO:0006310 (28%);GO:0006478 (7%);GO:0009103 (5%),DNA recombination (28%);peptidyl-tyrosine sulfation (7%);lipopolysaccharide biosynthetic process (5%),IPR001668 (26%);IPR027417 (18%);IPR000868 (16%),Plasmid recombination enzyme (26%);P-loop containing nucleoside triphosphate hydrolase (18%);Isochorismatase-like (16%),,,,,,,,,,,
NLNSVSVTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DCHDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000150 (50%);GO:0003677 (50%);GO:0003700 (50%),recombinase activity (50%);DNA binding (50%);DNA-binding transcription factor activity (50%),,,IPR000835 (33%);IPR003961 (33%);IPR006119 (33%),MarR-type HTH domain (33%);Fibronectin type III (33%);Resolvase, N-terminal catalytic domain (33%),,,,,,,,,,
QETNEECNAQGYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYLFMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (50%);7.1.1.2 (50%),Histidine kinase (50%);NADH:ubiquinone reductase (H(+)-translocating) (50%),GO:0016021 (33%);GO:0005737 (5%);GO:0000932 (3%),integral component of membrane (33%);cytoplasm (5%);P-body (3%),GO:0016491 (38%);GO:0016740 (15%);GO:0003677 (8%),oxidoreductase activity (38%);transferase activity (15%);DNA binding (8%),GO:0000132 (3%);GO:0006310 (3%);GO:0006352 (3%),establishment of mitotic spindle orientation (3%);DNA recombination (3%);DNA-templated transcription, initiation (3%),IPR000415 (31%);IPR029478 (31%);IPR003362 (16%),Nitroreductase-like (31%);Putative nitroreductase TM1586 (31%);Bacterial sugar transferase (16%),,,,,,,,,,
LSESNTPK,Clostridium cavendishii,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Clostridiaceae,,,,Clostridium,,,,Clostridium cavendishii,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC transporter permease protein domain (100%);MacB-like periplasmic core domain (100%),,,,,,,,,,,
FAVSLELK,Dikarya,Eukaryota,Fungi,Dikarya,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (100%),Acting on ester bonds (100%),GO:0005634 (50%);GO:0005737 (50%),nucleus (50%);cytoplasm (50%),GO:0003676 (100%);GO:0000175 (50%);GO:0004527 (50%),nucleic acid binding (100%);3'-5'-exoribonuclease activity (50%);exonuclease activity (50%),GO:0000467 (50%);GO:0034476 (50%),exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (50%);U5 snRNA 3'-end processing (50%),IPR011022 (50%);IPR012337 (50%);IPR013520 (50%),Arrestin C-terminal-like domain (50%);Ribonuclease H-like superfamily (50%);Exonuclease, RNase T/DNA polymerase III (50%),,,,,,,,
DFLALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (25%);3.6.4.12 (25%);2.1.2.9 (13%),Acting on ester bonds (25%);DNA helicase (25%);Methionyl-tRNA formyltransferase (13%),GO:0016021 (11%);GO:1990077 (11%);GO:0005737 (5%),integral component of membrane (11%);primosome complex (11%);cytoplasm (5%),GO:0005524 (26%);GO:0003677 (21%);GO:0016301 (16%),ATP binding (26%);DNA binding (21%);kinase activity (16%),GO:0015969 (21%);GO:0006269 (11%);GO:0016539 (11%),guanosine tetraphosphate metabolic process (21%);DNA replication, synthesis of RNA primer (11%);intein-mediated protein splicing (11%),IPR003607 (22%);IPR004095 (22%);IPR007685 (22%),HD/PDEase domain (22%);TGS (22%);RelA/SpoT (22%),,,,,,,,,,
SNNWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.4 (20%);4.99.1.1 (20%);3.6.4.12 (13%),Ribonuclease H (20%);Protoporphyrin ferrochelatase (20%);DNA helicase (13%),GO:0016021 (16%);GO:0005634 (3%);GO:0005737 (2%),integral component of membrane (16%);nucleus (3%);cytoplasm (2%),GO:0003677 (36%);GO:0003676 (10%);GO:0005524 (9%),DNA binding (36%);nucleic acid binding (10%);ATP binding (9%),GO:0006310 (33%);GO:0015074 (31%);GO:0005975 (2%),DNA recombination (33%);DNA integration (31%);carbohydrate metabolic process (2%),IPR002104 (21%);IPR011010 (21%);IPR013762 (21%),Integrase, catalytic domain (21%);DNA breaking-rejoining enzyme, catalytic core (21%);Integrase-like, catalytic domain superfamily (21%),,,,,,,,
ADAFANFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.99.6 (9%);6.1.1.14 (8%);2.1.1.- (7%),Epoxyqueuosine reductase (9%);Glycine--tRNA ligase (8%);Methyltransferases (7%),GO:0016021 (14%);GO:0005634 (12%);GO:0005737 (11%),integral component of membrane (14%);nucleus (12%);cytoplasm (11%),GO:0003677 (22%);GO:0005524 (20%);GO:0016887 (9%),DNA binding (22%);ATP binding (20%);ATPase activity (9%),GO:0006355 (13%);GO:0008033 (2%);GO:0008616 (2%),regulation of transcription, DNA-templated (13%);tRNA processing (2%);queuosine biosynthetic process (2%),IPR027417 (14%);IPR027153 (11%);IPR009071 (10%),P-loop containing nucleoside triphosphate hydrolase (14%);Transcription factor SOX-5/6 (11%);High mobility group box domain (10%),,,,,,,,,,
QALDNAGNNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GFTELLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (56%);2.7.7.19 (22%);1.2.1.58 (11%),Isoleucine--tRNA ligase (56%);Polynucleotide adenylyltransferase (22%);Phenylglyoxylate dehydrogenase (acylating) (11%),GO:0005737 (15%);GO:0016021 (9%);GO:0005887 (3%),cytoplasm (15%);integral component of membrane (9%);integral component of plasma membrane (3%),GO:0005524 (24%);GO:0003677 (18%);GO:0000049 (15%),ATP binding (24%);DNA binding (18%);tRNA binding (15%),GO:0006428 (15%);GO:0006378 (6%);GO:0032259 (6%),isoleucyl-tRNA aminoacylation (15%);mRNA polyadenylation (6%);methylation (6%),IPR021139 (27%);IPR025605 (25%);IPR001412 (10%),NYN domain, limkain-b1-type (27%);OST-HTH/LOTUS domain (25%);Aminoacyl-tRNA synthetase, class I, conserved site (10%),,,,,,,,
FENMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (50%);2.7.7.7 (20%);3.4.24.- (20%),Ribonucleoside-diphosphate reductase (50%);DNA-directed DNA polymerase (20%);Metalloendopeptidases (20%),GO:0016021 (57%);GO:0005886 (11%);GO:0005786 (4%),integral component of membrane (57%);plasma membrane (11%);signal recognition particle, endoplasmic reticulum targeting (4%),GO:0000166 (13%);GO:0004748 (11%);GO:0031419 (11%),nucleotide binding (13%);ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor (11%);cobalamin binding (11%),GO:0006260 (11%);GO:0071897 (11%);GO:0006261 (4%),DNA replication (11%);DNA biosynthetic process (11%);DNA-dependent DNA replication (4%),IPR018580 (28%);IPR011990 (9%);IPR013026 (9%),Uncharacterised protein family YfhO (28%);Tetratricopeptide-like helical domain superfamily (9%);Tetratricopeptide repeat-containing domain (9%),,,,,,,,,
MVWPAPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELVESAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (100%);GO:0009507 (20%);GO:0009536 (5%),ribosome (100%);chloroplast (20%);plastid (5%),GO:0003735 (93%);GO:0070180 (0%),structural constituent of ribosome (93%);large ribosomal subunit rRNA binding (0%),GO:0006412 (100%);GO:0042254 (0%),translation (100%);ribosome biogenesis (0%),IPR000206 (100%);IPR013823 (100%);IPR014719 (100%),Ribosomal protein L7/L12 (100%);Ribosomal protein L7/L12, C-terminal (100%);Ribosomal protein L7/L12, C-terminal/adaptor protein ClpS-like (100%),,,,,,,,,
LLEYER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.1 (42%);2.7.14.1 (22%);6.1.1.2 (8%),Glycine hydroxymethyltransferase (42%);Protein arginine kinase (22%);Tryptophan--tRNA ligase (8%),GO:0005737 (38%);GO:0016021 (13%);GO:0009380 (6%),cytoplasm (38%);integral component of membrane (13%);excinuclease repair complex (6%),GO:0005524 (18%);GO:0003677 (9%);GO:0016887 (7%),ATP binding (18%);DNA binding (9%);ATPase activity (7%),GO:0051301 (30%);GO:0007049 (30%);GO:0007059 (30%),cell division (30%);cell cycle (30%);chromosome segregation (30%),IPR003768 (24%);IPR027417 (11%);IPR014001 (7%),Segregation and condensation protein A (24%);P-loop containing nucleoside triphosphate hydrolase (11%);Helicase superfamily 1/2, ATP-binding domain (7%),,,,,,,,,,
LYTHFANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYFDYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.12 (50%);6.3.5.4 (50%),Teichoic acid poly(glycerol phosphate) polymerase (50%);Asparagine synthase (glutamine-hydrolyzing) (50%),GO:0016020 (25%);GO:0016021 (12%);GO:0005887 (2%),membrane (25%);integral component of membrane (12%);integral component of plasma membrane (2%),GO:0016740 (37%);GO:0047355 (25%);GO:0003677 (16%),transferase activity (37%);CDP-glycerol glycerophosphotransferase activity (25%);DNA binding (16%),GO:0006313 (16%);GO:0017004 (5%);GO:0006281 (2%),transposition, DNA-mediated (16%);cytochrome complex assembly (5%);DNA repair (2%),IPR016181 (41%);IPR038740 (41%);IPR007554 (23%),Acyl-CoA N-acyltransferase (41%);BioF2-like, acetyltransferase domain (41%);CDP-glycerol glycerophosphotransferase (23%),,,,,,,,,
YSYAAPR,Alistipes,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Rikenellaceae,,,,Alistipes,,,,,,,,,,,,,,,,IPR036942 (100%),TonB-dependent receptor-like, beta-barrel domain superfamily (100%),,,,,,,,,,
METVFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR006860 (50%);IPR012373 (50%);IPR023213 (50%),FecR protein (50%);Fe(2+)-dicitrate sensor, transmembrane component (50%);Chloramphenicol acetyltransferase-like domain superfamily (50%),,,,,,,,,,
WSNAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.2 (18%);5.6.2.2 (18%);1.1.5.3 (7%),Small monomeric GTPase (18%);DNA topoisomerase (ATP-hydrolyzing) (18%);Glycerol-3-phosphate dehydrogenase (7%),GO:0016021 (25%);GO:0019028 (7%);GO:0055036 (7%),integral component of membrane (25%);viral capsid (7%);virion membrane (7%),GO:0003824 (17%);GO:0005524 (16%);GO:0046872 (15%),catalytic activity (17%);ATP binding (16%);metal ion binding (15%),GO:0019062 (7%);GO:0039654 (7%);GO:0039694 (7%),virion attachment to host cell (7%);fusion of virus membrane with host endosome membrane (7%);viral RNA genome replication (7%),IPR027417 (15%);IPR001242 (11%);IPR023213 (11%),P-loop containing nucleoside triphosphate hydrolase (15%);Condensation domain (11%);Chloramphenicol acetyltransferase-like domain superfamily (11%),,,,,,,,,,,
VEANR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.9 (30%);2.6.1.13 (29%);2.7.7.7 (7%),Valine--tRNA ligase (30%);Ornithine aminotransferase (29%);DNA-directed DNA polymerase (7%),GO:0005737 (26%);GO:0016021 (15%);GO:0009341 (2%),cytoplasm (26%);integral component of membrane (15%);beta-galactosidase complex (2%),GO:0005524 (19%);GO:0004832 (12%);GO:0002161 (11%),ATP binding (19%);valine-tRNA ligase activity (12%);aminoacyl-tRNA editing activity (11%),GO:0006438 (12%);GO:0055129 (10%);GO:0032259 (7%),valyl-tRNA aminoacylation (12%);L-proline biosynthetic process (10%);methylation (7%),IPR014729 (10%);IPR009080 (10%);IPR013155 (9%),Rossmann-like alpha/beta/alpha sandwich fold (10%);Aminoacyl-tRNA synthetase, class Ia, anticodon-binding (10%);Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding (9%),,,,,,,,
QLLLFNESHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LADLLNEAASSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VELDALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.11 (25%);1.5.1.5 (13%);2.1.3.15 (13%),Serine--tRNA ligase (25%);Methylenetetrahydrofolate dehydrogenase (NADP(+)) (13%);Acetyl-CoA carboxytransferase (13%),GO:0009376 (21%);GO:0016021 (12%);GO:0005737 (4%),HslUV protease complex (21%);integral component of membrane (12%);cytoplasm (4%),GO:0008270 (30%);GO:0003676 (29%);GO:0005524 (27%),zinc ion binding (30%);nucleic acid binding (29%);ATP binding (27%),GO:0043335 (18%);GO:0006434 (1%);GO:0009236 (1%),protein unfolding (18%);seryl-tRNA aminoacylation (1%);cobalamin biosynthetic process (1%),IPR036875 (22%);IPR027417 (20%);IPR001878 (19%),Zinc finger, CCHC-type superfamily (22%);P-loop containing nucleoside triphosphate hydrolase (20%);Zinc finger, CCHC-type (19%),,,,,,,,,
SLMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.18 (76%);6.1.1.4 (3%);1.1.1.205 (3%),1,4-alpha-glucan branching enzyme (76%);Leucine--tRNA ligase (3%);IMP dehydrogenase (3%),GO:0016021 (9%);GO:0005737 (3%);GO:0005634 (2%),integral component of membrane (9%);cytoplasm (3%);nucleus (2%),GO:0003755 (33%);GO:0003844 (31%);GO:0102752 (31%),peptidyl-prolyl cis-trans isomerase activity (33%);1,4-alpha-glucan branching enzyme activity (31%);1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) (31%),GO:0005978 (31%);GO:0006457 (23%);GO:0006429 (1%),glycogen biosynthetic process (31%);protein folding (23%);leucyl-tRNA aminoacylation (1%),IPR036322 (30%);IPR015943 (30%);IPR001680 (30%),WD40-repeat-containing domain superfamily (30%);WD40/YVTN repeat-like-containing domain superfamily (30%);WD40 repeat (30%),,,,,,,,
LAWEQLLEYHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.3 (20%);3.6.4.12 (16%);2.7.13.3 (13%),Dihydroorotase (20%);DNA helicase (16%);Histidine kinase (13%),GO:0016021 (22%);GO:0005737 (6%);GO:0005634 (3%),integral component of membrane (22%);cytoplasm (6%);nucleus (3%),GO:0005524 (19%);GO:0003677 (11%);GO:0016740 (10%),ATP binding (19%);DNA binding (11%);transferase activity (10%),GO:0006355 (5%);GO:1901135 (3%);GO:0000723 (3%),regulation of transcription, DNA-templated (5%);carbohydrate derivative metabolic process (3%);telomere maintenance (3%),IPR027417 (13%);IPR002477 (7%);IPR005490 (7%),P-loop containing nucleoside triphosphate hydrolase (13%);Peptidoglycan binding-like (7%);L,D-transpeptidase catalytic domain (7%),,,,,,,,,
TLWFHVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEYPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.3.1 (19%);2.2.1.7 (19%);1.3.1.2 (15%),Transferred entry: 1.3.98.1 (19%);1-deoxy-D-xylulose-5-phosphate synthase (19%);Dihydropyrimidine dehydrogenase (NADP(+)) (15%),GO:0005874 (98%);GO:0005737 (46%);GO:0016021 (1%),microtubule (98%);cytoplasm (46%);integral component of membrane (1%),GO:0003924 (98%);GO:0005525 (98%);GO:0005200 (94%),GTPase activity (98%);GTP binding (98%);structural constituent of cytoskeleton (94%),GO:0007017 (94%);GO:0000226 (5%);GO:0000278 (5%),microtubule-based process (94%);microtubule cytoskeleton organization (5%);mitotic cell cycle (5%),IPR036525 (98%);IPR000217 (98%);IPR003008 (97%),Tubulin/FtsZ, GTPase domain superfamily (98%);Tubulin (98%);Tubulin/FtsZ, GTPase domain (97%),,,,,,,,,
QNENELNPHHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLETESPTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANTLWAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DEELANGGAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6.1.1 (13%);2.4.1.- (12%);2.7.7.48 (4%),Adenylate cyclase (13%);Hexosyltransferases (12%);RNA-directed RNA polymerase (4%),GO:0016021 (35%);GO:0043190 (7%);GO:0005886 (4%),integral component of membrane (35%);ATP-binding cassette (ABC) transporter complex (7%);plasma membrane (4%),GO:0005524 (16%);GO:0022857 (8%);GO:0046872 (5%),ATP binding (16%);transmembrane transporter activity (8%);metal ion binding (5%),GO:0071705 (4%);GO:0003333 (3%);GO:0055085 (2%),nitrogen compound transport (4%);amino acid transmembrane transport (3%);transmembrane transport (2%),IPR027417 (8%);IPR035906 (7%);IPR000515 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);MetI-like superfamily (7%);ABC transporter type 1, transmembrane domain MetI-like (7%),,,,,,,,,,
YPGLAYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (100%),Isoleucine--tRNA ligase (100%),GO:0005737 (50%),cytoplasm (50%),GO:0000049 (50%);GO:0002161 (50%);GO:0004822 (50%),tRNA binding (50%);aminoacyl-tRNA editing activity (50%);isoleucine-tRNA ligase activity (50%),GO:0006428 (50%),isoleucyl-tRNA aminoacylation (50%),IPR003749 (50%);IPR012675 (50%);IPR016155 (50%),Sulfur carrier ThiS/MoaD-like (50%);Beta-grasp domain superfamily (50%);Molybdopterin synthase/thiamin biosynthesis sulphur carrier, beta-grasp (50%),,,,,,,,,,
SFVGDEAQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVALLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.24 (24%);5.3.3.2 (12%);2.7.7.61 (8%),Porphobilinogen synthase (24%);Isopentenyl-diphosphate Delta-isomerase (12%);Citrate lyase holo-[acyl-carrier protein] synthase (8%),GO:0005737 (13%);GO:0015935 (12%);GO:0016021 (12%),cytoplasm (13%);small ribosomal subunit (12%);integral component of membrane (12%),GO:0003677 (33%);GO:0005524 (18%);GO:0003743 (14%),DNA binding (33%);ATP binding (18%);translation initiation factor activity (14%),GO:0006310 (18%);GO:0015074 (17%);GO:0006412 (13%),DNA recombination (18%);DNA integration (17%);translation (13%),IPR027417 (24%);IPR002104 (18%);IPR011010 (18%),P-loop containing nucleoside triphosphate hydrolase (24%);Integrase, catalytic domain (18%);DNA breaking-rejoining enzyme, catalytic core (18%),,,,,,,,,
GTADDAAGLQLGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFQMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (17%);5.2.1.8 (15%);5.6.2.2 (15%),Transferring groups other than amino-acyl groups (17%);Peptidylprolyl isomerase (15%);DNA topoisomerase (ATP-hydrolyzing) (15%),GO:0016021 (35%);GO:0005886 (11%);GO:0005615 (6%),integral component of membrane (35%);plasma membrane (11%);extracellular space (6%),GO:0005524 (22%);GO:0003677 (17%);GO:0003700 (10%),ATP binding (22%);DNA binding (17%);DNA-binding transcription factor activity (10%),GO:0006352 (9%);GO:0006281 (8%);GO:0006260 (4%),DNA-templated transcription, initiation (9%);DNA repair (8%);DNA replication (4%),IPR027417 (10%);IPR036388 (8%);IPR039321 (8%),P-loop containing nucleoside triphosphate hydrolase (10%);Winged helix-like DNA-binding domain superfamily (8%);Increased DNA methylation 2/3-like (8%),,,,,,,,,,
CHAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.-.-.- (50%);2.1.1.164 (25%);2.6.1.- (25%),Hydrolases (50%);Demethylrebeccamycin-D-glucose O-methyltransferase (25%);Transaminases (25%),GO:0016021 (33%);GO:0005887 (13%);GO:0043190 (13%),integral component of membrane (33%);integral component of plasma membrane (13%);ATP-binding cassette (ABC) transporter complex (13%),GO:0046872 (13%);GO:0008271 (10%);GO:0003723 (9%),metal ion binding (13%);secondary active sulfate transmembrane transporter activity (10%);RNA binding (9%),GO:0006824 (13%);GO:0005975 (9%);GO:0006355 (3%),cobalt ion transport (13%);carbohydrate metabolic process (9%);regulation of transcription, DNA-templated (3%),IPR003339 (13%);IPR012809 (12%);IPR002645 (11%),ABC/ECF transporter, transmembrane component (13%);Cobalt ECF transporter T component CbiQ (12%);STAS domain (11%),,,,,,,,,
LLDEAASSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDEDDYRPDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVVEQPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.19 (57%);2.7.7.59 (3%);3.1.4.- (3%),Nicotinate-nucleotide diphosphorylase (carboxylating) (57%);[Protein-PII] uridylyltransferase (3%);Phosphoric diester hydrolases (3%),GO:0016021 (14%);GO:0005576 (5%);GO:0005737 (4%),integral component of membrane (14%);extracellular region (5%);cytoplasm (4%),GO:0004514 (39%);GO:0005524 (6%);GO:0008083 (5%),nicotinate-nucleotide diphosphorylase (carboxylating) activity (39%);ATP binding (6%);growth factor activity (5%),GO:0009435 (37%);GO:0006355 (2%);GO:0070897 (1%),NAD biosynthetic process (37%);regulation of transcription, DNA-templated (2%);transcription preinitiation complex assembly (1%),IPR013785 (34%);IPR036068 (33%);IPR002638 (33%),Aldolase-type TIM barrel (34%);Nicotinate phosphoribosyltransferase-like, C-terminal (33%);Quinolinate phosphoribosyl transferase, C-terminal (33%),,,,,,,,
LNLFDALK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.27 (100%),Undecaprenyl-diphosphate phosphatase (100%),GO:0005886 (43%);GO:0016021 (43%),plasma membrane (43%);integral component of membrane (43%),GO:0005524 (43%);GO:0050380 (43%);GO:0016810 (14%),ATP binding (43%);undecaprenyl-diphosphatase activity (43%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (14%),GO:0008360 (43%);GO:0009252 (43%);GO:0016311 (43%),regulation of cell shape (43%);peptidoglycan biosynthetic process (43%);dephosphorylation (43%),IPR001482 (43%);IPR003824 (43%);IPR006321 (43%),Type II/IV secretion system protein (43%);Undecaprenyl-diphosphatase UppP (43%);Pilus retraction protein PilT (43%),,,,,,,,,,
GYFDYTK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0047355 (100%),CDP-glycerol glycerophosphotransferase activity (100%),,,IPR007554 (100%);IPR001173 (50%);IPR029044 (50%),CDP-glycerol glycerophosphotransferase (100%);Glycosyltransferase 2-like (50%);Nucleotide-diphospho-sugar transferases (50%),,,,,,,,,,,
NVLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.6 (37%);2.4.1.1 (11%);2.1.1.163 (5%),Acetolactate synthase (37%);Glycogen phosphorylase (11%);Demethylmenaquinone methyltransferase (5%),GO:0016021 (16%);GO:0005737 (3%);GO:0005886 (2%),integral component of membrane (16%);cytoplasm (3%);plasma membrane (2%),GO:0050660 (41%);GO:0009055 (31%);GO:0030976 (10%),flavin adenine dinucleotide binding (41%);electron transfer activity (31%);thiamine pyrophosphate binding (10%),GO:0009097 (9%);GO:0009099 (9%);GO:0005975 (3%),isoleucine biosynthetic process (9%);valine biosynthetic process (9%);carbohydrate metabolic process (3%),IPR029035 (37%);IPR014729 (29%);IPR014730 (29%),DHS-like NAD/FAD-binding domain superfamily (37%);Rossmann-like alpha/beta/alpha sandwich fold (29%);Electron transfer flavoprotein, alpha/beta-subunit, N-terminal (29%),,,,,,,,,
NEVVDAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (94%);GO:0005886 (88%),integral component of membrane (94%);plasma membrane (88%),GO:0003676 (6%),nucleic acid binding (6%),GO:0055085 (88%);GO:0015074 (6%);GO:0030420 (6%),transmembrane transport (88%);DNA integration (6%);establishment of competence for transformation (6%),IPR000515 (67%);IPR035906 (67%);IPR021920 (10%),ABC transporter type 1, transmembrane domain MetI-like (67%);MetI-like superfamily (67%);Protein of unknown function DUF3531 (10%),,,,,,,,,,
ELELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.71 (16%);5.6.2.2 (8%);2.7.7.6 (6%),Shikimate kinase (16%);DNA topoisomerase (ATP-hydrolyzing) (8%);DNA-directed RNA polymerase (6%),GO:0016021 (21%);GO:0005737 (11%);GO:0005886 (2%),integral component of membrane (21%);cytoplasm (11%);plasma membrane (2%),GO:0005524 (23%);GO:0003677 (15%);GO:0046872 (6%),ATP binding (23%);DNA binding (15%);metal ion binding (6%),GO:0006304 (3%);GO:0006355 (3%);GO:0009073 (3%),DNA modification (3%);regulation of transcription, DNA-templated (3%);aromatic amino acid family biosynthetic process (3%),IPR027417 (16%);IPR003593 (4%);IPR036388 (3%),P-loop containing nucleoside triphosphate hydrolase (16%);AAA+ ATPase domain (4%);Winged helix-like DNA-binding domain superfamily (3%),,,,,,,,,,
SLMNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.18 (13%);2.7.7.7 (8%);2.7.13.3 (7%),1,4-alpha-glucan branching enzyme (13%);DNA-directed DNA polymerase (8%);Histidine kinase (7%),GO:0016021 (24%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (24%);cytoplasm (5%);nucleus (2%),GO:0005524 (12%);GO:0003677 (10%);GO:0003700 (7%),ATP binding (12%);DNA binding (10%);DNA-binding transcription factor activity (7%),GO:0035556 (3%);GO:0000160 (3%);GO:0006355 (3%),intracellular signal transduction (3%);phosphorelay signal transduction system (3%);regulation of transcription, DNA-templated (3%),IPR027417 (9%);IPR023214 (6%);IPR036412 (6%),P-loop containing nucleoside triphosphate hydrolase (9%);HAD superfamily (6%);HAD-like superfamily (6%),,,,,,,,,
WANVGVVLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDALSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.88 (25%);2.7.7.7 (10%);1.1.1.22 (4%),Peptide deformylase (25%);DNA-directed DNA polymerase (10%);UDP-glucose 6-dehydrogenase (4%),GO:0016021 (20%);GO:0005737 (7%);GO:0005886 (3%),integral component of membrane (20%);cytoplasm (7%);plasma membrane (3%),GO:0005524 (16%);GO:0046872 (8%);GO:0003677 (8%),ATP binding (16%);metal ion binding (8%);DNA binding (8%),GO:0006412 (6%);GO:0000160 (3%);GO:0006260 (3%),translation (6%);phosphorelay signal transduction system (3%);DNA replication (3%),IPR027417 (14%);IPR009057 (5%);IPR003593 (5%),P-loop containing nucleoside triphosphate hydrolase (14%);Homeobox-like domain superfamily (5%);AAA+ ATPase domain (5%),,,,,,,,,,,
EDEAMALEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFQASEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.25.1 (100%),Proteasome endopeptidase complex (100%),GO:0005634 (43%);GO:0005737 (43%);GO:0019774 (43%),nucleus (43%);cytoplasm (43%);proteasome core complex, beta-subunit complex (43%),GO:0004298 (43%);GO:0008270 (29%);GO:0003677 (14%),threonine-type endopeptidase activity (43%);zinc ion binding (29%);DNA binding (14%),GO:0043161 (43%),proteasome-mediated ubiquitin-dependent protein catabolic process (43%),IPR001353 (27%);IPR016050 (27%);IPR023333 (27%),Proteasome, subunit alpha/beta (27%);Proteasome beta-type subunit, conserved site (27%);Proteasome B-type subunit (27%),,,,,,,,
QNAGDMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMWLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (33%);1.8.1.8 (33%);1.9.3.1 (33%),Pyruvate dehydrogenase (acetyl-transferring) (33%);Protein-disulfide reductase (33%);Cytochrome-c oxidase (33%),GO:0016021 (76%);GO:0005623 (8%);GO:0005634 (4%),integral component of membrane (76%);cell (8%);nucleus (4%),GO:0020037 (8%);GO:0046872 (8%);GO:0047134 (8%),heme binding (8%);metal ion binding (8%);protein-disulfide reductase activity (8%),GO:0017004 (8%);GO:0045454 (8%);GO:0006086 (4%),cytochrome complex assembly (8%);cell redox homeostasis (8%);acetyl-CoA biosynthetic process from pyruvate (4%),IPR012912 (19%);IPR024047 (19%);IPR001017 (8%),Plasmid pRiA4b, Orf3 (19%);MM3350-like superfamily (19%);Dehydrogenase, E1 component (8%),,,,,,,,,
LTQNNGGADVTGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVEPNNTLQNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELPVHGQVNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDPDVEEN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANPHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.42 (60%);2.8.1.7 (8%);5.6.2.2 (6%),Isocitrate dehydrogenase (NADP(+)) (60%);Cysteine desulfurase (8%);DNA topoisomerase (ATP-hydrolyzing) (6%),GO:0016021 (50%);GO:0005634 (12%);GO:0005737 (7%),integral component of membrane (50%);nucleus (12%);cytoplasm (7%),GO:0005315 (41%);GO:0046872 (12%);GO:0003684 (10%),inorganic phosphate transmembrane transporter activity (41%);metal ion binding (12%);damaged DNA binding (10%),GO:0006817 (41%);GO:0006099 (8%);GO:0006097 (8%),phosphate ion transport (41%);tricarboxylic acid cycle (8%);glyoxylate cycle (8%),IPR001204 (39%);IPR009061 (10%);IPR022656 (10%),Phosphate transporter (39%);Putative DNA-binding domain superfamily (10%);XPA, C-terminal (10%),,,,,,,,,,
TVETELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.2 (33%);3.1.1.- (33%);3.6.4.- (33%),Non-specific protein-tyrosine kinase (33%);Carboxylic ester hydrolases (33%);Acting on ATP; involved in cellular and subcellular movement (33%),GO:0005737 (33%);GO:0016021 (27%);GO:0032040 (10%),cytoplasm (33%);integral component of membrane (27%);small-subunit processome (10%),GO:0050660 (33%);GO:0003677 (10%);GO:0003676 (7%),flavin adenine dinucleotide binding (33%);DNA binding (10%);nucleic acid binding (7%),GO:0002098 (30%);GO:0006364 (10%);GO:0000070 (3%),tRNA wobble uridine modification (30%);rRNA processing (10%);mitotic sister chromatid segregation (3%),IPR002218 (29%);IPR004416 (29%);IPR020595 (29%),tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG-related (29%);tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (29%);MnmG-related, conserved site (29%),,,,,,,,,,
NFLDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.13 (12%);1.6.5.2 (10%);5.3.1.17 (10%),Glutamate synthase (NADPH) (12%);NAD(P)H dehydrogenase (quinone) (10%);5-dehydro-4-deoxy-D-glucuronate isomerase (10%),GO:0016021 (22%);GO:0005737 (8%);GO:0005886 (3%),integral component of membrane (22%);cytoplasm (8%);plasma membrane (3%),GO:0005524 (13%);GO:0016491 (11%);GO:0003677 (10%),ATP binding (13%);oxidoreductase activity (11%);DNA binding (10%),GO:0006537 (9%);GO:0006281 (4%);GO:0006310 (3%),glutamate biosynthetic process (9%);DNA repair (4%);DNA recombination (3%),IPR029039 (13%);IPR005025 (12%);IPR036188 (9%),Flavoprotein-like superfamily (13%);NADPH-dependent FMN reductase-like (12%);FAD/NAD(P)-binding domain superfamily (9%),,,,,,,,,,,
YADLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (38%);GO:0009279 (15%),integral component of membrane (38%);cell outer membrane (15%),GO:0003677 (54%);GO:0005524 (54%);GO:0004386 (38%),DNA binding (54%);ATP binding (54%);helicase activity (38%),GO:0043165 (15%);GO:0051205 (15%);GO:0017004 (8%),Gram-negative-bacterium-type cell outer membrane assembly (15%);protein insertion into membrane (15%);cytochrome complex assembly (8%),IPR001650 (53%);IPR006935 (53%);IPR014001 (53%),Helicase, C-terminal (53%);Helicase/UvrB, N-terminal (53%);Helicase superfamily 1/2, ATP-binding domain (53%),,,,,,,,
MANWLSATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLSSTLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNVGTLHDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEMQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.227 (86%);1.3.5.1 (1%);1.6.99.5 (1%),Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (86%);Succinate dehydrogenase (quinone) (1%);Transferred entry: 1.6.5.11 (1%),GO:0005886 (40%);GO:0016021 (23%);GO:0031011 (3%),plasma membrane (40%);integral component of membrane (23%);Ino80 complex (3%),GO:0050511 (39%);GO:0051991 (39%);GO:0005524 (10%),undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase activity (39%);UDP-N-acetyl-D-glucosamine:N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine-diphosphoundecaprenol 4-beta-N-acetylglucosaminlytransferase activity (39%);ATP binding (10%),GO:0030259 (44%);GO:0005975 (42%);GO:0051301 (39%),lipid glycosylation (44%);carbohydrate metabolic process (42%);cell division (39%),IPR004276 (41%);IPR007235 (40%);IPR006009 (36%),Glycosyltransferase family 28, N-terminal domain (41%);Glycosyl transferase, family 28, C-terminal (40%);N-acetylglucosaminyltransferase, MurG (36%),,,,,,
VDNYNDK,Paramicrosporidium saccamoebae,Eukaryota,Fungi,,,Cryptomycota,,,,,,,,,,,,,,,,Paramicrosporidium,,,,Paramicrosporidium saccamoebae,,,,,,,,,,,,IPR001680 (100%);IPR015943 (100%);IPR017986 (100%),WD40 repeat (100%);WD40/YVTN repeat-like-containing domain superfamily (100%);WD40-repeat-containing domain (100%),,,,,,,,,,,
MPLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.47 (15%);3.5.4.6 (6%);3.6.4.- (5%),8-amino-7-oxononanoate synthase (15%);AMP deaminase (6%);Acting on ATP; involved in cellular and subcellular movement (5%),GO:0016021 (24%);GO:0005615 (14%);GO:0005737 (6%),integral component of membrane (24%);extracellular space (14%);cytoplasm (6%),GO:0004725 (14%);GO:0005524 (8%);GO:0016787 (6%),protein tyrosine phosphatase activity (14%);ATP binding (8%);hydrolase activity (6%),GO:0009102 (2%);GO:0055085 (2%);GO:0055072 (1%),biotin biosynthetic process (2%);transmembrane transport (2%);iron ion homeostasis (1%),IPR011070 (17%);IPR015203 (17%);IPR037168 (17%),Globular protein, non-globular alpha/beta subunit (17%);SicP binding (17%);Virulence factor YopE, GAP domain superfamily (17%),,,,,,,,,
TNLGWAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004560 (100%),alpha-L-fucosidase activity (100%),,,IPR003961 (100%);IPR008928 (100%);IPR012341 (100%),Fibronectin type III (100%);Six-hairpin glycosidase superfamily (100%);Six-hairpin glycosidase-like superfamily (100%),,,,,,,,,,,
VPGVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNDVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (13%);1.1.5.12 (6%);7.-.-.- (5%),Oxidoreductases (13%);D-lactate dehydrogenase (quinone) (6%);Translocases (5%),GO:0016021 (13%);GO:0005737 (3%);GO:0043190 (3%),integral component of membrane (13%);cytoplasm (3%);ATP-binding cassette (ABC) transporter complex (3%),GO:0016491 (32%);GO:0008168 (13%);GO:0005524 (6%),oxidoreductase activity (32%);methyltransferase activity (13%);ATP binding (6%),GO:0032259 (11%);GO:0055085 (4%);GO:0009058 (3%),methylation (11%);transmembrane transport (4%);biosynthetic process (3%),IPR036291 (29%);IPR011032 (28%);IPR041694 (28%),NAD(P)-binding domain superfamily (29%);GroES-like superfamily (28%);Oxidoreductase, N-terminal domain (28%),,,,,,,,,,
DMMEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (17%);2.1.1.248 (8%);2.1.1.163 (5%),Beta-galactosidase (17%);[Methylamine--corrinoid protein] Co-methyltransferase (8%);Demethylmenaquinone methyltransferase (5%),GO:0016021 (30%);GO:0005737 (6%);GO:0005886 (5%),integral component of membrane (30%);cytoplasm (6%);plasma membrane (5%),GO:0046872 (13%);GO:0005524 (10%);GO:0020037 (8%),metal ion binding (13%);ATP binding (10%);heme binding (8%),GO:0032259 (8%);GO:0005975 (3%);GO:0015986 (3%),methylation (8%);carbohydrate metabolic process (3%);ATP synthesis coupled proton transport (3%),IPR001199 (7%);IPR027417 (7%);IPR036400 (7%),Cytochrome b5-like heme/steroid binding domain (7%);P-loop containing nucleoside triphosphate hydrolase (7%);Cytochrome b5-like heme/steroid binding domain superfamily (7%),,,,,,,,,,,
SNATGEC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNPDVMAQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HDEEEEGEAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAGDMNFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVDAYEGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVVKPNK,Rhodotorula taiwanensis,Eukaryota,Fungi,Dikarya,,Basidiomycota,Pucciniomycotina,,Microbotryomycetes,,,,Sporidiobolales,,,,,Sporidiobolaceae,,,,Rhodotorula,,,,Rhodotorula taiwanensis,,,,,,,,GO:0003824 (67%);GO:0016787 (33%),catalytic activity (67%);hydrolase activity (33%),,,IPR008928 (100%);IPR011613 (100%);IPR012341 (100%),Six-hairpin glycosidase superfamily (100%);GH15-like domain (100%);Six-hairpin glycosidase-like superfamily (100%),,,,,,,,,,,
VEGTGGDVEWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPSLVVNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YALNGMLNDVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LENAPEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.23 (100%);3.5.4.19 (100%);3.6.1.31 (100%),Histidinol dehydrogenase (100%);Phosphoribosyl-AMP cyclohydrolase (100%);Phosphoribosyl-ATP diphosphatase (100%),GO:0016021 (40%);GO:0005737 (7%);GO:0005886 (7%),integral component of membrane (40%);cytoplasm (7%);plasma membrane (7%),GO:0005524 (27%);GO:0004180 (20%);GO:0004399 (20%),ATP binding (27%);carboxypeptidase activity (20%);histidinol dehydrogenase activity (20%),GO:0000105 (20%);GO:0006289 (7%);GO:0006813 (7%),histidine biosynthetic process (20%);nucleotide-excision repair (7%);potassium ion transport (7%),IPR008969 (46%);IPR001692 (12%);IPR002496 (12%),Carboxypeptidase-like, regulatory domain superfamily (46%);Histidinol dehydrogenase, conserved site (12%);Phosphoribosyl-AMP cyclohydrolase domain (12%),,,,,,,,,
LNAVLSYR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000150 (100%);GO:0003677 (100%),recombinase activity (100%);DNA binding (100%),,,IPR006119 (100%);IPR011109 (100%);IPR025827 (100%),Resolvase, N-terminal catalytic domain (100%);DNA-binding recombinase domain (100%);Recombinase zinc beta ribbon domain (100%),,,,,,,,,,
EALLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.21 (16%);1.5.1.2 (13%);3.1.1.31 (9%),Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (16%);Pyrroline-5-carboxylate reductase (13%);6-phosphogluconolactonase (9%),GO:0016021 (21%);GO:0005737 (13%);GO:0005886 (5%),integral component of membrane (21%);cytoplasm (13%);plasma membrane (5%),GO:0005524 (14%);GO:0003677 (13%);GO:0016705 (5%),ATP binding (14%);DNA binding (13%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (5%),GO:0006355 (9%);GO:0000160 (7%);GO:0005975 (6%),regulation of transcription, DNA-templated (9%);phosphorelay signal transduction system (7%);carbohydrate metabolic process (6%),IPR027417 (9%);IPR036388 (6%);IPR032675 (6%),P-loop containing nucleoside triphosphate hydrolase (9%);Winged helix-like DNA-binding domain superfamily (6%);Leucine-rich repeat domain superfamily (6%),,,,,,,,
VLGQNEAVNAVSNALR,Enterobacterales,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Enterobacterales,,,,,,,,,,,,,,,,,,,GO:0005737 (100%),cytoplasm (100%),GO:0005524 (100%);GO:0008233 (100%),ATP binding (100%);peptidase activity (100%),GO:0009408 (100%);GO:0042026 (100%),response to heat (100%);protein refolding (100%),IPR001270 (100%);IPR003593 (100%);IPR003959 (100%),ClpA/B family (100%);AAA+ ATPase domain (100%);ATPase, AAA-type, core (100%),,,,,,,,,
AFYMYLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANNNAELGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYLNDTVENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQVDMTLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLSVTFAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVDVNSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (27%),integral component of membrane (27%),GO:0016491 (36%);GO:0020037 (27%);GO:0046872 (27%),oxidoreductase activity (36%);heme binding (27%);metal ion binding (27%),GO:0035556 (9%),intracellular signal transduction (9%),IPR005117 (27%);IPR006066 (27%);IPR006067 (27%),Nitrite/Sulfite reductase ferredoxin-like domain (27%);Nitrite/sulphite reductase iron-sulphur/sirohaem-binding site (27%);Nitrite/sulphite reductase 4Fe-4S domain (27%),,,,,,,,,,,
VVVVGGDDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPSTATPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTTFHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (50%);3.4.24.55 (25%);3.5.1.88 (25%),DNA helicase (50%);Pitrilysin (25%);Peptide deformylase (25%),GO:0016021 (27%);GO:0030286 (17%);GO:0005634 (7%),integral component of membrane (27%);dynein complex (17%);nucleus (7%),GO:0005524 (33%);GO:0003777 (17%);GO:0016740 (10%),ATP binding (33%);microtubule motor activity (17%);transferase activity (10%),GO:0007018 (17%);GO:0006412 (10%);GO:0009058 (7%),microtubule-based movement (17%);translation (10%);biosynthetic process (7%),IPR027417 (29%);IPR003593 (13%);IPR004273 (13%),P-loop containing nucleoside triphosphate hydrolase (29%);AAA+ ATPase domain (13%);Dynein heavy chain region D6 P-loop domain (13%),,,,,,,,,,,
AMGHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.22 (20%);3.1.3.16 (20%);3.4.21.105 (20%),UMP kinase (20%);Protein-serine/threonine phosphatase (20%);Rhomboid protease (20%),GO:0016021 (67%);GO:0005634 (7%);GO:0005737 (1%),integral component of membrane (67%);nucleus (7%);cytoplasm (1%),GO:0008324 (57%);GO:0003924 (13%);GO:0005525 (13%),cation transmembrane transporter activity (57%);GTPase activity (13%);GTP binding (13%),GO:0007188 (12%);GO:0007049 (6%);GO:0010468 (6%),adenylate cyclase-modulating G protein-coupled receptor signaling pathway (12%);cell cycle (6%);regulation of gene expression (6%),IPR001036 (59%);IPR027463 (59%);IPR004763 (58%),Acriflavin resistance protein (59%);Multidrug efflux transporter AcrB TolC docking domain, DN/DC subdomains (59%);Cation efflux system CzcA/CusA/SilA/NccA/HelA/CnrA (58%),,,,,,,,,,
TWDEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.6 (33%);2.3.1.46 (17%);2.7.11.1 (17%),Acetolactate synthase (33%);Homoserine O-succinyltransferase (17%);Non-specific serine/threonine protein kinase (17%),GO:0016021 (19%);GO:0005886 (6%);GO:0005737 (1%),integral component of membrane (19%);plasma membrane (6%);cytoplasm (1%),GO:0004310 (18%);GO:0051996 (18%);GO:0016787 (8%),farnesyl-diphosphate farnesyltransferase activity (18%);squalene synthase activity (18%);hydrolase activity (8%),GO:0006696 (18%);GO:0007165 (15%);GO:0008643 (5%),ergosterol biosynthetic process (18%);signal transduction (15%);carbohydrate transport (5%),IPR006059 (48%);IPR008949 (9%);IPR019845 (9%),Bacterial extracellular solute-binding protein (48%);Isoprenoid synthase domain superfamily (9%);Squalene/phytoene synthase, conserved site (9%),,,,,,,,,,
EENEAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.19 (100%),Arginine--tRNA ligase (100%),GO:0005737 (38%);GO:0016021 (19%),cytoplasm (38%);integral component of membrane (19%),GO:0004814 (48%);GO:0005524 (48%);GO:0004177 (24%),arginine-tRNA ligase activity (48%);ATP binding (48%);aminopeptidase activity (24%),GO:0006420 (48%),arginyl-tRNA aminoacylation (48%),IPR001278 (42%);IPR008909 (42%);IPR009080 (42%),Arginine-tRNA ligase (42%);DALR anticodon binding (42%);Aminoacyl-tRNA synthetase, class Ia, anticodon-binding (42%),,,,,,,,,
RPVPTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.25 (45%);3.4.24.- (23%);1.3.1.- (14%),Inositol-phosphate phosphatase (45%);Metalloendopeptidases (23%);With NAD(+) or NADP(+) as acceptor (14%),GO:0016021 (29%);GO:0005886 (9%);GO:0001518 (7%),integral component of membrane (29%);plasma membrane (9%);voltage-gated sodium channel complex (7%),GO:0046872 (27%);GO:0005524 (20%);GO:0004672 (19%),metal ion binding (27%);ATP binding (20%);protein kinase activity (19%),GO:0046854 (11%);GO:0046855 (11%);GO:0034765 (7%),phosphatidylinositol phosphorylation (11%);inositol phosphate dephosphorylation (11%);regulation of ion transmembrane transport (7%),IPR000719 (22%);IPR011009 (22%);IPR000760 (13%),Protein kinase domain (22%);Protein kinase-like domain superfamily (22%);Inositol monophosphatase-like (13%),,,,,,,,,,,
WNYSHLSEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTMHWMLLPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATGLMAK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008081 (50%),phosphoric diester hydrolase activity (50%),GO:0006629 (50%);GO:0007165 (50%),lipid metabolic process (50%);signal transduction (50%),IPR000157 (50%);IPR017946 (50%);IPR032075 (50%),Toll/interleukin-1 receptor homology (TIR) domain (50%);PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily (50%);Phosphoinositide phospholipase C, Ca2+-dependent (50%),,,,,,,,,
AMLEEGNK,Alcaligenaceae,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Alcaligenaceae,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0004888 (100%),transmembrane signaling receptor activity (100%),GO:0006935 (100%);GO:0007165 (100%),chemotaxis (100%);signal transduction (100%),IPR003122 (50%);IPR003660 (50%);IPR004089 (50%),Chemotaxis methyl-accepting receptor Tar-related, ligand-binding (50%);HAMP domain (50%);Methyl-accepting chemotaxis protein (MCP) signalling domain (50%),,,,,,,,,,
SELQAAAK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (50%);GO:0009279 (50%);GO:0016021 (50%),cytoplasm (50%);cell outer membrane (50%);integral component of membrane (50%),GO:0004109 (50%);GO:0046872 (50%);GO:0051539 (50%),coproporphyrinogen oxidase activity (50%);metal ion binding (50%);4 iron, 4 sulfur cluster binding (50%),GO:0006779 (50%),porphyrin-containing compound biosynthetic process (50%),IPR004559 (50%);IPR006638 (50%);IPR006664 (50%),Heme chaperone HemW-like (50%);Elp3/MiaB/NifB (50%);Outer membrane protein, bacterial (50%),,,,,,,,,
NSFELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.95 (42%);1.1.1.399 (37%);2.7.11.1 (21%),Phosphoglycerate dehydrogenase (42%);2-oxoglutarate reductase (37%);Non-specific serine/threonine protein kinase (21%),GO:0043190 (31%);GO:0016021 (23%);GO:0005886 (3%),ATP-binding cassette (ABC) transporter complex (31%);integral component of membrane (23%);plasma membrane (3%),GO:0051287 (13%);GO:0016616 (8%);GO:0005524 (7%),NAD binding (13%);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (8%);ATP binding (7%),GO:0055085 (31%);GO:0006564 (4%);GO:0009058 (3%),transmembrane transport (31%);L-serine biosynthetic process (4%);biosynthetic process (3%),IPR000914 (25%);IPR030678 (25%);IPR039424 (25%),Solute-binding protein family 5 domain (25%);Peptide/nickel binding protein, MppA-type (25%);Solute-binding protein family 5 (25%),,,,,,,,
VEPVMVVNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDFNDMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLTLPACK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.59 (7%);2.7.7.7 (6%);2.7.11.1 (4%),3-hydroxyacyl-[acyl-carrier-protein] dehydratase (7%);DNA-directed DNA polymerase (6%);Non-specific serine/threonine protein kinase (4%),GO:0016021 (15%);GO:0005737 (4%);GO:0005829 (3%),integral component of membrane (15%);cytoplasm (4%);cytosol (3%),GO:0008080 (21%);GO:0003677 (12%);GO:0005524 (9%),N-acetyltransferase activity (21%);DNA binding (12%);ATP binding (9%),GO:0006044 (3%);GO:0006517 (3%);GO:0006696 (2%),N-acetylglucosamine metabolic process (3%);protein deglycosylation (3%);ergosterol biosynthetic process (2%),IPR016181 (24%);IPR000182 (16%);IPR017853 (9%),Acyl-CoA N-acyltransferase (24%);GNAT domain (16%);Glycoside hydrolase superfamily (9%),,,,,,,,,,,
FLQHMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (77%);GO:0005643 (3%),integral component of membrane (77%);nuclear pore (3%),GO:0003824 (10%);GO:0008168 (7%);GO:0004930 (3%),catalytic activity (10%);methyltransferase activity (7%);G protein-coupled receptor activity (3%),GO:0005992 (10%);GO:0032259 (7%),trehalose biosynthetic process (10%);methylation (7%),IPR011012 (62%);IPR001830 (8%);IPR023214 (8%),Longin-like domain superfamily (62%);Glycosyl transferase, family 20 (8%);HAD superfamily (8%),,,,,,,,,,
DTVLMAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.19 (90%);4.4.1.1 (10%),3-phosphoshikimate 1-carboxyvinyltransferase (90%);Cystathionine gamma-lyase (10%),GO:0005737 (69%);GO:0005887 (15%),cytoplasm (69%);integral component of plasma membrane (15%),GO:0003866 (69%);GO:0004123 (8%);GO:0016491 (8%),3-phosphoshikimate 1-carboxyvinyltransferase activity (69%);cystathionine gamma-lyase activity (8%);oxidoreductase activity (8%),GO:0009073 (69%);GO:0009423 (69%);GO:0009306 (15%),aromatic amino acid family biosynthetic process (69%);chorismate biosynthetic process (69%);protein secretion (15%),IPR001986 (56%);IPR006264 (56%);IPR013792 (56%),Enolpyruvate transferase domain (56%);3-phosphoshikimate 1-carboxyvinyltransferase (56%);RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta (56%),,,,,,,,,,
DMFGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.1 (64%);2.1.1.297 (7%);2.7.7.6 (2%),Tyrosine--tRNA ligase (64%);Peptide chain release factor N(5)-glutamine methyltransferase (7%);DNA-directed RNA polymerase (2%),GO:0005737 (27%);GO:0016021 (17%);GO:0009274 (5%),cytoplasm (27%);integral component of membrane (17%);peptidoglycan-based cell wall (5%),GO:0005524 (34%);GO:0003723 (25%);GO:0004831 (24%),ATP binding (34%);RNA binding (25%);tyrosine-tRNA ligase activity (24%),GO:0006437 (24%);GO:0008360 (6%);GO:0009252 (6%),tyrosyl-tRNA aminoacylation (24%);regulation of cell shape (6%);peptidoglycan biosynthetic process (6%),IPR002307 (21%);IPR014729 (21%);IPR024088 (21%),Tyrosine-tRNA ligase (21%);Rossmann-like alpha/beta/alpha sandwich fold (21%);Tyrosine-tRNA ligase, bacterial-type (21%),,,,,,,,,,
TGAWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (26%);1.8.1.2 (13%);5.3.1.9 (4%),Acting on polysaccharides (26%);Assimilatory sulfite reductase (NADPH) (13%);Glucose-6-phosphate isomerase (4%),GO:0016021 (44%);GO:0005886 (15%);GO:0005887 (4%),integral component of membrane (44%);plasma membrane (15%);integral component of plasma membrane (4%),GO:0004890 (19%);GO:0005230 (14%);GO:0051539 (9%),GABA-A receptor activity (19%);extracellular ligand-gated ion channel activity (14%);4 iron, 4 sulfur cluster binding (9%),GO:0007214 (19%);GO:0006821 (15%);GO:0005975 (6%),gamma-aminobutyric acid signaling pathway (19%);chloride transport (15%);carbohydrate metabolic process (6%),IPR006201 (18%);IPR036719 (18%);IPR006028 (18%),Neurotransmitter-gated ion-channel (18%);Neurotransmitter-gated ion-channel transmembrane domain superfamily (18%);Gamma-aminobutyric acid A receptor/Glycine receptor alpha (18%),,,,,,,,,,
NYLNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (16%);6.1.1.6 (16%);6.3.4.14 (9%),Peptidylprolyl isomerase (16%);Lysine--tRNA ligase (16%);Biotin carboxylase (9%),GO:0016021 (37%);GO:0008278 (9%);GO:0005737 (7%),integral component of membrane (37%);cohesin complex (9%);cytoplasm (7%),GO:0005524 (23%);GO:0003677 (9%);GO:0003682 (9%),ATP binding (23%);DNA binding (9%);chromatin binding (9%),GO:0007064 (9%);GO:0009405 (4%);GO:0009734 (3%),mitotic sister chromatid cohesion (9%);pathogenesis (4%);auxin-activated signaling pathway (3%),IPR011204 (34%);IPR008023 (11%);IPR027417 (9%),Virulence protein RhuM-like (34%);Protein of unknown function DUF748 (11%);P-loop containing nucleoside triphosphate hydrolase (9%),,,,,,,,,,,
QVTWLQPCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.3.1.1 (47%);2.3.1.199 (10%);2.7.7.7 (4%),Adenosylhomocysteinase (47%);Very-long-chain 3-oxoacyl-CoA synthase (10%);DNA-directed DNA polymerase (4%),GO:0016021 (43%);GO:0009279 (23%);GO:0005737 (8%),integral component of membrane (43%);cell outer membrane (23%);cytoplasm (8%),GO:0015344 (23%);GO:0038023 (23%);GO:0046872 (9%),siderophore uptake transmembrane transporter activity (23%);signaling receptor activity (23%);metal ion binding (9%),GO:0006730 (6%);GO:0055085 (4%);GO:0001100 (1%),one-carbon metabolic process (6%);transmembrane transport (4%);negative regulation of exit from mitosis (1%),IPR000531 (19%);IPR012910 (19%);IPR036942 (19%),TonB-dependent receptor-like, beta-barrel (19%);TonB-dependent receptor, plug domain (19%);TonB-dependent receptor-like, beta-barrel domain superfamily (19%),,,,,,,,
QPFGQLFPDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNGSSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (100%),Non-specific serine/threonine protein kinase (100%),GO:0016021 (27%);GO:0009279 (10%);GO:0005634 (5%),integral component of membrane (27%);cell outer membrane (10%);nucleus (5%),GO:0003677 (17%);GO:0003676 (10%);GO:0046872 (10%),DNA binding (17%);nucleic acid binding (10%);metal ion binding (10%),GO:0055085 (5%);GO:0000272 (2%);GO:0005975 (2%),transmembrane transport (5%);polysaccharide catabolic process (2%);carbohydrate metabolic process (2%),IPR003695 (11%);IPR006674 (11%);IPR013378 (8%),Ppx/GppA phosphatase (11%);HD domain (11%);Listeria/Bacterioides repeat (8%),,,,,,,,,,,
NYSLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.1 (27%);1.3.1.98 (18%);2.4.2.54 (9%),Tyrosine--tRNA ligase (27%);UDP-N-acetylmuramate dehydrogenase (18%);Beta-ribofuranosylphenol 5'-phosphate synthase (9%),GO:0016021 (35%);GO:0005737 (6%);GO:0005886 (2%),integral component of membrane (35%);cytoplasm (6%);plasma membrane (2%),GO:0005524 (13%);GO:0003677 (7%);GO:0003824 (6%),ATP binding (13%);DNA binding (7%);catalytic activity (6%),GO:0006437 (3%);GO:0006665 (3%);GO:0045493 (2%),tyrosyl-tRNA aminoacylation (3%);sphingolipid metabolic process (3%);xylan catabolic process (2%),IPR015943 (10%);IPR001680 (9%);IPR017986 (9%),WD40/YVTN repeat-like-containing domain superfamily (10%);WD40 repeat (9%);WD40-repeat-containing domain (9%),,,,,,,,,,,
DEEVNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (100%),DNA topoisomerase (100%),GO:0005737 (50%);GO:0005694 (25%);GO:0016021 (25%),cytoplasm (50%);chromosome (25%);integral component of membrane (25%),GO:0003700 (50%);GO:0003723 (50%);GO:0003677 (25%),DNA-binding transcription factor activity (50%);RNA binding (50%);DNA binding (25%),GO:0006353 (50%);GO:0031564 (50%);GO:0006265 (25%),DNA-templated transcription, termination (50%);transcription antitermination (50%);DNA topological change (25%),IPR004087 (50%);IPR009019 (50%);IPR010213 (50%),K Homology domain (50%);K homology domain superfamily, prokaryotic type (50%);Transcription termination factor NusA (50%),,,,,,,,,
HTAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.241 (12%);2.4.2.29 (12%);1.2.4.1 (8%),Kdo(2)-lipid IV(A) lauroyltransferase (12%);tRNA-guanine(34) transglycosylase (12%);Pyruvate dehydrogenase (acetyl-transferring) (8%),GO:0016021 (24%);GO:0005737 (7%);GO:0005576 (5%),integral component of membrane (24%);cytoplasm (7%);extracellular region (5%),GO:0005524 (12%);GO:0003677 (11%);GO:0003700 (6%),ATP binding (12%);DNA binding (11%);DNA-binding transcription factor activity (6%),GO:0007275 (4%);GO:0016055 (4%);GO:0006464 (3%),multicellular organism development (4%);Wnt signaling pathway (4%);cellular protein modification process (3%),IPR010752 (7%);IPR027417 (5%);IPR036388 (5%),Protein of unknown function DUF1329 (7%);P-loop containing nucleoside triphosphate hydrolase (5%);Winged helix-like DNA-binding domain superfamily (5%),,,,,,,,,,,
TGDAVLVGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMNMEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEEQLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.2 (9%);2.7.7.7 (8%);3.6.4.12 (8%),Adenylosuccinate lyase (9%);DNA-directed DNA polymerase (8%);DNA helicase (8%),GO:0016021 (14%);GO:0005737 (8%);GO:0090498 (6%),integral component of membrane (14%);cytoplasm (8%);extrinsic component of Golgi membrane (6%),GO:0005524 (18%);GO:0046872 (14%);GO:0003677 (12%),ATP binding (18%);metal ion binding (14%);DNA binding (12%),GO:0007283 (6%);GO:0006457 (5%);GO:0007018 (2%),spermatogenesis (6%);protein folding (5%);microtubule-based movement (2%),IPR027417 (17%);IPR013083 (11%);IPR011011 (8%),P-loop containing nucleoside triphosphate hydrolase (17%);Zinc finger, RING/FYVE/PHD-type (11%);Zinc finger, FYVE/PHD-type (8%),,,,,,,,,
MHLVLHSGNFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WTVMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.4 (25%);4.6.1.1 (25%);1.8.-.- (13%),Phospholipase D (25%);Adenylate cyclase (25%);Acting on a sulfur group of donors (13%),GO:0016021 (62%);GO:0043190 (9%);GO:0005887 (4%),integral component of membrane (62%);ATP-binding cassette (ABC) transporter complex (9%);integral component of plasma membrane (4%),GO:0016849 (14%);GO:0046872 (14%);GO:0020037 (11%),phosphorus-oxygen lyase activity (14%);metal ion binding (14%);heme binding (11%),GO:0009190 (16%);GO:0035556 (16%);GO:0043953 (3%),cyclic nucleotide biosynthetic process (16%);intracellular signal transduction (16%);protein transport by the Tat complex (3%),IPR006652 (18%);IPR015915 (18%);IPR036047 (18%),Kelch repeat type 1 (18%);Kelch-type beta propeller (18%);F-box-like domain superfamily (18%),,,,,,,,,,,
CELQAMVPQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVDSDFNYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNVLDSAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR008966 (100%);IPR013783 (100%);IPR022464 (100%),Adhesion domain superfamily (100%);Immunoglobulin-like fold (100%);Streptococcal pilin isopeptide linker (100%),,,,,,,,,,,
TLLTSMVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQMETK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (8%);GO:0005576 (4%);GO:0005634 (4%),integral component of membrane (8%);extracellular region (4%);nucleus (4%),GO:0005506 (73%);GO:0016705 (73%);GO:0020037 (73%),iron ion binding (73%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (73%);heme binding (73%),GO:0000027 (4%);GO:0009405 (4%),ribosomal large subunit assembly (4%);pathogenesis (4%),IPR001128 (73%);IPR002401 (73%);IPR036396 (73%),Cytochrome P450 (73%);Cytochrome P450, E-class, group I (73%);Cytochrome P450 superfamily (73%),,,,,,,
TDQQTLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNLENVNSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVWLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.3.12 (22%);2.3.1.15 (19%);6.3.2.8 (15%),Agmatine deiminase (22%);Glycerol-3-phosphate 1-O-acyltransferase (19%);UDP-N-acetylmuramate--L-alanine ligase (15%),GO:0016020 (18%);GO:0016021 (13%);GO:0005634 (10%),membrane (18%);integral component of membrane (13%);nucleus (10%),GO:0004668 (25%);GO:0005524 (14%);GO:0004861 (9%),protein-arginine deiminase activity (25%);ATP binding (14%);cyclin-dependent protein serine/threonine kinase inhibitor activity (9%),GO:0009446 (25%);GO:0007346 (10%);GO:0072331 (10%),putrescine biosynthetic process (25%);regulation of mitotic cell cycle (10%);signal transduction by p53 class mediator (10%),IPR007466 (26%);IPR029841 (9%);IPR003175 (8%),Peptidyl-arginine deiminase, Porphyromonas-type (26%);Cyclin-dependent kinase inhibitor 1 (9%);Cyclin-dependent kinase inhibitor (8%),,,,,,,,,,
WGAPFACK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNFEGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (50%);2.4.99.17 (42%);3.2.1.1 (8%),Beta-galactosidase (50%);S-adenosylmethionine:tRNA ribosyltransferase-isomerase (42%);Alpha-amylase (8%),GO:0005737 (17%);GO:0030286 (17%);GO:0016021 (11%),cytoplasm (17%);dynein complex (17%);integral component of membrane (11%),GO:0004565 (27%);GO:0005524 (20%);GO:0003777 (17%),beta-galactosidase activity (27%);ATP binding (20%);microtubule motor activity (17%),GO:0005975 (34%);GO:0007018 (17%);GO:0008616 (14%),carbohydrate metabolic process (34%);microtubule-based movement (17%);queuosine biosynthetic process (14%),IPR017853 (29%);IPR001944 (25%);IPR031330 (25%),Glycoside hydrolase superfamily (29%);Glycoside hydrolase, family 35 (25%);Glycoside hydrolase 35, catalytic domain (25%),,,,,,,,,
MGVSEWQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNYDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (100%),Proline--tRNA ligase (100%),GO:0005737 (25%),cytoplasm (25%),GO:0005524 (50%);GO:0002161 (25%);GO:0003676 (25%),ATP binding (50%);aminoacyl-tRNA editing activity (25%);nucleic acid binding (25%),GO:0006433 (25%);GO:0015074 (25%),prolyl-tRNA aminoacylation (25%);DNA integration (25%),IPR000719 (14%);IPR001173 (14%);IPR001180 (14%),Protein kinase domain (14%);Glycosyltransferase 2-like (14%);Citron homology (CNH) domain (14%),,,,,,,,,,,
EVNLVEWVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNELEFGTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLNQSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (33%);1.2.4.1 (17%);2.7.13.3 (17%),DNA topoisomerase (ATP-hydrolyzing) (33%);Pyruvate dehydrogenase (acetyl-transferring) (17%);Histidine kinase (17%),GO:0016459 (15%);GO:0016021 (9%);GO:0005737 (4%),myosin complex (15%);integral component of membrane (9%);cytoplasm (4%),GO:0003677 (46%);GO:0005524 (22%);GO:0003774 (15%),DNA binding (46%);ATP binding (22%);motor activity (15%),GO:0007015 (9%);GO:0006261 (2%);GO:0006265 (2%),actin filament organization (9%);DNA-dependent DNA replication (2%);DNA topological change (2%),IPR001647 (35%);IPR009057 (35%);IPR036271 (35%),DNA-binding HTH domain, TetR-type (35%);Homeobox-like domain superfamily (35%);Tetracyclin repressor-like, C-terminal domain superfamily (35%),,,,,,,,,
DGSENPYVAGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NKPEVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%);GO:0005737 (13%),integral component of membrane (25%);cytoplasm (13%),GO:0046872 (19%);GO:0004519 (13%);GO:0005525 (13%),metal ion binding (19%);endonuclease activity (13%);GTP binding (13%),GO:0001525 (6%);GO:0009401 (6%),angiogenesis (6%);phosphoenolpyruvate-dependent sugar phosphotransferase system (6%),IPR004518 (22%);IPR003347 (19%);IPR041070 (19%),NTP pyrophosphohydrolase MazG, putative catalytic core (22%);JmjC domain (19%);Jumonji, helical domain (19%),,,,,,,,,
LLVGFER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (67%);2.7.11.5 (33%);3.1.3.- (33%),Acting on ester bonds (67%);[Isocitrate dehydrogenase (NADP(+))] kinase (33%);Phosphoric monoester hydrolases (33%),GO:0016021 (35%);GO:0005737 (18%);GO:0005623 (6%),integral component of membrane (35%);cytoplasm (18%);cell (6%),GO:0003677 (18%);GO:0000014 (12%);GO:0004553 (12%),DNA binding (18%);single-stranded DNA endodeoxyribonuclease activity (12%);hydrolase activity, hydrolyzing O-glycosyl compounds (12%),GO:0005975 (12%);GO:0006935 (12%);GO:0007165 (12%),carbohydrate metabolic process (12%);chemotaxis (12%);signal transduction (12%),IPR026832 (18%);IPR029060 (14%);IPR000731 (7%),Asteroid (18%);PIN-like domain superfamily (14%);Sterol-sensing domain (7%),,,,,,,,,,
VDAGVGYMNTAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YSVNLPDGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEDNMCALPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVDFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.23 (29%);6.1.1.12 (14%);6.1.1.15 (13%),Aspartate--tRNA(Asn) ligase (29%);Aspartate--tRNA ligase (14%);Proline--tRNA ligase (13%),GO:0005737 (33%);GO:0016021 (14%);GO:0000124 (4%),cytoplasm (33%);integral component of membrane (14%);SAGA complex (4%),GO:0005524 (38%);GO:0004815 (17%);GO:0003676 (17%),ATP binding (38%);aspartate-tRNA ligase activity (17%);nucleic acid binding (17%),GO:0006422 (17%);GO:0006433 (5%);GO:0006357 (4%),aspartyl-tRNA aminoacylation (17%);prolyl-tRNA aminoacylation (5%);regulation of transcription by RNA polymerase II (4%),IPR006195 (19%);IPR012340 (16%);IPR004364 (15%),Aminoacyl-tRNA synthetase, class II (19%);Nucleic acid-binding, OB-fold (16%);Aminoacyl-tRNA synthetase, class II (D/K/N) (15%),,,,,,,,
LVNGWWHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEGTEGTNPLVNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLNMCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.- (45%);2.5.1.72 (18%);3.6.3.14 (18%),Acid--amino-acid ligases (peptide synthases) (45%);Quinolinate synthase (18%);Transferred entry: 7.1.2.2 (18%),GO:0016021 (35%);GO:0005739 (22%);GO:0005737 (9%),integral component of membrane (35%);mitochondrion (22%);cytoplasm (9%),GO:0046872 (24%);GO:0009055 (22%);GO:0020037 (22%),metal ion binding (24%);electron transfer activity (22%);heme binding (22%),GO:0034220 (10%);GO:0007049 (8%);GO:0008360 (6%),ion transmembrane transport (10%);cell cycle (8%);regulation of cell shape (6%),IPR011685 (20%);IPR036909 (20%);IPR009056 (19%),LETM1-like (20%);Cytochrome c-like domain superfamily (20%);Cytochrome c-like domain (19%),,,,,,,,,,,
VEDTAAFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QDTSEEVCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPTNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.5 (100%),Exodeoxyribonuclease V (100%),GO:0016021 (67%);GO:0009338 (33%),integral component of membrane (67%);exodeoxyribonuclease V complex (33%),GO:0003677 (33%);GO:0003678 (33%);GO:0005524 (33%),DNA binding (33%);DNA helicase activity (33%);ATP binding (33%),GO:0000724 (33%),double-strand break repair via homologous recombination (33%),IPR006212 (25%);IPR006697 (25%);IPR009030 (25%),Furin-like repeat (25%);RecBCD enzyme subunit RecC (25%);Growth factor receptor cysteine-rich domain superfamily (25%),,,,,,,,,,,
TVMLLSNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%);GO:0005886 (50%),integral component of membrane (100%);plasma membrane (50%),GO:0005524 (50%);GO:0019829 (50%);GO:0046872 (50%),ATP binding (50%);ATPase-coupled cation transmembrane transporter activity (50%);metal ion binding (50%),GO:0030001 (50%),metal ion transport (50%),IPR001757 (50%);IPR003740 (50%);IPR006121 (50%),P-type ATPase (50%);Uncharacterised membrane protein YitT (50%);Heavy metal-associated domain, HMA (50%),,,,,,,,,,
AQPANDALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEEWEMAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPMLVMVPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEEEEMYAPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVNQSLLELQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNNFGMNPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNSQDLQEFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPYNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (75%);2.7.7.7 (13%);6.1.1.9 (13%),Metalloendopeptidases (75%);DNA-directed DNA polymerase (13%);Valine--tRNA ligase (13%),GO:0016021 (40%);GO:0005737 (10%),integral component of membrane (40%);cytoplasm (10%),GO:0004222 (30%);GO:0046872 (30%);GO:0003677 (15%),metalloendopeptidase activity (30%);metal ion binding (30%);DNA binding (15%),GO:0006261 (5%);GO:0006281 (5%);GO:0006438 (5%),DNA-dependent DNA replication (5%);DNA repair (5%);valyl-tRNA aminoacylation (5%),IPR001506 (30%);IPR024079 (30%);IPR013032 (20%),Peptidase M12A (30%);Metallopeptidase, catalytic domain superfamily (30%);EGF-like, conserved site (20%),,,,,,,,,
MYNAQLR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016798 (100%),hydrolase activity, acting on glycosyl bonds (100%),,,IPR001119 (100%);IPR003305 (100%);IPR005102 (100%),S-layer homology domain (100%);Carbohydrate-binding, CenC-like (100%);Carbohydrate binding  X2 domain (100%),,,,,,,,,
WDLDVDENR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDDEHPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (20%),integral component of membrane (20%),GO:0005524 (80%);GO:0016817 (80%),ATP binding (80%);hydrolase activity, acting on acid anhydrides (80%),,,IPR000330 (73%);IPR001650 (73%);IPR013967 (73%),SNF2-related, N-terminal domain (73%);Helicase, C-terminal (73%);Rad54, N-terminal (73%),,,,,,,
VLYFEFK,Ensete ventricosum,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,Petrosaviidae,,,Zingiberales,,,,,Musaceae,,,,Ensete,,,,Ensete ventricosum,,,,,,,,GO:0003676 (100%);GO:0004523 (100%),nucleic acid binding (100%);RNA-DNA hybrid ribonuclease activity (100%),,,IPR002156 (100%);IPR012337 (100%);IPR036397 (100%),Ribonuclease H domain (100%);Ribonuclease H-like superfamily (100%);Ribonuclease H superfamily (100%),,,,,,,,,,,
LSGHFTK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.5.2.7 (100%),ABC-type D-ribose transporter (100%),GO:0005886 (100%),plasma membrane (100%),GO:0005524 (100%);GO:0015611 (100%);GO:0016887 (100%),ATP binding (100%);D-ribose-importing ATPase activity (100%);ATPase activity (100%),,,IPR003731 (67%);IPR036105 (67%);IPR003439 (33%),Dinitrogenase iron-molybdenum cofactor biosynthesis (67%);Dinitrogenase iron-molybdenum cofactor biosynthesis superfamily (67%);ABC transporter-like (33%),,,,,,,,,,,
FAGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.24 (10%);2.7.7.6 (9%);6.1.1.19 (8%),Phosphoribosylanthranilate isomerase (10%);DNA-directed RNA polymerase (9%);Arginine--tRNA ligase (8%),GO:0016021 (44%);GO:0005886 (13%);GO:0005737 (5%),integral component of membrane (44%);plasma membrane (13%);cytoplasm (5%),GO:0016301 (11%);GO:0022872 (10%);GO:0005524 (10%),kinase activity (11%);protein-N(PI)-phosphohistidine-mannitol phosphotransferase system transmembrane transporter activity (10%);ATP binding (10%),GO:0009401 (11%);GO:0007165 (5%);GO:0006813 (3%),phosphoenolpyruvate-dependent sugar phosphotransferase system (11%);signal transduction (5%);potassium ion transport (3%),IPR002178 (9%);IPR003352 (9%);IPR003501 (9%),PTS EIIA type-2 domain (9%);Phosphotransferase system, EIIC (9%);Phosphotransferase system, EIIB component, type 2/3 (9%),,,,,,,,
WVEHAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (60%);1.9.3.1 (20%);3.2.2.0 (20%),Carboxylic ester hydrolases (60%);Cytochrome-c oxidase (20%); (20%),GO:0016021 (41%);GO:0005886 (6%);GO:0070469 (6%),integral component of membrane (41%);plasma membrane (6%);respirasome (6%),GO:0016787 (24%);GO:0003824 (18%);GO:0003677 (6%),hydrolase activity (24%);catalytic activity (18%);DNA binding (6%),GO:0009058 (18%);GO:0009691 (6%);GO:0015969 (6%),biosynthetic process (18%);cytokinin biosynthetic process (6%);guanosine tetraphosphate metabolic process (6%),IPR006214 (25%);IPR025567 (21%);IPR004821 (13%),Bax inhibitor 1-related (25%);Domain of unknown function DUF4332 (21%);Cytidyltransferase-like domain (13%),,,,,,,,,,,
TEATNYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDQLEDAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALPLLDEAAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPNSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.45 (81%);3.1.26.12 (3%);5.3.1.12 (3%),Thymidylate synthase (81%);Ribonuclease E (3%);Glucuronate isomerase (3%),GO:0005737 (35%);GO:0016021 (16%);GO:0016020 (1%),cytoplasm (35%);integral component of membrane (16%);membrane (1%),GO:0004799 (35%);GO:0016740 (9%);GO:0046872 (7%),thymidylate synthase activity (35%);transferase activity (9%);metal ion binding (7%),GO:0032259 (35%);GO:0006231 (34%);GO:0006235 (32%),methylation (35%);dTMP biosynthetic process (34%);dTTP biosynthetic process (32%),IPR023451 (31%);IPR036926 (31%);IPR000398 (31%),Thymidylate synthase/dCMP hydroxymethylase domain (31%);Thymidylate synthase/dCMP hydroxymethylase superfamily (31%);Thymidylate synthase (31%),,,,,,,,,,,
LTTLDVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (100%),Acting on ester bonds (100%),GO:0005737 (50%),cytoplasm (50%),GO:0000014 (50%);GO:0003677 (50%);GO:0016810 (50%),single-stranded DNA endodeoxyribonuclease activity (50%);DNA binding (50%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (50%),,,IPR002793 (50%);IPR006680 (50%);IPR011059 (50%),Endonuclease NucS (50%);Amidohydrolase-related (50%);Metal-dependent hydrolase, composite domain superfamily (50%),,,,,,,,,
EEVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (35%);1.1.1.267 (6%);4.2.1.104 (4%),Acting on ester bonds (35%);1-deoxy-D-xylulose-5-phosphate reductoisomerase (6%);Cyanase (4%),GO:0016021 (36%);GO:0005886 (11%);GO:0015935 (6%),integral component of membrane (36%);plasma membrane (11%);small ribosomal subunit (6%),GO:0005524 (14%);GO:0003723 (7%);GO:0016853 (7%),ATP binding (14%);RNA binding (7%);isomerase activity (7%),GO:0006412 (7%);GO:0006402 (6%);GO:0010212 (3%),translation (7%);mRNA catabolic process (6%);response to ionizing radiation (3%),IPR036420 (9%);IPR001357 (9%);IPR036412 (7%),BRCT domain superfamily (9%);BRCT domain (9%);HAD-like superfamily (7%),,,,,,,,,,,
FAVAEAVMVNGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.2.- (22%);2.2.1.7 (13%);3.6.4.- (6%),Sulfotransferases (22%);1-deoxy-D-xylulose-5-phosphate synthase (13%);Acting on ATP; involved in cellular and subcellular movement (6%),GO:0016021 (31%);GO:0005737 (12%);GO:0000139 (4%),integral component of membrane (31%);cytoplasm (12%);Golgi membrane (4%),GO:0003677 (14%);GO:0005524 (11%);GO:0008146 (4%),DNA binding (14%);ATP binding (11%);sulfotransferase activity (4%),GO:0006355 (9%);GO:0016051 (4%);GO:0006979 (4%),regulation of transcription, DNA-templated (9%);carbohydrate biosynthetic process (4%);response to oxidative stress (4%),IPR027417 (11%);IPR002881 (9%);IPR002876 (5%),P-loop containing nucleoside triphosphate hydrolase (11%);Domain of unknown function DUF58 (9%);Transcriptional regulator TACO1-like (5%),,,,,,,,,,
FEDNVLVLGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPQDVEEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPNTEAK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (100%),Signal peptidase I (100%),GO:0005737 (50%);GO:0016021 (50%),cytoplasm (50%);integral component of membrane (50%),GO:0003743 (50%);GO:0003924 (50%);GO:0005525 (50%),translation initiation factor activity (50%);GTPase activity (50%);GTP binding (50%),,,IPR000178 (50%);IPR000223 (50%);IPR000795 (50%),Translation initiation factor aIF-2, bacterial-like (50%);Peptidase S26A, signal peptidase I (50%);Transcription factor, GTP-binding domain (50%),,,,,,,,
FEYSDEHMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMDPVLMGEGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSGSSNQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLEYVMETPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSLVKPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (50%);3.4.23.43 (50%);6.1.1.21 (50%),Methyltransferases (50%);Prepilin peptidase (50%);Histidine--tRNA ligase (50%),GO:0016021 (40%);GO:0005737 (20%);GO:0005886 (20%),integral component of membrane (40%);cytoplasm (20%);plasma membrane (20%),GO:0003677 (40%);GO:0005524 (40%);GO:0004190 (20%),DNA binding (40%);ATP binding (40%);aspartic-type endopeptidase activity (20%),GO:0006270 (20%);GO:0006427 (20%);GO:0032259 (20%),DNA replication initiation (20%);histidyl-tRNA aminoacylation (20%);methylation (20%),IPR000045 (14%);IPR000182 (14%);IPR001005 (14%),Prepilin type IV endopeptidase, peptidase domain (14%);GNAT domain (14%);SANT/Myb domain (14%),,,,,,,,,,
EPGTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (43%);2.7.2.4 (5%);5.4.99.- (5%),DNA topoisomerase (ATP-hydrolyzing) (43%);Aspartate kinase (5%);Transferring other groups (5%),GO:0005634 (19%);GO:0016021 (17%);GO:0000785 (14%),nucleus (19%);integral component of membrane (17%);chromatin (14%),GO:0005524 (16%);GO:0031492 (14%);GO:0003677 (12%),ATP binding (16%);nucleosomal DNA binding (14%);DNA binding (12%),GO:0045944 (16%);GO:0061178 (13%);GO:0006265 (6%),positive regulation of transcription by RNA polymerase II (16%);regulation of insulin secretion involved in cellular response to glucose stimulus (13%);DNA topological change (6%),IPR000079 (11%);IPR031073 (11%);IPR007527 (6%),High mobility group protein HMGN (11%);High mobility group protein HMGN3 (11%);Zinc finger, SWIM-type (6%),,,,,,,,,,
NNPGNEVNER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YTTTHGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNMFVMLDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DAYLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.42 (26%);4.2.1.2 (10%);6.1.1.15 (9%),Branched-chain-amino-acid transaminase (26%);Fumarate hydratase (10%);Proline--tRNA ligase (9%),GO:0016021 (20%);GO:0005737 (11%);GO:0005634 (2%),integral component of membrane (20%);cytoplasm (11%);nucleus (2%),GO:0005524 (14%);GO:0003677 (12%);GO:0052654 (7%),ATP binding (14%);DNA binding (12%);L-leucine transaminase activity (7%),GO:0009097 (7%);GO:0009098 (7%);GO:0009099 (7%),isoleucine biosynthetic process (7%);leucine biosynthetic process (7%);valine biosynthetic process (7%),IPR027417 (9%);IPR036038 (7%);IPR001544 (7%),P-loop containing nucleoside triphosphate hydrolase (9%);Aminotransferase-like, PLP-dependent enzymes (7%);Aminotransferase class IV (7%),,,,,,,,,,
LLNSHDASNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEEQENSYDETR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLLEEDLN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFVFGQTGAGNNAVSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGNLVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%),integral component of membrane (60%),GO:0000155 (20%);GO:0003676 (20%);GO:0005524 (20%),phosphorelay sensor kinase activity (20%);nucleic acid binding (20%);ATP binding (20%),GO:0031047 (20%),gene silencing by RNA (20%),IPR013491 (33%);IPR000033 (17%);IPR002182 (17%),Caudovirus, tape measure, N-terminal (33%);LDLR class B repeat (17%);NB-ARC (17%),,,,,,,,,
LALSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.16.4 (59%);4.1.99.19 (18%);1.-.-.- (6%),Serine-type D-Ala-D-Ala carboxypeptidase (59%);2-iminoacetate synthase (18%);Oxidoreductases (6%),GO:0016021 (26%);GO:0005887 (5%);GO:0005886 (1%),integral component of membrane (26%);integral component of plasma membrane (5%);plasma membrane (1%),GO:0016740 (54%);GO:0022857 (7%);GO:0003677 (5%),transferase activity (54%);transmembrane transporter activity (7%);DNA binding (5%),GO:0009252 (5%);GO:0000917 (5%);GO:0008360 (5%),peptidoglycan biosynthetic process (5%);division septum assembly (5%);regulation of cell shape (5%),IPR029044 (41%);IPR000195 (9%);IPR001452 (9%),Nucleotide-diphospho-sugar transferases (41%);Rab-GTPase-TBC domain (9%);SH3 domain (9%),,,,,,,,,,,
TFNDELVK,Pedobacter,Bacteria,,,,Bacteroidetes,,,Sphingobacteriia,,,,Sphingobacteriales,,,,,Sphingobacteriaceae,,,,Pedobacter,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0009103 (100%),lipopolysaccharide biosynthetic process (100%),IPR003856 (100%),Polysaccharide chain length determinant N-terminal domain (100%),,,,,,,,,,,
MSLNTLEFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMVTVHK,Deltaproteobacteria,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLTRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.61 (33%);4.2.1.75 (33%);2.1.1.107 (17%),Hydroxymethylbilane synthase (33%);Uroporphyrinogen-III synthase (33%);Uroporphyrinogen-III C-methyltransferase (17%),GO:0016021 (53%);GO:0005819 (29%);GO:0005874 (29%),integral component of membrane (53%);spindle (29%);microtubule (29%),GO:0008324 (14%);GO:0016491 (13%);GO:0004852 (9%),cation transmembrane transporter activity (14%);oxidoreductase activity (13%);uroporphyrinogen-III synthase activity (9%),GO:0032147 (29%);GO:0060236 (29%);GO:0006629 (14%),activation of protein kinase activity (29%);regulation of mitotic spindle organization (29%);lipid metabolic process (14%),IPR009675 (29%);IPR027330 (29%);IPR027329 (25%),TPX2 (29%);TPX2 central domain (29%);TPX2, C-terminal (25%),,,,,,,,,,
GPDVFAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008168 (50%);GO:0008410 (50%),methyltransferase activity (50%);CoA-transferase activity (50%),GO:0032259 (50%),methylation (50%),IPR029063 (50%);IPR004165 (25%);IPR007848 (25%),S-adenosyl-L-methionine-dependent methyltransferase (50%);Coenzyme A transferase family I (25%);Methyltransferase small domain (25%),,,,,,,,,,,
DPTTWLYHTMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YQTVTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.8 (25%);5.6.2.2 (25%);5.99.1.2 (25%),Endo-1,4-beta-xylanase (25%);DNA topoisomerase (ATP-hydrolyzing) (25%);Transferred entry: 5.6.2.1 (25%),GO:0016021 (38%);GO:0005886 (14%);GO:0005737 (5%),integral component of membrane (38%);plasma membrane (14%);cytoplasm (5%),GO:0003677 (19%);GO:0008270 (19%);GO:0003824 (11%),DNA binding (19%);zinc ion binding (19%);catalytic activity (11%),GO:0009103 (8%);GO:0045226 (8%);GO:0006265 (5%),lipopolysaccharide biosynthetic process (8%);extracellular polysaccharide biosynthetic process (8%);DNA topological change (5%),IPR011992 (21%);IPR015153 (21%);IPR001202 (19%),EF-hand domain pair (21%);EF-hand domain, type 1 (21%);WW domain (19%),,,,,,,,,
EAEHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.2 (33%);6.3.3.1 (32%);6.3.4.13 (32%),Phosphoribosylglycinamide formyltransferase (33%);Phosphoribosylformylglycinamidine cyclo-ligase (32%);Phosphoribosylamine--glycine ligase (32%),GO:0016021 (15%);GO:0005737 (8%);GO:0008305 (3%),integral component of membrane (15%);cytoplasm (8%);integrin complex (3%),GO:0005524 (21%);GO:0016301 (11%);GO:0046872 (9%),ATP binding (21%);kinase activity (11%);metal ion binding (9%),GO:0006189 (7%);GO:0009113 (6%);GO:0007229 (3%),'de novo' IMP biosynthetic process (7%);purine nucleobase biosynthetic process (6%);integrin-mediated signaling pathway (3%),IPR000600 (13%);IPR027417 (11%);IPR035965 (6%),ROK family (13%);P-loop containing nucleoside triphosphate hydrolase (11%);PAS domain superfamily (6%),,,,,,,,,,,
NSDEYVLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVDETALK,Opitutae bacterium,Bacteria,,,,Verrucomicrobia,,,Opitutae,,,,,,,,,,,,,,,,,Opitutae bacterium,,,,2.4.2.8 (100%),Hypoxanthine phosphoribosyltransferase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0000166 (100%);GO:0004422 (100%);GO:0046872 (100%),nucleotide binding (100%);hypoxanthine phosphoribosyltransferase activity (100%);metal ion binding (100%),GO:0006166 (100%);GO:0032264 (100%),purine ribonucleoside salvage (100%);IMP salvage (100%),IPR000836 (100%);IPR005904 (100%);IPR029057 (100%),Phosphoribosyltransferase domain (100%);Hypoxanthine phosphoribosyl transferase (100%);Phosphoribosyltransferase-like (100%),,,,,,,,,,,
FDLAEAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENGQWPHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VALDAGNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YALTTGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.- (100%),Acid--thiol ligases (100%),GO:0016021 (50%);GO:0009279 (25%),integral component of membrane (50%);cell outer membrane (25%),GO:0003677 (25%);GO:0016874 (25%);GO:0030246 (25%),DNA binding (25%);ligase activity (25%);carbohydrate binding (25%),,,IPR000531 (14%);IPR000719 (14%);IPR000847 (14%),TonB-dependent receptor-like, beta-barrel (14%);Protein kinase domain (14%);Transcription regulator HTH, LysR (14%),,,,,,,,,
TVQDDNASWSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDQLVGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (14%),cytoplasm (14%),GO:0003824 (71%);GO:0005524 (29%);GO:0004496 (14%),catalytic activity (71%);ATP binding (29%);mevalonate kinase activity (14%),GO:0005992 (57%);GO:0008299 (14%);GO:0019538 (14%),trehalose biosynthetic process (57%);isoprenoid biosynthetic process (14%);protein metabolic process (14%),IPR001830 (44%);IPR002591 (22%);IPR003337 (22%),Glycosyl transferase, family 20 (44%);Type I phosphodiesterase/nucleotide pyrophosphatase/phosphate transferase (22%);Trehalose-phosphatase (22%),,,,,,,,,,
LDPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.0 (50%);1.5.1.5 (5%);3.5.4.9 (5%), (50%);Methylenetetrahydrofolate dehydrogenase (NADP(+)) (5%);Methenyltetrahydrofolate cyclohydrolase (5%),GO:0016021 (16%);GO:0005737 (7%);GO:0015935 (4%),integral component of membrane (16%);cytoplasm (7%);small ribosomal subunit (4%),GO:0000287 (14%);GO:0005085 (13%);GO:0002094 (12%),magnesium ion binding (14%);guanyl-nucleotide exchange factor activity (13%);polyprenyltransferase activity (12%),GO:0007264 (13%);GO:0046474 (12%);GO:0006412 (6%),small GTPase mediated signal transduction (13%);glycerophospholipid biosynthetic process (12%);translation (6%),IPR010703 (12%);IPR027357 (12%);IPR026791 (12%),Dedicator of cytokinesis, C-terminal (12%);DHR-2 domain (12%);Dedicator of cytokinesis (12%),,,,,,,,,,
DESTGTLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLWANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.233 (80%);2.7.7.48 (20%),[Phosphatase 2A protein]-leucine-carboxy methyltransferase (80%);RNA-directed RNA polymerase (20%),GO:0016021 (42%);GO:0005886 (8%),integral component of membrane (42%);plasma membrane (8%),GO:0008168 (33%);GO:0005506 (25%);GO:0016705 (25%),methyltransferase activity (33%);iron ion binding (25%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (25%),GO:0032259 (33%);GO:0006886 (8%),methylation (33%);intracellular protein transport (8%),IPR001810 (30%);IPR011043 (30%);IPR036047 (30%),F-box domain (30%);Galactose oxidase/kelch, beta-propeller (30%);F-box-like domain superfamily (30%),,,,,,,,
NDLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.14 (47%);3.1.4.- (22%);6.3.4.2 (8%),5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (47%);Phosphoric diester hydrolases (22%);CTP synthase (glutamine hydrolyzing) (8%),GO:0016021 (21%);GO:0005737 (4%);GO:0005886 (3%),integral component of membrane (21%);cytoplasm (4%);plasma membrane (3%),GO:0008270 (21%);GO:0003871 (20%);GO:0046872 (18%),zinc ion binding (21%);5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity (20%);metal ion binding (18%),GO:0032259 (21%);GO:0009086 (20%);GO:0006541 (3%),methylation (21%);methionine biosynthetic process (20%);glutamine metabolic process (3%),IPR002629 (17%);IPR038071 (17%);IPR013215 (17%),Cobalamin-independent methionine synthase MetE, C-terminal/archaeal (17%);UROD/MetE-like superfamily (17%);Cobalamin-independent methionine synthase MetE, N-terminal (17%),,,,,,,,,
EPMLLANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLMFTFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNWFTER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFDLPVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.21 (48%);6.3.5.5 (32%);1.2.1.- (4%),Nicotinate phosphoribosyltransferase (48%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (32%);With NAD(+) or NADP(+) as acceptor (4%),GO:0009898 (25%);GO:0032153 (25%);GO:0016021 (8%),cytoplasmic side of plasma membrane (25%);cell division site (25%);integral component of membrane (8%),GO:0008270 (41%);GO:0004514 (9%);GO:0004516 (8%),zinc ion binding (41%);nicotinate-nucleotide diphosphorylase (carboxylating) activity (9%);nicotinate phosphoribosyltransferase activity (8%),GO:0043093 (25%);GO:0009435 (9%);GO:0044205 (6%),FtsZ-dependent cytokinesis (25%);NAD biosynthetic process (9%);'de novo' UMP biosynthetic process (6%),IPR004181 (40%);IPR013083 (40%);IPR003494 (25%),Zinc finger, MIZ-type (40%);Zinc finger, RING/FYVE/PHD-type (40%);SHS2 domain inserted in FtsA (25%),,,,,,,,,
QNPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (11%);3.1.22.4 (9%);1.2.7.1 (7%),Peptidylprolyl isomerase (11%);Crossover junction endodeoxyribonuclease (9%);Pyruvate synthase (7%),GO:0016021 (32%);GO:0009279 (7%);GO:0005886 (6%),integral component of membrane (32%);cell outer membrane (7%);plasma membrane (6%),GO:0003677 (9%);GO:0005524 (8%);GO:0005506 (8%),DNA binding (9%);ATP binding (8%);iron ion binding (8%),GO:0022900 (6%);GO:0006493 (2%);GO:0006281 (2%),electron transport chain (6%);protein O-linked glycosylation (2%);DNA repair (2%),IPR008863 (18%);IPR027417 (7%);IPR016024 (5%),Toxic anion resistance (18%);P-loop containing nucleoside triphosphate hydrolase (7%);Armadillo-type fold (5%),,,,,,,,,,,
LLLPWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.-.- (32%);2.5.1.- (14%);3.1.1.- (9%),Transferring phosphorus-containing groups (32%);Transferring alkyl or aryl groups, other than methyl groups (14%);Carboxylic ester hydrolases (9%),GO:0016021 (93%);GO:0005886 (5%);GO:0005783 (1%),integral component of membrane (93%);plasma membrane (5%);endoplasmic reticulum (1%),GO:0016740 (6%);GO:0016746 (3%);GO:0005524 (2%),transferase activity (6%);transferase activity, transferring acyl groups (3%);ATP binding (2%),GO:0055085 (3%);GO:0006744 (2%);GO:0006506 (1%),transmembrane transport (3%);ubiquinone biosynthetic process (2%);GPI anchor biosynthetic process (1%),IPR004299 (71%);IPR010607 (10%);IPR036465 (10%),Membrane bound O-acyl transferase, MBOAT (71%);Protein of unknown function DUF1194 (10%);von Willebrand factor A-like domain superfamily (10%),,,,,,,,
AYVGDEAQSK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR004000 (100%);IPR004001 (100%);IPR020902 (100%),Actin family (100%);Actin, conserved site (100%);Actin/actin-like conserved site (100%),,,,,,,,,,
GDDPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (44%);GO:0005886 (11%),integral component of membrane (44%);plasma membrane (11%),GO:0003723 (22%);GO:0009982 (22%);GO:0003677 (11%),RNA binding (22%);pseudouridine synthase activity (22%);DNA binding (11%),GO:0001522 (22%);GO:0006629 (11%);GO:0009306 (11%),pseudouridine synthesis (22%);lipid metabolic process (11%);protein secretion (11%),IPR002942 (22%);IPR006145 (22%);IPR006224 (22%),RNA-binding S4 domain (22%);Pseudouridine synthase, RsuA/RluA (22%);Pseudouridine synthase, RluC/RluD, conserved site (22%),,,,,,,,
VNLLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.3.2.2 (50%);2.8.1.10 (14%);2.3.1.269 (7%),ABC-type phosphonate transporter (50%);Thiazole synthase (14%);Apolipoprotein N-acyltransferase (7%),GO:0016021 (25%);GO:0005886 (20%);GO:0005737 (8%),integral component of membrane (25%);plasma membrane (20%);cytoplasm (8%),GO:0005524 (36%);GO:0016887 (27%);GO:0015416 (16%),ATP binding (36%);ATPase activity (27%);ATPase-coupled organic phosphonate transmembrane transporter activity (16%),GO:0009228 (5%);GO:0009229 (5%);GO:0005975 (2%),thiamine biosynthetic process (5%);thiamine diphosphate biosynthetic process (5%);carbohydrate metabolic process (2%),IPR027417 (28%);IPR003593 (25%);IPR003439 (25%),P-loop containing nucleoside triphosphate hydrolase (28%);AAA+ ATPase domain (25%);ABC transporter-like (25%),,,,,,,,,,,
AMPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.- (98%);5.4.99.25 (0%);1.11.1.6 (0%),Sulfurtransferases (98%);tRNA pseudouridine(55) synthase (0%);Catalase (0%),GO:0005737 (87%);GO:0016021 (2%);GO:0005634 (1%),cytoplasm (87%);integral component of membrane (2%);nucleus (1%),GO:0005524 (89%);GO:0051539 (87%);GO:0000049 (86%),ATP binding (89%);4 iron, 4 sulfur cluster binding (87%);tRNA binding (86%),GO:0034227 (84%);GO:0008033 (4%);GO:0031119 (0%),tRNA thio-modification (84%);tRNA processing (4%);tRNA pseudouridine synthesis (0%),IPR014729 (85%);IPR011063 (85%);IPR012089 (84%),Rossmann-like alpha/beta/alpha sandwich fold (85%);tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal (85%);tRNA-cytidine(32) 2-sulfurtransferase (84%),,,,,,,,,
EFGVELMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAPTAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (21%);2.5.1.78 (14%);5.6.2.1 (14%),Glycogen phosphorylase (21%);6,7-dimethyl-8-ribityllumazine synthase (14%);DNA topoisomerase (14%),GO:0005840 (21%);GO:0016021 (7%);GO:0005634 (6%),ribosome (21%);integral component of membrane (7%);nucleus (6%),GO:0046872 (25%);GO:0003735 (22%);GO:0016491 (17%),metal ion binding (25%);structural constituent of ribosome (22%);oxidoreductase activity (17%),GO:0006412 (21%);GO:0006139 (3%);GO:0005975 (2%),translation (21%);nucleobase-containing compound metabolic process (3%);carbohydrate metabolic process (2%),IPR025736 (21%);IPR042070 (21%);IPR008599 (19%),PucR C-terminal helix-turn-helix domain (21%);PucR C-terminal helix-turn-helix domain superfamily (21%);Putative sugar diacid recognition (19%),,,,,,,,,,
TEPNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (65%);2.6.1.16 (7%);2.1.1.192 (3%),RNA-directed RNA polymerase (65%);Glutamine--fructose-6-phosphate transaminase (isomerizing) (7%);23S rRNA (adenine(2503)-C(2))-methyltransferase (3%),GO:0016021 (17%);GO:0016020 (15%);GO:0030430 (14%),integral component of membrane (17%);membrane (15%);host cell cytoplasm (14%),GO:0003723 (23%);GO:0003968 (22%);GO:0000166 (20%),RNA binding (23%);RNA-directed 5'-3' RNA polymerase activity (22%);nucleotide binding (20%),GO:0006351 (23%);GO:0019079 (22%);GO:0051027 (13%),transcription, DNA-templated (23%);viral genome replication (22%);DNA transport (13%),IPR008723 (20%);IPR007097 (20%);IPR000263 (12%),RNA-dependent RNA polymerase, orbiviral (20%);RNA-directed RNA polymerase, reovirus (20%);Geminivirus AR1/BR1 coat protein (12%),,,,,,,,
NVVQSNTNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAQVLATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.3.3 (100%),Factor independent urate hydroxylase (100%),GO:0005777 (50%);GO:0005886 (50%);GO:0016021 (50%),peroxisome (50%);plasma membrane (50%);integral component of membrane (50%),GO:0004846 (50%);GO:0005524 (50%);GO:0019829 (50%),urate oxidase activity (50%);ATP binding (50%);ATPase-coupled cation transmembrane transporter activity (50%),GO:0006144 (50%);GO:0019628 (50%);GO:0030001 (50%),purine nucleobase metabolic process (50%);urate catabolic process (50%);metal ion transport (50%),IPR001757 (50%);IPR002042 (50%);IPR006121 (50%),P-type ATPase (50%);Uricase (50%);Heavy metal-associated domain, HMA (50%),,,,,,,,,,
GDPCTNGEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEDNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (65%);7.1.1.- (12%);6.1.1.7 (2%),Metalloendopeptidases (65%);Hydron translocation or charge separation linked to oxidoreductase reactions (12%);Alanine--tRNA ligase (2%),GO:0016021 (38%);GO:0005886 (27%);GO:0005634 (7%),integral component of membrane (38%);plasma membrane (27%);nucleus (7%),GO:0005524 (40%);GO:0008270 (28%);GO:0016887 (24%),ATP binding (40%);zinc ion binding (28%);ATPase activity (24%),GO:0030163 (23%);GO:0051301 (13%);GO:0006303 (6%),protein catabolic process (23%);cell division (13%);double-strand break repair via nonhomologous end joining (6%),IPR027417 (28%);IPR003593 (22%);IPR000642 (22%),P-loop containing nucleoside triphosphate hydrolase (28%);AAA+ ATPase domain (22%);Peptidase M41 (22%),,,,,,,,,,,
DSYEEQLVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAYEHYVQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVGDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.4.1.2 (26%);6.3.4.14 (26%);4.2.1.104 (5%),Acetyl-CoA carboxylase (26%);Biotin carboxylase (26%);Cyanase (5%),GO:0016021 (18%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (18%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (19%);GO:0003677 (14%);GO:0046872 (14%),ATP binding (19%);DNA binding (14%);metal ion binding (14%),GO:0000160 (7%);GO:0006633 (6%);GO:2001295 (6%),phosphorelay signal transduction system (7%);fatty acid biosynthetic process (6%);malonyl-CoA biosynthetic process (6%),IPR001789 (7%);IPR011006 (7%);IPR013973 (6%),Signal transduction response regulator, receiver domain (7%);CheY-like superfamily (7%);PglZ domain (6%),,,,,,,,,,
DFYLSLYFK,Thermoanaerobacter,Bacteria,,,,Firmicutes,,,Clostridia,,,,Thermoanaerobacterales,,,,,Thermoanaerobacteraceae,,,,Thermoanaerobacter,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEPSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (33%);2.1.1.- (11%);2.7.4.9 (11%),DNA helicase (33%);Methyltransferases (11%);dTMP kinase (11%),GO:0016021 (13%);GO:0005737 (3%);GO:0070461 (2%),integral component of membrane (13%);cytoplasm (3%);SAGA-type complex (2%),GO:0003677 (23%);GO:0008080 (16%);GO:0005524 (13%),DNA binding (23%);N-acetyltransferase activity (16%);ATP binding (13%),GO:0000266 (3%);GO:0016559 (3%);GO:0006751 (2%),mitochondrial fission (3%);peroxisome fission (3%);glutathione catabolic process (2%),IPR000182 (14%);IPR016181 (14%);IPR027417 (12%),GNAT domain (14%);Acyl-CoA N-acyltransferase (14%);P-loop containing nucleoside triphosphate hydrolase (12%),,,,,,,,,,,
FVLDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.33 (55%);2.4.2.- (13%);1.1.1.2 (5%),Pantothenate kinase (55%);Pentosyltransferases (13%);Alcohol dehydrogenase (NADP(+)) (5%),GO:0016021 (27%);GO:0005737 (8%);GO:0005887 (2%),integral component of membrane (27%);cytoplasm (8%);integral component of plasma membrane (2%),GO:0016491 (18%);GO:0008270 (17%);GO:0005524 (16%),oxidoreductase activity (18%);zinc ion binding (17%);ATP binding (16%),GO:0015937 (7%);GO:0009253 (5%);GO:0006355 (2%),coenzyme A biosynthetic process (7%);peptidoglycan catabolic process (5%);regulation of transcription, DNA-templated (2%),IPR036291 (18%);IPR013149 (18%);IPR011032 (16%),NAD(P)-binding domain superfamily (18%);Alcohol dehydrogenase, C-terminal (18%);GroES-like superfamily (16%),,,,,,,,,
SSTVHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.12 (68%);2.7.7.12 (15%);3.1.11.5 (5%),Phosphogluconate dehydratase (68%);UDP-glucose--hexose-1-phosphate uridylyltransferase (15%);Exodeoxyribonuclease V (5%),GO:0016021 (30%);GO:0005737 (6%);GO:0005634 (5%),integral component of membrane (30%);cytoplasm (6%);nucleus (5%),GO:0004456 (28%);GO:0046872 (27%);GO:0051539 (27%),phosphogluconate dehydratase activity (28%);metal ion binding (27%);4 iron, 4 sulfur cluster binding (27%),GO:0009255 (27%);GO:0046177 (27%);GO:0043048 (11%),Entner-Doudoroff pathway through 6-phosphogluconate (27%);D-gluconate catabolic process (27%);dolichyl monophosphate biosynthetic process (11%),IPR000581 (23%);IPR004786 (23%);IPR020558 (23%),Dihydroxy-acid/6-phosphogluconate dehydratase (23%);6-phosphogluconate dehydratase (23%);Dihydroxy-acid/6-phosphogluconate dehydratase, conserved site (23%),,,,,,,,,
LACEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.2 (49%);1.5.1.5 (11%);3.5.4.9 (11%),Deoxyribonuclease IV (49%);Methylenetetrahydrofolate dehydrogenase (NADP(+)) (11%);Methenyltetrahydrofolate cyclohydrolase (11%),GO:0016021 (16%);GO:0005737 (8%);GO:0016459 (1%),integral component of membrane (16%);cytoplasm (8%);myosin complex (1%),GO:0008833 (21%);GO:0003677 (20%);GO:0008270 (15%),deoxyribonuclease IV (phage-T4-induced) activity (21%);DNA binding (20%);zinc ion binding (15%),GO:0006281 (13%);GO:0006164 (5%);GO:0000105 (5%),DNA repair (13%);purine nucleotide biosynthetic process (5%);histidine biosynthetic process (5%),IPR036237 (18%);IPR013022 (18%);IPR001719 (17%),Xylose isomerase-like superfamily (18%);Xylose isomerase-like, TIM barrel domain (18%);AP endonuclease 2 (17%),,,,,,,,,,
ETCSYSYFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNVSDASLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTDEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.13.9 (50%);1.-.-.- (25%);3.4.11.9 (25%),Xaa-Pro dipeptidase (50%);Oxidoreductases (25%);Xaa-Pro aminopeptidase (25%),GO:0016021 (50%);GO:0009279 (2%);GO:0030286 (2%),integral component of membrane (50%);cell outer membrane (2%);dynein complex (2%),GO:0070006 (20%);GO:0003677 (11%);GO:0005524 (11%),metalloaminopeptidase activity (20%);DNA binding (11%);ATP binding (11%),GO:0007018 (5%);GO:0006637 (2%);GO:0009306 (2%),microtubule-based movement (5%);acyl-CoA metabolic process (2%);protein secretion (2%),IPR014825 (34%);IPR016024 (34%);IPR000587 (15%),DNA alkylation repair enzyme (34%);Armadillo-type fold (34%);Creatinase, N-terminal (15%),,,,,,,,,,
SGCDAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLGNEAVNAVSSAAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLNGSLNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLADMFNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.- (13%);2.7.7.7 (12%);6.5.1.1 (11%),Forming phosphoric ester bonds (13%);DNA-directed DNA polymerase (12%);DNA ligase (ATP) (11%),GO:0016021 (24%);GO:0005739 (12%);GO:0005737 (7%),integral component of membrane (24%);mitochondrion (12%);cytoplasm (7%),GO:0005524 (15%);GO:0003677 (10%);GO:0005085 (10%),ATP binding (15%);DNA binding (10%);guanyl-nucleotide exchange factor activity (10%),GO:0006120 (16%);GO:0007264 (10%);GO:0032981 (5%),mitochondrial electron transport, NADH to ubiquinone (16%);small GTPase mediated signal transduction (10%);mitochondrial respiratory chain complex I assembly (5%),IPR036322 (21%);IPR015943 (15%);IPR033034 (11%),WD40-repeat-containing domain superfamily (21%);WD40/YVTN repeat-like-containing domain superfamily (15%);NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (11%),,,,,,,,,,
QLLLEYDVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFEYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.6 (50%);6.1.1.21 (50%),Exodeoxyribonuclease VII (50%);Histidine--tRNA ligase (50%),GO:0016021 (22%);GO:0005737 (11%);GO:0009507 (11%),integral component of membrane (22%);cytoplasm (11%);chloroplast (11%),GO:0000155 (17%);GO:0005509 (17%);GO:0030246 (17%),phosphorelay sensor kinase activity (17%);calcium ion binding (17%);carbohydrate binding (17%),GO:0006397 (11%);GO:0008033 (11%);GO:0008380 (11%),mRNA processing (11%);tRNA processing (11%);RNA splicing (11%),IPR001789 (14%);IPR002048 (14%);IPR003594 (14%),Signal transduction response regulator, receiver domain (14%);EF-hand domain (14%);Histidine kinase/HSP90-like ATPase (14%),,,,,,,,,,
QLYNPVLENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVEEVMPK,Parastagonospora nodorum,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Dothideomycetes,Pleosporomycetidae,,,Pleosporales,Pleosporineae,,,,Phaeosphaeriaceae,,,,Parastagonospora,,,,Parastagonospora nodorum,,,,,,GO:0000127 (100%),transcription factor TFIIIC complex (100%),,,GO:0006384 (100%);GO:0042791 (100%),transcription initiation from RNA polymerase III promoter (100%);5S class rRNA transcription by RNA polymerase III (100%),,,,,,,,,,,,,
QCWKPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QDMNELNEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVEQPEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLPVLLGVSMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEDLQTSPMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLLPEPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008236 (100%),serine-type peptidase activity (100%),,,IPR005151 (100%);IPR029045 (100%),Tail specific protease (100%);ClpP/crotonase-like domain superfamily (100%),,,,,,,,,,,
TNTALWER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNQPEVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSNNLNQGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QSNDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.4 (50%);4.3.1.12 (50%),Malate dehydrogenase (quinone) (50%);Ornithine cyclodeaminase (50%),GO:0016021 (24%);GO:0005576 (3%);GO:0005618 (3%),integral component of membrane (24%);extracellular region (3%);cell wall (3%),GO:0003676 (18%);GO:0003677 (11%);GO:0008270 (11%),nucleic acid binding (18%);DNA binding (11%);zinc ion binding (11%),GO:0015074 (18%);GO:0006310 (11%);GO:0006099 (3%),DNA integration (18%);DNA recombination (11%);tricarboxylic acid cycle (3%),IPR013103 (48%);IPR003615 (9%);IPR005162 (6%),Reverse transcriptase, RNA-dependent DNA polymerase (48%);HNH nuclease (9%);Retrotransposon gag domain (6%),,,,,,,,,,
APYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.2 (35%);4.3.3.6 (35%);3.1.3.77 (9%),Glutaminase (35%);Pyridoxal 5'-phosphate synthase (glutamine hydrolyzing) (35%);Acireductone synthase (9%),GO:0016021 (18%);GO:0005634 (5%);GO:0005737 (5%),integral component of membrane (18%);nucleus (5%);cytoplasm (5%),GO:0005524 (23%);GO:0004359 (10%);GO:0036381 (8%),ATP binding (23%);glutaminase activity (10%);pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity (8%),GO:0042823 (10%);GO:0006543 (8%);GO:0019509 (4%),pyridoxal phosphate biosynthetic process (10%);glutamine catabolic process (8%);L-methionine salvage from methylthioadenosine (4%),IPR027417 (18%);IPR003593 (15%);IPR038729 (15%),P-loop containing nucleoside triphosphate hydrolase (18%);AAA+ ATPase domain (15%);Rad50/SbcC-type AAA domain (15%),,,,,,,,,,,
LTSLDCLK,Genlisea aurea,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Lamiales,,,,,Lentibulariaceae,,,,Genlisea,,,,Genlisea aurea,,,,,,,,,,,,IPR001611 (100%);IPR003591 (100%);IPR032675 (100%),Leucine-rich repeat (100%);Leucine-rich repeat, typical subtype (100%);Leucine-rich repeat domain superfamily (100%),,,,,,,,,,
VSDGLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.1 (55%);3.1.13.- (18%);3.4.11.- (9%),Carbonic anhydrase (55%);Exoribonucleases producing 5'-phosphomonoesters (18%);Aminopeptidases (9%),GO:0016021 (18%);GO:0005737 (4%);GO:0000932 (3%),integral component of membrane (18%);cytoplasm (4%);P-body (3%),GO:0016787 (22%);GO:0046872 (15%);GO:0008270 (12%),hydrolase activity (22%);metal ion binding (15%);zinc ion binding (12%),GO:0015976 (7%);GO:0051301 (4%);GO:0017000 (3%),carbon utilization (7%);cell division (4%);antibiotic biosynthetic process (3%),IPR027417 (14%);IPR008928 (10%);IPR008979 (10%),P-loop containing nucleoside triphosphate hydrolase (14%);Six-hairpin glycosidase superfamily (10%);Galactose-binding-like domain superfamily (10%),,,,,,,,,,,
ELNGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.44 (80%);2.7.7.9 (14%);1.1.1.22 (2%),Phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (80%);UTP--glucose-1-phosphate uridylyltransferase (14%);UDP-glucose 6-dehydrogenase (2%),GO:0016021 (22%);GO:0000444 (1%);GO:0005634 (1%),integral component of membrane (22%);MIS12/MIND type complex (1%);nucleus (1%),GO:0004616 (43%);GO:0050661 (38%);GO:0003983 (9%),phosphogluconate dehydrogenase (decarboxylating) activity (43%);NADP binding (38%);UTP:glucose-1-phosphate uridylyltransferase activity (9%),GO:0006098 (42%);GO:0019521 (41%);GO:0006011 (9%),pentose-phosphate shunt (42%);D-gluconate metabolic process (41%);UDP-glucose metabolic process (9%),IPR008927 (28%);IPR006114 (27%);IPR006183 (27%),6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily (28%);6-phosphogluconate dehydrogenase, C-terminal (27%);6-phosphogluconate dehydrogenase (27%),,,,,,,,
NNLESVLTVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEVVCHYLAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNSGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.41 (76%);2.7.2.11 (76%);6.5.1.1 (18%),Glutamate-5-semialdehyde dehydrogenase (76%);Glutamate 5-kinase (76%);DNA ligase (ATP) (18%),GO:0005739 (41%);GO:0005737 (14%);GO:0016021 (12%),mitochondrion (41%);cytoplasm (14%);integral component of membrane (12%),GO:0004350 (52%);GO:0005524 (52%);GO:0004349 (51%),glutamate-5-semialdehyde dehydrogenase activity (52%);ATP binding (52%);glutamate 5-kinase activity (51%),GO:0055129 (40%);GO:0006561 (12%);GO:0006310 (10%),L-proline biosynthetic process (40%);proline biosynthetic process (12%);DNA recombination (10%),IPR000965 (45%);IPR015590 (45%);IPR016161 (45%),GPR domain (45%);Aldehyde dehydrogenase domain (45%);Aldehyde/histidinol dehydrogenase (45%),,,,,,,,,,,
LGDLLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.107 (30%);6.3.4.2 (11%);1.12.98.3 (5%),Peptidase Do (30%);CTP synthase (glutamine hydrolyzing) (11%);Methanosarcina-phenazine hydrogenase (5%),GO:0016021 (22%);GO:0005737 (2%);GO:0000015 (2%),integral component of membrane (22%);cytoplasm (2%);phosphopyruvate hydratase complex (2%),GO:0003723 (21%);GO:0016887 (14%);GO:0004252 (12%),RNA binding (21%);ATPase activity (14%);serine-type endopeptidase activity (12%),GO:0009297 (14%);GO:0019243 (3%);GO:0006096 (2%),pilus assembly (14%);methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (3%);glycolytic process (2%),IPR037257 (35%);IPR007831 (21%);IPR042181 (21%),General secretory system II, protein E, N-terminal superfamily (35%);General secretory system II, protein E, N-terminal (21%);Type II secretion system, protein E, N-terminal (21%),,,,,
TCQPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.48 (100%),Histone acetyltransferase (100%),GO:0016021 (75%);GO:0072487 (25%),integral component of membrane (75%);MSL complex (25%),GO:0004402 (25%);GO:0008199 (25%);GO:0016702 (25%),histone acetyltransferase activity (25%);ferric iron binding (25%);oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (25%),GO:0006355 (25%);GO:0006725 (25%),regulation of transcription, DNA-templated (25%);cellular aromatic compound metabolic process (25%),IPR000742 (80%);IPR013032 (80%);IPR000627 (20%),EGF-like domain (80%);EGF-like, conserved site (80%);Intradiol ring-cleavage dioxygenase, C-terminal (20%),,,,,,
MVMYPSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAEALLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.7 (13%);1.2.1.41 (9%);3.4.24.- (9%),Cysteine desulfurase (13%);Glutamate-5-semialdehyde dehydrogenase (9%);Metalloendopeptidases (9%),GO:0016021 (15%);GO:0005737 (11%);GO:0005886 (3%),integral component of membrane (15%);cytoplasm (11%);plasma membrane (3%),GO:0046872 (19%);GO:0005524 (14%);GO:0016491 (9%),metal ion binding (19%);ATP binding (14%);oxidoreductase activity (9%),GO:0009253 (4%);GO:0006534 (3%);GO:0051301 (3%),peptidoglycan catabolic process (4%);cysteine metabolic process (3%);cell division (3%),IPR002110 (10%);IPR020683 (10%);IPR036770 (10%),Ankyrin repeat (10%);Ankyrin repeat-containing domain (10%);Ankyrin repeat-containing domain superfamily (10%),,,,,,,,,,,
WHFLSLMVVPPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESYLPDEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVVLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.19 (19%);2.3.3.13 (14%);5.3.1.5 (10%),Polynucleotide adenylyltransferase (19%);2-isopropylmalate synthase (14%);Xylose isomerase (10%),GO:0016021 (22%);GO:0005737 (13%);GO:0005634 (6%),integral component of membrane (22%);cytoplasm (13%);nucleus (6%),GO:0005524 (23%);GO:0005525 (10%);GO:0003743 (9%),ATP binding (23%);GTP binding (10%);translation initiation factor activity (9%),GO:0007155 (6%);GO:0006955 (5%);GO:0043631 (5%),cell adhesion (6%);immune response (5%);RNA polyadenylation (5%),IPR027417 (17%);IPR009000 (8%);IPR015760 (8%),P-loop containing nucleoside triphosphate hydrolase (17%);Translation protein, beta-barrel domain superfamily (8%);Translation initiation factor IF- 2 (8%),,,,,,,,,,
LVMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.18 (16%);2.7.1.35 (13%);3.1.-.- (11%),5-(carboxyamino)imidazole ribonucleotide synthase (16%);Pyridoxal kinase (13%);Acting on ester bonds (11%),GO:0016021 (22%);GO:0005737 (8%);GO:0005634 (4%),integral component of membrane (22%);cytoplasm (8%);nucleus (4%),GO:0005524 (14%);GO:0008270 (9%);GO:0003700 (8%),ATP binding (14%);zinc ion binding (9%);DNA-binding transcription factor activity (8%),GO:0055085 (3%);GO:0006189 (3%);GO:0006865 (3%),transmembrane transport (3%);'de novo' IMP biosynthetic process (3%);amino acid transport (3%),IPR027417 (13%);IPR036388 (10%);IPR008984 (9%),P-loop containing nucleoside triphosphate hydrolase (13%);Winged helix-like DNA-binding domain superfamily (10%);SMAD/FHA domain superfamily (9%),,,,,,,,,,,
LVFAQNK,Metazoa,Eukaryota,Metazoa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR003599 (100%);IPR007110 (100%);IPR013106 (100%),Immunoglobulin subtype (100%);Immunoglobulin-like domain (100%);Immunoglobulin V-set domain (100%),,,,,,,,,,,
NPDQSVYMGAWNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EELPFFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.- (100%),Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (100%),GO:0016021 (50%);GO:0005886 (25%);GO:0016020 (25%),integral component of membrane (50%);plasma membrane (25%);membrane (25%),GO:0046872 (50%);GO:0004571 (25%);GO:0005509 (25%),metal ion binding (50%);mannosyl-oligosaccharide 1,2-alpha-mannosidase activity (25%);calcium ion binding (25%),GO:0008152 (25%);GO:0019646 (25%),metabolic process (25%);aerobic electron transport chain (25%),IPR001602 (22%);IPR024385 (22%);IPR034154 (22%),Uncharacterised protein family UPF0047 (22%);Domain of unknown function DUF3854 (22%);Archaeal primase DnaG/twinkle, TOPRIM domain (22%),,,,,,,,
LCEPNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.3 (96%);3.5.4.10 (96%);2.7.7.7 (4%),Phosphoribosylaminoimidazolecarboxamide formyltransferase (96%);IMP cyclohydrolase (96%);DNA-directed DNA polymerase (4%),,,GO:0003937 (72%);GO:0004643 (72%);GO:0003677 (6%),IMP cyclohydrolase activity (72%);phosphoribosylaminoimidazolecarboxamide formyltransferase activity (72%);DNA binding (6%),GO:0006189 (69%);GO:0035082 (9%);GO:0060294 (9%),'de novo' IMP biosynthetic process (69%);axoneme assembly (9%);cilium movement involved in cell motility (9%),IPR002695 (61%);IPR016193 (61%);IPR024051 (61%),Bifunctional purine biosynthesis protein PurH-like (61%);Cytidine deaminase-like (61%);AICAR transformylase, duplicated domain superfamily (61%),,,,,,,,,,
MTAEATR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.-.- (25%);6.3.5.3 (25%);2.1.2.- (13%),Acting on acid anhydrides (25%);Phosphoribosylformylglycinamidine synthase (25%);Hydroxymethyl-, formyl- and related transferases (13%),GO:0016021 (22%);GO:0005737 (11%);GO:0005886 (2%),integral component of membrane (22%);cytoplasm (11%);plasma membrane (2%),GO:0003677 (40%);GO:0005524 (11%);GO:0000287 (7%),DNA binding (40%);ATP binding (11%);magnesium ion binding (7%),GO:0006189 (7%);GO:0006400 (4%);GO:0006099 (2%),'de novo' IMP biosynthetic process (7%);tRNA modification (4%);tricarboxylic acid cycle (2%),IPR001647 (39%);IPR009057 (39%);IPR036271 (39%),DNA-binding HTH domain, TetR-type (39%);Homeobox-like domain superfamily (39%);Tetracyclin repressor-like, C-terminal domain superfamily (39%),,,,,,,,
LAGLSEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.271 (100%),GDP-L-fucose synthase (100%),GO:0016021 (14%),integral component of membrane (14%),GO:0016491 (43%);GO:0071949 (43%);GO:0003700 (29%),oxidoreductase activity (43%);FAD binding (43%);DNA-binding transcription factor activity (29%),GO:0042351 (14%),'de novo' GDP-L-fucose biosynthetic process (14%),IPR002346 (38%);IPR005107 (38%);IPR016166 (38%),Molybdopterin dehydrogenase, FAD-binding (38%);CO dehydrogenase flavoprotein, C-terminal (38%);FAD-binding domain, PCMH-type (38%),,,,,,,,
VLTLANDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTPMMMAELPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.8 (55%);3.6.3.- (6%);3.6.5.- (5%),Guanylate kinase (55%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (6%);Acting on GTP; involved in cellular and subcellular movement (5%),GO:0016021 (22%);GO:0005737 (12%);GO:0030256 (3%),integral component of membrane (22%);cytoplasm (12%);type I protein secretion system complex (3%),GO:0005524 (51%);GO:0016887 (27%);GO:0004385 (10%),ATP binding (51%);ATPase activity (27%);guanylate kinase activity (10%),GO:0002949 (3%);GO:0030253 (3%);GO:0031124 (2%),tRNA threonylcarbamoyladenosine modification (3%);protein secretion by the type I secretion system (3%);mRNA 3'-end processing (2%),IPR027417 (75%);IPR003593 (43%);IPR003439 (22%),P-loop containing nucleoside triphosphate hydrolase (75%);AAA+ ATPase domain (43%);ABC transporter-like (22%),,,,,,,,,,,
VTTTQTDAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LENHLSFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAMYTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0004190 (93%);GO:0042500 (7%),aspartic-type endopeptidase activity (93%);aspartic endopeptidase activity, intramembrane cleaving (7%),GO:0040019 (7%);GO:0042395 (7%);GO:0061062 (7%),positive regulation of embryonic development (7%);ecdysis, collagen and cuticulin-based cuticle (7%);regulation of nematode larval development (7%),IPR006639 (88%);IPR007369 (88%);IPR001466 (6%),Presenilin/signal peptide peptidase (88%);Peptidase A22B, signal peptide peptidase (88%);Beta-lactamase-related (6%),,,,,,,,
ELHFSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.18 (50%);1.18.1.2 (15%);1.3.99.- (10%),Glutamine--tRNA ligase (50%);Ferredoxin--NADP(+) reductase (15%);With other acceptors (10%),GO:0016021 (44%);GO:0005886 (25%);GO:0005737 (15%),integral component of membrane (44%);plasma membrane (25%);cytoplasm (15%),GO:0042813 (29%);GO:0005524 (15%);GO:0050660 (15%),Wnt-activated receptor activity (29%);ATP binding (15%);flavin adenine dinucleotide binding (15%),GO:0001947 (24%);GO:0003146 (24%);GO:0007223 (24%),heart looping (24%);heart jogging (24%);Wnt signaling pathway, calcium modulating pathway (24%),IPR000539 (20%);IPR015526 (20%);IPR017981 (20%),Frizzled/Smoothened, transmembrane domain (20%);Frizzled/secreted frizzled-related protein (20%);GPCR, family 2-like (20%),,,,,,,,
TVNDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.4.1.1 (8%);3.4.17.19 (8%);2.7.7.65 (7%),Pyruvate carboxylase (8%);Carboxypeptidase Taq (8%);Diguanylate cyclase (7%),GO:0016021 (36%);GO:0033644 (4%);GO:0044220 (4%),integral component of membrane (36%);host cell membrane (4%);host cell perinuclear region of cytoplasm (4%),GO:0003677 (24%);GO:0005524 (9%);GO:0003723 (5%),DNA binding (24%);ATP binding (9%);RNA binding (5%),GO:0006310 (9%);GO:0015074 (9%);GO:0006355 (8%),DNA recombination (9%);DNA integration (9%);regulation of transcription, DNA-templated (8%),IPR029787 (16%);IPR000160 (16%);IPR024457 (9%),Nucleotide cyclase (16%);GGDEF domain (16%);Putative integrase, N-terminal (9%),,,,,,,,,
NDTDLLSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DFQMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.23 (28%);5.3.1.6 (17%);1.5.1.3 (11%),Orotidine-5'-phosphate decarboxylase (28%);Ribose-5-phosphate isomerase (17%);Dihydrofolate reductase (11%),GO:0016021 (16%);GO:0005634 (2%);GO:0005737 (2%),integral component of membrane (16%);nucleus (2%);cytoplasm (2%),GO:0003824 (16%);GO:0004590 (14%);GO:0008964 (11%),catalytic activity (16%);orotidine-5'-phosphate decarboxylase activity (14%);phosphoenolpyruvate carboxylase activity (11%),GO:0006207 (14%);GO:0044205 (14%);GO:0006099 (11%),'de novo' pyrimidine nucleobase biosynthetic process (14%);'de novo' UMP biosynthetic process (14%);tricarboxylic acid cycle (11%),IPR022644 (17%);IPR029066 (17%);IPR000183 (15%),Orn/DAP/Arg decarboxylase 2, N-terminal (17%);PLP-binding barrel (17%);Ornithine/DAP/Arg decarboxylase (15%),,,,,,,,,,
CDTMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.13 (25%);2.7.-.- (25%);3.6.4.12 (25%),Glutamate synthase (NADPH) (25%);Transferring phosphorus-containing groups (25%);DNA helicase (25%),GO:0016021 (17%);GO:0015935 (6%);GO:0000139 (4%),integral component of membrane (17%);small ribosomal subunit (6%);Golgi membrane (4%),GO:0008270 (30%);GO:0019843 (9%);GO:0003723 (8%),zinc ion binding (30%);rRNA binding (9%);RNA binding (8%),GO:0006412 (9%);GO:0006886 (4%);GO:0007018 (4%),translation (9%);intracellular protein transport (4%);microtubule-based movement (4%),IPR011124 (27%);IPR027417 (13%);IPR001912 (8%),Zinc finger, CW-type (27%);P-loop containing nucleoside triphosphate hydrolase (13%);Ribosomal protein S4/S9, N-terminal (8%),,,,,,,,,
LTDGNPER,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.100 (100%),3-oxoacyl-[acyl-carrier-protein] reductase (100%),,,GO:0016491 (71%);GO:0004316 (29%);GO:0102131 (29%),oxidoreductase activity (71%);3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity (29%);3-oxo-glutaryl-[acp] methyl ester reductase activity (29%),,,IPR036291 (100%);IPR002347 (96%);IPR020904 (96%),NAD(P)-binding domain superfamily (100%);Short-chain dehydrogenase/reductase SDR (96%);Short-chain dehydrogenase/reductase, conserved site (96%),,,,,,,,,,
SNQYGGNTALNVAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMELEVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (100%),cytoplasm (100%),GO:0003743 (100%);GO:0003924 (100%);GO:0005525 (100%),translation initiation factor activity (100%);GTPase activity (100%);GTP binding (100%),,,IPR011108 (67%);IPR036866 (67%);IPR041636 (67%),Zn-dependent metallo-hydrolase, RNA specificity domain (67%);Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (67%);Ribonuclease J, C-terminal (67%),,,,,,,,,
DLLELAFHGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYDNQTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADEHVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FYLNYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (20%);3.2.1.4 (20%);3.6.4.12 (20%),DNA-directed DNA polymerase (20%);Cellulase (20%);DNA helicase (20%),GO:0016021 (65%);GO:0005680 (1%);GO:0005743 (1%),integral component of membrane (65%);anaphase-promoting complex (1%);mitochondrial inner membrane (1%),GO:0003677 (7%);GO:0016779 (6%);GO:0004553 (4%),DNA binding (7%);nucleotidyltransferase activity (6%);hydrolase activity, hydrolyzing O-glycosyl compounds (4%),GO:0005975 (5%);GO:0009058 (2%);GO:0005992 (1%),carbohydrate metabolic process (5%);biosynthetic process (2%);trehalose biosynthetic process (1%),IPR005318 (13%);IPR023614 (13%);IPR001387 (9%),Outer membrane porin, bacterial (13%);Porin domain superfamily (13%);Cro/C1-type helix-turn-helix domain (9%),,,,,,,,,
NGFVDNK,Prevotella salivae,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Prevotellaceae,,,,Prevotella,,,,Prevotella salivae,,,,4.2.2.- (100%),Acting on polysaccharides (100%),,,GO:0008932 (100%);GO:0016829 (100%),lytic endotransglycosylase activity (100%);lyase activity (100%),GO:0000270 (100%);GO:0071555 (100%),peptidoglycan metabolic process (100%);cell wall organization (100%),IPR009009 (100%);IPR012997 (100%);IPR034718 (100%),RlpA-like protein, double-psi beta-barrel domain (100%);Rare lipoprotein A (100%);Endolytic peptidoglycan transglycosylase RlpA (100%),,,,,,,,,,
TLMSDLMWHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVEELLAEWAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LESPMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGALRPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVLEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (29%);3.6.4.12 (6%);2.7.7.- (4%),Acting on ATP; involved in cellular and subcellular movement (29%);DNA helicase (6%);Nucleotidyltransferases (4%),GO:0016021 (24%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (24%);cytoplasm (5%);nucleus (2%),GO:0005524 (28%);GO:0003677 (16%);GO:0016887 (12%),ATP binding (28%);DNA binding (16%);ATPase activity (12%),GO:0006355 (7%);GO:0006614 (5%);GO:0005975 (3%),regulation of transcription, DNA-templated (7%);SRP-dependent cotranslational protein targeting to membrane (5%);carbohydrate metabolic process (3%),IPR027417 (29%);IPR003593 (15%);IPR003439 (10%),P-loop containing nucleoside triphosphate hydrolase (29%);AAA+ ATPase domain (15%);ABC transporter-like (10%),,,,,,,,,,
AFNEWVTCAWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLYLHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.21 (50%);2.7.4.21 (50%);2.7.4.24 (50%),Starch synthase (50%);Inositol-hexakisphosphate kinase (50%);Diphosphoinositol-pentakisphosphate kinase (50%),GO:0016021 (25%);GO:0005886 (10%);GO:0005634 (5%),integral component of membrane (25%);plasma membrane (10%);nucleus (5%),GO:0003824 (45%);GO:0004252 (10%);GO:0000386 (5%),catalytic activity (45%);serine-type endopeptidase activity (10%);second spliceosomal transesterification activity (5%),GO:0000398 (5%);GO:0005978 (5%);GO:0006310 (5%),mRNA splicing, via spliceosome (5%);glycogen biosynthetic process (5%);DNA recombination (5%),IPR001736 (45%);IPR015679 (45%);IPR025202 (41%),Phospholipase D/Transphosphatidylase (45%);Phospholipase D family (45%);Phospholipase D-like domain (41%),,,,,,,,,,
DLMVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (30%);1.3.1.9 (17%);2.4.1.- (17%),Glycogen phosphorylase (30%);Enoyl-[acyl-carrier-protein] reductase (NADH) (17%);Hexosyltransferases (17%),GO:0016021 (15%);GO:0009424 (11%);GO:0005794 (4%),integral component of membrane (15%);bacterial-type flagellum hook (11%);Golgi apparatus (4%),GO:0005524 (18%);GO:0005198 (11%);GO:0102250 (11%),ATP binding (18%);structural molecule activity (11%);linear malto-oligosaccharide phosphorylase activity (11%),GO:0005975 (13%);GO:0044780 (11%);GO:0006310 (6%),carbohydrate metabolic process (13%);bacterial-type flagellum assembly (11%);DNA recombination (6%),IPR002371 (10%);IPR000811 (10%);IPR010810 (10%),Flagellar hook-associated protein 1 (10%);Glycosyl transferase, family 35 (10%);Flagellin hook, IN motif (10%),,,,,,,,,
VAFPSLVGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTVLTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (40%),integral component of membrane (40%),GO:0003723 (40%);GO:0008173 (40%);GO:0043531 (20%),RNA binding (40%);RNA methyltransferase activity (40%);ADP binding (20%),GO:0006396 (40%),RNA processing (40%),IPR001537 (40%);IPR029026 (40%);IPR029028 (40%),tRNA/rRNA methyltransferase, SpoU type (40%);tRNA (guanine-N1-)-methyltransferase, N-terminal (40%);Alpha/beta knot methyltransferases (40%),,,,,,,,,
VFMVSPVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VENSRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVMSVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.1 (67%);2.5.1.41 (33%),Alanine racemase (67%);Phosphoglycerol geranylgeranyltransferase (33%),GO:0016021 (41%);GO:0016459 (7%);GO:0005886 (5%),integral component of membrane (41%);myosin complex (7%);plasma membrane (5%),GO:0005524 (43%);GO:0051082 (16%);GO:0042626 (11%),ATP binding (43%);unfolded protein binding (16%);ATPase-coupled transmembrane transporter activity (11%),GO:0006457 (16%);GO:0042777 (7%);GO:0030632 (5%),protein folding (16%);plasma membrane ATP synthesis coupled proton transport (7%);D-alanine biosynthetic process (5%),IPR013126 (17%);IPR018181 (17%);IPR029047 (17%),Heat shock protein 70 family (17%);Heat shock protein 70, conserved site (17%);Heat shock protein 70kD, peptide-binding domain superfamily (17%),,,,,,,,,
TQLWNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNYMYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (90%);GO:0009279 (20%),integral component of membrane (90%);cell outer membrane (20%),GO:0000155 (10%);GO:0005524 (10%),phosphorelay sensor kinase activity (10%);ATP binding (10%),GO:0043165 (10%);GO:0051205 (10%),Gram-negative-bacterium-type cell outer membrane assembly (10%);protein insertion into membrane (10%),IPR000531 (14%);IPR002931 (14%);IPR003594 (14%),TonB-dependent receptor-like, beta-barrel (14%);Transglutaminase-like (14%);Histidine kinase/HSP90-like ATPase (14%),,,,,,,,,,
MMLDAHR,Actinobacteria,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (25%);GO:0016021 (25%),plasma membrane (25%);integral component of membrane (25%),GO:0003700 (75%);GO:0043565 (75%),DNA-binding transcription factor activity (75%);sequence-specific DNA binding (75%),,,IPR009057 (75%);IPR013096 (75%);IPR014710 (75%),Homeobox-like domain superfamily (75%);Cupin 2, conserved barrel (75%);RmlC-like jelly roll fold (75%),,,,,,,,,,
NLLEKPGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FYLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.79 (34%);2.1.1.163 (34%);2.7.11.1 (9%),Succinate-semialdehyde dehydrogenase (NADP(+)) (34%);Demethylmenaquinone methyltransferase (34%);Non-specific serine/threonine protein kinase (9%),GO:0016021 (32%);GO:0005886 (5%);GO:0005737 (4%),integral component of membrane (32%);plasma membrane (5%);cytoplasm (4%),GO:0009013 (12%);GO:0102955 (10%);GO:0005524 (8%),succinate-semialdehyde dehydrogenase [NAD(P)+] activity (12%);S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity (10%);ATP binding (8%),GO:0009450 (11%);GO:0032259 (11%);GO:0009234 (10%),gamma-aminobutyric acid catabolic process (11%);methylation (11%);menaquinone biosynthetic process (10%),IPR015590 (16%);IPR016161 (16%);IPR016162 (16%),Aldehyde dehydrogenase domain (16%);Aldehyde/histidinol dehydrogenase (16%);Aldehyde dehydrogenase, N-terminal (16%),,,,,,,,,,
LDQEEANTLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDLMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.75 (19%);1.17.4.1 (15%);2.1.3.15 (12%),tRNA dimethylallyltransferase (19%);Ribonucleoside-diphosphate reductase (15%);Acetyl-CoA carboxytransferase (12%),GO:0016021 (60%);GO:0005886 (46%);GO:0005737 (2%),integral component of membrane (60%);plasma membrane (46%);cytoplasm (2%),GO:0005524 (9%);GO:0016491 (8%);GO:0003677 (3%),ATP binding (9%);oxidoreductase activity (8%);DNA binding (3%),GO:0055085 (41%);GO:0005975 (3%);GO:0008033 (2%),transmembrane transport (41%);carbohydrate metabolic process (3%);tRNA processing (2%),IPR000515 (40%);IPR035906 (40%);IPR036291 (8%),ABC transporter type 1, transmembrane domain MetI-like (40%);MetI-like superfamily (40%);NAD(P)-binding domain superfamily (8%),,,,,,,,,,
WSQDLNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSLLFYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.7 (100%),Diaminopimelate epimerase (100%),GO:0016021 (81%);GO:0005737 (4%);GO:0016020 (1%),integral component of membrane (81%);cytoplasm (4%);membrane (1%),GO:0003676 (9%);GO:0003964 (6%);GO:0004190 (6%),nucleic acid binding (9%);RNA-directed DNA polymerase activity (6%);aspartic-type endopeptidase activity (6%),GO:0055085 (54%);GO:0009089 (3%);GO:0005975 (1%),transmembrane transport (54%);lysine biosynthetic process via diaminopimelate (3%);carbohydrate metabolic process (1%),IPR004752 (54%);IPR036259 (54%);IPR011701 (51%),AmpG-like permease/Acetyl-coenzyme A transporter 1 (54%);MFS transporter superfamily (54%);Major facilitator superfamily (51%),,,,,,,,,,,
VNAPESYMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNLLVFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLLFDFELDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QADNALDNGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LANLLDEAAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLTSMQHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSFTSTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVVDDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.7.4 (73%);6.1.1.7 (13%);1.3.8.3 (7%),4-hydroxy-3-methylbut-2-enyl diphosphate reductase (73%);Alanine--tRNA ligase (13%);(R)-benzylsuccinyl-CoA dehydrogenase (7%),GO:0016021 (20%);GO:0005737 (6%);GO:0005634 (2%),integral component of membrane (20%);cytoplasm (6%);nucleus (2%),GO:0046872 (20%);GO:0051539 (17%);GO:0051745 (17%),metal ion binding (20%);4 iron, 4 sulfur cluster binding (17%);4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity (17%),GO:0019288 (17%);GO:0050992 (17%);GO:0016114 (15%),isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (17%);dimethylallyl diphosphate biosynthetic process (17%);terpenoid biosynthetic process (15%),IPR003451 (15%);IPR000873 (10%);IPR011762 (10%),4-hydroxy-3-methylbut-2-enyl diphosphate reductase (15%);AMP-dependent synthetase/ligase (10%);Acetyl-coenzyme A carboxyltransferase, N-terminal (10%),,,,,,,,
VNVGDHNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLDYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (13%);3.1.3.- (5%);2.7.1.39 (5%),DNA helicase (13%);Phosphoric monoester hydrolases (5%);Homoserine kinase (5%),GO:0016021 (29%);GO:0033644 (7%);GO:0044220 (7%),integral component of membrane (29%);host cell membrane (7%);host cell perinuclear region of cytoplasm (7%),GO:0005524 (15%);GO:0003723 (9%);GO:0008270 (8%),ATP binding (15%);RNA binding (9%);zinc ion binding (8%),GO:0019082 (7%);GO:0039520 (7%);GO:0032259 (4%),viral protein processing (7%);induction by virus of host autophagy (7%);methylation (4%),IPR027417 (11%);IPR002589 (6%);IPR009003 (6%),P-loop containing nucleoside triphosphate hydrolase (11%);Macro domain (6%);Peptidase S1, PA clan (6%),,,,,,,,,,
TCLVMPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTAVVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.13 (50%);3.1.11.6 (50%),Glutamate synthase (NADPH) (50%);Exodeoxyribonuclease VII (50%),GO:0016021 (14%);GO:0005737 (7%);GO:0005786 (7%),integral component of membrane (14%);cytoplasm (7%);signal recognition particle, endoplasmic reticulum targeting (7%),GO:0005524 (29%);GO:0016887 (21%);GO:0003723 (7%),ATP binding (29%);ATPase activity (21%);RNA binding (7%),GO:0006537 (14%);GO:0005975 (7%);GO:0006308 (7%),glutamate biosynthetic process (14%);carbohydrate metabolic process (7%);DNA catabolic process (7%),IPR003593 (20%);IPR027417 (20%);IPR003439 (15%),AAA+ ATPase domain (20%);P-loop containing nucleoside triphosphate hydrolase (20%);ABC transporter-like (15%),,,,,,,,,,
MSYHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.15 (31%);3.4.19.12 (13%);3.1.3.11 (11%),Peroxiredoxin (31%);Ubiquitinyl hydrolase 1 (13%);Fructose-bisphosphatase (11%),GO:0016021 (25%);GO:0005737 (7%);GO:0005886 (3%),integral component of membrane (25%);cytoplasm (7%);plasma membrane (3%),GO:0005524 (14%);GO:0003677 (12%);GO:0003676 (8%),ATP binding (14%);DNA binding (12%);nucleic acid binding (8%),GO:0005975 (3%);GO:0006511 (3%);GO:0016579 (3%),carbohydrate metabolic process (3%);ubiquitin-dependent protein catabolic process (3%);protein deubiquitination (3%),IPR040943 (19%);IPR041686 (18%);IPR036388 (8%),Protein of unknown function DUF5571 (19%);Zinc-finger CCCH domain (18%);Winged helix-like DNA-binding domain superfamily (8%),,,,,,,,,,,
YMYSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.2 (17%);2.7.1.148 (13%);2.7.8.- (13%),NADH:ubiquinone reductase (H(+)-translocating) (17%);4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase (13%);Transferases for other substituted phosphate groups (13%),GO:0016021 (65%);GO:0009279 (23%);GO:0019028 (5%),integral component of membrane (65%);cell outer membrane (23%);viral capsid (5%),GO:0005525 (14%);GO:0003924 (14%);GO:0003677 (10%),GTP binding (14%);GTPase activity (14%);DNA binding (10%),GO:0051301 (4%);GO:0007019 (3%);GO:0007029 (3%),cell division (4%);microtubule depolymerization (3%);endoplasmic reticulum organization (3%),IPR000531 (20%);IPR012910 (20%);IPR037066 (20%),TonB-dependent receptor-like, beta-barrel (20%);TonB-dependent receptor, plug domain (20%);TonB-dependent receptor, plug domain superfamily (20%),,,,,,,,
EDGLAFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.29 (67%);1.14.14.10 (33%),tRNA-guanine(34) transglycosylase (67%);Nitrilotriacetate monooxygenase (33%),GO:0016021 (41%);GO:0005737 (9%),integral component of membrane (41%);cytoplasm (9%),GO:0046872 (14%);GO:0003746 (9%);GO:0003924 (9%),metal ion binding (14%);translation elongation factor activity (9%);GTPase activity (9%),GO:0007165 (36%);GO:0001514 (9%);GO:0008616 (9%),signal transduction (36%);selenocysteine incorporation (9%);queuosine biosynthetic process (9%),IPR000160 (32%);IPR003660 (32%);IPR029787 (32%),GGDEF domain (32%);HAMP domain (32%);Nucleotide cyclase (32%),,,,,,,,,,,
LPFLNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.2.12 (38%);2.7.4.1 (33%);1.7.2.2 (6%),Phosphoglycerate mutase (2,3-diphosphoglycerate-independent) (38%);Polyphosphate kinase (33%);Nitrite reductase (cytochrome; ammonia-forming) (6%),GO:0016021 (59%);GO:0005737 (8%);GO:0009358 (5%),integral component of membrane (59%);cytoplasm (8%);polyphosphate kinase complex (5%),GO:0005524 (11%);GO:0046872 (10%);GO:0008658 (8%),ATP binding (11%);metal ion binding (10%);penicillin binding (8%),GO:0046677 (7%);GO:0006096 (7%);GO:0006007 (6%),response to antibiotic (7%);glycolytic process (7%);glucose catabolic process (6%),IPR012338 (8%);IPR001460 (8%);IPR005311 (8%),Beta-lactamase/transpeptidase-like (8%);Penicillin-binding protein, transpeptidase (8%);Penicillin-binding protein, dimerisation domain (8%),,,,,,,,
NVAQAEAEEAMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEAESANQDWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFALNSNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.6.1 (100%),Ribose-phosphate diphosphokinase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0000287 (100%);GO:0004749 (100%);GO:0005524 (100%),magnesium ion binding (100%);ribose phosphate diphosphokinase activity (100%);ATP binding (100%),GO:0006015 (100%);GO:0009116 (100%);GO:0009156 (100%),5-phosphoribose 1-diphosphate biosynthetic process (100%);nucleoside metabolic process (100%);ribonucleoside monophosphate biosynthetic process (100%),IPR000836 (100%);IPR000842 (100%);IPR005946 (100%),Phosphoribosyltransferase domain (100%);Phosphoribosyl pyrophosphate synthetase, conserved site (100%);Ribose-phosphate pyrophosphokinase (100%),,,,,,,,,,
EFNAHVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPNACAEPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPVMNAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLQENNQCQATGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVLVLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.- (40%);1.17.4.1 (20%);2.7.1.68 (20%),With NADH or NADPH as one donor, and incorporation of one atom of oxygen (40%);Ribonucleoside-diphosphate reductase (20%);1-phosphatidylinositol-4-phosphate 5-kinase (20%),GO:0009279 (14%);GO:0031314 (14%);GO:0000145 (7%),cell outer membrane (14%);extrinsic component of mitochondrial inner membrane (14%);exocyst (7%),GO:0005524 (14%);GO:0008909 (14%);GO:0016709 (14%),ATP binding (14%);isochorismate synthase activity (14%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (14%),GO:0006535 (14%);GO:0006744 (14%);GO:0009058 (14%),cysteine biosynthetic process from serine (14%);ubiquinone biosynthetic process (14%);biosynthetic process (14%),IPR001216 (18%);IPR001926 (18%);IPR036052 (18%),Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site (18%);Pyridoxal-phosphate dependent enzyme (18%);Tryptophan synthase beta subunit-like PLP-dependent enzyme (18%),,,,,
WNEVDGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGCVENR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR008321 (100%),Uncharacterised conserved protein UCP032146 (100%),,,,,,,,,,,
VLTALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.61 (64%);3.5.1.44 (64%);6.2.1.26 (23%),Protein-glutamate methylesterase (64%);Protein-glutamine glutaminase (64%);o-succinylbenzoate--CoA ligase (23%),GO:0005737 (22%);GO:0016021 (21%);GO:0005840 (4%),cytoplasm (22%);integral component of membrane (21%);ribosome (4%),GO:0005524 (24%);GO:0000156 (21%);GO:0008984 (21%),ATP binding (24%);phosphorelay response regulator activity (21%);protein-glutamate methylesterase activity (21%),GO:0006482 (21%);GO:0006935 (21%);GO:0018277 (21%),protein demethylation (21%);chemotaxis (21%);protein deamination (21%),IPR001789 (18%);IPR011006 (18%);IPR000673 (17%),Signal transduction response regulator, receiver domain (18%);CheY-like superfamily (18%);Signal transduction response regulator, chemotaxis, protein-glutamate methylesterase (17%),,,,,,,,
TLLPMPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.21 (100%),Starch synthase (100%),GO:0016021 (67%),integral component of membrane (67%),GO:0000155 (33%);GO:0004373 (33%);GO:0005524 (33%),phosphorelay sensor kinase activity (33%);glycogen (starch) synthase activity (33%);ATP binding (33%),GO:0005978 (33%),glycogen biosynthetic process (33%),IPR027417 (40%);IPR001296 (20%);IPR003593 (20%),P-loop containing nucleoside triphosphate hydrolase (40%);Glycosyl transferase, family 1 (20%);AAA+ ATPase domain (20%),,,,,,,,,,
TNTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.28 (30%);2.7.7.56 (13%);4.1.1.36 (8%),N-acetylmuramoyl-L-alanine amidase (30%);tRNA nucleotidyltransferase (13%);Phosphopantothenoylcysteine decarboxylase (8%),GO:0016021 (35%);GO:0005576 (7%);GO:0005618 (6%),integral component of membrane (35%);extracellular region (7%);cell wall (6%),GO:0005524 (6%);GO:0003677 (5%);GO:0003824 (5%),ATP binding (6%);DNA binding (5%);catalytic activity (5%),GO:0030638 (3%);GO:0006412 (2%);GO:0006364 (2%),polyketide metabolic process (3%);translation (2%);rRNA processing (2%),IPR025855 (7%);IPR013783 (5%);IPR019931 (5%),Plasmid replication-relaxation (7%);Immunoglobulin-like fold (5%);LPXTG cell wall anchor domain (5%),,,,,,,,,,,
LDLDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.9 (18%);3.1.26.4 (7%);2.8.1.10 (6%),Thioredoxin-disulfide reductase (18%);Ribonuclease H (7%);Thiazole synthase (6%),GO:0005737 (24%);GO:0016021 (20%);GO:0005623 (4%),cytoplasm (24%);integral component of membrane (20%);cell (4%),GO:0005524 (21%);GO:0004818 (9%);GO:0004827 (7%),ATP binding (21%);glutamate-tRNA ligase activity (9%);proline-tRNA ligase activity (7%),GO:0006424 (9%);GO:0006433 (7%);GO:0007165 (7%),glutamyl-tRNA aminoacylation (9%);prolyl-tRNA aminoacylation (7%);signal transduction (7%),IPR027417 (21%);IPR011035 (7%);IPR014729 (7%),P-loop containing nucleoside triphosphate hydrolase (21%);Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain superfamily (7%);Rossmann-like alpha/beta/alpha sandwich fold (7%),,,,,,,,,,
FVALNER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0016903 (33%);GO:0003677 (17%);GO:0008641 (17%),oxidoreductase activity, acting on the aldehyde or oxo group of donors (33%);DNA binding (17%);ubiquitin-like modifier activating enzyme activity (17%),GO:0006310 (17%);GO:0015074 (17%),DNA recombination (17%);DNA integration (17%),IPR002869 (33%);IPR019752 (33%);IPR000594 (17%),Pyruvate-flavodoxin oxidoreductase, central domain (33%);Pyruvate/ketoisovalerate oxidoreductase, catalytic domain (33%);THIF-type NAD/FAD binding fold (17%),,,,,,,,
HLLLTSAYAFSEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SEPMSFVVAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPVVVDK,Peptococcaceae,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Peptococcaceae,,,,,,,,,,,,,,,,GO:0004800 (100%),thyroxine 5'-deiodinase activity (100%),,,IPR000643 (50%);IPR014729 (50%);IPR014730 (50%),Iodothyronine deiodinase (50%);Rossmann-like alpha/beta/alpha sandwich fold (50%);Electron transfer flavoprotein, alpha/beta-subunit, N-terminal (50%),,,,,,,,,
LAMFMGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFKPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (54%);3.2.1.39 (23%);3.2.1.8 (23%),DNA-directed RNA polymerase (54%);Glucan endo-1,3-beta-D-glucosidase (23%);Endo-1,4-beta-xylanase (23%),GO:0005634 (18%);GO:0016021 (15%);GO:0005886 (9%),nucleus (18%);integral component of membrane (15%);plasma membrane (9%),GO:0003677 (45%);GO:0000287 (21%);GO:0003899 (21%),DNA binding (45%);magnesium ion binding (21%);DNA-directed 5'-3' RNA polymerase activity (21%),GO:0006351 (21%);GO:0007049 (9%);GO:0007059 (9%),transcription, DNA-templated (21%);cell cycle (9%);chromosome segregation (9%),IPR027417 (29%);IPR000722 (18%);IPR006592 (18%),P-loop containing nucleoside triphosphate hydrolase (29%);RNA polymerase, alpha subunit (18%);RNA polymerase, N-terminal (18%),,,,,,
AEENDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005759 (3%);GO:0016020 (3%);GO:0016021 (3%),mitochondrial matrix (3%);membrane (3%);integral component of membrane (3%),GO:0005524 (73%);GO:0016301 (9%);GO:0046872 (9%),ATP binding (73%);kinase activity (9%);metal ion binding (9%),GO:0005975 (3%);GO:0006139 (3%);GO:0006627 (3%),carbohydrate metabolic process (3%);nucleobase-containing compound metabolic process (3%);protein processing involved in protein targeting to mitochondrion (3%),IPR027417 (71%);IPR000330 (59%);IPR001650 (59%),P-loop containing nucleoside triphosphate hydrolase (71%);SNF2-related, N-terminal domain (59%);Helicase, C-terminal (59%),,,,,,,,,
LLANDQGNR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%),ATP binding (100%),,,IPR013126 (100%);IPR018181 (81%);IPR029047 (41%),Heat shock protein 70 family (100%);Heat shock protein 70, conserved site (81%);Heat shock protein 70kD, peptide-binding domain superfamily (41%),,,,,,,,,
LDLLDEANQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MENLELKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMLFGVSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MALDVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.18 (33%);5.6.2.1 (33%);6.3.2.2 (33%),5-(carboxyamino)imidazole ribonucleotide mutase (33%);DNA topoisomerase (33%);Glutamate--cysteine ligase (33%),GO:0016021 (39%),integral component of membrane (39%),GO:0016740 (29%);GO:0008658 (26%);GO:0004180 (18%),transferase activity (29%);penicillin binding (26%);carboxypeptidase activity (18%),GO:0015074 (8%);GO:0006189 (3%);GO:0006265 (3%),DNA integration (8%);'de novo' IMP biosynthetic process (3%);DNA topological change (3%),IPR001264 (38%);IPR001460 (38%);IPR012338 (38%),Glycosyl transferase, family 51 (38%);Penicillin-binding protein, transpeptidase (38%);Beta-lactamase/transpeptidase-like (38%),,,,,,,,,
SSEGAGTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNVVVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (80%);1.3.7.9 (20%),DNA topoisomerase (80%);4-hydroxybenzoyl-CoA reductase (20%),GO:0005694 (40%);GO:0016021 (10%),chromosome (40%);integral component of membrane (10%),GO:0003677 (40%);GO:0003917 (40%);GO:0016491 (30%),DNA binding (40%);DNA topoisomerase type I (single strand cut, ATP-independent) activity (40%);oxidoreductase activity (30%),GO:0006265 (40%),DNA topological change (40%),IPR000674 (40%);IPR001631 (40%);IPR008274 (40%),Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead (40%);DNA topoisomerase I (40%);Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding (40%),,,,,,,,
AEDLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.227 (29%);2.7.1.33 (14%);2.6.1.- (4%),Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (29%);Pantothenate kinase (14%);Transaminases (4%),GO:0016021 (17%);GO:0005886 (10%);GO:0005737 (9%),integral component of membrane (17%);plasma membrane (10%);cytoplasm (9%),GO:0046872 (14%);GO:0005524 (12%);GO:0004222 (8%),metal ion binding (14%);ATP binding (12%);metalloendopeptidase activity (8%),GO:0009252 (8%);GO:0051301 (8%);GO:0071555 (8%),peptidoglycan biosynthetic process (8%);cell division (8%);cell wall organization (8%),IPR007863 (9%);IPR011249 (9%);IPR011765 (9%),Peptidase M16, C-terminal (9%);Metalloenzyme, LuxS/M16 peptidase-like (9%);Peptidase M16, N-terminal (9%),,,,,,,,
DVTLPSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (100%),Ribonucleoside-diphosphate reductase (100%),GO:0016021 (50%),integral component of membrane (50%),GO:0005524 (33%);GO:0035091 (33%);GO:0047617 (33%),ATP binding (33%);phosphatidylinositol binding (33%);acyl-CoA hydrolase activity (33%),GO:0055085 (33%);GO:0006260 (17%);GO:0006355 (17%),transmembrane transport (33%);DNA replication (17%);regulation of transcription, DNA-templated (17%),IPR028090 (31%);IPR001411 (15%);IPR001683 (15%),JAB domain, prokaryotic (31%);Tetracycline resistance protein/drug resistance transporter (15%);Phox homologous domain (15%),,,,,,,,,
FNFPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.33 (50%);6.1.1.20 (50%),Pantothenate kinase (50%);Phenylalanine--tRNA ligase (50%),GO:0016021 (80%);GO:0005886 (72%);GO:0005737 (6%),integral component of membrane (80%);plasma membrane (72%);cytoplasm (6%),GO:0016787 (9%);GO:0005524 (6%);GO:0000049 (4%),hydrolase activity (9%);ATP binding (6%);tRNA binding (4%),GO:0055085 (78%);GO:0008643 (7%);GO:0006289 (2%),transmembrane transport (78%);carbohydrate transport (7%);nucleotide-excision repair (2%),IPR000515 (74%);IPR035906 (74%);IPR026555 (11%),ABC transporter type 1, transmembrane domain MetI-like (74%);MetI-like superfamily (74%);KAT8 regulatory NSL complex subunit 3/Testis-expressed sequence 30 protein (11%),,,,,,,,,,
LNDNFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (50%);6.1.1.5 (50%),Cytochrome-c oxidase (50%);Isoleucine--tRNA ligase (50%),GO:0016021 (17%);GO:0031411 (17%);GO:0005737 (8%),integral component of membrane (17%);gas vesicle (17%);cytoplasm (8%),GO:0005524 (42%);GO:0000166 (25%);GO:0004657 (25%),ATP binding (42%);nucleotide binding (25%);proline dehydrogenase activity (25%),GO:0010133 (25%);GO:0031412 (17%);GO:0006097 (8%),proline catabolic process to glutamate (25%);gas vesicle organization (17%);glyoxylate cycle (8%),IPR002872 (20%);IPR008219 (20%);IPR015659 (20%),Proline dehydrogenase domain (20%);Proline dehydrogenase, bacteria and archaea (20%);Proline oxidase family (20%),,,,,,,,,,
MENLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (16%);1.5.5.1 (9%);2.7.7.80 (9%),Acting on ester bonds (16%);Electron-transferring-flavoprotein dehydrogenase (9%);Molybdopterin-synthase adenylyltransferase (9%),GO:0016021 (19%);GO:0005737 (15%);GO:0000145 (5%),integral component of membrane (19%);cytoplasm (15%);exocyst (5%),GO:0005524 (9%);GO:0046872 (9%);GO:0050660 (8%),ATP binding (9%);metal ion binding (9%);flavin adenine dinucleotide binding (8%),GO:0002098 (7%);GO:0006887 (5%);GO:0048278 (5%),tRNA wobble uridine modification (7%);exocytosis (5%);vesicle docking (5%),IPR036188 (9%);IPR027417 (8%);IPR002218 (6%),FAD/NAD(P)-binding domain superfamily (9%);P-loop containing nucleoside triphosphate hydrolase (8%);tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG-related (6%),,,,,,,,,,,
NAEFENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%);GO:0005737 (33%),integral component of membrane (67%);cytoplasm (33%),GO:0051536 (33%),iron-sulfur cluster binding (33%),GO:0006606 (33%),protein import into nucleus (33%),IPR004017 (67%);IPR009051 (33%);IPR016024 (33%),Cysteine-rich domain (67%);Alpha-helical ferredoxin (33%);Armadillo-type fold (33%),,,,,,,,,,,
RPSLDTMMLHVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVQLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.7 (22%);1.4.1.2 (16%);3.1.11.5 (13%),Glutathione-disulfide reductase (22%);Glutamate dehydrogenase (16%);Exodeoxyribonuclease V (13%),GO:0009338 (12%);GO:0016021 (12%);GO:0005737 (9%),exodeoxyribonuclease V complex (12%);integral component of membrane (12%);cytoplasm (9%),GO:0004352 (26%);GO:0003677 (24%);GO:0005524 (22%),glutamate dehydrogenase (NAD+) activity (26%);DNA binding (24%);ATP binding (22%),GO:0019551 (26%);GO:0006355 (6%);GO:0006749 (5%),glutamate catabolic process to 2-oxoglutarate (26%);regulation of transcription, DNA-templated (6%);glutathione metabolic process (5%),IPR036291 (27%);IPR007780 (24%);IPR028971 (24%),NAD(P)-binding domain superfamily (27%);NAD-glutamate dehydrogenase, bacteria (24%);NAD-glutamate dehydrogenase (24%),,,,,,,,,
WGEALMAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVYLFPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDVVFGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.39 (100%),Glucan endo-1,3-beta-D-glucosidase (100%),GO:0016021 (36%),integral component of membrane (36%),GO:0005524 (36%);GO:0003677 (9%);GO:0003700 (9%),ATP binding (36%);DNA binding (9%);DNA-binding transcription factor activity (9%),GO:0008152 (9%);GO:0032259 (9%),metabolic process (9%);methylation (9%),IPR003439 (36%);IPR027417 (36%);IPR002549 (27%),ABC transporter-like (36%);P-loop containing nucleoside triphosphate hydrolase (36%);Transmembrane protein TqsA-like (27%),,,,,,,,,,
FNNLLDNK,Flavobacterium,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Flavobacterium,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0000155 (67%),phosphorelay sensor kinase activity (67%),,,IPR010559 (100%);IPR036890 (50%),Signal transduction histidine kinase, internal region (100%);Histidine kinase/HSP90-like ATPase superfamily (50%),,,,,,,,,,
LGMASHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SCSNGLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (14%),transmembrane transporter activity (14%),,,IPR022139 (63%);IPR001036 (13%);IPR001480 (13%),Protein of unknown function DUF3671 (63%);Acriflavin resistance protein (13%);Bulb-type lectin domain (13%),,,,,,,,,,,
EVWTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (50%);6.1.1.9 (50%),Glycogen phosphorylase (50%);Valine--tRNA ligase (50%),GO:0005737 (40%);GO:0005777 (20%),cytoplasm (40%);peroxisome (20%),GO:0005524 (40%);GO:0002161 (20%);GO:0003857 (20%),ATP binding (40%);aminoacyl-tRNA editing activity (20%);3-hydroxyacyl-CoA dehydrogenase activity (20%),GO:0005975 (20%);GO:0006435 (20%);GO:0006438 (20%),carbohydrate metabolic process (20%);threonyl-tRNA aminoacylation (20%);valyl-tRNA aminoacylation (20%),IPR002372 (45%);IPR011047 (45%);IPR015943 (45%),Pyrrolo-quinoline quinone repeat (45%);Quinoprotein alcohol dehydrogenase-like superfamily (45%);WD40/YVTN repeat-like-containing domain superfamily (45%),,,,,,,,,,,
TTLELPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.7.1 (50%);3.4.23.1 (50%),Glutamate synthase (ferredoxin) (50%);Pepsin A (50%),GO:0005783 (33%);GO:0016021 (33%),endoplasmic reticulum (33%);integral component of membrane (33%),GO:0004190 (33%);GO:0015020 (33%);GO:0016041 (33%),aspartic-type endopeptidase activity (33%);glucuronosyltransferase activity (33%);glutamate synthase (ferredoxin) activity (33%),GO:0006486 (33%);GO:0006537 (33%);GO:0015012 (33%),protein glycosylation (33%);glutamate biosynthetic process (33%);heparan sulfate proteoglycan biosynthetic process (33%),IPR013783 (33%);IPR001461 (17%);IPR001969 (17%),Immunoglobulin-like fold (33%);Aspartic peptidase A1 family (17%);Aspartic peptidase, active site (17%),,,,,,,,,,
QYLLNHLMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTNTDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0042834 (100%),peptidoglycan binding (100%),,,IPR005607 (50%);IPR007730 (50%);IPR035925 (50%),BSD domain (50%);Sporulation-like domain (50%);BSD domain superfamily (50%),,,,,,,,,,,
DPVNQAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEMVLYK,Dorcoceras hygrometricum,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Lamiales,,,,,Gesneriaceae,Didymocarpoideae,Trichosporeae,Loxocarpinae,Dorcoceras,,,,Dorcoceras hygrometricum,,,,,,,,,,,,,,,,,,,,,,,,
DDKPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (12%);5.6.2.1 (9%);2.4.2.14 (9%),Transferring other groups (12%);DNA topoisomerase (9%);Amidophosphoribosyltransferase (9%),GO:0016021 (35%);GO:0005886 (6%);GO:0005737 (4%),integral component of membrane (35%);plasma membrane (6%);cytoplasm (4%),GO:0003723 (13%);GO:0005524 (13%);GO:0003677 (6%),RNA binding (13%);ATP binding (13%);DNA binding (6%),GO:0015031 (6%);GO:0006457 (2%);GO:0006265 (2%),protein transport (6%);protein folding (2%);DNA topological change (2%),IPR027417 (9%);IPR008490 (8%);IPR025668 (7%),P-loop containing nucleoside triphosphate hydrolase (9%);Transposase InsH, N-terminal (8%);Transposase DDE domain (7%),,,,,,,,,,
VMCMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.44 (63%);3.1.4.- (38%);3.1.4.38 (38%),Phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (63%);Phosphoric diester hydrolases (38%);Glycerophosphocholine cholinephosphodiesterase (38%),GO:0005886 (89%);GO:0005576 (46%);GO:0016021 (5%),plasma membrane (89%);extracellular region (46%);integral component of membrane (5%),GO:0047390 (88%);GO:0008889 (46%);GO:0004616 (9%),glycerophosphocholine cholinephosphodiesterase activity (88%);glycerophosphodiester phosphodiesterase activity (46%);phosphogluconate dehydrogenase (decarboxylating) activity (9%),GO:0006629 (46%);GO:0019695 (46%);GO:0006098 (9%),lipid metabolic process (46%);choline metabolic process (46%);pentose-phosphate shunt (9%),IPR002591 (85%);IPR017850 (85%);IPR029889 (85%),Type I phosphodiesterase/nucleotide pyrophosphatase/phosphate transferase (85%);Alkaline-phosphatase-like, core domain superfamily (85%);Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 (85%),,,,,,,,,
WETSMKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLEEAEHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016459 (100%),myosin complex (100%),GO:0003774 (100%);GO:0005524 (33%);GO:0051015 (33%),motor activity (100%);ATP binding (33%);actin filament binding (33%),,,IPR002928 (100%);IPR000048 (33%);IPR001609 (33%),Myosin tail (100%);IQ motif, EF-hand binding site (33%);Myosin head, motor domain (33%),,,,,,,,,
FVADADAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMLSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (10%);2.4.1.- (10%);1.2.4.1 (5%),Cytochrome-c oxidase (10%);Hexosyltransferases (10%);Pyruvate dehydrogenase (acetyl-transferring) (5%),GO:0016021 (29%);GO:0005886 (7%);GO:0005737 (6%),integral component of membrane (29%);plasma membrane (7%);cytoplasm (6%),GO:0003677 (14%);GO:0005524 (13%);GO:0016887 (8%),DNA binding (14%);ATP binding (13%);ATPase activity (8%),GO:0005975 (3%);GO:0055085 (3%);GO:0006355 (3%),carbohydrate metabolic process (3%);transmembrane transport (3%);regulation of transcription, DNA-templated (3%),IPR027417 (8%);IPR016181 (7%);IPR000182 (6%),P-loop containing nucleoside triphosphate hydrolase (8%);Acyl-CoA N-acyltransferase (7%);GNAT domain (6%),,,,,,,,,,
EVNQYPR,Legionella busanensis,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Legionellales,,,,,Legionellaceae,,,,Legionella,,,,Legionella busanensis,,,,,,,,GO:0008080 (100%),N-acetyltransferase activity (100%),,,IPR000182 (100%);IPR016181 (100%),GNAT domain (100%);Acyl-CoA N-acyltransferase (100%),,,,,,,,,,,
MAPEEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (100%),DNA ligase (NAD(+)) (100%),GO:0000124 (22%);GO:0030288 (22%);GO:0030874 (22%),SAGA complex (22%);outer membrane-bounded periplasmic space (22%);nucleolar chromatin (22%),GO:0003677 (44%);GO:0003911 (44%);GO:0046872 (33%),DNA binding (44%);DNA ligase (NAD+) activity (44%);metal ion binding (33%),GO:0006260 (44%);GO:0006281 (44%);GO:0001178 (22%),DNA replication (44%);DNA repair (44%);regulation of transcriptional start site selection at RNA polymerase II promoter (22%),IPR014127 (31%);IPR001679 (25%);IPR003583 (25%),Conserved hypothetical protein CHP02757 (31%);NAD-dependent DNA ligase (25%);Helix-hairpin-helix DNA-binding motif, class 1 (25%),,,,,,,,,,
ANEALLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.27 (23%);3.4.11.9 (23%);1.1.1.1 (14%),Uracil-DNA glycosylase (23%);Xaa-Pro aminopeptidase (23%);Alcohol dehydrogenase (14%),GO:0016021 (26%);GO:0035097 (13%);GO:0005737 (4%),integral component of membrane (26%);histone methyltransferase complex (13%);cytoplasm (4%),GO:0046872 (42%);GO:0004177 (22%);GO:0042800 (16%),metal ion binding (42%);aminopeptidase activity (22%);histone methyltransferase activity (H3-K4 specific) (16%),GO:0000027 (4%);GO:0006412 (4%);GO:0008284 (4%),ribosomal large subunit assembly (4%);translation (4%);positive regulation of cell population proliferation (4%),IPR003746 (20%);IPR036591 (20%);IPR000994 (16%),Protein of unknown function DUF167 (20%);YggU-like superfamily (20%);Peptidase M24 (16%),,,,,,,,,,,
FMESNQAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEYLQQPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAPYLQQLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVSVQATCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFMMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (95%);6.3.4.13 (1%);1.14.13.- (1%),Proline--tRNA ligase (95%);Phosphoribosylamine--glycine ligase (1%);With NADH or NADPH as one donor, and incorporation of one atom of oxygen (1%),GO:0005737 (71%);GO:0016021 (11%);GO:0005886 (4%),cytoplasm (71%);integral component of membrane (11%);plasma membrane (4%),GO:0005524 (74%);GO:0004827 (71%);GO:0002161 (25%),ATP binding (74%);proline-tRNA ligase activity (71%);aminoacyl-tRNA editing activity (25%),GO:0006433 (71%);GO:0009306 (5%);GO:0044781 (4%),prolyl-tRNA aminoacylation (71%);protein secretion (5%);bacterial-type flagellum organization (4%),IPR006195 (66%);IPR002314 (66%);IPR002316 (65%),Aminoacyl-tRNA synthetase, class II (66%);Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) (66%);Proline-tRNA ligase, class IIa (65%),,,,,,,
WWNLDAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAAEAECEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNPLMFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DESYEETLVER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAAGANYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGPANHEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVEAHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0016021 (15%);GO:0005634 (8%),integral component of membrane (15%);nucleus (8%),GO:0003677 (38%);GO:0005524 (23%);GO:0008233 (15%),DNA binding (38%);ATP binding (23%);peptidase activity (15%),GO:0006355 (23%);GO:0000160 (8%);GO:0006013 (8%),regulation of transcription, DNA-templated (23%);phosphorelay signal transduction system (8%);mannose metabolic process (8%),IPR000792 (27%);IPR016032 (27%);IPR036388 (27%),Transcription regulator LuxR, C-terminal (27%);Signal transduction response regulator, C-terminal effector (27%);Winged helix-like DNA-binding domain superfamily (27%),,,,,,,,
LASDLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.274 (14%);4.2.2.0 (14%);1.1.1.257 (7%),Phosphate acyltransferase (14%); (14%);4-(hydroxymethyl)benzenesulfonate dehydrogenase (7%),GO:0005737 (18%);GO:0016021 (16%);GO:0005623 (8%),cytoplasm (18%);integral component of membrane (16%);cell (8%),GO:0003824 (16%);GO:0005524 (13%);GO:0003677 (11%),catalytic activity (16%);ATP binding (13%);DNA binding (11%),GO:0030643 (8%);GO:0045936 (8%);GO:0006281 (5%),cellular phosphate ion homeostasis (8%);negative regulation of phosphate metabolic process (8%);DNA repair (5%),IPR017853 (10%);IPR003790 (9%);IPR013785 (9%),Glycoside hydrolase superfamily (10%);Glycosyl hydrolase-like 10 (9%);Aldolase-type TIM barrel (9%),,,,,,,,,,,
LEASRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.9 (100%),dTMP kinase (100%),GO:0005634 (64%);GO:0016021 (14%),nucleus (64%);integral component of membrane (14%),GO:0000981 (64%);GO:0008270 (64%);GO:0030798 (7%),DNA-binding transcription factor activity, RNA polymerase II-specific (64%);zinc ion binding (64%);trans-aconitate 2-methyltransferase activity (7%),GO:0006233 (4%);GO:0006235 (4%);GO:0006351 (4%),dTDP biosynthetic process (4%);dTTP biosynthetic process (4%);transcription, DNA-templated (4%),IPR001138 (67%);IPR036864 (67%);IPR023149 (7%),Zn(2)-C6 fungal-type DNA-binding domain (67%);Zn(2)-C6 fungal-type DNA-binding domain superfamily (67%);Trans-aconitate 2-methyltransferase, C-terminal (7%),,,,,,,,
LLEVSPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%);GO:0005886 (25%),integral component of membrane (100%);plasma membrane (25%),GO:0035091 (50%);GO:0015079 (25%),phosphatidylinositol binding (50%);potassium ion transmembrane transporter activity (25%),GO:0007155 (25%),cell adhesion (25%),IPR001683 (50%);IPR036871 (50%);IPR003855 (25%),Phox homologous domain (50%);PX domain superfamily (50%);Potassium transporter (25%),,,,,,,,,,,
GFETNFLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLEDVSMAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNLLAVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (100%),Transferring groups other than amino-acyl groups (100%),GO:0043190 (44%);GO:0005737 (11%);GO:0005783 (11%),ATP-binding cassette (ABC) transporter complex (44%);cytoplasm (11%);endoplasmic reticulum (11%),GO:0004553 (11%);GO:0008117 (11%);GO:0016149 (11%),hydrolase activity, hydrolyzing O-glycosyl compounds (11%);sphinganine-1-phosphate aldolase activity (11%);translation release factor activity, codon specific (11%),GO:0055085 (33%);GO:0005975 (11%);GO:0006665 (11%),transmembrane transport (33%);carbohydrate metabolic process (11%);sphingolipid metabolic process (11%),IPR000412 (31%);IPR013525 (31%);IPR011990 (15%),ABC-2 transporter (31%);ABC-2 type transporter (31%);Tetratricopeptide-like helical domain superfamily (15%),,,,,,,,,
LVDLMPSTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVPLVSFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGCALAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.95 (100%),Phosphoglycerate dehydrogenase (100%),GO:0016021 (43%);GO:0005576 (29%),integral component of membrane (43%);extracellular region (29%),GO:0004518 (14%);GO:0004617 (14%);GO:0008233 (14%),nuclease activity (14%);phosphoglycerate dehydrogenase activity (14%);peptidase activity (14%),GO:0006281 (14%);GO:0006564 (14%),DNA repair (14%);L-serine biosynthetic process (14%),IPR014044 (62%);IPR035940 (62%);IPR001283 (57%),CAP domain (62%);CAP superfamily (62%);Cysteine-rich  secretory protein-related (57%),,,,,,,,,,,
YNYEVSQEAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGDLHAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0016747 (33%);GO:0003824 (17%);GO:0016491 (17%),transferase activity, transferring acyl groups other than amino-acyl groups (33%);catalytic activity (17%);oxidoreductase activity (17%),,,IPR002656 (29%);IPR001736 (14%);IPR008928 (14%),Acyltransferase 3 (29%);Phospholipase D/Transphosphatidylase (14%);Six-hairpin glycosidase superfamily (14%),,,,,,,,,,
QGDPAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.45 (22%);5.1.3.2 (22%);6.3.4.2 (22%),Carboxymethylenebutenolidase (22%);UDP-glucose 4-epimerase (22%);CTP synthase (glutamine hydrolyzing) (22%),GO:0016021 (20%);GO:0005886 (4%);GO:0005634 (2%),integral component of membrane (20%);plasma membrane (4%);nucleus (2%),GO:0003677 (22%);GO:0016787 (16%);GO:0005524 (12%),DNA binding (22%);hydrolase activity (16%);ATP binding (12%),GO:0006355 (14%);GO:0000160 (10%);GO:0005975 (6%),regulation of transcription, DNA-templated (14%);phosphorelay signal transduction system (10%);carbohydrate metabolic process (6%),IPR011990 (15%);IPR013026 (15%);IPR019734 (15%),Tetratricopeptide-like helical domain superfamily (15%);Tetratricopeptide repeat-containing domain (15%);Tetratricopeptide repeat (15%),,,,,,,,,,
LMQEAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.11 (7%);4.2.99.18 (4%);1.2.1.- (3%),Aspartate-semialdehyde dehydrogenase (7%);DNA-(apurinic or apyrimidinic site) lyase (4%);With NAD(+) or NADP(+) as acceptor (3%),GO:0016021 (20%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (20%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (14%);GO:0003677 (14%);GO:0046872 (8%),ATP binding (14%);DNA binding (14%);metal ion binding (8%),GO:0006355 (4%);GO:0006596 (3%);GO:0000160 (3%),regulation of transcription, DNA-templated (4%);polyamine biosynthetic process (3%);phosphorelay signal transduction system (3%),IPR027417 (11%);IPR036770 (6%);IPR020683 (6%),P-loop containing nucleoside triphosphate hydrolase (11%);Ankyrin repeat-containing domain superfamily (6%);Ankyrin repeat-containing domain (6%),,,,,,,,,,
TVVGTMMSVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMYHWEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQDVVQPSQSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHFSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.11 (41%);2.5.1.19 (19%);3.5.4.16 (4%),6-phosphofructokinase (41%);3-phosphoshikimate 1-carboxyvinyltransferase (19%);GTP cyclohydrolase I (4%),GO:0016021 (16%);GO:0005737 (13%);GO:0005832 (5%),integral component of membrane (16%);cytoplasm (13%);chaperonin-containing T-complex (5%),GO:0005524 (33%);GO:0046872 (10%);GO:0003676 (9%),ATP binding (33%);metal ion binding (10%);nucleic acid binding (9%),GO:0015074 (8%);GO:0006457 (6%);GO:0006002 (5%),DNA integration (8%);protein folding (6%);fructose 6-phosphate metabolic process (5%),IPR027417 (12%);IPR002611 (7%);IPR003593 (7%),P-loop containing nucleoside triphosphate hydrolase (12%);IstB-like ATP-binding protein (7%);AAA+ ATPase domain (7%),,,,,,,,,,,
NTHNQLPK,Verrucomicrobiales bacterium,Bacteria,,,,Verrucomicrobia,,,Verrucomicrobiae,,,,Verrucomicrobiales,,,,,,,,,,,,,Verrucomicrobiales bacterium,,,,,,,,GO:0042301 (100%),phosphate ion binding (100%),,,IPR011862 (100%);IPR024370 (100%),Phosphate binding protein (100%);PBP domain (100%),,,,,,,,,,,
TLPDVVSMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGNSALSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVNVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.31 (29%);6.5.1.2 (29%);2.3.3.10 (14%),6-phosphogluconolactonase (29%);DNA ligase (NAD(+)) (29%);Hydroxymethylglutaryl-CoA synthase (14%),GO:0016021 (48%);GO:0043190 (5%);GO:0005618 (3%),integral component of membrane (48%);ATP-binding cassette (ABC) transporter complex (5%);cell wall (3%),GO:0005524 (10%);GO:0003824 (8%);GO:0016787 (6%),ATP binding (10%);catalytic activity (8%);hydrolase activity (6%),GO:0055085 (27%);GO:0005975 (5%);GO:0006098 (3%),transmembrane transport (27%);carbohydrate metabolic process (5%);pentose-phosphate shunt (3%),IPR011701 (20%);IPR020846 (20%);IPR036259 (20%),Major facilitator superfamily (20%);Major facilitator superfamily domain (20%);MFS transporter superfamily (20%),,,,,,,,,,,
DTDTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.9 (10%);2.6.1.- (10%);3.1.4.4 (10%),Uracil phosphoribosyltransferase (10%);Transaminases (10%);Phospholipase D (10%),GO:0016021 (29%);GO:0005634 (4%);GO:0005737 (3%),integral component of membrane (29%);nucleus (4%);cytoplasm (3%),GO:0003677 (21%);GO:0008170 (17%);GO:0005524 (6%),DNA binding (21%);N-methyltransferase activity (17%);ATP binding (6%),GO:0006306 (16%);GO:0009405 (3%);GO:0006571 (2%),DNA methylation (16%);pathogenesis (3%);tyrosine biosynthetic process (2%),IPR029063 (16%);IPR002052 (15%);IPR002941 (15%),S-adenosyl-L-methionine-dependent methyltransferase (16%);DNA methylase, N-6 adenine-specific, conserved site (15%);DNA methylase N-4/N-6 (15%),,,,,,,,,
LGAENASEVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGSSDSMLVPVNGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGNDESTNMFLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVVPNEEVDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVVMAELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR009880 (50%);IPR010760 (50%);IPR011043 (50%),Glyoxal oxidase, N-terminal (50%);DNA repair protein, Swi5 (50%);Galactose oxidase/kelch, beta-propeller (50%),,,,,,,,
YPEVQNK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.16.- (100%),Serine-type carboxypeptidases (100%),GO:0016021 (80%);GO:0005737 (20%);GO:0043231 (20%),integral component of membrane (80%);cytoplasm (20%);intracellular membrane-bounded organelle (20%),GO:0005506 (80%);GO:0020037 (80%);GO:0016705 (40%),iron ion binding (80%);heme binding (80%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (40%),GO:0006082 (20%);GO:0006805 (20%);GO:0019373 (20%),organic acid metabolic process (20%);xenobiotic metabolic process (20%);epoxygenase P450 pathway (20%),IPR001128 (80%);IPR002401 (80%);IPR036396 (80%),Cytochrome P450 (80%);Cytochrome P450, E-class, group I (80%);Cytochrome P450 superfamily (80%),,,,,,,
WVEVDPLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EQLNDVQQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLWLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.3.12 (95%);1.1.1.29 (2%);6.1.1.5 (1%),Agmatine deiminase (95%);Glycerate dehydrogenase (2%);Isoleucine--tRNA ligase (1%),GO:0016021 (5%);GO:0016020 (3%);GO:0005737 (0%),integral component of membrane (5%);membrane (3%);cytoplasm (0%),GO:0004668 (82%);GO:0047632 (64%);GO:0047355 (3%),protein-arginine deiminase activity (82%);agmatine deiminase activity (64%);CDP-glycerol glycerophosphotransferase activity (3%),GO:0009446 (82%);GO:0006355 (1%);GO:0005975 (0%),putrescine biosynthetic process (82%);regulation of transcription, DNA-templated (1%);carbohydrate metabolic process (0%),IPR007466 (83%);IPR017754 (63%);IPR007554 (2%),Peptidyl-arginine deiminase, Porphyromonas-type (83%);Agmatine deiminase (63%);CDP-glycerol glycerophosphotransferase (2%),,,,,,,,,
DWTMHLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLQLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.5 (20%);2.7.13.3 (15%);3.6.3.3 (13%),Xylose isomerase (20%);Histidine kinase (15%);Transferred entry: 7.2.2.21 (13%),GO:0016021 (23%);GO:0005886 (3%);GO:0005737 (2%),integral component of membrane (23%);plasma membrane (3%);cytoplasm (2%),GO:0003677 (37%);GO:0003700 (13%);GO:0043565 (13%),DNA binding (37%);DNA-binding transcription factor activity (13%);sequence-specific DNA binding (13%),GO:0045892 (33%);GO:0000160 (3%);GO:0009250 (2%),negative regulation of transcription, DNA-templated (33%);phosphorelay signal transduction system (3%);glucan biosynthetic process (2%),IPR029016 (28%);IPR021153 (28%);IPR002571 (28%),GAF-like domain superfamily (28%);Heat-inducible transcription repressor HrcA, C-terminal (28%);Heat-inducible transcription repressor HrcA (28%),,,,,,,,,
SSLLVDFR,Alphaproteobacteria,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (67%);GO:0016021 (33%),membrane (67%);integral component of membrane (33%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR006143 (100%);IPR032317 (100%),RND efflux pump, membrane fusion protein (100%);RND efflux pump, membrane fusion protein, barrel-sandwich domain (100%),,,,,,,,
APMER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.3 (60%);1.2.1.70 (11%);2.3.1.274 (3%),Homoserine dehydrogenase (60%);Glutamyl-tRNA reductase (11%);Phosphate acyltransferase (3%),GO:0016021 (43%);GO:0016020 (2%);GO:0005737 (2%),integral component of membrane (43%);membrane (2%);cytoplasm (2%),GO:0005524 (14%);GO:0050661 (12%);GO:0004412 (11%),ATP binding (14%);NADP binding (12%);homoserine dehydrogenase activity (11%),GO:0009086 (10%);GO:0009088 (10%);GO:0009097 (10%),methionine biosynthetic process (10%);threonine biosynthetic process (10%);isoleucine biosynthetic process (10%),IPR011990 (23%);IPR010817 (23%);IPR016982 (23%),Tetratricopeptide-like helical domain superfamily (23%);HemY, N-terminal (23%);Probable magnetosome protein Mms48 (23%),,,,,,,,,,
MFLMLPK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR032054 (100%),DNA replication factor Cdt1, C-terminal (100%),,,,,,,,,,
GPFPNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDLFMDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTEVVPLTVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.20 (57%);6.1.1.6 (11%);2.7.2.11 (5%),7-cyano-7-deazaguanine synthase (57%);Lysine--tRNA ligase (11%);Glutamate 5-kinase (5%),GO:0016021 (16%);GO:0005737 (11%);GO:0005623 (2%),integral component of membrane (16%);cytoplasm (11%);cell (2%),GO:0005524 (42%);GO:0008270 (27%);GO:0016879 (26%),ATP binding (42%);zinc ion binding (27%);ligase activity, forming carbon-nitrogen bonds (26%),GO:0008616 (26%);GO:0006430 (5%);GO:0005975 (4%),queuosine biosynthetic process (26%);lysyl-tRNA aminoacylation (5%);carbohydrate metabolic process (4%),IPR014729 (24%);IPR018317 (23%);IPR027417 (6%),Rossmann-like alpha/beta/alpha sandwich fold (24%);Queuosine biosynthesis protein QueC (23%);P-loop containing nucleoside triphosphate hydrolase (6%),,,,,,,,,,
FANQLSQQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEADDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.9 (33%);1.17.4.1 (12%);2.6.1.9 (9%),UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (33%);Ribonucleoside-diphosphate reductase (12%);Histidinol-phosphate transaminase (9%),GO:0016021 (25%);GO:0005737 (7%);GO:0005634 (5%),integral component of membrane (25%);cytoplasm (7%);nucleus (5%),GO:0005524 (19%);GO:0003677 (12%);GO:0003676 (5%),ATP binding (19%);DNA binding (12%);nucleic acid binding (5%),GO:0006355 (6%);GO:0007049 (5%);GO:0008360 (5%),regulation of transcription, DNA-templated (6%);cell cycle (5%);regulation of cell shape (5%),IPR027417 (14%);IPR021994 (6%);IPR029045 (4%),P-loop containing nucleoside triphosphate hydrolase (14%);Protein of unknown function DUF3592 (6%);ClpP/crotonase-like domain superfamily (4%),,,,,,,,,,
VLVFGCAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAATCSEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEYFLHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNTALFMNAWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFEPM,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR032710 (67%);IPR032549 (33%);IPR037401 (33%),NTF2-like domain superfamily (67%);Domain of unknown function DUF4939 (33%);SnoaL-like domain (33%),,,,,,,,,,,
CLTDYFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (25%);2.7.2.11 (10%);6.3.4.2 (9%),Endopeptidase La (25%);Glutamate 5-kinase (10%);CTP synthase (glutamine hydrolyzing) (9%),GO:0005737 (19%);GO:0016021 (15%);GO:0005886 (2%),cytoplasm (19%);integral component of membrane (15%);plasma membrane (2%),GO:0005524 (27%);GO:0046872 (10%);GO:0004252 (10%),ATP binding (27%);metal ion binding (10%);serine-type endopeptidase activity (10%),GO:0006515 (8%);GO:0034605 (8%);GO:0006541 (4%),protein quality control for misfolded or incompletely synthesized proteins (8%);cellular response to heat (8%);glutamine metabolic process (4%),IPR027417 (17%);IPR015947 (11%);IPR003593 (9%),P-loop containing nucleoside triphosphate hydrolase (17%);PUA-like superfamily (11%);AAA+ ATPase domain (9%),,,,,,,,,,,
DLVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.25.2 (9%);2.1.1.182 (5%);3.6.5.0 (5%),HslU--HslV peptidase (9%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (5%); (5%),GO:0016021 (14%);GO:0005737 (12%);GO:0005886 (4%),integral component of membrane (14%);cytoplasm (12%);plasma membrane (4%),GO:0005524 (19%);GO:0046872 (10%);GO:0003677 (6%),ATP binding (19%);metal ion binding (10%);DNA binding (6%),GO:0006412 (4%);GO:0051603 (2%);GO:0006457 (2%),translation (4%);proteolysis involved in cellular protein catabolic process (2%);protein folding (2%),IPR027417 (11%);IPR036291 (6%);IPR003593 (3%),P-loop containing nucleoside triphosphate hydrolase (11%);NAD(P)-binding domain superfamily (6%);AAA+ ATPase domain (3%),,,,,,,,,,,
FMVEFELPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CTLAFESLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGFPSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (50%);2.7.1.153 (50%),Methyltransferases (50%);Phosphatidylinositol-4,5-bisphosphate 3-kinase (50%),GO:0005654 (17%);GO:0005829 (17%);GO:0005737 (8%),nucleoplasm (17%);cytosol (17%);cytoplasm (8%),GO:0003676 (33%);GO:0008168 (17%);GO:0004467 (8%),nucleic acid binding (33%);methyltransferase activity (17%);long-chain fatty acid-CoA ligase activity (8%),GO:0032259 (17%);GO:0006113 (8%);GO:0006633 (8%),methylation (17%);fermentation (8%);fatty acid biosynthetic process (8%),IPR013087 (31%);IPR036236 (31%);IPR025714 (23%),Zinc finger C2H2-type (31%);Zinc finger C2H2 superfamily (31%);Methyltransferase domain (23%),,,,,,,,,,
VAWEC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMEMLPK,Candidatus Aenigmarchaeota archaeon,Archaea,,,,Candidatus Aenigmarchaeota,,,,,,,,,,,,,,,,,,,,Candidatus Aenigmarchaeota archaeon,,,,,,,,,,,,,,,,,,,,,,,,
TQSYVLSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EALELEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (74%);2.2.1.1 (5%);2.1.2.11 (2%),Acting on ester bonds (74%);Transketolase (5%);3-methyl-2-oxobutanoate hydroxymethyltransferase (2%),GO:0005634 (34%);GO:0005737 (23%);GO:0016021 (13%),nucleus (34%);cytoplasm (23%);integral component of membrane (13%),GO:0046872 (40%);GO:0018024 (33%);GO:0008270 (18%),metal ion binding (40%);histone-lysine N-methyltransferase activity (33%);zinc ion binding (18%),GO:0006364 (16%);GO:0045893 (8%);GO:2001255 (8%),rRNA processing (16%);positive regulation of transcription, DNA-templated (8%);positive regulation of histone H3-K36 trimethylation (8%),IPR013083 (27%);IPR000313 (26%);IPR001214 (26%),Zinc finger, RING/FYVE/PHD-type (27%);PWWP domain (26%);SET domain (26%),,,,,,,,,
QVQLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (10%);1.6.1.1 (9%);3.4.21.- (6%),Glycogen phosphorylase (10%);NAD(P)(+) transhydrogenase (Si-specific) (9%);Serine endopeptidases (6%),GO:0016021 (22%);GO:0005886 (6%);GO:0005737 (5%),integral component of membrane (22%);plasma membrane (6%);cytoplasm (5%),GO:0005524 (13%);GO:0016787 (10%);GO:0008270 (7%),ATP binding (13%);hydrolase activity (10%);zinc ion binding (7%),GO:0005975 (3%);GO:0051301 (2%);GO:0007049 (2%),carbohydrate metabolic process (3%);cell division (2%);cell cycle (2%),IPR029058 (13%);IPR000073 (11%);IPR027417 (8%),Alpha/Beta hydrolase fold (13%);Alpha/beta hydrolase fold-1 (11%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
MPFLLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.- (56%);3.2.2.9 (25%);2.4.99.12 (13%),With NAD(+) or NADP(+) as acceptor (56%);Adenosylhomocysteine nucleosidase (25%);Lipid IV(A) 3-deoxy-D-manno-octulosonic acid transferase (13%),GO:0016021 (45%);GO:0005886 (6%),integral component of membrane (45%);plasma membrane (6%),GO:0017150 (29%);GO:0050660 (29%);GO:0008782 (13%),tRNA dihydrouridine synthase activity (29%);flavin adenine dinucleotide binding (29%);adenosylhomocysteine nucleosidase activity (13%),GO:0006813 (13%);GO:0009164 (13%);GO:0019509 (13%),potassium ion transport (13%);nucleoside catabolic process (13%);L-methionine salvage from methylthioadenosine (13%),IPR001269 (28%);IPR013785 (28%);IPR018517 (28%),tRNA-dihydrouridine synthase (28%);Aldolase-type TIM barrel (28%);tRNA-dihydrouridine synthase, conserved site (28%),,,,,,,,,,
MWWQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.196 (25%);2.4.1.25 (25%);2.7.13.3 (25%),Cobalt-precorrin-6B (C(15))-methyltransferase (decarboxylating) (25%);4-alpha-glucanotransferase (25%);Histidine kinase (25%),GO:0016021 (69%);GO:0005886 (10%);GO:0005794 (5%),integral component of membrane (69%);plasma membrane (10%);Golgi apparatus (5%),GO:0030246 (15%);GO:0016740 (8%);GO:0005524 (5%),carbohydrate binding (15%);transferase activity (8%);ATP binding (5%),GO:0006605 (10%);GO:0043952 (10%);GO:0065002 (10%),protein targeting (10%);protein transport by the Sec complex (10%);intracellular protein transmembrane transport (10%),IPR011990 (36%);IPR024302 (26%);IPR001602 (17%),Tetratricopeptide-like helical domain superfamily (36%);SusD-like (26%);Uncharacterised protein family UPF0047 (17%),,,,,,,,,,,
TLNLMSEPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPESALANVTHDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYWMVN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNLVLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR010281 (100%),Protein of unknown function DUF885 (100%),,,,,,,,,,,
MLTSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.2 (43%);1.8.1.4 (7%);1.8.4.12 (7%),Glutamine synthetase (43%);Dihydrolipoyl dehydrogenase (7%);Peptide-methionine (R)-S-oxide reductase (7%),GO:0016021 (10%);GO:0005840 (6%);GO:0005737 (5%),integral component of membrane (10%);ribosome (6%);cytoplasm (5%),GO:0004356 (36%);GO:0003723 (6%);GO:0005524 (6%),glutamate-ammonia ligase activity (36%);RNA binding (6%);ATP binding (6%),GO:0006807 (36%);GO:0006396 (6%);GO:0006412 (5%),nitrogen compound metabolic process (36%);RNA processing (6%);translation (5%),IPR008146 (31%);IPR014746 (31%);IPR022147 (31%),Glutamine synthetase, catalytic domain (31%);Glutamine synthetase/guanido kinase, catalytic domain (31%);Glutamine synthetase type III N-terminal (31%),,,,,,,,,
EPSAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (23%);6.3.2.8 (13%);2.4.1.- (7%),Exoribonuclease II (23%);UDP-N-acetylmuramate--L-alanine ligase (13%);Hexosyltransferases (7%),GO:0005874 (27%);GO:0016021 (16%);GO:0005737 (8%),microtubule (27%);integral component of membrane (16%);cytoplasm (8%),GO:0005516 (31%);GO:0030507 (28%);GO:0008017 (27%),calmodulin binding (31%);spectrin binding (28%);microtubule binding (27%),GO:0031175 (26%);GO:0031113 (4%);GO:1903358 (4%),neuron projection development (26%);regulation of microtubule polymerization (4%);regulation of Golgi organization (4%),IPR011033 (27%);IPR014797 (27%);IPR032940 (27%),PRC-barrel-like superfamily (27%);CKK domain (27%);Calmodulin-regulated spectrin-associated protein (27%),,,,,,,,,,,
CLNTNMK,Glossina fuscipes fuscipes,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Diptera,Brachycera,Muscomorpha,,Hippoboscoidea,Glossinidae,,,,Glossina,Nemorhina,,,Glossina fuscipes,Glossina fuscipes fuscipes,,,,,,,,,,,,,,,,,,,,,,,
MHAYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (45%);6.1.1.2 (12%);3.7.1.22 (9%),Glycogen phosphorylase (45%);Tryptophan--tRNA ligase (12%);3D-(3,5/4)-trihydroxycyclohexane-1,2-dione acylhydrolase (decyclizing) (9%),GO:0016021 (13%);GO:0005737 (8%);GO:0030288 (3%),integral component of membrane (13%);cytoplasm (8%);outer membrane-bounded periplasmic space (3%),GO:0102250 (18%);GO:0102499 (18%);GO:0008184 (17%),linear malto-oligosaccharide phosphorylase activity (18%);SHG alpha-glucan phosphorylase activity (18%);glycogen phosphorylase activity (17%),GO:0005975 (19%);GO:0008299 (12%);GO:0006436 (7%),carbohydrate metabolic process (19%);isoprenoid biosynthetic process (12%);tryptophanyl-tRNA aminoacylation (7%),IPR007505 (27%);IPR018633 (25%);IPR000811 (12%),PD-(D/E)XK nuclease superfamily  7 (27%);Domain of unknown function DUF2357 (25%);Glycosyl transferase, family 35 (12%),,,,,,,,
QNDESGLLAVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEEVQNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLAFEVMEPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EALPVVTMPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGPLTMK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.42 (100%),Branched-chain-amino-acid transaminase (100%),GO:0016021 (50%),integral component of membrane (50%),GO:0052654 (50%);GO:0052655 (50%);GO:0052656 (50%),L-leucine transaminase activity (50%);L-valine transaminase activity (50%);L-isoleucine transaminase activity (50%),GO:0009097 (50%);GO:0009098 (50%);GO:0009099 (50%),isoleucine biosynthetic process (50%);leucine biosynthetic process (50%);valine biosynthetic process (50%),IPR000620 (50%);IPR001544 (50%);IPR005785 (50%),EamA domain (50%);Aminotransferase class IV (50%);Branched-chain amino acid aminotransferase I (50%),,,,,,,,,,,
QTASSGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNLEETLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YGNDWDAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLGTTYMGC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVMFFANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGNNSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0036459 (50%);GO:0003677 (25%);GO:0008170 (25%),thiol-dependent ubiquitinyl hydrolase activity (50%);DNA binding (25%);N-methyltransferase activity (25%),GO:0006511 (50%);GO:0016579 (50%);GO:0006306 (25%),ubiquitin-dependent protein catabolic process (50%);protein deubiquitination (50%);DNA methylation (25%),IPR001394 (50%);IPR018200 (50%);IPR028889 (50%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (50%);Ubiquitin specific protease, conserved site (50%);Ubiquitin specific protease domain (50%),,,,,,,,,
VVWNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.-.- (50%);3.1.30.- (50%),Glycosyltransferases (50%);Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters (50%),GO:0016021 (48%),integral component of membrane (48%),GO:0003677 (45%);GO:0016740 (45%);GO:0003700 (39%),DNA binding (45%);transferase activity (45%);DNA-binding transcription factor activity (39%),,,IPR001173 (35%);IPR029044 (35%);IPR000847 (30%),Glycosyltransferase 2-like (35%);Nucleotide-diphospho-sugar transferases (35%);Transcription regulator HTH, LysR (30%),,,,,,,,,,
METVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (23%);2.5.1.61 (10%);4.2.1.136 (8%),Acting on ATP; involved in cellular and subcellular movement (23%);Hydroxymethylbilane synthase (10%);ADP-dependent NAD(P)H-hydrate dehydratase (8%),GO:0016021 (23%);GO:0005737 (8%);GO:0009380 (5%),integral component of membrane (23%);cytoplasm (8%);excinuclease repair complex (5%),GO:0005524 (21%);GO:0046872 (10%);GO:0003677 (7%),ATP binding (21%);metal ion binding (10%);DNA binding (7%),GO:0006355 (7%);GO:0009432 (5%);GO:0000716 (5%),regulation of transcription, DNA-templated (7%);SOS response (5%);transcription-coupled nucleotide-excision repair, DNA damage recognition (5%),IPR027417 (12%);IPR014001 (6%);IPR001650 (6%),P-loop containing nucleoside triphosphate hydrolase (12%);Helicase superfamily 1/2, ATP-binding domain (6%);Helicase, C-terminal (6%),,,,,,,
LFCPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%);GO:0019028 (27%),integral component of membrane (60%);viral capsid (27%),GO:0005524 (40%);GO:0016887 (40%);GO:0042626 (40%),ATP binding (40%);ATPase activity (40%);ATPase-coupled transmembrane transporter activity (40%),GO:0006865 (7%),amino acid transport (7%),IPR027417 (48%);IPR003439 (26%);IPR003593 (26%),P-loop containing nucleoside triphosphate hydrolase (48%);ABC transporter-like (26%);AAA+ ATPase domain (26%),,,,,,,,,,,
SLWELAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.4 (33%);2.7.3.- (33%);3.1.1.4 (33%),Dihydrolipoyl dehydrogenase (33%);Phosphotransferases with a nitrogenous group as acceptor (33%);Phospholipase A(2) (33%),GO:0016021 (55%);GO:0005576 (9%);GO:0005623 (9%),integral component of membrane (55%);extracellular region (9%);cell (9%),GO:0000155 (45%);GO:0005524 (36%);GO:0009055 (18%),phosphorelay sensor kinase activity (45%);ATP binding (36%);electron transfer activity (18%),GO:0006355 (9%);GO:0006644 (9%);GO:0015942 (9%),regulation of transcription, DNA-templated (9%);phospholipid metabolic process (9%);formate metabolic process (9%),IPR000014 (42%);IPR000700 (42%);IPR003661 (42%),PAS domain (42%);PAS-associated, C-terminal (42%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (42%),,,,,,,,
AMLDANDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLFENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.-.- (12%);1.1.1.94 (9%);1.1.99.1 (9%),Forming carbon-nitrogen bonds (12%);Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (9%);Choline dehydrogenase (9%),GO:0016021 (28%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (28%);cytoplasm (5%);plasma membrane (4%),GO:0005524 (16%);GO:0008270 (11%);GO:0016491 (11%),ATP binding (16%);zinc ion binding (11%);oxidoreductase activity (11%),GO:0055085 (4%);GO:0006464 (3%);GO:0006355 (3%),transmembrane transport (4%);cellular protein modification process (3%);regulation of transcription, DNA-templated (3%),IPR036291 (12%);IPR027417 (11%);IPR011032 (9%),NAD(P)-binding domain superfamily (12%);P-loop containing nucleoside triphosphate hydrolase (11%);GroES-like superfamily (9%),,,,,,,,,,
VGLFDALDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNLTRPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.5 (14%);3.2.1.86 (11%);2.7.7.6 (7%),NAD(+) synthase (14%);6-phospho-beta-glucosidase (11%);DNA-directed RNA polymerase (7%),GO:0016021 (30%);GO:0005737 (8%);GO:0005886 (8%),integral component of membrane (30%);cytoplasm (8%);plasma membrane (8%),GO:0005524 (19%);GO:0046872 (11%);GO:0008324 (7%),ATP binding (19%);metal ion binding (11%);cation transmembrane transporter activity (7%),GO:0005975 (7%);GO:0051262 (4%);GO:0009435 (3%),carbohydrate metabolic process (7%);protein tetramerization (4%);NAD biosynthetic process (3%),IPR027417 (7%);IPR017853 (6%);IPR001036 (6%),P-loop containing nucleoside triphosphate hydrolase (7%);Glycoside hydrolase superfamily (6%);Acriflavin resistance protein (6%),,,,,,,,,,,
NPPAFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAWLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (47%);1.1.5.3 (6%);2.1.1.33 (6%),Pyruvate dehydrogenase (acetyl-transferring) (47%);Glycerol-3-phosphate dehydrogenase (6%);tRNA (guanine(46)-N(7))-methyltransferase (6%),GO:0016021 (24%);GO:0005737 (6%);GO:0009507 (6%),integral component of membrane (24%);cytoplasm (6%);chloroplast (6%),GO:0004739 (12%);GO:0003677 (10%);GO:0022857 (6%),pyruvate dehydrogenase (acetyl-transferring) activity (12%);DNA binding (10%);transmembrane transporter activity (6%),GO:0006086 (12%);GO:0007040 (7%);GO:0030420 (6%),acetyl-CoA biosynthetic process from pyruvate (12%);lysosome organization (7%);establishment of competence for transformation (6%),IPR029061 (13%);IPR001017 (10%);IPR017597 (10%),Thiamin diphosphate-binding fold (13%);Dehydrogenase, E1 component (10%);Pyruvate dehydrogenase (acetyl-transferring) E1 component, alpha subunit, subgroup y (10%),,,,,,,,
VCEVMPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTSANVEEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNLQTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.3 (70%);1.17.4.1 (5%);1.3.5.2 (5%),Aconitate hydratase (70%);Ribonucleoside-diphosphate reductase (5%);Dihydroorotate dehydrogenase (quinone) (5%),GO:0016021 (40%);GO:0005634 (6%);GO:0005737 (3%),integral component of membrane (40%);nucleus (6%);cytoplasm (3%),GO:0003994 (19%);GO:0047780 (19%);GO:0051539 (19%),aconitate hydratase activity (19%);citrate dehydratase activity (19%);4 iron, 4 sulfur cluster binding (19%),GO:0000160 (6%);GO:0006355 (3%);GO:0005975 (1%),phosphorelay signal transduction system (6%);regulation of transcription, DNA-templated (3%);carbohydrate metabolic process (1%),IPR000573 (16%);IPR001030 (16%);IPR006249 (16%),Aconitase A/isopropylmalate dehydratase small subunit, swivel domain (16%);Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha domain (16%);Aconitase/Iron-responsive element-binding protein 2 (16%),,,,,,,
VMMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.6 (74%);2.4.1.21 (13%);4.1.1.49 (3%),Biotin synthase (74%);Starch synthase (13%);Phosphoenolpyruvate carboxykinase (ATP) (3%),GO:0042597 (15%);GO:0016021 (13%);GO:0005576 (6%),periplasmic space (15%);integral component of membrane (13%);extracellular region (6%),GO:0051539 (32%);GO:0004076 (31%);GO:0051537 (31%),4 iron, 4 sulfur cluster binding (32%);biotin synthase activity (31%);2 iron, 2 sulfur cluster binding (31%),GO:0009102 (30%);GO:0015846 (15%);GO:0006355 (9%),biotin biosynthetic process (30%);polyamine transport (15%);regulation of transcription, DNA-templated (9%),IPR013785 (31%);IPR002684 (30%);IPR006638 (30%),Aldolase-type TIM barrel (31%);Biotin synthase/Biotin biosynthesis bifunctional protein BioAB (30%);Elp3/MiaB/NifB (30%),,,,,,,,
EYEVQWHYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALNDVVVNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVTEEPQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGVMLLPEANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAVAELPWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLNPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.2.11 (36%);2.7.1.11 (11%);1.4.4.2 (5%),Phosphoglycerate mutase (2,3-diphosphoglycerate-dependent) (36%);6-phosphofructokinase (11%);Glycine dehydrogenase (aminomethyl-transferring) (5%),GO:0016021 (25%);GO:0005829 (7%);GO:0005768 (6%),integral component of membrane (25%);cytosol (7%);endosome (6%),GO:0005524 (11%);GO:0008270 (9%);GO:0008745 (9%),ATP binding (11%);zinc ion binding (9%);N-acetylmuramoyl-L-alanine amidase activity (9%),GO:0009253 (9%);GO:0006094 (8%);GO:0006096 (8%),peptidoglycan catabolic process (9%);gluconeogenesis (8%);glycolytic process (8%),IPR029063 (8%);IPR002502 (7%);IPR006619 (7%),S-adenosyl-L-methionine-dependent methyltransferase (8%);N-acetylmuramoyl-L-alanine amidase domain (7%);Peptidoglycan recognition protein family domain, metazoa/bacteria (7%),,,,,,,,,
LQEETDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (83%);3.1.-.- (17%),Acting on ATP; involved in cellular and subcellular movement (83%);Acting on ester bonds (17%),GO:0016021 (60%);GO:0000220 (48%);GO:0005634 (25%),integral component of membrane (60%);vacuolar proton-transporting V-type ATPase, V0 domain (48%);nucleus (25%),GO:0015078 (49%);GO:0003676 (19%);GO:0005524 (7%),proton transmembrane transporter activity (49%);nucleic acid binding (19%);ATP binding (7%),GO:0001503 (24%);GO:0002158 (24%);GO:0002377 (24%),ossification (24%);osteoclast proliferation (24%);immunoglobulin production (24%),IPR002490 (56%);IPR026028 (51%);IPR012337 (19%),V-type  ATPase, V0 complex, 116kDa subunit family (56%);ATPase, V0 complex, subunit 116kDa, eukaryotic (51%);Ribonuclease H-like superfamily (19%),,,,,
FPLEAYPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NASLQSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.21 (100%),Beta-glucosidase (100%),GO:0016021 (80%);GO:0005634 (10%);GO:0043231 (3%),integral component of membrane (80%);nucleus (10%);intracellular membrane-bounded organelle (3%),GO:0003676 (10%);GO:0004526 (10%);GO:0004553 (5%),nucleic acid binding (10%);ribonuclease P activity (10%);hydrolase activity, hydrolyzing O-glycosyl compounds (5%),GO:0008033 (10%);GO:0005975 (8%);GO:0006869 (3%),tRNA processing (10%);carbohydrate metabolic process (8%);lipid transport (3%),IPR026307 (44%);IPR031435 (44%);IPR031437 (33%),Transmembrane protein 132 (44%);Transmembrane protein TMEM132, N-terminal (44%);Transmembrane protein family 132, middle domain (33%),,,,,,,,
DDVEGEVEYMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNDLVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (40%),integral component of membrane (40%),GO:0003700 (40%);GO:0043565 (40%);GO:0000155 (20%),DNA-binding transcription factor activity (40%);sequence-specific DNA binding (40%);phosphorelay sensor kinase activity (20%),GO:0000160 (40%);GO:0006310 (20%);GO:0015074 (20%),phosphorelay signal transduction system (40%);DNA recombination (20%);DNA integration (20%),IPR001789 (25%);IPR009057 (25%);IPR011006 (25%),Signal transduction response regulator, receiver domain (25%);Homeobox-like domain superfamily (25%);CheY-like superfamily (25%),,,,,,,,,,
NPQFN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004601 (100%);GO:0009055 (100%);GO:0020037 (100%),peroxidase activity (100%);electron transfer activity (100%);heme binding (100%),,,IPR004852 (100%);IPR009056 (100%);IPR026259 (100%),Di-haem cytochrome c peroxidase (100%);Cytochrome c-like domain (100%);Di-c-type haem protein, MauG/cytochrome c peroxidase (100%),,,,,,,,,,
HVDMMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000139 (25%);GO:0016021 (25%);GO:0017119 (25%),Golgi membrane (25%);integral component of membrane (25%);Golgi transport complex (25%),GO:0016788 (25%),hydrolase activity, acting on ester bonds (25%),GO:0006310 (25%);GO:0006891 (25%);GO:0009058 (25%),DNA recombination (25%);intra-Golgi vesicle-mediated transport (25%);biosynthetic process (25%),IPR000731 (17%);IPR001031 (17%);IPR002104 (17%),Sterol-sensing domain (17%);Thioesterase (17%);Integrase, catalytic domain (17%),,,,,,,,,
EHVLEFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000814 (40%),ESCRT II complex (40%),GO:0016491 (40%);GO:0043130 (40%);GO:0016787 (20%),oxidoreductase activity (40%);ubiquitin binding (40%);hydrolase activity (20%),GO:0032509 (40%);GO:0016042 (20%),endosome transport via multivesicular body sorting pathway (40%);lipid catabolic process (20%),IPR036188 (63%);IPR023753 (25%);IPR036388 (25%),FAD/NAD(P)-binding domain superfamily (63%);FAD/NAD(P)-binding domain (25%);Winged helix-like DNA-binding domain superfamily (25%),,,,,,,,,,,
LVPDALSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003723 (33%);GO:0004525 (33%);GO:0016787 (33%),RNA binding (33%);ribonuclease III activity (33%);hydrolase activity (33%),GO:0006396 (33%);GO:0019988 (33%),RNA processing (33%);charged-tRNA amino acid modification (33%),IPR000999 (33%);IPR007306 (33%);IPR013830 (33%),Ribonuclease III domain (33%);tRNA A64-2'-O-ribosylphosphate transferase (33%);SGNH hydrolase-type esterase domain (33%),,,,,,,,,,,
VVTVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0008134 (100%);GO:0043565 (100%),ATP binding (100%);transcription factor binding (100%);sequence-specific DNA binding (100%),GO:0000160 (100%);GO:0006355 (100%),phosphorelay signal transduction system (100%);regulation of transcription, DNA-templated (100%),IPR001789 (100%);IPR002078 (100%);IPR002197 (100%),Signal transduction response regulator, receiver domain (100%);RNA polymerase sigma factor 54 interaction domain (100%);DNA binding HTH domain,  Fis-type (100%),,,,,,,,
DVQTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.3 (24%);5.2.1.8 (10%);6.1.1.11 (4%),Phosphoribosylformylglycinamidine synthase (24%);Peptidylprolyl isomerase (10%);Serine--tRNA ligase (4%),GO:0016021 (22%);GO:0005737 (11%);GO:0016459 (10%),integral component of membrane (22%);cytoplasm (11%);myosin complex (10%),GO:0005524 (29%);GO:0003774 (10%);GO:0051015 (10%),ATP binding (29%);motor activity (10%);actin filament binding (10%),GO:0006541 (5%);GO:0006189 (4%);GO:0006351 (3%),glutamine metabolic process (5%);'de novo' IMP biosynthetic process (4%);transcription, DNA-templated (3%),IPR027417 (18%);IPR027401 (8%);IPR001609 (8%),P-loop containing nucleoside triphosphate hydrolase (18%);Myosin IQ motif-containing domain superfamily (8%);Myosin head, motor domain (8%),,,,,,,,,
TVELSEQEASQDER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYSYFYK,Colletotrichum spinosum,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Glomerellales,,,,,Glomerellaceae,,,,Colletotrichum,,,,Colletotrichum spinosum,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
VMAGGYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.4 (100%),Ribonuclease H (100%),GO:0005737 (25%),cytoplasm (25%),GO:0016301 (50%);GO:0016773 (50%);GO:0000287 (25%),kinase activity (50%);phosphotransferase activity, alcohol group as acceptor (50%);magnesium ion binding (25%),GO:0006401 (25%),RNA catabolic process (25%),IPR002139 (50%);IPR002173 (50%);IPR011611 (50%),Ribokinase/fructokinase (50%);Carbohydrate/puine kinase, PfkB, conserved site (50%);Carbohydrate kinase PfkB (50%),,,,,,,,
VPFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.5.2.6 (10%);2.5.1.145 (9%);2.4.1.- (7%),ABC-type lipid A-core oligosaccharide transporter (10%);Phosphatidylglycerol--prolipoprotein diacylglyceryl transferase (9%);Hexosyltransferases (7%),GO:0016021 (35%);GO:0005886 (10%);GO:0005694 (7%),integral component of membrane (35%);plasma membrane (10%);chromosome (7%),GO:0003677 (33%);GO:0005524 (14%);GO:0016887 (7%),DNA binding (33%);ATP binding (14%);ATPase activity (7%),GO:0006355 (11%);GO:0006310 (8%);GO:0006417 (8%),regulation of transcription, DNA-templated (11%);DNA recombination (8%);regulation of translation (8%),IPR000119 (24%);IPR010992 (24%);IPR020816 (13%),Histone-like DNA-binding protein (24%);Integration host factor (IHF)-like DNA-binding domain superfamily (24%);Histone-like DNA-binding protein, conserved site (13%),,,,,,,,,
MFPLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.20 (67%);3.4.-.- (33%),Diaminopimelate decarboxylase (67%);Acting on peptide bonds (peptidases) (33%),GO:0016021 (29%);GO:0005737 (9%);GO:0005623 (3%),integral component of membrane (29%);cytoplasm (9%);cell (3%),GO:0046872 (24%);GO:0003682 (12%);GO:0005524 (12%),metal ion binding (24%);chromatin binding (12%);ATP binding (12%),GO:0009089 (6%);GO:0009408 (6%);GO:0042026 (6%),lysine biosynthetic process via diaminopimelate (6%);response to heat (6%);protein refolding (6%),IPR027417 (13%);IPR001025 (11%);IPR001460 (11%),P-loop containing nucleoside triphosphate hydrolase (13%);Bromo adjacent homology (BAH) domain (11%);Penicillin-binding protein, transpeptidase (11%),,,,,,,,,,
MEALN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.3 (100%),Homoserine dehydrogenase (100%),GO:0016021 (0%),integral component of membrane (0%),GO:0004412 (100%);GO:0050661 (97%),homoserine dehydrogenase activity (100%);NADP binding (97%),GO:0009086 (99%);GO:0009088 (99%);GO:0009097 (99%),methionine biosynthetic process (99%);threonine biosynthetic process (99%);isoleucine biosynthetic process (99%),IPR001342 (100%);IPR002912 (100%);IPR019811 (99%),Homoserine dehydrogenase, catalytic (100%);ACT domain (100%);Homoserine dehydrogenase, conserved site (99%),,,,,,,,,
NEWDATEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELMMSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDMLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.2.2 (50%);2.3.1.225 (50%),Cytochrome-b5 reductase (50%);Protein S-acyltransferase (50%),GO:0016021 (25%);GO:0005634 (5%),integral component of membrane (25%);nucleus (5%),GO:0008270 (25%);GO:0003676 (15%);GO:0004181 (15%),zinc ion binding (25%);nucleic acid binding (15%);metallocarboxypeptidase activity (15%),GO:0006813 (5%),potassium ion transport (5%),IPR002477 (16%);IPR005490 (16%);IPR025893 (16%),Peptidoglycan binding-like (16%);L,D-transpeptidase catalytic domain (16%);Tocopherol cyclase (16%),,,,,,,,,,
LVFHGNR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (50%);GO:0016021 (50%),plasma membrane (50%);integral component of membrane (50%),GO:0004890 (50%);GO:0005230 (50%);GO:0016740 (50%),GABA-A receptor activity (50%);extracellular ligand-gated ion channel activity (50%);transferase activity (50%),,,IPR000873 (50%);IPR001227 (50%);IPR001242 (50%),AMP-dependent synthetase/ligase (50%);Acyl transferase domain superfamily (50%);Condensation domain (50%),,,,,,,,,,,
MVLDGVMPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.40 (23%);2.3.1.8 (10%);2.7.7.7 (10%),Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP(+)) (23%);Phosphate acetyltransferase (10%);DNA-directed DNA polymerase (10%),GO:0016021 (47%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (47%);cytoplasm (5%);plasma membrane (3%),GO:0003677 (10%);GO:0005524 (9%);GO:0046872 (8%),DNA binding (10%);ATP binding (9%);metal ion binding (8%),GO:0006108 (4%);GO:0055085 (3%);GO:0006313 (3%),malate metabolic process (4%);transmembrane transport (3%);transposition, DNA-mediated (3%),IPR022187 (8%);IPR027417 (7%);IPR011990 (6%),Conjugative transposon, TraM (8%);P-loop containing nucleoside triphosphate hydrolase (7%);Tetratricopeptide-like helical domain superfamily (6%),,,,,,,,,
TGSLAEDVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGGTLVSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (24%);4.2.2.0 (13%);1.3.1.98 (10%),RNA helicase (24%); (13%);UDP-N-acetylmuramate dehydrogenase (10%),GO:0016021 (22%);GO:0045211 (10%);GO:0030054 (10%),integral component of membrane (22%);postsynaptic membrane (10%);cell junction (10%),GO:0003723 (14%);GO:0005524 (11%);GO:0004970 (8%),RNA binding (14%);ATP binding (11%);ionotropic glutamate receptor activity (8%),GO:0006412 (4%);GO:0071555 (3%);GO:0006355 (3%),translation (4%);cell wall organization (3%);regulation of transcription, DNA-templated (3%),IPR027417 (10%);IPR028082 (10%);IPR001828 (10%),P-loop containing nucleoside triphosphate hydrolase (10%);Periplasmic binding protein-like I (10%);Receptor, ligand binding region (10%),,,,,,,,,
MVFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.77 (30%);3.5.1.88 (11%);3.4.13.9 (7%),Protein-L-isoaspartate(D-aspartate) O-methyltransferase (30%);Peptide deformylase (11%);Xaa-Pro dipeptidase (7%),GO:0016021 (34%);GO:0005581 (16%);GO:0005887 (6%),integral component of membrane (34%);collagen trimer (16%);integral component of plasma membrane (6%),GO:0005524 (13%);GO:0003677 (7%);GO:0008237 (7%),ATP binding (13%);DNA binding (7%);metallopeptidase activity (7%),GO:0060385 (5%);GO:0030091 (4%);GO:0005975 (4%),axonogenesis involved in innervation (5%);protein repair (4%);carbohydrate metabolic process (4%),IPR008160 (27%);IPR029058 (5%);IPR002510 (5%),Collagen triple helix repeat (27%);Alpha/Beta hydrolase fold (5%);Metalloprotease TldD/PmbA (5%),,,,,,,,,,,
AFLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (14%);2.7.7.6 (12%);2.7.7.49 (12%),DNA-directed DNA polymerase (14%);DNA-directed RNA polymerase (12%);RNA-directed DNA polymerase (12%),GO:0016021 (24%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (24%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (22%);GO:0003677 (14%);GO:0046872 (11%),ATP binding (22%);DNA binding (14%);metal ion binding (11%),GO:0006457 (10%);GO:0006260 (5%);GO:0039503 (3%),protein folding (10%);DNA replication (5%);suppression by virus of host innate immune response (3%),IPR027417 (11%);IPR013126 (9%);IPR029047 (9%),P-loop containing nucleoside triphosphate hydrolase (11%);Heat shock protein 70 family (9%);Heat shock protein 70kD, peptide-binding domain superfamily (9%),,,,,,,,,,
QYAANDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008239 (100%),dipeptidyl-peptidase activity (100%),,,IPR039461 (100%),Peptidase family M49 (100%),,,,,,,,,,,
MLVLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.99.17 (25%);2.4.-.- (20%);3.1.-.- (20%),S-adenosylmethionine:tRNA ribosyltransferase-isomerase (25%);Glycosyltransferases (20%);Acting on ester bonds (20%),GO:0005737 (25%);GO:0016021 (14%);GO:0005623 (4%),cytoplasm (25%);integral component of membrane (14%);cell (4%),GO:0016740 (26%);GO:0016151 (13%);GO:0051082 (13%),transferase activity (26%);nickel cation binding (13%);unfolded protein binding (13%),GO:0006457 (13%);GO:0018307 (13%);GO:0019627 (13%),protein folding (13%);enzyme active site formation (13%);urea metabolic process (13%),IPR001296 (21%);IPR028098 (21%);IPR004029 (10%),Glycosyl transferase, family 1 (21%);Glycosyltransferase subfamily 4-like, N-terminal domain (21%);UreE urease accessory, N-terminal (10%),,,,,,,,
QNWVYENCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTANRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%);GO:0005634 (20%);GO:0005886 (20%),integral component of membrane (60%);nucleus (20%);plasma membrane (20%),GO:0000981 (20%);GO:0008168 (20%);GO:0008270 (20%),DNA-binding transcription factor activity, RNA polymerase II-specific (20%);methyltransferase activity (20%);zinc ion binding (20%),GO:0055085 (60%);GO:0022900 (20%);GO:0032259 (20%),transmembrane transport (60%);electron transport chain (20%);methylation (20%),IPR004338 (38%);IPR006342 (38%);IPR029063 (38%),Ion-translocating oxidoreductase NqrB/RnfD (38%);Methyltransferase FkbM (38%);S-adenosyl-L-methionine-dependent methyltransferase (38%),,,,,,,,,,
AMLVTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (58%);GO:0016020 (8%),integral component of membrane (58%);membrane (8%),GO:0003677 (17%);GO:0004177 (17%);GO:0016651 (8%),DNA binding (17%);aminopeptidase activity (17%);oxidoreductase activity, acting on NAD(P)H (8%),GO:0006313 (8%);GO:0006355 (8%);GO:0015074 (8%),transposition, DNA-mediated (8%);regulation of transcription, DNA-templated (8%);DNA integration (8%),IPR001466 (25%);IPR004681 (25%);IPR010656 (25%),Beta-lactamase-related (25%);TRAP transporter large membrane protein DctM (25%);TRAP C4-dicarboxylate transport system permease DctM subunit (25%),,,,,,,,
CLTWSNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAWVVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (46%);5.2.1.8 (24%);6.3.4.19 (15%),Pyruvate dehydrogenase (acetyl-transferring) (46%);Peptidylprolyl isomerase (24%);tRNA(Ile)-lysidine synthetase (15%),GO:0043231 (33%);GO:0005737 (11%);GO:0016021 (7%),intracellular membrane-bounded organelle (33%);cytoplasm (11%);integral component of membrane (7%),GO:0004739 (33%);GO:0003755 (18%);GO:0005524 (11%),pyruvate dehydrogenase (acetyl-transferring) activity (33%);peptidyl-prolyl cis-trans isomerase activity (18%);ATP binding (11%),GO:0006086 (33%);GO:0006400 (11%);GO:0006564 (9%),acetyl-CoA biosynthetic process from pyruvate (33%);tRNA modification (11%);L-serine biosynthetic process (9%),IPR001017 (24%);IPR017597 (24%);IPR029061 (24%),Dehydrogenase, E1 component (24%);Pyruvate dehydrogenase (acetyl-transferring) E1 component, alpha subunit, subgroup y (24%);Thiamin diphosphate-binding fold (24%),,,,,,,,
CGLSSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.9 (20%);2.7.13.3 (20%);2.7.2.3 (20%),2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylic-acisynthase (20%);Histidine kinase (20%);Phosphoglycerate kinase (20%),GO:0000139 (14%);GO:0017119 (14%);GO:0043231 (10%),Golgi membrane (14%);Golgi transport complex (14%);intracellular membrane-bounded organelle (10%),GO:0005524 (44%);GO:0016887 (36%);GO:0051537 (10%),ATP binding (44%);ATPase activity (36%);2 iron, 2 sulfur cluster binding (10%),GO:0006891 (14%);GO:0015031 (14%);GO:0006351 (5%),intra-Golgi vesicle-mediated transport (14%);protein transport (14%);transcription, DNA-templated (5%),IPR027417 (38%);IPR003439 (35%);IPR017871 (35%),P-loop containing nucleoside triphosphate hydrolase (38%);ABC transporter-like (35%);ABC transporter, conserved site (35%),,,,,,,,
DEGPDVK,Bradyrhizobium lablabi,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Bradyrhizobiaceae,,,,Bradyrhizobium,,,,Bradyrhizobium lablabi,,,,,,,,,,,,,,,,,,,,,,,,
WNGTALNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTPVNGDHTEVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALASEGFK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (99%),cytoplasm (99%),GO:0003676 (90%);GO:0003677 (7%);GO:0004866 (0%),nucleic acid binding (90%);DNA binding (7%);endopeptidase inhibitor activity (0%),GO:0042558 (0%),pteridine-containing compound metabolic process (0%),IPR002059 (99%);IPR012340 (99%);IPR011129 (99%),Cold-shock protein, DNA-binding (99%);Nucleic acid-binding, OB-fold (99%);Cold shock domain (99%),,,,,,,,,
YYLAMDLGHSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDFGPPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0016491 (33%);GO:0019534 (33%);GO:0071949 (33%),oxidoreductase activity (33%);toxin transmembrane transporter activity (33%);FAD binding (33%),GO:0043213 (33%),bacteriocin transport (33%),IPR006093 (50%);IPR006094 (50%);IPR012951 (50%),Oxygen oxidoreductase covalent FAD-binding site (50%);FAD linked oxidase, N-terminal (50%);Berberine/berberine-like (50%),,,,,,,,,,
DLVEDDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009706 (11%);GO:0016021 (11%),chloroplast inner membrane (11%);integral component of membrane (11%),GO:0003824 (44%);GO:0008017 (22%);GO:0004146 (11%),catalytic activity (44%);microtubule binding (22%);dihydrofolate reductase activity (11%),GO:0007059 (22%);GO:0051301 (22%);GO:0015031 (11%),chromosome segregation (22%);cell division (22%);protein transport (11%),IPR003692 (44%);IPR009829 (22%);IPR042031 (22%),Hydantoinase B/oxoprolinase (44%);Spindle and kinetochore-associated protein 1 (22%);SKA1 microtubule binding domain (22%),,,,,,,,,,,
LNPNFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (33%);GO:0004312 (33%);GO:0016301 (33%),catalytic activity (33%);fatty acid synthase activity (33%);kinase activity (33%),GO:0009058 (33%);GO:0043388 (33%);GO:0043697 (33%),biosynthetic process (33%);positive regulation of DNA binding (33%);cell dedifferentiation (33%),IPR001031 (33%);IPR001227 (33%);IPR002125 (33%),Thioesterase (33%);Acyl transferase domain superfamily (33%);Cytidine and deoxycytidylate deaminase domain (33%),,,,,,,,,,,
VYPYNYMVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLHQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.108 (16%);1.1.1.205 (12%);2.7.10.2 (5%),UDP-3-O-acyl-N-acetylglucosamine deacetylase (16%);IMP dehydrogenase (12%);Non-specific protein-tyrosine kinase (5%),GO:0016021 (22%);GO:0005737 (3%);GO:0008180 (3%),integral component of membrane (22%);cytoplasm (3%);COP9 signalosome (3%),GO:0005524 (14%);GO:0003677 (8%);GO:0046872 (7%),ATP binding (14%);DNA binding (8%);metal ion binding (7%),GO:0006355 (5%);GO:0006635 (5%);GO:0016567 (4%),regulation of transcription, DNA-templated (5%);fatty acid beta-oxidation (5%);protein ubiquitination (4%),IPR027417 (10%);IPR036388 (6%);IPR036291 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Winged helix-like DNA-binding domain superfamily (6%);NAD(P)-binding domain superfamily (6%),,,,,,,,,,
LDVQLNNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SHNNDLDSVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELFFLYNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGTMASNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDWLELVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDESFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.52 (100%),Beta-N-acetylhexosaminidase (100%),GO:0005737 (21%);GO:0005861 (14%);GO:0016021 (14%),cytoplasm (21%);troponin complex (14%);integral component of membrane (14%),GO:0008080 (36%);GO:0004563 (7%);GO:0016853 (7%),N-acetyltransferase activity (36%);beta-N-acetylhexosaminidase activity (7%);isomerase activity (7%),GO:0030490 (21%);GO:0005975 (14%);GO:0006937 (14%),maturation of SSU-rRNA (21%);carbohydrate metabolic process (14%);regulation of muscle contraction (14%),IPR000182 (26%);IPR016181 (26%);IPR010653 (21%),GNAT domain (26%);Acyl-CoA N-acyltransferase (26%);NlpB/DapX lipoprotein (21%),,,,,,,,,,,
TVPLVDTMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSAENDDYNSPMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLQCMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005886 (25%);GO:0043005 (25%),integral component of membrane (50%);plasma membrane (25%);neuron projection (25%),GO:0009055 (38%);GO:0020037 (38%);GO:0046872 (38%),electron transfer activity (38%);heme binding (38%);metal ion binding (38%),,,IPR000175 (50%);IPR037272 (50%);IPR004155 (38%),Sodium:neurotransmitter symporter (50%);Sodium:neurotransmitter symporter superfamily (50%);PBS lyase HEAT-like repeat (38%),,,,,,,,,,,
AGDMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.3 (19%);2.7.3.9 (8%);1.11.1.21 (4%),Dihydroorotase (19%);Phosphoenolpyruvate--protein phosphotransferase (8%);Catalase peroxidase (4%),GO:0016021 (21%);GO:0005737 (4%);GO:0009279 (2%),integral component of membrane (21%);cytoplasm (4%);cell outer membrane (2%),GO:0003924 (12%);GO:0005525 (12%);GO:0003677 (10%),GTPase activity (12%);GTP binding (12%);DNA binding (10%),GO:0006352 (5%);GO:0006355 (2%);GO:0044205 (2%),DNA-templated transcription, initiation (5%);regulation of transcription, DNA-templated (2%);'de novo' UMP biosynthetic process (2%),IPR027417 (18%);IPR014721 (10%);IPR020568 (10%),P-loop containing nucleoside triphosphate hydrolase (18%);Ribosomal protein S5 domain 2-type fold, subgroup (10%);Ribosomal protein S5 domain 2-type fold (10%),,,,,,,,
DPWTGTNVAEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FTNWAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%);GO:0016020 (7%),integral component of membrane (33%);membrane (7%),GO:0004672 (27%);GO:0005524 (27%);GO:0016740 (27%),protein kinase activity (27%);ATP binding (27%);transferase activity (27%),,,IPR020022 (37%);IPR014917 (26%);IPR000719 (15%),N-acetyl sugar amidotransferase (37%);Protein of unknown function DUF1800 (26%);Protein kinase domain (15%),,,,,,,,,,,
DLPTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (24%);2.5.1.61 (16%);4.2.1.3 (9%),DNA topoisomerase (24%);Hydroxymethylbilane synthase (16%);Aconitate hydratase (9%),GO:0016021 (21%);GO:0005694 (4%);GO:0005737 (3%),integral component of membrane (21%);chromosome (4%);cytoplasm (3%),GO:0003677 (14%);GO:0046872 (12%);GO:0005524 (10%),DNA binding (14%);metal ion binding (12%);ATP binding (10%),GO:0005975 (8%);GO:0006265 (6%);GO:0006541 (3%),carbohydrate metabolic process (8%);DNA topological change (6%);glutamine metabolic process (3%),IPR017853 (7%);IPR006047 (6%);IPR027417 (6%),Glycoside hydrolase superfamily (7%);Glycosyl hydrolase, family 13, catalytic domain (6%);P-loop containing nucleoside triphosphate hydrolase (6%),,,,,,,,,
VAAEQWVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLMVDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDNGNSVQLDDNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLPDVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (80%);2.3.1.269 (10%);3.6.4.- (10%),RNA-directed RNA polymerase (80%);Apolipoprotein N-acyltransferase (10%);Acting on ATP; involved in cellular and subcellular movement (10%),GO:0016021 (53%);GO:0005886 (37%);GO:0005623 (35%),integral component of membrane (53%);plasma membrane (37%);cell (35%),GO:0015385 (34%);GO:0005524 (17%);GO:0004386 (11%),sodium:proton antiporter activity (34%);ATP binding (17%);helicase activity (11%),GO:0030004 (33%);GO:0000027 (4%);GO:0000716 (1%),cellular monovalent inorganic cation homeostasis (33%);ribosomal large subunit assembly (4%);transcription-coupled nucleotide-excision repair, DNA damage recognition (1%),IPR006153 (36%);IPR027417 (36%);IPR004712 (32%),Cation/H+ exchanger (36%);P-loop containing nucleoside triphosphate hydrolase (36%);Na+/H+ antiporter, fungi (32%),,,,,,,,,
DVSDMLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTCNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMLLVQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%);GO:0003700 (100%);GO:0016987 (100%),DNA binding (100%);DNA-binding transcription factor activity (100%);sigma factor activity (100%),GO:0006352 (100%),DNA-templated transcription, initiation (100%),IPR004360 (33%);IPR007627 (33%);IPR013249 (33%),Glyoxalase/fosfomycin resistance/dioxygenase domain (33%);RNA polymerase sigma-70 region 2 (33%);RNA polymerase sigma factor 70, region 4 type 2 (33%),,,,,,,,,
LPVQPELFHEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAEDPSVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003677 (25%);GO:0003824 (25%);GO:0004499 (25%),DNA binding (25%);catalytic activity (25%);N,N-dimethylaniline monooxygenase activity (25%),GO:0006857 (25%),oligopeptide transport (25%),IPR000685 (67%);IPR033966 (67%);IPR036376 (67%),Ribulose bisphosphate carboxylase, large subunit, C-terminal (67%);RuBisCO (67%);Ribulose bisphosphate carboxylase, large subunit, C-terminal domain superfamily (67%),,,,,,
MDLWPNGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTMMPALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTSNYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.- (40%);2.7.1.148 (20%);3.4.23.- (20%),Carbon--nitrogen ligases with glutamine as amido-N-donor (40%);4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase (20%);Aspartic endopeptidases (20%),GO:0016021 (60%);GO:0005886 (25%);GO:0005887 (4%),integral component of membrane (60%);plasma membrane (25%);integral component of plasma membrane (4%),GO:0005524 (16%);GO:0005509 (11%);GO:0022857 (11%),ATP binding (16%);calcium ion binding (11%);transmembrane transporter activity (11%),GO:0007156 (11%);GO:0006605 (4%);GO:0043952 (4%),homophilic cell adhesion via plasma membrane adhesion molecules (11%);protein targeting (4%);protein transport by the Sec complex (4%),IPR016024 (11%);IPR025481 (11%);IPR025614 (11%),Armadillo-type fold (11%);Cell morphogenesis protein C-terminal (11%);Cell morphogenesis protein N-terminal (11%),,,,,,,,,,,
SSGGDSLGK,Blastocatellia bacterium,Bacteria,,,,Acidobacteria,,,Blastocatellia,,,,,,,,,,,,,,,,,Blastocatellia bacterium,,,,,,,,,,,,IPR011050 (100%);IPR024535 (100%),Pectin lyase fold/virulence factor (100%);Pectate lyase superfamily protein (100%),,,,,,,,,,,
WHGMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGPSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (25%);3.2.1.52 (25%);6.5.1.4 (25%),L-aspartate oxidase (25%);Beta-N-acetylhexosaminidase (25%);RNA 3'-terminal-phosphate cyclase (ATP) (25%),GO:0016021 (25%);GO:0005737 (12%);GO:0032153 (4%),integral component of membrane (25%);cytoplasm (12%);cell division site (4%),GO:0009055 (32%);GO:0020037 (32%);GO:0046872 (18%),electron transfer activity (32%);heme binding (32%);metal ion binding (18%),GO:0032259 (5%);GO:0000917 (4%);GO:0009451 (4%),methylation (5%);division septum assembly (4%);RNA modification (4%),IPR013078 (34%);IPR029033 (34%);IPR017070 (33%),Histidine phosphatase superfamily, clade-1 (34%);Histidine phosphatase superfamily (34%);Uncharacterised conserved protein UCP036920, phosphoglycerate mutase, plant X4/Y4 (33%),,,,,,,,
LGLSCHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (50%);GO:0004527 (50%);GO:0005524 (50%),DNA binding (50%);exonuclease activity (50%);ATP binding (50%),GO:0006281 (50%);GO:0006355 (50%),DNA repair (50%);regulation of transcription, DNA-templated (50%),IPR000792 (50%);IPR016032 (50%);IPR027417 (50%),Transcription regulator LuxR, C-terminal (50%);Signal transduction response regulator, C-terminal effector (50%);P-loop containing nucleoside triphosphate hydrolase (50%),,,,,,,,
WQGSM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNAALEHANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGPTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (19%);2.4.2.- (13%);3.4.11.1 (11%),Histidine kinase (19%);Pentosyltransferases (13%);Leucyl aminopeptidase (11%),GO:0016021 (14%);GO:0005634 (3%);GO:0005737 (2%),integral component of membrane (14%);nucleus (3%);cytoplasm (2%),GO:0005524 (39%);GO:0003910 (30%);GO:0003677 (9%),ATP binding (39%);DNA ligase (ATP) activity (30%);DNA binding (9%),GO:0006281 (31%);GO:0006310 (31%);GO:0007015 (5%),DNA repair (31%);DNA recombination (31%);actin filament organization (5%),IPR012340 (31%);IPR012309 (31%);IPR014143 (31%),Nucleic acid-binding, OB-fold (31%);DNA ligase, ATP-dependent, C-terminal (31%);DNA ligase D (31%),,,,,,,,
TSMLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.6 (50%);1.14.11.- (25%);6.3.4.4 (25%),Phosphoribosylaminoimidazolesuccinocarboxamide synthase (50%);With 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (25%);Adenylosuccinate synthase (25%),GO:0005840 (64%);GO:0036128 (12%);GO:0097228 (12%),ribosome (64%);CatSper complex (12%);sperm principal piece (12%),GO:0008270 (63%);GO:0019843 (63%);GO:0003735 (61%),zinc ion binding (63%);rRNA binding (63%);structural constituent of ribosome (61%),GO:0006412 (64%);GO:0055010 (5%);GO:0006355 (4%),translation (64%);ventricular cardiac muscle tissue morphogenesis (5%);regulation of transcription, DNA-templated (4%),IPR001209 (55%);IPR018271 (54%);IPR023053 (54%),Ribosomal protein S14 (55%);Ribosomal protein S14, conserved site (54%);Ribosomal protein S14, type Z (54%),,,,,,,
QVDANCEVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVWDNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (67%);3.5.1.115 (33%),Hexosyltransferases (67%);Mycothiol S-conjugate amidase (33%),GO:0016021 (50%),integral component of membrane (50%),GO:0016757 (33%);GO:0016874 (33%);GO:0016787 (17%),transferase activity, transferring glycosyl groups (33%);ligase activity (33%);hydrolase activity (17%),GO:0055085 (17%),transmembrane transport (17%),IPR001322 (59%);IPR036415 (59%);IPR012340 (18%),Lamin tail domain (59%);Lamin tail domain superfamily (59%);Nucleic acid-binding, OB-fold (18%),,,,,,,,,
NVLMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.99.4 (68%);7.2.2.- (14%);3.6.5.0 (9%),Nitrate reductase (68%);Linked to the hydrolysis of a nucleoside triphosphate (14%); (9%),GO:0009325 (59%);GO:0016021 (24%);GO:0005886 (5%),nitrate reductase complex (59%);integral component of membrane (24%);plasma membrane (5%),GO:0046872 (71%);GO:0051539 (66%);GO:0008940 (62%),metal ion binding (71%);4 iron, 4 sulfur cluster binding (66%);nitrate reductase activity (62%),GO:0042126 (59%);GO:0006812 (5%);GO:0006629 (3%),nitrate metabolic process (59%);cation transport (5%);lipid metabolic process (3%),IPR006655 (64%);IPR006656 (64%);IPR006657 (64%),Molybdopterin oxidoreductase, prokaryotic, conserved site (64%);Molybdopterin oxidoreductase (64%);Molybdopterin dinucleotide-binding domain (64%),,,,,,,,
FNENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (16%);2.1.1.33 (10%);7.1.1.- (8%),Nucleotidyltransferases (16%);tRNA (guanine(46)-N(7))-methyltransferase (10%);Hydron translocation or charge separation linked to oxidoreductase reactions (8%),GO:0016021 (33%);GO:0005634 (7%);GO:0005737 (4%),integral component of membrane (33%);nucleus (7%);cytoplasm (4%),GO:0005524 (9%);GO:0003677 (7%);GO:0003684 (6%),ATP binding (9%);DNA binding (7%);damaged DNA binding (6%),GO:0032012 (4%);GO:0042276 (4%);GO:0006281 (3%),regulation of ARF protein signal transduction (4%);error-prone translesion synthesis (4%);DNA repair (3%),IPR027417 (11%);IPR004869 (7%);IPR000731 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);Membrane transport protein MMPL domain (7%);Sterol-sensing domain (7%),,,,,,,,,,,
WQVEEYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGLVPWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (50%);GO:0016021 (50%),nucleus (50%);integral component of membrane (50%),GO:0010484 (50%),H3 histone acetyltransferase activity (50%),GO:0043618 (50%),regulation of transcription from RNA polymerase II promoter in response to stress (50%),IPR026174 (75%);IPR011990 (13%);IPR013178 (13%),Coiled-coil domain-containing protein 191 (75%);Tetratricopeptide-like helical domain superfamily (13%);Histone acetyltransferase Rtt109/CBP (13%),,,,,,,,,,,
QNGQGGLGVSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WAQMSLDWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQLTDSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (40%),integral component of membrane (40%),GO:0004386 (40%);GO:0004725 (20%),helicase activity (40%);protein tyrosine phosphatase activity (20%),,,IPR027417 (30%);IPR011528 (20%);IPR012550 (20%),P-loop containing nucleoside triphosphate hydrolase (30%);Nuclease-related domain, NERD (20%);Protein of unknown function DUF1706 (20%),,,,,,,,,,
TATYVMLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNNADVMVQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MENYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.2 (7%);3.2.1.17 (6%);2.7.7.7 (5%),Fumarate hydratase (7%);Lysozyme (6%);DNA-directed DNA polymerase (5%),GO:0016021 (27%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (27%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (13%);GO:0003677 (8%);GO:0046872 (8%),ATP binding (13%);DNA binding (8%);metal ion binding (8%),GO:0006313 (3%);GO:0002098 (3%);GO:0034227 (3%),transposition, DNA-mediated (3%);tRNA wobble uridine modification (3%);tRNA thio-modification (3%),IPR027417 (7%);IPR025544 (4%);IPR017896 (3%),P-loop containing nucleoside triphosphate hydrolase (7%);YhzD-like protein (4%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (3%),,,,,,,,,
LTMAVAHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLVNLWYMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMLLEAQQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNDELLDLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.8 (11%);2.3.1.180 (6%);2.7.11.1 (5%),Polyribonucleotide nucleotidyltransferase (11%);Beta-ketoacyl-[acyl-carrier-protein] synthase III (6%);Non-specific serine/threonine protein kinase (5%),GO:0016021 (31%);GO:0005634 (7%);GO:0005737 (7%),integral component of membrane (31%);nucleus (7%);cytoplasm (7%),GO:0005524 (12%);GO:0031625 (7%);GO:0003677 (6%),ATP binding (12%);ubiquitin protein ligase binding (7%);DNA binding (6%),GO:0043161 (5%);GO:0006511 (5%);GO:0006355 (3%),proteasome-mediated ubiquitin-dependent protein catabolic process (5%);ubiquitin-dependent protein catabolic process (5%);regulation of transcription, DNA-templated (3%),IPR036388 (7%);IPR036390 (6%);IPR015943 (6%),Winged helix-like DNA-binding domain superfamily (7%);Winged helix DNA-binding domain superfamily (6%);WD40/YVTN repeat-like-containing domain superfamily (6%),,,,,,,,,,
TLPVAWEWGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVEVNDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.6 (40%);1.3.98.3 (20%);1.8.1.4 (20%),Exodeoxyribonuclease VII (40%);Coproporphyrinogen dehydrogenase (20%);Dihydrolipoyl dehydrogenase (20%),GO:0016021 (23%);GO:0005737 (10%);GO:0009318 (7%),integral component of membrane (23%);cytoplasm (10%);exodeoxyribonuclease VII complex (7%),GO:0003887 (33%);GO:0005524 (23%);GO:0000155 (20%),DNA-directed DNA polymerase activity (33%);ATP binding (23%);phosphorelay sensor kinase activity (20%),GO:0006270 (33%);GO:0006355 (20%);GO:0006308 (7%),DNA replication initiation (33%);regulation of transcription, DNA-templated (20%);DNA catabolic process (7%),IPR036390 (33%);IPR036388 (28%);IPR000525 (26%),Winged helix DNA-binding domain superfamily (33%);Winged helix-like DNA-binding domain superfamily (28%);Initiator Rep protein (26%),,,,,,,,,,
EVPVLLWFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WDSLKPDAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YFTNSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTVMLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0015934 (60%);GO:0009536 (40%);GO:0016021 (40%),large ribosomal subunit (60%);plastid (40%);integral component of membrane (40%),GO:0003735 (60%);GO:0003723 (40%);GO:0004176 (40%),structural constituent of ribosome (60%);RNA binding (40%);ATP-dependent peptidase activity (40%),GO:0006412 (60%);GO:0030163 (40%),translation (60%);protein catabolic process (40%),IPR002143 (50%);IPR005878 (50%);IPR016095 (50%),Ribosomal protein L1 (50%);Ribosomal protein L1, bacterial-type (50%);Ribosomal protein L1, 3-layer alpha/beta-sandwich (50%),,,,,,,,,
TEQEWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.4.12 (94%);1.1.1.- (2%);1.8.4.11 (2%),Peptide-methionine (R)-S-oxide reductase (94%);With NAD(+) or NADP(+) as acceptor (2%);Peptide-methionine (S)-S-oxide reductase (2%),GO:0016021 (19%);GO:0016020 (3%);GO:0005634 (1%),integral component of membrane (19%);membrane (3%);nucleus (1%),GO:0033743 (46%);GO:0046872 (20%);GO:0008270 (15%),peptide-methionine (R)-S-oxide reductase activity (46%);metal ion binding (20%);zinc ion binding (15%),GO:0006979 (33%);GO:0030091 (33%);GO:0007165 (6%),response to oxidative stress (33%);protein repair (33%);signal transduction (6%),IPR002579 (46%);IPR011057 (46%);IPR028427 (37%),Peptide methionine sulphoxide reductase MrsB (46%);Mss4-like superfamily (46%);Peptide methionine sulfoxide reductase (37%),,,,,,,,,,,
AAHDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.2 (21%);3.6.4.- (12%);3.7.1.3 (5%),Oxoglutarate dehydrogenase (succinyl-transferring) (21%);Acting on ATP; involved in cellular and subcellular movement (12%);Kynureninase (5%),GO:0016021 (19%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (19%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (17%);GO:0003677 (8%);GO:0016787 (7%),ATP binding (17%);DNA binding (8%);hydrolase activity (7%),GO:0006807 (7%);GO:0006099 (5%);GO:0006096 (5%),nitrogen compound metabolic process (7%);tricarboxylic acid cycle (5%);glycolytic process (5%),IPR027417 (8%);IPR014993 (7%);IPR003010 (6%),P-loop containing nucleoside triphosphate hydrolase (8%);Protein of unknown function DUF1841 (7%);Carbon-nitrogen hydrolase (6%),,,,,,,,,,,
FEAGDLVAR,Streptomyces acidiscabies,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Streptomycetales,,,,,Streptomycetaceae,,,,Streptomyces,,,,Streptomyces acidiscabies,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016887 (100%);GO:0042626 (100%),ATP binding (100%);ATPase activity (100%);ATPase-coupled transmembrane transporter activity (100%),,,IPR003439 (100%);IPR003593 (100%);IPR011527 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);ABC transporter type 1, transmembrane domain (100%),,,,,,,,,,
DSVLAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.9 (100%),Hydrogenobyrinic acid a,c-diamide synthase (glutamine-hydrolyzing) (100%),GO:0016021 (9%),integral component of membrane (9%),GO:0003677 (55%);GO:0003700 (45%);GO:0003824 (9%),DNA binding (55%);DNA-binding transcription factor activity (45%);catalytic activity (9%),GO:0006541 (9%);GO:0009058 (9%);GO:0009236 (9%),glutamine metabolic process (9%);biosynthetic process (9%);cobalamin biosynthetic process (9%),IPR000847 (50%);IPR005119 (50%);IPR036388 (50%),Transcription regulator HTH, LysR (50%);LysR, substrate-binding (50%);Winged helix-like DNA-binding domain superfamily (50%),,,,,,,,
MFWLAEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVGHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.1.4 (27%);6.2.1.4 (16%);2.5.1.- (11%),Nitrite reductase (NAD(P)H) (27%);Succinate--CoA ligase (GDP-forming) (16%);Transferring alkyl or aryl groups, other than methyl groups (11%),GO:0005840 (29%);GO:0016021 (14%);GO:0005739 (2%),ribosome (29%);integral component of membrane (14%);mitochondrion (2%),GO:0003735 (30%);GO:0019843 (29%);GO:0046872 (18%),structural constituent of ribosome (30%);rRNA binding (29%);metal ion binding (18%),GO:0006412 (30%);GO:0042128 (17%);GO:0006310 (6%),translation (30%);nitrate assimilation (17%);DNA recombination (6%),IPR000589 (20%);IPR005290 (20%);IPR009068 (20%),Ribosomal protein S15 (20%);Ribosomal protein S15, bacterial-type (20%);S15/NS1, RNA-binding (20%),,,,,,,,
NAPLEMSQVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMLLVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.11 (100%),cAMP-dependent protein kinase (100%),GO:0016021 (57%),integral component of membrane (57%),GO:0003677 (36%);GO:0004691 (7%);GO:0005524 (7%),DNA binding (36%);cAMP-dependent protein kinase activity (7%);ATP binding (7%),GO:0006355 (36%);GO:0055085 (21%);GO:0008360 (7%),regulation of transcription, DNA-templated (36%);transmembrane transport (21%);regulation of cell shape (7%),IPR000792 (33%);IPR013783 (33%);IPR015943 (33%),Transcription regulator LuxR, C-terminal (33%);Immunoglobulin-like fold (33%);WD40/YVTN repeat-like-containing domain superfamily (33%),,,,,,,,,
EELNLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.19 (25%);2.7.7.12 (16%);4.2.1.10 (8%),Arginine--tRNA ligase (25%);UDP-glucose--hexose-1-phosphate uridylyltransferase (16%);3-dehydroquinate dehydratase (8%),GO:0016021 (16%);GO:0005737 (11%);GO:0005634 (5%),integral component of membrane (16%);cytoplasm (11%);nucleus (5%),GO:0005524 (18%);GO:0003743 (17%);GO:0003677 (9%),ATP binding (18%);translation initiation factor activity (17%);DNA binding (9%),GO:0060325 (7%);GO:0007018 (5%);GO:0006420 (4%),face morphogenesis (7%);microtubule-based movement (5%);arginyl-tRNA aminoacylation (4%),IPR036872 (18%);IPR040166 (17%);IPR001715 (16%),CH domain superfamily (18%);Cytospin-A (17%);Calponin homology domain (16%),,,,,,,,,,,
QLAECEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.99.20 (100%),2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (100%),GO:0005737 (11%);GO:0016021 (11%),cytoplasm (11%);integral component of membrane (11%),GO:0003677 (44%);GO:0004803 (44%);GO:0003697 (11%),DNA binding (44%);transposase activity (44%);single-stranded DNA binding (11%),GO:0006313 (44%);GO:0006260 (11%);GO:0006281 (11%),transposition, DNA-mediated (44%);DNA replication (11%);DNA repair (11%),IPR021896 (44%);IPR006612 (33%);IPR026516 (33%),Transposase protein (44%);THAP-type zinc finger (33%);THAP domain-containing protein 1 (33%),,,,,,,,,
LDAPYFK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0005737 (0%),cytoplasm (0%),GO:0003887 (100%);GO:0003677 (100%);GO:0008408 (96%),DNA-directed DNA polymerase activity (100%);DNA binding (100%);3'-5' exonuclease activity (96%),GO:0006261 (100%);GO:0006281 (99%),DNA-dependent DNA replication (100%);DNA repair (99%),IPR002298 (100%);IPR001098 (100%);IPR036397 (100%),DNA polymerase A (100%);DNA-directed DNA polymerase, family A, palm domain (100%);Ribonuclease H superfamily (100%),,,,,,,,,
MFVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (63%);7.2.2.10 (4%);2.7.2.- (3%),Ribonucleoside-diphosphate reductase (63%);P-type Ca(2+) transporter (4%);Phosphotransferases with a carboxy group as acceptor (3%),GO:0016021 (37%);GO:0005886 (17%);GO:0045263 (14%),integral component of membrane (37%);plasma membrane (17%);proton-transporting ATP synthase complex, coupling factor F(o) (14%),GO:0005524 (26%);GO:0004748 (17%);GO:0046933 (14%),ATP binding (26%);ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor (17%);proton-transporting ATP synthase activity, rotational mechanism (14%),GO:0006260 (17%);GO:0015986 (14%);GO:0055085 (3%),DNA replication (17%);ATP synthesis coupled proton transport (14%);transmembrane transport (3%),IPR005144 (14%);IPR008926 (14%);IPR039718 (14%),ATP-cone domain (14%);Ribonucleotide reductase R1 subunit, N-terminal (14%);Ribonucleoside-diphosphate reductase large subunit (14%),,,,,,,
DHVPAHR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0005524 (50%);GO:0008080 (50%);GO:0046872 (50%),ATP binding (50%);N-acetyltransferase activity (50%);metal ion binding (50%),,,IPR000182 (50%);IPR003781 (50%);IPR011761 (50%),GNAT domain (50%);CoA-binding (50%);ATP-grasp fold (50%),,,,,,,,,,,
EHMVVEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDWLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (76%);1.8.1.4 (7%);6.2.1.1 (4%),DNA-directed RNA polymerase (76%);Dihydrolipoyl dehydrogenase (7%);Acetate--CoA ligase (4%),GO:0009507 (47%);GO:0009536 (11%);GO:0016021 (7%),chloroplast (47%);plastid (11%);integral component of membrane (7%),GO:0003677 (60%);GO:0003899 (57%);GO:0008270 (42%),DNA binding (60%);DNA-directed 5'-3' RNA polymerase activity (57%);zinc ion binding (42%),GO:0006351 (57%);GO:0045454 (4%);GO:0019427 (2%),transcription, DNA-templated (57%);cell redox homeostasis (4%);acetyl-CoA biosynthetic process from acetate (2%),IPR007081 (53%);IPR038120 (51%);IPR007083 (51%),RNA polymerase Rpb1, domain 5 (53%);RNA polymerase Rpb1, funnel domain superfamily (51%);RNA polymerase Rpb1, domain 4 (51%),,,,,,,
HVALETMAEMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQVTATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.4 (100%),Dihydrolipoyl dehydrogenase (100%),GO:0005623 (96%);GO:0005739 (28%);GO:0045252 (28%),cell (96%);mitochondrion (28%);oxoglutarate dehydrogenase complex (28%),GO:0050660 (96%);GO:0004148 (93%);GO:0009055 (92%),flavin adenine dinucleotide binding (96%);dihydrolipoyl dehydrogenase activity (93%);electron transfer activity (92%),GO:0045454 (96%);GO:0106077 (27%);GO:0006120 (19%),cell redox homeostasis (96%);histone succinylation (27%);mitochondrial electron transport, NADH to ubiquinone (19%),IPR023753 (99%);IPR036188 (99%);IPR004099 (98%),FAD/NAD(P)-binding domain (99%);FAD/NAD(P)-binding domain superfamily (99%);Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain (98%),,,,,,,,,
WNWYSLLGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVSPAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0055085 (100%),transmembrane transport (100%),IPR011701 (50%);IPR020846 (50%);IPR036259 (50%),Major facilitator superfamily (50%);Major facilitator superfamily domain (50%);MFS transporter superfamily (50%),,,,,,,,,,,
LAVTVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.164 (56%);3.4.11.- (22%);2.1.1.- (7%),Demethylrebeccamycin-D-glucose O-methyltransferase (56%);Aminopeptidases (22%);Methyltransferases (7%),GO:0016021 (4%);GO:0009570 (0%),integral component of membrane (4%);chloroplast stroma (0%),GO:0008168 (88%);GO:0102082 (3%);GO:0008270 (2%),methyltransferase activity (88%);demethylrebeccamycin--D-glucose O-methyltransferase activity (3%);zinc ion binding (2%),GO:0032259 (90%);GO:0005975 (0%);GO:0006355 (0%),methylation (90%);carbohydrate metabolic process (0%);regulation of transcription, DNA-templated (0%),IPR029063 (90%);IPR013216 (89%);IPR026669 (9%),S-adenosyl-L-methionine-dependent methyltransferase (90%);Methyltransferase type 11 (89%);Arsenite methyltransferase-like (9%),,,,,,,,,,
MAGGYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (50%);4.1.99.12 (50%),Cytochrome-c oxidase (50%);3,4-dihydroxy-2-butanone-4-phosphate synthase (50%),GO:0016021 (35%);GO:0005886 (15%);GO:0005737 (4%),integral component of membrane (35%);plasma membrane (15%);cytoplasm (4%),GO:0015562 (15%);GO:0022857 (15%);GO:0005524 (8%),efflux transmembrane transporter activity (15%);transmembrane transporter activity (15%);ATP binding (8%),GO:0042908 (15%);GO:0006084 (4%);GO:0006357 (4%),xenobiotic transport (15%);acetyl-CoA metabolic process (4%);regulation of transcription by RNA polymerase II (4%),IPR001036 (24%);IPR027463 (24%);IPR003423 (12%),Acriflavin resistance protein (24%);Multidrug efflux transporter AcrB TolC docking domain, DN/DC subdomains (24%);Outer membrane efflux protein (12%),,,,,,,,,
LLDPNVVGDLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESFNYHHYGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EWAFVNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAQNN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (80%),integral component of membrane (80%),GO:0008519 (80%);GO:0016787 (20%),ammonium transmembrane transporter activity (80%);hydrolase activity (20%),GO:0046856 (20%),phosphatidylinositol dephosphorylation (20%),IPR001905 (67%);IPR018047 (67%);IPR024041 (67%),Ammonium transporter (67%);Ammonium transporter, conserved site (67%);Ammonium transporter AmtB-like domain (67%),,,,,,,,,,
MHLMHLTFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVTSMFVLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYDWELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALDVLLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0031461 (12%);GO:0000145 (8%);GO:0005829 (4%),cullin-RING ubiquitin ligase complex (12%);exocyst (8%);cytosol (4%),GO:0004856 (24%);GO:0004176 (20%);GO:0004252 (20%),xylulokinase activity (24%);ATP-dependent peptidase activity (20%);serine-type endopeptidase activity (20%),GO:0042732 (24%);GO:0006511 (20%);GO:0030163 (20%),D-xylose metabolic process (24%);ubiquitin-dependent protein catabolic process (20%);protein catabolic process (20%),IPR018484 (21%);IPR027417 (21%);IPR042024 (21%),Carbohydrate kinase, FGGY, N-terminal (21%);P-loop containing nucleoside triphosphate hydrolase (21%);D-xylulose kinase (21%),,,,,,,,,
EMEQENGWVVGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPCERPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.225 (10%);1.2.7.4 (5%);2.1.3.3 (4%),Protein S-acyltransferase (10%);Anaerobic carbon-monoxide dehydrogenase (5%);Ornithine carbamoyltransferase (4%),GO:0016021 (24%);GO:0005737 (5%);GO:0033644 (4%),integral component of membrane (24%);cytoplasm (5%);host cell membrane (4%),GO:0005524 (14%);GO:0008270 (12%);GO:0004197 (11%),ATP binding (14%);zinc ion binding (12%);cysteine-type endopeptidase activity (11%),GO:1901053 (7%);GO:0039694 (4%);GO:0039520 (4%),sarcosine catabolic process (7%);viral RNA genome replication (4%);induction by virus of host autophagy (4%),IPR027417 (13%);IPR027266 (8%);IPR007375 (8%),P-loop containing nucleoside triphosphate hydrolase (13%);GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1 (8%);Sarcosine oxidase, gamma subunit (8%),,,,,,,,,
TTEETMELR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GHAMTLK,Chloroflexi,Bacteria,,,,Chloroflexi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVLADDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.4 (57%);2.7.1.40 (29%);6.1.1.17 (14%),Aspartate kinase (57%);Pyruvate kinase (29%);Glutamate--tRNA ligase (14%),GO:0005828 (72%);GO:0005881 (72%);GO:0016021 (7%),kinetochore microtubule (72%);cytoplasmic microtubule (72%);integral component of membrane (7%),GO:0043515 (72%);GO:0051010 (72%);GO:0004072 (5%),kinetochore binding (72%);microtubule plus-end binding (72%);aspartate kinase activity (5%),GO:0009088 (5%);GO:0009089 (5%);GO:0006352 (1%),threonine biosynthetic process (5%);lysine biosynthetic process via diaminopimelate (5%);DNA-templated transcription, initiation (1%),IPR011989 (71%);IPR016024 (71%);IPR024395 (71%),Armadillo-like helical (71%);Armadillo-type fold (71%);CLASP N-terminal domain (71%),,,,,,,,,,
DALSQMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNEQVLCNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEFLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.4 (28%);1.1.1.108 (27%);4.6.1.1 (6%),Ribonuclease H (28%);Carnitine 3-dehydrogenase (27%);Adenylate cyclase (6%),GO:0016021 (26%);GO:0005737 (12%);GO:0005634 (6%),integral component of membrane (26%);cytoplasm (12%);nucleus (6%),GO:0003677 (19%);GO:0005524 (15%);GO:0003723 (6%),DNA binding (19%);ATP binding (15%);RNA binding (6%),GO:0006310 (11%);GO:0015074 (11%);GO:0007018 (6%),DNA recombination (11%);DNA integration (11%);microtubule-based movement (6%),IPR027417 (15%);IPR002104 (9%);IPR011010 (9%),P-loop containing nucleoside triphosphate hydrolase (15%);Integrase, catalytic domain (9%);DNA breaking-rejoining enzyme, catalytic core (9%),,,,,,,,,
TLVDVLMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVGLECHPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNEWVEMQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMWLFR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (45%);GO:0016020 (9%),integral component of membrane (45%);membrane (9%),GO:0009055 (45%);GO:0020037 (45%);GO:0022857 (18%),electron transfer activity (45%);heme binding (45%);transmembrane transporter activity (18%),,,IPR011429 (60%);IPR011444 (60%);IPR013320 (60%),Cytochrome C, Planctomycete-type (60%);Domain of unknown function DUF1549 (60%);Concanavalin A-like lectin/glucanase domain superfamily (60%),,,,,,,,,,
WPCPMHELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGVVMPLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLDVQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (95%);2.7.7.6 (2%);2.1.1.190 (1%),Isoleucine--tRNA ligase (95%);DNA-directed RNA polymerase (2%);23S rRNA (uracil(1939)-C(5))-methyltransferase (1%),GO:0005737 (43%);GO:0016021 (8%);GO:0030286 (7%),cytoplasm (43%);integral component of membrane (8%);dynein complex (7%),GO:0005524 (53%);GO:0004822 (45%);GO:0002161 (40%),ATP binding (53%);isoleucine-tRNA ligase activity (45%);aminoacyl-tRNA editing activity (40%),GO:0006428 (44%);GO:0007018 (8%);GO:0006629 (2%),isoleucyl-tRNA aminoacylation (44%);microtubule-based movement (8%);lipid metabolic process (2%),IPR002300 (42%);IPR001412 (41%);IPR002301 (41%),Aminoacyl-tRNA synthetase, class Ia (42%);Aminoacyl-tRNA synthetase, class I, conserved site (41%);Isoleucine-tRNA ligase (41%),,,,,,,,
NATHMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LADAFFVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPDGQVLTLNDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FYNWFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLQLGGGR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR016024 (100%),Armadillo-type fold (100%),,,,,,,,,,,
ESTVENMSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPALLESR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (100%),L-aspartate oxidase (100%),GO:0005737 (50%),cytoplasm (50%),GO:0008270 (50%);GO:0008734 (50%);GO:0044318 (50%),zinc ion binding (50%);L-aspartate oxidase activity (50%);L-aspartate:fumarate oxidoreductase activity (50%),GO:0009086 (50%);GO:0009435 (50%);GO:0032259 (50%),methionine biosynthetic process (50%);NAD biosynthetic process (50%);methylation (50%),IPR003726 (25%);IPR003953 (25%);IPR005288 (25%),Homocysteine-binding domain (25%);FAD-dependent oxidoreductase 2, FAD binding domain (25%);L-aspartate oxidase (25%),,,,,,,,,,
EAWLLLVR,Alphaproteobacteria bacterium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,,,,,,,,,,,,,,Alphaproteobacteria bacterium,,,,,,,,,,,,IPR002502 (100%);IPR036505 (100%),N-acetylmuramoyl-L-alanine amidase domain (100%);N-acetylmuramoyl-L-alanine amidase/PGRP domain superfamily (100%),,,,,,,,,,,
TVPLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.90 (68%);1.8.4.8 (11%);6.5.1.2 (3%),Diphosphate--fructose-6-phosphate 1-phosphotransferase (68%);Phosphoadenylyl-sulfate reductase (thioredoxin) (11%);DNA ligase (NAD(+)) (3%),GO:0005737 (44%);GO:0016021 (10%);GO:0005886 (1%),cytoplasm (44%);integral component of membrane (10%);plasma membrane (1%),GO:0046872 (34%);GO:0005524 (32%);GO:0003872 (31%),metal ion binding (34%);ATP binding (32%);6-phosphofructokinase activity (31%),GO:0006002 (28%);GO:0070814 (5%);GO:0019379 (5%),fructose 6-phosphate metabolic process (28%);hydrogen sulfide biosynthetic process (5%);sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) (5%),IPR000023 (28%);IPR012829 (28%);IPR015912 (28%),Phosphofructokinase domain (28%);Phosphofructokinase, mixed-substrate PFK group III (28%);Phosphofructokinase, conserved site (28%),,,,,,,,
ADLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.3.8 (18%);5.2.1.8 (12%);2.7.7.7 (7%),Glutamate-1-semialdehyde 2,1-aminomutase (18%);Peptidylprolyl isomerase (12%);DNA-directed DNA polymerase (7%),GO:0016021 (22%);GO:0005737 (12%);GO:0005634 (3%),integral component of membrane (22%);cytoplasm (12%);nucleus (3%),GO:0003677 (17%);GO:0005524 (17%);GO:0030170 (8%),DNA binding (17%);ATP binding (17%);pyridoxal phosphate binding (8%),GO:0006782 (4%);GO:0006289 (3%);GO:0009432 (3%),protoporphyrinogen IX biosynthetic process (4%);nucleotide-excision repair (3%);SOS response (3%),IPR027417 (11%);IPR015424 (7%);IPR015421 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);Pyridoxal phosphate-dependent transferase (7%);Pyridoxal phosphate-dependent transferase, major domain (7%),,,,,,,,,
WYLYVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (90%),integral component of membrane (90%),GO:0022857 (20%);GO:0030599 (10%),transmembrane transporter activity (20%);pectinesterase activity (10%),GO:0042545 (10%),cell wall modification (10%),IPR013057 (50%);IPR001248 (30%);IPR021922 (30%),Amino acid transporter, transmembrane domain (50%);Purine-cytosine permease (30%);Par3/HAL, N-terminal (30%),,,,,,,,,
SSVTTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR001680 (100%);IPR015943 (100%);IPR017986 (100%),WD40 repeat (100%);WD40/YVTN repeat-like-containing domain superfamily (100%);WD40-repeat-containing domain (100%),,,,,,,,,,,
NLLDLLDAK,Nitrosopumilales,Archaea,,,,Thaumarchaeota,,,,,,,Nitrosopumilales,,,,,,,,,,,,,,,,,,,,,GO:0016740 (100%),transferase activity (100%),GO:0006541 (100%),glutamine metabolic process (100%),IPR017926 (100%);IPR029062 (100%),Glutamine amidotransferase (100%);Class I glutamine amidotransferase-like (100%),,,,,,,,,,,
TFLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.25.1 (49%);2.3.1.97 (13%);2.2.1.6 (2%),Proteasome endopeptidase complex (49%);Glycylpeptide N-tetradecanoyltransferase (13%);Acetolactate synthase (2%),GO:0005737 (20%);GO:0019773 (18%);GO:0016021 (17%),cytoplasm (20%);proteasome core complex, alpha-subunit complex (18%);integral component of membrane (17%),GO:0004298 (18%);GO:0005524 (10%);GO:0019992 (9%),threonine-type endopeptidase activity (18%);ATP binding (10%);diacylglycerol binding (9%),GO:0006511 (11%);GO:0035556 (8%);GO:0007268 (5%),ubiquitin-dependent protein catabolic process (11%);intracellular signal transduction (8%);chemical synaptic transmission (5%),IPR029055 (15%);IPR001353 (15%);IPR034644 (14%),Nucleophile aminohydrolases, N-terminal (15%);Proteasome, subunit alpha/beta (15%);Proteasome subunit alpha2 (14%),,,,,,,,
TLFEMFVDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNNDFGMVAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLSVLMGTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLWLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.- (20%);5.6.2.2 (13%);2.6.1.1 (12%),Transferases for other substituted phosphate groups (20%);DNA topoisomerase (ATP-hydrolyzing) (13%);Aspartate transaminase (12%),GO:0016021 (33%);GO:0005886 (8%);GO:0005737 (8%),integral component of membrane (33%);plasma membrane (8%);cytoplasm (8%),GO:0005524 (16%);GO:0003677 (13%);GO:0046872 (5%),ATP binding (16%);DNA binding (13%);metal ion binding (5%),GO:0000398 (7%);GO:0032049 (5%);GO:0055085 (4%),mRNA splicing, via spliceosome (7%);cardiolipin biosynthetic process (5%);transmembrane transport (4%),IPR011990 (9%);IPR027417 (8%);IPR013026 (7%),Tetratricopeptide-like helical domain superfamily (9%);P-loop containing nucleoside triphosphate hydrolase (8%);Tetratricopeptide repeat-containing domain (7%),,,,,,,,,,
TPTYFNMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPDWQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.5 (40%);1.-.-.- (20%);1.1.1.133 (20%),Exodeoxyribonuclease V (40%);Oxidoreductases (20%);dTDP-4-dehydrorhamnose reductase (20%),GO:0016021 (11%);GO:0005623 (4%);GO:0009338 (4%),integral component of membrane (11%);cell (4%);exodeoxyribonuclease V complex (4%),GO:0004386 (42%);GO:0005524 (9%);GO:0003677 (7%),helicase activity (42%);ATP binding (9%);DNA binding (7%),GO:0000724 (4%);GO:0005975 (4%);GO:0045454 (4%),double-strand break repair via homologous recombination (4%);carbohydrate metabolic process (4%);cell redox homeostasis (4%),IPR027417 (24%);IPR000917 (12%);IPR017850 (12%),P-loop containing nucleoside triphosphate hydrolase (24%);Sulfatase, N-terminal (12%);Alkaline-phosphatase-like, core domain superfamily (12%),,,,,,,,,
QGDPCGEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPYDWVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNTHPPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPVLLWVNKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVHPDTGLSSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000786 (99%);GO:0005634 (89%);GO:0005654 (11%),nucleosome (99%);nucleus (89%);nucleoplasm (11%),GO:0003677 (100%);GO:0046982 (98%);GO:0042393 (1%),DNA binding (100%);protein heterodimerization activity (98%);histone binding (1%),GO:0006334 (10%);GO:0050830 (3%);GO:0002227 (3%),nucleosome assembly (10%);defense response to Gram-positive bacterium (3%);innate immune response in mucosa (3%),IPR009072 (100%);IPR000558 (100%);IPR007125 (100%),Histone-fold (100%);Histone H2B (100%);Histone H2A/H2B/H3 (100%),,,,,,,,,,,
WNLMMLAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.88 (90%);1.5.5.2 (90%);3.1.-.- (2%),L-glutamate gamma-semialdehyde dehydrogenase (90%);Proline dehydrogenase (90%);Acting on ester bonds (2%),GO:0016021 (16%);GO:0005737 (3%);GO:0005634 (1%),integral component of membrane (16%);cytoplasm (3%);nucleus (1%),GO:0003677 (58%);GO:0004657 (55%);GO:0003842 (55%),DNA binding (58%);proline dehydrogenase activity (55%);1-pyrroline-5-carboxylate dehydrogenase activity (55%),GO:0010133 (55%);GO:0006561 (55%);GO:0006364 (1%),proline catabolic process to glutamate (55%);proline biosynthetic process (55%);rRNA processing (1%),IPR029041 (50%);IPR002872 (50%);IPR015590 (49%),FAD-linked oxidoreductase-like (50%);Proline dehydrogenase domain (50%);Aldehyde dehydrogenase domain (49%),,,,,,,,,,,
LVVPLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (42%);GO:0005801 (39%);GO:0016021 (30%),membrane (42%);cis-Golgi network (39%);integral component of membrane (30%),GO:0008657 (12%);GO:0008236 (6%);GO:0000155 (3%),DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) inhibitor activity (12%);serine-type peptidase activity (6%);phosphorelay sensor kinase activity (3%),GO:0006886 (39%);GO:0006276 (12%);GO:0008643 (3%),intracellular protein transport (39%);plasmid maintenance (12%);carbohydrate transport (3%),IPR007265 (30%);IPR002712 (9%);IPR011067 (9%),Conserved oligomeric Golgi complex, subunit 3 (30%);Toxin CcdB (9%);Plasmid maintenance toxin/Cell growth inhibitor (9%),,,,,,,,,
DPECQLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WHPMSWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YSSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (49%);2.7.7.9 (9%);1.4.99.- (4%),Histidine kinase (49%);UTP--glucose-1-phosphate uridylyltransferase (9%);With other acceptors (4%),GO:0016021 (28%);GO:0005737 (2%);GO:0005634 (1%),integral component of membrane (28%);cytoplasm (2%);nucleus (1%),GO:0003676 (23%);GO:0005524 (10%);GO:0000155 (7%),nucleic acid binding (23%);ATP binding (10%);phosphorelay sensor kinase activity (7%),GO:0032196 (31%);GO:0015074 (29%);GO:0006355 (11%),transposition (31%);DNA integration (29%);regulation of transcription, DNA-templated (11%),IPR038965 (30%);IPR025948 (26%);IPR012337 (26%),Transposase InsF-like (30%);HTH-like domain (26%);Ribonuclease H-like superfamily (26%),,,,,,,,,,
LVNNYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),GO:0016021 (35%);GO:0005634 (18%);GO:0042025 (12%),integral component of membrane (35%);nucleus (18%);host cell nucleus (12%),GO:0005524 (41%);GO:0003677 (24%);GO:0003678 (24%),ATP binding (41%);DNA binding (24%);DNA helicase activity (24%),GO:0006260 (12%);GO:0006270 (12%);GO:0007049 (12%),DNA replication (12%);DNA replication initiation (12%);cell cycle (12%),IPR027417 (19%);IPR000253 (9%);IPR001959 (9%),P-loop containing nucleoside triphosphate hydrolase (19%);Forkhead-associated (FHA) domain (9%);Probable transposase, IS891/IS1136/IS1341 (9%),,,,,,,,,,
FAAEPMDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VWDYEWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ACGPQAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLLTDFHQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ATDADENGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YAVTSSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYEPLDEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (100%);GO:0050662 (100%),catalytic activity (100%);coenzyme binding (100%),,,IPR001509 (100%);IPR036291 (100%),NAD-dependent epimerase/dehydratase (100%);NAD(P)-binding domain superfamily (100%),,,,,,,,,,,
VLDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.2 (28%);1.1.1.94 (13%);6.3.3.1 (11%),Phosphoribosylglycinamide formyltransferase (28%);Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (13%);Phosphoribosylformylglycinamidine cyclo-ligase (11%),GO:0016021 (17%);GO:0005737 (5%);GO:0009331 (5%),integral component of membrane (17%);cytoplasm (5%);glycerol-3-phosphate dehydrogenase complex (5%),GO:0005524 (13%);GO:0004644 (8%);GO:0003677 (7%),ATP binding (13%);phosphoribosylglycinamide formyltransferase activity (8%);DNA binding (7%),GO:0006355 (16%);GO:0006189 (9%);GO:0005975 (4%),regulation of transcription, DNA-templated (16%);'de novo' IMP biosynthetic process (9%);carbohydrate metabolic process (4%),IPR031963 (15%);IPR024137 (14%);IPR002376 (8%),Histone deacetylase complex subunit SAP130, C-terminal domain (15%);Histone deacetylase complex subunit SAP130 (14%);Formyl transferase, N-terminal (8%),,,,,,,,
TTDEEHTSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEANSTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YTLPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (50%);4.2.2.- (25%);7.1.1.- (25%),DNA helicase (50%);Acting on polysaccharides (25%);Hydron translocation or charge separation linked to oxidoreductase reactions (25%),GO:0016021 (15%);GO:0005886 (6%);GO:0005634 (3%),integral component of membrane (15%);plasma membrane (6%);nucleus (3%),GO:0005524 (12%);GO:0003677 (9%);GO:0004672 (9%),ATP binding (12%);DNA binding (9%);protein kinase activity (9%),GO:0000160 (39%);GO:0006605 (4%);GO:0065002 (4%),phosphorelay signal transduction system (39%);protein targeting (4%);intracellular protein transmembrane transport (4%),IPR022719 (31%);IPR022720 (31%);IPR001789 (24%),Gliding motility-associated protein GldM, C-terminal (31%);Gliding motility-associated protein GldM, N-terminal (31%);Signal transduction response regulator, receiver domain (24%),,,,,,,,
FFEAYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.45 (56%);7.1.1.- (13%);2.7.13.3 (6%),Glucosylceramidase (56%);Hydron translocation or charge separation linked to oxidoreductase reactions (13%);Histidine kinase (6%),GO:0016021 (46%);GO:0009279 (5%);GO:0015934 (2%),integral component of membrane (46%);cell outer membrane (5%);large ribosomal subunit (2%),GO:0000155 (32%);GO:0004348 (16%);GO:0008484 (5%),phosphorelay sensor kinase activity (32%);glucosylceramidase activity (16%);sulfuric ester hydrolase activity (5%),GO:0006665 (16%);GO:0008610 (4%);GO:0031123 (4%),sphingolipid metabolic process (16%);lipid biosynthetic process (4%);RNA 3'-end processing (4%),IPR001789 (26%);IPR003594 (26%);IPR003661 (26%),Signal transduction response regulator, receiver domain (26%);Histidine kinase/HSP90-like ATPase (26%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (26%),,,,,,,,,
NQMLELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000941 (40%);GO:0016021 (40%);GO:0005783 (20%),condensed nuclear chromosome inner kinetochore (40%);integral component of membrane (40%);endoplasmic reticulum (20%),GO:0010859 (20%),calcium-dependent cysteine-type endopeptidase inhibitor activity (20%),GO:0000070 (40%);GO:0051382 (40%);GO:0097340 (20%),mitotic sister chromatid segregation (40%);kinetochore assembly (40%);inhibition of cysteine-type endopeptidase activity (20%),IPR020993 (40%);IPR001259 (20%);IPR011944 (20%),Centromere protein Cenp-K (40%);Proteinase inhibitor I27, calpastatin (20%);Steroid delta5-4-isomerase (20%),,,,,,,,,,
DVTLQER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.18 (100%),5-(carboxyamino)imidazole ribonucleotide mutase (100%),GO:0016021 (6%),integral component of membrane (6%),GO:0051536 (61%);GO:0003723 (17%);GO:0016829 (11%),iron-sulfur cluster binding (61%);RNA binding (17%);lyase activity (11%),GO:0006189 (11%),'de novo' IMP biosynthetic process (11%),IPR009051 (58%);IPR017896 (58%);IPR017900 (58%),Alpha-helical ferredoxin (58%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (58%);4Fe-4S ferredoxin, iron-sulphur binding, conserved site (58%),,,,,,,,
EETLQQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.13 (100%),tRNA-uridine 2-sulfurtransferase (100%),GO:0016021 (82%);GO:0005737 (6%),integral component of membrane (82%);cytoplasm (6%),GO:0005524 (12%);GO:0000049 (6%);GO:0003677 (6%),ATP binding (12%);tRNA binding (6%);DNA binding (6%),GO:0006400 (6%);GO:0032259 (6%),tRNA modification (6%);methylation (6%),IPR011055 (67%);IPR016047 (67%);IPR015915 (10%),Duplicated hybrid motif (67%);Peptidase M23 (67%);Kelch-type beta propeller (10%),,,,,,,,,,,
AACMVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.1 (100%);3.4.11.10 (100%),Leucyl aminopeptidase (100%);Bacterial leucyl aminopeptidase (100%),GO:0005777 (33%);GO:0005737 (17%);GO:0016021 (17%),peroxisome (33%);cytoplasm (17%);integral component of membrane (17%),GO:0003997 (33%);GO:0071949 (33%);GO:0004177 (17%),acyl-CoA oxidase activity (33%);FAD binding (33%);aminopeptidase activity (17%),GO:0006635 (33%),fatty acid beta-oxidation (33%),IPR015057 (40%);IPR038070 (40%);IPR002655 (20%),Protein of unknown function DUF1876 (40%);Rv2632c-like superfamily (40%);Acyl-CoA oxidase, C-terminal (20%),,,,,,,,,,
ASLETELK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0016021 (67%),integral component of membrane (67%),GO:0003755 (33%);GO:0004591 (17%);GO:0030976 (17%),peptidyl-prolyl cis-trans isomerase activity (33%);oxoglutarate dehydrogenase (succinyl-transferring) activity (17%);thiamine pyrophosphate binding (17%),GO:0006099 (17%),tricarboxylic acid cycle (17%),IPR000297 (50%);IPR027304 (50%);IPR001017 (25%),Peptidyl-prolyl cis-trans isomerase, PpiC-type (50%);Trigger factor/SurA domain superfamily (50%);Dehydrogenase, E1 component (25%),,,,,,,,,
YLTMGGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSTEVMLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTLDFSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (40%);6.4.1.8 (40%);3.5.2.9 (20%),DNA-directed RNA polymerase (40%);Acetophenone carboxylase (40%);5-oxoprolinase (ATP-hydrolyzing) (20%),GO:0016021 (6%);GO:0016020 (2%);GO:0005576 (1%),integral component of membrane (6%);membrane (2%);extracellular region (1%),GO:0003824 (62%);GO:0005524 (11%);GO:0003677 (6%),catalytic activity (62%);ATP binding (11%);DNA binding (6%),GO:0006281 (9%);GO:0006310 (9%);GO:0000160 (4%),DNA repair (9%);DNA recombination (9%);phosphorelay signal transduction system (4%),IPR003692 (66%);IPR027417 (9%);IPR003395 (8%),Hydantoinase B/oxoprolinase (66%);P-loop containing nucleoside triphosphate hydrolase (9%);RecF/RecN/SMC, N-terminal (8%),,,,,,,,,,
NTTVANQVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLTSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (14%);1.2.1.10 (13%);3.6.4.12 (7%),Acting on GTP; involved in cellular and subcellular movement (14%);Acetaldehyde dehydrogenase (acetylating) (13%);DNA helicase (7%),GO:0016021 (14%);GO:0005737 (6%);GO:0015935 (4%),integral component of membrane (14%);cytoplasm (6%);small ribosomal subunit (4%),GO:0016831 (34%);GO:0005524 (11%);GO:0016620 (8%),carboxy-lyase activity (34%);ATP binding (11%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (8%),GO:0006412 (4%);GO:0055085 (3%);GO:0042254 (2%),translation (4%);transmembrane transport (3%);ribosome biogenesis (2%),IPR002830 (31%);IPR022390 (31%);IPR027417 (10%),UbiD decarboxylyase family (31%);4-hydroxybenzoate decarboxylase subunit C (31%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,,
LNLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.157 (9%);1.9.3.1 (7%);3.6.1.11 (5%),3-hydroxybutyryl-CoA dehydrogenase (9%);Cytochrome-c oxidase (7%);Exopolyphosphatase (5%),GO:0016021 (34%);GO:0005886 (6%);GO:0005737 (5%),integral component of membrane (34%);plasma membrane (6%);cytoplasm (5%),GO:0005524 (21%);GO:0046872 (10%);GO:0003677 (6%),ATP binding (21%);metal ion binding (10%);DNA binding (6%),GO:0006631 (3%);GO:0030001 (3%);GO:0006793 (2%),fatty acid metabolic process (3%);metal ion transport (3%);phosphorus metabolic process (2%),IPR027417 (13%);IPR003593 (4%);IPR036291 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);AAA+ ATPase domain (4%);NAD(P)-binding domain superfamily (4%),,,,,,,,,,,
LGGNEAAK,Chitinophagaceae,Bacteria,,,,Bacteroidetes,,,Chitinophagia,,,,Chitinophagales,,,,,Chitinophagaceae,,,,,,,,,,,,,,,,GO:0047661 (100%),amino-acid racemase activity (100%),GO:0006807 (100%),nitrogen compound metabolic process (100%),IPR001920 (100%);IPR004380 (100%);IPR015942 (100%),Asp/Glu racemase (100%);Aspartate racemase (100%);Asp/Glu/hydantoin racemase (100%),,,,,,,,,,,
LAGLAEHENR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVWLEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.9.3 (100%),Selenide, water dikinase (100%),GO:0005815 (50%);GO:0098536 (50%),microtubule organizing center (50%);deuterosome (50%),GO:0000287 (50%);GO:0004756 (50%);GO:0005524 (50%),magnesium ion binding (50%);selenide, water dikinase activity (50%);ATP binding (50%),GO:0007099 (50%);GO:0016260 (50%);GO:0098535 (50%),centriole replication (50%);selenocysteine biosynthetic process (50%);de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (50%),IPR000717 (50%);IPR004536 (50%);IPR010918 (50%),Proteasome component (PCI) domain (50%);Selenophosphate synthetase (50%);PurM-like, C-terminal domain (50%),,,,,,,,
EVMPTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (53%);GO:0005634 (6%);GO:0005886 (6%),integral component of membrane (53%);nucleus (6%);plasma membrane (6%),GO:0005524 (35%);GO:0016887 (24%);GO:0042626 (18%),ATP binding (35%);ATPase activity (24%);ATPase-coupled transmembrane transporter activity (18%),GO:0000160 (6%);GO:0007165 (6%);GO:0051301 (6%),phosphorelay signal transduction system (6%);signal transduction (6%);cell division (6%),IPR027417 (33%);IPR003776 (22%);IPR003593 (19%),P-loop containing nucleoside triphosphate hydrolase (33%);YcaO-like domain (22%);AAA+ ATPase domain (19%),,,,,,,,,,,
TLTLSAMVPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DFLSNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.11.- (28%);2.7.7.- (11%);6.1.1.6 (11%),With 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (28%);Nucleotidyltransferases (11%);Lysine--tRNA ligase (11%),GO:0016021 (21%);GO:0005634 (7%);GO:0016459 (4%),integral component of membrane (21%);nucleus (7%);myosin complex (4%),GO:0005524 (46%);GO:0004386 (29%);GO:0003676 (27%),ATP binding (46%);helicase activity (29%);nucleic acid binding (27%),GO:0007015 (4%);GO:0000462 (3%);GO:0006281 (2%),actin filament organization (4%);maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (3%);DNA repair (2%),IPR027417 (38%);IPR001650 (24%);IPR014001 (24%),P-loop containing nucleoside triphosphate hydrolase (38%);Helicase, C-terminal (24%);Helicase superfamily 1/2, ATP-binding domain (24%),,,,,,
TPNSGPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APPYTFHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.7 (92%);2.7.1.21 (5%);5.2.1.8 (1%),Cysteine desulfurase (92%);Thymidine kinase (5%);Peptidylprolyl isomerase (1%),GO:0005737 (55%);GO:0016021 (5%);GO:0005886 (3%),cytoplasm (55%);integral component of membrane (5%);plasma membrane (3%),GO:0031071 (69%);GO:0046872 (66%);GO:0030170 (64%),cysteine desulfurase activity (69%);metal ion binding (66%);pyridoxal phosphate binding (64%),GO:0044571 (64%);GO:0071897 (4%);GO:0006520 (2%),[2Fe-2S] cluster assembly (64%);DNA biosynthetic process (4%);cellular amino acid metabolic process (2%),IPR015424 (76%);IPR015421 (76%);IPR000192 (76%),Pyridoxal phosphate-dependent transferase (76%);Pyridoxal phosphate-dependent transferase, major domain (76%);Aminotransferase class V domain (76%),,,,,,,,,,
MVLLARPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVMSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.7 (50%);2.7.1.191 (50%),Peroxidase (50%);Protein-N(pi)-phosphohistidine--D-mannose phosphotransferase (50%),GO:0005833 (17%);GO:0016021 (17%),hemoglobin complex (17%);integral component of membrane (17%),GO:0008982 (50%);GO:0003676 (17%);GO:0005344 (17%),protein-N(PI)-phosphohistidine-sugar phosphotransferase activity (50%);nucleic acid binding (17%);oxygen carrier activity (17%),GO:0009401 (50%);GO:0019835 (17%),phosphoenolpyruvate-dependent sugar phosphotransferase system (50%);cytolysis (17%),IPR003501 (33%);IPR013011 (33%);IPR036095 (33%),Phosphotransferase system, EIIB component, type 2/3 (33%);Phosphotransferase system, EIIB component, type 2 (33%);PTS system IIB component-like superfamily (33%),,,,,,,
QQCGNQLQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVTAEAQYHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTVVMSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLLNDMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.4 (12%);2.7.7.- (8%);1.4.3.16 (7%),Asparagine synthase (glutamine-hydrolyzing) (12%);Nucleotidyltransferases (8%);L-aspartate oxidase (7%),GO:0016021 (17%);GO:0005737 (2%);GO:0009279 (2%),integral component of membrane (17%);cytoplasm (2%);cell outer membrane (2%),GO:0005524 (63%);GO:0003677 (55%);GO:0008270 (53%),ATP binding (63%);DNA binding (55%);zinc ion binding (53%),GO:0045892 (52%);GO:0009166 (2%);GO:0006260 (1%),negative regulation of transcription, DNA-templated (52%);nucleotide catabolic process (2%);DNA replication (1%),IPR005144 (46%);IPR003796 (46%);IPR027417 (8%),ATP-cone domain (46%);Ribonucleotide reductase regulator NrdR-like (46%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
FNDNDGDLHGTLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (8%);3.6.4.12 (6%);2.7.1.69 (6%),DNA-directed DNA polymerase (8%);DNA helicase (6%);Transferred entry: 2.7.1.191, 2.7.1.192, 2.7.1.193, 2.7.1.194, 2.7.1.1952.7.1.196, 2.7.1.197, 2.7.1.198, 2.7.1.199, 2.7.1.200, 2.7.1.2012.7.1.202, 2.7.1.20 (6%),GO:0016021 (32%);GO:0005886 (11%);GO:0015934 (8%),integral component of membrane (32%);plasma membrane (11%);large ribosomal subunit (8%),GO:0003735 (11%);GO:0005524 (10%);GO:0016301 (9%),structural constituent of ribosome (11%);ATP binding (10%);kinase activity (9%),GO:0006412 (9%);GO:0009401 (9%);GO:0051301 (2%),translation (9%);phosphoenolpyruvate-dependent sugar phosphotransferase system (9%);cell division (2%),IPR005721 (9%);IPR036394 (9%);IPR001063 (9%),Ribosomal protein L22/L17, eukaryotic/archaeal (9%);Ribosomal protein L22/L17 superfamily (9%);Ribosomal protein L22/L17 (9%)
EVHGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.7 (11%);1.1.1.- (6%);1.1.1.26 (6%),Cysteine desulfurase (11%);With NAD(+) or NADP(+) as acceptor (6%);Glyoxylate reductase (6%),GO:0016021 (16%);GO:0005737 (5%);GO:0005765 (2%),integral component of membrane (16%);cytoplasm (5%);lysosomal membrane (2%),GO:0051287 (26%);GO:0016616 (24%);GO:0003676 (19%),NAD binding (26%);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (24%);nucleic acid binding (19%),GO:0006886 (3%);GO:0007033 (3%);GO:0006355 (2%),intracellular protein transport (3%);vacuole organization (3%);regulation of transcription, DNA-templated (2%),IPR036291 (25%);IPR006139 (23%);IPR006140 (23%),NAD(P)-binding domain superfamily (25%);D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (23%);D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain (23%),,,,,,
LNTSLGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (16%);5.4.99.- (11%);3.6.1.9 (6%),Glycogen phosphorylase (16%);Transferring other groups (11%);Nucleotide diphosphatase (6%),GO:0016021 (29%);GO:0008076 (5%);GO:0005737 (4%),integral component of membrane (29%);voltage-gated potassium channel complex (5%);cytoplasm (4%),GO:0005524 (11%);GO:0046872 (8%);GO:0003677 (6%),ATP binding (11%);metal ion binding (8%);DNA binding (6%),GO:0005975 (5%);GO:0007154 (3%);GO:0016573 (2%),carbohydrate metabolic process (5%);cell communication (3%);histone acetylation (2%),IPR027417 (6%);IPR013821 (5%);IPR003948 (5%),P-loop containing nucleoside triphosphate hydrolase (6%);Potassium channel, voltage dependent, KCNQ, C-terminal (5%);Potassium channel, voltage dependent, KCNQ3 (5%),,,,,,
QLEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.1 (7%);2.7.13.3 (5%);6.1.1.19 (4%),Aspartate--ammonia ligase (7%);Histidine kinase (5%);Arginine--tRNA ligase (4%),GO:0016021 (16%);GO:0005737 (14%);GO:0016459 (8%),integral component of membrane (16%);cytoplasm (14%);myosin complex (8%),GO:0005524 (26%);GO:0003677 (17%);GO:0003774 (7%),ATP binding (26%);DNA binding (17%);motor activity (7%),GO:0009432 (4%);GO:0006289 (4%);GO:0007165 (3%),SOS response (4%);nucleotide-excision repair (4%);signal transduction (3%),IPR027417 (20%);IPR002928 (6%);IPR036961 (6%),P-loop containing nucleoside triphosphate hydrolase (20%);Myosin tail (6%);Kinesin motor domain superfamily (6%),,,,,,,,,,,
VMNNWVADWVHMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WCMYVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYNVVGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNSAGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.94 (33%);5.4.99.- (33%);7.1.1.- (33%),Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (33%);Transferring other groups (33%);Hydron translocation or charge separation linked to oxidoreductase reactions (33%),GO:0016021 (17%);GO:0019867 (14%);GO:0005694 (9%),integral component of membrane (17%);outer membrane (14%);chromosome (9%),GO:0003723 (23%);GO:0016740 (11%);GO:0005524 (9%),RNA binding (23%);transferase activity (11%);ATP binding (9%),GO:0006260 (6%);GO:0007062 (6%);GO:0030261 (6%),DNA replication (6%);sister chromatid cohesion (6%);chromosome condensation (6%),IPR001890 (13%);IPR008816 (13%);IPR035920 (13%),RNA-binding, CRM domain (13%);Glycine zipper 2TM domain (13%);YhbY-like superfamily (13%),,,,,,,,,,
GTELEGEVGFHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WETLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.15 (29%);6.1.1.5 (21%);1.2.7.1 (14%),DNA-deoxyinosine glycosylase (29%);Isoleucine--tRNA ligase (21%);Pyruvate synthase (14%),GO:0016021 (48%);GO:0005886 (25%);GO:0005737 (6%),integral component of membrane (48%);plasma membrane (25%);cytoplasm (6%),GO:0005315 (21%);GO:0005524 (12%);GO:0046872 (8%),inorganic phosphate transmembrane transporter activity (21%);ATP binding (12%);metal ion binding (8%),GO:0006817 (21%);GO:0005975 (4%);GO:0008152 (3%),phosphate ion transport (21%);carbohydrate metabolic process (4%);metabolic process (3%),IPR000515 (22%);IPR035906 (22%);IPR011864 (17%),ABC transporter type 1, transmembrane domain MetI-like (22%);MetI-like superfamily (22%);Phosphate ABC transporter, permease protein PstC (17%),,,,,,,,,
GFPTLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (50%);GO:0005199 (50%),DNA binding (50%);structural constituent of cell wall (50%),GO:0006310 (50%);GO:0015074 (50%),DNA recombination (50%);DNA integration (50%),IPR002104 (50%);IPR003882 (50%);IPR011010 (50%),Integrase, catalytic domain (50%);Pistil-specific extensin-like protein (50%);DNA breaking-rejoining enzyme, catalytic core (50%),,,,,,,,,
TPLNQER,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016757 (100%),transferase activity, transferring glycosyl groups (100%),,,IPR002201 (75%);IPR008258 (25%);IPR018392 (25%),Glycosyl transferase, family 9 (75%);Transglycosylase SLT domain 1 (25%);LysM domain (25%),,,,,,,,,
LLPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.5 (28%);3.1.3.- (28%);2.3.2.3 (5%),[Isocitrate dehydrogenase (NADP(+))] kinase (28%);Phosphoric monoester hydrolases (28%);Lysyltransferase (5%),GO:0016021 (22%);GO:0005737 (20%);GO:0005886 (4%),integral component of membrane (22%);cytoplasm (20%);plasma membrane (4%),GO:0005524 (20%);GO:0003746 (9%);GO:0003677 (8%),ATP binding (20%);translation elongation factor activity (9%);DNA binding (8%),GO:0006099 (6%);GO:0006097 (6%);GO:0006006 (5%),tricarboxylic acid cycle (6%);glyoxylate cycle (6%);glucose metabolic process (5%),IPR027417 (11%);IPR001816 (7%);IPR014039 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);Translation elongation factor EFTs/EF1B (7%);Translation elongation factor EFTs/EF1B, dimerisation (7%),,,,,,,,,,
THNPELAALTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMVLDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.98 (100%),UDP-N-acetylmuramate dehydrogenase (100%),GO:0016021 (48%);GO:0005737 (14%),integral component of membrane (48%);cytoplasm (14%),GO:0003676 (10%);GO:0003677 (10%);GO:0003824 (10%),nucleic acid binding (10%);DNA binding (10%);catalytic activity (10%),GO:0015074 (14%);GO:0032196 (14%);GO:0016051 (10%),DNA integration (14%);transposition (14%);carbohydrate biosynthetic process (10%),IPR000160 (31%);IPR001633 (31%);IPR029787 (31%),GGDEF domain (31%);EAL domain (31%);Nucleotide cyclase (31%),,,,,,,,,,,
MGVDVFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.17 (100%),Enoyl-CoA hydratase (100%),GO:0009337 (7%),sulfite reductase complex (NADPH) (7%),GO:0008233 (73%);GO:0004300 (7%);GO:0004672 (7%),peptidase activity (73%);enoyl-CoA hydratase activity (7%);protein kinase activity (7%),GO:0008652 (7%),cellular amino acid biosynthetic process (7%),IPR001539 (67%);IPR036188 (17%);IPR000719 (6%),Peptidase U32 (67%);FAD/NAD(P)-binding domain superfamily (17%);Protein kinase domain (6%),,,,,,,,,,,
TDTWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.3.12 (45%);1.1.5.3 (16%);3.2.1.1 (11%),Agmatine deiminase (45%);Glycerol-3-phosphate dehydrogenase (16%);Alpha-amylase (11%),GO:0016021 (22%);GO:0009331 (11%);GO:0005634 (2%),integral component of membrane (22%);glycerol-3-phosphate dehydrogenase complex (11%);nucleus (2%),GO:0005524 (11%);GO:0047632 (10%);GO:0004668 (9%),ATP binding (11%);agmatine deiminase activity (10%);protein-arginine deiminase activity (9%),GO:0006072 (11%);GO:0009446 (9%);GO:0006352 (3%),glycerol-3-phosphate metabolic process (11%);putrescine biosynthetic process (9%);DNA-templated transcription, initiation (3%),IPR027417 (10%);IPR036188 (10%);IPR000447 (9%),P-loop containing nucleoside triphosphate hydrolase (10%);FAD/NAD(P)-binding domain superfamily (10%);FAD-dependent glycerol-3-phosphate dehydrogenase (9%),,,,,,,,,,
WLTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.193 (30%);3.5.4.26 (30%);4.1.2.4 (20%),5-amino-6-(5-phosphoribosylamino)uracil reductase (30%);Diaminohydroxyphosphoribosylaminopyrimidine deaminase (30%);Deoxyribose-phosphate aldolase (20%),GO:0016021 (16%);GO:0005737 (13%);GO:0019012 (10%),integral component of membrane (16%);cytoplasm (13%);virion (10%),GO:0005524 (25%);GO:0008270 (11%);GO:0008703 (10%),ATP binding (25%);zinc ion binding (11%);5-amino-6-(5-phosphoribosylamino)uracil reductase activity (10%),GO:0009231 (10%);GO:0009264 (7%);GO:0006556 (4%),riboflavin biosynthetic process (10%);deoxyribonucleotide catabolic process (7%);S-adenosylmethionine biosynthetic process (4%),IPR002734 (9%);IPR024072 (9%);IPR002125 (9%),Bacterial bifunctional deaminase-reductase, C-terminal (9%);Dihydrofolate reductase-like domain superfamily (9%);Cytidine and deoxycytidylate deaminase domain (9%),,,,,,,,,,
VAWQTACK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVPGSTAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MWPGFLHTLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQVELGPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTCEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.2 (43%);2.1.2.3 (14%);3.6.1.- (14%),5-formyltetrahydrofolate cyclo-ligase (43%);Phosphoribosylaminoimidazolecarboxamide formyltransferase (14%);In phosphorus-containing anhydrides (14%),GO:0016021 (68%);GO:0005768 (22%);GO:0060187 (22%),integral component of membrane (68%);endosome (22%);cell pole (22%),GO:0005509 (23%);GO:0043533 (23%);GO:0046872 (15%),calcium ion binding (23%);inositol 1,3,4,5 tetrakisphosphate binding (23%);metal ion binding (15%),GO:0048105 (22%);GO:2000009 (22%);GO:0006355 (13%),establishment of body hair planar orientation (22%);negative regulation of protein localization to cell surface (22%);regulation of transcription, DNA-templated (13%),IPR026995 (74%);IPR040510 (74%);IPR040685 (74%),Astrotactin (74%);Astrotactin-2, C-terminal beta-hairpin domain (74%);Annexin-like domain (74%),,,,,,
DPVADVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLHMWNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTEALNPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEETNDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLLLNEAASSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNYSAAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMPSDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (33%);GO:0016021 (33%),membrane (33%);integral component of membrane (33%),GO:0004181 (33%);GO:0005524 (33%);GO:0016301 (33%),metallocarboxypeptidase activity (33%);ATP binding (33%);kinase activity (33%),GO:0006605 (33%);GO:0017038 (33%),protein targeting (33%);protein import (33%),IPR000185 (33%);IPR001261 (33%);IPR002933 (33%),Protein translocase subunit SecA (33%);ArgE/DapE/ACY1/CPG2/YscS, conserved site (33%);Peptidase M20 (33%),,,,,,,,,,
NPSLQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (41%);6.1.1.3 (24%);1.14.13.- (6%),Acting on ester bonds (41%);Threonine--tRNA ligase (24%);With NADH or NADPH as one donor, and incorporation of one atom of oxygen (6%),GO:0016021 (26%);GO:0043564 (6%);GO:0042597 (5%),integral component of membrane (26%);Ku70:Ku80 complex (6%);periplasmic space (5%),GO:0005524 (13%);GO:0003677 (10%);GO:0005506 (10%),ATP binding (13%);DNA binding (10%);iron ion binding (10%),GO:0000723 (6%);GO:0006303 (6%);GO:0006355 (6%),telomere maintenance (6%);double-strand break repair via nonhomologous end joining (6%);regulation of transcription, DNA-templated (6%),IPR027417 (8%);IPR005184 (7%);IPR038670 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);Domain of unknown function DUF306, Meta/HslJ (7%);HslJ-like superfamily (7%),,,,,,,,
VNCTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0030729 (100%),acetoacetate-CoA ligase activity (100%),GO:0006629 (100%),lipid metabolic process (100%),IPR000873 (50%);IPR005914 (50%);IPR020845 (50%),AMP-dependent synthetase/ligase (50%);Acetoacetyl-CoA synthase (50%);AMP-binding, conserved site (50%),,,,,,,,,,
YVALWNK,Ancylostoma ceylanicum,Eukaryota,Metazoa,,,Nematoda,,,Chromadorea,,,,Strongylida,,,,Ancylostomatoidea,Ancylostomatidae,Ancylostomatinae,,,Ancylostoma,,,,Ancylostoma ceylanicum,,,,,,,,,,,,,,,,,,,,,,,,
FMVPNK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (100%),ribosome (100%),,,,,IPR001440 (50%);IPR011990 (50%);IPR013026 (50%),Tetratricopeptide repeat 1 (50%);Tetratricopeptide-like helical domain superfamily (50%);Tetratricopeptide repeat-containing domain (50%),,,,,,,,,,,
NNEEKPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0005634 (29%);GO:0005663 (14%);GO:0009360 (14%),nucleus (29%);DNA replication factor C complex (14%);DNA polymerase III complex (14%),GO:0036459 (43%);GO:0005524 (29%);GO:0003677 (14%),thiol-dependent ubiquitinyl hydrolase activity (43%);ATP binding (29%);DNA binding (14%),GO:0006511 (43%);GO:0016579 (43%);GO:0006260 (29%),ubiquitin-dependent protein catabolic process (43%);protein deubiquitination (43%);DNA replication (29%),IPR001394 (50%);IPR002083 (50%);IPR008974 (50%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (50%);MATH/TRAF domain (50%);TRAF-like (50%),,,,,,,,,,
TGLDPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.9 (56%);2.3.1.16 (20%);3.1.-.- (16%),Acetyl-CoA C-acetyltransferase (56%);Acetyl-CoA C-acyltransferase (20%);Acting on ester bonds (16%),GO:0016021 (9%);GO:0005737 (8%);GO:0005694 (1%),integral component of membrane (9%);cytoplasm (8%);chromosome (1%),GO:0016747 (19%);GO:0003985 (18%);GO:0003677 (12%),transferase activity, transferring acyl groups other than amino-acyl groups (19%);acetyl-CoA C-acetyltransferase activity (18%);DNA binding (12%),GO:0045892 (10%);GO:0006364 (5%);GO:0006284 (1%),negative regulation of transcription, DNA-templated (10%);rRNA processing (5%);base-excision repair (1%),IPR016039 (46%);IPR020616 (45%);IPR002155 (44%),Thiolase-like (46%);Thiolase, N-terminal (45%);Thiolase (44%),,,,,,,,
YEPVPSVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGTTLHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVWVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (100%),Acting on GTP; involved in cellular and subcellular movement (100%),GO:0016021 (50%);GO:0005886 (8%),integral component of membrane (50%);plasma membrane (8%),GO:0004668 (25%);GO:0003676 (8%);GO:0003746 (8%),protein-arginine deiminase activity (25%);nucleic acid binding (8%);translation elongation factor activity (8%),GO:0009446 (25%);GO:0055085 (8%),putrescine biosynthetic process (25%);transmembrane transport (8%),IPR036047 (21%);IPR007466 (16%);IPR011004 (16%),F-box-like domain superfamily (21%);Peptidyl-arginine deiminase, Porphyromonas-type (16%);Trimeric LpxA-like superfamily (16%),,,,,,,,,,
EPTSLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (100%),RING-type E3 ubiquitin transferase (100%),GO:0005576 (30%);GO:0016021 (20%);GO:0005886 (10%),extracellular region (30%);integral component of membrane (20%);plasma membrane (10%),GO:0005104 (30%);GO:0008083 (30%);GO:0004672 (10%),fibroblast growth factor receptor binding (30%);growth factor activity (30%);protein kinase activity (10%),GO:0008543 (30%),fibroblast growth factor receptor signaling pathway (30%),IPR002209 (25%);IPR028249 (25%);IPR008996 (17%),Fibroblast growth factor family (25%);Fibroblast growth factor 8 (25%);Cytokine IL1/FGF (17%),,,,,,,,,,,
LNTGLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (60%);GO:0016021 (10%),cell outer membrane (60%);integral component of membrane (10%),GO:0015344 (50%);GO:0038023 (50%);GO:0003677 (20%),siderophore uptake transmembrane transporter activity (50%);signaling receptor activity (50%);DNA binding (20%),,,IPR012910 (55%);IPR036942 (55%);IPR037066 (55%),TonB-dependent receptor, plug domain (55%);TonB-dependent receptor-like, beta-barrel domain superfamily (55%);TonB-dependent receptor, plug domain superfamily (55%),,,,,,,,
WVDAEYK,Deltaproteobacteria,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043565 (100%),sequence-specific DNA binding (100%),,,IPR010921 (100%),Trp repressor/replication initiator (100%),,,,,,,,,,,
NEHWPVHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNVASHR,Tetraodon nigroviridis,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,,Tetraodontiformes,Tetraodontoidei,,,Tetradontoidea,Tetraodontidae,,,,Tetraodon,,,,Tetraodon nigroviridis,,,,,,GO:0008305 (100%),integrin complex (100%),,,GO:0007155 (100%);GO:0007229 (100%),cell adhesion (100%);integrin-mediated signaling pathway (100%),IPR000413 (100%);IPR002035 (100%);IPR013517 (100%),Integrin alpha chain (100%);von Willebrand factor, type A (100%);FG-GAP repeat (100%),,,,,,,,,,
VEYFFMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLGSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (95%);2.7.3.- (2%);2.6.1.19 (1%),Histidine kinase (95%);Phosphotransferases with a nitrogenous group as acceptor (2%);4-aminobutyrate--2-oxoglutarate transaminase (1%),GO:0016021 (5%);GO:0009279 (3%);GO:0031012 (2%),integral component of membrane (5%);cell outer membrane (3%);extracellular matrix (2%),GO:0005524 (88%);GO:0000155 (82%);GO:0004673 (6%),ATP binding (88%);phosphorelay sensor kinase activity (82%);protein histidine kinase activity (6%),GO:0006355 (60%);GO:0007229 (2%);GO:0000160 (0%),regulation of transcription, DNA-templated (60%);integrin-mediated signaling pathway (2%);phosphorelay signal transduction system (0%),IPR005467 (87%);IPR036890 (87%);IPR003594 (87%),Histidine kinase domain (87%);Histidine kinase/HSP90-like ATPase superfamily (87%);Histidine kinase/HSP90-like ATPase (87%),,,,,,,,,,
SYTQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.19 (67%);2.1.1.182 (33%),Arginine--tRNA ligase (67%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (33%),GO:0016580 (71%);GO:0016021 (16%);GO:0005737 (11%),Sin3 complex (71%);integral component of membrane (16%);cytoplasm (11%),GO:0003714 (71%);GO:0004814 (5%);GO:0005524 (5%),transcription corepressor activity (71%);arginine-tRNA ligase activity (5%);ATP binding (5%),GO:0006355 (66%);GO:0006420 (5%);GO:0000122 (3%),regulation of transcription, DNA-templated (66%);arginyl-tRNA aminoacylation (5%);negative regulation of transcription by RNA polymerase II (3%),IPR013194 (73%);IPR037969 (73%);IPR039774 (73%),Histone deacetylase interacting domain (73%);Transcriptional regulatory protein Sin3a (73%);Transcriptional regulatory protein Sin3-like (73%),,,,,,,,,,
TDPAYHEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMNPLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (34%);2.4.1.182 (6%);3.6.4.12 (4%),DNA ligase (NAD(+)) (34%);Lipid-A-disaccharide synthase (6%);DNA helicase (4%),GO:0016021 (28%);GO:0005737 (7%);GO:0005634 (2%),integral component of membrane (28%);cytoplasm (7%);nucleus (2%),GO:0003677 (16%);GO:0005524 (16%);GO:0046872 (14%),DNA binding (16%);ATP binding (16%);metal ion binding (14%),GO:0006281 (11%);GO:0006260 (10%);GO:0006813 (3%),DNA repair (11%);DNA replication (10%);potassium ion transport (3%),IPR012340 (9%);IPR013839 (8%);IPR013840 (8%),Nucleic acid-binding, OB-fold (9%);NAD-dependent DNA ligase, adenylation (8%);NAD-dependent DNA ligase, N-terminal (8%),,,,,,,,
QSSVEDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (100%),RNA helicase (100%),GO:0005737 (50%);GO:0009380 (50%),cytoplasm (50%);excinuclease repair complex (50%),GO:0005524 (100%);GO:0003677 (50%);GO:0003723 (50%),ATP binding (100%);DNA binding (50%);RNA binding (50%),GO:0006289 (50%);GO:0009432 (50%),nucleotide-excision repair (50%);SOS response (50%),IPR001650 (100%);IPR014001 (100%);IPR027417 (100%),Helicase, C-terminal (100%);Helicase superfamily 1/2, ATP-binding domain (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,
EADLDELWK,Microbacteriaceae,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Micrococcales,,,,,Microbacteriaceae,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016887 (100%);GO:0042626 (100%),ATP binding (100%);ATPase activity (100%);ATPase-coupled transmembrane transporter activity (100%),,,IPR003439 (100%);IPR003593 (100%);IPR011527 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);ABC transporter type 1, transmembrane domain (100%),,,,,,,,,,
TPNLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.5 (33%);3.5.4.9 (33%);3.1.6.1 (13%),Methylenetetrahydrofolate dehydrogenase (NADP(+)) (33%);Methenyltetrahydrofolate cyclohydrolase (33%);Arylsulfatase (type I) (13%),GO:0016021 (14%);GO:0005887 (4%);GO:0032153 (4%),integral component of membrane (14%);integral component of plasma membrane (4%);cell division site (4%),GO:0008484 (10%);GO:0005524 (6%);GO:0004477 (4%),sulfuric ester hydrolase activity (10%);ATP binding (6%);methenyltetrahydrofolate cyclohydrolase activity (4%),GO:0006323 (40%);GO:0043093 (4%);GO:0000105 (4%),DNA packaging (40%);FtsZ-dependent cytokinesis (4%);histidine biosynthetic process (4%),IPR035413 (38%);IPR035412 (37%);IPR006437 (36%),Phage terminase large subunit, C-terminal (38%);Phage terminase large subunit, N-terminal (37%);Bacteriophage terminase, large subunit (36%),,,,,,,,
LLALLTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003723 (33%);GO:0004674 (33%);GO:0005524 (33%),RNA binding (33%);protein serine/threonine kinase activity (33%);ATP binding (33%),,,IPR000330 (25%);IPR000873 (25%);IPR001650 (25%),SNF2-related, N-terminal domain (25%);AMP-dependent synthetase/ligase (25%);Helicase, C-terminal (25%),,,,,,,,,
WMEYVPGMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.2 (20%);4.1.1.15 (12%);3.1.1.61 (8%),GMP synthase (glutamine-hydrolyzing) (20%);Glutamate decarboxylase (12%);Protein-glutamate methylesterase (8%),GO:0016021 (22%);GO:0019013 (9%);GO:0005737 (5%),integral component of membrane (22%);viral nucleocapsid (9%);cytoplasm (5%),GO:0005524 (22%);GO:0003677 (11%);GO:0003723 (10%),ATP binding (22%);DNA binding (11%);RNA binding (10%),GO:0006355 (4%);GO:0006511 (3%);GO:0006541 (3%),regulation of transcription, DNA-templated (4%);ubiquitin-dependent protein catabolic process (3%);glutamine metabolic process (3%),IPR027417 (19%);IPR003593 (7%);IPR001784 (7%),P-loop containing nucleoside triphosphate hydrolase (19%);AAA+ ATPase domain (7%);Bunyavirus nucleocapsid (N) protein (7%),,,,,,,,,,
TVALNVPR,Streptomyces,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Streptomycetales,,,,,Streptomycetaceae,,,,Streptomyces,,,,,,,,,,,,GO:0003824 (100%);GO:0031177 (100%),catalytic activity (100%);phosphopantetheine binding (100%),,,IPR000873 (100%);IPR001242 (100%);IPR006162 (100%),AMP-dependent synthetase/ligase (100%);Condensation domain (100%);Phosphopantetheine attachment site (100%),,,,,,,,,,,
VKPLFNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLNCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (13%);3.6.4.12 (12%);2.5.1.15 (8%),DNA-directed DNA polymerase (13%);DNA helicase (12%);Dihydropteroate synthase (8%),GO:0016021 (20%);GO:0005737 (8%);GO:0005634 (4%),integral component of membrane (20%);cytoplasm (8%);nucleus (4%),GO:0005524 (19%);GO:0003677 (17%);GO:0046872 (8%),ATP binding (19%);DNA binding (17%);metal ion binding (8%),GO:0009396 (5%);GO:0006260 (4%);GO:0006351 (4%),folic acid-containing compound biosynthetic process (5%);DNA replication (4%);transcription, DNA-templated (4%),IPR003738 (55%);IPR036590 (55%);IPR027417 (7%),SOS response associated peptidase (SRAP) (55%);SOS response associated peptidase-like (55%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,
ESQAMYGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLADMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.4.1.8 (27%);6.1.1.4 (14%);6.3.4.3 (13%),Cystathionine beta-lyase (27%);Leucine--tRNA ligase (14%);Formate--tetrahydrofolate ligase (13%),GO:0005737 (13%);GO:0016021 (7%);GO:0009380 (2%),cytoplasm (13%);integral component of membrane (7%);excinuclease repair complex (2%),GO:0004121 (28%);GO:0030170 (27%);GO:0005524 (20%),cystathionine beta-lyase activity (28%);pyridoxal phosphate binding (27%);ATP binding (20%),GO:0019346 (27%);GO:0009228 (8%);GO:0006429 (6%),transsulfuration (27%);thiamine biosynthetic process (8%);leucyl-tRNA aminoacylation (6%),IPR000277 (25%);IPR006233 (25%);IPR015421 (25%),Cys/Met metabolism, pyridoxal phosphate-dependent enzyme (25%);Cystathionine beta-lyase, bacterial (25%);Pyridoxal phosphate-dependent transferase, major domain (25%),,,,,,,,
SLVHM,Mameliella alba,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhodobacterales,,,,,Rhodobacteraceae,,,,Mameliella,,,,Mameliella alba,,,,,,,,GO:0008483 (100%),transaminase activity (100%),,,,,,,,,,,,,,,
MADGDVPK,Pyrenophora tritici-repentis,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Dothideomycetes,Pleosporomycetidae,,,Pleosporales,Pleosporineae,,,,Pleosporaceae,,,,Pyrenophora,,,,Pyrenophora tritici-repentis,,,,,,,,GO:0004553 (100%),hydrolase activity, hydrolyzing O-glycosyl compounds (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR017853 (100%);IPR001547 (67%),Glycoside hydrolase superfamily (100%);Glycoside hydrolase, family 5 (67%),,,,,,,,,
LDLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (42%);6.3.4.19 (7%);6.3.4.2 (4%),DNA helicase (42%);tRNA(Ile)-lysidine synthetase (7%);CTP synthase (glutamine hydrolyzing) (4%),GO:0016021 (22%);GO:0005737 (9%);GO:0005886 (6%),integral component of membrane (22%);cytoplasm (9%);plasma membrane (6%),GO:0005524 (23%);GO:0003677 (20%);GO:0009378 (10%),ATP binding (23%);DNA binding (20%);four-way junction helicase activity (10%),GO:0006310 (12%);GO:0006281 (10%);GO:0009432 (10%),DNA recombination (12%);DNA repair (10%);SOS response (10%),IPR027417 (16%);IPR036388 (13%);IPR036390 (12%),P-loop containing nucleoside triphosphate hydrolase (16%);Winged helix-like DNA-binding domain superfamily (13%);Winged helix DNA-binding domain superfamily (12%),,,,,,,,,,,
MENLMEKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDLEFWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (67%);GO:0031177 (67%);GO:0016829 (33%),catalytic activity (67%);phosphopantetheine binding (67%);lyase activity (33%),,,IPR000873 (50%);IPR001242 (50%);IPR006162 (50%),AMP-dependent synthetase/ligase (50%);Condensation domain (50%);Phosphopantetheine attachment site (50%),,,,,,,,,,,
DSYLQDVNLGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (14%);3.1.11.6 (6%);2.7.11.- (5%),Ribonucleoside-diphosphate reductase (14%);Exodeoxyribonuclease VII (6%);Protein-serine/threonine kinases (5%),GO:0016021 (26%);GO:0009507 (4%);GO:0005737 (3%),integral component of membrane (26%);chloroplast (4%);cytoplasm (3%),GO:0003677 (15%);GO:0003676 (13%);GO:0005524 (13%),DNA binding (15%);nucleic acid binding (13%);ATP binding (13%),GO:0006352 (8%);GO:0006081 (3%);GO:0006955 (2%),DNA-templated transcription, initiation (8%);cellular aldehyde metabolic process (3%);immune response (2%),IPR013087 (12%);IPR036236 (12%);IPR034729 (11%),Zinc finger C2H2-type (12%);Zinc finger C2H2 superfamily (12%);Zinc finger CCHC HIVEP-type (11%),,,,,,,,,,
VSMTSRPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DFTER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.17 (38%);2.7.11.1 (6%);2.7.13.3 (5%),Glutamate--tRNA ligase (38%);Non-specific serine/threonine protein kinase (6%);Histidine kinase (5%),GO:0016021 (32%);GO:0005886 (17%);GO:0005737 (14%),integral component of membrane (32%);plasma membrane (17%);cytoplasm (14%),GO:0005524 (24%);GO:0015565 (14%);GO:0022889 (14%),ATP binding (24%);threonine efflux transmembrane transporter activity (14%);serine transmembrane transporter activity (14%),GO:0006424 (9%);GO:0006355 (4%);GO:0018298 (2%),glutamyl-tRNA aminoacylation (9%);regulation of transcription, DNA-templated (4%);protein-chromophore linkage (2%),IPR023726 (12%);IPR018227 (11%);IPR004694 (11%),Threonine/serine transporter TdcC (12%);Amino acid/polyamine transporter 2 (11%);Hydroxy amino acid transporter (11%),,,,,,,,,,
DNEAVDAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNVAQTPGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPGNDENQVQVVDLGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDTAQAVR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.31 (100%),Phosphoenolpyruvate carboxylase (100%),,,GO:0008964 (98%);GO:0000287 (93%);GO:0003677 (1%),phosphoenolpyruvate carboxylase activity (98%);magnesium ion binding (93%);DNA binding (1%),GO:0015977 (98%);GO:0006099 (95%);GO:0006107 (93%),carbon fixation (98%);tricarboxylic acid cycle (95%);oxaloacetate metabolic process (93%),IPR015813 (98%);IPR018129 (98%);IPR021135 (98%),Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (98%);Phosphoenolpyruvate carboxylase, Lys active site (98%);Phosphoenolpyruvate carboxylase (98%),,,,,,,,,,
AAPNTLSVGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVLNEAAMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSNAGGKPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCMFVK,Oxytrichidae,Eukaryota,,,,Ciliophora,Intramacronucleata,,Spirotrichea,Stichotrichia,,,Sporadotrichida,,,,,Oxytrichidae,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR035965 (100%),PAS domain superfamily (100%),,,,,,,,,,,
LSPWTPVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENGMTSFNLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMEVSGR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005956 (100%),protein kinase CK2 complex (100%),GO:0016301 (100%);GO:0019887 (100%),kinase activity (100%);protein kinase regulator activity (100%),,,IPR000704 (50%);IPR005123 (50%);IPR016149 (50%),Casein kinase II, regulatory subunit (50%);Oxoglutarate/iron-dependent dioxygenase (50%);Casein kinase II, regulatory subunit, N-terminal (50%),,,,,,,,
DHEQNPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPATWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016874 (50%),ligase activity (50%),GO:0055085 (50%),transmembrane transport (50%),IPR000873 (50%);IPR011701 (50%);IPR020846 (50%),AMP-dependent synthetase/ligase (50%);Major facilitator superfamily (50%);Major facilitator superfamily domain (50%),,,,,,,,,,,
ALSLLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.3 (50%);1.3.5.2 (25%);1.3.-.- (13%),Glutamate racemase (50%);Dihydroorotate dehydrogenase (quinone) (25%);Acting on the CH-CH group of donors (13%),GO:0016021 (25%);GO:0005737 (8%);GO:0005634 (3%),integral component of membrane (25%);cytoplasm (8%);nucleus (3%),GO:0005524 (21%);GO:0003677 (8%);GO:0016887 (8%),ATP binding (21%);DNA binding (8%);ATPase activity (8%),GO:0006396 (25%);GO:0006304 (4%);GO:0008360 (4%),RNA processing (25%);DNA modification (4%);regulation of cell shape (4%),IPR011990 (20%);IPR013026 (20%);IPR003107 (18%),Tetratricopeptide-like helical domain superfamily (20%);Tetratricopeptide repeat-containing domain (20%);HAT (Half-A-TPR) repeat (18%),,,,,,,,,,,
QQEPNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (25%);2.3.1.247 (25%);2.8.1.12 (25%),Methyltransferases (25%);3-keto-5-aminohexanoate cleavage enzyme (25%);Molybdopterin synthase (25%),GO:0016021 (7%);GO:0005886 (4%);GO:0005737 (2%),integral component of membrane (7%);plasma membrane (4%);cytoplasm (2%),GO:0004386 (67%);GO:0003677 (4%);GO:0008270 (4%),helicase activity (67%);DNA binding (4%);zinc ion binding (4%),GO:0015031 (4%);GO:0019475 (4%);GO:0006777 (2%),protein transport (4%);L-lysine catabolic process to acetate (4%);Mo-molybdopterin cofactor biosynthetic process (2%),IPR027417 (75%);IPR041677 (73%);IPR041679 (73%),P-loop containing nucleoside triphosphate hydrolase (75%);DNA2/NAM7 helicase, AAA domain (73%);DNA2/NAM7 helicase-like, AAA domain (73%),,,,,,,,,
LTMALMSMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGNNWMLVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFVAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003676 (35%);GO:0004888 (35%);GO:0005230 (35%),nucleic acid binding (35%);transmembrane signaling receptor activity (35%);extracellular ligand-gated ion channel activity (35%),GO:0006281 (35%);GO:0006310 (35%);GO:0005975 (10%),DNA repair (35%);DNA recombination (35%);carbohydrate metabolic process (10%),IPR010352 (51%);IPR001667 (17%);IPR003156 (17%),Protein of unknown function DUF945 (51%);DDH domain (17%);DHHA1 domain (17%),,,,,,,,,,,
WVPTYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.3.2.5 (100%),ABC-type molybdate transporter (100%),GO:0005886 (67%);GO:0016021 (33%),plasma membrane (67%);integral component of membrane (33%),GO:0005524 (67%);GO:0015412 (67%);GO:0016887 (67%),ATP binding (67%);ATPase-coupled molybdate transmembrane transporter activity (67%);ATPase activity (67%),,,IPR003439 (29%);IPR003593 (29%);IPR005116 (29%),ABC transporter-like (29%);AAA+ ATPase domain (29%);Transport-associated OB, type 1 (29%),,,,,,,,,,
SPQAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (15%);2.1.1.- (13%);1.1.1.42 (6%),Oxidoreductases (15%);Methyltransferases (13%);Isocitrate dehydrogenase (NADP(+)) (6%),GO:0016021 (26%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (26%);cytoplasm (5%);nucleus (2%),GO:0003677 (12%);GO:0005524 (11%);GO:0046872 (6%),DNA binding (12%);ATP binding (11%);metal ion binding (6%),GO:0015074 (7%);GO:0015969 (3%);GO:0032196 (2%),DNA integration (7%);guanosine tetraphosphate metabolic process (3%);transposition (2%),IPR027417 (9%);IPR011990 (9%);IPR013026 (7%),P-loop containing nucleoside triphosphate hydrolase (9%);Tetratricopeptide-like helical domain superfamily (9%);Tetratricopeptide repeat-containing domain (7%),,,,,,,,,,,
ADTTAYVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVENALEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAELVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (20%);4.1.2.25 (15%);2.1.1.298 (10%),DNA-directed DNA polymerase (20%);Dihydroneopterin aldolase (15%);Ribosomal protein L3 N(5)-glutamine methyltransferase (10%),GO:0016021 (12%);GO:0005886 (8%);GO:0005737 (3%),integral component of membrane (12%);plasma membrane (8%);cytoplasm (3%),GO:0003677 (21%);GO:0003700 (19%);GO:0019903 (14%),DNA binding (21%);DNA-binding transcription factor activity (19%);protein phosphatase binding (14%),GO:0043666 (14%);GO:0007156 (8%);GO:0006260 (3%),regulation of phosphoprotein phosphatase activity (14%);homophilic cell adhesion via plasma membrane adhesion molecules (8%);DNA replication (3%),IPR016024 (48%);IPR011989 (39%);IPR034085 (38%),Armadillo-type fold (48%);Armadillo-like helical (39%);TOG domain (38%),,,,,,,,,,,
WNNVVAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNFELPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLEDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.9 (23%);2.6.1.59 (5%);4.2.1.3 (3%),Malate synthase (23%);dTDP-4-amino-4,6-dideoxygalactose transaminase (5%);Aconitate hydratase (3%),GO:0016021 (18%);GO:0005737 (10%);GO:0005886 (3%),integral component of membrane (18%);cytoplasm (10%);plasma membrane (3%),GO:0005524 (21%);GO:0003677 (9%);GO:0004474 (6%),ATP binding (21%);DNA binding (9%);malate synthase activity (6%),GO:0006097 (6%);GO:0006099 (6%);GO:0016477 (5%),glyoxylate cycle (6%);tricarboxylic acid cycle (6%);cell migration (5%),IPR027417 (17%);IPR003593 (6%);IPR027717 (5%),P-loop containing nucleoside triphosphate hydrolase (17%);AAA+ ATPase domain (6%);Girdin (5%),,,,,,,,,,
FVMSKPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDNPDYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005788 (61%);GO:0005783 (21%);GO:0016021 (18%),endoplasmic reticulum lumen (61%);endoplasmic reticulum (21%);integral component of membrane (18%),GO:0005509 (82%);GO:0051082 (82%);GO:0004672 (6%),calcium ion binding (82%);unfolded protein binding (82%);protein kinase activity (6%),GO:0006457 (82%),protein folding (82%),IPR001580 (83%);IPR009033 (83%);IPR013320 (83%),Calreticulin/calnexin (83%);Calreticulin/calnexin, P domain superfamily (83%);Concanavalin A-like lectin/glucanase domain superfamily (83%),,,,,,,,,,
LCAADGSNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QFGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.2 (22%);1.2.1.- (6%);6.1.1.5 (6%),Adenylosuccinate lyase (22%);With NAD(+) or NADP(+) as acceptor (6%);Isoleucine--tRNA ligase (6%),GO:0019031 (67%);GO:0055036 (67%);GO:0016021 (24%),viral envelope (67%);virion membrane (67%);integral component of membrane (24%),GO:0005198 (18%);GO:0016620 (7%);GO:0003677 (4%),structural molecule activity (18%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (7%);DNA binding (4%),GO:0019062 (67%);GO:0039663 (60%);GO:0019064 (7%),virion attachment to host cell (67%);membrane fusion involved in viral entry into host cell (60%);fusion of virus membrane with host plasma membrane (7%),IPR000777 (64%);IPR036377 (64%);IPR000328 (17%),Human immunodeficiency virus 1, envelope glycoprotein Gp120 (64%);Gp120 core superfamily (64%);Retroviral envelope protein GP41-like (17%),,,,,,,,
TQLVMYMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLHNHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSPATGSVAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
STLAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.51 (33%);2.7.1.25 (8%);2.7.1.71 (8%),Prephenate dehydratase (33%);Adenylyl-sulfate kinase (8%);Shikimate kinase (8%),GO:0016021 (20%);GO:0005737 (7%);GO:0005829 (3%),integral component of membrane (20%);cytoplasm (7%);cytosol (3%),GO:0016787 (17%);GO:0005524 (13%);GO:0005506 (10%),hydrolase activity (17%);ATP binding (13%);iron ion binding (10%),GO:0009058 (3%);GO:0000103 (2%);GO:0001522 (2%),biosynthetic process (3%);sulfate assimilation (2%);pseudouridine synthesis (2%),IPR027417 (17%);IPR002933 (11%);IPR017439 (11%),P-loop containing nucleoside triphosphate hydrolase (17%);Peptidase M20 (11%);Amidohydrolase (11%),,,,,,,,,,,
AENDLVAK,Ensete ventricosum,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,Petrosaviidae,,,Zingiberales,,,,,Musaceae,,,,Ensete,,,,Ensete ventricosum,,,,,,,,,,,,,,,,,,,,,,,,
YPFFSNLENTHDGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MALNSDLLNAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFGPGLFWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LERPDFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.156 (100%);2.7.7.62 (100%),Adenosylcobinamide kinase (100%);Adenosylcobinamide-phosphate guanylyltransferase (100%),GO:0016021 (78%),integral component of membrane (78%),GO:0005524 (22%);GO:0003676 (11%);GO:0004386 (11%),ATP binding (22%);nucleic acid binding (11%);helicase activity (11%),GO:0009236 (11%),cobalamin biosynthetic process (11%),IPR001611 (86%);IPR003591 (86%);IPR013210 (86%),Leucine-rich repeat (86%);Leucine-rich repeat, typical subtype (86%);Leucine-rich repeat-containing N-terminal, plant-type (86%),,,,,,,,,
WLFQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.99.- (57%);1.1.1.- (14%);2.7.11.1 (8%),With other acceptors (57%);With NAD(+) or NADP(+) as acceptor (14%);Non-specific serine/threonine protein kinase (8%),GO:0016021 (22%);GO:0098978 (5%);GO:0005737 (2%),integral component of membrane (22%);glutamatergic synapse (5%);cytoplasm (2%),GO:0030215 (24%);GO:0016491 (19%);GO:0008718 (14%),semaphorin receptor binding (24%);oxidoreductase activity (19%);D-amino-acid dehydrogenase activity (14%),GO:0019478 (14%);GO:0048843 (5%);GO:0021612 (5%),D-amino acid catabolic process (14%);negative regulation of axon extension involved in axon guidance (5%);facial nerve structural organization (5%),IPR027231 (21%);IPR001627 (21%);IPR036352 (21%),Semaphorin (21%);Sema domain (21%);Sema domain superfamily (21%),,,,,,,,,,,
MLGSGTTK,Pectobacterium odoriferum,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Enterobacterales,,,,,Pectobacteriaceae,,,,Pectobacterium,,,,Pectobacterium odoriferum,,,,,,,,,,,,,,,,,,,,,,,,
SNPTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (63%);3.1.-.- (63%);2.4.2.9 (7%),RING-type E3 ubiquitin transferase (63%);Acting on ester bonds (63%);Uracil phosphoribosyltransferase (7%),GO:0016021 (29%);GO:0005634 (26%);GO:0005737 (3%),integral component of membrane (29%);nucleus (26%);cytoplasm (3%),GO:0008270 (18%);GO:0043565 (16%);GO:0061630 (15%),zinc ion binding (18%);sequence-specific DNA binding (16%);ubiquitin protein ligase activity (15%),GO:0010390 (15%);GO:0030183 (15%);GO:0033077 (15%),histone monoubiquitination (15%);B cell differentiation (15%);T cell differentiation in thymus (15%),IPR018809 (20%);IPR024627 (9%);IPR000408 (4%),Protein of unknown function DUF2406 (20%);V(D)J recombination-activating protein 1 (9%);Regulator of chromosome condensation, RCC1 (4%),,,,,,,,,,
LSDNLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (18%);5.6.2.1 (11%);1.12.-.- (7%),Polyphosphate kinase (18%);DNA topoisomerase (11%);Acting on hydrogen as donors (7%),GO:0016021 (32%);GO:0030014 (13%);GO:0005829 (4%),integral component of membrane (32%);CCR4-NOT complex (13%);cytosol (4%),GO:0005524 (15%);GO:0016887 (4%);GO:0004672 (4%),ATP binding (15%);ATPase activity (4%);protein kinase activity (4%),GO:0006402 (13%);GO:0006895 (4%);GO:0000289 (4%),mRNA catabolic process (13%);Golgi to endosome transport (4%);nuclear-transcribed mRNA poly(A) tail shortening (4%),IPR011989 (16%);IPR016024 (16%);IPR007216 (16%),Armadillo-like helical (16%);Armadillo-type fold (16%);CCR4-NOT transcription complex subunit 9 (16%),,,,,,,,,,,
LVTPTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),GO:0016021 (70%);GO:0005576 (50%);GO:0005618 (50%),integral component of membrane (70%);extracellular region (50%);cell wall (50%),GO:0005524 (30%);GO:0003824 (20%);GO:0008233 (20%),ATP binding (30%);catalytic activity (20%);peptidase activity (20%),GO:0006281 (10%);GO:0006310 (10%);GO:0009432 (10%),DNA repair (10%);DNA recombination (10%);SOS response (10%),IPR021197 (29%);IPR026345 (29%);IPR032300 (29%),Cross-wall-targeting lipoprotein motif (29%);Adhesin isopeptide-forming adherence domain (29%);Cell surface antigen, C-terminal (29%),,,,,,,,,,
GDANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (63%);3.4.21.89 (10%);4.1.1.23 (6%),Isoleucine--tRNA ligase (63%);Signal peptidase I (10%);Orotidine-5'-phosphate decarboxylase (6%),GO:0005737 (21%);GO:0016021 (20%);GO:0016020 (18%),cytoplasm (21%);integral component of membrane (20%);membrane (18%),GO:0005524 (25%);GO:0004822 (19%);GO:0000049 (16%),ATP binding (25%);isoleucine-tRNA ligase activity (19%);tRNA binding (16%),GO:0006428 (18%);GO:0006465 (7%);GO:0006412 (2%),isoleucyl-tRNA aminoacylation (18%);signal peptide processing (7%);translation (2%),IPR001107 (18%);IPR036013 (18%);IPR001972 (18%),Band 7 domain (18%);Band 7/SPFH domain superfamily (18%);Stomatin family (18%),,,,,,,,,,,
GVDVHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016887 (100%);GO:0042626 (100%),ATP binding (100%);ATPase activity (100%);ATPase-coupled transmembrane transporter activity (100%),,,IPR003439 (100%);IPR026082 (100%);IPR027417 (100%),ABC transporter-like (100%);ABC transporter A (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,,,
EVCPPPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNTEDLEGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAAEYYVTYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EWLHDLLR,Thermotoga naphthophila,Bacteria,,,,Thermotogae,,,Thermotogae,,,,Thermotogales,,,,,Thermotogaceae,,,,Thermotoga,,,,Thermotoga naphthophila,,,,,,,,GO:0016301 (100%);GO:0016773 (100%),kinase activity (100%);phosphotransferase activity, alcohol group as acceptor (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR000577 (100%);IPR018484 (100%);IPR018485 (100%),Carbohydrate kinase, FGGY (100%);Carbohydrate kinase, FGGY, N-terminal (100%);Carbohydrate kinase, FGGY, C-terminal (100%),,,,,
WNPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (38%);7.1.3.1 (17%);2.1.1.- (4%),Ribonucleoside-diphosphate reductase (38%);H(+)-exporting diphosphatase (17%);Methyltransferases (4%),GO:0009279 (29%);GO:0046930 (27%);GO:0016021 (21%),cell outer membrane (29%);pore complex (27%);integral component of membrane (21%),GO:0015288 (27%);GO:0016491 (8%);GO:0030599 (8%),porin activity (27%);oxidoreductase activity (8%);pectinesterase activity (8%),GO:0006811 (27%);GO:0042545 (8%);GO:0005975 (4%),ion transport (27%);cell wall modification (8%);carbohydrate metabolic process (4%),IPR003684 (25%);IPR011050 (7%);IPR012334 (7%),Porin, alpha proteobacteria type (25%);Pectin lyase fold/virulence factor (7%);Pectin lyase fold (7%),,,,,,,,,,
LLAADER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.8 (42%);3.4.11.- (14%);3.2.1.23 (8%),Polyribonucleotide nucleotidyltransferase (42%);Aminopeptidases (14%);Beta-galactosidase (8%),GO:0016021 (18%);GO:0005737 (13%);GO:0009341 (2%),integral component of membrane (18%);cytoplasm (13%);beta-galactosidase complex (2%),GO:0005524 (21%);GO:0003677 (19%);GO:0003723 (12%),ATP binding (21%);DNA binding (19%);RNA binding (12%),GO:0006355 (12%);GO:0006402 (12%);GO:0000160 (11%),regulation of transcription, DNA-templated (12%);mRNA catabolic process (12%);phosphorelay signal transduction system (11%),IPR027417 (21%);IPR012340 (12%);IPR003029 (11%),P-loop containing nucleoside triphosphate hydrolase (21%);Nucleic acid-binding, OB-fold (12%);S1 domain (11%),,,,,,,,,
MVGGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.3 (37%);2.7.4.6 (17%);2.7.1.144 (3%),Guanine deaminase (37%);Nucleoside-diphosphate kinase (17%);Tagatose-6-phosphate kinase (3%),GO:0016021 (21%);GO:0005737 (7%);GO:0005886 (3%),integral component of membrane (21%);cytoplasm (7%);plasma membrane (3%),GO:0005524 (16%);GO:0008270 (10%);GO:0046872 (8%),ATP binding (16%);zinc ion binding (10%);metal ion binding (8%),GO:0006147 (8%);GO:0006183 (4%);GO:0006228 (4%),guanine catabolic process (8%);GTP biosynthetic process (4%);UTP biosynthetic process (4%),IPR027417 (9%);IPR032466 (8%);IPR006680 (8%),P-loop containing nucleoside triphosphate hydrolase (9%);Metal-dependent hydrolase (8%);Amidohydrolase-related (8%),,,,,,,,,,,
LLDLSNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.6.3 (29%);2.3.1.269 (12%);2.7.1.113 (12%),2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase (29%);Apolipoprotein N-acyltransferase (12%);Deoxyguanosine kinase (12%),GO:0016021 (11%);GO:0005634 (2%);GO:0005886 (2%),integral component of membrane (11%);nucleus (2%);plasma membrane (2%),GO:0003700 (30%);GO:0005524 (13%);GO:0003677 (11%),DNA-binding transcription factor activity (30%);ATP binding (13%);DNA binding (11%),GO:0009396 (9%);GO:0006355 (5%);GO:0009058 (4%),folic acid-containing compound biosynthetic process (9%);regulation of transcription, DNA-templated (5%);biosynthetic process (4%),IPR027417 (25%);IPR004827 (24%);IPR000550 (9%),P-loop containing nucleoside triphosphate hydrolase (25%);Basic-leucine zipper domain (24%);7,8-Dihydro-6-hydroxymethylpterin-pyrophosphokinase, HPPK (9%),,,,,,,,
LHLSLYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.- (33%);4.1.2.17 (33%);4.2.1.109 (33%),Phosphotransferases with an alcohol group as acceptor (33%);L-fuculose-phosphate aldolase (33%);Methylthioribulose 1-phosphate dehydratase (33%),GO:0005623 (13%);GO:0005634 (13%);GO:0016021 (13%),cell (13%);nucleus (13%);integral component of membrane (13%),GO:0003677 (25%);GO:0003824 (25%);GO:0004396 (13%),DNA binding (25%);catalytic activity (25%);hexokinase activity (13%),GO:0001678 (13%);GO:0006096 (13%);GO:0006313 (13%),cellular glucose homeostasis (13%);glycolytic process (13%);transposition, DNA-mediated (13%),IPR001303 (43%);IPR036409 (43%);IPR000873 (14%),Class II aldolase/adducin N-terminal (43%);Class II aldolase/adducin N-terminal domain superfamily (43%);AMP-dependent synthetase/ligase (14%),,,,,,,,,,
MLDGHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.42 (40%);2.7.7.89 (40%);1.5.1.2 (20%),[Glutamine synthetase] adenylyltransferase (40%);[Glutamine synthetase]-adenylyl-L-tyrosine phosphorylase (40%);Pyrroline-5-carboxylate reductase (20%),GO:0016021 (29%);GO:0005886 (8%),integral component of membrane (29%);plasma membrane (8%),GO:0005524 (19%);GO:0004364 (10%);GO:0022857 (10%),ATP binding (19%);glutathione transferase activity (10%);transmembrane transporter activity (10%),GO:0032366 (15%);GO:0000820 (4%);GO:0006529 (4%),intracellular sterol transport (15%);regulation of glutamine family amino acid metabolic process (4%);asparagine biosynthetic process (4%),IPR039564 (19%);IPR003172 (10%);IPR014756 (10%),Peptidase C39-like (19%);MD-2-related lipid-recognition domain (10%);Immunoglobulin E-set (10%),,,,,,,,,,,
EATNPMR,Syntrophobacter fumaroxidans,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Syntrophobacterales,,,,,Syntrophobacteraceae,,,,Syntrophobacter,,,,Syntrophobacter fumaroxidans,,,,,,,,,,,,,,,,,,,,,,,,
TQWVCAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YMNTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (24%);3.5.4.25 (16%);4.1.99.12 (16%),Nucleotidyltransferases (24%);GTP cyclohydrolase II (16%);3,4-dihydroxy-2-butanone-4-phosphate synthase (16%),GO:0016021 (25%);GO:0005634 (8%);GO:0009279 (4%),integral component of membrane (25%);nucleus (8%);cell outer membrane (4%),GO:0003677 (19%);GO:0005524 (14%);GO:0008270 (7%),DNA binding (19%);ATP binding (14%);zinc ion binding (7%),GO:0017000 (18%);GO:0006281 (7%);GO:0009116 (5%),antibiotic biosynthetic process (18%);DNA repair (7%);nucleoside metabolic process (5%),IPR004964 (14%);IPR032710 (13%);IPR028081 (11%),Phenazine biosynthesis protein A/B (14%);NTF2-like domain superfamily (13%);Leucine-binding protein domain (11%),,,,,,,,,,
MMELLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%);GO:0005886 (29%),integral component of membrane (100%);plasma membrane (29%),GO:0000155 (43%);GO:0005524 (43%),phosphorelay sensor kinase activity (43%);ATP binding (43%),GO:0055085 (14%),transmembrane transport (14%),IPR003594 (43%);IPR003661 (43%);IPR004358 (43%),Histidine kinase/HSP90-like ATPase (43%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (43%);Signal transduction histidine kinase-related protein, C-terminal (43%),,,,,,,,,
ANGVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.1 (9%);2.1.2.11 (7%);1.11.1.15 (6%),Acetate--CoA ligase (9%);3-methyl-2-oxobutanoate hydroxymethyltransferase (7%);Peroxiredoxin (6%),GO:0016021 (13%);GO:0005737 (6%);GO:0005623 (3%),integral component of membrane (13%);cytoplasm (6%);cell (3%),GO:0005524 (15%);GO:0030975 (11%);GO:0046872 (9%),ATP binding (15%);thiamine binding (11%);metal ion binding (9%),GO:0015888 (11%);GO:0005975 (5%);GO:0045454 (3%),thiamine transport (11%);carbohydrate metabolic process (5%);cell redox homeostasis (3%),IPR027417 (11%);IPR005948 (10%);IPR036291 (5%),P-loop containing nucleoside triphosphate hydrolase (11%);Thiamine/thiamin pyrophosphate-binding periplasmic protein, ABC transporter (10%);NAD(P)-binding domain superfamily (5%),,,,,,,,,,
YELAPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (86%);GO:0005887 (7%),integral component of membrane (86%);integral component of plasma membrane (7%),GO:0022857 (86%);GO:0005351 (7%);GO:0008483 (7%),transmembrane transporter activity (86%);carbohydrate:proton symporter activity (7%);transaminase activity (7%),GO:0046323 (7%),glucose import (7%),IPR005828 (81%);IPR020846 (81%);IPR036259 (81%),Major facilitator,  sugar transporter-like (81%);Major facilitator superfamily domain (81%);MFS transporter superfamily (81%),,,,,,,,,,
VVNSPGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMASVMK,Rubrivivax,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,,,,,Rubrivivax,,,,,,,,3.4.16.4 (100%),Serine-type D-Ala-D-Ala carboxypeptidase (100%),,,GO:0009002 (100%),serine-type D-Ala-D-Ala carboxypeptidase activity (100%),,,IPR000667 (100%);IPR012338 (100%),Peptidase S13, D-Ala-D-Ala carboxypeptidase C (100%);Beta-lactamase/transpeptidase-like (100%),,,,,,,,,,
LNVLMPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.35 (100%),tRNA (uracil(54)-C(5))-methyltransferase (100%),,,GO:0016301 (50%);GO:0003824 (25%);GO:0030697 (25%),kinase activity (50%);catalytic activity (25%);S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity (25%),GO:0055114 (25%),oxidation-reduction process (25%),IPR011611 (50%);IPR029056 (50%);IPR001093 (25%),Carbohydrate kinase PfkB (50%);Ribokinase-like (50%);IMP dehydrogenase/GMP reductase (25%),,,,,,,,,,,
LLASTDLMGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPNTLMLGMHGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVVMGKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLFHHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.11 (50%);1.8.4.11 (50%),Aspartate-semialdehyde dehydrogenase (50%);Peptide-methionine (S)-S-oxide reductase (50%),GO:0016021 (70%);GO:0005886 (10%);GO:0016020 (10%),integral component of membrane (70%);plasma membrane (10%);membrane (10%),GO:0000225 (10%);GO:0004073 (10%);GO:0005044 (10%),N-acetylglucosaminylphosphatidylinositol deacetylase activity (10%);aspartate-semialdehyde dehydrogenase activity (10%);scavenger receptor activity (10%),GO:0050909 (20%);GO:0006464 (10%);GO:0006506 (10%),sensory perception of taste (20%);cellular protein modification process (10%);GPI anchor biosynthetic process (10%),IPR004045 (19%);IPR036249 (19%);IPR036282 (19%),Glutathione S-transferase, N-terminal (19%);Thioredoxin-like superfamily (19%);Glutathione S-transferase, C-terminal domain superfamily (19%),,,,,,,,,
YLNGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (17%);2.7.2.11 (17%);1.2.4.1 (14%),Nucleotidyltransferases (17%);Glutamate 5-kinase (17%);Pyruvate dehydrogenase (acetyl-transferring) (14%),GO:0016021 (35%);GO:0005737 (7%);GO:1990077 (4%),integral component of membrane (35%);cytoplasm (7%);primosome complex (4%),GO:0003677 (25%);GO:0005524 (16%);GO:0004553 (8%),DNA binding (25%);ATP binding (16%);hydrolase activity, hydrolyzing O-glycosyl compounds (8%),GO:0005975 (7%);GO:0019538 (4%);GO:0006355 (4%),carbohydrate metabolic process (7%);protein metabolic process (4%);regulation of transcription, DNA-templated (4%),IPR001387 (14%);IPR010982 (13%);IPR021224 (10%),Cro/C1-type helix-turn-helix domain (14%);Lambda repressor-like, DNA-binding domain superfamily (13%);Protein of unknown function DUF2690 (10%),,,,,,,,
SALVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.2 (26%);5.3.1.26 (16%);6.1.1.5 (9%),Glutamine synthetase (26%);Galactose-6-phosphate isomerase (16%);Isoleucine--tRNA ligase (9%),GO:0016021 (16%);GO:0005737 (11%);GO:0005634 (2%),integral component of membrane (16%);cytoplasm (11%);nucleus (2%),GO:0004356 (20%);GO:0005524 (18%);GO:0003677 (10%),glutamate-ammonia ligase activity (20%);ATP binding (18%);DNA binding (10%),GO:0006542 (19%);GO:0019388 (4%);GO:0019512 (4%),glutamine biosynthetic process (19%);galactose catabolic process (4%);lactose catabolic process via tagatose-6-phosphate (4%),IPR014746 (18%);IPR008146 (18%);IPR036651 (17%),Glutamine synthetase/guanido kinase, catalytic domain (18%);Glutamine synthetase, catalytic domain (18%);Glutamine synthetase, N-terminal domain superfamily (17%),,,,,,,,
LSMLLSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (100%);GO:0005623 (100%);GO:0031232 (100%),extracellular space (100%);cell (100%);extrinsic component of external side of plasma membrane (100%),GO:0004252 (100%);GO:0005102 (100%);GO:0019900 (100%),serine-type endopeptidase activity (100%);signaling receptor binding (100%);kinase binding (100%),GO:0007596 (100%);GO:0010812 (100%);GO:0022617 (100%),blood coagulation (100%);negative regulation of cell-substrate adhesion (100%);extracellular matrix disassembly (100%),IPR000001 (100%);IPR001254 (100%);IPR001314 (100%),Kringle (100%);Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%),,,,,,,,,
MLGPDVMAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVVEDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (37%);GO:0005887 (1%);GO:0005886 (0%),integral component of membrane (37%);integral component of plasma membrane (1%);plasma membrane (0%),GO:0000155 (62%);GO:0003677 (28%);GO:0005524 (5%),phosphorelay sensor kinase activity (62%);DNA binding (28%);ATP binding (5%),GO:0000160 (32%);GO:0006355 (30%);GO:0030154 (1%),phosphorelay signal transduction system (32%);regulation of transcription, DNA-templated (30%);cell differentiation (1%),IPR001789 (99%);IPR011006 (99%);IPR005467 (68%),Signal transduction response regulator, receiver domain (99%);CheY-like superfamily (99%);Histidine kinase domain (68%),,,,,,,,,
NEEMHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.5.11 (50%);6.3.3.1 (50%),NADH dehydrogenase (quinone) (50%);Phosphoribosylformylglycinamidine cyclo-ligase (50%),GO:0016021 (96%);GO:0030870 (0%);GO:0043190 (0%),integral component of membrane (96%);Mre11 complex (0%);ATP-binding cassette (ABC) transporter complex (0%),GO:0051536 (91%);GO:0005524 (1%);GO:0047429 (1%),iron-sulfur cluster binding (91%);ATP binding (1%);nucleoside-triphosphate diphosphatase activity (1%),GO:0009143 (1%);GO:0006302 (0%);GO:0006355 (0%),nucleoside triphosphate catabolic process (1%);double-strand break repair (0%);regulation of transcription, DNA-templated (0%),IPR004017 (97%);IPR009051 (95%);IPR017896 (95%),Cysteine-rich domain (97%);Alpha-helical ferredoxin (95%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (95%),,,,,,,,,
FDAMLNAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGVDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.9 (22%);2.7.1.33 (14%);3.6.-.- (7%),Xaa-Pro aminopeptidase (22%);Pantothenate kinase (14%);Acting on acid anhydrides (7%),GO:0016021 (16%);GO:0005737 (12%);GO:0005886 (2%),integral component of membrane (16%);cytoplasm (12%);plasma membrane (2%),GO:0005524 (13%);GO:0004177 (10%);GO:0046872 (9%),ATP binding (13%);aminopeptidase activity (10%);metal ion binding (9%),GO:0015937 (4%);GO:0006813 (3%);GO:0006400 (2%),coenzyme A biosynthetic process (4%);potassium ion transport (3%);tRNA modification (2%),IPR036005 (8%);IPR029149 (8%);IPR000994 (8%),Creatinase/aminopeptidase-like (8%);Creatinase/Aminopeptidase P/Spt16, N-terminal (8%);Peptidase M24 (8%),,,,,,,,,,
QVVAQTAVPDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FYNMFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (50%);6.1.1.27 (50%),Peptidylprolyl isomerase (50%);O-phosphoserine--tRNA ligase (50%),GO:0016021 (11%),integral component of membrane (11%),GO:0003824 (22%);GO:0005506 (22%);GO:0016706 (22%),catalytic activity (22%);iron ion binding (22%);2-oxoglutarate-dependent dioxygenase activity (22%),GO:0006412 (11%);GO:0043039 (11%),translation (11%);tRNA aminoacylation (11%),IPR001173 (30%);IPR029044 (30%);IPR000873 (20%),Glycosyltransferase 2-like (30%);Nucleotide-diphospho-sugar transferases (30%);AMP-dependent synthetase/ligase (20%),,,,,,,,,,,
NLAMRPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (50%);GO:0016021 (50%),plasma membrane (50%);integral component of membrane (50%),GO:0005524 (50%);GO:0022857 (50%),ATP binding (50%);transmembrane transporter activity (50%),GO:0071705 (50%),nitrogen compound transport (50%),IPR000060 (50%);IPR001482 (50%);IPR003593 (50%),BCCT transporter family (50%);Type II/IV secretion system protein (50%);AAA+ ATPase domain (50%),,,,,,,,,,,
QLMMSTLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGLSVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.88 (9%);1.5.5.2 (9%);3.5.1.44 (9%),L-glutamate gamma-semialdehyde dehydrogenase (9%);Proline dehydrogenase (9%);Protein-glutamine glutaminase (9%),GO:0016021 (37%);GO:0008290 (4%);GO:0005634 (3%),integral component of membrane (37%);F-actin capping protein complex (4%);nucleus (3%),GO:0005524 (15%);GO:0022857 (12%);GO:0003676 (6%),ATP binding (15%);transmembrane transporter activity (12%);nucleic acid binding (6%),GO:0051016 (4%);GO:0000077 (3%);GO:0051301 (2%),barbed-end actin filament capping (4%);DNA damage checkpoint (3%);cell division (2%),IPR015168 (14%);IPR001638 (13%);IPR001036 (7%),SsuA/THI5-like (14%);Solute-binding protein  family 3/N-terminal domain of MltF (13%);Acriflavin resistance protein (7%),,,,,,,,,,,
NQEAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WCGAPNSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QATLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (73%);2.7.13.3 (2%);2.7.11.1 (2%),DNA helicase (73%);Histidine kinase (2%);Non-specific serine/threonine protein kinase (2%),GO:0016021 (20%);GO:0005737 (4%);GO:0005886 (2%),integral component of membrane (20%);cytoplasm (4%);plasma membrane (2%),GO:0005524 (35%);GO:0003678 (26%);GO:0003676 (24%),ATP binding (35%);DNA helicase activity (26%);nucleic acid binding (24%),GO:0006310 (24%);GO:0006281 (24%);GO:0005975 (6%),DNA recombination (24%);DNA repair (24%);carbohydrate metabolic process (6%),IPR027417 (33%);IPR014001 (23%);IPR001650 (23%),P-loop containing nucleoside triphosphate hydrolase (33%);Helicase superfamily 1/2, ATP-binding domain (23%);Helicase, C-terminal (23%),,,,,,,,,
NALSSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (50%);3.1.21.2 (50%),Hexosyltransferases (50%);Deoxyribonuclease IV (50%),GO:0016021 (63%);GO:0000139 (16%);GO:0005576 (11%),integral component of membrane (63%);Golgi membrane (16%);extracellular region (11%),GO:0003677 (16%);GO:0008270 (16%);GO:0008378 (16%),DNA binding (16%);zinc ion binding (16%);galactosyltransferase activity (16%),GO:0006281 (16%);GO:0006486 (16%);GO:0015031 (5%),DNA repair (16%);protein glycosylation (16%);protein transport (5%),IPR000620 (39%);IPR001719 (17%);IPR002659 (17%),EamA domain (39%);AP endonuclease 2 (17%);Glycosyl transferase, family 31 (17%),,,,,,,,,,
TLPQMNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QANNSWMGNLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTVLPELDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDLTQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.83 (20%);3.2.1.8 (20%);3.5.1.9 (20%),Precorrin-3B synthase (20%);Endo-1,4-beta-xylanase (20%);Arylformamidase (20%),GO:0016021 (11%);GO:0005654 (3%);GO:0005886 (3%),integral component of membrane (11%);nucleoplasm (3%);plasma membrane (3%),GO:0003676 (45%);GO:0046872 (31%);GO:0003677 (16%),nucleic acid binding (45%);metal ion binding (31%);DNA binding (16%),GO:0006355 (47%);GO:0000160 (4%);GO:0006306 (2%),regulation of transcription, DNA-templated (47%);phosphorelay signal transduction system (4%);DNA methylation (2%),IPR001909 (40%);IPR036051 (40%);IPR013087 (30%),Krueppel-associated box (40%);KRAB domain superfamily (40%);Zinc finger C2H2-type (30%),,,,,,,,,
WGLDLLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0030915 (96%);GO:0005634 (4%);GO:0009279 (4%),Smc5-Smc6 complex (96%);nucleus (4%);cell outer membrane (4%),GO:0016787 (25%);GO:0005524 (8%);GO:0003779 (4%),hydrolase activity (25%);ATP binding (8%);actin binding (4%),GO:0000724 (96%);GO:0007062 (96%);GO:0000160 (4%),double-strand break repair via homologous recombination (96%);sister chromatid cohesion (96%);phosphorelay signal transduction system (4%),IPR027131 (96%);IPR027417 (79%);IPR003395 (50%),Structural maintenance of chromosomes protein 5 (96%);P-loop containing nucleoside triphosphate hydrolase (79%);RecF/RecN/SMC, N-terminal (50%),,,,,,,,,,
GNGPVSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (33%);GO:0009279 (33%);GO:0015627 (33%),nucleus (33%);cell outer membrane (33%);type II protein secretion system complex (33%),,,GO:0015628 (33%);GO:0015891 (33%),protein secretion by the type II secretion system (33%);siderophore transport (33%),IPR038765 (29%);IPR000531 (14%);IPR000600 (14%),Papain-like cysteine peptidase superfamily (29%);TonB-dependent receptor-like, beta-barrel (14%);ROK family (14%),,,,,,,,,,
NMYDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.225 (26%);3.2.1.- (21%);2.4.2.1 (5%),Protein S-acyltransferase (26%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (21%);Purine-nucleoside phosphorylase (5%),GO:0016021 (27%);GO:0030286 (7%);GO:0016020 (2%),integral component of membrane (27%);dynein complex (7%);membrane (2%),GO:0005524 (31%);GO:0003777 (7%);GO:0003677 (4%),ATP binding (31%);microtubule motor activity (7%);DNA binding (4%),GO:0007018 (7%);GO:0008299 (4%);GO:0030242 (4%),microtubule-based movement (7%);isoprenoid biosynthetic process (4%);autophagy of peroxisome (4%),IPR027417 (23%);IPR003714 (16%);IPR002716 (15%),P-loop containing nucleoside triphosphate hydrolase (23%);PhoH-like protein (16%);PIN domain (15%),,,,,,,,,,
LVAGQLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFDSWMYVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEMDTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (80%);4.1.1.36 (20%);6.3.2.5 (20%),L-aspartate oxidase (80%);Phosphopantothenoylcysteine decarboxylase (20%);Phosphopantothenate--cysteine ligase (CTP) (20%),GO:0005737 (44%);GO:0016021 (15%);GO:0005634 (4%),cytoplasm (44%);integral component of membrane (15%);nucleus (4%),GO:0008734 (44%);GO:0044318 (44%);GO:0004632 (11%),L-aspartate oxidase activity (44%);L-aspartate:fumarate oxidoreductase activity (44%);phosphopantothenate--cysteine ligase activity (11%),GO:0009435 (44%);GO:0015937 (11%);GO:0015941 (11%),NAD biosynthetic process (44%);coenzyme A biosynthetic process (11%);pantothenate catabolic process (11%),IPR003953 (41%);IPR005288 (41%);IPR015939 (41%),FAD-dependent oxidoreductase 2, FAD binding domain (41%);L-aspartate oxidase (41%);Fumarate reductase/succinate dehydrogenase flavoprotein-like, C-terminal (41%),,,,,,,,,
FVVLGSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAGYQANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLCNQVR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0005737 (80%),cytoplasm (80%),GO:0003887 (80%);GO:0008408 (80%);GO:0005524 (20%),DNA-directed DNA polymerase activity (80%);3'-5' exonuclease activity (80%);ATP binding (20%),GO:0006260 (80%),DNA replication (80%),IPR003141 (80%);IPR004013 (80%);IPR004805 (80%),Polymerase/histidinol phosphatase, N-terminal (80%);PHP domain (80%);DNA polymerase III, alpha subunit (80%),,,,,,,,,
SLNATSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVALPDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.8 (88%);3.1.26.11 (13%),Polyribonucleotide nucleotidyltransferase (88%);Ribonuclease Z (13%),GO:0005737 (70%);GO:0016021 (20%),cytoplasm (70%);integral component of membrane (20%),GO:0000287 (70%);GO:0003723 (70%);GO:0004654 (70%),magnesium ion binding (70%);RNA binding (70%);polyribonucleotide nucleotidyltransferase activity (70%),GO:0006402 (70%);GO:0006396 (60%);GO:0034414 (10%),mRNA catabolic process (70%);RNA processing (60%);tRNA 3'-trailer cleavage, endonucleolytic (10%),IPR001247 (78%);IPR003029 (78%);IPR004087 (78%),Exoribonuclease, phosphorolytic domain 1 (78%);S1 domain (78%);K Homology domain (78%),,,,,,,,,
VEALNNGNNTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLSVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (73%);2.3.1.- (22%);3.6.4.12 (1%),Acting on ATP; involved in cellular and subcellular movement (73%);Transferring groups other than amino-acyl groups (22%);DNA helicase (1%),GO:0016021 (37%);GO:1990077 (34%);GO:0005789 (5%),integral component of membrane (37%);primosome complex (34%);endoplasmic reticulum membrane (5%),GO:0003677 (42%);GO:0005524 (37%);GO:0003678 (36%),DNA binding (42%);ATP binding (37%);DNA helicase activity (36%),GO:0006268 (34%);GO:0006269 (34%);GO:0019432 (5%),DNA unwinding involved in DNA replication (34%);DNA replication, synthesis of RNA primer (34%);triglyceride biosynthetic process (5%),IPR005259 (25%);IPR041222 (25%);IPR042115 (25%),Primosomal protein N' (25%);Primosomal protein N', 3' DNA-binding domain (25%);Primosomal protein N', 3' DNA-binding domain superfamily (25%),,,,,,,,
TNTWTSQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMFFSNLCAFFGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMGEVLNVLDDTHMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGVLVWK,Flavobacteriales,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,,,,,,,,,,,,,,,,,GO:0005509 (100%),calcium ion binding (100%),,,IPR026341 (100%);IPR018247 (50%);IPR028974 (50%),Gliding motility-associated, C-terminal domain (100%);EF-Hand 1, calcium-binding site (50%);TSP type-3 repeat (50%),,,,,,,,,
FGALSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.3 (43%);1.12.7.2 (14%);2.7.7.7 (14%),Deoxyribodipyrimidine photo-lyase (43%);Ferredoxin hydrogenase (14%);DNA-directed DNA polymerase (14%),GO:0016021 (22%);GO:0005737 (5%);GO:0005769 (3%),integral component of membrane (22%);cytoplasm (5%);early endosome (3%),GO:0016829 (30%);GO:0046872 (14%);GO:0051539 (14%),lyase activity (30%);metal ion binding (14%);4 iron, 4 sulfur cluster binding (14%),GO:0018298 (30%);GO:0000724 (3%);GO:0006261 (3%),protein-chromophore linkage (30%);double-strand break repair via homologous recombination (3%);DNA-dependent DNA replication (3%),IPR014729 (41%);IPR005101 (39%);IPR006050 (39%),Rossmann-like alpha/beta/alpha sandwich fold (41%);Cryptochrome/DNA photolyase, FAD-binding domain (39%);DNA photolyase, N-terminal (39%),,,,,,,,
NGTVMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (70%);GO:0005886 (35%);GO:0005840 (5%),integral component of membrane (70%);plasma membrane (35%);ribosome (5%),GO:0022857 (15%);GO:0003676 (5%);GO:0003677 (5%),transmembrane transporter activity (15%);nucleic acid binding (5%);DNA binding (5%),GO:0055085 (25%);GO:0006355 (5%);GO:0006412 (5%),transmembrane transport (25%);regulation of transcription, DNA-templated (5%);translation (5%),IPR000515 (21%);IPR010330 (21%);IPR021176 (21%),ABC transporter type 1, transmembrane domain MetI-like (21%);Competence-induced protein CoiA-like (21%);Competence-induced protein CoiA (21%),,,,,,,,,
AENVLGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WCFTLPK,Pusillimonas ginsengisoli,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Alcaligenaceae,,,,Pusillimonas,,,,Pusillimonas ginsengisoli,,,,,,,,GO:0003677 (100%);GO:0003700 (50%),DNA binding (100%);DNA-binding transcription factor activity (50%),,,IPR000847 (100%);IPR005119 (100%);IPR036388 (100%),Transcription regulator HTH, LysR (100%);LysR, substrate-binding (100%);Winged helix-like DNA-binding domain superfamily (100%),,,,,,,,,
QASLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.88 (44%);2.7.1.130 (8%);1.11.1.6 (7%),Hydroxymethylglutaryl-CoA reductase (44%);Tetraacyldisaccharide 4'-kinase (8%);Catalase (7%),GO:0016021 (47%);GO:0005886 (30%);GO:0005737 (4%),integral component of membrane (47%);plasma membrane (30%);cytoplasm (4%),GO:0015649 (31%);GO:0005524 (9%);GO:0008017 (8%),2-keto-3-deoxygluconate:proton symporter activity (31%);ATP binding (9%);microtubule binding (8%),GO:0010497 (7%);GO:0015936 (7%);GO:0005975 (4%),plasmodesmata-mediated intercellular transport (7%);coenzyme A metabolic process (7%);carbohydrate metabolic process (4%),IPR004684 (45%);IPR027417 (6%);IPR040289 (5%),2-keto-3-deoxygluconate permease (45%);P-loop containing nucleoside triphosphate hydrolase (6%);Microtubule binding protein 2C (5%),,,,,,,,,,,
FTLSVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (100%),Acting on peptide bonds (peptidases) (100%),GO:0016021 (67%);GO:0009279 (50%),integral component of membrane (67%);cell outer membrane (50%),GO:0008233 (17%);GO:0016746 (17%);GO:0016787 (17%),peptidase activity (17%);transferase activity, transferring acyl groups (17%);hydrolase activity (17%),,,IPR002878 (44%);IPR012340 (44%);IPR022002 (44%),Domain of unknown function DUF35, OB-fold, C-terminal (44%);Nucleic acid-binding, OB-fold (44%);Domain of unknown function DUF35, rubredoxin-like zinc ribbon domain, N-terminal (44%),,,,,
LLFLTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.228 (56%);3.6.4.12 (22%);1.14.-.- (11%),tRNA (guanine(37)-N(1))-methyltransferase (56%);DNA helicase (22%);Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2) (11%),GO:0016021 (17%);GO:0005737 (12%);GO:0005634 (5%),integral component of membrane (17%);cytoplasm (12%);nucleus (5%),GO:0003700 (35%);GO:0003677 (22%);GO:0005524 (17%),DNA-binding transcription factor activity (35%);DNA binding (22%);ATP binding (17%),GO:0006310 (8%);GO:0006260 (3%);GO:0006281 (3%),DNA recombination (8%);DNA replication (3%);DNA repair (3%),IPR036388 (45%);IPR036390 (40%);IPR000835 (22%),Winged helix-like DNA-binding domain superfamily (45%);Winged helix DNA-binding domain superfamily (40%);MarR-type HTH domain (22%),,,,,,,,,,
SGSALSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAPLDEALGPWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSLQLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (100%),RING-type E3 ubiquitin transferase (100%),GO:0016021 (50%);GO:0005634 (14%);GO:0009654 (7%),integral component of membrane (50%);nucleus (14%);photosystem II oxygen evolving complex (7%),GO:0016491 (21%);GO:0004842 (14%);GO:0046872 (14%),oxidoreductase activity (21%);ubiquitin-protein transferase activity (14%);metal ion binding (14%),GO:0010390 (14%);GO:0007165 (7%);GO:0015979 (7%),histone monoubiquitination (14%);signal transduction (7%);photosynthesis (7%),IPR001841 (20%);IPR002347 (20%);IPR013083 (20%),Zinc finger, RING-type (20%);Short-chain dehydrogenase/reductase SDR (20%);Zinc finger, RING/FYVE/PHD-type (20%),,,,,,,,,
ASGDTLQSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DALPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.- (9%);1.4.1.2 (7%);5.6.2.2 (6%),Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (9%);Glutamate dehydrogenase (7%);DNA topoisomerase (ATP-hydrolyzing) (6%),GO:0016021 (16%);GO:0005737 (5%);GO:0005778 (3%),integral component of membrane (16%);cytoplasm (5%);peroxisomal membrane (3%),GO:0005524 (12%);GO:0004197 (7%);GO:0003677 (7%),ATP binding (12%);cysteine-type endopeptidase activity (7%);DNA binding (7%),GO:0044780 (4%);GO:0006629 (4%);GO:0016560 (3%),bacterial-type flagellum assembly (4%);lipid metabolic process (4%);protein import into peroxisome matrix, docking (3%),IPR027417 (7%);IPR038765 (6%);IPR004134 (6%),P-loop containing nucleoside triphosphate hydrolase (7%);Papain-like cysteine peptidase superfamily (6%);Peptidase C1B, bleomycin hydrolase (6%),,,,,,,,
EDLWPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (50%);3.6.3.28 (50%),DNA-directed DNA polymerase (50%);Transferred entry: 7.3.2.2 (50%),GO:0016021 (29%);GO:0005737 (2%);GO:0070824 (2%),integral component of membrane (29%);cytoplasm (2%);SHREC complex (2%),GO:0003677 (19%);GO:0016853 (13%);GO:0046872 (10%),DNA binding (19%);isomerase activity (13%);metal ion binding (10%),GO:0055085 (13%);GO:0005975 (8%);GO:0006429 (4%),transmembrane transport (13%);carbohydrate metabolic process (8%);leucyl-tRNA aminoacylation (4%),IPR036259 (16%);IPR001647 (12%);IPR009057 (12%),MFS transporter superfamily (16%);DNA-binding HTH domain, TetR-type (12%);Homeobox-like domain superfamily (12%),,,,,,,,,,
MEWFGSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVLMANK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0005737 (13%);GO:0016021 (13%);GO:0031977 (13%),cytoplasm (13%);integral component of membrane (13%);thylakoid lumen (13%),GO:0003824 (63%);GO:0050662 (63%);GO:0003887 (13%),catalytic activity (63%);coenzyme binding (63%);DNA-directed DNA polymerase activity (13%),GO:0006260 (13%);GO:0015979 (13%);GO:0055085 (13%),DNA replication (13%);photosynthesis (13%);transmembrane transport (13%),IPR001509 (67%);IPR036291 (67%);IPR003141 (11%),NAD-dependent epimerase/dehydratase (67%);NAD(P)-binding domain superfamily (67%);Polymerase/histidinol phosphatase, N-terminal (11%),,,,,,,,,,
EYDESGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (67%);GO:0004672 (33%),ATP binding (67%);protein kinase activity (33%),GO:0000160 (33%);GO:0006281 (33%);GO:0006310 (33%),phosphorelay signal transduction system (33%);DNA repair (33%);DNA recombination (33%),IPR011652 (55%);IPR027417 (36%);IPR008978 (32%),MORN variant (55%);P-loop containing nucleoside triphosphate hydrolase (36%);HSP20-like chaperone (32%),,,,,,,,,,,
MLGSADNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDQGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (12%);3.1.2.6 (11%);2.7.13.3 (5%),DNA topoisomerase (ATP-hydrolyzing) (12%);Hydroxyacylglutathione hydrolase (11%);Histidine kinase (5%),GO:0016021 (18%);GO:0005634 (7%);GO:0005576 (4%),integral component of membrane (18%);nucleus (7%);extracellular region (4%),GO:0003824 (13%);GO:0005524 (13%);GO:0003677 (10%),catalytic activity (13%);ATP binding (13%);DNA binding (10%),GO:0007218 (6%);GO:0006351 (4%);GO:0006397 (2%),neuropeptide signaling pathway (6%);transcription, DNA-templated (4%);mRNA processing (2%),IPR036291 (10%);IPR001509 (9%);IPR027417 (8%),NAD(P)-binding domain superfamily (10%);NAD-dependent epimerase/dehydratase (9%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
TEMLDVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.2.10 (61%);2.6.1.16 (6%);1.14.13.81 (3%),Phosphoglucosamine mutase (61%);Glutamine--fructose-6-phosphate transaminase (isomerizing) (6%);Magnesium-protoporphyrin IX monomethyl ester (oxidative) cyclase (3%),GO:0016021 (12%);GO:0005737 (9%);GO:0043190 (2%),integral component of membrane (12%);cytoplasm (9%);ATP-binding cassette (ABC) transporter complex (2%),GO:0008966 (30%);GO:0000287 (27%);GO:0005524 (10%),phosphoglucosamine mutase activity (30%);magnesium ion binding (27%);ATP binding (10%),GO:0005975 (29%);GO:1901137 (3%);GO:0006633 (3%),carbohydrate metabolic process (29%);carbohydrate derivative biosynthetic process (3%);fatty acid biosynthetic process (3%),IPR016055 (26%);IPR005846 (26%);IPR005845 (25%),Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III (26%);Alpha-D-phosphohexomutase, alpha/beta/alpha domain III (26%);Alpha-D-phosphohexomutase, alpha/beta/alpha domain II (25%),,,,,,,,
NMTVMMDALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFETPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.-.-.- (29%);6.3.2.2 (29%);1.4.1.2 (16%),Lyases (29%);Glutamate--cysteine ligase (29%);Glutamate dehydrogenase (16%),GO:0016021 (19%);GO:0005737 (2%);GO:0005634 (1%),integral component of membrane (19%);cytoplasm (2%);nucleus (1%),GO:0004352 (22%);GO:0003700 (21%);GO:0043565 (21%),glutamate dehydrogenase (NAD+) activity (22%);DNA-binding transcription factor activity (21%);sequence-specific DNA binding (21%),GO:0019551 (21%);GO:0055085 (11%);GO:0008616 (6%),glutamate catabolic process to 2-oxoglutarate (21%);transmembrane transport (11%);queuosine biosynthetic process (6%),IPR009057 (19%);IPR036291 (19%);IPR007780 (18%),Homeobox-like domain superfamily (19%);NAD(P)-binding domain superfamily (19%);NAD-glutamate dehydrogenase, bacteria (18%),,,,,,,,,,
VNSSLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (70%);GO:0005743 (22%);GO:0005634 (4%),integral component of membrane (70%);mitochondrial inner membrane (22%);nucleus (4%),GO:0003677 (13%);GO:0004519 (9%);GO:0003824 (4%),DNA binding (13%);endonuclease activity (9%);catalytic activity (4%),GO:0009307 (9%);GO:0006351 (4%);GO:0016999 (4%),DNA restriction-modification system (9%);transcription, DNA-templated (4%);antibiotic metabolic process (4%),IPR019133 (33%);IPR007560 (13%);IPR011335 (13%),Mitochondrial inner membrane protein Mitofilin (33%);Restriction endonuclease type IV,  Mrr (13%);Restriction endonuclease  type II-like (13%),,,,,,,,,
TLPEECNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEEDLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (61%);6.1.1.9 (7%);3.2.1.- (6%),Histidine kinase (61%);Valine--tRNA ligase (7%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (6%),GO:0016021 (52%);GO:0005737 (7%);GO:0005634 (2%),integral component of membrane (52%);cytoplasm (7%);nucleus (2%),GO:0005524 (43%);GO:0000155 (29%);GO:0004386 (8%),ATP binding (43%);phosphorelay sensor kinase activity (29%);helicase activity (8%),GO:0006260 (2%);GO:0006438 (2%);GO:0006511 (2%),DNA replication (2%);valyl-tRNA aminoacylation (2%);ubiquitin-dependent protein catabolic process (2%),IPR003594 (25%);IPR005467 (25%);IPR036890 (25%),Histidine kinase/HSP90-like ATPase (25%);Histidine kinase domain (25%);Histidine kinase/HSP90-like ATPase superfamily (25%),,,,,,,,,,
SVNLPDGR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016757 (100%),transferase activity, transferring glycosyl groups (100%),GO:0009058 (100%),biosynthetic process (100%),IPR004629 (100%),Glycosyl transferase WecB/TagA/CpsF (100%),,,,,,,,,,
APLGLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.3 (100%),Lysyltransferase (100%),GO:0016021 (84%);GO:0005886 (48%),integral component of membrane (84%);plasma membrane (48%),GO:0050071 (48%);GO:0003676 (8%);GO:0004519 (8%),lysyltransferase activity (48%);nucleic acid binding (8%);endonuclease activity (8%),GO:0006629 (48%);GO:0046677 (48%);GO:0055085 (12%),lipid metabolic process (48%);response to antibiotic (48%);transmembrane transport (12%),IPR016181 (57%);IPR022791 (57%);IPR024320 (57%),Acyl-CoA N-acyltransferase (57%);Lysylphosphatidylglycerol synthetase/glycosyltransferase AglD (57%);Phosphatidylglycerol lysyltransferase, C-terminal (57%),,,,,,,,,,
MNAAHEHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPTEYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),GO:0016021 (38%);GO:0009279 (19%);GO:0016020 (13%),integral component of membrane (38%);cell outer membrane (19%);membrane (13%),GO:0015276 (13%);GO:0003676 (6%);GO:0003700 (6%),ligand-gated ion channel activity (13%);nucleic acid binding (6%);DNA-binding transcription factor activity (6%),GO:0006260 (6%);GO:0006281 (6%);GO:0006310 (6%),DNA replication (6%);DNA repair (6%);DNA recombination (6%),IPR011990 (21%);IPR025676 (21%);IPR000531 (13%),Tetratricopeptide-like helical domain superfamily (21%);Clr5 domain (21%);TonB-dependent receptor-like, beta-barrel (13%),,,,,,,,,,
TAMVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.18 (61%);7.1.1.1 (9%);3.6.4.12 (8%),1,4-alpha-glucan branching enzyme (61%);Proton-translocating NAD(P)(+) transhydrogenase (9%);DNA helicase (8%),GO:0016021 (5%);GO:0005737 (2%);GO:0005886 (2%),integral component of membrane (5%);cytoplasm (2%);plasma membrane (2%),GO:0005524 (82%);GO:0003844 (8%);GO:0043169 (8%),ATP binding (82%);1,4-alpha-glucan branching enzyme activity (8%);cation binding (8%),GO:0019069 (77%);GO:0005978 (8%);GO:0006081 (1%),viral capsid assembly (77%);glycogen biosynthetic process (8%);cellular aldehyde metabolic process (1%),IPR035421 (82%);IPR004921 (78%);IPR010332 (72%),Terminase, large subunit gp17-like (82%);Terminase large subunit, T4likevirus-type (78%);ATPase terminase subunit, putative (72%),,,,,,
LTYMLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (25%);GO:0016021 (25%),cytoplasm (25%);integral component of membrane (25%),GO:0016462 (25%);GO:0016788 (25%);GO:0030234 (25%),pyrophosphatase activity (25%);hydrolase activity, acting on ester bonds (25%);enzyme regulator activity (25%),GO:0006808 (25%);GO:0009245 (25%),regulation of nitrogen utilization (25%);lipid A biosynthetic process (25%),IPR002187 (25%);IPR010138 (25%);IPR010156 (25%),Nitrogen regulatory protein PII (25%);UDP-2,3-diacylglucosamine hydrolase (25%);CRISPR-associated protein, Cas6 (25%),,,,,,,,
TYQFTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (25%);GO:0016021 (25%);GO:0005840 (13%),membrane (25%);integral component of membrane (25%);ribosome (13%),GO:0003677 (13%);GO:0003700 (13%);GO:0003735 (13%),DNA binding (13%);DNA-binding transcription factor activity (13%);structural constituent of ribosome (13%),GO:0006412 (13%),translation (13%),IPR006665 (38%);IPR036737 (38%);IPR006664 (25%),OmpA-like domain (38%);OmpA-like domain superfamily (38%);Outer membrane protein, bacterial (25%),,,,,,,,,,
YPQALAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGVLTLCPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VQMLENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.9 (100%),Enoyl-[acyl-carrier-protein] reductase (NADH) (100%),GO:0035327 (17%),transcriptionally active chromatin (17%),GO:0016301 (67%);GO:0004318 (17%);GO:0016631 (17%),kinase activity (67%);enoyl-[acyl-carrier-protein] reductase (NADH) activity (17%);enoyl-[acyl-carrier-protein] reductase activity (17%),GO:0046854 (67%);GO:0048015 (67%);GO:0000398 (17%),phosphatidylinositol phosphorylation (67%);phosphatidylinositol-mediated signaling (67%);mRNA splicing, via spliceosome (17%),IPR000403 (57%);IPR001263 (57%);IPR011009 (57%),Phosphatidylinositol 3-/4-kinase, catalytic domain (57%);Phosphoinositide 3-kinase, accessory (PIK) domain (57%);Protein kinase-like domain superfamily (57%),,,,,,,,
EPMGLLR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),GO:0016021 (20%),integral component of membrane (20%),GO:0003677 (80%);GO:0003678 (80%);GO:0005524 (80%),DNA binding (80%);DNA helicase activity (80%);ATP binding (80%),,,IPR000212 (80%);IPR027417 (80%);IPR014016 (60%),DNA helicase, UvrD/REP type (80%);P-loop containing nucleoside triphosphate hydrolase (80%);UvrD-like helicase, ATP-binding domain (60%),,,,,,,,,
TGNDPDWHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNWLVDLSWMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFLDSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.- (100%),Hydrolyzing N-glycosyl compounds (100%),GO:0005615 (25%),extracellular space (25%),GO:0004185 (25%);GO:0004674 (25%);GO:0019104 (25%),serine-type carboxypeptidase activity (25%);protein serine/threonine kinase activity (25%);DNA N-glycosylase activity (25%),GO:0006281 (25%),DNA repair (25%),IPR000215 (25%);IPR000667 (25%);IPR003180 (25%),Serpin family (25%);Peptidase S13, D-Ala-D-Ala carboxypeptidase C (25%);Methylpurine-DNA glycosylase (25%),,,,,,,,,,
LLENATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.11 (21%);2.7.7.24 (16%);1.13.11.- (11%),Acetylornithine transaminase (21%);Glucose-1-phosphate thymidylyltransferase (16%);With incorporation of two atoms of oxygen (11%),GO:0005664 (9%);GO:0016021 (8%);GO:0001650 (5%),nuclear origin of replication recognition complex (9%);integral component of membrane (8%);fibrillar center (5%),GO:0030170 (15%);GO:0008483 (14%);GO:0003677 (8%),pyridoxal phosphate binding (15%);transaminase activity (14%);DNA binding (8%),GO:0006260 (8%);GO:0009253 (6%);GO:0032259 (6%),DNA replication (8%);peptidoglycan catabolic process (6%);methylation (6%),IPR005814 (17%);IPR015421 (17%);IPR015422 (17%),Aminotransferase class-III (17%);Pyridoxal phosphate-dependent transferase, major domain (17%);Pyridoxal phosphate-dependent transferase domain 1 (17%),,,,,,,,,,
QENAEEEGNGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEAPAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.199 (74%);3.6.4.- (5%);2.1.3.2 (5%),16S rRNA (cytosine(1402)-N(4))-methyltransferase (74%);Acting on ATP; involved in cellular and subcellular movement (5%);Aspartate carbamoyltransferase (5%),GO:0005737 (43%);GO:0016021 (14%);GO:0005886 (2%),cytoplasm (43%);integral component of membrane (14%);plasma membrane (2%),GO:0071424 (37%);GO:0005524 (9%);GO:0003677 (4%),rRNA (cytosine-N4-)-methyltransferase activity (37%);ATP binding (9%);DNA binding (4%),GO:0070475 (37%);GO:0032259 (4%);GO:0006353 (3%),rRNA base methylation (37%);methylation (4%);DNA-templated transcription, termination (3%),IPR029063 (37%);IPR002903 (36%);IPR023397 (36%),S-adenosyl-L-methionine-dependent methyltransferase (37%);Ribosomal RNA small subunit methyltransferase H (36%);S-adenosyl-L-methionine-dependent methyltransferase, MraW, recognition domain superfamily (36%),,,,,,,,
EYPSVAFHGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLSLSPSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),GO:0005763 (27%);GO:0009507 (18%);GO:0043190 (18%),mitochondrial small ribosomal subunit (27%);chloroplast (18%);ATP-binding cassette (ABC) transporter complex (18%),GO:0003677 (27%);GO:0003899 (27%);GO:0032549 (27%),DNA binding (27%);DNA-directed 5'-3' RNA polymerase activity (27%);ribonucleoside binding (27%),GO:0006351 (27%);GO:0055085 (18%);GO:0005975 (9%),transcription, DNA-templated (27%);transmembrane transport (18%);carbohydrate metabolic process (9%),IPR007120 (27%);IPR007121 (27%);IPR007641 (27%),DNA-directed RNA polymerase, subunit 2, hybrid-binding domain (27%);RNA polymerase, beta subunit, conserved site (27%);RNA polymerase Rpb2, domain 7 (27%),,,,,
LSNYGAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (25%);GO:0016021 (25%),nucleus (25%);integral component of membrane (25%),GO:0008270 (25%);GO:0016798 (25%);GO:0016849 (25%),zinc ion binding (25%);hydrolase activity, acting on glycosyl bonds (25%);phosphorus-oxygen lyase activity (25%),GO:0008152 (25%);GO:0009190 (25%);GO:0035556 (25%),metabolic process (25%);cyclic nucleotide biosynthetic process (25%);intracellular signal transduction (25%),IPR006357 (22%);IPR011990 (22%);IPR023214 (22%),HAD-superfamily hydrolase, subfamily IIA (22%);Tetratricopeptide-like helical domain superfamily (22%);HAD superfamily (22%),,,,,,,,,
NFGPLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.13 (100%),tRNA-uridine 2-sulfurtransferase (100%),GO:0016021 (36%);GO:0016020 (14%);GO:0005737 (7%),integral component of membrane (36%);membrane (14%);cytoplasm (7%),GO:0003676 (43%);GO:0003700 (43%);GO:0008270 (43%),nucleic acid binding (43%);DNA-binding transcription factor activity (43%);zinc ion binding (43%),GO:0042773 (14%);GO:1990961 (14%);GO:0006400 (7%),ATP synthesis coupled electron transport (14%);xenobiotic detoxification by transmembrane export across the plasma membrane (14%);tRNA modification (7%),IPR006059 (58%);IPR006311 (58%);IPR001878 (16%),Bacterial extracellular solute-binding protein (58%);Twin-arginine translocation pathway, signal sequence (58%);Zinc finger, CCHC-type (16%),,,,,,,,,
LTKPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (61%);3.5.1.108 (5%);5.6.2.1 (4%),Histidine kinase (61%);UDP-3-O-acyl-N-acetylglucosamine deacetylase (5%);DNA topoisomerase (4%),GO:0016021 (33%);GO:0005737 (2%);GO:0005840 (1%),integral component of membrane (33%);cytoplasm (2%);ribosome (1%),GO:0008237 (33%);GO:0005524 (17%);GO:0000155 (14%),metallopeptidase activity (33%);ATP binding (17%);phosphorelay sensor kinase activity (14%),GO:0007165 (5%);GO:0006935 (2%);GO:0006412 (2%),signal transduction (5%);chemotaxis (2%);translation (2%),IPR036059 (29%);IPR002510 (28%);IPR035068 (28%),Metalloprotease TldD/PmbA superfamily (29%);Metalloprotease TldD/PmbA (28%);Metalloprotease TldD/PmbA, N-terminal (28%),,,,,,,,,,
MFAAWTDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAFFQQVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATEVTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.1 (45%);1.8.4.11 (33%);1.5.1.5 (12%),Tyrosine--tRNA ligase (45%);Peptide-methionine (S)-S-oxide reductase (33%);Methylenetetrahydrofolate dehydrogenase (NADP(+)) (12%),GO:0005737 (8%);GO:0005739 (7%);GO:0016021 (7%),cytoplasm (8%);mitochondrion (7%);integral component of membrane (7%),GO:0005524 (54%);GO:0004831 (25%);GO:0008113 (19%),ATP binding (54%);tyrosine-tRNA ligase activity (25%);peptide-methionine (S)-S-oxide reductase activity (19%),GO:0006437 (20%);GO:0006464 (19%);GO:0000105 (7%),tyrosyl-tRNA aminoacylation (20%);cellular protein modification process (19%);histidine biosynthetic process (7%),IPR014729 (24%);IPR001412 (22%);IPR002305 (20%),Rossmann-like alpha/beta/alpha sandwich fold (24%);Aminoacyl-tRNA synthetase, class I, conserved site (22%);Aminoacyl-tRNA synthetase, class Ic (20%),,,,,,,,
VTVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (16%);5.2.1.8 (10%);7.-.-.- (7%),Signal peptidase I (16%);Peptidylprolyl isomerase (10%);Translocases (7%),GO:0016021 (24%);GO:0005737 (12%);GO:0000127 (10%),integral component of membrane (24%);cytoplasm (12%);transcription factor TFIIIC complex (10%),GO:0003677 (13%);GO:0009381 (8%);GO:0005524 (8%),DNA binding (13%);excinuclease ABC activity (8%);ATP binding (8%),GO:0006384 (10%);GO:0006289 (8%);GO:0009432 (8%),transcription initiation from RNA polymerase III promoter (10%);nucleotide-excision repair (8%);SOS response (8%),IPR040454 (8%);IPR041499 (8%);IPR019136 (8%),Transcription factor IIIC subunit  Tfc1/Sfc1 (8%);Transcription factor IIIC subunit Tfc1/Sfc1, triple barrel domain (8%);Transcription factor IIIC subunit 5, HTH domain (8%),,,,,,,,,
DYLVDAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPLNPTDNSNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMYESNGAAGNPNSQYSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLNELPEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016903 (50%),oxidoreductase activity, acting on the aldehyde or oxo group of donors (50%),,,IPR002869 (50%);IPR002880 (50%);IPR007658 (50%),Pyruvate-flavodoxin oxidoreductase, central domain (50%);Pyruvate flavodoxin/ferredoxin oxidoreductase, N-terminal (50%);Protein of unknown function DUF594 (50%),,,,,,,,
LQANALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (33%);2.7.13.3 (33%);4.1.1.23 (33%),Pyruvate dehydrogenase (acetyl-transferring) (33%);Histidine kinase (33%);Orotidine-5'-phosphate decarboxylase (33%),GO:0016021 (30%);GO:0005887 (10%);GO:0016020 (10%),integral component of membrane (30%);integral component of plasma membrane (10%);membrane (10%),GO:0008483 (20%);GO:0030170 (20%);GO:0000155 (10%),transaminase activity (20%);pyridoxal phosphate binding (20%);phosphorelay sensor kinase activity (10%),GO:0006207 (10%);GO:0043093 (10%);GO:0044205 (10%),'de novo' pyrimidine nucleobase biosynthetic process (10%);FtsZ-dependent cytokinesis (10%);'de novo' UMP biosynthetic process (10%),IPR003594 (14%);IPR005467 (14%);IPR005814 (14%),Histidine kinase/HSP90-like ATPase (14%);Histidine kinase domain (14%);Aminotransferase class-III (14%),,,,,,,,,,,
QSVLVNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ACNDVLTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLVLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0003676 (50%);GO:0008408 (50%);GO:0004386 (25%),nucleic acid binding (50%);3'-5' exonuclease activity (50%);helicase activity (25%),,,IPR002562 (50%);IPR002782 (50%);IPR012337 (50%),3'-5' exonuclease domain (50%);Mut7-C RNAse domain (50%);Ribonuclease H-like superfamily (50%),,,,,,,,,,,
FALGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.99.12 (11%);4.2.2.- (8%);4.2.99.18 (7%),Lipid IV(A) 3-deoxy-D-manno-octulosonic acid transferase (11%);Acting on polysaccharides (8%);DNA-(apurinic or apyrimidinic site) lyase (7%),GO:0016021 (32%);GO:0005737 (7%);GO:0005886 (4%),integral component of membrane (32%);cytoplasm (7%);plasma membrane (4%),GO:0005524 (11%);GO:0003677 (10%);GO:0050660 (6%),ATP binding (11%);DNA binding (10%);flavin adenine dinucleotide binding (6%),GO:0005975 (2%);GO:0009244 (2%);GO:0055085 (1%),carbohydrate metabolic process (2%);lipopolysaccharide core region biosynthetic process (2%);transmembrane transport (1%),IPR027417 (12%);IPR011990 (5%);IPR013026 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);Tetratricopeptide-like helical domain superfamily (5%);Tetratricopeptide repeat-containing domain (4%),,,,,,,,,,,
FVGPELEAMLGSTAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLNSDLDYYVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWMFLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTVYMFTSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HESDLGLEVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQPNGQVLTLVNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDDENFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.5 (100%),Type III site-specific deoxyribonuclease (100%),GO:0016021 (0%),integral component of membrane (0%),GO:0003677 (96%);GO:0005524 (96%);GO:0004386 (67%),DNA binding (96%);ATP binding (96%);helicase activity (67%),GO:0006304 (0%);GO:0032259 (0%),DNA modification (0%);methylation (0%),IPR027417 (99%);IPR006935 (99%);IPR014001 (98%),P-loop containing nucleoside triphosphate hydrolase (99%);Helicase/UvrB, N-terminal (99%);Helicase superfamily 1/2, ATP-binding domain (98%),,,,,,,,,
TENELLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0000166 (100%);GO:0003676 (100%);GO:0008270 (100%),nucleotide binding (100%);nucleic acid binding (100%);zinc ion binding (100%),,,IPR003604 (50%);IPR013087 (50%);IPR017964 (50%),Matrin/U1-C-like, C2H2-type zinc finger (50%);Zinc finger C2H2-type (50%);DNA-directed DNA polymerase, family B, conserved site (50%),,,,,,,,
FVPLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (44%);2.3.3.5 (12%);2.3.3.16 (10%),Acting on ester bonds (44%);2-methylcitrate synthase (12%);Citrate synthase (unknown stereospecificity) (10%),GO:0005737 (55%);GO:0016021 (7%);GO:0009279 (3%),cytoplasm (55%);integral component of membrane (7%);cell outer membrane (3%),GO:0046912 (46%);GO:0016787 (8%);GO:0003676 (7%),transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer (46%);hydrolase activity (8%);nucleic acid binding (7%),GO:0006099 (46%);GO:0015628 (3%);GO:0009086 (2%),tricarboxylic acid cycle (46%);protein secretion by the type II secretion system (3%);methionine biosynthetic process (2%),IPR002020 (46%);IPR016142 (46%);IPR016143 (46%),Citrate synthase (46%);Citrate synthase-like, large alpha subdomain (46%);Citrate synthase-like, small alpha subdomain (46%),,,,,,,
LYMAMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPDLPGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VETTMMLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDPMPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEVGFVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.54 (23%);2.5.1.54 (19%);2.4.1.- (13%),Allophanate hydrolase (23%);3-deoxy-7-phosphoheptulonate synthase (19%);Hexosyltransferases (13%),GO:0016021 (28%);GO:0005681 (3%);GO:0005737 (3%),integral component of membrane (28%);spliceosomal complex (3%);cytoplasm (3%),GO:0016787 (13%);GO:0005524 (9%);GO:0016740 (8%),hydrolase activity (13%);ATP binding (9%);transferase activity (8%),GO:0009073 (3%);GO:0009423 (3%);GO:0000398 (3%),aromatic amino acid family biosynthetic process (3%);chorismate biosynthetic process (3%);mRNA splicing, via spliceosome (3%),IPR003778 (20%);IPR029000 (20%);IPR016024 (14%),Carboxyltransferase domain, subdomain A and B (20%);Cyclophilin-like domain superfamily (20%);Armadillo-type fold (14%),,,,,,,,,
SGDEPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.7 (19%);4.99.1.1 (14%);6.3.2.4 (14%),Imidazolonepropionase (19%);Protoporphyrin ferrochelatase (14%);D-alanine--D-alanine ligase (14%),GO:0016021 (17%);GO:0005737 (13%);GO:0005634 (7%),integral component of membrane (17%);cytoplasm (13%);nucleus (7%),GO:0005524 (25%);GO:0003676 (22%);GO:0004386 (20%),ATP binding (25%);nucleic acid binding (22%);helicase activity (20%),GO:0006355 (7%);GO:0019556 (4%);GO:0051301 (4%),regulation of transcription, DNA-templated (7%);histidine catabolic process to glutamate and formamide (4%);cell division (4%),IPR027417 (16%);IPR006652 (13%);IPR015915 (13%),P-loop containing nucleoside triphosphate hydrolase (16%);Kelch repeat type 1 (13%);Kelch-type beta propeller (13%),,,,,,,,,,
MGLVAVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.14 (88%);6.4.1.2 (88%);3.1.4.4 (13%),Biotin carboxylase (88%);Acetyl-CoA carboxylase (88%);Phospholipase D (13%),,,GO:0003989 (58%);GO:0004075 (58%);GO:0005524 (58%),acetyl-CoA carboxylase activity (58%);biotin carboxylase activity (58%);ATP binding (58%),GO:0006633 (58%);GO:2001295 (58%);GO:0006654 (8%),fatty acid biosynthetic process (58%);malonyl-CoA biosynthetic process (58%);phosphatidic acid biosynthetic process (8%),IPR004549 (50%);IPR005479 (50%);IPR005481 (50%),Acetyl-CoA carboxylase, biotin carboxylase (50%);Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain (50%);Biotin carboxylase-like, N-terminal domain (50%),,,,,,,,
EEVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (7%);1.2.4.1 (5%);2.7.7.7 (5%),Leucine--tRNA ligase (7%);Pyruvate dehydrogenase (acetyl-transferring) (5%);DNA-directed DNA polymerase (5%),GO:0016021 (16%);GO:0005737 (10%);GO:0005623 (5%),integral component of membrane (16%);cytoplasm (10%);cell (5%),GO:0005524 (25%);GO:0046872 (10%);GO:0003677 (7%),ATP binding (25%);metal ion binding (10%);DNA binding (7%),GO:0072383 (4%);GO:0006457 (3%);GO:0055085 (3%),plus-end-directed vesicle transport along microtubule (4%);protein folding (3%);transmembrane transport (3%),IPR027417 (14%);IPR001752 (4%);IPR036961 (4%),P-loop containing nucleoside triphosphate hydrolase (14%);Kinesin motor domain (4%);Kinesin motor domain superfamily (4%),,,,,,,,,,,
NNMQDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFYVGGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (10%),integral component of membrane (10%),GO:0003677 (86%);GO:0003916 (86%);GO:0003743 (14%),DNA binding (86%);DNA topoisomerase activity (86%);translation initiation factor activity (14%),GO:0006270 (86%);GO:0009847 (5%),DNA replication initiation (86%);spore germination (5%),IPR003491 (86%);IPR017850 (10%);IPR036278 (10%),Replication initiation factor (86%);Alkaline-phosphatase-like, core domain superfamily (10%);Sialidase superfamily (10%),,,,,,,,,,
YDLSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.16 (55%);3.6.4.- (10%);4.2.1.75 (10%),Acetylornithine deacetylase (55%);Acting on ATP; involved in cellular and subcellular movement (10%);Uroporphyrinogen-III synthase (10%),GO:0016021 (29%);GO:0005737 (6%);GO:0009279 (3%),integral component of membrane (29%);cytoplasm (6%);cell outer membrane (3%),GO:0046872 (15%);GO:0008777 (11%);GO:0008237 (10%),metal ion binding (15%);acetylornithine deacetylase activity (11%);metallopeptidase activity (10%),GO:0006526 (11%);GO:0006289 (8%);GO:0006355 (6%),arginine biosynthetic process (11%);nucleotide-excision repair (8%);regulation of transcription, DNA-templated (6%),IPR032485 (38%);IPR031841 (37%);IPR027417 (6%),Domain of unknown function DUF5050 (38%);DL-endopeptidase inhibitor IseA (37%);P-loop containing nucleoside triphosphate hydrolase (6%),,,,,,,,,,
NVPGMEATYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFDQLEGK,Desulfobulbus oralis,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Desulfobacterales,,,,,Desulfobulbaceae,,,,Desulfobulbus,,,,Desulfobulbus oralis,,,,,,,,GO:0003824 (100%),catalytic activity (100%),,,IPR001150 (100%);IPR004184 (100%);IPR019777 (100%),Glycine radical domain (100%);Pyruvate formate lyase domain (100%);Formate C-acetyltransferase glycine radical, conserved site (100%),,,,,,,,,,
VAPSM,Ascosphaera apis,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Eurotiomycetidae,,,Onygenales,,,,,Ascosphaeraceae,,,,Ascosphaera,,,,Ascosphaera apis,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016887 (100%),ATP binding (100%);ATPase activity (100%),,,IPR003439 (100%);IPR003593 (100%);IPR013525 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);ABC-2 type transporter (100%),,,,,,,,,,,
MPNEAVDAVSASAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MELDVMLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSQMHLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QDYCNPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APEFFSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (75%);2.1.1.148 (25%),DNA-directed DNA polymerase (75%);Thymidylate synthase (FAD) (25%),GO:0016021 (13%),integral component of membrane (13%),GO:0003887 (75%);GO:0008408 (38%);GO:0050660 (13%),DNA-directed DNA polymerase activity (75%);3'-5' exonuclease activity (38%);flavin adenine dinucleotide binding (13%),GO:0006260 (38%);GO:0006231 (13%);GO:0006235 (13%),DNA replication (38%);dTMP biosynthetic process (13%);dTTP biosynthetic process (13%),IPR027417 (67%);IPR004622 (33%);IPR004474 (22%),P-loop containing nucleoside triphosphate hydrolase (67%);DNA polymerase III, delta prime subunit (33%);Cell envelope-related transcriptional attenuator domain (22%),,,,,,,,,,
AAMAAAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPWNEAVDAVQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNGELENNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TALNSMSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (22%);3.4.21.107 (8%);2.8.1.4 (8%),Acting on ester bonds (22%);Peptidase Do (8%);tRNA uracil 4-sulfurtransferase (8%),GO:0016021 (25%);GO:0005737 (14%);GO:0005623 (5%),integral component of membrane (25%);cytoplasm (14%);cell (5%),GO:0005524 (19%);GO:0003677 (11%);GO:0016787 (8%),ATP binding (19%);DNA binding (11%);hydrolase activity (8%),GO:0006096 (4%);GO:0001678 (4%);GO:0031460 (3%),glycolytic process (4%);cellular glucose homeostasis (4%);glycine betaine transport (3%),IPR027417 (10%);IPR015797 (7%);IPR000086 (7%),P-loop containing nucleoside triphosphate hydrolase (10%);NUDIX hydrolase-like domain superfamily (7%);NUDIX hydrolase domain (7%),,,,,,,,,,,
FELLNGHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALEAQLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (90%);2.7.1.24 (1%);3.6.4.12 (1%),DNA ligase (NAD(+)) (90%);Dephospho-CoA kinase (1%);DNA helicase (1%),GO:0005634 (11%);GO:0016021 (8%);GO:0005737 (4%),nucleus (11%);integral component of membrane (8%);cytoplasm (4%),GO:0003677 (59%);GO:0003911 (46%);GO:0046872 (46%),DNA binding (59%);DNA ligase (NAD+) activity (46%);metal ion binding (46%),GO:0006281 (46%);GO:0006260 (46%);GO:0006351 (9%),DNA repair (46%);DNA replication (46%);transcription, DNA-templated (9%),IPR001357 (42%);IPR010994 (42%);IPR036420 (42%),BRCT domain (42%);RuvA domain 2-like (42%);BRCT domain superfamily (42%),,,,,,,,,,
NFHSSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.- (67%);2.7.13.3 (33%),Carboxy-lyases (67%);Histidine kinase (33%),GO:0016021 (63%);GO:0005886 (4%);GO:0016592 (4%),integral component of membrane (63%);plasma membrane (4%);mediator complex (4%),GO:0004222 (54%);GO:0005524 (15%);GO:0000155 (13%),metalloendopeptidase activity (54%);ATP binding (15%);phosphorelay sensor kinase activity (13%),GO:0001302 (2%);GO:0006465 (2%);GO:0008152 (2%),replicative cell aging (2%);signal peptide processing (2%);metabolic process (2%),IPR031100 (82%);IPR005269 (37%);IPR001590 (8%),LOG family (82%);Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG (37%);Peptidase M12B, ADAM/reprolysin (8%),,,,,,,,,,
EPFDTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (33%);2.8.1.13 (33%);2.7.13.3 (17%),Oxidoreductases (33%);tRNA-uridine 2-sulfurtransferase (33%);Histidine kinase (17%),GO:0016021 (26%);GO:0005737 (11%);GO:0005886 (4%),integral component of membrane (26%);cytoplasm (11%);plasma membrane (4%),GO:0005524 (22%);GO:0016491 (15%);GO:0016787 (15%),ATP binding (22%);oxidoreductase activity (15%);hydrolase activity (15%),GO:0006400 (7%);GO:0006282 (4%);GO:0006355 (4%),tRNA modification (7%);regulation of DNA repair (4%);regulation of transcription, DNA-templated (4%),IPR011762 (28%);IPR011763 (28%);IPR029045 (28%),Acetyl-coenzyme A carboxyltransferase, N-terminal (28%);Acetyl-coenzyme A carboxyltransferase, C-terminal (28%);ClpP/crotonase-like domain superfamily (28%),,,,,,,,
VHPWWTSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVPTMFYAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANESGQLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLYGYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (100%);3.6.4.12 (100%),Acting on ester bonds (100%);DNA helicase (100%),GO:0016021 (32%),integral component of membrane (32%),GO:0008236 (36%);GO:0003676 (5%);GO:0003677 (5%),serine-type peptidase activity (36%);nucleic acid binding (5%);DNA binding (5%),GO:0005975 (9%);GO:0006281 (5%);GO:0015074 (5%),carbohydrate metabolic process (9%);DNA repair (5%);DNA integration (5%),IPR029058 (29%);IPR001375 (26%);IPR005754 (18%),Alpha/Beta hydrolase fold (29%);Peptidase S9, prolyl oligopeptidase, catalytic domain (26%);Sortase family (18%),,,,,,,,,
LESPATAK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR027417 (100%);IPR011990 (50%);IPR013026 (50%),P-loop containing nucleoside triphosphate hydrolase (100%);Tetratricopeptide-like helical domain superfamily (50%);Tetratricopeptide repeat-containing domain (50%),,,,,,,,,,,
ELVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.42 (25%);6.4.1.1 (12%);2.7.7.6 (5%),Isocitrate dehydrogenase (NADP(+)) (25%);Pyruvate carboxylase (12%);DNA-directed RNA polymerase (5%),GO:0005737 (21%);GO:0016021 (14%);GO:0005634 (2%),cytoplasm (21%);integral component of membrane (14%);nucleus (2%),GO:0005524 (20%);GO:0000155 (14%);GO:0046872 (9%),ATP binding (20%);phosphorelay sensor kinase activity (14%);metal ion binding (9%),GO:0006935 (13%);GO:0006099 (7%);GO:0006097 (5%),chemotaxis (13%);tricarboxylic acid cycle (7%);glyoxylate cycle (5%),IPR036890 (13%);IPR003594 (13%);IPR005467 (13%),Histidine kinase/HSP90-like ATPase superfamily (13%);Histidine kinase/HSP90-like ATPase (13%);Histidine kinase domain (13%),,,,,,,,,,,
ANPLVER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.17 (50%);4.2.1.9 (50%),ATP phosphoribosyltransferase (50%);Dihydroxy-acid dehydratase (50%),GO:0005737 (13%);GO:0005886 (13%);GO:0016021 (13%),cytoplasm (13%);plasma membrane (13%);integral component of membrane (13%),GO:0005524 (25%);GO:0003879 (13%);GO:0004160 (13%),ATP binding (25%);ATP phosphoribosyltransferase activity (13%);dihydroxy-acid dehydratase activity (13%),GO:0000105 (13%);GO:0032259 (13%);GO:0055085 (13%),histidine biosynthetic process (13%);methylation (13%);transmembrane transport (13%),IPR032675 (59%);IPR000581 (9%);IPR020558 (9%),Leucine-rich repeat domain superfamily (59%);Dihydroxy-acid/6-phosphogluconate dehydratase (9%);Dihydroxy-acid/6-phosphogluconate dehydratase, conserved site (9%),,,,,,,,,,
WMLPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0004499 (33%);GO:0050660 (33%);GO:0050661 (33%),N,N-dimethylaniline monooxygenase activity (33%);flavin adenine dinucleotide binding (33%);NADP binding (33%),,,IPR002018 (67%);IPR029058 (67%);IPR000960 (33%),Carboxylesterase, type B (67%);Alpha/Beta hydrolase fold (67%);Flavin monooxygenase FMO (33%),,,,,,,,,
ANGEELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.1 (50%);2.4.1.129 (25%);6.3.2.10 (25%),NAD(+) synthase (glutamine-hydrolyzing) (50%);Peptidoglycan glycosyltransferase (25%);UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (25%),GO:0005737 (19%);GO:0016020 (19%);GO:0042597 (13%),cytoplasm (19%);membrane (19%);periplasmic space (13%),GO:0005524 (69%);GO:0016887 (25%);GO:0003952 (13%),ATP binding (69%);ATPase activity (25%);NAD+ synthase (glutamine-hydrolyzing) activity (13%),GO:0008360 (13%);GO:0009252 (13%);GO:0009435 (13%),regulation of cell shape (13%);peptidoglycan biosynthetic process (13%);NAD biosynthetic process (13%),IPR003439 (36%);IPR003593 (36%);IPR027417 (36%),ABC transporter-like (36%);AAA+ ATPase domain (36%);P-loop containing nucleoside triphosphate hydrolase (36%),,,,,,,,,,,
VGPLVMLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLQFLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (16%);3.2.1.41 (9%);5.4.99.1 (9%),DNA-directed RNA polymerase (16%);Pullulanase (9%);Methylaspartate mutase (9%),GO:0016021 (91%);GO:0042613 (3%);GO:0005856 (0%),integral component of membrane (91%);MHC class II protein complex (3%);cytoskeleton (0%),GO:0003677 (1%);GO:0016787 (1%);GO:0008773 (1%),DNA binding (1%);hydrolase activity (1%);[protein-PII] uridylyltransferase activity (1%),GO:0006955 (3%);GO:0019882 (3%);GO:0007165 (1%),immune response (3%);antigen processing and presentation (3%);signal transduction (1%),IPR007383 (88%);IPR016024 (5%);IPR000353 (2%),Protein of unknown function DUF445 (88%);Armadillo-type fold (5%);MHC class II, beta chain, N-terminal (2%),,,,,,,,,
NSNSERPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGLDNASHMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYDAAEVTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DYEGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.14 (100%),Amidophosphoribosyltransferase (100%),GO:0016021 (25%);GO:0005887 (13%);GO:0015934 (13%),integral component of membrane (25%);integral component of plasma membrane (13%);large ribosomal subunit (13%),GO:0046872 (25%);GO:0000287 (13%);GO:0003735 (13%),metal ion binding (25%);magnesium ion binding (13%);structural constituent of ribosome (13%),GO:0006189 (13%);GO:0006412 (13%);GO:0006541 (13%),'de novo' IMP biosynthetic process (13%);translation (13%);glutamine metabolic process (13%),IPR000409 (15%);IPR001680 (15%);IPR011009 (15%),BEACH domain (15%);WD40 repeat (15%);Protein kinase-like domain superfamily (15%),,,,,,,,,,,
EAYDMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.4.1.3 (45%);2.8.1.6 (36%);3.1.13.- (18%),Propionyl-CoA carboxylase (45%);Biotin synthase (36%);Exoribonucleases producing 5'-phosphomonoesters (18%),GO:0005634 (25%),nucleus (25%),GO:0016874 (33%);GO:0003676 (25%);GO:0004534 (25%),ligase activity (33%);nucleic acid binding (25%);5'-3' exoribonuclease activity (25%),GO:0009102 (17%);GO:0006397 (8%);GO:0006396 (4%),biotin biosynthetic process (17%);mRNA processing (8%);RNA processing (4%),IPR011762 (46%);IPR011763 (46%);IPR029045 (46%),Acetyl-coenzyme A carboxyltransferase, N-terminal (46%);Acetyl-coenzyme A carboxyltransferase, C-terminal (46%);ClpP/crotonase-like domain superfamily (46%),,,,,,,,,
EVENDLPK,Faecalicoccus pleomorphus,Bacteria,,,,Firmicutes,,,Erysipelotrichia,,,,Erysipelotrichales,,,,,Erysipelotrichaceae,,,,Faecalicoccus,,,,Faecalicoccus pleomorphus,,,,3.1.21.4 (100%),Type II site-specific deoxyribonuclease (100%),,,GO:0003677 (100%);GO:0009036 (100%),DNA binding (100%);type II site-specific deoxyribonuclease activity (100%),,,IPR011335 (100%);IPR011337 (100%);IPR037057 (100%),Restriction endonuclease  type II-like (100%);DNA mismatch repair MutH/Restriction endonuclease, type II (100%);DNA mismatch repair MutH/Restriction endonuclease, type II superfamily (100%),,,,,,,,,
SPGAHMEGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLEDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (24%);1.2.1.11 (6%);1.17.4.1 (5%),DNA topoisomerase (24%);Aspartate-semialdehyde dehydrogenase (6%);Ribonucleoside-diphosphate reductase (5%),GO:0016021 (19%);GO:0005737 (9%);GO:0005694 (6%),integral component of membrane (19%);cytoplasm (9%);chromosome (6%),GO:0005524 (17%);GO:0003677 (16%);GO:0046872 (12%),ATP binding (17%);DNA binding (16%);metal ion binding (12%),GO:0006265 (6%);GO:0006313 (2%);GO:0006355 (2%),DNA topological change (6%);transposition, DNA-mediated (2%);regulation of transcription, DNA-templated (2%),IPR027417 (11%);IPR036388 (5%);IPR000380 (5%),P-loop containing nucleoside triphosphate hydrolase (11%);Winged helix-like DNA-binding domain superfamily (5%);DNA topoisomerase, type IA (5%),,,,,,,,
NTMYFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009055 (40%);GO:0020037 (40%);GO:0005524 (20%),electron transfer activity (40%);heme binding (40%);ATP binding (20%),,,IPR015943 (30%);IPR001680 (20%);IPR007434 (20%),WD40/YVTN repeat-like-containing domain superfamily (30%);WD40 repeat (20%);Peptidogalycan biosysnthesis/recognition (20%),,,,,,,,,,,
AYADLPAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNLNPDLDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMNGGAAFGPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMFGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.- (50%);3.1.11.5 (50%),With NAD(+) or NADP(+) as acceptor (50%);Exodeoxyribonuclease V (50%),GO:0016021 (50%);GO:0009338 (8%),integral component of membrane (50%);exodeoxyribonuclease V complex (8%),GO:0003824 (25%);GO:0003677 (8%);GO:0003678 (8%),catalytic activity (25%);DNA binding (8%);DNA helicase activity (8%),GO:0000160 (8%);GO:0000724 (8%);GO:0006006 (8%),phosphorelay signal transduction system (8%);double-strand break repair via homologous recombination (8%);glucose metabolic process (8%),IPR011041 (30%);IPR011042 (30%);IPR012938 (30%),Soluble quinoprotein glucose/sorbosone dehydrogenase (30%);Six-bladed beta-propeller, TolB-like (30%);Glucose/Sorbosone dehydrogenase (30%),,,,,,,,,,
NNAQNGPFMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEFLATVSTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLSTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.11 (25%);6.2.1.27 (25%);1.14.13.24 (13%),Fructose-bisphosphatase (25%);4-hydroxybenzoate--CoA ligase (25%);3-hydroxybenzoate 6-monooxygenase (13%),GO:0016021 (56%);GO:0005886 (35%);GO:0005840 (6%),integral component of membrane (56%);plasma membrane (35%);ribosome (6%),GO:1901515 (11%);GO:0005524 (6%);GO:0016491 (6%),poly-beta-1,6-N-acetyl-D-glucosamine transmembrane transporter activity (11%);ATP binding (6%);oxidoreductase activity (6%),GO:0006865 (30%);GO:0000716 (2%);GO:0005975 (2%),amino acid transport (30%);transcription-coupled nucleotide-excision repair, DNA damage recognition (2%);carbohydrate metabolic process (2%),IPR003347 (27%);IPR039994 (27%);IPR001123 (23%),JmjC domain (27%);JmjC domain-containing (27%);Amino acid exporter protein, LeuE-type (23%),,,,,,,,
SSAQYASPEGQAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLNNMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.3 (89%);2.4.1.- (6%);3.4.-.- (6%),Phosphoglycerate kinase (89%);Hexosyltransferases (6%);Acting on peptide bonds (peptidases) (6%),GO:0016021 (15%);GO:0005623 (6%);GO:0030018 (6%),integral component of membrane (15%);cell (6%);Z disc (6%),GO:0005524 (46%);GO:0004618 (36%);GO:0008658 (29%),ATP binding (46%);phosphoglycerate kinase activity (36%);penicillin binding (29%),GO:0006096 (36%);GO:0007268 (6%);GO:0046716 (6%),glycolytic process (36%);chemical synaptic transmission (6%);muscle cell cellular homeostasis (6%),IPR001576 (35%);IPR015824 (35%);IPR036043 (35%),Phosphoglycerate kinase (35%);Phosphoglycerate kinase, N-terminal (35%);Phosphoglycerate kinase superfamily (35%),,,,,,,,,,
TAASSSER,Geodermatophilus,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Geodermatophilales,,,,,Geodermatophilaceae,,,,Geodermatophilus,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MELDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.59 (50%);6.3.2.13 (11%);3.5.4.19 (8%),3-hydroxyacyl-[acyl-carrier-protein] dehydratase (50%);UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (11%);Phosphoribosyl-AMP cyclohydrolase (8%),GO:0005737 (23%);GO:0016459 (19%);GO:0016021 (12%),cytoplasm (23%);myosin complex (19%);integral component of membrane (12%),GO:0005524 (37%);GO:0051015 (19%);GO:0003774 (19%),ATP binding (37%);actin filament binding (19%);motor activity (19%),GO:0006633 (14%);GO:0009245 (13%);GO:0008360 (9%),fatty acid biosynthetic process (14%);lipid A biosynthetic process (13%);regulation of cell shape (9%),IPR027417 (25%);IPR002928 (20%);IPR001609 (20%),P-loop containing nucleoside triphosphate hydrolase (25%);Myosin tail (20%);Myosin head, motor domain (20%),,,,,,,,,
WLFCPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VANVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (57%);1.1.1.23 (17%);2.7.7.7 (9%),DNA helicase (57%);Histidinol dehydrogenase (17%);DNA-directed DNA polymerase (9%),GO:0016021 (24%);GO:0009279 (14%);GO:0000796 (2%),integral component of membrane (24%);cell outer membrane (14%);condensin complex (2%),GO:0003677 (49%);GO:0003887 (33%);GO:0005524 (19%),DNA binding (49%);DNA-directed DNA polymerase activity (33%);ATP binding (19%),GO:0006260 (19%);GO:0006261 (14%);GO:0000105 (4%),DNA replication (19%);DNA-dependent DNA replication (14%);histidine biosynthetic process (4%),IPR012337 (34%);IPR001098 (26%);IPR027417 (14%),Ribonuclease H-like superfamily (34%);DNA-directed DNA polymerase, family A, palm domain (26%);P-loop containing nucleoside triphosphate hydrolase (14%),,,,,,,,,
EEELWWDLPEFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLLFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.117 (100%),2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (100%),GO:0016021 (47%);GO:0005634 (7%);GO:0005737 (7%),integral component of membrane (47%);nucleus (7%);cytoplasm (7%),GO:0003677 (33%);GO:0000981 (7%);GO:0004674 (7%),DNA binding (33%);DNA-binding transcription factor activity, RNA polymerase II-specific (7%);protein serine/threonine kinase activity (7%),GO:0006351 (7%);GO:0006468 (7%);GO:0007165 (7%),transcription, DNA-templated (7%);protein phosphorylation (7%);signal transduction (7%),IPR001387 (29%);IPR010982 (29%);IPR000719 (7%),Cro/C1-type helix-turn-helix domain (29%);Lambda repressor-like, DNA-binding domain superfamily (29%);Protein kinase domain (7%),,,,
ALAEMPER,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.193 (92%);5.1.1.12 (8%),tRNA(Met) cytidine acetyltransferase (92%);Ornithine racemase (8%),GO:0005737 (73%),cytoplasm (73%),GO:0000049 (73%);GO:0005524 (73%);GO:0051392 (73%),tRNA binding (73%);ATP binding (73%);tRNA N-acetyltransferase activity (73%),GO:0002101 (73%);GO:0051391 (73%);GO:0006352 (7%),tRNA wobble cytosine modification (73%);tRNA acetylation (73%);DNA-templated transcription, initiation (7%),IPR000182 (75%);IPR007807 (75%);IPR013562 (75%),GNAT domain (75%);Helicase domain (75%);tRNA(Met) cytidine acetyltransferase TmcA, N-terminal (75%),,,,,,,,,
GNQANNPNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMVVQALAQGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSNGTLEAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQEEHLANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAALEAAGGCNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLKPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.9 (83%);1.3.1.44 (14%);1.3.1.- (1%),Enoyl-[acyl-carrier-protein] reductase (NADH) (83%);Trans-2-enoyl-CoA reductase (NAD(+)) (14%);With NAD(+) or NADP(+) as acceptor (1%),GO:0016021 (6%);GO:0005737 (2%);GO:0032153 (2%),integral component of membrane (6%);cytoplasm (2%);cell division site (2%),GO:0051287 (82%);GO:0004318 (70%);GO:0016631 (70%),NAD binding (82%);enoyl-[acyl-carrier-protein] reductase (NADH) activity (70%);enoyl-[acyl-carrier-protein] reductase activity (70%),GO:0006633 (84%);GO:0000917 (2%);GO:0043093 (2%),fatty acid biosynthetic process (84%);division septum assembly (2%);FtsZ-dependent cytokinesis (2%),IPR010758 (78%);IPR024910 (78%);IPR024906 (77%),Trans-2-enoyl-CoA reductase (78%);Trans-2-enoyl-CoA reductase catalytic domain, putative (78%);Enoyl reductase FAD binding domain (77%),,,,,,,,,,
DHVVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (38%);3.1.11.5 (25%);1.3.8.2 (13%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (38%);Exodeoxyribonuclease V (25%);4,4'-diapophytoene desaturase (4,4'-diapolycopene-forming) (13%),GO:0005634 (22%);GO:0016021 (12%);GO:0031011 (8%),nucleus (22%);integral component of membrane (12%);Ino80 complex (8%),GO:0003682 (27%);GO:0008270 (26%);GO:0043565 (26%),chromatin binding (27%);zinc ion binding (26%);sequence-specific DNA binding (26%),GO:0006355 (22%);GO:0016117 (7%);GO:0006307 (5%),regulation of transcription, DNA-templated (22%);carotenoid biosynthetic process (7%);DNA dealkylation involved in DNA repair (5%),IPR000949 (24%);IPR001025 (24%);IPR000679 (23%),ELM2 domain (24%);Bromo adjacent homology (BAH) domain (24%);Zinc finger, GATA-type (23%),,,,,,,
MSFALNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GHFAPFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GFSYPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.40 (29%);6.3.4.- (29%);1.7.2.3 (14%),UDP-N-acetylgalactosamine-undecaprenyl-phosphatN-acetylgalactosaminephosphotransferase (29%);Other carbon--nitrogen ligases (29%);Trimethylamine-N-oxide reductase (14%),GO:0016021 (36%);GO:0005737 (14%);GO:0098793 (4%),integral component of membrane (36%);cytoplasm (14%);presynapse (4%),GO:0016740 (25%);GO:0003676 (18%);GO:0004519 (14%),transferase activity (25%);nucleic acid binding (18%);endonuclease activity (14%),GO:0006694 (11%);GO:0006400 (7%);GO:0000716 (4%),steroid biosynthetic process (11%);tRNA modification (7%);transcription-coupled nucleotide-excision repair, DNA damage recognition (4%),IPR003615 (23%);IPR003870 (23%);IPR003362 (13%),HNH nuclease (23%);Domain of unknown function DUF222 (23%);Bacterial sugar transferase (13%),,,,,,,,,,
NVLEAEPK,Caulobacter,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Caulobacterales,,,,,Caulobacteraceae,,,,Caulobacter,,,,,,,,,,,,GO:0003824 (86%);GO:0016787 (14%),catalytic activity (86%);hydrolase activity (14%),,,IPR001310 (100%);IPR011146 (100%);IPR036265 (100%),Histidine triad (HIT) protein (100%);HIT-like domain (100%);HIT-like superfamily (100%),,,,,,,,,,,
SPWWAFLANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVATQGLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLADLNDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSVTGHMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDAEPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (43%);GO:0005737 (21%);GO:0016020 (14%),integral component of membrane (43%);cytoplasm (21%);membrane (14%),GO:0008324 (43%);GO:0016301 (29%);GO:0004430 (14%),cation transmembrane transporter activity (43%);kinase activity (29%);1-phosphatidylinositol 4-kinase activity (14%),GO:0006813 (43%);GO:0046854 (36%);GO:0048015 (36%),potassium ion transport (43%);phosphatidylinositol phosphorylation (36%);phosphatidylinositol-mediated signaling (36%),IPR001263 (47%);IPR016024 (47%);IPR006037 (35%),Phosphoinositide 3-kinase, accessory (PIK) domain (47%);Armadillo-type fold (47%);Regulator of K+ conductance, C-terminal (35%),,,,,,,,,
CYVSFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTGPPNYEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLHMLSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNFLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (17%);5.3.1.28 (14%);6.1.1.22 (10%),DNA-directed DNA polymerase (17%);D-sedoheptulose 7-phosphate isomerase (14%);Asparagine--tRNA ligase (10%),GO:0016021 (45%);GO:0005737 (4%);GO:0005886 (4%),integral component of membrane (45%);cytoplasm (4%);plasma membrane (4%),GO:0005524 (18%);GO:0016740 (11%);GO:0003677 (9%),ATP binding (18%);transferase activity (11%);DNA binding (9%),GO:0007165 (6%);GO:0006396 (5%);GO:1901135 (5%),signal transduction (6%);RNA processing (5%);carbohydrate derivative metabolic process (5%),IPR027417 (15%);IPR011006 (11%);IPR003362 (9%),P-loop containing nucleoside triphosphate hydrolase (15%);CheY-like superfamily (11%);Bacterial sugar transferase (9%),,,,,,,,,,,
NCAAAAFQAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGNEYYK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019867 (100%),outer membrane (100%),,,GO:0009405 (100%);GO:0019062 (50%),pathogenesis (100%);virion attachment to host cell (50%),IPR005594 (100%);IPR008635 (100%);IPR011049 (100%),YadA-like, C-terminal (100%);Coiled stalk of trimeric autotransporter adhesin (100%);Serralysin-like metalloprotease, C-terminal (100%),,,,,,,,,
MMLMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.44 (25%);3.1.11.1 (25%);4.2.2.- (25%),Phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (25%);Exodeoxyribonuclease I (25%);Acting on polysaccharides (25%),GO:0016021 (33%);GO:0009360 (14%);GO:0005887 (5%),integral component of membrane (33%);DNA polymerase III complex (14%);integral component of plasma membrane (5%),GO:0003677 (24%);GO:0003887 (14%);GO:0016740 (14%),DNA binding (24%);DNA-directed DNA polymerase activity (14%);transferase activity (14%),GO:0006260 (14%);GO:0006098 (10%);GO:0006281 (10%),DNA replication (14%);pentose-phosphate shunt (10%);DNA repair (10%),IPR027417 (18%);IPR001173 (14%);IPR005790 (14%),P-loop containing nucleoside triphosphate hydrolase (18%);Glycosyltransferase 2-like (14%);DNA polymerase III, delta subunit (14%),,,,,,,,,
QRPAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.31 (17%);3.6.4.12 (11%);3.1.26.12 (6%),Adenine glycosylase (17%);DNA helicase (11%);Ribonuclease E (6%),GO:0016021 (23%);GO:0000124 (7%);GO:0005737 (4%),integral component of membrane (23%);SAGA complex (7%);cytoplasm (4%),GO:0005524 (13%);GO:0003676 (11%);GO:0003677 (9%),ATP binding (13%);nucleic acid binding (11%);DNA binding (9%),GO:0006284 (3%);GO:0007229 (3%);GO:0006313 (2%),base-excision repair (3%);integrin-mediated signaling pathway (3%);transposition, DNA-mediated (2%),IPR027417 (11%);IPR024079 (7%);IPR001590 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);Metallopeptidase, catalytic domain superfamily (7%);Peptidase M12B, ADAM/reprolysin (7%),,,,,,,,
NVNFQVVTLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YFWWYK,Aquicella lusitana,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Legionellales,,,,,Coxiellaceae,,,,Aquicella,,,,Aquicella lusitana,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR006597 (100%);IPR011990 (100%),Sel1-like repeat (100%);Tetratricopeptide-like helical domain superfamily (100%),,,,,,,,,,,
MNVMVFVGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLTMVSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALPVAPAFWGGKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDVEPNDTTAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFQLAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (75%);GO:0016887 (75%);GO:0046872 (13%),ATP binding (75%);ATPase activity (75%);metal ion binding (13%),GO:0009253 (6%),peptidoglycan catabolic process (6%),IPR003439 (75%);IPR027417 (75%);IPR003593 (63%),ABC transporter-like (75%);P-loop containing nucleoside triphosphate hydrolase (75%);AAA+ ATPase domain (63%),,,,,,,,,,,
TVMLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.189 (15%);2.1.1.- (12%);2.7.7.7 (10%),23S rRNA (uracil(747)-C(5))-methyltransferase (15%);Methyltransferases (12%);DNA-directed DNA polymerase (10%),GO:0016021 (16%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (16%);cytoplasm (5%);plasma membrane (4%),GO:0005524 (23%);GO:0008173 (10%);GO:0016787 (9%),ATP binding (23%);RNA methyltransferase activity (10%);hydrolase activity (9%),GO:0006396 (11%);GO:0006281 (4%);GO:0055085 (2%),RNA processing (11%);DNA repair (4%);transmembrane transport (2%),IPR027417 (23%);IPR029063 (10%);IPR012340 (10%),P-loop containing nucleoside triphosphate hydrolase (23%);S-adenosyl-L-methionine-dependent methyltransferase (10%);Nucleic acid-binding, OB-fold (10%),,,,,,,,,,
YLDSVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.9 (20%);2.1.1.63 (7%);2.2.1.7 (7%),UTP--glucose-1-phosphate uridylyltransferase (20%);Methylated-DNA--[protein]-cysteine S-methyltransferase (7%);1-deoxy-D-xylulose-5-phosphate synthase (7%),GO:0016021 (9%);GO:0005737 (3%);GO:0009279 (2%),integral component of membrane (9%);cytoplasm (3%);cell outer membrane (2%),GO:0003677 (43%);GO:0003700 (38%);GO:0016740 (12%),DNA binding (43%);DNA-binding transcription factor activity (38%);transferase activity (12%),GO:0006352 (4%);GO:0008360 (3%);GO:0006281 (2%),DNA-templated transcription, initiation (4%);regulation of cell shape (3%);DNA repair (2%),IPR036388 (36%);IPR036390 (31%);IPR000847 (30%),Winged helix-like DNA-binding domain superfamily (36%);Winged helix DNA-binding domain superfamily (31%);Transcription regulator HTH, LysR (30%),,,,,,,,,
EVWTDMTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQWLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (70%);GO:0016021 (40%),cell outer membrane (70%);integral component of membrane (40%),GO:0004519 (20%);GO:0004527 (10%);GO:0005525 (10%),endonuclease activity (20%);exonuclease activity (10%);GTP binding (10%),,,IPR000531 (70%);IPR012910 (70%);IPR036942 (70%),TonB-dependent receptor-like, beta-barrel (70%);TonB-dependent receptor, plug domain (70%);TonB-dependent receptor-like, beta-barrel domain superfamily (70%),,,,,,,,
QNSWMMER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFVDLSGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
METLWPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVVVNDPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CWENDAGVTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPQVEGTGGDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CEGQSNGLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFSPEFGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFDVETWER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTMNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (16%);2.7.7.7 (8%);3.1.-.- (8%),Histidine kinase (16%);DNA-directed DNA polymerase (8%);Acting on ester bonds (8%),GO:0016021 (37%);GO:0005886 (4%);GO:0005634 (3%),integral component of membrane (37%);plasma membrane (4%);nucleus (3%),GO:0005524 (16%);GO:0046872 (8%);GO:0004553 (6%),ATP binding (16%);metal ion binding (8%);hydrolase activity, hydrolyzing O-glycosyl compounds (6%),GO:0005975 (7%);GO:0007165 (6%);GO:0007155 (5%),carbohydrate metabolic process (7%);signal transduction (6%);cell adhesion (5%),IPR010835 (12%);IPR013783 (11%);IPR017853 (6%),Protein of unknown function DUF1439 (12%);Immunoglobulin-like fold (11%);Glycoside hydrolase superfamily (6%),,,,,,,,,,
WCVDVK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (100%),Oxidoreductases (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0004499 (50%);GO:0050660 (50%);GO:0050661 (50%),N,N-dimethylaniline monooxygenase activity (50%);flavin adenine dinucleotide binding (50%);NADP binding (50%),,,IPR000960 (50%);IPR001680 (50%);IPR015943 (50%),Flavin monooxygenase FMO (50%);WD40 repeat (50%);WD40/YVTN repeat-like-containing domain superfamily (50%),,,,,,,,,,
LANLLEAMR,Butyrivibrio,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Lachnospiraceae,,,,Butyrivibrio,,,,,,,,,,,,GO:0003677 (100%);GO:0003700 (100%),DNA binding (100%);DNA-binding transcription factor activity (100%),,,IPR001034 (100%);IPR013196 (100%);IPR026881 (100%),DeoR-type HTH domain (100%);Helix-turn-helix, type 11 (100%);WYL domain (100%),,,,,,,,,,
DLNLLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.- (40%);3.1.-.- (20%);3.1.1.5 (20%),Other oxidoreductases (40%);Acting on ester bonds (20%);Lysophospholipase (20%),GO:0016021 (12%),integral component of membrane (12%),GO:0005525 (36%);GO:0005524 (9%);GO:0016829 (9%),GTP binding (36%);ATP binding (9%);lyase activity (9%),GO:0018298 (6%);GO:0009395 (3%);GO:0043571 (3%),protein-chromophore linkage (6%);phospholipid catabolic process (3%);maintenance of CRISPR repeat elements (3%),IPR027417 (40%);IPR006073 (27%);IPR040576 (27%),P-loop containing nucleoside triphosphate hydrolase (40%);GTP binding domain (27%);Dynamin-like helical domain (27%),,,,,,,,,,,
MVHDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (32%);4.1.1.83 (12%);3.4.11.- (6%),Histidine kinase (32%);4-hydroxyphenylacetate decarboxylase (12%);Aminopeptidases (6%),GO:0016021 (25%);GO:0005634 (3%);GO:0005886 (1%),integral component of membrane (25%);nucleus (3%);plasma membrane (1%),GO:0045301 (18%);GO:0003677 (13%);GO:0000155 (11%),tRNA-(2-methylthio-N-6-(cis-hydroxy)isopentenyl adenosine)-hydroxylase activity (18%);DNA binding (13%);phosphorelay sensor kinase activity (11%),GO:0006260 (8%);GO:0006355 (6%);GO:0009584 (4%),DNA replication (8%);regulation of transcription, DNA-templated (6%);detection of visible light (4%),IPR009078 (17%);IPR010386 (17%);IPR012347 (17%),Ferritin-like superfamily (17%);tRNA-hydroxylase MiaE (17%);Ferritin-like (17%),,,,,,,,,,
DLQALAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.25 (100%),Inositol-phosphate phosphatase (100%),,,GO:0004222 (50%);GO:0003924 (17%);GO:0004151 (17%),metalloendopeptidase activity (50%);GTPase activity (17%);dihydroorotase activity (17%),GO:0019856 (17%);GO:0046854 (17%);GO:0046855 (17%),pyrimidine nucleobase biosynthetic process (17%);phosphatidylinositol phosphorylation (17%);inositol phosphate dephosphorylation (17%),IPR001915 (50%);IPR000760 (17%);IPR002195 (17%),Peptidase M48 (50%);Inositol monophosphatase-like (17%);Dihydroorotase, conserved site (17%),,,,,,,,,,
MPLTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.3 (31%);3.2.1.- (10%);2.1.1.200 (7%),Guanine deaminase (31%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (10%);tRNA (cytidine(32)/uridine(32)-2'-O)-methyltransferase (7%),GO:0016021 (19%);GO:0005737 (6%);GO:0016020 (2%),integral component of membrane (19%);cytoplasm (6%);membrane (2%),GO:0003677 (14%);GO:0005524 (14%);GO:0008270 (7%),DNA binding (14%);ATP binding (14%);zinc ion binding (7%),GO:0006281 (8%);GO:0006147 (7%);GO:0006355 (2%),DNA repair (8%);guanine catabolic process (7%);regulation of transcription, DNA-templated (2%),IPR027417 (10%);IPR006311 (6%);IPR032466 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Twin-arginine translocation pathway, signal sequence (6%);Metal-dependent hydrolase (6%),,,,,,,,
TNSFSVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004672 (100%);GO:0005524 (100%),protein kinase activity (100%);ATP binding (100%),,,IPR000719 (100%);IPR008271 (100%);IPR011009 (100%),Protein kinase domain (100%);Serine/threonine-protein kinase, active site (100%);Protein kinase-like domain superfamily (100%),,,,,,,,,,
AAPAEAYHPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVQYLMLPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVDSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.14.5 (15%);3.6.4.- (11%);1.2.1.10 (7%),Dipeptidyl-peptidase IV (15%);Acting on ATP; involved in cellular and subcellular movement (11%);Acetaldehyde dehydrogenase (acetylating) (7%),GO:0016021 (53%);GO:0005737 (2%);GO:0005886 (1%),integral component of membrane (53%);cytoplasm (2%);plasma membrane (1%),GO:0008236 (27%);GO:0015210 (11%);GO:0005524 (4%),serine-type peptidase activity (27%);uracil transmembrane transporter activity (11%);ATP binding (4%),GO:0043484 (2%);GO:0051726 (2%);GO:0006351 (1%),regulation of RNA splicing (2%);regulation of cell cycle (2%);transcription, DNA-templated (1%),IPR003798 (37%);IPR002469 (25%);IPR038554 (25%),DNA recombination RmuC (37%);Dipeptidylpeptidase IV, N-terminal domain (25%);Dipeptidylpeptidase IV, N-terminal domain superfamily (25%),,,,,,,,
DFLEDYAWYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVVLCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.11 (43%);2.1.1.198 (14%);2.7.7.7 (14%),Fructose-bisphosphatase (43%);16S rRNA (cytidine(1402)-2'-O)-methyltransferase (14%);DNA-directed DNA polymerase (14%),GO:0016021 (23%);GO:0005634 (17%);GO:0005576 (2%),integral component of membrane (23%);nucleus (17%);extracellular region (2%),GO:0003677 (19%);GO:0003700 (16%);GO:0005524 (10%),DNA binding (19%);DNA-binding transcription factor activity (16%);ATP binding (10%),GO:0000160 (4%);GO:0006094 (4%);GO:0006310 (2%),phosphorelay signal transduction system (4%);gluconeogenesis (4%);DNA recombination (2%),IPR002110 (14%);IPR020683 (14%);IPR036770 (14%),Ankyrin repeat (14%);Ankyrin repeat-containing domain (14%);Ankyrin repeat-containing domain superfamily (14%),,,,,,,,,,,
LAEWQTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.9 (100%),Valine--tRNA ligase (100%),GO:0005737 (15%);GO:0016021 (5%),cytoplasm (15%);integral component of membrane (5%),GO:0016787 (80%);GO:0004832 (15%);GO:0005524 (15%),hydrolase activity (80%);valine-tRNA ligase activity (15%);ATP binding (15%),GO:0009166 (80%);GO:0006438 (15%),nucleotide catabolic process (80%);valyl-tRNA aminoacylation (15%),IPR006179 (71%);IPR008334 (71%);IPR029052 (71%),5'-Nucleotidase/apyrase (71%);5'-Nucleotidase, C-terminal (71%);Metallo-dependent phosphatase-like (71%),,,,,,,,,,
VTNTEHDVYLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMYVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.8 (50%);3.2.1.89 (50%),Arginyltransferase (50%);Arabinogalactan endo-beta-1,4-galactanase (50%),GO:0016021 (45%);GO:0000922 (27%);GO:0005815 (27%),integral component of membrane (45%);spindle pole (27%);microtubule organizing center (27%),GO:0043015 (27%);GO:0003676 (9%);GO:0004057 (9%),gamma-tubulin binding (27%);nucleic acid binding (9%);arginyltransferase activity (9%),GO:0007020 (27%);GO:0055085 (18%);GO:0008152 (9%),microtubule nucleation (27%);transmembrane transport (18%);metabolic process (9%),IPR007259 (19%);IPR040457 (19%);IPR041470 (19%),Gamma-tubulin complex component protein (19%);Gamma tubulin complex component, C-terminal (19%);Gamma tubulin complex component protein, N-terminal (19%),,,,,,,,
LVEFLMLPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLESGVNTNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLSAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.126 (25%);4.2.1.19 (25%);6.1.1.21 (25%),N-acetylmuramic acid 6-phosphate etherase (25%);Imidazoleglycerol-phosphate dehydratase (25%);Histidine--tRNA ligase (25%),GO:0009366 (18%);GO:0005737 (12%);GO:0016021 (6%),enterobactin synthetase complex (18%);cytoplasm (12%);integral component of membrane (6%),GO:0000287 (18%);GO:0005524 (18%);GO:0008897 (18%),magnesium ion binding (18%);ATP binding (18%);holo-[acyl-carrier-protein] synthase activity (18%),GO:0009239 (18%);GO:0005975 (12%);GO:0006044 (12%),enterobactin biosynthetic process (18%);carbohydrate metabolic process (12%);N-acetylglucosamine metabolic process (12%),IPR003542 (14%);IPR008278 (14%);IPR037143 (14%),Enterobactin synthetase-like, component D (14%);4'-phosphopantetheinyl transferase domain (14%);4'-phosphopantetheinyl transferase domain superfamily (14%),,,,,,,,,,
MEDQPLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLDSVGTDVPEAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLELSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.1.8 (14%);3.1.4.- (9%);4.3.2.2 (6%),4-hydroxy-tetrahydrodipicolinate reductase (14%);Phosphoric diester hydrolases (9%);Adenylosuccinate lyase (6%),GO:0016021 (31%);GO:0005737 (6%);GO:0005886 (4%),integral component of membrane (31%);cytoplasm (6%);plasma membrane (4%),GO:0005524 (17%);GO:0003677 (8%);GO:0046872 (4%),ATP binding (17%);DNA binding (8%);metal ion binding (4%),GO:0006355 (3%);GO:0005975 (2%);GO:0009103 (2%),regulation of transcription, DNA-templated (3%);carbohydrate metabolic process (2%);lipopolysaccharide biosynthetic process (2%),IPR027417 (13%);IPR012467 (5%);IPR003593 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);Protein of unknown function DUF1684 (5%);AAA+ ATPase domain (4%),,,,,,,,,,
FSEQTESK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAGTM,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005886 (11%),integral component of membrane (50%);plasma membrane (11%),GO:0005524 (89%);GO:0004672 (61%);GO:0004674 (25%),ATP binding (89%);protein kinase activity (61%);protein serine/threonine kinase activity (25%),GO:0046777 (11%),protein autophosphorylation (11%),IPR000719 (97%);IPR011009 (97%);IPR008271 (95%),Protein kinase domain (97%);Protein kinase-like domain superfamily (97%);Serine/threonine-protein kinase, active site (95%),,,,,,,,,,
EELWEQLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (100%),cytoplasm (100%),GO:0008861 (100%);GO:0016829 (100%),formate C-acetyltransferase activity (100%);lyase activity (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR001150 (100%);IPR004184 (100%);IPR005949 (100%),Glycine radical domain (100%);Pyruvate formate lyase domain (100%);Formate acetyltransferase (100%),,,,,,,,,,,
AMEEAELPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYFLHGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTNADVMDQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (13%);1.9.3.1 (10%);1.16.3.2 (6%),Methyltransferases (13%);Cytochrome-c oxidase (10%);Bacterial non-heme ferritin (6%),GO:0016021 (24%);GO:0005737 (7%);GO:0005886 (7%),integral component of membrane (24%);cytoplasm (7%);plasma membrane (7%),GO:0005524 (14%);GO:0046872 (11%);GO:0003677 (9%),ATP binding (14%);metal ion binding (11%);DNA binding (9%),GO:0032259 (4%);GO:0006364 (3%);GO:0009060 (3%),methylation (4%);rRNA processing (3%);aerobic respiration (3%),IPR027417 (12%);IPR003593 (5%);IPR029063 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);AAA+ ATPase domain (5%);S-adenosyl-L-methionine-dependent methyltransferase (4%),,,,,,,,,,,
MCVLHLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (37%);6.5.1.2 (7%);4.2.1.9 (5%),Protein-serine/threonine phosphatase (37%);DNA ligase (NAD(+)) (7%);Dihydroxy-acid dehydratase (5%),GO:0016021 (16%);GO:0005737 (8%);GO:0000164 (5%),integral component of membrane (16%);cytoplasm (8%);protein phosphatase type 1 complex (5%),GO:0046872 (20%);GO:0005524 (15%);GO:0003677 (12%),metal ion binding (20%);ATP binding (15%);DNA binding (12%),GO:0006260 (5%);GO:0006281 (3%);GO:0006797 (3%),DNA replication (5%);DNA repair (3%);polyphosphate metabolic process (3%),IPR027417 (16%);IPR029052 (11%);IPR004843 (10%),P-loop containing nucleoside triphosphate hydrolase (16%);Metallo-dependent phosphatase-like (11%);Calcineurin-like phosphoesterase domain, ApaH type (10%),,,,,,,,,,
NLVPTGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVFENHFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LHCTYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (33%);GO:0016021 (22%),nucleus (33%);integral component of membrane (22%),GO:0003677 (56%);GO:0046872 (33%);GO:0003887 (22%),DNA binding (56%);metal ion binding (33%);DNA-directed DNA polymerase activity (22%),GO:0006261 (22%),DNA-dependent DNA replication (22%),IPR036770 (33%);IPR004333 (25%);IPR036893 (25%),Ankyrin repeat-containing domain superfamily (33%);SBP domain (25%);SBP domain superfamily (25%),,,,,,,,,,,
DDQQADNLTVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.2 (6%);1.2.1.41 (5%);1.1.1.37 (4%),Assimilatory sulfite reductase (NADPH) (6%);Glutamate-5-semialdehyde dehydrogenase (5%);Malate dehydrogenase (4%),GO:0016021 (29%);GO:0009279 (3%);GO:0043190 (3%),integral component of membrane (29%);cell outer membrane (3%);ATP-binding cassette (ABC) transporter complex (3%),GO:0005524 (16%);GO:0016887 (7%);GO:0003677 (6%),ATP binding (16%);ATPase activity (7%);DNA binding (6%),GO:0015074 (3%);GO:0071705 (2%);GO:0000266 (2%),DNA integration (3%);nitrogen compound transport (2%);mitochondrial fission (2%),IPR027417 (13%);IPR036249 (7%);IPR003593 (5%),P-loop containing nucleoside triphosphate hydrolase (13%);Thioredoxin-like superfamily (7%);AAA+ ATPase domain (5%),,,,,,,,,,,
NTLEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (34%);3.4.21.89 (12%);1.8.1.4 (8%),Beta-galactosidase (34%);Signal peptidase I (12%);Dihydrolipoyl dehydrogenase (8%),GO:0016021 (37%);GO:0009341 (6%);GO:0005737 (4%),integral component of membrane (37%);beta-galactosidase complex (6%);cytoplasm (4%),GO:0016491 (12%);GO:0050661 (12%);GO:0003723 (10%),oxidoreductase activity (12%);NADP binding (12%);RNA binding (10%),GO:0006520 (12%);GO:0005975 (10%);GO:1990961 (7%),cellular amino acid metabolic process (12%);carbohydrate metabolic process (10%);xenobiotic detoxification by transmembrane export across the plasma membrane (7%),IPR013783 (14%);IPR039562 (13%);IPR036291 (12%),Immunoglobulin-like fold (14%);Membrane fusion protein, biotin-lipoyl like domain (13%);NAD(P)-binding domain superfamily (12%),,,,,,,,,,
ADFALPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (98%);3.2.1.- (2%),Molybdopterin molybdotransferase (98%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (2%),GO:0016021 (4%);GO:0005634 (2%),integral component of membrane (4%);nucleus (2%),GO:0046872 (85%);GO:0061599 (85%);GO:0005509 (4%),metal ion binding (85%);molybdopterin molybdotransferase activity (85%);calcium ion binding (4%),GO:0006777 (85%);GO:0032324 (85%);GO:0006306 (2%),Mo-molybdopterin cofactor biosynthetic process (85%);molybdopterin cofactor biosynthetic process (85%);DNA methylation (2%),IPR001453 (81%);IPR005110 (81%);IPR005111 (81%),MoaB/Mog domain (81%);MoeA, N-terminal and linker domain (81%);MoeA, C-terminal, domain IV (81%),,,,,,,
MAEGPYWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLADDSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYTYYYR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (100%),Carboxylic ester hydrolases (100%),GO:0009279 (20%);GO:0016021 (20%),cell outer membrane (20%);integral component of membrane (20%),GO:0016787 (60%);GO:0000155 (20%);GO:0005524 (20%),hydrolase activity (60%);phosphorelay sensor kinase activity (20%);ATP binding (20%),,,IPR002018 (60%);IPR019826 (60%);IPR029058 (60%),Carboxylesterase, type B (60%);Carboxylesterase type B, active site (60%);Alpha/Beta hydrolase fold (60%),,,,,,,,,
APTLNSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.24 (100%),Mitogen-activated protein kinase (100%),GO:0015627 (33%);GO:0016021 (33%),type II protein secretion system complex (33%);integral component of membrane (33%),GO:0004707 (33%);GO:0005524 (33%),MAP kinase activity (33%);ATP binding (33%),GO:0015628 (33%),protein secretion by the type II secretion system (33%),IPR000719 (50%);IPR000983 (50%);IPR003527 (50%),Protein kinase domain (50%);Bacterial general secretion pathway protein G-type pilin (50%);Mitogen-activated protein (MAP) kinase, conserved site (50%),,,,,,,,,,
NNVLPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.133 (100%),dTDP-4-dehydrorhamnose reductase (100%),,,GO:0004553 (40%);GO:0004672 (20%);GO:0005507 (20%),hydrolase activity, hydrolyzing O-glycosyl compounds (40%);protein kinase activity (20%);copper ion binding (20%),GO:0005975 (40%);GO:0019305 (20%);GO:0051301 (20%),carbohydrate metabolic process (40%);dTDP-rhamnose biosynthetic process (20%);cell division (20%),IPR012340 (31%);IPR022967 (31%);IPR001764 (15%),Nucleic acid-binding, OB-fold (31%);RNA-binding domain, S1 (31%);Glycoside hydrolase, family 3, N-terminal (15%),,,,,,
SFSSYCAHGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QALSGNAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016852 (100%),sirohydrochlorin cobaltochelatase activity (100%),GO:0009236 (100%),cobalamin biosynthetic process (100%),IPR001611 (50%);IPR002762 (50%);IPR003591 (50%),Leucine-rich repeat (50%);Cobalamin (vitamin B12) biosynthesis CbiX (50%);Leucine-rich repeat, typical subtype (50%),,,,,,,,,,
MNFTSHALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGDLVLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (100%),Molybdopterin molybdotransferase (100%),,,GO:0046872 (78%);GO:0061599 (78%);GO:0016740 (11%),metal ion binding (78%);molybdopterin molybdotransferase activity (78%);transferase activity (11%),GO:0032324 (89%);GO:0006777 (78%);GO:0000160 (11%),molybdopterin cofactor biosynthetic process (89%);Mo-molybdopterin cofactor biosynthetic process (78%);phosphorelay signal transduction system (11%),IPR001453 (89%);IPR005110 (89%);IPR005111 (89%),MoaB/Mog domain (89%);MoeA, N-terminal and linker domain (89%);MoeA, C-terminal, domain IV (89%),,,,,,,,
LGVAMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (25%);GO:0016021 (25%),plasma membrane (25%);integral component of membrane (25%),GO:0004642 (50%);GO:0003677 (25%);GO:0004803 (25%),phosphoribosylformylglycinamidine synthase activity (50%);DNA binding (25%);transposase activity (25%),GO:0006189 (50%);GO:0006313 (25%),'de novo' IMP biosynthetic process (50%);transposition, DNA-mediated (25%),IPR002725 (43%);IPR010075 (29%);IPR029062 (29%),Protein of unknown function DUF45 (43%);Phosphoribosylformylglycinamidine synthase subunit PurQ (29%);Class I glutamine amidotransferase-like (29%),,,,,,,,,,
MTVTGTETPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSNGPWLMSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELMLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.-.- (22%);1.1.1.22 (11%);2.7.13.3 (11%),Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2) (22%);UDP-glucose 6-dehydrogenase (11%);Histidine kinase (11%),GO:0016021 (21%);GO:0005654 (6%);GO:0005730 (6%),integral component of membrane (21%);nucleoplasm (6%);nucleolus (6%),GO:0050660 (23%);GO:0016491 (14%);GO:0016793 (7%),flavin adenine dinucleotide binding (23%);oxidoreductase activity (14%);triphosphoric monoester hydrolase activity (7%),GO:0000463 (5%);GO:0000466 (5%);GO:0005975 (4%),maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (5%);maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (5%);carbohydrate metabolic process (4%),IPR000644 (23%);IPR005170 (20%);IPR016169 (20%),CBS domain (23%);Transporter-associated domain (20%);FAD-binding, type PCMH, subdomain 2 (20%),,,,
ALPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.5 (77%);3.6.1.9 (3%);6.3.2.6 (3%),Exodeoxyribonuclease V (77%);Nucleotide diphosphatase (3%);Phosphoribosylaminoimidazolesuccinocarboxamide synthase (3%),GO:0016021 (41%);GO:0009338 (22%);GO:0005886 (13%),integral component of membrane (41%);exodeoxyribonuclease V complex (22%);plasma membrane (13%),GO:0005524 (32%);GO:0003677 (26%);GO:0003678 (24%),ATP binding (32%);DNA binding (26%);DNA helicase activity (24%),GO:0000724 (23%);GO:0055085 (9%);GO:0042254 (4%),double-strand break repair via homologous recombination (23%);transmembrane transport (9%);ribosome biogenesis (4%),IPR027417 (33%);IPR011335 (21%);IPR041500 (21%),P-loop containing nucleoside triphosphate hydrolase (33%);Restriction endonuclease  type II-like (21%);RecC, C-terminal (21%),,,,,,,,,,
WLMWLFPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNGAAAPR,Bradyrhizobiaceae,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Bradyrhizobiaceae,,,,,,,,,,,,,,GO:0043190 (100%),ATP-binding cassette (ABC) transporter complex (100%),GO:0005524 (100%);GO:0016887 (100%),ATP binding (100%);ATPase activity (100%),GO:0055085 (100%),transmembrane transport (100%),IPR003439 (100%);IPR003593 (100%);IPR017871 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);ABC transporter, conserved site (100%),,,,,,,,,,
CEEELTLVVQMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPYNMVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMAVTQR,Acidobacteria bacterium,Bacteria,,,,Acidobacteria,,,,,,,,,,,,,,,,,,,,Acidobacteria bacterium,,,,2.2.1.6 (100%),Acetolactate synthase (100%),,,GO:0000287 (100%);GO:0003984 (100%);GO:0030976 (100%),magnesium ion binding (100%);acetolactate synthase activity (100%);thiamine pyrophosphate binding (100%),GO:0009097 (100%);GO:0009099 (100%),isoleucine biosynthetic process (100%);valine biosynthetic process (100%),IPR000399 (100%);IPR011766 (100%);IPR012000 (100%),TPP-binding enzyme, conserved site (100%);Thiamine pyrophosphate enzyme, C-terminal TPP-binding (100%);Thiamine pyrophosphate enzyme, central domain (100%),,,,,,,,
MYGKPTDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CDPMPVLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.13 (15%);2.3.2.31 (8%);2.7.7.7 (8%),Phosphoribosylamine--glycine ligase (15%);RBR-type E3 ubiquitin transferase (8%);DNA-directed DNA polymerase (8%),GO:0016021 (20%);GO:0005634 (6%);GO:0042719 (3%),integral component of membrane (20%);nucleus (6%);mitochondrial intermembrane space protein transporter complex (3%),GO:0005524 (20%);GO:0005509 (13%);GO:0003677 (10%),ATP binding (20%);calcium ion binding (13%);DNA binding (10%),GO:0006260 (8%);GO:0006351 (3%);GO:0006807 (3%),DNA replication (8%);transcription, DNA-templated (3%);nitrogen compound metabolic process (3%),IPR027417 (19%);IPR000152 (9%);IPR000742 (9%),P-loop containing nucleoside triphosphate hydrolase (19%);EGF-type aspartate/asparagine hydroxylation site (9%);EGF-like domain (9%),,,,,,,,,,
MANHAPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDVYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.- (9%);1.1.1.25 (8%);2.5.1.19 (8%),In phosphorus-containing anhydrides (9%);Shikimate dehydrogenase (8%);3-phosphoshikimate 1-carboxyvinyltransferase (8%),GO:0016021 (15%);GO:0005737 (12%);GO:0005886 (5%),integral component of membrane (15%);cytoplasm (12%);plasma membrane (5%),GO:0016491 (28%);GO:0071949 (28%);GO:0003677 (11%),oxidoreductase activity (28%);FAD binding (28%);DNA binding (11%),GO:0006352 (5%);GO:0043165 (4%);GO:0051205 (4%),DNA-templated transcription, initiation (5%);Gram-negative-bacterium-type cell outer membrane assembly (4%);protein insertion into membrane (4%),IPR006094 (22%);IPR016166 (22%);IPR036318 (22%),FAD linked oxidase, N-terminal (22%);FAD-binding domain, PCMH-type (22%);FAD-binding, type PCMH-like superfamily (22%),,,,,,,
ATELMHK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.2 (100%),Acid phosphatase (100%),GO:0016021 (92%),integral component of membrane (92%),GO:0003993 (8%),acid phosphatase activity (8%),,,IPR002549 (83%);IPR000326 (17%);IPR001011 (17%),Transmembrane protein TqsA-like (83%);Phosphatidic acid phosphatase type 2/haloperoxidase (17%);Acid phosphatase, class A, bacterial (17%),,,,,,,,,
WGHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (50%);2.3.1.180 (25%);3.4.21.- (25%),Glycine--tRNA ligase (50%);Beta-ketoacyl-[acyl-carrier-protein] synthase III (25%);Serine endopeptidases (25%),GO:0016021 (29%);GO:0009360 (21%);GO:0005634 (6%),integral component of membrane (29%);DNA polymerase III complex (21%);nucleus (6%),GO:0003677 (27%);GO:0005524 (25%);GO:0003887 (21%),DNA binding (27%);ATP binding (25%);DNA-directed DNA polymerase activity (21%),GO:0006260 (19%);GO:0006313 (6%);GO:0005976 (5%),DNA replication (19%);transposition, DNA-mediated (6%);polysaccharide metabolic process (5%),IPR008921 (18%);IPR012763 (18%);IPR022754 (18%),DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal (18%);DNA polymerase III, subunit gamma/ tau (18%);DNA polymerase III, gamma subunit, domain III (18%),,,,
MPLVALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.0 (50%);6.3.4.20 (33%);3.4.21.89 (17%), (50%);7-cyano-7-deazaguanine synthase (33%);Signal peptidase I (17%),GO:0016021 (17%);GO:0005634 (8%),integral component of membrane (17%);nucleus (8%),GO:0005524 (25%);GO:0016787 (25%);GO:0003677 (17%),ATP binding (25%);hydrolase activity (25%);DNA binding (17%),GO:0006355 (17%);GO:0008616 (8%),regulation of transcription, DNA-templated (17%);queuosine biosynthetic process (8%),IPR002509 (19%);IPR011330 (19%);IPR014729 (19%),NodB homology domain (19%);Glycoside hydrolase/deacetylase, beta/alpha-barrel (19%);Rossmann-like alpha/beta/alpha sandwich fold (19%),,,,,,,,,
LEAHMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NCWPNYAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNDVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.2 (73%);1.-.-.- (5%);6.3.5.5 (3%),Glutamine synthetase (73%);Oxidoreductases (5%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (3%),GO:0005737 (36%);GO:0016021 (9%);GO:0043190 (4%),cytoplasm (36%);integral component of membrane (9%);ATP-binding cassette (ABC) transporter complex (4%),GO:0005524 (44%);GO:0004356 (38%);GO:0016491 (7%),ATP binding (44%);glutamate-ammonia ligase activity (38%);oxidoreductase activity (7%),GO:0006542 (33%);GO:0055085 (4%);GO:0006807 (2%),glutamine biosynthetic process (33%);transmembrane transport (4%);nitrogen compound metabolic process (2%),IPR036651 (34%);IPR008147 (34%);IPR008146 (34%),Glutamine synthetase, N-terminal domain superfamily (34%);Glutamine synthetase, beta-Grasp domain (34%);Glutamine synthetase, catalytic domain (34%),,,,,,,,
EMWMHNGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLAMYTTFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYDYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (72%);4.2.1.- (25%);2.1.2.1 (1%),DNA helicase (72%);Hydro-lyases (25%);Glycine hydroxymethyltransferase (1%),GO:0009379 (60%);GO:0005739 (19%);GO:0005829 (5%),Holliday junction helicase complex (60%);mitochondrion (19%);cytosol (5%),GO:0005524 (67%);GO:0003677 (65%);GO:0009378 (65%),ATP binding (67%);DNA binding (65%);four-way junction helicase activity (65%),GO:0006281 (65%);GO:0006310 (65%);GO:0009432 (64%),DNA repair (65%);DNA recombination (65%);SOS response (64%),IPR012340 (63%);IPR013849 (63%);IPR000085 (62%),Nucleic acid-binding, OB-fold (63%);DNA helicase, Holliday junction RuvA type, domain I, bacterial (63%);Bacterial DNA recombination protein RuvA (62%),,,,,,,
ALSLEQNK,Paenibacillus bovis,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Paenibacillaceae,,,,Paenibacillus,,,,Paenibacillus bovis,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016301 (100%),ATP binding (100%);kinase activity (100%),,,IPR003594 (100%);IPR004358 (100%);IPR005467 (100%),Histidine kinase/HSP90-like ATPase (100%);Signal transduction histidine kinase-related protein, C-terminal (100%);Histidine kinase domain (100%),,,,,,,,,,
LTNLLQYLK,Spathaspora,Eukaryota,Fungi,Dikarya,,Ascomycota,Saccharomycotina,,Saccharomycetes,,,,Saccharomycetales,,,,,Debaryomycetaceae,,,,Spathaspora,,,,,,,,,,,,GO:0004851 (100%),uroporphyrin-III C-methyltransferase activity (100%),GO:0000103 (100%);GO:0019354 (100%);GO:0032259 (100%),sulfate assimilation (100%);siroheme biosynthetic process (100%);methylation (100%),IPR000878 (100%);IPR003043 (100%);IPR006366 (100%),Tetrapyrrole methylase (100%);Uroporphiryn-III C-methyltransferase, conserved site (100%);Uroporphyrin-III C-methyltransferase (100%),,,,,,,,,,
QSSWNVDAMEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVVDAMGMESPPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.2.2 (6%);2.7.7.6 (3%);2.7.1.19 (3%),H(+)-transporting two-sector ATPase (6%);DNA-directed RNA polymerase (3%);Phosphoribulokinase (3%),GO:0016021 (18%);GO:0005737 (9%);GO:0005840 (6%),integral component of membrane (18%);cytoplasm (9%);ribosome (6%),GO:0005524 (16%);GO:0003677 (12%);GO:0046872 (9%),ATP binding (16%);DNA binding (12%);metal ion binding (9%),GO:0006412 (6%);GO:0006355 (3%);GO:0005975 (2%),translation (6%);regulation of transcription, DNA-templated (3%);carbohydrate metabolic process (2%),IPR027417 (12%);IPR036388 (5%);IPR008932 (5%),P-loop containing nucleoside triphosphate hydrolase (12%);Winged helix-like DNA-binding domain superfamily (5%);Ribosomal protein L7/L12, oligomerisation (5%),,,,,,,,,
QNEWVGQALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNLDFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005886 (9%);GO:0009276 (2%),integral component of membrane (50%);plasma membrane (9%);Gram-negative-bacterium-type cell wall (2%),GO:0046872 (39%);GO:0004070 (11%);GO:0005524 (11%),metal ion binding (39%);aspartate carbamoyltransferase activity (11%);ATP binding (11%),GO:0006207 (11%);GO:0006541 (9%);GO:0035556 (7%),'de novo' pyrimidine nucleobase biosynthetic process (11%);glutamine metabolic process (9%);intracellular signal transduction (7%),IPR032880 (39%);IPR027815 (35%);IPR003864 (33%),Calcium permeable stress-gated cation channel 1, N-terminal transmembrane domain (39%);10TM putative phosphate transporter, cytosolic domain (35%);Calcium-dependent channel, 7TM region, putative phosphate (33%),,,,,,,
QGGFSNPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.1 (41%);2.1.1.37 (12%);3.5.1.2 (5%),Tryptophanase (41%);DNA (cytosine-5-)-methyltransferase (12%);Glutaminase (5%),GO:0016021 (28%);GO:0005737 (12%);GO:0005634 (4%),integral component of membrane (28%);cytoplasm (12%);nucleus (4%),GO:0005524 (13%);GO:0009034 (12%);GO:0003677 (9%),ATP binding (13%);tryptophanase activity (12%);DNA binding (9%),GO:0042274 (4%);GO:0005975 (3%);GO:0055085 (2%),ribosomal small subunit biogenesis (4%);carbohydrate metabolic process (3%);transmembrane transport (2%),IPR015421 (11%);IPR015424 (11%);IPR001597 (10%),Pyridoxal phosphate-dependent transferase, major domain (11%);Pyridoxal phosphate-dependent transferase (11%);Aromatic amino acid beta-eliminating lyase/threonine aldolase (10%),,,,,,,,,,
DALEMLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0015930 (50%);GO:0016491 (50%),glutamate synthase activity (50%);oxidoreductase activity (50%),GO:0006537 (50%),glutamate biosynthetic process (50%),IPR002489 (50%);IPR002932 (50%);IPR006982 (50%),Glutamate synthase, alpha subunit, C-terminal (50%);Glutamate synthase domain (50%);Glutamate synthase, central-N (50%),,,,,,,,
TLNLVSESPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSFGPVER,Gracilariopsis chorda,Eukaryota,,,,Rhodophyta,,,Florideophyceae,Rhodymeniophycidae,,,Gracilariales,,,,,Gracilariaceae,,,,Gracilariopsis,,,,Gracilariopsis chorda,,,,,,,,,,,,IPR002110 (100%);IPR020683 (100%);IPR036770 (100%),Ankyrin repeat (100%);Ankyrin repeat-containing domain (100%);Ankyrin repeat-containing domain superfamily (100%),,,,,,,,,,,
TCNMVPYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGNLVDELHGCYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNQAEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.11 (100%),Ribonuclease Z (100%),GO:0016020 (8%);GO:0016021 (8%),membrane (8%);integral component of membrane (8%),GO:0003824 (54%);GO:0008270 (23%);GO:0042781 (23%),catalytic activity (54%);zinc ion binding (23%);3'-tRNA processing endoribonuclease activity (23%),,,IPR001932 (35%);IPR006528 (35%);IPR036457 (35%),PPM-type phosphatase domain (35%);Phage head morphogenesis domain (35%);PPM-type phosphatase domain superfamily (35%),,,,,,,,,,,
MSNTYVDK,Candidatus Aminicenantes bacterium,Bacteria,,,,Candidatus Aminicenantes,,,,,,,,,,,,,,,,,,,,Candidatus Aminicenantes bacterium,,,,,,,,,,,,IPR002510 (100%);IPR025502 (100%);IPR035068 (100%),Metalloprotease TldD/PmbA (100%);TldD (100%);Metalloprotease TldD/PmbA, N-terminal (100%),,,,,,,,,,
FVLMPVR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0005737 (62%);GO:0009360 (57%);GO:0005576 (33%),cytoplasm (62%);DNA polymerase III complex (57%);extracellular region (33%),GO:0003677 (67%);GO:0003887 (67%);GO:0008408 (57%),DNA binding (67%);DNA-directed DNA polymerase activity (67%);3'-5' exonuclease activity (57%),GO:0006260 (67%);GO:0044780 (29%);GO:0071973 (29%),DNA replication (67%);bacterial-type flagellum assembly (29%);bacterial-type flagellum-dependent cell motility (29%),IPR001001 (67%);IPR022634 (67%);IPR022635 (67%),DNA polymerase III, beta sliding clamp (67%);DNA polymerase III, beta sliding clamp, N-terminal (67%);DNA polymerase III, beta sliding clamp, C-terminal (67%),,,,,,
EYCLLLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTVLSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),GO:0016021 (40%),integral component of membrane (40%),GO:0003677 (40%);GO:0003678 (20%);GO:0005524 (20%),DNA binding (40%);DNA helicase activity (20%);ATP binding (20%),GO:0006310 (20%);GO:0015074 (20%),DNA recombination (20%);DNA integration (20%),IPR000212 (20%);IPR001878 (20%);IPR002104 (20%),DNA helicase, UvrD/REP type (20%);Zinc finger, CCHC-type (20%);Integrase, catalytic domain (20%),,,,,,,,
WPVFMHNLYSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVDVN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),GO:0016021 (28%);GO:0005874 (4%),integral component of membrane (28%);microtubule (4%),GO:0003677 (64%);GO:0003899 (64%);GO:0003777 (4%),DNA binding (64%);DNA-directed 5'-3' RNA polymerase activity (64%);microtubule motor activity (4%),GO:0006351 (64%);GO:0007018 (4%),transcription, DNA-templated (64%);microtubule-based movement (4%),IPR006591 (64%);IPR023464 (64%);IPR029040 (64%),RNA polymerase archaeal subunit P/eukaryotic subunit RPABC4 (64%);DNA-directed RNA polymerase subunit P (Rpo12) (64%);RNA polymerase subunit RPABC4/transcription elongation factor Spt4 (64%),,,,,,,,,,
FVLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.7 (60%);3.1.4.- (5%);3.1.3.23 (4%),Diaminopimelate epimerase (60%);Phosphoric diester hydrolases (5%);Sugar-phosphatase (4%),GO:0005737 (29%);GO:0016021 (16%);GO:0005623 (2%),cytoplasm (29%);integral component of membrane (16%);cell (2%),GO:0008837 (20%);GO:0005524 (7%);GO:0046872 (6%),diaminopimelate epimerase activity (20%);ATP binding (7%);metal ion binding (6%),GO:0009089 (21%);GO:0048015 (5%);GO:0046854 (4%),lysine biosynthetic process via diaminopimelate (21%);phosphatidylinositol-mediated signaling (5%);phosphatidylinositol phosphorylation (4%),IPR001653 (17%);IPR018510 (17%);IPR027417 (7%),Diaminopimelate epimerase, DapF (17%);Diaminopimelate epimerase, active site (17%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,
LTWLQEVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLDAELAAVNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMSPDANEDQVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDPLVQPELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDSEDLPWRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANGYFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.177 (100%),Alpha-D-xyloside xylohydrolase (100%),,,GO:0016787 (50%);GO:0030246 (50%);GO:0061634 (50%),hydrolase activity (50%);carbohydrate binding (50%);alpha-D-xyloside xylohydrolase (50%),GO:0005975 (50%),carbohydrate metabolic process (50%),IPR000322 (33%);IPR002925 (33%);IPR003961 (33%),Glycoside hydrolase family 31 (33%);Dienelactone hydrolase (33%);Fibronectin type III (33%),,,,,,,,,,,
EVLDCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.19.- (35%);4.2.1.11 (19%);6.3.3.2 (19%),Omega peptidases (35%);Phosphopyruvate hydratase (19%);5-formyltetrahydrofolate cyclo-ligase (19%),GO:0005737 (13%);GO:0000015 (5%);GO:0005576 (5%),cytoplasm (13%);phosphopyruvate hydratase complex (5%);extracellular region (5%),GO:0016740 (24%);GO:0016810 (18%);GO:0046872 (18%),transferase activity (24%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (18%);metal ion binding (18%),GO:0006096 (6%);GO:0000737 (2%);GO:0006537 (2%),glycolytic process (6%);DNA catabolic process, endonucleolytic (2%);glutamate biosynthetic process (2%),IPR003778 (43%);IPR029000 (43%);IPR011059 (20%),Carboxyltransferase domain, subdomain A and B (43%);Cyclophilin-like domain superfamily (43%);Metal-dependent hydrolase, composite domain superfamily (20%),,,,,,,
LLEDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.17 (16%);3.4.19.12 (14%);6.3.4.14 (6%),Propionate--CoA ligase (16%);Ubiquitinyl hydrolase 1 (14%);Biotin carboxylase (6%),GO:0005856 (30%);GO:0016021 (14%);GO:0005737 (9%),cytoskeleton (30%);integral component of membrane (14%);cytoplasm (9%),GO:0003779 (33%);GO:0005509 (29%);GO:0008017 (29%),actin binding (33%);calcium ion binding (29%);microtubule binding (29%),GO:0045454 (2%);GO:0001578 (2%);GO:0006412 (2%),cell redox homeostasis (2%);microtubule bundle formation (2%);translation (2%),IPR002017 (33%);IPR018159 (33%);IPR011992 (32%),Spectrin repeat (33%);Spectrin/alpha-actinin (33%);EF-hand domain pair (32%),,,,,,,,,,,
FVEWLMVAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMYLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.99.16 (50%);3.1.13.- (50%),Isoquinoline 1-oxidoreductase (50%);Exoribonucleases producing 5'-phosphomonoesters (50%),GO:0016021 (46%);GO:0043190 (8%);GO:0005634 (5%),integral component of membrane (46%);ATP-binding cassette (ABC) transporter complex (8%);nucleus (5%),GO:0016491 (32%);GO:0046872 (30%);GO:0004534 (5%),oxidoreductase activity (32%);metal ion binding (30%);5'-3' exoribonuclease activity (5%),GO:0035556 (8%);GO:0055085 (8%);GO:0006397 (5%),intracellular signal transduction (8%);transmembrane transport (8%);mRNA processing (5%),IPR000674 (34%);IPR006311 (34%);IPR008274 (34%),Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead (34%);Twin-arginine translocation pathway, signal sequence (34%);Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding (34%),,,,,,,,
QVSGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (87%);1.5.1.20 (4%);2.1.1.10 (4%),DNA helicase (87%);Methylenetetrahydrofolate reductase (NAD(P)H) (4%);Homocysteine S-methyltransferase (4%),GO:0016021 (19%);GO:0005576 (1%);GO:0005618 (1%),integral component of membrane (19%);extracellular region (1%);cell wall (1%),GO:0005524 (59%);GO:0003677 (58%);GO:0003678 (58%),ATP binding (59%);DNA binding (58%);DNA helicase activity (58%),GO:0055085 (10%);GO:0031119 (3%);GO:0032259 (3%),transmembrane transport (10%);tRNA pseudouridine synthesis (3%);methylation (3%),IPR027417 (52%);IPR000212 (49%);IPR014016 (49%),P-loop containing nucleoside triphosphate hydrolase (52%);DNA helicase, UvrD/REP type (49%);UvrD-like helicase, ATP-binding domain (49%),,,,,,,,,
MQDYPMFLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YWDMPSVHDSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTLLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.48 (60%);5.6.2.2 (7%);1.2.1.10 (4%),Indole-3-glycerol-phosphate synthase (60%);DNA topoisomerase (ATP-hydrolyzing) (7%);Acetaldehyde dehydrogenase (acetylating) (4%),GO:0016021 (16%);GO:0005634 (5%);GO:0005737 (3%),integral component of membrane (16%);nucleus (5%);cytoplasm (3%),GO:0004425 (26%);GO:0005524 (14%);GO:0003677 (11%),indole-3-glycerol-phosphate synthase activity (26%);ATP binding (14%);DNA binding (11%),GO:0000162 (26%);GO:0006265 (3%);GO:0006979 (3%),tryptophan biosynthetic process (26%);DNA topological change (3%);response to oxidative stress (3%),IPR013785 (25%);IPR011060 (23%);IPR013798 (23%),Aldolase-type TIM barrel (25%);Ribulose-phosphate binding barrel (23%);Indole-3-glycerol phosphate synthase (23%),,,,,,,,,,,
TADFGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.68 (100%),1-phosphatidylinositol-4-phosphate 5-kinase (100%),GO:0005634 (18%);GO:0005829 (18%);GO:0016020 (18%),nucleus (18%);cytosol (18%);membrane (18%),GO:0005524 (94%);GO:0016308 (88%);GO:0016307 (6%),ATP binding (94%);1-phosphatidylinositol-4-phosphate 5-kinase activity (88%);phosphatidylinositol phosphate kinase activity (6%),GO:0005975 (18%);GO:0006520 (18%),carbohydrate metabolic process (18%);cellular amino acid metabolic process (18%),IPR002498 (94%);IPR003409 (94%);IPR023610 (94%),Phosphatidylinositol-4-phosphate 5-kinase, core (94%);MORN motif (94%);Phosphatidylinositol-4-phosphate 5-kinase (94%),,,,,,,,,,
LSWPMYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNLWMLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SQHTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.8.7 (18%);3.2.1.28 (14%);1.14.13.- (7%),Medium-chain acyl-CoA dehydrogenase (18%);Alpha,alpha-trehalase (14%);With NADH or NADPH as one donor, and incorporation of one atom of oxygen (7%),GO:0005739 (20%);GO:0005634 (15%);GO:0016021 (13%),mitochondrion (20%);nucleus (15%);integral component of membrane (13%),GO:0050660 (28%);GO:0070991 (20%);GO:0043565 (10%),flavin adenine dinucleotide binding (28%);medium-chain-acyl-CoA dehydrogenase activity (20%);sequence-specific DNA binding (10%),GO:0006635 (15%);GO:0033539 (7%);GO:0019254 (7%),fatty acid beta-oxidation (15%);fatty acid beta-oxidation using acyl-CoA dehydrogenase (7%);carnitine metabolic process, CoA-linked (7%),IPR009100 (23%);IPR013786 (23%);IPR006089 (20%),Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily (23%);Acyl-CoA dehydrogenase/oxidase, N-terminal (23%);Acyl-CoA dehydrogenase, conserved site (20%),,,,,
TEVDVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.2 (62%);1.14.99.44 (5%);1.15.1.1 (5%),GMP synthase (glutamine-hydrolyzing) (62%);Diapolycopene oxygenase (5%);Superoxide dismutase (5%),GO:0016021 (19%);GO:0005623 (3%);GO:0005832 (2%),integral component of membrane (19%);cell (3%);chaperonin-containing T-complex (2%),GO:0005524 (27%);GO:0003922 (14%);GO:0016462 (11%),ATP binding (27%);GMP synthase (glutamine-hydrolyzing) activity (14%);pyrophosphatase activity (11%),GO:0006541 (15%);GO:0006865 (3%);GO:0030255 (3%),glutamine metabolic process (15%);amino acid transport (3%);protein secretion by the type IV secretion system (3%),IPR005220 (11%);IPR036700 (11%);IPR014729 (10%),Bacterial OB-fold (11%);Bacterial OB-fold superfamily (11%);Rossmann-like alpha/beta/alpha sandwich fold (10%),,,,,,,,,,,
MLAHSHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLLPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (21%);2.7.13.3 (12%);1.1.1.49 (11%),Leucine--tRNA ligase (21%);Histidine kinase (12%);Glucose-6-phosphate dehydrogenase (NADP(+)) (11%),GO:0016021 (50%);GO:0030314 (31%);GO:0005886 (21%),integral component of membrane (50%);junctional membrane complex (31%);plasma membrane (21%),GO:0005524 (18%);GO:0003824 (7%);GO:0046872 (5%),ATP binding (18%);catalytic activity (7%);metal ion binding (5%),GO:0007612 (5%);GO:0050885 (5%);GO:0007613 (5%),learning (5%);neuromuscular process controlling balance (5%);memory (5%),IPR017191 (27%);IPR003409 (27%);IPR036291 (8%),Junctophilin (27%);MORN motif (27%);NAD(P)-binding domain superfamily (8%),,,,,,,,,,,
FDVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.22 (29%);1.17.7.3 (4%);2.3.1.15 (4%),Asparagine--tRNA ligase (29%);(E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (4%);Glycerol-3-phosphate 1-O-acyltransferase (4%),GO:0016021 (32%);GO:0005737 (9%);GO:0033644 (9%),integral component of membrane (32%);cytoplasm (9%);host cell membrane (9%),GO:0005524 (23%);GO:0003723 (11%);GO:0008270 (10%),ATP binding (23%);RNA binding (11%);zinc ion binding (10%),GO:0039520 (9%);GO:0019082 (8%);GO:0032259 (6%),induction by virus of host autophagy (9%);viral protein processing (8%);methylation (6%),IPR027417 (11%);IPR009003 (8%);IPR002589 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);Peptidase S1, PA clan (8%);Macro domain (7%),,,,,,,,,,
TQPMMHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMMASK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000124 (33%);GO:0005669 (33%);GO:0016021 (33%),SAGA complex (33%);transcription factor TFIID complex (33%);integral component of membrane (33%),GO:0003743 (33%);GO:0003824 (33%);GO:0008270 (33%),translation initiation factor activity (33%);catalytic activity (33%);zinc ion binding (33%),GO:0006357 (33%);GO:0006367 (33%),regulation of transcription by RNA polymerase II (33%);transcription initiation from RNA polymerase II promoter (33%),IPR002885 (25%);IPR004823 (25%);IPR007197 (25%),Pentatricopeptide repeat (25%);TATA box binding protein associated factor (TAF) (25%);Radical SAM (25%),,,,,,,,,,,
MLALQMVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETTPPSLHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NHPYVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.4.1 (100%),Protein disulfide-isomerase (100%),GO:0005623 (33%);GO:0005783 (33%);GO:0016021 (33%),cell (33%);endoplasmic reticulum (33%);integral component of membrane (33%),GO:0000155 (33%);GO:0003756 (33%);GO:0005524 (33%),phosphorelay sensor kinase activity (33%);protein disulfide isomerase activity (33%);ATP binding (33%),GO:0006457 (33%);GO:0034976 (33%);GO:0045454 (33%),protein folding (33%);response to endoplasmic reticulum stress (33%);cell redox homeostasis (33%),IPR003594 (33%);IPR003661 (33%);IPR004358 (33%),Histidine kinase/HSP90-like ATPase (33%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (33%);Signal transduction histidine kinase-related protein, C-terminal (33%),,,,,,,,,
MNELTPNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSTLDELENMVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSLLCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.2 (33%);2.7.7.7 (15%);7.6.2.1 (15%),Aspartate carbamoyltransferase (33%);DNA-directed DNA polymerase (15%);P-type phospholipid transporter (15%),GO:0016021 (23%);GO:0030018 (9%);GO:0005643 (5%),integral component of membrane (23%);Z disc (9%);nuclear pore (5%),GO:0008270 (11%);GO:0005524 (10%);GO:0004070 (10%),zinc ion binding (11%);ATP binding (10%);aspartate carbamoyltransferase activity (10%),GO:0044205 (9%);GO:0006207 (8%);GO:0006520 (8%),'de novo' UMP biosynthetic process (9%);'de novo' pyrimidine nucleobase biosynthetic process (8%);cellular amino acid metabolic process (8%),IPR007051 (14%);IPR008978 (14%);IPR039790 (14%),CHORD domain (14%);HSP20-like chaperone (14%);CHORD domain containing protein (14%),,,,,,,,,,,
ETLNNFMTVLMPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTVMVGEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DQAFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.99.1 (33%);2.7.7.49 (17%);3.4.24.- (17%),Deleted entry (33%);RNA-directed DNA polymerase (17%);Metalloendopeptidases (17%),GO:0016021 (47%);GO:0005886 (31%);GO:0005694 (6%),integral component of membrane (47%);plasma membrane (31%);chromosome (6%),GO:0005524 (17%);GO:0046872 (14%);GO:0000104 (8%),ATP binding (17%);metal ion binding (14%);succinate dehydrogenase activity (8%),GO:0007049 (22%);GO:0051301 (22%);GO:0007165 (6%),cell cycle (22%);cell division (22%);signal transduction (6%),IPR004513 (21%);IPR040690 (21%);IPR000089 (8%),Cell division protein FtsX (21%);FtsX, extracellular domain (21%);Biotin/lipoyl attachment (8%),,,,,,,,,,
MVTVSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.- (50%);1.2.4.1 (21%);1.17.4.1 (9%),With NAD(+) or NADP(+) as acceptor (50%);Pyruvate dehydrogenase (acetyl-transferring) (21%);Ribonucleoside-diphosphate reductase (9%),GO:0016021 (30%);GO:0005634 (3%);GO:0005783 (2%),integral component of membrane (30%);nucleus (3%);endoplasmic reticulum (2%),GO:0016624 (26%);GO:0005524 (14%);GO:0004739 (6%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor (26%);ATP binding (14%);pyruvate dehydrogenase (acetyl-transferring) activity (6%),GO:0043335 (4%);GO:0006260 (2%);GO:0071897 (2%),protein unfolding (4%);DNA replication (2%);DNA biosynthetic process (2%),IPR001680 (34%);IPR015943 (34%);IPR017986 (34%),WD40 repeat (34%);WD40/YVTN repeat-like-containing domain superfamily (34%);WD40-repeat-containing domain (34%),,,,,,,,,
LAPVANAEMVLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSDLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (56%);7.1.1.2 (8%);4.1.1.19 (5%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (56%);NADH:ubiquinone reductase (H(+)-translocating) (8%);Arginine decarboxylase (5%),GO:0016021 (35%);GO:0033644 (13%);GO:0044220 (13%),integral component of membrane (35%);host cell membrane (13%);host cell perinuclear region of cytoplasm (13%),GO:0005524 (41%);GO:0046872 (25%);GO:0004088 (18%),ATP binding (41%);metal ion binding (25%);carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity (18%),GO:0006807 (16%);GO:0039520 (13%);GO:0019082 (12%),nitrogen compound metabolic process (16%);induction by virus of host autophagy (13%);viral protein processing (12%),IPR016185 (17%);IPR005479 (16%);IPR011761 (16%),Pre-ATP-grasp domain superfamily (17%);Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain (16%);ATP-grasp fold (16%),,,,,,,,,,
TQVLGADSSVEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APAYDPR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042597 (6%);GO:0005576 (3%),periplasmic space (6%);extracellular region (3%),GO:0016620 (45%);GO:0016874 (45%);GO:0019808 (6%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (45%);ligase activity (45%);polyamine binding (6%),GO:0006081 (45%);GO:0015846 (6%),cellular aldehyde metabolic process (45%);polyamine transport (6%),IPR011762 (45%);IPR011763 (45%);IPR012394 (45%),Acetyl-coenzyme A carboxyltransferase, N-terminal (45%);Acetyl-coenzyme A carboxyltransferase, C-terminal (45%);Aldehyde dehydrogenase NAD(P)-dependent (45%),,,,,,,
AFQEWDR,Panicum hallii,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,Petrosaviidae,,,Poales,,,,,Poaceae,Panicoideae,Paniceae,Panicinae,Panicum,,,,Panicum hallii,,,,1.13.11.- (100%),With incorporation of two atoms of oxygen (100%),,,GO:0016702 (100%);GO:0046872 (100%),oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (100%);metal ion binding (100%),GO:0031408 (100%),oxylipin biosynthetic process (100%),IPR000907 (100%);IPR001024 (100%);IPR001246 (100%),Lipoxygenase (100%);PLAT/LH2 domain (100%);Lipoxygenase, plant (100%),,,,,,,,
MDELQEDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLVDLALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (9%);GO:0016021 (9%);GO:0031514 (3%),cell outer membrane (9%);integral component of membrane (9%);motile cilium (3%),GO:0004527 (45%);GO:0016787 (15%);GO:0003824 (12%),exonuclease activity (45%);hydrolase activity (15%);catalytic activity (12%),GO:0005975 (3%);GO:0008610 (3%),carbohydrate metabolic process (3%);lipid biosynthetic process (3%),IPR004843 (59%);IPR014576 (59%);IPR029052 (59%),Calcineurin-like phosphoesterase domain, ApaH type (59%);Predicted phosphoesterase, YhaO type (59%);Metallo-dependent phosphatase-like (59%),,,,,,,,,
FDFLMMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPTTGQGLSAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPGLNSMPLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FQNENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (71%);2.4.1.212 (14%);6.1.1.22 (14%),Transferring groups other than amino-acyl groups (71%);Hyaluronan synthase (14%);Asparagine--tRNA ligase (14%),GO:0016021 (22%);GO:0005634 (13%);GO:0009507 (13%),integral component of membrane (22%);nucleus (13%);chloroplast (13%),GO:0005524 (16%);GO:0016746 (16%);GO:0003676 (6%),ATP binding (16%);transferase activity, transferring acyl groups (16%);nucleic acid binding (6%),GO:0030488 (9%);GO:0036265 (9%);GO:0005975 (6%),tRNA methylation (9%);RNA (guanine-N7)-methylation (9%);carbohydrate metabolic process (6%),IPR000089 (10%);IPR001078 (10%);IPR001680 (10%),Biotin/lipoyl attachment (10%);2-oxoacid dehydrogenase acyltransferase, catalytic domain (10%);WD40 repeat (10%),,,,,,,,,
EYPMSGPSLVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLADEPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFVFVNTLMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HHELPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (50%);3.1.11.1 (17%);3.1.3.1 (17%),DNA-directed DNA polymerase (50%);Exodeoxyribonuclease I (17%);Alkaline phosphatase (17%),GO:0005737 (17%);GO:0016021 (17%);GO:0005623 (6%),cytoplasm (17%);integral component of membrane (17%);cell (6%),GO:0003676 (28%);GO:0046872 (22%);GO:0003887 (17%),nucleic acid binding (28%);metal ion binding (22%);DNA-directed DNA polymerase activity (17%),GO:0006260 (17%);GO:0001522 (6%);GO:0006281 (6%),DNA replication (17%);pseudouridine synthesis (6%);DNA repair (6%),IPR001763 (15%);IPR036873 (15%);IPR000571 (12%),Rhodanese-like domain (15%);Rhodanese-like domain superfamily (15%);Zinc finger, CCCH-type (12%),,,,,,,,,,
NYGTVLSEMHDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTAMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.20 (12%);6.1.1.7 (12%);2.7.1.71 (9%),Tryptophan synthase (12%);Alanine--tRNA ligase (12%);Shikimate kinase (9%),GO:0016021 (90%);GO:0019028 (86%);GO:0055036 (83%),integral component of membrane (90%);viral capsid (86%);virion membrane (83%),GO:0005198 (85%);GO:0046983 (82%);GO:0005524 (72%),structural molecule activity (85%);protein dimerization activity (82%);ATP binding (72%),GO:0019062 (83%);GO:0039654 (80%);GO:0039520 (61%),virion attachment to host cell (83%);fusion of virus membrane with host endosome membrane (80%);induction by virus of host autophagy (61%),IPR001122 (84%);IPR037172 (84%);IPR038688 (84%),Flavivirus capsid protein C (84%);Flavivirus capsid protein C superfamily (84%);Flavivirus polyprotein propeptide superfamily (84%),,,,,,,,,,,
VLNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.9 (12%);6.3.1.2 (7%);2.7.7.6 (3%),Thioredoxin-disulfide reductase (12%);Glutamine synthetase (7%);DNA-directed RNA polymerase (3%),GO:0016021 (23%);GO:0005737 (10%);GO:0005886 (2%),integral component of membrane (23%);cytoplasm (10%);plasma membrane (2%),GO:0003677 (26%);GO:0005524 (17%);GO:0004386 (7%),DNA binding (26%);ATP binding (17%);helicase activity (7%),GO:0006355 (12%);GO:0006304 (5%);GO:0045892 (4%),regulation of transcription, DNA-templated (12%);DNA modification (5%);negative regulation of transcription, DNA-templated (4%),IPR027417 (13%);IPR010982 (10%);IPR000843 (9%),P-loop containing nucleoside triphosphate hydrolase (13%);Lambda repressor-like, DNA-binding domain superfamily (10%);LacI-type HTH domain (9%),,,,,,,,
DTGSER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.15 (48%);2.7.1.167 (13%);2.7.7.70 (13%),Dihydropteroate synthase (48%);D-glycero-beta-D-manno-heptose-7-phosphate kinase (13%);D-glycero-beta-D-manno-heptose 1-phosphate adenylyltransferase (13%),GO:0016021 (32%);GO:0019867 (7%);GO:0005737 (3%),integral component of membrane (32%);outer membrane (7%);cytoplasm (3%),GO:0046872 (23%);GO:0005524 (22%);GO:0004156 (17%),metal ion binding (23%);ATP binding (22%);dihydropteroate synthase activity (17%),GO:0046654 (17%);GO:0046656 (17%);GO:0071709 (7%),tetrahydrofolate biosynthetic process (17%);folic acid biosynthetic process (17%);membrane assembly (7%),IPR000489 (13%);IPR006390 (13%);IPR011005 (13%),Pterin-binding domain (13%);Dihydropteroate synthase (13%);Dihydropteroate synthase-like (13%),,,,,,,,,,,
NYNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (15%);2.7.7.6 (14%);2.4.1.21 (11%),Histidine kinase (15%);DNA-directed RNA polymerase (14%);Starch synthase (11%),GO:0016021 (29%);GO:0005737 (3%);GO:0005634 (3%),integral component of membrane (29%);cytoplasm (3%);nucleus (3%),GO:0005524 (16%);GO:0003677 (12%);GO:0003700 (7%),ATP binding (16%);DNA binding (12%);DNA-binding transcription factor activity (7%),GO:0006310 (3%);GO:0006355 (3%);GO:0006351 (3%),DNA recombination (3%);regulation of transcription, DNA-templated (3%);transcription, DNA-templated (3%),IPR027417 (10%);IPR009057 (8%);IPR018060 (4%),P-loop containing nucleoside triphosphate hydrolase (10%);Homeobox-like domain superfamily (8%);DNA binding HTH domain, AraC-type (4%),,,,,,,,
VALTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (9%);1.4.3.- (7%);1.17.4.1 (6%),Non-specific serine/threonine protein kinase (9%);With oxygen as acceptor (7%);Ribonucleoside-diphosphate reductase (6%),GO:0016021 (23%);GO:0005737 (15%);GO:0005886 (3%),integral component of membrane (23%);cytoplasm (15%);plasma membrane (3%),GO:0005524 (26%);GO:0003688 (7%);GO:0003677 (6%),ATP binding (26%);DNA replication origin binding (7%);DNA binding (6%),GO:0006270 (7%);GO:0006275 (7%);GO:0000160 (3%),DNA replication initiation (7%);regulation of DNA replication (7%);phosphorelay signal transduction system (3%),IPR027417 (14%);IPR003593 (10%);IPR001957 (6%),P-loop containing nucleoside triphosphate hydrolase (14%);AAA+ ATPase domain (10%);Chromosomal replication control, initiator DnaA (6%),,,,,,,,,,
LYMVPGK,Dendrothele bispora,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Agaricomycetes,Agaricomycetidae,,,Agaricales,,,,,,,,,Dendrothele,,,,Dendrothele bispora,,,,,,,,GO:0003723 (100%),RNA binding (100%),,,IPR000504 (100%);IPR012677 (100%);IPR035979 (100%),RNA recognition motif domain (100%);Nucleotide-binding alpha-beta plait domain superfamily (100%);RNA-binding domain superfamily (100%),,,,,,,,,,,
APAWTTVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMFFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.234 (33%);4.2.1.20 (33%);6.3.4.19 (33%),N(6)-L-threonylcarbamoyladenine synthase (33%);Tryptophan synthase (33%);tRNA(Ile)-lysidine synthetase (33%),GO:0016021 (47%);GO:0005737 (11%);GO:0000276 (5%),integral component of membrane (47%);cytoplasm (11%);mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) (5%),GO:0004843 (26%);GO:0005524 (16%);GO:0016301 (11%),thiol-dependent ubiquitin-specific protease activity (26%);ATP binding (16%);kinase activity (11%),GO:0006511 (26%);GO:0016579 (26%);GO:0046854 (11%),ubiquitin-dependent protein catabolic process (26%);protein deubiquitination (26%);phosphatidylinositol phosphorylation (11%),IPR001394 (28%);IPR006615 (28%);IPR018200 (28%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (28%);Peptidase C19, ubiquitin-specific peptidase, DUSP domain (28%);Ubiquitin specific protease, conserved site (28%),,,,,,
QYPPSLVYVFTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSLSNTFAHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HHLLAHAFGYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDWEM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLSDAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (10%);3.4.24.- (8%);4.3.2.10 (6%),DNA-directed DNA polymerase (10%);Metalloendopeptidases (8%);Imidazole glycerol-phosphate synthase (6%),GO:0016021 (21%);GO:0005737 (8%);GO:0005886 (3%),integral component of membrane (21%);cytoplasm (8%);plasma membrane (3%),GO:0005524 (14%);GO:0008168 (11%);GO:0003677 (8%),ATP binding (14%);methyltransferase activity (11%);DNA binding (8%),GO:0032259 (11%);GO:0006281 (4%);GO:0006298 (3%),methylation (11%);DNA repair (4%);mismatch repair (3%),IPR027417 (10%);IPR029063 (10%);IPR001525 (10%),P-loop containing nucleoside triphosphate hydrolase (10%);S-adenosyl-L-methionine-dependent methyltransferase (10%);C-5 cytosine methyltransferase (10%),,,,,,,,,,,
NAGVCLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDMLMGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELPQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.7 (17%);6.1.1.20 (9%);1.4.1.13 (7%),Alanine--tRNA ligase (17%);Phenylalanine--tRNA ligase (9%);Glutamate synthase (NADPH) (7%),GO:0016021 (23%);GO:0005737 (14%);GO:0005886 (2%),integral component of membrane (23%);cytoplasm (14%);plasma membrane (2%),GO:0005524 (23%);GO:0008270 (9%);GO:0003677 (8%),ATP binding (23%);zinc ion binding (9%);DNA binding (8%),GO:0006419 (5%);GO:0006537 (4%);GO:0006432 (2%),alanyl-tRNA aminoacylation (5%);glutamate biosynthetic process (4%);phenylalanyl-tRNA aminoacylation (2%),IPR027417 (14%);IPR009000 (5%);IPR002318 (4%),P-loop containing nucleoside triphosphate hydrolase (14%);Translation protein, beta-barrel domain superfamily (5%);Alanine-tRNA ligase, class IIc (4%),,,,,,,,,
FLDLEAWPLADNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DYVVQALNDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLVGHGCSWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THVYHGNGMNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNTVYGANR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WTAYMFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWYFLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLDHNCNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MENDLYVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLMDLGMK,Ditaxis biseriata,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,Neuropterida,Neuroptera,Hemerobiiformia,,,,Mantispidae,,,,Ditaxis,,,,Ditaxis biseriata,,,,7.1.1.2 (100%),NADH:ubiquinone reductase (H(+)-translocating) (100%),GO:0016021 (100%);GO:0031966 (100%);GO:0070469 (100%),integral component of membrane (100%);mitochondrial membrane (100%);respirasome (100%),GO:0008137 (100%),NADH dehydrogenase (ubiquinone) activity (100%),GO:0006120 (100%),mitochondrial electron transport, NADH to ubiquinone (100%),IPR000260 (100%);IPR001750 (100%);IPR003918 (100%),NADH:ubiquinone oxidoreductase chain 4, N-terminal (100%);NADH:quinone oxidoreductase/Mrp antiporter, membrane subunit (100%);NADH:ubiquinone oxidoreductase (100%),,,,,,,,
LCGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.7.4 (74%);2.1.3.3 (6%);2.1.3.2 (4%),4-hydroxy-3-methylbut-2-enyl diphosphate reductase (74%);Ornithine carbamoyltransferase (6%);Aspartate carbamoyltransferase (4%),GO:0016021 (9%);GO:0005737 (5%);GO:0005634 (3%),integral component of membrane (9%);cytoplasm (5%);nucleus (3%),GO:0046872 (34%);GO:0051539 (32%);GO:0051745 (32%),metal ion binding (34%);4 iron, 4 sulfur cluster binding (32%);4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity (32%),GO:0019288 (32%);GO:0050992 (32%);GO:0016114 (32%),isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (32%);dimethylallyl diphosphate biosynthetic process (32%);terpenoid biosynthetic process (32%),IPR003451 (29%);IPR011009 (20%);IPR000719 (19%),4-hydroxy-3-methylbut-2-enyl diphosphate reductase (29%);Protein kinase-like domain superfamily (20%);Protein kinase domain (19%),,,,,,,,,
SENVEHYMSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.9.1.1 (20%);6.3.5.4 (4%);3.6.4.12 (4%),L-seryl-tRNA(Sec) selenium transferase (20%);Asparagine synthase (glutamine-hydrolyzing) (4%);DNA helicase (4%),GO:0016021 (23%);GO:0005737 (19%);GO:0009380 (9%),integral component of membrane (23%);cytoplasm (19%);excinuclease repair complex (9%),GO:0005524 (32%);GO:0003677 (18%);GO:0016887 (10%),ATP binding (32%);DNA binding (18%);ATPase activity (10%),GO:0009432 (12%);GO:0006289 (10%);GO:0007411 (4%),SOS response (12%);nucleotide-excision repair (10%);axon guidance (4%),IPR027417 (16%);IPR014001 (9%);IPR001650 (9%),P-loop containing nucleoside triphosphate hydrolase (16%);Helicase superfamily 1/2, ATP-binding domain (9%);Helicase, C-terminal (9%),,,,,,,,,
LLGFNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.-.- (39%);6.3.4.- (28%);7.6.2.1 (6%),Glycosyltransferases (39%);Other carbon--nitrogen ligases (28%);P-type phospholipid transporter (6%),GO:0016021 (15%);GO:0005737 (6%);GO:0009279 (2%),integral component of membrane (15%);cytoplasm (6%);cell outer membrane (2%),GO:0016740 (58%);GO:0005524 (8%);GO:0016757 (7%),transferase activity (58%);ATP binding (8%);transferase activity, transferring glycosyl groups (7%),GO:0006400 (5%);GO:0010033 (2%);GO:0015920 (2%),tRNA modification (5%);response to organic substance (2%);lipopolysaccharide transport (2%),IPR001296 (63%);IPR038770 (6%);IPR016833 (6%),Glycosyl transferase, family 1 (63%);Sodium/solute  symporter  superfamily (6%);Putative sodium bile acid cotransporter (6%),,,,,,,,,
FGWMFFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMSDVPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.192 (67%);2.3.1.157 (33%);2.7.7.23 (33%),23S rRNA (adenine(2503)-C(2))-methyltransferase (67%);Glucosamine-1-phosphate N-acetyltransferase (33%);UDP-N-acetylglucosamine diphosphorylase (33%),GO:0016021 (96%);GO:0005886 (95%);GO:0005737 (3%),integral component of membrane (96%);plasma membrane (95%);cytoplasm (3%),GO:0000049 (2%);GO:0002935 (2%);GO:0019843 (2%),tRNA binding (2%);tRNA (adenine-C2-)-methyltransferase activity (2%);rRNA binding (2%),GO:0009306 (93%);GO:0044780 (93%);GO:0015031 (2%),protein secretion (93%);bacterial-type flagellum assembly (93%);protein transport (2%),IPR006135 (96%);IPR029025 (96%);IPR006136 (95%),Type III secretion system substrate exporter (96%);Type III secretion system substrate exporter, C-terminal (96%);Flagellar biosynthetic protein FlhB (95%),,,,,,,,,,
FDDLAKPALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPFVLTPR,Planctomycetes,Bacteria,,,,Planctomycetes,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.9 (100%),Thioredoxin-disulfide reductase (100%),,,GO:0004791 (100%),thioredoxin-disulfide reductase activity (100%),,,IPR008255 (100%);IPR023753 (100%);IPR036188 (100%),Pyridine nucleotide-disulphide oxidoreductase, class-II, active site (100%);FAD/NAD(P)-binding domain (100%);FAD/NAD(P)-binding domain superfamily (100%),,,,,,,,,
ALNLLDEAAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWLMYEK,Monoglobus,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,,,,,Monoglobus,,,,,,,,2.7.7.8 (100%),Polyribonucleotide nucleotidyltransferase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0000287 (100%);GO:0003723 (100%);GO:0004654 (100%),magnesium ion binding (100%);RNA binding (100%);polyribonucleotide nucleotidyltransferase activity (100%),GO:0006396 (100%);GO:0006402 (100%),RNA processing (100%);mRNA catabolic process (100%),IPR001247 (100%);IPR003029 (100%);IPR004087 (100%),Exoribonuclease, phosphorolytic domain 1 (100%);S1 domain (100%);K Homology domain (100%),,,,,,,,,,
QVVAETAVSMVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEHLLAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVEVVMFHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.11 (39%);2.7.-.- (13%);3.1.-.- (6%),6-phosphofructokinase (39%);Transferring phosphorus-containing groups (13%);Acting on ester bonds (6%),GO:0016021 (26%);GO:0005737 (22%);GO:0032153 (8%),integral component of membrane (26%);cytoplasm (22%);cell division site (8%),GO:0005524 (20%);GO:0003677 (11%);GO:0046872 (10%),ATP binding (20%);DNA binding (11%);metal ion binding (10%),GO:0000917 (8%);GO:0043093 (8%);GO:0051258 (8%),division septum assembly (8%);FtsZ-dependent cytokinesis (8%);protein polymerization (8%),IPR013860 (19%);IPR021711 (19%);IPR027417 (8%),Nitrogen regulatory protein areA, GATA-like domain (19%);Protein of unknown function DUF3295 (19%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
WVVDLDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTMSLR,Metazoa,Eukaryota,Metazoa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR036427 (67%);IPR011989 (33%);IPR016024 (33%),Bromodomain-like superfamily (67%);Armadillo-like helical (33%);Armadillo-type fold (33%),,,,,,,,,,,
MLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.18 (13%);3.1.-.- (5%);2.8.2.- (3%),Methionyl aminopeptidase (13%);Acting on ester bonds (5%);Sulfotransferases (3%),GO:0005737 (32%);GO:0005840 (23%);GO:0016021 (13%),cytoplasm (32%);ribosome (23%);integral component of membrane (13%),GO:0019843 (21%);GO:0000049 (21%);GO:0003735 (20%),rRNA binding (21%);tRNA binding (21%);structural constituent of ribosome (20%),GO:0006412 (21%);GO:0051301 (17%);GO:0007049 (17%),translation (21%);cell division (17%);cell cycle (17%),IPR036920 (18%);IPR000114 (18%);IPR016180 (18%),Ribosomal protein L10e/L16 superfamily (18%);Ribosomal protein L16 (18%);Ribosomal protein L10e/L16 (18%),,,,,,,,,,,
MYFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (25%);4.-.-.- (7%);2.3.1.- (5%),Signal peptidase I (25%);Lyases (7%);Transferring groups other than amino-acyl groups (5%),GO:0016021 (49%);GO:0005634 (5%);GO:0005886 (3%),integral component of membrane (49%);nucleus (5%);plasma membrane (3%),GO:0005524 (12%);GO:0016740 (5%);GO:0003677 (4%),ATP binding (12%);transferase activity (5%);DNA binding (4%),GO:0006355 (4%);GO:0006438 (3%);GO:0007165 (3%),regulation of transcription, DNA-templated (4%);valyl-tRNA aminoacylation (3%);signal transduction (3%),IPR027417 (9%);IPR001173 (5%);IPR029044 (5%),P-loop containing nucleoside triphosphate hydrolase (9%);Glycosyltransferase 2-like (5%);Nucleotide-diphospho-sugar transferases (5%),,,,,,,,,,
MVLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.3 (9%);2.6.1.42 (8%);4.3.1.24 (5%),Adenosinetriphosphatase (9%);Branched-chain-amino-acid transaminase (8%);Phenylalanine ammonia-lyase (5%),GO:0016021 (27%);GO:0005737 (5%);GO:0005886 (5%),integral component of membrane (27%);cytoplasm (5%);plasma membrane (5%),GO:0005524 (12%);GO:0003677 (11%);GO:0003824 (8%),ATP binding (12%);DNA binding (11%);catalytic activity (8%),GO:0015074 (3%);GO:0005975 (2%);GO:0055085 (2%),DNA integration (3%);carbohydrate metabolic process (2%);transmembrane transport (2%),IPR027417 (7%);IPR000873 (5%);IPR020845 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);AMP-dependent synthetase/ligase (5%);AMP-binding, conserved site (5%),,,,,,,,,,
YLVNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.3 (43%);3.4.21.83 (11%);3.2.1.31 (7%),Pantetheine-phosphate adenylyltransferase (43%);Oligopeptidase B (11%);Beta-glucuronidase (7%),GO:0016021 (25%);GO:0005737 (13%);GO:0005886 (3%),integral component of membrane (25%);cytoplasm (13%);plasma membrane (3%),GO:0005524 (20%);GO:0004252 (13%);GO:0070008 (12%),ATP binding (20%);serine-type endopeptidase activity (13%);serine-type exopeptidase activity (12%),GO:0015937 (11%);GO:0005975 (9%);GO:0006355 (4%),coenzyme A biosynthetic process (11%);carbohydrate metabolic process (9%);regulation of transcription, DNA-templated (4%),IPR029058 (13%);IPR001375 (11%);IPR002470 (11%),Alpha/Beta hydrolase fold (13%);Peptidase S9, prolyl oligopeptidase, catalytic domain (11%);Peptidase S9A, prolyl oligopeptidase (11%),,,,,,,
QGTLSTNGMQNGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLEALENPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQSHFEK,Hypocrella siamensis,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Hypocreales,,,,,Clavicipitaceae,,,,Hypocrella,,,,Hypocrella siamensis,,,,,,GO:0005680 (100%),anaphase-promoting complex (100%),,,,,IPR011990 (100%);IPR026000 (100%);IPR037679 (100%),Tetratricopeptide-like helical domain superfamily (100%);Anaphase-promoting complex subunit 5 domain (100%);Anaphase-promoting complex subunit 5 (100%),,,,,,,,,,,
MTVGQGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.33 (100%),tRNA (guanine(46)-N(7))-methyltransferase (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0003676 (25%);GO:0008176 (25%);GO:0008233 (25%),nucleic acid binding (25%);tRNA (guanine-N7-)-methyltransferase activity (25%);peptidase activity (25%),,,IPR003358 (33%);IPR012337 (33%);IPR029063 (33%),tRNA (guanine-N-7) methyltransferase, Trmb type (33%);Ribonuclease H-like superfamily (33%);S-adenosyl-L-methionine-dependent methyltransferase (33%),,,,,,,,,,
DAENVQQEWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VCDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.14 (67%);3.4.21.53 (5%);2.7.2.4 (4%),5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (67%);Endopeptidase La (5%);Aspartate kinase (4%),GO:0016021 (16%);GO:0005737 (8%);GO:0005950 (4%),integral component of membrane (16%);cytoplasm (8%);anthranilate synthase complex (4%),GO:0008270 (20%);GO:0003871 (20%);GO:0005524 (16%),zinc ion binding (20%);5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity (20%);ATP binding (16%),GO:0009086 (20%);GO:0032259 (20%);GO:0000162 (8%),methionine biosynthetic process (20%);methylation (20%);tryptophan biosynthetic process (8%),IPR002629 (15%);IPR006276 (15%);IPR013215 (15%),Cobalamin-independent methionine synthase MetE, C-terminal/archaeal (15%);Cobalamin-independent methionine synthase (15%);Cobalamin-independent methionine synthase MetE, N-terminal (15%),,,,,,,,,
ESVLPEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.-.-.- (50%);2.1.1.197 (25%);5.2.1.1 (25%),Transferases (50%);Malonyl-[acyl-carrier protein] O-methyltransferase (25%);Maleate isomerase (25%),GO:0016021 (24%);GO:0005886 (12%);GO:0000159 (6%),integral component of membrane (24%);plasma membrane (12%);protein phosphatase type 2A complex (6%),GO:0016757 (18%);GO:0046983 (18%);GO:0015450 (12%),transferase activity, transferring glycosyl groups (18%);protein dimerization activity (18%);P-P-bond-hydrolysis-driven protein transmembrane transporter activity (12%),GO:0009103 (18%);GO:0006355 (12%);GO:0009306 (12%),lipopolysaccharide biosynthetic process (18%);regulation of transcription, DNA-templated (12%);protein secretion (12%),IPR011011 (24%);IPR013083 (24%);IPR033616 (24%),Zinc finger, FYVE/PHD-type (24%);Zinc finger, RING/FYVE/PHD-type (24%);Protein KIAA1109 (24%),,,,,,,
LLEALEN,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005506 (50%);GO:0016491 (50%),iron ion binding (50%);oxidoreductase activity (50%),GO:0000160 (50%),phosphorelay signal transduction system (50%),IPR001789 (50%);IPR011006 (50%);IPR024934 (50%),Signal transduction response regulator, receiver domain (50%);CheY-like superfamily (50%);Rubredoxin-like domain (50%),,,,,,,,,,
MLLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6.1.12 (9%);2.7.7.41 (8%);3.2.1.23 (4%),2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (9%);Phosphatidate cytidylyltransferase (8%);Beta-galactosidase (4%),GO:0005840 (25%);GO:0005737 (22%);GO:0016021 (17%),ribosome (25%);cytoplasm (22%);integral component of membrane (17%),GO:0000049 (24%);GO:0019843 (24%);GO:0003735 (23%),tRNA binding (24%);rRNA binding (24%);structural constituent of ribosome (23%),GO:0006412 (25%);GO:0051301 (20%);GO:0007049 (20%),translation (25%);cell division (20%);cell cycle (20%),IPR036920 (22%);IPR000114 (22%);IPR016180 (22%),Ribosomal protein L10e/L16 superfamily (22%);Ribosomal protein L16 (22%);Ribosomal protein L10e/L16 (22%),,,,,,,,,,
MPMLVPEK,Bradyrhizobium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Bradyrhizobiaceae,,,,Bradyrhizobium,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR000620 (100%),EamA domain (100%),,,,,,,,,,,
NWCMTPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (11%);1.1.1.88 (10%);2.7.7.18 (7%),Histidine kinase (11%);Hydroxymethylglutaryl-CoA reductase (10%);Nicotinate-nucleotide adenylyltransferase (7%),GO:0016021 (31%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (31%);cytoplasm (5%);plasma membrane (4%),GO:0005524 (15%);GO:0003677 (10%);GO:0003700 (5%),ATP binding (15%);DNA binding (10%);DNA-binding transcription factor activity (5%),GO:0055085 (4%);GO:0006281 (3%);GO:0006511 (2%),transmembrane transport (4%);DNA repair (3%);ubiquitin-dependent protein catabolic process (2%),IPR010106 (8%);IPR027417 (8%);IPR036388 (5%),Recombination-promoting nuclease RpnA (8%);P-loop containing nucleoside triphosphate hydrolase (8%);Winged helix-like DNA-binding domain superfamily (5%),,,,,,,,,,,
TTLSNLPR,Acidobacteria bacterium,Bacteria,,,,Acidobacteria,,,,,,,,,,,,,,,,,,,,Acidobacteria bacterium,,,,7.1.1.- (100%),Hydron translocation or charge separation linked to oxidoreductase reactions (100%),GO:0005886 (100%),plasma membrane (100%),GO:0005506 (100%);GO:0048038 (100%);GO:0050136 (100%),iron ion binding (100%);quinone binding (100%);NADH dehydrogenase (quinone) activity (100%),,,IPR010226 (100%);IPR017896 (100%);IPR017900 (100%),NADH-quinone oxidoreductase, chain I (100%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (100%);4Fe-4S ferredoxin, iron-sulphur binding, conserved site (100%),,,,,,,
VATEPSAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.267 (100%),1-deoxy-D-xylulose-5-phosphate reductoisomerase (100%),,,GO:0016853 (100%);GO:0030604 (100%);GO:0046872 (100%),isomerase activity (100%);1-deoxy-D-xylulose-5-phosphate reductoisomerase activity (100%);metal ion binding (100%),GO:0016114 (100%);GO:0019288 (100%),terpenoid biosynthetic process (100%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (100%),IPR003821 (100%);IPR013512 (100%);IPR013644 (100%),1-deoxy-D-xylulose 5-phosphate reductoisomerase (100%);1-deoxy-D-xylulose 5-phosphate reductoisomerase, N-terminal (100%);1-deoxy-D-xylulose 5-phosphate reductoisomerase, C-terminal (100%),,,,,,,,
TLNYGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.84 (29%);2.1.3.2 (29%);2.1.1.266 (14%),Alcohol-forming fatty acyl-CoA reductase (29%);Aspartate carbamoyltransferase (29%);23S rRNA (adenine(2030)-N(6))-methyltransferase (14%),GO:0016021 (64%);GO:0005886 (28%);GO:0005887 (9%),integral component of membrane (64%);plasma membrane (28%);integral component of plasma membrane (9%),GO:0022857 (30%);GO:0003677 (12%);GO:0003700 (9%),transmembrane transporter activity (30%);DNA binding (12%);DNA-binding transcription factor activity (9%),GO:0015031 (30%);GO:0051301 (11%);GO:0007049 (9%),protein transport (30%);cell division (11%);cell cycle (9%),IPR003400 (32%);IPR014168 (31%);IPR000847 (10%),Biopolymer transport protein ExbD/TolR (32%);Tol-Pal system protein TolR (31%);Transcription regulator HTH, LysR (10%),,,,,,,,,,
DCAATLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (50%);5.3.1.9 (50%),DNA (cytosine-5-)-methyltransferase (50%);Glucose-6-phosphate isomerase (50%),GO:0016021 (20%);GO:0005737 (10%),integral component of membrane (20%);cytoplasm (10%),GO:0000155 (20%);GO:0005524 (20%);GO:0008168 (20%),phosphorelay sensor kinase activity (20%);ATP binding (20%);methyltransferase activity (20%),GO:0032259 (20%);GO:0006094 (10%);GO:0006096 (10%),methylation (20%);gluconeogenesis (10%);glycolytic process (10%),IPR003594 (33%);IPR003661 (33%);IPR004358 (33%),Histidine kinase/HSP90-like ATPase (33%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (33%);Signal transduction histidine kinase-related protein, C-terminal (33%),,,,,,,,,
EVLMAPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.1 (100%),Pantoate--beta-alanine ligase (AMP-forming) (100%),GO:0005737 (50%),cytoplasm (50%),GO:0005524 (100%);GO:0004592 (50%),ATP binding (100%);pantoate-beta-alanine ligase activity (50%),GO:0015940 (50%),pantothenate biosynthetic process (50%),IPR001482 (50%);IPR003593 (50%);IPR003721 (50%),Type II/IV secretion system protein (50%);AAA+ ATPase domain (50%);Pantoate-beta-alanine ligase (50%),,,,,,,,,,,
TFSAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.7 (9%);3.4.21.107 (6%);5.6.2.1 (4%),1-deoxy-D-xylulose-5-phosphate synthase (9%);Peptidase Do (6%);DNA topoisomerase (4%),GO:0005840 (35%);GO:0016021 (15%);GO:0005737 (4%),ribosome (35%);integral component of membrane (15%);cytoplasm (4%),GO:0003735 (33%);GO:0005524 (9%);GO:0003677 (6%),structural constituent of ribosome (33%);ATP binding (9%);DNA binding (6%),GO:0006412 (35%);GO:0006633 (4%);GO:0055114 (3%),translation (35%);fatty acid biosynthetic process (4%);oxidation-reduction process (3%),IPR036899 (30%);IPR005822 (30%);IPR005823 (29%),Ribosomal protein L13 superfamily (30%);Ribosomal protein L13 (30%);Ribosomal protein L13, bacterial-type (29%),,,,,,,,,,
DLWMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.22 (71%);6.1.1.16 (14%);6.2.1.1 (14%),Alpha-galactosidase (71%);Cysteine--tRNA ligase (14%);Acetate--CoA ligase (14%),GO:0005737 (13%);GO:0016021 (13%),cytoplasm (13%);integral component of membrane (13%),GO:0052692 (63%);GO:0005524 (25%);GO:0003987 (13%),raffinose alpha-galactosidase activity (63%);ATP binding (25%);acetate-CoA ligase activity (13%),GO:0005975 (63%);GO:0006423 (13%);GO:0019427 (13%),carbohydrate metabolic process (63%);cysteinyl-tRNA aminoacylation (13%);acetyl-CoA biosynthetic process from acetate (13%),IPR002241 (71%);IPR013780 (71%);IPR013785 (71%),Glycoside hydrolase, family 27 (71%);Glycosyl hydrolase, all-beta (71%);Aldolase-type TIM barrel (71%),,,,,,,,,
TEMPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (50%);6.2.1.16 (50%),Acting on polysaccharides (50%);Acetoacetate--CoA ligase (50%),GO:0005886 (9%);GO:0016021 (9%),plasma membrane (9%);integral component of membrane (9%),GO:0003700 (27%);GO:0043565 (27%);GO:0005524 (18%),DNA-binding transcription factor activity (27%);sequence-specific DNA binding (27%);ATP binding (18%),GO:0006633 (9%);GO:0009847 (9%);GO:0009908 (9%),fatty acid biosynthetic process (9%);spore germination (9%);flower development (9%),IPR003313 (21%);IPR009057 (21%);IPR014710 (21%),AraC-type arabinose-binding/dimerisation domain (21%);Homeobox-like domain superfamily (21%);RmlC-like jelly roll fold (21%),,,,,,,,,,,
AEFLDEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (80%);1.5.1.2 (20%),Proline--tRNA ligase (80%);Pyrroline-5-carboxylate reductase (20%),GO:0005737 (50%);GO:0009279 (10%);GO:0016021 (10%),cytoplasm (50%);cell outer membrane (10%);integral component of membrane (10%),GO:0004827 (40%);GO:0005524 (40%);GO:0002161 (30%),proline-tRNA ligase activity (40%);ATP binding (40%);aminoacyl-tRNA editing activity (30%),GO:0006433 (40%);GO:0006629 (10%);GO:0055129 (10%),prolyl-tRNA aminoacylation (40%);lipid metabolic process (10%);L-proline biosynthetic process (10%),IPR002314 (40%);IPR002316 (40%);IPR004154 (40%),Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) (40%);Proline-tRNA ligase, class IIa (40%);Anticodon-binding (40%),,,,,,,,,
MAVLTAALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WANQPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEQAATLK,Candidatus Thermochlorobacter aerophilum,Bacteria,,,,Chlorobi,,,Chlorobia,,,,Chlorobiales,,,,,Candidatus Thermochlorobacteriaceae,,,,Candidatus Thermochlorobacter,,,,Candidatus Thermochlorobacter aerophilum,,,,,,GO:0005737 (100%);GO:0009380 (100%),cytoplasm (100%);excinuclease repair complex (100%),GO:0009381 (100%),excinuclease ABC activity (100%),GO:0006289 (100%),nucleotide-excision repair (100%),IPR000305 (100%);IPR001162 (100%);IPR001943 (100%),GIY-YIG endonuclease (100%);UvrC family homology region (100%);UVR domain (100%),,,,,,,,,,,
MPVAETAVCNYVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DQPGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.47 (50%);4.1.2.25 (50%),8-amino-7-oxononanoate synthase (50%);Dihydroneopterin aldolase (50%),GO:0005737 (8%);GO:0016021 (8%),cytoplasm (8%);integral component of membrane (8%),GO:0003700 (71%);GO:0043565 (71%);GO:0003677 (10%),DNA-binding transcription factor activity (71%);sequence-specific DNA binding (71%);DNA binding (10%),GO:0009102 (2%);GO:0015942 (2%);GO:0046654 (2%),biotin biosynthetic process (2%);formate metabolic process (2%);tetrahydrofolate biosynthetic process (2%),IPR009057 (64%);IPR018060 (64%);IPR018062 (62%),Homeobox-like domain superfamily (64%);DNA binding HTH domain, AraC-type (64%);HTH domain AraC-type, conserved site (62%),,,,,,,,,
FEGNGNLAMMLTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLWWLMGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFYLVDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVDVAVTCHHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFSAYFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLNLVFHANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FCENHSK,Chryseobacterium lactis,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Chryseobacterium,,,,Chryseobacterium lactis,,,,,,,,,,,,,,,,,,,,,,,,
FGGAETMSTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HTQVDANPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDNDGDLHSALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMLNTLLYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GQMPNSK,Chryseobacterium,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Chryseobacterium,,,,,,,,,,GO:0016021 (4%),integral component of membrane (4%),GO:0008236 (76%);GO:0016787 (20%);GO:0016798 (4%),serine-type peptidase activity (76%);hydrolase activity (20%);hydrolase activity, acting on glycosyl bonds (4%),GO:0045493 (4%),xylan catabolic process (4%),IPR001375 (100%);IPR029058 (100%);IPR013094 (46%),Peptidase S9, prolyl oligopeptidase, catalytic domain (100%);Alpha/Beta hydrolase fold (100%);Alpha/beta hydrolase fold-3 (46%),,,,,,,,
FNSSSGEAHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALNADCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0003824 (33%);GO:0008168 (33%),catalytic activity (33%);methyltransferase activity (33%),GO:0032259 (33%),methylation (33%),IPR029063 (50%);IPR000873 (25%);IPR009081 (25%),S-adenosyl-L-methionine-dependent methyltransferase (50%);AMP-dependent synthetase/ligase (25%);Phosphopantetheine binding ACP domain (25%),,,,,,,,,,,
EMVLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (88%);1.4.1.13 (4%);2.7.13.3 (4%),Transferring other groups (88%);Glutamate synthase (NADPH) (4%);Histidine kinase (4%),GO:0016021 (12%);GO:0000145 (2%);GO:0005829 (2%),integral component of membrane (12%);exocyst (2%);cytosol (2%),GO:0003723 (59%);GO:0009982 (53%);GO:0004332 (8%),RNA binding (59%);pseudouridine synthase activity (53%);fructose-bisphosphate aldolase activity (8%),GO:0001522 (53%);GO:0006096 (8%);GO:0030388 (8%),pseudouridine synthesis (53%);glycolytic process (8%);fructose 1,6-bisphosphate metabolic process (8%),IPR002942 (48%);IPR006145 (48%);IPR006224 (48%),RNA-binding S4 domain (48%);Pseudouridine synthase, RsuA/RluA (48%);Pseudouridine synthase, RluC/RluD, conserved site (48%),,,,,,,
ALEEAESALNLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLNVGDAVELVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GEEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (17%);1.2.1.11 (6%);2.4.2.29 (4%),Methyltransferases (17%);Aspartate-semialdehyde dehydrogenase (6%);tRNA-guanine(34) transglycosylase (4%),GO:0016021 (22%);GO:0005737 (8%);GO:0005634 (4%),integral component of membrane (22%);cytoplasm (8%);nucleus (4%),GO:0005524 (16%);GO:0003677 (6%);GO:0005525 (5%),ATP binding (16%);DNA binding (6%);GTP binding (5%),GO:0006355 (5%);GO:0032259 (4%);GO:0009584 (3%),regulation of transcription, DNA-templated (5%);methylation (4%);detection of visible light (3%),IPR027417 (13%);IPR029063 (5%);IPR020568 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);S-adenosyl-L-methionine-dependent methyltransferase (5%);Ribosomal protein S5 domain 2-type fold (4%),,,,,,,,,,
MFGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.199 (23%);5.2.1.8 (9%);5.4.2.10 (9%),Very-long-chain 3-oxoacyl-CoA synthase (23%);Peptidylprolyl isomerase (9%);Phosphoglucosamine mutase (9%),GO:0016021 (36%);GO:0016020 (5%);GO:0030288 (5%),integral component of membrane (36%);membrane (5%);outer membrane-bounded periplasmic space (5%),GO:0005524 (8%);GO:0016491 (7%);GO:0022857 (6%),ATP binding (8%);oxidoreductase activity (7%);transmembrane transporter activity (6%),GO:0071705 (6%);GO:0055085 (4%);GO:0009058 (3%),nitrogen compound transport (6%);transmembrane transport (4%);biosynthetic process (3%),IPR027417 (9%);IPR001638 (5%);IPR004113 (5%),P-loop containing nucleoside triphosphate hydrolase (9%);Solute-binding protein  family 3/N-terminal domain of MltF (5%);FAD-linked oxidase, C-terminal (5%),,,,,,,,,,
TWQEVPER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPTEECVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYEADR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.- (33%);2.7.3.- (33%);5.3.1.5 (33%),With oxygen as acceptor (33%);Phosphotransferases with a nitrogenous group as acceptor (33%);Xylose isomerase (33%),GO:0016021 (22%);GO:0005887 (10%);GO:0016020 (8%),integral component of membrane (22%);integral component of plasma membrane (10%);membrane (8%),GO:0003677 (8%);GO:0003824 (8%);GO:0016651 (8%),DNA binding (8%);catalytic activity (8%);oxidoreductase activity, acting on NAD(P)H (8%),GO:0000160 (16%);GO:0006935 (14%);GO:0009306 (10%),phosphorelay signal transduction system (16%);chemotaxis (14%);protein secretion (10%),IPR001789 (14%);IPR002491 (14%);IPR011006 (14%),Signal transduction response regulator, receiver domain (14%);ABC transporter periplasmic binding domain (14%);CheY-like superfamily (14%),,,,,,,,,
VLELYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.7 (22%);4.3.2.1 (9%);6.3.1.2 (6%),Alanine--tRNA ligase (22%);Argininosuccinate lyase (9%);Glutamine synthetase (6%),GO:0016021 (30%);GO:0005737 (11%);GO:0016459 (2%),integral component of membrane (30%);cytoplasm (11%);myosin complex (2%),GO:0005524 (13%);GO:0004356 (10%);GO:0003677 (8%),ATP binding (13%);glutamate-ammonia ligase activity (10%);DNA binding (8%),GO:0006542 (10%);GO:0006419 (5%);GO:0005975 (2%),glutamine biosynthetic process (10%);alanyl-tRNA aminoacylation (5%);carbohydrate metabolic process (2%),IPR008146 (10%);IPR014746 (10%);IPR036651 (10%),Glutamine synthetase, catalytic domain (10%);Glutamine synthetase/guanido kinase, catalytic domain (10%);Glutamine synthetase, N-terminal domain superfamily (10%),,,,,,,,
LVSTLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.7 (29%);6.5.1.2 (14%);4.1.1.31 (10%),Alanine--tRNA ligase (29%);DNA ligase (NAD(+)) (14%);Phosphoenolpyruvate carboxylase (10%),GO:0016021 (43%);GO:0005886 (10%);GO:0005737 (9%),integral component of membrane (43%);plasma membrane (10%);cytoplasm (9%),GO:0015128 (20%);GO:0005524 (14%);GO:0003677 (12%),gluconate transmembrane transporter activity (20%);ATP binding (14%);DNA binding (12%),GO:0000160 (7%);GO:0006355 (6%);GO:0006419 (4%),phosphorelay signal transduction system (7%);regulation of transcription, DNA-templated (6%);alanyl-tRNA aminoacylation (4%),IPR003474 (17%);IPR027417 (8%);IPR000276 (7%),Gluconate transporter (17%);P-loop containing nucleoside triphosphate hydrolase (8%);G protein-coupled receptor, rhodopsin-like (7%),,,,,,,,,
LLNVDDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0005737 (44%);GO:0016021 (15%);GO:0005634 (4%),cytoplasm (44%);integral component of membrane (15%);nucleus (4%),GO:0003755 (41%);GO:0004386 (19%);GO:0003676 (15%),peptidyl-prolyl cis-trans isomerase activity (41%);helicase activity (19%);nucleic acid binding (15%),GO:0006457 (41%);GO:0007049 (41%);GO:0015031 (41%),protein folding (41%);cell cycle (41%);protein transport (41%),IPR001179 (37%);IPR005215 (37%);IPR008880 (37%),FKBP-type peptidyl-prolyl cis-trans isomerase domain (37%);Trigger factor (37%);Trigger factor, C-terminal (37%),,,,,,,,,,
ESVVESEAETLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMFGAENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVATSAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVETTGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TADMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.25 (9%);2.7.1.170 (8%);2.7.8.- (6%),Inositol-phosphate phosphatase (9%);Anhydro-N-acetylmuramic acid kinase (8%);Transferases for other substituted phosphate groups (6%),GO:0016021 (36%);GO:0005737 (3%);GO:0005886 (3%),integral component of membrane (36%);cytoplasm (3%);plasma membrane (3%),GO:0005524 (21%);GO:0004386 (11%);GO:0016787 (11%),ATP binding (21%);helicase activity (11%);hydrolase activity (11%),GO:0006313 (2%);GO:0032259 (2%);GO:0005975 (2%),transposition, DNA-mediated (2%);methylation (2%);carbohydrate metabolic process (2%),IPR027417 (18%);IPR001650 (13%);IPR014001 (12%),P-loop containing nucleoside triphosphate hydrolase (18%);Helicase, C-terminal (13%);Helicase superfamily 1/2, ATP-binding domain (12%),,,,,,,,
NVALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.2 (8%);6.3.2.3 (6%);6.3.1.11 (6%),Glutamine synthetase (8%);Glutathione synthase (6%);Glutamate--putrescine ligase (6%),GO:0016021 (21%);GO:0005737 (4%);GO:0005886 (1%),integral component of membrane (21%);cytoplasm (4%);plasma membrane (1%),GO:0005524 (17%);GO:0046872 (12%);GO:0020037 (9%),ATP binding (17%);metal ion binding (12%);heme binding (9%),GO:0006511 (5%);GO:0016579 (5%);GO:0006542 (3%),ubiquitin-dependent protein catabolic process (5%);protein deubiquitination (5%);glutamine biosynthetic process (3%),IPR027417 (15%);IPR003593 (8%);IPR036909 (7%),P-loop containing nucleoside triphosphate hydrolase (15%);AAA+ ATPase domain (8%);Cytochrome c-like domain superfamily (7%),,,,,,,,,,,
EMLEGTQAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVFLLMNAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.71 (74%);3.2.1.28 (6%);6.1.1.21 (4%),Succinylglutamate-semialdehyde dehydrogenase (74%);Alpha,alpha-trehalase (6%);Histidine--tRNA ligase (4%),GO:0016021 (27%);GO:0005737 (5%);GO:0015934 (2%),integral component of membrane (27%);cytoplasm (5%);large ribosomal subunit (2%),GO:0043824 (23%);GO:0005524 (14%);GO:0003677 (12%),succinylglutamate-semialdehyde dehydrogenase activity (23%);ATP binding (14%);DNA binding (12%),GO:0019544 (22%);GO:0019545 (22%);GO:0055085 (4%),arginine catabolic process to glutamate (22%);arginine catabolic process to succinate (22%);transmembrane transport (4%),IPR010884 (17%);IPR038160 (17%);IPR015590 (16%),6-Cysteine (6-Cys) domain (17%);6-Cysteine (6-Cys) domain superfamily (17%);Aldehyde dehydrogenase domain (16%),,,,,,,,,,
MLEENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.5 (22%);5.6.2.2 (19%);2.8.1.13 (13%),NAD(+) synthase (22%);DNA topoisomerase (ATP-hydrolyzing) (19%);tRNA-uridine 2-sulfurtransferase (13%),GO:0016021 (25%);GO:0005737 (21%);GO:0005694 (6%),integral component of membrane (25%);cytoplasm (21%);chromosome (6%),GO:0005524 (30%);GO:0046872 (17%);GO:0003677 (16%),ATP binding (30%);metal ion binding (17%);DNA binding (16%),GO:0009435 (7%);GO:0006265 (6%);GO:0006261 (6%),NAD biosynthetic process (7%);DNA topological change (6%);DNA-dependent DNA replication (6%),IPR027417 (13%);IPR014729 (11%);IPR012338 (10%),P-loop containing nucleoside triphosphate hydrolase (13%);Rossmann-like alpha/beta/alpha sandwich fold (11%);Beta-lactamase/transpeptidase-like (10%),,,,,,,,,,,
FETLVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016491 (50%);GO:0046872 (50%),oxidoreductase activity (50%);metal ion binding (50%),,,IPR005123 (100%);IPR026992 (100%);IPR027443 (100%),Oxoglutarate/iron-dependent dioxygenase (100%);Non-haem dioxygenase N-terminal domain (100%);Isopenicillin N synthase-like (100%),,,,,,,,,,,
LVVDAGVNFYDGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSTENQQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLLTSEMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VCGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.2 (93%);1.8.-.- (2%);2.7.7.38 (1%),Aspartate carbamoyltransferase (93%);Acting on a sulfur group of donors (2%);3-deoxy-manno-octulosonate cytidylyltransferase (1%),GO:0016021 (7%);GO:0016020 (2%);GO:0033644 (1%),integral component of membrane (7%);membrane (2%);host cell membrane (1%),GO:0004070 (71%);GO:0016597 (64%);GO:0046872 (4%),aspartate carbamoyltransferase activity (71%);amino acid binding (64%);metal ion binding (4%),GO:0044205 (68%);GO:0006207 (64%);GO:0006520 (64%),'de novo' UMP biosynthetic process (68%);'de novo' pyrimidine nucleobase biosynthetic process (64%);cellular amino acid metabolic process (64%),IPR002082 (67%);IPR006130 (67%);IPR036901 (67%),Aspartate carbamoyltransferase (67%);Aspartate/ornithine carbamoyltransferase (67%);Aspartate/ornithine carbamoyltransferase superfamily (67%),,,,,,,,,,,
FALAEVSR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (20%);GO:0005777 (20%);GO:0016021 (20%),cytoplasm (20%);peroxisome (20%);integral component of membrane (20%),GO:0003700 (20%);GO:0003997 (20%);GO:0008168 (20%),DNA-binding transcription factor activity (20%);acyl-CoA oxidase activity (20%);methyltransferase activity (20%),GO:0006635 (20%);GO:0032259 (20%),fatty acid beta-oxidation (20%);methylation (20%),IPR002655 (25%);IPR004559 (25%);IPR006638 (25%),Acyl-CoA oxidase, C-terminal (25%);Heme chaperone HemW-like (25%);Elp3/MiaB/NifB (25%),,,,,,,,,,
ATAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.5 (35%);1.4.1.13 (25%);4.2.1.136 (13%),NAD(+) synthase (35%);Glutamate synthase (NADPH) (25%);ADP-dependent NAD(P)H-hydrate dehydratase (13%),GO:0005737 (13%);GO:0016021 (6%);GO:0005634 (2%),cytoplasm (13%);integral component of membrane (6%);nucleus (2%),GO:0051536 (35%);GO:0016639 (28%);GO:0005524 (20%),iron-sulfur cluster binding (35%);oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor (28%);ATP binding (20%),GO:0006537 (34%);GO:0009435 (9%);GO:0032196 (5%),glutamate biosynthetic process (34%);NAD biosynthetic process (9%);transposition (5%),IPR036188 (32%);IPR009051 (31%);IPR028261 (31%),FAD/NAD(P)-binding domain superfamily (32%);Alpha-helical ferredoxin (31%);Dihydroprymidine dehydrogenase domain II (31%),,,,,,,,,
QYLLNTGNVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAAQVWLGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELQMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (15%);6.1.1.12 (10%);3.1.-.- (8%),Histidine kinase (15%);Aspartate--tRNA ligase (10%);Acting on ester bonds (8%),GO:0016021 (26%);GO:0005737 (13%);GO:0005623 (12%),integral component of membrane (26%);cytoplasm (13%);cell (12%),GO:0005524 (28%);GO:0003677 (12%);GO:0016887 (11%),ATP binding (28%);DNA binding (12%);ATPase activity (11%),GO:0090286 (11%);GO:0006289 (7%);GO:0009432 (7%),cytoskeletal anchoring at nuclear membrane (11%);nucleotide-excision repair (7%);SOS response (7%),IPR027417 (18%);IPR002017 (9%);IPR018159 (9%),P-loop containing nucleoside triphosphate hydrolase (18%);Spectrin repeat (9%);Spectrin/alpha-actinin (9%),,,,,,,,,,,
LSCTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.18 (63%);1.3.3.4 (13%);2.7.11.1 (13%),5-(carboxyamino)imidazole ribonucleotide mutase (63%);Protoporphyrinogen oxidase (13%);Non-specific serine/threonine protein kinase (13%),GO:0016021 (53%);GO:0005634 (2%);GO:0005789 (2%),integral component of membrane (53%);nucleus (2%);endoplasmic reticulum membrane (2%),GO:0005524 (24%);GO:0004674 (13%);GO:0004672 (11%),ATP binding (24%);protein serine/threonine kinase activity (13%);protein kinase activity (11%),GO:0016192 (24%);GO:0006189 (11%);GO:0006355 (2%),vesicle-mediated transport (24%);'de novo' IMP biosynthetic process (11%);regulation of transcription, DNA-templated (2%),IPR000719 (17%);IPR001388 (17%);IPR008271 (17%),Protein kinase domain (17%);Synaptobrevin (17%);Serine/threonine-protein kinase, active site (17%),,,,,,,,,
QVNVLTVR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016740 (50%);GO:0016849 (50%),transferase activity (50%);phosphorus-oxygen lyase activity (50%),GO:0009190 (50%);GO:0035556 (50%),cyclic nucleotide biosynthetic process (50%);intracellular signal transduction (50%),IPR001054 (50%);IPR003660 (50%);IPR007345 (50%),Adenylyl cyclase class-3/4/guanylyl cyclase (50%);HAMP domain (50%);Polysaccharide pyruvyl transferase (50%),,,,,,,,,,,
MTHNDFVHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPLAFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.3 (100%);3.5.4.10 (100%),Phosphoribosylaminoimidazolecarboxamide formyltransferase (100%);IMP cyclohydrolase (100%),,,GO:0003937 (50%);GO:0004643 (50%);GO:0046914 (50%),IMP cyclohydrolase activity (50%);phosphoribosylaminoimidazolecarboxamide formyltransferase activity (50%);transition metal ion binding (50%),GO:0006189 (50%),'de novo' IMP biosynthetic process (50%),IPR002695 (50%);IPR007167 (50%);IPR008988 (50%),Bifunctional purine biosynthesis protein PurH-like (50%);Ferrous iron transporter FeoA domain (50%);Transcriptional repressor, C-terminal (50%),,,,,,,,,,
TSMEGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GEMDVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.48 (100%),tRNA-guanine(15) transglycosylase (100%),,,GO:0016763 (100%);GO:0046872 (100%),transferase activity, transferring pentosyl groups (100%);metal ion binding (100%),GO:0006400 (100%),tRNA modification (100%),IPR002616 (100%);IPR004804 (100%);IPR036511 (100%),tRNA-guanine(15) transglycosylase-like (100%);tRNA-guanine(15) transglycosylase (100%);Queuine tRNA-ribosyltransferase-like (100%),,,,,,,,,,
VFLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.61 (72%);3.1.22.4 (3%);3.1.26.3 (2%),Hydroxymethylbilane synthase (72%);Crossover junction endodeoxyribonuclease (3%);Ribonuclease III (2%),GO:0016021 (16%);GO:0009507 (8%);GO:0005634 (3%),integral component of membrane (16%);chloroplast (8%);nucleus (3%),GO:0004418 (23%);GO:0003723 (13%);GO:0005524 (7%),hydroxymethylbilane synthase activity (23%);RNA binding (13%);ATP binding (7%),GO:0006782 (23%);GO:0018160 (22%);GO:0006397 (8%),protoporphyrinogen IX biosynthetic process (23%);peptidyl-pyrromethane cofactor linkage (22%);mRNA processing (8%),IPR000860 (21%);IPR036803 (21%);IPR022417 (21%),Porphobilinogen deaminase (21%);Porphobilinogen deaminase, C-terminal domain superfamily (21%);Porphobilinogen deaminase, N-terminal (21%),,,,,,,,,
QVTLSMVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.5.1 (59%);1.4.3.16 (12%);1.1.98.2 (8%),Succinate dehydrogenase (quinone) (59%);L-aspartate oxidase (12%);Glucose-6-phosphate dehydrogenase (coenzyme-F420) (8%),GO:0016021 (17%);GO:0005886 (15%);GO:0016020 (12%),integral component of membrane (17%);plasma membrane (15%);membrane (12%),GO:0050660 (36%);GO:0008177 (26%);GO:0009055 (13%),flavin adenine dinucleotide binding (36%);succinate dehydrogenase (ubiquinone) activity (26%);electron transfer activity (13%),GO:0006099 (27%);GO:0022900 (25%);GO:0009435 (6%),tricarboxylic acid cycle (27%);electron transport chain (25%);NAD biosynthetic process (6%),IPR036188 (32%);IPR003953 (31%);IPR027477 (31%),FAD/NAD(P)-binding domain superfamily (32%);FAD-dependent oxidoreductase 2, FAD binding domain (31%);Succinate dehydrogenase/fumarate reductase flavoprotein, catalytic domain superfamily (31%),,,,,,,,,
NPWVLTLSCVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFLPVAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (20%);GO:0016021 (20%),cytoplasm (20%);integral component of membrane (20%),GO:0000155 (40%);GO:0003677 (20%);GO:0003700 (20%),phosphorelay sensor kinase activity (40%);DNA binding (20%);DNA-binding transcription factor activity (20%),GO:0006004 (20%),fucose metabolic process (20%),IPR003594 (33%);IPR005467 (33%);IPR036890 (33%),Histidine kinase/HSP90-like ATPase (33%);Histidine kinase domain (33%);Histidine kinase/HSP90-like ATPase superfamily (33%),,,,,,,,,,,
EAQTVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLPDQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (25%);2.3.1.181 (13%);2.7.1.148 (13%),Peptidylprolyl isomerase (25%);Lipoyl(octanoyl) transferase (13%);4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase (13%),GO:0016021 (30%);GO:0005669 (8%);GO:0005787 (8%),integral component of membrane (30%);transcription factor TFIID complex (8%);signal peptidase complex (8%),GO:0005524 (14%);GO:0008233 (11%);GO:0003743 (8%),ATP binding (14%);peptidase activity (11%);translation initiation factor activity (8%),GO:0006367 (11%);GO:0006465 (8%);GO:0006357 (5%),transcription initiation from RNA polymerase II promoter (11%);signal peptide processing (8%);regulation of transcription by RNA polymerase II (5%),IPR036291 (20%);IPR002347 (16%);IPR013783 (9%),NAD(P)-binding domain superfamily (20%);Short-chain dehydrogenase/reductase SDR (16%);Immunoglobulin-like fold (9%),,,,,,,,,,,
WLTDPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (40%);2.4.1.276 (40%);2.1.1.182 (20%),Oxidoreductases (40%);Zeaxanthin glucosyltransferase (40%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (20%),GO:0016021 (26%);GO:0005886 (5%);GO:0005750 (2%),integral component of membrane (26%);plasma membrane (5%);mitochondrial respiratory chain complex III (2%),GO:0009055 (27%);GO:0020037 (27%);GO:0046872 (16%),electron transfer activity (27%);heme binding (27%);metal ion binding (16%),GO:0016999 (13%);GO:0008202 (9%);GO:0000271 (3%),antibiotic metabolic process (13%);steroid metabolic process (9%);polysaccharide biosynthetic process (3%),IPR022655 (29%);IPR011444 (28%);IPR011429 (23%),Domain of unknown function DUF1553 (29%);Domain of unknown function DUF1549 (28%);Cytochrome C, Planctomycete-type (23%),,,,,,,,,,
TNLFDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.1 (30%);2.3.-.- (20%);2.8.1.10 (10%),Carbonic anhydrase (30%);Acyltransferases (20%);Thiazole synthase (10%),GO:0016021 (48%);GO:0005737 (8%);GO:0009380 (6%),integral component of membrane (48%);cytoplasm (8%);excinuclease repair complex (6%),GO:0005524 (15%);GO:0003677 (11%);GO:0016887 (9%),ATP binding (15%);DNA binding (11%);ATPase activity (9%),GO:0006289 (6%);GO:0009432 (6%);GO:0006506 (5%),nucleotide-excision repair (6%);SOS response (6%);GPI anchor biosynthetic process (5%),IPR027417 (21%);IPR001650 (6%);IPR014001 (6%),P-loop containing nucleoside triphosphate hydrolase (21%);Helicase, C-terminal (6%);Helicase superfamily 1/2, ATP-binding domain (6%),,,,,,,,,
TLVEMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000155 (50%);GO:0002953 (50%),phosphorelay sensor kinase activity (50%);5'-deoxynucleotidase activity (50%),,,IPR000014 (50%);IPR000700 (50%);IPR001610 (50%),PAS domain (50%);PAS-associated, C-terminal (50%);PAC motif (50%),,,,,,,,,,
LNYNPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.19 (100%),Arginine--tRNA ligase (100%),GO:0016021 (64%);GO:0005737 (36%);GO:0009279 (9%),integral component of membrane (64%);cytoplasm (36%);cell outer membrane (9%),GO:0003700 (55%);GO:0043565 (55%);GO:0004814 (36%),DNA-binding transcription factor activity (55%);sequence-specific DNA binding (55%);arginine-tRNA ligase activity (36%),GO:0006420 (36%),arginyl-tRNA aminoacylation (36%),IPR009057 (46%);IPR018060 (46%);IPR018062 (38%),Homeobox-like domain superfamily (46%);DNA binding HTH domain, AraC-type (46%);HTH domain AraC-type, conserved site (38%),,,,,,,,,
DSVFAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.1 (33%);3.4.-.- (33%);6.3.2.- (22%),Citrate (Si)-synthase (33%);Acting on peptide bonds (peptidases) (33%);Acid--amino-acid ligases (peptide synthases) (22%),GO:0016021 (25%);GO:0000502 (10%);GO:0005886 (3%),integral component of membrane (25%);proteasome complex (10%);plasma membrane (3%),GO:0008233 (21%);GO:0016811 (21%);GO:0003677 (19%),peptidase activity (21%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (21%);DNA binding (19%),GO:0010498 (22%);GO:0019941 (22%);GO:0006355 (8%),proteasomal protein catabolic process (22%);modification-dependent protein catabolic process (22%);regulation of transcription, DNA-templated (8%),IPR004347 (18%);IPR022366 (17%);IPR004872 (11%),Pup ligase/deamidase (18%);Pup deamidase (17%);Lipoprotein NlpA family (11%),,,,,,,,
EHLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.13 (29%);3.5.2.6 (13%);2.7.1.30 (8%),2-isopropylmalate synthase (29%);Beta-lactamase (13%);Glycerol kinase (8%),GO:0016021 (5%);GO:0005737 (2%);GO:0005634 (1%),integral component of membrane (5%);cytoplasm (2%);nucleus (1%),GO:0003964 (65%);GO:0004190 (54%);GO:0003677 (11%),RNA-directed DNA polymerase activity (65%);aspartic-type endopeptidase activity (54%);DNA binding (11%),GO:0015074 (7%);GO:0006310 (7%);GO:0044826 (5%),DNA integration (7%);DNA recombination (7%);viral genome integration into host DNA (5%),IPR000477 (63%);IPR021109 (46%);IPR001995 (46%),Reverse transcriptase domain (63%);Aspartic peptidase domain superfamily (46%);Peptidase A2A, retrovirus, catalytic (46%),,,,,,,,,
MSALSSYPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAGDMAASLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGSEPVLDHGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QEPAQSTGVVVVWQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNFENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.4.2 (52%);1.2.1.88 (13%);1.5.5.2 (13%),Isochorismate synthase (52%);L-glutamate gamma-semialdehyde dehydrogenase (13%);Proline dehydrogenase (13%),GO:0016021 (15%);GO:0005737 (3%);GO:0005930 (3%),integral component of membrane (15%);cytoplasm (3%);axoneme (3%),GO:0008909 (24%);GO:0003677 (12%);GO:0016787 (8%),isochorismate synthase activity (24%);DNA binding (12%);hydrolase activity (8%),GO:0009058 (24%);GO:0006260 (5%);GO:0003341 (3%),biosynthetic process (24%);DNA replication (5%);cilium movement (3%),IPR004561 (20%);IPR005801 (20%);IPR015890 (20%),Isochorismate synthase (20%);ADC synthase (20%);Chorismate-utilising enzyme, C-terminal (20%),,,,,,,,,,
QVYVAQTAPVDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEYLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (33%);2.4.-.- (33%);2.7.7.75 (33%),Molybdopterin molybdotransferase (33%);Glycosyltransferases (33%);Molybdopterin adenylyltransferase (33%),GO:0016021 (51%);GO:0016020 (12%);GO:0005886 (10%),integral component of membrane (51%);membrane (12%);plasma membrane (10%),GO:0016740 (15%);GO:0003677 (10%);GO:0047355 (10%),transferase activity (15%);DNA binding (10%);CDP-glycerol glycerophosphotransferase activity (10%),GO:0015031 (7%);GO:0006310 (5%);GO:0015074 (5%),protein transport (7%);DNA recombination (5%);DNA integration (5%),IPR008969 (36%);IPR037066 (36%);IPR041700 (36%),Carboxypeptidase-like, regulatory domain superfamily (36%);TonB-dependent receptor, plug domain superfamily (36%);Outer membrane protein beta-barrel domain 3 (36%),,,,,,,,,
AVMHYNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLPFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (25%);6.1.1.19 (25%);2.8.1.2 (11%),Proline--tRNA ligase (25%);Arginine--tRNA ligase (25%);3-mercaptopyruvate sulfurtransferase (11%),GO:0019013 (64%);GO:0042025 (59%);GO:0019029 (58%),viral nucleocapsid (64%);host cell nucleus (59%);helical viral capsid (58%),GO:0005198 (63%);GO:0003723 (58%);GO:0005524 (8%),structural molecule activity (63%);RNA binding (58%);ATP binding (8%),GO:0075732 (58%);GO:0046718 (58%);GO:0015969 (4%),viral penetration into host nucleus (58%);viral entry into host cell (58%);guanosine tetraphosphate metabolic process (4%),IPR002141 (42%);IPR011004 (23%);IPR011444 (4%),Influenza virus nucleoprotein (NP) (42%);Trimeric LpxA-like superfamily (23%);Domain of unknown function DUF1549 (4%),,,,,,,,,,,
AAADSGNLATGQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYTSNAHSNVDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVFDADLMSTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPDEEDTSWTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTNTMLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTFLWYGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEQELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (25%);1.7.1.7 (16%);3.6.4.- (14%),DNA topoisomerase (ATP-hydrolyzing) (25%);GMP reductase (16%);Acting on ATP; involved in cellular and subcellular movement (14%),GO:0016021 (18%);GO:0005737 (12%);GO:0005694 (8%),integral component of membrane (18%);cytoplasm (12%);chromosome (8%),GO:0005524 (25%);GO:0003677 (19%);GO:0046872 (12%),ATP binding (25%);DNA binding (19%);metal ion binding (12%),GO:0006265 (9%);GO:0006355 (8%);GO:0007059 (8%),DNA topological change (9%);regulation of transcription, DNA-templated (8%);chromosome segregation (8%),IPR027417 (14%);IPR005176 (7%);IPR014764 (7%),P-loop containing nucleoside triphosphate hydrolase (14%);Potentiating neddylation domain (7%);Defective-in-cullin neddylation protein (7%),,,,,,,,,,
MVDLLAFTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QANQYYGWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEMGDDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSAWGPR,Emiliania huxleyi,Eukaryota,,,,Haptista,,,Haptophyta,,,,Isochrysidales,,,,,Noelaerhabdaceae,,,,Emiliania,,,,Emiliania huxleyi,,,,,,,,GO:0005506 (100%);GO:0016705 (100%);GO:0031418 (100%),iron ion binding (100%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (100%);L-ascorbic acid binding (100%),,,IPR005123 (100%);IPR006620 (100%),Oxoglutarate/iron-dependent dioxygenase (100%);Prolyl 4-hydroxylase, alpha subunit (100%),,,,,,,,
EEDWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.4 (13%);6.1.1.23 (8%);2.1.1.- (7%),Malate dehydrogenase (quinone) (13%);Aspartate--tRNA(Asn) ligase (8%);Methyltransferases (7%),GO:0008180 (21%);GO:0005737 (17%);GO:0016021 (8%),COP9 signalosome (21%);cytoplasm (17%);integral component of membrane (8%),GO:0005524 (7%);GO:0003723 (6%);GO:0003677 (4%),ATP binding (7%);RNA binding (6%);DNA binding (4%),GO:0016226 (26%);GO:0015074 (2%);GO:0006310 (2%),iron-sulfur cluster assembly (26%);DNA integration (2%);DNA recombination (2%),IPR011542 (24%);IPR037284 (24%);IPR000825 (24%),SUF system FeS cluster assembly, SufD (24%);SUF system FeS cluster assembly, SufBD superfamily (24%);SUF system FeS cluster assembly, SufBD (24%),,,,,,,,
NPTVNQTVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLEFGLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLDLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.4.4 (46%);3.6.3.- (14%);2.7.7.7 (11%),[Ribosomal protein S12] (aspartate(89)-C(3))-methylthiotransferase (46%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (14%);DNA-directed DNA polymerase (11%),GO:0016021 (27%);GO:0005737 (9%);GO:0005840 (4%),integral component of membrane (27%);cytoplasm (9%);ribosome (4%),GO:0005524 (23%);GO:0043531 (12%);GO:0004672 (9%),ATP binding (23%);ADP binding (12%);protein kinase activity (9%),GO:0018339 (6%);GO:0006400 (6%);GO:0006260 (5%),peptidyl-L-beta-methylthioaspartic acid biosynthetic process from peptidyl-aspartic acid (6%);tRNA modification (6%);DNA replication (5%),IPR032675 (31%);IPR001611 (24%);IPR003591 (19%),Leucine-rich repeat domain superfamily (31%);Leucine-rich repeat (24%);Leucine-rich repeat, typical subtype (19%),,,,,,,,,,
WLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (57%);1.17.4.1 (5%);1.5.1.2 (5%),DNA helicase (57%);Ribonucleoside-diphosphate reductase (5%);Pyrroline-5-carboxylate reductase (5%),GO:0016021 (32%);GO:0005737 (2%);GO:0005886 (2%),integral component of membrane (32%);cytoplasm (2%);plasma membrane (2%),GO:0005524 (27%);GO:0003678 (9%);GO:0003676 (9%),ATP binding (27%);DNA helicase activity (9%);nucleic acid binding (9%),GO:0006310 (9%);GO:0006281 (9%);GO:0055085 (2%),DNA recombination (9%);DNA repair (9%);transmembrane transport (2%),IPR027417 (23%);IPR014001 (17%);IPR001650 (16%),P-loop containing nucleoside triphosphate hydrolase (23%);Helicase superfamily 1/2, ATP-binding domain (17%);Helicase, C-terminal (16%),,,,,,,,,
MAETNMQHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GDYMVNK,Cuscuta campestris,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Solanales,,,,,Convolvulaceae,,Cuscuteae,,Cuscuta,Grammica,,,Cuscuta campestris,,,,,,,,,,GO:0009396 (100%),folic acid-containing compound biosynthetic process (100%),IPR005801 (100%);IPR005802 (100%);IPR006805 (100%),ADC synthase (100%);Aminodeoxychorismate synthase, component I (100%);Anthranilate synthase component I, N-terminal (100%),,,,,,,,,
YDEMVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.7 (88%);2.5.1.75 (13%),Alanine--tRNA ligase (88%);tRNA dimethylallyltransferase (13%),GO:0005737 (21%);GO:0016021 (21%);GO:0005576 (3%),cytoplasm (21%);integral component of membrane (21%);extracellular region (3%),GO:0005524 (41%);GO:0008270 (24%);GO:0000049 (21%),ATP binding (41%);zinc ion binding (24%);tRNA binding (21%),GO:0006419 (21%);GO:0006541 (9%);GO:0045900 (9%),alanyl-tRNA aminoacylation (21%);glutamine metabolic process (9%);negative regulation of translational elongation (9%),IPR002318 (19%);IPR003156 (19%);IPR009000 (19%),Alanine-tRNA ligase, class IIc (19%);DHHA1 domain (19%);Translation protein, beta-barrel domain superfamily (19%),,,,,,,,,
FQFYSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0003950 (25%);GO:0005524 (25%);GO:0008061 (25%),NAD+ ADP-ribosyltransferase activity (25%);ATP binding (25%);chitin binding (25%),GO:0005975 (25%);GO:0006355 (25%),carbohydrate metabolic process (25%);regulation of transcription, DNA-templated (25%),IPR000014 (29%);IPR000160 (29%);IPR001633 (29%),PAS domain (29%);GGDEF domain (29%);EAL domain (29%),,,,,,,,,,
WGLEDNNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (13%);6.1.1.20 (10%);2.7.13.3 (5%),DNA-directed DNA polymerase (13%);Phenylalanine--tRNA ligase (10%);Histidine kinase (5%),GO:0016021 (15%);GO:0005737 (10%);GO:0015935 (7%),integral component of membrane (15%);cytoplasm (10%);small ribosomal subunit (7%),GO:0003677 (19%);GO:0005524 (14%);GO:0000049 (10%),DNA binding (19%);ATP binding (14%);tRNA binding (10%),GO:0006412 (8%);GO:0006355 (4%);GO:0005975 (4%),translation (8%);regulation of transcription, DNA-templated (4%);carbohydrate metabolic process (4%),IPR027417 (8%);IPR036388 (7%);IPR000235 (6%),P-loop containing nucleoside triphosphate hydrolase (8%);Winged helix-like DNA-binding domain superfamily (7%);Ribosomal protein S5/S7 (6%),,,,,,,,,,
TNGDNASNTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPTVPVVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEPTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.3.2.2 (15%);3.6.3.32 (14%);3.6.4.12 (12%),ABC-type phosphonate transporter (15%);Transferred entry: 7.6.2.9 (14%);DNA helicase (12%),GO:0016020 (54%);GO:0016021 (7%);GO:0005737 (3%),membrane (54%);integral component of membrane (7%);cytoplasm (3%),GO:0005524 (80%);GO:0016887 (63%);GO:0016740 (3%),ATP binding (80%);ATPase activity (63%);transferase activity (3%),GO:0031460 (54%);GO:0015833 (3%);GO:0006270 (1%),glycine betaine transport (54%);peptide transport (3%);DNA replication initiation (1%),IPR027417 (75%);IPR003439 (73%);IPR003593 (71%),P-loop containing nucleoside triphosphate hydrolase (75%);ABC transporter-like (73%);AAA+ ATPase domain (71%),,,,,,,,,,,
EHMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.2.2 (57%);1.2.4.1 (7%);1.13.11.11 (5%),H(+)-transporting two-sector ATPase (57%);Pyruvate dehydrogenase (acetyl-transferring) (7%);Tryptophan 2,3-dioxygenase (5%),GO:0005886 (18%);GO:0016021 (13%);GO:0045261 (12%),plasma membrane (18%);integral component of membrane (13%);proton-transporting ATP synthase complex, catalytic core F(1) (12%),GO:0003677 (19%);GO:0005524 (18%);GO:0003700 (13%),DNA binding (19%);ATP binding (18%);DNA-binding transcription factor activity (13%),GO:0015986 (12%);GO:0015074 (7%);GO:0006352 (5%),ATP synthesis coupled proton transport (12%);DNA integration (7%);DNA-templated transcription, initiation (5%),IPR029044 (20%);IPR001173 (20%);IPR027417 (10%),Nucleotide-diphospho-sugar transferases (20%);Glycosyltransferase 2-like (20%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,
SLDVLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (98%);1.1.99.33 (0%);1.14.13.22 (0%),DNA helicase (98%);Transferred entry: 1.17.99.7 (0%);Cyclohexanone monooxygenase (0%),GO:0005634 (80%);GO:0042555 (73%);GO:0016021 (4%),nucleus (80%);MCM complex (73%);integral component of membrane (4%),GO:0005524 (83%);GO:0003678 (79%);GO:0003677 (78%),ATP binding (83%);DNA helicase activity (79%);DNA binding (78%),GO:0006270 (75%);GO:0006260 (6%);GO:0000727 (6%),DNA replication initiation (75%);DNA replication (6%);double-strand break repair via break-induced replication (6%),IPR031327 (77%);IPR012340 (77%);IPR027417 (76%),Mini-chromosome maintenance protein (77%);Nucleic acid-binding, OB-fold (77%);P-loop containing nucleoside triphosphate hydrolase (76%),,,,,,,,,,
ETFAALQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.170 (100%),16S rRNA (guanine(527)-N(7))-methyltransferase (100%),GO:0005737 (33%),cytoplasm (33%),GO:0003824 (67%);GO:0070043 (33%),catalytic activity (67%);rRNA (guanine-N7-)-methyltransferase activity (33%),,,IPR004352 (50%);IPR013785 (50%);IPR017853 (50%),Glycoside-hydrolase family GH114, TIM-barrel domain (50%);Aldolase-type TIM barrel (50%);Glycoside hydrolase superfamily (50%),,,,,,,,,,
ALAGSVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (83%);2.4.1.182 (17%),Histidine kinase (83%);Lipid-A-disaccharide synthase (17%),GO:0005737 (45%),cytoplasm (45%),GO:0005524 (45%);GO:0016887 (23%);GO:0000155 (14%),ATP binding (45%);ATPase activity (23%);phosphorelay sensor kinase activity (14%),GO:0006355 (14%);GO:0009245 (5%);GO:0051409 (5%),regulation of transcription, DNA-templated (14%);lipid A biosynthetic process (5%);response to nitrosative stress (5%),IPR001611 (53%);IPR032675 (53%);IPR025265 (47%),Leucine-rich repeat (53%);Leucine-rich repeat domain superfamily (53%);WPP domain (47%),,,,,,,,,,
NVVLFAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (71%);GO:0005737 (14%),integral component of membrane (71%);cytoplasm (14%),GO:0022857 (43%);GO:0000155 (29%);GO:0005524 (29%),transmembrane transporter activity (43%);phosphorelay sensor kinase activity (29%);ATP binding (29%),GO:0006351 (14%);GO:0006826 (14%);GO:0042779 (14%),transcription, DNA-templated (14%);iron ion transport (14%);tRNA 3'-trailer cleavage (14%),IPR001734 (43%);IPR003594 (29%);IPR003661 (29%),Sodium/solute symporter (43%);Histidine kinase/HSP90-like ATPase (29%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (29%),,,,,,,,,
TCVLLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.8 (100%),Hypoxanthine phosphoribosyltransferase (100%),GO:0005737 (52%);GO:0016021 (22%);GO:0005887 (4%),cytoplasm (52%);integral component of membrane (22%);integral component of plasma membrane (4%),GO:0004422 (59%);GO:0000166 (52%);GO:0046872 (52%),hypoxanthine phosphoribosyltransferase activity (59%);nucleotide binding (52%);metal ion binding (52%),GO:0006166 (59%);GO:0032264 (52%);GO:0006396 (4%),purine ribonucleoside salvage (59%);IMP salvage (52%);RNA processing (4%),IPR000836 (61%);IPR029057 (61%);IPR005904 (57%),Phosphoribosyltransferase domain (61%);Phosphoribosyltransferase-like (61%);Hypoxanthine phosphoribosyl transferase (57%),,,,,,,,,,,
WLPVAWEMALLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HHLEELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (43%);2.7.13.3 (29%);5.3.1.9 (14%),DNA-directed RNA polymerase (43%);Histidine kinase (29%);Glucose-6-phosphate isomerase (14%),GO:0005737 (23%);GO:0016021 (18%);GO:0005623 (14%),cytoplasm (23%);integral component of membrane (18%);cell (14%),GO:0003677 (23%);GO:0003899 (14%);GO:0005524 (14%),DNA binding (23%);DNA-directed 5'-3' RNA polymerase activity (14%);ATP binding (14%),GO:0006351 (14%);GO:0006817 (14%);GO:0030643 (14%),transcription, DNA-templated (14%);phosphate ion transport (14%);cellular phosphate ion homeostasis (14%),IPR007120 (12%);IPR007121 (12%);IPR007641 (12%),DNA-directed RNA polymerase, subunit 2, hybrid-binding domain (12%);RNA polymerase, beta subunit, conserved site (12%);RNA polymerase Rpb2, domain 7 (12%),,,,,
WVPTMGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVADFFR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0003677 (50%);GO:0008408 (50%);GO:0000155 (25%),DNA binding (50%);3'-5' exonuclease activity (50%);phosphorelay sensor kinase activity (25%),GO:0006261 (25%);GO:0006281 (25%);GO:0033567 (25%),DNA-dependent DNA replication (25%);DNA repair (25%);DNA replication, Okazaki fragment processing (25%),IPR010657 (89%);IPR017740 (89%);IPR002421 (6%),ImpA, N-terminal (89%);Type VI secretion system-associated, ImpA (89%);5'-3' exonuclease, N-terminal (6%),,,,,,,
ALFEEEVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPPYMVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CEMLSLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDGVPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.5.2.6 (43%);2.1.1.354 (29%);6.1.1.7 (14%),ABC-type lipid A-core oligosaccharide transporter (43%);[Histone H3]-lysine(4) N-trimethyltransferase (29%);Alanine--tRNA ligase (14%),GO:0016021 (47%);GO:0005886 (7%);GO:0005694 (4%),integral component of membrane (47%);plasma membrane (7%);chromosome (4%),GO:0005524 (47%);GO:0016887 (33%);GO:0042626 (27%),ATP binding (47%);ATPase activity (33%);ATPase-coupled transmembrane transporter activity (27%),GO:0043631 (22%);GO:0031123 (11%);GO:0005975 (2%),RNA polyadenylation (22%);RNA 3'-end processing (11%);carbohydrate metabolic process (2%),IPR027417 (39%);IPR003439 (37%);IPR003593 (37%),P-loop containing nucleoside triphosphate hydrolase (39%);ABC transporter-like (37%);AAA+ ATPase domain (37%),,,,,,,,,,,
LHQFGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.26 (50%);2.7.7.2 (50%);3.4.21.53 (20%),Riboflavin kinase (50%);FAD synthase (50%);Endopeptidase La (20%),GO:0016021 (75%);GO:0005885 (54%);GO:0005737 (3%),integral component of membrane (75%);Arp2/3 protein complex (54%);cytoplasm (3%),GO:0005267 (66%);GO:0005524 (66%);GO:0003919 (7%),potassium channel activity (66%);ATP binding (66%);FMN adenylyltransferase activity (7%),GO:0034314 (54%);GO:0006747 (7%);GO:0009231 (7%),Arp2/3 complex-mediated actin nucleation (54%);FAD biosynthetic process (7%);riboflavin biosynthetic process (7%),IPR013099 (57%);IPR003280 (56%);IPR003092 (53%),Potassium channel domain (57%);Two pore domain potassium channel (56%);Two pore domain potassium channel, TASK family (53%),,,,,,,,,,
NFLATR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (59%);1.1.1.86 (26%);4.1.3.27 (6%),Acting on peptide bonds (peptidases) (59%);Ketol-acid reductoisomerase (NADP(+)) (26%);Anthranilate synthase (6%),GO:0016021 (25%);GO:0016459 (9%);GO:1904423 (3%),integral component of membrane (25%);myosin complex (9%);dehydrodolichyl diphosphate synthase complex (3%),GO:0000287 (20%);GO:0008233 (14%);GO:0008897 (14%),magnesium ion binding (20%);peptidase activity (14%);holo-[acyl-carrier-protein] synthase activity (14%),GO:0000160 (8%);GO:0006355 (7%);GO:0009097 (6%),phosphorelay signal transduction system (8%);regulation of transcription, DNA-templated (7%);isoleucine biosynthetic process (6%),IPR027417 (22%);IPR037143 (13%);IPR007484 (12%),P-loop containing nucleoside triphosphate hydrolase (22%);4'-phosphopantetheinyl transferase domain superfamily (13%);Peptidase M28 (12%),,,,,,,,,,
QNQENGPDVMAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLCTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.99.18 (67%);5.2.1.8 (33%),DNA-(apurinic or apyrimidinic site) lyase (67%);Peptidylprolyl isomerase (33%),GO:0005634 (39%);GO:0016021 (22%);GO:0009279 (9%),nucleus (39%);integral component of membrane (22%);cell outer membrane (9%),GO:0003677 (30%);GO:0000981 (26%);GO:0008270 (26%),DNA binding (30%);DNA-binding transcription factor activity, RNA polymerase II-specific (26%);zinc ion binding (26%),GO:0006351 (26%);GO:0006284 (9%);GO:0006355 (9%),transcription, DNA-templated (26%);base-excision repair (9%);regulation of transcription, DNA-templated (9%),IPR001138 (23%);IPR007219 (23%);IPR036864 (23%),Zn(2)-C6 fungal-type DNA-binding domain (23%);Transcription factor domain, fungi (23%);Zn(2)-C6 fungal-type DNA-binding domain superfamily (23%),,,,,,,
EAGLSENR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WAWNMMLSPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLLVLEDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNAATEMMTPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPADAACMALPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALGDQGYEMVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNVLGTVAAVMTPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MELELPQK,Pedobacter,Bacteria,,,,Bacteroidetes,,,Sphingobacteriia,,,,Sphingobacteriales,,,,,Sphingobacteriaceae,,,,Pedobacter,,,,,,,,,,,,GO:0005524 (100%);GO:0043565 (100%),ATP binding (100%);sequence-specific DNA binding (100%),GO:0006270 (100%);GO:0006275 (100%),DNA replication initiation (100%);regulation of DNA replication (100%),IPR010921 (100%);IPR013159 (100%),Trp repressor/replication initiator (100%);Chromosomal replication initiator, DnaA C-terminal (100%),,,,,,,,,,
SLVNETYAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVEWELMQTNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAMVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (24%);5.2.1.8 (12%);1.17.1.- (6%),DNA-directed DNA polymerase (24%);Peptidylprolyl isomerase (12%);With NAD(+) or NADP(+) as acceptor (6%),GO:0016021 (26%);GO:0005886 (6%);GO:0009279 (4%),integral component of membrane (26%);plasma membrane (6%);cell outer membrane (4%),GO:0003677 (44%);GO:0003700 (37%);GO:0046872 (11%),DNA binding (44%);DNA-binding transcription factor activity (37%);metal ion binding (11%),GO:0006887 (9%);GO:0051301 (4%);GO:0007049 (4%),exocytosis (9%);cell division (4%);cell cycle (4%),IPR036390 (39%);IPR014036 (35%);IPR037171 (35%),Winged helix DNA-binding domain superfamily (39%);DeoR C-terminal sensor domain (35%);NagB/RpiA transferase-like (35%),,,,,,,,,,,
WVPNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),,,GO:0006904 (50%);GO:0055085 (50%),vesicle docking involved in exocytosis (50%);transmembrane transport (50%),IPR001810 (29%);IPR032675 (29%);IPR001619 (14%),F-box domain (29%);Leucine-rich repeat domain superfamily (29%);Sec1-like protein (14%),,,,,,,,,,,
WNLPDVLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVFVHFAVQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CPSQDPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPEPWHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYDVLEDPVELLDAEAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DELEDLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.2.2 (60%);6.1.1.1 (40%),Cytochrome-b5 reductase (60%);Tyrosine--tRNA ligase (40%),GO:0016021 (44%);GO:0005737 (22%);GO:0005886 (11%),integral component of membrane (44%);cytoplasm (22%);plasma membrane (11%),GO:0004128 (33%);GO:0003723 (22%);GO:0004831 (22%),cytochrome-b5 reductase activity, acting on NAD(P)H (33%);RNA binding (22%);tyrosine-tRNA ligase activity (22%),GO:0006437 (22%),tyrosyl-tRNA aminoacylation (22%),IPR001433 (21%);IPR001709 (21%);IPR001834 (21%),Oxidoreductase FAD/NAD(P)-binding (21%);Flavoprotein pyridine nucleotide cytochrome reductase (21%);NADH:cytochrome b5 reductase-like (21%),,,,,,,,,,
TPCLGPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNVLNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.- (63%);3.1.-.- (11%);3.2.1.18 (6%),Transferases for other substituted phosphate groups (63%);Acting on ester bonds (11%);Exo-alpha-sialidase (6%),GO:0016021 (26%);GO:0005886 (17%);GO:0009279 (2%),integral component of membrane (26%);plasma membrane (17%);cell outer membrane (2%),GO:0005524 (17%);GO:0008808 (14%);GO:0004672 (8%),ATP binding (17%);cardiolipin synthase activity (14%);protein kinase activity (8%),GO:0032049 (14%);GO:0007049 (3%);GO:0043937 (3%),cardiolipin biosynthetic process (14%);cell cycle (3%);regulation of sporulation (3%),IPR001736 (13%);IPR025202 (13%);IPR030872 (13%),Phospholipase D/Transphosphatidylase (13%);Phospholipase D-like domain (13%);Cardiolipin synthase B (13%),,,,,,,,,,,
HMVMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (27%);5.3.1.17 (18%);1.3.99.- (9%),Non-specific serine/threonine protein kinase (27%);5-dehydro-4-deoxy-D-glucuronate isomerase (18%);With other acceptors (9%),GO:0016021 (14%);GO:0005576 (10%);GO:0005634 (6%),integral component of membrane (14%);extracellular region (10%);nucleus (6%),GO:0005524 (16%);GO:0050660 (15%);GO:0003995 (13%),ATP binding (16%);flavin adenine dinucleotide binding (15%);acyl-CoA dehydrogenase activity (13%),GO:0006869 (13%);GO:0042157 (13%);GO:0006457 (8%),lipid transport (13%);lipoprotein metabolic process (13%);protein folding (8%),IPR006089 (14%);IPR006091 (14%);IPR009075 (14%),Acyl-CoA dehydrogenase, conserved site (14%);Acyl-CoA oxidase/dehydrogenase, central domain (14%);Acyl-CoA dehydrogenase/oxidase C-terminal (14%),,,,,,,,,
ALQSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.275 (26%);1.1.1.42 (6%);6.3.5.5 (6%),Acyl phosphate:glycerol-3-phosphate acyltransferase (26%);Isocitrate dehydrogenase (NADP(+)) (6%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (6%),GO:0016021 (32%);GO:0005886 (7%);GO:0005737 (5%),integral component of membrane (32%);plasma membrane (7%);cytoplasm (5%),GO:0005524 (17%);GO:0003677 (13%);GO:0000155 (12%),ATP binding (17%);DNA binding (13%);phosphorelay sensor kinase activity (12%),GO:0071555 (11%);GO:0006310 (9%);GO:0006281 (8%),cell wall organization (11%);DNA recombination (9%);DNA repair (8%),IPR027417 (17%);IPR036890 (11%);IPR003594 (10%),P-loop containing nucleoside triphosphate hydrolase (17%);Histidine kinase/HSP90-like ATPase superfamily (11%);Histidine kinase/HSP90-like ATPase (10%),,,,,,,,,,,
TDQDGSADMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLANAEMDLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYEETLN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPPNMYDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVLPLTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.21 (56%);2.3.1.- (11%);2.3.1.94 (11%),D-amino-acid transaminase (56%);Transferring groups other than amino-acyl groups (11%);6-deoxyerythronolide-B synthase (11%),GO:0016021 (19%);GO:0005737 (2%);GO:0042597 (1%),integral component of membrane (19%);cytoplasm (2%);periplasmic space (1%),GO:0003677 (36%);GO:0008483 (17%);GO:0017154 (16%),DNA binding (36%);transaminase activity (17%);semaphorin receptor activity (16%),GO:0046416 (3%);GO:0006520 (2%);GO:0005980 (1%),D-amino acid metabolic process (3%);cellular amino acid metabolic process (2%);glycogen catabolic process (1%),IPR001387 (28%);IPR010982 (28%);IPR001544 (20%),Cro/C1-type helix-turn-helix domain (28%);Lambda repressor-like, DNA-binding domain superfamily (28%);Aminotransferase class IV (20%),,,,,,,,,,
LSWTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (50%);6.3.2.2 (50%),Acting on ester bonds (50%);Glutamate--cysteine ligase (50%),GO:0016021 (32%);GO:0043190 (5%);GO:0048471 (5%),integral component of membrane (32%);ATP-binding cassette (ABC) transporter complex (5%);perinuclear region of cytoplasm (5%),GO:0016810 (22%);GO:0003723 (8%);GO:0005089 (8%),hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (22%);RNA binding (8%);Rho guanyl-nucleotide exchange factor activity (8%),GO:0009704 (5%);GO:0009845 (5%);GO:0010218 (5%),de-etiolation (5%);seed germination (5%);response to far red light (5%),IPR011059 (15%);IPR013108 (15%);IPR032466 (15%),Metal-dependent hydrolase, composite domain superfamily (15%);Amidohydrolase 3 (15%);Metal-dependent hydrolase (15%),,,,,,,,,
LTWMMGPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVGNDYSNNQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMVWPHLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLGTPCYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVFNPFNTACVPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVPYMPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEVGCPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNMYWLDTMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GVNLMTQEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQQEDVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%);GO:0005576 (20%);GO:0005618 (20%),integral component of membrane (60%);extracellular region (20%);cell wall (20%),GO:0003743 (40%);GO:0003924 (40%);GO:0005525 (40%),translation initiation factor activity (40%);GTPase activity (40%);GTP binding (40%),GO:0009306 (40%),protein secretion (40%),IPR000178 (40%);IPR000795 (40%);IPR005225 (40%),Translation initiation factor aIF-2, bacterial-like (40%);Transcription factor, GTP-binding domain (40%);Small GTP-binding protein domain (40%),,,,,,,,,
TEFLMVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLELNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (30%);7.1.2.2 (20%);1.11.1.6 (3%),Histidine kinase (30%);H(+)-transporting two-sector ATPase (20%);Catalase (3%),GO:0016021 (34%);GO:0005886 (14%);GO:0005737 (8%),integral component of membrane (34%);plasma membrane (14%);cytoplasm (8%),GO:0005524 (26%);GO:0003677 (17%);GO:0000155 (8%),ATP binding (26%);DNA binding (17%);phosphorelay sensor kinase activity (8%),GO:0006355 (10%);GO:0006310 (5%);GO:0015986 (5%),regulation of transcription, DNA-templated (10%);DNA recombination (5%);ATP synthesis coupled proton transport (5%),IPR027417 (13%);IPR001789 (9%);IPR011006 (9%),P-loop containing nucleoside triphosphate hydrolase (13%);Signal transduction response regulator, receiver domain (9%);CheY-like superfamily (9%),,,,,,,,,
TTMYDLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAPYLTGNPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLVSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.200 (93%);2.7.13.3 (4%);3.6.4.12 (1%),tRNA (cytidine(32)/uridine(32)-2'-O)-methyltransferase (93%);Histidine kinase (4%);DNA helicase (1%),GO:0005737 (58%);GO:0016021 (33%);GO:0005794 (3%),cytoplasm (58%);integral component of membrane (33%);Golgi apparatus (3%),GO:0003723 (57%);GO:0008173 (57%);GO:0015558 (14%),RNA binding (57%);RNA methyltransferase activity (57%);secondary active p-aminobenzoyl-glutamate transmembrane transporter activity (14%),GO:0008033 (58%);GO:1902604 (14%);GO:0032259 (3%),tRNA processing (58%);p-aminobenzoyl-glutamate transmembrane transport (14%);methylation (3%),IPR001537 (55%);IPR004384 (55%);IPR029026 (55%),tRNA/rRNA methyltransferase, SpoU type (55%);RNA methyltransferase TrmJ/LasT (55%);tRNA (guanine-N1-)-methyltransferase, N-terminal (55%),,,,,,,,,
VNGQVPMDTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EATVLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.3 (33%);2.4.2.17 (17%);3.1.-.- (17%),Pantetheine-phosphate adenylyltransferase (33%);ATP phosphoribosyltransferase (17%);Acting on ester bonds (17%),GO:0016021 (15%);GO:0005737 (12%);GO:0005615 (3%),integral component of membrane (15%);cytoplasm (12%);extracellular space (3%),GO:0005524 (18%);GO:0003677 (15%);GO:0003700 (12%),ATP binding (18%);DNA binding (15%);DNA-binding transcription factor activity (12%),GO:0000160 (9%);GO:0015937 (6%);GO:0000105 (3%),phosphorelay signal transduction system (9%);coenzyme A biosynthetic process (6%);histidine biosynthetic process (3%),IPR000847 (10%);IPR005119 (10%);IPR036388 (10%),Transcription regulator HTH, LysR (10%);LysR, substrate-binding (10%);Winged helix-like DNA-binding domain superfamily (10%),,,,,,,,,
MNNFLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.99.- (33%);2.7.7.19 (33%);4.1.1.36 (33%),With other acceptors (33%);Polynucleotide adenylyltransferase (33%);Phosphopantothenoylcysteine decarboxylase (33%),GO:0016021 (62%);GO:0005886 (38%);GO:0000131 (4%),integral component of membrane (62%);plasma membrane (38%);incipient cellular bud site (4%),GO:0008982 (27%);GO:0004559 (8%);GO:0030246 (6%),protein-N(PI)-phosphohistidine-sugar phosphotransferase activity (27%);alpha-mannosidase activity (8%);carbohydrate binding (6%),GO:0009401 (27%);GO:0007165 (17%);GO:0043087 (13%),phosphoenolpyruvate-dependent sugar phosphotransferase system (27%);signal transduction (17%);regulation of GTPase activity (13%),IPR003352 (29%);IPR004501 (29%);IPR004796 (29%),Phosphotransferase system, EIIC (29%);Phosphotransferase system, EIIC component, type 3 (29%);Phosphotransferase system, cellobiose-type IIC component (29%),,,,,,,
LLSDQVHHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSTSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.1 (100%);3.4.11.10 (100%),Leucyl aminopeptidase (100%);Bacterial leucyl aminopeptidase (100%),GO:0005634 (22%);GO:0005737 (22%);GO:0015627 (11%),nucleus (22%);cytoplasm (22%);type II protein secretion system complex (11%),GO:0008234 (33%);GO:0000981 (22%);GO:0003677 (22%),cysteine-type peptidase activity (33%);DNA-binding transcription factor activity, RNA polymerase II-specific (22%);DNA binding (22%),GO:0006351 (22%);GO:0015628 (11%),transcription, DNA-templated (22%);protein secretion by the type II secretion system (11%),IPR003653 (30%);IPR038765 (30%);IPR000819 (20%),Ulp1 protease family, C-terminal catalytic domain (30%);Papain-like cysteine peptidase superfamily (30%);Peptidase M17, leucyl aminopeptidase, C-terminal (20%),,,,,,
AEFFVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.1.13 (60%);3.2.1.55 (20%);3.2.1.23 (10%),PreQ(1) synthase (60%);Non-reducing end alpha-L-arabinofuranosidase (20%);Beta-galactosidase (10%),GO:0016021 (22%);GO:0005737 (13%);GO:0009341 (2%),integral component of membrane (22%);cytoplasm (13%);beta-galactosidase complex (2%),GO:0016491 (28%);GO:0033739 (13%);GO:0004553 (11%),oxidoreductase activity (28%);preQ1 synthase activity (13%);hydrolase activity, hydrolyzing O-glycosyl compounds (11%),GO:0005975 (17%);GO:0008616 (13%);GO:0000160 (2%),carbohydrate metabolic process (17%);queuosine biosynthetic process (13%);phosphorelay signal transduction system (2%),IPR036291 (27%);IPR000683 (24%);IPR006710 (11%),NAD(P)-binding domain superfamily (27%);Oxidoreductase, N-terminal (24%);Glycoside hydrolase, family 43 (11%),,,,,,,,
WAAAAQGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNENLAAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPQPNLK,Paramecium tetraurelia,Eukaryota,,,,Ciliophora,Intramacronucleata,,Oligohymenophorea,,,,Peniculida,,,,,Parameciidae,,,,Paramecium,,,,Paramecium tetraurelia,,,,,,,,,,,,,,,,,,,,,,,,
MAVSNLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0016301 (67%);GO:0016773 (67%),kinase activity (67%);phosphotransferase activity, alcohol group as acceptor (67%),,,IPR002173 (67%);IPR011611 (67%);IPR029056 (67%),Carbohydrate/puine kinase, PfkB, conserved site (67%);Carbohydrate kinase PfkB (67%);Ribokinase-like (67%),,,,,,,,
EATVQVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (56%);GO:0016020 (11%);GO:0030915 (11%),integral component of membrane (56%);membrane (11%);Smc5-Smc6 complex (11%),GO:0004674 (11%);GO:0005524 (11%);GO:0016787 (11%),protein serine/threonine kinase activity (11%);ATP binding (11%);hydrolase activity (11%),GO:0007165 (56%);GO:0000724 (11%);GO:0006355 (11%),signal transduction (56%);double-strand break repair via homologous recombination (11%);regulation of transcription, DNA-templated (11%),IPR004089 (50%);IPR003660 (30%);IPR004090 (20%),Methyl-accepting chemotaxis protein (MCP) signalling domain (50%);HAMP domain (30%);Chemotaxis methyl-accepting receptor (20%),,,,,,,,,,
LVSVDMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005694 (67%);GO:0005737 (67%),chromosome (67%);cytoplasm (67%),GO:0005524 (100%);GO:0003677 (67%);GO:0004326 (33%),ATP binding (100%);DNA binding (67%);tetrahydrofolylpolyglutamate synthase activity (33%),GO:0006260 (67%);GO:0007062 (67%);GO:0030261 (67%),DNA replication (67%);sister chromatid cohesion (67%);chromosome condensation (67%),IPR013783 (83%);IPR027417 (13%);IPR003395 (9%),Immunoglobulin-like fold (83%);P-loop containing nucleoside triphosphate hydrolase (13%);RecF/RecN/SMC, N-terminal (9%),,,,,,,,,,
DFSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.99.3 (10%);3.6.4.12 (7%);2.4.2.9 (6%),7-carboxy-7-deazaguanine synthase (10%);DNA helicase (7%);Uracil phosphoribosyltransferase (6%),GO:0016021 (33%);GO:0005737 (9%);GO:0005886 (5%),integral component of membrane (33%);cytoplasm (9%);plasma membrane (5%),GO:0005524 (21%);GO:0016887 (8%);GO:0046872 (7%),ATP binding (21%);ATPase activity (8%);metal ion binding (7%),GO:0007155 (5%);GO:0006396 (4%);GO:0006605 (3%),cell adhesion (5%);RNA processing (4%);protein targeting (3%),IPR027417 (17%);IPR003593 (9%);IPR003439 (7%),P-loop containing nucleoside triphosphate hydrolase (17%);AAA+ ATPase domain (9%);ABC transporter-like (7%),,,,,,,,,,,
FSVLWNK,Cryptotermes secundus,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Blattodea,,,,Blattoidea,Kalotermitidae,Cryptotermitinae,,,Cryptotermes,,,,Cryptotermes secundus,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
TPPMTLEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNFPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.80 (100%),Protein-glutamate O-methyltransferase (100%),GO:0016021 (33%);GO:0005886 (11%),integral component of membrane (33%);plasma membrane (11%),GO:0004181 (33%);GO:0008270 (33%);GO:0005524 (22%),metallocarboxypeptidase activity (33%);zinc ion binding (33%);ATP binding (22%),GO:0055085 (11%),transmembrane transport (11%),IPR000834 (31%);IPR033810 (31%);IPR003959 (15%),Peptidase M14, carboxypeptidase A (31%);Carboxypeptidase T (31%);ATPase, AAA-type, core (15%),,,,,,,,
ANTPMYAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALFDCYVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADEYEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (100%),Exoribonuclease II (100%),GO:0005737 (40%),cytoplasm (40%),GO:0003723 (40%);GO:0008859 (40%);GO:0016491 (40%),RNA binding (40%);exoribonuclease II activity (40%);oxidoreductase activity (40%),,,IPR009288 (50%);IPR013024 (50%);IPR036568 (50%),Gamma-glutamylcyclotransferase, AIG2-like (50%);Gamma-glutamyl cyclotransferase-like (50%);Gamma-glutamyl cyclotransferase-like superfamily (50%),,,,,,,,,,
WVLGNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGLTMHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CSVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.43 (28%);2.4.1.- (19%);2.7.11.1 (19%),Transferred entry: 2.1.1.354 (28%);Hexosyltransferases (19%);Non-specific serine/threonine protein kinase (19%),GO:0016021 (19%);GO:0001527 (6%);GO:0005576 (5%),integral component of membrane (19%);microfibril (6%);extracellular region (5%),GO:0005509 (49%);GO:0042803 (8%);GO:0046872 (8%),calcium ion binding (49%);protein homodimerization activity (8%);metal ion binding (8%),GO:0007155 (11%);GO:0043010 (6%);GO:0048048 (6%),cell adhesion (11%);camera-type eye development (6%);embryonic eye morphogenesis (6%),IPR000152 (47%);IPR000742 (47%);IPR001881 (47%),EGF-type aspartate/asparagine hydroxylation site (47%);EGF-like domain (47%);EGF-like calcium-binding domain (47%),,,,,,,,,,,
MLGLAQWHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YTAEYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (36%);GO:0005737 (3%);GO:0008023 (3%),integral component of membrane (36%);cytoplasm (3%);transcription elongation factor complex (3%),GO:0003677 (28%);GO:0004803 (23%);GO:0016627 (10%),DNA binding (28%);transposase activity (23%);oxidoreductase activity, acting on the CH-CH group of donors (10%),GO:0006313 (23%);GO:0022900 (10%);GO:0006270 (5%),transposition, DNA-mediated (23%);electron transport chain (10%);DNA replication initiation (5%),IPR002514 (24%);IPR009057 (22%);IPR002797 (13%),Transposase IS3/IS911family (24%);Homeobox-like domain superfamily (22%);Polysaccharide biosynthesis protein (13%),,,,,,,,,
TEVLAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005634 (25%),integral component of membrane (50%);nucleus (25%),GO:0003677 (25%);GO:0003924 (25%);GO:0005525 (25%),DNA binding (25%);GTPase activity (25%);GTP binding (25%),GO:0009103 (25%),lipopolysaccharide biosynthetic process (25%),IPR001806 (25%);IPR003856 (25%);IPR005225 (25%),Small GTPase (25%);Polysaccharide chain length determinant N-terminal domain (25%);Small GTP-binding protein domain (25%),,,,,,,,,,,
SSMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.2.10 (50%);3.1.4.11 (10%);6.3.5.- (10%),P-type Ca(2+) transporter (50%);Phosphoinositide phospholipase C (10%);Carbon--nitrogen ligases with glutamine as amido-N-donor (10%),GO:0016021 (42%);GO:0005737 (4%);GO:0005634 (3%),integral component of membrane (42%);cytoplasm (4%);nucleus (3%),GO:0005524 (23%);GO:0008324 (8%);GO:0003677 (7%),ATP binding (23%);cation transmembrane transporter activity (8%);DNA binding (7%),GO:0005975 (5%);GO:0006428 (3%);GO:0032259 (3%),carbohydrate metabolic process (5%);isoleucyl-tRNA aminoacylation (3%);methylation (3%),IPR027417 (7%);IPR020683 (7%);IPR036770 (7%),P-loop containing nucleoside triphosphate hydrolase (7%);Ankyrin repeat-containing domain (7%);Ankyrin repeat-containing domain superfamily (7%),,,,,,,,,,,
LYPFAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WDPLALR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043565 (67%);GO:0005524 (33%);GO:0016887 (33%),sequence-specific DNA binding (67%);ATP binding (33%);ATPase activity (33%),,,IPR000485 (67%);IPR007421 (67%);IPR011991 (67%),AsnC-type HTH domain (67%);Schlafen, AlbA_2 domain (67%);ArsR-like helix-turn-helix domain (67%),,,,,,,,,,
QVNFLLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLEPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003676 (17%);GO:0003824 (17%);GO:0004386 (17%),nucleic acid binding (17%);catalytic activity (17%);helicase activity (17%),,,IPR000683 (17%);IPR006311 (17%);IPR010699 (17%),Oxidoreductase, N-terminal (17%);Twin-arginine translocation pathway, signal sequence (17%);Protein of unknown function DUF1275 (17%),,,,,,,,,
VKPFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (38%);3.5.2.6 (25%);1.3.-.- (13%),Transferring other groups (38%);Beta-lactamase (25%);Acting on the CH-CH group of donors (13%),GO:0016021 (44%);GO:0005886 (6%);GO:0005940 (3%),integral component of membrane (44%);plasma membrane (6%);septin ring (3%),GO:0005524 (32%);GO:0003723 (12%);GO:0009982 (12%),ATP binding (32%);RNA binding (12%);pseudouridine synthase activity (12%),GO:0001522 (12%);GO:0006304 (9%);GO:0009190 (6%),pseudouridine synthesis (12%);DNA modification (9%);cyclic nucleotide biosynthetic process (6%),IPR027417 (24%);IPR007050 (22%);IPR011579 (16%),P-loop containing nucleoside triphosphate hydrolase (24%);Bacterioopsin activator-type, HTH domain (22%);ATPase domain (16%),,,,,,,,,,
DGVEEEDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVECSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (29%);2.1.3.2 (21%);2.4.2.18 (14%),Exoribonuclease II (29%);Aspartate carbamoyltransferase (21%);Anthranilate phosphoribosyltransferase (14%),GO:0016021 (49%);GO:0005737 (10%);GO:0005886 (6%),integral component of membrane (49%);cytoplasm (10%);plasma membrane (6%),GO:0005524 (48%);GO:0016887 (26%);GO:0042626 (24%),ATP binding (48%);ATPase activity (26%);ATPase-coupled transmembrane transporter activity (24%),GO:0000105 (8%);GO:0006260 (4%);GO:0006605 (4%),histidine biosynthetic process (8%);DNA replication (4%);protein targeting (4%),IPR027417 (32%);IPR003593 (24%);IPR003439 (22%),P-loop containing nucleoside triphosphate hydrolase (32%);AAA+ ATPase domain (24%);ABC transporter-like (22%),,,,,,,,,,,
CDVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (48%);3.6.4.12 (13%);1.7.99.1 (6%),Histidine kinase (48%);DNA helicase (13%);Hydroxylamine reductase (6%),GO:0016021 (28%);GO:0005634 (18%);GO:0019031 (3%),integral component of membrane (28%);nucleus (18%);viral envelope (3%),GO:0003677 (25%);GO:0005524 (20%);GO:0008270 (15%),DNA binding (25%);ATP binding (20%);zinc ion binding (15%),GO:0006351 (11%);GO:0006355 (3%);GO:0005975 (3%),transcription, DNA-templated (11%);regulation of transcription, DNA-templated (3%);carbohydrate metabolic process (3%),IPR011990 (16%);IPR013026 (16%);IPR003594 (10%),Tetratricopeptide-like helical domain superfamily (16%);Tetratricopeptide repeat-containing domain (16%);Histidine kinase/HSP90-like ATPase (10%),,,,,,,,,
FVEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.1 (53%);5.2.1.8 (4%);1.6.1.2 (3%),Phosphodiesterase I (53%);Peptidylprolyl isomerase (4%);NAD(P)(+) transhydrogenase (Re/Si-specific) (3%),GO:0016021 (17%);GO:0005634 (14%);GO:0005737 (4%),integral component of membrane (17%);nucleus (14%);cytoplasm (4%),GO:0046872 (19%);GO:0003676 (16%);GO:0005524 (16%),metal ion binding (19%);nucleic acid binding (16%);ATP binding (16%),GO:0036297 (14%);GO:0009307 (3%);GO:0006313 (2%),interstrand cross-link repair (14%);DNA restriction-modification system (3%);transposition, DNA-mediated (2%),IPR011856 (17%);IPR014883 (13%);IPR033315 (12%),tRNA endonuclease-like domain superfamily (17%);VRR-NUC domain (13%);Fanconi-associated nuclease 1-like (12%),,,,,,,,,,
NLVYQDAQSVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNELVALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%);GO:0005886 (50%),integral component of membrane (100%);plasma membrane (50%),GO:0004222 (50%);GO:0004888 (50%);GO:0046872 (50%),metalloendopeptidase activity (50%);transmembrane signaling receptor activity (50%);metal ion binding (50%),GO:0006935 (50%);GO:0007165 (50%),chemotaxis (50%);signal transduction (50%),IPR001478 (50%);IPR003660 (50%);IPR004089 (50%),PDZ domain (50%);HAMP domain (50%);Methyl-accepting chemotaxis protein (MCP) signalling domain (50%),,,,,,,,,,,
WMMPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFSDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.25 (38%);2.8.1.8 (10%);2.7.7.8 (5%),4-alpha-glucanotransferase (38%);Lipoyl synthase (10%);Polyribonucleotide nucleotidyltransferase (5%),GO:0016021 (11%);GO:0005634 (9%);GO:0032865 (6%),integral component of membrane (11%);nucleus (9%);ERMES complex (6%),GO:0000287 (24%);GO:0004722 (23%);GO:0030145 (23%),magnesium ion binding (24%);protein serine/threonine phosphatase activity (23%);manganese ion binding (23%),GO:0006325 (7%);GO:0006869 (6%);GO:0000002 (5%),chromatin organization (7%);lipid transport (6%);mitochondrial genome maintenance (5%),IPR000222 (19%);IPR001932 (19%);IPR015655 (19%),PPM-type phosphatase, divalent cation binding (19%);PPM-type phosphatase domain (19%);Protein phosphatase 2C family (19%),,,,,,,,,,
LVDASHSVPCSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNPNGQVLTVGDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMESK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (57%);2.7.13.3 (20%);2.1.1.192 (8%),RNA-directed RNA polymerase (57%);Histidine kinase (20%);23S rRNA (adenine(2503)-C(2))-methyltransferase (8%),GO:0005634 (16%);GO:0016021 (15%);GO:0005737 (3%),nucleus (16%);integral component of membrane (15%);cytoplasm (3%),GO:0005524 (26%);GO:0003676 (23%);GO:0008270 (16%),ATP binding (26%);nucleic acid binding (23%);zinc ion binding (16%),GO:0039694 (8%);GO:0006313 (3%);GO:0000160 (1%),viral RNA genome replication (8%);transposition, DNA-mediated (3%);phosphorelay signal transduction system (1%),IPR027417 (21%);IPR013087 (16%);IPR036236 (16%),P-loop containing nucleoside triphosphate hydrolase (21%);Zinc finger C2H2-type (16%);Zinc finger C2H2 superfamily (16%),,,,,,,,,,
WMENSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTGNSAPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMPLLTDK,Lactobacillus aviarius,Bacteria,,,,Firmicutes,,,Bacilli,,,,Lactobacillales,,,,,Lactobacillaceae,,,,Lactobacillus,,,,Lactobacillus aviarius,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016887 (75%),ATP binding (100%);ATPase activity (75%),,,IPR003439 (100%);IPR003593 (100%);IPR027417 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,,,
WFEVLMMTMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLEVLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MASLANGTTAQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFELNFEYTPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMDMVPK,Clostridium cylindrosporum,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Clostridiaceae,,,,Clostridium,,,,Clostridium cylindrosporum,,,,4.1.1.37 (100%),Uroporphyrinogen decarboxylase (100%),,,GO:0004853 (100%),uroporphyrinogen decarboxylase activity (100%),GO:0006779 (100%),porphyrin-containing compound biosynthetic process (100%),IPR000257 (100%);IPR038071 (100%),Uroporphyrinogen decarboxylase (URO-D) (100%);UROD/MetE-like superfamily (100%),,,,,,,,,,,
GFLPLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (100%),DNA topoisomerase (ATP-hydrolyzing) (100%),GO:0000329 (33%);GO:0005623 (33%);GO:0016021 (33%),fungal-type vacuole membrane (33%);cell (33%);integral component of membrane (33%),GO:0003677 (33%);GO:0003918 (33%);GO:0005524 (33%),DNA binding (33%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (33%);ATP binding (33%),GO:0006265 (33%);GO:0006826 (33%);GO:0006879 (33%),DNA topological change (33%);iron ion transport (33%);cellular iron ion homeostasis (33%),IPR039910 (67%);IPR000184 (17%);IPR001046 (17%),Surface antigen D15-like (67%);Bacterial surface antigen (D15) (17%);NRAMP family (17%),,,,,,,,,,
TPTYFCTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NCWNLHGETNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDPNYEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVSMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.88 (72%);5.99.1.2 (7%);3.4.21.53 (5%),L-glutamate gamma-semialdehyde dehydrogenase (72%);Transferred entry: 5.6.2.1 (7%);Endopeptidase La (5%),GO:0016021 (13%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (13%);cytoplasm (5%);plasma membrane (4%),GO:0016620 (28%);GO:0003842 (27%);GO:0003677 (26%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (28%);1-pyrroline-5-carboxylate dehydrogenase activity (27%);DNA binding (26%),GO:0010133 (27%);GO:0006265 (24%);GO:0006515 (2%),proline catabolic process to glutamate (27%);DNA topological change (24%);protein quality control for misfolded or incompletely synthesized proteins (2%),IPR025589 (26%);IPR015590 (25%);IPR016161 (25%),Topoisomerase C-terminal repeat (26%);Aldehyde dehydrogenase domain (25%);Aldehyde/histidinol dehydrogenase (25%),,,,,,,,,
VGAMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.2.2 (22%);2.3.1.- (20%);6.3.4.5 (7%),Nitrite reductase (cytochrome; ammonia-forming) (22%);Transferring groups other than amino-acyl groups (20%);Argininosuccinate synthase (7%),GO:0016021 (55%);GO:0042597 (4%);GO:0005886 (3%),integral component of membrane (55%);periplasmic space (4%);plasma membrane (3%),GO:0016746 (39%);GO:0046872 (12%);GO:0004197 (6%),transferase activity, transferring acyl groups (39%);metal ion binding (12%);cysteine-type endopeptidase activity (6%),GO:0006807 (2%);GO:0008360 (2%);GO:1990961 (1%),nitrogen compound metabolic process (2%);regulation of cell shape (2%);xenobiotic detoxification by transmembrane export across the plasma membrane (1%),IPR004960 (31%);IPR038765 (6%);IPR004134 (5%),Bacterial lipid A biosynthesis acyltransferase (31%);Papain-like cysteine peptidase superfamily (6%);Peptidase C1B, bleomycin hydrolase (5%),,,,,,,,,
TCFLLMLFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HVSAAHEM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNLAAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.17 (100%),Phosphomethylpyrimidine synthase (100%),GO:0016021 (20%),integral component of membrane (20%),GO:0030170 (40%);GO:0008483 (20%);GO:0016829 (20%),pyridoxal phosphate binding (40%);transaminase activity (20%);lyase activity (20%),GO:0009058 (40%);GO:0016042 (10%),biosynthetic process (40%);lipid catabolic process (10%),IPR004839 (36%);IPR015421 (36%);IPR015422 (36%),Aminotransferase, class I/classII (36%);Pyridoxal phosphate-dependent transferase, major domain (36%);Pyridoxal phosphate-dependent transferase domain 1 (36%),,,,,,,,,
TWYTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPPWSK,Cicer arietinum,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Fabales,,,,,Fabaceae,Papilionoideae,Cicereae,,Cicer,,,,Cicer arietinum,,,,,,,,,,,,IPR016024 (100%),Armadillo-type fold (100%),,,,,,,,,,,
NTEFVFGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NHLGWYNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NCQDQVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (19%);4.6.1.12 (10%);2.5.1.3 (5%),Beta-galactosidase (19%);2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (10%);Thiamine phosphate synthase (5%),GO:0016021 (28%);GO:0005737 (9%);GO:0009341 (3%),integral component of membrane (28%);cytoplasm (9%);beta-galactosidase complex (3%),GO:0005524 (11%);GO:0046872 (5%);GO:0016787 (5%),ATP binding (11%);metal ion binding (5%);hydrolase activity (5%),GO:0005975 (5%);GO:0007049 (3%);GO:0051301 (3%),carbohydrate metabolic process (5%);cell cycle (3%);cell division (3%),IPR027417 (8%);IPR013783 (4%);IPR008979 (3%),P-loop containing nucleoside triphosphate hydrolase (8%);Immunoglobulin-like fold (4%);Galactose-binding-like domain superfamily (3%),,,,,,,,,,
AMTNHMDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPVNLLAQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VHCPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (25%);2.1.1.220 (25%);2.7.7.7 (25%),Methyltransferases (25%);tRNA (adenine(58)-N(1))-methyltransferase (25%);DNA-directed DNA polymerase (25%),GO:0016021 (30%);GO:0005737 (8%);GO:0009380 (6%),integral component of membrane (30%);cytoplasm (8%);excinuclease repair complex (6%),GO:0003676 (16%);GO:0008270 (12%);GO:0003677 (10%),nucleic acid binding (16%);zinc ion binding (12%);DNA binding (10%),GO:0006355 (10%);GO:0032259 (8%);GO:0006289 (6%),regulation of transcription, DNA-templated (10%);methylation (8%);nucleotide-excision repair (6%),IPR008727 (10%);IPR029063 (10%);IPR027417 (8%),PAAR motif (10%);S-adenosyl-L-methionine-dependent methyltransferase (10%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
EVSQGHTVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGFDNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.99.1.2 (100%),Transferred entry: 5.6.2.1 (100%),GO:0005576 (1%),extracellular region (1%),GO:0003677 (93%);GO:0003917 (93%);GO:0016853 (4%),DNA binding (93%);DNA topoisomerase type I (single strand cut, ATP-independent) activity (93%);isomerase activity (4%),GO:0006265 (93%);GO:0005975 (2%);GO:0008033 (1%),DNA topological change (93%);carbohydrate metabolic process (2%);tRNA processing (1%),IPR000380 (94%);IPR003601 (94%);IPR006171 (94%),DNA topoisomerase, type IA (94%);DNA topoisomerase, type IA, domain 2 (94%);TOPRIM  domain (94%),,,,,,,
VYSLLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (23%);GO:0005886 (18%);GO:0005623 (9%),integral component of membrane (23%);plasma membrane (18%);cell (9%),GO:0016787 (59%);GO:0005525 (18%);GO:0015093 (18%),hydrolase activity (59%);GTP binding (18%);ferrous iron transmembrane transporter activity (18%),GO:0055072 (18%);GO:0006751 (14%);GO:0006397 (9%),iron ion homeostasis (18%);glutathione catabolic process (14%);mRNA processing (9%),IPR013094 (38%);IPR029058 (38%);IPR003373 (19%),Alpha/beta hydrolase fold-3 (38%);Alpha/Beta hydrolase fold (38%);Ferrous iron transport protein B (19%),,,,,,,,,,,
NLNVESR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0000155 (100%),phosphorelay sensor kinase activity (100%),,,IPR025157 (92%);IPR008638 (35%);IPR010069 (35%),Hemagglutinin repeat (92%);Filamentous haemagglutinin, N-terminal (35%);Filamentous haemagglutinin, 20-residue x2 repeat (35%),,,,,,,,,
ETLVGLVPELHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLVN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.1 (50%);6.3.4.13 (50%),Thiosulfate sulfurtransferase (50%);Phosphoribosylamine--glycine ligase (50%),GO:0016021 (22%);GO:0005737 (11%);GO:0015627 (11%),integral component of membrane (22%);cytoplasm (11%);type II protein secretion system complex (11%),GO:0005524 (33%);GO:0016836 (22%);GO:0004637 (11%),ATP binding (33%);hydro-lyase activity (22%);phosphoribosylamine-glycine ligase activity (11%),GO:0006189 (11%);GO:0009113 (11%);GO:0015628 (11%),'de novo' IMP biosynthetic process (11%);purine nucleobase biosynthetic process (11%);protein secretion by the type II secretion system (11%),IPR011827 (14%);IPR015928 (14%);IPR027417 (14%),Hydrolyase LeuD/HacB/DmdB (14%);Aconitase/3-isopropylmalate dehydratase, swivel (14%);P-loop containing nucleoside triphosphate hydrolase (14%),,,,,,,,,,
TCPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.-.- (67%);2.7.7.7 (17%);2.7.-.- (4%),Forming carbon-sulfur bonds (67%);DNA-directed DNA polymerase (17%);Transferring phosphorus-containing groups (4%),GO:0016021 (13%);GO:0005634 (4%);GO:0005576 (4%),integral component of membrane (13%);nucleus (4%);extracellular region (4%),GO:0046872 (28%);GO:0016787 (23%);GO:0003677 (16%),metal ion binding (28%);hydrolase activity (23%);DNA binding (16%),GO:0023051 (14%);GO:0030155 (14%);GO:0046944 (6%),regulation of signaling (14%);regulation of cell adhesion (14%);protein carbamoylation (6%),IPR036420 (33%);IPR022047 (33%);IPR001357 (32%),BRCT domain superfamily (33%);Microcephalin-like (33%);BRCT domain (32%),,,,,,,,,,,
VETNTLNTWMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLWSEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.141 (50%);3.6.4.12 (25%);6.3.2.- (25%),4-alpha-D-((1->4)-alpha-D-glucano)trehalose trehalohydrolase (50%);DNA helicase (25%);Acid--amino-acid ligases (peptide synthases) (25%),GO:0016021 (22%);GO:0005869 (19%);GO:0005737 (6%),integral component of membrane (22%);dynactin complex (19%);cytoplasm (6%),GO:0003723 (15%);GO:0003676 (11%);GO:0003677 (11%),RNA binding (15%);nucleic acid binding (11%);DNA binding (11%),GO:0000398 (13%);GO:0015074 (11%);GO:0032196 (11%),mRNA splicing, via spliceosome (13%);DNA integration (11%);transposition (11%),IPR015943 (27%);IPR000409 (22%);IPR023362 (22%),WD40/YVTN repeat-like-containing domain superfamily (27%);BEACH domain (22%);PH-BEACH domain (22%),,,,,,,,,,
VVANHVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDFLTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.267 (33%);2.6.1.11 (17%);2.7.11.1 (17%),1-deoxy-D-xylulose-5-phosphate reductoisomerase (33%);Acetylornithine transaminase (17%);Non-specific serine/threonine protein kinase (17%),GO:0016021 (33%);GO:0005886 (3%),integral component of membrane (33%);plasma membrane (3%),GO:0016787 (23%);GO:0008168 (20%);GO:0015562 (18%),hydrolase activity (23%);methyltransferase activity (20%);efflux transmembrane transporter activity (18%),GO:0032259 (20%);GO:0009294 (5%);GO:0016114 (5%),methylation (20%);DNA mediated transformation (5%);terpenoid biosynthetic process (5%),IPR001667 (16%);IPR038763 (16%);IPR003423 (14%),DDH domain (16%);DHH phosphoesterase superfamily (16%);Outer membrane efflux protein (14%),,,,,,,,,,,
EMPDLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (91%);4.1.99.18 (9%),DNA topoisomerase (ATP-hydrolyzing) (91%);Transferred entry: 4.1.99.22 and 4.6.1.17 (9%),GO:0005634 (54%);GO:0032044 (25%);GO:0005694 (2%),nucleus (54%);DSIF complex (25%);chromosome (2%),GO:0003746 (27%);GO:0003824 (4%);GO:0003677 (3%),translation elongation factor activity (27%);catalytic activity (4%);DNA binding (3%),GO:0006357 (64%);GO:0032784 (64%);GO:0032968 (24%),regulation of transcription by RNA polymerase II (64%);regulation of DNA-templated transcription, elongation (64%);positive regulation of transcription elongation from RNA polymerase II promoter (24%),IPR039659 (85%);IPR005824 (85%);IPR014722 (85%),Transcription elongation factor SPT5 (85%);KOW (85%);Ribosomal protein L2, domain 2 (85%),,,,,,,,,
NFNLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.9 (13%);4.2.2.- (13%);3.1.1.- (6%),Histidinol-phosphate transaminase (13%);Acting on polysaccharides (13%);Carboxylic ester hydrolases (6%),GO:0016021 (41%);GO:0005737 (5%);GO:0016020 (4%),integral component of membrane (41%);cytoplasm (5%);membrane (4%),GO:0005524 (11%);GO:0000155 (5%);GO:0046872 (5%),ATP binding (11%);phosphorelay sensor kinase activity (5%);metal ion binding (5%),GO:0015031 (4%);GO:0005975 (4%);GO:0006865 (4%),protein transport (4%);carbohydrate metabolic process (4%);amino acid transport (4%),IPR027417 (8%);IPR036890 (5%);IPR003594 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);Histidine kinase/HSP90-like ATPase superfamily (5%);Histidine kinase/HSP90-like ATPase (5%),,,,,,,,,,,
TQLGMMLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSENADSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVVWMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLSSNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.- (75%);6.3.2.2 (25%),Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (75%);Glutamate--cysteine ligase (25%),GO:0005737 (93%);GO:0009380 (88%);GO:0016021 (3%),cytoplasm (93%);excinuclease repair complex (88%);integral component of membrane (3%),GO:0005524 (94%);GO:0003677 (93%);GO:0046872 (93%),ATP binding (94%);DNA binding (93%);metal ion binding (93%),GO:0006289 (88%);GO:0006281 (6%);GO:0008152 (1%),nucleotide-excision repair (88%);DNA repair (6%);metabolic process (1%),IPR027417 (92%);IPR041102 (91%);IPR017871 (91%),P-loop containing nucleoside triphosphate hydrolase (92%);UvrA, interaction domain (91%);ABC transporter, conserved site (91%),,,,,,,,
VLTMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (62%);7.6.2.- (8%);1.1.1.100 (3%),DNA helicase (62%);Linked to the hydrolysis of a nucleoside triphosphate (8%);3-oxoacyl-[acyl-carrier-protein] reductase (3%),GO:0016021 (21%);GO:0005886 (6%);GO:0005737 (4%),integral component of membrane (21%);plasma membrane (6%);cytoplasm (4%),GO:0005524 (36%);GO:0003677 (30%);GO:0003678 (18%),ATP binding (36%);DNA binding (30%);DNA helicase activity (18%),GO:0032259 (4%);GO:0051301 (3%);GO:0007049 (3%),methylation (4%);cell division (3%);cell cycle (3%),IPR027417 (32%);IPR000212 (17%);IPR014016 (16%),P-loop containing nucleoside triphosphate hydrolase (32%);DNA helicase, UvrD/REP type (17%);UvrD-like helicase, ATP-binding domain (16%),,,,,,,,,
NAYLVMEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNYEMEGLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETWMEMVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSLEDGFGEQTLSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFVACK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.1 (100%),DNA ligase (ATP) (100%),,,GO:0003677 (100%);GO:0003910 (100%);GO:0005524 (100%),DNA binding (100%);DNA ligase (ATP) activity (100%);ATP binding (100%),GO:0006260 (100%);GO:0006310 (100%);GO:0051103 (100%),DNA replication (100%);DNA recombination (100%);DNA ligation involved in DNA repair (100%),IPR000977 (64%);IPR012308 (64%);IPR012309 (64%),DNA ligase, ATP-dependent (64%);DNA ligase, ATP-dependent, N-terminal (64%);DNA ligase, ATP-dependent, C-terminal (64%),,,,,,
NNQCMAAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDVSTVEAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNGLAHSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALMTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.5.2.7 (15%);7.-.-.- (10%);1.3.1.9 (5%),ABC-type D-ribose transporter (15%);Translocases (10%);Enoyl-[acyl-carrier-protein] reductase (NADH) (5%),GO:0016021 (23%);GO:0005886 (9%);GO:0005737 (4%),integral component of membrane (23%);plasma membrane (9%);cytoplasm (4%),GO:0005524 (17%);GO:0016874 (8%);GO:0016887 (7%),ATP binding (17%);ligase activity (8%);ATPase activity (7%),GO:0055085 (5%);GO:0006355 (2%);GO:0005975 (2%),transmembrane transport (5%);regulation of transcription, DNA-templated (2%);carbohydrate metabolic process (2%),IPR027417 (11%);IPR000873 (8%);IPR020845 (8%),P-loop containing nucleoside triphosphate hydrolase (11%);AMP-dependent synthetase/ligase (8%);AMP-binding, conserved site (8%),,,,,,,,,
FPFLLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0004497 (100%);GO:0005506 (100%);GO:0016705 (100%),monooxygenase activity (100%);iron ion binding (100%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (100%),,,IPR001128 (40%);IPR002403 (40%);IPR017972 (40%),Cytochrome P450 (40%);Cytochrome P450, E-class, group IV (40%);Cytochrome P450, conserved site (40%),,,,,,
NNPDMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (50%);3.6.4.12 (50%),Non-specific serine/threonine protein kinase (50%);DNA helicase (50%),GO:0016021 (22%),integral component of membrane (22%),GO:0005524 (56%);GO:0004674 (33%);GO:0004672 (17%),ATP binding (56%);protein serine/threonine kinase activity (33%);protein kinase activity (17%),GO:0005975 (17%);GO:0009405 (11%);GO:0006355 (6%),carbohydrate metabolic process (17%);pathogenesis (11%);regulation of transcription, DNA-templated (6%),IPR000719 (43%);IPR008271 (43%);IPR011009 (43%),Protein kinase domain (43%);Serine/threonine-protein kinase, active site (43%);Protein kinase-like domain superfamily (43%),,,,,,,,,
AFLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.17 (15%);5.1.3.2 (9%);4.1.3.36 (7%),Enoyl-CoA hydratase (15%);UDP-glucose 4-epimerase (9%);1,4-dihydroxy-2-naphthoyl-CoA synthase (7%),GO:0016021 (12%);GO:0005737 (8%);GO:0005886 (1%),integral component of membrane (12%);cytoplasm (8%);plasma membrane (1%),GO:0003824 (16%);GO:0005524 (12%);GO:0046872 (7%),catalytic activity (16%);ATP binding (12%);metal ion binding (7%),GO:0006012 (3%);GO:0006099 (3%);GO:0009234 (2%),galactose metabolic process (3%);tricarboxylic acid cycle (3%);menaquinone biosynthetic process (2%),IPR029045 (22%);IPR001753 (22%);IPR014748 (21%),ClpP/crotonase-like domain superfamily (22%);Enoyl-CoA hydratase/isomerase (22%);Enoyl-CoA hydratase, C-terminal (21%),,,,,,,,,
YSFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.3 (21%);2.3.2.3 (9%);2.4.2.53 (9%),Aconitate hydratase (21%);Lysyltransferase (9%);Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase (9%),GO:0016021 (38%);GO:0005886 (13%);GO:0005737 (8%),integral component of membrane (38%);plasma membrane (13%);cytoplasm (8%),GO:0005524 (14%);GO:0005509 (7%);GO:0003677 (5%),ATP binding (14%);calcium ion binding (7%);DNA binding (5%),GO:0007156 (7%);GO:0007605 (6%);GO:0007626 (6%),homophilic cell adhesion via plasma membrane adhesion molecules (7%);sensory perception of sound (6%);locomotory behavior (6%),IPR027417 (10%);IPR002126 (6%);IPR015919 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Cadherin-like (6%);Cadherin-like superfamily (6%),,,,,,,,,,,
SFTVLMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (54%);3.2.2.23 (13%);4.2.99.18 (13%),DNA-directed DNA polymerase (54%);DNA-formamidopyrimidine glycosylase (13%);DNA-(apurinic or apyrimidinic site) lyase (13%),GO:0042025 (77%);GO:0019012 (77%);GO:0033650 (49%),host cell nucleus (77%);virion (77%);host cell mitochondrion (49%),GO:0003723 (78%);GO:0003968 (75%);GO:0003677 (4%),RNA binding (78%);RNA-directed 5'-3' RNA polymerase activity (75%);DNA binding (4%),GO:0006351 (78%);GO:0039694 (77%);GO:0006370 (77%),transcription, DNA-templated (78%);viral RNA genome replication (77%);7-methylguanosine mRNA capping (77%),IPR001591 (75%);IPR037258 (74%);IPR001837 (3%),Influenza RNA-dependent RNA polymerase subunit PB2 (75%);PB2, C-terminal (74%);Adenylate cyclase-associated CAP (3%),,,,,,,,,
NALLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (35%);4.1.1.20 (22%);4.2.1.75 (7%),DNA-directed DNA polymerase (35%);Diaminopimelate decarboxylase (22%);Uroporphyrinogen-III synthase (7%),GO:0016021 (22%);GO:0005737 (6%);GO:0005840 (4%),integral component of membrane (22%);cytoplasm (6%);ribosome (4%),GO:0003677 (21%);GO:0005524 (11%);GO:0046872 (9%),DNA binding (21%);ATP binding (11%);metal ion binding (9%),GO:0006260 (7%);GO:0006304 (6%);GO:0015074 (6%),DNA replication (7%);DNA modification (6%);DNA integration (6%),IPR012337 (11%);IPR036397 (10%);IPR027417 (8%),Ribonuclease H-like superfamily (11%);Ribonuclease H superfamily (10%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
YLFLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (13%);2.3.2.27 (13%);2.8.4.3 (13%),Transferring groups other than amino-acyl groups (13%);RING-type E3 ubiquitin transferase (13%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (13%),GO:0016021 (24%);GO:0005874 (10%);GO:0005881 (5%),integral component of membrane (24%);microtubule (10%);cytoplasmic microtubule (5%),GO:0008270 (64%);GO:0008017 (15%);GO:0042803 (15%),zinc ion binding (64%);microtubule binding (15%);protein homodimerization activity (15%),GO:0035372 (15%);GO:0010508 (10%);GO:0032897 (10%),protein localization to microtubule (15%);positive regulation of autophagy (10%);negative regulation of viral transcription (10%),IPR003961 (70%);IPR036116 (70%);IPR013320 (69%),Fibronectin type III (70%);Fibronectin type III superfamily (70%);Concanavalin A-like lectin/glucanase domain superfamily (69%),,,,,,,,,,,
NNMYVPNNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YGLLAFFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YTMHTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.- (100%),With oxygen as acceptor (100%),GO:0016021 (93%),integral component of membrane (93%),GO:0004553 (4%);GO:0005507 (4%);GO:0008131 (4%),hydrolase activity, hydrolyzing O-glycosyl compounds (4%);copper ion binding (4%);primary amine oxidase activity (4%),GO:0005975 (4%);GO:0009308 (4%),carbohydrate metabolic process (4%);amine metabolic process (4%),IPR000269 (25%);IPR000537 (25%);IPR006103 (25%),Copper amine oxidase (25%);UbiA prenyltransferase family (25%);Glycoside hydrolase family 2, catalytic domain (25%),,,,,,,,,
DLAQM,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.133 (100%),dTDP-4-dehydrorhamnose reductase (100%),GO:0016021 (2%),integral component of membrane (2%),GO:0008236 (98%);GO:0004180 (8%);GO:0008831 (2%),serine-type peptidase activity (98%);carboxypeptidase activity (8%);dTDP-4-dehydrorhamnose reductase activity (2%),GO:0019305 (2%),dTDP-rhamnose biosynthetic process (2%),IPR029058 (98%);IPR008758 (87%);IPR042269 (65%),Alpha/Beta hydrolase fold (98%);Peptidase S28 (87%);Serine carboxypeptidase S28, SKS domain (65%),,,,,,,,,,
NMEDLLSLNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYCEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.13 (19%);2.7.8.- (17%);6.3.4.19 (17%),Ornithine aminotransferase (19%);Transferases for other substituted phosphate groups (17%);tRNA(Ile)-lysidine synthetase (17%),GO:0016021 (29%);GO:0005737 (13%);GO:0005886 (5%),integral component of membrane (29%);cytoplasm (13%);plasma membrane (5%),GO:0005524 (16%);GO:0046872 (11%);GO:0030170 (6%),ATP binding (16%);metal ion binding (11%);pyridoxal phosphate binding (6%),GO:0055129 (5%);GO:0006400 (4%);GO:0006355 (3%),L-proline biosynthetic process (5%);tRNA modification (4%);regulation of transcription, DNA-templated (3%),IPR027417 (7%);IPR011990 (5%);IPR014729 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Tetratricopeptide-like helical domain superfamily (5%);Rossmann-like alpha/beta/alpha sandwich fold (5%),,,,,,,,,,
NPLLLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.6 (33%);1.1.1.42 (27%);5.4.2.10 (20%),Glycerol dehydrogenase (33%);Isocitrate dehydrogenase (NADP(+)) (27%);Phosphoglucosamine mutase (20%),GO:0016021 (13%);GO:0005737 (5%);GO:0009325 (3%),integral component of membrane (13%);cytoplasm (5%);nitrate reductase complex (3%),GO:0046872 (25%);GO:0000287 (15%);GO:0008233 (15%),metal ion binding (25%);magnesium ion binding (15%);peptidase activity (15%),GO:0006099 (10%);GO:0005975 (8%);GO:0006102 (8%),tricarboxylic acid cycle (10%);carbohydrate metabolic process (8%);isocitrate metabolic process (8%),IPR021109 (44%);IPR001670 (10%);IPR016205 (10%),Aspartic peptidase domain superfamily (44%);Alcohol dehydrogenase, iron-type/glycerol dehydrogenase GldA (10%);Glycerol dehydrogenase (10%),,,,,,,,,,
EMFFGHMDPYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLPVSSHVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMGQTGAGNNASVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANGGVYYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELSDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.25 (14%);3.2.2.27 (4%);6.1.1.16 (4%),Mitogen-activated protein kinase kinase kinase (14%);Uracil-DNA glycosylase (4%);Cysteine--tRNA ligase (4%),GO:0016021 (22%);GO:0005737 (11%);GO:0005886 (3%),integral component of membrane (22%);cytoplasm (11%);plasma membrane (3%),GO:0005524 (23%);GO:0003677 (11%);GO:0046872 (4%),ATP binding (23%);DNA binding (11%);metal ion binding (4%),GO:0046777 (4%);GO:0007064 (3%);GO:0006355 (2%),protein autophosphorylation (4%);mitotic sister chromatid cohesion (3%);regulation of transcription, DNA-templated (2%),IPR027417 (12%);IPR011009 (4%);IPR000719 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);Protein kinase-like domain superfamily (4%);Protein kinase domain (4%),,,,,,,,,,
EVMMMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTEPVSYNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVENLVDPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLDEEAWK,Methylorubrum extorquens,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Methylobacteriaceae,,,,Methylorubrum,,,,Methylorubrum extorquens,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR029030 (100%),Caspase-like domain superfamily (100%),,,,,,,,,,,
TDGTVMDGYLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNVLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (29%);2.4.2.- (19%);2.7.7.41 (14%),Peptidylprolyl isomerase (29%);Pentosyltransferases (19%);Phosphatidate cytidylyltransferase (14%),GO:0016021 (42%);GO:0005634 (3%);GO:0005737 (3%),integral component of membrane (42%);nucleus (3%);cytoplasm (3%),GO:0003700 (26%);GO:0043565 (26%);GO:0005524 (10%),DNA-binding transcription factor activity (26%);sequence-specific DNA binding (26%);ATP binding (10%),GO:0006310 (2%);GO:0007029 (2%);GO:0016024 (2%),DNA recombination (2%);endoplasmic reticulum organization (2%);CDP-diacylglycerol biosynthetic process (2%),IPR009057 (25%);IPR018060 (25%);IPR032687 (25%),Homeobox-like domain superfamily (25%);DNA binding HTH domain, AraC-type (25%);HTH-type transcriptional regulator AraC-type, N-terminal (25%),,,,,,,,,
NVNVTGLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVAHLYK,Candidatus Methanoperedenaceae,Archaea,,,,Euryarchaeota,,,Methanomicrobia,,,,Methanosarcinales,,,,,Candidatus Methanoperedenaceae,,,,,,,,,,,,,,,,GO:0003676 (100%);GO:0005524 (100%),nucleic acid binding (100%);ATP binding (100%),,,IPR001650 (100%);IPR006474 (100%);IPR006483 (100%),Helicase, C-terminal (100%);Helicase Cas3, CRISPR-associated, core (100%);CRISPR-associated  Cas3-type HD domain (100%),,,,,,,,
TVLSGGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.11 (76%);2.7.13.3 (10%);2.7.1.35 (3%),Pectinesterase (76%);Histidine kinase (10%);Pyridoxal kinase (3%),GO:0016021 (53%);GO:0005576 (7%);GO:0005618 (7%),integral component of membrane (53%);extracellular region (7%);cell wall (7%),GO:0030599 (49%);GO:0045330 (49%);GO:0004857 (31%),pectinesterase activity (49%);aspartyl esterase activity (49%);enzyme inhibitor activity (31%),GO:0045490 (48%);GO:0042545 (47%);GO:0007155 (7%),pectin catabolic process (48%);cell wall modification (47%);cell adhesion (7%),IPR000070 (42%);IPR011050 (42%);IPR012334 (42%),Pectinesterase, catalytic (42%);Pectin lyase fold/virulence factor (42%);Pectin lyase fold (42%),,,,,,,,,,
CLYLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (50%);1.3.1.98 (25%);3.2.1.2 (25%),Methyltransferases (50%);UDP-N-acetylmuramate dehydrogenase (25%);Beta-amylase (25%),GO:0016021 (42%);GO:0005634 (12%);GO:0005576 (4%),integral component of membrane (42%);nucleus (12%);extracellular region (4%),GO:0016757 (23%);GO:0005524 (12%);GO:0003677 (8%),transferase activity, transferring glycosyl groups (23%);ATP binding (12%);DNA binding (8%),GO:0006486 (23%);GO:0045892 (12%);GO:0000272 (4%),protein glycosylation (23%);negative regulation of transcription, DNA-templated (12%);polysaccharide catabolic process (4%),IPR022751 (20%);IPR029044 (20%);IPR001611 (10%),Alpha-mannosyltransferase (20%);Nucleotide-diphospho-sugar transferases (20%);Leucine-rich repeat (10%),,,,,,,,,
FMPAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.6.6 (22%);3.1.1.- (14%);2.3.1.179 (10%),Choline-sulfatase (22%);Carboxylic ester hydrolases (14%);Beta-ketoacyl-[acyl-carrier-protein] synthase II (10%),GO:0016021 (62%);GO:0005886 (3%);GO:0005737 (1%),integral component of membrane (62%);plasma membrane (3%);cytoplasm (1%),GO:0015209 (43%);GO:0003677 (7%);GO:0016787 (5%),cytosine transmembrane transporter activity (43%);DNA binding (7%);hydrolase activity (5%),GO:0055085 (7%);GO:0000160 (1%);GO:0015969 (1%),transmembrane transport (7%);phosphorelay signal transduction system (1%);guanosine tetraphosphate metabolic process (1%),IPR038271 (41%);IPR030191 (41%);IPR036291 (4%),Purine-cytosine permease superfamily (41%);Cytosine permease (41%);NAD(P)-binding domain superfamily (4%),,,,,,,,,,,
TSGHVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DQNQNLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YWLPMAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNEVLTNK,Firmicutes,Bacteria,,,,Firmicutes,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008236 (100%),serine-type peptidase activity (100%),,,IPR001375 (50%);IPR029058 (50%);IPR032830 (50%),Peptidase S9, prolyl oligopeptidase, catalytic domain (50%);Alpha/Beta hydrolase fold (50%);Helicase XPB/Ssl2, N-terminal domain (50%),,,,,,,,
TLNEWEMVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.16 (13%);2.7.7.7 (9%);2.7.7.4 (5%),Cysteine--tRNA ligase (13%);DNA-directed DNA polymerase (9%);Sulfate adenylyltransferase (5%),GO:0019028 (15%);GO:0016021 (15%);GO:0005737 (13%),viral capsid (15%);integral component of membrane (15%);cytoplasm (13%),GO:0005524 (22%);GO:0005198 (16%);GO:0003677 (11%),ATP binding (22%);structural molecule activity (16%);DNA binding (11%),GO:0000160 (4%);GO:0006935 (4%);GO:0006423 (3%),phosphorelay signal transduction system (4%);chemotaxis (4%);cysteinyl-tRNA aminoacylation (3%),IPR003138 (14%);IPR036988 (14%);IPR029053 (14%),Picornavirus coat protein VP4 (14%);Picornavirus coat protein VP4 superfamily (14%);Viral coat protein subunit (14%),,,,,,,,,,,
TDGAAVDLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAGELN,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (98%);GO:0003700 (92%);GO:0016491 (2%),DNA binding (98%);DNA-binding transcription factor activity (92%);oxidoreductase activity (2%),,,IPR000847 (98%);IPR005119 (98%);IPR036388 (98%),Transcription regulator HTH, LysR (98%);LysR, substrate-binding (98%);Winged helix-like DNA-binding domain superfamily (98%),,,,,,,,,
NPNANEAVDAMANVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTEGPSAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAMLMFHQPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEEHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.7 (69%);2.7.7.7 (7%);3.2.1.8 (6%),1-deoxy-D-xylulose-5-phosphate synthase (69%);DNA-directed DNA polymerase (7%);Endo-1,4-beta-xylanase (6%),GO:0016021 (14%);GO:0005737 (9%);GO:0005856 (1%),integral component of membrane (14%);cytoplasm (9%);cytoskeleton (1%),GO:0008661 (32%);GO:0000287 (32%);GO:0030976 (31%),1-deoxy-D-xylulose-5-phosphate synthase activity (32%);magnesium ion binding (32%);thiamine pyrophosphate binding (31%),GO:0016114 (32%);GO:0009228 (32%);GO:0052865 (32%),terpenoid biosynthetic process (32%);thiamine biosynthetic process (32%);1-deoxy-D-xylulose 5-phosphate biosynthetic process (32%),IPR005475 (28%);IPR005477 (28%);IPR009014 (28%),Transketolase-like, pyrimidine-binding domain (28%);Deoxyxylulose-5-phosphate synthase (28%);Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II (28%),,,,,,,,,
SFLAFPR,Pedobacter cryoconitis,Bacteria,,,,Bacteroidetes,,,Sphingobacteriia,,,,Sphingobacteriales,,,,,Sphingobacteriaceae,,,,Pedobacter,,,,Pedobacter cryoconitis,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR008979 (100%);IPR025060 (100%),Galactose-binding-like domain superfamily (100%);Protein of unknown function DUF3999 (100%),,,,,,,,,,,
YMMVELLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNYFWPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLAN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.60 (25%);1.2.1.11 (17%);3.1.3.5 (17%),2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (25%);Aspartate-semialdehyde dehydrogenase (17%);5'-nucleotidase (17%),GO:0016021 (26%);GO:0005576 (12%);GO:0005743 (5%),integral component of membrane (26%);extracellular region (12%);mitochondrial inner membrane (5%),GO:0016787 (13%);GO:0004252 (12%);GO:0046872 (7%),hydrolase activity (13%);serine-type endopeptidase activity (12%);metal ion binding (7%),GO:0006122 (5%);GO:0009089 (5%);GO:0019877 (5%),mitochondrial electron transport, ubiquinol to cytochrome c (5%);lysine biosynthetic process via diaminopimelate (5%);diaminopimelate biosynthetic process (5%),IPR023214 (13%);IPR026444 (13%);IPR036412 (13%),HAD superfamily (13%);Secretion system C-terminal sorting domain (13%);HAD-like superfamily (13%),,,,,,,,,,
VEYTCSGGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLTMNTDK,Clostridiales,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,,,,,,,,,,,,,1.1.1.133 (100%),dTDP-4-dehydrorhamnose reductase (100%),,,GO:0008831 (100%),dTDP-4-dehydrorhamnose reductase activity (100%),GO:0019305 (100%),dTDP-rhamnose biosynthetic process (100%),IPR005913 (100%);IPR029903 (100%);IPR036291 (100%),dTDP-4-dehydrorhamnose reductase family (100%);RmlD-like substrate binding domain (100%);NAD(P)-binding domain superfamily (100%),,,,,,,,,,,
NLAELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (52%);3.6.1.9 (9%);5.3.3.2 (6%),Acting on ATP; involved in cellular and subcellular movement (52%);Nucleotide diphosphatase (9%);Isopentenyl-diphosphate Delta-isomerase (6%),GO:0005737 (29%);GO:0016021 (13%);GO:0019867 (9%),cytoplasm (29%);integral component of membrane (13%);outer membrane (9%),GO:0005524 (27%);GO:0003677 (24%);GO:0016787 (16%),ATP binding (27%);DNA binding (24%);hydrolase activity (16%),GO:0006355 (16%);GO:0000716 (15%);GO:0006310 (13%),regulation of transcription, DNA-templated (16%);transcription-coupled nucleotide-excision repair, DNA damage recognition (15%);DNA recombination (13%),IPR027417 (19%);IPR014001 (14%);IPR001650 (14%),P-loop containing nucleoside triphosphate hydrolase (19%);Helicase superfamily 1/2, ATP-binding domain (14%);Helicase, C-terminal (14%),,,,,,,
MGELEATAPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LADLLNEAMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FADELHSDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFGHFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNLDTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.8 (71%);2.-.-.- (8%);3.6.4.12 (7%),CDP-diacylglycerol--serine O-phosphatidyltransferase (71%);Transferases (8%);DNA helicase (7%),GO:0016021 (59%);GO:0016020 (1%);GO:0009279 (0%),integral component of membrane (59%);membrane (1%);cell outer membrane (0%),GO:0016780 (45%);GO:0016757 (32%);GO:0003882 (8%),phosphotransferase activity, for other substituted phosphate groups (45%);transferase activity, transferring glycosyl groups (32%);CDP-diacylglycerol-serine O-phosphatidyltransferase activity (8%),GO:0008654 (52%);GO:0009103 (32%);GO:0006281 (1%),phospholipid biosynthetic process (52%);lipopolysaccharide biosynthetic process (32%);DNA repair (1%),IPR000462 (56%);IPR002201 (32%);IPR011910 (32%),CDP-alcohol phosphatidyltransferase (56%);Glycosyl transferase, family 9 (32%);ADP-heptose--LPS heptosyltransferase 2 (32%),,,,,,,,
TVFVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.3 (18%);4.2.2.0 (16%);4.3.99.3 (15%),Phosphoglycerate kinase (18%); (16%);7-carboxy-7-deazaguanine synthase (15%),GO:0016021 (28%);GO:0005737 (5%);GO:0043190 (4%),integral component of membrane (28%);cytoplasm (5%);ATP-binding cassette (ABC) transporter complex (4%),GO:0005524 (11%);GO:0016787 (9%);GO:0003677 (7%),ATP binding (11%);hydrolase activity (9%);DNA binding (7%),GO:0016042 (8%);GO:0055085 (5%);GO:0006096 (3%),lipid catabolic process (8%);transmembrane transport (5%);glycolytic process (3%),IPR016035 (7%);IPR002641 (7%);IPR027417 (7%),Acyl transferase/acyl hydrolase/lysophospholipase (7%);Patatin-like phospholipase domain (7%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,,
SSANPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.25 (88%);2.7.11.1 (3%);3.1.-.- (3%),(d)CMP kinase (88%);Non-specific serine/threonine protein kinase (3%);Acting on ester bonds (3%),GO:0005737 (20%);GO:0016021 (10%);GO:0019867 (10%),cytoplasm (20%);integral component of membrane (10%);outer membrane (10%),GO:0003677 (35%);GO:0005524 (19%);GO:0004127 (16%),DNA binding (35%);ATP binding (19%);cytidylate kinase activity (16%),GO:0006220 (16%);GO:0006614 (4%);GO:0005975 (2%),pyrimidine nucleotide metabolic process (16%);SRP-dependent cotranslational protein targeting to membrane (4%);carbohydrate metabolic process (2%),IPR009091 (40%);IPR000408 (39%);IPR017956 (23%),Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II (40%);Regulator of chromosome condensation, RCC1 (39%);AT hook, DNA-binding motif (23%),,,,,,,,,
TAGYMCTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLNFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.19 (40%);2.1.1.148 (20%);2.1.2.11 (20%),Polynucleotide adenylyltransferase (40%);Thymidylate synthase (FAD) (20%);3-methyl-2-oxobutanoate hydroxymethyltransferase (20%),GO:0016021 (62%);GO:0005737 (10%);GO:0043231 (5%),integral component of membrane (62%);cytoplasm (10%);intracellular membrane-bounded organelle (5%),GO:0005524 (19%);GO:0003723 (10%);GO:0004652 (10%),ATP binding (19%);RNA binding (10%);polynucleotide adenylyltransferase activity (10%),GO:0007165 (19%);GO:0006378 (10%);GO:0032259 (10%),signal transduction (19%);mRNA polyadenylation (10%);methylation (10%),IPR004089 (23%);IPR029151 (18%);IPR033479 (18%),Methyl-accepting chemotaxis protein (MCP) signalling domain (23%);Periplasmic sensor-like domain superfamily (18%);Double Cache domain 1 (18%),,,,,,,,,,,
ENNQQDGYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LANPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (12%);4.1.1.4 (12%);5.4.99.- (11%),Non-specific serine/threonine protein kinase (12%);Acetoacetate decarboxylase (12%);Transferring other groups (11%),GO:0005737 (17%);GO:0016021 (16%);GO:0005886 (4%),cytoplasm (17%);integral component of membrane (16%);plasma membrane (4%),GO:0005524 (29%);GO:0003723 (18%);GO:0000287 (16%),ATP binding (29%);RNA binding (18%);magnesium ion binding (16%),GO:0006432 (14%);GO:0007064 (4%);GO:0055085 (4%),phenylalanyl-tRNA aminoacylation (14%);mitotic sister chromatid cohesion (4%);transmembrane transport (4%),IPR041616 (12%);IPR009061 (12%);IPR005147 (12%),Phenylalanyl tRNA synthetase beta chain, core domain (12%);Putative DNA-binding domain superfamily (12%);tRNA synthetase, B5-domain (12%),,,,,,,,,
TYQQFEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QELLFYMMLGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.51 (11%);1.2.4.2 (10%);7.1.2.2 (10%),1-acylglycerol-3-phosphate O-acyltransferase (11%);Oxoglutarate dehydrogenase (succinyl-transferring) (10%);H(+)-transporting two-sector ATPase (10%),GO:0016021 (21%);GO:0005840 (11%);GO:0005737 (6%),integral component of membrane (21%);ribosome (11%);cytoplasm (6%),GO:0003735 (11%);GO:0005524 (8%);GO:0016746 (8%),structural constituent of ribosome (11%);ATP binding (8%);transferase activity, transferring acyl groups (8%),GO:0006412 (12%);GO:0006614 (4%);GO:0016197 (2%),translation (12%);SRP-dependent cotranslational protein targeting to membrane (4%);endosomal transport (2%),IPR013823 (10%);IPR014719 (10%);IPR000206 (10%),Ribosomal protein L7/L12, C-terminal (10%);Ribosomal protein L7/L12, C-terminal/adaptor protein ClpS-like (10%);Ribosomal protein L7/L12 (10%),,,,,,,,
EMENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (24%);5.6.2.1 (19%);6.1.1.3 (10%),Acting on ester bonds (24%);DNA topoisomerase (19%);Threonine--tRNA ligase (10%),GO:0016021 (19%);GO:0005737 (7%);GO:0005886 (5%),integral component of membrane (19%);cytoplasm (7%);plasma membrane (5%),GO:0005524 (31%);GO:0043565 (11%);GO:0008134 (9%),ATP binding (31%);sequence-specific DNA binding (11%);transcription factor binding (9%),GO:0000160 (10%);GO:0006355 (10%);GO:0046314 (4%),phosphorelay signal transduction system (10%);regulation of transcription, DNA-templated (10%);phosphocreatine biosynthetic process (4%),IPR027417 (17%);IPR009057 (10%);IPR001789 (9%),P-loop containing nucleoside triphosphate hydrolase (17%);Homeobox-like domain superfamily (10%);Signal transduction response regulator, receiver domain (9%),,,,,,,,,
QNENEDLVEC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VWESR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.3 (19%);2.1.2.9 (18%);2.7.7.7 (13%),Aldose 1-epimerase (19%);Methionyl-tRNA formyltransferase (18%);DNA-directed DNA polymerase (13%),GO:0016021 (34%);GO:0005737 (2%);GO:0005634 (2%),integral component of membrane (34%);cytoplasm (2%);nucleus (2%),GO:0003677 (14%);GO:0016787 (13%);GO:0016491 (11%),DNA binding (14%);hydrolase activity (13%);oxidoreductase activity (11%),GO:0006629 (9%);GO:0006352 (7%);GO:0006260 (3%),lipid metabolic process (9%);DNA-templated transcription, initiation (7%);DNA replication (3%),IPR029058 (14%);IPR006963 (9%);IPR036388 (8%),Alpha/Beta hydrolase fold (14%);Molybdopterin oxidoreductase, 4Fe-4S domain (9%);Winged helix-like DNA-binding domain superfamily (8%),,,,,,,,,
FASVQNK,Catenovulum maritimum,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Alteromonadales,,,,,Alteromonadaceae,,,,Catenovulum,,,,Catenovulum maritimum,,,,,,,,GO:0008767 (100%),UDP-galactopyranose mutase activity (100%),,,IPR004379 (100%);IPR015899 (100%),UDP-galactopyranose mutase (100%);UDP-galactopyranose mutase, C-terminal (100%),,,,,,,,,,
NCMQENDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
METMNNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.25 (100%),4-alpha-glucanotransferase (100%),,,GO:0004134 (87%);GO:0102500 (73%);GO:0003677 (7%),4-alpha-glucanotransferase activity (87%);beta-maltose 4-alpha-glucanotransferase activity (73%);DNA binding (7%),GO:0006310 (7%);GO:0015074 (7%),DNA recombination (7%);DNA integration (7%),IPR003385 (87%);IPR017853 (87%);IPR002104 (7%),Glycoside hydrolase, family 77 (87%);Glycoside hydrolase superfamily (87%);Integrase, catalytic domain (7%),,,,,,,,,
VSETMLGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNFDYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.23 (40%);5.4.99.- (40%);2.7.7.7 (20%),Orotidine-5'-phosphate decarboxylase (40%);Transferring other groups (40%);DNA-directed DNA polymerase (20%),GO:0016021 (16%);GO:0005811 (11%),integral component of membrane (16%);lipid droplet (11%),GO:0003677 (16%);GO:0005524 (16%);GO:0016301 (16%),DNA binding (16%);ATP binding (16%);kinase activity (16%),GO:0006004 (11%);GO:0006207 (11%);GO:0006355 (11%),fucose metabolic process (11%);'de novo' pyrimidine nucleobase biosynthetic process (11%);regulation of transcription, DNA-templated (11%),IPR003018 (14%);IPR029016 (14%);IPR036890 (14%),GAF domain (14%);GAF-like domain superfamily (14%);Histidine kinase/HSP90-like ATPase superfamily (14%),,,,,,,,,,
MCGANAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTENQNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (33%);GO:0008278 (33%);GO:0016021 (33%),nucleus (33%);cohesin complex (33%);integral component of membrane (33%),GO:0005524 (50%);GO:0003682 (33%);GO:0046982 (33%),ATP binding (50%);chromatin binding (33%);protein heterodimerization activity (33%),GO:0007064 (33%);GO:0016485 (17%);GO:0035556 (17%),mitotic sister chromatid cohesion (33%);protein processing (17%);intracellular signal transduction (17%),IPR003395 (33%);IPR010935 (33%);IPR024704 (33%),RecF/RecN/SMC, N-terminal (33%);SMCs flexible hinge (33%);Structural maintenance of chromosomes protein (33%),,,,,,,,,,
SMGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.21.4.2 (22%);1.21.4.3 (21%);1.4.4.2 (14%),Glycine reductase (22%);Sarcosine reductase (21%);Glycine dehydrogenase (aminomethyl-transferring) (14%),GO:0016021 (24%);GO:0009376 (5%);GO:0005634 (4%),integral component of membrane (24%);HslUV protease complex (5%);nucleus (4%),GO:0005524 (22%);GO:0046872 (11%);GO:0003677 (8%),ATP binding (22%);metal ion binding (11%);DNA binding (8%),GO:0006633 (7%);GO:0006355 (4%);GO:0043335 (4%),fatty acid biosynthetic process (7%);regulation of transcription, DNA-templated (4%);protein unfolding (4%),IPR027417 (20%);IPR036691 (15%);IPR005135 (11%),P-loop containing nucleoside triphosphate hydrolase (20%);Endonuclease/exonuclease/phosphatase superfamily (15%);Endonuclease/exonuclease/phosphatase (11%),,,,,,,,,,
MELEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.0 (40%);2.1.1.72 (10%);2.3.2.27 (10%), (40%);Site-specific DNA-methyltransferase (adenine-specific) (10%);RING-type E3 ubiquitin transferase (10%),GO:0016021 (22%);GO:0005634 (8%);GO:0005737 (5%),integral component of membrane (22%);nucleus (8%);cytoplasm (5%),GO:0003677 (12%);GO:0005524 (12%);GO:0016787 (8%),DNA binding (12%);ATP binding (12%);hydrolase activity (8%),GO:0009691 (5%);GO:0006306 (3%);GO:0030163 (3%),cytokinin biosynthetic process (5%);DNA methylation (3%);protein catabolic process (3%),IPR027417 (10%);IPR022221 (6%);IPR000504 (4%),P-loop containing nucleoside triphosphate hydrolase (10%);Type III restriction/modification enzyme methylation subunit (6%);RNA recognition motif domain (4%),,,,,,,,,,,
VYMFVK,Candidatus Micrarchaeota,Archaea,,,,Candidatus Micrarchaeota,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016491 (100%),oxidoreductase activity (100%),,,IPR008255 (100%);IPR023753 (100%);IPR036188 (100%),Pyridine nucleotide-disulphide oxidoreductase, class-II, active site (100%);FAD/NAD(P)-binding domain (100%);FAD/NAD(P)-binding domain superfamily (100%),,,,,,,,,
QNELEAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MWMLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0003677 (33%),DNA binding (33%),,,IPR004878 (33%);IPR011031 (33%);IPR023155 (33%),Otopetrin (33%);Multihaem cytochrome (33%);Cytochrome c-552/4 (33%),,,,,,,,,,,
TNEEPMVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNYMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.2 (50%);5.1.1.7 (50%),Non-specific protein-tyrosine kinase (50%);Diaminopimelate epimerase (50%),GO:0016021 (29%);GO:0005737 (7%),integral component of membrane (29%);cytoplasm (7%),GO:0003824 (21%);GO:0030976 (21%);GO:0005085 (14%),catalytic activity (21%);thiamine pyrophosphate binding (21%);guanyl-nucleotide exchange factor activity (14%),GO:0006281 (7%);GO:0006629 (7%);GO:0009089 (7%),DNA repair (7%);lipid metabolic process (7%);lysine biosynthetic process via diaminopimelate (7%),IPR011766 (25%);IPR029061 (25%);IPR000219 (17%),Thiamine pyrophosphate enzyme, C-terminal TPP-binding (25%);Thiamin diphosphate-binding fold (25%);Dbl homology (DH) domain (17%),,,,,,,,,,
DASNQLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%);GO:0030915 (33%),integral component of membrane (67%);Smc5-Smc6 complex (33%),GO:0000155 (33%);GO:0005524 (33%),phosphorelay sensor kinase activity (33%);ATP binding (33%),GO:0000724 (33%);GO:0007062 (33%),double-strand break repair via homologous recombination (33%);sister chromatid cohesion (33%),IPR007460 (33%);IPR038573 (33%);IPR001107 (11%),Ribonuclease toxin, BrnT, of type II toxin-antitoxin system (33%);Ribonuclease toxin BrnT superfamily (33%);Band 7 domain (11%),,,,,,,,,
EMVWPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (100%),cytoplasm (100%),GO:0003688 (100%);GO:0005524 (100%),DNA replication origin binding (100%);ATP binding (100%),GO:0006270 (100%);GO:0006275 (100%),DNA replication initiation (100%);regulation of DNA replication (100%),IPR001957 (50%);IPR003593 (50%);IPR010921 (50%),Chromosomal replication control, initiator DnaA (50%);AAA+ ATPase domain (50%);Trp repressor/replication initiator (50%),,,,,,,,,,
FLLLVFGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELCWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.133 (35%);2.7.7.7 (21%);2.7.7.60 (8%),dTDP-4-dehydrorhamnose reductase (35%);DNA-directed DNA polymerase (21%);2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (8%),GO:0016021 (19%);GO:0030286 (6%);GO:0005737 (5%),integral component of membrane (19%);dynein complex (6%);cytoplasm (5%),GO:0003676 (15%);GO:0005524 (15%);GO:0008831 (8%),nucleic acid binding (15%);ATP binding (15%);dTDP-4-dehydrorhamnose reductase activity (8%),GO:0006397 (12%);GO:0019305 (8%);GO:0015969 (7%),mRNA processing (12%);dTDP-rhamnose biosynthetic process (8%);guanosine tetraphosphate metabolic process (7%),IPR026847 (11%);IPR009543 (11%);IPR027417 (11%),Vacuolar protein sorting-associated protein 13 (11%);Vacuolar protein sorting-associated protein 13, SHR-binding domain (11%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,,,
MLNNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.27 (52%);2.1.1.63 (22%);1.1.1.94 (8%),Uracil-DNA glycosylase (52%);Methylated-DNA--[protein]-cysteine S-methyltransferase (22%);Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (8%),GO:0005737 (28%);GO:0016021 (16%);GO:0005773 (2%),cytoplasm (28%);integral component of membrane (16%);vacuole (2%),GO:0003723 (16%);GO:0004844 (15%);GO:0005524 (9%),RNA binding (16%);uracil DNA N-glycosylase activity (15%);ATP binding (9%),GO:0006284 (16%);GO:0032259 (7%);GO:0006307 (6%),base-excision repair (16%);methylation (7%);DNA dealkylation involved in DNA repair (6%),IPR002043 (13%);IPR005122 (13%);IPR018085 (13%),Uracil-DNA glycosylase family 1 (13%);Uracil-DNA glycosylase-like (13%);Uracil-DNA glycosylase, active site (13%),,,,,,,,,,
TLQGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.1 (32%);1.17.4.1 (10%);2.3.1.47 (5%),Tyrosine--tRNA ligase (32%);Ribonucleoside-diphosphate reductase (10%);8-amino-7-oxononanoate synthase (5%),GO:0005840 (27%);GO:0016021 (15%);GO:0005737 (12%),ribosome (27%);integral component of membrane (15%);cytoplasm (12%),GO:0003735 (24%);GO:0019843 (24%);GO:0005524 (17%),structural constituent of ribosome (24%);rRNA binding (24%);ATP binding (17%),GO:0006412 (25%);GO:0006437 (6%);GO:0006260 (2%),translation (25%);tyrosyl-tRNA aminoacylation (6%);DNA replication (2%),IPR012340 (23%);IPR000266 (23%);IPR019984 (23%),Nucleic acid-binding, OB-fold (23%);Ribosomal protein S17/S11 (23%);30S ribosomal protein S17 (23%),,,,,,,,,,
MDDLPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (75%),integral component of membrane (75%),GO:0003677 (25%);GO:0003700 (25%);GO:0016987 (25%),DNA binding (25%);DNA-binding transcription factor activity (25%);sigma factor activity (25%),GO:0006352 (25%),DNA-templated transcription, initiation (25%),IPR005625 (29%);IPR025711 (29%);IPR000477 (14%),PepSY-associated TM protein (29%);PepSY domain (29%);Reverse transcriptase domain (14%),,,,,,,,,,
TWVGYMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNYSLYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
TYMSGNK,Enterococcus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Lactobacillales,,,,,Enterococcaceae,,,,Enterococcus,,,,,,,,,,,,,,,,IPR024411 (100%),Minor capsid protein, bacteriophage (100%),,,,,,,,,,
MDELVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (13%);6.1.1.3 (13%);6.1.1.19 (10%),DNA helicase (13%);Threonine--tRNA ligase (13%);Arginine--tRNA ligase (10%),GO:0016021 (21%);GO:0005737 (17%);GO:0043190 (4%),integral component of membrane (21%);cytoplasm (17%);ATP-binding cassette (ABC) transporter complex (4%),GO:0005524 (19%);GO:0003677 (12%);GO:0046872 (7%),ATP binding (19%);DNA binding (12%);metal ion binding (7%),GO:0005975 (4%);GO:0055085 (4%);GO:0006269 (3%),carbohydrate metabolic process (4%);transmembrane transport (4%);DNA replication, synthesis of RNA primer (3%),IPR021332 (12%);IPR027417 (7%);IPR005009 (5%),Protein of unknown function DUF2944 (12%);P-loop containing nucleoside triphosphate hydrolase (7%);Poxvirus mRNA capping enzyme, small subunit (5%),,,,,,,,,
QDEHFSEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVHNLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.31 (100%),3-hydroxyisobutyrate dehydrogenase (100%),GO:0005887 (9%),integral component of plasma membrane (9%),GO:0003743 (27%);GO:0045301 (27%);GO:0050661 (27%),translation initiation factor activity (27%);tRNA-(2-methylthio-N-6-(cis-hydroxy)isopentenyl adenosine)-hydroxylase activity (27%);NADP binding (27%),GO:0006574 (18%);GO:0006313 (9%);GO:0007034 (9%),valine catabolic process (18%);transposition, DNA-mediated (9%);vacuolar transport (9%),IPR003029 (23%);IPR006115 (23%);IPR009078 (23%),S1 domain (23%);6-phosphogluconate dehydrogenase, NADP-binding (23%);Ferritin-like superfamily (23%),,,,,,,,,
MLNVLPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDSQYGGNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELNEMALGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLMDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (27%);GO:0005634 (13%);GO:0005737 (13%),integral component of membrane (27%);nucleus (13%);cytoplasm (13%),GO:0005524 (27%);GO:0000287 (13%);GO:0003677 (13%),ATP binding (27%);magnesium ion binding (13%);DNA binding (13%),GO:0002098 (7%);GO:0006351 (7%);GO:0006352 (7%),tRNA wobble uridine modification (7%);transcription, DNA-templated (7%);DNA-templated transcription, initiation (7%),IPR000399 (11%);IPR003594 (11%);IPR011766 (11%),TPP-binding enzyme, conserved site (11%);Histidine kinase/HSP90-like ATPase (11%);Thiamine pyrophosphate enzyme, C-terminal TPP-binding (11%),,,,,,,
TLNMPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003676 (67%);GO:0003677 (33%);GO:0003678 (33%),nucleic acid binding (67%);DNA binding (33%);DNA helicase activity (33%),GO:0015074 (67%);GO:0032196 (67%),DNA integration (67%);transposition (67%),IPR001345 (40%);IPR001584 (40%);IPR012337 (40%),Phosphoglycerate/bisphosphoglycerate mutase, active site (40%);Integrase, catalytic core (40%);Ribonuclease H-like superfamily (40%),,,,,,,,,
WWFMGANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTMEHLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVSKPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (75%),integral component of membrane (75%),GO:0003677 (25%),DNA binding (25%),,,IPR036514 (33%);IPR000477 (17%);IPR001434 (17%),SGNH hydrolase superfamily (33%);Reverse transcriptase domain (17%);Domain of unknown function DUF11 (17%),,,,,,,,,,,
NPLDTHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016740 (50%),transferase activity (50%),,,IPR027417 (100%),P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,,,
GNNVAVQVAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVAESPAK,Candidatus Thorarchaeota archaeon,Archaea,,,,Candidatus Thorarchaeota,,,,,,,,,,,,,,,,,,,,Candidatus Thorarchaeota archaeon,,,,,,,,GO:0008987 (100%);GO:0051539 (100%),quinolinate synthetase A activity (100%);4 iron, 4 sulfur cluster binding (100%),GO:0009435 (100%),NAD biosynthetic process (100%),IPR003473 (100%);IPR036094 (100%),Quinolinate synthetase A (100%);Quinolinate synthetase A superfamily (100%),,,,,,,,,,
NLPSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.49 (35%);1.9.3.1 (15%);5.4.99.- (10%),Glucose-6-phosphate dehydrogenase (NADP(+)) (35%);Cytochrome-c oxidase (15%);Transferring other groups (10%),GO:0016021 (22%);GO:0005840 (2%);GO:0005743 (1%),integral component of membrane (22%);ribosome (2%);mitochondrial inner membrane (1%),GO:0003677 (9%);GO:0016740 (7%);GO:0008168 (7%),DNA binding (9%);transferase activity (7%);methyltransferase activity (7%),GO:0006355 (18%);GO:0032259 (7%);GO:0006417 (5%),regulation of transcription, DNA-templated (18%);methylation (7%);regulation of translation (5%),IPR016024 (18%);IPR022031 (14%);IPR000637 (13%),Armadillo-type fold (18%);Telomere-associated protein Rif1, N-terminal (14%);HMG-I/HMG-Y, DNA-binding, conserved site (13%),,,,,,,
CFHAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.161 (24%);2.7.2.11 (12%);2.7.7.40 (12%),CTP-dependent riboflavin kinase (24%);Glutamate 5-kinase (12%);D-ribitol-5-phosphate cytidylyltransferase (12%),GO:0005634 (9%);GO:0016021 (9%);GO:0005737 (6%),nucleus (9%);integral component of membrane (9%);cytoplasm (6%),GO:0016491 (26%);GO:0050662 (24%);GO:0003677 (15%),oxidoreductase activity (26%);coenzyme binding (24%);DNA binding (15%),GO:0009231 (15%);GO:0006351 (9%);GO:0006979 (9%),riboflavin biosynthetic process (15%);transcription, DNA-templated (9%);response to oxidative stress (9%),IPR036291 (23%);IPR013131 (22%);IPR008927 (20%),NAD(P)-binding domain superfamily (23%);Mannitol dehydrogenase, N-terminal (22%);6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily (20%),,,,,,,,
AELVGVDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EWLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.10 (24%);4.1.1.37 (11%);1.1.1.193 (10%),Methionine--tRNA ligase (24%);Uroporphyrinogen decarboxylase (11%);5-amino-6-(5-phosphoribosylamino)uracil reductase (10%),GO:0016021 (28%);GO:0005737 (8%);GO:0016020 (6%),integral component of membrane (28%);cytoplasm (8%);membrane (6%),GO:0046872 (23%);GO:0005524 (17%);GO:0003677 (15%),metal ion binding (23%);ATP binding (17%);DNA binding (15%),GO:0006352 (8%);GO:0006431 (5%);GO:0019058 (4%),DNA-templated transcription, initiation (8%);methionyl-tRNA aminoacylation (5%);viral life cycle (4%),IPR009056 (11%);IPR036909 (11%);IPR011031 (10%),Cytochrome c-like domain (11%);Cytochrome c-like domain superfamily (11%);Multihaem cytochrome (10%),,,,,,,,,,
EVSLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.176 (33%);2.1.2.2 (33%);5.4.99.- (33%),16S rRNA (cytosine(967)-C(5))-methyltransferase (33%);Phosphoribosylglycinamide formyltransferase (33%);Transferring other groups (33%),GO:0016021 (31%);GO:0005886 (10%);GO:0005737 (7%),integral component of membrane (31%);plasma membrane (10%);cytoplasm (7%),GO:0008641 (17%);GO:0003677 (14%);GO:0003887 (14%),ubiquitin-like modifier activating enzyme activity (17%);DNA binding (14%);DNA-directed DNA polymerase activity (14%),GO:0006260 (14%);GO:0055085 (10%);GO:0006310 (7%),DNA replication (14%);transmembrane transport (10%);DNA recombination (7%),IPR000594 (13%);IPR035985 (13%);IPR002792 (11%),THIF-type NAD/FAD binding fold (13%);Ubiquitin-activating enzyme (13%);TRAM domain (11%),,,,,,,,,,,
WEQENQDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFKPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.2 (85%);2.4.1.18 (7%);2.7.11.1 (7%),Oxoglutarate dehydrogenase (succinyl-transferring) (85%);1,4-alpha-glucan branching enzyme (7%);Non-specific serine/threonine protein kinase (7%),GO:0016021 (10%);GO:0005634 (1%);GO:0005739 (1%),integral component of membrane (10%);nucleus (1%);mitochondrion (1%),GO:0004591 (62%);GO:0030976 (57%);GO:0008484 (8%),oxoglutarate dehydrogenase (succinyl-transferring) activity (62%);thiamine pyrophosphate binding (57%);sulfuric ester hydrolase activity (8%),GO:0006099 (57%);GO:0005978 (3%);GO:0006304 (1%),tricarboxylic acid cycle (57%);glycogen biosynthetic process (3%);DNA modification (1%),IPR005475 (59%);IPR011603 (59%);IPR029061 (59%),Transketolase-like, pyrimidine-binding domain (59%);2-oxoglutarate dehydrogenase E1 component (59%);Thiamin diphosphate-binding fold (59%),,,,,,,,,
DDVGGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000932 (17%);GO:0005634 (17%);GO:0005681 (17%),P-body (17%);nucleus (17%);spliceosomal complex (17%),GO:0004674 (33%);GO:0005524 (33%);GO:0003723 (17%),protein serine/threonine kinase activity (33%);ATP binding (33%);RNA binding (17%),GO:0000387 (17%);GO:0000956 (17%);GO:0006396 (17%),spliceosomal snRNP assembly (17%);nuclear-transcribed mRNA catabolic process (17%);RNA processing (17%),IPR000719 (29%);IPR008271 (29%);IPR011009 (29%),Protein kinase domain (29%);Serine/threonine-protein kinase, active site (29%);Protein kinase-like domain superfamily (29%),,,,,,,,,,
GVMYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (21%);1.4.3.- (10%);2.7.7.6 (10%),Peptidylprolyl isomerase (21%);With oxygen as acceptor (10%);DNA-directed RNA polymerase (10%),GO:0016021 (26%);GO:0005840 (15%);GO:0005737 (10%),integral component of membrane (26%);ribosome (15%);cytoplasm (10%),GO:0008270 (14%);GO:0046872 (14%);GO:0003735 (13%),zinc ion binding (14%);metal ion binding (14%);structural constituent of ribosome (13%),GO:0006412 (14%);GO:0000103 (8%);GO:0055085 (7%),translation (14%);sulfate assimilation (8%);transmembrane transport (7%),IPR000873 (12%);IPR020845 (12%);IPR042099 (12%),AMP-dependent synthetase/ligase (12%);AMP-binding, conserved site (12%);AMP-dependent synthetase-like superfamily (12%),,,,,,,,,,
MLQAVHK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.9.1 (100%),Pyruvate, phosphate dikinase (100%),GO:0016021 (20%),integral component of membrane (20%),GO:0050242 (100%);GO:0016301 (80%);GO:0005524 (60%),pyruvate, phosphate dikinase activity (100%);kinase activity (80%);ATP binding (60%),GO:0006090 (100%);GO:0016310 (20%),pyruvate metabolic process (100%);phosphorylation (20%),IPR000121 (100%);IPR010121 (100%);IPR015813 (100%),PEP-utilising enzyme, C-terminal (100%);Pyruvate, phosphate dikinase (100%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (100%),,,,,,,
TQTEMCPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLAAPASNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLDVHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (25%);5.3.1.13 (25%);2.4.99.16 (13%),DNA helicase (25%);Arabinose-5-phosphate isomerase (25%);Starch synthase (maltosyl-transferring) (13%),GO:0016021 (40%);GO:0009279 (19%);GO:0005634 (2%),integral component of membrane (40%);cell outer membrane (19%);nucleus (2%),GO:0003824 (19%);GO:0015344 (19%);GO:0030170 (19%),catalytic activity (19%);siderophore uptake transmembrane transporter activity (19%);pyridoxal phosphate binding (19%),GO:0019346 (19%);GO:0000723 (5%);GO:0005975 (5%),transsulfuration (19%);telomere maintenance (5%);carbohydrate metabolic process (5%),IPR000277 (16%);IPR000531 (16%);IPR010105 (16%),Cys/Met metabolism, pyridoxal phosphate-dependent enzyme (16%);TonB-dependent receptor-like, beta-barrel (16%);TonB-dependent siderophore receptor (16%),,,,,,,,,
TPPMQMSEVSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAAASASM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPGELER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (100%),Molybdopterin molybdotransferase (100%),GO:0016021 (23%);GO:0005886 (16%);GO:0005737 (5%),integral component of membrane (23%);plasma membrane (16%);cytoplasm (5%),GO:0005524 (27%);GO:0004672 (20%);GO:0016874 (11%),ATP binding (27%);protein kinase activity (20%);ligase activity (11%),GO:0055085 (16%);GO:0006468 (4%);GO:0035556 (4%),transmembrane transport (16%);protein phosphorylation (4%);intracellular signal transduction (4%),IPR000719 (21%);IPR008271 (21%);IPR011009 (21%),Protein kinase domain (21%);Serine/threonine-protein kinase, active site (21%);Protein kinase-like domain superfamily (21%),,,,,,,,,,
NFTLLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (71%);GO:0005634 (2%);GO:0005643 (2%),integral component of membrane (71%);nucleus (2%);nuclear pore (2%),GO:0005524 (21%);GO:0016887 (19%);GO:0042626 (19%),ATP binding (21%);ATPase activity (19%);ATPase-coupled transmembrane transporter activity (19%),GO:0005975 (10%);GO:0032007 (5%);GO:0034198 (5%),carbohydrate metabolic process (10%);negative regulation of TOR signaling (5%);cellular response to amino acid starvation (5%),IPR003439 (26%);IPR003593 (26%);IPR017871 (26%),ABC transporter-like (26%);AAA+ ATPase domain (26%);ABC transporter, conserved site (26%),,,,,,,,,,
TALMVGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLKPCVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.1.19 (100%),Threonine ammonia-lyase (100%),,,GO:0004794 (100%),L-threonine ammonia-lyase activity (100%),,,IPR001926 (67%);IPR036052 (67%);IPR001296 (33%),Pyridoxal-phosphate dependent enzyme (67%);Tryptophan synthase beta subunit-like PLP-dependent enzyme (67%);Glycosyl transferase, family 1 (33%),,,,,,,,,,
TCQQDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0062023 (50%),collagen-containing extracellular matrix (50%),GO:0003677 (50%);GO:0003700 (50%);GO:0005509 (50%),DNA binding (50%);DNA-binding transcription factor activity (50%);calcium ion binding (50%),GO:0030198 (50%),extracellular matrix organization (50%),IPR000560 (33%);IPR000742 (33%);IPR000847 (33%),Histidine phosphatase superfamily, clade-2 (33%);EGF-like domain (33%);Transcription regulator HTH, LysR (33%),,,,,,,,,
YHANPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (17%);GO:0043190 (8%),integral component of membrane (17%);ATP-binding cassette (ABC) transporter complex (8%),GO:0008168 (17%);GO:0016158 (17%);GO:0016740 (17%),methyltransferase activity (17%);3-phytase activity (17%);transferase activity (17%),GO:0006281 (17%);GO:0006310 (17%);GO:0055085 (8%),DNA repair (17%);DNA recombination (17%);transmembrane transport (8%),IPR002035 (55%);IPR036465 (55%);IPR013694 (45%),von Willebrand factor, type A (55%);von Willebrand factor A-like domain superfamily (55%);VIT domain (45%),,,,,,,,,,
DNLEALYDSDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.16.4 (67%);3.1.3.16 (33%),Serine-type D-Ala-D-Ala carboxypeptidase (67%);Protein-serine/threonine phosphatase (33%),GO:0016021 (42%);GO:0005634 (3%);GO:0005737 (3%),integral component of membrane (42%);nucleus (3%);cytoplasm (3%),GO:0009002 (17%);GO:0046983 (10%);GO:0003677 (5%),serine-type D-Ala-D-Ala carboxypeptidase activity (17%);protein dimerization activity (10%);DNA binding (5%),GO:0061588 (10%);GO:0007399 (5%);GO:0005975 (3%),calcium activated phospholipid scrambling (10%);nervous system development (5%);carbohydrate metabolic process (3%),IPR018337 (12%);IPR001967 (9%);IPR004919 (9%),Cell wall/choline-binding repeat (12%);Peptidase S11, D-alanyl-D-alanine carboxypeptidase A, N-terminal (9%);Domain of unknown function DUF262 (9%),,,,,,,,,
FVETC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAALPVMTMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLFVSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPSPYNGPNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSNWLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.1 (17%);6.3.1.5 (13%);3.1.-.- (9%),DNA ligase (ATP) (17%);NAD(+) synthase (13%);Acting on ester bonds (9%),GO:0016021 (45%);GO:0005634 (6%);GO:0005737 (5%),integral component of membrane (45%);nucleus (6%);cytoplasm (5%),GO:0005524 (14%);GO:0005516 (14%);GO:0003677 (11%),ATP binding (14%);calmodulin binding (14%);DNA binding (11%),GO:0006952 (19%);GO:0009607 (14%);GO:0006139 (3%),defense response (19%);response to biotic stimulus (14%);nucleobase-containing compound metabolic process (3%),IPR004326 (18%);IPR006059 (7%);IPR027417 (7%),Mlo-related protein (18%);Bacterial extracellular solute-binding protein (7%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,,
ELWWYEDSPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWHMVSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNDWQYEAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WCVVPGDDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLDNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.30 (41%);2.1.1.14 (12%);4.2.2.- (7%),Phenylacetate--CoA ligase (41%);5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (12%);Acting on polysaccharides (7%),GO:0016021 (26%);GO:0005737 (4%);GO:0005634 (3%),integral component of membrane (26%);cytoplasm (4%);nucleus (3%),GO:0047475 (13%);GO:0000166 (12%);GO:0016491 (11%),phenylacetate-CoA ligase activity (13%);nucleotide binding (12%);oxidoreductase activity (11%),GO:0010124 (12%);GO:0032259 (3%);GO:0009086 (3%),phenylacetate catabolic process (12%);methylation (3%);methionine biosynthetic process (3%),IPR042099 (12%);IPR028154 (12%);IPR000873 (12%),AMP-dependent synthetase-like superfamily (12%);AMP-dependent ligase, C-terminal (12%);AMP-dependent synthetase/ligase (12%),,,,,,,,,,
VEAAEAER,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (40%);GO:0016021 (20%),cytoplasm (40%);integral component of membrane (20%),GO:0005524 (40%);GO:0003824 (20%);GO:0015562 (20%),ATP binding (40%);catalytic activity (20%);efflux transmembrane transporter activity (20%),GO:0009408 (40%);GO:0019538 (40%);GO:0042026 (40%),response to heat (40%);protein metabolic process (40%);protein refolding (40%),IPR001270 (40%);IPR003593 (40%);IPR003959 (40%),ClpA/B family (40%);AAA+ ATPase domain (40%);ATPase, AAA-type, core (40%),,,,,,,,,
QNFGWEYHNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPANQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.11 (74%);2.4.2.14 (15%);1.1.1.219 (4%),Phosphoinositide phospholipase C (74%);Amidophosphoribosyltransferase (15%);Dihydroflavanol 4-reductase (4%),GO:0016021 (15%);GO:0005886 (9%);GO:0005623 (4%),integral component of membrane (15%);plasma membrane (9%);cell (4%),GO:0004435 (35%);GO:0050811 (35%);GO:0070679 (35%),phosphatidylinositol phospholipase C activity (35%);GABA receptor binding (35%);inositol 1,4,5 trisphosphate binding (35%),GO:0016042 (35%);GO:0032228 (35%);GO:0035556 (31%),lipid catabolic process (35%);regulation of synaptic transmission, GABAergic (35%);intracellular signal transduction (31%),IPR000008 (25%);IPR000909 (25%);IPR001192 (25%),C2 domain (25%);Phosphatidylinositol-specific phospholipase C, X domain (25%);Phosphoinositide phospholipase C family (25%),,,,,,,
VDNSEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.6 (43%);3.5.4.19 (29%);2.4.1.- (14%),Catalase (43%);Phosphoribosyl-AMP cyclohydrolase (29%);Hexosyltransferases (14%),GO:0016021 (26%);GO:0000139 (1%);GO:0005634 (1%),integral component of membrane (26%);Golgi membrane (1%);nucleus (1%),GO:0008270 (35%);GO:0046983 (31%);GO:0005524 (6%),zinc ion binding (35%);protein dimerization activity (31%);ATP binding (6%),GO:0009116 (33%);GO:0000105 (3%);GO:0006428 (3%),nucleoside metabolic process (33%);histidine biosynthetic process (3%);isoleucyl-tRNA aminoacylation (3%),IPR029057 (29%);IPR000836 (28%);IPR004457 (28%),Phosphoribosyltransferase-like (29%);Phosphoribosyltransferase domain (28%);Zinc finger, ZPR1-type (28%),,,,,,,,,,
LYSRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (100%),Hexosyltransferases (100%),GO:0016021 (14%);GO:0005634 (7%);GO:0005730 (5%),integral component of membrane (14%);nucleus (7%);nucleolus (5%),GO:0016491 (26%);GO:0003677 (10%);GO:0016301 (10%),oxidoreductase activity (26%);DNA binding (10%);kinase activity (10%),GO:0006338 (7%);GO:0000027 (2%);GO:0006355 (2%),chromatin remodeling (7%);ribosomal large subunit assembly (2%);regulation of transcription, DNA-templated (2%),IPR003598 (11%);IPR003599 (11%);IPR007110 (11%),Immunoglobulin subtype 2 (11%);Immunoglobulin subtype (11%);Immunoglobulin-like domain (11%),,,,,,,,,,
QNEEMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.9 (38%);5.4.2.3 (25%);2.3.1.48 (13%),Valine--tRNA ligase (38%);Phosphoacetylglucosamine mutase (25%);Histone acetyltransferase (13%),GO:0016021 (66%);GO:0005634 (8%);GO:0005886 (7%),integral component of membrane (66%);nucleus (8%);plasma membrane (7%),GO:0046873 (39%);GO:0005525 (7%);GO:0015087 (7%),metal ion transmembrane transporter activity (39%);GTP binding (7%);cobalt ion transmembrane transporter activity (7%),GO:0006348 (5%);GO:0005975 (4%);GO:0006897 (4%),chromatin silencing at telomere (5%);carbohydrate metabolic process (4%);endocytosis (4%),IPR002523 (46%);IPR027417 (8%);IPR004488 (7%),Mg2+ transporter protein, CorA-like/Zinc transport protein ZntB (46%);P-loop containing nucleoside triphosphate hydrolase (8%);Magnesium/cobalt transport protein CorA (7%),,,,,,,,,,
LSNANENYEMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLSSPSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (29%);GO:0005634 (14%);GO:0005623 (5%),integral component of membrane (29%);nucleus (14%);cell (5%),GO:0003824 (19%);GO:0003676 (14%);GO:0004553 (14%),catalytic activity (19%);nucleic acid binding (14%);hydrolase activity, hydrolyzing O-glycosyl compounds (14%),GO:0005975 (14%);GO:0006351 (5%);GO:0015031 (5%),carbohydrate metabolic process (14%);transcription, DNA-templated (5%);protein transport (5%),IPR016634 (27%);IPR026881 (27%);IPR040381 (17%),WYL domain protein, s026 type (27%);WYL domain (27%);Uncharacterized protein At4g14450-like (17%),,,,,,,,
FEGKPDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.27 (29%);4.2.1.42 (19%);5.6.2.1 (6%),Glucose-1-phosphate adenylyltransferase (29%);Galactarate dehydratase (19%);DNA topoisomerase (6%),GO:0016021 (13%);GO:0005634 (6%);GO:0005737 (6%),integral component of membrane (13%);nucleus (6%);cytoplasm (6%),GO:0005524 (20%);GO:0008878 (9%);GO:0016740 (9%),ATP binding (20%);glucose-1-phosphate adenylyltransferase activity (9%);transferase activity (9%),GO:0005978 (8%);GO:0046392 (5%);GO:0005975 (2%),glycogen biosynthetic process (8%);galactarate catabolic process (5%);carbohydrate metabolic process (2%),IPR027417 (12%);IPR029044 (9%);IPR005490 (9%),P-loop containing nucleoside triphosphate hydrolase (12%);Nucleotide-diphospho-sugar transferases (9%);L,D-transpeptidase catalytic domain (9%),,,,,,,,,,
WPNQVQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLVLVQGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APKPSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0005524 (67%);GO:0003676 (33%);GO:0004386 (33%),ATP binding (67%);nucleic acid binding (33%);helicase activity (33%),GO:0007165 (33%),signal transduction (33%),IPR000198 (33%);IPR000719 (33%);IPR001650 (33%),Rho GTPase-activating protein domain (33%);Protein kinase domain (33%);Helicase, C-terminal (33%),,,,,,,,,,
SLVFHYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003824 (100%),catalytic activity (100%),,,IPR028919 (81%);IPR001932 (6%);IPR008775 (6%),Viral movement protein (81%);PPM-type phosphatase domain (6%);Phytanoyl-CoA dioxygenase (6%),,,,,,,,,,,
NDATKPEFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMTHTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (100%),Oxidoreductases (100%),GO:0016021 (71%),integral component of membrane (71%),GO:0005524 (14%);GO:0010181 (14%);GO:0016491 (14%),ATP binding (14%);FMN binding (14%);oxidoreductase activity (14%),,,IPR001155 (33%);IPR003959 (33%);IPR006015 (33%),NADH:flavin oxidoreductase/NADH oxidase, N-terminal (33%);ATPase, AAA-type, core (33%);Universal stress protein A family (33%),,,,,,,,
TAMLNDVNSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.50 (10%);3.1.3.33 (10%);2.4.1.- (6%),mRNA guanylyltransferase (10%);Polynucleotide 5'-phosphatase (10%);Hexosyltransferases (6%),GO:0016021 (34%);GO:0005886 (3%);GO:0005634 (2%),integral component of membrane (34%);plasma membrane (3%);nucleus (2%),GO:0005524 (12%);GO:0000155 (6%);GO:0003677 (5%),ATP binding (12%);phosphorelay sensor kinase activity (6%);DNA binding (5%),GO:0006355 (5%);GO:0005975 (2%);GO:0032259 (2%),regulation of transcription, DNA-templated (5%);carbohydrate metabolic process (2%);methylation (2%),IPR027417 (6%);IPR036890 (6%);IPR003594 (5%),P-loop containing nucleoside triphosphate hydrolase (6%);Histidine kinase/HSP90-like ATPase superfamily (6%);Histidine kinase/HSP90-like ATPase (5%),,,,,,,,,,
LESTLNPMPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLGVLWSEVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFTDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.99.- (29%);1.2.4.1 (13%);2.4.1.1 (11%),With other acceptors (29%);Pyruvate dehydrogenase (acetyl-transferring) (13%);Glycogen phosphorylase (11%),GO:0016021 (20%);GO:0005737 (5%);GO:0005886 (5%),integral component of membrane (20%);cytoplasm (5%);plasma membrane (5%),GO:0008718 (9%);GO:0003677 (7%);GO:0046872 (5%),D-amino-acid dehydrogenase activity (9%);DNA binding (7%);metal ion binding (5%),GO:0019478 (9%);GO:0006364 (5%);GO:0009103 (4%),D-amino acid catabolic process (9%);rRNA processing (5%);lipopolysaccharide biosynthetic process (4%),IPR036291 (10%);IPR036188 (8%);IPR006076 (7%),NAD(P)-binding domain superfamily (10%);FAD/NAD(P)-binding domain superfamily (8%);FAD dependent oxidoreductase (7%),,,,,,,,,,,
CPGGGWQQTLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CYVQLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGMLAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLNLLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.24 (14%);1.97.1.9 (7%);2.1.1.14 (7%),Porphobilinogen synthase (14%);Selenate reductase (7%);5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (7%),GO:0016021 (34%);GO:0019031 (15%);GO:0044175 (15%),integral component of membrane (34%);viral envelope (15%);host cell endosome membrane (15%),GO:0005198 (15%);GO:0005524 (10%);GO:0016491 (8%),structural molecule activity (15%);ATP binding (10%);oxidoreductase activity (8%),GO:0019062 (15%);GO:0019064 (13%);GO:0019082 (13%),virion attachment to host cell (15%);fusion of virus membrane with host plasma membrane (13%);viral protein processing (13%),IPR011990 (66%);IPR013026 (66%);IPR019734 (44%),Tetratricopeptide-like helical domain superfamily (66%);Tetratricopeptide repeat-containing domain (66%);Tetratricopeptide repeat (44%),,,,,,,,,,,
VANQLMPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNNVANAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLVLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.46 (38%);6.3.2.10 (20%);5.4.99.12 (9%),dTDP-glucose 4,6-dehydratase (38%);UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (20%);tRNA pseudouridine(38-40) synthase (9%),GO:0016021 (17%);GO:0005654 (6%);GO:0005829 (6%),integral component of membrane (17%);nucleoplasm (6%);cytosol (6%),GO:0008234 (38%);GO:0005524 (12%);GO:0070139 (7%),cysteine-type peptidase activity (38%);ATP binding (12%);SUMO-specific endopeptidase activity (7%),GO:0016926 (7%);GO:0090169 (7%);GO:0090234 (7%),protein desumoylation (7%);regulation of spindle assembly (7%);regulation of kinetochore assembly (7%),IPR003653 (40%);IPR038765 (40%);IPR036291 (5%),Ulp1 protease family, C-terminal catalytic domain (40%);Papain-like cysteine peptidase superfamily (40%);NAD(P)-binding domain superfamily (5%),,,,,,,,,
NNDKPLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFFHTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.72 (100%),Site-specific DNA-methyltransferase (adenine-specific) (100%),GO:0016021 (60%);GO:0005886 (20%);GO:0030127 (20%),integral component of membrane (60%);plasma membrane (20%);COPII vesicle coat (20%),GO:0003676 (20%);GO:0003824 (20%);GO:0008270 (20%),nucleic acid binding (20%);catalytic activity (20%);zinc ion binding (20%),GO:0006886 (20%);GO:0006888 (20%);GO:0007165 (20%),intracellular protein transport (20%);endoplasmic reticulum to Golgi vesicle-mediated transport (20%);signal transduction (20%),IPR015168 (25%);IPR000515 (13%);IPR001680 (13%),SsuA/THI5-like (25%);ABC transporter type 1, transmembrane domain MetI-like (13%);WD40 repeat (13%),,,,,,,,,,
MELWHLK,Chloroflexi bacterium,Bacteria,,,,Chloroflexi,,,,,,,,,,,,,,,,,,,,Chloroflexi bacterium,,,,,,,,,,,,IPR011059 (100%);IPR013108 (100%);IPR032466 (100%),Metal-dependent hydrolase, composite domain superfamily (100%);Amidohydrolase 3 (100%);Metal-dependent hydrolase (100%),,,,,,,,,,
DLNQGSYK,Cystobacter ferrugineus,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Myxococcales,Cystobacterineae,,,,Archangiaceae,,,,Cystobacter,,,,Cystobacter ferrugineus,,,,,,GO:0005623 (100%),cell (100%),GO:0016209 (100%);GO:0016491 (100%),antioxidant activity (100%);oxidoreductase activity (100%),GO:0045454 (100%),cell redox homeostasis (100%),IPR000866 (100%);IPR013766 (100%);IPR024706 (100%),Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant (100%);Thioredoxin domain (100%);Peroxiredoxin, AhpC-type (100%),,,,,,,,,,
MYSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.12 (57%);2.4.2.14 (11%);3.1.-.- (7%),UDP-glucose--hexose-1-phosphate uridylyltransferase (57%);Amidophosphoribosyltransferase (11%);Acting on ester bonds (7%),GO:0016021 (40%);GO:0009279 (11%);GO:0005886 (3%),integral component of membrane (40%);cell outer membrane (11%);plasma membrane (3%),GO:0008270 (12%);GO:0008108 (11%);GO:0015473 (8%),zinc ion binding (12%);UDP-glucose:hexose-1-phosphate uridylyltransferase activity (11%);fimbrial usher porin activity (8%),GO:0033499 (11%);GO:0009297 (8%);GO:0055085 (5%),galactose catabolic process via UDP-galactose (11%);pilus assembly (8%);transmembrane transport (5%),IPR001937 (10%);IPR005849 (10%);IPR005850 (10%),Galactose-1-phosphate uridyl transferase, class I (10%);Galactose-1-phosphate uridyl transferase, N-terminal (10%);Galactose-1-phosphate uridyl transferase, C-terminal (10%),,,,,,,,
LVPELLNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005887 (14%),integral component of plasma membrane (14%),GO:0008901 (43%);GO:0016151 (43%);GO:0009055 (14%),ferredoxin hydrogenase activity (43%);nickel cation binding (43%);electron transfer activity (14%),GO:0009058 (14%);GO:0009306 (14%),biosynthetic process (14%);protein secretion (14%),IPR001501 (43%);IPR018194 (43%);IPR029014 (43%),Nickel-dependent hydrogenase, large subunit (43%);Nickel-dependent hydrogenase, large subunit, nickel binding site (43%);[NiFe]-hydrogenase, large subunit (43%),,,,,,,
NPAVSLHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTGLLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.5 (27%);3.2.2.0 (27%);1.2.7.8 (13%),Lysophospholipase (27%); (27%);Indolepyruvate ferredoxin oxidoreductase (13%),GO:0016021 (28%);GO:0009279 (4%);GO:0005789 (3%),integral component of membrane (28%);cell outer membrane (4%);endoplasmic reticulum membrane (3%),GO:0008080 (20%);GO:0005524 (11%);GO:0016740 (11%),N-acetyltransferase activity (20%);ATP binding (11%);transferase activity (11%),GO:0006281 (6%);GO:0009691 (3%);GO:0016042 (3%),DNA repair (6%);cytokinin biosynthetic process (3%);lipid catabolic process (3%),IPR032675 (24%);IPR001611 (23%);IPR003591 (20%),Leucine-rich repeat domain superfamily (24%);Leucine-rich repeat (23%);Leucine-rich repeat, typical subtype (20%),,,,,,,,,,
NAMDNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVSNCFYNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYMLVPMGYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYFFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.- (18%);5.6.2.2 (12%);2.7.7.49 (10%),Phosphoric diester hydrolases (18%);DNA topoisomerase (ATP-hydrolyzing) (12%);RNA-directed DNA polymerase (10%),GO:0016021 (30%);GO:0009507 (11%);GO:0031012 (11%),integral component of membrane (30%);chloroplast (11%);extracellular matrix (11%),GO:0008270 (12%);GO:0004222 (12%);GO:0003723 (11%),zinc ion binding (12%);metalloendopeptidase activity (12%);RNA binding (11%),GO:0006397 (11%);GO:0008033 (11%);GO:0007275 (10%),mRNA processing (11%);tRNA processing (11%);multicellular organism development (10%),IPR018487 (10%);IPR036375 (10%);IPR027417 (10%),Hemopexin-like repeats (10%);Hemopexin-like domain superfamily (10%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,,,,
DLQQTDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.12 (100%),D-lactate dehydrogenase (quinone) (100%),GO:0016021 (56%);GO:0005887 (19%);GO:0031234 (19%),integral component of membrane (56%);integral component of plasma membrane (19%);extrinsic component of cytoplasmic side of plasma membrane (19%),GO:0005524 (50%);GO:0008556 (50%);GO:0046872 (50%),ATP binding (50%);potassium transmembrane transporter activity, phosphorylative mechanism (50%);metal ion binding (50%),GO:0019516 (19%);GO:0022904 (19%);GO:0055085 (19%),lactate oxidation (19%);respiratory electron transport chain (19%);transmembrane transport (19%),IPR001757 (47%);IPR004014 (47%);IPR005775 (47%),P-type ATPase (47%);Cation-transporting P-type ATPase, N-terminal (47%);P-type ATPase subfamily IIC, subunit alpha (47%),,,,,,,,
YYEAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.0 (41%);4.2.1.126 (22%);6.3.5.- (22%), (41%);N-acetylmuramic acid 6-phosphate etherase (22%);Carbon--nitrogen ligases with glutamine as amido-N-donor (22%),GO:0016021 (13%);GO:0005634 (10%);GO:0008180 (8%),integral component of membrane (13%);nucleus (10%);COP9 signalosome (8%),GO:0016787 (18%);GO:0005524 (15%);GO:0003677 (12%),hydrolase activity (18%);ATP binding (15%);DNA binding (12%),GO:0009691 (14%);GO:0016055 (10%);GO:0005975 (8%),cytokinin biosynthetic process (14%);Wnt signaling pathway (10%);carbohydrate metabolic process (8%),IPR031100 (18%);IPR005269 (11%);IPR025647 (11%),LOG family (18%);Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG (11%);Putative component of 'biosynthetic module' (11%),,,,,,,,,,,
EFFYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.12 (50%);2.1.1.- (25%);2.4.2.17 (25%),Aspartate--tRNA ligase (50%);Methyltransferases (25%);ATP phosphoribosyltransferase (25%),GO:0005737 (20%);GO:0016021 (20%),cytoplasm (20%);integral component of membrane (20%),GO:0005524 (25%);GO:0016787 (15%);GO:0000287 (10%),ATP binding (25%);hydrolase activity (15%);magnesium ion binding (10%),GO:0032259 (15%);GO:0006422 (10%);GO:0000105 (5%),methylation (15%);aspartyl-tRNA aminoacylation (10%);histidine biosynthetic process (5%),IPR006059 (16%);IPR000073 (10%);IPR029058 (10%),Bacterial extracellular solute-binding protein (16%);Alpha/beta hydrolase fold-1 (10%);Alpha/Beta hydrolase fold (10%),,,,,,,,,,,
SGLNDQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.16 (100%),Cysteine--tRNA ligase (100%),GO:0005737 (14%);GO:0016021 (14%),cytoplasm (14%);integral component of membrane (14%),GO:0016301 (29%);GO:0004386 (14%);GO:0004471 (14%),kinase activity (29%);helicase activity (14%);malate dehydrogenase (decarboxylating) (NAD+) activity (14%),GO:0006108 (14%);GO:0006423 (14%);GO:0006935 (14%),malate metabolic process (14%);cysteinyl-tRNA aminoacylation (14%);chemotaxis (14%),IPR011611 (29%);IPR029056 (29%);IPR001650 (14%),Carbohydrate kinase PfkB (29%);Ribokinase-like (29%);Helicase, C-terminal (14%),,,,,,,,,,
LMMMDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (100%),Cytochrome-c oxidase (100%),GO:0005743 (82%);GO:0016021 (82%);GO:0070469 (82%),mitochondrial inner membrane (82%);integral component of membrane (82%);respirasome (82%),GO:0004129 (82%);GO:0020037 (82%);GO:0046872 (82%),cytochrome-c oxidase activity (82%);heme binding (82%);metal ion binding (82%),GO:0006119 (82%);GO:0009060 (82%);GO:0006807 (2%),oxidative phosphorylation (82%);aerobic respiration (82%);nitrogen compound metabolic process (2%),IPR000883 (74%);IPR023616 (74%);IPR036927 (74%),Cytochrome c oxidase subunit I (74%);Cytochrome c oxidase-like, subunit I domain (74%);Cytochrome c oxidase-like, subunit I  superfamily (74%),,,,,,,,,
QNASEMPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDELEDSNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPTHLYK,Oncopeltus fasciatus,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Hemiptera,Heteroptera,Pentatomomorpha,,Lygaeoidea,Lygaeidae,Lygaeinae,,,Oncopeltus,,,,Oncopeltus fasciatus,,,,,,,,GO:0004672 (100%);GO:0005524 (100%),protein kinase activity (100%);ATP binding (100%),,,IPR000719 (100%);IPR011009 (100%),Protein kinase domain (100%);Protein kinase-like domain superfamily (100%),,,,,,,,,,,
FGPVATNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSLTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.30.- (26%);2.7.4.9 (17%);1.11.1.15 (13%),Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters (26%);dTMP kinase (17%);Peroxiredoxin (13%),GO:0016021 (29%);GO:0009279 (8%);GO:0005737 (2%),integral component of membrane (29%);cell outer membrane (8%);cytoplasm (2%),GO:0003676 (18%);GO:0022857 (17%);GO:0046872 (17%),nucleic acid binding (18%);transmembrane transporter activity (17%);metal ion binding (17%),GO:0005991 (6%);GO:0006233 (3%);GO:0006235 (3%),trehalose metabolic process (6%);dTDP biosynthetic process (3%);dTTP biosynthetic process (3%),IPR001958 (14%);IPR011701 (14%);IPR020846 (14%),Tetracycline resistance protein TetA/multidrug resistance protein MdtG (14%);Major facilitator superfamily (14%);Major facilitator superfamily domain (14%),,,,,,,,,,,
TLYLDEGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (50%);5.3.1.23 (50%),RING-type E3 ubiquitin transferase (50%);S-methyl-5-thioribose-1-phosphate isomerase (50%),,,GO:0008270 (50%);GO:0046523 (50%);GO:0061630 (50%),zinc ion binding (50%);S-methyl-5-thioribose-1-phosphate isomerase activity (50%);ubiquitin protein ligase activity (50%),GO:0019284 (50%);GO:0019509 (50%);GO:0071596 (50%),L-methionine salvage from S-adenosylmethionine (50%);L-methionine salvage from methylthioadenosine (50%);ubiquitin-dependent protein catabolic process via the N-end rule pathway (50%),IPR011990 (50%);IPR019734 (50%);IPR000649 (25%),Tetratricopeptide-like helical domain superfamily (50%);Tetratricopeptide repeat (50%);Initiation factor 2B-related (25%),,,,,,,,,,,
NQMHLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLVEGHDAER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGPFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (50%);3.6.3.- (50%),Acting on ester bonds (50%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (50%),GO:0016021 (29%),integral component of membrane (29%),GO:0005524 (43%);GO:0016491 (29%);GO:0016757 (29%),ATP binding (43%);oxidoreductase activity (29%);transferase activity, transferring glycosyl groups (29%),GO:0006281 (14%),DNA repair (14%),IPR036188 (44%);IPR027417 (33%);IPR002201 (22%),FAD/NAD(P)-binding domain superfamily (44%);P-loop containing nucleoside triphosphate hydrolase (33%);Glycosyl transferase, family 9 (22%),,,,,,,,,
TVQQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (18%);1.3.1.- (8%);2.7.11.1 (6%),DNA helicase (18%);With NAD(+) or NADP(+) as acceptor (8%);Non-specific serine/threonine protein kinase (6%),GO:0016021 (29%);GO:0005634 (16%);GO:0000178 (8%),integral component of membrane (29%);nucleus (16%);exosome (RNase complex) (8%),GO:0005524 (18%);GO:0003723 (10%);GO:0008536 (10%),ATP binding (18%);RNA binding (10%);Ran GTPase binding (10%),GO:0006606 (11%);GO:0006396 (8%);GO:0006633 (4%),protein import into nucleus (11%);RNA processing (8%);fatty acid biosynthetic process (4%),IPR016024 (11%);IPR040122 (10%);IPR011989 (10%),Armadillo-type fold (11%);Importin beta family (10%);Armadillo-like helical (10%),,,,,,,,,,,
WTSFFLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MALMHVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.4.1 (21%);6.1.1.7 (11%);1.2.1.11 (8%),Protein disulfide-isomerase (21%);Alanine--tRNA ligase (11%);Aspartate-semialdehyde dehydrogenase (8%),GO:0016021 (19%);GO:0005737 (10%);GO:0005623 (9%),integral component of membrane (19%);cytoplasm (10%);cell (9%),GO:0005524 (16%);GO:0008270 (8%);GO:0003756 (6%),ATP binding (16%);zinc ion binding (8%);protein disulfide isomerase activity (6%),GO:0045454 (9%);GO:0005975 (4%);GO:0032259 (4%),cell redox homeostasis (9%);carbohydrate metabolic process (4%);methylation (4%),IPR036249 (8%);IPR036291 (8%);IPR027417 (8%),Thioredoxin-like superfamily (8%);NAD(P)-binding domain superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
TQAGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.8 (100%),Mannose-6-phosphate isomerase (100%),GO:0016021 (13%);GO:0005730 (7%);GO:0005737 (7%),integral component of membrane (13%);nucleolus (7%);cytoplasm (7%),GO:0005524 (20%);GO:0000155 (13%);GO:0004553 (13%),ATP binding (20%);phosphorelay sensor kinase activity (13%);hydrolase activity, hydrolyzing O-glycosyl compounds (13%),GO:0005975 (27%);GO:0000469 (7%);GO:0006355 (7%),carbohydrate metabolic process (27%);cleavage involved in rRNA processing (7%);regulation of transcription, DNA-templated (7%),IPR000322 (9%);IPR001849 (9%);IPR003594 (9%),Glycoside hydrolase family 31 (9%);Pleckstrin homology domain (9%);Histidine kinase/HSP90-like ATPase (9%),,,,,,,,,
FHEWGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (100%),Acting on ATP; involved in cellular and subcellular movement (100%),GO:0016021 (17%),integral component of membrane (17%),GO:0005506 (56%);GO:0016705 (56%);GO:0020037 (56%),iron ion binding (56%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (56%);heme binding (56%),GO:0006351 (22%),transcription, DNA-templated (22%),IPR001128 (53%);IPR002401 (53%);IPR036396 (53%),Cytochrome P450 (53%);Cytochrome P450, E-class, group I (53%);Cytochrome P450 superfamily (53%),,,,,,
TEVAAAEPLRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.90 (28%);3.1.26.11 (16%);4.2.1.59 (16%),L-rhamnonate dehydratase (28%);Ribonuclease Z (16%);3-hydroxyacyl-[acyl-carrier-protein] dehydratase (16%),GO:0016021 (24%);GO:0005737 (12%);GO:0005886 (4%),integral component of membrane (24%);cytoplasm (12%);plasma membrane (4%),GO:0000287 (13%);GO:0005524 (12%);GO:0050032 (12%),magnesium ion binding (13%);ATP binding (12%);L-rhamnonate dehydratase activity (12%),GO:0009063 (8%);GO:0009245 (7%);GO:0006633 (7%),cellular amino acid catabolic process (8%);lipid A biosynthetic process (7%);fatty acid biosynthetic process (7%),IPR013341 (10%);IPR013342 (10%);IPR029017 (10%),Mandelate racemase/muconate lactonizing enzyme, N-terminal domain (10%);Mandelate racemase/muconate lactonizing enzyme, C-terminal (10%);Enolase-like, N-terminal (10%),,,,,,,,
DNGTVLPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLVVLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.22 (100%),UDP-glucose 6-dehydrogenase (100%),GO:0016021 (22%);GO:0005634 (3%);GO:0009279 (3%),integral component of membrane (22%);nucleus (3%);cell outer membrane (3%),GO:0003677 (28%);GO:0003924 (8%);GO:0005525 (8%),DNA binding (28%);GTPase activity (8%);GTP binding (8%),GO:0006310 (28%);GO:0015074 (28%);GO:0002098 (3%),DNA recombination (28%);DNA integration (28%);tRNA wobble uridine modification (3%),IPR002104 (24%);IPR004107 (24%);IPR010998 (24%),Integrase, catalytic domain (24%);Integrase, SAM-like, N-terminal (24%);Integrase/recombinase, N-terminal (24%),,,,,,,
FLTMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (36%);2.6.1.62 (10%);1.17.4.1 (5%),Metalloendopeptidases (36%);Adenosylmethionine--8-amino-7-oxononanoate transaminase (10%);Ribonucleoside-diphosphate reductase (5%),GO:0016021 (28%);GO:0005737 (3%);GO:0005615 (3%),integral component of membrane (28%);cytoplasm (3%);extracellular space (3%),GO:0005524 (20%);GO:0008270 (8%);GO:0004222 (5%),ATP binding (20%);zinc ion binding (8%);metalloendopeptidase activity (5%),GO:0000350 (9%);GO:0042777 (3%);GO:0006457 (3%),generation of catalytic spliceosome for second transesterification step (9%);plasma membrane ATP synthesis coupled proton transport (3%);protein folding (3%),IPR005301 (12%);IPR036703 (12%);IPR027417 (8%),MOB kinase activator family (12%);MOB kinase activator superfamily (12%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
MDVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.14 (19%);3.1.-.- (8%);5.2.1.8 (4%),5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (19%);Acting on ester bonds (8%);Peptidylprolyl isomerase (4%),GO:0016021 (19%);GO:0005737 (11%);GO:0005634 (4%),integral component of membrane (19%);cytoplasm (11%);nucleus (4%),GO:0005524 (14%);GO:0003677 (8%);GO:0008270 (6%),ATP binding (14%);DNA binding (8%);zinc ion binding (6%),GO:0032465 (14%);GO:0006897 (14%);GO:0006914 (12%),regulation of cytokinesis (14%);endocytosis (14%);autophagy (12%),IPR007243 (13%);IPR032913 (13%);IPR040455 (13%),Atg6/Beclin (13%);Beclin-1 (13%);Atg6, BARA domain (13%),,,,,,,,,,
TQMVVDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLVALNNK,Gammaproteobacteria bacterium,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,Gammaproteobacteria bacterium,,,,1.1.1.85 (100%),3-isopropylmalate dehydrogenase (100%),GO:0005737 (67%),cytoplasm (67%),GO:0000287 (67%);GO:0003862 (67%);GO:0051287 (67%),magnesium ion binding (67%);3-isopropylmalate dehydrogenase activity (67%);NAD binding (67%),GO:0009098 (67%),leucine biosynthetic process (67%),IPR004429 (67%);IPR019818 (67%);IPR024084 (67%),Isopropylmalate dehydrogenase (67%);Isocitrate/isopropylmalate dehydrogenase, conserved site (67%);Isopropylmalate dehydrogenase-like domain (67%),,,,,,,,,,
VFGQSGAADVADAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNALKPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016740 (25%);GO:0016765 (25%),transferase activity (25%);transferase activity, transferring alkyl or aryl (other than methyl) groups (25%),GO:0009058 (25%),biosynthetic process (25%),IPR001296 (25%);IPR002060 (25%);IPR008949 (25%),Glycosyl transferase, family 1 (25%);Squalene/phytoene synthase (25%);Isoprenoid synthase domain superfamily (25%),,,,,,,,,
NFEQEGGGWGLGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QATAHWEANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVPYQGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVDMNPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQFNTNK,Lachnospiraceae,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Lachnospiraceae,,,,,,,,,,,,,,,,,,,,IPR000160 (100%);IPR001638 (100%);IPR006059 (100%),GGDEF domain (100%);Solute-binding protein  family 3/N-terminal domain of MltF (100%);Bacterial extracellular solute-binding protein (100%),,,,,,,,,,,
WMWMAEVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFLAAEPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGANFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (50%),cytoplasm (50%),GO:0003746 (67%);GO:0005525 (67%);GO:0003924 (50%),translation elongation factor activity (67%);GTP binding (67%);GTPase activity (50%),GO:0000723 (17%);GO:0006281 (17%);GO:0030908 (17%),telomere maintenance (17%);DNA repair (17%);protein splicing (17%),IPR027417 (83%);IPR000640 (67%);IPR000795 (67%),P-loop containing nucleoside triphosphate hydrolase (83%);Elongation factor EFG, domain V-like (67%);Transcription factor, GTP-binding domain (67%),,,,,,,,,
SEPYPPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLMTLNNLLQNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMHSMNSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AANALEPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SAAGYEWCESK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLYVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.2 (15%);2.7.7.6 (11%);2.7.11.1 (9%),UDP-glucose 4-epimerase (15%);DNA-directed RNA polymerase (11%);Non-specific serine/threonine protein kinase (9%),GO:0016021 (15%);GO:0005840 (3%);GO:0000123 (2%),integral component of membrane (15%);ribosome (3%);histone acetyltransferase complex (2%),GO:0004519 (26%);GO:0003824 (12%);GO:0050662 (12%),endonuclease activity (26%);catalytic activity (12%);coenzyme binding (12%),GO:0006351 (3%);GO:0006412 (3%);GO:0016573 (2%),transcription, DNA-templated (3%);translation (3%);histone acetylation (2%),IPR036691 (26%);IPR036291 (21%);IPR016040 (11%),Endonuclease/exonuclease/phosphatase superfamily (26%);NAD(P)-binding domain superfamily (21%);NAD(P)-binding domain (11%),,,,,,,,,,
WCPLPTK,Ruminococcus,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Ruminococcaceae,,,,Ruminococcus,,,,,,,,,,,,,,,,IPR001242 (100%);IPR023213 (100%),Condensation domain (100%);Chloramphenicol acetyltransferase-like domain superfamily (100%),,,,,,,,,,,
NVAKPVNK,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,GO:0019867 (100%),outer membrane (100%),,,,,IPR008816 (100%),Glycine zipper 2TM domain (100%),,,,,,,,,,,
AFWELTMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYPPVPK,Spirobacillus cienkowskii,Bacteria,,,,Proteobacteria,,,Oligoflexia,,,,Silvanigrellales,,,,,,,,,Spirobacillus,,,,Spirobacillus cienkowskii,,,,,,,,,,,,IPR036513 (100%),STAS domain superfamily (100%),,,,,,,,,,,
MPWTQLANYSASLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGMVVGQHSVPHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LANTLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (71%);2.3.1.30 (7%);2.4.1.227 (7%),DNA helicase (71%);Serine O-acetyltransferase (7%);Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (7%),GO:0016021 (18%);GO:0005887 (3%);GO:0005737 (2%),integral component of membrane (18%);integral component of plasma membrane (3%);cytoplasm (2%),GO:0003677 (28%);GO:0005524 (24%);GO:0003824 (10%),DNA binding (28%);ATP binding (24%);catalytic activity (10%),GO:0006355 (15%);GO:0006281 (12%);GO:0006310 (10%),regulation of transcription, DNA-templated (15%);DNA repair (12%);DNA recombination (10%),IPR036388 (26%);IPR036390 (25%);IPR027417 (21%),Winged helix-like DNA-binding domain superfamily (26%);Winged helix DNA-binding domain superfamily (25%);P-loop containing nucleoside triphosphate hydrolase (21%),,,,,,,,,,
GFAGMVAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMVVLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016887 (100%);GO:0042626 (100%),ATP binding (100%);ATPase activity (100%);ATPase-coupled transmembrane transporter activity (100%),,,IPR003439 (100%);IPR003593 (100%);IPR011527 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);ABC transporter type 1, transmembrane domain (100%),,,,,,,,,,
QPYPEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.169 (100%),Protein O-GlcNAcase (100%),GO:0016021 (4%);GO:0005634 (1%);GO:0005794 (1%),integral component of membrane (4%);nucleus (1%);Golgi apparatus (1%),GO:0003676 (93%);GO:0004523 (81%);GO:0003857 (1%),nucleic acid binding (93%);RNA-DNA hybrid ribonuclease activity (81%);3-hydroxyacyl-CoA dehydrogenase activity (1%),GO:0015074 (83%);GO:0006355 (1%);GO:0006635 (1%),DNA integration (83%);regulation of transcription, DNA-templated (1%);fatty acid beta-oxidation (1%),IPR012337 (78%);IPR036397 (78%);IPR005162 (73%),Ribonuclease H-like superfamily (78%);Ribonuclease H superfamily (78%);Retrotransposon gag domain (73%),,,,,,,,,,
DLFTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.44 (66%);2.1.3.15 (5%);6.1.1.14 (2%),Phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (66%);Acetyl-CoA carboxytransferase (5%);Glycine--tRNA ligase (2%),GO:0016021 (18%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (18%);cytoplasm (6%);plasma membrane (3%),GO:0004616 (28%);GO:0050661 (22%);GO:0005524 (17%),phosphogluconate dehydrogenase (decarboxylating) activity (28%);NADP binding (22%);ATP binding (17%),GO:0006098 (25%);GO:0019521 (24%);GO:0005975 (4%),pentose-phosphate shunt (25%);D-gluconate metabolic process (24%);carbohydrate metabolic process (4%),IPR036291 (24%);IPR008927 (24%);IPR013328 (24%),NAD(P)-binding domain superfamily (24%);6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily (24%);6-phosphogluconate dehydrogenase, domain 2 (24%),,,,,,,,
TEEVFPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0016301 (50%),kinase activity (50%),,,IPR000719 (50%);IPR008271 (50%);IPR011009 (50%),Protein kinase domain (50%);Serine/threonine-protein kinase, active site (50%);Protein kinase-like domain superfamily (50%),,,,,,,,,,
ESNVEHVNC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFSYCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.12 (100%),Glucuronate isomerase (100%),GO:0016021 (8%),integral component of membrane (8%),GO:0004725 (33%);GO:0003677 (25%);GO:0003676 (17%),protein tyrosine phosphatase activity (33%);DNA binding (25%);nucleic acid binding (17%),GO:0005975 (8%);GO:0006064 (8%);GO:0006313 (8%),carbohydrate metabolic process (8%);glucuronate catabolic process (8%);transposition, DNA-mediated (8%),IPR003595 (31%);IPR010569 (31%);IPR016130 (31%),Protein-tyrosine phosphatase, catalytic (31%);Myotubularin-like phosphatase domain (31%);Protein-tyrosine phosphatase, active site (31%),,,,,,,,
ALLTEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.10 (20%);5.3.1.23 (8%);3.4.24.- (7%),UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (20%);S-methyl-5-thioribose-1-phosphate isomerase (8%);Metalloendopeptidases (7%),GO:0016021 (23%);GO:0005737 (11%);GO:0005623 (10%),integral component of membrane (23%);cytoplasm (11%);cell (10%),GO:0005524 (17%);GO:0003677 (7%);GO:0051015 (7%),ATP binding (17%);DNA binding (7%);actin filament binding (7%),GO:0090286 (7%);GO:0051301 (5%);GO:0007049 (4%),cytoskeletal anchoring at nuclear membrane (7%);cell division (5%);cell cycle (4%),IPR027417 (10%);IPR018159 (6%);IPR030266 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Spectrin/alpha-actinin (6%);Nesprin-2 (6%),,,,,,,,,,,
LEQMLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.2 (100%),Adenylosuccinate lyase (100%),GO:0016021 (20%),integral component of membrane (20%),GO:0016787 (30%);GO:0004222 (20%);GO:0004018 (10%),hydrolase activity (30%);metalloendopeptidase activity (20%);N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity (10%),GO:0006189 (10%);GO:0016192 (10%);GO:0019619 (10%),'de novo' IMP biosynthetic process (10%);vesicle-mediated transport (10%);3,4-dihydroxybenzoate catabolic process (10%),IPR024445 (74%);IPR024442 (46%);IPR000073 (6%),ISXO2-like transposase domain (74%);Transposase, zinc-ribbon (46%);Alpha/beta hydrolase fold-1 (6%),,,,,,,,
TPGHVWMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDHYSDVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMYELVHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSAHMSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0016740 (100%),transferase activity (100%),,,IPR003362 (50%);IPR015637 (50%);IPR017473 (50%),Bacterial sugar transferase (50%);G/U mismatch-specific DNA glycosylase (50%);Undecaprenyl-phosphate glucose phosphotransferase, WcaJ (50%),,,,,,,,,,
SPNYVDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLVLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.71 (40%);2.7.1.21 (20%);3.1.11.5 (20%),Shikimate kinase (40%);Thymidine kinase (20%);Exodeoxyribonuclease V (20%),GO:0016021 (24%);GO:0009338 (12%);GO:0005737 (10%),integral component of membrane (24%);exodeoxyribonuclease V complex (12%);cytoplasm (10%),GO:0003824 (16%);GO:0004386 (12%);GO:0005524 (12%),catalytic activity (16%);helicase activity (12%);ATP binding (12%),GO:0006302 (12%);GO:0006310 (12%);GO:0006633 (10%),double-strand break repair (12%);DNA recombination (12%);fatty acid biosynthetic process (10%),IPR000873 (27%);IPR042099 (27%);IPR020845 (22%),AMP-dependent synthetase/ligase (27%);AMP-dependent synthetase-like superfamily (27%);AMP-binding, conserved site (22%),,,,,,,,,,
LGDVHTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR027417 (100%);IPR041677 (100%);IPR041679 (100%),P-loop containing nucleoside triphosphate hydrolase (100%);DNA2/NAM7 helicase, AAA domain (100%);DNA2/NAM7 helicase-like, AAA domain (100%),,,,,,,,,
NSTNLPTFEEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLDAHPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLVGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (29%);2.7.13.3 (14%);2.7.4.22 (14%),DNA helicase (29%);Histidine kinase (14%);UMP kinase (14%),GO:0016021 (36%);GO:0019028 (35%);GO:0005737 (6%),integral component of membrane (36%);viral capsid (35%);cytoplasm (6%),GO:0005198 (35%);GO:0005524 (30%);GO:0000155 (17%),structural molecule activity (35%);ATP binding (30%);phosphorelay sensor kinase activity (17%),GO:0006268 (6%);GO:0016079 (3%);GO:0032049 (3%),DNA unwinding involved in DNA replication (6%);synaptic vesicle exocytosis (3%);cardiolipin biosynthetic process (3%),IPR007589 (29%);IPR000014 (15%);IPR029151 (15%),Baculovirus major capsid protein VP39 (29%);PAS domain (15%);Periplasmic sensor-like domain superfamily (15%),,,,,,,,,,,
QGSPDDNGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TWEANMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLWCMVALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYLFLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.16 (67%);3.4.11.9 (33%),Glutamine--fructose-6-phosphate transaminase (isomerizing) (67%);Xaa-Pro aminopeptidase (33%),GO:0005576 (25%);GO:0005737 (25%);GO:0005604 (8%),extracellular region (25%);cytoplasm (25%);basement membrane (8%),GO:0004360 (25%);GO:0004519 (25%);GO:0003677 (8%),glutamine-fructose-6-phosphate transaminase (isomerizing) activity (25%);endonuclease activity (25%);DNA binding (8%),GO:0005975 (17%);GO:0006355 (8%);GO:0008045 (8%),carbohydrate metabolic process (17%);regulation of transcription, DNA-templated (8%);motor neuron axon guidance (8%),IPR001134 (25%);IPR008993 (25%);IPR018933 (25%),Netrin domain (25%);Tissue inhibitor of metalloproteinases-like, OB-fold (25%);Netrin module, non-TIMP type (25%),,,,,,,,
MVSLAFVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNPYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (61%);3.6.4.12 (8%);2.4.1.129 (4%),Isoleucine--tRNA ligase (61%);DNA helicase (8%);Peptidoglycan glycosyltransferase (4%),GO:0005737 (23%);GO:0016021 (17%);GO:0005887 (1%),cytoplasm (23%);integral component of membrane (17%);integral component of plasma membrane (1%),GO:0005524 (26%);GO:0004822 (20%);GO:0008270 (19%),ATP binding (26%);isoleucine-tRNA ligase activity (20%);zinc ion binding (19%),GO:0006428 (19%);GO:0006817 (4%);GO:0006281 (3%),isoleucyl-tRNA aminoacylation (19%);phosphate ion transport (4%);DNA repair (3%),IPR014729 (18%);IPR002300 (17%);IPR002301 (17%),Rossmann-like alpha/beta/alpha sandwich fold (18%);Aminoacyl-tRNA synthetase, class Ia (17%);Isoleucine-tRNA ligase (17%),,,,,,,,,,
VPMLDMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVEYFMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016614 (50%);GO:0050660 (50%);GO:0003677 (25%),oxidoreductase activity, acting on CH-OH group of donors (50%);flavin adenine dinucleotide binding (50%);DNA binding (25%),GO:0006310 (25%);GO:0015074 (25%),DNA recombination (25%);DNA integration (25%),IPR000172 (50%);IPR007867 (50%);IPR036188 (50%),Glucose-methanol-choline oxidoreductase, N-terminal (50%);Glucose-methanol-choline oxidoreductase, C-terminal (50%);FAD/NAD(P)-binding domain superfamily (50%),,,,,,,,
NYFLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.9.2 (26%);2.7.11.1 (8%);1.17.4.1 (5%),Pyruvate, water dikinase (26%);Non-specific serine/threonine protein kinase (8%);Ribonucleoside-diphosphate reductase (5%),GO:0016021 (27%);GO:0005737 (5%);GO:0005623 (3%),integral component of membrane (27%);cytoplasm (5%);cell (3%),GO:0005524 (18%);GO:0046872 (12%);GO:0003677 (7%),ATP binding (18%);metal ion binding (12%);DNA binding (7%),GO:0006090 (7%);GO:0006094 (7%);GO:0006260 (3%),pyruvate metabolic process (7%);gluconeogenesis (7%);DNA replication (3%),IPR014959 (15%);IPR038226 (15%);IPR027417 (5%),Protein of unknown function DUF1827 (15%);LMG 18311 protein-like superfamily (15%);P-loop containing nucleoside triphosphate hydrolase (5%),,,,,,,,,,
EVDAFYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFYDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.86 (24%);3.1.21.3 (20%);3.6.5.- (15%),Ketol-acid reductoisomerase (NADP(+)) (24%);Type I site-specific deoxyribonuclease (20%);Acting on GTP; involved in cellular and subcellular movement (15%),GO:0016021 (21%);GO:0005737 (10%);GO:0009279 (1%),integral component of membrane (21%);cytoplasm (10%);cell outer membrane (1%),GO:0003677 (19%);GO:0000287 (13%);GO:0005524 (12%),DNA binding (19%);magnesium ion binding (13%);ATP binding (12%),GO:0009097 (9%);GO:0009099 (9%);GO:0006633 (8%),isoleucine biosynthetic process (9%);valine biosynthetic process (9%);fatty acid biosynthetic process (8%),IPR027417 (14%);IPR036388 (8%);IPR006683 (7%),P-loop containing nucleoside triphosphate hydrolase (14%);Winged helix-like DNA-binding domain superfamily (8%);Thioesterase domain (7%),,,,,,,,,,,
NNWLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%);GO:0033179 (7%);GO:0005623 (3%),integral component of membrane (67%);proton-transporting V-type ATPase, V0 domain (7%);cell (3%),GO:0016740 (10%);GO:0000166 (7%);GO:0004077 (7%),transferase activity (10%);nucleotide binding (7%);biotin-[acetyl-CoA-carboxylase] ligase activity (7%),GO:0006464 (7%);GO:0009058 (3%);GO:0035435 (3%),cellular protein modification process (7%);biosynthetic process (3%);phosphate ion transmembrane transport (3%),IPR032176 (11%);IPR007016 (8%);IPR014844 (8%),Domain of unknown function DUF5009 (11%);O-antigen ligase-related (8%);PalH/RIM21 (8%),,,,,,,,,,
TLMVGLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (33%),transmembrane transporter activity (33%),,,IPR025684 (97%);IPR026377 (97%);IPR006143 (2%),Gliding motility protein SprA N-terminal domain (97%);Cell surface SprA (97%);RND efflux pump, membrane fusion protein (2%),,,,,,,,,,
CATAAAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAELSPASAQSWEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFYATAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.182 (100%),Lipid-A-disaccharide synthase (100%),GO:0005739 (33%),mitochondrion (33%),GO:0004252 (33%);GO:0008915 (33%),serine-type endopeptidase activity (33%);lipid-A-disaccharide synthase activity (33%),GO:0009245 (33%),lipid A biosynthetic process (33%),IPR000209 (50%);IPR003835 (50%);IPR015500 (50%),Peptidase S8/S53 domain (50%);Glycosyl transferase, family 19 (50%);Peptidase S8, subtilisin-related (50%),,,,,,,,,
TLTQLALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (100%),Hexosyltransferases (100%),GO:0005669 (81%);GO:0019031 (8%);GO:0055036 (8%),transcription factor TFIID complex (81%);viral envelope (8%);virion membrane (8%),GO:0008237 (69%);GO:0008270 (69%);GO:0003743 (39%),metallopeptidase activity (69%);zinc ion binding (69%);translation initiation factor activity (39%),GO:0006367 (13%);GO:0045944 (13%);GO:0019062 (8%),transcription initiation from RNA polymerase II promoter (13%);positive regulation of transcription by RNA polymerase II (13%);virion attachment to host cell (8%),IPR037813 (85%);IPR016024 (79%);IPR014782 (74%),Transcription initiation factor TFIID subunit 2 (85%);Armadillo-type fold (79%);Peptidase M1, membrane alanine aminopeptidase (74%),,,,,,,,,,
ASSMVENDNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AYDLAFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.3 (100%);3.5.4.10 (100%),Phosphoribosylaminoimidazolecarboxamide formyltransferase (100%);IMP cyclohydrolase (100%),,,GO:0003937 (50%);GO:0004643 (50%),IMP cyclohydrolase activity (50%);phosphoribosylaminoimidazolecarboxamide formyltransferase activity (50%),GO:0006189 (50%);GO:0006281 (50%),'de novo' IMP biosynthetic process (50%);DNA repair (50%),IPR001453 (22%);IPR008135 (22%);IPR008136 (22%),MoaB/Mog domain (22%);Competence-induced protein CinA (22%);CinA, C-terminal (22%),,,,,,,,,,
MHFDSGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALPVAGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (56%);2.1.1.49 (11%);2.3.2.- (11%),Molybdopterin molybdotransferase (56%);Amine N-methyltransferase (11%);Aminoacyltransferases (11%),GO:0016021 (56%);GO:0005737 (1%);GO:0005840 (1%),integral component of membrane (56%);cytoplasm (1%);ribosome (1%),GO:0016740 (24%);GO:0003857 (6%);GO:0016787 (4%),transferase activity (24%);3-hydroxyacyl-CoA dehydrogenase activity (6%);hydrolase activity (4%),GO:0006825 (15%);GO:0006635 (6%);GO:0006777 (4%),copper ion transport (15%);fatty acid beta-oxidation (6%);Mo-molybdopterin cofactor biosynthetic process (4%),IPR019108 (48%);IPR041280 (26%);IPR005490 (25%),Cytochrome c oxidase caa3-type, assembly factor CtaG-related (48%);Bacterial Ig domain, transpeptidase-associated (26%);L,D-transpeptidase catalytic domain (25%),,,,,,,,
FVLSNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.5.- (50%);3.1.-.- (50%),With a quinone or similar compound as acceptor (50%);Acting on ester bonds (50%),GO:0016021 (50%);GO:0005634 (17%);GO:0005887 (17%),integral component of membrane (50%);nucleus (17%);integral component of plasma membrane (17%),GO:0003700 (17%);GO:0008271 (17%);GO:0015301 (17%),DNA-binding transcription factor activity (17%);secondary active sulfate transmembrane transporter activity (17%);anion:anion antiporter activity (17%),GO:0030091 (17%);GO:0042128 (17%),protein repair (17%);nitrate assimilation (17%),IPR000232 (20%);IPR000572 (20%);IPR001810 (20%),Heat shock factor (HSF)-type, DNA-binding (20%);Oxidoreductase, molybdopterin-binding domain (20%);F-box domain (20%),,,,,,,,,
MNPEVVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LANEAYDLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.61 (29%);3.1.-.- (14%);2.3.2.27 (11%),Protein-glutamate methylesterase (29%);Acting on ester bonds (14%);RING-type E3 ubiquitin transferase (11%),GO:0005737 (25%);GO:0016021 (19%);GO:0005634 (8%),cytoplasm (25%);integral component of membrane (19%);nucleus (8%),GO:0005524 (19%);GO:0008270 (11%);GO:0008984 (7%),ATP binding (19%);zinc ion binding (11%);protein-glutamate methylesterase activity (7%),GO:0006457 (8%);GO:0006935 (8%);GO:0006260 (6%),protein folding (8%);chemotaxis (8%);DNA replication (6%),IPR027417 (9%);IPR000673 (6%);IPR035909 (6%),P-loop containing nucleoside triphosphate hydrolase (9%);Signal transduction response regulator, chemotaxis, protein-glutamate methylesterase (6%);Methylesterase CheB, C-terminal (6%),,,,,,,,
DCVTNWDQAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNNNAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.11 (29%);2.1.1.37 (14%);2.7.9.3 (14%),Pectinesterase (29%);DNA (cytosine-5-)-methyltransferase (14%);Selenide, water dikinase (14%),GO:0016021 (46%);GO:0005694 (8%);GO:0005737 (4%),integral component of membrane (46%);chromosome (8%);cytoplasm (4%),GO:0005524 (19%);GO:0003676 (12%);GO:0003677 (8%),ATP binding (19%);nucleic acid binding (12%);DNA binding (8%),GO:0006265 (8%);GO:0017000 (8%);GO:0042545 (8%),DNA topological change (8%);antibiotic biosynthetic process (8%);cell wall modification (8%),IPR013783 (15%);IPR027417 (15%);IPR000629 (11%),Immunoglobulin-like fold (15%);P-loop containing nucleoside triphosphate hydrolase (15%);ATP-dependent RNA helicase DEAD-box, conserved site (11%),,,,,,,,,
NQLWVFK,Paenibacillus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Paenibacillaceae,,,,Paenibacillus,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNMLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALPDFLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.31 (44%);2.4.99.17 (22%);3.1.-.- (22%),Phosphoenolpyruvate carboxylase (44%);S-adenosylmethionine:tRNA ribosyltransferase-isomerase (22%);Acting on ester bonds (22%),GO:0005634 (53%);GO:0005737 (4%);GO:0009279 (4%),nucleus (53%);cytoplasm (4%);cell outer membrane (4%),GO:0005096 (52%);GO:0005524 (6%);GO:0000287 (5%),GTPase activator activity (52%);ATP binding (6%);magnesium ion binding (5%),GO:0051056 (52%);GO:0006099 (6%);GO:0006107 (5%),regulation of small GTPase mediated signal transduction (52%);tricarboxylic acid cycle (6%);oxaloacetate metabolic process (5%),IPR000331 (49%);IPR016024 (49%);IPR018515 (49%),Rap GTPase activating protein domain (49%);Armadillo-type fold (49%);Tuberin-type domain (49%),,,,,,,,,,,
TGMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.2.12 (21%);6.5.1.2 (16%);1.2.1.4 (10%),Phosphoglycerate mutase (2,3-diphosphoglycerate-independent) (21%);DNA ligase (NAD(+)) (16%);Aldehyde dehydrogenase (NADP(+)) (10%),GO:0016021 (14%);GO:0005737 (8%);GO:0016020 (1%),integral component of membrane (14%);cytoplasm (8%);membrane (1%),GO:0016620 (35%);GO:0003677 (9%);GO:0046872 (5%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (35%);DNA binding (9%);metal ion binding (5%),GO:0006355 (4%);GO:0019068 (4%);GO:0006096 (3%),regulation of transcription, DNA-templated (4%);virion assembly (4%);glycolytic process (3%),IPR015590 (34%);IPR016161 (34%);IPR016162 (34%),Aldehyde dehydrogenase domain (34%);Aldehyde/histidinol dehydrogenase (34%);Aldehyde dehydrogenase, N-terminal (34%),,,,,,
TPVVGTAHAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.170 (39%);6.3.3.1 (28%);3.1.3.16 (9%),Anhydro-N-acetylmuramic acid kinase (39%);Phosphoribosylformylglycinamidine cyclo-ligase (28%);Protein-serine/threonine phosphatase (9%),GO:0016459 (62%);GO:0016021 (7%);GO:0005737 (6%),myosin complex (62%);integral component of membrane (7%);cytoplasm (6%),GO:0005524 (77%);GO:0003774 (62%);GO:0051015 (57%),ATP binding (77%);motor activity (62%);actin filament binding (57%),GO:0005975 (6%);GO:0006040 (6%);GO:0009254 (6%),carbohydrate metabolic process (6%);amino sugar metabolic process (6%);peptidoglycan turnover (6%),IPR027417 (65%);IPR001609 (63%);IPR004009 (62%),P-loop containing nucleoside triphosphate hydrolase (65%);Myosin head, motor domain (63%);Myosin, N-terminal, SH3-like (62%),,,,,,,,
EAMGSPQPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDVLKPQWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPQLWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLFSFGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MQGTGASMKPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCWWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFFMMKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVPDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.49 (11%);4.1.2.- (11%);5.1.3.15 (11%),Glucose-6-phosphate dehydrogenase (NADP(+)) (11%);Aldehyde-lyases (11%);Glucose-6-phosphate 1-epimerase (11%),GO:0016021 (34%);GO:0005623 (3%);GO:0005737 (2%),integral component of membrane (34%);cell (3%);cytoplasm (2%),GO:0005524 (14%);GO:0016491 (13%);GO:0000155 (12%),ATP binding (14%);oxidoreductase activity (13%);phosphorelay sensor kinase activity (12%),GO:0006355 (11%);GO:0006486 (8%);GO:0045454 (3%),regulation of transcription, DNA-templated (11%);protein glycosylation (8%);cell redox homeostasis (3%),IPR036890 (11%);IPR000014 (10%);IPR000700 (10%),Histidine kinase/HSP90-like ATPase superfamily (11%);PAS domain (10%);PAS-associated, C-terminal (10%),,,,,,,,,
WSWPMMLNVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVYEDAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (6%);GO:0005634 (3%),integral component of membrane (6%);nucleus (3%),GO:0005524 (67%);GO:0016887 (56%);GO:0004325 (8%),ATP binding (67%);ATPase activity (56%);ferrochelatase activity (8%),GO:0015833 (56%);GO:0019354 (8%);GO:0010001 (6%),peptide transport (56%);siroheme biosynthetic process (8%);glial cell differentiation (6%),IPR027417 (72%);IPR003439 (62%);IPR013563 (62%),P-loop containing nucleoside triphosphate hydrolase (72%);ABC transporter-like (62%);Oligopeptide/dipeptide ABC transporter, C-terminal (62%),,,,,,,,,,
MVLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.10 (21%);1.3.99.- (6%);4.1.1.15 (5%),Formyltetrahydrofolate deformylase (21%);With other acceptors (6%);Glutamate decarboxylase (5%),GO:0016021 (29%);GO:0005886 (4%);GO:0005737 (3%),integral component of membrane (29%);plasma membrane (4%);cytoplasm (3%),GO:0003677 (16%);GO:0050660 (15%);GO:0003995 (12%),DNA binding (16%);flavin adenine dinucleotide binding (15%);acyl-CoA dehydrogenase activity (12%),GO:0006189 (4%);GO:0006730 (3%);GO:0006355 (2%),'de novo' IMP biosynthetic process (4%);one-carbon metabolic process (3%);regulation of transcription, DNA-templated (2%),IPR036250 (13%);IPR009075 (13%);IPR009100 (13%),Acyl-CoA dehydrogenase-like, C-terminal (13%);Acyl-CoA dehydrogenase/oxidase C-terminal (13%);Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily (13%),,,,,,,,
QGSGAKPDDAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NELAQDK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%);GO:0005737 (17%);GO:0005886 (17%),integral component of membrane (33%);cytoplasm (17%);plasma membrane (17%),GO:0000156 (17%);GO:0005524 (17%);GO:0008134 (17%),phosphorelay response regulator activity (17%);ATP binding (17%);transcription factor binding (17%),GO:0010038 (50%);GO:0006355 (17%);GO:0006808 (17%),response to metal ion (50%);regulation of transcription, DNA-templated (17%);regulation of nitrogen utilization (17%),IPR004323 (43%);IPR011322 (43%);IPR015867 (43%),Divalent ion tolerance protein, CutA (43%);Nitrogen regulatory PII-like, alpha/beta (43%);Nitrogen regulatory protein PII/ATP phosphoribosyltransferase, C-terminal (43%),,,,,,,
LPQVESCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLYENYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.2 (100%),NADH:ubiquinone reductase (H(+)-translocating) (100%),GO:0016021 (33%);GO:0005634 (27%);GO:0009536 (27%),integral component of membrane (33%);nucleus (27%);plastid (27%),GO:0009824 (27%);GO:0016740 (13%);GO:0000150 (7%),AMP dimethylallyltransferase activity (27%);transferase activity (13%);recombinase activity (7%),GO:0008033 (47%);GO:0009691 (27%);GO:0042773 (7%),tRNA processing (47%);cytokinin biosynthetic process (27%);ATP synthesis coupled electron transport (7%),IPR027417 (50%);IPR018022 (44%);IPR039657 (44%),P-loop containing nucleoside triphosphate hydrolase (50%);IPP transferase (44%);Dimethylallyltransferase (44%),,,,,,,,,,,
HMLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.- (59%);2.4.1.- (11%);1.5.1.5 (3%),Phosphoric diester hydrolases (59%);Hexosyltransferases (11%);Methylenetetrahydrofolate dehydrogenase (NADP(+)) (3%),GO:0016021 (16%);GO:0005886 (4%);GO:0005737 (3%),integral component of membrane (16%);plasma membrane (4%);cytoplasm (3%),GO:0046872 (21%);GO:0004114 (19%);GO:0004842 (15%),metal ion binding (21%);3',5'-cyclic-nucleotide phosphodiesterase activity (19%);ubiquitin-protein transferase activity (15%),GO:0007165 (20%);GO:0009250 (3%);GO:0006397 (3%),signal transduction (20%);glucan biosynthetic process (3%);mRNA processing (3%),IPR002073 (18%);IPR036971 (18%);IPR023088 (18%),3'5'-cyclic nucleotide phosphodiesterase, catalytic domain (18%);3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily (18%);3'5'-cyclic nucleotide phosphodiesterase (18%),,,,,,,,
EEWQAQLR,Nocardioides ganghwensis,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Propionibacteriales,,,,,Nocardioidaceae,,,,Nocardioides,,,,Nocardioides ganghwensis,,,,,,,,,,,,IPR003829 (100%);IPR008778 (100%);IPR011051 (100%),Pirin, N-terminal domain (100%);Pirin, C-terminal domain (100%);RmlC-like cupin domain superfamily (100%),,,,,,,,,
TGGNVVCENR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (22%);5.2.1.8 (22%);1.3.7.7 (11%),Non-specific serine/threonine protein kinase (22%);Peptidylprolyl isomerase (22%);Ferredoxin:protochlorophyllide reductase (ATP-dependent) (11%),GO:0016021 (61%);GO:0000139 (55%);GO:0005801 (55%),integral component of membrane (61%);Golgi membrane (55%);cis-Golgi network (55%),GO:0005524 (10%);GO:0016887 (4%);GO:0003677 (3%),ATP binding (10%);ATPase activity (4%);DNA binding (3%),GO:0006888 (55%);GO:0015031 (47%);GO:0044874 (13%),endoplasmic reticulum to Golgi vesicle-mediated transport (55%);protein transport (47%);lipoprotein localization to outer membrane (13%),IPR023601 (51%);IPR004564 (13%);IPR018323 (13%),Golgi SNAP receptor complex, subunit 1 (51%);Outer membrane lipoprotein carrier protein LolA-like (13%);Outer membrane lipoprotein carrier protein LolA, Proteobacteria (13%),,,,,,,,,
TADVTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (44%);3.1.4.- (44%);6.1.1.10 (11%),Transaminases (44%);Phosphoric diester hydrolases (44%);Methionine--tRNA ligase (11%),GO:0005737 (9%);GO:0016021 (9%),cytoplasm (9%);integral component of membrane (9%),GO:0008483 (36%);GO:0046872 (36%);GO:0004114 (27%),transaminase activity (36%);metal ion binding (36%);3',5'-cyclic-nucleotide phosphodiesterase activity (27%),GO:0007165 (27%);GO:0009058 (27%);GO:0006431 (9%),signal transduction (27%);biosynthetic process (27%);methionyl-tRNA aminoacylation (9%),IPR002073 (36%);IPR003607 (36%);IPR004838 (36%),3'5'-cyclic nucleotide phosphodiesterase, catalytic domain (36%);HD/PDEase domain (36%);Aminotransferases, class-I, pyridoxal-phosphate-binding site (36%),,,,,,,
ASSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.2.4 (34%);2.3.2.27 (6%);7.1.1.- (5%),Deoxyribose-phosphate aldolase (34%);RING-type E3 ubiquitin transferase (6%);Hydron translocation or charge separation linked to oxidoreductase reactions (5%),GO:0016021 (26%);GO:0005737 (10%);GO:0005634 (4%),integral component of membrane (26%);cytoplasm (10%);nucleus (4%),GO:0005524 (12%);GO:0003677 (9%);GO:0004139 (7%),ATP binding (12%);DNA binding (9%);deoxyribose-phosphate aldolase activity (7%),GO:0009264 (5%);GO:0016052 (5%);GO:0046386 (5%),deoxyribonucleotide catabolic process (5%);carbohydrate catabolic process (5%);deoxyribose phosphate catabolic process (5%),IPR027417 (8%);IPR013785 (6%);IPR011343 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);Aldolase-type TIM barrel (6%);Deoxyribose-phosphate aldolase (5%),,,,,,,,,,,
MPVLPTPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (100%),catalytic activity (100%),,,IPR008928 (100%),Six-hairpin glycosidase superfamily (100%),,,,,,,,,,,
NMTHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.163 (99%);2.1.1.201 (98%);2.1.1.- (1%),Demethylmenaquinone methyltransferase (99%);2-methoxy-6-polyprenyl-1,4-benzoquinol methylase (98%);Methyltransferases (1%),GO:0016605 (2%);GO:0016021 (1%);GO:0005634 (1%),PML body (2%);integral component of membrane (1%);nucleus (1%),GO:0102955 (82%);GO:0043333 (82%);GO:0008270 (12%),S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity (82%);2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity (82%);zinc ion binding (12%),GO:0032259 (84%);GO:0009234 (82%);GO:0006744 (82%),methylation (84%);menaquinone biosynthetic process (82%);ubiquinone biosynthetic process (82%),IPR029063 (83%);IPR004033 (83%);IPR023576 (82%),S-adenosyl-L-methionine-dependent methyltransferase (83%);UbiE/COQ5 methyltransferase (83%);UbiE/COQ5 methyltransferase, conserved site (82%),,,,,,,,
GFDAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.47 (16%);2.3.1.179 (6%);1.8.1.4 (6%),GDP-mannose 4,6-dehydratase (16%);Beta-ketoacyl-[acyl-carrier-protein] synthase II (6%);Dihydrolipoyl dehydrogenase (6%),GO:0016021 (25%);GO:0005737 (6%);GO:0005886 (5%),integral component of membrane (25%);cytoplasm (6%);plasma membrane (5%),GO:0005524 (16%);GO:0003677 (8%);GO:0046872 (8%),ATP binding (16%);DNA binding (8%);metal ion binding (8%),GO:0030001 (5%);GO:0009401 (5%);GO:0045454 (5%),metal ion transport (5%);phosphoenolpyruvate-dependent sugar phosphotransferase system (5%);cell redox homeostasis (5%),IPR027417 (7%);IPR009057 (5%);IPR023214 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Homeobox-like domain superfamily (5%);HAD superfamily (5%),,,,,,,,,,
FEEDDWLVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEVPSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (75%);6.3.5.11 (25%),Polyphosphate kinase (75%);Cobyrinate a,c-diamide synthase (glutamine-hydrolyzing) (25%),GO:0009358 (34%);GO:0016021 (23%);GO:0005885 (6%),polyphosphate kinase complex (34%);integral component of membrane (23%);Arp2/3 protein complex (6%),GO:0005524 (57%);GO:0008976 (34%);GO:0046872 (34%),ATP binding (57%);polyphosphate kinase activity (34%);metal ion binding (34%),GO:0006799 (34%);GO:0006541 (11%);GO:0009236 (11%),polyphosphate biosynthetic process (34%);glutamine metabolic process (11%);cobalamin biosynthetic process (11%),IPR027417 (34%);IPR002789 (25%);IPR003414 (21%),P-loop containing nucleoside triphosphate hydrolase (34%);Helicase HerA, central domain (25%);Polyphosphate kinase (21%),,,,,,,,,
YLNNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (8%);3.1.22.4 (7%);5.6.2.1 (7%),Histidine kinase (8%);Crossover junction endodeoxyribonuclease (7%);DNA topoisomerase (7%),GO:0016021 (25%);GO:0019867 (15%);GO:0005737 (6%),integral component of membrane (25%);outer membrane (15%);cytoplasm (6%),GO:0005524 (15%);GO:0003677 (9%);GO:0030170 (6%),ATP binding (15%);DNA binding (9%);pyridoxal phosphate binding (6%),GO:0005975 (3%);GO:0006355 (2%);GO:0006310 (2%),carbohydrate metabolic process (3%);regulation of transcription, DNA-templated (2%);DNA recombination (2%),IPR000184 (11%);IPR015018 (9%);IPR027417 (7%),Bacterial surface antigen (D15) (11%);Protein of unknown function DUF1905 (9%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,
DAMEVLTHMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWYSASAQGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNSFHMR,Terrimicrobium sacchariphilum,Bacteria,,,,Verrucomicrobia,,,Spartobacteria,,,,,,,,,,,,,Terrimicrobium,,,,Terrimicrobium sacchariphilum,,,,,,,,,,,,IPR006311 (100%);IPR009045 (100%);IPR013230 (100%),Twin-arginine translocation pathway, signal sequence (100%);Hedgehog signalling/DD-peptidase zinc-binding domain superfamily (100%);Peptidase M15A, C-terminal (100%),,,,,,,,,
MYSPNVGVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMDVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (100%),Acting on ester bonds (100%),GO:0005737 (33%),cytoplasm (33%),GO:0003723 (33%);GO:0004521 (33%);GO:0004534 (33%),RNA binding (33%);endoribonuclease activity (33%);5'-3' exoribonuclease activity (33%),GO:0006364 (33%);GO:0006511 (33%),rRNA processing (33%);ubiquitin-dependent protein catabolic process (33%),IPR000182 (33%);IPR001279 (33%);IPR001587 (33%),GNAT domain (33%);Metallo-beta-lactamase (33%);Ribonuclease J, conserved site (33%),,,,,,,,,,
ELMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.205 (11%);2.3.2.27 (10%);1.1.1.169 (9%),IMP dehydrogenase (11%);RING-type E3 ubiquitin transferase (10%);2-dehydropantoate 2-reductase (9%),GO:0016021 (16%);GO:0005737 (3%);GO:1990077 (2%),integral component of membrane (16%);cytoplasm (3%);primosome complex (2%),GO:0005524 (33%);GO:0046872 (15%);GO:0003677 (6%),ATP binding (33%);metal ion binding (15%);DNA binding (6%),GO:0007264 (4%);GO:0005975 (3%);GO:0006268 (3%),small GTPase mediated signal transduction (4%);carbohydrate metabolic process (3%);DNA unwinding involved in DNA replication (3%),IPR027417 (18%);IPR008862 (6%);IPR014001 (6%),P-loop containing nucleoside triphosphate hydrolase (18%);T-complex 11 (6%);Helicase superfamily 1/2, ATP-binding domain (6%),,,,,,,,,,
NNPLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.16 (75%);4.2.1.24 (25%),Ribulokinase (75%);Porphobilinogen synthase (25%),GO:0016021 (32%);GO:0016020 (4%),integral component of membrane (32%);membrane (4%),GO:0005524 (32%);GO:0008741 (24%);GO:0004655 (12%),ATP binding (32%);ribulokinase activity (24%);porphobilinogen synthase activity (12%),GO:0019569 (24%);GO:0033014 (12%),L-arabinose catabolic process to xylulose 5-phosphate (24%);tetrapyrrole biosynthetic process (12%),IPR000577 (22%);IPR005929 (22%);IPR018484 (22%),Carbohydrate kinase, FGGY (22%);Ribulokinase (22%);Carbohydrate kinase, FGGY, N-terminal (22%),,,,,,,,
AFGER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.141 (49%);2.7.7.7 (12%);5.4.99.- (4%),4-alpha-D-((1->4)-alpha-D-glucano)trehalose trehalohydrolase (49%);DNA-directed DNA polymerase (12%);Transferring other groups (4%),GO:0005737 (23%);GO:0016021 (15%);GO:0005886 (3%),cytoplasm (23%);integral component of membrane (15%);plasma membrane (3%),GO:0033942 (18%);GO:0005524 (15%);GO:0003677 (13%),4-alpha-D-(1->4)-alpha-D-glucanotrehalose trehalohydrolase activity (18%);ATP binding (15%);DNA binding (13%),GO:0005992 (19%);GO:0006281 (6%);GO:0006261 (5%),trehalose biosynthetic process (19%);DNA repair (6%);DNA-dependent DNA replication (5%),IPR017853 (18%);IPR006047 (17%);IPR013783 (17%),Glycoside hydrolase superfamily (18%);Glycosyl hydrolase, family 13, catalytic domain (17%);Immunoglobulin-like fold (17%),,,,,,,,,
LSLACSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (43%);GO:0005634 (7%);GO:0005802 (7%),integral component of membrane (43%);nucleus (7%);trans-Golgi network (7%),GO:0003723 (14%);GO:0004672 (14%);GO:0005524 (14%),RNA binding (14%);protein kinase activity (14%);ATP binding (14%),GO:0016485 (7%);GO:0016486 (7%);GO:0032259 (7%),protein processing (7%);peptide hormone processing (7%);methylation (7%),IPR000719 (25%);IPR011009 (25%);IPR016024 (25%),Protein kinase domain (25%);Protein kinase-like domain superfamily (25%);Armadillo-type fold (25%),,,,,,,,,,,
TPESTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.1 (86%);3.6.1.- (74%);4.2.99.18 (9%),Nicotinamide-nucleotide adenylyltransferase (86%);In phosphorus-containing anhydrides (74%);DNA-(apurinic or apyrimidinic site) lyase (9%),GO:0016021 (12%);GO:0005623 (11%);GO:0005634 (8%),integral component of membrane (12%);cell (11%);nucleus (8%),GO:0016787 (42%);GO:0000309 (25%);GO:0003677 (9%),hydrolase activity (42%);nicotinamide-nucleotide adenylyltransferase activity (25%);DNA binding (9%),GO:0009058 (35%);GO:0045454 (11%);GO:0006285 (5%),biosynthetic process (35%);cell redox homeostasis (11%);base-excision repair, AP site formation (5%),IPR000086 (24%);IPR014729 (24%);IPR015797 (24%),NUDIX hydrolase domain (24%);Rossmann-like alpha/beta/alpha sandwich fold (24%);NUDIX hydrolase-like domain superfamily (24%),,,,,,,,,,
FRPYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (44%);2.1.1.199 (21%);3.1.26.4 (21%),Metalloendopeptidases (44%);16S rRNA (cytosine(1402)-N(4))-methyltransferase (21%);Ribonuclease H (21%),GO:0016021 (69%);GO:0005737 (4%);GO:0005615 (3%),integral component of membrane (69%);cytoplasm (4%);extracellular space (3%),GO:0022857 (8%);GO:0008270 (6%);GO:0004222 (5%),transmembrane transporter activity (8%);zinc ion binding (6%);metalloendopeptidase activity (5%),GO:0010923 (11%);GO:0015074 (3%);GO:0006401 (2%),negative regulation of phosphatase activity (11%);DNA integration (3%);RNA catabolic process (2%),IPR001611 (39%);IPR032675 (39%);IPR003591 (38%),Leucine-rich repeat (39%);Leucine-rich repeat domain superfamily (39%);Leucine-rich repeat, typical subtype (38%),,,,,,,,,,
LNLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (31%);2.7.11.1 (4%);3.6.4.12 (3%),Ribonucleoside-diphosphate reductase (31%);Non-specific serine/threonine protein kinase (4%);DNA helicase (3%),GO:0016021 (22%);GO:0005737 (10%);GO:0005623 (2%),integral component of membrane (22%);cytoplasm (10%);cell (2%),GO:0005524 (23%);GO:0003677 (8%);GO:0004748 (8%),ATP binding (23%);DNA binding (8%);ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor (8%),GO:0006260 (9%);GO:0006281 (2%);GO:0045454 (2%),DNA replication (9%);DNA repair (2%);cell redox homeostasis (2%),IPR027417 (11%);IPR005144 (7%);IPR008926 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);ATP-cone domain (7%);Ribonucleotide reductase R1 subunit, N-terminal (7%),,,,,,,,,
DVPDVDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.- (100%),Phosphotransferases with an alcohol group as acceptor (100%),GO:0009279 (5%);GO:0016021 (5%),cell outer membrane (5%);integral component of membrane (5%),GO:0016740 (60%);GO:0016301 (20%);GO:0046872 (20%),transferase activity (60%);kinase activity (20%);metal ion binding (20%),GO:0046677 (5%),response to antibiotic (5%),IPR002575 (75%);IPR011009 (75%);IPR041726 (71%),Aminoglycoside phosphotransferase (75%);Protein kinase-like domain superfamily (75%);Acyl-CoA dehydrogenase family member 10/11, N-terminal (71%),,,,,,,,,,
SPAMLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (74%);GO:0005743 (3%),integral component of membrane (74%);mitochondrial inner membrane (3%),GO:0003824 (9%);GO:0008168 (6%);GO:0016747 (6%),catalytic activity (9%);methyltransferase activity (6%);transferase activity, transferring acyl groups other than amino-acyl groups (6%),GO:0032259 (6%);GO:0006004 (3%),methylation (6%);fucose metabolic process (3%),IPR000731 (63%);IPR004869 (63%);IPR002656 (11%),Sterol-sensing domain (63%);Membrane transport protein MMPL domain (63%);Acyltransferase 3 (11%),,,,,,,,,,
SNAESTDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLLVMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.136 (91%);1.1.1.22 (3%);3.2.2.- (3%),ADP-dependent NAD(P)H-hydrate dehydratase (91%);UDP-glucose 6-dehydrogenase (3%);Hydrolyzing N-glycosyl compounds (3%),GO:0016021 (27%);GO:0005634 (8%);GO:0009279 (7%),integral component of membrane (27%);nucleus (8%);cell outer membrane (7%),GO:0005524 (39%);GO:0052855 (30%);GO:0016301 (13%),ATP binding (39%);ADP-dependent NAD(P)H-hydrate dehydratase activity (30%);kinase activity (13%),GO:0046496 (30%);GO:0006886 (7%);GO:0006465 (2%),nicotinamide nucleotide metabolic process (30%);intracellular protein transport (7%);signal peptide processing (2%),IPR000631 (26%);IPR029056 (26%);IPR017953 (23%),ATP-dependent (S)-NAD(P)H-hydrate dehydratase (26%);Ribokinase-like (26%);Carbohydrate kinase, predicted, conserved site (23%),,,,,,,,,
LNGTLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (29%);3.1.3.5 (14%);3.1.3.8 (14%),Transferring other groups (29%);5'-nucleotidase (14%);3-phytase (14%),GO:0016021 (22%);GO:0005737 (6%);GO:0005886 (6%),integral component of membrane (22%);cytoplasm (6%);plasma membrane (6%),GO:0005524 (25%);GO:0000287 (22%);GO:0003824 (19%),ATP binding (25%);magnesium ion binding (22%);catalytic activity (19%),GO:0001522 (6%);GO:0002098 (6%);GO:0006011 (3%),pseudouridine synthesis (6%);tRNA wobble uridine modification (6%);UDP-glucose metabolic process (3%),IPR027417 (26%);IPR001482 (20%);IPR011766 (14%),P-loop containing nucleoside triphosphate hydrolase (26%);Type II/IV secretion system protein (20%);Thiamine pyrophosphate enzyme, C-terminal TPP-binding (14%),,,,,,,,,,
WCPLSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMNTVLYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTNDTMMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVASNPR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (11%);GO:0016021 (11%),cytoplasm (11%);integral component of membrane (11%),GO:0003677 (67%);GO:0003700 (44%);GO:0003688 (11%),DNA binding (67%);DNA-binding transcription factor activity (44%);DNA replication origin binding (11%),GO:0006270 (11%);GO:0006275 (11%);GO:0006537 (11%),DNA replication initiation (11%);regulation of DNA replication (11%);glutamate biosynthetic process (11%),IPR000847 (67%);IPR005119 (67%);IPR036388 (67%),Transcription regulator HTH, LysR (67%);LysR, substrate-binding (67%);Winged helix-like DNA-binding domain superfamily (67%),,,,,,,,,
QTSYYLGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPLPAGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009366 (20%),enterobactin synthetase complex (20%),GO:0008909 (40%);GO:0016787 (40%);GO:0016833 (40%),isochorismate synthase activity (40%);hydrolase activity (40%);oxo-acid-lyase activity (40%),GO:0009058 (40%);GO:0009239 (20%),biosynthetic process (40%);enterobactin biosynthetic process (20%),IPR029058 (57%);IPR000073 (29%);IPR003832 (29%),Alpha/Beta hydrolase fold (57%);Alpha/beta hydrolase fold-1 (29%);Protein of unknown function DUF212 (29%),,,,,,,,,,,
WLFLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (50%);2.7.11.1 (25%);3.2.1.52 (25%),Hexosyltransferases (50%);Non-specific serine/threonine protein kinase (25%);Beta-N-acetylhexosaminidase (25%),GO:0016021 (79%);GO:0005886 (21%);GO:0000139 (5%),integral component of membrane (79%);plasma membrane (21%);Golgi membrane (5%),GO:0005524 (16%);GO:0003677 (11%);GO:0003824 (5%),ATP binding (16%);DNA binding (11%);catalytic activity (5%),GO:0055085 (13%);GO:0007049 (11%);GO:0007059 (11%),transmembrane transport (13%);cell cycle (11%);chromosome segregation (11%),IPR000515 (10%);IPR002543 (10%);IPR002549 (10%),ABC transporter type 1, transmembrane domain MetI-like (10%);FtsK domain (10%);Transmembrane protein TqsA-like (10%),,,,,,,,,,
YYAPGPK,Danio rerio,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,Cypriniphysae,Cypriniformes,Cyprinoidei,,,,Cyprinidae,,,,Danio,,,,Danio rerio,,,,,,GO:0001725 (33%);GO:0005737 (33%);GO:0005925 (33%),stress fiber (33%);cytoplasm (33%);focal adhesion (33%),GO:0046872 (100%),metal ion binding (100%),GO:0007165 (33%);GO:1901224 (33%),signal transduction (33%);positive regulation of NIK/NF-kappaB signaling (33%),IPR001781 (100%),Zinc finger, LIM-type (100%),,,,,,,,,,
MVMPSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0008270 (33%),zinc ion binding (33%),,,IPR000073 (50%);IPR029058 (50%);IPR006564 (25%),Alpha/beta hydrolase fold-1 (50%);Alpha/Beta hydrolase fold (50%);Zinc finger, PMZ-type (25%),,,,,,,,,,
FNGALNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.3.9 (100%),Phosphoenolpyruvate--protein phosphotransferase (100%),GO:0005737 (71%);GO:0009279 (29%),cytoplasm (71%);cell outer membrane (29%),GO:0008965 (71%);GO:0016301 (71%);GO:0046872 (71%),phosphoenolpyruvate-protein phosphotransferase activity (71%);kinase activity (71%);metal ion binding (71%),GO:0009401 (71%),phosphoenolpyruvate-dependent sugar phosphotransferase system (71%),IPR000121 (45%);IPR006318 (45%);IPR008279 (45%),PEP-utilising enzyme, C-terminal (45%);Phosphotransferase system, enzyme I-like (45%);PEP-utilising enzyme, mobile domain (45%),,,,,,,,
MLPPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (35%);6.3.4.19 (17%);3.6.5.0 (13%),DNA-directed DNA polymerase (35%);tRNA(Ile)-lysidine synthetase (17%); (13%),GO:0016021 (14%);GO:0005737 (12%);GO:0031251 (7%),integral component of membrane (14%);cytoplasm (12%);PAN complex (7%),GO:0008270 (15%);GO:0005524 (13%);GO:0046872 (7%),zinc ion binding (15%);ATP binding (13%);metal ion binding (7%),GO:2000574 (17%);GO:0000289 (7%);GO:0006397 (7%),regulation of microtubule motor activity (17%);nuclear-transcribed mRNA poly(A) tail shortening (7%);mRNA processing (7%),IPR006964 (15%);IPR033494 (15%);IPR010507 (11%),NUDE domain (15%);NUDE family (15%);Zinc finger, MYM-type (11%),,,,,,,,,,
QNTAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (17%);2.1.1.177 (13%);3.4.21.88 (12%),Phenylalanine--tRNA ligase (17%);23S rRNA (pseudouridine(1915)-N(3))-methyltransferase (13%);Repressor LexA (12%),GO:0016021 (29%);GO:0005737 (13%);GO:0005694 (5%),integral component of membrane (29%);cytoplasm (13%);chromosome (5%),GO:0005524 (20%);GO:0003677 (11%);GO:0051721 (7%),ATP binding (20%);DNA binding (11%);protein phosphatase 2A binding (7%),GO:0006260 (7%);GO:0007084 (7%);GO:0035307 (7%),DNA replication (7%);mitotic nuclear envelope reassembly (7%);positive regulation of protein dephosphorylation (7%),IPR027417 (12%);IPR036770 (7%);IPR035007 (6%),P-loop containing nucleoside triphosphate hydrolase (12%);Ankyrin repeat-containing domain superfamily (7%);Ankyrin repeat and LEM domain-containing protein 2 (6%),,,,,,,,,,,
NCQQLQQGDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTDNTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (44%);GO:0005634 (11%);GO:0005730 (11%),integral component of membrane (44%);nucleus (11%);nucleolus (11%),GO:0003676 (22%);GO:0003723 (22%);GO:0008236 (11%),nucleic acid binding (22%);RNA binding (22%);serine-type peptidase activity (11%),GO:0042255 (22%);GO:0042273 (11%),ribosome assembly (22%);ribosomal large subunit biogenesis (11%),IPR017500 (40%);IPR017501 (40%);IPR023908 (40%),Phage infection protein, YhgE, N-terminal (40%);Phage infection protein, YhgE, C-terminal (40%);xxxLxxG heptad repeat (40%),,,,,,,
AGTLDLSLK,Aurantimonas,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Aurantimonadaceae,,,,Aurantimonas,,,,,,,,,,,,,,,,IPR003812 (100%);IPR036597 (100%);IPR040198 (100%),Fido domain (100%);Fido-like domain superfamily (100%);Fido domain-containing protein (100%),,,,,,,,,,,
TPVLMVTPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLSTLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (33%);2.3.1.184 (8%);2.4.1.16 (8%),Acting on ATP; involved in cellular and subcellular movement (33%);Acyl-homoserine-lactone synthase (8%);Chitin synthase (8%),GO:0016021 (21%);GO:0005737 (8%);GO:1990077 (4%),integral component of membrane (21%);cytoplasm (8%);primosome complex (4%),GO:0046872 (32%);GO:0016491 (25%);GO:0003677 (15%),metal ion binding (32%);oxidoreductase activity (25%);DNA binding (15%),GO:0006268 (4%);GO:0006269 (4%);GO:0035556 (4%),DNA unwinding involved in DNA replication (4%);DNA replication, synthesis of RNA primer (4%);intracellular signal transduction (4%),IPR005123 (28%);IPR027443 (28%);IPR026992 (25%),Oxoglutarate/iron-dependent dioxygenase (28%);Isopenicillin N synthase-like (28%);Non-haem dioxygenase N-terminal domain (25%),,,,,,,,,,
VWDDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.11 (49%);6.1.1.4 (11%);2.7.7.6 (6%),Acetylornithine transaminase (49%);Leucine--tRNA ligase (11%);DNA-directed RNA polymerase (6%),GO:0016021 (17%);GO:0005618 (9%);GO:0005576 (8%),integral component of membrane (17%);cell wall (9%);extracellular region (8%),GO:0003677 (29%);GO:0008270 (26%);GO:0016491 (24%),DNA binding (29%);zinc ion binding (26%);oxidoreductase activity (24%),GO:0032259 (12%);GO:0007155 (8%);GO:0006349 (7%),methylation (12%);cell adhesion (8%);regulation of gene expression by genetic imprinting (7%),IPR036388 (23%);IPR036188 (23%);IPR002937 (23%),Winged helix-like DNA-binding domain superfamily (23%);FAD/NAD(P)-binding domain superfamily (23%);Amine oxidase (23%),,,,,,,,,,,
CWNWMVEDATLSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLTPGEFMMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EADNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.3 (50%);2.7.4.1 (25%);3.4.21.- (25%),Glycerol-3-phosphate dehydrogenase (50%);Polyphosphate kinase (25%);Serine endopeptidases (25%),GO:0016021 (29%);GO:0005759 (24%);GO:0001405 (7%),integral component of membrane (29%);mitochondrial matrix (24%);PAM complex, Tim23 associated import motor (7%),GO:0000774 (26%);GO:0042803 (26%);GO:0051087 (26%),adenyl-nucleotide exchange factor activity (26%);protein homodimerization activity (26%);chaperone binding (26%),GO:0006457 (26%);GO:0006336 (7%);GO:0030150 (7%),protein folding (26%);DNA replication-independent nucleosome assembly (7%);protein import into mitochondrial matrix (7%),IPR000740 (26%);IPR013805 (26%);IPR009012 (22%),GrpE nucleotide exchange factor (26%);GrpE nucleotide exchange factor, coiled-coil (26%);GrpE nucleotide exchange factor, head (22%),,,,,,,,
LAVLSMHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QELAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (15%);1.1.1.100 (15%);1.17.4.1 (8%),Oxidoreductases (15%);3-oxoacyl-[acyl-carrier-protein] reductase (15%);Ribonucleoside-diphosphate reductase (8%),GO:0009376 (40%);GO:0016021 (9%);GO:0005840 (1%),HslUV protease complex (40%);integral component of membrane (9%);ribosome (1%),GO:0005524 (54%);GO:0016887 (43%);GO:0070011 (38%),ATP binding (54%);ATPase activity (43%);peptidase activity, acting on L-amino acid peptides (38%),GO:0043335 (38%);GO:0006310 (4%);GO:0006281 (3%),protein unfolding (38%);DNA recombination (4%);DNA repair (3%),IPR027417 (49%);IPR003593 (38%);IPR004491 (36%),P-loop containing nucleoside triphosphate hydrolase (49%);AAA+ ATPase domain (38%);Heat shock protein HslU (36%),,,,,,,,,,
DVTSAEWR,Haloplanus,Archaea,,,,Euryarchaeota,,,Halobacteria,,,,Haloferacales,,,,,Haloferacaceae,,,,Haloplanus,,,,,,,,2.7.7.7 (100%);3.1.11.1 (100%),DNA-directed DNA polymerase (100%);Exodeoxyribonuclease I (100%),,,GO:0003677 (100%);GO:0003887 (100%);GO:0008408 (100%),DNA binding (100%);DNA-directed DNA polymerase activity (100%);3'-5' exonuclease activity (100%),GO:0000738 (100%);GO:0006261 (100%);GO:0016539 (50%),DNA catabolic process, exonucleolytic (100%);DNA-dependent DNA replication (100%);intein-mediated protein splicing (50%),IPR004475 (100%);IPR016033 (100%);IPR003586 (50%),DNA polymerase II large subunit DP2 (100%);DNA polymerase II large subunit DP2, N-terminal (100%);Hint domain C-terminal (50%),,,,,,,,,
ANQAPLR,Corynespora cassiicola,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Dothideomycetes,Pleosporomycetidae,,,Pleosporales,,,,,Corynesporascaceae,,,,Corynespora,,,,Corynespora cassiicola,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
TLALSMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.234 (50%);2.7.11.1 (50%);3.1.3.1 (50%),N(6)-L-threonylcarbamoyladenine synthase (50%);Non-specific serine/threonine protein kinase (50%);Alkaline phosphatase (50%),GO:0005737 (50%);GO:0016021 (20%);GO:0000408 (5%),cytoplasm (50%);integral component of membrane (20%);EKC/KEOPS complex (5%),GO:0005524 (50%);GO:0003697 (45%);GO:0004497 (15%),ATP binding (50%);single-stranded DNA binding (45%);monooxygenase activity (15%),GO:0006281 (45%);GO:0006260 (40%);GO:0009432 (40%),DNA repair (45%);DNA replication (40%);SOS response (40%),IPR024234 (82%);IPR001238 (8%);IPR027417 (8%),Protein of unknown function DUF3801 (82%);DNA-binding, RecF (8%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
YGKPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.77 (25%);2.4.1.18 (5%);2.4.2.9 (5%),Molybdenum cofactor guanylyltransferase (25%);1,4-alpha-glucan branching enzyme (5%);Uracil phosphoribosyltransferase (5%),GO:0016021 (33%);GO:0005840 (6%);GO:0005737 (4%),integral component of membrane (33%);ribosome (6%);cytoplasm (4%),GO:0016810 (15%);GO:0008061 (14%);GO:0016740 (13%),hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (15%);chitin binding (14%);transferase activity (13%),GO:0005975 (17%);GO:0006412 (6%);GO:0015074 (5%),carbohydrate metabolic process (17%);translation (6%);DNA integration (5%),IPR029044 (21%);IPR017853 (14%);IPR002509 (12%),Nucleotide-diphospho-sugar transferases (21%);Glycoside hydrolase superfamily (14%);NodB homology domain (12%),,,,,,,,,
QLNWLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.- (23%);6.5.1.2 (23%);1.1.1.22 (8%),Other carbon--nitrogen ligases (23%);DNA ligase (NAD(+)) (23%);UDP-glucose 6-dehydrogenase (8%),GO:0016021 (8%);GO:0005737 (1%);GO:0019012 (1%),integral component of membrane (8%);cytoplasm (1%);virion (1%),GO:0016787 (75%);GO:0003677 (6%);GO:0005524 (6%),hydrolase activity (75%);DNA binding (6%);ATP binding (6%),GO:0006306 (5%);GO:0009403 (3%);GO:0006351 (2%),DNA methylation (5%);toxin biosynthetic process (3%);transcription, DNA-templated (2%),IPR029052 (73%);IPR004843 (73%);IPR003961 (71%),Metallo-dependent phosphatase-like (73%);Calcineurin-like phosphoesterase domain, ApaH type (73%);Fibronectin type III (71%),,,,,,,,,
FVLDLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WMSVGHMPNEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLEVCHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQQGGPASPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVNNMTHER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYDMQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.3.1.1 (67%);2.7.7.48 (8%);3.6.1.1 (8%),Adenosylhomocysteinase (67%);RNA-directed RNA polymerase (8%);Inorganic diphosphatase (8%),GO:0005737 (54%);GO:0016021 (33%);GO:0005886 (10%),cytoplasm (54%);integral component of membrane (33%);plasma membrane (10%),GO:0016149 (51%);GO:0046873 (18%);GO:0015087 (10%),translation release factor activity, codon specific (51%);metal ion transmembrane transporter activity (18%);cobalt ion transmembrane transporter activity (10%),GO:0006730 (3%);GO:0005975 (1%);GO:0009264 (1%),one-carbon metabolic process (3%);carbohydrate metabolic process (1%);deoxyribonucleotide catabolic process (1%),IPR000352 (53%);IPR005139 (51%);IPR004373 (47%),Peptide chain release factor class I (53%);Peptide chain release factor (51%);Peptide chain release factor 1 (47%),,,,,,,,,,
DVAHGGYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMALPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.15 (25%);2.1.1.176 (25%);2.7.7.80 (25%),Peroxiredoxin (25%);16S rRNA (cytosine(967)-C(5))-methyltransferase (25%);Molybdopterin-synthase adenylyltransferase (25%),GO:0016021 (19%);GO:0005623 (6%);GO:0005737 (5%),integral component of membrane (19%);cell (6%);cytoplasm (5%),GO:0008641 (19%);GO:0016779 (11%);GO:0000287 (8%),ubiquitin-like modifier activating enzyme activity (19%);nucleotidyltransferase activity (11%);magnesium ion binding (8%),GO:0006777 (24%);GO:0031047 (6%);GO:0045454 (6%),Mo-molybdopterin cofactor biosynthetic process (24%);gene silencing by RNA (6%);cell redox homeostasis (6%),IPR000594 (14%);IPR012730 (14%);IPR035985 (14%),THIF-type NAD/FAD binding fold (14%);Molybdopterin synthase sulfurylase MoeB (14%);Ubiquitin-activating enzyme (14%),,,,,,,,,,,
ATLYTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0005737 (75%),cytoplasm (75%),GO:0016783 (75%);GO:0097163 (75%);GO:0003755 (25%),sulfurtransferase activity (75%);sulfur carrier activity (75%);peptidyl-prolyl cis-trans isomerase activity (25%),GO:0006777 (75%);GO:0006457 (25%),Mo-molybdopterin cofactor biosynthetic process (75%);protein folding (25%),IPR003786 (67%);IPR016193 (67%);IPR002130 (22%),Sulfur carrier protein FdhD (67%);Cytidine deaminase-like (67%);Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain (22%),,,,,,,,,,,
QVHMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (62%);GO:0009279 (46%),integral component of membrane (62%);cell outer membrane (46%),GO:0005524 (31%);GO:0046872 (15%);GO:0016301 (8%),ATP binding (31%);metal ion binding (15%);kinase activity (8%),,,IPR006664 (60%);IPR006665 (60%);IPR036737 (60%),Outer membrane protein, bacterial (60%);OmpA-like domain (60%);OmpA-like domain superfamily (60%),,,,,,,,,,
YALDNDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.42 (56%);7.6.2.1 (42%);4.2.1.46 (3%),Isocitrate dehydrogenase (NADP(+)) (56%);P-type phospholipid transporter (42%);dTDP-glucose 4,6-dehydratase (3%),GO:0016021 (38%);GO:0005737 (2%);GO:0005886 (2%),integral component of membrane (38%);cytoplasm (2%);plasma membrane (2%),GO:0000287 (77%);GO:0004450 (47%);GO:0051287 (43%),magnesium ion binding (77%);isocitrate dehydrogenase (NADP+) activity (47%);NAD binding (43%),GO:0006099 (45%);GO:0015914 (34%);GO:0006289 (2%),tricarboxylic acid cycle (45%);phospholipid transport (34%);nucleotide-excision repair (2%),IPR004439 (44%);IPR024084 (44%);IPR019818 (42%),Isocitrate dehydrogenase NADP-dependent, dimeric, prokaryotic (44%);Isopropylmalate dehydrogenase-like domain (44%);Isocitrate/isopropylmalate dehydrogenase, conserved site (42%),,,,,,,
NAPLSYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (80%);2.7.11.21 (20%),DNA-directed RNA polymerase (80%);Polo kinase (20%),GO:0016021 (52%);GO:0000790 (19%);GO:0042613 (5%),integral component of membrane (52%);nuclear chromatin (19%);MHC class II protein complex (5%),GO:0003899 (38%);GO:0003677 (33%);GO:0032549 (33%),DNA-directed 5'-3' RNA polymerase activity (38%);DNA binding (33%);ribonucleoside binding (33%),GO:0055085 (38%);GO:0006351 (33%);GO:0006955 (5%),transmembrane transport (38%);transcription, DNA-templated (33%);immune response (5%),IPR011701 (48%);IPR020846 (48%);IPR036259 (48%),Major facilitator superfamily (48%);Major facilitator superfamily domain (48%);MFS transporter superfamily (48%),,,,,,,,,,
NEDQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.5 (89%);1.8.4.11 (1%);2.3.3.13 (1%),Chorismate synthase (89%);Peptide-methionine (S)-S-oxide reductase (1%);2-isopropylmalate synthase (1%),GO:0016021 (18%);GO:0009279 (3%);GO:0005634 (2%),integral component of membrane (18%);cell outer membrane (3%);nucleus (2%),GO:0004107 (44%);GO:0005524 (8%);GO:0003677 (5%),chorismate synthase activity (44%);ATP binding (8%);DNA binding (5%),GO:0009073 (44%);GO:0009423 (43%);GO:0042026 (2%),aromatic amino acid family biosynthetic process (44%);chorismate biosynthetic process (43%);protein refolding (2%),IPR000453 (42%);IPR035904 (42%);IPR020541 (42%),Chorismate synthase (42%);Chorismate synthase AroC superfamily (42%);Chorismate synthase, conserved site (42%),,,,,,,,,,
MEVHSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008233 (100%),peptidase activity (100%),,,IPR001539 (50%);IPR009730 (50%);IPR032525 (50%),Peptidase U32 (50%);Micro-fibrillar-associated protein 1, C-terminal (50%);Peptidase family U32, C-terminal (50%),,,,,,,,,
AYFLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (52%);2.7.7.6 (11%);3.1.11.6 (11%),Protein-serine/threonine phosphatase (52%);DNA-directed RNA polymerase (11%);Exodeoxyribonuclease VII (11%),GO:0005856 (65%);GO:0043190 (9%);GO:0016021 (7%),cytoskeleton (65%);ATP-binding cassette (ABC) transporter complex (9%);integral component of membrane (7%),GO:0005085 (69%);GO:0008092 (46%);GO:0005524 (4%),guanyl-nucleotide exchange factor activity (69%);cytoskeletal protein binding (46%);ATP binding (4%),GO:0055085 (9%);GO:0070940 (4%);GO:0015969 (2%),transmembrane transport (9%);dephosphorylation of RNA polymerase II C-terminal domain (4%);guanosine tetraphosphate metabolic process (2%),IPR035899 (69%);IPR000219 (69%);IPR011993 (68%),Dbl homology (DH) domain superfamily (69%);Dbl homology (DH) domain (69%);PH-like domain superfamily (68%),,,,,,,,,,,
LVELAGFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQEAAGTNVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVPYAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.43 (100%),Transferred entry: 7.4.2.5 (100%),GO:0016021 (63%);GO:0005886 (7%),integral component of membrane (63%);plasma membrane (7%),GO:0022857 (33%);GO:0003677 (26%);GO:0003700 (26%),transmembrane transporter activity (33%);DNA binding (26%);DNA-binding transcription factor activity (26%),GO:0006857 (33%);GO:0006817 (7%);GO:0071467 (4%),oligopeptide transport (33%);phosphate ion transport (7%);cellular response to pH (4%),IPR000109 (41%);IPR018456 (41%);IPR036259 (41%),Proton-dependent oligopeptide transporter family (41%);PTR2 family proton/oligopeptide symporter, conserved site (41%);MFS transporter superfamily (41%),,,,,,,,,,
MPMDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (50%);3.6.3.- (50%),Protein-serine/threonine phosphatase (50%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (50%),GO:0005737 (61%);GO:0005576 (6%);GO:0005618 (6%),cytoplasm (61%);extracellular region (6%);cell wall (6%),GO:0016151 (61%);GO:0003677 (6%);GO:0005524 (6%),nickel cation binding (61%);DNA binding (6%);ATP binding (6%),GO:0006807 (61%);GO:0008643 (3%),nitrogen compound metabolic process (61%);carbohydrate transport (3%),IPR002669 (59%);IPR009459 (13%);IPR005877 (9%),Urease accessory protein UreD (59%);MucBP domain (13%);YSIRK Gram-positive signal peptide (9%),,,,,,,,,,,
LAPVAN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAVLTLGNDFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNPVSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (40%);3.4.-.- (20%);3.4.22.47 (20%),Peptidylprolyl isomerase (40%);Acting on peptide bonds (peptidases) (20%);Gingipain K (20%),GO:0016021 (70%);GO:0005737 (2%);GO:0042597 (2%),integral component of membrane (70%);cytoplasm (2%);periplasmic space (2%),GO:0008658 (16%);GO:0016740 (16%);GO:0003677 (9%),penicillin binding (16%);transferase activity (16%);DNA binding (9%),GO:0006310 (6%);GO:0015074 (6%);GO:0006457 (3%),DNA recombination (6%);DNA integration (6%);protein folding (3%),IPR000620 (42%);IPR006994 (14%);IPR001264 (12%),EamA domain (42%);TCF25/Rqc1 (14%);Glycosyl transferase, family 51 (12%),,,,,,,,,,
MVLTMFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSTGWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003682 (50%);GO:0003824 (50%);GO:0050662 (50%),chromatin binding (50%);catalytic activity (50%);coenzyme binding (50%),,,IPR001025 (50%);IPR001509 (50%);IPR036291 (50%),Bromo adjacent homology (BAH) domain (50%);NAD-dependent epimerase/dehydratase (50%);NAD(P)-binding domain superfamily (50%),,,,,,,,,,,
THMMMTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMGPNSK,Chryseobacterium,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Chryseobacterium,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR010090 (100%),Phage tail tape measure protein (100%),,,,,,,,,,,
YGSTAAGTLNMAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HEPLMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMEQEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.99.1 (12%);6.3.2.4 (12%);2.7.1.71 (6%),Hydroxylamine reductase (12%);D-alanine--D-alanine ligase (12%);Shikimate kinase (6%),GO:0016021 (19%);GO:0005737 (7%);GO:0005856 (4%),integral component of membrane (19%);cytoplasm (7%);cytoskeleton (4%),GO:0005524 (18%);GO:0051287 (14%);GO:0016616 (14%),ATP binding (18%);NAD binding (14%);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (14%),GO:0006886 (4%);GO:0007018 (2%);GO:0030001 (2%),intracellular protein transport (4%);microtubule-based movement (2%);metal ion transport (2%),IPR036291 (12%);IPR006140 (11%);IPR006139 (11%),NAD(P)-binding domain superfamily (12%);D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain (11%);D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (11%),,,,,,,
ALVAAYDK,Jannaschia pohangensis,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhodobacterales,,,,,Rhodobacteraceae,,,,Jannaschia,,,,Jannaschia pohangensis,,,,,,,,GO:0016829 (100%),lyase activity (100%),,,IPR000887 (100%);IPR013785 (100%),KDPG/KHG aldolase (100%);Aldolase-type TIM barrel (100%),,,,,,,,,,,
FEYMSMYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLTLANNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (100%),catalytic activity (100%),,,IPR001736 (50%);IPR006626 (50%);IPR010994 (50%),Phospholipase D/Transphosphatidylase (50%);Parallel beta-helix repeat (50%);RuvA domain 2-like (50%),,,,,,,,,,,
SGPFNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042128 (100%),nitrate assimilation (100%),IPR036374 (100%),Oxidoreductase, molybdopterin-binding domain superfamily (100%),,,,,,,,,,
QSWEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (17%);GO:0005634 (8%);GO:0005874 (8%),cell outer membrane (17%);nucleus (8%);microtubule (8%),GO:0008703 (42%);GO:0000287 (8%);GO:0003677 (8%),5-amino-6-(5-phosphoribosylamino)uracil reductase activity (42%);magnesium ion binding (8%);DNA binding (8%),GO:0009231 (42%);GO:0000226 (8%);GO:0006432 (8%),riboflavin biosynthetic process (42%);microtubule cytoskeleton organization (8%);phenylalanyl-tRNA aminoacylation (8%),IPR002734 (38%);IPR024072 (38%);IPR000531 (15%),Bacterial bifunctional deaminase-reductase, C-terminal (38%);Dihydrofolate reductase-like domain superfamily (38%);TonB-dependent receptor-like, beta-barrel (15%),,,,,,,,,
MWGFFLMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNQTTSEN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YACPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (50%);5.6.2.1 (30%);2.4.1.57 (10%),Leucine--tRNA ligase (50%);DNA topoisomerase (30%);Transferred entry: 2.4.1.345 (10%),GO:0005737 (18%);GO:0009380 (15%);GO:0016021 (5%),cytoplasm (18%);excinuclease repair complex (15%);integral component of membrane (5%),GO:0001000 (48%);GO:0003677 (19%);GO:0005524 (19%),bacterial-type RNA polymerase core enzyme binding (48%);DNA binding (19%);ATP binding (19%),GO:0045893 (48%);GO:0006289 (17%);GO:0009432 (9%),positive regulation of transcription, DNA-templated (48%);nucleotide-excision repair (17%);SOS response (9%),IPR024474 (29%);IPR025182 (29%);IPR038638 (29%),Zinc-finger binding domain of transposase IS66 (29%);RNA polymerase-binding protein RbpA (29%);RbpA superfamily (29%),,,,,,,,,,
MHENNLQVVDLGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (33%);2.7.7.7 (22%);3.2.1.- (6%),Hydron translocation or charge separation linked to oxidoreductase reactions (33%);DNA-directed DNA polymerase (22%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (6%),GO:0016021 (21%);GO:0005634 (20%);GO:0005694 (18%),integral component of membrane (21%);nucleus (20%);chromosome (18%),GO:0008270 (22%);GO:0002039 (19%);GO:0018024 (16%),zinc ion binding (22%);p53 binding (19%);histone-lysine N-methyltransferase activity (16%),GO:0019684 (4%);GO:0000122 (4%);GO:0006260 (3%),photosynthesis, light reaction (4%);negative regulation of transcription by RNA polymerase II (4%);DNA replication (3%),IPR036770 (17%);IPR002110 (16%);IPR020683 (16%),Ankyrin repeat-containing domain superfamily (17%);Ankyrin repeat (16%);Ankyrin repeat-containing domain (16%),,,,,,,,,
TYPFLMNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDPPLNTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPAGC,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (100%),Endopeptidase La (100%),,,GO:0004176 (100%);GO:0004252 (100%);GO:0005524 (100%),ATP-dependent peptidase activity (100%);serine-type endopeptidase activity (100%);ATP binding (100%),GO:0030163 (100%),protein catabolic process (100%),IPR008269 (100%);IPR014721 (100%);IPR020568 (100%),Peptidase S16, Lon proteolytic domain (100%);Ribosomal protein S5 domain 2-type fold, subgroup (100%);Ribosomal protein S5 domain 2-type fold (100%),,,,,,,,,
QMWCHLTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEYVELEQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLEVGCHDLPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYDYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.7 (15%);3.6.3.41 (9%);3.1.-.- (7%),Peroxidase (15%);Transferred entry: 7.6.2.5 (9%);Acting on ester bonds (7%),GO:0016021 (11%);GO:0005737 (4%);GO:0005576 (2%),integral component of membrane (11%);cytoplasm (4%);extracellular region (2%),GO:0005524 (60%);GO:0016887 (50%);GO:0016740 (18%),ATP binding (60%);ATPase activity (50%);transferase activity (18%),GO:0006281 (3%);GO:0005975 (2%);GO:0006438 (2%),DNA repair (3%);carbohydrate metabolic process (2%);valyl-tRNA aminoacylation (2%),IPR027417 (50%);IPR003439 (46%);IPR003593 (46%),P-loop containing nucleoside triphosphate hydrolase (50%);ABC transporter-like (46%);AAA+ ATPase domain (46%),,,,,,,,,,,
MAEMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.5.1 (55%);3.6.4.- (17%);7.1.1.- (7%),Succinate dehydrogenase (quinone) (55%);Acting on ATP; involved in cellular and subcellular movement (17%);Hydron translocation or charge separation linked to oxidoreductase reactions (7%),GO:0016020 (11%);GO:0016021 (10%);GO:0005737 (4%),membrane (11%);integral component of membrane (10%);cytoplasm (4%),GO:0046872 (27%);GO:0051539 (25%);GO:0005524 (25%),metal ion binding (27%);4 iron, 4 sulfur cluster binding (25%);ATP binding (25%),GO:0006099 (20%);GO:0031460 (11%);GO:0006353 (8%),tricarboxylic acid cycle (20%);glycine betaine transport (11%);DNA-templated transcription, termination (8%),IPR036010 (22%);IPR012675 (22%);IPR009051 (22%),2Fe-2S ferredoxin-like superfamily (22%);Beta-grasp domain superfamily (22%);Alpha-helical ferredoxin (22%),,,,,,,,,
VVWPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (99%);3.6.1.66 (1%),Nucleotidyltransferases (99%);XTP/dITP diphosphatase (1%),GO:1990077 (63%);GO:0016021 (30%);GO:0005886 (12%),primosome complex (63%);integral component of membrane (30%);plasma membrane (12%),GO:0003677 (63%);GO:0003896 (63%);GO:0008270 (63%),DNA binding (63%);DNA primase activity (63%);zinc ion binding (63%),GO:0006260 (1%);GO:0007020 (1%);GO:0009117 (1%),DNA replication (1%);microtubule nucleation (1%);nucleotide metabolic process (1%),IPR006171 (62%);IPR013264 (62%);IPR034151 (62%),TOPRIM  domain (62%);DNA primase, catalytic core, N-terminal (62%);Bacterial DnaG primase, TOPRIM domain (62%),,,,,,,,
FYAASDFNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVLPSDGYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.6 (17%);1.1.1.262 (13%);3.1.26.3 (5%),Acetolactate synthase (17%);4-hydroxythreonine-4-phosphate dehydrogenase (13%);Ribonuclease III (5%),GO:0016021 (38%);GO:0005886 (14%);GO:0005737 (12%),integral component of membrane (38%);plasma membrane (14%);cytoplasm (12%),GO:0003677 (10%);GO:0000287 (10%);GO:0003824 (8%),DNA binding (10%);magnesium ion binding (10%);catalytic activity (8%),GO:0055085 (10%);GO:0009401 (4%);GO:0005975 (3%),transmembrane transport (10%);phosphoenolpyruvate-dependent sugar phosphotransferase system (4%);carbohydrate metabolic process (3%),IPR012001 (6%);IPR029061 (6%);IPR029035 (6%),Thiamine pyrophosphate enzyme, N-terminal TPP-binding domain (6%);Thiamin diphosphate-binding fold (6%);DHS-like NAD/FAD-binding domain superfamily (6%),,,,,,,,,,
GWHLVNK,Alphaproteobacteria bacterium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,,,,,,,,,,,,,,Alphaproteobacteria bacterium,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
LLESHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.18 (10%);2.7.7.27 (7%);6.1.1.10 (7%),5-(carboxyamino)imidazole ribonucleotide mutase (10%);Glucose-1-phosphate adenylyltransferase (7%);Methionine--tRNA ligase (7%),GO:0016021 (22%);GO:0005737 (8%);GO:0005886 (3%),integral component of membrane (22%);cytoplasm (8%);plasma membrane (3%),GO:0005524 (23%);GO:0003677 (14%);GO:0046872 (6%),ATP binding (23%);DNA binding (14%);metal ion binding (6%),GO:0006355 (4%);GO:0006189 (3%);GO:0009432 (2%),regulation of transcription, DNA-templated (4%);'de novo' IMP biosynthetic process (3%);SOS response (2%),IPR027417 (10%);IPR036390 (7%);IPR036890 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Winged helix DNA-binding domain superfamily (7%);Histidine kinase/HSP90-like ATPase superfamily (6%),,,,,,,,,,
TLWMLSLMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLVMHR,Candidatus Marinimicrobia bacterium,Bacteria,,,,Candidatus Marinimicrobia,,,,,,,,,,,,,,,,,,,,Candidatus Marinimicrobia bacterium,,,,,,,,GO:0004146 (100%),dihydrofolate reductase activity (100%),GO:0046654 (100%),tetrahydrofolate biosynthetic process (100%),IPR001796 (100%);IPR024072 (100%),Dihydrofolate reductase domain (100%);Dihydrofolate reductase-like domain superfamily (100%),,,,,,,,,,,
LLEGNDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.61 (75%);3.5.1.44 (75%);3.1.3.1 (8%),Protein-glutamate methylesterase (75%);Protein-glutamine glutaminase (75%);Alkaline phosphatase (8%),GO:0005737 (24%);GO:0005840 (12%);GO:0016021 (12%),cytoplasm (24%);ribosome (12%);integral component of membrane (12%),GO:0008984 (21%);GO:0050568 (21%);GO:0000156 (19%),protein-glutamate methylesterase activity (21%);protein-glutamine glutaminase activity (21%);phosphorelay response regulator activity (19%),GO:0006482 (21%);GO:0006935 (21%);GO:0018277 (21%),protein demethylation (21%);chemotaxis (21%);protein deamination (21%),IPR000673 (18%);IPR001789 (18%);IPR008248 (18%),Signal transduction response regulator, chemotaxis, protein-glutamate methylesterase (18%);Signal transduction response regulator, receiver domain (18%);Protein-glutamate methylesterase/protein-glutamine glutaminase, CheB type (18%),,,,,,,
DDHNPVLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDLGDAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.37 (57%);2.3.1.8 (14%);3.5.1.4 (14%),Uroporphyrinogen decarboxylase (57%);Phosphate acetyltransferase (14%);Amidase (14%),GO:0016021 (33%);GO:0005737 (14%);GO:0005886 (5%),integral component of membrane (33%);cytoplasm (14%);plasma membrane (5%),GO:0005524 (14%);GO:0004853 (12%);GO:0043138 (10%),ATP binding (14%);uroporphyrinogen decarboxylase activity (12%);3'-5' DNA helicase activity (10%),GO:0006260 (10%);GO:0006281 (10%);GO:0006310 (10%),DNA replication (10%);DNA repair (10%);DNA recombination (10%),IPR027417 (27%);IPR000257 (8%);IPR038071 (8%),P-loop containing nucleoside triphosphate hydrolase (27%);Uroporphyrinogen decarboxylase (URO-D) (8%);UROD/MetE-like superfamily (8%),,,,,,,,,,,
DFVLLMVLN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLFMTLFANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVHNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.37 (42%);1.8.1.9 (41%);2.3.1.- (2%),Uroporphyrinogen decarboxylase (42%);Thioredoxin-disulfide reductase (41%);Transferring groups other than amino-acyl groups (2%),GO:0016021 (37%);GO:0005737 (25%);GO:0005634 (2%),integral component of membrane (37%);cytoplasm (25%);nucleus (2%),GO:0004853 (13%);GO:0004791 (13%);GO:0003677 (6%),uroporphyrinogen decarboxylase activity (13%);thioredoxin-disulfide reductase activity (13%);DNA binding (6%),GO:0006782 (13%);GO:0019430 (13%);GO:0006352 (2%),protoporphyrinogen IX biosynthetic process (13%);removal of superoxide radicals (13%);DNA-templated transcription, initiation (2%),IPR036188 (14%);IPR000257 (13%);IPR008255 (13%),FAD/NAD(P)-binding domain superfamily (14%);Uroporphyrinogen decarboxylase (URO-D) (13%);Pyridine nucleotide-disulphide oxidoreductase, class-II, active site (13%),,,,,,,,
TLVSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.-.-.- (10%);3.1.4.- (9%);2.3.1.54 (9%),Lyases (10%);Phosphoric diester hydrolases (9%);Formate C-acetyltransferase (9%),GO:0016021 (18%);GO:0005737 (9%);GO:0009279 (4%),integral component of membrane (18%);cytoplasm (9%);cell outer membrane (4%),GO:0005524 (14%);GO:0046872 (11%);GO:0003677 (9%),ATP binding (14%);metal ion binding (11%);DNA binding (9%),GO:0005975 (5%);GO:0007165 (2%);GO:0008616 (2%),carbohydrate metabolic process (5%);signal transduction (2%);queuosine biosynthetic process (2%),IPR027417 (8%);IPR036396 (6%);IPR001128 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);Cytochrome P450 superfamily (6%);Cytochrome P450 (5%),,,,,,,,,,,
TSTLELVGGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WSAATPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVTWYWWYM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSCSEYYDLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLDDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.99.17 (65%);7.1.1.- (8%);3.4.21.53 (1%),S-adenosylmethionine:tRNA ribosyltransferase-isomerase (65%);Hydron translocation or charge separation linked to oxidoreductase reactions (8%);Endopeptidase La (1%),GO:0005737 (33%);GO:0016021 (16%);GO:0005886 (2%),cytoplasm (33%);integral component of membrane (16%);plasma membrane (2%),GO:0016853 (31%);GO:0016740 (19%);GO:0016757 (14%),isomerase activity (31%);transferase activity (19%);transferase activity, transferring glycosyl groups (14%),GO:0008616 (26%);GO:0006420 (2%);GO:0006355 (2%),queuosine biosynthetic process (26%);arginyl-tRNA aminoacylation (2%);regulation of transcription, DNA-templated (2%),IPR003699 (27%);IPR036100 (27%);IPR042118 (27%),S-adenosylmethionine:tRNA ribosyltransferase-isomerase,  QueA (27%);S-adenosylmethionine:tRNA ribosyltransferase-isomerase,  QueA superfamily (27%);QueA, domain 1 (27%),,,,,,
TMFSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.3 (11%);3.6.4.- (11%);3.1.-.- (8%),Glycerol-3-phosphate dehydrogenase (11%);Acting on ATP; involved in cellular and subcellular movement (11%);Acting on ester bonds (8%),GO:0048188 (52%);GO:0016021 (13%);GO:0044666 (6%),Set1C/COMPASS complex (52%);integral component of membrane (13%);MLL3/4 complex (6%),GO:0008168 (15%);GO:0003677 (9%);GO:0044212 (8%),methyltransferase activity (15%);DNA binding (9%);transcription regulatory region DNA binding (8%),GO:0051568 (47%);GO:0006974 (6%);GO:0008284 (6%),histone H3-K4 methylation (47%);cellular response to DNA damage stimulus (6%);positive regulation of cell population proliferation (6%),IPR037353 (47%);IPR013320 (46%);IPR003877 (45%),Histone methyltransferase complex subunit ASH2 (47%);Concanavalin A-like lectin/glucanase domain superfamily (46%);SPRY domain (45%),,,,,,,,,,,
QFVVSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (33%);3.4.24.- (33%);5.2.1.8 (17%),Histidine kinase (33%);Metalloendopeptidases (33%);Peptidylprolyl isomerase (17%),GO:0016021 (35%);GO:0005886 (6%);GO:0005737 (3%),integral component of membrane (35%);plasma membrane (6%);cytoplasm (3%),GO:0008234 (21%);GO:0005524 (18%);GO:0000155 (14%),cysteine-type peptidase activity (21%);ATP binding (18%);phosphorelay sensor kinase activity (14%),GO:0006355 (15%);GO:0051409 (6%);GO:0006813 (4%),regulation of transcription, DNA-templated (15%);response to nitrosative stress (6%);potassium ion transport (4%),IPR038765 (22%);IPR003653 (17%);IPR035965 (13%),Papain-like cysteine peptidase superfamily (22%);Ulp1 protease family, C-terminal catalytic domain (17%);PAS domain superfamily (13%),,,,,,,,,
FEWCNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WELFVMVSNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFLVYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.27 (50%);3.6.4.12 (25%);2.3.2.3 (13%),Undecaprenyl-diphosphate phosphatase (50%);DNA helicase (25%);Lysyltransferase (13%),GO:0016021 (74%);GO:0005886 (7%);GO:0000408 (1%),integral component of membrane (74%);plasma membrane (7%);EKC/KEOPS complex (1%),GO:0003824 (49%);GO:0003677 (5%);GO:0003746 (5%),catalytic activity (49%);DNA binding (5%);translation elongation factor activity (5%),GO:0046677 (5%);GO:0008360 (4%);GO:0009252 (4%),response to antibiotic (5%);regulation of cell shape (4%);peptidoglycan biosynthetic process (4%),IPR000873 (44%);IPR042099 (44%);IPR020845 (40%),AMP-dependent synthetase/ligase (44%);AMP-dependent synthetase-like superfamily (44%);AMP-binding, conserved site (40%),,,,,,,,,,
LEVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.13 (7%);1.3.1.54 (6%);4.1.99.17 (6%),2-isopropylmalate synthase (7%);Precorrin-6A reductase (6%);Phosphomethylpyrimidine synthase (6%),GO:0016021 (18%);GO:0005737 (9%);GO:0005886 (3%),integral component of membrane (18%);cytoplasm (9%);plasma membrane (3%),GO:0005524 (20%);GO:0003677 (8%);GO:0003700 (8%),ATP binding (20%);DNA binding (8%);DNA-binding transcription factor activity (8%),GO:0009236 (4%);GO:0000105 (4%);GO:0006355 (3%),cobalamin biosynthetic process (4%);histidine biosynthetic process (4%);regulation of transcription, DNA-templated (3%),IPR027417 (14%);IPR003593 (7%);IPR003439 (7%),P-loop containing nucleoside triphosphate hydrolase (14%);AAA+ ATPase domain (7%);ABC transporter-like (7%),,,,,,,,,,
SEVDLSEYENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEGFMVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVLNNYYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPTVVCNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPNQALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.5.2.7 (100%),ABC-type D-ribose transporter (100%),GO:0005886 (11%);GO:0016021 (11%),plasma membrane (11%);integral component of membrane (11%),GO:0003824 (33%);GO:0003676 (22%);GO:0051536 (22%),catalytic activity (33%);nucleic acid binding (22%);iron-sulfur cluster binding (22%),GO:0015074 (22%);GO:0006306 (11%),DNA integration (22%);DNA methylation (11%),IPR006638 (33%);IPR007197 (33%);IPR013785 (33%),Elp3/MiaB/NifB (33%);Radical SAM (33%);Aldolase-type TIM barrel (33%),,,,,,,,,,,
DAVEVVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),GO:0015450 (80%),P-P-bond-hydrolysis-driven protein transmembrane transporter activity (80%),GO:0006605 (100%);GO:0043952 (100%);GO:0065002 (100%),protein targeting (100%);protein transport by the Sec complex (100%);intracellular protein transmembrane transport (100%),IPR005791 (83%);IPR022645 (83%);IPR022646 (83%),Protein translocase subunit SecD (83%);Protein-export membrane protein SecD/SecF, bacterial (83%);Protein-export membrane protein SecD/SecF/SecDF, conserved site (83%),,,,,,,,,
WNPCVNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDVLLVNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAVWPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAGDFYGHLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EQQDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (18%);6.1.1.20 (18%);2.4.1.- (9%),DNA-directed DNA polymerase (18%);Phenylalanine--tRNA ligase (18%);Hexosyltransferases (9%),GO:0016021 (30%);GO:0005737 (14%);GO:0005634 (8%),integral component of membrane (30%);cytoplasm (14%);nucleus (8%),GO:0005524 (17%);GO:0003723 (8%);GO:0003677 (7%),ATP binding (17%);RNA binding (8%);DNA binding (7%),GO:0070929 (5%);GO:0006260 (2%);GO:0006281 (2%),trans-translation (5%);DNA replication (2%);DNA repair (2%),IPR027417 (16%);IPR012683 (15%);IPR013083 (13%),P-loop containing nucleoside triphosphate hydrolase (16%);Conserved hypothetical protein CHP02302, transmembrane (15%);Zinc finger, RING/FYVE/PHD-type (13%),,,,,,,,,
ANSLLTFR,Bacteroidales bacterium,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,,,,,,,,,Bacteroidales bacterium,,,,,,,,,,,,,,,,,,,,,,,,
TLTPSHGANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NATTNPR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (33%),nucleus (33%),GO:0003723 (67%);GO:0000981 (33%);GO:0003677 (33%),RNA binding (67%);DNA-binding transcription factor activity, RNA polymerase II-specific (33%);DNA binding (33%),GO:0006351 (33%),transcription, DNA-templated (33%),IPR014720 (67%);IPR001138 (33%);IPR007219 (33%),Double-stranded RNA-binding domain (67%);Zn(2)-C6 fungal-type DNA-binding domain (33%);Transcription factor domain, fungi (33%),,,,,,,,
NLPLGQLSLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVMFTYEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFMLPNK,Basidiobolus meristosporus,Eukaryota,Fungi,,,Zoopagomycota,Entomophthoromycotina,,Basidiobolomycetes,,,,Basidiobolales,,,,,Basidiobolaceae,,,,Basidiobolus,,,,Basidiobolus meristosporus,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0017176 (100%),phosphatidylinositol N-acetylglucosaminyltransferase activity (100%),GO:0006506 (100%),GPI anchor biosynthetic process (100%),IPR007720 (100%),N-acetylglucosaminyl transferase component (100%),,,,,,,,,,,
YMMDLWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TELNQMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.3.9 (100%),Phosphoenolpyruvate--protein phosphotransferase (100%),GO:0005634 (25%);GO:0005737 (25%),nucleus (25%);cytoplasm (25%),GO:0003676 (25%);GO:0008270 (25%);GO:0008965 (25%),nucleic acid binding (25%);zinc ion binding (25%);phosphoenolpyruvate-protein phosphotransferase activity (25%),GO:0009401 (25%),phosphoenolpyruvate-dependent sugar phosphotransferase system (25%),IPR011059 (40%);IPR013108 (40%);IPR032466 (40%),Metal-dependent hydrolase, composite domain superfamily (40%);Amidohydrolase 3 (40%);Metal-dependent hydrolase (40%),,,,,,,,,,
MLLEELTCQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSDQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.4 (22%);1.1.1.38 (16%);3.6.4.- (9%),Phospholipase A(2) (22%);Malate dehydrogenase (oxaloacetate-decarboxylating) (16%);Acting on ATP; involved in cellular and subcellular movement (9%),GO:0016021 (25%);GO:0005737 (13%);GO:0009279 (2%),integral component of membrane (25%);cytoplasm (13%);cell outer membrane (2%),GO:0005524 (17%);GO:0003677 (14%);GO:0046872 (12%),ATP binding (17%);DNA binding (14%);metal ion binding (12%),GO:0009395 (6%);GO:0006353 (3%);GO:0006355 (3%),phospholipid catabolic process (6%);DNA-templated transcription, termination (3%);regulation of transcription, DNA-templated (3%),IPR027417 (10%);IPR036291 (7%);IPR016035 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);NAD(P)-binding domain superfamily (7%);Acyl transferase/acyl hydrolase/lysophospholipase (6%),,,,,,,,,
SGCLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (19%);4.2.1.9 (5%);1.2.1.70 (4%),Phenylalanine--tRNA ligase (19%);Dihydroxy-acid dehydratase (5%);Glutamyl-tRNA reductase (4%),GO:0005634 (20%);GO:0016021 (19%);GO:0005737 (8%),nucleus (20%);integral component of membrane (19%);cytoplasm (8%),GO:0000977 (15%);GO:0005524 (11%);GO:0003677 (9%),RNA polymerase II regulatory region sequence-specific DNA binding (15%);ATP binding (11%);DNA binding (9%),GO:0006355 (16%);GO:0006432 (2%);GO:0015074 (1%),regulation of transcription, DNA-templated (16%);phenylalanyl-tRNA aminoacylation (2%);DNA integration (1%),IPR005172 (63%);IPR033467 (63%);IPR028307 (58%),CRC domain (63%);Tesmin/TSO1-like CXC domain (63%);Lin-54 family (58%),,,,,,,,,,
GFNTVFR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (21%);GO:0005886 (7%),integral component of membrane (21%);plasma membrane (7%),GO:0005524 (86%);GO:0004386 (57%);GO:0000155 (7%),ATP binding (86%);helicase activity (57%);phosphorelay sensor kinase activity (7%),GO:0006355 (7%);GO:0042908 (7%),regulation of transcription, DNA-templated (7%);xenobiotic transport (7%),IPR000330 (52%);IPR001650 (52%);IPR014001 (52%),SNF2-related, N-terminal domain (52%);Helicase, C-terminal (52%);Helicase superfamily 1/2, ATP-binding domain (52%),,,,,,,
TPPGTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0003677 (33%);GO:0003824 (33%);GO:0004222 (4%),DNA binding (33%);catalytic activity (33%);metalloendopeptidase activity (4%),GO:0006355 (33%);GO:0055085 (13%),regulation of transcription, DNA-templated (33%);transmembrane transport (13%),IPR000843 (33%);IPR010982 (33%);IPR028082 (33%),LacI-type HTH domain (33%);Lambda repressor-like, DNA-binding domain superfamily (33%);Periplasmic binding protein-like I (33%),,,,,,,,,
QAFMDMTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAAWGNPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EACEAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EADWPNSPDMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEDAAEVPACFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVAWFLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CESLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.3 (38%);1.1.5.3 (13%);1.4.3.19 (13%),Uridine phosphorylase (38%);Glycerol-3-phosphate dehydrogenase (13%);Glycine oxidase (13%),GO:0016021 (8%);GO:0005737 (2%);GO:0030286 (1%),integral component of membrane (8%);cytoplasm (2%);dynein complex (1%),GO:0008887 (13%);GO:0003677 (7%);GO:0003700 (5%),glycerate kinase activity (13%);DNA binding (7%);DNA-binding transcription factor activity (5%),GO:0031023 (51%);GO:0051225 (51%);GO:0031388 (13%),microtubule organizing center organization (51%);spindle assembly (51%);organic acid phosphorylation (13%),IPR028346 (43%);IPR004381 (11%);IPR036129 (11%),HAUS augmin-like complex subunit 2 (43%);Glycerate kinase (11%);Glycerate kinase superfamily (11%),,,,,,,,,,,
WSMDDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.2 (100%),Non-specific protein-tyrosine kinase (100%),GO:0005886 (67%);GO:0016021 (11%),plasma membrane (67%);integral component of membrane (11%),GO:0003677 (11%);GO:0004715 (11%);GO:0005524 (11%),DNA binding (11%);non-membrane spanning protein tyrosine kinase activity (11%);ATP binding (11%),,,IPR003760 (60%);IPR024453 (20%);IPR038765 (20%),ABC transporter substrate-binding protein PnrA-like (60%);Permuted papain-like amidase enzyme, YaeF/YiiX, C92 family (20%);Papain-like cysteine peptidase superfamily (20%),,,,,,,,,
SLGCDQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTEQNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.10 (100%),Bacterial leucyl aminopeptidase (100%),GO:0005856 (50%);GO:0009276 (8%);GO:0015627 (8%),cytoskeleton (50%);Gram-negative-bacterium-type cell wall (8%);type II protein secretion system complex (8%),GO:0003779 (42%);GO:0008270 (17%);GO:0003676 (8%),actin binding (42%);zinc ion binding (17%);nucleic acid binding (8%),GO:0006260 (8%);GO:0015628 (8%),DNA replication (8%);protein secretion by the type II secretion system (8%),IPR000299 (50%);IPR000798 (50%);IPR011993 (50%),FERM domain (50%);Ezrin/radixin/moesin-like (50%);PH-like domain superfamily (50%),,,,,,,,,,,
LPVAWETMPLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVLMMPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLLTPAR,Pelagibaca abyssi,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhodobacterales,,,,,Rhodobacteraceae,,,,Pelagibaca,,,,Pelagibaca abyssi,,,,5.1.3.13 (100%),dTDP-4-dehydrorhamnose 3,5-epimerase (100%),,,GO:0008830 (100%),dTDP-4-dehydrorhamnose 3,5-epimerase activity (100%),GO:0019305 (100%),dTDP-rhamnose biosynthetic process (100%),IPR000888 (100%);IPR011051 (100%);IPR014710 (100%),dTDP-4-dehydrorhamnose 3,5-epimerase-related (100%);RmlC-like cupin domain superfamily (100%);RmlC-like jelly roll fold (100%),,,,,,,,
FDLDLFFFVPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYLQGHVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESSEVFCPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNFHLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (100%),Acting on ATP; involved in cellular and subcellular movement (100%),GO:0005886 (67%);GO:0070382 (11%);GO:1990077 (11%),plasma membrane (67%);exocytic vesicle (11%);primosome complex (11%),GO:0005524 (89%);GO:0016887 (67%);GO:0001786 (11%),ATP binding (89%);ATPase activity (67%);phosphatidylserine binding (11%),GO:0051301 (78%);GO:0007049 (67%);GO:0006268 (11%),cell division (78%);cell cycle (67%);DNA unwinding involved in DNA replication (11%),IPR027417 (89%);IPR003439 (78%);IPR003593 (78%),P-loop containing nucleoside triphosphate hydrolase (89%);ABC transporter-like (78%);AAA+ ATPase domain (78%),,,,,,,,,,,
VELDHVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLNEPSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.4 (50%);3.6.5.- (50%),Amidase (50%);Acting on GTP; involved in cellular and subcellular movement (50%),GO:0016021 (50%);GO:0005634 (25%);GO:0005737 (25%),integral component of membrane (50%);nucleus (25%);cytoplasm (25%),GO:0004040 (25%);GO:0005525 (25%);GO:0016740 (25%),amidase activity (25%);GTP binding (25%);transferase activity (25%),,,IPR000120 (33%);IPR003123 (33%);IPR004130 (33%),Amidase (33%);VPS9 domain (33%);GPN-loop GTPase (33%),,,,,,,,,,,
MAPYMPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMSLVPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QSMPLAALHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAGTALPR,Massilia,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Oxalobacteraceae,,,,Massilia,,,,,,,,,,,,GO:0005524 (100%);GO:0016887 (100%),ATP binding (100%);ATPase activity (100%),,,IPR003439 (100%);IPR003593 (100%);IPR017871 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);ABC transporter, conserved site (100%),,,,,,,,,,
DMNHWPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNLFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.13 (31%);2.4.1.- (10%);2.7.7.49 (10%),tRNA-uridine 2-sulfurtransferase (31%);Hexosyltransferases (10%);RNA-directed DNA polymerase (10%),GO:0016021 (49%);GO:0005737 (11%);GO:0005886 (4%),integral component of membrane (49%);cytoplasm (11%);plasma membrane (4%),GO:0005524 (12%);GO:0016740 (8%);GO:0016783 (6%),ATP binding (12%);transferase activity (8%);sulfurtransferase activity (6%),GO:0006400 (5%);GO:0019290 (3%);GO:0006282 (2%),tRNA modification (5%);siderophore biosynthetic process (3%);regulation of DNA repair (2%),IPR003362 (8%);IPR014729 (6%);IPR004506 (5%),Bacterial sugar transferase (8%);Rossmann-like alpha/beta/alpha sandwich fold (6%);tRNA-specific 2-thiouridylase (5%),,,,,,,,,,,
EHWLCQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTWASWPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLENSSTPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYNNDEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGDTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.34 (41%);1.8.1.8 (17%);7.4.2.11 (7%),2,4-dienoyl-CoA reductase (NADPH) (41%);Protein-disulfide reductase (17%);ABC-type methionine transporter (7%),GO:0016021 (20%);GO:0005623 (19%);GO:0005737 (11%),integral component of membrane (20%);cell (19%);cytoplasm (11%),GO:0005524 (22%);GO:0015035 (19%);GO:0003684 (10%),ATP binding (22%);protein disulfide oxidoreductase activity (19%);damaged DNA binding (10%),GO:0006662 (19%);GO:0045454 (19%);GO:0006310 (18%),glycerol ether metabolic process (19%);cell redox homeostasis (19%);DNA recombination (18%),IPR027417 (18%);IPR005746 (16%);IPR013766 (16%),P-loop containing nucleoside triphosphate hydrolase (18%);Thioredoxin (16%);Thioredoxin domain (16%),,,,,,,,,,
YAQMVMTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYAQVMSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLHALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.129 (100%),Flavin prenyltransferase (100%),GO:0009898 (50%);GO:0032153 (50%);GO:0016021 (11%),cytoplasmic side of plasma membrane (50%);cell division site (50%);integral component of membrane (11%),GO:0003700 (11%);GO:0043565 (11%);GO:0016829 (6%),DNA-binding transcription factor activity (11%);sequence-specific DNA binding (11%);lyase activity (6%),GO:0043093 (50%);GO:0051301 (22%);GO:0051188 (6%),FtsZ-dependent cytokinesis (50%);cell division (22%);cofactor biosynthetic process (6%),IPR003494 (45%);IPR020823 (45%);IPR011045 (34%),SHS2 domain inserted in FtsA (45%);Cell division protein FtsA (45%);Nitrous oxide reductase, N-terminal (34%),,,,,,,,,,
LLATGMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.78 (45%);2.7.3.9 (18%);3.1.-.- (18%),6,7-dimethyl-8-ribityllumazine synthase (45%);Phosphoenolpyruvate--protein phosphotransferase (18%);Acting on ester bonds (18%),GO:0005737 (2%);GO:0009349 (2%);GO:0016021 (1%),cytoplasm (2%);riboflavin synthase complex (2%);integral component of membrane (1%),GO:0003723 (72%);GO:0003677 (20%);GO:0046872 (10%),RNA binding (72%);DNA binding (20%);metal ion binding (10%),GO:0006355 (12%);GO:0045892 (5%);GO:0046677 (5%),regulation of transcription, DNA-templated (12%);negative regulation of transcription, DNA-templated (5%);response to antibiotic (5%),IPR036442 (71%);IPR016103 (70%);IPR021065 (66%),ProQ/FinO domain superfamily (71%);ProQ/FinO domain (70%);Fertility inhibition protein FinO, N-terminal (66%),,,,,,,
SEALSPAK,Octopus bimaculoides,Eukaryota,Metazoa,,,Mollusca,,,Cephalopoda,Coleoidea,Neocoleoidea,Octopodiformes,Octopoda,Incirrata,,,,Octopodidae,,,,Octopus,,,,Octopus bimaculoides,,,,,,,,GO:0003723 (100%),RNA binding (100%),,,IPR003652 (100%);IPR036096 (100%),Ataxin, AXH domain (100%);Ataxin, AXH domain superfamily (100%),,,,,,,,,
WEQNYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.2 (100%),UDP-glucose 4-epimerase (100%),,,GO:0003978 (100%);GO:0050662 (40%),UDP-glucose 4-epimerase activity (100%);coenzyme binding (40%),GO:0006012 (100%),galactose metabolic process (100%),IPR005886 (83%);IPR036291 (83%);IPR016040 (50%),UDP-glucose 4-epimerase (83%);NAD(P)-binding domain superfamily (83%);NAD(P)-binding domain (50%),,,,,,,,,,,
TPFLDDCYGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVMYDLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHVVVLFAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNATGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.12 (29%);3.1.21.3 (27%);6.1.1.23 (10%),tRNA pseudouridine(38-40) synthase (29%);Type I site-specific deoxyribonuclease (27%);Aspartate--tRNA(Asn) ligase (10%),GO:0005737 (14%);GO:0016021 (12%);GO:0019867 (4%),cytoplasm (14%);integral component of membrane (12%);outer membrane (4%),GO:0005524 (18%);GO:0003677 (16%);GO:0003723 (11%),ATP binding (18%);DNA binding (16%);RNA binding (11%),GO:0031119 (11%);GO:0006457 (10%);GO:0009307 (9%),tRNA pseudouridine synthesis (11%);protein folding (10%);DNA restriction-modification system (9%),IPR027417 (11%);IPR001406 (9%);IPR020095 (9%),P-loop containing nucleoside triphosphate hydrolase (11%);Pseudouridine synthase I, TruA (9%);Pseudouridine synthase I, TruA, C-terminal (9%),,,,,,,,
QTLEDAQMYVDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFYLGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLPPTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.3 (51%);2.7.7.27 (13%);3.4.21.89 (8%),Glycerol-3-phosphate dehydrogenase (51%);Glucose-1-phosphate adenylyltransferase (13%);Signal peptidase I (8%),GO:0009331 (18%);GO:0016021 (16%);GO:0005737 (2%),glycerol-3-phosphate dehydrogenase complex (18%);integral component of membrane (16%);cytoplasm (2%),GO:0000155 (12%);GO:0005524 (12%);GO:0052591 (12%),phosphorelay sensor kinase activity (12%);ATP binding (12%);sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity (12%),GO:0006072 (18%);GO:0006396 (4%);GO:0007283 (4%),glycerol-3-phosphate metabolic process (18%);RNA processing (4%);spermatogenesis (4%),IPR036188 (15%);IPR000447 (14%);IPR006076 (14%),FAD/NAD(P)-binding domain superfamily (15%);FAD-dependent glycerol-3-phosphate dehydrogenase (14%);FAD dependent oxidoreductase (14%),,,,,,,,,,,
HLFATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAEVPGNHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNTYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.2.11 (28%);3.1.3.2 (9%);3.2.2.0 (9%),Phosphoglycerate mutase (2,3-diphosphoglycerate-dependent) (28%);Acid phosphatase (9%); (9%),GO:0016021 (21%);GO:0005737 (5%);GO:0009279 (4%),integral component of membrane (21%);cytoplasm (5%);cell outer membrane (4%),GO:0003677 (19%);GO:0008170 (15%);GO:0046872 (11%),DNA binding (19%);N-methyltransferase activity (15%);metal ion binding (11%),GO:0006306 (15%);GO:0006096 (6%);GO:0032259 (5%),DNA methylation (15%);glycolytic process (6%);methylation (5%),IPR041635 (17%);IPR029063 (15%);IPR003356 (14%),Type ISP restriction-modification enzyme LLaBIII, C-terminal specificity domain (17%);S-adenosyl-L-methionine-dependent methyltransferase (15%);DNA methylase, adenine-specific (14%),,,,,,,,
TLQNMVAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSMQSAVR,Deinococcus,Bacteria,,,,Deinococcus-Thermus,,,Deinococci,,,,Deinococcales,,,,,Deinococcaceae,,,,Deinococcus,,,,,,,,,,,,GO:0003824 (50%);GO:0004386 (50%);GO:0005524 (50%),catalytic activity (50%);helicase activity (50%);ATP binding (50%),,,IPR001736 (100%);IPR025202 (100%);IPR000330 (50%),Phospholipase D/Transphosphatidylase (100%);Phospholipase D-like domain (100%);SNF2-related, N-terminal domain (50%),,,,,,,,,,
NFEWMESNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNSALAVVTVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEPPAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (19%);3.2.1.132 (14%);3.1.21.1 (8%),DNA-directed DNA polymerase (19%);Chitosanase (14%);Deoxyribonuclease I (8%),GO:0016021 (20%);GO:0005886 (4%);GO:0005737 (2%),integral component of membrane (20%);plasma membrane (4%);cytoplasm (2%),GO:0004045 (18%);GO:0005524 (15%);GO:0003677 (7%),aminoacyl-tRNA hydrolase activity (18%);ATP binding (15%);DNA binding (7%),GO:0015833 (6%);GO:0006355 (3%);GO:0006310 (3%),peptide transport (6%);regulation of transcription, DNA-templated (3%);DNA recombination (3%),IPR002833 (17%);IPR023476 (17%);IPR027417 (13%),Peptidyl-tRNA hydrolase, PTH2 (17%);Peptidyl-tRNA hydrolase II domain superfamily (17%);P-loop containing nucleoside triphosphate hydrolase (13%),,,,,,,,,
TSSFYLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.129 (100%),Peptidoglycan glycosyltransferase (100%),GO:0005887 (50%);GO:0016021 (17%),integral component of plasma membrane (50%);integral component of membrane (17%),GO:0008955 (50%);GO:0003676 (17%);GO:0004386 (17%),peptidoglycan glycosyltransferase activity (50%);nucleic acid binding (17%);helicase activity (17%),GO:0008360 (50%);GO:0009252 (50%);GO:0051301 (50%),regulation of cell shape (50%);peptidoglycan biosynthetic process (50%);cell division (50%),IPR001182 (33%);IPR010095 (33%);IPR011923 (33%),Probable peptidoglycan glycosyltransferase FtsW/RodA (33%);Transposase IS605, OrfB, C-terminal (33%);Probable peptidoglycan glycosyltransferase RodA/MrdB (33%),,,,,,,,,
LNAMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (32%);2.4.2.14 (10%);2.4.1.21 (8%),Polyphosphate kinase (32%);Amidophosphoribosyltransferase (10%);Starch synthase (8%),GO:0016021 (20%);GO:0005737 (5%);GO:0005634 (5%),integral component of membrane (20%);cytoplasm (5%);nucleus (5%),GO:0008976 (27%);GO:0005524 (14%);GO:0003677 (8%),polyphosphate kinase activity (27%);ATP binding (14%);DNA binding (8%),GO:0007165 (5%);GO:0000027 (4%);GO:0051301 (3%),signal transduction (5%);ribosomal large subunit assembly (4%);cell division (3%),IPR027417 (38%);IPR022488 (27%);IPR022486 (26%),P-loop containing nucleoside triphosphate hydrolase (38%);Polyphosphate kinase-2-related (27%);Polyphosphate kinase 2, PA0141 (26%),,,,,,,,,,
SSTLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.15 (35%);2.3.3.9 (13%);1.2.1.50 (7%),Biotin--[biotin carboxyl-carrier protein] ligase (35%);Malate synthase (13%);Long-chain-fatty-acyl-CoA reductase (7%),GO:0016021 (15%);GO:0005737 (8%);GO:0009279 (3%),integral component of membrane (15%);cytoplasm (8%);cell outer membrane (3%),GO:0004077 (18%);GO:0005524 (11%);GO:0003677 (8%),biotin-[acetyl-CoA-carboxylase] ligase activity (18%);ATP binding (11%);DNA binding (8%),GO:0006355 (19%);GO:0006464 (15%);GO:0006097 (4%),regulation of transcription, DNA-templated (19%);cellular protein modification process (15%);glyoxylate cycle (4%),IPR036388 (17%);IPR036390 (16%);IPR004143 (14%),Winged helix-like DNA-binding domain superfamily (17%);Winged helix DNA-binding domain superfamily (16%);Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain (14%),,,,,,,,,
VFFSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.1 (50%);2.1.1.216 (25%);2.7.8.26 (25%),Phosphoribosylformylglycinamidine cyclo-ligase (50%);tRNA (guanine(26)-N(2))-dimethyltransferase (25%);Adenosylcobinamide-GDP ribazoletransferase (25%),GO:0005874 (23%);GO:0016021 (11%);GO:0005737 (5%),microtubule (23%);integral component of membrane (11%);cytoplasm (5%),GO:0008080 (36%);GO:0008017 (23%);GO:0003824 (11%),N-acetyltransferase activity (36%);microtubule binding (23%);catalytic activity (11%),GO:0044038 (7%);GO:0006189 (5%);GO:0009236 (2%),cell wall macromolecule biosynthetic process (7%);'de novo' IMP biosynthetic process (5%);cobalamin biosynthetic process (2%),IPR016181 (43%);IPR038740 (39%);IPR000182 (36%),Acyl-CoA N-acyltransferase (43%);BioF2-like, acetyltransferase domain (39%);GNAT domain (36%),,,,,,,,,,
EPVNDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.48 (67%);3.2.1.24 (17%);6.2.1.- (17%),Histone acetyltransferase (67%);Alpha-mannosidase (17%);Acid--thiol ligases (17%),GO:0016021 (12%);GO:0035267 (7%);GO:0005634 (2%),integral component of membrane (12%);NuA4 histone acetyltransferase complex (7%);nucleus (2%),GO:0005096 (51%);GO:0003676 (19%);GO:0004402 (7%),GTPase activator activity (51%);nucleic acid binding (19%);histone acetyltransferase activity (7%),GO:0007165 (37%);GO:0006355 (7%);GO:0006779 (2%),signal transduction (37%);regulation of transcription, DNA-templated (7%);porphyrin-containing compound biosynthetic process (2%),IPR000198 (55%);IPR008936 (55%);IPR025757 (54%),Rho GTPase-activating protein domain (55%);Rho GTPase activation protein (55%);Ternary complex factor MIP1, leucine-zipper (54%),,,,,,,,,
MEQMTGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EATDVMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTLWVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (33%);3.6.4.12 (33%);4.2.1.24 (33%),Beta-galactosidase (33%);DNA helicase (33%);Porphobilinogen synthase (33%),GO:0016021 (50%);GO:0005886 (5%),integral component of membrane (50%);plasma membrane (5%),GO:0003743 (18%);GO:0005524 (14%);GO:0030144 (14%),translation initiation factor activity (18%);ATP binding (14%);alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity (14%),GO:0006487 (14%);GO:0005975 (9%);GO:0006779 (5%),protein N-linked glycosylation (14%);carbohydrate metabolic process (9%);porphyrin-containing compound biosynthetic process (5%),IPR001253 (15%);IPR006196 (15%);IPR012340 (15%),Translation initiation factor 1A (eIF-1A) (15%);RNA-binding domain, S1, IF1 type (15%);Nucleic acid-binding, OB-fold (15%),,,,,,,
ASHMYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR001322 (50%);IPR003961 (50%);IPR013783 (50%),Lamin tail domain (50%);Fibronectin type III (50%);Immunoglobulin-like fold (50%),,,,,,,,,,,
QNEGTQGTPSLGSPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENMEGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SAYVVVK,Eubacterium plexicaudatum,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Eubacteriaceae,,,,Eubacterium,,,,Eubacterium plexicaudatum,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC transporter permease protein domain (100%);MacB-like periplasmic core domain (100%),,,,,,,,,,,
MLNSVAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPQLAFAPETRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQWFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000148 (20%);GO:0016021 (20%),1,3-beta-D-glucan synthase complex (20%);integral component of membrane (20%),GO:0016746 (80%);GO:0003843 (20%);GO:0016874 (20%),transferase activity, transferring acyl groups (80%);1,3-beta-D-glucan synthase activity (20%);ligase activity (20%),GO:0006075 (20%),(1->3)-beta-D-glucan biosynthetic process (20%),IPR000873 (80%);IPR002123 (80%);IPR020845 (80%),AMP-dependent synthetase/ligase (80%);Phospholipid/glycerol acyltransferase (80%);AMP-binding, conserved site (80%),,,,,,,
HLVLLEGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPLEECGLRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVETLYK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),,,IPR001279 (100%);IPR036866 (100%),Metallo-beta-lactamase (100%);Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (100%),,,,,,,,,,,
STVETMDGVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPWTMNVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLEAQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.61 (21%);2.6.1.- (12%);4.1.1.37 (9%),Hydroxymethylbilane synthase (21%);Transaminases (12%);Uroporphyrinogen decarboxylase (9%),GO:0005737 (46%);GO:0009380 (42%);GO:0016021 (5%),cytoplasm (46%);excinuclease repair complex (42%);integral component of membrane (5%),GO:0005524 (50%);GO:0003677 (49%);GO:0016887 (43%),ATP binding (50%);DNA binding (49%);ATPase activity (43%),GO:0006289 (46%);GO:0009432 (44%);GO:0030036 (15%),nucleotide-excision repair (46%);SOS response (44%);actin cytoskeleton organization (15%),IPR027417 (39%);IPR004807 (36%);IPR041471 (36%),P-loop containing nucleoside triphosphate hydrolase (39%);UvrABC system, subunit B (36%);UvrB, interaction domain (36%),,,,,,,,,
MLALAPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVDGRPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMQNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (50%);1.1.1.100 (7%);1.1.1.88 (7%),Acting on GTP; involved in cellular and subcellular movement (50%);3-oxoacyl-[acyl-carrier-protein] reductase (7%);Hydroxymethylglutaryl-CoA reductase (7%),GO:0016021 (30%);GO:0005789 (8%);GO:0005634 (7%),integral component of membrane (30%);endoplasmic reticulum membrane (8%);nucleus (7%),GO:0004180 (32%);GO:0005525 (8%);GO:0003924 (5%),carboxypeptidase activity (32%);GTP binding (8%);GTPase activity (5%),GO:0009306 (5%);GO:0044780 (5%);GO:0009847 (3%),protein secretion (5%);bacterial-type flagellum assembly (5%);spore germination (3%),IPR003507 (32%);IPR027461 (32%);IPR027478 (32%),Peptidase family S66 (32%);LD-carboxypeptidase A, C-terminal domain superfamily (32%);Murein tetrapeptide carboxypeptidase, N-terminal (32%),,,,,,,,,
ESVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.2.2 (40%);1.1.1.284 (18%);2.7.7.7 (5%),H(+)-transporting two-sector ATPase (40%);S-(hydroxymethyl)glutathione dehydrogenase (18%);DNA-directed DNA polymerase (5%),GO:0016021 (19%);GO:0005840 (18%);GO:0005886 (10%),integral component of membrane (19%);ribosome (18%);plasma membrane (10%),GO:0003735 (18%);GO:0005524 (17%);GO:0008270 (8%),structural constituent of ribosome (18%);ATP binding (17%);zinc ion binding (8%),GO:0006412 (18%);GO:0015986 (7%);GO:0006069 (3%),translation (18%);ATP synthesis coupled proton transport (7%);ethanol oxidation (3%),IPR027417 (15%);IPR014719 (15%);IPR000206 (15%),P-loop containing nucleoside triphosphate hydrolase (15%);Ribosomal protein L7/L12, C-terminal/adaptor protein ClpS-like (15%);Ribosomal protein L7/L12 (15%),,,,,,,,,,
WSCHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (67%);1.14.14.94 (11%);3.6.4.12 (11%),Methyltransferases (67%);Leukotriene-B(4) 20-monooxygenase (11%);DNA helicase (11%),GO:0016021 (50%);GO:0005737 (11%);GO:0005768 (6%),integral component of membrane (50%);cytoplasm (11%);endosome (6%),GO:0008168 (28%);GO:0004198 (11%);GO:0005524 (11%),methyltransferase activity (28%);calcium-dependent cysteine-type endopeptidase activity (11%);ATP binding (11%),GO:0032259 (28%);GO:0006352 (6%);GO:0006426 (6%),methylation (28%);DNA-templated transcription, initiation (6%);glycyl-tRNA aminoacylation (6%),IPR004159 (21%);IPR029063 (21%);IPR011430 (14%),Putative S-adenosyl-L-methionine-dependent methyltransferase (21%);S-adenosyl-L-methionine-dependent methyltransferase (21%);Down-regulated-in-metastasis protein (14%),,,,,,,,,,
FVFVSHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPMNLTYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLEWWMLEAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
METLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.141 (5%);3.6.1.23 (4%);2.2.1.6 (3%),Heme o synthase (5%);dUTP diphosphatase (4%);Acetolactate synthase (3%),GO:0016021 (30%);GO:0005737 (10%);GO:0005886 (5%),integral component of membrane (30%);cytoplasm (10%);plasma membrane (5%),GO:0005524 (14%);GO:0003677 (8%);GO:0046872 (6%),ATP binding (14%);DNA binding (8%);metal ion binding (6%),GO:0006355 (2%);GO:0006289 (2%);GO:0009432 (2%),regulation of transcription, DNA-templated (2%);nucleotide-excision repair (2%);SOS response (2%),IPR027417 (8%);IPR023224 (4%);IPR015138 (4%),P-loop containing nucleoside triphosphate hydrolase (8%);Salmonella invasion protein A, C-terminal actin-binding domain superfamily (4%);Salmonella invasion protein A, N-terminal (4%),,,,,,,,
NDMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (15%);3.1.-.- (12%);2.5.1.- (9%),DNA helicase (15%);Acting on ester bonds (12%);Transferring alkyl or aryl groups, other than methyl groups (9%),GO:0016021 (36%);GO:0005737 (7%);GO:0019031 (3%),integral component of membrane (36%);cytoplasm (7%);viral envelope (3%),GO:0003677 (11%);GO:0005524 (9%);GO:0016491 (7%),DNA binding (11%);ATP binding (9%);oxidoreductase activity (7%),GO:0006310 (5%);GO:0005975 (2%);GO:0006364 (2%),DNA recombination (5%);carbohydrate metabolic process (2%);rRNA processing (2%),IPR036291 (12%);IPR013783 (12%);IPR003404 (11%),NAD(P)-binding domain superfamily (12%);Immunoglobulin-like fold (12%);Envelope glycoprotein E (11%),,,,,,,,,,
QEMYGLSQWPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVNNLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (50%);3.1.21.5 (50%),DNA-directed DNA polymerase (50%);Type III site-specific deoxyribonuclease (50%),GO:0005634 (3%),nucleus (3%),GO:0003677 (61%);GO:0005524 (56%);GO:0004519 (36%),DNA binding (61%);ATP binding (56%);endonuclease activity (36%),GO:0006260 (3%);GO:0006304 (3%),DNA replication (3%);DNA modification (3%),IPR027417 (51%);IPR006935 (49%);IPR023210 (28%),P-loop containing nucleoside triphosphate hydrolase (51%);Helicase/UvrB, N-terminal (49%);NADP-dependent oxidoreductase domain (28%),,,,,,,,,,
TNCQGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (100%),Transferring groups other than amino-acyl groups (100%),GO:0005730 (20%);GO:0016021 (20%),nucleolus (20%);integral component of membrane (20%),GO:0005044 (40%);GO:0008080 (40%);GO:0030247 (40%),scavenger receptor activity (40%);N-acetyltransferase activity (40%);polysaccharide binding (40%),GO:0006955 (40%);GO:0000154 (20%);GO:0042274 (20%),immune response (40%);rRNA modification (20%);ribosomal small subunit biogenesis (20%),IPR001212 (40%);IPR013562 (40%);IPR018487 (40%),Somatomedin B domain (40%);tRNA(Met) cytidine acetyltransferase TmcA, N-terminal (40%);Hemopexin-like repeats (40%),,,,,,,,,,
NVSLEEMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETLLHANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFLPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.266 (63%);2.3.1.48 (18%);2.7.7.18 (8%),23S rRNA (adenine(2030)-N(6))-methyltransferase (63%);Histone acetyltransferase (18%);Nicotinate-nucleotide adenylyltransferase (8%),GO:0005730 (44%);GO:0016021 (13%);GO:0005654 (12%),nucleolus (44%);integral component of membrane (13%);nucleoplasm (12%),GO:0003723 (69%);GO:0036307 (11%);GO:0005509 (4%),RNA binding (69%);23S rRNA (adenine(2030)-N(6))-methyltransferase activity (11%);calcium ion binding (4%),GO:0006364 (43%);GO:0070475 (11%);GO:0006974 (3%),rRNA processing (43%);rRNA base methylation (11%);cellular response to DNA damage stimulus (3%),IPR024166 (57%);IPR036612 (55%);IPR041174 (53%),Ribosomal RNA assembly KRR1 (57%);K Homology domain, type 1 superfamily (55%);Krr1, KH1 domain (53%),,,,,,,,,
KPDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.267 (6%);2.7.4.1 (6%);1.2.1.- (4%),1-deoxy-D-xylulose-5-phosphate reductoisomerase (6%);Polyphosphate kinase (6%);With NAD(+) or NADP(+) as acceptor (4%),GO:0016021 (24%);GO:0005737 (4%);GO:0005634 (2%),integral component of membrane (24%);cytoplasm (4%);nucleus (2%),GO:0005524 (23%);GO:0004672 (16%);GO:0003677 (10%),ATP binding (23%);protein kinase activity (16%);DNA binding (10%),GO:0006310 (2%);GO:0015074 (2%);GO:0036297 (2%),DNA recombination (2%);DNA integration (2%);interstrand cross-link repair (2%),IPR011009 (15%);IPR000719 (14%);IPR013783 (14%),Protein kinase-like domain superfamily (15%);Protein kinase domain (14%);Immunoglobulin-like fold (14%),,,,,,,,,,,
VSDHFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (33%),integral component of membrane (33%),GO:0000155 (33%);GO:0004497 (33%);GO:0004672 (33%),phosphorelay sensor kinase activity (33%);monooxygenase activity (33%);protein kinase activity (33%),,,IPR000014 (33%);IPR000700 (33%);IPR000719 (33%),PAS domain (33%);PAS-associated, C-terminal (33%);Protein kinase domain (33%),,,,,,,,,,
VLSDLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (13%);3.2.1.52 (13%);2.7.7.7 (6%),Exoribonuclease II (13%);Beta-N-acetylhexosaminidase (13%);DNA-directed DNA polymerase (6%),GO:0016021 (24%);GO:0005737 (8%);GO:0005576 (2%),integral component of membrane (24%);cytoplasm (8%);extracellular region (2%),GO:0003677 (13%);GO:0005524 (9%);GO:0003824 (7%),DNA binding (13%);ATP binding (9%);catalytic activity (7%),GO:0006355 (5%);GO:0000160 (5%);GO:0005975 (4%),regulation of transcription, DNA-templated (5%);phosphorelay signal transduction system (5%);carbohydrate metabolic process (4%),IPR027417 (15%);IPR001789 (7%);IPR011006 (7%),P-loop containing nucleoside triphosphate hydrolase (15%);Signal transduction response regulator, receiver domain (7%);CheY-like superfamily (7%),,,,,,,,,
FMHVDSDELR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGSSQAAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TWSADSWALPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVGFCAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HFPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.5.1 (36%);2.8.1.8 (10%);3.6.3.- (9%),Succinate dehydrogenase (quinone) (36%);Lipoyl synthase (10%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (9%),GO:0016021 (8%);GO:0005737 (2%);GO:0016459 (1%),integral component of membrane (8%);cytoplasm (2%);myosin complex (1%),GO:0005524 (52%);GO:0016887 (39%);GO:0003677 (18%),ATP binding (52%);ATPase activity (39%);DNA binding (18%),GO:0015833 (38%);GO:0006099 (3%);GO:0032259 (3%),peptide transport (38%);tricarboxylic acid cycle (3%);methylation (3%),IPR027417 (43%);IPR003439 (42%);IPR003593 (41%),P-loop containing nucleoside triphosphate hydrolase (43%);ABC transporter-like (42%);AAA+ ATPase domain (41%),,,,,,,,,,,
ADEAYVN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.33 (37%);1.1.1.193 (10%);3.5.4.26 (10%),Pantothenate kinase (37%);5-amino-6-(5-phosphoribosylamino)uracil reductase (10%);Diaminohydroxyphosphoribosylaminopyrimidine deaminase (10%),GO:0016021 (22%);GO:0005737 (15%);GO:0005886 (4%),integral component of membrane (22%);cytoplasm (15%);plasma membrane (4%),GO:0046872 (17%);GO:0005524 (16%);GO:0004594 (10%),metal ion binding (17%);ATP binding (16%);pantothenate kinase activity (10%),GO:0015937 (10%);GO:0009231 (5%);GO:0010468 (3%),coenzyme A biosynthetic process (10%);riboflavin biosynthetic process (5%);regulation of gene expression (3%),IPR004619 (8%);IPR027417 (6%);IPR001959 (5%),Type III pantothenate kinase (8%);P-loop containing nucleoside triphosphate hydrolase (6%);Probable transposase, IS891/IS1136/IS1341 (5%),,,,,,,,,,
SLTTDPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (47%);GO:0005840 (6%);GO:0005887 (6%),integral component of membrane (47%);ribosome (6%);integral component of plasma membrane (6%),GO:0016620 (29%);GO:0016740 (18%);GO:0003735 (6%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (29%);transferase activity (18%);structural constituent of ribosome (6%),GO:0005992 (6%);GO:0006414 (6%),trehalose biosynthetic process (6%);translational elongation (6%),IPR036047 (24%);IPR001810 (21%);IPR015590 (17%),F-box-like domain superfamily (24%);F-box domain (21%);Aldehyde dehydrogenase domain (17%),,,,,,,,,
NNALDQTQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVQPTCDQDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTFLLTNK,Arabidopsis thaliana,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Brassicales,,,,,Brassicaceae,,Camelineae,,Arabidopsis,,,,Arabidopsis thaliana,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
ALNFDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.14 (33%);2.7.1.90 (33%);3.1.21.3 (33%),Amidophosphoribosyltransferase (33%);Diphosphate--fructose-6-phosphate 1-phosphotransferase (33%);Type I site-specific deoxyribonuclease (33%),GO:0016021 (15%);GO:0005737 (4%),integral component of membrane (15%);cytoplasm (4%),GO:0016757 (30%);GO:0016740 (26%);GO:0003676 (15%),transferase activity, transferring glycosyl groups (30%);transferase activity (26%);nucleic acid binding (15%),GO:0009116 (33%);GO:0008360 (11%);GO:0009252 (11%),nucleoside metabolic process (33%);regulation of cell shape (11%);peptidoglycan biosynthetic process (11%),IPR017932 (33%);IPR029055 (33%);IPR029057 (33%),Glutamine amidotransferase type 2 domain (33%);Nucleophile aminohydrolases, N-terminal (33%);Phosphoribosyltransferase-like (33%),,,,,,,,,
MLYFNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.23 (17%);2.3.1.234 (17%);2.3.2.3 (17%),Histidinol dehydrogenase (17%);N(6)-L-threonylcarbamoyladenine synthase (17%);Lysyltransferase (17%),GO:0016021 (49%);GO:0005814 (15%);GO:0000242 (13%),integral component of membrane (49%);centriole (15%);pericentriolar material (13%),GO:0060090 (13%);GO:0005524 (9%);GO:0016887 (7%),molecular adaptor activity (13%);ATP binding (9%);ATPase activity (7%),GO:0007099 (15%);GO:0060271 (15%);GO:0007140 (13%),centriole replication (15%);cilium assembly (15%);male meiotic nuclear division (13%),IPR009852 (44%);IPR026581 (44%);IPR011990 (6%),T-complex protein 10, C-terminal domain (44%);T-complex protein 10 family (44%);Tetratricopeptide-like helical domain superfamily (6%),,,,,,,,,,
QMESPLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003723 (100%),RNA binding (100%),,,IPR004538 (100%),Haemolysin A /rRNA methyltransferase TlyA (100%),,,,,,,,,,,
AEGHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (56%);2.7.2.4 (6%);3.1.13.1 (5%),3-methyl-2-oxobutanoate hydroxymethyltransferase (56%);Aspartate kinase (6%);Exoribonuclease II (5%),GO:0005737 (24%);GO:0016021 (24%);GO:0016020 (5%),cytoplasm (24%);integral component of membrane (24%);membrane (5%),GO:0046872 (27%);GO:0003864 (20%);GO:0008168 (20%),metal ion binding (27%);3-methyl-2-oxobutanoate hydroxymethyltransferase activity (20%);methyltransferase activity (20%),GO:0015940 (20%);GO:0032259 (20%);GO:0006113 (3%),pantothenate biosynthetic process (20%);methylation (20%);fermentation (3%),IPR003700 (17%);IPR015813 (17%);IPR040442 (17%),Ketopantoate hydroxymethyltransferase (17%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (17%);Pyruvate kinase-like domain superfamily (17%),,,,,,,,,,,
YLTVFAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.1.13 (100%),PreQ(1) synthase (100%),GO:0005737 (75%);GO:0016021 (25%),cytoplasm (75%);integral component of membrane (25%),GO:0033739 (75%);GO:0046857 (75%),preQ1 synthase activity (75%);oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor (75%),GO:0008616 (75%),queuosine biosynthetic process (75%),IPR016428 (75%);IPR029139 (75%);IPR029500 (75%),NADPH-dependent 7-cyano-7-deazaguanine reductase, QueF type 2 (75%);NADPH-dependent 7-cyano-7-deazaguanine reductase, N-terminal (75%);NADPH-dependent 7-cyano-7-deazaguanine reductase QueF (75%),,,,,,,
DDGHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.193 (23%);3.5.4.26 (23%);6.3.2.- (22%),5-amino-6-(5-phosphoribosylamino)uracil reductase (23%);Diaminohydroxyphosphoribosylaminopyrimidine deaminase (23%);Acid--amino-acid ligases (peptide synthases) (22%),GO:0016021 (34%);GO:0005737 (9%);GO:0016586 (5%),integral component of membrane (34%);cytoplasm (9%);RSC-type complex (5%),GO:0005524 (20%);GO:0008270 (9%);GO:0000287 (8%),ATP binding (20%);zinc ion binding (9%);magnesium ion binding (8%),GO:0007049 (7%);GO:0008360 (7%);GO:0009252 (7%),cell cycle (7%);regulation of cell shape (7%);peptidoglycan biosynthetic process (7%),IPR036291 (22%);IPR027417 (8%);IPR000713 (5%),NAD(P)-binding domain superfamily (22%);P-loop containing nucleoside triphosphate hydrolase (8%);Mur ligase, N-terminal catalytic domain (5%),,,,,,,,,,
NAGEPTANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QSNGYTVVMVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGKPLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (11%),integral component of membrane (11%),GO:0004474 (44%);GO:0004519 (33%);GO:0008408 (33%),malate synthase activity (44%);endonuclease activity (33%);3'-5' exonuclease activity (33%),GO:0006097 (44%);GO:0006260 (33%);GO:0006310 (33%),glyoxylate cycle (44%);DNA replication (33%);DNA recombination (33%),IPR001465 (44%);IPR006252 (44%);IPR011076 (44%),Malate synthase (44%);Malate synthase A (44%);Malate synthase-like superfamily (44%),,,,,,,,,,,
QLWQWADK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DCLGANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPGYMLVYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSMLGQNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPMTWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.7 (50%);3.5.1.46 (50%),Holo-[acyl-carrier-protein] synthase (50%);6-aminohexanoate-oligomer exohydrolase (50%),GO:0016021 (44%);GO:0005886 (33%);GO:0005737 (11%),integral component of membrane (44%);plasma membrane (33%);cytoplasm (11%),GO:0016787 (22%);GO:0000287 (11%);GO:0008897 (11%),hydrolase activity (22%);magnesium ion binding (11%);holo-[acyl-carrier-protein] synthase activity (11%),GO:0006865 (33%);GO:0006633 (11%),amino acid transport (33%);fatty acid biosynthetic process (11%),IPR029199 (42%);IPR001123 (16%);IPR001466 (16%),THRAP3/BCLAF1 family (42%);Amino acid exporter protein, LeuE-type (16%);Beta-lactamase-related (16%),,,,,,,,,,
EALLPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.21 (22%);1.17.7.4 (11%);3.1.21.3 (11%),Beta-glucosidase (22%);4-hydroxy-3-methylbut-2-enyl diphosphate reductase (11%);Type I site-specific deoxyribonuclease (11%),GO:0016021 (19%);GO:1990718 (2%);GO:0000228 (1%),integral component of membrane (19%);axonemal central pair projection (2%);nuclear chromosome (1%),GO:0016791 (31%);GO:0046872 (10%);GO:0003677 (6%),phosphatase activity (31%);metal ion binding (10%);DNA binding (6%),GO:0005975 (6%);GO:0002064 (2%);GO:0003341 (2%),carbohydrate metabolic process (6%);epithelial cell development (2%);cilium movement (2%),IPR027417 (26%);IPR017850 (22%);IPR001952 (21%),P-loop containing nucleoside triphosphate hydrolase (26%);Alkaline-phosphatase-like, core domain superfamily (22%);Alkaline phosphatase (21%),,,,,,,,,,
MLVAYSCWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVVVAELEVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVAFPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFFLTHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (40%);3.4.21.26 (40%);1.5.5.1 (20%),Protein-serine/threonine phosphatase (40%);Prolyl oligopeptidase (40%);Electron-transferring-flavoprotein dehydrogenase (20%),GO:0016021 (39%),integral component of membrane (39%),GO:0004252 (50%);GO:0070008 (50%);GO:0004721 (7%),serine-type endopeptidase activity (50%);serine-type exopeptidase activity (50%);phosphoprotein phosphatase activity (7%),,,IPR029058 (89%);IPR001375 (52%);IPR002470 (52%),Alpha/Beta hydrolase fold (89%);Peptidase S9, prolyl oligopeptidase, catalytic domain (52%);Peptidase S9A, prolyl oligopeptidase (52%),,,,,,,,
MLGLQGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (50%);3.1.1.- (50%),Transferring groups other than amino-acyl groups (50%);Carboxylic ester hydrolases (50%),GO:0016021 (33%);GO:0005737 (25%);GO:0034099 (8%),integral component of membrane (33%);cytoplasm (25%);luminal surveillance complex (8%),GO:0005524 (25%);GO:0003677 (17%);GO:0046872 (17%),ATP binding (25%);DNA binding (17%);metal ion binding (17%),GO:0016226 (17%);GO:0000742 (8%);GO:0006352 (8%),iron-sulfur cluster assembly (17%);karyogamy involved in conjugation with cellular fusion (8%);DNA-templated transcription, initiation (8%),IPR019591 (14%);IPR027417 (14%);IPR028600 (14%),Mrp/NBP35 ATP-binding protein (14%);P-loop containing nucleoside triphosphate hydrolase (14%);Cytosolic Fe-S cluster assembly factor NUBP2/Cfd1, eukaryotes (14%),,,,,,,,,
QMMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (24%);1.3.5.1 (11%);2.3.1.51 (9%),DNA-directed RNA polymerase (24%);Succinate dehydrogenase (quinone) (11%);1-acylglycerol-3-phosphate O-acyltransferase (9%),GO:0016021 (27%);GO:0000145 (23%);GO:0005886 (12%),integral component of membrane (27%);exocyst (23%);plasma membrane (12%),GO:0008168 (10%);GO:0003676 (7%);GO:0005524 (7%),methyltransferase activity (10%);nucleic acid binding (7%);ATP binding (7%),GO:0006887 (23%);GO:0009306 (10%);GO:0044780 (10%),exocytosis (23%);protein secretion (10%);bacterial-type flagellum assembly (10%),IPR019160 (21%);IPR028258 (19%);IPR006135 (9%),Exocyst complex component Sec3, C-terminal (21%);Exocyst complex component Sec3, PIP2-binding N-terminal domain (19%);Type III secretion system substrate exporter (9%),,,,,,,,,
FLLGPPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (71%),integral component of membrane (71%),GO:0003677 (79%);GO:0008253 (14%),DNA binding (79%);5'-nucleotidase activity (14%),GO:0006310 (14%);GO:0009264 (14%);GO:0015074 (14%),DNA recombination (14%);deoxyribonucleotide catabolic process (14%);DNA integration (14%),IPR001387 (64%);IPR010982 (64%);IPR013783 (57%),Cro/C1-type helix-turn-helix domain (64%);Lambda repressor-like, DNA-binding domain superfamily (64%);Immunoglobulin-like fold (57%),,,,,,,,,,
MHGDLPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYTVWFFAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NETLQNPK,Flavobacterium sp. ABG,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Flavobacterium,,,,Flavobacterium sp. ABG,,,,,,,,,,,,IPR021862 (100%);IPR031712 (100%),Protein of unknown function DUF3472 (100%);Domain of unknown function DUF5077 (100%),,,,,,,,,,,
CQALLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (71%),integral component of membrane (71%),GO:0005524 (29%);GO:0017168 (29%);GO:0004842 (14%),ATP binding (29%);5-oxoprolinase (ATP-hydrolyzing) activity (29%);ubiquitin-protein transferase activity (14%),GO:0005975 (29%),carbohydrate metabolic process (29%),IPR000225 (63%);IPR010309 (63%);IPR010314 (63%),Armadillo (63%);E3 ubiquitin ligase, domain of unknown function DUF908 (63%);E3 ubiquitin ligase, domain of unknown function DUF913 (63%),,,,,,,,,
TLQER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (22%);2.3.2.27 (5%);5.2.1.8 (4%),DNA topoisomerase (ATP-hydrolyzing) (22%);RING-type E3 ubiquitin transferase (5%);Peptidylprolyl isomerase (4%),GO:0005737 (15%);GO:0016021 (13%);GO:0005694 (5%),cytoplasm (15%);integral component of membrane (13%);chromosome (5%),GO:0005524 (23%);GO:0003677 (19%);GO:0008170 (8%),ATP binding (23%);DNA binding (19%);N-methyltransferase activity (8%),GO:0006306 (8%);GO:0007165 (7%);GO:0006265 (5%),DNA methylation (8%);signal transduction (7%);DNA topological change (5%),IPR027417 (18%);IPR029063 (9%);IPR001650 (8%),P-loop containing nucleoside triphosphate hydrolase (18%);S-adenosyl-L-methionine-dependent methyltransferase (9%);Helicase, C-terminal (8%),,,,,,,,,,
YVLDLMFVEDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMEFHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.7 (100%),Glutaminyl-tRNA synthase (glutamine-hydrolyzing) (100%),GO:0030956 (33%),glutamyl-tRNA(Gln) amidotransferase complex (33%),GO:0003677 (33%);GO:0004040 (33%);GO:0005524 (33%),DNA binding (33%);amidase activity (33%);ATP binding (33%),GO:0006412 (33%);GO:0009058 (33%),translation (33%);biosynthetic process (33%),IPR000120 (25%);IPR001387 (25%);IPR004412 (25%),Amidase (25%);Cro/C1-type helix-turn-helix domain (25%);Glutamyl-tRNA(Gln) amidotransferase A subunit (25%),,,,,,,,,,,
QFCTFAGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DQALLSPVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPTAMEVGAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNAELPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),,,GO:0051301 (33%),cell division (33%),IPR000477 (50%);IPR008023 (50%),Reverse transcriptase domain (50%);Protein of unknown function DUF748 (50%),,,,,,,,,,,
FAMLCSVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNMGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.158 (16%);2.4.2.14 (13%);2.5.1.9 (13%),Alpha-agarase (16%);Amidophosphoribosyltransferase (13%);Riboflavin synthase (13%),GO:0016021 (49%);GO:0009279 (28%);GO:0005666 (5%),integral component of membrane (49%);cell outer membrane (28%);RNA polymerase III complex (5%),GO:0005509 (32%);GO:0005524 (9%);GO:0003677 (7%),calcium ion binding (32%);ATP binding (9%);DNA binding (7%),GO:0007155 (27%);GO:0000724 (12%);GO:0006383 (4%),cell adhesion (27%);double-strand break repair via homologous recombination (12%);transcription by RNA polymerase III (4%),IPR018247 (27%);IPR011250 (25%);IPR028974 (25%),EF-Hand 1, calcium-binding site (27%);Outer membrane protein/outer membrane enzyme PagP,  beta-barrel (25%);TSP type-3 repeat (25%),,,,,,,,,
EMGQPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (100%),Metalloendopeptidases (100%),GO:0016021 (83%);GO:0005886 (42%),integral component of membrane (83%);plasma membrane (42%),GO:0004222 (58%);GO:0005524 (58%);GO:0008270 (42%),metalloendopeptidase activity (58%);ATP binding (58%);zinc ion binding (42%),GO:0051301 (50%);GO:0030163 (42%);GO:0006857 (8%),cell division (50%);protein catabolic process (42%);oligopeptide transport (8%),IPR000642 (58%);IPR037219 (58%);IPR003593 (42%),Peptidase M41 (58%);Peptidase M41-like (58%);AAA+ ATPase domain (42%),,,,,,,,,,,
CDVTNWANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPTSNNMVHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QCYWLLAPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLMLAEPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEWPADLTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLFMWCK,Anaerolineales bacterium,Bacteria,,,,Chloroflexi,,,Anaerolineae,,,,Anaerolineales,,,,,,,,,,,,,Anaerolineales bacterium,,,,,,,,GO:0046872 (100%),metal ion binding (100%),,,IPR005000 (100%);IPR015813 (100%);IPR040442 (100%),HpcH/HpaI aldolase/citrate lyase domain (100%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (100%);Pyruvate kinase-like domain superfamily (100%),,,,,,,,,,,
WHFLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005737 (33%);GO:0009279 (33%),integral component of membrane (50%);cytoplasm (33%);cell outer membrane (33%),GO:0000287 (33%);GO:0004427 (33%),magnesium ion binding (33%);inorganic diphosphatase activity (33%),GO:0006796 (33%),phosphate-containing compound metabolic process (33%),IPR000531 (33%);IPR008162 (33%);IPR012910 (33%),TonB-dependent receptor-like, beta-barrel (33%);Inorganic pyrophosphatase (33%);TonB-dependent receptor, plug domain (33%),,,,,,,,,
EMDLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.9 (14%);2.7.11.1 (14%);2.7.13.3 (9%),Acetyl-CoA C-acetyltransferase (14%);Non-specific serine/threonine protein kinase (14%);Histidine kinase (9%),GO:0016021 (41%);GO:0005739 (3%);GO:0044666 (3%),integral component of membrane (41%);mitochondrion (3%);MLL3/4 complex (3%),GO:0005524 (14%);GO:0003677 (8%);GO:0003700 (7%),ATP binding (14%);DNA binding (8%);DNA-binding transcription factor activity (7%),GO:0006865 (7%);GO:0009058 (4%);GO:0006355 (3%),amino acid transport (7%);biosynthetic process (4%);regulation of transcription, DNA-templated (3%),IPR032675 (19%);IPR001611 (17%);IPR003591 (12%),Leucine-rich repeat domain superfamily (19%);Leucine-rich repeat (17%);Leucine-rich repeat, typical subtype (12%),,,,,,,,,
TTTVVEFR,Rhizobium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Rhizobiaceae,,,,Rhizobium,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALGANVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.7 (67%);2.4.2.- (33%),UDP-N-acetylglucosamine 1-carboxyvinyltransferase (67%);Pentosyltransferases (33%),GO:0048500 (50%);GO:0005737 (33%),signal recognition particle (50%);cytoplasm (33%),GO:0003924 (50%);GO:0005525 (50%);GO:0008312 (33%),GTPase activity (50%);GTP binding (50%);7S RNA binding (33%),GO:0006614 (33%);GO:0007049 (33%);GO:0008360 (33%),SRP-dependent cotranslational protein targeting to membrane (33%);cell cycle (33%);regulation of cell shape (33%),IPR000897 (43%);IPR003593 (43%);IPR004125 (43%),Signal recognition particle, SRP54 subunit, GTPase domain (43%);AAA+ ATPase domain (43%);Signal recognition particle, SRP54 subunit, M-domain (43%),,,,,,,
QYGVWDK,Carnobacterium divergens,Bacteria,,,,Firmicutes,,,Bacilli,,,,Lactobacillales,,,,,Carnobacteriaceae,,,,Carnobacterium,,,,Carnobacterium divergens,,,,,,,,,,,,IPR010090 (100%),Phage tail tape measure protein (100%),,,,,,,,,,,
TAFVELDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNTNGQQGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSNDAGVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLNHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.195 (13%);2.7.-.- (9%);2.7.11.21 (5%),Cobalt-precorrin-5B (C(1))-methyltransferase (13%);Transferring phosphorus-containing groups (9%);Polo kinase (5%),GO:0016021 (13%);GO:0005737 (2%);GO:0005634 (2%),integral component of membrane (13%);cytoplasm (2%);nucleus (2%),GO:0003677 (40%);GO:0003700 (32%);GO:0016810 (15%),DNA binding (40%);DNA-binding transcription factor activity (32%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (15%),GO:0032259 (4%);GO:0009236 (2%);GO:0006355 (2%),methylation (4%);cobalamin biosynthetic process (2%);regulation of transcription, DNA-templated (2%),IPR036388 (28%);IPR036390 (28%);IPR000524 (27%),Winged helix-like DNA-binding domain superfamily (28%);Winged helix DNA-binding domain superfamily (28%);Transcription regulator HTH, GntR (27%),,,,,,,,
LLNPSSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (100%),Acting on peptide bonds (peptidases) (100%),GO:0016021 (23%);GO:0005737 (3%),integral component of membrane (23%);cytoplasm (3%),GO:0003677 (28%);GO:0004803 (23%);GO:0016805 (8%),DNA binding (28%);transposase activity (23%);dipeptidase activity (8%),GO:0006313 (23%);GO:0006044 (5%);GO:0007140 (5%),transposition, DNA-mediated (23%);N-acetylglucosamine metabolic process (5%);male meiotic nuclear division (5%),IPR002559 (23%);IPR012337 (23%);IPR001087 (9%),Transposase, IS4-like (23%);Ribonuclease H-like superfamily (23%);GDSL lipase/esterase (9%),,,,,,,,,
TQPNDWSLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSMNPQAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAEGSMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.- (100%),Carbon--nitrogen ligases with glutamine as amido-N-donor (100%),GO:0005739 (25%);GO:0016021 (25%);GO:0030956 (25%),mitochondrion (25%);integral component of membrane (25%);glutamyl-tRNA(Gln) amidotransferase complex (25%),GO:0000287 (25%);GO:0003700 (25%);GO:0003824 (25%),magnesium ion binding (25%);DNA-binding transcription factor activity (25%);catalytic activity (25%),GO:0032543 (25%);GO:0070681 (25%),mitochondrial translation (25%);glutaminyl-tRNAGln biosynthesis via transamidation (25%),IPR001034 (20%);IPR001763 (20%);IPR003789 (20%),DeoR-type HTH domain (20%);Rhodanese-like domain (20%);Aspartyl/glutamyl-tRNA amidotransferase subunit B-like (20%),,,,,,,,,,,
LNGELGPK,Niastella caeni,Bacteria,,,,Bacteroidetes,,,Chitinophagia,,,,Chitinophagales,,,,,Chitinophagaceae,,,,Niastella,,,,Niastella caeni,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (50%);IPR007110 (50%);IPR008969 (50%),TonB-dependent receptor-like, beta-barrel (50%);Immunoglobulin-like domain (50%);Carboxypeptidase-like, regulatory domain superfamily (50%),,,,,,,,,
DNEVVM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMTETLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.70 (41%);3.6.4.12 (4%);3.1.-.- (3%),Mannosyl-3-phosphoglycerate phosphatase (41%);DNA helicase (4%);Acting on ester bonds (3%),GO:0016021 (31%);GO:0005737 (8%);GO:0005634 (3%),integral component of membrane (31%);cytoplasm (8%);nucleus (3%),GO:0005524 (11%);GO:0005096 (8%);GO:0050531 (7%),ATP binding (11%);GTPase activator activity (8%);mannosyl-3-phosphoglycerate phosphatase activity (7%),GO:0016192 (13%);GO:0035556 (7%);GO:0051479 (5%),vesicle-mediated transport (13%);intracellular signal transduction (7%);mannosylglycerate biosynthetic process (5%),IPR042855 (11%);IPR001388 (11%);IPR011012 (11%),v-SNARE, coiled-coil homology domain (11%);Synaptobrevin (11%);Longin-like domain superfamily (11%),,,,,,,,,,
FLLNVMFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLNHLAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QWMAHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGWYAFK,Bacillus cereus group,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Bacillaceae,,,,Bacillus,,Bacillus cereus group,,,,,,,,,,,,,,IPR041047 (100%),Large polyvalent protein-associated domain 1 (100%),,,,,,,,,,,
DTYTTLMWSPVPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSLDDHMLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSTDAPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR000421 (100%);IPR000601 (100%);IPR007541 (100%),Coagulation factor 5/8 C-terminal domain (100%);PKD domain (100%);Uncharacterised protein family, basic secretory protein (100%),,,,,,,,,,
SPSYVNR,Alistipes,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Rikenellaceae,,,,Alistipes,,,,,,,,,,,,GO:0003677 (100%),DNA binding (100%),GO:0006310 (100%);GO:0015074 (100%),DNA recombination (100%);DNA integration (100%),IPR002104 (100%);IPR010998 (100%);IPR011010 (100%),Integrase, catalytic domain (100%);Integrase/recombinase, N-terminal (100%);DNA breaking-rejoining enzyme, catalytic core (100%),,,,,,,,
LEVMNAAK,Paenibacillus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Paenibacillaceae,,,,Paenibacillus,,,,,,,,6.1.1.12 (100%),Aspartate--tRNA ligase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0003676 (100%);GO:0004815 (100%);GO:0005524 (100%),nucleic acid binding (100%);aspartate-tRNA ligase activity (100%);ATP binding (100%),GO:0006422 (100%),aspartyl-tRNA aminoacylation (100%),IPR002312 (100%);IPR004115 (100%);IPR004364 (100%),Aspartyl/Asparaginyl-tRNA synthetase, class IIb (100%);GAD-like domain superfamily (100%);Aminoacyl-tRNA synthetase, class II (D/K/N) (100%),,,,,,,,,
VSLHPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005506 (50%);GO:0016714 (50%);GO:0003824 (25%),iron ion binding (50%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen (50%);catalytic activity (25%),GO:0009072 (50%),aromatic amino acid family metabolic process (50%),IPR001273 (33%);IPR018301 (33%);IPR019774 (33%),Aromatic amino acid hydroxylase (33%);Aromatic amino acid hydroxylase, iron/copper binding site (33%);Aromatic amino acid hydroxylase, C-terminal (33%),,,,,
VTLDGNQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFSEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.81 (67%);2.1.1.- (17%);2.6.1.17 (17%),Succinylornithine transaminase (67%);Methyltransferases (17%);Succinyldiaminopimelate transaminase (17%),GO:0016021 (27%);GO:0005634 (3%);GO:0005886 (3%),integral component of membrane (27%);nucleus (3%);plasma membrane (3%),GO:0016787 (15%);GO:0030170 (15%);GO:0003677 (12%),hydrolase activity (15%);pyridoxal phosphate binding (15%);DNA binding (12%),GO:0051301 (12%);GO:0006355 (6%);GO:0009166 (6%),cell division (12%);regulation of transcription, DNA-templated (6%);nucleotide catabolic process (6%),IPR011990 (31%);IPR013026 (31%);IPR019734 (31%),Tetratricopeptide-like helical domain superfamily (31%);Tetratricopeptide repeat-containing domain (31%);Tetratricopeptide repeat (31%),,,,,,,,,,
VLEMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.59 (35%);3.1.4.- (35%);3.5.4.19 (9%),[Protein-PII] uridylyltransferase (35%);Phosphoric diester hydrolases (35%);Phosphoribosyl-AMP cyclohydrolase (9%),GO:0016021 (18%);GO:0005634 (12%);GO:0005886 (8%),integral component of membrane (18%);nucleus (12%);plasma membrane (8%),GO:0005524 (25%);GO:0043565 (24%);GO:0008270 (16%),ATP binding (25%);sequence-specific DNA binding (24%);zinc ion binding (16%),GO:0006355 (17%);GO:0000160 (10%);GO:0045893 (8%),regulation of transcription, DNA-templated (17%);phosphorelay signal transduction system (10%);positive regulation of transcription, DNA-templated (8%),IPR027417 (21%);IPR003593 (16%);IPR001789 (15%),P-loop containing nucleoside triphosphate hydrolase (21%);AAA+ ATPase domain (16%);Signal transduction response regulator, receiver domain (15%),,,,,,,,
LLSHNCYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NESHDLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAHLEPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVTSRPPK,Ursus maritimus,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Laurasiatheria,Carnivora,Caniformia,,,,Ursidae,,,,Ursus,,,,Ursus maritimus,,,,,,GO:0005634 (100%),nucleus (100%),GO:0003677 (100%),DNA binding (100%),GO:0001889 (100%);GO:0006357 (100%);GO:0030073 (100%),liver development (100%);regulation of transcription by RNA polymerase II (100%);insulin secretion (100%),IPR001356 (100%);IPR006897 (100%);IPR006899 (100%),Homeobox domain (100%);Hepatocyte nuclear factor 1, beta isoform, C-terminal (100%);Hepatocyte nuclear factor 1, N-terminal (100%),,,,,,,,
MMTVEPVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLVPLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.4 (18%);2.5.1.17 (18%);3.5.4.25 (18%),[Formate-C-acetyltransferase]-activating enzyme (18%);Corrinoid adenosyltransferase (18%);GTP cyclohydrolase II (18%),GO:0016021 (15%);GO:0005737 (5%),integral component of membrane (15%);cytoplasm (5%),GO:0003677 (41%);GO:0004803 (32%);GO:0005524 (14%),DNA binding (41%);transposase activity (32%);ATP binding (14%),GO:0006313 (32%);GO:0006355 (6%);GO:0009231 (3%),transposition, DNA-mediated (32%);regulation of transcription, DNA-templated (6%);riboflavin biosynthetic process (3%),IPR002559 (28%);IPR012337 (27%);IPR000326 (19%),Transposase, IS4-like (28%);Ribonuclease H-like superfamily (27%);Phosphatidic acid phosphatase type 2/haloperoxidase (19%),,,,,,,,
TSPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.99.12 (29%);1.11.1.6 (5%);1.3.5.2 (5%),Lipid IV(A) 3-deoxy-D-manno-octulosonic acid transferase (29%);Catalase (5%);Dihydroorotate dehydrogenase (quinone) (5%),GO:0016021 (30%);GO:0005886 (10%);GO:0005634 (3%),integral component of membrane (30%);plasma membrane (10%);nucleus (3%),GO:0005524 (8%);GO:0003677 (8%);GO:0016740 (7%),ATP binding (8%);DNA binding (8%);transferase activity (7%),GO:0009244 (4%);GO:0006355 (2%);GO:0006351 (2%),lipopolysaccharide core region biosynthetic process (4%);regulation of transcription, DNA-templated (2%);transcription, DNA-templated (2%),IPR008928 (6%);IPR029058 (6%);IPR027414 (6%),Six-hairpin glycosidase superfamily (6%);Alpha/Beta hydrolase fold (6%);Glycosyl hydrolase family 95, N-terminal domain (6%),,,,,,,,
VMNPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (21%);GO:0009288 (8%);GO:0031514 (8%),integral component of membrane (21%);bacterial-type flagellum (8%);motile cilium (8%),GO:0008270 (29%);GO:0003677 (21%);GO:0003700 (17%),zinc ion binding (29%);DNA binding (21%);DNA-binding transcription factor activity (17%),GO:0006935 (8%);GO:0071973 (8%);GO:0006113 (4%),chemotaxis (8%);bacterial-type flagellum-dependent cell motility (8%);fermentation (4%),IPR018553 (25%);IPR000315 (19%);IPR001107 (19%),Protein of unknown function DUF2009 (25%);B-box-type zinc finger (19%);Band 7 domain (19%),,,,,,,,,,,
YSDPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.1.19 (30%);1.-.-.- (10%);1.11.1.7 (10%),Threonine ammonia-lyase (30%);Oxidoreductases (10%);Peroxidase (10%),GO:0016021 (26%);GO:0005737 (1%);GO:0005743 (1%),integral component of membrane (26%);cytoplasm (1%);mitochondrial inner membrane (1%),GO:0004190 (63%);GO:0003677 (5%);GO:0003676 (4%),aspartic-type endopeptidase activity (63%);DNA binding (5%);nucleic acid binding (4%),GO:0006508 (11%);GO:0030163 (11%);GO:0009097 (3%),proteolysis (11%);protein catabolic process (11%);isoleucine biosynthetic process (3%),IPR021109 (54%);IPR033121 (54%);IPR001461 (53%),Aspartic peptidase domain superfamily (54%);Peptidase family A1 domain (54%);Aspartic peptidase A1 family (53%),,,,,,,,,,,
FLLNEPNK,Metazoa,Eukaryota,Metazoa,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (100%),Hexosyltransferases (100%),GO:0000139 (100%);GO:0016021 (100%);GO:0005783 (50%),Golgi membrane (100%);integral component of membrane (100%);endoplasmic reticulum (50%),GO:0008375 (50%);GO:0008376 (50%);GO:0008378 (50%),acetylglucosaminyltransferase activity (50%);acetylgalactosaminyltransferase activity (50%);galactosyltransferase activity (50%),GO:0006486 (100%);GO:0006487 (50%);GO:0006493 (50%),protein glycosylation (100%);protein N-linked glycosylation (50%);protein O-linked glycosylation (50%),IPR002659 (100%);IPR029044 (50%),Glycosyl transferase, family 31 (100%);Nucleotide-diphospho-sugar transferases (50%),,,,,,,,,,
TEALTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.31 (100%),Adenine glycosylase (100%),GO:0016021 (18%);GO:0005886 (9%),integral component of membrane (18%);plasma membrane (9%),GO:0016787 (55%);GO:0003677 (9%);GO:0004672 (9%),hydrolase activity (55%);DNA binding (9%);protein kinase activity (9%),GO:0006284 (9%);GO:0009306 (9%),base-excision repair (9%);protein secretion (9%),IPR016181 (46%);IPR039968 (46%);IPR000286 (15%),Acyl-CoA N-acyltransferase (46%);Uncharacterized protein YghO-like (46%);Histone deacetylase family (15%),,,,,,,,,,,
TSFPSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.5 (100%),Exodeoxyribonuclease V (100%),GO:0016021 (83%);GO:0009338 (17%),integral component of membrane (83%);exodeoxyribonuclease V complex (17%),GO:0004386 (17%);GO:0008854 (17%),helicase activity (17%);exodeoxyribonuclease V activity (17%),GO:0006302 (17%);GO:0006310 (17%),double-strand break repair (17%);DNA recombination (17%),IPR006344 (100%);IPR027417 (100%);IPR027785 (100%),RecBCD enzyme subunit RecD (100%);P-loop containing nucleoside triphosphate hydrolase (100%);UvrD-like helicase C-terminal domain (100%),,,,,,,,,,,
QVTNEMSLPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENGELVDYAEGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVVQPTMSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSNLSPNMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMYYLMYNLSPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGWVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.99.18 (35%);3.2.2.23 (31%);5.4.99.12 (16%),DNA-(apurinic or apyrimidinic site) lyase (35%);DNA-formamidopyrimidine glycosylase (31%);tRNA pseudouridine(38-40) synthase (16%),GO:0016021 (45%);GO:0005886 (3%);GO:0005737 (1%),integral component of membrane (45%);plasma membrane (3%);cytoplasm (1%),GO:0003677 (7%);GO:0005524 (7%);GO:0140078 (7%),DNA binding (7%);ATP binding (7%);class I DNA-(apurinic or apyrimidinic site) endonuclease activity (7%),GO:0006284 (6%);GO:0006289 (6%);GO:0055085 (3%),base-excision repair (6%);nucleotide-excision repair (6%);transmembrane transport (3%),IPR027417 (7%);IPR029058 (6%);IPR002469 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Alpha/Beta hydrolase fold (6%);Dipeptidylpeptidase IV, N-terminal domain (5%),,,,,,,,,,
VALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (35%);5.4.99.13 (35%);2.7.7.19 (13%),Acting on GTP; involved in cellular and subcellular movement (35%);Isobutyryl-CoA mutase (35%);Polynucleotide adenylyltransferase (13%),GO:0016021 (30%);GO:0005886 (14%);GO:0005634 (7%),integral component of membrane (30%);plasma membrane (14%);nucleus (7%),GO:0005524 (13%);GO:0003677 (10%);GO:0031419 (8%),ATP binding (13%);DNA binding (10%);cobalamin binding (8%),GO:0015986 (7%);GO:0006637 (7%);GO:0006412 (7%),ATP synthesis coupled proton transport (7%);acyl-CoA metabolic process (7%);translation (7%),IPR027417 (12%);IPR016176 (7%);IPR006099 (7%),P-loop containing nucleoside triphosphate hydrolase (12%);Cobalamin (vitamin B12)-dependent enzyme, catalytic (7%);Methylmalonyl-CoA mutase, alpha/beta chain, catalytic (7%),,,,,,,,
QDSMPLK,Attini,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Hymenoptera,Apocrita,Aculeata,,Formicoidea,Formicidae,Myrmicinae,Attini,,,,,,,,,,,,,,GO:0003723 (100%),RNA binding (100%),,,IPR000504 (100%);IPR012677 (100%);IPR035979 (100%),RNA recognition motif domain (100%);Nucleotide-binding alpha-beta plait domain superfamily (100%);RNA-binding domain superfamily (100%),,,,,,,,,,,
QLPEMAMTLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDTTNPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVPVFFLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFLSPNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VHDYEAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVEESPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.72 (50%);4.1.1.32 (50%),Quinolinate synthase (50%);Phosphoenolpyruvate carboxykinase (GTP) (50%),GO:0005737 (20%);GO:0005840 (10%);GO:0005886 (10%),cytoplasm (20%);ribosome (10%);plasma membrane (10%),GO:0005525 (60%);GO:0003924 (50%);GO:0003746 (40%),GTP binding (60%);GTPase activity (50%);translation elongation factor activity (40%),GO:0000160 (10%);GO:0006094 (10%);GO:0006412 (10%),phosphorelay signal transduction system (10%);gluconeogenesis (10%);translation (10%),IPR000795 (42%);IPR004160 (42%);IPR004161 (42%),Transcription factor, GTP-binding domain (42%);Translation elongation factor EFTu/EF1A, C-terminal (42%);Translation elongation factor EFTu-like, domain 2 (42%),,,,,,,,
VNVVPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0008270 (63%);GO:0016805 (63%);GO:0008237 (8%),zinc ion binding (63%);dipeptidase activity (63%);metallopeptidase activity (8%),,,IPR002933 (52%);IPR010964 (52%);IPR036264 (52%),Peptidase M20 (52%);Peptidase M20A, peptidase V-related (52%);Bacterial exopeptidase dimerisation domain (52%),,,,,,,,,,
EVWTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000228 (17%);GO:0005669 (17%);GO:0005737 (17%),nuclear chromosome (17%);transcription factor TFIID complex (17%);cytoplasm (17%),GO:0003723 (17%);GO:0003743 (17%);GO:0003924 (17%),RNA binding (17%);translation initiation factor activity (17%);GTPase activity (17%),GO:0002098 (17%);GO:0006338 (17%);GO:0009060 (17%),tRNA wobble uridine modification (17%);chromatin remodeling (17%);aerobic respiration (17%),IPR000178 (14%);IPR000504 (14%);IPR000795 (14%),Translation initiation factor aIF-2, bacterial-like (14%);RNA recognition motif domain (14%);Transcription factor, GTP-binding domain (14%),,,,,,,,,
WDNER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (45%);2.1.1.- (10%);3.6.3.4 (10%),DNA helicase (45%);Methyltransferases (10%);Transferred entry: 7.2.2.9 (10%),GO:0016021 (20%);GO:0005886 (4%);GO:0043190 (2%),integral component of membrane (20%);plasma membrane (4%);ATP-binding cassette (ABC) transporter complex (2%),GO:0005524 (18%);GO:0051015 (14%);GO:0003677 (12%),ATP binding (18%);actin filament binding (14%);DNA binding (12%),GO:0007010 (14%);GO:0006268 (4%);GO:0032259 (4%),cytoskeleton organization (14%);DNA unwinding involved in DNA replication (4%);methylation (4%),IPR027417 (12%);IPR007122 (10%);IPR029006 (10%),P-loop containing nucleoside triphosphate hydrolase (12%);Villin/Gelsolin (10%);ADF-H/Gelsolin-like domain superfamily (10%),,,,,,,,,,,
GNEAVNAAVMNAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEDLQTSHMVTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVMLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (60%);3.6.4.12 (60%);3.2.1.4 (27%),Acting on ester bonds (60%);DNA helicase (60%);Cellulase (27%),GO:0016021 (38%);GO:0005886 (18%);GO:0005737 (4%),integral component of membrane (38%);plasma membrane (18%);cytoplasm (4%),GO:0005524 (17%);GO:0022857 (17%);GO:0003678 (12%),ATP binding (17%);transmembrane transporter activity (17%);DNA helicase activity (12%),GO:0000724 (12%);GO:0030245 (5%);GO:0055085 (5%),double-strand break repair via homologous recombination (12%);cellulose catabolic process (5%);transmembrane transport (5%),IPR027417 (17%);IPR001851 (12%);IPR000212 (10%),P-loop containing nucleoside triphosphate hydrolase (17%);ABC transporter, permease (12%);DNA helicase, UvrD/REP type (10%),,,,,,,,,
QAVLSGADR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNNPPTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAPQWFPNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GTVMMPGLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLYGDFVNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFDVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.- (34%);2.1.3.15 (3%);4.2.1.33 (3%),With oxygen as acceptor (34%);Acetyl-CoA carboxytransferase (3%);3-isopropylmalate dehydratase (3%),GO:0016021 (25%);GO:0000139 (7%);GO:0030127 (7%),integral component of membrane (25%);Golgi membrane (7%);COPII vesicle coat (7%),GO:0005524 (9%);GO:0005085 (7%);GO:0005096 (7%),ATP binding (9%);guanyl-nucleotide exchange factor activity (7%);GTPase activator activity (7%),GO:0007264 (7%);GO:1904263 (7%);GO:0015031 (7%),small GTPase mediated signal transduction (7%);positive regulation of TORC1 signaling (7%);protein transport (7%),IPR015943 (20%);IPR036322 (19%);IPR001680 (19%),WD40/YVTN repeat-like-containing domain superfamily (20%);WD40-repeat-containing domain superfamily (19%);WD40 repeat (19%),,,,,,,,,,,
WYLPLGMAGNGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVALWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (25%);3.6.1.- (25%);3.6.4.12 (25%),Transferring groups other than amino-acyl groups (25%);In phosphorus-containing anhydrides (25%);DNA helicase (25%),GO:0005634 (38%);GO:0016021 (8%);GO:0001673 (3%),nucleus (38%);integral component of membrane (8%);male germ cell nucleus (3%),GO:0000981 (33%);GO:0008270 (33%);GO:0003677 (18%),DNA-binding transcription factor activity, RNA polymerase II-specific (33%);zinc ion binding (33%);DNA binding (18%),GO:0005975 (15%);GO:0007283 (5%);GO:0002098 (3%),carbohydrate metabolic process (15%);spermatogenesis (5%);tRNA wobble uridine modification (3%),IPR001138 (25%);IPR036864 (25%);IPR012337 (13%),Zn(2)-C6 fungal-type DNA-binding domain (25%);Zn(2)-C6 fungal-type DNA-binding domain superfamily (25%);Ribonuclease H-like superfamily (13%),,,,,,,,,,
TCGVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.1 (100%),Alanine racemase (100%),GO:0016021 (40%);GO:0005634 (5%);GO:0005887 (5%),integral component of membrane (40%);nucleus (5%);integral component of plasma membrane (5%),GO:0003677 (25%);GO:0000155 (20%);GO:0004022 (20%),DNA binding (25%);phosphorelay sensor kinase activity (20%);alcohol dehydrogenase (NAD+) activity (20%),GO:0006066 (20%);GO:0015976 (20%);GO:0006310 (5%),alcohol metabolic process (20%);carbon utilization (20%);DNA recombination (5%),IPR001670 (17%);IPR001789 (17%);IPR003594 (17%),Alcohol dehydrogenase, iron-type/glycerol dehydrogenase GldA (17%);Signal transduction response regulator, receiver domain (17%);Histidine kinase/HSP90-like ATPase (17%),,,,,,,,,
TLEGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.171 (7%);3.4.16.4 (6%);2.5.1.78 (6%),16S rRNA (guanine(966)-N(2))-methyltransferase (7%);Serine-type D-Ala-D-Ala carboxypeptidase (6%);6,7-dimethyl-8-ribityllumazine synthase (6%),GO:0016021 (18%);GO:0005737 (7%);GO:0005840 (4%),integral component of membrane (18%);cytoplasm (7%);ribosome (4%),GO:0005524 (14%);GO:0046872 (8%);GO:0003677 (8%),ATP binding (14%);metal ion binding (8%);DNA binding (8%),GO:0006412 (4%);GO:0006869 (4%);GO:0042157 (3%),translation (4%);lipid transport (4%);lipoprotein metabolic process (3%),IPR027417 (7%);IPR029063 (5%);IPR002052 (4%),P-loop containing nucleoside triphosphate hydrolase (7%);S-adenosyl-L-methionine-dependent methyltransferase (5%);DNA methylase, N-6 adenine-specific, conserved site (4%),,,,,,,,
NYYMSLKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYMEVHANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPWYVMTRPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLDEVHQNAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLMSSLMGNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (67%);4.2.3.5 (33%),RNA helicase (67%);Chorismate synthase (33%),GO:0016021 (53%);GO:0005634 (5%);GO:0005654 (5%),integral component of membrane (53%);nucleus (5%);nucleoplasm (5%),GO:0003677 (16%);GO:0016740 (16%);GO:0003723 (11%),DNA binding (16%);transferase activity (16%);RNA binding (11%),GO:0045892 (11%);GO:0006351 (5%);GO:0009073 (5%),negative regulation of transcription, DNA-templated (11%);transcription, DNA-templated (5%);aromatic amino acid family biosynthetic process (5%),IPR003362 (14%);IPR005226 (14%);IPR000008 (10%),Bacterial sugar transferase (14%);UPF0014 family (14%);C2 domain (10%),,,,,,,,,
WMQQGLEDESR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGLASNPQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMYLYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (56%);GO:0009279 (33%),integral component of membrane (56%);cell outer membrane (33%),GO:0004066 (11%);GO:0004222 (11%);GO:0005524 (11%),asparagine synthase (glutamine-hydrolyzing) activity (11%);metalloendopeptidase activity (11%);ATP binding (11%),GO:0006323 (11%);GO:0006529 (11%);GO:0006541 (11%),DNA packaging (11%);asparagine biosynthetic process (11%);glutamine metabolic process (11%),IPR000531 (30%);IPR012910 (30%);IPR036942 (30%),TonB-dependent receptor-like, beta-barrel (30%);TonB-dependent receptor, plug domain (30%);TonB-dependent receptor-like, beta-barrel domain superfamily (30%),,,,,,,,
VEQKPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008017 (75%);GO:0008168 (13%);GO:0008449 (13%),microtubule binding (75%);methyltransferase activity (13%);N-acetylglucosamine-6-sulfatase activity (13%),GO:0030203 (13%);GO:0032259 (13%),glycosaminoglycan metabolic process (13%);methylation (13%),IPR033336 (67%);IPR000917 (11%);IPR001227 (11%),Stabilizer of axonemal microtubules 1/2 (67%);Sulfatase, N-terminal (11%);Acyl transferase domain superfamily (11%),,,,,,,,,,
QVNHVWVFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLYEEVK,Cetobacterium ceti,Bacteria,,,,Fusobacteria,,,Fusobacteriia,,,,Fusobacteriales,,,,,Fusobacteriaceae,,,,Cetobacterium,,,,Cetobacterium ceti,,,,,,GO:0005737 (100%),cytoplasm (100%),,,GO:0030490 (100%),maturation of SSU-rRNA (100%),IPR000238 (100%);IPR015946 (100%);IPR020053 (100%),Ribosome-binding factor A (100%);K homology domain-like, alpha/beta (100%);Ribosome-binding factor A, conserved site (100%),,,,,,,,,
FALVSNK,Gemella haemolysans,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,,,,,Gemella,,,,Gemella haemolysans,,,,,,GO:0005576 (100%);GO:0005618 (100%);GO:0016021 (100%),extracellular region (100%);cell wall (100%);integral component of membrane (100%),,,,,IPR019931 (100%),LPXTG cell wall anchor domain (100%),,,,,,,,,,,
FVQHLSEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVEPWATR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPENPPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYWPMVER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (12%);2.1.2.1 (9%);5.3.1.16 (8%),Metalloendopeptidases (12%);Glycine hydroxymethyltransferase (9%);1-(5-phosphoribosyl)-5((5-phosphoribosylamino)methylideneamino)imidazole-4-carboxamidisomerase (8%),GO:0016021 (29%);GO:0005737 (6%);GO:0015934 (5%),integral component of membrane (29%);cytoplasm (6%);large ribosomal subunit (5%),GO:0003677 (15%);GO:0005524 (12%);GO:0003735 (6%),DNA binding (15%);ATP binding (12%);structural constituent of ribosome (6%),GO:0006412 (6%);GO:0006355 (5%);GO:0032259 (3%),translation (6%);regulation of transcription, DNA-templated (5%);methylation (3%),IPR027417 (7%);IPR011050 (7%);IPR012334 (7%),P-loop containing nucleoside triphosphate hydrolase (7%);Pectin lyase fold/virulence factor (7%);Pectin lyase fold (7%),,,,,,,,,,
MMLSLTPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEPMLLPK,Ficedula albicollis,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Aves,,Neognathae,,Passeriformes,,,,,Muscicapidae,,,,Ficedula,,,,Ficedula albicollis,,,,,,,,,,GO:0000070 (100%);GO:1902412 (100%),mitotic sister chromatid segregation (100%);regulation of mitotic cytokinesis (100%),IPR005635 (100%);IPR022006 (100%);IPR039130 (100%),Inner centromere protein, ARK-binding domain (100%);Chromosome passenger complex (CPC) protein INCENP N-terminal (100%);Inner centromere protein (100%),,,,,,,,,,
TSPDLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (33%);4.2.1.- (33%);6.3.1.14 (33%),L-aspartate oxidase (33%);Hydro-lyases (33%);Diphthine--ammonia ligase (33%),GO:0009288 (36%);GO:1990316 (14%);GO:0016021 (9%),bacterial-type flagellum (36%);Atg1/ULK1 kinase complex (14%);integral component of membrane (9%),GO:0003774 (36%);GO:0005524 (20%);GO:0008734 (5%),motor activity (36%);ATP binding (20%);L-aspartate oxidase activity (5%),GO:0006935 (36%);GO:0071973 (36%);GO:0000045 (10%),chemotaxis (36%);bacterial-type flagellum-dependent cell motility (36%);autophagosome assembly (10%),IPR000090 (25%);IPR011002 (25%);IPR023087 (25%),Flagellar motor switch protein FliG (25%);Flagellar motor switch protein FliG, alpha-helical (25%);Flagellar motor switch protein FliG, C-terminal (25%),,,,,,,,,
MNFYANTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLDLSSLQCWPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFLTEVMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLVEMDVVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMEYHVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LHVDNVSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPAGPLLVDFAGKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNNAVSVVTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASNDAGYELLGWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYTCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.5.11 (38%);3.6.1.1 (19%);2.1.1.43 (6%),NADH dehydrogenase (quinone) (38%);Inorganic diphosphatase (19%);Transferred entry: 2.1.1.354 (6%),GO:0016021 (42%);GO:0005634 (11%);GO:0005737 (7%),integral component of membrane (42%);nucleus (11%);cytoplasm (7%),GO:0046872 (24%);GO:0008137 (17%);GO:0010181 (17%),metal ion binding (24%);NADH dehydrogenase (ubiquinone) activity (17%);FMN binding (17%),GO:0006796 (5%);GO:0046677 (5%);GO:0006260 (3%),phosphate-containing compound metabolic process (5%);response to antibiotic (5%);DNA replication (3%),IPR007110 (21%);IPR013783 (21%);IPR036179 (21%),Immunoglobulin-like domain (21%);Immunoglobulin-like fold (21%);Immunoglobulin-like domain superfamily (21%),,,,,,,,,,,
WLSSFHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNNLYSAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAAGGCFVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVLLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.75 (100%),Uroporphyrinogen-III synthase (100%),GO:0016021 (81%);GO:0005886 (13%);GO:0042597 (2%),integral component of membrane (81%);plasma membrane (13%);periplasmic space (2%),GO:0008324 (30%);GO:0003824 (13%);GO:0005452 (11%),cation transmembrane transporter activity (30%);catalytic activity (13%);inorganic anion exchanger activity (11%),GO:0055085 (13%);GO:0006780 (4%);GO:0006782 (4%),transmembrane transport (13%);uroporphyrinogen III biosynthetic process (4%);protoporphyrinogen IX biosynthetic process (4%),IPR001036 (30%);IPR027463 (30%);IPR004763 (28%),Acriflavin resistance protein (30%);Multidrug efflux transporter AcrB TolC docking domain, DN/DC subdomains (30%);Cation efflux system CzcA/CusA/SilA/NccA/HelA/CnrA (28%),,,,,,,,,,
DMPWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (25%);2.7.11.1 (17%);3.6.4.12 (17%),RNA helicase (25%);Non-specific serine/threonine protein kinase (17%);DNA helicase (17%),GO:0016021 (41%);GO:0005737 (7%);GO:0005789 (6%),integral component of membrane (41%);cytoplasm (7%);endoplasmic reticulum membrane (6%),GO:0005524 (14%);GO:0003678 (12%);GO:0003677 (8%),ATP binding (14%);DNA helicase activity (12%);DNA binding (8%),GO:0006269 (12%);GO:0055085 (10%);GO:0006355 (5%),DNA replication, synthesis of RNA primer (12%);transmembrane transport (10%);regulation of transcription, DNA-templated (5%),IPR027417 (17%);IPR025997 (9%);IPR027044 (9%),P-loop containing nucleoside triphosphate hydrolase (17%);Periplasmic binding protein (9%);DNA helicase B (9%),,,,,,,,,
FTSHLVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPTMAPSSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLMVNMSLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WSNPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (100%),Metalloendopeptidases (100%),GO:0005886 (11%);GO:0016021 (11%);GO:0070469 (11%),plasma membrane (11%);integral component of membrane (11%);respirasome (11%),GO:0008237 (44%);GO:0000213 (22%);GO:0003676 (22%),metallopeptidase activity (44%);tRNA-intron endonuclease activity (22%);nucleic acid binding (22%),GO:0006388 (22%),tRNA splicing, via endonucleolytic cleavage and ligation (22%),IPR008757 (33%);IPR001930 (22%);IPR006677 (22%),Peptidase M6-like, domain (33%);Peptidase M1, alanine aminopeptidase/leukotriene A4 hydrolase (22%);tRNA intron endonuclease, catalytic domain-like (22%),,,,,,,
SCTGFSDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FQNYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.3 (47%);3.4.11.1 (9%);3.4.11.10 (9%),Phosphoribosylformylglycinamidine synthase (47%);Leucyl aminopeptidase (9%);Bacterial leucyl aminopeptidase (9%),GO:0016021 (39%);GO:0005737 (8%);GO:0005886 (2%),integral component of membrane (39%);cytoplasm (8%);plasma membrane (2%),GO:0003677 (15%);GO:0005524 (13%);GO:0004519 (12%),DNA binding (15%);ATP binding (13%);endonuclease activity (12%),GO:0009307 (10%);GO:0006541 (6%);GO:0006189 (6%),DNA restriction-modification system (10%);glutamine metabolic process (6%);'de novo' IMP biosynthetic process (6%),IPR041409 (10%);IPR007560 (10%);IPR011990 (8%),Restriction endonuclease AspBHI, N-terminal (10%);Restriction endonuclease type IV,  Mrr (10%);Tetratricopeptide-like helical domain superfamily (8%),,,,,,,,,
TALASSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNFFMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (33%);2.1.1.34 (33%);7.1.1.2 (33%),Cytochrome-c oxidase (33%);tRNA (guanosine(18)-2'-O)-methyltransferase (33%);NADH:ubiquinone reductase (H(+)-translocating) (33%),GO:0016021 (98%);GO:0070469 (4%);GO:0005576 (2%),integral component of membrane (98%);respirasome (4%);extracellular region (2%),GO:0003723 (2%);GO:0004129 (2%);GO:0004553 (2%),RNA binding (2%);cytochrome-c oxidase activity (2%);hydrolase activity, hydrolyzing O-glycosyl compounds (2%),GO:0005975 (2%);GO:0006119 (2%);GO:0009060 (2%),carbohydrate metabolic process (2%);oxidative phosphorylation (2%);aerobic respiration (2%),IPR002549 (71%);IPR006571 (14%);IPR000260 (2%),Transmembrane protein TqsA-like (71%);TLDc domain (14%);NADH:ubiquinone oxidoreductase chain 4, N-terminal (2%),,,,,,,,,
YFMELLTLAATPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPPVVFK,Streptomyces,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Streptomycetales,,,,,Streptomycetaceae,,,,Streptomyces,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQGVVM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DEPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.18 (36%);3.5.1.28 (7%);1.1.1.42 (6%),Lysine decarboxylase (36%);N-acetylmuramoyl-L-alanine amidase (7%);Isocitrate dehydrogenase (NADP(+)) (6%),GO:0005737 (25%);GO:0016021 (25%);GO:0055036 (3%),cytoplasm (25%);integral component of membrane (25%);virion membrane (3%),GO:0016831 (13%);GO:0005524 (12%);GO:0008923 (9%),carboxy-lyase activity (13%);ATP binding (12%);lysine decarboxylase activity (9%),GO:0006520 (19%);GO:0019082 (4%);GO:0039694 (4%),cellular amino acid metabolic process (19%);viral protein processing (4%);viral RNA genome replication (4%),IPR005308 (24%);IPR000310 (24%);IPR015421 (24%),Orn/Lys/Arg decarboxylase, N-terminal (24%);Orn/Lys/Arg decarboxylase, major domain (24%);Pyridoxal phosphate-dependent transferase, major domain (24%),,,,,,,,
CPDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.5 (63%);6.1.1.2 (10%);2.3.2.31 (7%),Chorismate synthase (63%);Tryptophan--tRNA ligase (10%);RBR-type E3 ubiquitin transferase (7%),GO:0016021 (11%);GO:0005737 (8%);GO:0005887 (1%),integral component of membrane (11%);cytoplasm (8%);integral component of plasma membrane (1%),GO:0004107 (30%);GO:0046872 (20%);GO:0005524 (12%),chorismate synthase activity (30%);metal ion binding (20%);ATP binding (12%),GO:0009073 (30%);GO:0009423 (29%);GO:0006436 (5%),aromatic amino acid family biosynthetic process (30%);chorismate biosynthetic process (29%);tryptophanyl-tRNA aminoacylation (5%),IPR000453 (26%);IPR020541 (26%);IPR035904 (26%),Chorismate synthase (26%);Chorismate synthase, conserved site (26%);Chorismate synthase AroC superfamily (26%),,,,,,,,,,
QNLLTAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.9 (50%);5.1.1.1 (50%),Malate synthase (50%);Alanine racemase (50%),GO:0043190 (76%);GO:0016021 (7%);GO:0005886 (3%),ATP-binding cassette (ABC) transporter complex (76%);integral component of membrane (7%);plasma membrane (3%),GO:0015562 (7%);GO:0005524 (3%);GO:0000150 (1%),efflux transmembrane transporter activity (7%);ATP binding (3%);recombinase activity (1%),GO:0055085 (76%);GO:0006097 (1%);GO:0006099 (1%),transmembrane transport (76%);glyoxylate cycle (1%);tricarboxylic acid cycle (1%),IPR000914 (70%);IPR039424 (70%);IPR030678 (68%),Solute-binding protein family 5 domain (70%);Solute-binding protein family 5 (70%);Peptide/nickel binding protein, MppA-type (68%),,,,,,,,,,
NLDSAMLPLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SALWDWR,Endogone,Eukaryota,Fungi,,,Mucoromycota,Mucoromycotina,,Endogonomycetes,,,,Endogonales,,,,,Endogonaceae,,,,Endogone,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0008146 (100%);GO:0016787 (100%),sulfotransferase activity (100%);hydrolase activity (100%),,,IPR000863 (100%);IPR027417 (100%);IPR037359 (100%),Sulfotransferase domain (100%);P-loop containing nucleoside triphosphate hydrolase (100%);Heparan sulfate sulfotransferase (100%),,,,,,,,,,,
NNAWLLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNHAFLR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016758 (100%),transferase activity, transferring hexosyl groups (100%),,,IPR000531 (50%);IPR007235 (50%),TonB-dependent receptor-like, beta-barrel (50%);Glycosyl transferase, family 28, C-terminal (50%),,,,,,,
AWMNHVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLLFNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.27 (36%);6.3.2.9 (16%);6.3.5.3 (14%),tRNA pseudouridine(13) synthase (36%);UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (16%);Phosphoribosylformylglycinamidine synthase (14%),GO:0016021 (31%);GO:0005737 (9%);GO:0005886 (3%),integral component of membrane (31%);cytoplasm (9%);plasma membrane (3%),GO:0005525 (15%);GO:0005524 (13%);GO:0003723 (9%),GTP binding (15%);ATP binding (13%);RNA binding (9%),GO:0031119 (8%);GO:0008360 (7%);GO:0007049 (4%),tRNA pseudouridine synthesis (8%);regulation of cell shape (7%);cell cycle (4%),IPR027417 (18%);IPR006073 (11%);IPR030389 (9%),P-loop containing nucleoside triphosphate hydrolase (18%);GTP binding domain (11%);FeoB-type guanine nucleotide-binding (G) domain (9%),,,,,,,,,,,
TFNPADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (67%);GO:0016021 (33%),cytoplasm (67%);integral component of membrane (33%),GO:0003746 (67%),translation elongation factor activity (67%),GO:0009291 (33%),unidirectional conjugation (33%),IPR001059 (40%);IPR008991 (40%);IPR011768 (40%),Translation elongation factor P/YeiP, central (40%);Translation protein SH3-like domain superfamily (40%);Translation elongation factor P (40%),,,,,,,,,,
TPPTQLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLFGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005344 (50%);GO:0005524 (50%);GO:0016887 (50%),oxygen carrier activity (50%);ATP binding (50%);ATPase activity (50%),GO:0015833 (50%),peptide transport (50%),IPR000971 (50%);IPR003439 (50%);IPR003593 (50%),Globin (50%);ABC transporter-like (50%);AAA+ ATPase domain (50%),,,,,,,,,,,
WMGHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (63%);2.7.11.21 (25%);2.7.10.2 (4%),DNA topoisomerase (ATP-hydrolyzing) (63%);Polo kinase (25%);Non-specific protein-tyrosine kinase (4%),GO:0016021 (32%);GO:0019897 (27%);GO:0005694 (21%),integral component of membrane (32%);extrinsic component of plasma membrane (27%);chromosome (21%),GO:0005524 (38%);GO:0003677 (34%);GO:0003918 (27%),ATP binding (38%);DNA binding (34%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (27%),GO:0006265 (27%);GO:0007059 (27%);GO:0006310 (5%),DNA topological change (27%);chromosome segregation (27%);DNA recombination (5%),IPR002205 (24%);IPR005742 (24%);IPR013757 (24%),DNA topoisomerase, type IIA, subunit A/C-terminal (24%);DNA topoisomerase IV, subunit A, Gram-negative (24%);Type IIA DNA topoisomerase subunit A, alpha-helical domain superfamily (24%),,,,,
SDMTMLR,Tannerella forsythia,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Tannerellaceae,,,,Tannerella,,,,Tannerella forsythia,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (100%);IPR008969 (100%);IPR012910 (100%),TonB-dependent receptor-like, beta-barrel (100%);Carboxypeptidase-like, regulatory domain superfamily (100%);TonB-dependent receptor, plug domain (100%),,,,,,,,
EAMVWTTDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESGNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.137 (65%);4.2.1.12 (4%);5.2.1.8 (4%),Phosphatidylinositol 3-kinase (65%);Phosphogluconate dehydratase (4%);Peptidylprolyl isomerase (4%),GO:0016021 (21%);GO:0005634 (5%);GO:0005737 (3%),integral component of membrane (21%);nucleus (5%);cytoplasm (3%),GO:0005524 (31%);GO:0016303 (24%);GO:0003677 (8%),ATP binding (31%);1-phosphatidylinositol-3-kinase activity (24%);DNA binding (8%),GO:0048015 (25%);GO:0046854 (3%);GO:0032465 (3%),phosphatidylinositol-mediated signaling (25%);phosphatidylinositol phosphorylation (3%);regulation of cytokinesis (3%),IPR016024 (24%);IPR011009 (23%);IPR015433 (22%),Armadillo-type fold (24%);Protein kinase-like domain superfamily (23%);Phosphatidylinositol kinase (22%),,,,,,,,,,,
WTLEDDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.96 (100%),4a-hydroxytetrahydrobiopterin dehydratase (100%),GO:0016021 (40%);GO:0043190 (20%),integral component of membrane (40%);ATP-binding cassette (ABC) transporter complex (20%),GO:0004672 (20%);GO:0005524 (20%);GO:0008124 (20%),protein kinase activity (20%);ATP binding (20%);4-alpha-hydroxytetrahydrobiopterin dehydratase activity (20%),GO:0006729 (20%);GO:0055085 (20%),tetrahydrobiopterin biosynthetic process (20%);transmembrane transport (20%),IPR003343 (33%);IPR008964 (33%);IPR000719 (17%),Bacterial Ig-like, group 2 (33%);Invasin/intimin cell-adhesion fragments (33%);Protein kinase domain (17%),,,,,,,,,,
HMSDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.2 (33%);1.1.99.- (9%);1.1.5.12 (7%),Adenylosuccinate lyase (33%);With other acceptors (9%);D-lactate dehydrogenase (quinone) (7%),GO:0016021 (14%);GO:0015935 (5%);GO:0005737 (2%),integral component of membrane (14%);small ribosomal subunit (5%);cytoplasm (2%),GO:0005524 (15%);GO:0046872 (13%);GO:0003824 (11%),ATP binding (15%);metal ion binding (13%);catalytic activity (11%),GO:0007264 (9%);GO:0055085 (5%);GO:0006189 (5%),small GTPase mediated signal transduction (9%);transmembrane transport (5%);'de novo' IMP biosynthetic process (5%),IPR027417 (12%);IPR013785 (10%);IPR007197 (10%),P-loop containing nucleoside triphosphate hydrolase (12%);Aldolase-type TIM barrel (10%);Radical SAM (10%),,,,,,,,,,,
NMLGNPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVFVMFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGFTMLSSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPTLLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.19 (17%);1.11.1.- (8%);1.11.1.10 (8%),tRNA(Ile)-lysidine synthetase (17%);Peroxidases (8%);Chloride peroxidase (8%),GO:0016021 (18%);GO:0005886 (11%);GO:0005737 (1%),integral component of membrane (18%);plasma membrane (11%);cytoplasm (1%),GO:0016787 (28%);GO:0008460 (20%);GO:0008239 (20%),hydrolase activity (28%);dTDP-glucose 4,6-dehydratase activity (20%);dipeptidyl-peptidase activity (20%),GO:0009225 (20%);GO:0055085 (11%);GO:0006355 (2%),nucleotide-sugar metabolic process (20%);transmembrane transport (11%);regulation of transcription, DNA-templated (2%),IPR029058 (48%);IPR036291 (24%);IPR000073 (24%),Alpha/Beta hydrolase fold (48%);NAD(P)-binding domain superfamily (24%);Alpha/beta hydrolase fold-1 (24%),,,,,,,,,
NTTYLGYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQWNFVGLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPYQDSPDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFCLQHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFMMC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGHSTNK,Planctomycetes,Bacteria,,,,Planctomycetes,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR006143 (100%);IPR032317 (100%),RND efflux pump, membrane fusion protein (100%);RND efflux pump, membrane fusion protein, barrel-sandwich domain (100%),,,,,,,,
WYCTFALPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNVFYYMPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVELNPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGMEYMPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVVDNMYHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAGYDDEGPWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLVVHLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.2 (19%);5.6.2.1 (15%);3.1.1.61 (14%),Transaldolase (19%);DNA topoisomerase (15%);Protein-glutamate methylesterase (14%),GO:0005840 (16%);GO:0005737 (8%);GO:0016021 (6%),ribosome (16%);cytoplasm (8%);integral component of membrane (6%),GO:0019843 (16%);GO:0008080 (16%);GO:0003735 (14%),rRNA binding (16%);N-acetyltransferase activity (16%);structural constituent of ribosome (14%),GO:0006412 (18%);GO:0006355 (7%);GO:0005975 (6%),translation (18%);regulation of transcription, DNA-templated (7%);carbohydrate metabolic process (6%),IPR000529 (15%);IPR014717 (15%);IPR016181 (15%),Ribosomal protein S6 (15%);Translation elongation factor EF1B/ribosomal protein S6 (15%);Acyl-CoA N-acyltransferase (15%),,,,,,,,,,
VNPNSSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000790 (33%);GO:0005576 (33%);GO:0005634 (33%),nuclear chromatin (33%);extracellular region (33%);nucleus (33%),GO:0000977 (33%);GO:0001102 (33%);GO:0001228 (33%),RNA polymerase II regulatory region sequence-specific DNA binding (33%);RNA polymerase II activating transcription factor binding (33%);DNA-binding transcription activator activity, RNA polymerase II-specific (33%),GO:0000122 (33%);GO:0001707 (33%);GO:0001708 (33%),negative regulation of transcription by RNA polymerase II (33%);mesoderm formation (33%);cell fate specification (33%),IPR007225 (60%);IPR042044 (60%);IPR042045 (60%),Exocyst complex component EXOC6/Sec15 (60%);Exocyst complex component EXOC6/Sec15, C-terminal, domain 2 (60%);Exocyst complex component EXOC6/Sec15, C-terminal, domain 1 (60%),,,,,,
VTQEDLECQATGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CYLFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005887 (10%);GO:0016021 (10%);GO:0043190 (10%),integral component of plasma membrane (10%);integral component of membrane (10%);ATP-binding cassette (ABC) transporter complex (10%),GO:0004553 (40%);GO:0030246 (40%);GO:0003676 (20%),hydrolase activity, hydrolyzing O-glycosyl compounds (40%);carbohydrate binding (40%);nucleic acid binding (20%),GO:0016052 (40%);GO:0006807 (10%);GO:0031167 (10%),carbohydrate catabolic process (40%);nitrogen compound metabolic process (10%);rRNA methylation (10%),IPR008979 (31%);IPR010502 (31%);IPR017853 (31%),Galactose-binding-like domain superfamily (31%);Carbohydrate-binding domain, family 9 (31%);Glycoside hydrolase superfamily (31%),,,,,,,,,
QNWCNEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPPVPHR,Streptomyces coelicoflavus,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Streptomycetales,,,,,Streptomycetaceae,,,,Streptomyces,,,,Streptomyces coelicoflavus,,,,,,,,,,,,,,,,,,,,,,,,
EAWVYMFGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTLFTNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYPTFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008236 (88%);GO:0016787 (13%),serine-type peptidase activity (88%);hydrolase activity (13%),,,IPR001375 (78%);IPR029058 (78%);IPR003607 (11%),Peptidase S9, prolyl oligopeptidase, catalytic domain (78%);Alpha/Beta hydrolase fold (78%);HD/PDEase domain (11%),,,,,,,,,
LLRPYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000145 (25%),exocyst (25%),GO:0046912 (50%);GO:0003676 (25%);GO:0004527 (25%),transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer (50%);nucleic acid binding (25%);exonuclease activity (25%),GO:0019752 (50%);GO:0006887 (25%);GO:0015031 (25%),carboxylic acid metabolic process (50%);exocytosis (25%);protein transport (25%),IPR000891 (50%);IPR002034 (50%);IPR013785 (50%),Pyruvate carboxyltransferase (50%);Alpha-isopropylmalate/homocitrate synthase, conserved site (50%);Aldolase-type TIM barrel (50%),,,,,,,,
FMEGRPK,Peptococcaceae bacterium DCMF,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Peptococcaceae,,,,,,,,Peptococcaceae bacterium DCMF,,,,2.5.1.17 (100%),Corrinoid adenosyltransferase (100%),,,GO:0005524 (100%);GO:0008817 (100%),ATP binding (100%);cob(I)yrinic acid a,c-diamide adenosyltransferase activity (100%),GO:0009236 (100%),cobalamin biosynthetic process (100%),IPR005624 (100%);IPR016030 (100%);IPR029499 (100%),Haem-degrading (100%);Cobalamin adenosyltransferase-like (100%);ATP:cob(I)alamin adenosyltransferase, PduO-type (100%),,,,,,,,,
MLLQDLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLNSLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.58 (20%);2.4.1.15 (20%);2.7.7.- (20%),Tagaturonate reductase (20%);Alpha,alpha-trehalose-phosphate synthase (UDP-forming) (20%);Nucleotidyltransferases (20%),GO:0005737 (7%);GO:0005840 (7%);GO:0015934 (7%),cytoplasm (7%);ribosome (7%);large ribosomal subunit (7%),GO:0004672 (29%);GO:0005524 (29%);GO:0008270 (21%),protein kinase activity (29%);ATP binding (29%);zinc ion binding (21%),GO:0005975 (7%);GO:0005992 (7%);GO:0006351 (7%),carbohydrate metabolic process (7%);trehalose biosynthetic process (7%);transcription, DNA-templated (7%),IPR000719 (24%);IPR011009 (24%);IPR011989 (24%),Protein kinase domain (24%);Protein kinase-like domain superfamily (24%);Armadillo-like helical (24%),,,,,,,,,
TPADMSDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMPANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.6.5 (80%);3.1.6.1 (20%),GTP diphosphokinase (80%);Arylsulfatase (type I) (20%),GO:0016021 (36%);GO:0005886 (5%);GO:0009431 (5%),integral component of membrane (36%);plasma membrane (5%);bacterial-type flagellum basal body, MS ring (5%),GO:0008728 (18%);GO:0016301 (18%);GO:0016787 (14%),GTP diphosphokinase activity (18%);kinase activity (18%);hydrolase activity (14%),GO:0015969 (45%);GO:0006357 (5%);GO:0006886 (5%),guanosine tetraphosphate metabolic process (45%);regulation of transcription by RNA polymerase II (5%);intracellular protein transport (5%),IPR002912 (55%);IPR003607 (55%);IPR004095 (55%),ACT domain (55%);HD/PDEase domain (55%);TGS (55%),,,,,,,,,,
TGEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (18%);6.5.1.2 (12%);1.11.1.21 (7%),Signal peptidase I (18%);DNA ligase (NAD(+)) (12%);Catalase peroxidase (7%),GO:0016021 (23%);GO:0005737 (10%);GO:0016020 (2%),integral component of membrane (23%);cytoplasm (10%);membrane (2%),GO:0005524 (15%);GO:0046872 (10%);GO:0003677 (9%),ATP binding (15%);metal ion binding (10%);DNA binding (9%),GO:0006270 (7%);GO:0006275 (7%);GO:0006281 (4%),DNA replication initiation (7%);regulation of DNA replication (7%);DNA repair (4%),IPR027417 (9%);IPR011990 (8%);IPR004165 (8%),P-loop containing nucleoside triphosphate hydrolase (9%);Tetratricopeptide-like helical domain superfamily (8%);Coenzyme A transferase family I (8%),,,,,,,,,,,
HFETNNQYSQDTGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMHSVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (31%);GO:0005694 (15%);GO:0005737 (15%),integral component of membrane (31%);chromosome (15%);cytoplasm (15%),GO:0003676 (23%);GO:0003677 (15%);GO:0005524 (15%),nucleic acid binding (23%);DNA binding (15%);ATP binding (15%),GO:0006260 (15%);GO:0007062 (15%);GO:0030261 (15%),DNA replication (15%);sister chromatid cohesion (15%);chromosome condensation (15%),IPR000073 (20%);IPR006050 (20%);IPR014729 (20%),Alpha/beta hydrolase fold-1 (20%);DNA photolyase, N-terminal (20%);Rossmann-like alpha/beta/alpha sandwich fold (20%),,,,,,,,,,
EHWFMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0000155 (33%);GO:0016772 (33%),phosphorelay sensor kinase activity (33%);transferase activity, transferring phosphorus-containing groups (33%),GO:0000160 (33%);GO:0016310 (33%),phosphorelay signal transduction system (33%);phosphorylation (33%),IPR001789 (100%);IPR003594 (100%);IPR004358 (100%),Signal transduction response regulator, receiver domain (100%);Histidine kinase/HSP90-like ATPase (100%);Signal transduction histidine kinase-related protein, C-terminal (100%),,,,,,,,
EVHWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (57%);3.2.1.3 (14%);2.3.1.- (7%),Transferring other groups (57%);Glucan 1,4-alpha-glucosidase (14%);Transferring groups other than amino-acyl groups (7%),GO:0016021 (12%);GO:0005634 (2%);GO:0005887 (1%),integral component of membrane (12%);nucleus (2%);integral component of plasma membrane (1%),GO:0016787 (12%);GO:0005524 (12%);GO:0003677 (10%),hydrolase activity (12%);ATP binding (12%);DNA binding (10%),GO:0032259 (9%);GO:0005975 (7%);GO:0001522 (6%),methylation (9%);carbohydrate metabolic process (7%);pseudouridine synthesis (6%),IPR008928 (18%);IPR012341 (18%);IPR027417 (16%),Six-hairpin glycosidase superfamily (18%);Six-hairpin glycosidase-like superfamily (18%);P-loop containing nucleoside triphosphate hydrolase (16%),,,,,,,,,,
GFLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (13%);2.7.7.7 (9%);1.2.4.1 (9%),DNA topoisomerase (13%);DNA-directed DNA polymerase (9%);Pyruvate dehydrogenase (acetyl-transferring) (9%),GO:0016021 (38%);GO:0005886 (5%);GO:0005634 (3%),integral component of membrane (38%);plasma membrane (5%);nucleus (3%),GO:0003677 (20%);GO:0022857 (17%);GO:0005524 (7%),DNA binding (20%);transmembrane transporter activity (17%);ATP binding (7%),GO:0006355 (12%);GO:0000160 (12%);GO:0006865 (3%),regulation of transcription, DNA-templated (12%);phosphorelay signal transduction system (12%);amino acid transport (3%),IPR018108 (13%);IPR023395 (13%);IPR002067 (12%),Mitochondrial substrate/solute carrier (13%);Mitochondrial carrier domain superfamily (13%);Mitochondrial carrier protein (12%),,,,,,,,,,
WWNDFVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEQVTANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSGEVTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.107 (50%);6.3.5.- (50%),Peptidase Do (50%);Carbon--nitrogen ligases with glutamine as amido-N-donor (50%),GO:0005737 (33%);GO:0042597 (33%),cytoplasm (33%);periplasmic space (33%),GO:0004252 (33%);GO:0004812 (33%);GO:0005524 (33%),serine-type endopeptidase activity (33%);aminoacyl-tRNA ligase activity (33%);ATP binding (33%),GO:0006412 (33%),translation (33%),IPR000674 (20%);IPR001478 (20%);IPR001940 (20%),Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead (20%);PDZ domain (20%);Peptidase S1C (20%),,,,,,,,,,
QVSLNC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNMRPYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNGYLSSLLVC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FWMDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0004553 (50%);GO:0030246 (50%),hydrolase activity, hydrolyzing O-glycosyl compounds (50%);carbohydrate binding (50%),GO:0005975 (50%),carbohydrate metabolic process (50%),IPR000322 (50%);IPR002159 (50%);IPR011013 (50%),Glycoside hydrolase family 31 (50%);CD36 family (50%);Galactose mutarotase-like domain superfamily (50%),,,,,,,,,,
NALTMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.- (53%);1.3.1.- (35%);2.3.1.- (6%),Peroxidases (53%);With NAD(+) or NADP(+) as acceptor (35%);Transferring groups other than amino-acyl groups (6%),GO:0005623 (22%);GO:0016021 (22%);GO:0005737 (2%),cell (22%);integral component of membrane (22%);cytoplasm (2%),GO:0046872 (24%);GO:0004601 (22%);GO:0017150 (22%),metal ion binding (24%);peroxidase activity (22%);tRNA dihydrouridine synthase activity (22%),GO:0033212 (22%);GO:0006310 (7%);GO:0015074 (7%),iron import into cell (22%);DNA recombination (7%);DNA integration (7%),IPR001269 (18%);IPR004652 (18%);IPR006311 (18%),tRNA-dihydrouridine synthase (18%);tRNA-dihydrouridine synthase, TIM-barrel, NifR3 (18%);Twin-arginine translocation pathway, signal sequence (18%),,,,,,,,
QYEVSCSWVNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANEPNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLVTVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (100%),DNA topoisomerase (ATP-hydrolyzing) (100%),GO:0016021 (71%);GO:0005634 (14%);GO:0005794 (7%),integral component of membrane (71%);nucleus (14%);Golgi apparatus (7%),GO:0003677 (46%);GO:0022857 (7%);GO:0003887 (4%),DNA binding (46%);transmembrane transporter activity (7%);DNA-directed DNA polymerase activity (4%),GO:0000160 (36%);GO:0006355 (36%);GO:0015031 (7%),phosphorelay signal transduction system (36%);regulation of transcription, DNA-templated (36%);protein transport (7%),IPR001867 (33%);IPR016032 (33%);IPR036388 (33%),OmpR/PhoB-type DNA-binding domain (33%);Signal transduction response regulator, C-terminal effector (33%);Winged helix-like DNA-binding domain superfamily (33%),,,,,,,,,
LEENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (25%);2.7.13.3 (5%);2.7.7.6 (3%),DNA-directed DNA polymerase (25%);Histidine kinase (5%);DNA-directed RNA polymerase (3%),GO:0016021 (29%);GO:0005737 (6%);GO:0005634 (4%),integral component of membrane (29%);cytoplasm (6%);nucleus (4%),GO:0005524 (18%);GO:0003677 (16%);GO:0003887 (5%),ATP binding (18%);DNA binding (16%);DNA-directed DNA polymerase activity (5%),GO:0006261 (5%);GO:0006281 (5%);GO:0015031 (2%),DNA-dependent DNA replication (5%);DNA repair (5%);protein transport (2%),IPR027417 (14%);IPR036890 (4%);IPR003593 (4%),P-loop containing nucleoside triphosphate hydrolase (14%);Histidine kinase/HSP90-like ATPase superfamily (4%);AAA+ ATPase domain (4%),,,,,,,,,,,
MVNDNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.2 (100%),NADH:ubiquinone reductase (H(+)-translocating) (100%),GO:0016021 (75%);GO:0031966 (38%);GO:0070469 (38%),integral component of membrane (75%);mitochondrial membrane (38%);respirasome (38%),GO:0008137 (38%);GO:0003677 (13%);GO:0004888 (13%),NADH dehydrogenase (ubiquinone) activity (38%);DNA binding (13%);transmembrane signaling receptor activity (13%),GO:0007165 (25%);GO:0006355 (13%);GO:0006935 (13%),signal transduction (25%);regulation of transcription, DNA-templated (13%);chemotaxis (13%),IPR001457 (30%);IPR042106 (30%);IPR003798 (20%),NADH:ubiquinone/plastoquinone oxidoreductase, chain 6 (30%);NADH-ubiquinone/plastoquinone oxidoreductase chain 6, subunit NuoJ (30%);DNA recombination RmuC (20%),,,,,,,,
LTYPMPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (6%);6.3.2.3 (6%);1.3.1.98 (4%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (6%);Glutathione synthase (6%);UDP-N-acetylmuramate dehydrogenase (4%),GO:0016021 (23%);GO:0005737 (6%);GO:0005886 (5%),integral component of membrane (23%);cytoplasm (6%);plasma membrane (5%),GO:0005524 (24%);GO:0004672 (9%);GO:0003677 (8%),ATP binding (24%);protein kinase activity (9%);DNA binding (8%),GO:0005975 (3%);GO:0006537 (2%);GO:0006304 (2%),carbohydrate metabolic process (3%);glutamate biosynthetic process (2%);DNA modification (2%),IPR011009 (10%);IPR000719 (10%);IPR008271 (10%),Protein kinase-like domain superfamily (10%);Protein kinase domain (10%);Serine/threonine-protein kinase, active site (10%),,,,,,,,,,
DGAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.2 (18%);5.2.1.8 (14%);2.7.7.7 (5%),Tryptophan--tRNA ligase (18%);Peptidylprolyl isomerase (14%);DNA-directed DNA polymerase (5%),GO:0016021 (19%);GO:0005737 (12%);GO:0005615 (5%),integral component of membrane (19%);cytoplasm (12%);extracellular space (5%),GO:0005524 (14%);GO:0004866 (6%);GO:0046872 (6%),ATP binding (14%);endopeptidase inhibitor activity (6%);metal ion binding (6%),GO:0006508 (6%);GO:0006436 (5%);GO:0006412 (2%),proteolysis (6%);tryptophanyl-tRNA aminoacylation (5%);translation (2%),IPR027417 (6%);IPR002890 (6%);IPR021868 (6%),P-loop containing nucleoside triphosphate hydrolase (6%);Macroglobulin domain (6%);Alpha-2-macroglobulin MG3 domain (6%),,,,,,,,,,,
WSLSGWGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MWYVLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQEMDHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSFTALFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMEYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.76 (31%);2.3.1.- (25%);2.3.2.27 (9%),Diaminobutyrate--2-oxoglutarate transaminase (31%);Transferring groups other than amino-acyl groups (25%);RING-type E3 ubiquitin transferase (9%),GO:0005815 (27%);GO:0016021 (13%);GO:0005730 (5%),microtubule organizing center (27%);integral component of membrane (13%);nucleolus (5%),GO:0005524 (13%);GO:0030170 (7%);GO:0045303 (7%),ATP binding (13%);pyridoxal phosphate binding (7%);diaminobutyrate-2-oxoglutarate transaminase activity (7%),GO:0019491 (7%);GO:0051391 (5%);GO:0042274 (5%),ectoine biosynthetic process (7%);tRNA acetylation (5%);ribosomal small subunit biogenesis (5%),IPR029058 (47%);IPR000801 (18%);IPR024545 (13%),Alpha/Beta hydrolase fold (47%);Putative esterase (18%);Mto2p-binding domain (13%),,,,,,,,,,,
FELGQHK,Lachnospiraceae,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Lachnospiraceae,,,,,,,,,,,,,,,,GO:0000150 (100%);GO:0003677 (100%),recombinase activity (100%);DNA binding (100%),,,IPR011109 (100%);IPR038109 (100%);IPR006119 (50%),DNA-binding recombinase domain (100%);DNA-binding recombinase domain superfamily (100%);Resolvase, N-terminal catalytic domain (50%),,,,,,,,,,
QWVEALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.3 (100%),Long-chain-fatty-acid--CoA ligase (100%),,,GO:0016491 (27%);GO:0016787 (27%);GO:0005524 (18%),oxidoreductase activity (27%);hydrolase activity (27%);ATP binding (18%),GO:0009058 (9%);GO:0055114 (9%),biosynthetic process (9%);oxidation-reduction process (9%),IPR000683 (27%);IPR006311 (27%);IPR006680 (27%),Oxidoreductase, N-terminal (27%);Twin-arginine translocation pathway, signal sequence (27%);Amidohydrolase-related (27%),,,,,,,,,
VDGSCHPEEGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVWQDGTCSSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MANEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.2 (5%);2.7.13.3 (4%);3.1.22.4 (4%),Transaldolase (5%);Histidine kinase (4%);Crossover junction endodeoxyribonuclease (4%),GO:0016021 (28%);GO:0005737 (10%);GO:0005789 (9%),integral component of membrane (28%);cytoplasm (10%);endoplasmic reticulum membrane (9%),GO:0003677 (12%);GO:0005524 (12%);GO:0046872 (6%),DNA binding (12%);ATP binding (12%);metal ion binding (6%),GO:0015031 (9%);GO:0006412 (6%);GO:0006355 (5%),protein transport (9%);translation (6%);regulation of transcription, DNA-templated (5%),IPR027417 (9%);IPR010580 (8%);IPR009228 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);Stress-associated endoplasmic reticulum protein (8%);Capsid scaffolding protein GpO (4%),,,,,,,,,,
VEPAWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.2 (33%);3.2.2.- (25%);5.4.2.12 (17%),UDP-glucose 4-epimerase (33%);Hydrolyzing N-glycosyl compounds (25%);Phosphoglycerate mutase (2,3-diphosphoglycerate-independent) (17%),GO:0016021 (12%);GO:0005737 (3%);GO:0005886 (2%),integral component of membrane (12%);cytoplasm (3%);plasma membrane (2%),GO:0003824 (66%);GO:0003677 (64%);GO:0051539 (58%),catalytic activity (66%);DNA binding (64%);4 iron, 4 sulfur cluster binding (58%),GO:0006284 (66%);GO:0006012 (4%);GO:0006007 (2%),base-excision repair (66%);galactose metabolic process (4%);glucose catabolic process (2%),IPR011257 (70%);IPR003265 (69%);IPR023170 (69%),DNA glycosylase (70%);HhH-GPD domain (69%);Helix-turn-helix, base-excision DNA repair, C-terminal (69%),,,,,,,
MTLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.65 (33%);1.11.1.15 (24%);4.1.1.15 (5%),Phosphatidylserine decarboxylase (33%);Peroxiredoxin (24%);Glutamate decarboxylase (5%),GO:0016021 (20%);GO:0005840 (14%);GO:0005886 (11%),integral component of membrane (20%);ribosome (14%);plasma membrane (11%),GO:0004601 (25%);GO:0003735 (13%);GO:0004609 (9%),peroxidase activity (25%);structural constituent of ribosome (13%);phosphatidylserine decarboxylase activity (9%),GO:0006979 (25%);GO:0006412 (14%);GO:0006646 (8%),response to oxidative stress (25%);translation (14%);phosphatidylethanolamine biosynthetic process (8%),IPR015946 (29%);IPR036102 (29%);IPR003718 (29%),K homology domain-like, alpha/beta (29%);OsmC/Ohr superfamily (29%);OsmC/Ohr family (29%),,,,,,,,,,
DVAHLYK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,1.8.5.- (100%),With a quinone or similar compound as acceptor (100%),,,GO:0046872 (100%);GO:0000166 (50%);GO:0016672 (50%),metal ion binding (100%);nucleotide binding (50%);oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor (50%),GO:0009166 (50%);GO:0030091 (50%);GO:0042128 (50%),nucleotide catabolic process (50%);protein repair (50%);nitrate assimilation (50%),IPR000572 (50%);IPR004843 (50%);IPR006146 (50%),Oxidoreductase, molybdopterin-binding domain (50%);Calcineurin-like phosphoesterase domain, ApaH type (50%);5'-Nucleotidase, conserved site (50%),,,,,,
VFANAEGYPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.- (32%);3.1.-.- (19%);3.4.21.53 (16%),Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (32%);Acting on ester bonds (19%);Endopeptidase La (16%),GO:0016021 (42%);GO:0005737 (6%);GO:0030688 (2%),integral component of membrane (42%);cytoplasm (6%);preribosome, small subunit precursor (2%),GO:0003700 (16%);GO:0003677 (12%);GO:0005524 (12%),DNA-binding transcription factor activity (16%);DNA binding (12%);ATP binding (12%),GO:0008152 (7%);GO:0030255 (7%);GO:0000398 (5%),metabolic process (7%);protein secretion by the type IV secretion system (7%);mRNA splicing, via spliceosome (5%),IPR027417 (10%);IPR005119 (8%);IPR000847 (8%),P-loop containing nucleoside triphosphate hydrolase (10%);LysR, substrate-binding (8%);Transcription regulator HTH, LysR (8%),,,,,,
QNDYNDSGTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.3 (97%);5.6.2.2 (0%);3.4.21.107 (0%),Ornithine carbamoyltransferase (97%);DNA topoisomerase (ATP-hydrolyzing) (0%);Peptidase Do (0%),GO:0005737 (77%);GO:0016021 (5%);GO:0005886 (1%),cytoplasm (77%);integral component of membrane (5%);plasma membrane (1%),GO:0004585 (82%);GO:0016597 (75%);GO:0005524 (3%),ornithine carbamoyltransferase activity (82%);amino acid binding (75%);ATP binding (3%),GO:0006526 (1%);GO:0019547 (1%);GO:0055085 (1%),arginine biosynthetic process (1%);arginine catabolic process to ornithine (1%);transmembrane transport (1%),IPR006131 (80%);IPR036901 (80%);IPR006130 (79%),Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain (80%);Aspartate/ornithine carbamoyltransferase superfamily (80%);Aspartate/ornithine carbamoyltransferase (79%),,,,,,,,,,
NGAATR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.3.6 (39%);2.6.1.16 (28%);1.6.99.3 (11%),Arginine deiminase (39%);Glutamine--fructose-6-phosphate transaminase (isomerizing) (28%);NADH dehydrogenase (11%),GO:0016021 (23%);GO:0005737 (12%);GO:0005634 (9%),integral component of membrane (23%);cytoplasm (12%);nucleus (9%),GO:0003677 (15%);GO:0005524 (11%);GO:0016755 (11%),DNA binding (15%);ATP binding (11%);transferase activity, transferring amino-acyl groups (11%),GO:0044038 (11%);GO:0019547 (7%);GO:0005975 (6%),cell wall macromolecule biosynthetic process (11%);arginine catabolic process to ornithine (7%);carbohydrate metabolic process (6%),IPR003447 (10%);IPR016181 (10%);IPR009057 (8%),FemABX peptidyl transferase (10%);Acyl-CoA N-acyltransferase (10%);Homeobox-like domain superfamily (8%),,,,,,,,,,
MMFNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.10.3.- (50%);2.7.7.59 (50%),With oxygen as acceptor (50%);[Protein-PII] uridylyltransferase (50%),GO:0016021 (98%);GO:0005634 (1%);GO:0005886 (1%),integral component of membrane (98%);nucleus (1%);plasma membrane (1%),GO:0003677 (1%);GO:0004129 (1%);GO:0005507 (1%),DNA binding (1%);cytochrome-c oxidase activity (1%);copper ion binding (1%),,,IPR002823 (94%);IPR003746 (1%);IPR003749 (1%),Protein of unknown function DUF112, transmembrane (94%);Protein of unknown function DUF167 (1%);Sulfur carrier ThiS/MoaD-like (1%),,,,,,,,,,
MFESGYK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.- (100%),Phosphotransferases with an alcohol group as acceptor (100%),GO:0043190 (50%),ATP-binding cassette (ABC) transporter complex (50%),GO:0016773 (50%),phosphotransferase activity, alcohol group as acceptor (50%),GO:0006388 (50%);GO:0055085 (50%),tRNA splicing, via endonucleolytic cleavage and ligation (50%);transmembrane transport (50%),IPR000412 (33%);IPR002745 (33%);IPR013525 (33%),ABC-2 transporter (33%);Phosphotransferase KptA/Tpt1 (33%);ABC-2 type transporter (33%),,,,,,,,,
YEDEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.22.- (100%),Cysteine endopeptidases (100%),GO:0016021 (43%);GO:0000139 (14%);GO:0005737 (14%),integral component of membrane (43%);Golgi membrane (14%);cytoplasm (14%),GO:0003676 (43%);GO:0003777 (14%);GO:0004197 (14%),nucleic acid binding (43%);microtubule motor activity (14%);cysteine-type endopeptidase activity (14%),GO:0006914 (14%);GO:0007018 (14%);GO:0015031 (14%),autophagy (14%);microtubule-based movement (14%);protein transport (14%),IPR011093 (35%);IPR036388 (35%);IPR036390 (35%),Putative conjugal transfer nickase/helicase TraI, C-terminal (35%);Winged helix-like DNA-binding domain superfamily (35%);Winged helix DNA-binding domain superfamily (35%),,,,,,,,,,
RPNNEDQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTLMSPNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMAFYEVTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTMSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.4 (100%),Cellulase (100%),GO:0005737 (19%);GO:0016021 (19%);GO:0005886 (10%),cytoplasm (19%);integral component of membrane (19%);plasma membrane (10%),GO:0000155 (14%);GO:0000156 (14%);GO:0005524 (14%),phosphorelay sensor kinase activity (14%);phosphorelay response regulator activity (14%);ATP binding (14%),GO:0006935 (14%);GO:0006355 (10%);GO:0007049 (10%),chemotaxis (14%);regulation of transcription, DNA-templated (10%);cell cycle (10%),IPR000014 (14%);IPR000673 (14%);IPR000700 (14%),PAS domain (14%);Signal transduction response regulator, chemotaxis, protein-glutamate methylesterase (14%);PAS-associated, C-terminal (14%),,,,,,,
MVPLVMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000159 (33%),protein phosphatase type 2A complex (33%),GO:0005509 (33%);GO:0008168 (33%);GO:0019888 (33%),calcium ion binding (33%);methyltransferase activity (33%);protein phosphatase regulator activity (33%),GO:0032259 (33%),methylation (33%),IPR029063 (60%);IPR041698 (60%);IPR000009 (20%),S-adenosyl-L-methionine-dependent methyltransferase (60%);Methyltransferase domain 25 (60%);Protein phosphatase 2A regulatory subunit PR55 (20%),,,,,,,,,,,
MQVLWSPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTMHSLVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GANAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.3 (31%);3.6.1.9 (14%);3.6.1.8 (9%),Dihydroorotase (31%);Nucleotide diphosphatase (14%);ATP diphosphatase (9%),GO:0016021 (16%);GO:0005737 (4%);GO:0005886 (3%),integral component of membrane (16%);cytoplasm (4%);plasma membrane (3%),GO:0016787 (18%);GO:0005524 (15%);GO:0008270 (10%),hydrolase activity (18%);ATP binding (15%);zinc ion binding (10%),GO:0044205 (8%);GO:0006313 (2%);GO:0006270 (2%),'de novo' UMP biosynthetic process (8%);transposition, DNA-mediated (2%);DNA replication initiation (2%),IPR004518 (19%);IPR011551 (19%);IPR027417 (8%),NTP pyrophosphohydrolase MazG, putative catalytic core (19%);NTP pyrophosphohydrolase MazG (19%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,
LPYEPPYSTYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVFSTPSNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLNLMAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGTGLVSCLGGKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DELLVFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSTSVGSSYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVYVVMAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVAKPLSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALLSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.10 (60%);2.4.1.227 (13%);2.3.1.- (7%),Hydroxymethylglutaryl-CoA synthase (60%);Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (13%);Transferring groups other than amino-acyl groups (7%),GO:0016021 (65%);GO:0019031 (58%);GO:0044175 (58%),integral component of membrane (65%);viral envelope (58%);host cell endosome membrane (58%),GO:0005198 (58%);GO:0003677 (13%);GO:0003700 (10%),structural molecule activity (58%);DNA binding (13%);DNA-binding transcription factor activity (10%),GO:0019062 (58%);GO:0019064 (58%);GO:0019082 (58%),virion attachment to host cell (58%);fusion of virus membrane with host plasma membrane (58%);viral protein processing (58%),IPR000328 (54%);IPR000777 (54%);IPR036377 (54%),Retroviral envelope protein GP41-like (54%);Human immunodeficiency virus 1, envelope glycoprotein Gp120 (54%);Gp120 core superfamily (54%),,,,,,,,,,
NLLVDNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (40%);2.1.3.15 (40%);3.4.24.- (20%),DNA (cytosine-5-)-methyltransferase (40%);Acetyl-CoA carboxytransferase (40%);Metalloendopeptidases (20%),GO:0016021 (29%);GO:0005741 (18%);GO:0005832 (18%),integral component of membrane (29%);mitochondrial outer membrane (18%);chaperonin-containing T-complex (18%),GO:0005524 (59%);GO:0051082 (47%);GO:0003924 (9%),ATP binding (59%);unfolded protein binding (47%);GTPase activity (9%),GO:0006457 (47%);GO:0006633 (6%);GO:2001295 (6%),protein folding (47%);fatty acid biosynthetic process (6%);malonyl-CoA biosynthetic process (6%),IPR002194 (46%);IPR002423 (46%);IPR017998 (46%),Chaperonin TCP-1, conserved site (46%);Chaperonin Cpn60/TCP-1 family (46%);Chaperone tailless complex polypeptide 1 (TCP-1) (46%),,,,,,,,,,
DQYGMHFLVELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVVVMSHDDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNSTVNEVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MQDQFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EANLNENHGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVAPENMEMTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEKPMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (99%);1.17.7.3 (1%),DNA-directed RNA polymerase (99%);(E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (1%),GO:0005665 (17%);GO:0031618 (9%);GO:0010494 (7%),RNA polymerase II, core complex (17%);nuclear pericentric heterochromatin (9%);cytoplasmic stress granule (7%),GO:0003677 (95%);GO:0032549 (95%);GO:0003899 (87%),DNA binding (95%);ribonucleoside binding (95%);DNA-directed 5'-3' RNA polymerase activity (87%),GO:0006351 (78%);GO:0006366 (10%);GO:0031048 (9%),transcription, DNA-templated (78%);transcription by RNA polymerase II (10%);chromatin silencing by small RNA (9%),IPR007120 (94%);IPR015712 (94%);IPR037033 (93%),DNA-directed RNA polymerase, subunit 2, hybrid-binding domain (94%);DNA-directed RNA polymerase, subunit 2 (94%);DNA-directed RNA polymerase, subunit 2, hybrid-binding domain superfamily (93%),,,,
DENLVQQEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVLSHLMTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAMGMWESHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTNQMVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYCFYK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (17%),integral component of membrane (17%),GO:0004519 (83%);GO:0000155 (17%);GO:0003700 (17%),endonuclease activity (83%);phosphorelay sensor kinase activity (17%);DNA-binding transcription factor activity (17%),,,IPR019065 (80%);IPR001789 (15%);IPR003594 (15%),Restriction endonuclease, type II, NgoFVII (80%);Signal transduction response regulator, receiver domain (15%);Histidine kinase/HSP90-like ATPase (15%),,,,,,,,
WYPDNLYLGAQAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETTMPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.6.2.1 (100%),P-type phospholipid transporter (100%),GO:0016021 (75%),integral component of membrane (75%),GO:0005524 (100%);GO:0000287 (75%);GO:0140326 (75%),ATP binding (100%);magnesium ion binding (75%);ATPase-coupled intramembrane lipid transporter activity (75%),GO:0015914 (75%),phospholipid transport (75%),IPR008969 (56%);IPR041700 (56%);IPR006539 (33%),Carboxypeptidase-like, regulatory domain superfamily (56%);Outer membrane protein beta-barrel domain 3 (56%);P-type ATPase, subfamily IV (33%),,,,,,,,,
VYHMVSPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FALELSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNFSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.13 (45%);2.1.1.173 (12%);2.1.1.264 (12%),IgA-specific metalloendopeptidase (45%);23S rRNA (guanine(2445)-N(2))-methyltransferase (12%);23S rRNA (guanine(2069)-N(7))-methyltransferase (12%),GO:0016021 (64%);GO:0005576 (10%);GO:0005618 (10%),integral component of membrane (64%);extracellular region (10%);cell wall (10%),GO:0005524 (13%);GO:0004527 (11%);GO:0004222 (10%),ATP binding (13%);exonuclease activity (11%);metalloendopeptidase activity (10%),GO:0007340 (17%);GO:0009405 (10%);GO:0006310 (10%),acrosome reaction (17%);pathogenesis (10%);DNA recombination (10%),IPR000008 (21%);IPR001565 (21%);IPR035892 (21%),C2 domain (21%);Synaptotagmin (21%);C2 domain superfamily (21%),,,,,,,,,,,
MDELPALTVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLYQDFHQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVYDYEWYDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CSYVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.1 (100%),Alanine racemase (100%),GO:0016021 (29%);GO:0000145 (14%);GO:0005737 (14%),integral component of membrane (29%);exocyst (14%);cytoplasm (14%),GO:0003677 (29%);GO:0004519 (14%);GO:0005198 (14%),DNA binding (29%);endonuclease activity (14%);structural molecule activity (14%),GO:0006024 (14%);GO:0006304 (14%);GO:0006355 (14%),glycosaminoglycan biosynthetic process (14%);DNA modification (14%);regulation of transcription, DNA-templated (14%),IPR000055 (14%);IPR000477 (14%);IPR000843 (14%),Restriction endonuclease, type I, HsdS (14%);Reverse transcriptase domain (14%);LacI-type HTH domain (14%),,,,,,,,
QGEYAETNYVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSEHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (17%);1.2.7.8 (8%);2.1.1.74 (8%),Hexosyltransferases (17%);Indolepyruvate ferredoxin oxidoreductase (8%);Methylenetetrahydrofolate--tRNA-(uracil(54)-C(5))-methyltransferas(NAD(P)H-oxidizing) (8%),GO:0016021 (28%);GO:0000151 (6%);GO:0016592 (6%),integral component of membrane (28%);ubiquitin ligase complex (6%);mediator complex (6%),GO:0005524 (23%);GO:0003677 (10%);GO:0004672 (9%),ATP binding (23%);DNA binding (10%);protein kinase activity (9%),GO:0006357 (6%);GO:0006511 (6%);GO:0006935 (6%),regulation of transcription by RNA polymerase II (6%);ubiquitin-dependent protein catabolic process (6%);chemotaxis (6%),IPR016024 (12%);IPR012978 (9%);IPR000719 (8%),Armadillo-type fold (12%);Uncharacterised domain NUC173 (9%);Protein kinase domain (8%),,,,,,,,,,,
TETQLSLK,Deltaproteobacteria bacterium,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,,,,,,,,,,,,,,Deltaproteobacteria bacterium,,,,,,,,,,,,IPR006260 (100%),TonB/TolA, C-terminal (100%),,,,,,,,,,
TPAEHDK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004665 (100%);GO:0008977 (100%),prephenate dehydrogenase (NADP+) activity (100%);prephenate dehydrogenase (NAD+) activity (100%),GO:0006571 (100%),tyrosine biosynthetic process (100%),IPR016875 (50%);IPR003099 (25%);IPR004830 (25%),Uncharacterised conserved protein UCP028200 (50%);Prephenate dehydrogenase (25%);Leucine rich repeat variant (25%),,,,,,,,,,,
VPVSNPPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVTESVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYGPLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0004497 (67%);GO:0005506 (67%);GO:0016705 (67%),monooxygenase activity (67%);iron ion binding (67%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (67%),GO:0032259 (33%),methylation (33%),IPR001128 (67%);IPR017972 (67%);IPR036396 (67%),Cytochrome P450 (67%);Cytochrome P450, conserved site (67%);Cytochrome P450 superfamily (67%),,,,,,,,
NGNGRPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSALEDNSLQVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPAHMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WAALGM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCSSLNSK,Homalodisca liturata,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Hemiptera,Auchenorrhyncha,Cicadomorpha,,Membracoidea,Cicadellidae,Cicadellinae,Proconiini,,Homalodisca,,,,Homalodisca liturata,,,,,,,,,,,,,,,,,,,,,,,,
TYLLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6.1.2 (58%);6.3.2.17 (10%);3.4.24.- (8%),Guanylate cyclase (58%);Tetrahydrofolate synthase (10%);Metalloendopeptidases (8%),GO:0016021 (40%);GO:0005623 (4%);GO:0005886 (4%),integral component of membrane (40%);cell (4%);plasma membrane (4%),GO:0005524 (25%);GO:0004713 (12%);GO:0004383 (10%),ATP binding (25%);protein tyrosine kinase activity (12%);guanylate cyclase activity (10%),GO:0007165 (7%);GO:0006355 (4%);GO:0045454 (4%),signal transduction (7%);regulation of transcription, DNA-templated (4%);cell redox homeostasis (4%),IPR000719 (10%);IPR001245 (10%);IPR011009 (10%),Protein kinase domain (10%);Serine-threonine/tyrosine-protein kinase, catalytic domain (10%);Protein kinase-like domain superfamily (10%),,,,,,,,,
AEEGDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (100%),Non-specific serine/threonine protein kinase (100%),GO:0016021 (10%);GO:0005737 (3%),integral component of membrane (10%);cytoplasm (3%),GO:0016491 (68%);GO:0046872 (68%);GO:0051539 (68%),oxidoreductase activity (68%);metal ion binding (68%);4 iron, 4 sulfur cluster binding (68%),GO:0042128 (5%);GO:0001525 (3%);GO:0006281 (3%),nitrate assimilation (5%);angiogenesis (3%);DNA repair (3%),IPR005117 (60%);IPR006066 (60%);IPR006067 (60%),Nitrite/Sulfite reductase ferredoxin-like domain (60%);Nitrite/sulphite reductase iron-sulphur/sirohaem-binding site (60%);Nitrite/sulphite reductase 4Fe-4S domain (60%),,,,,,,,,,
MFEVVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FCYVQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQSPDDDN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLMLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (74%);6.3.1.2 (15%);2.8.2.- (2%),Pyruvate dehydrogenase (acetyl-transferring) (74%);Glutamine synthetase (15%);Sulfotransferases (2%),GO:0016021 (7%);GO:0005737 (2%);GO:0005634 (1%),integral component of membrane (7%);cytoplasm (2%);nucleus (1%),GO:0004356 (50%);GO:0046872 (27%);GO:0004739 (27%),glutamate-ammonia ligase activity (50%);metal ion binding (27%);pyruvate dehydrogenase (acetyl-transferring) activity (27%),GO:0006542 (49%);GO:0005975 (1%);GO:0006281 (0%),glutamine biosynthetic process (49%);carbohydrate metabolic process (1%);DNA repair (0%),IPR014746 (49%);IPR036651 (48%);IPR008147 (48%),Glutamine synthetase/guanido kinase, catalytic domain (49%);Glutamine synthetase, N-terminal domain superfamily (48%);Glutamine synthetase, beta-Grasp domain (48%),,,,,,,,
AGMSDPQCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDELDYHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEWNPLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMMLPVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TWWVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (30%),integral component of membrane (30%),GO:0003676 (90%);GO:0008270 (90%);GO:0004553 (10%),nucleic acid binding (90%);zinc ion binding (90%);hydrolase activity, hydrolyzing O-glycosyl compounds (10%),GO:0016052 (10%),carbohydrate catabolic process (10%),IPR005162 (77%);IPR032567 (77%);IPR001878 (69%),Retrotransposon gag domain (77%);LDOC1-related (77%);Zinc finger, CCHC-type (69%),,,,,,,,,
DMNPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.12 (75%);3.5.1.88 (13%);6.5.1.1 (13%),D-aspartate ligase (75%);Peptide deformylase (13%);DNA ligase (ATP) (13%),GO:0016021 (6%);GO:0016459 (2%),integral component of membrane (6%);myosin complex (2%),GO:0005524 (85%);GO:0046872 (83%);GO:0016874 (45%),ATP binding (85%);metal ion binding (83%);ligase activity (45%),GO:0006260 (2%);GO:0006310 (2%);GO:0006412 (2%),DNA replication (2%);DNA recombination (2%);translation (2%),IPR011761 (76%);IPR000048 (2%);IPR000620 (2%),ATP-grasp fold (76%);IQ motif, EF-hand binding site (2%);EamA domain (2%),,,,,,,,,,
VEEQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.99.6 (15%);2.7.7.59 (7%);3.1.4.- (7%),Epoxyqueuosine reductase (15%);[Protein-PII] uridylyltransferase (7%);Phosphoric diester hydrolases (7%),GO:0016021 (36%);GO:0005737 (10%);GO:0005886 (8%),integral component of membrane (36%);cytoplasm (10%);plasma membrane (8%),GO:0005524 (14%);GO:0046872 (7%);GO:0003677 (6%),ATP binding (14%);metal ion binding (7%);DNA binding (6%),GO:0006355 (8%);GO:0006457 (6%);GO:0006260 (6%),regulation of transcription, DNA-templated (8%);protein folding (6%);DNA replication (6%),IPR025120 (24%);IPR027417 (8%);IPR012533 (5%),Domain of unknown function DUF4047 (24%);P-loop containing nucleoside triphosphate hydrolase (8%);YcnI-like (5%),,,,,,,,,,
FMELPNWVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVCNGSWSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLMCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.48 (16%);2.7.7.6 (11%);3.1.-.- (8%),Histone acetyltransferase (16%);DNA-directed RNA polymerase (11%);Acting on ester bonds (8%),GO:0016021 (28%);GO:0005623 (13%);GO:0005634 (6%),integral component of membrane (28%);cell (13%);nucleus (6%),GO:0016787 (15%);GO:0005509 (11%);GO:0005219 (9%),hydrolase activity (15%);calcium ion binding (11%);ryanodine-sensitive calcium-release channel activity (9%),GO:0006355 (6%);GO:0005975 (6%);GO:0051209 (4%),regulation of transcription, DNA-templated (6%);carbohydrate metabolic process (6%);release of sequestered calcium ion into cytosol (4%),IPR000086 (11%);IPR015797 (11%);IPR013320 (8%),NUDIX hydrolase domain (11%);NUDIX hydrolase-like domain superfamily (11%);Concanavalin A-like lectin/glucanase domain superfamily (8%),,,,,,,,,,
MPNELENLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFEPCSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDDMFSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDVPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.3 (46%);3.6.3.30 (18%);1.17.1.4 (7%),Aldose 1-epimerase (46%);Transferred entry: 7.2.2.7 (18%);Xanthine dehydrogenase (7%),GO:0016021 (22%);GO:0005634 (6%);GO:0005737 (1%),integral component of membrane (22%);nucleus (6%);cytoplasm (1%),GO:0005524 (21%);GO:0016887 (13%);GO:0015930 (10%),ATP binding (21%);ATPase activity (13%);glutamate synthase activity (10%),GO:0006537 (10%);GO:0006511 (10%);GO:0016579 (10%),glutamate biosynthetic process (10%);ubiquitin-dependent protein catabolic process (10%);protein deubiquitination (10%),IPR027417 (20%);IPR002932 (11%);IPR003439 (11%),P-loop containing nucleoside triphosphate hydrolase (20%);Glutamate synthase domain (11%);ABC transporter-like (11%),,,,,,,,,,,
TAYLNNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLMFVNK,Alistipes,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Rikenellaceae,,,,Alistipes,,,,,,,,,,,,,,,,IPR006513 (100%),Conserved hypothetical protein CHP01626, YtfJ (100%),,,,,,,,,,
QLGSHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (50%),nucleus (50%),GO:0003677 (50%);GO:0003700 (50%),DNA binding (50%);DNA-binding transcription factor activity (50%),,,IPR001034 (33%);IPR001044 (33%);IPR006084 (33%),DeoR-type HTH domain (33%);XPG/Rad2 endonuclease, eukaryotes (33%);XPG/Rad2 endonuclease (33%),,,,,,,,,,
MVNHTLNK,Flavobacteriaceae,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,,,,,,,,,,,,,GO:0016779 (100%),nucleotidyltransferase activity (100%),GO:0009058 (100%),biosynthetic process (100%),IPR000644 (100%);IPR005835 (100%);IPR029044 (100%),CBS domain (100%);Nucleotidyl transferase domain (100%);Nucleotide-diphospho-sugar transferases (100%),,,,,,,,,,,
LANVTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.23 (67%);3.4.21.- (33%),Histidinol dehydrogenase (67%);Serine endopeptidases (33%),GO:0005737 (20%),cytoplasm (20%),GO:0004399 (40%);GO:0008270 (40%);GO:0051287 (40%),histidinol dehydrogenase activity (40%);zinc ion binding (40%);NAD binding (40%),GO:0000105 (40%),histidine biosynthetic process (40%),IPR012131 (29%);IPR016161 (29%);IPR001692 (14%),Histidinol dehydrogenase (29%);Aldehyde/histidinol dehydrogenase (29%);Histidinol dehydrogenase, conserved site (14%),,,,,,,,,,
VFMSAGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMQSYTFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLQPNECMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPAPTGLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPFVDVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYAFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.1 (24%);2.3.1.29 (18%);6.1.1.21 (18%),Tyrosine--tRNA ligase (24%);Glycine C-acetyltransferase (18%);Histidine--tRNA ligase (18%),GO:0016021 (22%);GO:0005634 (9%);GO:0005737 (9%),integral component of membrane (22%);nucleus (9%);cytoplasm (9%),GO:0046872 (15%);GO:0005524 (13%);GO:0003723 (12%),metal ion binding (15%);ATP binding (13%);RNA binding (12%),GO:0006437 (4%);GO:0008299 (4%);GO:0009058 (3%),tyrosyl-tRNA aminoacylation (4%);isoprenoid biosynthetic process (4%);biosynthetic process (3%),IPR006441 (24%);IPR000571 (8%);IPR036770 (7%),Bacteriophage P2, GpN, major capsid (24%);Zinc finger, CCCH-type (8%);Ankyrin repeat-containing domain superfamily (7%),,,,,,,,
MDVPESLNVM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPDVHTTNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLLVNGCAEALWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWSSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0005524 (33%);GO:0008080 (33%);GO:0016887 (33%),ATP binding (33%);N-acetyltransferase activity (33%);ATPase activity (33%),GO:0055085 (33%),transmembrane transport (33%),IPR000182 (17%);IPR001737 (17%);IPR001849 (17%),GNAT domain (17%);Ribosomal RNA adenine methyltransferase KsgA/Erm (17%);Pleckstrin homology domain (17%),,,,,,,,,,,
WPWPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016746 (100%),transferase activity, transferring acyl groups (100%),,,IPR002123 (100%),Phospholipid/glycerol acyltransferase (100%),,,,,,,,,,
SLYMFSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGGPVGWNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLLTMDYNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMSLYMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YDTPNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (100%),Serine endopeptidases (100%),GO:0016021 (81%);GO:0005737 (6%),integral component of membrane (81%);cytoplasm (6%),GO:0004252 (6%);GO:0004497 (6%);GO:0005506 (6%),serine-type endopeptidase activity (6%);monooxygenase activity (6%);iron ion binding (6%),,,IPR011444 (29%);IPR022655 (29%);IPR029063 (29%),Domain of unknown function DUF1549 (29%);Domain of unknown function DUF1553 (29%);S-adenosyl-L-methionine-dependent methyltransferase (29%),,,,,,,,,,,
DEHDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (65%);GO:0005739 (4%);GO:0005777 (4%),integral component of membrane (65%);mitochondrion (4%);peroxisome (4%),GO:0022857 (39%);GO:0050660 (13%);GO:0004553 (9%),transmembrane transporter activity (39%);flavin adenine dinucleotide binding (13%);hydrolase activity, hydrolyzing O-glycosyl compounds (9%),GO:0005975 (9%);GO:0006367 (4%);GO:0009405 (4%),carbohydrate metabolic process (9%);transcription initiation from RNA polymerase II promoter (4%);pathogenesis (4%),IPR002293 (33%);IPR000644 (11%);IPR002550 (11%),Amino acid/polyamine transporter I (33%);CBS domain (11%);CNNM, transmembrane domain (11%),,,,,,,,,
FLENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (15%);2.6.1.- (10%);2.1.1.192 (8%),Pyruvate dehydrogenase (acetyl-transferring) (15%);Transaminases (10%);23S rRNA (adenine(2503)-C(2))-methyltransferase (8%),GO:0016021 (20%);GO:0005737 (6%);GO:0016020 (2%),integral component of membrane (20%);cytoplasm (6%);membrane (2%),GO:0005525 (21%);GO:0005524 (15%);GO:0003677 (7%),GTP binding (21%);ATP binding (15%);DNA binding (7%),GO:0042254 (21%);GO:0006096 (3%);GO:0009058 (3%),ribosome biogenesis (21%);glycolytic process (3%);biosynthetic process (3%),IPR027417 (28%);IPR015946 (19%);IPR032859 (19%),P-loop containing nucleoside triphosphate hydrolase (28%);K homology domain-like, alpha/beta (19%);GTPase Der, C-terminal KH-domain-like (19%),,,,,,,,,
CTQTLEYTLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFVMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.8 (50%);2.7.1.23 (7%);3.4.19.12 (7%),Acetylglutamate kinase (50%);NAD(+) kinase (7%);Ubiquitinyl hydrolase 1 (7%),GO:0016021 (37%);GO:0005737 (11%);GO:0005886 (2%),integral component of membrane (37%);cytoplasm (11%);plasma membrane (2%),GO:0005524 (20%);GO:0003991 (8%);GO:0022857 (8%),ATP binding (20%);acetylglutamate kinase activity (8%);transmembrane transporter activity (8%),GO:0042450 (8%);GO:0007049 (3%);GO:0051301 (3%),arginine biosynthetic process via ornithine (8%);cell cycle (3%);cell division (3%),IPR001048 (7%);IPR036393 (7%);IPR009003 (7%),Aspartate/glutamate/uridylate kinase (7%);Acetylglutamate kinase-like superfamily (7%);Peptidase S1, PA clan (7%),,,,,,,,,,
ANCNQQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FYCNNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (33%);6.1.1.14 (26%);1.17.7.4 (10%),Carboxylic ester hydrolases (33%);Glycine--tRNA ligase (26%);4-hydroxy-3-methylbut-2-enyl diphosphate reductase (10%),GO:0016021 (25%);GO:0005737 (7%);GO:0005886 (2%),integral component of membrane (25%);cytoplasm (7%);plasma membrane (2%),GO:0003677 (18%);GO:0004553 (13%);GO:0005524 (12%),DNA binding (18%);hydrolase activity, hydrolyzing O-glycosyl compounds (13%);ATP binding (12%),GO:0005975 (14%);GO:0006420 (5%);GO:0006426 (5%),carbohydrate metabolic process (14%);arginyl-tRNA aminoacylation (5%);glycyl-tRNA aminoacylation (5%),IPR029058 (18%);IPR013783 (17%);IPR014756 (11%),Alpha/Beta hydrolase fold (18%);Immunoglobulin-like fold (17%);Immunoglobulin E-set (11%),,,,,,,,,,
YDVLEDPVELLDNER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVTACAPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVEFQMEPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHNLEYYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYDWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.207 (52%);2.7.6.1 (21%);2.7.7.7 (12%),tRNA (cytidine(34)-2'-O)-methyltransferase (52%);Ribose-phosphate diphosphokinase (21%);DNA-directed DNA polymerase (12%),GO:0005737 (23%);GO:0016021 (19%);GO:0005634 (3%),cytoplasm (23%);integral component of membrane (19%);nucleus (3%),GO:0003723 (20%);GO:0000287 (18%);GO:0008175 (17%),RNA binding (20%);magnesium ion binding (18%);tRNA methyltransferase activity (17%),GO:0009165 (14%);GO:0009156 (12%);GO:0009116 (12%),nucleotide biosynthetic process (14%);ribonucleoside monophosphate biosynthetic process (12%);nucleoside metabolic process (12%),IPR004919 (32%);IPR011089 (28%);IPR001537 (11%),Domain of unknown function DUF262 (32%);Domain of unknown function DUF1524 (28%);tRNA/rRNA methyltransferase, SpoU type (11%),,,,,,,,,,
NMVHMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFWPTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPVYQDNTAESHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFLMVVDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLVGPGDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (20%);GO:0016021 (20%),plasma membrane (20%);integral component of membrane (20%),GO:0003824 (60%);GO:0031177 (60%);GO:0003677 (20%),catalytic activity (60%);phosphopantetheine binding (60%);DNA binding (20%),,,IPR000873 (60%);IPR001242 (60%);IPR006162 (60%),AMP-dependent synthetase/ligase (60%);Condensation domain (60%);Phosphopantetheine attachment site (60%),,,,,,,,,,,
MAEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (8%);5.6.2.2 (6%);3.6.4.12 (4%),Transferring other groups (8%);DNA topoisomerase (ATP-hydrolyzing) (6%);DNA helicase (4%),GO:0016021 (19%);GO:0005737 (7%);GO:0005840 (4%),integral component of membrane (19%);cytoplasm (7%);ribosome (4%),GO:0005524 (13%);GO:0003677 (9%);GO:0003735 (7%),ATP binding (13%);DNA binding (9%);structural constituent of ribosome (7%),GO:0006520 (8%);GO:0006412 (8%);GO:0035556 (3%),cellular amino acid metabolic process (8%);translation (8%);intracellular signal transduction (3%),IPR027417 (9%);IPR036291 (8%);IPR006096 (6%),P-loop containing nucleoside triphosphate hydrolase (9%);NAD(P)-binding domain superfamily (8%);Glutamate/phenylalanine/leucine/valine dehydrogenase, C-terminal (6%),,,,,,,,,,
QQWLVYVEYFNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVNGLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.7 (32%);6.3.2.9 (12%);2.7.7.9 (10%),Alanine--tRNA ligase (32%);UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (12%);UTP--glucose-1-phosphate uridylyltransferase (10%),GO:0016021 (56%);GO:0005737 (10%);GO:0005886 (5%),integral component of membrane (56%);cytoplasm (10%);plasma membrane (5%),GO:0005524 (14%);GO:0046872 (8%);GO:0008270 (7%),ATP binding (14%);metal ion binding (8%);zinc ion binding (7%),GO:0006419 (6%);GO:0009166 (4%);GO:0006011 (3%),alanyl-tRNA aminoacylation (6%);nucleotide catabolic process (4%);UDP-glucose metabolic process (3%),IPR029052 (40%);IPR019079 (38%);IPR032811 (8%),Metallo-dependent phosphatase-like (40%);Capsule synthesis protein, CapA (38%);Putative conjugal transfer protein TraF-related (8%),,,,,,,,,,
LPDGFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.2 (60%);1.1.1.49 (7%);2.7.7.27 (7%),GMP synthase (glutamine-hydrolyzing) (60%);Glucose-6-phosphate dehydrogenase (NADP(+)) (7%);Glucose-1-phosphate adenylyltransferase (7%),GO:0016021 (13%);GO:1990077 (4%);GO:0005737 (2%),integral component of membrane (13%);primosome complex (4%);cytoplasm (2%),GO:0005524 (31%);GO:0003677 (17%);GO:0003922 (14%),ATP binding (31%);DNA binding (17%);GMP synthase (glutamine-hydrolyzing) activity (14%),GO:0006541 (14%);GO:0006269 (4%);GO:0006352 (3%),glutamine metabolic process (14%);DNA replication, synthesis of RNA primer (4%);DNA-templated transcription, initiation (3%),IPR029062 (12%);IPR017926 (12%);IPR014729 (12%),Class I glutamine amidotransferase-like (12%);Glutamine amidotransferase (12%);Rossmann-like alpha/beta/alpha sandwich fold (12%),,,,,,,,,
MFVVAPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLVVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.4 (25%);2.4.1.280 (13%);2.4.1.283 (13%),Dihydrolipoyl dehydrogenase (25%);N,N'-diacetylchitobiose phosphorylase (13%);2-deoxystreptamine N-acetyl-D-glucosaminyltransferase (13%),GO:0005737 (37%);GO:0016021 (14%);GO:0016020 (10%),cytoplasm (37%);integral component of membrane (14%);membrane (10%),GO:0005524 (42%);GO:0003688 (36%);GO:0022857 (11%),ATP binding (42%);DNA replication origin binding (36%);transmembrane transporter activity (11%),GO:0006270 (38%);GO:0006275 (36%);GO:0006464 (3%),DNA replication initiation (38%);regulation of DNA replication (36%);cellular protein modification process (3%),IPR027417 (37%);IPR003593 (34%);IPR001957 (31%),P-loop containing nucleoside triphosphate hydrolase (37%);AAA+ ATPase domain (34%);Chromosomal replication control, initiator DnaA (31%),,,,,,,,,
WMCQGAYSTGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEGQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.5 (12%);6.3.5.2 (8%);2.7.13.3 (7%),Allantoinase (12%);GMP synthase (glutamine-hydrolyzing) (8%);Histidine kinase (7%),GO:0016021 (32%);GO:0016592 (11%);GO:0005737 (6%),integral component of membrane (32%);mediator complex (11%);cytoplasm (6%),GO:0005524 (12%);GO:0003712 (11%);GO:0003677 (8%),ATP binding (12%);transcription coregulator activity (11%);DNA binding (8%),GO:0006357 (11%);GO:0006541 (2%);GO:0009103 (2%),regulation of transcription by RNA polymerase II (11%);glutamine metabolic process (2%);lipopolysaccharide biosynthetic process (2%),IPR014801 (10%);IPR027417 (9%);IPR024605 (5%),Mediator complex, subunit Med5, fungi (10%);P-loop containing nucleoside triphosphate hydrolase (9%);NAD(P) transhydrogenase, alpha subunit, C-terminal (5%),,,,,,,
FVEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (13%);4.1.1.17 (11%);6.1.1.5 (11%),Hydron translocation or charge separation linked to oxidoreductase reactions (13%);Ornithine decarboxylase (11%);Isoleucine--tRNA ligase (11%),GO:0016021 (20%);GO:0005737 (14%);GO:0016020 (5%),integral component of membrane (20%);cytoplasm (14%);membrane (5%),GO:0005524 (18%);GO:0003677 (10%);GO:0016831 (7%),ATP binding (18%);DNA binding (10%);carboxy-lyase activity (7%),GO:0006520 (8%);GO:0055085 (5%);GO:0043666 (3%),cellular amino acid metabolic process (8%);transmembrane transport (5%);regulation of phosphoprotein phosphatase activity (3%),IPR001507 (10%);IPR027417 (7%);IPR015421 (7%),Zona pellucida domain (10%);P-loop containing nucleoside triphosphate hydrolase (7%);Pyridoxal phosphate-dependent transferase, major domain (7%),,,,,,,,,,
LFPPCFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (23%);3.2.1.23 (21%);2.7.1.30 (6%),DNA topoisomerase (ATP-hydrolyzing) (23%);Beta-galactosidase (21%);Glycerol kinase (6%),GO:0016021 (17%);GO:0005737 (7%);GO:0009279 (4%),integral component of membrane (17%);cytoplasm (7%);cell outer membrane (4%),GO:0005524 (71%);GO:0008233 (39%);GO:0016887 (7%),ATP binding (71%);peptidase activity (39%);ATPase activity (7%),GO:0019538 (23%);GO:0043335 (7%);GO:0009408 (6%),protein metabolic process (23%);protein unfolding (7%);response to heat (6%),IPR027417 (65%);IPR041546 (64%);IPR003959 (64%),P-loop containing nucleoside triphosphate hydrolase (65%);ClpA/ClpB, AAA lid domain (64%);ATPase, AAA-type, core (64%),,,,,,,,
SLWNSLPSLVYHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.22 (36%);1.3.99.33 (17%);4.2.99.18 (5%),UMP kinase (36%);Urocanate reductase (17%);DNA-(apurinic or apyrimidinic site) lyase (5%),GO:0016021 (15%);GO:0005737 (14%);GO:0016020 (5%),integral component of membrane (15%);cytoplasm (14%);membrane (5%),GO:0005524 (20%);GO:0005085 (12%);GO:0033862 (10%),ATP binding (20%);guanyl-nucleotide exchange factor activity (12%);UMP kinase activity (10%),GO:0035556 (14%);GO:0044210 (10%);GO:0007018 (5%),intracellular signal transduction (14%);'de novo' CTP biosynthetic process (10%);microtubule-based movement (5%),IPR036388 (14%);IPR036390 (14%);IPR036034 (13%),Winged helix-like DNA-binding domain superfamily (14%);Winged helix DNA-binding domain superfamily (14%);PDZ superfamily (13%),,,,,,,,,,,
LTQGDQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0003677 (67%),DNA binding (67%),GO:0006355 (67%),regulation of transcription, DNA-templated (67%),IPR011990 (75%);IPR016032 (75%);IPR019734 (75%),Tetratricopeptide-like helical domain superfamily (75%);Signal transduction response regulator, C-terminal effector (75%);Tetratricopeptide repeat (75%),,,,,,,,,
DAAAAVRPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0008168 (50%);GO:0031419 (50%);GO:0046872 (50%),methyltransferase activity (50%);cobalamin binding (50%);metal ion binding (50%),GO:0032259 (50%);GO:0042558 (50%),methylation (50%);pteridine-containing compound metabolic process (50%),IPR000489 (100%);IPR003726 (100%);IPR003759 (100%),Pterin-binding domain (100%);Homocysteine-binding domain (100%);Cobalamin (vitamin B12)-binding module, cap domain (100%),,,,,,,,,,
VTLSQQHVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYLLVVFLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAECTPK,Genlisea aurea,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Lamiales,,,,,Lentibulariaceae,,,,Genlisea,,,,Genlisea aurea,,,,,,,,GO:0004471 (100%);GO:0051287 (100%),malate dehydrogenase (decarboxylating) (NAD+) activity (100%);NAD binding (100%),,,IPR001891 (100%);IPR012302 (100%);IPR036291 (100%),Malic oxidoreductase (100%);Malic enzyme, NAD-binding (100%);NAD(P)-binding domain superfamily (100%),,,,,,,,,,
DLHNWFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EESLGQNMGTPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLLVHNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.6.5 (50%);1.8.-.- (25%);3.2.1.23 (25%),GTP diphosphokinase (50%);Acting on a sulfur group of donors (25%);Beta-galactosidase (25%),GO:0016021 (50%);GO:0009279 (13%);GO:0009341 (13%),integral component of membrane (50%);cell outer membrane (13%);beta-galactosidase complex (13%),GO:0008728 (25%);GO:0016301 (25%);GO:0004565 (13%),GTP diphosphokinase activity (25%);kinase activity (25%);beta-galactosidase activity (13%),GO:0015969 (25%);GO:0005975 (13%),guanosine tetraphosphate metabolic process (25%);carbohydrate metabolic process (13%),IPR036188 (38%);IPR039650 (38%);IPR002912 (15%),FAD/NAD(P)-binding domain superfamily (38%);H(2):CoB-CoM heterodisulfide,ferredoxin reductase subunit A-like (38%);ACT domain (15%),,,,,,,,,,
RPVAPNNALPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEHDYMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLYDGWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPQLTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003676 (17%);GO:0008270 (17%),nucleic acid binding (17%);zinc ion binding (17%),GO:0000160 (17%),phosphorelay signal transduction system (17%),IPR006852 (63%);IPR000315 (13%);IPR001789 (13%),Protein of unknown function DUF616 (63%);B-box-type zinc finger (13%);Signal transduction response regulator, receiver domain (13%),,,,,,,,,,
NSQEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (71%);1.14.11.27 (14%);5.6.2.2 (14%),DNA helicase (71%);[Histone H3]-dimethyl-L-lysine(36) demethylase (14%);DNA topoisomerase (ATP-hydrolyzing) (14%),GO:0016586 (52%);GO:0005634 (19%);GO:0005694 (4%),RSC-type complex (52%);nucleus (19%);chromosome (4%),GO:0005524 (30%);GO:0003676 (19%);GO:0003678 (19%),ATP binding (30%);nucleic acid binding (19%);DNA helicase activity (19%),GO:0006338 (52%);GO:0006310 (19%);GO:0042981 (7%),chromatin remodeling (52%);DNA recombination (19%);regulation of apoptotic process (7%),IPR001487 (42%);IPR036427 (42%);IPR037382 (42%),Bromodomain (42%);Bromodomain-like superfamily (42%);Remodelling complex subunit Rsc/polybromo (42%),,,,,,,,,,,
LLVSFQTANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAVVNHHHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLWMFALPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYPLDMPLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDSWDVGDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPNDQGCNLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NCGMFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEFNALWANHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMLATPALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNLVQGSNGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYEETPK,Aquilegia coerulea,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Ranunculales,,,,,Ranunculaceae,Thalictroideae,,,Aquilegia,,,,Aquilegia coerulea,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005506 (100%);GO:0016491 (100%),iron ion binding (100%);oxidoreductase activity (100%),GO:0008610 (100%),lipid biosynthetic process (100%),IPR006694 (100%);IPR021940 (100%);IPR036291 (100%),Fatty acid hydroxylase (100%);Uncharacterised domain Wax2, C-terminal (100%);NAD(P)-binding domain superfamily (100%),,,,,,,,,,
FVLFMVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELDYEMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLLPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (60%);3.1.4.4 (10%);6.1.1.17 (9%),DNA-directed RNA polymerase (60%);Phospholipase D (10%);Glutamate--tRNA ligase (9%),GO:0016021 (23%);GO:0009507 (16%);GO:0005886 (3%),integral component of membrane (23%);chloroplast (16%);plasma membrane (3%),GO:0003677 (38%);GO:0003899 (18%);GO:0008270 (14%),DNA binding (38%);DNA-directed 5'-3' RNA polymerase activity (18%);zinc ion binding (14%),GO:0006351 (18%);GO:0006310 (15%);GO:0015074 (14%),transcription, DNA-templated (18%);DNA recombination (15%);DNA integration (14%),IPR007081 (15%);IPR007083 (15%);IPR012756 (15%),RNA polymerase Rpb1, domain 5 (15%);RNA polymerase Rpb1, domain 4 (15%);DNA-directed RNA polymerase, subunit beta'' (15%),,,,,,,
LVTGQNMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAMLTSNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPAWHCPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNGLTHMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVVHMYR,Firmicutes,Bacteria,,,,Firmicutes,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016740 (100%),transferase activity (100%),,,IPR001296 (100%);IPR028098 (100%),Glycosyl transferase, family 1 (100%);Glycosyltransferase subfamily 4-like, N-terminal domain (100%),,,,,,,,,
EMVLSMR,Pythiaceae,Eukaryota,,,,,,,Oomycota,,,,Pythiales,,,,,Pythiaceae,,,,,,,,,,,,,,,,,,,,IPR001478 (100%);IPR001849 (100%);IPR011993 (100%),PDZ domain (100%);Pleckstrin homology domain (100%);PH-like domain superfamily (100%),,,,,,,,,,,
GYLYPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.10 (50%);1.4.1.13 (17%);2.7.10.1 (17%),Methionine--tRNA ligase (50%);Glutamate synthase (NADPH) (17%);Receptor protein-tyrosine kinase (17%),GO:0016021 (23%);GO:0005737 (19%),integral component of membrane (23%);cytoplasm (19%),GO:0005524 (42%);GO:0004825 (23%);GO:0046872 (19%),ATP binding (42%);methionine-tRNA ligase activity (23%);metal ion binding (19%),GO:0006431 (23%);GO:0007169 (6%);GO:0009058 (6%),methionyl-tRNA aminoacylation (23%);transmembrane receptor protein tyrosine kinase signaling pathway (6%);biosynthetic process (6%),IPR014729 (16%);IPR015413 (16%);IPR029038 (16%),Rossmann-like alpha/beta/alpha sandwich fold (16%);Methionyl/Leucyl tRNA synthetase (16%);Methionyl-tRNA synthetase, Zn-domain (16%),,,,,,,,,,
NYAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (57%);3.5.3.1 (10%);2.1.3.3 (4%),3-isopropylmalate dehydratase (57%);Arginase (10%);Ornithine carbamoyltransferase (4%),GO:0016021 (10%);GO:0000932 (3%);GO:0005667 (3%),integral component of membrane (10%);P-body (3%);transcription factor complex (3%),GO:0003677 (53%);GO:0005524 (52%);GO:0046872 (16%),DNA binding (53%);ATP binding (52%);metal ion binding (16%),GO:0009098 (7%);GO:0001666 (3%);GO:0035331 (3%),leucine biosynthetic process (7%);response to hypoxia (3%);negative regulation of hippo signaling (3%),IPR027417 (47%);IPR018145 (45%);IPR002543 (45%),P-loop containing nucleoside triphosphate hydrolase (47%);CagE, TrbE, VirB component of type IV transporter system, central domain (45%);FtsK domain (45%),,,,,,,,
MSFFAQEAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYEMMAVSVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVEGQLYTAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLANDFNEDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAKPNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0032039 (50%),integrator complex (50%),GO:0003677 (50%);GO:0008170 (50%),DNA binding (50%);N-methyltransferase activity (50%),GO:0006306 (50%);GO:0034474 (50%),DNA methylation (50%);U2 snRNA 3'-end processing (50%),IPR000055 (25%);IPR001849 (25%);IPR002052 (25%),Restriction endonuclease, type I, HsdS (25%);Pleckstrin homology domain (25%);DNA methylase, N-6 adenine-specific, conserved site (25%),,,,,,,
GNDGPEGPQGLYHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPAGQMEHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVFWAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.198 (67%);3.6.1.- (33%),16S rRNA (cytidine(1402)-2'-O)-methyltransferase (67%);In phosphorus-containing anhydrides (33%),GO:0016021 (96%);GO:0005737 (1%);GO:0005886 (1%),integral component of membrane (96%);cytoplasm (1%);plasma membrane (1%),GO:0005216 (77%);GO:0022857 (13%);GO:0070677 (1%),ion channel activity (77%);transmembrane transporter activity (13%);rRNA (cytosine-2'-O-)-methyltransferase activity (1%),GO:0000453 (1%),enzyme-directed rRNA 2'-O-methylation (1%),IPR001425 (81%);IPR018229 (77%);IPR005828 (15%),Archaeal/bacterial/fungal rhodopsins (81%);Rhodopsin, retinal binding site (77%);Major facilitator,  sugar transporter-like (15%),,,,,,,,,
TEPVAPAMFAVPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNDNNHAMQYLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEWVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.75 (78%);6.1.1.5 (22%),tRNA dimethylallyltransferase (78%);Isoleucine--tRNA ligase (22%),GO:0016021 (14%);GO:0005737 (5%),integral component of membrane (14%);cytoplasm (5%),GO:0005524 (36%);GO:0052381 (32%);GO:0003676 (27%),ATP binding (36%);tRNA dimethylallyltransferase activity (32%);nucleic acid binding (27%),GO:0008033 (32%);GO:0006281 (5%);GO:0006428 (5%),tRNA processing (32%);DNA repair (5%);isoleucyl-tRNA aminoacylation (5%),IPR018022 (23%);IPR027417 (23%);IPR039657 (23%),IPP transferase (23%);P-loop containing nucleoside triphosphate hydrolase (23%);Dimethylallyltransferase (23%),,,,,,,,,,,
DMSNQEMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFGVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.99.17 (29%);3.4.24.- (13%);2.7.1.6 (8%),S-adenosylmethionine:tRNA ribosyltransferase-isomerase (29%);Metalloendopeptidases (13%);Galactokinase (8%),GO:0016021 (36%);GO:0005737 (14%);GO:0005840 (8%),integral component of membrane (36%);cytoplasm (14%);ribosome (8%),GO:0046872 (16%);GO:0005524 (11%);GO:0004222 (9%),metal ion binding (16%);ATP binding (11%);metalloendopeptidase activity (9%),GO:0006412 (8%);GO:0008616 (7%);GO:0006355 (2%),translation (8%);queuosine biosynthetic process (7%);regulation of transcription, DNA-templated (2%),IPR036034 (7%);IPR027417 (7%);IPR008915 (7%),PDZ superfamily (7%);P-loop containing nucleoside triphosphate hydrolase (7%);Peptidase M50 (7%),,,,,,,,,,
WAFLNMHGGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MCELHLHK,Peniophora sp. CONT,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Agaricomycetes,,,,Russulales,,,,,Peniophoraceae,,,,Peniophora,,,,Peniophora sp. CONT,,,,,,,,,,,,,,,,,,,,,,,,
SPNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.4 (18%);3.5.-.- (9%);2.4.1.- (7%),Dihydrolipoyl dehydrogenase (18%);Acting on carbon-nitrogen bonds, other than peptide bonds (9%);Hexosyltransferases (7%),GO:0016021 (24%);GO:0005634 (12%);GO:0005829 (4%),integral component of membrane (24%);nucleus (12%);cytosol (4%),GO:0005524 (15%);GO:0003682 (11%);GO:0003677 (7%),ATP binding (15%);chromatin binding (11%);DNA binding (7%),GO:0010468 (7%);GO:0007049 (6%);GO:0005975 (5%),regulation of gene expression (7%);cell cycle (6%);carbohydrate metabolic process (5%),IPR016024 (9%);IPR033031 (9%);IPR012337 (9%),Armadillo-type fold (9%);SCC2/Nipped-B family (9%);Ribonuclease H-like superfamily (9%),,,,,,,,,,
QCLMNMLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLFVDNVK,Lutzomyia longipalpis,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Diptera,Nematocera,Psychodomorpha,,Psychodoidea,Psychodidae,Phlebotominae,,,Lutzomyia,Lutzomyia,,,Lutzomyia longipalpis,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
MPELVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.16 (10%);4.1.1.36 (10%);6.3.2.5 (10%),Glutamine--fructose-6-phosphate transaminase (isomerizing) (10%);Phosphopantothenoylcysteine decarboxylase (10%);Phosphopantothenate--cysteine ligase (CTP) (10%),GO:0016021 (37%);GO:0005623 (9%);GO:0005886 (4%),integral component of membrane (37%);cell (9%);plasma membrane (4%),GO:0005524 (6%);GO:0003677 (5%);GO:0004370 (4%),ATP binding (6%);DNA binding (5%);glycerol kinase activity (4%),GO:0072659 (9%);GO:0006879 (9%);GO:0030097 (8%),protein localization to plasma membrane (9%);cellular iron ion homeostasis (9%);hemopoiesis (8%),IPR026900 (18%);IPR011990 (17%);IPR036873 (16%),Tetratricopeptide repeat protein 7A (18%);Tetratricopeptide-like helical domain superfamily (17%);Rhodanese-like domain superfamily (16%),,,,,,,,,,,
NVPPQMAGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YPDTVMPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (24%);3.6.4.12 (10%);6.1.1.20 (10%),DNA-directed RNA polymerase (24%);DNA helicase (10%);Phenylalanine--tRNA ligase (10%),GO:0016021 (14%);GO:0005737 (2%);GO:0005739 (1%),integral component of membrane (14%);cytoplasm (2%);mitochondrion (1%),GO:0003677 (29%);GO:0003700 (22%);GO:0004553 (20%),DNA binding (29%);DNA-binding transcription factor activity (22%);hydrolase activity, hydrolyzing O-glycosyl compounds (20%),GO:0005975 (21%);GO:0006310 (2%);GO:0006351 (2%),carbohydrate metabolic process (21%);DNA recombination (2%);transcription, DNA-templated (2%),IPR036388 (21%);IPR036390 (21%);IPR000847 (21%),Winged helix-like DNA-binding domain superfamily (21%);Winged helix DNA-binding domain superfamily (21%);Transcription regulator HTH, LysR (21%),,,,,,,,
MMLELPQK,Ruminococcaceae bacterium,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Ruminococcaceae,,,,,,,,Ruminococcaceae bacterium,,,,,,,,GO:0003676 (100%);GO:0043138 (100%);GO:0005524 (80%),nucleic acid binding (100%);3'-5' DNA helicase activity (100%);ATP binding (80%),GO:0006260 (100%);GO:0006281 (100%);GO:0006310 (100%),DNA replication (100%);DNA repair (100%);DNA recombination (100%),IPR001650 (100%);IPR002121 (100%);IPR004589 (100%),Helicase, C-terminal (100%);HRDC domain (100%);DNA helicase, ATP-dependent, RecQ type (100%),,,,,,,,
TTGFLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005887 (33%),integral component of plasma membrane (33%),GO:0015648 (33%);GO:0003676 (17%);GO:0003677 (17%),lipid-linked peptidoglycan transporter activity (33%);nucleic acid binding (17%);DNA binding (17%),GO:0008360 (33%);GO:0009252 (33%);GO:0071555 (33%),regulation of cell shape (33%);peptidoglycan biosynthetic process (33%);cell wall organization (33%),IPR027417 (43%);IPR004268 (29%);IPR024402 (29%),P-loop containing nucleoside triphosphate hydrolase (43%);Peptidoglycan biosynthesis protein MurJ (29%);Domain of unknown function DUF2726 (29%),,,,,,,,,,,
NLLEYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (25%);2.4.1.8 (24%);2.4.1.230 (21%),DNA-directed DNA polymerase (25%);Maltose phosphorylase (24%);Kojibiose phosphorylase (21%),GO:0016021 (28%);GO:0005886 (5%);GO:0020002 (4%),integral component of membrane (28%);plasma membrane (5%);host cell plasma membrane (4%),GO:0030246 (19%);GO:0003677 (12%);GO:0005524 (9%),carbohydrate binding (19%);DNA binding (12%);ATP binding (9%),GO:0005975 (22%);GO:0006397 (15%);GO:0006281 (10%),carbohydrate metabolic process (22%);mRNA processing (15%);DNA repair (10%),IPR011013 (17%);IPR005195 (17%);IPR005196 (17%),Galactose mutarotase-like domain superfamily (17%);Glycoside hydrolase, family 65, central catalytic (17%);Glycoside hydrolase, family 65, N-terminal (17%),,,,,,,
WVEESYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVEHNAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.7 (100%),Peroxidase (100%),GO:0005576 (72%);GO:0009505 (17%);GO:0009506 (17%),extracellular region (72%);plant-type cell wall (17%);plasmodesma (17%),GO:0004601 (89%);GO:0020037 (89%);GO:0046872 (89%),peroxidase activity (89%);heme binding (89%);metal ion binding (89%),GO:0006979 (89%);GO:0042744 (78%),response to oxidative stress (89%);hydrogen peroxide catabolic process (78%),IPR000823 (80%);IPR002016 (80%);IPR010255 (80%),Plant peroxidase (80%);Haem peroxidase (80%);Haem peroxidase superfamily (80%),,,,,,,,,,,
FFFGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.107 (80%);3.1.4.46 (20%),Peptidase Do (80%);Glycerophosphodiester phosphodiesterase (20%),GO:0042597 (40%);GO:0016021 (20%);GO:0005886 (7%),periplasmic space (40%);integral component of membrane (20%);plasma membrane (7%),GO:0004252 (37%);GO:0003824 (10%);GO:0008889 (10%),serine-type endopeptidase activity (37%);catalytic activity (10%);glycerophosphodiester phosphodiesterase activity (10%),GO:0046854 (7%);GO:0048015 (7%);GO:0055085 (7%),phosphatidylinositol phosphorylation (7%);phosphatidylinositol-mediated signaling (7%);transmembrane transport (7%),IPR001478 (34%);IPR001940 (34%);IPR009003 (34%),PDZ domain (34%);Peptidase S1C (34%);Peptidase S1, PA clan (34%),,,,,,,,,,
WQYCMLMDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVQDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (21%);3.1.-.- (5%);5.2.1.8 (5%),Methyltransferases (21%);Acting on ester bonds (5%);Peptidylprolyl isomerase (5%),GO:0016021 (15%);GO:0005634 (11%);GO:0005737 (10%),integral component of membrane (15%);nucleus (11%);cytoplasm (10%),GO:0005524 (14%);GO:0003682 (13%);GO:0003677 (8%),ATP binding (14%);chromatin binding (13%);DNA binding (8%),GO:0010468 (10%);GO:0007049 (10%);GO:0007018 (5%),regulation of gene expression (10%);cell cycle (10%);microtubule-based movement (5%),IPR016024 (15%);IPR033031 (12%);IPR027417 (11%),Armadillo-type fold (15%);SCC2/Nipped-B family (12%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,,,,
APLGLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.7.3 (50%);2.5.1.3 (50%),2-oxoglutarate synthase (50%);Thiamine phosphate synthase (50%),GO:0016021 (15%);GO:0043190 (5%);GO:0005783 (3%),integral component of membrane (15%);ATP-binding cassette (ABC) transporter complex (5%);endoplasmic reticulum (3%),GO:0030976 (35%);GO:0003824 (33%);GO:0003980 (30%),thiamine pyrophosphate binding (35%);catalytic activity (33%);UDP-glucose:glycoprotein glucosyltransferase activity (30%),GO:0006486 (28%);GO:0070880 (13%);GO:0009086 (5%),protein glycosylation (28%);fungal-type cell wall beta-glucan biosynthetic process (13%);methionine biosynthetic process (5%),IPR011766 (35%);IPR029061 (35%);IPR009448 (26%),Thiamine pyrophosphate enzyme, C-terminal TPP-binding (35%);Thiamin diphosphate-binding fold (35%);UDP-glucose:Glycoprotein Glucosyltransferase (26%),,,,,,,,,,
DMLFPGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEPDER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.94 (100%),6-deoxyerythronolide-B synthase (100%),GO:0016021 (29%);GO:0000347 (6%);GO:0009279 (6%),integral component of membrane (29%);THO complex (6%);cell outer membrane (6%),GO:0043531 (24%);GO:0000150 (12%);GO:0003677 (12%),ADP binding (24%);recombinase activity (12%);DNA binding (12%),GO:0000160 (6%);GO:0006397 (6%);GO:0006406 (6%),phosphorelay signal transduction system (6%);mRNA processing (6%);mRNA export from nucleus (6%),IPR002182 (19%);IPR027417 (19%);IPR032675 (19%),NB-ARC (19%);P-loop containing nucleoside triphosphate hydrolase (19%);Leucine-rich repeat domain superfamily (19%),,,,,,,,,,,
APFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (28%);2.1.1.77 (26%);3.1.26.5 (4%),Nucleotidyltransferases (28%);Protein-L-isoaspartate(D-aspartate) O-methyltransferase (26%);Ribonuclease P (4%),GO:0016021 (12%);GO:0005737 (7%);GO:1990077 (7%),integral component of membrane (12%);cytoplasm (7%);primosome complex (7%),GO:0004719 (22%);GO:0003677 (19%);GO:0005524 (16%),protein-L-isoaspartate (D-aspartate) O-methyltransferase activity (22%);DNA binding (19%);ATP binding (16%),GO:0045892 (8%);GO:0030091 (4%);GO:0032259 (3%),negative regulation of transcription, DNA-templated (8%);protein repair (4%);methylation (3%),IPR029063 (22%);IPR000682 (20%);IPR005144 (7%),S-adenosyl-L-methionine-dependent methyltransferase (22%);Protein-L-isoaspartate(D-aspartate) O-methyltransferase (20%);ATP-cone domain (7%),,,,,,,,,,
SPDSYLPMPLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNGVTAQQAGGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNTVLVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLLPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.59 (50%);3.1.4.- (50%);3.6.5.- (50%),[Protein-PII] uridylyltransferase (50%);Phosphoric diester hydrolases (50%);Acting on GTP; involved in cellular and subcellular movement (50%),GO:0016021 (67%);GO:0005615 (4%),integral component of membrane (67%);extracellular space (4%),GO:0015293 (21%);GO:0003677 (8%);GO:0016491 (8%),symporter activity (21%);DNA binding (8%);oxidoreductase activity (8%),GO:0006637 (4%);GO:0006807 (4%);GO:0006808 (4%),acyl-CoA metabolic process (4%);nitrogen compound metabolic process (4%);regulation of nitrogen utilization (4%),IPR000555 (24%);IPR015063 (24%);IPR037518 (24%),JAB1/MPN/MOV34 metalloenzyme domain (24%);USP8 dimerisation domain (24%);MPN domain (24%),,,,,,,,,,,
SLENSEQEATEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMWFLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDLPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.-.- (53%);6.1.1.9 (18%);1.2.7.7 (6%),Acting on acid anhydrides (53%);Valine--tRNA ligase (18%);3-methyl-2-oxobutanoate dehydrogenase (ferredoxin) (6%),GO:0005737 (18%);GO:0016021 (16%);GO:0005634 (4%),cytoplasm (18%);integral component of membrane (16%);nucleus (4%),GO:0005524 (26%);GO:0046872 (15%);GO:0003924 (12%),ATP binding (26%);metal ion binding (15%);GTPase activity (12%),GO:0005975 (12%);GO:0006400 (12%);GO:0006438 (4%),carbohydrate metabolic process (12%);tRNA modification (12%);valyl-tRNA aminoacylation (4%),IPR027417 (29%);IPR000330 (11%);IPR014001 (11%),P-loop containing nucleoside triphosphate hydrolase (29%);SNF2-related, N-terminal domain (11%);Helicase superfamily 1/2, ATP-binding domain (11%),,,,,,,,,
LMVSMNGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNEQHC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTWMHR,Methylacidimicrobium cyclopophantes,Bacteria,,,,Verrucomicrobia,,,,,,,,,,,,,,,,Methylacidimicrobium,,,,Methylacidimicrobium cyclopophantes,,,,,,,,,,,,,,,,,,,,,,,,
LLSFEPSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008168 (50%),methyltransferase activity (50%),GO:0007064 (50%);GO:0032259 (50%),mitotic sister chromatid cohesion (50%);methylation (50%),IPR006342 (50%);IPR016024 (50%);IPR029063 (50%),Methyltransferase FkbM (50%);Armadillo-type fold (50%);S-adenosyl-L-methionine-dependent methyltransferase (50%),,,,,,,,,,,
SYEMC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HCFVPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTDWNMVDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNDMLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (94%),integral component of membrane (94%),GO:0003677 (23%);GO:0015299 (10%);GO:0004180 (3%),DNA binding (23%);solute:proton antiporter activity (10%);carboxypeptidase activity (3%),GO:0009405 (26%);GO:0000160 (23%);GO:0006355 (23%),pathogenesis (26%);phosphorelay signal transduction system (23%);regulation of transcription, DNA-templated (23%),IPR021707 (35%);IPR010901 (26%);IPR024730 (26%),Protein of unknown function DUF3290 (35%);Merozoite surface 1, C-terminal (26%);Merozoite surface protein, EGF domain 1 (26%),,,,,,,,
CAVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.20 (39%);1.17.7.3 (16%);3.2.1.28 (11%),Methylenetetrahydrofolate reductase (NAD(P)H) (39%);(E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (16%);Alpha,alpha-trehalase (11%),GO:0016021 (11%);GO:0019898 (7%);GO:0005737 (4%),integral component of membrane (11%);extrinsic component of membrane (7%);cytoplasm (4%),GO:0008270 (26%);GO:0003723 (21%);GO:0046872 (11%),zinc ion binding (26%);RNA binding (21%);metal ion binding (11%),GO:0006555 (7%);GO:0009920 (7%);GO:0035999 (7%),methionine metabolic process (7%);cell plate formation involved in plant-type cell wall biogenesis (7%);tetrahydrofolate interconversion (7%),IPR000504 (22%);IPR012677 (22%);IPR035979 (22%),RNA recognition motif domain (22%);Nucleotide-binding alpha-beta plait domain superfamily (22%);RNA-binding domain superfamily (22%),,,,,,,,,,
FFTQMDLPFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFYVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.2 (29%);3.1.-.- (9%);2.1.1.13 (6%),Proline dehydrogenase (29%);Acting on ester bonds (9%);Methionine synthase (6%),GO:0016021 (61%);GO:0043231 (12%);GO:1902937 (10%),integral component of membrane (61%);intracellular membrane-bounded organelle (12%);inward rectifier potassium channel complex (10%),GO:0005267 (13%);GO:0022841 (11%);GO:0005272 (11%),potassium channel activity (13%);potassium ion leak channel activity (11%);sodium channel activity (11%),GO:0060075 (11%);GO:0071805 (4%);GO:0030322 (3%),regulation of resting membrane potential (11%);potassium ion transmembrane transport (4%);stabilization of membrane potential (3%),IPR013099 (21%);IPR001779 (20%);IPR003280 (20%),Potassium channel domain (21%);Two pore domain potassium channel, TWIK-1 (20%);Two pore domain potassium channel (20%),,,,,,,,,,
AMNAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.8 (50%);3.6.4.12 (50%),Polyribonucleotide nucleotidyltransferase (50%);DNA helicase (50%),GO:0016021 (58%);GO:0005886 (12%);GO:0005737 (6%),integral component of membrane (58%);plasma membrane (12%);cytoplasm (6%),GO:0020037 (18%);GO:0004129 (15%);GO:0005507 (15%),heme binding (18%);cytochrome-c oxidase activity (15%);copper ion binding (15%),GO:0032259 (6%);GO:0005996 (3%);GO:0006355 (3%),methylation (6%);monosaccharide metabolic process (3%);regulation of transcription, DNA-templated (3%),IPR006059 (23%);IPR009056 (11%);IPR036909 (11%),Bacterial extracellular solute-binding protein (23%);Cytochrome c-like domain (11%);Cytochrome c-like domain superfamily (11%),,,,,,,,,,
MLLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.5 (36%);3.5.1.88 (16%);2.3.1.- (15%),Chorismate mutase (36%);Peptide deformylase (16%);Transferring groups other than amino-acyl groups (15%),GO:0016021 (24%);GO:0005886 (3%);GO:0005737 (2%),integral component of membrane (24%);plasma membrane (3%);cytoplasm (2%),GO:0004106 (12%);GO:0005524 (10%);GO:0046872 (9%),chorismate mutase activity (12%);ATP binding (10%);metal ion binding (9%),GO:0006412 (7%);GO:0046417 (7%);GO:0000160 (2%),translation (7%);chorismate metabolic process (7%);phosphorelay signal transduction system (2%),IPR026444 (12%);IPR036263 (9%);IPR002701 (9%),Secretion system C-terminal sorting domain (12%);Chorismate mutase type II superfamily (9%);Chorismate mutase II, prokaryotic-type (9%),,,,,,,,,,
KPAEYLHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEEENPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDLVGMK,Hordeum vulgare subsp. vulgare,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,Petrosaviidae,,,Poales,,,,,Poaceae,Pooideae,Triticeae,Hordeinae,Hordeum,,,,Hordeum vulgare,Hordeum vulgare subsp. vulgare,,,,,GO:0005634 (50%),nucleus (50%),GO:0003677 (100%);GO:0001085 (50%);GO:0003714 (50%),DNA binding (100%);RNA polymerase II transcription factor binding (50%);transcription corepressor activity (50%),,,IPR009057 (100%),Homeobox-like domain superfamily (100%),,,,,,,,,,,
TTLLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.0 (80%);3.1.-.- (8%);3.6.4.12 (8%), (80%);Acting on ester bonds (8%);DNA helicase (8%),GO:0005666 (38%);GO:0005886 (14%);GO:0016021 (6%),RNA polymerase III complex (38%);plasma membrane (14%);integral component of membrane (6%),GO:0003899 (47%);GO:0003746 (14%);GO:0003924 (14%),DNA-directed 5'-3' RNA polymerase activity (47%);translation elongation factor activity (14%);GTPase activity (14%),GO:0006383 (47%);GO:0045727 (14%);GO:0000724 (1%),transcription by RNA polymerase III (47%);positive regulation of translation (14%);double-strand break repair via homologous recombination (1%),IPR024661 (45%);IPR027417 (14%);IPR000640 (12%),DNA-directed RNA polymerase III, subunit Rpc31 (45%);P-loop containing nucleoside triphosphate hydrolase (14%);Elongation factor EFG, domain V-like (12%),,,,,,,,,
LLHMMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.10 (40%);3.4.21.53 (20%);6.1.1.17 (20%),Methionine--tRNA ligase (40%);Endopeptidase La (20%);Glutamate--tRNA ligase (20%),GO:0005737 (17%);GO:0016021 (17%),cytoplasm (17%);integral component of membrane (17%),GO:0005524 (44%);GO:0000049 (17%);GO:0003677 (17%),ATP binding (44%);tRNA binding (17%);DNA binding (17%),GO:0006431 (11%);GO:0006090 (6%);GO:0006424 (6%),methionyl-tRNA aminoacylation (11%);pyruvate metabolic process (6%);glutamyl-tRNA aminoacylation (6%),IPR036388 (17%);IPR036390 (17%);IPR001845 (13%),Winged helix-like DNA-binding domain superfamily (17%);Winged helix DNA-binding domain superfamily (17%);HTH ArsR-type DNA-binding domain (13%),,,,,,,,,,,
WNFYLSTVTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WELSEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (100%),Cytochrome-c oxidase (100%),GO:0016020 (13%);GO:0016021 (13%),membrane (13%);integral component of membrane (13%),GO:0004842 (50%);GO:0004129 (25%);GO:0005085 (25%),ubiquitin-protein transferase activity (50%);cytochrome-c oxidase activity (25%);guanyl-nucleotide exchange factor activity (25%),,,IPR003613 (36%);IPR011990 (36%);IPR013026 (36%),U box domain (36%);Tetratricopeptide-like helical domain superfamily (36%);Tetratricopeptide repeat-containing domain (36%),,,,,,,,,,,
VMPMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.3.1.1 (72%);7.2.1.1 (8%);2.7.1.33 (7%),Adenosylhomocysteinase (72%);NADH:ubiquinone reductase (Na(+)-transporting) (8%);Pantothenate kinase (7%),GO:0005737 (25%);GO:0016021 (20%);GO:0009279 (4%),cytoplasm (25%);integral component of membrane (20%);cell outer membrane (4%),GO:0004013 (28%);GO:0005524 (8%);GO:0046872 (7%),adenosylhomocysteinase activity (28%);ATP binding (8%);metal ion binding (7%),GO:0006730 (25%);GO:0055085 (10%);GO:0006811 (4%),one-carbon metabolic process (25%);transmembrane transport (10%);ion transport (4%),IPR036291 (21%);IPR000043 (20%);IPR015878 (20%),NAD(P)-binding domain superfamily (21%);Adenosylhomocysteinase-like (20%);S-adenosyl-L-homocysteine hydrolase, NAD binding domain (20%),,,,,,,,,,
VDWNHALFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNVNPTK,Plasmodium falciparum,Eukaryota,,,,Apicomplexa,,,Aconoidasida,,,,Haemosporida,,,,,Plasmodiidae,,,,Plasmodium,Plasmodium (Laverania),,,Plasmodium falciparum,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0046789 (100%),host cell surface receptor binding (100%),GO:0009405 (100%),pathogenesis (100%),IPR004258 (100%);IPR008602 (100%);IPR029210 (100%),Duffy-binding-like domain (100%);Duffy-antigen binding (100%);Plasmodium falciparum erythrocyte membrane protein-1, N-terminal segment (100%),,,,,,,,,,
DNGDDVEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTYVTSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLMGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (67%);2.3.2.3 (17%);5.1.1.3 (17%),Hydron translocation or charge separation linked to oxidoreductase reactions (67%);Lysyltransferase (17%);Glutamate racemase (17%),GO:0016021 (49%);GO:0005886 (22%);GO:0005737 (11%),integral component of membrane (49%);plasma membrane (22%);cytoplasm (11%),GO:0003824 (11%);GO:0008137 (11%);GO:0048038 (11%),catalytic activity (11%);NADH dehydrogenase (ubiquinone) activity (11%);quinone binding (11%),GO:0005975 (11%);GO:0015986 (8%);GO:0045454 (8%),carbohydrate metabolic process (11%);ATP synthesis coupled proton transport (8%);cell redox homeostasis (8%),IPR000568 (13%);IPR023011 (13%);IPR035908 (13%),ATP synthase, F0 complex, subunit A (13%);ATP synthase, F0 complex, subunit A, active site (13%);ATP synthase, F0 complex, subunit A superfamily (13%),,,,
LFEYSLDVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVHPAMMVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVANAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%);GO:0000123 (20%),integral component of membrane (60%);histone acetyltransferase complex (20%),GO:0016301 (20%);GO:0016810 (20%),kinase activity (20%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (20%),GO:0016573 (20%),histone acetylation (20%),IPR000403 (50%);IPR003151 (50%);IPR003152 (50%),Phosphatidylinositol 3-/4-kinase, catalytic domain (50%);PIK-related kinase, FAT (50%);FATC domain (50%),,,,,,,,
TCVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.16 (47%);2.3.1.- (12%);2.1.1.- (8%),Ribulokinase (47%);Transferring groups other than amino-acyl groups (12%);Methyltransferases (8%),GO:0016021 (29%);GO:0005634 (5%);GO:0005576 (4%),integral component of membrane (29%);nucleus (5%);extracellular region (4%),GO:0005524 (15%);GO:0008270 (11%);GO:0008741 (9%),ATP binding (15%);zinc ion binding (11%);ribulokinase activity (9%),GO:0019569 (9%);GO:0015074 (5%);GO:0006633 (2%),L-arabinose catabolic process to xylulose 5-phosphate (9%);DNA integration (5%);fatty acid biosynthetic process (2%),IPR027417 (16%);IPR005035 (7%);IPR000577 (7%),P-loop containing nucleoside triphosphate hydrolase (16%);Herpesvirus UL3 (7%);Carbohydrate kinase, FGGY (7%),,,,,,,,,,
FAVAER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.74 (40%);2.10.1.1 (8%);1.1.1.47 (4%),Methylenetetrahydrofolate--tRNA-(uracil(54)-C(5))-methyltransferas(NAD(P)H-oxidizing) (40%);Molybdopterin molybdotransferase (8%);Glucose 1-dehydrogenase (NAD(P)(+)) (4%),GO:0016021 (38%);GO:0005737 (10%);GO:0005886 (1%),integral component of membrane (38%);cytoplasm (10%);plasma membrane (1%),GO:0008168 (11%);GO:0046872 (11%);GO:0008745 (9%),methyltransferase activity (11%);metal ion binding (11%);N-acetylmuramoyl-L-alanine amidase activity (9%),GO:0032259 (11%);GO:0009253 (9%);GO:0042558 (9%),methylation (11%);peptidoglycan catabolic process (9%);pteridine-containing compound metabolic process (9%),IPR000489 (8%);IPR002502 (8%);IPR011005 (8%),Pterin-binding domain (8%);N-acetylmuramoyl-L-alanine amidase domain (8%);Dihydropteroate synthase-like (8%),,,,,,,,,,,
MASDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (60%);2.7.1.12 (15%);1.7.2.2 (5%),Endopeptidase La (60%);Gluconokinase (15%);Nitrite reductase (cytochrome; ammonia-forming) (5%),GO:0005737 (21%);GO:0016021 (13%);GO:0005739 (2%),cytoplasm (21%);integral component of membrane (13%);mitochondrion (2%),GO:0005524 (35%);GO:0004176 (21%);GO:0004252 (21%),ATP binding (35%);ATP-dependent peptidase activity (21%);serine-type endopeptidase activity (21%),GO:0030163 (15%);GO:0006515 (6%);GO:0034605 (6%),protein catabolic process (15%);protein quality control for misfolded or incompletely synthesized proteins (6%);cellular response to heat (6%),IPR027417 (29%);IPR003959 (19%);IPR008269 (19%),P-loop containing nucleoside triphosphate hydrolase (29%);ATPase, AAA-type, core (19%);Peptidase S16, Lon proteolytic domain (19%),,,,,,,,
YGLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.15 (22%);5.4.99.- (20%);6.3.2.2 (8%),Glycerol-3-phosphate 1-O-acyltransferase (22%);Transferring other groups (20%);Glutamate--cysteine ligase (8%),GO:0016021 (28%);GO:0016020 (7%);GO:0005634 (5%),integral component of membrane (28%);membrane (7%);nucleus (5%),GO:0005524 (11%);GO:0003964 (8%);GO:0003676 (7%),ATP binding (11%);RNA-directed DNA polymerase activity (8%);nucleic acid binding (7%),GO:0016024 (5%);GO:0001522 (4%);GO:0045944 (3%),CDP-diacylglycerol biosynthetic process (5%);pseudouridine synthesis (4%);positive regulation of transcription by RNA polymerase II (3%),IPR027417 (8%);IPR000160 (7%);IPR029787 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);GGDEF domain (7%);Nucleotide cyclase (7%),,,,,,,,,,,
HYVMNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR012442 (100%),Protein of unknown function DUF1645, plant (100%),,,,,,,,,,
FPLEVGMMSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMFGRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGSNALVR,Nitrosospira multiformis,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Nitrosomonadales,,,,,Nitrosomonadaceae,,,,Nitrosospira,,,,Nitrosospira multiformis,,,,,,,,,,,,,,,,,,,,,,,,
VNYLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (25%);6.1.1.7 (25%);2.1.1.245 (13%),Methyltransferases (25%);Alanine--tRNA ligase (25%);5-methyltetrahydrosarcinapterin:corrinoid/iron-sulfur proteiCo-methyltransferase (13%),GO:0016021 (23%);GO:0005737 (3%);GO:0005694 (2%),integral component of membrane (23%);cytoplasm (3%);chromosome (2%),GO:0005524 (11%);GO:0003677 (5%);GO:0008168 (3%),ATP binding (11%);DNA binding (5%);methyltransferase activity (3%),GO:0016226 (48%);GO:0032259 (3%);GO:0000160 (3%),iron-sulfur cluster assembly (48%);methylation (3%);phosphorelay signal transduction system (3%),IPR000825 (47%);IPR011542 (47%);IPR037284 (47%),SUF system FeS cluster assembly, SufBD (47%);SUF system FeS cluster assembly, SufD (47%);SUF system FeS cluster assembly, SufBD superfamily (47%),,,,,,,,
TVLFASMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.17 (53%);6.1.1.9 (7%);6.1.1.1 (2%),Phosphomethylpyrimidine synthase (53%);Valine--tRNA ligase (7%);Tyrosine--tRNA ligase (2%),GO:0016021 (22%);GO:0005737 (5%);GO:0005886 (2%),integral component of membrane (22%);cytoplasm (5%);plasma membrane (2%),GO:0051539 (17%);GO:0008270 (16%);GO:0016830 (15%),4 iron, 4 sulfur cluster binding (17%);zinc ion binding (16%);carbon-carbon lyase activity (15%),GO:0009228 (17%);GO:0009229 (16%);GO:0009225 (8%),thiamine biosynthetic process (17%);thiamine diphosphate biosynthetic process (16%);nucleotide-sugar metabolic process (8%),IPR036291 (14%);IPR002817 (13%);IPR038521 (13%),NAD(P)-binding domain superfamily (14%);Phosphomethylpyrimidine synthase ThiC/5-hydroxybenzimidazole synthase BzaA/B (13%);ThiC/Bza superfamily (13%),,,,,,,,,,
DGLNHSR,Lyngbya aestuarii,Bacteria,,,,Cyanobacteria,,,,Oscillatoriophycideae,,,Oscillatoriales,,,,,Oscillatoriaceae,,,,Lyngbya,,,,Lyngbya aestuarii,,,,,,,,GO:0003677 (100%),DNA binding (100%),,,IPR001387 (100%);IPR004155 (100%);IPR007111 (100%),Cro/C1-type helix-turn-helix domain (100%);PBS lyase HEAT-like repeat (100%);NACHT nucleoside triphosphatase (100%),,,,,,,,,,,
QNLNVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.10 (29%);7.1.1.1 (21%);2.3.1.181 (7%),Imidazole glycerol-phosphate synthase (29%);Proton-translocating NAD(P)(+) transhydrogenase (21%);Lipoyl(octanoyl) transferase (7%),GO:0016021 (27%);GO:0005737 (9%);GO:0005886 (5%),integral component of membrane (27%);cytoplasm (9%);plasma membrane (5%),GO:0003677 (24%);GO:0005524 (8%);GO:0016787 (8%),DNA binding (24%);ATP binding (8%);hydrolase activity (8%),GO:0000105 (6%);GO:0006313 (6%);GO:0071973 (3%),histidine biosynthetic process (6%);transposition, DNA-mediated (6%);bacterial-type flagellum-dependent cell motility (3%),IPR003115 (13%);IPR036086 (13%);IPR004437 (12%),ParB/Sulfiredoxin (13%);ParB/Sulfiredoxin superfamily (13%);ParB/RepB/Spo0J partition protein (12%),,,,,,,,,,
NEDLLVVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (50%),ribosome (50%),GO:0000150 (50%);GO:0003677 (50%);GO:0003735 (50%),recombinase activity (50%);DNA binding (50%);structural constituent of ribosome (50%),GO:0006412 (50%),translation (50%),IPR002136 (50%);IPR006119 (50%);IPR013005 (50%),Ribosomal protein L4/L1e (50%);Resolvase, N-terminal catalytic domain (50%);50S ribosomal protein uL4 (50%),,,,,,,,,,
YNFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.3 (31%);3.6.4.12 (16%);5.6.2.2 (7%),Aconitate hydratase (31%);DNA helicase (16%);DNA topoisomerase (ATP-hydrolyzing) (7%),GO:0016021 (29%);GO:0005737 (9%);GO:0005694 (5%),integral component of membrane (29%);cytoplasm (9%);chromosome (5%),GO:0005524 (20%);GO:0003677 (15%);GO:0003994 (8%),ATP binding (20%);DNA binding (15%);aconitate hydratase activity (8%),GO:0000271 (4%);GO:0006260 (3%);GO:0007062 (3%),polysaccharide biosynthetic process (4%);DNA replication (3%);sister chromatid cohesion (3%),IPR027417 (12%);IPR001030 (7%);IPR036008 (7%),P-loop containing nucleoside triphosphate hydrolase (12%);Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha domain (7%);Aconitase, iron-sulfur domain (7%),,,,,,,,,
TVVMLGNK,Trifolium,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Fabales,,,,,Fabaceae,Papilionoideae,Trifolieae,,Trifolium,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016787 (100%),ATP binding (100%);hydrolase activity (100%),,,IPR000407 (100%),Nucleoside phosphatase GDA1/CD39 (100%),,,,,,,,,,,
FDLEM,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009380 (50%);GO:0016021 (50%),excinuclease repair complex (50%);integral component of membrane (50%),GO:0003677 (50%);GO:0005524 (50%);GO:0016887 (50%),DNA binding (50%);ATP binding (50%);ATPase activity (50%),GO:0006289 (50%),nucleotide-excision repair (50%),IPR004807 (50%);IPR006935 (50%);IPR010840 (50%),UvrABC system, subunit B (50%);Helicase/UvrB, N-terminal (50%);Protein of unknown function DUF1449 (50%),,,,,,,,,
RPNFPDK,Bacilli,Bacteria,,,,Firmicutes,,,Bacilli,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR036597 (100%);IPR003812 (93%);IPR040198 (93%),Fido-like domain superfamily (100%);Fido domain (93%);Fido domain-containing protein (93%),,,,,,,,,,,
AAAYDQYAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVSLLLRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLEVTPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HYYLSSLLVTTGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLFLDVNK,Gaeumannomyces tritici,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Sordariomycetidae,,,Magnaporthales,,,,,Magnaporthaceae,,,,Gaeumannomyces,,,,Gaeumannomyces tritici,,,,,,,,,,,,,,,,,,,,,,,,
MVWWMEALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GEGNDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.13 (25%);3.6.4.12 (25%);2.1.1.77 (8%),dCTP deaminase (25%);DNA helicase (25%);Protein-L-isoaspartate(D-aspartate) O-methyltransferase (8%),GO:0016021 (15%);GO:0005737 (10%);GO:0032153 (5%),integral component of membrane (15%);cytoplasm (10%);cell division site (5%),GO:0004553 (23%);GO:0005524 (16%);GO:0003677 (9%),hydrolase activity, hydrolyzing O-glycosyl compounds (23%);ATP binding (16%);DNA binding (9%),GO:0005975 (24%);GO:0006915 (13%);GO:0000917 (5%),carbohydrate metabolic process (24%);apoptotic process (13%);division septum assembly (5%),IPR006102 (20%);IPR008979 (20%);IPR013783 (20%),Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich (20%);Galactose-binding-like domain superfamily (20%);Immunoglobulin-like fold (20%),,,,,,,,
NVARPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.18 (40%);5.3.1.1 (40%);3.1.6.1 (20%),Anthranilate phosphoribosyltransferase (40%);Triose-phosphate isomerase (40%);Arylsulfatase (type I) (20%),GO:0005737 (79%);GO:0005576 (4%);GO:0016021 (3%),cytoplasm (79%);extracellular region (4%);integral component of membrane (3%),GO:0005524 (78%);GO:0003688 (77%);GO:0005102 (3%),ATP binding (78%);DNA replication origin binding (77%);signaling receptor binding (3%),GO:0006270 (77%);GO:0006275 (77%);GO:0009755 (4%),DNA replication initiation (77%);regulation of DNA replication (77%);hormone-mediated signaling pathway (4%),IPR001957 (75%);IPR010921 (75%);IPR013159 (75%),Chromosomal replication control, initiator DnaA (75%);Trp repressor/replication initiator (75%);Chromosomal replication initiator, DnaA C-terminal (75%),,,,,,,,,
SNGLGGWMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YENESGNYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVGYGYMELPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVLSGYCMLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDYDFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QALEEYGCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FANEDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLANHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.18 (34%);1.2.1.38 (10%);2.4.1.182 (9%),Nicotinate-nucleotide adenylyltransferase (34%);N-acetyl-gamma-glutamyl-phosphate reductase (10%);Lipid-A-disaccharide synthase (9%),GO:0016021 (20%);GO:0005737 (8%);GO:0030915 (4%),integral component of membrane (20%);cytoplasm (8%);Smc5-Smc6 complex (4%),GO:0005524 (31%);GO:0004515 (9%);GO:0046872 (9%),ATP binding (31%);nicotinate-nucleotide adenylyltransferase activity (9%);metal ion binding (9%),GO:0009435 (9%);GO:0006355 (5%);GO:0000724 (4%),NAD biosynthetic process (9%);regulation of transcription, DNA-templated (5%);double-strand break repair via homologous recombination (4%),IPR013560 (26%);IPR007553 (25%);IPR017087 (25%),Domain of unknown function DUF1722 (26%);Domain of unknown function DUF523 (25%);Uncharacterised conserved protein UCP037004 (25%),,,,,,,,,,
EPDHAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.267 (100%),1-deoxy-D-xylulose-5-phosphate reductoisomerase (100%),GO:0016021 (20%);GO:0005615 (3%);GO:0019867 (3%),integral component of membrane (20%);extracellular space (3%);outer membrane (3%),GO:0046872 (57%);GO:0030604 (54%);GO:0070402 (54%),metal ion binding (57%);1-deoxy-D-xylulose-5-phosphate reductoisomerase activity (54%);NADPH binding (54%),GO:0016114 (54%);GO:0019288 (54%);GO:0033539 (3%),terpenoid biosynthetic process (54%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (54%);fatty acid beta-oxidation using acyl-CoA dehydrogenase (3%),IPR003821 (46%);IPR013512 (46%);IPR013644 (46%),1-deoxy-D-xylulose 5-phosphate reductoisomerase (46%);1-deoxy-D-xylulose 5-phosphate reductoisomerase, N-terminal (46%);1-deoxy-D-xylulose 5-phosphate reductoisomerase, C-terminal (46%),,,,,,,,
LMFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.9.1 (76%);7.4.2.11 (8%);4.1.2.48 (3%),Pyruvate, phosphate dikinase (76%);ABC-type methionine transporter (8%);Low-specificity L-threonine aldolase (3%),GO:0005634 (23%);GO:0016021 (16%);GO:0005737 (9%),nucleus (23%);integral component of membrane (16%);cytoplasm (9%),GO:0005524 (31%);GO:0046872 (28%);GO:0008270 (26%),ATP binding (31%);metal ion binding (28%);zinc ion binding (26%),GO:0006090 (24%);GO:0000122 (6%);GO:0010875 (6%),pyruvate metabolic process (24%);negative regulation of transcription by RNA polymerase II (6%);positive regulation of cholesterol efflux (6%),IPR000536 (26%);IPR035500 (26%);IPR023257 (25%),Nuclear hormone receptor, ligand-binding domain (26%);Nuclear hormone receptor-like domain superfamily (26%);Liver X receptor (25%),,,,,,,,,
TYPVPNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGWPDLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAEPEALTAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAVEAPQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (20%),cytoplasm (20%),GO:0016758 (40%);GO:0016787 (40%);GO:0003677 (20%),transferase activity, transferring hexosyl groups (40%);hydrolase activity (40%);DNA binding (20%),GO:0006289 (20%);GO:0009432 (20%),nucleotide-excision repair (20%);SOS response (20%),IPR000073 (40%);IPR002213 (40%);IPR029058 (40%),Alpha/beta hydrolase fold-1 (40%);UDP-glucuronosyl/UDP-glucosyltransferase (40%);Alpha/Beta hydrolase fold (40%),,,,,,,,,,
NMNNQAK,Mucuna pruriens,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Fabales,,,,,Fabaceae,Papilionoideae,Phaseoleae,,Mucuna,,,,Mucuna pruriens,,,,,,,,,,,,IPR012337 (100%);IPR013103 (100%),Ribonuclease H-like superfamily (100%);Reverse transcriptase, RNA-dependent DNA polymerase (100%),,,,,,,,,,
LHLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (33%);2.7.13.3 (8%);3.4.-.- (4%),Transferring other groups (33%);Histidine kinase (8%);Acting on peptide bonds (peptidases) (4%),GO:0016021 (25%);GO:0005737 (21%);GO:0005811 (8%),integral component of membrane (25%);cytoplasm (21%);lipid droplet (8%),GO:0005524 (28%);GO:0008134 (18%);GO:0043565 (17%),ATP binding (28%);transcription factor binding (18%);sequence-specific DNA binding (17%),GO:0006355 (19%);GO:0009399 (18%);GO:0006808 (17%),regulation of transcription, DNA-templated (19%);nitrogen fixation (18%);regulation of nitrogen utilization (17%),IPR027417 (20%);IPR011006 (18%);IPR001789 (18%),P-loop containing nucleoside triphosphate hydrolase (20%);CheY-like superfamily (18%);Signal transduction response regulator, receiver domain (18%),,,,,,,,,
SALDTFSNQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGPDAPWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVEEASYMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPAPPFLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FCNGFANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMHLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.107 (100%),Diacylglycerol kinase (ATP) (100%),GO:0016021 (56%),integral component of membrane (56%),GO:0003676 (44%);GO:0016788 (11%);GO:0046872 (11%),nucleic acid binding (44%);hydrolase activity, acting on ester bonds (11%);metal ion binding (11%),,,IPR013320 (42%);IPR013087 (33%);IPR016024 (33%),Concanavalin A-like lectin/glucanase domain superfamily (42%);Zinc finger C2H2-type (33%);Armadillo-type fold (33%),,,,,,,,,,
VWNYMFLGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THEYLPVPNMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.18 (15%);1.3.-.- (6%);2.3.1.- (5%),5-(carboxyamino)imidazole ribonucleotide synthase (15%);Acting on the CH-CH group of donors (6%);Transferring groups other than amino-acyl groups (5%),GO:0016021 (26%);GO:0005737 (8%);GO:0005886 (5%),integral component of membrane (26%);cytoplasm (8%);plasma membrane (5%),GO:0005524 (14%);GO:0046872 (9%);GO:0003677 (8%),ATP binding (14%);metal ion binding (9%);DNA binding (8%),GO:0006189 (3%);GO:0006355 (3%);GO:0006520 (2%),'de novo' IMP biosynthetic process (3%);regulation of transcription, DNA-templated (3%);cellular amino acid metabolic process (2%),IPR027417 (9%);IPR003593 (5%);IPR009061 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);AAA+ ATPase domain (5%);Putative DNA-binding domain superfamily (4%),,,,,,,,,,
TGSTEQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR040607 (67%);IPR042051 (67%);IPR011990 (33%),Actin-like protein, N-terminal (67%);ParM-like (67%);Tetratricopeptide-like helical domain superfamily (33%),,,,,,,,,,
DHPAFNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AHATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.2 (18%);2.4.2.18 (14%);6.2.1.5 (7%),Acid phosphatase (18%);Anthranilate phosphoribosyltransferase (14%);Succinate--CoA ligase (ADP-forming) (7%),GO:0016021 (26%);GO:0005840 (4%);GO:0016020 (4%),integral component of membrane (26%);ribosome (4%);membrane (4%),GO:0005524 (7%);GO:0046872 (6%);GO:0003677 (5%),ATP binding (7%);metal ion binding (6%);DNA binding (5%),GO:0051726 (10%);GO:0006412 (4%);GO:0000162 (3%),regulation of cell cycle (10%);translation (4%);tryptophan biosynthetic process (3%),IPR026907 (8%);IPR011050 (8%);IPR027417 (8%),Cyclin-D1-binding protein 1 (8%);Pectin lyase fold/virulence factor (8%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
KPQEPGETDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLAAMMHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.5 (29%);2.5.1.7 (23%);2.7.7.7 (6%),Pyridoxal 5'-phosphate synthase (29%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (23%);DNA-directed DNA polymerase (6%),GO:0016021 (24%);GO:0005634 (16%);GO:0005737 (13%),integral component of membrane (24%);nucleus (16%);cytoplasm (13%),GO:0003700 (16%);GO:0043565 (13%);GO:0003677 (8%),DNA-binding transcription factor activity (16%);sequence-specific DNA binding (13%);DNA binding (8%),GO:0008615 (8%);GO:0071555 (6%);GO:0008360 (6%),pyridoxine biosynthetic process (8%);cell wall organization (6%);regulation of cell shape (6%),IPR036388 (14%);IPR036390 (13%);IPR027725 (12%),Winged helix-like DNA-binding domain superfamily (14%);Winged helix DNA-binding domain superfamily (13%);Heat shock transcription factor family (12%),,,,,,,,,,,
AVNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.55 (60%);2.5.1.7 (11%);1.1.1.103 (5%),3-deoxy-8-phosphooctulonate synthase (60%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (11%);L-threonine 3-dehydrogenase (5%),GO:0005737 (34%);GO:0016021 (17%);GO:0005887 (12%),cytoplasm (34%);integral component of membrane (17%);integral component of plasma membrane (12%),GO:0008676 (22%);GO:0005524 (7%);GO:0046872 (7%),3-deoxy-8-phosphooctulonate synthase activity (22%);ATP binding (7%);metal ion binding (7%),GO:0019294 (16%);GO:0043093 (10%);GO:0009103 (6%),keto-3-deoxy-D-manno-octulosonic acid biosynthetic process (16%);FtsZ-dependent cytokinesis (10%);lipopolysaccharide biosynthetic process (6%),IPR013785 (21%);IPR006218 (20%);IPR006269 (20%),Aldolase-type TIM barrel (21%);DAHP synthetase I/KDSA (20%);3-deoxy-8-phosphooctulonate synthase (20%),,,,,,,,,,,
EMVDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.3 (100%),Deoxyribodipyrimidine photo-lyase (100%),GO:0005886 (3%);GO:0009506 (3%),plasma membrane (3%);plasmodesma (3%),GO:0003924 (34%);GO:0005525 (34%);GO:0003746 (28%),GTPase activity (34%);GTP binding (34%);translation elongation factor activity (28%),GO:0006511 (14%);GO:0016579 (14%);GO:0018298 (10%),ubiquitin-dependent protein catabolic process (14%);protein deubiquitination (14%);protein-chromophore linkage (10%),IPR000640 (30%);IPR000795 (30%);IPR004161 (30%),Elongation factor EFG, domain V-like (30%);Transcription factor, GTP-binding domain (30%);Translation elongation factor EFTu-like, domain 2 (30%),,,,,,,,
EPYYDVVLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YDDANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (33%);6.1.1.19 (33%);6.5.1.2 (33%),Methyltransferases (33%);Arginine--tRNA ligase (33%);DNA ligase (NAD(+)) (33%),GO:0016021 (36%);GO:0019867 (23%);GO:0000123 (5%),integral component of membrane (36%);outer membrane (23%);histone acetyltransferase complex (5%),GO:0004386 (6%);GO:0005524 (6%);GO:0000155 (5%),helicase activity (6%);ATP binding (6%);phosphorelay sensor kinase activity (5%),GO:0009405 (23%);GO:0055085 (11%);GO:0016573 (5%),pathogenesis (23%);transmembrane transport (11%);histone acetylation (5%),IPR011990 (29%);IPR013026 (26%);IPR019734 (22%),Tetratricopeptide-like helical domain superfamily (29%);Tetratricopeptide repeat-containing domain (26%);Tetratricopeptide repeat (22%),,,,,,,,,,,
FLMPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (22%);2.7.11.1 (13%);6.5.1.2 (7%),DNA-directed DNA polymerase (22%);Non-specific serine/threonine protein kinase (13%);DNA ligase (NAD(+)) (7%),GO:0016021 (22%);GO:0005886 (5%);GO:0005737 (2%),integral component of membrane (22%);plasma membrane (5%);cytoplasm (2%),GO:0005524 (35%);GO:0004222 (17%);GO:0003677 (13%),ATP binding (35%);metalloendopeptidase activity (17%);DNA binding (13%),GO:0006260 (4%);GO:0006310 (3%);GO:0006397 (3%),DNA replication (4%);DNA recombination (3%);mRNA processing (3%),IPR037219 (19%);IPR027417 (13%);IPR014001 (11%),Peptidase M41-like (19%);P-loop containing nucleoside triphosphate hydrolase (13%);Helicase superfamily 1/2, ATP-binding domain (11%),,,,,,,,,,
QYPPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.141 (41%);3.1.-.- (29%);5.5.1.4 (12%),N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase (41%);Acting on ester bonds (29%);Inositol-3-phosphate synthase (12%),GO:0005783 (14%);GO:0005737 (12%);GO:0016021 (6%),endoplasmic reticulum (14%);cytoplasm (12%);integral component of membrane (6%),GO:0016491 (25%);GO:0004577 (14%);GO:0000155 (12%),oxidoreductase activity (25%);N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity (14%);phosphorelay sensor kinase activity (12%),GO:0006488 (14%);GO:0006364 (10%);GO:0006021 (4%),dolichol-linked oligosaccharide biosynthetic process (14%);rRNA processing (10%);inositol biosynthetic process (4%),IPR007969 (17%);IPR006656 (12%);IPR001623 (11%),Domain of unknown function DUF732 (17%);Molybdopterin oxidoreductase (12%);DnaJ domain (11%),,,,,,,,,,,
YHLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (50%);2.3.1.180 (5%);2.1.1.- (4%),Transferring other groups (50%);Beta-ketoacyl-[acyl-carrier-protein] synthase III (5%);Methyltransferases (4%),GO:0016021 (17%);GO:0019013 (9%);GO:0044172 (8%),integral component of membrane (17%);viral nucleocapsid (9%);host cell endoplasmic reticulum-Golgi intermediate compartment (8%),GO:0003723 (24%);GO:0009982 (13%);GO:0005524 (12%),RNA binding (24%);pseudouridine synthase activity (13%);ATP binding (12%),GO:0001522 (13%);GO:0006355 (4%);GO:0006281 (2%),pseudouridine synthesis (13%);regulation of transcription, DNA-templated (4%);DNA repair (2%),IPR016024 (18%);IPR011989 (18%);IPR040108 (18%),Armadillo-type fold (18%);Armadillo-like helical (18%);Laa1/Sip1/HEATR5 (18%),,,,,,,,,,
AFPLTSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0008270 (25%);GO:0016491 (25%);GO:0050661 (25%),zinc ion binding (25%);oxidoreductase activity (25%);NADP binding (25%),GO:0007165 (25%),signal transduction (25%),IPR027796 (33%);IPR001841 (17%);IPR003660 (17%),OTT_1508-like deaminase (33%);Zinc finger, RING-type (17%);HAMP domain (17%),,,,,,,,,,
TELLYMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.11 (58%);2.7.3.9 (33%);2.1.1.72 (8%),Acetylornithine transaminase (58%);Phosphoenolpyruvate--protein phosphotransferase (33%);Site-specific DNA-methyltransferase (adenine-specific) (8%),GO:0005737 (79%);GO:0016021 (18%);GO:0005783 (4%),cytoplasm (79%);integral component of membrane (18%);endoplasmic reticulum (4%),GO:0003992 (50%);GO:0030170 (32%);GO:0008965 (29%),N2-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase activity (50%);pyridoxal phosphate binding (32%);phosphoenolpyruvate-protein phosphotransferase activity (29%),GO:0006526 (46%);GO:0009401 (29%);GO:0006886 (4%),arginine biosynthetic process (46%);phosphoenolpyruvate-dependent sugar phosphotransferase system (29%);intracellular protein transport (4%),IPR004636 (50%);IPR005814 (50%);IPR015421 (50%),Acetylornithine/Succinylornithine transaminase family (50%);Aminotransferase class-III (50%);Pyridoxal phosphate-dependent transferase, major domain (50%),,,,,,,,,,
MSTTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.17 (18%);2.1.2.3 (10%);3.5.4.10 (10%),Phosphomethylpyrimidine synthase (18%);Phosphoribosylaminoimidazolecarboxamide formyltransferase (10%);IMP cyclohydrolase (10%),GO:0016021 (30%);GO:0005737 (8%);GO:0005886 (5%),integral component of membrane (30%);cytoplasm (8%);plasma membrane (5%),GO:0005524 (12%);GO:0003677 (7%);GO:0008270 (6%),ATP binding (12%);DNA binding (7%);zinc ion binding (6%),GO:0009228 (4%);GO:0009229 (4%);GO:0006189 (4%),thiamine biosynthetic process (4%);thiamine diphosphate biosynthetic process (4%);'de novo' IMP biosynthetic process (4%),IPR027417 (6%);IPR018733 (4%);IPR036291 (4%),P-loop containing nucleoside triphosphate hydrolase (6%);Protein of unknown function DUF2274 (4%);NAD(P)-binding domain superfamily (4%),,,,,,,,,,,
MDVMEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVWNQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.15 (100%),Ribokinase (100%),GO:0016021 (43%);GO:0005737 (14%),integral component of membrane (43%);cytoplasm (14%),GO:0008417 (29%);GO:0003677 (14%);GO:0003700 (14%),fucosyltransferase activity (29%);DNA binding (14%);DNA-binding transcription factor activity (14%),GO:0006004 (29%);GO:0007219 (29%);GO:0019303 (14%),fucose metabolic process (29%);Notch signaling pathway (29%);D-ribose catabolic process (14%),IPR019378 (50%);IPR039922 (50%);IPR000847 (25%),GDP-fucose protein O-fucosyltransferase (50%);GDP-fucose protein O-fucosyltransferase 1 (50%);Transcription regulator HTH, LysR (25%),,,,,,,,,,
EVWMMLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMFFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.2 (67%);2.7.7.48 (33%),Aspartate carbamoyltransferase (67%);RNA-directed RNA polymerase (33%),GO:0035097 (40%);GO:0016021 (33%);GO:0005730 (10%),histone methyltransferase complex (40%);integral component of membrane (33%);nucleolus (10%),GO:0042800 (40%);GO:0046872 (40%);GO:0003677 (13%),histone methyltransferase activity (H3-K4 specific) (40%);metal ion binding (40%);DNA binding (13%),GO:0006355 (13%);GO:0006207 (7%);GO:0006520 (7%),regulation of transcription, DNA-templated (13%);'de novo' pyrimidine nucleobase biosynthetic process (7%);cellular amino acid metabolic process (7%),IPR003609 (37%);IPR013083 (30%);IPR001214 (28%),PAN/Apple domain (37%);Zinc finger, RING/FYVE/PHD-type (30%);SET domain (28%),,,,,,,,,
MLVLPEEM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENLVNSSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPDHPQGQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDSETWK,Tamlana sedimentorum,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Tamlana,,,,Tamlana sedimentorum,,,,,,,,GO:0004781 (100%),sulfate adenylyltransferase (ATP) activity (100%),,,IPR005181 (50%);IPR014729 (50%);IPR015947 (50%),Sialate O-acetylesterase domain (50%);Rossmann-like alpha/beta/alpha sandwich fold (50%);PUA-like superfamily (50%),,,,,,,,,,,
EVFFCAER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (27%);3.2.1.- (21%);1.2.1.88 (9%),Serine endopeptidases (27%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (21%);L-glutamate gamma-semialdehyde dehydrogenase (9%),GO:0016020 (34%);GO:0005737 (13%);GO:0016021 (7%),membrane (34%);cytoplasm (13%);integral component of membrane (7%),GO:0008933 (34%);GO:0048037 (18%);GO:0003723 (12%),lytic transglycosylase activity (34%);cofactor binding (18%);RNA binding (12%),GO:0000270 (34%);GO:0070929 (11%);GO:0010133 (2%),peptidoglycan metabolic process (34%);trans-translation (11%);proline catabolic process to glutamate (2%),IPR008258 (30%);IPR023346 (30%);IPR000189 (29%),Transglycosylase SLT domain 1 (30%);Lysozyme-like domain superfamily (30%);Prokaryotic transglycosylase, active site (29%),,,,,,,,,
AACLWNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGHVM,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.5 (100%),Chorismate mutase (100%),,,GO:0004106 (100%),chorismate mutase activity (100%),GO:0046417 (100%),chorismate metabolic process (100%),IPR002701 (50%);IPR004038 (50%);IPR010958 (50%),Chorismate mutase II, prokaryotic-type (50%);Ribosomal protein L7Ae/L30e/S12e/Gadd45 (50%);Chorismate mutase, high GC Gram-positive bacteria/archaeal (50%),,,,,,,,,
LMPTVPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016491 (50%),oxidoreductase activity (50%),,,IPR011415 (50%);IPR011642 (50%);IPR015904 (50%),Predicted bifunctional spore maturation protein, fused SpmA/SpmB (50%);Nucleoside transporter/FeoB GTPase, Gate domain (50%);Sulphide quinone-reductase (50%),,,,,,,,,
WMLTPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDHAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.6 (70%);5.6.2.2 (5%);2.1.1.13 (3%),Exodeoxyribonuclease VII (70%);DNA topoisomerase (ATP-hydrolyzing) (5%);Methionine synthase (3%),GO:0005737 (32%);GO:0009318 (27%);GO:0016021 (15%),cytoplasm (32%);exodeoxyribonuclease VII complex (27%);integral component of membrane (15%),GO:0008855 (28%);GO:0003676 (27%);GO:0003677 (14%),exodeoxyribonuclease VII activity (28%);nucleic acid binding (27%);DNA binding (14%),GO:0006308 (28%);GO:0006367 (8%);GO:0006265 (2%),DNA catabolic process (28%);transcription initiation from RNA polymerase II promoter (8%);DNA topological change (2%),IPR012893 (29%);IPR017508 (27%);IPR003753 (19%),HipA-like, C-terminal (29%);HipA, N-terminal subdomain 1 (27%);Exonuclease VII, large subunit (19%),,,,,,,,
GTLPTDPK,Paenibacillus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Paenibacillaceae,,,,Paenibacillus,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMNTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (62%);6.1.1.21 (9%);1.2.4.2 (6%),Acting on peptide bonds (peptidases) (62%);Histidine--tRNA ligase (9%);Oxoglutarate dehydrogenase (succinyl-transferring) (6%),GO:0016021 (45%);GO:0005787 (21%);GO:0005737 (4%),integral component of membrane (45%);signal peptidase complex (21%);cytoplasm (4%),GO:0008233 (22%);GO:0005524 (19%);GO:0004672 (6%),peptidase activity (22%);ATP binding (19%);protein kinase activity (6%),GO:0006465 (21%);GO:0006457 (4%);GO:0006099 (3%),signal peptide processing (21%);protein folding (4%);tricarboxylic acid cycle (3%),IPR007653 (19%);IPR027417 (7%);IPR011009 (7%),Signal peptidase complex subunit 3 (19%);P-loop containing nucleoside triphosphate hydrolase (7%);Protein kinase-like domain superfamily (7%),,,,,,,,,,,
DVFLDVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVMTLPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0003677 (33%);GO:0004519 (33%);GO:0016740 (33%),DNA binding (33%);endonuclease activity (33%);transferase activity (33%),GO:0009307 (33%),DNA restriction-modification system (33%),IPR001296 (50%);IPR007560 (50%);IPR011335 (50%),Glycosyl transferase, family 1 (50%);Restriction endonuclease type IV,  Mrr (50%);Restriction endonuclease  type II-like (50%),,,,,,,,,
FLHLMTMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEAEAASSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLSNDLSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVELLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (33%);3.1.13.1 (22%);7.6.2.1 (22%),Carboxylic ester hydrolases (33%);Exoribonuclease II (22%);P-type phospholipid transporter (22%),GO:0016021 (32%);GO:0005737 (6%);GO:0042597 (3%),integral component of membrane (32%);cytoplasm (6%);periplasmic space (3%),GO:0005524 (19%);GO:0003723 (13%);GO:0000287 (6%),ATP binding (19%);RNA binding (13%);magnesium ion binding (6%),GO:0006396 (11%);GO:0000398 (6%);GO:0001522 (6%),RNA processing (11%);mRNA splicing, via spliceosome (6%);pseudouridine synthesis (6%),IPR011990 (34%);IPR013026 (33%);IPR019734 (25%),Tetratricopeptide-like helical domain superfamily (34%);Tetratricopeptide repeat-containing domain (33%);Tetratricopeptide repeat (25%),,,,,,,,,,
WSGPTGPDEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLGHWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.105 (100%),Rhomboid protease (100%),GO:0016021 (77%);GO:0005886 (23%),integral component of membrane (77%);plasma membrane (23%),GO:0004252 (31%);GO:0003824 (15%);GO:0008233 (8%),serine-type endopeptidase activity (31%);catalytic activity (15%);peptidase activity (8%),GO:0055085 (23%);GO:0008643 (8%),transmembrane transport (23%);carbohydrate transport (8%),IPR022764 (42%);IPR035952 (42%);IPR000515 (25%),Peptidase S54, rhomboid domain (42%);Rhomboid-like superfamily (42%);ABC transporter type 1, transmembrane domain MetI-like (25%),,,,,,,,,
YGCVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.25 (83%);3.4.22.40 (17%),4-alpha-glucanotransferase (83%);Bleomycin hydrolase (17%),GO:0005737 (8%);GO:0005778 (8%);GO:0043190 (8%),cytoplasm (8%);peroxisomal membrane (8%);ATP-binding cassette (ABC) transporter complex (8%),GO:0004134 (38%);GO:0102500 (38%);GO:0004197 (23%),4-alpha-glucanotransferase activity (38%);beta-maltose 4-alpha-glucanotransferase activity (38%);cysteine-type endopeptidase activity (23%),GO:0006012 (8%);GO:0006355 (8%);GO:0016560 (8%),galactose metabolic process (8%);regulation of transcription, DNA-templated (8%);protein import into peroxisome matrix, docking (8%),IPR003385 (38%);IPR017853 (38%);IPR000169 (23%),Glycoside hydrolase, family 77 (38%);Glycoside hydrolase superfamily (38%);Cysteine peptidase, cysteine active site (23%),,,,,,,
QNNLGVSPAEGAGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAQAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (97%);2.3.1.- (2%);3.1.26.4 (2%),Protein-serine/threonine phosphatase (97%);Transferring groups other than amino-acyl groups (2%);Ribonuclease H (2%),GO:0016021 (29%);GO:0005886 (19%);GO:0009425 (17%),integral component of membrane (29%);plasma membrane (19%);bacterial-type flagellum basal body (17%),GO:0046872 (35%);GO:0004721 (29%);GO:0003676 (11%),metal ion binding (35%);phosphoprotein phosphatase activity (29%);nucleic acid binding (11%),GO:0006935 (18%);GO:0071973 (17%);GO:0015074 (8%),chemotaxis (18%);bacterial-type flagellum-dependent cell motility (17%);DNA integration (8%),IPR004843 (29%);IPR006186 (29%);IPR029052 (28%),Calcineurin-like phosphoesterase domain, ApaH type (29%);Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase (29%);Metallo-dependent phosphatase-like (28%),,,,,,,,,,
TNWYNTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDEYFMK,Clostridiales bacterium,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,,,,,,,,,Clostridiales bacterium,,,,3.5.4.33 (100%),tRNA(adenine(34)) deaminase (100%),,,GO:0008270 (100%);GO:0052717 (100%),zinc ion binding (100%);tRNA-specific adenosine-34 deaminase activity (100%),GO:0002100 (100%),tRNA wobble adenosine to inosine editing (100%),IPR002125 (100%);IPR016192 (100%);IPR016193 (100%),Cytidine and deoxycytidylate deaminase domain (100%);APOBEC/CMP deaminase, zinc-binding (100%);Cytidine deaminase-like (100%),,,,,,,,,,
LNWGLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.23 (42%);3.4.21.89 (17%);6.1.1.10 (17%),NAD(+) kinase (42%);Signal peptidase I (17%);Methionine--tRNA ligase (17%),GO:0016021 (15%);GO:0005737 (8%);GO:0005887 (5%),integral component of membrane (15%);cytoplasm (8%);integral component of plasma membrane (5%),GO:0005524 (38%);GO:0004825 (30%);GO:0008080 (15%),ATP binding (38%);methionine-tRNA ligase activity (30%);N-acetyltransferase activity (15%),GO:0006431 (29%);GO:0006412 (7%);GO:0006741 (7%),methionyl-tRNA aminoacylation (29%);translation (7%);NADP biosynthetic process (7%),IPR014729 (28%);IPR009080 (26%);IPR014758 (26%),Rossmann-like alpha/beta/alpha sandwich fold (28%);Aminoacyl-tRNA synthetase, class Ia, anticodon-binding (26%);Methionyl-tRNA synthetase (26%),,,,,,,,,
DHLLVHER,Actinobacteria,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002372 (100%);IPR011047 (100%);IPR015943 (100%),Pyrrolo-quinoline quinone repeat (100%);Quinoprotein alcohol dehydrogenase-like superfamily (100%);WD40/YVTN repeat-like-containing domain superfamily (100%),,,,,,,,,,,
AQNLPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.28 (100%),Alpha,alpha-trehalase (100%),GO:0043190 (25%),ATP-binding cassette (ABC) transporter complex (25%),GO:0004555 (25%);GO:0005543 (25%);GO:0016787 (25%),alpha,alpha-trehalase activity (25%);phospholipid binding (25%);hydrolase activity (25%),GO:0005991 (25%);GO:0006887 (25%);GO:0055085 (25%),trehalose metabolic process (25%);exocytosis (25%);transmembrane transport (25%),IPR000008 (40%);IPR008928 (40%);IPR012341 (40%),C2 domain (40%);Six-hairpin glycosidase superfamily (40%);Six-hairpin glycosidase-like superfamily (40%),,,,,,,,,
TLLFFMTENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLHHPSMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVEMQNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAMTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.17 (79%);3.4.16.4 (11%);2.10.1.1 (5%),Lysozyme (79%);Serine-type D-Ala-D-Ala carboxypeptidase (11%);Molybdopterin molybdotransferase (5%),GO:0016021 (16%);GO:0005634 (5%);GO:0005887 (5%),integral component of membrane (16%);nucleus (5%);integral component of plasma membrane (5%),GO:0003796 (35%);GO:0003677 (12%);GO:0046872 (9%),lysozyme activity (35%);DNA binding (12%);metal ion binding (9%),GO:0019835 (35%);GO:0042742 (35%);GO:0009253 (23%),cytolysis (35%);defense response to bacterium (35%);peptidoglycan catabolic process (23%),IPR023346 (33%);IPR002196 (31%);IPR000203 (6%),Lysozyme-like domain superfamily (33%);Glycoside hydrolase, family 24 (31%);GPS motif (6%),,,,,,,,,,
LGLMNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.13 (20%);3.6.4.12 (20%);2.4.1.- (10%),Glutamate synthase (NADPH) (20%);DNA helicase (20%);Hexosyltransferases (10%),GO:0016021 (29%);GO:0009279 (12%);GO:0046930 (12%),integral component of membrane (29%);cell outer membrane (12%);pore complex (12%),GO:0005524 (23%);GO:0016887 (15%);GO:0015288 (12%),ATP binding (23%);ATPase activity (15%);porin activity (12%),GO:0006811 (12%);GO:0008643 (12%);GO:0055085 (6%),ion transport (12%);carbohydrate transport (12%);transmembrane transport (6%),IPR027417 (16%);IPR003593 (10%);IPR003439 (9%),P-loop containing nucleoside triphosphate hydrolase (16%);AAA+ ATPase domain (10%);ABC transporter-like (9%),,,,,,,,,,,
EFEEESYETSTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SELADVPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLFTQYDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTFMTEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESSGVGSANALGMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVFLWNK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000178 (50%);GO:0016021 (50%),exosome (RNase complex) (50%);integral component of membrane (50%),GO:0003723 (50%),RNA binding (50%),,,IPR011990 (100%);IPR039278 (100%),Tetratricopeptide-like helical domain superfamily (100%);Protein Red1 (100%),,,,,,,,,,,
DPMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.99.4 (11%);1.1.1.- (10%);2.6.1.13 (8%),Nitrate reductase (11%);With NAD(+) or NADP(+) as acceptor (10%);Ornithine aminotransferase (8%),GO:0016021 (24%);GO:0009325 (5%);GO:0005886 (3%),integral component of membrane (24%);nitrate reductase complex (5%);plasma membrane (3%),GO:0005524 (10%);GO:0003677 (6%);GO:0008374 (6%),ATP binding (10%);DNA binding (6%);O-acyltransferase activity (6%),GO:0044255 (6%);GO:0042126 (5%);GO:0005975 (2%),cellular lipid metabolic process (6%);nitrate metabolic process (5%);carbohydrate metabolic process (2%),IPR027417 (7%);IPR029061 (5%);IPR001017 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Thiamin diphosphate-binding fold (5%);Dehydrogenase, E1 component (5%),,,,,,,,,,
MPLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.2 (26%);3.1.21.- (20%);2.7.7.7 (2%),Adenine deaminase (26%);Endodeoxyribonucleases producing 5'-phosphomonoesters (20%);DNA-directed DNA polymerase (2%),GO:0016021 (19%);GO:0005840 (4%);GO:0042025 (4%),integral component of membrane (19%);ribosome (4%);host cell nucleus (4%),GO:0005524 (18%);GO:0003677 (12%);GO:0003735 (7%),ATP binding (18%);DNA binding (12%);structural constituent of ribosome (7%),GO:0006412 (8%);GO:0009117 (5%);GO:0006146 (5%),translation (8%);nucleotide metabolic process (5%);adenine catabolic process (5%),IPR027417 (10%);IPR003714 (6%);IPR002716 (5%),P-loop containing nucleoside triphosphate hydrolase (10%);PhoH-like protein (6%);PIN domain (5%),,,,,,,,,,,
EVRPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (56%);5.6.2.2 (11%);1.1.1.1 (6%),Acting on ATP; involved in cellular and subcellular movement (56%);DNA topoisomerase (ATP-hydrolyzing) (11%);Alcohol dehydrogenase (6%),GO:0016021 (23%);GO:1990077 (19%);GO:0030014 (6%),integral component of membrane (23%);primosome complex (19%);CCR4-NOT complex (6%),GO:0003677 (31%);GO:0005524 (27%);GO:0003678 (20%),DNA binding (31%);ATP binding (27%);DNA helicase activity (20%),GO:0006268 (19%);GO:0006269 (19%);GO:0006261 (4%),DNA unwinding involved in DNA replication (19%);DNA replication, synthesis of RNA primer (19%);DNA-dependent DNA replication (4%),IPR027417 (19%);IPR001650 (18%);IPR014001 (17%),P-loop containing nucleoside triphosphate hydrolase (19%);Helicase, C-terminal (18%);Helicase superfamily 1/2, ATP-binding domain (17%),,,,,,,,
ELFQMVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (33%);2.7.7.6 (13%);1.4.9.2 (7%),Acting on polysaccharides (33%);DNA-directed RNA polymerase (13%);Aralkylamine dehydrogenase (azurin) (7%),GO:0015934 (36%);GO:0016021 (19%);GO:0005840 (10%),large ribosomal subunit (36%);integral component of membrane (19%);ribosome (10%),GO:0003735 (37%);GO:0005247 (12%);GO:0005524 (5%),structural constituent of ribosome (37%);voltage-gated chloride channel activity (12%);ATP binding (5%),GO:0006412 (47%);GO:0000270 (2%);GO:0006355 (2%),translation (47%);peptidoglycan metabolic process (2%);regulation of transcription, DNA-templated (2%),IPR016082 (41%);IPR036919 (41%);IPR005996 (41%),Ribosomal protein L30, ferredoxin-like fold domain (41%);Ribosomal protein L30, ferredoxin-like fold domain superfamily (41%);Ribosomal protein L30, bacterial-type (41%),,,,,,,
DLEVTYMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QSDGLMMLPQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPLLFQEPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLDVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (38%);6.3.1.2 (19%);3.2.2.23 (7%),3-isopropylmalate dehydratase (38%);Glutamine synthetase (19%);DNA-formamidopyrimidine glycosylase (7%),GO:0016021 (13%);GO:0005737 (10%);GO:0005623 (5%),integral component of membrane (13%);cytoplasm (10%);cell (5%),GO:0046872 (18%);GO:0051539 (16%);GO:0003861 (15%),metal ion binding (18%);4 iron, 4 sulfur cluster binding (16%);3-isopropylmalate dehydratase activity (15%),GO:0009098 (15%);GO:0006629 (10%);GO:0006542 (7%),leucine biosynthetic process (15%);lipid metabolic process (10%);glutamine biosynthetic process (7%),IPR001030 (13%);IPR015931 (13%);IPR036008 (13%),Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha domain (13%);Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 1/3 (13%);Aconitase, iron-sulfur domain (13%),,,,,,
ESNVEM,Trifolium medium,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Fabales,,,,,Fabaceae,Papilionoideae,Trifolieae,,Trifolium,,,,Trifolium medium,,,,,,,,,,,,,,,,,,,,,,,,
MTQWGDQDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NATHYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003676 (50%);GO:0003677 (50%),nucleic acid binding (50%);DNA binding (50%),GO:0015074 (100%);GO:0032196 (50%),DNA integration (100%);transposition (50%),IPR001584 (100%);IPR012337 (100%);IPR036397 (100%),Integrase, catalytic core (100%);Ribonuclease H-like superfamily (100%);Ribonuclease H superfamily (100%),,,,,,,,,,
FGVEGQSNLLSNC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNYYTEDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLWESK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.49 (50%);6.1.1.19 (50%),RNA-directed DNA polymerase (50%);Arginine--tRNA ligase (50%),GO:0005634 (23%);GO:0000781 (8%);GO:0005737 (8%),nucleus (23%);chromosome, telomeric region (8%);cytoplasm (8%),GO:0005524 (31%);GO:0003677 (23%);GO:0004672 (15%),ATP binding (31%);DNA binding (23%);protein kinase activity (15%),GO:0032259 (15%);GO:0005975 (8%);GO:0006260 (8%),methylation (15%);carbohydrate metabolic process (8%);DNA replication (8%),IPR029063 (26%);IPR021829 (16%);IPR000719 (11%),S-adenosyl-L-methionine-dependent methyltransferase (26%);Protein of unknown function DUF3419 (16%);Protein kinase domain (11%),,,,,,,,,,
SVYYPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.2 (100%),5-formyltetrahydrofolate cyclo-ligase (100%),GO:0005911 (17%);GO:0016021 (17%);GO:0019867 (6%),cell-cell junction (17%);integral component of membrane (17%);outer membrane (6%),GO:0046872 (28%);GO:0015562 (17%);GO:0016788 (17%),metal ion binding (28%);efflux transmembrane transporter activity (17%);hydrolase activity, acting on ester bonds (17%),GO:0005975 (6%);GO:0019346 (6%),carbohydrate metabolic process (6%);transsulfuration (6%),IPR003423 (14%);IPR007036 (14%);IPR016708 (14%),Outer membrane efflux protein (14%);Succinylglutamate desuccinylase/aspartoacylase (14%);Aspartoacylase (14%),,,,,,,,,,
EEAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.27 (11%);2.8.1.13 (7%);3.6.4.12 (6%),Undecaprenyl-diphosphate phosphatase (11%);tRNA-uridine 2-sulfurtransferase (7%);DNA helicase (6%),GO:0016021 (25%);GO:0005737 (8%);GO:0005886 (6%),integral component of membrane (25%);cytoplasm (8%);plasma membrane (6%),GO:0005524 (18%);GO:0003677 (9%);GO:0046872 (5%),ATP binding (18%);DNA binding (9%);metal ion binding (5%),GO:0007601 (4%);GO:0006412 (2%);GO:0008360 (2%),visual perception (4%);translation (2%);regulation of cell shape (2%),IPR027417 (13%);IPR003593 (5%);IPR036291 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);AAA+ ATPase domain (5%);NAD(P)-binding domain superfamily (4%),,,,,,,,,,,
FCNAPVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YYWPLLMATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMPNGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (95%);3.6.4.12 (5%),Transaminases (95%);DNA helicase (5%),GO:0016021 (28%);GO:0005887 (5%);GO:0043190 (5%),integral component of membrane (28%);integral component of plasma membrane (5%);ATP-binding cassette (ABC) transporter complex (5%),GO:0008483 (49%);GO:0030170 (44%);GO:0005524 (13%),transaminase activity (49%);pyridoxal phosphate binding (44%);ATP binding (13%),GO:0009058 (44%);GO:0055085 (5%);GO:0000160 (3%),biosynthetic process (44%);transmembrane transport (5%);phosphorelay signal transduction system (3%),IPR004838 (43%);IPR004839 (43%);IPR015421 (43%),Aminotransferases, class-I, pyridoxal-phosphate-binding site (43%);Aminotransferase, class I/classII (43%);Pyridoxal phosphate-dependent transferase, major domain (43%),,,,,,,
TCLTAEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLVPANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0003824 (100%),catalytic activity (100%),,,IPR001736 (50%);IPR007454 (50%);IPR027471 (50%),Phospholipase D/Transphosphatidylase (50%);Uncharacterised protein family UPF0250 (50%);YbeD-like domain superfamily (50%),,,,,,,,,,,
VFVDGWR,Trypanosoma cruzi,Eukaryota,,,,Euglenozoa,,,Kinetoplastea,Metakinetoplastina,,,Trypanosomatida,,,,,Trypanosomatidae,,,,Trypanosoma,Schizotrypanum,,,Trypanosoma cruzi,,,,,,,,,,,,,,,,,,,,,,,,
TNNVMYDDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNLNQVMEPNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDQMEVLK,Archaea,Archaea,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
HSECR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.14 (25%);2.1.1.77 (25%);3.1.-.- (25%),Glutamate synthase (NADH) (25%);Protein-L-isoaspartate(D-aspartate) O-methyltransferase (25%);Acting on ester bonds (25%),GO:0016021 (25%);GO:0005634 (8%);GO:0005737 (3%),integral component of membrane (25%);nucleus (8%);cytoplasm (3%),GO:0003676 (16%);GO:0046872 (14%);GO:0003677 (9%),nucleic acid binding (16%);metal ion binding (14%);DNA binding (9%),GO:0006355 (10%);GO:0006826 (8%);GO:0006284 (4%),regulation of transcription, DNA-templated (10%);iron ion transport (8%);base-excision repair (4%),IPR006578 (26%);IPR039353 (24%);IPR000884 (10%),MADF domain (26%);Transcription factor Adf-1 (24%);Thrombospondin type-1 (TSP1) repeat (10%),,,,,,,,,,
NQYPC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNNGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.3.27 (15%);2.7.7.6 (13%);3.6.4.12 (8%),Anthranilate synthase (15%);DNA-directed RNA polymerase (13%);DNA helicase (8%),GO:0016021 (30%);GO:0009279 (6%);GO:0005737 (5%),integral component of membrane (30%);cell outer membrane (6%);cytoplasm (5%),GO:0005524 (15%);GO:0003677 (10%);GO:0046872 (5%),ATP binding (15%);DNA binding (10%);metal ion binding (5%),GO:0006310 (3%);GO:0015074 (3%);GO:0000162 (3%),DNA recombination (3%);DNA integration (3%);tryptophan biosynthetic process (3%),IPR027417 (7%);IPR011009 (5%);IPR012910 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Protein kinase-like domain superfamily (5%);TonB-dependent receptor, plug domain (5%),,,,,,,,,,
FPMLQMGANPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVLLQTYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000166 (100%);GO:0016639 (100%),nucleotide binding (100%);oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor (100%),GO:0006520 (100%),cellular amino acid metabolic process (100%),IPR016071 (80%);IPR035437 (80%);IPR006095 (20%),Staphylococcal nuclease (SNase-like), OB-fold (80%);SNase-like, OB-fold superfamily (80%);Glutamate/phenylalanine/leucine/valine dehydrogenase (20%),,,,,,,
TYVVMFVANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPWWLEAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAEQDNLVVMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVPVAHQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMFELYSK,Candidatus Pacearchaeota archaeon,Archaea,,,,,,,,,,,,,,,,,,,,,,,,Candidatus Pacearchaeota archaeon,,,,,,,,,,,,,,,,,,,,,,,,
MVPWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.2 (70%);1.17.1.9 (11%);2.4.1.- (7%),Transferred entry: 1.17.1.9 (70%);Formate dehydrogenase (11%);Hexosyltransferases (7%),GO:0016021 (10%);GO:0005886 (2%);GO:0030288 (2%),integral component of membrane (10%);plasma membrane (2%);outer membrane-bounded periplasmic space (2%),GO:0046872 (85%);GO:0051536 (83%);GO:0009055 (79%),metal ion binding (85%);iron-sulfur cluster binding (83%);electron transfer activity (79%),GO:0015942 (78%);GO:0015031 (2%);GO:0055085 (1%),formate metabolic process (78%);protein transport (2%);transmembrane transport (1%),IPR006963 (85%);IPR006656 (84%);IPR017896 (84%),Molybdopterin oxidoreductase, 4Fe-4S domain (85%);Molybdopterin oxidoreductase (84%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (84%),,,,,,,,,
DVLLTPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVPLLVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVMLEPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%);GO:0003700 (100%),DNA binding (100%);DNA-binding transcription factor activity (100%),,,IPR000524 (100%);IPR001761 (100%);IPR028082 (100%),Transcription regulator HTH, GntR (100%);Periplasmic binding protein/LacI sugar binding domain (100%);Periplasmic binding protein-like I (100%),,,,,,,,,,
TDVWESPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TELDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.38 (46%);3.4.21.53 (4%);3.1.-.- (3%),Malate dehydrogenase (oxaloacetate-decarboxylating) (46%);Endopeptidase La (4%);Acting on ester bonds (3%),GO:0016021 (25%);GO:0005737 (8%);GO:0005886 (5%),integral component of membrane (25%);cytoplasm (8%);plasma membrane (5%),GO:0005524 (15%);GO:0046872 (15%);GO:0004471 (11%),ATP binding (15%);metal ion binding (15%);malate dehydrogenase (decarboxylating) (NAD+) activity (11%),GO:0055072 (3%);GO:0005975 (2%);GO:0055085 (2%),iron ion homeostasis (3%);carbohydrate metabolic process (2%);transmembrane transport (2%),IPR027417 (12%);IPR036291 (11%);IPR012301 (10%),P-loop containing nucleoside triphosphate hydrolase (12%);NAD(P)-binding domain superfamily (11%);Malic enzyme, N-terminal domain (10%),,,,,,,,,,
RPGQC,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR029082 (100%),Immunity protein 35 (100%),,,,,,,,,,,
EVMYMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (98%);1.2.4.4 (2%),Pyruvate dehydrogenase (acetyl-transferring) (98%);3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) (2%),GO:0005886 (6%);GO:0016021 (6%);GO:0005737 (1%),plasma membrane (6%);integral component of membrane (6%);cytoplasm (1%),GO:0004739 (88%);GO:0003676 (1%);GO:0003863 (1%),pyruvate dehydrogenase (acetyl-transferring) activity (88%);nucleic acid binding (1%);3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity (1%),GO:0006086 (78%);GO:0009847 (7%);GO:0006260 (1%),acetyl-CoA biosynthetic process from pyruvate (78%);spore germination (7%);DNA replication (1%),IPR009014 (85%);IPR027110 (85%);IPR033248 (85%),Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II (85%);Pyruvate dehydrogenase E1 component subunit beta (85%);Transketolase, C-terminal domain (85%),,,,,,,,,,
TGQTYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (54%);2.3.1.117 (15%);3.1.13.1 (15%),Non-specific serine/threonine protein kinase (54%);2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (15%);Exoribonuclease II (15%),GO:0016021 (15%);GO:0005681 (5%);GO:0005737 (4%),integral component of membrane (15%);spliceosomal complex (5%);cytoplasm (4%),GO:0003677 (50%);GO:0005524 (7%);GO:0004672 (5%),DNA binding (50%);ATP binding (7%);protein kinase activity (5%),GO:0015074 (9%);GO:0000387 (5%);GO:0032196 (3%),DNA integration (9%);spliceosomal snRNP assembly (5%);transposition (3%),IPR005532 (38%);IPR016187 (38%);IPR042095 (38%),Sulfatase-modifying factor enzyme (38%);C-type lectin fold (38%);Sulfatase-modifying factor enzyme superfamily (38%),,,,,,,
LNVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.2.10 (28%);6.3.2.29 (7%);3.6.4.12 (6%),P-type Ca(2+) transporter (28%);Cyanophycin synthase (L-aspartate-adding) (7%);DNA helicase (6%),GO:0016021 (25%);GO:0005634 (12%);GO:0005737 (5%),integral component of membrane (25%);nucleus (12%);cytoplasm (5%),GO:0005524 (18%);GO:0046872 (14%);GO:0003723 (13%),ATP binding (18%);metal ion binding (14%);RNA binding (13%),GO:0006397 (12%);GO:0006412 (4%);GO:0006817 (4%),mRNA processing (12%);translation (4%);phosphate ion transport (4%),IPR012677 (13%);IPR035979 (13%);IPR000504 (12%),Nucleotide-binding alpha-beta plait domain superfamily (13%);RNA-binding domain superfamily (13%);RNA recognition motif domain (12%),,,,,,,,,,,
NMNDTVR,Flavonifractor,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Ruminococcaceae,,,,Flavonifractor,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR021509 (100%),Protein of unknown function DUF3169 (100%),,,,,,,,,,,
MLAVHMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (100%);3.6.4.- (100%),RING-type E3 ubiquitin transferase (100%);Acting on ATP; involved in cellular and subcellular movement (100%),GO:0005634 (20%);GO:0005829 (20%),nucleus (20%);cytosol (20%),GO:0004842 (40%);GO:0016491 (40%);GO:0016887 (40%),ubiquitin-protein transferase activity (40%);oxidoreductase activity (40%);ATPase activity (40%),GO:0002040 (20%);GO:0006511 (20%);GO:0008015 (20%),sprouting angiogenesis (20%);ubiquitin-dependent protein catabolic process (20%);blood circulation (20%),IPR027417 (50%);IPR031248 (50%);IPR001841 (33%),P-loop containing nucleoside triphosphate hydrolase (50%);E3 ubiquitin-protein ligase RNF213 (50%);Zinc finger, RING-type (33%),,,,,,,,,,
TLEEDVNK,Oryzias melastigma,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,Atherinomorphae,Beloniformes,Adrianichthyoidei,,,,Adrianichthyidae,Oryziinae,,,Oryzias,,,,Oryzias melastigma,,,,2.1.1.- (100%),Methyltransferases (100%),GO:0005730 (100%),nucleolus (100%),GO:0008168 (100%),methyltransferase activity (100%),GO:0006364 (100%);GO:0032259 (100%),rRNA processing (100%);methylation (100%),IPR007823 (100%);IPR029063 (100%);IPR042036 (100%),Ribosomal RNA processing protein 8 (100%);S-adenosyl-L-methionine-dependent methyltransferase (100%);Ribosomal RNA-processing protein 8, N-terminal domain (100%),,,,,,,,,,
VMPAMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (50%);2.5.1.74 (38%);2.1.1.13 (6%),Protein-serine/threonine phosphatase (50%);1,4-dihydroxy-2-naphthoate polyprenyltransferase (38%);Methionine synthase (6%),GO:0005634 (44%);GO:0005887 (32%);GO:0016021 (5%),nucleus (44%);integral component of plasma membrane (32%);integral component of membrane (5%),GO:0008420 (44%);GO:0046428 (32%);GO:0008270 (7%),RNA polymerase II CTD heptapeptide repeat phosphatase activity (44%);1,4-dihydroxy-2-naphthoate octaprenyltransferase activity (32%);zinc ion binding (7%),GO:0070940 (44%);GO:0009234 (32%);GO:0042558 (9%),dephosphorylation of RNA polymerase II C-terminal domain (44%);menaquinone biosynthetic process (32%);pteridine-containing compound metabolic process (9%),IPR001357 (42%);IPR004274 (42%);IPR011947 (42%),BRCT domain (42%);FCP1 homology domain (42%);FCP1-like phosphatase, phosphatase domain (42%),,,,,,,,
YLHEWPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.12 (96%);1.2.7.8 (1%);4.-.-.- (0%),Photosystem I (96%);Indolepyruvate ferredoxin oxidoreductase (1%);Lyases (0%),GO:0016021 (88%);GO:0009522 (81%);GO:0009535 (52%),integral component of membrane (88%);photosystem I (81%);chloroplast thylakoid membrane (52%),GO:0000287 (67%);GO:0009055 (67%);GO:0051539 (67%),magnesium ion binding (67%);electron transfer activity (67%);4 iron, 4 sulfur cluster binding (67%),GO:0015979 (84%);GO:0018298 (67%);GO:0006355 (0%),photosynthesis (84%);protein-chromophore linkage (67%);regulation of transcription, DNA-templated (0%),IPR001280 (83%);IPR036408 (83%);IPR006244 (81%),Photosystem I PsaA/PsaB (83%);Photosystem I PsaA/PsaB superfamily (83%);Photosystem I PsaB (81%),,,,,,,,,
TALCFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.61 (50%);4.2.3.105 (50%);4.2.3.106 (50%),4-hydroxymuconic-semialdehyde dehydrogenase (50%);Tricyclene synthase (50%);(E)-beta-ocimene synthase (50%),GO:0016021 (21%);GO:0005783 (11%);GO:0009570 (5%),integral component of membrane (21%);endoplasmic reticulum (11%);chloroplast stroma (5%),GO:0016620 (21%);GO:0005524 (16%);GO:0003824 (11%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (21%);ATP binding (16%);catalytic activity (11%),GO:0048193 (11%);GO:0006952 (5%);GO:0009611 (5%),Golgi vesicle transport (11%);defense response (5%);response to wounding (5%),IPR015590 (24%);IPR016160 (24%);IPR016161 (24%),Aldehyde dehydrogenase domain (24%);Aldehyde dehydrogenase, cysteine active site (24%);Aldehyde/histidinol dehydrogenase (24%),,,,,,,,
FNYYNMMPDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEFMHDGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFLAFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (14%),integral component of membrane (14%),GO:0003684 (86%);GO:0005524 (86%);GO:0008094 (86%),damaged DNA binding (86%);ATP binding (86%);DNA-dependent ATPase activity (86%),GO:0000725 (86%);GO:0032259 (14%),recombinational repair (86%);methylation (14%),IPR003593 (86%);IPR004504 (86%);IPR014721 (86%),AAA+ ATPase domain (86%);DNA repair protein RadA (86%);Ribosomal protein S5 domain 2-type fold, subgroup (86%),,,,,,,,,,
FVLDFEDMNENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDESDAAER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YYFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.12 (31%);2.7.7.7 (13%);3.1.11.5 (7%),tRNA pseudouridine(38-40) synthase (31%);DNA-directed DNA polymerase (13%);Exodeoxyribonuclease V (7%),GO:0016021 (29%);GO:0005886 (6%);GO:0005737 (3%),integral component of membrane (29%);plasma membrane (6%);cytoplasm (3%),GO:0003676 (25%);GO:0003677 (10%);GO:0003723 (9%),nucleic acid binding (25%);DNA binding (10%);RNA binding (9%),GO:0015074 (27%);GO:0001522 (8%);GO:0006260 (4%),DNA integration (27%);pseudouridine synthesis (8%);DNA replication (4%),IPR012337 (19%);IPR001584 (19%);IPR019853 (18%),Ribonuclease H-like superfamily (19%);Integrase, catalytic core (19%);Gliding motility-associated lipoprotein, GldB (18%),,,,,,,,,
QAPTALAYMRPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLYWMAEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASHDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (16%);2.7.13.3 (8%);1.1.1.169 (6%),Type I site-specific deoxyribonuclease (16%);Histidine kinase (8%);2-dehydropantoate 2-reductase (6%),GO:0016021 (28%);GO:0016020 (3%);GO:0042597 (3%),integral component of membrane (28%);membrane (3%);periplasmic space (3%),GO:0005524 (14%);GO:0003677 (12%);GO:0003676 (4%),ATP binding (14%);DNA binding (12%);nucleic acid binding (4%),GO:0006807 (4%);GO:0055085 (4%);GO:0009307 (3%),nitrogen compound metabolic process (4%);transmembrane transport (4%);DNA restriction-modification system (3%),IPR008862 (9%);IPR027417 (6%);IPR000914 (4%),T-complex 11 (9%);P-loop containing nucleoside triphosphate hydrolase (6%);Solute-binding protein family 5 domain (4%),,,,,,,,,,,
VLASNHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.63 (100%),Methylated-DNA--[protein]-cysteine S-methyltransferase (100%),GO:0016021 (50%);GO:0005737 (25%);GO:0030256 (25%),integral component of membrane (50%);cytoplasm (25%);type I protein secretion system complex (25%),GO:0003908 (25%);GO:0005524 (25%);GO:0016491 (25%),methylated-DNA-[protein]-cysteine S-methyltransferase activity (25%);ATP binding (25%);oxidoreductase activity (25%),GO:0006307 (25%);GO:0030253 (25%);GO:0032259 (25%),DNA dealkylation involved in DNA repair (25%);protein secretion by the type I secretion system (25%);methylation (25%),IPR001497 (25%);IPR003864 (25%);IPR010128 (25%),Methylated-DNA-[protein]-cysteine S-methyltransferase, active site (25%);Calcium-dependent channel, 7TM region, putative phosphate (25%);ATPase, type I secretion system, PrtD (25%),,,,,,
MWTVVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR010434 (73%);IPR008538 (18%);IPR011335 (18%),Protein of unknown function DUF1033 (73%);Domain of unknown function DUF820 (18%);Restriction endonuclease  type II-like (18%),,,,,,,,,,,
YLGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.4 (18%);4.2.1.136 (14%);3.6.4.- (12%),D-alanine--D-alanine ligase (18%);ADP-dependent NAD(P)H-hydrate dehydratase (14%);Acting on ATP; involved in cellular and subcellular movement (12%),GO:0016021 (36%);GO:0005737 (8%);GO:0015935 (4%),integral component of membrane (36%);cytoplasm (8%);small ribosomal subunit (4%),GO:0005524 (18%);GO:0016705 (13%);GO:0019843 (7%),ATP binding (18%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (13%);rRNA binding (7%),GO:0006412 (7%);GO:0005975 (4%);GO:0006355 (3%),translation (7%);carbohydrate metabolic process (4%);regulation of transcription, DNA-templated (3%),IPR036661 (13%);IPR011251 (13%);IPR019949 (13%),Luciferase-like domain superfamily (13%);Luciferase-like domain (13%);Luciferase family oxidoreductase, group 1 (13%),,,,,,,
ETSVGHC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MELPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.9 (13%);3.6.4.- (12%);2.4.1.21 (10%),Valine--tRNA ligase (13%);Acting on ATP; involved in cellular and subcellular movement (12%);Starch synthase (10%),GO:0016021 (28%);GO:0005737 (10%);GO:0005886 (4%),integral component of membrane (28%);cytoplasm (10%);plasma membrane (4%),GO:0005524 (21%);GO:0003677 (8%);GO:0004674 (7%),ATP binding (21%);DNA binding (8%);protein serine/threonine kinase activity (7%),GO:0051262 (4%);GO:0006355 (3%);GO:0006438 (3%),protein tetramerization (4%);regulation of transcription, DNA-templated (3%);valyl-tRNA aminoacylation (3%),IPR014729 (8%);IPR027417 (7%);IPR011009 (7%),Rossmann-like alpha/beta/alpha sandwich fold (8%);P-loop containing nucleoside triphosphate hydrolase (7%);Protein kinase-like domain superfamily (7%),,,,,,,,,,
AAGLSNLSNCYEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQEPNAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFYFGDEAEEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYNSER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (64%);3.2.1.78 (10%);3.1.4.4 (8%),DNA-directed RNA polymerase (64%);Mannan endo-1,4-beta-mannosidase (10%);Phospholipase D (8%),GO:0016021 (10%);GO:0005737 (1%);GO:0005634 (1%),integral component of membrane (10%);cytoplasm (1%);nucleus (1%),GO:0003677 (22%);GO:0004630 (17%);GO:0035091 (17%),DNA binding (22%);phospholipase D activity (17%);phosphatidylinositol binding (17%),GO:0006654 (17%);GO:0048017 (17%);GO:0006351 (16%),phosphatidic acid biosynthetic process (17%);inositol lipid-mediated signaling (17%);transcription, DNA-templated (16%),IPR011990 (21%);IPR005112 (20%);IPR037516 (20%),Tetratricopeptide-like helical domain superfamily (21%);dDENN domain (20%);Tripartite DENN domain (20%),,,,,,,,,
EAQELC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLVFATAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYSMFHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VHMHDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (90%);GO:0005681 (10%),integral component of membrane (90%);spliceosomal complex (10%),,,GO:0000398 (10%),mRNA splicing, via spliceosome (10%),IPR026300 (100%);IPR027417 (100%);IPR032174 (100%),CWF11 family (100%);P-loop containing nucleoside triphosphate hydrolase (100%);Intron-binding protein aquarius, N-terminal (100%),,,,,,,,,
GLTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.1 (9%);2.7.1.40 (9%);3.2.2.- (8%),Amino-acid N-acetyltransferase (9%);Pyruvate kinase (9%);Hydrolyzing N-glycosyl compounds (8%),GO:0016021 (31%);GO:0005737 (10%);GO:0005623 (5%),integral component of membrane (31%);cytoplasm (10%);cell (5%),GO:0005524 (11%);GO:0003677 (10%);GO:0022857 (10%),ATP binding (11%);DNA binding (10%);transmembrane transporter activity (10%),GO:0006879 (5%);GO:0006396 (3%);GO:0010040 (3%),cellular iron ion homeostasis (5%);RNA processing (3%);response to iron(II) ion (3%),IPR023395 (10%);IPR018108 (10%);IPR002067 (7%),Mitochondrial carrier domain superfamily (10%);Mitochondrial substrate/solute carrier (10%);Mitochondrial carrier protein (7%),,,,,,,,,,,
DALASNPASR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHNGNTLDDGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MANPGSLVDVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVDEEWGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CSLPWLDNGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDLSTSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0003677 (75%);GO:0003968 (25%),DNA binding (75%);RNA-directed 5'-3' RNA polymerase activity (25%),,,IPR018873 (44%);IPR001173 (11%);IPR001387 (11%),KilA-N, DNA-binding domain (44%);Glycosyltransferase 2-like (11%);Cro/C1-type helix-turn-helix domain (11%),,,,,,,,,,
TVAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.166 (21%);3.2.1.3 (10%);2.7.7.59 (4%),23S rRNA (uridine(2552)-2'-O)-methyltransferase (21%);Glucan 1,4-alpha-glucosidase (10%);[Protein-PII] uridylyltransferase (4%),GO:0016021 (23%);GO:0005737 (8%);GO:0005886 (3%),integral component of membrane (23%);cytoplasm (8%);plasma membrane (3%),GO:0005524 (12%);GO:0003677 (10%);GO:0046872 (5%),ATP binding (12%);DNA binding (10%);metal ion binding (5%),GO:0005975 (4%);GO:0015833 (3%);GO:0032259 (3%),carbohydrate metabolic process (4%);peptide transport (3%);methylation (3%),IPR027417 (10%);IPR029063 (8%);IPR036388 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);S-adenosyl-L-methionine-dependent methyltransferase (8%);Winged helix-like DNA-binding domain superfamily (6%),,,,,,,,,,
QMVFGTK,Graphocephala atropunctata,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Hemiptera,Auchenorrhyncha,Cicadomorpha,,Membracoidea,Cicadellidae,Cicadellinae,Cicadellini,,Graphocephala,,,,Graphocephala atropunctata,,,,,,,,,,,,IPR010512 (100%),Protein of unknown function DUF1091 (100%),,,,,,,,,,,
HVVFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.1 (99%);2.7.11.14 (1%);5.2.1.8 (1%),Phosphoribosylformylglycinamidine cyclo-ligase (99%);Rhodopsin kinase (1%);Peptidylprolyl isomerase (1%),GO:0005737 (83%);GO:0005840 (7%);GO:0016021 (4%),cytoplasm (83%);ribosome (7%);integral component of membrane (4%),GO:0004641 (85%);GO:0005524 (84%);GO:0019843 (7%),phosphoribosylformylglycinamidine cyclo-ligase activity (85%);ATP binding (84%);rRNA binding (7%),GO:0006189 (83%);GO:0006412 (7%);GO:0022904 (2%),'de novo' IMP biosynthetic process (83%);translation (7%);respiratory electron transport chain (2%),IPR004733 (81%);IPR010918 (81%);IPR016188 (81%),Phosphoribosylformylglycinamidine cyclo-ligase (81%);PurM-like, C-terminal domain (81%);PurM-like, N-terminal domain (81%),,,,,,,,,
WLHTSMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEMVN,Oceanobacillus caeni,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Bacillaceae,,,,Oceanobacillus,,,,Oceanobacillus caeni,,,,3.5.1.2 (100%);4.3.3.6 (100%),Glutaminase (100%);Pyridoxal 5'-phosphate synthase (glutamine hydrolyzing) (100%),,,GO:0004359 (100%);GO:0016740 (100%);GO:0036381 (100%),glutaminase activity (100%);transferase activity (100%);pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity (100%),GO:0006543 (100%);GO:0042823 (100%),glutamine catabolic process (100%);pyridoxal phosphate biosynthetic process (100%),IPR002161 (100%);IPR021196 (100%);IPR029062 (100%),Pyridoxal 5'-phosphate synthase subunit PdxT/SNO (100%);PdxT/SNO family, conserved site (100%);Class I glutamine amidotransferase-like (100%),,,,,,,,,,
DWETK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.176 (16%);2.7.1.11 (14%);6.1.1.3 (11%),16S rRNA (cytosine(967)-C(5))-methyltransferase (16%);6-phosphofructokinase (14%);Threonine--tRNA ligase (11%),GO:0005737 (19%);GO:0016021 (12%);GO:0005759 (6%),cytoplasm (19%);integral component of membrane (12%);mitochondrial matrix (6%),GO:0005524 (19%);GO:0050662 (18%);GO:0003824 (15%),ATP binding (19%);coenzyme binding (18%);catalytic activity (15%),GO:0006355 (10%);GO:0032981 (5%);GO:0007623 (4%),regulation of transcription, DNA-templated (10%);mitochondrial respiratory chain complex I assembly (5%);circadian rhythm (4%),IPR036291 (23%);IPR001509 (14%);IPR027417 (12%),NAD(P)-binding domain superfamily (23%);NAD-dependent epimerase/dehydratase (14%);P-loop containing nucleoside triphosphate hydrolase (12%),,,,,,,,,,
HVMDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.1 (43%);1.11.1.15 (9%);2.3.1.180 (6%),Ribulose-phosphate 3-epimerase (43%);Peroxiredoxin (9%);Beta-ketoacyl-[acyl-carrier-protein] synthase III (6%),GO:0016021 (12%);GO:0005623 (7%);GO:0005634 (3%),integral component of membrane (12%);cell (7%);nucleus (3%),GO:0020037 (18%);GO:0051537 (17%);GO:0008942 (17%),heme binding (18%);2 iron, 2 sulfur cluster binding (17%);nitrite reductase [NAD(P)H] activity (17%),GO:0006633 (12%);GO:0005975 (12%);GO:0006098 (11%),fatty acid biosynthetic process (12%);carbohydrate metabolic process (12%);pentose-phosphate shunt (11%),IPR036188 (17%);IPR023753 (16%);IPR005117 (15%),FAD/NAD(P)-binding domain superfamily (17%);FAD/NAD(P)-binding domain (16%);Nitrite/Sulfite reductase ferredoxin-like domain (15%),,,,,,,,,,
DVPLMMK,Clostridium,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Clostridiaceae,,,,Clostridium,,,,,,,,,,,,,,,,IPR003812 (100%);IPR036597 (100%);IPR040198 (100%),Fido domain (100%);Fido-like domain superfamily (100%);Fido domain-containing protein (100%),,,,,,,,,,,
NFNTVFK,Pedobacter,Bacteria,,,,Bacteroidetes,,,Sphingobacteriia,,,,Sphingobacteriales,,,,,Sphingobacteriaceae,,,,Pedobacter,,,,,,,,,,,,,,,,IPR001130 (100%);IPR032466 (100%),TatD family (100%);Metal-dependent hydrolase (100%),,,,,,,,,,,
FLAHFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (17%),integral component of membrane (17%),GO:0004644 (83%);GO:0022857 (17%),phosphoribosylglycinamide formyltransferase activity (83%);transmembrane transporter activity (17%),GO:0006189 (83%),'de novo' IMP biosynthetic process (83%),IPR001555 (83%);IPR002376 (83%);IPR004607 (83%),Phosphoribosylglycinamide formyltransferase, active site (83%);Formyl transferase, N-terminal (83%);Phosphoribosylglycinamide formyltransferase (83%),,,,,,,,,
NLVNYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.180 (17%);2.1.1.- (8%);2.1.1.177 (8%),FAD:protein FMN transferase (17%);Methyltransferases (8%);23S rRNA (pseudouridine(1915)-N(3))-methyltransferase (8%),GO:0005886 (16%);GO:0016021 (16%);GO:0005623 (15%),plasma membrane (16%);integral component of membrane (16%);cell (15%),GO:0003779 (15%);GO:0005198 (15%);GO:0003677 (14%),actin binding (15%);structural molecule activity (15%);DNA binding (14%),GO:0001558 (15%);GO:0007016 (15%);GO:0030866 (15%),regulation of cell growth (15%);cytoskeletal anchoring at plasma membrane (15%);cortical actin cytoskeleton organization (15%),IPR000299 (14%);IPR000798 (14%);IPR007477 (14%),FERM domain (14%);Ezrin/radixin/moesin-like (14%);SAB domain (14%),,,,,,,,,,,
EPLNNAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR011009 (100%),Protein kinase-like domain superfamily (100%),,,,,,,,,,,
TTEWQAPGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNWMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (85%);GO:0016021 (8%),cell (85%);integral component of membrane (8%),GO:0008199 (85%);GO:0016722 (85%);GO:0003677 (31%),ferric iron binding (85%);oxidoreductase activity, oxidizing metal ions (85%);DNA binding (31%),GO:0006879 (85%);GO:0007165 (8%);GO:0009052 (8%),cellular iron ion homeostasis (85%);signal transduction (8%);pentose-phosphate shunt, non-oxidative branch (8%),IPR002177 (85%);IPR008331 (85%);IPR009078 (85%),DNA-binding protein Dps (85%);Ferritin/DPS protein domain (85%);Ferritin-like superfamily (85%),,,,,,,,,
QTPMSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VQAGMTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DENYPDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMHLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.99.3 (50%);2.3.2.2 (25%);4.1.1.31 (25%),NADH dehydrogenase (50%);Gamma-glutamyltransferase (25%);Phosphoenolpyruvate carboxylase (25%),GO:0016021 (22%);GO:0005886 (9%);GO:0005882 (4%),integral component of membrane (22%);plasma membrane (9%);intermediate filament (4%),GO:0016491 (26%);GO:0003954 (9%);GO:0022857 (9%),oxidoreductase activity (26%);NADH dehydrogenase activity (9%);transmembrane transporter activity (9%),GO:0006751 (9%);GO:0009306 (9%);GO:0006099 (4%),glutathione catabolic process (9%);protein secretion (9%);tricarboxylic acid cycle (4%),IPR023753 (31%);IPR036188 (31%);IPR011989 (12%),FAD/NAD(P)-binding domain (31%);FAD/NAD(P)-binding domain superfamily (31%);Armadillo-like helical (12%),,,,,,,,,,,
HLYWMLAGLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GQLVDETMSHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLLVVM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMEEVER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.6.1 (100%),Arylsulfatase (type I) (100%),GO:0016021 (67%);GO:0005615 (33%);GO:0005764 (33%),integral component of membrane (67%);extracellular space (33%);lysosome (33%),GO:0004065 (33%);GO:0004197 (33%);GO:0004423 (33%),arylsulfatase activity (33%);cysteine-type endopeptidase activity (33%);iduronate-2-sulfatase activity (33%),GO:0006955 (33%);GO:0051603 (33%),immune response (33%);proteolysis involved in cellular protein catabolic process (33%),IPR000169 (33%);IPR000668 (33%);IPR003961 (33%),Cysteine peptidase, cysteine active site (33%);Peptidase C1A, papain C-terminal (33%);Fibronectin type III (33%),,,,,,,,,
TMQGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.22 (67%);1.2.4.2 (33%),UDP-glucose 6-dehydrogenase (67%);Oxoglutarate dehydrogenase (succinyl-transferring) (33%),GO:0005856 (25%),cytoskeleton (25%),GO:0003979 (50%);GO:0051287 (50%);GO:0004591 (25%),UDP-glucose 6-dehydrogenase activity (50%);NAD binding (50%);oxoglutarate dehydrogenase (succinyl-transferring) activity (25%),GO:0000271 (50%);GO:0007165 (25%),polysaccharide biosynthetic process (50%);signal transduction (25%),IPR001732 (33%);IPR008927 (33%);IPR014026 (33%),UDP-glucose/GDP-mannose dehydrogenase, N-terminal (33%);6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily (33%);UDP-glucose/GDP-mannose dehydrogenase, dimerisation (33%),,,,,,,,
NLHSASK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.31 (100%),Adenine glycosylase (100%),GO:0005634 (17%),nucleus (17%),GO:0003677 (50%);GO:0016740 (33%);GO:0019104 (33%),DNA binding (50%);transferase activity (33%);DNA N-glycosylase activity (33%),GO:0006284 (33%);GO:0006351 (17%);GO:0006629 (17%),base-excision repair (33%);transcription, DNA-templated (17%);lipid metabolic process (17%),IPR000445 (25%);IPR001173 (25%);IPR003265 (25%),Helix-hairpin-helix motif (25%);Glycosyltransferase 2-like (25%);HhH-GPD domain (25%),,,,,,,,,,
WHTLCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0016787 (33%),hydrolase activity (33%),,,IPR001279 (100%);IPR036866 (100%),Metallo-beta-lactamase (100%);Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (100%),,,,,,,,,,,
TGLWNPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GFNTVLCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EASNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.7.1 (20%);1.2.7.- (10%);2.4.1.13 (6%),Pyruvate synthase (20%);With an iron-sulfur protein as acceptor (10%);Sucrose synthase (6%),GO:0016021 (18%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (18%);cytoplasm (5%);plasma membrane (4%),GO:0005506 (14%);GO:0051539 (13%);GO:0030976 (13%),iron ion binding (14%);4 iron, 4 sulfur cluster binding (13%);thiamine pyrophosphate binding (13%),GO:0022900 (14%);GO:0007165 (6%);GO:0046856 (5%),electron transport chain (14%);signal transduction (6%);phosphatidylinositol dephosphorylation (5%),IPR017896 (13%);IPR029061 (12%);IPR017900 (12%),4Fe-4S ferredoxin-type, iron-sulphur binding domain (13%);Thiamin diphosphate-binding fold (12%);4Fe-4S ferredoxin, iron-sulphur binding, conserved site (12%),,,,,,,
EAQMDVK,Phycisphaerae bacterium,Bacteria,,,,Planctomycetes,,,Phycisphaerae,,,,,,,,,,,,,,,,,Phycisphaerae bacterium,,,,,,,,,,,,,,,,,,,,,,,,
EPHPELVYPPQQWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVEPLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.-.-.- (24%);2.1.1.- (12%);3.6.4.13 (12%),Lyases (24%);Methyltransferases (12%);RNA helicase (12%),GO:0016021 (20%);GO:0005886 (1%);GO:0005623 (1%),integral component of membrane (20%);plasma membrane (1%);cell (1%),GO:0016829 (37%);GO:0003677 (15%);GO:0003700 (12%),lyase activity (37%);DNA binding (15%);DNA-binding transcription factor activity (12%),GO:0009307 (3%);GO:0006261 (1%);GO:0002098 (1%),DNA restriction-modification system (3%);DNA-dependent DNA replication (1%);tRNA wobble uridine modification (1%),IPR016024 (56%);IPR004155 (55%);IPR011989 (43%),Armadillo-type fold (56%);PBS lyase HEAT-like repeat (55%);Armadillo-like helical (43%),,,,,,,,,,,
HMSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (21%);7.-.-.- (21%);2.1.1.72 (11%),Non-specific serine/threonine protein kinase (21%);Translocases (21%);Site-specific DNA-methyltransferase (adenine-specific) (11%),GO:0005634 (73%);GO:0005886 (10%);GO:0005737 (8%),nucleus (73%);plasma membrane (10%);cytoplasm (8%),GO:0005496 (66%);GO:0008270 (65%);GO:0030284 (62%),steroid binding (66%);zinc ion binding (65%);estrogen receptor activity (62%),GO:0006355 (12%);GO:0030520 (10%);GO:0071392 (9%),regulation of transcription, DNA-templated (12%);intracellular estrogen receptor signaling pathway (10%);cellular response to estradiol stimulus (9%),IPR035500 (79%);IPR000536 (78%);IPR001723 (74%),Nuclear hormone receptor-like domain superfamily (79%);Nuclear hormone receptor, ligand-binding domain (78%);Nuclear hormone receptor (74%),,,,,,,,,
GPLWPSGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDPTYQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.- (100%),Endodeoxyribonucleases producing 5'-phosphomonoesters (100%),GO:0016021 (73%),integral component of membrane (73%),GO:0016787 (18%);GO:0004518 (9%),hydrolase activity (18%);nuclease activity (9%),,,IPR007346 (100%),Endonuclease I (100%),,,,,,,,,,,
LMWSDATYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAMNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.17 (26%);3.6.5.0 (9%);2.3.2.27 (7%),Enoyl-CoA hydratase (26%); (9%);RING-type E3 ubiquitin transferase (7%),GO:0005737 (43%);GO:0016021 (9%);GO:0005886 (3%),cytoplasm (43%);integral component of membrane (9%);plasma membrane (3%),GO:0003677 (50%);GO:0016987 (44%);GO:0003700 (44%),DNA binding (50%);sigma factor activity (44%);DNA-binding transcription factor activity (44%),GO:0001123 (42%);GO:0009408 (42%);GO:0006355 (4%),transcription initiation from bacterial-type RNA polymerase promoter (42%);response to heat (42%);regulation of transcription, DNA-templated (4%),IPR007630 (41%);IPR013324 (41%);IPR000943 (41%),RNA polymerase sigma-70 region 4 (41%);RNA polymerase sigma factor, region 3/4-like (41%);RNA polymerase sigma-70 (41%),,,,,,,,,
MFMNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.54 (13%);2.8.1.13 (13%);2.1.1.163 (8%),Formate C-acetyltransferase (13%);tRNA-uridine 2-sulfurtransferase (13%);Demethylmenaquinone methyltransferase (8%),GO:0016021 (40%);GO:0005737 (7%);GO:0009279 (5%),integral component of membrane (40%);cytoplasm (7%);cell outer membrane (5%),GO:0005524 (10%);GO:0042834 (8%);GO:0003677 (6%),ATP binding (10%);peptidoglycan binding (8%);DNA binding (6%),GO:0055085 (10%);GO:0051301 (6%);GO:0006302 (4%),transmembrane transport (10%);cell division (6%);double-strand break repair (4%),IPR011701 (6%);IPR036259 (6%);IPR007730 (6%),Major facilitator superfamily (6%);MFS transporter superfamily (6%);Sporulation-like domain (6%),,,,,,,,,,,
MVFAVGPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLHTMFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDDHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.32 (18%);2.1.1.74 (8%);2.5.1.61 (6%),L-rhamnose mutarotase (18%);Methylenetetrahydrofolate--tRNA-(uracil(54)-C(5))-methyltransferas(NAD(P)H-oxidizing) (8%);Hydroxymethylbilane synthase (6%),GO:0016021 (18%);GO:0005737 (5%);GO:0005685 (4%),integral component of membrane (18%);cytoplasm (5%);U1 snRNP (4%),GO:0005524 (13%);GO:0046872 (8%);GO:0003677 (7%),ATP binding (13%);metal ion binding (8%);DNA binding (7%),GO:0006098 (7%);GO:0035556 (4%);GO:0000398 (3%),pentose-phosphate shunt (7%);intracellular signal transduction (4%);mRNA splicing, via spliceosome (3%),IPR017686 (13%);IPR026325 (13%);IPR036291 (7%),Phage/plasmid-like protein (13%);Protein of unknown function DUF932 (13%);NAD(P)-binding domain superfamily (7%),,,,,,,,,,
TAMGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.3 (41%);2.3.1.16 (21%);3.6.5.0 (9%),Threonine--tRNA ligase (41%);Acetyl-CoA C-acyltransferase (21%); (9%),GO:0005737 (16%);GO:0016021 (11%);GO:0005886 (4%),cytoplasm (16%);integral component of membrane (11%);plasma membrane (4%),GO:0005524 (27%);GO:0003700 (18%);GO:0003677 (16%),ATP binding (27%);DNA-binding transcription factor activity (18%);DNA binding (16%),GO:0006298 (13%);GO:0006435 (9%);GO:0006635 (5%),mismatch repair (13%);threonyl-tRNA aminoacylation (9%);fatty acid beta-oxidation (5%),IPR036388 (17%);IPR027417 (15%);IPR036390 (15%),Winged helix-like DNA-binding domain superfamily (17%);P-loop containing nucleoside triphosphate hydrolase (15%);Winged helix DNA-binding domain superfamily (15%),,,,,,,,,,,
AHLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.15 (10%);2.7.7.48 (7%);6.1.1.20 (7%),Glutamate decarboxylase (10%);RNA-directed RNA polymerase (7%);Phenylalanine--tRNA ligase (7%),GO:0016021 (25%);GO:0005886 (10%);GO:0005737 (6%),integral component of membrane (25%);plasma membrane (10%);cytoplasm (6%),GO:0003677 (8%);GO:0005524 (8%);GO:0046872 (7%),DNA binding (8%);ATP binding (8%);metal ion binding (7%),GO:0032259 (2%);GO:0006351 (2%);GO:0006536 (2%),methylation (2%);transcription, DNA-templated (2%);glutamate metabolic process (2%),IPR001638 (7%);IPR011990 (5%);IPR027417 (4%),Solute-binding protein  family 3/N-terminal domain of MltF (7%);Tetratricopeptide-like helical domain superfamily (5%);P-loop containing nucleoside triphosphate hydrolase (4%),,,,,,,,,,
ESSLNLCGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPPLPLLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLYSSMFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEPALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.10 (75%);1.1.1.23 (13%);3.1.-.- (13%),Methionine--tRNA ligase (75%);Histidinol dehydrogenase (13%);Acting on ester bonds (13%),GO:0016021 (12%);GO:0005886 (9%);GO:0005737 (6%),integral component of membrane (12%);plasma membrane (9%);cytoplasm (6%),GO:0005524 (25%);GO:0008484 (25%);GO:0046872 (25%),ATP binding (25%);sulfuric ester hydrolase activity (25%);metal ion binding (25%),GO:0055070 (8%);GO:0006431 (7%);GO:0031398 (3%),copper ion homeostasis (8%);methionyl-tRNA aminoacylation (7%);positive regulation of protein ubiquitination (3%),IPR000917 (19%);IPR017850 (19%);IPR024607 (19%),Sulfatase, N-terminal (19%);Alkaline-phosphatase-like, core domain superfamily (19%);Sulfatase, conserved site (19%),,,,,,,,
TMLQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (20%);3.1.-.- (20%);1.4.1.13 (10%),DNA helicase (20%);Acting on ester bonds (20%);Glutamate synthase (NADPH) (10%),GO:0016021 (19%);GO:0005737 (5%);GO:0030694 (4%),integral component of membrane (19%);cytoplasm (5%);bacterial-type flagellum basal body, rod (4%),GO:0008168 (21%);GO:0005524 (15%);GO:0003723 (13%),methyltransferase activity (21%);ATP binding (15%);RNA binding (13%),GO:0032259 (20%);GO:0071973 (5%);GO:0000724 (3%),methylation (20%);bacterial-type flagellum-dependent cell motility (5%);double-strand break repair via homologous recombination (3%),IPR029063 (18%);IPR027417 (18%);IPR023269 (10%),S-adenosyl-L-methionine-dependent methyltransferase (18%);P-loop containing nucleoside triphosphate hydrolase (18%);RNA (C5-cytosine) methyltransferase, subfamily 9 (10%),,,,,,,,,
EEAGGLPWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YYLLHAYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDVTER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.54 (20%);1.-.-.- (10%);2.7.11.1 (10%),3-deoxy-7-phosphoheptulonate synthase (20%);Oxidoreductases (10%);Non-specific serine/threonine protein kinase (10%),GO:0016021 (25%);GO:0005886 (7%);GO:0005737 (5%),integral component of membrane (25%);plasma membrane (7%);cytoplasm (5%),GO:0003924 (25%);GO:0005525 (25%);GO:0046872 (13%),GTPase activity (25%);GTP binding (25%);metal ion binding (13%),GO:0032482 (21%);GO:0035556 (7%);GO:0007049 (5%),Rab protein signal transduction (21%);intracellular signal transduction (7%);cell cycle (5%),IPR027417 (23%);IPR001806 (17%);IPR005225 (17%),P-loop containing nucleoside triphosphate hydrolase (23%);Small GTPase (17%);Small GTP-binding protein domain (17%),,,,,,,,,,,
FALPDWNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDAEHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (67%);2.4.1.129 (7%);2.6.1.- (7%),3-isopropylmalate dehydratase (67%);Peptidoglycan glycosyltransferase (7%);Transaminases (7%),GO:0016021 (10%);GO:0005634 (2%);GO:0005886 (2%),integral component of membrane (10%);nucleus (2%);plasma membrane (2%),GO:0046872 (34%);GO:0016491 (22%);GO:0003861 (17%),metal ion binding (34%);oxidoreductase activity (22%);3-isopropylmalate dehydratase activity (17%),GO:0009098 (17%);GO:0009058 (3%);GO:0035556 (3%),leucine biosynthetic process (17%);biosynthetic process (3%);intracellular signal transduction (3%),IPR001030 (14%);IPR004430 (14%);IPR015931 (14%),Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha domain (14%);3-isopropylmalate dehydratase, large subunit (14%);Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 1/3 (14%),,,,,,,
DPNDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (32%);3.2.1.22 (10%);2.7.11.1 (9%),Transferring other groups (32%);Alpha-galactosidase (10%);Non-specific serine/threonine protein kinase (9%),GO:0016021 (19%);GO:0019031 (6%);GO:0005737 (4%),integral component of membrane (19%);viral envelope (6%);cytoplasm (4%),GO:0005524 (17%);GO:0003700 (16%);GO:0003677 (11%),ATP binding (17%);DNA-binding transcription factor activity (16%);DNA binding (11%),GO:0001522 (5%);GO:0005975 (2%);GO:0006457 (1%),pseudouridine synthesis (5%);carbohydrate metabolic process (2%);protein folding (1%),IPR036388 (16%);IPR036390 (16%);IPR000835 (15%),Winged helix-like DNA-binding domain superfamily (16%);Winged helix DNA-binding domain superfamily (16%);MarR-type HTH domain (15%),,,,,,,,,,,
GMMSLVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEGTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.13 (26%);1.2.1.88 (14%);1.5.5.2 (14%),Glutamate synthase (NADPH) (26%);L-glutamate gamma-semialdehyde dehydrogenase (14%);Proline dehydrogenase (14%),GO:0016021 (20%);GO:0005737 (7%);GO:0005634 (2%),integral component of membrane (20%);cytoplasm (7%);nucleus (2%),GO:0051536 (18%);GO:0003700 (15%);GO:0005524 (11%),iron-sulfur cluster binding (18%);DNA-binding transcription factor activity (15%);ATP binding (11%),GO:0006537 (18%);GO:0010133 (4%);GO:0006561 (3%),glutamate biosynthetic process (18%);proline catabolic process to glutamate (4%);proline biosynthetic process (3%),IPR036188 (17%);IPR023753 (17%);IPR009051 (17%),FAD/NAD(P)-binding domain superfamily (17%);FAD/NAD(P)-binding domain (17%);Alpha-helical ferredoxin (17%),,,,,,,,,,,
SQGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (39%);1.3.1.9 (10%);1.11.1.- (8%),DNA helicase (39%);Enoyl-[acyl-carrier-protein] reductase (NADH) (10%);Peroxidases (8%),GO:0016021 (25%);GO:0005737 (11%);GO:0005886 (5%),integral component of membrane (25%);cytoplasm (11%);plasma membrane (5%),GO:0005524 (20%);GO:0003677 (11%);GO:0003678 (9%),ATP binding (20%);DNA binding (11%);DNA helicase activity (9%),GO:0006268 (7%);GO:0055085 (6%);GO:0006979 (3%),DNA unwinding involved in DNA replication (7%);transmembrane transport (6%);response to oxidative stress (3%),IPR027417 (12%);IPR036322 (10%);IPR001680 (9%),P-loop containing nucleoside triphosphate hydrolase (12%);WD40-repeat-containing domain superfamily (10%);WD40 repeat (9%),,,,,,,,,,,
DAEDGPCNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (26%);3.1.-.- (23%);6.3.4.18 (16%),RNA-directed RNA polymerase (26%);Acting on ester bonds (23%);5-(carboxyamino)imidazole ribonucleotide synthase (16%),GO:0016021 (23%);GO:0019012 (7%);GO:0030430 (7%),integral component of membrane (23%);virion (7%);host cell cytoplasm (7%),GO:0005524 (23%);GO:0046872 (10%);GO:0000166 (10%),ATP binding (23%);metal ion binding (10%);nucleotide binding (10%),GO:0006189 (7%);GO:0039689 (6%);GO:0075526 (6%),'de novo' IMP biosynthetic process (7%);negative stranded viral RNA replication (6%);cap snatching (6%),IPR027417 (15%);IPR007099 (7%);IPR010453 (7%),P-loop containing nucleoside triphosphate hydrolase (15%);RNA-directed RNA polymerase, negative-strand RNA virus (7%);RNA polymerase, arenaviral (7%),,,,,,,,,
YLQQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.41 (8%);6.1.1.6 (7%);2.7.7.- (5%),Beta-ketoacyl-[acyl-carrier-protein] synthase I (8%);Lysine--tRNA ligase (7%);Nucleotidyltransferases (5%),GO:0016021 (22%);GO:0005737 (7%);GO:0005886 (4%),integral component of membrane (22%);cytoplasm (7%);plasma membrane (4%),GO:0005524 (17%);GO:0031177 (12%);GO:0016788 (12%),ATP binding (17%);phosphopantetheine binding (12%);hydrolase activity, acting on ester bonds (12%),GO:0009058 (12%);GO:0055085 (3%);GO:0007399 (2%),biosynthetic process (12%);transmembrane transport (3%);nervous system development (2%),IPR029063 (12%);IPR027417 (11%);IPR029058 (11%),S-adenosyl-L-methionine-dependent methyltransferase (12%);P-loop containing nucleoside triphosphate hydrolase (11%);Alpha/Beta hydrolase fold (11%),,,,,,,,,,
CVDLQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.3 (50%);3.1.13.1 (50%),Glycerol-3-phosphate dehydrogenase (50%);Exoribonuclease II (50%),GO:0016021 (31%);GO:0005737 (6%);GO:0009331 (4%),integral component of membrane (31%);cytoplasm (6%);glycerol-3-phosphate dehydrogenase complex (4%),GO:0008080 (19%);GO:0016491 (10%);GO:0000155 (4%),N-acetyltransferase activity (19%);oxidoreductase activity (10%);phosphorelay sensor kinase activity (4%),GO:0006072 (4%);GO:0006307 (4%);GO:0006336 (4%),glycerol-3-phosphate metabolic process (4%);DNA dealkylation involved in DNA repair (4%);DNA replication-independent nucleosome assembly (4%),IPR011990 (25%);IPR024983 (23%);IPR027383 (23%),Tetratricopeptide-like helical domain superfamily (25%);CHAT domain (23%);Putative zinc-finger (23%),,,,,,,,,,,
WHDQCYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGYSMMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYMWTPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (17%);5.2.1.8 (11%);3.1.4.- (8%),DNA-directed RNA polymerase (17%);Peptidylprolyl isomerase (11%);Phosphoric diester hydrolases (8%),GO:0016021 (24%);GO:0005634 (5%);GO:0005737 (4%),integral component of membrane (24%);nucleus (5%);cytoplasm (4%),GO:0003677 (16%);GO:0005524 (9%);GO:0005525 (5%),DNA binding (16%);ATP binding (9%);GTP binding (5%),GO:0006355 (5%);GO:0006289 (4%);GO:0006351 (4%),regulation of transcription, DNA-templated (5%);nucleotide-excision repair (4%);transcription, DNA-templated (4%),IPR027417 (9%);IPR004343 (5%);IPR036128 (5%),P-loop containing nucleoside triphosphate hydrolase (9%);Plus-3 domain (5%);Plus3-like superfamily (5%),,,,,,,,,
VLMSDLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWFLLMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNMLMFLTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LWYGQDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMVYLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016592 (67%),mediator complex (67%),GO:0003712 (67%);GO:0016849 (33%);GO:0042802 (33%),transcription coregulator activity (67%);phosphorus-oxygen lyase activity (33%);identical protein binding (33%),GO:0006357 (67%);GO:0009190 (33%);GO:0035556 (33%),regulation of transcription by RNA polymerase II (67%);cyclic nucleotide biosynthetic process (33%);intracellular signal transduction (33%),IPR014801 (50%);IPR027417 (50%);IPR001054 (25%),Mediator complex, subunit Med5, fungi (50%);P-loop containing nucleoside triphosphate hydrolase (50%);Adenylyl cyclase class-3/4/guanylyl cyclase (25%),,,,,,,,,
LDEPNVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TALRPSPK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004725 (50%);GO:0008138 (50%);GO:0046983 (50%),protein tyrosine phosphatase activity (50%);protein tyrosine/serine/threonine phosphatase activity (50%);protein dimerization activity (50%),,,IPR000340 (50%);IPR000387 (50%);IPR016130 (50%),Dual specificity phosphatase, catalytic domain (50%);Tyrosine specific protein phosphatases domain (50%);Protein-tyrosine phosphatase, active site (50%),,,,,,,,,
HAQFSNNQMDVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GHTVLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (33%),membrane (33%),GO:0016740 (67%),transferase activity (67%),GO:0015031 (33%),protein transport (33%),IPR001173 (67%);IPR011990 (67%);IPR029044 (67%),Glycosyltransferase 2-like (67%);Tetratricopeptide-like helical domain superfamily (67%);Nucleotide-diphospho-sugar transferases (67%),,,,,,,,,,,
QNLAVATNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYFYVMVSGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALDVVLSFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QASTHGSYAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLWMMLLR,Acinetobacter guillouiae,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Pseudomonadales,,,,,Moraxellaceae,,,,Acinetobacter,,,,Acinetobacter guillouiae,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%);GO:0016887 (100%);GO:0042626 (100%),ATP binding (100%);ATPase activity (100%);ATPase-coupled transmembrane transporter activity (100%),,,IPR003439 (100%);IPR003593 (100%);IPR011527 (100%),ABC transporter-like (100%);AAA+ ATPase domain (100%);ABC transporter type 1, transmembrane domain (100%),,,,,,,,,,
VPYHHMAMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLWYALAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVEYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.18 (67%);2.3.2.29 (5%);2.7.8.- (4%),Exo-alpha-sialidase (67%);Aspartate/glutamate leucyltransferase (5%);Transferases for other substituted phosphate groups (4%),GO:0016021 (50%);GO:0020002 (27%);GO:0055036 (27%),integral component of membrane (50%);host cell plasma membrane (27%);virion membrane (27%),GO:0046872 (31%);GO:0052794 (27%);GO:0052795 (27%),metal ion binding (31%);exo-alpha-(2->3)-sialidase activity (27%);exo-alpha-(2->6)-sialidase activity (27%),GO:0005975 (29%);GO:0046761 (26%);GO:0006352 (3%),carbohydrate metabolic process (29%);viral budding from plasma membrane (26%);DNA-templated transcription, initiation (3%),IPR036278 (21%);IPR001860 (21%);IPR033654 (20%),Sialidase superfamily (21%);Glycoside hydrolase, family 34 (21%);Sialidase, Influenza viruses A/B (20%),,,,,,,,
TYMTVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.96 (100%),Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (100%),GO:0071014 (40%);GO:0005684 (20%);GO:0016021 (20%),post-mRNA release spliceosomal complex (40%);U2-type spliceosomal complex (20%);integral component of membrane (20%),GO:0003676 (40%);GO:0005524 (40%);GO:0003724 (20%),nucleic acid binding (40%);ATP binding (40%);RNA helicase activity (20%),GO:0000390 (40%);GO:0000462 (20%);GO:0000463 (20%),spliceosomal complex disassembly (40%);maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (20%);maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (20%),IPR013783 (53%);IPR036116 (26%);IPR001650 (11%),Immunoglobulin-like fold (53%);Fibronectin type III superfamily (26%);Helicase, C-terminal (11%),,,,,,
YSSLFDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),GO:0016021 (40%);GO:0005739 (20%),integral component of membrane (40%);mitochondrion (20%),GO:0003677 (40%);GO:0003899 (20%);GO:0008168 (20%),DNA binding (40%);DNA-directed 5'-3' RNA polymerase activity (20%);methyltransferase activity (20%),GO:0006304 (20%);GO:0006351 (20%);GO:0007165 (20%),DNA modification (20%);transcription, DNA-templated (20%);signal transduction (20%),IPR018635 (40%);IPR000198 (20%);IPR001251 (20%),Uncharacterised protein family UPF0319 (40%);Rho GTPase-activating protein domain (20%);CRAL-TRIO lipid binding domain (20%),,,,,,,,,,
GNQNAAEAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NECPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (56%),integral component of membrane (56%),GO:0004674 (33%);GO:0005524 (33%);GO:0046983 (22%),protein serine/threonine kinase activity (33%);ATP binding (33%);protein dimerization activity (22%),GO:0006310 (11%);GO:0007229 (11%);GO:0015074 (11%),DNA recombination (11%);integrin-mediated signaling pathway (11%);DNA integration (11%),IPR001826 (31%);IPR006530 (31%);IPR022385 (31%),RHS protein (31%);YD repeat (31%);Rhs repeat-associated core (31%),,,,,,,,,,,
DLCWLVK,Candidatus Pelagibacter,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Pelagibacterales,,,,,Pelagibacteraceae,,,,Candidatus Pelagibacter,,,,,,,,2.4.1.227 (100%),Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (100%),GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),GO:0050511 (100%);GO:0051991 (100%),undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase activity (100%);UDP-N-acetyl-D-glucosamine:N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine-diphosphoundecaprenol 4-beta-N-acetylglucosaminlytransferase activity (100%),GO:0005975 (100%);GO:0007049 (100%);GO:0008360 (100%),carbohydrate metabolic process (100%);cell cycle (100%);regulation of cell shape (100%),IPR004276 (100%);IPR006009 (100%);IPR007235 (100%),Glycosyltransferase family 28, N-terminal domain (100%);N-acetylglucosaminyltransferase, MurG (100%);Glycosyl transferase, family 28, C-terminal (100%),,,,,,
DHLVGHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMVLMHK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.10 (100%),Methionine--tRNA ligase (100%),GO:0005737 (50%),cytoplasm (50%),GO:0005524 (100%);GO:0046872 (100%);GO:0000049 (50%),ATP binding (100%);metal ion binding (100%);tRNA binding (50%),GO:0006431 (50%),methionyl-tRNA aminoacylation (50%),IPR001412 (50%);IPR002547 (50%);IPR004495 (50%),Aminoacyl-tRNA synthetase, class I, conserved site (50%);tRNA-binding domain (50%);Methionyl-tRNA synthetase, beta subunit, C-terminal (50%),,,,,,,
APLLNMPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TWMLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.85 (100%),Diadenylate cyclase (100%),GO:0016021 (50%);GO:0005886 (25%),integral component of membrane (50%);plasma membrane (25%),GO:0003677 (25%);GO:0003700 (25%);GO:0004016 (25%),DNA binding (25%);DNA-binding transcription factor activity (25%);adenylate cyclase activity (25%),GO:0006171 (25%);GO:0019932 (25%),cAMP biosynthetic process (25%);second-messenger-mediated signaling (25%),IPR000847 (25%);IPR003390 (25%);IPR005119 (25%),Transcription regulator HTH, LysR (25%);DNA integrity scanning protein, DisA, N-terminal (25%);LysR, substrate-binding (25%),,,,,,,
VHVWVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMLDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.- (41%);2.7.7.7 (27%);4.2.2.- (15%),With NAD(+) or NADP(+) as acceptor (41%);DNA-directed DNA polymerase (27%);Acting on polysaccharides (15%),GO:0016021 (7%);GO:0005887 (6%);GO:0043190 (4%),integral component of membrane (7%);integral component of plasma membrane (6%);ATP-binding cassette (ABC) transporter complex (4%),GO:0050660 (32%);GO:0017150 (31%);GO:0003677 (14%),flavin adenine dinucleotide binding (32%);tRNA dihydrouridine synthase activity (31%);DNA binding (14%),GO:0006261 (11%);GO:0006281 (11%);GO:0009252 (6%),DNA-dependent DNA replication (11%);DNA repair (11%);peptidoglycan biosynthetic process (6%),IPR013785 (29%);IPR001269 (26%);IPR035587 (26%),Aldolase-type TIM barrel (29%);tRNA-dihydrouridine synthase (26%);DUS-like, FMN-binding domain (26%),,,,,,,,,,
LNGVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (82%);2.1.2.3 (2%);3.5.4.10 (2%),DNA topoisomerase (ATP-hydrolyzing) (82%);Phosphoribosylaminoimidazolecarboxamide formyltransferase (2%);IMP cyclohydrolase (2%),GO:0005737 (48%);GO:0005694 (44%);GO:0016021 (18%),cytoplasm (48%);chromosome (44%);integral component of membrane (18%),GO:0005524 (55%);GO:0003677 (47%);GO:0003918 (45%),ATP binding (55%);DNA binding (47%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (45%),GO:0006265 (45%);GO:0006261 (44%);GO:0007049 (3%),DNA topological change (45%);DNA-dependent DNA replication (44%);cell cycle (3%),IPR002205 (37%);IPR006691 (37%);IPR013757 (37%),DNA topoisomerase, type IIA, subunit A/C-terminal (37%);DNA gyrase/topoisomerase IV, subunit A, C-terminal repeat (37%);Type IIA DNA topoisomerase subunit A, alpha-helical domain superfamily (37%),,,,,
MLDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.11 (66%);2.5.1.6 (3%);3.2.2.31 (3%),Serine--tRNA ligase (66%);Methionine adenosyltransferase (3%);Adenine glycosylase (3%),GO:0005737 (38%);GO:0016021 (11%);GO:0005886 (2%),cytoplasm (38%);integral component of membrane (11%);plasma membrane (2%),GO:0005524 (50%);GO:0004828 (39%);GO:0003677 (7%),ATP binding (50%);serine-tRNA ligase activity (39%);DNA binding (7%),GO:0006434 (39%);GO:0016260 (29%);GO:0097056 (29%),seryl-tRNA aminoacylation (39%);selenocysteine biosynthetic process (29%);selenocysteinyl-tRNA(Sec) biosynthetic process (29%),IPR010978 (36%);IPR042103 (36%);IPR015866 (36%),Class I and II aminoacyl-tRNA synthetase, tRNA-binding arm (36%);Serine-tRNA synthetase, type1, N-terminal domain superfamily (36%);Serine-tRNA synthetase, type1, N-terminal (36%),,,,,,
LLLHSENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003700 (100%),DNA-binding transcription factor activity (100%),,,IPR001845 (100%);IPR011991 (100%);IPR022651 (100%),HTH ArsR-type DNA-binding domain (100%);ArsR-like helix-turn-helix domain (100%);S-layer protein, C-terminal (100%),,,,,,,,,,
LVQMMLPK,Odoribacter laneus,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Odoribacteraceae,,,,Odoribacter,,,,Odoribacter laneus,,,,,,,,,,GO:0006355 (100%),regulation of transcription, DNA-templated (100%),IPR036735 (100%),NusG, N-terminal domain superfamily (100%),,,,,,,,,
TLTYMPHLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYFAYHVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVSHMSGYLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEPTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (48%);2.7.7.7 (9%);3.1.3.1 (9%),Cytochrome-c oxidase (48%);DNA-directed DNA polymerase (9%);Alkaline phosphatase (9%),GO:0016021 (47%);GO:0045278 (8%);GO:0005634 (4%),integral component of membrane (47%);plasma membrane respiratory chain complex IV (8%);nucleus (4%),GO:0005524 (14%);GO:0046872 (13%);GO:0003677 (11%),ATP binding (14%);metal ion binding (13%);DNA binding (11%),GO:0009060 (9%);GO:0000160 (4%);GO:0006935 (2%),aerobic respiration (9%);phosphorelay signal transduction system (4%);chemotaxis (2%),IPR027417 (14%);IPR000883 (10%);IPR003468 (10%),P-loop containing nucleoside triphosphate hydrolase (14%);Cytochrome c oxidase subunit I (10%);Cytochrome c oxidase, monohaem subunit/FixO (10%),,,,,,,,,,
WMMNFMVSFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGCSPEAAENHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LERPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (39%);1.1.1.3 (21%);6.1.1.19 (18%),DNA ligase (NAD(+)) (39%);Homoserine dehydrogenase (21%);Arginine--tRNA ligase (18%),GO:0005737 (22%);GO:0016021 (16%);GO:0009380 (13%),cytoplasm (22%);integral component of membrane (16%);excinuclease repair complex (13%),GO:0003677 (31%);GO:0005524 (26%);GO:0016887 (14%),DNA binding (31%);ATP binding (26%);ATPase activity (14%),GO:0006289 (13%);GO:0009432 (12%);GO:0006281 (9%),nucleotide-excision repair (13%);SOS response (12%);DNA repair (9%),IPR027417 (17%);IPR017871 (13%);IPR003439 (13%),P-loop containing nucleoside triphosphate hydrolase (17%);ABC transporter, conserved site (13%);ABC transporter-like (13%),,,,,,,,,,
LWDSNGAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFNVETGDAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSALESWHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPSATEVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLHHMPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (46%);2.7.13.3 (6%);6.3.1.20 (4%),DNA helicase (46%);Histidine kinase (6%);Lipoate--protein ligase (4%),GO:0016021 (19%);GO:0009424 (16%);GO:1990077 (8%),integral component of membrane (19%);bacterial-type flagellum hook (16%);primosome complex (8%),GO:0005524 (26%);GO:0003677 (20%);GO:0005198 (16%),ATP binding (26%);DNA binding (20%);structural molecule activity (16%),GO:0044780 (16%);GO:0006269 (8%);GO:0006355 (3%),bacterial-type flagellum assembly (16%);DNA replication, synthesis of RNA primer (8%);regulation of transcription, DNA-templated (3%),IPR027417 (21%);IPR002371 (14%);IPR010930 (14%),P-loop containing nucleoside triphosphate hydrolase (21%);Flagellar hook-associated protein 1 (14%);Flagellar basal-body/hook protein, C-terminal domain (14%),,,,,,,,
LETNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (99%);5.2.1.8 (0%);2.7.7.7 (0%),Acting on ester bonds (99%);Peptidylprolyl isomerase (0%);DNA-directed DNA polymerase (0%),GO:0030430 (61%);GO:0042025 (61%);GO:0016021 (1%),host cell cytoplasm (61%);host cell nucleus (61%);integral component of membrane (1%),GO:0003723 (97%);GO:0046872 (61%);GO:0004519 (61%),RNA binding (97%);metal ion binding (61%);endonuclease activity (61%),GO:0039694 (95%);GO:0039523 (61%);GO:0075526 (61%),viral RNA genome replication (95%);suppression by virus of host RNA polymerase II activity (61%);cap snatching (61%),IPR038372 (95%);IPR001009 (95%);IPR037534 (60%),PA/PA-X superfamily (95%);Influenza RNA-dependent RNA polymerase subunit PA (95%);Polymerase acidic protein (60%),,,,,,,,,,,
FAQFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.6.2.- (18%);2.4.1.18 (17%);2.3.1.- (15%),Linked to the hydrolysis of a nucleoside triphosphate (18%);1,4-alpha-glucan branching enzyme (17%);Transferring groups other than amino-acyl groups (15%),GO:0005737 (41%);GO:0016021 (12%);GO:0045211 (11%),cytoplasm (41%);integral component of membrane (12%);postsynaptic membrane (11%),GO:0046872 (34%);GO:0051539 (30%);GO:0004109 (30%),metal ion binding (34%);4 iron, 4 sulfur cluster binding (30%);coproporphyrinogen oxidase activity (30%),GO:0006779 (30%);GO:0006355 (8%);GO:0005975 (3%),porphyrin-containing compound biosynthetic process (30%);regulation of transcription, DNA-templated (8%);carbohydrate metabolic process (3%),IPR007197 (27%);IPR006638 (26%);IPR023404 (26%),Radical SAM (27%);Elp3/MiaB/NifB (26%);Radical SAM, alpha/beta horseshoe (26%),,,,,,,
MPLPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (14%);2.7.1.36 (14%);4.1.2.- (14%),Transferring groups other than amino-acyl groups (14%);Mevalonate kinase (14%);Aldehyde-lyases (14%),GO:0016021 (44%);GO:0005737 (5%);GO:0005840 (1%),integral component of membrane (44%);cytoplasm (5%);ribosome (1%),GO:0005524 (14%);GO:0046872 (12%);GO:0003677 (8%),ATP binding (14%);metal ion binding (12%);DNA binding (8%),GO:0006412 (4%);GO:0009253 (4%);GO:0006432 (3%),translation (4%);peptidoglycan catabolic process (4%);phenylalanyl-tRNA aminoacylation (3%),IPR001633 (21%);IPR035919 (21%);IPR024744 (13%),EAL domain (21%);EAL domain superfamily (21%);Putative cyclic diguanylate phosphodiesterase, CSS motif-containing domain (13%),,,,,,,,,,
TSVEQAMGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMNMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.4 (18%);2.7.7.7 (13%);5.1.1.- (11%),3-dehydroquinate synthase (18%);DNA-directed DNA polymerase (13%);Acting on amino acids and derivatives (11%),GO:0016021 (17%);GO:0005737 (8%);GO:0005838 (4%),integral component of membrane (17%);cytoplasm (8%);proteasome regulatory particle (4%),GO:0008270 (18%);GO:0004089 (17%);GO:0005524 (13%),zinc ion binding (18%);carbonate dehydratase activity (17%);ATP binding (13%),GO:0006412 (4%);GO:0006260 (3%);GO:0009073 (3%),translation (4%);DNA replication (3%);aromatic amino acid family biosynthetic process (3%),IPR001765 (16%);IPR036874 (16%);IPR011990 (7%),Carbonic anhydrase (16%);Carbonic anhydrase superfamily (16%);Tetratricopeptide-like helical domain superfamily (7%),,,,,,,,,,,
WWLAQMVVGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYLVQTQWPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMLHMYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LWMMATLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGPQAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYSSMDK,Guillardia theta,Eukaryota,,,,,,,Cryptophyceae,,,,Pyrenomonadales,,,,,Geminigeraceae,,,,Guillardia,,,,Guillardia theta,,,,,,GO:0005737 (100%),cytoplasm (100%),GO:0005524 (100%);GO:0051082 (100%),ATP binding (100%);unfolded protein binding (100%),GO:0006457 (100%),protein folding (100%),IPR002194 (100%);IPR002423 (100%);IPR012717 (100%),Chaperonin TCP-1, conserved site (100%);Chaperonin Cpn60/TCP-1 family (100%);T-complex protein 1, delta subunit (100%),,,,,,,,,
FTEFNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.25 (33%);3.2.1.177 (33%);1.14.11.2 (11%),4-alpha-glucanotransferase (33%);Alpha-D-xyloside xylohydrolase (33%);Procollagen-proline 4-dioxygenase (11%),GO:0016021 (24%);GO:0005634 (11%);GO:0000781 (2%),integral component of membrane (24%);nucleus (11%);chromosome, telomeric region (2%),GO:0005524 (27%);GO:0030246 (22%);GO:0003676 (16%),ATP binding (27%);carbohydrate binding (22%);nucleic acid binding (16%),GO:0005975 (22%);GO:0006268 (7%);GO:0007129 (7%),carbohydrate metabolic process (22%);DNA unwinding involved in DNA replication (7%);synapsis (7%),IPR017853 (24%);IPR027417 (24%);IPR000322 (19%),Glycoside hydrolase superfamily (24%);P-loop containing nucleoside triphosphate hydrolase (24%);Glycoside hydrolase family 31 (19%),,,,,,,,,,
NNNEVVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDPQLDTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVLLHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (6%),integral component of membrane (6%),GO:0005506 (65%);GO:0009055 (65%);GO:0003677 (6%),iron ion binding (65%);electron transfer activity (65%);DNA binding (6%),GO:0006313 (6%);GO:0006355 (6%);GO:0008033 (6%),transposition, DNA-mediated (6%);regulation of transcription, DNA-templated (6%);tRNA processing (6%),IPR017896 (77%);IPR001080 (31%);IPR016181 (8%),4Fe-4S ferredoxin-type, iron-sulphur binding domain (77%);3Fe-4S ferredoxin (31%);Acyl-CoA N-acyltransferase (8%),,,,,,,,
TELSEVPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFLLWFMEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLVFPAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.4.3 (50%);3.1.11.6 (50%),tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (50%);Exodeoxyribonuclease VII (50%),GO:0005737 (67%);GO:0009318 (33%);GO:0016021 (17%),cytoplasm (67%);exodeoxyribonuclease VII complex (33%);integral component of membrane (17%),GO:0008855 (33%);GO:0035596 (33%);GO:0046872 (33%),exodeoxyribonuclease VII activity (33%);methylthiotransferase activity (33%);metal ion binding (33%),GO:0006308 (33%);GO:0006400 (33%),DNA catabolic process (33%);tRNA modification (33%),IPR002792 (50%);IPR023404 (50%);IPR003753 (40%),TRAM domain (50%);Radical SAM, alpha/beta horseshoe (50%);Exonuclease VII, large subunit (40%),,,,,,,,,
YPGEMSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFLYYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (100%),Hexosyltransferases (100%),GO:0016021 (30%);GO:0000139 (9%);GO:0005794 (4%),integral component of membrane (30%);Golgi membrane (9%);Golgi apparatus (4%),GO:0003700 (64%);GO:0003677 (13%);GO:0008378 (13%),DNA-binding transcription factor activity (64%);DNA binding (13%);galactosyltransferase activity (13%),GO:0006486 (13%);GO:0006352 (11%);GO:0000160 (4%),protein glycosylation (13%);DNA-templated transcription, initiation (11%);phosphorelay signal transduction system (4%),IPR036388 (56%);IPR036390 (45%);IPR001845 (44%),Winged helix-like DNA-binding domain superfamily (56%);Winged helix DNA-binding domain superfamily (45%);HTH ArsR-type DNA-binding domain (44%),,,,,,,,,,
WFFFMEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVEGLDHR,Xenorhabdus,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Enterobacterales,,,,,Morganellaceae,,,,Xenorhabdus,,,,,,,,,,,,GO:1901515 (100%),poly-beta-1,6-N-acetyl-D-glucosamine transmembrane transporter activity (100%),,,IPR011990 (100%);IPR023870 (100%),Tetratricopeptide-like helical domain superfamily (100%);Poly-beta-1,6 N-acetyl-D-glucosamine export porin PgaA (100%),,,,,,,,,
SMSTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.- (98%);3.1.4.17 (2%),Phosphoric diester hydrolases (98%);3',5'-cyclic-nucleotide phosphodiesterase (2%),GO:0016021 (3%);GO:0000444 (2%);GO:0005615 (2%),integral component of membrane (3%);MIS12/MIND type complex (2%);extracellular space (2%),GO:0046872 (77%);GO:0004114 (72%);GO:0003676 (12%),metal ion binding (77%);3',5'-cyclic-nucleotide phosphodiesterase activity (72%);nucleic acid binding (12%),GO:0007165 (73%);GO:0015074 (5%);GO:0006396 (3%),signal transduction (73%);DNA integration (5%);RNA processing (3%),IPR002073 (65%);IPR003607 (65%);IPR013706 (65%),3'5'-cyclic nucleotide phosphodiesterase, catalytic domain (65%);HD/PDEase domain (65%);3'5'-cyclic nucleotide phosphodiesterase N-terminal (65%),,,,,,,,
LALEDPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.- (36%);2.7.1.180 (36%);2.7.1.33 (9%),With oxygen as acceptor (36%);FAD:protein FMN transferase (36%);Pantothenate kinase (9%),GO:0030288 (31%);GO:0005634 (18%);GO:0016021 (8%),outer membrane-bounded periplasmic space (31%);nucleus (18%);integral component of membrane (8%),GO:0030975 (42%);GO:0000981 (14%);GO:0008270 (14%),thiamine binding (42%);DNA-binding transcription factor activity, RNA polymerase II-specific (14%);zinc ion binding (14%),GO:0015888 (42%);GO:0006355 (6%);GO:0055085 (6%),thiamine transport (42%);regulation of transcription, DNA-templated (6%);transmembrane transport (6%),IPR005948 (39%);IPR005967 (28%);IPR021858 (18%),Thiamine/thiamin pyrophosphate-binding periplasmic protein, ABC transporter (39%);Thiamin/thiamin pyrophosphate ABC transporter, substrate-binding protein, Proteobacteria (28%);Fungal transcription factor (18%),,,,,,
AQEPTHEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGMTVCLLMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQAPPMNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMELDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPLVAGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPFLEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.27 (50%);4.1.3.27 (50%),Uracil-DNA glycosylase (50%);Anthranilate synthase (50%),GO:0005576 (70%);GO:0016021 (9%);GO:0005634 (4%),extracellular region (70%);integral component of membrane (9%);nucleus (4%),GO:0008083 (74%);GO:0004049 (4%);GO:0004181 (4%),growth factor activity (74%);anthranilate synthase activity (4%);metallocarboxypeptidase activity (4%),GO:0000162 (4%);GO:0006284 (4%),tryptophan biosynthetic process (4%);base-excision repair (4%),IPR015615 (74%);IPR001839 (70%);IPR029034 (70%),Transforming growth factor-beta-related (74%);Transforming growth factor-beta, C-terminal (70%);Cystine-knot cytokine (70%),,,,,,,,,,
LSCMHVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMYVCDPHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPAGTYSCYHAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALLGMAPER,Burkholderiaceae,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Burkholderiaceae,,,,,,,,,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),,,IPR006311 (100%);IPR006680 (100%);IPR032466 (100%),Twin-arginine translocation pathway, signal sequence (100%);Amidohydrolase-related (100%);Metal-dependent hydrolase (100%),,,,,,,,,,
MLLEELMQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.21 (11%);2.1.1.63 (5%);3.6.4.12 (5%),Histidine--tRNA ligase (11%);Methylated-DNA--[protein]-cysteine S-methyltransferase (5%);DNA helicase (5%),GO:0016021 (34%);GO:0005886 (11%);GO:0000172 (5%),integral component of membrane (34%);plasma membrane (11%);ribonuclease MRP complex (5%),GO:0005524 (12%);GO:0015087 (9%);GO:0015095 (9%),ATP binding (12%);cobalt ion transmembrane transporter activity (9%);magnesium ion transmembrane transporter activity (9%),GO:0001682 (5%);GO:0006412 (2%);GO:0005975 (2%),tRNA 5'-leader removal (5%);translation (2%);carbohydrate metabolic process (2%),IPR002523 (9%);IPR004488 (8%);IPR027417 (6%),Mg2+ transporter protein, CorA-like/Zinc transport protein ZntB (9%);Magnesium/cobalt transport protein CorA (8%);P-loop containing nucleoside triphosphate hydrolase (6%),,,,,,,,,,
DFQGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.4 (14%);2.7.1.17 (13%);1.11.1.15 (10%),Glucosamine-phosphate N-acetyltransferase (14%);Xylulokinase (13%);Peroxiredoxin (10%),GO:0016021 (23%);GO:0005623 (7%);GO:0005886 (7%),integral component of membrane (23%);cell (7%);plasma membrane (7%),GO:0008080 (12%);GO:0005524 (9%);GO:0046872 (6%),N-acetyltransferase activity (12%);ATP binding (9%);metal ion binding (6%),GO:0045454 (7%);GO:0055085 (6%);GO:0006048 (2%),cell redox homeostasis (7%);transmembrane transport (6%);UDP-N-acetylglucosamine biosynthetic process (2%),IPR016181 (13%);IPR000182 (13%);IPR036249 (7%),Acyl-CoA N-acyltransferase (13%);GNAT domain (13%);Thioredoxin-like superfamily (7%),,,,,,,,,,,
QNTNDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (50%);3.6.4.12 (50%),Methyltransferases (50%);DNA helicase (50%),GO:0016021 (13%);GO:0005634 (3%);GO:0005886 (3%),integral component of membrane (13%);nucleus (3%);plasma membrane (3%),GO:0005524 (77%);GO:0003677 (3%);GO:0003678 (3%),ATP binding (77%);DNA binding (3%);DNA helicase activity (3%),GO:0000398 (3%);GO:0000724 (3%);GO:0006310 (3%),mRNA splicing, via spliceosome (3%);double-strand break repair via homologous recombination (3%);DNA recombination (3%),IPR000330 (50%);IPR014001 (50%);IPR027417 (50%),SNF2-related, N-terminal domain (50%);Helicase superfamily 1/2, ATP-binding domain (50%);P-loop containing nucleoside triphosphate hydrolase (50%),,,,,,,,
MWMNPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPPGHQHPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVNVDTFPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLGPLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.79 (93%);4.2.1.3 (36%);7.1.1.- (7%),2-methylcitrate dehydratase (93%);Aconitate hydratase (36%);Hydron translocation or charge separation linked to oxidoreductase reactions (7%),GO:0005886 (8%);GO:0005623 (3%);GO:0016021 (3%),plasma membrane (8%);cell (3%);integral component of membrane (3%),GO:0047547 (39%);GO:0051537 (29%);GO:0003994 (13%),2-methylcitrate dehydratase activity (39%);2 iron, 2 sulfur cluster binding (29%);aconitate hydratase activity (13%),GO:0019629 (29%);GO:0007166 (18%);GO:0006662 (3%),propionate catabolic process, 2-methylcitrate cycle (29%);cell surface receptor signaling pathway (18%);glycerol ether metabolic process (3%),IPR000225 (62%);IPR011989 (62%);IPR016024 (61%),Armadillo (62%);Armadillo-like helical (62%);Armadillo-type fold (61%),,,,,,,,,
VTMLMVDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAAEM,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (11%),integral component of membrane (11%),GO:0005524 (33%);GO:0010181 (22%);GO:0016491 (22%),ATP binding (33%);FMN binding (22%);oxidoreductase activity (22%),GO:0032259 (11%),methylation (11%),IPR001155 (23%);IPR003593 (23%);IPR003959 (23%),NADH:flavin oxidoreductase/NADH oxidase, N-terminal (23%);AAA+ ATPase domain (23%);ATPase, AAA-type, core (23%),,,,,,,,
DMPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.20 (16%);4.1.99.3 (13%);5.6.2.1 (11%),Diacylglycerol O-acyltransferase (16%);Deoxyribodipyrimidine photo-lyase (13%);DNA topoisomerase (11%),GO:0016021 (10%);GO:0005737 (3%);GO:0005576 (2%),integral component of membrane (10%);cytoplasm (3%);extracellular region (2%),GO:0016829 (29%);GO:0005524 (13%);GO:0046872 (9%),lyase activity (29%);ATP binding (13%);metal ion binding (9%),GO:0018298 (33%);GO:0006071 (3%);GO:0019432 (3%),protein-chromophore linkage (33%);glycerol metabolic process (3%);triglyceride biosynthetic process (3%),IPR002081 (29%);IPR005101 (29%);IPR036134 (29%),Cryptochrome/DNA photolyase class 1 (29%);Cryptochrome/DNA photolyase, FAD-binding domain (29%);Cryptochrome/DNA photolyase, FAD-binding domain-like superfamily (29%),,,,,,,,,
WMNMWLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVDQQNK,Salmonella enterica,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Enterobacterales,,,,,Enterobacteriaceae,,,,Salmonella,,,,Salmonella enterica,,,,,,GO:0019867 (100%),outer membrane (100%),,,GO:0009297 (100%);GO:0009306 (100%),pilus assembly (100%);protein secretion (100%),IPR001775 (100%);IPR004846 (100%);IPR011514 (100%),GspD/PilQ family (100%);Type II/III secretion system (100%);Secretin, N-terminal (100%),,,,,,,,,,
FFNLFMYMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (17%);2.7.7.6 (13%);4.2.2.0 (11%),DNA-directed DNA polymerase (17%);DNA-directed RNA polymerase (13%); (11%),GO:0016021 (21%);GO:0005634 (7%);GO:0009507 (6%),integral component of membrane (21%);nucleus (7%);chloroplast (6%),GO:0003824 (20%);GO:0005524 (9%);GO:0003677 (9%),catalytic activity (20%);ATP binding (9%);DNA binding (9%),GO:0007165 (5%);GO:0006412 (4%);GO:0006486 (3%),signal transduction (5%);translation (4%);protein glycosylation (3%),IPR042099 (18%);IPR000873 (18%);IPR037337 (17%),AMP-dependent synthetase-like superfamily (18%);AMP-dependent synthetase/ligase (18%);Dip2-like domain (17%),,,,,,,,,,,
MLYYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.20 (80%);1.1.1.42 (7%);3.1.-.- (7%),Diaminopimelate decarboxylase (80%);Isocitrate dehydrogenase (NADP(+)) (7%);Acting on ester bonds (7%),GO:0016021 (43%);GO:0005737 (4%);GO:0005886 (4%),integral component of membrane (43%);cytoplasm (4%);plasma membrane (4%),GO:0008836 (26%);GO:0030170 (26%);GO:0008080 (6%),diaminopimelate decarboxylase activity (26%);pyridoxal phosphate binding (26%);N-acetyltransferase activity (6%),GO:0009089 (26%);GO:0000967 (2%);GO:0006099 (2%),lysine biosynthetic process via diaminopimelate (26%);rRNA 5'-end processing (2%);tricarboxylic acid cycle (2%),IPR006059 (19%);IPR000183 (16%);IPR002986 (16%),Bacterial extracellular solute-binding protein (19%);Ornithine/DAP/Arg decarboxylase (16%);Diaminopimelate decarboxylase, LysA (16%),,,,,,,,,,
ADMYNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.2 (100%),GMP synthase (glutamine-hydrolyzing) (100%),GO:0016021 (60%),integral component of membrane (60%),GO:0005524 (40%);GO:0000155 (20%);GO:0003677 (20%),ATP binding (40%);phosphorelay sensor kinase activity (20%);DNA binding (20%),GO:0000160 (20%);GO:0006541 (20%),phosphorelay signal transduction system (20%);glutamine metabolic process (20%),IPR001674 (20%);IPR001789 (20%);IPR003439 (20%),GMP synthase, C-terminal (20%);Signal transduction response regulator, receiver domain (20%);ABC transporter-like (20%),,,,,,,,,
EHNMNTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YAWLDGPMGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAPFSHK,Operophtera brumata,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,Amphiesmenoptera,Lepidoptera,Glossata,Neolepidoptera,Heteroneura,Geometroidea,Geometridae,Larentiinae,,,Operophtera,,,,Operophtera brumata,,,,,,,,,,,,,,,,,,,,,,,,
LNQFNLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLQVYHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (32%);1.2.1.3 (7%);6.3.3.2 (7%),RNA-directed RNA polymerase (32%);Aldehyde dehydrogenase (NAD(+)) (7%);5-formyltetrahydrofolate cyclo-ligase (7%),GO:0016021 (24%);GO:0005737 (5%);GO:0005886 (5%),integral component of membrane (24%);cytoplasm (5%);plasma membrane (5%),GO:0005524 (12%);GO:0003995 (9%);GO:0003723 (9%),ATP binding (12%);acyl-CoA dehydrogenase activity (9%);RNA binding (9%),GO:0008218 (9%);GO:0031047 (7%);GO:0000725 (2%),bioluminescence (9%);gene silencing by RNA (7%);recombinational repair (2%),IPR016161 (15%);IPR027417 (9%);IPR016162 (8%),Aldehyde/histidinol dehydrogenase (15%);P-loop containing nucleoside triphosphate hydrolase (9%);Aldehyde dehydrogenase, N-terminal (8%),,,,,,,,,,
TGPAYDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAGMTWK,Kwoniella,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Tremellomycetes,,,,Tremellales,,,,,Cryptococcaceae,,,,Kwoniella,,,,,,,,,,GO:0005634 (100%),nucleus (100%),GO:0003700 (100%);GO:0043565 (100%),DNA-binding transcription factor activity (100%);sequence-specific DNA binding (100%),,,IPR001766 (100%);IPR030456 (100%);IPR036388 (100%),Fork head domain (100%);Fork head domain conserved site 2 (100%);Winged helix-like DNA-binding domain superfamily (100%),,,,,,,,,,,
DLANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.12 (14%);3.1.-.- (5%);6.1.1.2 (3%),3,4-dihydroxy-2-butanone-4-phosphate synthase (14%);Acting on ester bonds (5%);Tryptophan--tRNA ligase (3%),GO:0016021 (22%);GO:0005737 (12%);GO:0005886 (6%),integral component of membrane (22%);cytoplasm (12%);plasma membrane (6%),GO:0005524 (16%);GO:0003677 (8%);GO:0019843 (5%),ATP binding (16%);DNA binding (8%);rRNA binding (5%),GO:0006412 (5%);GO:0042773 (4%);GO:0006355 (3%),translation (5%);ATP synthesis coupled electron transport (4%);regulation of transcription, DNA-templated (3%),IPR027417 (10%);IPR001209 (4%);IPR028082 (4%),P-loop containing nucleoside triphosphate hydrolase (10%);Ribosomal protein S14 (4%);Periplasmic binding protein-like I (4%),,,,,,,,,
NLEHFLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYWVGHMLSAQHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAASSAPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.21 (46%);1.2.4.2 (18%);3.2.1.2 (7%),Histidine--tRNA ligase (46%);Oxoglutarate dehydrogenase (succinyl-transferring) (18%);Beta-amylase (7%),GO:0005737 (19%);GO:0016021 (18%);GO:0033644 (2%),cytoplasm (19%);integral component of membrane (18%);host cell membrane (2%),GO:0005524 (28%);GO:0004821 (16%);GO:0004591 (10%),ATP binding (28%);histidine-tRNA ligase activity (16%);oxoglutarate dehydrogenase (succinyl-transferring) activity (10%),GO:0006427 (15%);GO:0009228 (10%);GO:0006099 (9%),histidyl-tRNA aminoacylation (15%);thiamine biosynthetic process (10%);tricarboxylic acid cycle (9%),IPR006195 (14%);IPR041715 (14%);IPR004154 (13%),Aminoacyl-tRNA synthetase, class II (14%);Class II Histidinyl-tRNA synthetase (HisRS)-like catalytic core domain (14%);Anticodon-binding (13%),,,,,,,,,,
MYALLADMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDLNVMLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSNSPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.20 (50%);2.1.1.190 (25%);3.6.4.- (25%),Methylenetetrahydrofolate reductase (NAD(P)H) (50%);23S rRNA (uracil(1939)-C(5))-methyltransferase (25%);Acting on ATP; involved in cellular and subcellular movement (25%),GO:0016021 (14%);GO:0016035 (14%);GO:1990077 (14%),integral component of membrane (14%);zeta DNA polymerase complex (14%);primosome complex (14%),GO:0003676 (29%);GO:0004489 (29%);GO:0003677 (14%),nucleic acid binding (29%);methylenetetrahydrofolate reductase (NAD(P)H) activity (29%);DNA binding (14%),GO:0006555 (29%);GO:0035999 (29%);GO:0006268 (14%),methionine metabolic process (29%);tetrahydrofolate interconversion (29%);DNA unwinding involved in DNA replication (14%),IPR003171 (29%);IPR012337 (29%);IPR029041 (29%),Methylenetetrahydrofolate reductase (29%);Ribonuclease H-like superfamily (29%);FAD-linked oxidoreductase-like (29%),,,,,,,,,,,
TLSAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (60%);1.17.4.1 (3%);5.3.1.16 (3%),DNA (cytosine-5-)-methyltransferase (60%);Ribonucleoside-diphosphate reductase (3%);1-(5-phosphoribosyl)-5((5-phosphoribosylamino)methylideneamino)imidazole-4-carboxamidisomerase (3%),GO:0016021 (22%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (22%);cytoplasm (5%);plasma membrane (3%),GO:0003886 (20%);GO:0005524 (14%);GO:0003677 (8%),DNA (cytosine-5-)-methyltransferase activity (20%);ATP binding (14%);DNA binding (8%),GO:0032259 (4%);GO:0006355 (2%);GO:0006260 (2%),methylation (4%);regulation of transcription, DNA-templated (2%);DNA replication (2%),IPR029063 (20%);IPR001525 (19%);IPR018117 (18%),S-adenosyl-L-methionine-dependent methyltransferase (20%);C-5 cytosine methyltransferase (19%);DNA methylase, C-5 cytosine-specific, active site (18%),,,,,,,,
AYTWTGM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPQVMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVGWVPCPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDNQCHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.8 (34%);3.6.3.- (5%);4.2.1.104 (5%),Lipoyl synthase (34%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (5%);Cyanase (5%),GO:0016021 (21%);GO:0005737 (15%);GO:0005634 (15%),integral component of membrane (21%);cytoplasm (15%);nucleus (15%),GO:0003677 (21%);GO:0030337 (15%);GO:0046872 (12%),DNA binding (21%);DNA polymerase processivity factor activity (15%);metal ion binding (12%),GO:0006275 (15%);GO:0006260 (14%);GO:0009249 (5%),regulation of DNA replication (15%);DNA replication (14%);protein lipoylation (5%),IPR000730 (12%);IPR022648 (12%);IPR022649 (11%),Proliferating cell nuclear antigen, PCNA (12%);Proliferating cell nuclear antigen, PCNA, N-terminal (12%);Proliferating cell nuclear antigen, PCNA, C-terminal (11%),,,,,,
RPLAGNK,Pezizomycotina,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005743 (100%);GO:0016021 (100%),mitochondrial inner membrane (100%);integral component of membrane (100%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR002067 (50%);IPR002167 (50%);IPR011989 (50%),Mitochondrial carrier protein (50%);Graves disease carrier protein (50%);Armadillo-like helical (50%),,,,,,,,,,,
VNETDFTK,Caldithrix,Bacteria,,,,Calditrichaeota,,,Calditrichae,,,,Calditrichales,,,,,Calditrichaceae,,,,Caldithrix,,,,,,,,,,,,,,,,IPR001932 (100%);IPR003018 (100%);IPR029016 (100%),PPM-type phosphatase domain (100%);GAF domain (100%);GAF-like domain superfamily (100%),,,,,,,,,,,
LLVSFWEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYGWQYVDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVFPGGSEDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AYFLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.23 (50%);2.8.1.13 (29%);3.2.1.17 (8%),E2 ubiquitin-conjugating enzyme (50%);tRNA-uridine 2-sulfurtransferase (29%);Lysozyme (8%),GO:0005737 (7%);GO:0005623 (6%);GO:0005829 (6%),cytoplasm (7%);cell (6%);cytosol (6%),GO:0005524 (53%);GO:0016740 (41%);GO:0004197 (8%),ATP binding (53%);transferase activity (41%);cysteine-type endopeptidase activity (8%),GO:0010458 (10%);GO:0016567 (10%);GO:0031145 (10%),exit from mitosis (10%);protein ubiquitination (10%);anaphase-promoting complex-dependent catabolic process (10%),IPR000608 (35%);IPR016135 (35%);IPR023313 (35%),Ubiquitin-conjugating enzyme E2 (35%);Ubiquitin-conjugating enzyme/RWD-like (35%);Ubiquitin-conjugating enzyme, active site (35%),,,,,,,,,,
LLPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.1 (12%);2.3.1.39 (5%);3.1.4.11 (5%),Acetate--CoA ligase (12%);[Acyl-carrier-protein] S-malonyltransferase (5%);Phosphoinositide phospholipase C (5%),GO:0016021 (27%);GO:0005737 (6%);GO:0005886 (4%),integral component of membrane (27%);cytoplasm (6%);plasma membrane (4%),GO:0005524 (18%);GO:0046872 (10%);GO:0003677 (8%),ATP binding (18%);metal ion binding (10%);DNA binding (8%),GO:0005975 (3%);GO:0019427 (2%);GO:0032259 (2%),carbohydrate metabolic process (3%);acetyl-CoA biosynthetic process from acetate (2%);methylation (2%),IPR027417 (11%);IPR013783 (3%);IPR036388 (3%),P-loop containing nucleoside triphosphate hydrolase (11%);Immunoglobulin-like fold (3%);Winged helix-like DNA-binding domain superfamily (3%),,,,,,,,,,,
TFMCAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPSGNPESDHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLWFAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.5 (100%),Xylose isomerase (100%),GO:0016021 (75%);GO:0005737 (25%),integral component of membrane (75%);cytoplasm (25%),GO:0009045 (25%);GO:0022857 (25%);GO:0046872 (25%),xylose isomerase activity (25%);transmembrane transporter activity (25%);metal ion binding (25%),GO:0042732 (25%),D-xylose metabolic process (25%),IPR000731 (33%);IPR001036 (33%);IPR001998 (33%),Sterol-sensing domain (33%);Acriflavin resistance protein (33%);Xylose isomerase (33%),,,,,,,,,,,
MEPFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (37%);2.7.9.2 (20%);5.1.1.1 (13%),3-isopropylmalate dehydratase (37%);Pyruvate, water dikinase (20%);Alanine racemase (13%),GO:0016021 (23%);GO:0009316 (7%);GO:0005623 (4%),integral component of membrane (23%);3-isopropylmalate dehydratase complex (7%);cell (4%),GO:0005524 (21%);GO:0016887 (17%);GO:0004842 (11%),ATP binding (21%);ATPase activity (17%);ubiquitin-protein transferase activity (11%),GO:0006281 (8%);GO:0009098 (7%);GO:0006813 (5%),DNA repair (8%);leucine biosynthetic process (7%);potassium ion transport (5%),IPR027417 (18%);IPR003593 (11%);IPR010841 (11%),P-loop containing nucleoside triphosphate hydrolase (18%);AAA+ ATPase domain (11%);Elongation factor G-binding protein, N-terminal (11%),,,,,,,,,
TPVFSAQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMVLNEYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNMLMVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMAVAATR,Nitrosospira,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Nitrosomonadales,,,,,Nitrosomonadaceae,,,,Nitrosospira,,,,,,,,2.5.1.75 (100%),tRNA dimethylallyltransferase (100%),,,GO:0005524 (100%);GO:0052381 (100%),ATP binding (100%);tRNA dimethylallyltransferase activity (100%),GO:0008033 (100%),tRNA processing (100%),IPR018022 (100%);IPR027417 (100%);IPR039657 (100%),IPP transferase (100%);P-loop containing nucleoside triphosphate hydrolase (100%);Dimethylallyltransferase (100%),,,,,,,,,,,
HTHFDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAESGSNLDDCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLNVWPMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QDLLVPCEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVVSPDVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAWLFVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPAHLNWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CDGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.4.1.17 (66%);3.4.19.12 (7%);1.13.11.20 (4%),Holocytochrome-c synthase (66%);Ubiquitinyl hydrolase 1 (7%);Cysteine dioxygenase (4%),GO:0015935 (37%);GO:0016021 (16%);GO:0005743 (8%),small ribosomal subunit (37%);integral component of membrane (16%);mitochondrial inner membrane (8%),GO:0019843 (41%);GO:0003735 (37%);GO:0046872 (10%),rRNA binding (41%);structural constituent of ribosome (37%);metal ion binding (10%),GO:0006412 (41%);GO:0006904 (5%);GO:0006351 (4%),translation (41%);vesicle docking involved in exocytosis (5%);transcription, DNA-templated (4%),IPR001912 (37%);IPR002942 (37%);IPR005709 (37%),Ribosomal protein S4/S9, N-terminal (37%);RNA-binding S4 domain (37%);Ribosomal protein S4, bacterial-type (37%),,,,,,,,
TVPYAAGMTGVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (18%);2.7.7.7 (5%);3.1.21.2 (4%),DNA (cytosine-5-)-methyltransferase (18%);DNA-directed DNA polymerase (5%);Deoxyribonuclease IV (4%),GO:0016021 (30%);GO:0005634 (6%);GO:0019774 (5%),integral component of membrane (30%);nucleus (6%);proteasome core complex, beta-subunit complex (5%),GO:0005524 (14%);GO:0003677 (13%);GO:0046872 (5%),ATP binding (14%);DNA binding (13%);metal ion binding (5%),GO:0043161 (5%);GO:0006817 (4%);GO:0006355 (3%),proteasome-mediated ubiquitin-dependent protein catabolic process (5%);phosphate ion transport (4%);regulation of transcription, DNA-templated (3%),IPR027417 (10%);IPR029063 (5%);IPR029055 (4%),P-loop containing nucleoside triphosphate hydrolase (10%);S-adenosyl-L-methionine-dependent methyltransferase (5%);Nucleophile aminohydrolases, N-terminal (4%),,,,,,,,
HVSALFTMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLEC,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (100%);GO:0051536 (100%),catalytic activity (100%);iron-sulfur cluster binding (100%),,,IPR007197 (50%);IPR013785 (50%);IPR020201 (50%),Radical SAM (50%);Aldolase-type TIM barrel (50%);Autographa californica nuclear polyhedrosis virus (AcMNPV), Orf52 (50%),,,,,,,,,,
QCMSDLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NHCHVR,Phanerochaete carnosa,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Agaricomycetes,,,,Polyporales,,,,,Phanerochaetaceae,,,,Phanerochaete,,,,Phanerochaete carnosa,,,,,,,,,,,,IPR001810 (100%);IPR032675 (100%),F-box domain (100%);Leucine-rich repeat domain superfamily (100%),,,,,,,,,,,
LQLMDGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNPPMMNMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (46%);1.6.2.2 (3%);3.6.4.12 (2%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (46%);Cytochrome-b5 reductase (3%);DNA helicase (2%),GO:0016021 (11%);GO:0005737 (6%);GO:0042597 (5%),integral component of membrane (11%);cytoplasm (6%);periplasmic space (5%),GO:0005524 (26%);GO:0046872 (16%);GO:0004088 (12%),ATP binding (26%);metal ion binding (16%);carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity (12%),GO:0006807 (9%);GO:0015846 (5%);GO:0006306 (3%),nitrogen compound metabolic process (9%);polyamine transport (5%);DNA methylation (3%),IPR015424 (13%);IPR015421 (13%);IPR015422 (13%),Pyridoxal phosphate-dependent transferase (13%);Pyridoxal phosphate-dependent transferase, major domain (13%);Pyridoxal phosphate-dependent transferase domain 1 (13%),,,,,,,,,,
DEFMAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FWMNFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVWALAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHVLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (10%);GO:0005905 (10%);GO:0016021 (10%),cytoplasm (10%);clathrin-coated pit (10%);integral component of membrane (10%),GO:0036459 (50%);GO:0005524 (30%);GO:0008270 (30%),thiol-dependent ubiquitinyl hydrolase activity (50%);ATP binding (30%);zinc ion binding (30%),GO:0000245 (50%);GO:0016579 (50%);GO:0006426 (10%),spliceosomal complex assembly (50%);protein deubiquitination (50%);glycyl-tRNA aminoacylation (10%),IPR001394 (50%);IPR013083 (50%);IPR028889 (50%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (50%);Zinc finger, RING/FYVE/PHD-type (50%);Ubiquitin specific protease domain (50%),,,,,,,,,
MNMSCEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLPACR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016740 (38%);GO:0016758 (25%);GO:0018580 (25%),transferase activity (38%);transferase activity, transferring hexosyl groups (25%);nitronate monooxygenase activity (25%),GO:0005975 (25%);GO:0030259 (25%);GO:0000160 (13%),carbohydrate metabolic process (25%);lipid glycosylation (25%);phosphorelay signal transduction system (13%),IPR004136 (40%);IPR004276 (40%);IPR013785 (40%),Nitronate monooxygenase (40%);Glycosyltransferase family 28, N-terminal domain (40%);Aldolase-type TIM barrel (40%),,,,,,,,,
EPDLVGMLSLSNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWSWELVNHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFHAFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.3.2.3 (100%),ABC-type sulfate transporter (100%),GO:0043190 (68%);GO:0005886 (11%);GO:0016021 (1%),ATP-binding cassette (ABC) transporter complex (68%);plasma membrane (11%);integral component of membrane (1%),GO:0005524 (78%);GO:0015419 (78%);GO:0102025 (78%),ATP binding (78%);ATPase-coupled sulfate transmembrane transporter activity (78%);ATPase-coupled thiosulfate transmembrane transporter activity (78%),GO:0032259 (1%),methylation (1%),IPR027417 (77%);IPR003439 (75%);IPR003593 (75%),P-loop containing nucleoside triphosphate hydrolase (77%);ABC transporter-like (75%);AAA+ ATPase domain (75%),,,,,,,,,,,
TVMWMLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNLVFFK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0042597 (50%),integral component of membrane (50%);periplasmic space (50%),GO:0003700 (50%);GO:0019808 (50%);GO:0043565 (50%),DNA-binding transcription factor activity (50%);polyamine binding (50%);sequence-specific DNA binding (50%),GO:0015846 (50%),polyamine transport (50%),IPR001188 (25%);IPR003808 (25%);IPR006059 (25%),Bacterial periplasmic spermidine/putrescine-binding protein (25%);Fe-S metabolism associated domain, SufE-like (25%);Bacterial extracellular solute-binding protein (25%),,,,,,,,,,
NDQLGMMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPPTVGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSVHVVFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YGALDGYHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPMLGAMYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFFFMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDVLEFGMLMEAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYQLFMTVYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDYATNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DTMELEFPPLHQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVHMMVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNALPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.72 (100%),CCA tRNA nucleotidyltransferase (100%),,,GO:0000049 (50%);GO:0000287 (50%);GO:0005524 (50%),tRNA binding (50%);magnesium ion binding (50%);ATP binding (50%),GO:0001680 (50%);GO:0015031 (50%);GO:0042245 (50%),tRNA 3'-terminal CCA addition (50%);protein transport (50%);RNA repair (50%),IPR002646 (50%);IPR005565 (50%);IPR013686 (50%),Poly A polymerase, head domain (50%);Haemolysin activator HlyB, C-terminal (50%);Polypeptide-transport-associated, ShlB-type (50%),,,,,,,,
QAVLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (50%);4.3.2.2 (50%),Endopeptidase La (50%);Adenylosuccinate lyase (50%),GO:0016021 (63%),integral component of membrane (63%),GO:0022857 (19%);GO:0008658 (13%);GO:0004018 (6%),transmembrane transporter activity (19%);penicillin binding (13%);N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity (6%),GO:0006189 (6%);GO:0006464 (6%);GO:0015031 (6%),'de novo' IMP biosynthetic process (6%);cellular protein modification process (6%);protein transport (6%),IPR039562 (33%);IPR006143 (20%);IPR001460 (13%),Membrane fusion protein, biotin-lipoyl like domain (33%);RND efflux pump, membrane fusion protein (20%);Penicillin-binding protein, transpeptidase (13%),,,,,,,
DDPLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.23 (50%);4.2.99.18 (50%);1.2.99.2 (25%),DNA-formamidopyrimidine glycosylase (50%);DNA-(apurinic or apyrimidinic site) lyase (50%);Transferred entry: 1.2.7.4 (25%),GO:0016021 (31%);GO:0005623 (7%);GO:0005634 (1%),integral component of membrane (31%);cell (7%);nucleus (1%),GO:0016747 (13%);GO:0016874 (13%);GO:0003677 (7%),transferase activity, transferring acyl groups other than amino-acyl groups (13%);ligase activity (13%);DNA binding (7%),GO:0008610 (13%);GO:0045454 (7%);GO:0006284 (3%),lipid biosynthetic process (13%);cell redox homeostasis (7%);base-excision repair (3%),IPR000873 (10%);IPR009081 (10%);IPR020845 (10%),AMP-dependent synthetase/ligase (10%);Phosphopantetheine binding ACP domain (10%);AMP-binding, conserved site (10%),,,,,,,,,
FVQMLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (35%);4.99.1.1 (26%);3.1.3.- (9%),DNA-directed DNA polymerase (35%);Protoporphyrin ferrochelatase (26%);Phosphoric monoester hydrolases (9%),GO:0016021 (24%);GO:0005737 (17%);GO:0000145 (10%),integral component of membrane (24%);cytoplasm (17%);exocyst (10%),GO:0003677 (13%);GO:0016787 (11%);GO:0046872 (8%),DNA binding (13%);hydrolase activity (11%);metal ion binding (8%),GO:0006887 (10%);GO:0006261 (7%);GO:0009306 (7%),exocytosis (10%);DNA-dependent DNA replication (7%);protein secretion (7%),IPR010326 (13%);IPR042532 (12%);IPR003004 (10%),Exocyst complex component EXOC3/Sec6 (13%);Exocyst complex component EXOC3/Sec6, C-terminal domain (12%);GspF/PilC family (10%),,,,,,,,,,
TMATCVFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYFWVVLPLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYLGETYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SALEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.9 (73%);2.7.7.18 (9%);2.2.1.6 (3%),UTP--glucose-1-phosphate uridylyltransferase (73%);Nicotinate-nucleotide adenylyltransferase (9%);Acetolactate synthase (3%),GO:0016021 (14%);GO:0005737 (3%);GO:0009289 (3%),integral component of membrane (14%);cytoplasm (3%);pilus (3%),GO:0003983 (26%);GO:0003677 (17%);GO:0000150 (11%),UTP:glucose-1-phosphate uridylyltransferase activity (26%);DNA binding (17%);recombinase activity (11%),GO:0006011 (25%);GO:0007155 (3%);GO:0009435 (3%),UDP-glucose metabolic process (25%);cell adhesion (3%);NAD biosynthetic process (3%),IPR029044 (25%);IPR002618 (25%);IPR016267 (23%),Nucleotide-diphospho-sugar transferases (25%);UDPGP family (25%);UTP--glucose-1-phosphate uridylyltransferase (23%),,,,,,,,,,,
LLMFAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFQVNPMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (11%);2.7.4.29 (6%);2.7.7.6 (6%),Serine endopeptidases (11%);Kdo(2)-lipid A phosphotransferase (6%);DNA-directed RNA polymerase (6%),GO:0016021 (33%);GO:0005634 (20%);GO:0005694 (15%),integral component of membrane (33%);nucleus (20%);chromosome (15%),GO:0046975 (17%);GO:0005524 (12%);GO:0003677 (6%),histone methyltransferase activity (H3-K36 specific) (17%);ATP binding (12%);DNA binding (6%),GO:0097198 (17%);GO:0006355 (15%);GO:0006298 (6%),histone H3-K36 trimethylation (17%);regulation of transcription, DNA-templated (15%);mismatch repair (6%),IPR042294 (17%);IPR001214 (17%);IPR003616 (17%),Histone-lysine N-methyltransferase SETD2 (17%);SET domain (17%);Post-SET domain (17%),,,,,,,,,,
NEEVLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.10 (33%);2.3.1.9 (33%);2.7.4.21 (33%),Aminomethyltransferase (33%);Acetyl-CoA C-acetyltransferase (33%);Inositol-hexakisphosphate kinase (33%),GO:0005634 (26%);GO:0016021 (17%);GO:0005737 (2%),nucleus (26%);integral component of membrane (17%);cytoplasm (2%),GO:0005524 (32%);GO:0004672 (28%);GO:0003677 (23%),ATP binding (32%);protein kinase activity (28%);DNA binding (23%),GO:0006355 (23%);GO:0006397 (6%);GO:0005975 (4%),regulation of transcription, DNA-templated (23%);mRNA processing (6%);carbohydrate metabolic process (4%),IPR000477 (74%);IPR036691 (22%);IPR005135 (13%),Reverse transcriptase domain (74%);Endonuclease/exonuclease/phosphatase superfamily (22%);Endonuclease/exonuclease/phosphatase (13%),,,,,,,,,,
SCSLMSTFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNGVLEHMDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLANALGLR,Firmicutes,Bacteria,,,,Firmicutes,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%);GO:0003700 (67%);GO:0003824 (67%),DNA binding (100%);DNA-binding transcription factor activity (67%);catalytic activity (67%),GO:0009058 (67%),biosynthetic process (67%),IPR000524 (75%);IPR004839 (75%);IPR015421 (75%),Transcription regulator HTH, GntR (75%);Aminotransferase, class I/classII (75%);Pyridoxal phosphate-dependent transferase, major domain (75%),,,,,,,,
TVNFMMVTPFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLENLNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLVMDLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WQMWAVPTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLMYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (26%);2.1.1.80 (18%);2.4.1.18 (13%),Transferring other groups (26%);Protein-glutamate O-methyltransferase (18%);1,4-alpha-glucan branching enzyme (13%),GO:0016021 (34%);GO:0005737 (3%);GO:0005623 (3%),integral component of membrane (34%);cytoplasm (3%);cell (3%),GO:0003723 (15%);GO:0009982 (12%);GO:0005524 (12%),RNA binding (15%);pseudouridine synthase activity (12%);ATP binding (12%),GO:0001522 (12%);GO:0032259 (6%);GO:0055085 (4%),pseudouridine synthesis (12%);methylation (6%);transmembrane transport (4%),IPR020103 (10%);IPR002942 (10%);IPR036986 (10%),Pseudouridine synthase, catalytic domain superfamily (10%);RNA-binding S4 domain (10%);RNA-binding S4 domain superfamily (10%),,,,,,,,,
FHDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (36%);3.6.4.- (5%);1.-.-.- (4%),3-isopropylmalate dehydratase (36%);Acting on ATP; involved in cellular and subcellular movement (5%);Oxidoreductases (4%),GO:0016021 (3%);GO:0005886 (1%);GO:0005634 (1%),integral component of membrane (3%);plasma membrane (1%);nucleus (1%),GO:0003677 (88%);GO:0005524 (2%);GO:0016301 (1%),DNA binding (88%);ATP binding (2%);kinase activity (1%),GO:0006310 (88%);GO:0015074 (82%);GO:0006355 (1%),DNA recombination (88%);DNA integration (82%);regulation of transcription, DNA-templated (1%),IPR011010 (84%);IPR013762 (83%);IPR002104 (83%),DNA breaking-rejoining enzyme, catalytic core (84%);Integrase-like, catalytic domain superfamily (83%);Integrase, catalytic domain (83%),,,,,,,
GGHDFENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DELNTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.107 (24%);5.2.1.8 (14%);2.5.1.- (10%),Diacylglycerol kinase (ATP) (24%);Peptidylprolyl isomerase (14%);Transferring alkyl or aryl groups, other than methyl groups (10%),GO:0016021 (25%);GO:0016020 (9%);GO:0005730 (5%),integral component of membrane (25%);membrane (9%);nucleolus (5%),GO:0005524 (18%);GO:0003677 (8%);GO:0004519 (4%),ATP binding (18%);DNA binding (8%);endonuclease activity (4%),GO:0042254 (5%);GO:0006260 (3%);GO:0035556 (3%),ribosome biogenesis (5%);DNA replication (3%);intracellular signal transduction (3%),IPR001107 (10%);IPR018080 (10%);IPR036013 (10%),Band 7 domain (10%);Band 7/stomatin-like, conserved site (10%);Band 7/SPFH domain superfamily (10%),,,,,,,,,
MLVLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.187 (67%);6.3.5.3 (14%);5.1.3.13 (7%),N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-Dmannosaminyltransferase (67%);Phosphoribosylformylglycinamidine synthase (14%);dTDP-4-dehydrorhamnose 3,5-epimerase (7%),GO:0016021 (6%);GO:0005737 (3%);GO:0005615 (0%),integral component of membrane (6%);cytoplasm (3%);extracellular space (0%),GO:0051213 (46%);GO:0047244 (11%);GO:0003700 (7%),dioxygenase activity (46%);N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase activity (11%);DNA-binding transcription factor activity (7%),GO:0071555 (11%);GO:0019350 (11%);GO:0006189 (2%),cell wall organization (11%);teichoic acid biosynthetic process (11%);'de novo' IMP biosynthetic process (2%),IPR037151 (44%);IPR027450 (44%);IPR004574 (44%),Alpha-ketoglutarate-dependent dioxygenase AlkB-like superfamily (44%);Alpha-ketoglutarate-dependent dioxygenase AlkB-like (44%);Alkylated DNA repair protein AlkB (44%),,,,,,,,,,
SYCSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.49 (53%);2.3.2.31 (10%);2.7.1.50 (3%),RNA-directed DNA polymerase (53%);RBR-type E3 ubiquitin transferase (10%);Hydroxyethylthiazole kinase (3%),GO:0005634 (23%);GO:0016021 (17%);GO:0000781 (9%),nucleus (23%);integral component of membrane (17%);chromosome, telomeric region (9%),GO:0003677 (20%);GO:0016491 (17%);GO:0008270 (15%),DNA binding (20%);oxidoreductase activity (17%);zinc ion binding (15%),GO:0006351 (7%);GO:0005975 (5%);GO:0007268 (2%),transcription, DNA-templated (7%);carbohydrate metabolic process (5%);chemical synaptic transmission (2%),IPR017896 (13%);IPR017900 (13%);IPR023753 (13%),4Fe-4S ferredoxin-type, iron-sulphur binding domain (13%);4Fe-4S ferredoxin, iron-sulphur binding, conserved site (13%);FAD/NAD(P)-binding domain (13%),,,,,,
YLEHLLQR,Magnetospirillum,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhodospirillales,,,,,Rhodospirillaceae,,,,Magnetospirillum,,,,,,,,,,,,,,,,IPR003615 (100%),HNH nuclease (100%),,,,,,,,,,,
FANLTAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.26 (67%);2.7.7.2 (67%);2.3.2.17 (33%),Riboflavin kinase (67%);FAD synthase (67%);N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-(N(6)-glycyl)-D-alanyl-Dalanine-diphosphoundecaprenyl-N-acetylglucosamine:glycinglycyltransferase (33%),GO:0016021 (38%);GO:0005737 (8%),integral component of membrane (38%);cytoplasm (8%),GO:0016740 (31%);GO:0003919 (15%);GO:0004497 (15%),transferase activity (31%);FMN adenylyltransferase activity (15%);monooxygenase activity (15%),GO:0006747 (15%);GO:0009231 (15%);GO:0009398 (15%),FAD biosynthetic process (15%);riboflavin biosynthetic process (15%);FMN biosynthetic process (15%),IPR001763 (25%);IPR036873 (25%);IPR040503 (25%),Rhodanese-like domain (25%);Rhodanese-like domain superfamily (25%);UPF0176, acylphosphatase-like domain (25%),,,,,,,,,,
YEESMLYSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWWQQLTLEVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDVVMPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (100%),Transferring groups other than amino-acyl groups (100%),GO:0016021 (33%),integral component of membrane (33%),GO:0016746 (67%),transferase activity, transferring acyl groups (67%),,,IPR000089 (40%);IPR001078 (40%);IPR003016 (40%),Biotin/lipoyl attachment (40%);2-oxoacid dehydrogenase acyltransferase, catalytic domain (40%);2-oxo acid dehydrogenase, lipoyl-binding site (40%),,,,,,,,
DNHDVMAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FATADMFFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LASGYGNPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSAPEPQDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMHYMMLLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HHAHLGHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPNEAWWLRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVLETMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.7 (54%);2.8.1.7 (15%);2.7.1.30 (8%),Diaminopimelate epimerase (54%);Cysteine desulfurase (15%);Glycerol kinase (8%),GO:0005737 (31%);GO:0016021 (4%),cytoplasm (31%);integral component of membrane (4%),GO:0008837 (27%);GO:0046872 (12%);GO:0005524 (8%),diaminopimelate epimerase activity (27%);metal ion binding (12%);ATP binding (8%),GO:0009089 (27%);GO:0000184 (4%);GO:0005975 (4%),lysine biosynthetic process via diaminopimelate (27%);nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (4%);carbohydrate metabolic process (4%),IPR029045 (22%);IPR001653 (19%);IPR018510 (19%),ClpP/crotonase-like domain superfamily (22%);Diaminopimelate epimerase, DapF (19%);Diaminopimelate epimerase, active site (19%),,,,,,,,
GYSLLVLLAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FWMMDLSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYVTAPYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPWSLLFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFEENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (27%);2.1.1.37 (15%);3.1.3.5 (8%),Peptidylprolyl isomerase (27%);DNA (cytosine-5-)-methyltransferase (15%);5'-nucleotidase (8%),GO:0016021 (26%);GO:0005737 (4%);GO:0005730 (2%),integral component of membrane (26%);cytoplasm (4%);nucleolus (2%),GO:0046872 (12%);GO:0004842 (9%);GO:0005524 (9%),metal ion binding (12%);ubiquitin-protein transferase activity (9%);ATP binding (9%),GO:0009166 (6%);GO:0032259 (3%);GO:0000463 (2%),nucleotide catabolic process (6%);methylation (3%);maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (2%),IPR013584 (19%);IPR000900 (6%);IPR000569 (6%),RAP domain (19%);Nebulin repeat (6%);HECT domain (6%),,,,,,,,,
MFFVGAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDMVGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPVVHPDANR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLDSVPLSPWWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMLLSPNLSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYLLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.-.- (34%);6.3.4.6 (23%);6.-.-.- (14%),Transferring phosphorus-containing groups (34%);Urea carboxylase (23%);Ligases (14%),GO:0016021 (39%);GO:0005886 (7%);GO:0005634 (4%),integral component of membrane (39%);plasma membrane (7%);nucleus (4%),GO:0005524 (25%);GO:0008270 (14%);GO:0046872 (13%),ATP binding (25%);zinc ion binding (14%);metal ion binding (13%),GO:0006744 (6%);GO:0010795 (5%);GO:0009401 (4%),ubiquinone biosynthetic process (6%);regulation of ubiquinone biosynthetic process (5%);phosphoenolpyruvate-dependent sugar phosphotransferase system (4%),IPR011990 (11%);IPR003778 (10%);IPR003833 (10%),Tetratricopeptide-like helical domain superfamily (11%);Carboxyltransferase domain, subdomain A and B (10%);Carboxyltransferase domain, subdomain C and D (10%),,,,,,,,,
NMVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.11 (47%);3.6.3.- (20%);2.2.1.1 (6%),Fructose-bisphosphatase (47%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (20%);Transketolase (6%),GO:0016021 (7%);GO:0005737 (7%);GO:0016020 (3%),integral component of membrane (7%);cytoplasm (7%);membrane (3%),GO:0005524 (28%);GO:0016887 (23%);GO:0050660 (21%),ATP binding (28%);ATPase activity (23%);flavin adenine dinucleotide binding (21%),GO:0000160 (14%);GO:0016051 (5%);GO:0007165 (4%),phosphorelay signal transduction system (14%);carbohydrate biosynthetic process (5%);signal transduction (4%),IPR027417 (22%);IPR003439 (20%);IPR003593 (20%),P-loop containing nucleoside triphosphate hydrolase (22%);ABC transporter-like (20%);AAA+ ATPase domain (20%),,,,,,,,,,,
LLELTHDVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYMLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.15 (92%);2.3.1.- (2%);2.3.1.181 (2%),Biotin--[biotin carboxyl-carrier protein] ligase (92%);Transferring groups other than amino-acyl groups (2%);Lipoyl(octanoyl) transferase (2%),GO:0016021 (14%);GO:0016020 (3%);GO:0033179 (3%),integral component of membrane (14%);membrane (3%);proton-transporting V-type ATPase, V0 domain (3%),GO:0003677 (61%);GO:0005524 (61%);GO:0004077 (58%),DNA binding (61%);ATP binding (61%);biotin-[acetyl-CoA-carboxylase] ligase activity (58%),GO:0006355 (59%);GO:0009305 (58%);GO:0005975 (3%),regulation of transcription, DNA-templated (59%);protein biotinylation (58%);carbohydrate metabolic process (3%),IPR004143 (55%);IPR036388 (55%);IPR004408 (53%),Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain (55%);Winged helix-like DNA-binding domain superfamily (55%);Biotin--acetyl-CoA-carboxylase ligase (53%),,,,,,,,
WNSMNEAHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HNPEEQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
STRPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.320 (8%);3.1.26.12 (6%);3.6.1.- (4%),Type II protein arginine methyltransferase (8%);Ribonuclease E (6%);In phosphorus-containing anhydrides (4%),GO:0016021 (26%);GO:0005737 (15%);GO:0005886 (14%),integral component of membrane (26%);cytoplasm (15%);plasma membrane (14%),GO:0005524 (25%);GO:0046872 (15%);GO:0003677 (12%),ATP binding (25%);metal ion binding (15%);DNA binding (12%),GO:0006605 (12%);GO:0065002 (11%);GO:0017038 (11%),protein targeting (12%);intracellular protein transmembrane transport (11%);protein import (11%),IPR027417 (20%);IPR011115 (10%);IPR014018 (10%),P-loop containing nucleoside triphosphate hydrolase (20%);SecA DEAD-like, N-terminal (10%);SecA motor DEAD (10%),,,,,,,,,,
HMMAVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (33%);GO:0016021 (33%),nucleus (33%);integral component of membrane (33%),GO:0016740 (33%);GO:0043565 (33%),transferase activity (33%);sequence-specific DNA binding (33%),GO:0006355 (33%),regulation of transcription, DNA-templated (33%),IPR001296 (33%);IPR001356 (33%);IPR002539 (33%),Glycosyl transferase, family 1 (33%);Homeobox domain (33%);MaoC-like dehydratase domain (33%),,,,,,,,,
HVAENHMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTFAMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (69%);GO:0043190 (15%),integral component of membrane (69%);ATP-binding cassette (ABC) transporter complex (15%),GO:0016787 (15%);GO:0003677 (8%);GO:0003700 (8%),hydrolase activity (15%);DNA binding (8%);DNA-binding transcription factor activity (8%),GO:0055085 (15%),transmembrane transport (15%),IPR025263 (44%);IPR001194 (11%);IPR002885 (11%),Domain of unknown function DUF3971 (44%);cDENN domain (11%);Pentatricopeptide repeat (11%),,,,,,,,,,,
EEEMDTELNVQSQGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEVLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.225 (50%);2.1.1.193 (25%);3.4.24.84 (25%),Protein S-acyltransferase (50%);16S rRNA (uracil(1498)-N(3))-methyltransferase (25%);Ste24 endopeptidase (25%),GO:0016021 (74%);GO:0005886 (32%);GO:0031515 (2%),integral component of membrane (74%);plasma membrane (32%);tRNA (m1A) methyltransferase complex (2%),GO:0003677 (6%);GO:0008270 (3%);GO:0003824 (2%),DNA binding (6%);zinc ion binding (3%);catalytic activity (2%),GO:0055085 (34%);GO:0000160 (5%);GO:0046856 (3%),transmembrane transport (34%);phosphorelay signal transduction system (5%);phosphatidylinositol dephosphorylation (3%),IPR035906 (45%);IPR000515 (33%);IPR019286 (7%),MetI-like superfamily (45%);ABC transporter type 1, transmembrane domain MetI-like (33%);Protein of unknown function DUF2339, transmembrane (7%),,,,,,,,,
MFLQQNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMVNNTHVMTDAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMTMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (53%);6.1.1.5 (24%);1.-.-.- (12%),Leucine--tRNA ligase (53%);Isoleucine--tRNA ligase (24%);Oxidoreductases (12%),GO:0016021 (28%);GO:0005737 (13%);GO:0005829 (2%),integral component of membrane (28%);cytoplasm (13%);cytosol (2%),GO:0005524 (22%);GO:0016491 (17%);GO:0002161 (15%),ATP binding (22%);oxidoreductase activity (17%);aminoacyl-tRNA editing activity (15%),GO:0006429 (12%);GO:0016319 (10%);GO:0000209 (6%),leucyl-tRNA aminoacylation (12%);mushroom body development (10%);protein polyubiquitination (6%),IPR002300 (14%);IPR014729 (14%);IPR005017 (14%),Aminoacyl-tRNA synthetase, class Ia (14%);Rossmann-like alpha/beta/alpha sandwich fold (14%);Outer membrane protein transport protein (OMPP1/FadL/TodX) (14%),,,,,,,,,,
TEMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.12 (8%);6.2.1.54 (8%);2.7.7.9 (7%),Gluconokinase (8%);D-alanine--[D-alanyl-carrier protein] ligase (8%);UTP--glucose-1-phosphate uridylyltransferase (7%),GO:0016021 (24%);GO:0016593 (9%);GO:0005737 (7%),integral component of membrane (24%);Cdc73/Paf1 complex (9%);cytoplasm (7%),GO:0005524 (19%);GO:0003677 (6%);GO:0000155 (5%),ATP binding (19%);DNA binding (6%);phosphorelay sensor kinase activity (5%),GO:0006368 (9%);GO:0016570 (7%);GO:0032968 (3%),transcription elongation from RNA polymerase II promoter (9%);histone modification (7%);positive regulation of transcription elongation from RNA polymerase II promoter (3%),IPR027417 (11%);IPR007149 (8%);IPR013783 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);Leo1-like protein (8%);Immunoglobulin-like fold (7%),,,,,,,,,,,
QTLELGHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLNVFETVVLPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEATPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (93%);1.9.3.1 (7%),RING-type E3 ubiquitin transferase (93%);Cytochrome-c oxidase (7%),GO:0005634 (82%);GO:0005739 (50%);GO:0005737 (10%),nucleus (82%);mitochondrion (50%);cytoplasm (10%),GO:0046872 (83%);GO:0031624 (9%);GO:0061630 (9%),metal ion binding (83%);ubiquitin conjugating enzyme binding (9%);ubiquitin protein ligase activity (9%),GO:0006511 (82%);GO:0007275 (82%);GO:0016567 (74%),ubiquitin-dependent protein catabolic process (82%);multicellular organism development (82%);protein ubiquitination (74%),IPR004162 (84%);IPR008974 (84%);IPR018121 (84%),E3 ubiquitin-protein ligase SINA-like (84%);TRAF-like (84%);Seven-in-absentia protein, TRAF-like domain (84%),,,,,,,,,,
TMFVLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLMQGLTDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGVLYNGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPYFANQHYNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.20 (30%);2.7.1.26 (16%);2.7.7.2 (16%),Diaminopimelate decarboxylase (30%);Riboflavin kinase (16%);FAD synthase (16%),GO:0016021 (28%);GO:0005737 (9%);GO:0009279 (9%),integral component of membrane (28%);cytoplasm (9%);cell outer membrane (9%),GO:0005524 (14%);GO:0008836 (9%);GO:0030170 (9%),ATP binding (14%);diaminopimelate decarboxylase activity (9%);pyridoxal phosphate binding (9%),GO:0009089 (9%);GO:0006747 (5%);GO:0009398 (5%),lysine biosynthetic process via diaminopimelate (9%);FAD biosynthetic process (5%);FMN biosynthetic process (5%),IPR001638 (10%);IPR009006 (7%);IPR022643 (7%),Solute-binding protein  family 3/N-terminal domain of MltF (10%);Alanine racemase/group IV decarboxylase, C-terminal (7%);Orn/DAP/Arg decarboxylase 2, C-terminal (7%),,,,,,,,,
NYLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.4 (12%);2.1.1.37 (10%);5.6.2.2 (6%),Malate dehydrogenase (quinone) (12%);DNA (cytosine-5-)-methyltransferase (10%);DNA topoisomerase (ATP-hydrolyzing) (6%),GO:0016021 (31%);GO:0005737 (4%);GO:0009279 (3%),integral component of membrane (31%);cytoplasm (4%);cell outer membrane (3%),GO:0005524 (14%);GO:0003700 (13%);GO:0003677 (10%),ATP binding (14%);DNA-binding transcription factor activity (13%);DNA binding (10%),GO:0006352 (3%);GO:0032259 (3%);GO:0045892 (2%),DNA-templated transcription, initiation (3%);methylation (3%);negative regulation of transcription, DNA-templated (2%),IPR027417 (9%);IPR009057 (9%);IPR018060 (9%),P-loop containing nucleoside triphosphate hydrolase (9%);Homeobox-like domain superfamily (9%);DNA binding HTH domain, AraC-type (9%),,,,,,,,
TLALFMMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPALDHMLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNLNDAPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQKPTM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFEQHYWVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (9%);3.4.22.28 (9%);3.4.22.29 (9%),RNA-directed RNA polymerase (9%);Picornain 3C (9%);Picornain 2A (9%),GO:0016021 (23%);GO:0019028 (4%);GO:0005737 (4%),integral component of membrane (23%);viral capsid (4%);cytoplasm (4%),GO:0005524 (19%);GO:0046872 (9%);GO:0016491 (7%),ATP binding (19%);metal ion binding (9%);oxidoreductase activity (7%),GO:0009058 (4%);GO:0006351 (3%);GO:0055085 (3%),biosynthetic process (4%);transcription, DNA-templated (3%);transmembrane transport (3%),IPR027417 (10%);IPR003812 (7%);IPR011204 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Fido domain (7%);Virulence protein RhuM-like (6%),,,,,,,,,,
MLVNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.4.1.1 (83%);6.3.5.3 (9%);2.5.1.58 (4%),Pyruvate carboxylase (83%);Phosphoribosylformylglycinamidine synthase (9%);Protein farnesyltransferase (4%),GO:0016021 (21%);GO:0005737 (3%);GO:0005965 (2%),integral component of membrane (21%);cytoplasm (3%);protein farnesyltransferase complex (2%),GO:0005524 (37%);GO:0046872 (37%);GO:0004736 (30%),ATP binding (37%);metal ion binding (37%);pyruvate carboxylase activity (30%),GO:0006090 (30%);GO:0006094 (30%);GO:0006189 (3%),pyruvate metabolic process (30%);gluconeogenesis (30%);'de novo' IMP biosynthetic process (3%),IPR005479 (25%);IPR011761 (25%);IPR016185 (25%),Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain (25%);ATP-grasp fold (25%);Pre-ATP-grasp domain superfamily (25%),,,,,,,,,,
NPDALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.17 (27%);2.8.1.10 (14%);2.1.1.- (10%),Enoyl-CoA hydratase (27%);Thiazole synthase (14%);Methyltransferases (10%),GO:0016021 (17%);GO:0005737 (12%);GO:0031317 (2%),integral component of membrane (17%);cytoplasm (12%);tripartite ATP-independent periplasmic transporter complex (2%),GO:0008168 (18%);GO:0003824 (12%);GO:0005524 (11%),methyltransferase activity (18%);catalytic activity (12%);ATP binding (11%),GO:0032259 (17%);GO:0009228 (5%);GO:0009229 (5%),methylation (17%);thiamine biosynthetic process (5%);thiamine diphosphate biosynthetic process (5%),IPR001753 (16%);IPR029045 (16%);IPR014748 (15%),Enoyl-CoA hydratase/isomerase (16%);ClpP/crotonase-like domain superfamily (16%);Enoyl-CoA hydratase, C-terminal (15%),,,,,,,,,,
FEDASTFMAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSTVN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.3 (100%),Aldose 1-epimerase (100%),,,GO:0004034 (50%);GO:0004066 (50%);GO:0005524 (50%),aldose 1-epimerase activity (50%);asparagine synthase (glutamine-hydrolyzing) activity (50%);ATP binding (50%),GO:0006529 (50%);GO:0006541 (50%);GO:0019318 (50%),asparagine biosynthetic process (50%);glutamine metabolic process (50%);hexose metabolic process (50%),IPR001962 (33%);IPR006426 (33%);IPR008183 (33%),Asparagine synthase (33%);Asparagine synthase, glutamine-hydrolyzing (33%);Aldose 1-/Glucose-6-phosphate 1-epimerase (33%),,,,,,,,,,
SPEAASDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWYER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.130 (16%);1.8.4.- (11%);2.4.1.- (11%),Tetraacyldisaccharide 4'-kinase (16%);With a disulfide as acceptor (11%);Hexosyltransferases (11%),GO:0016021 (44%);GO:0005634 (8%);GO:0005737 (2%),integral component of membrane (44%);nucleus (8%);cytoplasm (2%),GO:0015103 (18%);GO:0015297 (18%);GO:0016740 (18%),inorganic anion transmembrane transporter activity (18%);antiporter activity (18%);transferase activity (18%),GO:0006260 (2%);GO:0006281 (2%);GO:0006355 (2%),DNA replication (2%);DNA repair (2%);regulation of transcription, DNA-templated (2%),IPR008532 (13%);IPR027417 (12%);IPR002657 (11%),NFACT, RNA-binding domain (13%);P-loop containing nucleoside triphosphate hydrolase (12%);Bile acid:sodium symporter/arsenical resistance protein  Acr3 (11%),,,,,,,,,
MENVMVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEVYPEDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYVSMR,Cordyceps fumosorosea,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Hypocreales,,,,,Cordycipitaceae,,,,Cordyceps,,,,Cordyceps fumosorosea,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),,,IPR013094 (100%);IPR029058 (100%),Alpha/beta hydrolase fold-3 (100%);Alpha/Beta hydrolase fold (100%),,,,,,,,,,,
MFVLHAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004497 (100%),monooxygenase activity (100%),,,IPR007138 (67%);IPR011008 (67%);IPR031440 (33%),Antibiotic biosynthesis monooxygenase domain (67%);Dimeric alpha-beta barrel (67%);Protein of unknown function DUF4670 (33%),,,,,,,,,,,
HAMVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.8 (100%),Phosphate acetyltransferase (100%),GO:0016021 (20%),integral component of membrane (20%),GO:0003677 (20%);GO:0005524 (20%);GO:0008959 (20%),DNA binding (20%);ATP binding (20%);phosphate acetyltransferase activity (20%),GO:0006310 (20%);GO:0015074 (20%),DNA recombination (20%);DNA integration (20%),IPR000008 (38%);IPR002505 (38%);IPR012147 (38%),C2 domain (38%);Phosphate acetyl/butaryl transferase (38%);Phosphate acetyl/butyryltransferase (38%),,,,,,,,,,,
SNGSEVSR,Pseudogymnoascus,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Leotiomycetes,,,,,,,,,Pseudeurotiaceae,,,,Pseudogymnoascus,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYNDHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.19 (100%),3-phosphoshikimate 1-carboxyvinyltransferase (100%),GO:0005737 (67%);GO:0016021 (11%);GO:0005634 (6%),cytoplasm (67%);integral component of membrane (11%);nucleus (6%),GO:0003866 (67%);GO:0003677 (11%);GO:0000981 (6%),3-phosphoshikimate 1-carboxyvinyltransferase activity (67%);DNA binding (11%);DNA-binding transcription factor activity, RNA polymerase II-specific (6%),GO:0009073 (67%);GO:0009423 (56%);GO:0006310 (6%),aromatic amino acid family biosynthetic process (67%);chorismate biosynthetic process (56%);DNA recombination (6%),IPR001986 (63%);IPR006264 (63%);IPR013792 (63%),Enolpyruvate transferase domain (63%);3-phosphoshikimate 1-carboxyvinyltransferase (63%);RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta (63%),,,,,,,,,
MLSFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.195 (8%);2.3.1.102 (8%);3.4.19.12 (6%),Cobalt-precorrin-5B (C(1))-methyltransferase (8%);N(6)-hydroxylysine O-acetyltransferase (8%);Ubiquitinyl hydrolase 1 (6%),GO:0016021 (30%);GO:0005737 (5%);GO:0016020 (4%),integral component of membrane (30%);cytoplasm (5%);membrane (4%),GO:0005524 (15%);GO:0016887 (7%);GO:0003677 (7%),ATP binding (15%);ATPase activity (7%);DNA binding (7%),GO:0009664 (3%);GO:0055085 (2%);GO:0032259 (2%),plant-type cell wall organization (3%);transmembrane transport (2%);methylation (2%),IPR027417 (12%);IPR003593 (7%);IPR003439 (6%),P-loop containing nucleoside triphosphate hydrolase (12%);AAA+ ATPase domain (7%);ABC transporter-like (6%),,,,,,,,,,,
MLLSGWSGVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPDVFFFLADNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFYVTYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LADSYLNPEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPMLEPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003676 (50%);GO:0004386 (50%);GO:0005524 (50%),nucleic acid binding (50%);helicase activity (50%);ATP binding (50%),GO:0006139 (50%),nucleobase-containing compound metabolic process (50%),IPR006555 (50%);IPR009051 (50%);IPR017927 (50%),ATP-dependent helicase, C-terminal (50%);Alpha-helical ferredoxin (50%);FAD-binding domain, ferredoxin reductase-type (50%),,,,,,,,,
TVMEVTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVYLLMTFDTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SHVDQHSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPAHPVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYNTLVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFDAALYTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDCHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HTTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.- (53%);2.7.1.39 (15%);2.3.1.31 (6%),In phosphorus-containing anhydrides (53%);Homoserine kinase (15%);Homoserine O-acetyltransferase (6%),GO:0016021 (25%);GO:0005737 (22%);GO:0009279 (5%),integral component of membrane (25%);cytoplasm (22%);cell outer membrane (5%),GO:0046872 (20%);GO:0003924 (19%);GO:0005525 (18%),metal ion binding (20%);GTPase activity (19%);GTP binding (18%),GO:0042274 (17%);GO:0005975 (8%);GO:0009088 (5%),ribosomal small subunit biogenesis (17%);carbohydrate metabolic process (8%);threonine biosynthetic process (5%),IPR027417 (20%);IPR004881 (15%);IPR010914 (15%),P-loop containing nucleoside triphosphate hydrolase (20%);Ribosome biogenesis GTPase RsgA (15%);RsgA GTPase domain (15%),,,,,,,,,,,
FLHNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.6.2.1 (23%);2.3.1.4 (14%);2.7.7.38 (8%),P-type phospholipid transporter (23%);Glucosamine-phosphate N-acetyltransferase (14%);3-deoxy-manno-octulosonate cytidylyltransferase (8%),GO:0016021 (59%);GO:0005886 (33%);GO:0005737 (5%),integral component of membrane (59%);plasma membrane (33%);cytoplasm (5%),GO:0005524 (14%);GO:0000287 (4%);GO:0140326 (4%),ATP binding (14%);magnesium ion binding (4%);ATPase-coupled intramembrane lipid transporter activity (4%),GO:0055085 (32%);GO:0015914 (4%);GO:0006048 (2%),transmembrane transport (32%);phospholipid transport (4%);UDP-N-acetylglucosamine biosynthetic process (2%),IPR000515 (28%);IPR035906 (28%);IPR025966 (28%),ABC transporter type 1, transmembrane domain MetI-like (28%);MetI-like superfamily (28%);Oligopeptide transport permease C-like, N-terminal domain (28%),,,,,,,,,
CMTPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.39 (100%),[Acyl-carrier-protein] S-malonyltransferase (100%),GO:0016021 (20%),integral component of membrane (20%),GO:0004314 (60%);GO:0003677 (20%),[acyl-carrier-protein] S-malonyltransferase activity (60%);DNA binding (20%),GO:0055085 (20%),transmembrane transport (20%),IPR003772 (40%);IPR039255 (40%);IPR001227 (30%),Large ribosomal RNA subunit accumulation protein YceD (40%);Large ribosomal RNA subunit accumulation protein YceD, bacteria (40%);Acyl transferase domain superfamily (30%),,,,,,,,,,
MLVFLMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTDVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.85 (50%);2.5.1.97 (50%),3-isopropylmalate dehydrogenase (50%);Pseudaminic acid synthase (50%),GO:0016021 (84%);GO:0009279 (81%);GO:0005737 (2%),integral component of membrane (84%);cell outer membrane (81%);cytoplasm (2%),GO:0005524 (10%);GO:0046872 (10%);GO:0016301 (8%),ATP binding (10%);metal ion binding (10%);kinase activity (8%),GO:0046677 (8%);GO:0000160 (2%);GO:0009098 (2%),response to antibiotic (8%);phosphorelay signal transduction system (2%);leucine biosynthetic process (2%),IPR000531 (81%);IPR012910 (81%);IPR037066 (81%),TonB-dependent receptor-like, beta-barrel (81%);TonB-dependent receptor, plug domain (81%);TonB-dependent receptor, plug domain superfamily (81%),,,,,,,,
QAHSNNFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VRPHNMLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFFFVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WTVCKPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ECEAPSK,Araneus ventricosus,Eukaryota,Metazoa,,,Arthropoda,Chelicerata,,Arachnida,,,,Araneae,Araneomorphae,,,Araneoidea,Araneidae,,,,Araneus,,,,Araneus ventricosus,,,,,,,,GO:0003676 (100%),nucleic acid binding (100%),GO:0015074 (100%),DNA integration (100%),IPR001584 (100%);IPR008042 (100%);IPR012337 (100%),Integrase, catalytic core (100%);Retrotransposon, Pao (100%);Ribonuclease H-like superfamily (100%),,,,,,,,,
YYGNDNNVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPQLQQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0005509 (50%);GO:0016491 (50%),calcium ion binding (50%);oxidoreductase activity (50%),,,IPR002048 (50%);IPR002347 (50%);IPR011992 (50%),EF-hand domain (50%);Short-chain dehydrogenase/reductase SDR (50%);EF-hand domain pair (50%),,,,,,,,,,,
AALLSLAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGTVVMEHWYAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGFDMLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.3 (100%),Uridine phosphorylase (100%),GO:0005886 (36%);GO:0005737 (27%);GO:0016021 (18%),plasma membrane (36%);cytoplasm (27%);integral component of membrane (18%),GO:0003824 (27%);GO:0004519 (9%);GO:0004850 (9%),catalytic activity (27%);endonuclease activity (9%);uridine phosphorylase activity (9%),GO:0009116 (36%),nucleoside metabolic process (36%),IPR000845 (33%);IPR035994 (33%);IPR007451 (25%),Nucleoside phosphorylase domain (33%);Nucleoside phosphorylase superfamily (33%);High frequency lysogenization protein HflD (25%),,,,,,,,,,,
TSTTAMR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEYGHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.55 (100%),Non-reducing end alpha-L-arabinofuranosidase (100%),GO:0016021 (27%);GO:0009279 (9%);GO:0005886 (3%),integral component of membrane (27%);cell outer membrane (9%);plasma membrane (3%),GO:0016639 (21%);GO:0051536 (21%);GO:0016740 (18%),oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor (21%);iron-sulfur cluster binding (21%);transferase activity (18%),GO:0006537 (21%);GO:0071709 (12%);GO:0006464 (9%),glutamate biosynthetic process (21%);membrane assembly (12%);cellular protein modification process (9%),IPR001296 (23%);IPR028098 (23%);IPR006005 (19%),Glycosyl transferase, family 1 (23%);Glycosyltransferase subfamily 4-like, N-terminal domain (23%);Glutamate synthase, NADH/NADPH, small subunit 1 (19%),,,,,
YTDMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.17 (40%);3.4.24.- (16%);1.11.1.21 (6%),5-dehydro-4-deoxy-D-glucuronate isomerase (40%);Metalloendopeptidases (16%);Catalase peroxidase (6%),GO:0016021 (32%);GO:0005886 (5%);GO:0005737 (3%),integral component of membrane (32%);plasma membrane (5%);cytoplasm (3%),GO:0008270 (17%);GO:0005524 (14%);GO:0008697 (11%),zinc ion binding (17%);ATP binding (14%);4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase activity (11%),GO:0045490 (11%);GO:0009103 (9%);GO:0045226 (9%),pectin catabolic process (11%);lipopolysaccharide biosynthetic process (9%);extracellular polysaccharide biosynthetic process (9%),IPR027417 (15%);IPR014710 (10%);IPR007045 (9%),P-loop containing nucleoside triphosphate hydrolase (15%);RmlC-like jelly roll fold (10%);5-keto 4-deoxyuronate isomerase (9%),,,,,,,,,,,
LLDAHMVMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WQQSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0005524 (100%),ATP binding (100%),GO:0006605 (100%);GO:0017038 (100%),protein targeting (100%);protein import (100%),IPR000185 (33%);IPR004027 (33%);IPR010330 (33%),Protein translocase subunit SecA (33%);SEC-C motif (33%);Competence-induced protein CoiA-like (33%),,,,,,,,,,,
GQTALDQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMALGNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0010181 (100%);GO:0016491 (100%),FMN binding (100%);oxidoreductase activity (100%),,,IPR001155 (100%);IPR013785 (100%),NADH:flavin oxidoreductase/NADH oxidase, N-terminal (100%);Aldolase-type TIM barrel (100%),,,,,,,,,,
GSSMQGHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFLNDVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPEYN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YCTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.169 (18%);1.18.6.1 (18%);2.6.1.52 (18%),2-dehydropantoate 2-reductase (18%);Nitrogenase (18%);Phosphoserine transaminase (18%),GO:0016021 (27%);GO:0005737 (8%);GO:0043190 (5%),integral component of membrane (27%);cytoplasm (8%);ATP-binding cassette (ABC) transporter complex (5%),GO:0003676 (19%);GO:0003677 (15%);GO:0005524 (14%),nucleic acid binding (19%);DNA binding (15%);ATP binding (14%),GO:0055085 (5%);GO:0006535 (4%);GO:0005975 (2%),transmembrane transport (5%);cysteine biosynthetic process from serine (4%);carbohydrate metabolic process (2%),IPR035979 (13%);IPR036388 (9%);IPR036390 (9%),RNA-binding domain superfamily (13%);Winged helix-like DNA-binding domain superfamily (9%);Winged helix DNA-binding domain superfamily (9%),,,,,,,,,,,
MSNHSFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005819 (50%);GO:0005874 (50%),spindle (50%);microtubule (50%),GO:0016829 (50%),lyase activity (50%),GO:0032147 (50%);GO:0060236 (50%),activation of protein kinase activity (50%);regulation of mitotic spindle organization (50%),IPR008794 (33%);IPR009675 (33%);IPR012669 (33%),Proline racemase family (33%);TPX2 (33%);Pectic acid lyase (33%),,,,,,,,,,,
NNYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (13%);1.1.1.17 (8%);5.6.2.2 (8%),Cytochrome-c oxidase (13%);Mannitol-1-phosphate 5-dehydrogenase (8%);DNA topoisomerase (ATP-hydrolyzing) (8%),GO:0016021 (36%);GO:0005737 (20%);GO:0005730 (3%),integral component of membrane (36%);cytoplasm (20%);nucleolus (3%),GO:0005524 (23%);GO:0003697 (11%);GO:0003677 (8%),ATP binding (23%);single-stranded DNA binding (11%);DNA binding (8%),GO:0006260 (13%);GO:0006281 (12%);GO:0009432 (11%),DNA replication (13%);DNA repair (12%);SOS response (11%),IPR027417 (15%);IPR003395 (9%);IPR001238 (9%),P-loop containing nucleoside triphosphate hydrolase (15%);RecF/RecN/SMC, N-terminal (9%);DNA-binding, RecF (9%),,,,,,,,,
EHNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (75%);1.17.7.4 (4%);2.3.1.275 (2%),DNA-directed RNA polymerase (75%);4-hydroxy-3-methylbut-2-enyl diphosphate reductase (4%);Acyl phosphate:glycerol-3-phosphate acyltransferase (2%),GO:0005634 (30%);GO:0016021 (16%);GO:0005736 (8%),nucleus (30%);integral component of membrane (16%);RNA polymerase I complex (8%),GO:0003677 (39%);GO:0008270 (37%);GO:0003899 (29%),DNA binding (39%);zinc ion binding (37%);DNA-directed 5'-3' RNA polymerase activity (29%),GO:0006351 (28%);GO:1904750 (7%);GO:0019538 (4%),transcription, DNA-templated (28%);negative regulation of protein localization to nucleolus (7%);protein metabolic process (4%),IPR015699 (33%);IPR006592 (32%);IPR000722 (32%),DNA-directed RNA pol I, largest subunit (33%);RNA polymerase, N-terminal (32%);RNA polymerase, alpha subunit (32%),,,,,,,
LVPNQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.17 (80%);3.5.1.18 (5%);1.17.99.6 (3%),Mannitol-1-phosphate 5-dehydrogenase (80%);Succinyl-diaminopimelate desuccinylase (5%);Epoxyqueuosine reductase (3%),GO:0016021 (8%);GO:0005634 (1%);GO:0005886 (1%),integral component of membrane (8%);nucleus (1%);plasma membrane (1%),GO:0016787 (55%);GO:0008926 (19%);GO:0050662 (16%),hydrolase activity (55%);mannitol-1-phosphate 5-dehydrogenase activity (19%);coenzyme binding (16%),GO:0019594 (16%);GO:0006355 (4%);GO:0006751 (2%),mannitol metabolic process (16%);regulation of transcription, DNA-templated (4%);glutathione catabolic process (2%),IPR002933 (52%);IPR011650 (52%);IPR036291 (18%),Peptidase M20 (52%);Peptidase M20, dimerisation domain (52%);NAD(P)-binding domain superfamily (18%),,,,,,,,,
AQAEGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.3 (15%);2.3.1.9 (8%);2.3.1.16 (6%),Adenylate kinase (15%);Acetyl-CoA C-acetyltransferase (8%);Acetyl-CoA C-acyltransferase (6%),GO:0016021 (22%);GO:0005886 (12%);GO:0005737 (9%),integral component of membrane (22%);plasma membrane (12%);cytoplasm (9%),GO:0005524 (17%);GO:0016747 (9%);GO:0046872 (8%),ATP binding (17%);transferase activity, transferring acyl groups other than amino-acyl groups (9%);metal ion binding (8%),GO:0015031 (10%);GO:0044209 (4%);GO:0006412 (3%),protein transport (10%);AMP salvage (4%);translation (3%),IPR027417 (12%);IPR016039 (12%);IPR020616 (12%),P-loop containing nucleoside triphosphate hydrolase (12%);Thiolase-like (12%);Thiolase, N-terminal (12%),,,,,,,,,
GMGGAATVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPNMNLFLASR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FTGMLGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPCYQMVYHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVDTPWWHASAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLENPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.2 (50%);1.10.3.1 (25%);2.4.-.- (13%),GMP synthase (glutamine-hydrolyzing) (50%);Catechol oxidase (25%);Glycosyltransferases (13%),GO:0005634 (13%);GO:0016020 (5%);GO:0016021 (5%),nucleus (13%);membrane (5%);integral component of membrane (5%),GO:0016740 (20%);GO:0005524 (18%);GO:0003676 (10%),transferase activity (20%);ATP binding (18%);nucleic acid binding (10%),GO:0006357 (10%);GO:0006541 (10%);GO:0006812 (5%),regulation of transcription by RNA polymerase II (10%);glutamine metabolic process (10%);cation transport (5%),IPR022155 (21%);IPR001296 (16%);IPR028098 (16%),Protein of unknown function DUF3684 (21%);Glycosyl transferase, family 1 (16%);Glycosyltransferase subfamily 4-like, N-terminal domain (16%),,,,,,,,,
GNNDTGLLDNNAHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGCLYDLTNEAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAWNPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (100%),Polyphosphate kinase (100%),GO:0009358 (14%);GO:0016021 (14%),polyphosphate kinase complex (14%);integral component of membrane (14%),GO:0046872 (86%);GO:0010181 (57%);GO:0016491 (57%),metal ion binding (86%);FMN binding (57%);oxidoreductase activity (57%),GO:0042128 (57%);GO:0006799 (29%),nitrate assimilation (57%);polyphosphate biosynthetic process (29%),IPR001094 (57%);IPR001433 (57%);IPR001709 (57%),Flavodoxin-like (57%);Oxidoreductase FAD/NAD(P)-binding (57%);Flavoprotein pyridine nucleotide cytochrome reductase (57%),,,,,,,,,,,
MPATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (12%);4.2.3.4 (7%);2.7.7.7 (6%),Type I site-specific deoxyribonuclease (12%);3-dehydroquinate synthase (7%);DNA-directed DNA polymerase (6%),GO:0016021 (25%);GO:0005737 (10%);GO:0043590 (5%),integral component of membrane (25%);cytoplasm (10%);bacterial nucleoid (5%),GO:0003677 (14%);GO:0005524 (10%);GO:0046872 (7%),DNA binding (14%);ATP binding (10%);metal ion binding (7%),GO:0051301 (5%);GO:0007049 (5%);GO:0010974 (5%),cell division (5%);cell cycle (5%);negative regulation of division septum assembly (5%),IPR011050 (17%);IPR023882 (17%);IPR006311 (17%),Pectin lyase fold/virulence factor (17%);Colanic acid biosynthesis WcaM (17%);Twin-arginine translocation pathway, signal sequence (17%),,,,,,,,,,
EAEAENTNWVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SAYPASELGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPNWEYPQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPPSASSHLAPGYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CEPDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.- (100%),Pentosyltransferases (100%),GO:0005634 (13%),nucleus (13%),GO:0004519 (71%);GO:0000981 (13%);GO:0003950 (13%),endonuclease activity (71%);DNA-binding transcription factor activity, RNA polymerase II-specific (13%);NAD+ ADP-ribosyltransferase activity (13%),GO:0006302 (13%);GO:0006471 (13%);GO:0006351 (4%),double-strand break repair (13%);protein ADP-ribosylation (13%);transcription, DNA-templated (4%),IPR002110 (71%);IPR003887 (71%);IPR011015 (71%),Ankyrin repeat (71%);LEM domain (71%);LEM/LEM-like domain superfamily (71%),,,,,,,,,
CQLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.15 (26%);2.3.1.37 (20%);2.3.1.286 (13%),Acetyl-CoA carboxytransferase (26%);5-aminolevulinate synthase (20%);Protein acetyllysine N-acetyltransferase (13%),GO:0016021 (18%);GO:0005737 (5%);GO:0005634 (5%),integral component of membrane (18%);cytoplasm (5%);nucleus (5%),GO:0005524 (29%);GO:0016887 (18%);GO:0003723 (9%),ATP binding (29%);ATPase activity (18%);RNA binding (9%),GO:0006633 (4%);GO:2001295 (4%);GO:0006782 (3%),fatty acid biosynthetic process (4%);malonyl-CoA biosynthetic process (4%);protoporphyrinogen IX biosynthetic process (3%),IPR027417 (24%);IPR003593 (18%);IPR003439 (16%),P-loop containing nucleoside triphosphate hydrolase (24%);AAA+ ATPase domain (18%);ABC transporter-like (16%),,,,,,,,,,,
SNEENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.107 (35%);6.3.5.1 (24%);3.1.3.- (18%),Diacylglycerol kinase (ATP) (35%);NAD(+) synthase (glutamine-hydrolyzing) (24%);Phosphoric monoester hydrolases (18%),GO:0016021 (53%);GO:0032421 (15%);GO:0005737 (3%),integral component of membrane (53%);stereocilium bundle (15%);cytoplasm (3%),GO:0004725 (41%);GO:0003700 (16%);GO:0005524 (8%),protein tyrosine phosphatase activity (41%);DNA-binding transcription factor activity (16%);ATP binding (8%),GO:0002244 (15%);GO:0050885 (15%);GO:0050910 (15%),hematopoietic progenitor cell differentiation (15%);neuromuscular process controlling balance (15%);detection of mechanical stimulus involved in sensory perception of sound (15%),IPR013783 (32%);IPR036116 (32%);IPR000242 (31%),Immunoglobulin-like fold (32%);Fibronectin type III superfamily (32%);PTP type protein phosphatase (31%),,,,,,,,,,,
NPSVPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR005653 (100%),Organic solvent tolerance-like, N-terminal (100%),,,,,,,,,,
DWLTGFTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNANPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (77%);2.7.2.1 (8%);3.4.-.- (8%),Metalloendopeptidases (77%);Acetate kinase (8%);Acting on peptide bonds (peptidases) (8%),GO:0016021 (48%);GO:0005886 (30%);GO:0005737 (9%),integral component of membrane (48%);plasma membrane (30%);cytoplasm (9%),GO:0005524 (48%);GO:0016887 (33%);GO:0004222 (30%),ATP binding (48%);ATPase activity (33%);metalloendopeptidase activity (30%),GO:0030163 (30%);GO:0006325 (6%);GO:0007029 (6%),protein catabolic process (30%);chromatin organization (6%);endoplasmic reticulum organization (6%),IPR027417 (35%);IPR003593 (28%);IPR003959 (28%),P-loop containing nucleoside triphosphate hydrolase (35%);AAA+ ATPase domain (28%);ATPase, AAA-type, core (28%),,,,,,,,,
WESTQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (75%);GO:0004553 (25%),catalytic activity (75%);hydrolase activity, hydrolyzing O-glycosyl compounds (25%),GO:0005975 (25%),carbohydrate metabolic process (25%),IPR003143 (60%);IPR011048 (60%);IPR001544 (20%),Cytochrome cd1-nitrite reductase, C-terminal domain superfamily (60%);Cytochrome cd1-nitrite reductase-like, haem d1 domain superfamily (60%);Aminotransferase class IV (20%),,,,,,,,
LVQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.115 (21%);4.2.1.- (15%);3.1.-.- (7%),UDP-N-acetylglucosamine 4,6-dehydratase (inverting) (21%);Hydro-lyases (15%);Acting on ester bonds (7%),GO:0016021 (23%);GO:0005737 (6%);GO:0005634 (4%),integral component of membrane (23%);cytoplasm (6%);nucleus (4%),GO:0005524 (14%);GO:0046872 (10%);GO:0016829 (10%),ATP binding (14%);metal ion binding (10%);lyase activity (10%),GO:0015031 (3%);GO:0006099 (2%);GO:0055085 (2%),protein transport (3%);tricarboxylic acid cycle (2%);transmembrane transport (2%),IPR036291 (16%);IPR003869 (15%);IPR020025 (15%),NAD(P)-binding domain superfamily (16%);Polysaccharide biosynthesis protein, CapD-like domain (15%);UDP-N-acetylglucosamine 4,6-dehydratase (inverting) (15%),,,,,,,,
ALHWVFDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLEMVMMELTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTTDWNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVPTVGNMAMFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CSLVMVNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNVTMHAEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QYENSSSMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSFADYR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0015299 (100%),solute:proton antiporter activity (100%),,,IPR006153 (50%);IPR010657 (50%);IPR017740 (50%),Cation/H+ exchanger (50%);ImpA, N-terminal (50%);Type VI secretion system-associated, ImpA (50%),,,,,,,,,
FLDSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.49 (27%);2.7.1.- (12%);4.4.1.11 (6%),O-acetylhomoserine aminocarboxypropyltransferase (27%);Phosphotransferases with an alcohol group as acceptor (12%);Methionine gamma-lyase (6%),GO:0016021 (24%);GO:0005737 (10%);GO:0030286 (4%),integral component of membrane (24%);cytoplasm (10%);dynein complex (4%),GO:0003824 (19%);GO:0030170 (17%);GO:0010181 (16%),catalytic activity (19%);pyridoxal phosphate binding (17%);FMN binding (16%),GO:0019346 (16%);GO:0055114 (15%);GO:0008033 (15%),transsulfuration (16%);oxidation-reduction process (15%);tRNA processing (15%),IPR013785 (17%);IPR007197 (17%);IPR013917 (15%),Aldolase-type TIM barrel (17%);Radical SAM (17%);tRNA wybutosine-synthesis (15%),,,,,,,,,,,
DDDLLVVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%);GO:0016020 (33%),integral component of membrane (67%);membrane (33%),GO:0005524 (33%);GO:0016887 (33%),ATP binding (33%);ATPase activity (33%),GO:0031460 (33%),glycine betaine transport (33%),IPR005182 (67%);IPR003439 (33%);IPR003593 (33%),Domain of unknown function DUF304 (67%);ABC transporter-like (33%);AAA+ ATPase domain (33%),,,,,,,,,,,
FAVTNWDNPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNLAAELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0008080 (67%),N-acetyltransferase activity (67%),,,IPR000182 (67%);IPR016181 (67%);IPR003892 (33%),GNAT domain (67%);Acyl-CoA N-acyltransferase (67%);Ubiquitin system component CUE (33%),,,,,,,,,,,
FLLELDDEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNFVTACSLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLAHMFMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEVATNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVNCPAPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPWWLK,Halopolyspora algeriensis,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,,,,,,,,,,Halopolyspora,,,,Halopolyspora algeriensis,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
MQYHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (45%);1.1.1.- (15%);1.14.13.7 (6%),Nucleotidyltransferases (45%);With NAD(+) or NADP(+) as acceptor (15%);Phenol 2-monooxygenase (NADPH) (6%),GO:1990077 (5%);GO:0016021 (3%);GO:0005737 (1%),primosome complex (5%);integral component of membrane (3%);cytoplasm (1%),GO:0016491 (76%);GO:0003677 (6%);GO:0008270 (6%),oxidoreductase activity (76%);DNA binding (6%);zinc ion binding (6%),GO:0006782 (1%);GO:0030632 (1%);GO:0006396 (0%),protoporphyrinogen IX biosynthetic process (1%);D-alanine biosynthetic process (1%);RNA processing (0%),IPR036812 (80%);IPR023210 (79%);IPR020471 (58%),NADP-dependent oxidoreductase domain superfamily (80%);NADP-dependent oxidoreductase domain (79%);Aldo/keto reductase (58%),,,,,,,,,,,
MSDMVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLDQQCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WMNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (40%);1.14.15.3 (20%);2.1.1.163 (20%),Transferring other groups (40%);Alkane 1-monooxygenase (20%);Demethylmenaquinone methyltransferase (20%),GO:0016021 (40%);GO:0005886 (12%);GO:0016020 (1%),integral component of membrane (40%);plasma membrane (12%);membrane (1%),GO:0003676 (18%);GO:0003677 (18%);GO:0008270 (13%),nucleic acid binding (18%);DNA binding (18%);zinc ion binding (13%),GO:0015074 (29%);GO:0006310 (14%);GO:0019835 (13%),DNA integration (29%);DNA recombination (14%);cytolysis (13%),IPR027417 (36%);IPR017818 (29%);IPR025669 (29%),P-loop containing nucleoside triphosphate hydrolase (36%);Plasmid partitioning protein, RepA (29%);AAA domain (29%),,,,,,,,,,
ENMAELR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.99.1 (50%);2.7.13.3 (50%),Deleted entry (50%);Histidine kinase (50%),GO:0016021 (11%),integral component of membrane (11%),GO:0016627 (67%);GO:0050660 (67%);GO:0000155 (11%),oxidoreductase activity, acting on the CH-CH group of donors (67%);flavin adenine dinucleotide binding (67%);phosphorelay sensor kinase activity (11%),GO:0022900 (67%),electron transport chain (67%),IPR003952 (67%);IPR003953 (67%);IPR014006 (67%),Fumarate reductase/succinate dehydrogenase, FAD-binding site (67%);FAD-dependent oxidoreductase 2, FAD binding domain (67%);Succinate dehydrogenase/fumarate reductase, flavoprotein subunit (67%),,,,,,,
STWTYPVGYYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNVCPGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WAELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.- (28%);6.1.1.5 (12%);3.2.1.23 (7%),Transferring alkyl or aryl groups, other than methyl groups (28%);Isoleucine--tRNA ligase (12%);Beta-galactosidase (7%),GO:0016021 (23%);GO:0005737 (8%);GO:0008091 (4%),integral component of membrane (23%);cytoplasm (8%);spectrin (4%),GO:0005524 (23%);GO:0003677 (14%);GO:0000287 (7%),ATP binding (23%);DNA binding (14%);magnesium ion binding (7%),GO:0006260 (4%);GO:0051693 (3%);GO:0005975 (3%),DNA replication (4%);actin filament capping (3%);carbohydrate metabolic process (3%),IPR027417 (16%);IPR003593 (6%);IPR008979 (6%),P-loop containing nucleoside triphosphate hydrolase (16%);AAA+ ATPase domain (6%);Galactose-binding-like domain superfamily (6%),,,,,,,,,,
MTLFAPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVQSMRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (15%);6.1.1.10 (10%);2.3.1.48 (8%),DNA helicase (15%);Methionine--tRNA ligase (10%);Histone acetyltransferase (8%),GO:0016021 (26%);GO:0005737 (7%);GO:0005829 (5%),integral component of membrane (26%);cytoplasm (7%);cytosol (5%),GO:0005524 (22%);GO:0004386 (11%);GO:0003676 (10%),ATP binding (22%);helicase activity (11%);nucleic acid binding (10%),GO:0009294 (11%);GO:0044806 (5%);GO:0006359 (4%),DNA mediated transformation (11%);G-quadruplex DNA unwinding (5%);regulation of transcription by RNA polymerase III (4%),IPR027417 (20%);IPR001650 (13%);IPR011709 (13%),P-loop containing nucleoside triphosphate hydrolase (20%);Helicase, C-terminal (13%);Domain of unknown function DUF1605 (13%),,,,,,,,,,
WGSSYSVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GWELLNNTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNAGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.-.- (31%);3.1.11.- (13%);3.1.-.- (7%),Acting on acid anhydrides (31%);Exodeoxyribonucleases producing 5'-phosphomonoesters (13%);Acting on ester bonds (7%),GO:0005737 (23%);GO:0016021 (19%);GO:0005886 (14%),cytoplasm (23%);integral component of membrane (19%);plasma membrane (14%),GO:0005525 (25%);GO:0003924 (18%);GO:0070181 (12%),GTP binding (25%);GTPase activity (18%);small ribosomal subunit rRNA binding (12%),GO:0042274 (12%);GO:0006400 (6%);GO:0055085 (4%),ribosomal small subunit biogenesis (12%);tRNA modification (6%);transmembrane transport (4%),IPR027417 (23%);IPR006073 (20%);IPR005225 (18%),P-loop containing nucleoside triphosphate hydrolase (23%);GTP binding domain (20%);Small GTP-binding protein domain (18%),,,,,,,,,,,
RPLSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (17%);3.1.13.5 (17%);2.8.2.- (11%),Hexosyltransferases (17%);Ribonuclease D (17%);Sulfotransferases (11%),GO:0016021 (20%);GO:0070761 (18%);GO:0005634 (7%),integral component of membrane (20%);pre-snoRNP complex (18%);nucleus (7%),GO:0046872 (49%);GO:0001094 (17%);GO:0042802 (17%),metal ion binding (49%);TFIID-class transcription factor complex binding (17%);identical protein binding (17%),GO:0000492 (18%);GO:0048254 (18%);GO:0051259 (17%),box C/D snoRNP assembly (18%);snoRNA localization (18%);protein complex oligomerization (17%),IPR007529 (50%);IPR027417 (6%);IPR014001 (5%),Zinc finger, HIT-type (50%);P-loop containing nucleoside triphosphate hydrolase (6%);Helicase superfamily 1/2, ATP-binding domain (5%),,,,,,,,,
TGSQWLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008146 (88%);GO:0016740 (12%),sulfotransferase activity (88%);transferase activity (12%),,,IPR000863 (89%);IPR027417 (89%);IPR002716 (4%),Sulfotransferase domain (89%);P-loop containing nucleoside triphosphate hydrolase (89%);PIN domain (4%),,,,,,,,,,,
DAVYLWTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SANSYLNLVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YGDEAHNPGMPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQVELHAEEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVFVDLEYNMFVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLNVSSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVNMLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0004553 (50%);GO:0003677 (25%),hydrolase activity, hydrolyzing O-glycosyl compounds (50%);DNA binding (25%),GO:0005975 (50%);GO:0006355 (25%),carbohydrate metabolic process (50%);regulation of transcription, DNA-templated (25%),IPR005064 (33%);IPR006710 (33%);IPR023296 (33%),Bordetella uptake gene (33%);Glycoside hydrolase, family 43 (33%);Glycosyl hydrolase, five-bladed beta-propellor domain superfamily (33%),,,,,,,
VWMMGLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MALSAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.74 (7%);2.7.1.23 (7%);6.3.2.10 (7%),Methylenetetrahydrofolate--tRNA-(uracil(54)-C(5))-methyltransferas(NAD(P)H-oxidizing) (7%);NAD(+) kinase (7%);UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (7%),GO:0016021 (25%);GO:0005840 (4%);GO:0005886 (4%),integral component of membrane (25%);ribosome (4%);plasma membrane (4%),GO:0005524 (13%);GO:0003677 (12%);GO:0004597 (7%),ATP binding (13%);DNA binding (12%);peptide-aspartate beta-dioxygenase activity (7%),GO:0042264 (7%);GO:0015689 (6%);GO:0006412 (6%),peptidyl-aspartic acid hydroxylation (7%);molybdate ion transport (6%);translation (6%),IPR027417 (7%);IPR005116 (6%);IPR007803 (6%),P-loop containing nucleoside triphosphate hydrolase (7%);Transport-associated OB, type 1 (6%);Aspartyl/asparaginy/proline hydroxylase (6%),,,,,,,,,,
TEQLGCHENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVWLMGHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENYFLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (93%);3.1.26.4 (7%),DNA-directed DNA polymerase (93%);Ribonuclease H (7%),GO:0009360 (61%);GO:0005737 (6%),DNA polymerase III complex (61%);cytoplasm (6%),GO:0003887 (78%);GO:0005524 (78%);GO:0003677 (56%),DNA-directed DNA polymerase activity (78%);ATP binding (78%);DNA binding (56%),GO:0006260 (78%);GO:0006401 (6%),DNA replication (78%);RNA catabolic process (6%),IPR003593 (38%);IPR012763 (38%);IPR022754 (38%),AAA+ ATPase domain (38%);DNA polymerase III, subunit gamma/ tau (38%);DNA polymerase III, gamma subunit, domain III (38%),,,,,,,,
MTQHFFGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVPCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.192 (22%);2.4.1.17 (22%);5.6.2.2 (17%),23S rRNA (adenine(2503)-C(2))-methyltransferase (22%);Glucuronosyltransferase (22%);DNA topoisomerase (ATP-hydrolyzing) (17%),GO:0016021 (21%);GO:0005576 (10%);GO:0005623 (7%),integral component of membrane (21%);extracellular region (10%);cell (7%),GO:0003676 (26%);GO:0046872 (10%);GO:0005524 (7%),nucleic acid binding (26%);metal ion binding (10%);ATP binding (7%),GO:0045454 (7%);GO:0070475 (3%);GO:0006265 (3%),cell redox homeostasis (7%);rRNA base methylation (3%);DNA topological change (3%),IPR001427 (23%);IPR023412 (23%);IPR029741 (23%),Pancreatic ribonuclease (23%);Ribonuclease A-domain (23%);Inactive ribonuclease-like protein 9 (23%),,,,,,,,,,,
HCHPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (20%);2.7.1.170 (20%);2.7.12.1 (20%),Oxidoreductases (20%);Anhydro-N-acetylmuramic acid kinase (20%);Dual-specificity kinase (20%),GO:0016021 (17%);GO:0005634 (3%);GO:0005737 (3%),integral component of membrane (17%);nucleus (3%);cytoplasm (3%),GO:0003677 (31%);GO:0005524 (17%);GO:0003676 (10%),DNA binding (31%);ATP binding (17%);nucleic acid binding (10%),GO:0005975 (10%);GO:0009307 (7%);GO:0000160 (3%),carbohydrate metabolic process (10%);DNA restriction-modification system (7%);phosphorelay signal transduction system (3%),IPR012337 (14%);IPR038717 (14%);IPR009057 (12%),Ribonuclease H-like superfamily (14%);Tc1-like transposase, DDE domain (14%);Homeobox-like domain superfamily (12%),,,,,,,,,,
GFSHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.35 (81%);4.2.1.17 (79%);5.1.2.3 (79%),3-hydroxyacyl-CoA dehydrogenase (81%);Enoyl-CoA hydratase (79%);3-hydroxybutyryl-CoA epimerase (79%),GO:0005737 (40%);GO:0016021 (12%);GO:0016459 (2%),cytoplasm (40%);integral component of membrane (12%);myosin complex (2%),GO:0003857 (34%);GO:0004300 (33%);GO:0008692 (33%),3-hydroxyacyl-CoA dehydrogenase activity (34%);enoyl-CoA hydratase activity (33%);3-hydroxybutyryl-CoA epimerase activity (33%),GO:0006635 (33%);GO:0006355 (4%);GO:0006282 (3%),fatty acid beta-oxidation (33%);regulation of transcription, DNA-templated (4%);regulation of DNA repair (3%),IPR036291 (42%);IPR006176 (41%);IPR006108 (41%),NAD(P)-binding domain superfamily (42%);3-hydroxyacyl-CoA dehydrogenase, NAD binding (41%);3-hydroxyacyl-CoA dehydrogenase, C-terminal (41%),,,,,,,,
QGNPCAPGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVVEVNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMTHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (10%),cytoplasm (10%),GO:0004364 (40%);GO:0016491 (30%);GO:0005524 (20%),glutathione transferase activity (40%);oxidoreductase activity (30%);ATP binding (20%),GO:0007346 (10%);GO:0023014 (10%);GO:0031098 (10%),regulation of mitotic cell cycle (10%);signal transduction by protein phosphorylation (10%);stress-activated protein kinase signaling cascade (10%),IPR000683 (29%);IPR004045 (29%);IPR010987 (29%),Oxidoreductase, N-terminal (29%);Glutathione S-transferase, N-terminal (29%);Glutathione S-transferase, C-terminal-like (29%),,,,,,,,
TMLFAAFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNLNFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.5 (75%);1.1.1.193 (4%);2.5.1.145 (4%),Succinate--CoA ligase (ADP-forming) (75%);5-amino-6-(5-phosphoribosylamino)uracil reductase (4%);Phosphatidylglycerol--prolipoprotein diacylglyceryl transferase (4%),GO:0005739 (42%);GO:0016021 (14%);GO:0005737 (7%),mitochondrion (42%);integral component of membrane (14%);cytoplasm (7%),GO:0005524 (53%);GO:0000287 (42%);GO:0004775 (42%),ATP binding (53%);magnesium ion binding (42%);succinate-CoA ligase (ADP-forming) activity (42%),GO:0006099 (42%);GO:0006104 (19%);GO:0000398 (5%),tricarboxylic acid cycle (42%);succinyl-CoA metabolic process (19%);mRNA splicing, via spliceosome (5%),IPR013815 (43%);IPR005809 (39%);IPR005811 (39%),ATP-grasp fold, subdomain 1 (43%);Succinate--CoA synthetase, beta subunit (39%);ATP-citrate lyase/succinyl-CoA ligase (39%),,,,,,,,
WWEMGAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNVLLANWQMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMLDLPDYVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SAGFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (36%);1.1.1.37 (18%);1.2.1.41 (18%),Peptidylprolyl isomerase (36%);Malate dehydrogenase (18%);Glutamate-5-semialdehyde dehydrogenase (18%),GO:0016021 (41%);GO:0005737 (7%);GO:0005886 (7%),integral component of membrane (41%);cytoplasm (7%);plasma membrane (7%),GO:0046983 (12%);GO:0000155 (10%);GO:0003755 (10%),protein dimerization activity (12%);phosphorelay sensor kinase activity (10%);peptidyl-prolyl cis-trans isomerase activity (10%),GO:0005975 (10%);GO:0006099 (7%);GO:0006457 (7%),carbohydrate metabolic process (10%);tricarboxylic acid cycle (7%);protein folding (7%),IPR001959 (14%);IPR021027 (14%);IPR010095 (12%),Probable transposase, IS891/IS1136/IS1341 (14%);Transposase, putative, helix-turn-helix domain (14%);Transposase IS605, OrfB, C-terminal (12%),,,,,,
EMFSHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THTLEM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMDTYTMTGHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GCPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.77 (19%);6.3.1.1 (13%);1.14.13.- (6%),Protein-L-isoaspartate(D-aspartate) O-methyltransferase (19%);Aspartate--ammonia ligase (13%);With NADH or NADPH as one donor, and incorporation of one atom of oxygen (6%),GO:0016021 (42%);GO:0009279 (21%);GO:0005739 (3%),integral component of membrane (42%);cell outer membrane (21%);mitochondrion (3%),GO:0005509 (30%);GO:0003676 (18%);GO:0003677 (6%),calcium ion binding (30%);nucleic acid binding (18%);DNA binding (6%),GO:0007155 (23%);GO:0006355 (5%);GO:2001311 (2%),cell adhesion (23%);regulation of transcription, DNA-templated (5%);lysobisphosphatidic acid metabolic process (2%),IPR028974 (25%);IPR003367 (20%);IPR006665 (19%),TSP type-3 repeat (25%);Thrombospondin, type 3-like repeat (20%);OmpA-like domain (19%),,,,,,,,
AESTMSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.107 (100%),Diacylglycerol kinase (ATP) (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0003951 (75%);GO:0004143 (75%);GO:0005524 (75%),NAD+ kinase activity (75%);diacylglycerol kinase activity (75%);ATP binding (75%),GO:0007205 (75%);GO:0035556 (75%),protein kinase C-activating G protein-coupled receptor signaling pathway (75%);intracellular signal transduction (75%),IPR000555 (75%);IPR000756 (75%);IPR001206 (75%),JAB1/MPN/MOV34 metalloenzyme domain (75%);Diacylglycerol kinase, accessory domain (75%);Diacylglycerol kinase, catalytic domain (75%),,,,,,,,,
QQLPEMM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEYGAGYDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GSSYFELDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.4.2 (25%);2.2.1.7 (18%);5.6.2.2 (18%),Glycine dehydrogenase (aminomethyl-transferring) (25%);1-deoxy-D-xylulose-5-phosphate synthase (18%);DNA topoisomerase (ATP-hydrolyzing) (18%),GO:0016021 (30%);GO:0005737 (14%);GO:0005694 (6%),integral component of membrane (30%);cytoplasm (14%);chromosome (6%),GO:0005524 (20%);GO:0003677 (16%);GO:0046872 (13%),ATP binding (20%);DNA binding (16%);metal ion binding (13%),GO:0006265 (8%);GO:0009228 (7%);GO:0016114 (7%),DNA topological change (8%);thiamine biosynthetic process (7%);terpenoid biosynthetic process (7%),IPR015422 (10%);IPR015424 (10%);IPR015421 (10%),Pyridoxal phosphate-dependent transferase domain 1 (10%);Pyridoxal phosphate-dependent transferase (10%);Pyridoxal phosphate-dependent transferase, major domain (10%),,,,,,,,,,
SCTDSPGPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLMHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (47%);3.1.3.11 (16%);3.2.1.22 (7%),Transaminases (47%);Fructose-bisphosphatase (16%);Alpha-galactosidase (7%),GO:0016021 (33%);GO:0005868 (16%);GO:0005737 (10%),integral component of membrane (33%);cytoplasmic dynein complex (16%);cytoplasm (10%),GO:0003777 (15%);GO:0005524 (12%);GO:0020037 (10%),microtubule motor activity (15%);ATP binding (12%);heme binding (10%),GO:0007018 (15%);GO:0009058 (8%);GO:0045454 (7%),microtubule-based movement (15%);biosynthetic process (8%);cell redox homeostasis (7%),IPR008467 (14%);IPR022780 (14%);IPR027417 (11%),Dynein 1 light intermediate chain (14%);Dynein family light intermediate chain (14%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,,,,
TQNHHTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWHFC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLVMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.1 (46%);5.6.2.2 (23%);2.-.-.- (8%),Alanine racemase (46%);DNA topoisomerase (ATP-hydrolyzing) (23%);Transferases (8%),GO:0016021 (24%);GO:0016020 (13%);GO:0005623 (11%),integral component of membrane (24%);membrane (13%);cell (11%),GO:0005524 (23%);GO:0022857 (13%);GO:0009055 (11%),ATP binding (23%);transmembrane transporter activity (13%);electron transfer activity (11%),GO:0015716 (14%);GO:0019634 (14%);GO:0045454 (11%),organic phosphonate transport (14%);organic phosphonate metabolic process (14%);cell redox homeostasis (11%),IPR011990 (22%);IPR013026 (21%);IPR019734 (21%),Tetratricopeptide-like helical domain superfamily (22%);Tetratricopeptide repeat-containing domain (21%);Tetratricopeptide repeat (21%),,,,,,,,,,,
DNGNGCSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGAVQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTGDYPLLEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWQPEQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVNWLNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYPELDPQLVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.8 (14%);2.7.4.8 (9%);4.2.1.17 (4%),Quinol--cytochrome-c reductase (14%);Guanylate kinase (9%);Enoyl-CoA hydratase (4%),GO:0016021 (27%);GO:0005737 (7%);GO:0005886 (6%),integral component of membrane (27%);cytoplasm (7%);plasma membrane (6%),GO:0003677 (16%);GO:0005524 (13%);GO:0003824 (5%),DNA binding (16%);ATP binding (13%);catalytic activity (5%),GO:0006355 (4%);GO:0055085 (3%);GO:0007165 (2%),regulation of transcription, DNA-templated (4%);transmembrane transport (3%);signal transduction (2%),IPR009057 (8%);IPR027417 (8%);IPR001647 (7%),Homeobox-like domain superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (8%);DNA-binding HTH domain, TetR-type (7%),,,,,,,,,
FYMNHSLDVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMYMTAGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEEFLPLFLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQYYTFNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVVPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.3 (82%);1.13.11.- (6%);2.1.1.228 (6%),Aldose 1-epimerase (82%);With incorporation of two atoms of oxygen (6%);tRNA (guanine(37)-N(1))-methyltransferase (6%),GO:0016021 (20%);GO:0005634 (7%);GO:0005886 (5%),integral component of membrane (20%);nucleus (7%);plasma membrane (5%),GO:0004034 (23%);GO:0030246 (23%);GO:0005524 (17%),aldose 1-epimerase activity (23%);carbohydrate binding (23%);ATP binding (17%),GO:0019318 (23%);GO:0006281 (3%);GO:0007186 (3%),hexose metabolic process (23%);DNA repair (3%);G protein-coupled receptor signaling pathway (3%),IPR008183 (22%);IPR011013 (22%);IPR014718 (22%),Aldose 1-/Glucose-6-phosphate 1-epimerase (22%);Galactose mutarotase-like domain superfamily (22%);Glycoside hydrolase-type carbohydrate-binding (22%),,,,,,,,,,,
AVYGMNK,Lasius niger,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Hymenoptera,Apocrita,Aculeata,,Formicoidea,Formicidae,Formicinae,Lasiini,,Lasius,Lasius,,,Lasius niger,,,,,,,,GO:0003824 (100%),catalytic activity (100%),,,IPR000873 (100%);IPR020845 (100%);IPR025110 (100%),AMP-dependent synthetase/ligase (100%);AMP-binding, conserved site (100%);AMP-binding enzyme, C-terminal domain (100%),,,,,,,,,
WGNFQDQDYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMHTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.17 (29%);3.1.26.12 (23%);3.6.4.12 (13%),Transferred entry: 7.5.2.8 (29%);Ribonuclease E (23%);DNA helicase (13%),GO:0016020 (46%);GO:0016021 (13%);GO:0005737 (7%),membrane (46%);integral component of membrane (13%);cytoplasm (7%),GO:0005524 (54%);GO:0016887 (47%);GO:0043211 (42%),ATP binding (54%);ATPase activity (47%);ATPase-coupled carbohydrate transmembrane transporter activity (42%),GO:0006364 (4%);GO:0006402 (3%);GO:0008033 (3%),rRNA processing (4%);mRNA catabolic process (3%);tRNA processing (3%),IPR027417 (45%);IPR003439 (40%);IPR017871 (39%),P-loop containing nucleoside triphosphate hydrolase (45%);ABC transporter-like (40%);ABC transporter, conserved site (39%),,,,,,,,,,
NALWAACK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HEMDGVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLPSSRPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VETMMLTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DFLMFDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDYFEVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPDPNVVTALQMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNTYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.6.1 (27%);2.7.7.85 (14%);2.4.1.18 (7%),Arylsulfatase (type I) (27%);Diadenylate cyclase (14%);1,4-alpha-glucan branching enzyme (7%),GO:0016021 (60%);GO:0009279 (3%);GO:0005886 (3%),integral component of membrane (60%);cell outer membrane (3%);plasma membrane (3%),GO:0046872 (23%);GO:0008484 (21%);GO:0005524 (10%),metal ion binding (23%);sulfuric ester hydrolase activity (21%);ATP binding (10%),GO:0018958 (5%);GO:0006541 (3%);GO:0009236 (3%),phenol-containing compound metabolic process (5%);glutamine metabolic process (3%);cobalamin biosynthetic process (3%),IPR017850 (25%);IPR000917 (25%);IPR012160 (20%),Alkaline-phosphatase-like, core domain superfamily (25%);Sulfatase, N-terminal (25%);Lipoteichoic acid synthase-like (20%),,,,,,,,
MMLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.40 (35%);5.6.2.2 (18%);2.7.1.26 (5%),Pyruvate kinase (35%);DNA topoisomerase (ATP-hydrolyzing) (18%);Riboflavin kinase (5%),GO:0016021 (43%);GO:0005886 (25%);GO:0005737 (4%),integral component of membrane (43%);plasma membrane (25%);cytoplasm (4%),GO:0015144 (20%);GO:0005524 (11%);GO:0000287 (9%),carbohydrate transmembrane transporter activity (20%);ATP binding (11%);magnesium ion binding (9%),GO:0055085 (7%);GO:0006265 (4%);GO:0006412 (3%),transmembrane transport (7%);DNA topological change (4%);translation (3%),IPR036259 (17%);IPR011701 (17%);IPR020846 (17%),MFS transporter superfamily (17%);Major facilitator superfamily (17%);Major facilitator superfamily domain (17%),,,,,,,,,,,
LPNHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.71 (14%);2.7.7.7 (9%);3.1.-.- (8%),Shikimate kinase (14%);DNA-directed DNA polymerase (9%);Acting on ester bonds (8%),GO:0005856 (70%);GO:0005886 (28%);GO:0005623 (24%),cytoskeleton (70%);plasma membrane (28%);cell (24%),GO:0003779 (62%);GO:0005198 (62%);GO:0003676 (7%),actin binding (62%);structural molecule activity (62%);nucleic acid binding (7%),GO:0030866 (56%);GO:0001558 (24%);GO:0007016 (24%),cortical actin cytoskeleton organization (56%);regulation of cell growth (24%);cytoskeletal anchoring at plasma membrane (24%),IPR018980 (66%);IPR011993 (66%);IPR000299 (66%),FERM, C-terminal PH-like domain (66%);PH-like domain superfamily (66%);FERM domain (66%),,,,,,,,,,
NYGGSLGFNSDGGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EQLTDQTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMNDNTNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEANTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.3 (93%);2.7.13.3 (7%),Phosphoribosylformylglycinamidine synthase (93%);Histidine kinase (7%),GO:0005829 (33%);GO:0016021 (10%);GO:0005739 (6%),cytosol (33%);integral component of membrane (10%);mitochondrion (6%),GO:0005524 (19%);GO:0046872 (18%);GO:0004642 (16%),ATP binding (19%);metal ion binding (18%);phosphoribosylformylglycinamidine synthase activity (16%),GO:0044780 (36%);GO:0006189 (16%);GO:0006541 (10%),bacterial-type flagellum assembly (36%);'de novo' IMP biosynthetic process (16%);glutamine metabolic process (10%),IPR003713 (37%);IPR036584 (37%);IPR010141 (14%),Flagellar protein FliS (37%);Flagellar protein FliS superfamily (37%);Phosphoribosylformylglycinamidine synthase, FGAM (14%),,,,,,,,,,
TCAEWPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVFASVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (33%);GO:0016021 (33%),plasma membrane (33%);integral component of membrane (33%),GO:0001664 (67%);GO:0003924 (67%);GO:0005525 (67%),G protein-coupled receptor binding (67%);GTPase activity (67%);GTP binding (67%),GO:0007186 (67%),G protein-coupled receptor signaling pathway (67%),IPR000654 (50%);IPR001019 (50%);IPR011025 (50%),G-protein alpha subunit, group Q (50%);Guanine nucleotide binding protein (G-protein), alpha subunit (50%);G protein alpha subunit, helical insertion (50%),,,,,,,,
NNLTMMTGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVVFVNMDMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WMVNHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR006175 (67%);IPR035959 (67%);IPR027839 (17%),YjgF/YER057c/UK114 family (67%);RutC-like superfamily (67%);Protein of unknown function DUF4432 (17%),,,,,,,,,,,
SAQLWDLPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPNAEVLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QCWLNLLGVVGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAWGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.8.1 (17%);1.3.99.- (17%);2.3.1.275 (17%),Short-chain acyl-CoA dehydrogenase (17%);With other acceptors (17%);Acyl phosphate:glycerol-3-phosphate acyltransferase (17%),GO:0016021 (56%);GO:0005634 (1%);GO:0005737 (1%),integral component of membrane (56%);nucleus (1%);cytoplasm (1%),GO:0005506 (43%);GO:0009055 (43%);GO:0020037 (43%),iron ion binding (43%);electron transfer activity (43%);heme binding (43%),GO:0001822 (3%);GO:0006355 (2%);GO:0009058 (2%),kidney development (3%);regulation of transcription, DNA-templated (2%);biosynthetic process (2%),IPR009351 (54%);IPR002323 (20%);IPR009056 (20%),Protein of unknown function DUF1006 (54%);Cytochrome c, class IE (20%);Cytochrome c-like domain (20%),,,,,,,,,
QVLAFEPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLEMNDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGHWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.76 (18%);3.1.6.1 (18%);7.2.2.- (18%),Molybdenum cofactor cytidylyltransferase (18%);Arylsulfatase (type I) (18%);Linked to the hydrolysis of a nucleoside triphosphate (18%),GO:0016021 (24%);GO:0005623 (4%);GO:0005886 (3%),integral component of membrane (24%);cell (4%);plasma membrane (3%),GO:0003677 (8%);GO:0005524 (7%);GO:0008484 (7%),DNA binding (8%);ATP binding (7%);sulfuric ester hydrolase activity (7%),GO:0045454 (4%);GO:0006281 (2%);GO:0006429 (2%),cell redox homeostasis (4%);DNA repair (2%);leucyl-tRNA aminoacylation (2%),IPR007435 (16%);IPR029016 (16%);IPR000917 (8%),Protein of unknown function DUF484 (16%);GAF-like domain superfamily (16%);Sulfatase, N-terminal (8%),,,,,,,,,,
ANLAAKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEGSVPR,Alphaproteobacteria,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,,,,,,,,,,,,,,,,,,1.18.6.1 (100%),Nitrogenase (100%),GO:0016612 (70%),molybdenum-iron nitrogenase complex (70%),GO:0005524 (100%);GO:0016163 (80%);GO:0018697 (80%),ATP binding (100%);nitrogenase activity (80%);carbonyl sulfide nitrogenase activity (80%),GO:0009399 (80%);GO:0000160 (20%);GO:0006355 (20%),nitrogen fixation (80%);phosphorelay signal transduction system (20%);regulation of transcription, DNA-templated (20%),IPR000318 (73%);IPR000510 (73%);IPR005976 (73%),Nitrogenase component 1, conserved site (73%);Nitrogenase/oxidoreductase, component 1 (73%);Nitrogenase molybdenum-iron protein beta chain (73%),,,,,,,,
TAGMMLTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYGPGAMHGMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEYNTNNLLAAHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYSLALPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WATLNPK,Schistosoma,Eukaryota,Metazoa,,,Platyhelminthes,,,Trematoda,Digenea,,,Strigeidida,,,,Schistosomatoidea,Schistosomatidae,,,,Schistosoma,,,,,,,,,,GO:0005739 (100%),mitochondrion (100%),GO:0019843 (100%);GO:0043024 (100%),rRNA binding (100%);ribosomal small subunit binding (100%),GO:0032543 (100%),mitochondrial translation (100%),IPR037387 (100%),Pentatricopeptide repeat domain-containing protein 3 (100%),,,,,,,,,,,
EASQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (12%);3.1.1.61 (11%);3.5.1.44 (11%),Glycogen phosphorylase (12%);Protein-glutamate methylesterase (11%);Protein-glutamine glutaminase (11%),GO:0016021 (28%);GO:0005737 (11%);GO:0005886 (8%),integral component of membrane (28%);cytoplasm (11%);plasma membrane (8%),GO:0005524 (19%);GO:0003677 (9%);GO:0046872 (7%),ATP binding (19%);DNA binding (9%);metal ion binding (7%),GO:0006605 (4%);GO:0017038 (4%);GO:0009306 (3%),protein targeting (4%);protein import (4%);protein secretion (3%),IPR027417 (12%);IPR011006 (4%);IPR000185 (3%),P-loop containing nucleoside triphosphate hydrolase (12%);CheY-like superfamily (4%);Protein translocase subunit SecA (3%),,,,,,,,,,,
DPVGNATLANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVNPWWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHTACDANHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.72 (36%);3.6.-.- (15%);3.6.4.12 (12%),Quinolinate synthase (36%);Acting on acid anhydrides (15%);DNA helicase (12%),GO:0016021 (21%);GO:0005737 (13%);GO:0005634 (3%),integral component of membrane (21%);cytoplasm (13%);nucleus (3%),GO:0003824 (17%);GO:0046872 (13%);GO:0005524 (12%),catalytic activity (17%);metal ion binding (13%);ATP binding (12%),GO:0009435 (8%);GO:0006400 (3%);GO:0006269 (3%),NAD biosynthetic process (8%);tRNA modification (3%);DNA replication, synthesis of RNA primer (3%),IPR001736 (16%);IPR025202 (16%);IPR027417 (9%),Phospholipase D/Transphosphatidylase (16%);Phospholipase D-like domain (16%);P-loop containing nucleoside triphosphate hydrolase (9%),,,,,,,,,,
MLVWEYK,Rhodobacter maris,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhodobacterales,,,,,Rhodobacteraceae,,,,Rhodobacter,,,,Rhodobacter maris,,,,,,,,,,,,,,,,,,,,,,,,
LVWPLDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (100%),Signal peptidase I (100%),GO:0016020 (54%);GO:0016021 (15%),membrane (54%);integral component of membrane (15%),GO:0008236 (46%);GO:0003743 (15%);GO:0008233 (15%),serine-type peptidase activity (46%);translation initiation factor activity (15%);peptidase activity (15%),GO:0031571 (15%);GO:0016042 (8%),mitotic G1 DNA damage checkpoint (15%);lipid catabolic process (8%),IPR000223 (62%);IPR015927 (62%);IPR036286 (62%),Peptidase S26A, signal peptidase I (62%);Peptidase S24/S26A/S26B/S26C (62%);LexA/Signal peptidase-like superfamily (62%),,,,,,,,,,
TEVTHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.50 (100%),Hydroxyethylthiazole kinase (100%),GO:0016021 (48%);GO:0009279 (4%);GO:0016020 (4%),integral component of membrane (48%);cell outer membrane (4%);membrane (4%),GO:0000287 (20%);GO:0004417 (20%);GO:0005524 (20%),magnesium ion binding (20%);hydroxyethylthiazole kinase activity (20%);ATP binding (20%),GO:0009228 (20%);GO:0009229 (20%);GO:0046854 (20%),thiamine biosynthetic process (20%);thiamine diphosphate biosynthetic process (20%);phosphatidylinositol phosphorylation (20%),IPR021496 (38%);IPR025157 (9%);IPR000417 (8%),Protein of unknown function DUF3150 (38%);Hemagglutinin repeat (9%);Hydroxyethylthiazole kinase (8%),,,,,,,,,,,
DHVMM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYSMALPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVAAPYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGDFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.29 (46%);3.5.4.16 (18%);2.1.1.74 (2%),tRNA-guanine(34) transglycosylase (46%);GTP cyclohydrolase I (18%);Methylenetetrahydrofolate--tRNA-(uracil(54)-C(5))-methyltransferas(NAD(P)H-oxidizing) (2%),GO:0016021 (38%);GO:0005886 (22%);GO:0005737 (3%),integral component of membrane (38%);plasma membrane (22%);cytoplasm (3%),GO:0046872 (14%);GO:0008479 (12%);GO:0003677 (8%),metal ion binding (14%);queuine tRNA-ribosyltransferase activity (12%);DNA binding (8%),GO:0008616 (12%);GO:0101030 (11%);GO:0035998 (5%),queuosine biosynthetic process (12%);tRNA-guanine transglycosylation (11%);7,8-dihydroneopterin 3'-triphosphate biosynthetic process (5%),IPR006507 (21%);IPR021147 (21%);IPR002616 (10%),Uncharacterised protein family UPF0283 (21%);Protein of unknown function DUF697 (21%);tRNA-guanine(15) transglycosylase-like (10%),,,,,,,,,,
GNLPPMANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPWAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.54 (29%);3.6.4.12 (21%);2.1.1.223 (14%),3-deoxy-7-phosphoheptulonate synthase (29%);DNA helicase (21%);tRNA(1)(Val) (adenine(37)-N(6))-methyltransferase (14%),GO:0016021 (30%);GO:0009360 (9%);GO:0005615 (6%),integral component of membrane (30%);DNA polymerase III complex (9%);extracellular space (6%),GO:0003677 (38%);GO:0005524 (30%);GO:0003678 (27%),DNA binding (38%);ATP binding (30%);DNA helicase activity (27%),GO:0006281 (27%);GO:0006260 (9%);GO:0009073 (6%),DNA repair (27%);DNA replication (9%);aromatic amino acid family biosynthetic process (6%),IPR027417 (35%);IPR000212 (25%);IPR011335 (25%),P-loop containing nucleoside triphosphate hydrolase (35%);DNA helicase, UvrD/REP type (25%);Restriction endonuclease  type II-like (25%),,,,,,,,,,
YMAGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.5 (33%);3.4.21.- (33%);7.1.1.- (33%),Cytochrome-c peroxidase (33%);Serine endopeptidases (33%);Hydron translocation or charge separation linked to oxidoreductase reactions (33%),GO:0016021 (36%);GO:0070469 (12%);GO:0005737 (2%),integral component of membrane (36%);respirasome (12%);cytoplasm (2%),GO:0016787 (53%);GO:0009055 (27%);GO:0046872 (22%),hydrolase activity (53%);electron transfer activity (27%);metal ion binding (22%),GO:0022904 (10%);GO:0055085 (2%);GO:0055114 (2%),respiratory electron transport chain (10%);transmembrane transport (2%);oxidation-reduction process (2%),IPR001279 (71%);IPR036866 (71%);IPR009056 (13%),Metallo-beta-lactamase (71%);Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (71%);Cytochrome c-like domain (13%),,,,,,,,,,,
LVAYFVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003824 (50%);GO:0008484 (50%);GO:0031177 (50%),catalytic activity (50%);sulfuric ester hydrolase activity (50%);phosphopantetheine binding (50%),,,IPR000873 (33%);IPR000917 (33%);IPR005202 (33%),AMP-dependent synthetase/ligase (33%);Sulfatase, N-terminal (33%);Transcription factor GRAS (33%),,,,,,,,,,
QAPLFDK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.1.1 (100%),NADH:ubiquinone reductase (Na(+)-transporting) (100%),GO:0005886 (50%);GO:0016021 (50%),plasma membrane (50%);integral component of membrane (50%),GO:0010181 (50%);GO:0016655 (50%);GO:0016787 (50%),FMN binding (50%);oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (50%);hydrolase activity (50%),GO:0006814 (50%);GO:0022904 (50%);GO:0055085 (50%),sodium ion transport (50%);respiratory electron transport chain (50%);transmembrane transport (50%),IPR004338 (50%);IPR010966 (50%);IPR015943 (50%),Ion-translocating oxidoreductase NqrB/RnfD (50%);Na(+)-translocating NADH-quinone reductase subunit B (50%);WD40/YVTN repeat-like-containing domain superfamily (50%),,,,,,,,,
TAQNDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.- (67%);2.4.1.- (33%),Transferring alkyl or aryl groups, other than methyl groups (67%);Hexosyltransferases (33%),GO:0016021 (40%);GO:0005882 (6%);GO:0005789 (3%),integral component of membrane (40%);intermediate filament (6%);endoplasmic reticulum membrane (3%),GO:0046872 (20%);GO:0009055 (17%);GO:0020037 (17%),metal ion binding (20%);electron transfer activity (17%);heme binding (17%),GO:0006506 (11%);GO:0006270 (3%);GO:0006275 (3%),GPI anchor biosynthetic process (11%);DNA replication initiation (3%);regulation of DNA replication (3%),IPR001611 (27%);IPR032675 (27%);IPR027417 (21%),Leucine-rich repeat (27%);Leucine-rich repeat domain superfamily (27%);P-loop containing nucleoside triphosphate hydrolase (21%),,,,,,,,,,
WNMGYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.267 (100%),1-deoxy-D-xylulose-5-phosphate reductoisomerase (100%),GO:0016021 (33%);GO:0005760 (17%),integral component of membrane (33%);gamma DNA polymerase complex (17%),GO:0030604 (50%);GO:0046872 (50%);GO:0070402 (50%),1-deoxy-D-xylulose-5-phosphate reductoisomerase activity (50%);metal ion binding (50%);NADPH binding (50%),GO:0016114 (50%);GO:0019288 (50%);GO:0006260 (17%),terpenoid biosynthetic process (50%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (50%);DNA replication (17%),IPR003821 (50%);IPR013512 (50%);IPR013644 (50%),1-deoxy-D-xylulose 5-phosphate reductoisomerase (50%);1-deoxy-D-xylulose 5-phosphate reductoisomerase, N-terminal (50%);1-deoxy-D-xylulose 5-phosphate reductoisomerase, C-terminal (50%),,,,,,,,
MLPLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.63 (49%);2.7.7.7 (14%);2.1.3.3 (8%),Methylated-DNA--[protein]-cysteine S-methyltransferase (49%);DNA-directed DNA polymerase (14%);Ornithine carbamoyltransferase (8%),GO:0016021 (51%);GO:0005737 (11%);GO:0000502 (1%),integral component of membrane (51%);cytoplasm (11%);proteasome complex (1%),GO:0003824 (11%);GO:0050662 (10%);GO:0003908 (8%),catalytic activity (11%);coenzyme binding (10%);methylated-DNA-[protein]-cysteine S-methyltransferase activity (8%),GO:0032259 (9%);GO:0006307 (8%);GO:0006865 (7%),methylation (9%);DNA dealkylation involved in DNA repair (8%);amino acid transport (7%),IPR002549 (30%);IPR036291 (12%);IPR001509 (11%),Transmembrane protein TqsA-like (30%);NAD(P)-binding domain superfamily (12%);NAD-dependent epimerase/dehydratase (11%),,,,,,,,,,,
EMALVVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGETVVGK,Candidatus Accumulibacter,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,,,,,,,,,,Candidatus Accumulibacter,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR032710 (100%);IPR037401 (100%),NTF2-like domain superfamily (100%);SnoaL-like domain (100%),,,,,,,,,,,
NSANWMTTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DAHHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.17 (41%);2.3.1.12 (6%);3.1.3.5 (6%),Glutamate--tRNA ligase (41%);Dihydrolipoyllysine-residue acetyltransferase (6%);5'-nucleotidase (6%),GO:0016021 (19%);GO:0005737 (10%);GO:0005886 (2%),integral component of membrane (19%);cytoplasm (10%);plasma membrane (2%),GO:0003677 (21%);GO:0005524 (18%);GO:0003700 (16%),DNA binding (21%);ATP binding (18%);DNA-binding transcription factor activity (16%),GO:1901135 (13%);GO:0006424 (7%);GO:0005975 (4%),carbohydrate derivative metabolic process (13%);glutamyl-tRNA aminoacylation (7%);carbohydrate metabolic process (4%),IPR009057 (13%);IPR036388 (12%);IPR000281 (11%),Homeobox-like domain superfamily (13%);Winged helix-like DNA-binding domain superfamily (12%);Helix-turn-helix protein RpiR (11%),,,,,,,,,,,
MFQLGAGNANLQEKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLHLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.95 (40%);1.1.1.399 (30%);3.4.24.- (30%),Phosphoglycerate dehydrogenase (40%);2-oxoglutarate reductase (30%);Metalloendopeptidases (30%),GO:0016021 (29%);GO:0005840 (7%);GO:0000139 (1%),integral component of membrane (29%);ribosome (7%);Golgi membrane (1%),GO:0016740 (30%);GO:0003735 (7%);GO:0003700 (6%),transferase activity (30%);structural constituent of ribosome (7%);DNA-binding transcription factor activity (6%),GO:0008299 (29%);GO:0006412 (7%);GO:0006564 (3%),isoprenoid biosynthetic process (29%);translation (7%);L-serine biosynthetic process (3%),IPR011055 (47%);IPR016047 (47%);IPR007340 (32%),Duplicated hybrid motif (47%);Peptidase M23 (47%);Opacity-associated protein A (32%),,,,,,,,,,,
MMVPNAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAVLFMLGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYVLSTFM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLLHVTK,Citrus,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Sapindales,,,,,Rutaceae,Aurantioideae,,,Citrus,,,,,,,,,,,,GO:0043531 (100%),ADP binding (100%),,,IPR002182 (100%);IPR027417 (100%);IPR001611 (67%),NB-ARC (100%);P-loop containing nucleoside triphosphate hydrolase (100%);Leucine-rich repeat (67%),,,,,,,,,,,
VLNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (23%);6.6.1.2 (7%);5.3.1.12 (5%),Metalloendopeptidases (23%);Cobaltochelatase (7%);Glucuronate isomerase (5%),GO:0016021 (32%);GO:0005886 (6%);GO:0005737 (4%),integral component of membrane (32%);plasma membrane (6%);cytoplasm (4%),GO:0005524 (14%);GO:0046872 (10%);GO:0016491 (10%),ATP binding (14%);metal ion binding (10%);oxidoreductase activity (10%),GO:0017000 (8%);GO:0009236 (5%);GO:0030163 (4%),antibiotic biosynthetic process (8%);cobalamin biosynthetic process (5%);protein catabolic process (4%),IPR027417 (12%);IPR008274 (8%);IPR037165 (8%),P-loop containing nucleoside triphosphate hydrolase (12%);Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding (8%);Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding domain superfamily (8%),,,,,,,,,
WHFENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.2.- (100%),Sulfotransferases (100%),GO:0016021 (12%),integral component of membrane (12%),GO:0008146 (88%),sulfotransferase activity (88%),,,IPR000863 (88%);IPR027417 (88%);IPR004242 (6%),Sulfotransferase domain (88%);P-loop containing nucleoside triphosphate hydrolase (88%);Transposon, En/Spm-like (6%),,,,,,,,,,
FFCGFFAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAVVNHQHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVNWGLPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLACVNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.12 (25%);4.2.3.- (13%);2.7.7.18 (5%),tRNA pseudouridine(38-40) synthase (25%);Acting on phosphates (13%);Nicotinate-nucleotide adenylyltransferase (5%),GO:0016021 (19%);GO:0005737 (8%);GO:0043190 (2%),integral component of membrane (19%);cytoplasm (8%);ATP-binding cassette (ABC) transporter complex (2%),GO:0005524 (12%);GO:0003677 (11%);GO:0046872 (11%),ATP binding (12%);DNA binding (11%);metal ion binding (11%),GO:0031119 (7%);GO:0055085 (4%);GO:0006355 (3%),tRNA pseudouridine synthesis (7%);transmembrane transport (4%);regulation of transcription, DNA-templated (3%),IPR001406 (6%);IPR020095 (6%);IPR020097 (6%),Pseudouridine synthase I, TruA (6%);Pseudouridine synthase I, TruA, C-terminal (6%);Pseudouridine synthase I, TruA, alpha/beta domain (6%),,,,,
FMLRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (100%),Type I site-specific deoxyribonuclease (100%),GO:0016021 (58%);GO:0019012 (26%);GO:0005634 (21%),integral component of membrane (58%);virion (26%);nucleus (21%),GO:0005524 (58%);GO:0003723 (47%);GO:0003968 (47%),ATP binding (58%);RNA binding (47%);RNA-directed 5'-3' RNA polymerase activity (47%),GO:0019087 (47%);GO:0039694 (47%);GO:0019062 (21%),transformation of host cell by virus (47%);viral RNA genome replication (47%);virion attachment to host cell (21%),IPR014001 (35%);IPR027417 (35%);IPR001650 (32%),Helicase superfamily 1/2, ATP-binding domain (35%);P-loop containing nucleoside triphosphate hydrolase (35%);Helicase, C-terminal (32%),,,,,,,,,
FEYQSWFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLTYWCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQQEAGAEQTAGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVSKPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (33%);GO:0016021 (33%),ribosome (33%);integral component of membrane (33%),GO:0003735 (33%);GO:0016491 (33%),structural constituent of ribosome (33%);oxidoreductase activity (33%),GO:0006412 (33%),translation (33%),IPR001611 (50%);IPR006553 (50%);IPR032675 (50%),Leucine-rich repeat (50%);Leucine-rich repeat, cysteine-containing subtype (50%);Leucine-rich repeat domain superfamily (50%),,,,,,,,,,
HELMDDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016810 (100%),hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR002509 (50%);IPR004375 (50%);IPR011330 (50%),NodB homology domain (50%);YhcH/YjgK/YiaL family (50%);Glycoside hydrolase/deacetylase, beta/alpha-barrel (50%),,,,,,,,,
QTLPVAWGAFGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNMLHYFGQAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDWVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.4 (50%);1.3.5.3 (25%);6.1.1.5 (25%),Dihydrolipoyl dehydrogenase (50%);Protoporphyrinogen IX dehydrogenase (menaquinone) (25%);Isoleucine--tRNA ligase (25%),GO:0016021 (24%);GO:0009279 (12%);GO:0005623 (4%),integral component of membrane (24%);cell outer membrane (12%);cell (4%),GO:0008168 (40%);GO:0004148 (8%);GO:0005524 (8%),methyltransferase activity (40%);dihydrolipoyl dehydrogenase activity (8%);ATP binding (8%),GO:0032259 (36%);GO:0010033 (12%);GO:0015920 (12%),methylation (36%);response to organic substance (12%);lipopolysaccharide transport (12%),IPR013216 (26%);IPR029063 (26%);IPR032675 (16%),Methyltransferase type 11 (26%);S-adenosyl-L-methionine-dependent methyltransferase (26%);Leucine-rich repeat domain superfamily (16%),,,,,,,,,,,
MDYALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.193 (36%);2.7.11.1 (18%);1.6.5.5 (9%),16S rRNA (uracil(1498)-N(3))-methyltransferase (36%);Non-specific serine/threonine protein kinase (18%);NADPH:quinone reductase (9%),GO:0016021 (22%);GO:0005737 (12%);GO:0005634 (1%),integral component of membrane (22%);cytoplasm (12%);nucleus (1%),GO:0005524 (15%);GO:0008080 (12%);GO:0003677 (7%),ATP binding (15%);N-acetyltransferase activity (12%);DNA binding (7%),GO:0032259 (7%);GO:0006364 (6%);GO:0043215 (6%),methylation (7%);rRNA processing (6%);daunorubicin transport (6%),IPR035169 (35%);IPR000182 (6%);IPR016181 (6%),Protein of unknown function DUF5318 (35%);GNAT domain (6%);Acyl-CoA N-acyltransferase (6%),,,,,,,,,,,
MDNVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.22 (7%);1.4.1.13 (7%);2.7.1.49 (7%),UDP-glucose 6-dehydrogenase (7%);Glutamate synthase (NADPH) (7%);Hydroxymethylpyrimidine kinase (7%),GO:0016021 (12%);GO:0005737 (7%);GO:0005886 (2%),integral component of membrane (12%);cytoplasm (7%);plasma membrane (2%),GO:0046872 (18%);GO:0003677 (15%);GO:0005524 (12%),metal ion binding (18%);DNA binding (15%);ATP binding (12%),GO:0006355 (15%);GO:0006474 (4%);GO:0006535 (3%),regulation of transcription, DNA-templated (15%);N-terminal protein amino acid acetylation (4%);cysteine biosynthetic process from serine (3%),IPR036388 (14%);IPR036390 (14%);IPR005471 (13%),Winged helix-like DNA-binding domain superfamily (14%);Winged helix DNA-binding domain superfamily (14%);Transcription regulator IclR, N-terminal (13%),,,,,,,,,
ELYETFMAYEDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVSWMPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPDQSTNDEYQGLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CQLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.61 (38%);3.4.19.12 (9%);2.7.7.7 (8%),Hydroxymethylbilane synthase (38%);Ubiquitinyl hydrolase 1 (9%);DNA-directed DNA polymerase (8%),GO:0016021 (26%);GO:0009535 (7%);GO:0005737 (4%),integral component of membrane (26%);chloroplast thylakoid membrane (7%);cytoplasm (4%),GO:0005524 (23%);GO:0003677 (14%);GO:0020037 (8%),ATP binding (23%);DNA binding (14%);heme binding (8%),GO:0006260 (10%);GO:0017004 (8%);GO:0006782 (7%),DNA replication (10%);cytochrome complex assembly (8%);protoporphyrinogen IX biosynthetic process (7%),IPR027417 (24%);IPR003593 (11%);IPR003959 (8%),P-loop containing nucleoside triphosphate hydrolase (24%);AAA+ ATPase domain (11%);ATPase, AAA-type, core (8%),,,,,,,,,
MQMAENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMAVAHDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DENAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (83%);1.5.1.5 (5%);3.5.4.9 (5%),Beta-galactosidase (83%);Methylenetetrahydrofolate dehydrogenase (NADP(+)) (5%);Methenyltetrahydrofolate cyclohydrolase (5%),GO:0009341 (44%);GO:0005634 (21%);GO:0016021 (8%),beta-galactosidase complex (44%);nucleus (21%);integral component of membrane (8%),GO:0004565 (44%);GO:0030246 (44%);GO:0003677 (21%),beta-galactosidase activity (44%);carbohydrate binding (44%);DNA binding (21%),GO:0005975 (44%);GO:0006260 (3%);GO:0006281 (3%),carbohydrate metabolic process (44%);DNA replication (3%);DNA repair (3%),IPR013783 (39%);IPR006104 (38%);IPR008979 (38%),Immunoglobulin-like fold (39%);Glycosyl hydrolases family 2, sugar binding domain (38%);Galactose-binding-like domain superfamily (38%),,,,,,,,,,
HEPNEMEWWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WDYNMNGLFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVTLTLSM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGNDER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.88 (22%);6.3.2.- (22%);2.3.3.13 (11%),Peptide deformylase (22%);Acid--amino-acid ligases (peptide synthases) (22%);2-isopropylmalate synthase (11%),GO:0016021 (16%);GO:0005737 (4%);GO:0005634 (3%),integral component of membrane (16%);cytoplasm (4%);nucleus (3%),GO:0051920 (23%);GO:0003677 (15%);GO:0016301 (15%),peroxiredoxin activity (23%);DNA binding (15%);kinase activity (15%),GO:0017004 (5%);GO:0006289 (3%);GO:0006412 (3%),cytochrome complex assembly (5%);nucleotide-excision repair (3%);translation (3%),IPR003779 (16%);IPR029032 (16%);IPR018660 (11%),Carboxymuconolactone decarboxylase-like (16%);AhpD-like (16%);C-type lysozyme inhibitor (11%),,,,,,,,,,,
DNPVNLWMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNVALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (50%),ribosome (50%),GO:0008276 (50%);GO:0015562 (25%),protein methyltransferase activity (50%);efflux transmembrane transporter activity (25%),GO:0009228 (25%),thiamine biosynthetic process (25%),IPR004498 (33%);IPR029063 (33%);IPR000421 (17%),Ribosomal protein L11 methyltransferase (33%);S-adenosyl-L-methionine-dependent methyltransferase (33%);Coagulation factor 5/8 C-terminal domain (17%),,,,,,,,,,,
WSGNPNSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVDDMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.7 (32%);2.7.1.35 (20%);4.3.2.10 (16%),Phosphooxymethylpyrimidine kinase (32%);Pyridoxal kinase (20%);Imidazole glycerol-phosphate synthase (16%),GO:0016021 (60%);GO:0030288 (36%);GO:0009279 (17%),integral component of membrane (60%);outer membrane-bounded periplasmic space (36%);cell outer membrane (17%),GO:0005524 (23%);GO:0008972 (17%);GO:0016301 (3%),ATP binding (23%);phosphomethylpyrimidine kinase activity (17%);kinase activity (3%),GO:0055085 (36%);GO:0009228 (17%);GO:0000105 (2%),transmembrane transport (36%);thiamine biosynthetic process (17%);histidine biosynthetic process (2%),IPR018389 (37%);IPR038404 (37%);IPR004682 (35%),TRAP transporter solute receptor DctP/TeaA (37%);TRAP transporter solute receptor DctP superfamily (37%);TRAP transporter solute receptor, DctP family (35%),,,,,,,,,,
TSMNVN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LHMDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (19%);3.2.1.17 (17%);2.4.1.230 (7%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (19%);Lysozyme (17%);Kojibiose phosphorylase (7%),GO:0016021 (25%);GO:0005634 (10%);GO:0005730 (4%),integral component of membrane (25%);nucleus (10%);nucleolus (4%),GO:0005524 (15%);GO:0043565 (7%);GO:0008270 (7%),ATP binding (15%);sequence-specific DNA binding (7%);zinc ion binding (7%),GO:0005975 (5%);GO:0009253 (4%);GO:0006412 (3%),carbohydrate metabolic process (5%);peptidoglycan catabolic process (4%);translation (3%),IPR027417 (12%);IPR012935 (6%);IPR009057 (5%),P-loop containing nucleoside triphosphate hydrolase (12%);Zinc finger, C3HC-like (6%);Homeobox-like domain superfamily (5%),,,,,,,,,,
VWMMAPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLNPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (47%);2.3.1.97 (43%);2.7.11.- (2%),DNA helicase (47%);Glycylpeptide N-tetradecanoyltransferase (43%);Protein-serine/threonine kinases (2%),GO:0016021 (12%);GO:0005829 (6%);GO:0005886 (3%),integral component of membrane (12%);cytosol (6%);plasma membrane (3%),GO:0005524 (33%);GO:0003678 (30%);GO:0004379 (27%),ATP binding (33%);DNA helicase activity (30%);glycylpeptide N-tetradecanoyltransferase activity (27%),GO:0006281 (31%);GO:0000723 (30%);GO:0006310 (29%),DNA repair (31%);telomere maintenance (30%);DNA recombination (29%),IPR027417 (25%);IPR010285 (25%);IPR016181 (23%),P-loop containing nucleoside triphosphate hydrolase (25%);DNA helicase Pif1-like (25%);Acyl-CoA N-acyltransferase (23%),,,,,,,,,,,
WSDGCPLVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQTAEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.9 (100%),Riboflavin synthase (100%),GO:0016021 (13%),integral component of membrane (13%),GO:0004746 (38%);GO:0004252 (25%);GO:0008168 (13%),riboflavin synthase activity (38%);serine-type endopeptidase activity (25%);methyltransferase activity (13%),GO:0032259 (13%),methylation (13%),IPR001783 (62%);IPR017938 (62%);IPR023366 (62%),Lumazine-binding protein (62%);Riboflavin synthase-like beta-barrel (62%);ATP synthase subunit alpha, N-terminal domain-like superfamily (62%),,,,,,,,,,
QGMFGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.30 (38%);4.1.1.86 (25%);2.7.7.8 (13%),Glycerol kinase (38%);Diaminobutyrate decarboxylase (25%);Polyribonucleotide nucleotidyltransferase (13%),GO:0016021 (6%);GO:0005737 (2%),integral component of membrane (6%);cytoplasm (2%),GO:0005524 (52%);GO:0030170 (29%);GO:0016887 (26%),ATP binding (52%);pyridoxal phosphate binding (29%);ATPase activity (26%),GO:0019752 (27%);GO:0015833 (26%);GO:0006072 (19%),carboxylic acid metabolic process (27%);peptide transport (26%);glycerol-3-phosphate metabolic process (19%),IPR027417 (30%);IPR015424 (27%);IPR002129 (26%),P-loop containing nucleoside triphosphate hydrolase (30%);Pyridoxal phosphate-dependent transferase (27%);Pyridoxal phosphate-dependent decarboxylase (26%),,,,,,,,,,,
FTPSVWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WSLPVAPAFCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVDEFPMDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGTPANHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAFCPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%);GO:0005886 (13%),integral component of membrane (25%);plasma membrane (13%),GO:0003995 (13%);GO:0016787 (13%);GO:0050660 (13%),acyl-CoA dehydrogenase activity (13%);hydrolase activity (13%);flavin adenine dinucleotide binding (13%),GO:0006270 (38%),DNA replication initiation (38%),IPR003874 (50%);IPR001846 (13%);IPR002919 (13%),CDC45 family (50%);von Willebrand factor, type D domain (13%);Trypsin Inhibitor-like, cysteine rich domain (13%),,,,,,,,,
QTMWAVPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAAHLMNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLCLPSLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LALSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.13 (12%);3.4.24.- (9%);3.6.4.12 (4%),Glutamate synthase (NADPH) (12%);Metalloendopeptidases (9%);DNA helicase (4%),GO:0016021 (30%);GO:0005886 (6%);GO:0005737 (4%),integral component of membrane (30%);plasma membrane (6%);cytoplasm (4%),GO:0005524 (20%);GO:0016887 (12%);GO:0003677 (10%),ATP binding (20%);ATPase activity (12%);DNA binding (10%),GO:0006355 (4%);GO:0006298 (3%);GO:0006412 (3%),regulation of transcription, DNA-templated (4%);mismatch repair (3%);translation (3%),IPR027417 (19%);IPR003593 (10%);IPR003439 (8%),P-loop containing nucleoside triphosphate hydrolase (19%);AAA+ ATPase domain (10%);ABC transporter-like (8%),,,,,,,,,,
EAQEMMLTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.15 (11%);2.7.2.3 (5%);7.1.1.8 (5%),Peroxiredoxin (11%);Phosphoglycerate kinase (5%);Quinol--cytochrome-c reductase (5%),GO:0016021 (28%);GO:0005737 (8%);GO:0005623 (3%),integral component of membrane (28%);cytoplasm (8%);cell (3%),GO:0005524 (13%);GO:0003677 (8%);GO:0003887 (8%),ATP binding (13%);DNA binding (8%);DNA-directed DNA polymerase activity (8%),GO:0006270 (8%);GO:0045454 (3%);GO:0032259 (2%),DNA replication initiation (8%);cell redox homeostasis (3%);methylation (2%),IPR027417 (7%);IPR036390 (7%);IPR036388 (7%),P-loop containing nucleoside triphosphate hydrolase (7%);Winged helix DNA-binding domain superfamily (7%);Winged helix-like DNA-binding domain superfamily (7%),,,,,,,,,,,
WVLLSC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CAAYLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.5.5 (100%),NADPH:quinone reductase (100%),GO:0016021 (13%),integral component of membrane (13%),GO:0008270 (63%);GO:0016491 (50%);GO:0016301 (25%),zinc ion binding (63%);oxidoreductase activity (50%);kinase activity (25%),GO:0005975 (13%),carbohydrate metabolic process (13%),IPR002364 (63%);IPR011032 (63%);IPR013149 (63%),Quinone oxidoreductase/zeta-crystallin, conserved site (63%);GroES-like superfamily (63%);Alcohol dehydrogenase, C-terminal (63%),,,,,,,,,
TMTDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (12%);2.7.1.40 (11%);2.7.13.3 (11%),Phenylalanine--tRNA ligase (12%);Pyruvate kinase (11%);Histidine kinase (11%),GO:0016021 (54%);GO:0005840 (24%);GO:0005737 (2%),integral component of membrane (54%);ribosome (24%);cytoplasm (2%),GO:0004930 (32%);GO:0003735 (23%);GO:0016740 (7%),G protein-coupled receptor activity (32%);structural constituent of ribosome (23%);transferase activity (7%),GO:0006412 (25%);GO:0006935 (4%);GO:0006364 (2%),translation (25%);chemotaxis (4%);rRNA processing (2%),IPR000276 (33%);IPR001277 (33%);IPR017452 (33%),G protein-coupled receptor, rhodopsin-like (33%);CXC chemokine receptor 4/atypical chemokine receptor 2 (33%);GPCR, rhodopsin-like, 7TM (33%),,,,,,,,
TPMAAYLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNWYLYFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTMHSPTMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLMVNMTVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MESHLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.- (40%);2.1.2.9 (20%);3.1.1.11 (20%),Phosphotransferases with an alcohol group as acceptor (40%);Methionyl-tRNA formyltransferase (20%);Pectinesterase (20%),GO:0031262 (38%);GO:0016021 (18%);GO:0005737 (7%),Ndc80 complex (38%);integral component of membrane (18%);cytoplasm (7%),GO:0005524 (11%);GO:0003677 (8%);GO:0016887 (7%),ATP binding (11%);DNA binding (8%);ATPase activity (7%),GO:0006289 (6%);GO:0009432 (6%);GO:0016573 (6%),nucleotide-excision repair (6%);SOS response (6%);histone acetylation (6%),IPR041112 (32%);IPR005549 (31%);IPR038275 (31%),Nuf2, DHR10 domain (32%);Kinetochore protein Nuf2 (31%);Nuf2, N-terminal domain superfamily (31%),,,,,,,,,
VYEDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.3.3 (64%);4.2.3.1 (18%);2.7.13.3 (9%),Vinylacetyl-CoA Delta-isomerase (64%);Threonine synthase (18%);Histidine kinase (9%),GO:0016021 (21%);GO:0005576 (2%);GO:0005777 (2%),integral component of membrane (21%);extracellular region (2%);peroxisome (2%),GO:0016627 (33%);GO:0050393 (17%);GO:0003824 (14%),oxidoreductase activity, acting on the CH-CH group of donors (33%);vinylacetyl-CoA delta-isomerase activity (17%);catalytic activity (14%),GO:0015031 (5%);GO:0009405 (2%);GO:0009446 (2%),protein transport (5%);pathogenesis (2%);putrescine biosynthetic process (2%),IPR004925 (26%);IPR009100 (26%);IPR024674 (26%),HpaB/PvcC/4-BUDH (26%);Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily (26%);HpaB/PvcC/4-BUDH N-terminal (26%),,,,,,,,,
MFDMCSVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EWEGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.5 (26%);3.6.1.9 (15%);1.1.1.193 (5%),Pyridoxal 5'-phosphate synthase (26%);Nucleotide diphosphatase (15%);5-amino-6-(5-phosphoribosylamino)uracil reductase (5%),GO:0016021 (21%);GO:0030286 (7%);GO:0005634 (6%),integral component of membrane (21%);dynein complex (7%);nucleus (6%),GO:0005524 (16%);GO:0003777 (9%);GO:0005509 (9%),ATP binding (16%);microtubule motor activity (9%);calcium ion binding (9%),GO:0007018 (8%);GO:0005975 (5%);GO:0003341 (4%),microtubule-based movement (8%);carbohydrate metabolic process (5%);cilium movement (4%),IPR036291 (15%);IPR002347 (12%);IPR027417 (12%),NAD(P)-binding domain superfamily (15%);Short-chain dehydrogenase/reductase SDR (12%);P-loop containing nucleoside triphosphate hydrolase (12%),,,,,,,,,,,
EDNLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.22 (43%);4.2.1.2 (12%);6.1.1.14 (5%),UDP-glucose 6-dehydrogenase (43%);Fumarate hydratase (12%);Glycine--tRNA ligase (5%),GO:0016021 (17%);GO:0005886 (8%);GO:0005737 (5%),integral component of membrane (17%);plasma membrane (8%);cytoplasm (5%),GO:0005524 (10%);GO:0003979 (10%);GO:0004252 (9%),ATP binding (10%);UDP-glucose 6-dehydrogenase activity (10%);serine-type endopeptidase activity (9%),GO:0005977 (7%);GO:0000271 (5%);GO:0031532 (5%),glycogen metabolic process (7%);polysaccharide biosynthetic process (5%);actin cytoskeleton reorganization (5%),IPR029058 (10%);IPR036291 (9%);IPR002471 (9%),Alpha/Beta hydrolase fold (10%);NAD(P)-binding domain superfamily (9%);Peptidase S9, serine active site (9%),,,,,,,,,,
YSVGDEAQAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTLVTQTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDTTYTK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (100%),DNA topoisomerase (ATP-hydrolyzing) (100%),,,GO:0003677 (100%);GO:0003918 (100%);GO:0005524 (100%),DNA binding (100%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (100%);ATP binding (100%),GO:0006265 (100%),DNA topological change (100%),IPR002205 (50%);IPR006691 (50%);IPR008969 (50%),DNA topoisomerase, type IIA, subunit A/C-terminal (50%);DNA gyrase/topoisomerase IV, subunit A, C-terminal repeat (50%);Carboxypeptidase-like, regulatory domain superfamily (50%),,,,,
TLLNTMMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNSLDELQVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDEAEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (37%);3.1.11.6 (13%);2.7.7.7 (4%),DNA topoisomerase (ATP-hydrolyzing) (37%);Exodeoxyribonuclease VII (13%);DNA-directed DNA polymerase (4%),GO:0016021 (24%);GO:0005737 (16%);GO:0005694 (8%),integral component of membrane (24%);cytoplasm (16%);chromosome (8%),GO:0005524 (21%);GO:0003677 (16%);GO:0003777 (8%),ATP binding (21%);DNA binding (16%);microtubule motor activity (8%),GO:0006265 (8%);GO:0006261 (7%);GO:0006355 (5%),DNA topological change (8%);DNA-dependent DNA replication (7%);regulation of transcription, DNA-templated (5%),IPR011990 (39%);IPR019734 (27%);IPR013026 (27%),Tetratricopeptide-like helical domain superfamily (39%);Tetratricopeptide repeat (27%);Tetratricopeptide repeat-containing domain (27%),,,,,,,,,,
NPPQNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (17%);GO:0005623 (8%);GO:0042597 (8%),integral component of membrane (17%);cell (8%);periplasmic space (8%),GO:0003723 (33%);GO:0003677 (25%);GO:0005524 (17%),RNA binding (33%);DNA binding (25%);ATP binding (17%),GO:0007051 (8%);GO:0045454 (8%),spindle organization (8%);cell redox homeostasis (8%),IPR000504 (21%);IPR012677 (21%);IPR025715 (21%),RNA recognition motif domain (21%);Nucleotide-binding alpha-beta plait domain superfamily (21%);Chromatin target of PRMT1 protein, C-terminal (21%),,,,,,,,,,
SSAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (38%);6.1.1.10 (21%);2.1.1.266 (3%),Polyphosphate kinase (38%);Methionine--tRNA ligase (21%);23S rRNA (adenine(2030)-N(6))-methyltransferase (3%),GO:0016021 (23%);GO:0005737 (10%);GO:0009358 (9%),integral component of membrane (23%);cytoplasm (10%);polyphosphate kinase complex (9%),GO:0005524 (24%);GO:0046872 (14%);GO:0008976 (10%),ATP binding (24%);metal ion binding (14%);polyphosphate kinase activity (10%),GO:0006799 (10%);GO:0006431 (5%);GO:0006355 (2%),polyphosphate biosynthetic process (10%);methionyl-tRNA aminoacylation (5%);regulation of transcription, DNA-templated (2%),IPR003414 (8%);IPR025200 (8%);IPR041108 (8%),Polyphosphate kinase (8%);Polyphosphate kinase C-terminal domain 2 (8%);Polyphosphate kinase, C-terminal domain 1 (8%),,,,,,,,,
MDVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.7.4 (13%);2.7.7.4 (6%);1.4.1.13 (5%),4-hydroxy-3-methylbut-2-enyl diphosphate reductase (13%);Sulfate adenylyltransferase (6%);Glutamate synthase (NADPH) (5%),GO:0016021 (26%);GO:0043190 (11%);GO:0005886 (5%),integral component of membrane (26%);ATP-binding cassette (ABC) transporter complex (11%);plasma membrane (5%),GO:0005524 (11%);GO:0003676 (7%);GO:0003677 (7%),ATP binding (11%);nucleic acid binding (7%);DNA binding (7%),GO:0055085 (11%);GO:0009058 (4%);GO:0006412 (2%),transmembrane transport (11%);biosynthetic process (4%);translation (2%),IPR035277 (12%);IPR030156 (12%);IPR035906 (12%),MalF, N-terminal (12%);Maltose/maltodextrin transport system permease protein MalF-like (12%);MetI-like superfamily (12%),,,,,,,,,,
EWLCHK,Exophiala mesophila,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Chaetothyriomycetidae,,,Chaetothyriales,,,,,Herpotrichiellaceae,,,,Exophiala,,,,Exophiala mesophila,,,,,,,,,,,,IPR036047 (100%),F-box-like domain superfamily (100%),,,,,,,,,,,
VLANNEAVNTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVNGSALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GQQGQPR,Massilia,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Oxalobacteraceae,,,,Massilia,,,,,,,,5.4.99.- (100%),Transferring other groups (100%),,,GO:0003723 (100%);GO:0009982 (100%),RNA binding (100%);pseudouridine synthase activity (100%),GO:0001522 (100%),pseudouridine synthesis (100%),IPR000748 (100%);IPR002942 (100%);IPR006145 (100%),Pseudouridine synthase, RsuA/RluB/E/F (100%);RNA-binding S4 domain (100%);Pseudouridine synthase, RsuA/RluA (100%),,,,,,,,,
DLCYVWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYVPNPMEVPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPVNLVNVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNMSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.181 (59%);1.8.3.2 (5%);2.7.1.71 (5%),23S rRNA (adenine(1618)-N(6))-methyltransferase (59%);Thiol oxidase (5%);Shikimate kinase (5%),GO:0005684 (12%);GO:0071014 (12%);GO:0005737 (10%),U2-type spliceosomal complex (12%);post-mRNA release spliceosomal complex (12%);cytoplasm (10%),GO:0003676 (75%);GO:0004386 (71%);GO:0005524 (71%),nucleic acid binding (75%);helicase activity (71%);ATP binding (71%),GO:0000390 (2%);GO:0006351 (2%);GO:0071973 (1%),spliceosomal complex disassembly (2%);transcription, DNA-templated (2%);bacterial-type flagellum-dependent cell motility (1%),IPR027417 (74%);IPR007502 (71%);IPR011709 (71%),P-loop containing nucleoside triphosphate hydrolase (74%);Helicase-associated domain (71%);Domain of unknown function DUF1605 (71%),,,,,,,,,,
YLHLNPYGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPEDFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005730 (13%),integral component of membrane (50%);nucleolus (13%),GO:0008821 (25%);GO:0003700 (13%);GO:0008168 (13%),crossover junction endodeoxyribonuclease activity (25%);DNA-binding transcription factor activity (13%);methyltransferase activity (13%),GO:0006281 (38%),DNA repair (38%),IPR005174 (50%);IPR001810 (38%);IPR036047 (38%),Domain unknown function DUF295 (50%);F-box domain (38%);F-box-like domain superfamily (38%),,,,,,,,,,,
EMMSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (47%);1.1.1.94 (11%);2.1.1.- (3%),DNA helicase (47%);Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (11%);Methyltransferases (3%),GO:0016021 (14%);GO:0005737 (6%);GO:0005643 (4%),integral component of membrane (14%);cytoplasm (6%);nuclear pore (4%),GO:0003677 (31%);GO:0005524 (18%);GO:0003678 (10%),DNA binding (31%);ATP binding (18%);DNA helicase activity (10%),GO:0007264 (5%);GO:0006281 (5%);GO:0005975 (3%),small GTPase mediated signal transduction (5%);DNA repair (5%);carbohydrate metabolic process (3%),IPR009057 (15%);IPR027417 (14%);IPR001647 (13%),Homeobox-like domain superfamily (15%);P-loop containing nucleoside triphosphate hydrolase (14%);DNA-binding HTH domain, TetR-type (13%),,,,,,,,,,
WGEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.129 (45%);1.97.1.4 (9%);2.4.2.45 (9%),Flavin prenyltransferase (45%);[Formate-C-acetyltransferase]-activating enzyme (9%);Decaprenyl-phosphate phosphoribosyltransferase (9%),GO:0016021 (28%);GO:0005737 (3%);GO:0005634 (2%),integral component of membrane (28%);cytoplasm (3%);nucleus (2%),GO:0016491 (9%);GO:0016301 (8%);GO:0008810 (7%),oxidoreductase activity (9%);kinase activity (8%);cellulase activity (7%),GO:0009291 (15%);GO:0000272 (8%);GO:0015969 (8%),unidirectional conjugation (15%);polysaccharide catabolic process (8%);guanosine tetraphosphate metabolic process (8%),IPR027417 (22%);IPR003688 (13%);IPR013785 (7%),P-loop containing nucleoside triphosphate hydrolase (22%);Type IV secretion system protein TraG/VirD4 (13%);Aldolase-type TIM barrel (7%),,,,,,,,,,,
FFVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.63 (23%);3.2.1.31 (21%);2.1.1.193 (11%),Methylated-DNA--[protein]-cysteine S-methyltransferase (23%);Beta-glucuronidase (21%);16S rRNA (uracil(1498)-N(3))-methyltransferase (11%),GO:0016021 (34%);GO:0005737 (9%);GO:0005887 (8%),integral component of membrane (34%);cytoplasm (9%);integral component of plasma membrane (8%),GO:0003677 (10%);GO:0005524 (9%);GO:0008320 (8%),DNA binding (10%);ATP binding (9%);protein transmembrane transporter activity (8%),GO:0032259 (9%);GO:0043953 (8%);GO:0005975 (6%),methylation (9%);protein transport by the Tat complex (8%);carbohydrate metabolic process (6%),IPR036388 (8%);IPR002033 (7%);IPR027417 (6%),Winged helix-like DNA-binding domain superfamily (8%);Sec-independent periplasmic protein translocase TatC (7%);P-loop containing nucleoside triphosphate hydrolase (6%),,,,,,,,,,,
WMGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.138 (67%);1.2.1.3 (7%);1.3.99.- (7%),Ceramide kinase (67%);Aldehyde dehydrogenase (NAD(+)) (7%);With other acceptors (7%),GO:0016021 (12%);GO:0005886 (1%);GO:0042765 (1%),integral component of membrane (12%);plasma membrane (1%);GPI-anchor transamidase complex (1%),GO:0003951 (50%);GO:0016620 (15%);GO:0050660 (10%),NAD+ kinase activity (50%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (15%);flavin adenine dinucleotide binding (10%),GO:0033339 (2%);GO:0043010 (2%);GO:0051216 (2%),pectoral fin development (2%);camera-type eye development (2%);cartilage development (2%),IPR016064 (53%);IPR001206 (49%);IPR017438 (48%),NAD kinase/diacylglycerol kinase-like domain superfamily (53%);Diacylglycerol kinase, catalytic domain (49%);Inorganic polyphosphate/ATP-NAD kinase, N-terminal (48%),,,,,,,
LSLETK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.11 (37%);2.4.1.- (11%);2.3.2.26 (7%),Phosphoinositide phospholipase C (37%);Hexosyltransferases (11%);HECT-type E3 ubiquitin transferase (7%),GO:0016021 (28%);GO:0005737 (9%);GO:0005789 (3%),integral component of membrane (28%);cytoplasm (9%);endoplasmic reticulum membrane (3%),GO:0004435 (9%);GO:0005509 (9%);GO:0005524 (8%),phosphatidylinositol phospholipase C activity (9%);calcium ion binding (9%);ATP binding (8%),GO:0016042 (10%);GO:0035556 (9%);GO:0002098 (5%),lipid catabolic process (10%);intracellular signal transduction (9%);tRNA wobble uridine modification (5%),IPR000008 (10%);IPR035892 (9%);IPR011992 (8%),C2 domain (10%);C2 domain superfamily (9%);EF-hand domain pair (8%),,,,,,,,,,,
QNMLTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.41 (83%);6.3.4.4 (17%),Phosphatidate cytidylyltransferase (83%);Adenylosuccinate synthase (17%),GO:0016021 (23%);GO:0030659 (16%);GO:0005634 (2%),integral component of membrane (23%);cytoplasmic vesicle membrane (16%);nucleus (2%),GO:0035091 (27%);GO:0005524 (16%);GO:0003677 (14%),phosphatidylinositol binding (27%);ATP binding (16%);DNA binding (14%),GO:0000281 (27%);GO:0006886 (27%);GO:0006897 (27%),mitotic cytokinesis (27%);intracellular protein transport (27%);endocytosis (27%),IPR019497 (25%);IPR027267 (25%);IPR028644 (25%),Sorting nexin protein, WASP-binding domain (25%);AH/BAR domain superfamily (25%);Sorting nexin-9 (25%),,,,,,,,,,
VFMFLAR,Trifolium medium,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Fabales,,,,,Fabaceae,Papilionoideae,Trifolieae,,Trifolium,,,,Trifolium medium,,,,,,,,,,,,,,,,,,,,,,,,
ESYVDLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLNFQEGNELVDLYLQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSHETSNPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VHTGVVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFAFCEK,Rhizobiaceae,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Rhizobiaceae,,,,,,,,,,,,,,,,,,GO:0000160 (100%),phosphorelay signal transduction system (100%),IPR000160 (100%);IPR001789 (100%);IPR011006 (100%),GGDEF domain (100%);Signal transduction response regulator, receiver domain (100%);CheY-like superfamily (100%),,,,,,,,,,
MFWTLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNSEKPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016592 (29%);GO:0016021 (14%),mediator complex (29%);integral component of membrane (14%),GO:0003700 (29%);GO:0003712 (29%);GO:0003723 (14%),DNA-binding transcription factor activity (29%);transcription coregulator activity (29%);RNA binding (14%),GO:0006357 (29%),regulation of transcription by RNA polymerase II (29%),IPR040356 (58%);IPR009401 (17%);IPR021643 (17%),SPEAR family (58%);Mediator complex subunit Med13, C-terminal (17%);Mediator complex, subunit Med13, N-terminal, metazoa/fungi (17%),,,,,,,
ECWFVVGAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVVPNHK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAANSAQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVMQGAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (67%);GO:0003779 (33%);GO:0017048 (33%),DNA binding (67%);actin binding (33%);Rho GTPase binding (33%),GO:0000160 (67%);GO:0006355 (67%);GO:0030036 (33%),phosphorelay signal transduction system (67%);regulation of transcription, DNA-templated (67%);actin cytoskeleton organization (33%),IPR000792 (67%);IPR001789 (67%);IPR011006 (67%),Transcription regulator LuxR, C-terminal (67%);Signal transduction response regulator, receiver domain (67%);CheY-like superfamily (67%),,,,,,,,
TVMVLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.-.- (100%),Transferring phosphorus-containing groups (100%),GO:0005886 (29%);GO:0016021 (29%),plasma membrane (29%);integral component of membrane (29%),GO:0031177 (43%);GO:0004672 (29%);GO:0005524 (29%),phosphopantetheine binding (43%);protein kinase activity (29%);ATP binding (29%),GO:0006744 (29%);GO:0010795 (29%);GO:0006464 (14%),ubiquinone biosynthetic process (29%);regulation of ubiquinone biosynthetic process (29%);cellular protein modification process (14%),IPR001227 (33%);IPR009081 (33%);IPR014030 (33%),Acyl transferase domain superfamily (33%);Phosphopantetheine binding ACP domain (33%);Beta-ketoacyl synthase, N-terminal (33%),,,,,,,,,,
MALVDEEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVGVQPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (50%);GO:0016021 (50%),cell (50%);integral component of membrane (50%),GO:0015035 (50%),protein disulfide oxidoreductase activity (50%),GO:0006662 (50%);GO:0045454 (50%),glycerol ether metabolic process (50%);cell redox homeostasis (50%),IPR005182 (50%);IPR005746 (50%);IPR013766 (50%),Domain of unknown function DUF304 (50%);Thioredoxin (50%);Thioredoxin domain (50%),,,,,,,,,,,
LNHVFEK,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR001036 (100%);IPR027463 (100%),Acriflavin resistance protein (100%);Multidrug efflux transporter AcrB TolC docking domain, DN/DC subdomains (100%),,,,,,,,,,
HMQQSNHNTMTFSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTVEDLEDTNQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNVTPFPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGELEEQAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLAMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (45%);3.1.11.5 (11%);2.1.1.170 (4%),Acting on ATP; involved in cellular and subcellular movement (45%);Exodeoxyribonuclease V (11%);16S rRNA (guanine(527)-N(7))-methyltransferase (4%),GO:0005737 (21%);GO:0016021 (13%);GO:0032039 (10%),cytoplasm (21%);integral component of membrane (13%);integrator complex (10%),GO:0005524 (32%);GO:0016787 (15%);GO:0003684 (14%),ATP binding (32%);hydrolase activity (15%);damaged DNA binding (14%),GO:0006355 (15%);GO:0000716 (14%);GO:0034474 (10%),regulation of transcription, DNA-templated (15%);transcription-coupled nucleotide-excision repair, DNA damage recognition (14%);U2 snRNA 3'-end processing (10%),IPR027417 (26%);IPR014001 (14%);IPR001650 (14%),P-loop containing nucleoside triphosphate hydrolase (26%);Helicase superfamily 1/2, ATP-binding domain (14%);Helicase, C-terminal (14%),,,,,,,
ALGSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.70 (18%);3.4.21.- (11%);1.17.7.4 (8%),Glutamyl-tRNA reductase (18%);Serine endopeptidases (11%);4-hydroxy-3-methylbut-2-enyl diphosphate reductase (8%),GO:0016021 (36%);GO:0005886 (6%);GO:0005737 (4%),integral component of membrane (36%);plasma membrane (6%);cytoplasm (4%),GO:0005524 (13%);GO:0003677 (11%);GO:0003723 (4%),ATP binding (13%);DNA binding (11%);RNA binding (4%),GO:0019290 (3%);GO:0070940 (3%);GO:0007059 (3%),siderophore biosynthetic process (3%);dephosphorylation of RNA polymerase II C-terminal domain (3%);chromosome segregation (3%),IPR027417 (10%);IPR036291 (7%);IPR032675 (5%),P-loop containing nucleoside triphosphate hydrolase (10%);NAD(P)-binding domain superfamily (7%);Leucine-rich repeat domain superfamily (5%),,,,,,,,,,,
DATMHGR,Methylophilus,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Nitrosomonadales,,,,,Methylophilaceae,,,,Methylophilus,,,,,,,,,,,,,,,,IPR002763 (100%);IPR036520 (100%),Protein of unknown function DUF72 (100%);UPF0759 superfamily (100%),,,,,,,,,,,
VSGEQGSASSNMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLFDVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR029063 (48%);IPR011478 (33%);IPR013036 (33%),S-adenosyl-L-methionine-dependent methyltransferase (48%);Domain of unknown function DUF1585 (33%);Domain of unknown function DUF1587 (33%),,,,,,,,,,,
TDLGALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (64%);1.3.8.3 (14%);2.3.1.20 (14%),DNA-directed DNA polymerase (64%);(R)-benzylsuccinyl-CoA dehydrogenase (14%);Diacylglycerol O-acyltransferase (14%),GO:0016021 (33%);GO:0005737 (21%);GO:0005634 (2%),integral component of membrane (33%);cytoplasm (21%);nucleus (2%),GO:0003887 (21%);GO:0008408 (21%);GO:0050660 (14%),DNA-directed DNA polymerase activity (21%);3'-5' exonuclease activity (21%);flavin adenine dinucleotide binding (14%),GO:0006260 (21%);GO:0006071 (5%);GO:0019432 (5%),DNA replication (21%);glycerol metabolic process (5%);triglyceride biosynthetic process (5%),IPR003141 (24%);IPR004013 (24%);IPR004805 (24%),Polymerase/histidinol phosphatase, N-terminal (24%);PHP domain (24%);DNA polymerase III, alpha subunit (24%),,,,,,,,,
TLPVFAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.40 (60%);1.2.4.1 (40%),Pyruvate kinase (60%);Pyruvate dehydrogenase (acetyl-transferring) (40%),GO:0016021 (64%),integral component of membrane (64%),GO:0000287 (12%);GO:0004743 (12%);GO:0016301 (12%),magnesium ion binding (12%);pyruvate kinase activity (12%);kinase activity (12%),GO:0019441 (4%),tryptophan catabolic process to kynurenine (4%),IPR000326 (56%);IPR026841 (56%);IPR036938 (56%),Phosphatidic acid phosphatase type 2/haloperoxidase (56%);Inositolphosphotransferase Aur1/Ipt1 (56%);Phosphatidic acid phosphatase type 2/haloperoxidase superfamily (56%),,,,,,,,,,,
MVAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (34%);2.8.4.4 (4%);5.1.3.2 (4%),Serine endopeptidases (34%);[Ribosomal protein S12] (aspartate(89)-C(3))-methylthiotransferase (4%);UDP-glucose 4-epimerase (4%),GO:0016021 (15%);GO:0005737 (9%);GO:0000145 (6%),integral component of membrane (15%);cytoplasm (9%);exocyst (6%),GO:0003677 (10%);GO:0016853 (9%);GO:0003690 (8%),DNA binding (10%);isomerase activity (9%);double-stranded DNA binding (8%),GO:0006310 (9%);GO:0006303 (9%);GO:0015031 (7%),DNA recombination (9%);double-strand break repair via nonhomologous end joining (9%);protein transport (7%),IPR036237 (12%);IPR013022 (12%);IPR014621 (11%),Xylose isomerase-like superfamily (12%);Xylose isomerase-like, TIM barrel domain (12%);Uncharacterised conserved protein UCP036778, sugar epimerase-type (11%),,,,,,,,,
WAESSM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FHSPGADETELALNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHPMPDAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPLFVPDVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSEQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.53 (10%);2.3.2.27 (8%);1.1.1.38 (6%),Oleate hydratase (10%);RING-type E3 ubiquitin transferase (8%);Malate dehydrogenase (oxaloacetate-decarboxylating) (6%),GO:0016021 (24%);GO:0005634 (16%);GO:0005737 (8%),integral component of membrane (24%);nucleus (16%);cytoplasm (8%),GO:0005096 (13%);GO:0005524 (13%);GO:0003677 (10%),GTPase activator activity (13%);ATP binding (13%);DNA binding (10%),GO:0051056 (12%);GO:0007155 (3%);GO:0006355 (3%),regulation of small GTPase mediated signal transduction (12%);cell adhesion (3%);regulation of transcription, DNA-templated (3%),IPR027107 (12%);IPR016024 (11%);IPR027417 (11%),Tuberin/Ral GTPase-activating protein subunit alpha (12%);Armadillo-type fold (11%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,,,
LHCYVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.40 (33%);3.4.11.5 (33%);4.1.1.65 (33%),Pyruvate kinase (33%);Prolyl aminopeptidase (33%);Phosphatidylserine decarboxylase (33%),GO:0005737 (20%);GO:0005886 (20%);GO:0016021 (20%),cytoplasm (20%);plasma membrane (20%);integral component of membrane (20%),GO:0000287 (20%);GO:0003950 (20%);GO:0004177 (20%),magnesium ion binding (20%);NAD+ ADP-ribosyltransferase activity (20%);aminopeptidase activity (20%),GO:0006302 (20%);GO:0006471 (20%);GO:0006646 (20%),double-strand break repair (20%);protein ADP-ribosylation (20%);phosphatidylethanolamine biosynthetic process (20%),IPR000073 (20%);IPR000713 (20%);IPR001697 (20%),Alpha/beta hydrolase fold-1 (20%);Mur ligase, N-terminal catalytic domain (20%);Pyruvate kinase (20%),,,,,,,,,,
TMGLNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.200 (53%);3.4.21.107 (29%);1.1.1.14 (6%),tRNA (cytidine(32)/uridine(32)-2'-O)-methyltransferase (53%);Peptidase Do (29%);L-iditol 2-dehydrogenase (6%),GO:0005737 (12%);GO:0016021 (11%);GO:0005623 (1%),cytoplasm (12%);integral component of membrane (11%);cell (1%),GO:0003723 (24%);GO:0008173 (24%);GO:0008233 (15%),RNA binding (24%);RNA methyltransferase activity (24%);peptidase activity (15%),GO:0006396 (16%);GO:0008033 (12%);GO:0043461 (5%),RNA processing (16%);tRNA processing (12%);proton-transporting ATP synthase complex assembly (5%),IPR001478 (23%);IPR001537 (23%);IPR004384 (23%),PDZ domain (23%);tRNA/rRNA methyltransferase, SpoU type (23%);RNA methyltransferase TrmJ/LasT (23%),,,,,,,,,,
AQWLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (77%);1.3.99.- (6%);1.3.8.1 (5%),DNA topoisomerase (ATP-hydrolyzing) (77%);With other acceptors (6%);Short-chain acyl-CoA dehydrogenase (5%),GO:0016021 (32%);GO:0005694 (16%);GO:0005737 (15%),integral component of membrane (32%);chromosome (16%);cytoplasm (15%),GO:0005524 (47%);GO:0050660 (40%);GO:0003995 (32%),ATP binding (47%);flavin adenine dinucleotide binding (40%);acyl-CoA dehydrogenase activity (32%),GO:0006265 (22%);GO:0006261 (14%);GO:0000160 (7%),DNA topological change (22%);DNA-dependent DNA replication (14%);phosphorelay signal transduction system (7%),IPR003594 (43%);IPR036890 (43%);IPR009100 (39%),Histidine kinase/HSP90-like ATPase (43%);Histidine kinase/HSP90-like ATPase superfamily (43%);Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily (39%),,,,,,,,,,
AFPANSTLWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLNFLMTPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (43%);1.8.4.8 (10%);7.1.1.- (9%),Non-specific serine/threonine protein kinase (43%);Phosphoadenylyl-sulfate reductase (thioredoxin) (10%);Hydron translocation or charge separation linked to oxidoreductase reactions (9%),GO:0016021 (31%);GO:0005737 (7%);GO:0005886 (4%),integral component of membrane (31%);cytoplasm (7%);plasma membrane (4%),GO:0005524 (21%);GO:0004674 (11%);GO:0008270 (9%),ATP binding (21%);protein serine/threonine kinase activity (11%);zinc ion binding (9%),GO:0070814 (4%);GO:0019379 (3%);GO:0050773 (2%),hydrogen sulfide biosynthetic process (4%);sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) (3%);regulation of dendrite development (2%),IPR011009 (11%);IPR000719 (10%);IPR017441 (10%),Protein kinase-like domain superfamily (11%);Protein kinase domain (10%);Protein kinase, ATP binding site (10%),,,,,,,,,
EWTTLVYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLGLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (33%);2.7.7.56 (16%);3.1.13.1 (13%),Hydron translocation or charge separation linked to oxidoreductase reactions (33%);tRNA nucleotidyltransferase (16%);Exoribonuclease II (13%),GO:0016021 (21%);GO:0005886 (12%);GO:0005737 (9%),integral component of membrane (21%);plasma membrane (12%);cytoplasm (9%),GO:0005524 (18%);GO:0051539 (14%);GO:0050136 (10%),ATP binding (18%);4 iron, 4 sulfur cluster binding (14%);NADH dehydrogenase (quinone) activity (10%),GO:0006364 (5%);GO:0008033 (4%);GO:0016075 (4%),rRNA processing (5%);tRNA processing (4%);rRNA catabolic process (4%),IPR017900 (12%);IPR017896 (12%);IPR010226 (11%),4Fe-4S ferredoxin, iron-sulphur binding, conserved site (12%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (12%);NADH-quinone oxidoreductase, chain I (11%),,,,,,
FNVTGDMAVNGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFVLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.9 (38%);5.4.99.- (29%);1.3.3.4 (10%),Thioredoxin-disulfide reductase (38%);Transferring other groups (29%);Protoporphyrinogen oxidase (10%),GO:0005737 (14%);GO:0016021 (14%);GO:0005886 (2%),cytoplasm (14%);integral component of membrane (14%);plasma membrane (2%),GO:0016757 (17%);GO:0016740 (15%);GO:0003723 (12%),transferase activity, transferring glycosyl groups (17%);transferase activity (15%);RNA binding (12%),GO:0001522 (12%);GO:0019430 (11%);GO:0006260 (2%),pseudouridine synthesis (12%);removal of superoxide radicals (11%);DNA replication (2%),IPR001173 (30%);IPR029044 (30%);IPR039528 (29%),Glycosyltransferase 2-like (30%);Nucleotide-diphospho-sugar transferases (30%);DPM1-like (29%),,,,,,,,,,
LAGNDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (33%);2.7.7.75 (33%);3.4.11.10 (33%),Molybdopterin molybdotransferase (33%);Molybdopterin adenylyltransferase (33%);Bacterial leucyl aminopeptidase (33%),GO:0016021 (9%);GO:0005886 (4%);GO:0005694 (1%),integral component of membrane (9%);plasma membrane (4%);chromosome (1%),GO:0016740 (75%);GO:0005524 (10%);GO:0016887 (5%),transferase activity (75%);ATP binding (10%);ATPase activity (5%),GO:0008299 (72%);GO:0007049 (4%);GO:0051301 (4%),isoprenoid biosynthetic process (72%);cell cycle (4%);cell division (4%),IPR000092 (69%);IPR008949 (69%);IPR033749 (69%),Polyprenyl synthetase (69%);Isoprenoid synthase domain superfamily (69%);Polyprenyl synthetase, conserved site (69%),,,,,,,,,,
DCPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (15%);6.3.2.17 (15%);1.1.1.86 (8%),Polyphosphate kinase (15%);Tetrahydrofolate synthase (15%);Ketol-acid reductoisomerase (NADP(+)) (8%),GO:0016021 (30%);GO:0005634 (6%);GO:0005737 (4%),integral component of membrane (30%);nucleus (6%);cytoplasm (4%),GO:0003824 (13%);GO:0005524 (11%);GO:0046872 (6%),catalytic activity (13%);ATP binding (11%);metal ion binding (6%),GO:0007155 (4%);GO:0007229 (4%);GO:0006799 (3%),cell adhesion (4%);integrin-mediated signaling pathway (4%);polyphosphate biosynthetic process (3%),IPR027417 (13%);IPR007822 (12%);IPR012341 (12%),P-loop containing nucleoside triphosphate hydrolase (13%);Lanthionine synthetase C-like (12%);Six-hairpin glycosidase-like superfamily (12%),,,,,,,,,,,
EDLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (13%);2.1.1.14 (9%);2.7.13.3 (8%),DNA-directed DNA polymerase (13%);5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (9%);Histidine kinase (8%),GO:0016021 (24%);GO:0005737 (23%);GO:0005634 (2%),integral component of membrane (24%);cytoplasm (23%);nucleus (2%),GO:0005524 (34%);GO:0008134 (20%);GO:0043565 (19%),ATP binding (34%);transcription factor binding (20%);sequence-specific DNA binding (19%),GO:0006355 (21%);GO:0009399 (18%);GO:0006808 (17%),regulation of transcription, DNA-templated (21%);nitrogen fixation (18%);regulation of nitrogen utilization (17%),IPR027417 (24%);IPR003593 (21%);IPR009057 (20%),P-loop containing nucleoside triphosphate hydrolase (24%);AAA+ ATPase domain (21%);Homeobox-like domain superfamily (20%),,,,,,,,,,
QGPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.4.11 (76%);2.1.1.14 (9%);2.7.4.21 (6%),Peptide-methionine (S)-S-oxide reductase (76%);5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (9%);Inositol-hexakisphosphate kinase (6%),GO:0016021 (18%);GO:0005886 (6%);GO:0005737 (5%),integral component of membrane (18%);plasma membrane (6%);cytoplasm (5%),GO:0008113 (42%);GO:0005524 (8%);GO:0008270 (7%),peptide-methionine (S)-S-oxide reductase activity (42%);ATP binding (8%);zinc ion binding (7%),GO:0006464 (40%);GO:0032259 (5%);GO:0009086 (5%),cellular protein modification process (40%);methylation (5%);methionine biosynthetic process (5%),IPR002569 (37%);IPR036509 (37%);IPR001959 (5%),Peptide methionine sulphoxide reductase MsrA (37%);Peptide methionine sulphoxide reductase MsrA superfamily (37%);Probable transposase, IS891/IS1136/IS1341 (5%),,,,,,,,,,
EMHWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.19.12 (36%);2.1.1.193 (9%);2.1.1.320 (9%),Ubiquitinyl hydrolase 1 (36%);16S rRNA (uracil(1498)-N(3))-methyltransferase (9%);Type II protein arginine methyltransferase (9%),GO:0005887 (33%);GO:0016021 (18%);GO:0005886 (4%),integral component of plasma membrane (33%);integral component of membrane (18%);plasma membrane (4%),GO:0030955 (33%);GO:0016787 (17%);GO:0008556 (14%),potassium ion binding (33%);hydrolase activity (17%);potassium transmembrane transporter activity, phosphorylative mechanism (14%),GO:0006813 (19%);GO:0005975 (13%);GO:0006511 (5%),potassium ion transport (19%);carbohydrate metabolic process (13%);ubiquitin-dependent protein catabolic process (5%),IPR004623 (28%);IPR005194 (13%);IPR005195 (13%),Potassium-transporting ATPase A chain (28%);Glycoside hydrolase family 65, C-terminal (13%);Glycoside hydrolase, family 65, central catalytic (13%),,,,,,,
DSSVCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (36%),integral component of membrane (36%),GO:0005524 (27%);GO:0016740 (27%);GO:0003676 (18%),ATP binding (27%);transferase activity (27%);nucleic acid binding (18%),GO:0007018 (9%);GO:0032259 (9%),microtubule-based movement (9%);methylation (9%),IPR000719 (17%);IPR001173 (17%);IPR011009 (17%),Protein kinase domain (17%);Glycosyltransferase 2-like (17%);Protein kinase-like domain superfamily (17%),,,,,,,,,,,
QNDPEAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (16%);2.7.1.5 (12%);2.7.11.21 (7%),Ribonucleoside-diphosphate reductase (16%);Rhamnulokinase (12%);Polo kinase (7%),GO:0016021 (26%);GO:0005783 (9%);GO:0005737 (6%),integral component of membrane (26%);endoplasmic reticulum (9%);cytoplasm (6%),GO:0005524 (19%);GO:0005220 (11%);GO:0070679 (11%),ATP binding (19%);inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (11%);inositol 1,4,5 trisphosphate binding (11%),GO:0006260 (4%);GO:0019752 (4%);GO:0019301 (3%),DNA replication (4%);carboxylic acid metabolic process (4%);rhamnose catabolic process (3%),IPR027417 (13%);IPR035910 (12%);IPR000699 (11%),P-loop containing nucleoside triphosphate hydrolase (13%);RyR/IP3 receptor binding core, RIH domain superfamily (12%);RIH domain (11%),,,,,,
WSEVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (18%);GO:0005634 (2%);GO:0016581 (2%),integral component of membrane (18%);nucleus (2%);NuRD complex (2%),GO:0046872 (11%);GO:0003824 (5%);GO:0031419 (5%),metal ion binding (11%);catalytic activity (5%);cobalamin binding (5%),GO:0016226 (70%);GO:0018095 (2%),iron-sulfur cluster assembly (70%);protein polyglutamylation (2%),IPR000825 (63%);IPR010231 (63%);IPR037284 (63%),SUF system FeS cluster assembly, SufBD (63%);SUF system FeS cluster assembly, SufB (63%);SUF system FeS cluster assembly, SufBD superfamily (63%),,,,,,,,
WWYYSFFLVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYLVMMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEPCWMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YWSPNYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVWLESSMEQNAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGADDDAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFSVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.2 (14%);3.4.24.- (9%);6.3.2.8 (6%),Gamma-glutamyltransferase (14%);Metalloendopeptidases (9%);UDP-N-acetylmuramate--L-alanine ligase (6%),GO:0016021 (34%);GO:0005840 (9%);GO:0005886 (5%),integral component of membrane (34%);ribosome (9%);plasma membrane (5%),GO:0005524 (14%);GO:0019843 (9%);GO:0003735 (8%),ATP binding (14%);rRNA binding (9%);structural constituent of ribosome (8%),GO:0006412 (9%);GO:0006355 (5%);GO:0008360 (2%),translation (9%);regulation of transcription, DNA-templated (5%);regulation of cell shape (2%),IPR027417 (9%);IPR012677 (7%);IPR012678 (7%),P-loop containing nucleoside triphosphate hydrolase (9%);Nucleotide-binding alpha-beta plait domain superfamily (7%);Ribosomal protein L23/L15e core domain superfamily (7%),,,,,,,,,,
NEDVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.25 (14%);4.1.99.12 (11%);3.6.4.12 (10%),GTP cyclohydrolase II (14%);3,4-dihydroxy-2-butanone-4-phosphate synthase (11%);DNA helicase (10%),GO:0016021 (22%);GO:0005576 (8%);GO:0005618 (8%),integral component of membrane (22%);extracellular region (8%);cell wall (8%),GO:0004519 (17%);GO:0008408 (17%);GO:0005524 (16%),endonuclease activity (17%);3'-5' exonuclease activity (17%);ATP binding (16%),GO:0006310 (17%);GO:0006260 (17%);GO:0007155 (8%),DNA recombination (17%);DNA replication (17%);cell adhesion (8%),IPR029052 (14%);IPR004843 (14%);IPR041796 (14%),Metallo-dependent phosphatase-like (14%);Calcineurin-like phosphoesterase domain, ApaH type (14%);Mre11 nuclease, N-terminal metallophosphatase domain (14%),,,,,,,,
WYLHNEAEANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NETTNMWAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HDMAEVSR,Sulfurimonas autotrophica,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Epsilonproteobacteria,,,,Campylobacterales,,,,,Helicobacteraceae,,,,Sulfurimonas,,,,Sulfurimonas autotrophica,,,,1.8.1.9 (100%),Thioredoxin-disulfide reductase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004791 (100%),thioredoxin-disulfide reductase activity (100%),GO:0019430 (100%),removal of superoxide radicals (100%),IPR005982 (100%);IPR008255 (100%);IPR023753 (100%),Thioredoxin reductase (100%);Pyridine nucleotide-disulphide oxidoreductase, class-II, active site (100%);FAD/NAD(P)-binding domain (100%),,,,,,,,,
SNYDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.3 (13%);2.7.7.6 (9%);4.2.1.93 (9%),RNA ligase (ATP) (13%);DNA-directed RNA polymerase (9%);ATP-dependent NAD(P)H-hydrate dehydratase (9%),GO:0016021 (43%);GO:0005737 (8%);GO:0016020 (7%),integral component of membrane (43%);cytoplasm (8%);membrane (7%),GO:0005524 (22%);GO:0022857 (9%);GO:0051082 (8%),ATP binding (22%);transmembrane transporter activity (9%);unfolded protein binding (8%),GO:0006457 (7%);GO:0006260 (7%);GO:0009408 (7%),protein folding (7%);DNA replication (7%);response to heat (7%),IPR001623 (12%);IPR036869 (12%);IPR018253 (9%),DnaJ domain (12%);Chaperone J-domain superfamily (12%);DnaJ domain, conserved site (9%),,,,,,,,,,
ANDLAFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.19 (100%),tRNA(Ile)-lysidine synthetase (100%),GO:0005737 (14%);GO:0005887 (14%);GO:0030286 (14%),cytoplasm (14%);integral component of plasma membrane (14%);dynein complex (14%),GO:0005524 (29%);GO:0016740 (29%);GO:0016787 (29%),ATP binding (29%);transferase activity (29%);hydrolase activity (29%),GO:0006400 (14%);GO:0007018 (14%);GO:0009306 (14%),tRNA modification (14%);microtubule-based movement (14%);protein secretion (14%),IPR031811 (29%);IPR001647 (14%);IPR004273 (14%),AlgX/AlgJ, SGNH hydrolase-like domain (29%);DNA-binding HTH domain, TetR-type (14%);Dynein heavy chain region D6 P-loop domain (14%),,,,,,,,,
SVLTFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.99.6 (75%);2.4.1.17 (13%);5.4.99.27 (13%),Epoxyqueuosine reductase (75%);Glucuronosyltransferase (13%);tRNA pseudouridine(13) synthase (13%),GO:0016021 (47%);GO:0005737 (13%);GO:0015935 (3%),integral component of membrane (47%);cytoplasm (13%);small ribosomal subunit (3%),GO:0052693 (20%);GO:0046872 (13%);GO:0051539 (13%),epoxyqueuosine reductase activity (20%);metal ion binding (13%);4 iron, 4 sulfur cluster binding (13%),GO:0008033 (23%);GO:0008616 (23%);GO:0001522 (7%),tRNA processing (23%);queuosine biosynthetic process (23%);pseudouridine synthesis (7%),IPR004453 (23%);IPR013542 (23%);IPR017896 (23%),Epoxyqueuosine reductase QueG (23%);Domain of unknown function DUF1730 (23%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (23%),,,,,,,,,
MMVTEAK,Rhizopus microsporus,Eukaryota,Fungi,,,Mucoromycota,Mucoromycotina,,Mucoromycetes,,,,Mucorales,Mucorineae,,,,Rhizopodaceae,,,,Rhizopus,,,,Rhizopus microsporus,,,,,,,,GO:0008017 (100%),microtubule binding (100%),,,IPR001715 (100%);IPR036872 (100%);IPR003108 (50%),Calponin homology domain (100%);CH domain superfamily (100%);GAR domain (50%),,,,,,,,,,,
DFATTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016787 (67%);GO:0009055 (33%);GO:0020037 (33%),hydrolase activity (67%);electron transfer activity (33%);heme binding (33%),,,IPR004843 (33%);IPR029052 (33%);IPR001357 (17%),Calcineurin-like phosphoesterase domain, ApaH type (33%);Metallo-dependent phosphatase-like (33%);BRCT domain (17%),,,,,,,,,,
TYCLVNPVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDPAC,Burkholderia multivorans,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Burkholderiaceae,,,,Burkholderia,,Burkholderia cepacia complex,,Burkholderia multivorans,,,,,,,,,,,,,,,,,,,,,,,,
CGDFGDER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.18 (22%);3.2.1.- (12%);2.1.1.45 (7%),Succinyl-diaminopimelate desuccinylase (22%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (12%);Thymidylate synthase (7%),GO:0030121 (34%);GO:0016021 (21%);GO:0005886 (6%),AP-1 adaptor complex (34%);integral component of membrane (21%);plasma membrane (6%),GO:0003677 (12%);GO:0046872 (8%);GO:0003700 (5%),DNA binding (12%);metal ion binding (8%);DNA-binding transcription factor activity (5%),GO:0006886 (40%);GO:0016192 (34%);GO:0016197 (4%),intracellular protein transport (40%);vesicle-mediated transport (34%);endosomal transport (4%),IPR016024 (37%);IPR002553 (37%);IPR011989 (37%),Armadillo-type fold (37%);Clathrin/coatomer adaptor, adaptin-like, N-terminal (37%);Armadillo-like helical (37%),,,,,,,,
NMDMEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWSLMMGGDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNPCTVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHCEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.6 (50%);3.6.4.12 (50%),Exodeoxyribonuclease VII (50%);DNA helicase (50%),GO:0005634 (56%);GO:0016021 (44%);GO:0005737 (11%),nucleus (56%);integral component of membrane (44%);cytoplasm (11%),GO:0008233 (44%);GO:0005524 (22%);GO:0003677 (11%),peptidase activity (44%);ATP binding (22%);DNA binding (11%),GO:0000723 (11%);GO:0006281 (11%);GO:0006308 (11%),telomere maintenance (11%);DNA repair (11%);DNA catabolic process (11%),IPR005314 (38%);IPR030397 (38%);IPR000533 (23%),Peptidase C50, separase (38%);SEPARIN core domain (38%);Tropomyosin (23%),,,,,,,,,,
QNSALAPDVSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNVLVQC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAEMMDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.234 (80%);1.17.1.8 (20%),N(6)-L-threonylcarbamoyladenine synthase (80%);4-hydroxy-tetrahydrodipicolinate reductase (20%),GO:0005737 (45%);GO:0005840 (9%),cytoplasm (45%);ribosome (9%),GO:0004222 (36%);GO:0005506 (36%);GO:0061711 (36%),metalloendopeptidase activity (36%);iron ion binding (36%);N(6)-L-threonylcarbamoyladenine synthase activity (36%),GO:0002949 (36%);GO:0046856 (18%);GO:0006412 (9%),tRNA threonylcarbamoyladenosine modification (36%);phosphatidylinositol dephosphorylation (18%);translation (9%),IPR000905 (38%);IPR017860 (31%);IPR017861 (31%),Gcp-like domain (38%);Peptidase M22, conserved site (31%);Kae1/TsaD family (31%),,,,,,,,,,
EHMLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (100%),DNA (cytosine-5-)-methyltransferase (100%),GO:0000502 (57%);GO:0016021 (36%);GO:0005886 (7%),proteasome complex (57%);integral component of membrane (36%);plasma membrane (7%),GO:0000155 (7%);GO:0003886 (7%);GO:0015450 (7%),phosphorelay sensor kinase activity (7%);DNA (cytosine-5-)-methyltransferase activity (7%);P-P-bond-hydrolysis-driven protein transmembrane transporter activity (7%),GO:0006605 (7%);GO:0043952 (7%);GO:0065002 (7%),protein targeting (7%);protein transport by the Sec complex (7%);intracellular protein transmembrane transport (7%),IPR000717 (50%);IPR035297 (50%);IPR036388 (50%),Proteasome component (PCI) domain (50%);26S Proteasome non-ATPase regulatory subunit 12 (50%);Winged helix-like DNA-binding domain superfamily (50%),,,,,,,,,,,
NRPLPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (27%);GO:0005634 (9%);GO:0043190 (5%),integral component of membrane (27%);nucleus (9%);ATP-binding cassette (ABC) transporter complex (5%),GO:0003677 (32%);GO:0000150 (14%);GO:0003723 (9%),DNA binding (32%);recombinase activity (14%);RNA binding (9%),GO:0006396 (9%);GO:0030001 (9%);GO:0006004 (5%),RNA processing (9%);metal ion transport (9%);fucose metabolic process (5%),IPR026104 (17%);IPR001387 (13%);IPR006119 (13%),Zinc finger C2HC domain-containing protein 1C (17%);Cro/C1-type helix-turn-helix domain (13%);Resolvase, N-terminal catalytic domain (13%),,,,,,,,,,
WLNGNYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTFQNNFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVNGHFNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYQVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.52 (80%);6.1.1.2 (20%),Beta-N-acetylhexosaminidase (80%);Tryptophan--tRNA ligase (20%),GO:0016021 (18%);GO:0005737 (12%);GO:0015627 (6%),integral component of membrane (18%);cytoplasm (12%);type II protein secretion system complex (6%),GO:0004563 (29%);GO:0102148 (24%);GO:0003824 (12%),beta-N-acetylhexosaminidase activity (29%);N-acetyl-beta-D-galactosaminidase activity (24%);catalytic activity (12%),GO:0005975 (29%);GO:0006508 (12%);GO:0006436 (6%),carbohydrate metabolic process (29%);proteolysis (12%);tryptophanyl-tRNA aminoacylation (6%),IPR015883 (31%);IPR017853 (31%);IPR025705 (31%),Glycoside hydrolase family 20, catalytic domain (31%);Glycoside hydrolase superfamily (31%);Beta-hexosaminidase (31%),,,,,,,,,,
MPPVLLMVTHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFEFTDFDGRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YCLPVMEQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAMLDNHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (61%);3.1.-.- (61%);2.5.1.26 (7%),DNA helicase (61%);Acting on ester bonds (61%);Alkylglycerone-phosphate synthase (7%),GO:0016021 (18%);GO:0005737 (3%);GO:0005777 (3%),integral component of membrane (18%);cytoplasm (3%);peroxisome (3%),GO:0005524 (43%);GO:0046872 (32%);GO:0003678 (29%),ATP binding (43%);metal ion binding (32%);DNA helicase activity (29%),GO:0000724 (29%);GO:0006915 (7%);GO:0008611 (3%),double-strand break repair via homologous recombination (29%);apoptotic process (7%);ether lipid biosynthetic process (3%),IPR027417 (34%);IPR000212 (26%);IPR038726 (26%),P-loop containing nucleoside triphosphate hydrolase (34%);DNA helicase, UvrD/REP type (26%);PD-(D/E)XK endonuclease-like domain, AddAB-type (26%),,,,,,,,,
LLPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.14 (9%);6.5.1.1 (5%);2.7.7.7 (4%),Amidophosphoribosyltransferase (9%);DNA ligase (ATP) (5%);DNA-directed DNA polymerase (4%),GO:0016021 (26%);GO:0005886 (19%);GO:0005737 (10%),integral component of membrane (26%);plasma membrane (19%);cytoplasm (10%),GO:0005524 (44%);GO:0016887 (24%);GO:0003677 (7%),ATP binding (44%);ATPase activity (24%);DNA binding (7%),GO:0051301 (19%);GO:0007049 (18%);GO:0006457 (5%),cell division (19%);cell cycle (18%);protein folding (5%),IPR027417 (32%);IPR003593 (28%);IPR003439 (22%),P-loop containing nucleoside triphosphate hydrolase (32%);AAA+ ATPase domain (28%);ABC transporter-like (22%),,,,,,,,,,,
ETQLGHELCNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APYYGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0009507 (25%),integral component of membrane (50%);chloroplast (25%),GO:0004222 (25%);GO:0004519 (25%);GO:0016740 (25%),metalloendopeptidase activity (25%);endonuclease activity (25%);transferase activity (25%),GO:0007155 (25%),cell adhesion (25%),IPR008775 (22%);IPR000305 (11%);IPR001173 (11%),Phytanoyl-CoA dioxygenase (22%);GIY-YIG endonuclease (11%);Glycosyltransferase 2-like (11%),,,,,,,,,,,
VYLYDYFPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AYNFGNWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMVQEAQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SAMLAPR,Betaproteobacteria,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,,,,,,,,,,,,,,,,,,4.2.3.1 (100%),Threonine synthase (100%),,,GO:0004795 (50%);GO:0016620 (25%);GO:0016709 (25%),threonine synthase activity (50%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (25%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (25%),GO:0006744 (25%),ubiquinone biosynthetic process (25%),IPR029144 (60%);IPR036052 (60%);IPR037158 (60%),Threonine synthase, N-terminal (60%);Tryptophan synthase beta subunit-like PLP-dependent enzyme (60%);Threonine synthase, N-terminal domain superfamily (60%),,,
SPPVQLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0004512 (50%);GO:0016874 (25%),inositol-3-phosphate synthase activity (50%);ligase activity (25%),GO:0006021 (50%);GO:0008654 (50%),inositol biosynthetic process (50%);phospholipid biosynthetic process (50%),IPR002587 (25%);IPR008907 (25%);IPR011762 (25%),Myo-inositol-1-phosphate synthase (25%);P25-alpha (25%);Acetyl-coenzyme A carboxyltransferase, N-terminal (25%),,,,,,,,,,
MLALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.187 (51%);2.5.1.72 (23%);3.6.4.12 (5%),N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-Dmannosaminyltransferase (51%);Quinolinate synthase (23%);DNA helicase (5%),GO:0016021 (31%);GO:0005737 (7%);GO:0005886 (4%),integral component of membrane (31%);cytoplasm (7%);plasma membrane (4%),GO:0047244 (15%);GO:0016757 (10%);GO:0046872 (8%),N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase activity (15%);transferase activity, transferring glycosyl groups (10%);metal ion binding (8%),GO:0071555 (14%);GO:0019350 (14%);GO:0009435 (7%),cell wall organization (14%);teichoic acid biosynthetic process (14%);NAD biosynthetic process (7%),IPR004629 (22%);IPR034714 (12%);IPR003473 (6%),Glycosyl transferase WecB/TagA/CpsF (22%);N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase (12%);Quinolinate synthetase A (6%),,,,,,,,,,
SMWQDSALPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPNNETMLAEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LHRPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (76%);2.4.1.21 (8%);4.2.1.17 (4%),DNA helicase (76%);Starch synthase (8%);Enoyl-CoA hydratase (4%),GO:0016021 (13%);GO:0005886 (5%);GO:0005840 (3%),integral component of membrane (13%);plasma membrane (5%);ribosome (3%),GO:0005524 (34%);GO:0003677 (29%);GO:0003678 (25%),ATP binding (34%);DNA binding (29%);DNA helicase activity (25%),GO:0009236 (4%);GO:0006412 (3%);GO:0006355 (2%),cobalamin biosynthetic process (4%);translation (3%);regulation of transcription, DNA-templated (2%),IPR013534 (38%);IPR027417 (21%);IPR000212 (15%),Starch synthase, catalytic domain (38%);P-loop containing nucleoside triphosphate hydrolase (21%);DNA helicase, UvrD/REP type (15%),,,,,,,,
VVAQTNHEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELEMDMAVNAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTSNPAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNPYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.4 (28%);3.2.1.- (22%);3.2.1.68 (15%),Ribonuclease H (28%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (22%);Isoamylase (15%),GO:0016021 (21%);GO:0005737 (5%);GO:0019028 (2%),integral component of membrane (21%);cytoplasm (5%);viral capsid (2%),GO:0004553 (24%);GO:0004133 (23%);GO:0046872 (13%),hydrolase activity, hydrolyzing O-glycosyl compounds (24%);glycogen debranching enzyme activity (23%);metal ion binding (13%),GO:0005980 (25%);GO:0006635 (8%);GO:0060030 (6%),glycogen catabolic process (25%);fatty acid beta-oxidation (8%);dorsal convergence (6%),IPR017853 (23%);IPR014756 (23%);IPR006047 (22%),Glycoside hydrolase superfamily (23%);Immunoglobulin E-set (23%);Glycosyl hydrolase, family 13, catalytic domain (22%),,,,,,,
ALFGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.1 (30%);2.7.1.24 (11%);2.7.7.6 (11%),Threonine synthase (30%);Dephospho-CoA kinase (11%);DNA-directed RNA polymerase (11%),GO:0016021 (38%);GO:0005886 (8%);GO:0005737 (5%),integral component of membrane (38%);plasma membrane (8%);cytoplasm (5%),GO:0003677 (14%);GO:0005524 (11%);GO:0004795 (7%),DNA binding (14%);ATP binding (11%);threonine synthase activity (7%),GO:0006113 (10%);GO:0006310 (5%);GO:0006306 (3%),fermentation (10%);DNA recombination (5%);DNA methylation (3%),IPR027417 (9%);IPR029636 (9%);IPR036052 (8%),P-loop containing nucleoside triphosphate hydrolase (9%);Protein Csf1 (9%);Tryptophan synthase beta subunit-like PLP-dependent enzyme (8%),,,,,,,,,,,
QGVLVTVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MCLPTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%),integral component of membrane (60%),GO:0003964 (40%);GO:0022857 (40%);GO:0004672 (20%),RNA-directed DNA polymerase activity (40%);transmembrane transporter activity (40%);protein kinase activity (20%),,,IPR000477 (40%);IPR005828 (40%);IPR005829 (40%),Reverse transcriptase domain (40%);Major facilitator,  sugar transporter-like (40%);Sugar transporter, conserved site (40%),,,,,,,,,
MAVAANTVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSNGWSQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETMLPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.31 (100%),Adenine glycosylase (100%),GO:0016021 (29%);GO:0032300 (14%),integral component of membrane (29%);mismatch repair complex (14%),GO:0004497 (43%);GO:0005506 (43%);GO:0016705 (43%),monooxygenase activity (43%);iron ion binding (43%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (43%),GO:0006284 (14%);GO:0006298 (14%),base-excision repair (14%);mismatch repair (14%),IPR001128 (38%);IPR002401 (38%);IPR017972 (38%),Cytochrome P450 (38%);Cytochrome P450, E-class, group I (38%);Cytochrome P450, conserved site (38%),,,,,,
NMCHMAHDAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HWFADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003676 (33%);GO:0003677 (33%);GO:0005524 (33%),nucleic acid binding (33%);DNA binding (33%);ATP binding (33%),,,IPR001647 (33%);IPR001650 (33%);IPR005232 (33%),DNA-binding HTH domain, TetR-type (33%);Helicase, C-terminal (33%);Pyridinium-3,5-bisthiocarboxylic acid mononucleotide synthase LarE (33%),,,,,,,,
QDGMLTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNVGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.297 (8%);3.4.13.- (5%);3.4.24.- (5%),Peptide chain release factor N(5)-glutamine methyltransferase (8%);Dipeptidases (5%);Metalloendopeptidases (5%),GO:0016021 (29%);GO:0005737 (7%);GO:0009279 (7%),integral component of membrane (29%);cytoplasm (7%);cell outer membrane (7%),GO:0005524 (31%);GO:0016887 (20%);GO:0003677 (7%),ATP binding (31%);ATPase activity (20%);DNA binding (7%),GO:0015833 (18%);GO:0008653 (4%);GO:0046890 (4%),peptide transport (18%);lipopolysaccharide metabolic process (4%);regulation of lipid biosynthetic process (4%),IPR027417 (26%);IPR003439 (18%);IPR017871 (18%),P-loop containing nucleoside triphosphate hydrolase (26%);ABC transporter-like (18%);ABC transporter, conserved site (18%),,,,,,,,,,
HLADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.2 (24%);3.6.4.- (14%);1.16.3.1 (8%),Adenylosuccinate lyase (24%);Acting on ATP; involved in cellular and subcellular movement (14%);Ferroxidase (8%),GO:0016021 (14%);GO:0005737 (8%);GO:0005623 (4%),integral component of membrane (14%);cytoplasm (8%);cell (4%),GO:0005524 (20%);GO:0004018 (9%);GO:0070626 (9%),ATP binding (20%);N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity (9%);(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity (9%),GO:0044208 (10%);GO:0006189 (9%);GO:0006353 (4%),'de novo' AMP biosynthetic process (10%);'de novo' IMP biosynthetic process (9%);DNA-templated transcription, termination (4%),IPR027417 (13%);IPR008948 (7%);IPR022761 (7%),P-loop containing nucleoside triphosphate hydrolase (13%);L-Aspartase-like (7%);Fumarate lyase, N-terminal (7%),,,,,,,,
MQETHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (100%),Phenylalanine--tRNA ligase (100%),GO:0016021 (58%);GO:0005737 (33%),integral component of membrane (58%);cytoplasm (33%),GO:0000049 (33%);GO:0000287 (33%);GO:0004826 (33%),tRNA binding (33%);magnesium ion binding (33%);phenylalanine-tRNA ligase activity (33%),GO:0006432 (33%);GO:0055085 (8%),phenylalanyl-tRNA aminoacylation (33%);transmembrane transport (8%),IPR025361 (41%);IPR002319 (18%);IPR004188 (18%),Protein of unknown function DUF4265 (41%);Phenylalanyl-tRNA synthetase (18%);Phenylalanine-tRNA ligase, class II, N-terminal (18%),,,,,,,,,
MWMEVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMAAWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (50%);2.7.7.7 (25%);3.11.1.1 (25%),Carboxylic ester hydrolases (50%);DNA-directed DNA polymerase (25%);Phosphonoacetaldehyde hydrolase (25%),GO:0005634 (34%);GO:0005737 (8%);GO:0005813 (5%),nucleus (34%);cytoplasm (8%);centrosome (5%),GO:0000981 (34%);GO:0008270 (34%);GO:0003677 (16%),DNA-binding transcription factor activity, RNA polymerase II-specific (34%);zinc ion binding (34%);DNA binding (16%),GO:0006260 (3%);GO:0006270 (3%);GO:0006281 (3%),DNA replication (3%);DNA replication initiation (3%);DNA repair (3%),IPR001138 (28%);IPR036864 (28%);IPR036388 (15%),Zn(2)-C6 fungal-type DNA-binding domain (28%);Zn(2)-C6 fungal-type DNA-binding domain superfamily (28%);Winged helix-like DNA-binding domain superfamily (15%),,,,,,,,,,
NNSSELHVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLMYPNLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSLLEMEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLGSHSYAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALVMLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.1 (80%);2.7.7.7 (10%);7.1.1.- (10%),Purine-nucleoside phosphorylase (80%);DNA-directed DNA polymerase (10%);Hydron translocation or charge separation linked to oxidoreductase reactions (10%),GO:0016021 (38%);GO:0005886 (30%);GO:0005623 (3%),integral component of membrane (38%);plasma membrane (30%);cell (3%),GO:0005298 (30%);GO:0031402 (30%);GO:0004731 (20%),proline:sodium symporter activity (30%);sodium ion binding (30%);purine-nucleoside phosphorylase activity (20%),GO:0015824 (30%);GO:0009116 (18%);GO:0006355 (5%),proline transport (30%);nucleoside metabolic process (18%);regulation of transcription, DNA-templated (5%),IPR001734 (23%);IPR011851 (23%);IPR038377 (23%),Sodium/solute symporter (23%);Sodium/proline symporter (23%);Sodium/glucose symporter superfamily (23%),,,,,,,,,,
DMEEVPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (100%),Endopeptidase La (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004176 (100%);GO:0004252 (100%);GO:0005524 (100%),ATP-dependent peptidase activity (100%);serine-type endopeptidase activity (100%);ATP binding (100%),GO:0006515 (67%);GO:0034605 (67%);GO:0030163 (33%),protein quality control for misfolded or incompletely synthesized proteins (67%);cellular response to heat (67%);protein catabolic process (33%),IPR003111 (100%);IPR003593 (100%);IPR003959 (100%),Lon, substrate-binding domain (100%);AAA+ ATPase domain (100%);ATPase, AAA-type, core (100%),,,,,,,,
DELMMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
STDVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.8.1.5 (40%);1.7.2.2 (20%);2.3.2.31 (20%),Haloalkane dehalogenase (40%);Nitrite reductase (cytochrome; ammonia-forming) (20%);RBR-type E3 ubiquitin transferase (20%),GO:0016021 (34%);GO:0005634 (7%);GO:0005737 (5%),integral component of membrane (34%);nucleus (7%);cytoplasm (5%),GO:0046872 (14%);GO:0003677 (7%);GO:0003824 (7%),metal ion binding (14%);DNA binding (7%);catalytic activity (7%),GO:0006189 (5%);GO:0032259 (5%);GO:0046718 (5%),'de novo' IMP biosynthetic process (5%);methylation (5%);viral entry into host cell (5%),IPR000073 (9%);IPR000639 (9%);IPR029058 (9%),Alpha/beta hydrolase fold-1 (9%);Epoxide hydrolase-like (9%);Alpha/Beta hydrolase fold (9%),,,,,,,,,,,
TFDTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.169 (12%);4.1.1.48 (10%);2.7.1.21 (4%),2-dehydropantoate 2-reductase (12%);Indole-3-glycerol-phosphate synthase (10%);Thymidine kinase (4%),GO:0016021 (25%);GO:0005886 (6%);GO:0016020 (2%),integral component of membrane (25%);plasma membrane (6%);membrane (2%),GO:0003677 (11%);GO:0005524 (9%);GO:0016787 (8%),DNA binding (11%);ATP binding (9%);hydrolase activity (8%),GO:0006310 (5%);GO:0015074 (5%);GO:0043488 (4%),DNA recombination (5%);DNA integration (5%);regulation of mRNA stability (4%),IPR018768 (9%);IPR027417 (7%);IPR002560 (5%),Domain of unknown function DUF2344 (9%);P-loop containing nucleoside triphosphate hydrolase (7%);Transposase IS204/IS1001/IS1096/IS1165, DDE domain (5%),,,,,,,,,,
WMMDLPK,Colletotrichum fructicola,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Glomerellales,,,,,Glomerellaceae,,,,Colletotrichum,,,,Colletotrichum fructicola,,,,,,,,,,,,,,,,,,,,,,,,
TKPDSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
MYEADGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (25%);IPR008416 (25%);IPR008969 (25%),TonB-dependent receptor-like, beta-barrel (25%);Baculovirus VP1054 (25%);Carboxypeptidase-like, regulatory domain superfamily (25%),,,,,,,,,
EENWMSMLDVDGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQFHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.15 (30%);1.1.-.- (10%);2.7.1.39 (10%),(1->4)-alpha-D-glucan 1-alpha-D-glucosylmutase (30%);Acting on the CH-OH group of donors (10%);Homoserine kinase (10%),GO:0016021 (21%);GO:0005737 (3%);GO:0005886 (1%),integral component of membrane (21%);cytoplasm (3%);plasma membrane (1%),GO:0003824 (38%);GO:0050662 (21%);GO:0005524 (9%),catalytic activity (38%);coenzyme binding (21%);ATP binding (9%),GO:0005975 (23%);GO:0055085 (3%);GO:0006897 (2%),carbohydrate metabolic process (23%);transmembrane transport (3%);endocytosis (2%),IPR036291 (22%);IPR017853 (21%);IPR006047 (21%),NAD(P)-binding domain superfamily (22%);Glycoside hydrolase superfamily (21%);Glycosyl hydrolase, family 13, catalytic domain (21%),,,,,,,,,
TVYCVAPNNGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EASNAEWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGQNLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005681 (30%);GO:0005856 (20%),spliceosomal complex (30%);cytoskeleton (20%),GO:0003779 (20%);GO:0005198 (20%);GO:0008745 (20%),actin binding (20%);structural molecule activity (20%);N-acetylmuramoyl-L-alanine amidase activity (20%),GO:0000244 (50%);GO:0009253 (20%);GO:0006397 (10%),spliceosomal tri-snRNP complex assembly (50%);peptidoglycan catabolic process (20%);mRNA processing (10%),IPR007946 (87%);IPR033647 (87%);IPR033648 (87%),A1 cistron-splicing factor, AAR2 (87%);AAR2, N-terminal (87%);AAR2, C-terminal (87%),,,,,,,,
LAMAGHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (26%),ribosome (26%),GO:0016614 (66%);GO:0050660 (66%);GO:0003735 (26%),oxidoreductase activity, acting on CH-OH group of donors (66%);flavin adenine dinucleotide binding (66%);structural constituent of ribosome (26%),GO:0006412 (26%),translation (26%),IPR000172 (66%);IPR036188 (66%);IPR007867 (64%),Glucose-methanol-choline oxidoreductase, N-terminal (66%);FAD/NAD(P)-binding domain superfamily (66%);Glucose-methanol-choline oxidoreductase, C-terminal (64%),,,,,,,,
QVALVLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.5.1 (11%);3.4.21.88 (10%);4.4.1.17 (6%),Succinate dehydrogenase (quinone) (11%);Repressor LexA (10%);Holocytochrome-c synthase (6%),GO:0016021 (22%);GO:0005737 (6%);GO:0005886 (5%),integral component of membrane (22%);cytoplasm (6%);plasma membrane (5%),GO:0005524 (14%);GO:0003677 (10%);GO:0046872 (5%),ATP binding (14%);DNA binding (10%);metal ion binding (5%),GO:0006541 (6%);GO:0006915 (5%);GO:0007411 (3%),glutamine metabolic process (6%);apoptotic process (5%);axon guidance (3%),IPR027417 (13%);IPR013783 (6%);IPR003961 (5%),P-loop containing nucleoside triphosphate hydrolase (13%);Immunoglobulin-like fold (6%);Fibronectin type III (5%),,,,,,,,,,,
VPYDDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR015915 (100%),Kelch-type beta propeller (100%),,,,,,,,,,,
FPMLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSSMTLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (11%);GO:0045261 (11%);GO:0048500 (11%),integral component of membrane (11%);proton-transporting ATP synthase complex, catalytic core F(1) (11%);signal recognition particle (11%),GO:0005524 (67%);GO:0008312 (11%);GO:0046933 (11%),ATP binding (67%);7S RNA binding (11%);proton-transporting ATP synthase activity, rotational mechanism (11%),GO:0019538 (67%);GO:0006614 (11%);GO:0015986 (11%),protein metabolic process (67%);SRP-dependent cotranslational protein targeting to membrane (11%);ATP synthesis coupled proton transport (11%),IPR001270 (55%);IPR003593 (55%);IPR003959 (55%),ClpA/B family (55%);AAA+ ATPase domain (55%);ATPase, AAA-type, core (55%),,,,,,,
DPLLLQFLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DYVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (21%);6.1.1.19 (21%);1.7.99.4 (8%),DNA topoisomerase (21%);Arginine--tRNA ligase (21%);Nitrate reductase (8%),GO:0005737 (36%);GO:0005886 (28%);GO:0016021 (7%),cytoplasm (36%);plasma membrane (28%);integral component of membrane (7%),GO:0005524 (54%);GO:0046872 (33%);GO:0016887 (14%),ATP binding (54%);metal ion binding (33%);ATPase activity (14%),GO:0006605 (30%);GO:0017038 (29%);GO:0065002 (27%),protein targeting (30%);protein import (29%);intracellular protein transmembrane transport (27%),IPR027417 (41%);IPR000185 (26%);IPR011130 (26%),P-loop containing nucleoside triphosphate hydrolase (41%);Protein translocase subunit SecA (26%);SecA, preprotein cross-linking domain (26%),,,,,,,,,,
MEMLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.83 (33%);4.1.2.40 (33%);7.2.3.- (33%),Pseudouridine kinase (33%);Tagatose-bisphosphate aldolase (33%);Linked to the hydrolysis of diphosphate (33%),GO:0016021 (34%);GO:0030127 (11%);GO:0009279 (6%),integral component of membrane (34%);COPII vesicle coat (11%);cell outer membrane (6%),GO:0008168 (11%);GO:0003677 (9%);GO:0008270 (6%),methyltransferase activity (11%);DNA binding (9%);zinc ion binding (6%),GO:0006886 (11%);GO:0006888 (11%);GO:0032259 (11%),intracellular protein transport (11%);endoplasmic reticulum to Golgi vesicle-mediated transport (11%);methylation (11%),IPR006900 (8%);IPR007123 (8%);IPR029006 (8%),Sec23/Sec24, helical domain (8%);Gelsolin-like domain (8%);ADF-H/Gelsolin-like domain superfamily (8%),,,,,,,,,,
DVLSYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.4 (42%);3.5.1.108 (24%);4.2.1.59 (20%),[Formate-C-acetyltransferase]-activating enzyme (42%);UDP-3-O-acyl-N-acetylglucosamine deacetylase (24%);3-hydroxyacyl-[acyl-carrier-protein] dehydratase (20%),GO:0009279 (48%);GO:0016021 (17%);GO:0005737 (9%),cell outer membrane (48%);integral component of membrane (17%);cytoplasm (9%),GO:0015344 (43%);GO:0038023 (43%);GO:0046872 (11%),siderophore uptake transmembrane transporter activity (43%);signaling receptor activity (43%);metal ion binding (11%),GO:0009245 (4%);GO:0000226 (3%);GO:0006633 (3%),lipid A biosynthetic process (4%);microtubule cytoskeleton organization (3%);fatty acid biosynthetic process (3%),IPR036942 (42%);IPR037066 (42%);IPR000531 (42%),TonB-dependent receptor-like, beta-barrel domain superfamily (42%);TonB-dependent receptor, plug domain superfamily (42%);TonB-dependent receptor-like, beta-barrel (42%),,,,,,,,
MDDLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.98 (19%);2.4.1.25 (6%);3.1.13.1 (5%),UDP-N-acetylmuramate dehydrogenase (19%);4-alpha-glucanotransferase (6%);Exoribonuclease II (5%),GO:0016021 (18%);GO:0005737 (5%);GO:0005886 (2%),integral component of membrane (18%);cytoplasm (5%);plasma membrane (2%),GO:0003677 (34%);GO:0005524 (15%);GO:0016740 (6%),DNA binding (34%);ATP binding (15%);transferase activity (6%),GO:0006355 (16%);GO:0051301 (3%);GO:0009291 (2%),regulation of transcription, DNA-templated (16%);cell division (3%);unidirectional conjugation (2%),IPR027417 (16%);IPR036390 (15%);IPR012318 (11%),P-loop containing nucleoside triphosphate hydrolase (16%);Winged helix DNA-binding domain superfamily (15%);Crp-type HTH domain (11%),,,,,,,,,,
NNEAELSSATPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSLMMTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDCGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.3 (20%);1.1.1.133 (18%);2.1.1.297 (8%),Dihydroorotase (20%);dTDP-4-dehydrorhamnose reductase (18%);Peptide chain release factor N(5)-glutamine methyltransferase (8%),GO:0016021 (15%);GO:0005737 (12%);GO:0016605 (7%),integral component of membrane (15%);cytoplasm (12%);PML body (7%),GO:0003676 (15%);GO:0016787 (9%);GO:0005524 (8%),nucleic acid binding (15%);hydrolase activity (9%);ATP binding (8%),GO:0006302 (7%);GO:0048666 (6%);GO:0044205 (5%),double-strand break repair (7%);neuron development (6%);'de novo' UMP biosynthetic process (5%),IPR036691 (25%);IPR005135 (17%);IPR009060 (14%),Endonuclease/exonuclease/phosphatase superfamily (25%);Endonuclease/exonuclease/phosphatase (17%);UBA-like superfamily (14%),,,,,,,,,,,
SCELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.21.98.4 (10%);3.1.26.4 (8%);3.5.4.3 (8%),PqqA peptide cyclase (10%);Ribonuclease H (8%);Guanine deaminase (8%),GO:0016021 (26%);GO:0005615 (6%);GO:0005737 (5%),integral component of membrane (26%);extracellular space (6%);cytoplasm (5%),GO:0005524 (13%);GO:0046872 (8%);GO:0003677 (6%),ATP binding (13%);metal ion binding (8%);DNA binding (6%),GO:0006590 (5%);GO:0015705 (5%);GO:0030878 (5%),thyroid hormone generation (5%);iodide transport (5%);thyroid gland development (5%),IPR029058 (7%);IPR000716 (7%);IPR036857 (7%),Alpha/Beta hydrolase fold (7%);Thyroglobulin type-1 (7%);Thyroglobulin type-1 superfamily (7%),,,,,,,,,,,
QAMLGSMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLMHYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0016742 (50%);GO:0016788 (50%);GO:0031177 (25%),hydroxymethyl-, formyl- and related transferase activity (50%);hydrolase activity, acting on ester bonds (50%);phosphopantetheine binding (25%),GO:0009058 (50%),biosynthetic process (50%),IPR000873 (40%);IPR001031 (40%);IPR002376 (40%),AMP-dependent synthetase/ligase (40%);Thioesterase (40%);Formyl transferase, N-terminal (40%),,,,,,,,
FFSEHSR,Rhizophagus clarus,Eukaryota,Fungi,,,Mucoromycota,Glomeromycotina,,Glomeromycetes,,,,Glomerales,,,,,Glomeraceae,,,,Rhizophagus,,,,Rhizophagus clarus,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005247 (100%),voltage-gated chloride channel activity (100%),,,IPR000644 (100%);IPR001807 (100%);IPR014743 (100%),CBS domain (100%);Chloride channel, voltage gated (100%);Chloride channel, core (100%),,,,,,,,,
MELPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (45%);4.2.1.20 (18%);2.1.1.80 (9%),DNA-directed DNA polymerase (45%);Tryptophan synthase (18%);Protein-glutamate O-methyltransferase (9%),GO:0005737 (34%);GO:0016021 (22%);GO:0005634 (2%),cytoplasm (34%);integral component of membrane (22%);nucleus (2%),GO:0003723 (37%);GO:0003677 (8%);GO:0003676 (6%),RNA binding (37%);DNA binding (8%);nucleic acid binding (6%),GO:0006281 (3%);GO:0006261 (2%);GO:0006355 (2%),DNA repair (3%);DNA-dependent DNA replication (2%);regulation of transcription, DNA-templated (2%),IPR021250 (37%);IPR038086 (37%);IPR000504 (21%),Protein of unknown function DUF2789 (37%);DUF2789 superfamily (37%);RNA recognition motif domain (21%),,,,,,,,,,
MDHMNEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNASHTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (75%);GO:0016887 (75%),ATP binding (75%);ATPase activity (75%),GO:0015833 (75%);GO:0035556 (25%),peptide transport (75%);intracellular signal transduction (25%),IPR003439 (60%);IPR003593 (60%);IPR013563 (60%),ABC transporter-like (60%);AAA+ ATPase domain (60%);Oligopeptide/dipeptide ABC transporter, C-terminal (60%),,,,,,,,,,
WLEVAVPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNELDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.2 (50%);6.1.1.4 (50%),Non-specific protein-tyrosine kinase (50%);Leucine--tRNA ligase (50%),GO:0016021 (50%);GO:0005737 (6%),integral component of membrane (50%);cytoplasm (6%),GO:0003779 (13%);GO:0005524 (13%);GO:0008157 (13%),actin binding (13%);ATP binding (13%);protein phosphatase 1 binding (13%),GO:0000160 (6%);GO:0006429 (6%);GO:0007264 (6%),phosphorelay signal transduction system (6%);leucyl-tRNA aminoacylation (6%);small GTPase mediated signal transduction (6%),IPR027417 (12%);IPR001107 (9%);IPR001452 (9%),P-loop containing nucleoside triphosphate hydrolase (12%);Band 7 domain (9%);SH3 domain (9%),,,,,,,,,,,
NGMMQLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLQPLLMSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLMHLAVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDLVM,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.11 (100%),Glutamate 5-kinase (100%),GO:0005737 (50%);GO:0009295 (25%),cytoplasm (50%);nucleoid (25%),GO:0003677 (50%);GO:0003723 (25%);GO:0004349 (25%),DNA binding (50%);RNA binding (25%);glutamate 5-kinase activity (25%),GO:0006355 (50%);GO:0006310 (25%);GO:0055129 (25%),regulation of transcription, DNA-templated (50%);DNA recombination (25%);L-proline biosynthetic process (25%),IPR000551 (60%);IPR009061 (60%);IPR001048 (20%),MerR-type HTH domain (60%);Putative DNA-binding domain superfamily (60%);Aspartate/glutamate/uridylate kinase (20%),,,,,,,,,,
NLEWYGGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFDSVTTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVLEAMPANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ATAEPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.5 (11%);3.2.2.- (11%);4.1.1.31 (11%),Ribonuclease P (11%);Hydrolyzing N-glycosyl compounds (11%);Phosphoenolpyruvate carboxylase (11%),GO:0016021 (39%);GO:0005886 (8%);GO:0005634 (3%),integral component of membrane (39%);plasma membrane (8%);nucleus (3%),GO:0003677 (11%);GO:0005524 (9%);GO:0015419 (5%),DNA binding (11%);ATP binding (9%);ATPase-coupled sulfate transmembrane transporter activity (5%),GO:0055085 (6%);GO:0006914 (5%);GO:0032259 (3%),transmembrane transport (6%);autophagy (5%);methylation (3%),IPR027417 (18%);IPR000515 (5%);IPR035906 (5%),P-loop containing nucleoside triphosphate hydrolase (18%);ABC transporter type 1, transmembrane domain MetI-like (5%);MetI-like superfamily (5%),,,,,,,,,,
MMELLEGSNSGSPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMVNDGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLVLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.82 (40%);2.4.1.18 (20%);2.7.1.17 (20%),Putrescine--2-oxoglutarate transaminase (40%);1,4-alpha-glucan branching enzyme (20%);Xylulokinase (20%),GO:0016021 (56%);GO:0005886 (7%);GO:0016020 (2%),integral component of membrane (56%);plasma membrane (7%);membrane (2%),GO:0003824 (24%);GO:0016874 (10%);GO:0003995 (9%),catalytic activity (24%);ligase activity (10%);acyl-CoA dehydrogenase activity (9%),GO:0033539 (9%);GO:0019290 (8%);GO:0055085 (5%),fatty acid beta-oxidation using acyl-CoA dehydrogenase (9%);siderophore biosynthetic process (8%);transmembrane transport (5%),IPR000873 (42%);IPR042099 (42%);IPR020845 (35%),AMP-dependent synthetase/ligase (42%);AMP-dependent synthetase-like superfamily (42%);AMP-binding, conserved site (35%),,,,,,,,,
DGVGPAGPVGAQGTAQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAVQQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (23%);3.1.-.- (15%);2.1.1.- (5%),Peptidylprolyl isomerase (23%);Acting on ester bonds (15%);Methyltransferases (5%),GO:0016021 (23%);GO:0005634 (10%);GO:0005737 (7%),integral component of membrane (23%);nucleus (10%);cytoplasm (7%),GO:0005524 (15%);GO:0003677 (15%);GO:0003690 (10%),ATP binding (15%);DNA binding (15%);double-stranded DNA binding (10%),GO:0007034 (6%);GO:0007548 (6%);GO:0030154 (6%),vacuolar transport (6%);sex differentiation (6%);cell differentiation (6%),IPR027417 (13%);IPR031419 (11%);IPR005176 (9%),P-loop containing nucleoside triphosphate hydrolase (13%);RAD51 interacting motif (11%);Potentiating neddylation domain (9%),,,,,,,,,,,
QSGPPYDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WHADLSYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLYVFHR,Myxococcales bacterium,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Myxococcales,,,,,,,,,,,,,Myxococcales bacterium,,,,,,,,,,,,IPR020958 (100%),Domain of unknown function DUF3686 (100%),,,,,,,,,,,
DLMVSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0005524 (100%),ATP binding (100%),GO:0006605 (100%);GO:0017038 (100%),protein targeting (100%);protein import (100%),IPR000185 (50%);IPR007122 (50%);IPR007123 (50%),Protein translocase subunit SecA (50%);Villin/Gelsolin (50%);Gelsolin-like domain (50%),,,,,,,,,,,
SCLVMVPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WSLLNDGPDMLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (28%);4.1.1.48 (6%);2.7.7.7 (6%),Acting on ATP; involved in cellular and subcellular movement (28%);Indole-3-glycerol-phosphate synthase (6%);DNA-directed DNA polymerase (6%),GO:0016021 (19%);GO:0005737 (9%);GO:0005886 (3%),integral component of membrane (19%);cytoplasm (9%);plasma membrane (3%),GO:0005524 (21%);GO:0003677 (20%);GO:0004386 (8%),ATP binding (21%);DNA binding (20%);helicase activity (8%),GO:0006355 (9%);GO:0006260 (3%);GO:0000162 (2%),regulation of transcription, DNA-templated (9%);DNA replication (3%);tryptophan biosynthetic process (2%),IPR027417 (17%);IPR001650 (8%);IPR014001 (8%),P-loop containing nucleoside triphosphate hydrolase (17%);Helicase, C-terminal (8%);Helicase superfamily 1/2, ATP-binding domain (8%),,,,,,,,
AYMFSLVSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HFPFTAAEVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTEGEAR,Sordariomycetes,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR001810 (50%);IPR015947 (50%);IPR036047 (50%),F-box domain (50%);PUA-like superfamily (50%);F-box-like domain superfamily (50%),,,,,,,,,,,
FMDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (19%);6.3.2.3 (19%);3.6.4.12 (9%),DNA topoisomerase (19%);Glutathione synthase (19%);DNA helicase (9%),GO:0016021 (30%);GO:0035101 (9%);GO:0005737 (6%),integral component of membrane (30%);FACT complex (9%);cytoplasm (6%),GO:0005524 (14%);GO:0003677 (13%);GO:0016787 (9%),ATP binding (14%);DNA binding (13%);hydrolase activity (9%),GO:0016042 (7%);GO:0032259 (5%);GO:0006364 (5%),lipid catabolic process (7%);methylation (5%);rRNA processing (5%),IPR004291 (7%);IPR029148 (7%);IPR029149 (7%),Transposase, IS66 (7%);FACT complex subunit Spt16, N-terminal lobe domain (7%);Creatinase/Aminopeptidase P/Spt16, N-terminal (7%),,,,,,,,
QEAENVECEGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TELNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.2 (16%);5.4.99.25 (12%);2.3.1.- (7%),Glutamate dehydrogenase (16%);tRNA pseudouridine(55) synthase (12%);Transferring groups other than amino-acyl groups (7%),GO:0016021 (21%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (21%);cytoplasm (6%);plasma membrane (3%),GO:0004352 (18%);GO:0005524 (15%);GO:0003677 (9%),glutamate dehydrogenase (NAD+) activity (18%);ATP binding (15%);DNA binding (9%),GO:0019551 (17%);GO:0006355 (3%);GO:0006260 (2%),glutamate catabolic process to 2-oxoglutarate (17%);regulation of transcription, DNA-templated (3%);DNA replication (2%),IPR036291 (17%);IPR028971 (15%);IPR007780 (15%),NAD(P)-binding domain superfamily (17%);NAD-glutamate dehydrogenase (15%);NAD-glutamate dehydrogenase, bacteria (15%),,,,,,,,,
LPVELYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.99.6 (100%),Glucosamine-6-phosphate deaminase (100%),GO:0016021 (44%);GO:0005743 (6%);GO:0005886 (6%),integral component of membrane (44%);mitochondrial inner membrane (6%);plasma membrane (6%),GO:0003676 (11%);GO:0004342 (11%);GO:0003677 (6%),nucleic acid binding (11%);glucosamine-6-phosphate deaminase activity (11%);DNA binding (6%),GO:0006408 (28%);GO:0006113 (17%);GO:0005975 (11%),snRNA export from nucleus (28%);fermentation (17%);carbohydrate metabolic process (11%),IPR019385 (26%);IPR038092 (26%);IPR039047 (26%),Phosphorylated adapter RNA export protein, RNA-binding domain (26%);Phosphorylated adapter RNA export protein, RNA-binding domain superfamily (26%);Phosphorylated adapter RNA export protein (26%),,,,,,,,,
AAYYMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.47 (89%);2.3.1.161 (5%);4.2.3.1 (5%),Cysteine synthase (89%);Lovastatin nonaketide synthase (5%);Threonine synthase (5%),GO:0000148 (8%);GO:0016021 (8%),1,3-beta-D-glucan synthase complex (8%);integral component of membrane (8%),GO:0004124 (76%);GO:0003677 (8%);GO:0003843 (8%),cysteine synthase activity (76%);DNA binding (8%);1,3-beta-D-glucan synthase activity (8%),GO:0006535 (68%);GO:0006075 (8%);GO:0006313 (8%),cysteine biosynthetic process from serine (68%);(1->3)-beta-D-glucan biosynthetic process (8%);transposition, DNA-mediated (8%),IPR001926 (77%);IPR036052 (77%);IPR005856 (73%),Pyridoxal-phosphate dependent enzyme (77%);Tryptophan synthase beta subunit-like PLP-dependent enzyme (77%);Cysteine synthase (73%),,,,,,,,
VWANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (25%);4.1.1.112 (16%);2.4.1.1 (12%),Ribonucleoside-diphosphate reductase (25%);Oxaloacetate decarboxylase (16%);Glycogen phosphorylase (12%),GO:0016021 (29%);GO:0005634 (6%);GO:0005737 (4%),integral component of membrane (29%);nucleus (6%);cytoplasm (4%),GO:0004222 (14%);GO:0005524 (12%);GO:0003677 (9%),metalloendopeptidase activity (14%);ATP binding (12%);DNA binding (9%),GO:0005975 (13%);GO:0071897 (7%);GO:0006260 (7%),carbohydrate metabolic process (13%);DNA biosynthetic process (7%);DNA replication (7%),IPR000718 (14%);IPR008753 (14%);IPR018497 (14%),Peptidase M13 (14%);Peptidase M13, N-terminal domain (14%);Peptidase M13, C-terminal domain (14%),,,,,,,,,
NNQER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.3.4 (41%);3.1.-.- (8%);3.6.4.12 (8%),Protoporphyrinogen oxidase (41%);Acting on ester bonds (8%);DNA helicase (8%),GO:0016021 (28%);GO:0005737 (18%);GO:0009279 (3%),integral component of membrane (28%);cytoplasm (18%);cell outer membrane (3%),GO:0003677 (18%);GO:0005524 (12%);GO:0004729 (10%),DNA binding (18%);ATP binding (12%);oxygen-dependent protoporphyrinogen oxidase activity (10%),GO:0006310 (15%);GO:0015074 (12%);GO:0006782 (10%),DNA recombination (15%);DNA integration (12%);protoporphyrinogen IX biosynthetic process (10%),IPR027417 (12%);IPR011010 (10%);IPR013762 (10%),P-loop containing nucleoside triphosphate hydrolase (12%);DNA breaking-rejoining enzyme, catalytic core (10%);Integrase-like, catalytic domain superfamily (10%),,,,,,,,,
MLTQAETPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVPVLMMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MENFLYAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WDVNSLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPLLMMVEGVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.28 (10%);6.1.1.1 (6%);4.2.1.33 (6%),Alpha,alpha-trehalase (10%);Tyrosine--tRNA ligase (6%);3-isopropylmalate dehydratase (6%),GO:0016021 (24%);GO:0005886 (8%);GO:0005737 (5%),integral component of membrane (24%);plasma membrane (8%);cytoplasm (5%),GO:0003677 (11%);GO:0005524 (10%);GO:0016491 (6%),DNA binding (11%);ATP binding (10%);oxidoreductase activity (6%),GO:0006355 (7%);GO:0009089 (2%);GO:0006412 (2%),regulation of transcription, DNA-templated (7%);lysine biosynthetic process via diaminopimelate (2%);translation (2%),IPR028082 (6%);IPR027417 (6%);IPR025997 (6%),Periplasmic binding protein-like I (6%);P-loop containing nucleoside triphosphate hydrolase (6%);Periplasmic binding protein (6%),,,,,,,,,
WYMWYK,Mucilaginibacter,Bacteria,,,,Bacteroidetes,,,Sphingobacteriia,,,,Sphingobacteriales,,,,,Sphingobacteriaceae,,,,Mucilaginibacter,,,,,,,,,,,,GO:0004553 (100%),hydrolase activity, hydrolyzing O-glycosyl compounds (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR006710 (100%);IPR023296 (100%),Glycoside hydrolase, family 43 (100%);Glycosyl hydrolase, five-bladed beta-propellor domain superfamily (100%),,,,,,,,
MVLHMSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TALQSWLLTNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLEENQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (67%);2.7.13.3 (33%),DNA-directed DNA polymerase (67%);Histidine kinase (33%),GO:0005737 (94%);GO:0016021 (1%);GO:0000407 (0%),cytoplasm (94%);integral component of membrane (1%);phagophore assembly site (0%),GO:0003676 (61%);GO:0003677 (29%);GO:0003697 (1%),nucleic acid binding (61%);DNA binding (29%);single-stranded DNA binding (1%),GO:0006260 (1%);GO:0006383 (0%);GO:0006457 (0%),DNA replication (1%);transcription by RNA polymerase III (0%);protein folding (0%),IPR012340 (93%);IPR002059 (92%);IPR011129 (92%),Nucleic acid-binding, OB-fold (93%);Cold-shock protein, DNA-binding (92%);Cold shock domain (92%),,,,,,,,,
QVMLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDPFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.2 (42%);3.1.-.- (33%);2.1.1.228 (8%),Glutamine synthetase (42%);Acting on ester bonds (33%);tRNA (guanine(37)-N(1))-methyltransferase (8%),GO:0016021 (24%);GO:0005737 (18%);GO:0005623 (13%),integral component of membrane (24%);cytoplasm (18%);cell (13%),GO:0004356 (21%);GO:0005524 (16%);GO:0016491 (13%),glutamate-ammonia ligase activity (21%);ATP binding (16%);oxidoreductase activity (13%),GO:0006542 (21%);GO:0045454 (13%);GO:0000967 (5%),glutamine biosynthetic process (21%);cell redox homeostasis (13%);rRNA 5'-end processing (5%),IPR008146 (18%);IPR008147 (18%);IPR014746 (18%),Glutamine synthetase, catalytic domain (18%);Glutamine synthetase, beta-Grasp domain (18%);Glutamine synthetase/guanido kinase, catalytic domain (18%),,,,,,,,
QDLNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (25%);2.7.7.15 (25%);6.2.1.3 (25%),DNA (cytosine-5-)-methyltransferase (25%);Choline-phosphate cytidylyltransferase (25%);Long-chain-fatty-acid--CoA ligase (25%),GO:0016021 (33%);GO:0005737 (11%);GO:0009380 (8%),integral component of membrane (33%);cytoplasm (11%);excinuclease repair complex (8%),GO:0003677 (13%);GO:0046872 (11%);GO:0016779 (9%),DNA binding (13%);metal ion binding (11%);nucleotidyltransferase activity (9%),GO:0006289 (8%);GO:0009432 (8%);GO:0000160 (5%),nucleotide-excision repair (8%);SOS response (8%);phosphorelay signal transduction system (5%),IPR029044 (20%);IPR025877 (18%);IPR000276 (8%),Nucleotide-diphospho-sugar transferases (20%);MobA-like NTP transferase (18%);G protein-coupled receptor, rhodopsin-like (8%),,,,,,,,,,
MMLETPEK,Euroglyphus maynei,Eukaryota,Metazoa,,,Arthropoda,Chelicerata,,Arachnida,Acari,,Acariformes,Sarcoptiformes,Astigmata,,Psoroptidia,Analgoidea,Pyroglyphidae,Pyroglyphinae,,,Euroglyphus,,,,Euroglyphus maynei,,,,,,,,GO:0003746 (100%);GO:0003924 (100%);GO:0005525 (100%),translation elongation factor activity (100%);GTPase activity (100%);GTP binding (100%),,,IPR000795 (100%);IPR009000 (100%);IPR027417 (100%),Transcription factor, GTP-binding domain (100%);Translation protein, beta-barrel domain superfamily (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,
QGGDALAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YCLLLGPLQTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GSMYSAPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (49%);2.7.7.7 (5%);2.1.1.- (4%),Transferring other groups (49%);DNA-directed DNA polymerase (5%);Methyltransferases (4%),GO:0016021 (15%);GO:0005737 (8%);GO:0005840 (7%),integral component of membrane (15%);cytoplasm (8%);ribosome (7%),GO:0046872 (27%);GO:0003723 (10%);GO:0009982 (7%),metal ion binding (27%);RNA binding (10%);pseudouridine synthase activity (7%),GO:0001522 (7%);GO:0006412 (7%);GO:0001682 (6%),pseudouridine synthesis (7%);translation (7%);tRNA 5'-leader removal (6%),IPR029052 (22%);IPR005235 (22%);IPR020103 (7%),Metallo-dependent phosphatase-like (22%);Metallophosphoesterase, YmdB-like (22%);Pseudouridine synthase, catalytic domain superfamily (7%),,,,,,,,,
ANLFYYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVCAWVK,Deltaproteobacteria bacterium,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,,,,,,,,,,,,,,Deltaproteobacteria bacterium,,,,,,,,,,,,IPR010327 (100%),FldB/FldC dehydratase alpha/beta subunit (100%),,,,,,,,,,,
MTMMQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CVMFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFFLMSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WMGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.53 (55%);3.1.6.1 (18%);1.5.5.1 (9%),Sialate O-acetylesterase (55%);Arylsulfatase (type I) (18%);Electron-transferring-flavoprotein dehydrogenase (9%),GO:0016021 (22%);GO:0019031 (9%);GO:0020002 (9%),integral component of membrane (22%);viral envelope (9%);host cell plasma membrane (9%),GO:0016868 (61%);GO:0000287 (54%);GO:0001681 (9%),intramolecular transferase activity, phosphotransferases (61%);magnesium ion binding (54%);sialate O-acetylesterase activity (9%),GO:0005975 (61%);GO:0019064 (9%);GO:0005992 (2%),carbohydrate metabolic process (61%);fusion of virus membrane with host plasma membrane (9%);trehalose biosynthetic process (2%),IPR016055 (63%);IPR005846 (62%);IPR005845 (58%),Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III (63%);Alpha-D-phosphohexomutase, alpha/beta/alpha domain III (62%);Alpha-D-phosphohexomutase, alpha/beta/alpha domain II (58%),,,,,,,
MENTVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (15%);2.4.2.1 (15%);3.6.1.1 (8%),Methyltransferases (15%);Purine-nucleoside phosphorylase (15%);Inorganic diphosphatase (8%),GO:0016021 (44%);GO:0005737 (20%);GO:0005886 (3%),integral component of membrane (44%);cytoplasm (20%);plasma membrane (3%),GO:0022857 (22%);GO:0003746 (12%);GO:0003677 (9%),transmembrane transporter activity (22%);translation elongation factor activity (12%);DNA binding (9%),GO:0006306 (4%);GO:0006355 (3%);GO:0006099 (2%),DNA methylation (4%);regulation of transcription, DNA-templated (3%);tricarboxylic acid cycle (2%),IPR001898 (15%);IPR030676 (14%);IPR001816 (10%),Solute carrier family 13 (15%);Citrate carrier CitT-related (14%);Translation elongation factor EFTs/EF1B (10%),,,,,,,,,,
AALHAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.9 (29%);3.4.16.- (24%);1.18.6.1 (4%),Histidinol-phosphate transaminase (29%);Serine-type carboxypeptidases (24%);Nitrogenase (4%),GO:0016021 (15%);GO:0005829 (7%);GO:0000938 (6%),integral component of membrane (15%);cytosol (7%);GARP complex (6%),GO:0005524 (10%);GO:0004400 (9%);GO:0004185 (9%),ATP binding (10%);histidinol-phosphate transaminase activity (9%);serine-type carboxypeptidase activity (9%),GO:0000105 (9%);GO:0042147 (6%);GO:0006355 (2%),histidine biosynthetic process (9%);retrograde transport, endosome to Golgi (6%);regulation of transcription, DNA-templated (2%),IPR015421 (9%);IPR015422 (9%);IPR015424 (9%),Pyridoxal phosphate-dependent transferase, major domain (9%);Pyridoxal phosphate-dependent transferase domain 1 (9%);Pyridoxal phosphate-dependent transferase (9%),,,,,,,,
NVCPESER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GDPLDCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (75%),integral component of membrane (75%),GO:0004672 (50%);GO:0005524 (50%);GO:0016740 (25%),protein kinase activity (50%);ATP binding (50%);transferase activity (25%),GO:0007165 (25%),signal transduction (25%),IPR000719 (40%);IPR008266 (40%);IPR011009 (40%),Protein kinase domain (40%);Tyrosine-protein kinase, active site (40%);Protein kinase-like domain superfamily (40%),,,,,,,,,,
FCEPTLPLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDYAANK,Siculibacillus lacustris,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Ancalomicrobiaceae,,,,Siculibacillus,,,,Siculibacillus lacustris,,,,,,,,,,,,IPR011051 (100%);IPR013096 (100%);IPR014710 (100%),RmlC-like cupin domain superfamily (100%);Cupin 2, conserved barrel (100%);RmlC-like jelly roll fold (100%),,,,,,,,,,
YEDQAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.7.1.22 (50%);3.1.-.- (25%);3.6.3.- (25%),3D-(3,5/4)-trihydroxycyclohexane-1,2-dione acylhydrolase (decyclizing) (50%);Acting on ester bonds (25%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (25%),GO:0016021 (14%);GO:0005777 (7%);GO:0005634 (5%),integral component of membrane (14%);peroxisome (7%);nucleus (5%),GO:0016301 (16%);GO:0016491 (16%);GO:0005524 (9%),kinase activity (16%);oxidoreductase activity (16%);ATP binding (9%),GO:0006813 (5%);GO:0019310 (5%);GO:0000160 (2%),potassium ion transport (5%);inositol catabolic process (5%);phosphorelay signal transduction system (2%),IPR027417 (20%);IPR036291 (12%);IPR002937 (8%),P-loop containing nucleoside triphosphate hydrolase (20%);NAD(P)-binding domain superfamily (12%);Amine oxidase (8%),,,,,,,,,
GCLQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (100%),Methyltransferases (100%),GO:0016021 (75%);GO:0005576 (25%);GO:0005737 (25%),integral component of membrane (75%);extracellular region (25%);cytoplasm (25%),GO:0003723 (25%);GO:0008061 (25%);GO:0008276 (25%),RNA binding (25%);chitin binding (25%);protein methyltransferase activity (25%),GO:0006030 (25%),chitin metabolic process (25%),IPR025948 (33%);IPR000504 (17%);IPR001841 (17%),HTH-like domain (33%);RNA recognition motif domain (17%);Zinc finger, RING-type (17%),,,,,,,,,,
VMVTDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YFMEWSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WTLMGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (60%);GO:0016021 (60%),plasma membrane (60%);integral component of membrane (60%),GO:0004497 (20%);GO:0004888 (20%);GO:0005230 (20%),monooxygenase activity (20%);transmembrane signaling receptor activity (20%);extracellular ligand-gated ion channel activity (20%),GO:0055085 (40%),transmembrane transport (40%),IPR000515 (29%);IPR035906 (29%);IPR001128 (14%),ABC transporter type 1, transmembrane domain MetI-like (29%);MetI-like superfamily (29%);Cytochrome P450 (14%),,,,,,,,,,
WTMENR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (80%);GO:0005785 (20%),integral component of membrane (80%);signal recognition particle receptor complex (20%),GO:0003677 (20%);GO:0003924 (20%);GO:0005047 (20%),DNA binding (20%);GTPase activity (20%);signal recognition particle binding (20%),GO:0006614 (20%),SRP-dependent cotranslational protein targeting to membrane (20%),IPR007401 (40%);IPR000897 (20%);IPR003593 (20%),Protein of unknown function DUF454 (40%);Signal recognition particle, SRP54 subunit, GTPase domain (20%);AAA+ ATPase domain (20%),,,,,,,,,
TVNMWWDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.- (7%);3.6.4.- (4%);5.3.2.- (4%),Other oxidoreductases (7%);Acting on ATP; involved in cellular and subcellular movement (4%);Interconverting keto- and enol-groups (4%),GO:0016021 (29%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (29%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (20%);GO:0016887 (9%);GO:0003677 (7%),ATP binding (20%);ATPase activity (9%);DNA binding (7%),GO:0006807 (3%);GO:0055085 (2%);GO:0032259 (1%),nitrogen compound metabolic process (3%);transmembrane transport (2%);methylation (1%),IPR027417 (11%);IPR003593 (8%);IPR003439 (8%),P-loop containing nucleoside triphosphate hydrolase (11%);AAA+ ATPase domain (8%);ABC transporter-like (8%),,,,,,,,,,,
NNGMMHVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GEDADLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.17 (75%);3.4.11.1 (25%);3.4.11.10 (25%),Phosphomethylpyrimidine synthase (75%);Leucyl aminopeptidase (25%);Bacterial leucyl aminopeptidase (25%),GO:0016021 (30%);GO:0005737 (20%);GO:0005634 (10%),integral component of membrane (30%);cytoplasm (20%);nucleus (10%),GO:0008270 (30%);GO:0016830 (30%);GO:0051539 (30%),zinc ion binding (30%);carbon-carbon lyase activity (30%);4 iron, 4 sulfur cluster binding (30%),GO:0009228 (30%);GO:0009229 (30%);GO:0006412 (10%),thiamine biosynthetic process (30%);thiamine diphosphate biosynthetic process (30%);translation (10%),IPR002817 (20%);IPR005646 (20%);IPR025747 (20%),Phosphomethylpyrimidine synthase ThiC/5-hydroxybenzimidazole synthase BzaA/B (20%);Flagellar assembly protein A (20%);ThiC-associated domain (20%),,,,,,,,,,
CSDLTNGNALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.23 (100%),Ceramidase (100%),GO:0016021 (83%),integral component of membrane (83%),GO:0005524 (24%);GO:0017040 (7%);GO:0102121 (7%),ATP binding (24%);N-acylsphingosine amidohydrolase activity (7%);ceramidase activity (7%),GO:0006665 (3%);GO:0046514 (3%),sphingolipid metabolic process (3%);ceramide catabolic process (3%),IPR025743 (43%);IPR036640 (22%);IPR003439 (19%),IcmF-related, N-terminal domain (43%);ABC transporter type 1, transmembrane domain superfamily (22%);ABC transporter-like (19%),,,,,,,,,
HHQDVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.8 (100%),UDP-N-acetylmuramate--L-alanine ligase (100%),GO:0005673 (33%);GO:0005737 (11%);GO:0005634 (6%),transcription factor TFIIE complex (33%);cytoplasm (11%);nucleus (6%),GO:0005524 (22%);GO:0003677 (17%);GO:0004553 (17%),ATP binding (22%);DNA binding (17%);hydrolase activity, hydrolyzing O-glycosyl compounds (17%),GO:0006367 (33%);GO:0005975 (17%);GO:0007049 (11%),transcription initiation from RNA polymerase II promoter (33%);carbohydrate metabolic process (17%);cell cycle (11%),IPR016656 (32%);IPR003166 (26%);IPR036388 (26%),Transcription initiation factor TFIIE, beta subunit (32%);Transcription factor TFIIE beta subunit, DNA-binding domain (26%);Winged helix-like DNA-binding domain superfamily (26%),,,,,,,,
NTVDVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.8 (33%);2.7.6.2 (33%);3.1.21.3 (33%),Protein-disulfide reductase (33%);Thiamine diphosphokinase (33%);Type I site-specific deoxyribonuclease (33%),GO:0016021 (39%);GO:0005887 (12%);GO:0005886 (8%),integral component of membrane (39%);integral component of plasma membrane (12%);plasma membrane (8%),GO:0005524 (8%);GO:0016757 (7%);GO:0022857 (7%),ATP binding (8%);transferase activity, transferring glycosyl groups (7%);transmembrane transporter activity (7%),GO:0009306 (12%);GO:0000105 (7%);GO:0015986 (7%),protein secretion (12%);histidine biosynthetic process (7%);ATP synthesis coupled proton transport (7%),IPR025157 (28%);IPR011050 (26%);IPR012334 (26%),Hemagglutinin repeat (28%);Pectin lyase fold/virulence factor (26%);Pectin lyase fold (26%),,,,,,,,,,
MNLESNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPEDALDMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNAAQALEMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HAAEPEK,Diplodia seriata,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Dothideomycetes,,,,Botryosphaeriales,,,,,Botryosphaeriaceae,,,,Diplodia,,,,Diplodia seriata,,,,,,GO:0005634 (100%),nucleus (100%),,,GO:0051028 (100%),mRNA transport (100%),IPR001611 (100%);IPR005637 (100%);IPR009060 (100%),Leucine-rich repeat (100%);TAP C-terminal (TAP-C) domain (100%);UBA-like superfamily (100%),,,,,,,,,,,
FFMLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.19 (100%),Arginine--tRNA ligase (100%),GO:0016021 (14%);GO:0005737 (5%);GO:0005840 (5%),integral component of membrane (14%);cytoplasm (5%);ribosome (5%),GO:0008168 (68%);GO:0030246 (14%);GO:0003824 (9%),methyltransferase activity (68%);carbohydrate binding (14%);catalytic activity (9%),GO:0032259 (68%);GO:0005975 (14%);GO:0006412 (5%),methylation (68%);carbohydrate metabolic process (14%);translation (5%),IPR007848 (68%);IPR029063 (68%);IPR008928 (14%),Methyltransferase small domain (68%);S-adenosyl-L-methionine-dependent methyltransferase (68%);Six-hairpin glycosidase superfamily (14%),,,,,,,,,,,
LNSQLVFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPMEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005096 (100%),GTPase activator activity (100%),GO:0051056 (100%),regulation of small GTPase mediated signal transduction (100%),IPR008893 (67%);IPR036930 (67%);IPR035974 (33%),WGR domain (67%);WGR domain superfamily (67%);Rap/Ran-GAP superfamily (33%),,,,,,,,,,,
VHMDSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005786 (80%);GO:0005618 (20%);GO:0016020 (20%),signal recognition particle, endoplasmic reticulum targeting (80%);cell wall (20%);membrane (20%),GO:0008312 (80%);GO:0030942 (80%);GO:0004252 (20%),7S RNA binding (80%);endoplasmic reticulum signal peptide binding (80%);serine-type endopeptidase activity (20%),GO:0006614 (80%),SRP-dependent cotranslational protein targeting to membrane (80%),IPR003210 (80%);IPR009018 (80%);IPR000209 (20%),Signal recognition particle, SRP14 subunit (80%);Signal recognition particle, SRP9/SRP14 subunit (80%);Peptidase S8/S53 domain (20%),,,,,,,,
DNLNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (15%);2.7.13.3 (14%);1.6.99.3 (6%),Phenylalanine--tRNA ligase (15%);Histidine kinase (14%);NADH dehydrogenase (6%),GO:0016021 (29%);GO:0005737 (15%);GO:0005886 (9%),integral component of membrane (29%);cytoplasm (15%);plasma membrane (9%),GO:0005524 (16%);GO:0003677 (11%);GO:0016491 (6%),ATP binding (16%);DNA binding (11%);oxidoreductase activity (6%),GO:0006355 (7%);GO:0006432 (3%);GO:0006260 (2%),regulation of transcription, DNA-templated (7%);phenylalanyl-tRNA aminoacylation (3%);DNA replication (2%),IPR027417 (8%);IPR002876 (5%);IPR017856 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);Transcriptional regulator TACO1-like (5%);Integrase-like, N-terminal (5%),,,,,,,,,
LQAGDFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (83%);2.7.13.3 (17%),Acting on polysaccharides (83%);Histidine kinase (17%),GO:0005887 (50%);GO:0016021 (20%),integral component of plasma membrane (50%);integral component of membrane (20%),GO:0008932 (50%);GO:0016829 (50%);GO:0005524 (20%),lytic endotransglycosylase activity (50%);lyase activity (50%);ATP binding (20%),GO:0009252 (50%);GO:0071555 (50%);GO:0006355 (10%),peptidoglycan biosynthetic process (50%);cell wall organization (50%);regulation of transcription, DNA-templated (10%),IPR003770 (46%);IPR000014 (8%);IPR000483 (8%),Endolytic murein transglycosylase (46%);PAS domain (8%);Cysteine-rich flanking region, C-terminal (8%),,,,,,,,,
ALAAFMGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPWTER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.12 (40%);1.2.1.88 (20%);2.3.1.275 (20%),Transferred entry: 1.2.1.88 (40%);L-glutamate gamma-semialdehyde dehydrogenase (20%);Acyl phosphate:glycerol-3-phosphate acyltransferase (20%),GO:0016021 (51%);GO:0005886 (7%);GO:0009279 (4%),integral component of membrane (51%);plasma membrane (7%);cell outer membrane (4%),GO:0016620 (20%);GO:0003842 (18%);GO:0016491 (7%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (20%);1-pyrroline-5-carboxylate dehydrogenase activity (18%);oxidoreductase activity (7%),GO:0010133 (18%);GO:0008654 (4%);GO:0032259 (4%),proline catabolic process to glutamate (18%);phospholipid biosynthetic process (4%);methylation (4%),IPR015590 (23%);IPR016160 (23%);IPR016161 (23%),Aldehyde dehydrogenase domain (23%);Aldehyde dehydrogenase, cysteine active site (23%);Aldehyde/histidinol dehydrogenase (23%),,,,,,,,
HVEVSYTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNDCWGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (72%);3.6.1.23 (5%);2.1.3.6 (2%),Pyruvate dehydrogenase (acetyl-transferring) (72%);dUTP diphosphatase (5%);Putrescine carbamoyltransferase (2%),GO:0016021 (24%);GO:0005886 (9%);GO:0005623 (1%),integral component of membrane (24%);plasma membrane (9%);cell (1%),GO:0046872 (21%);GO:0003676 (20%);GO:0004739 (14%),metal ion binding (21%);nucleic acid binding (20%);pyruvate dehydrogenase (acetyl-transferring) activity (14%),GO:0009306 (7%);GO:0044780 (7%);GO:0042128 (5%),protein secretion (7%);bacterial-type flagellum assembly (7%);nitrate assimilation (5%),IPR032411 (24%);IPR038315 (24%);IPR013087 (11%),Flagellar FLiS export co-chaperone, HP1076 (24%);FLiS export co-chaperone, HP1076 superfamily (24%);Zinc finger C2H2-type (11%),,,,,,,,,
DVMMPVK,Eggerthella,Bacteria,,,,Actinobacteria,,,Coriobacteriia,,,,Eggerthellales,,,,,Eggerthellaceae,,,,Eggerthella,,,,,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),,,IPR001279 (100%);IPR036866 (100%),Metallo-beta-lactamase (100%);Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (100%),,,,,,,,,,,
TTTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.141 (35%);3.1.4.4 (15%);2.6.1.42 (6%),4-alpha-D-((1->4)-alpha-D-glucano)trehalose trehalohydrolase (35%);Phospholipase D (15%);Branched-chain-amino-acid transaminase (6%),GO:0016021 (27%);GO:0005737 (9%);GO:0005634 (5%),integral component of membrane (27%);cytoplasm (9%);nucleus (5%),GO:0005524 (10%);GO:0003677 (8%);GO:0033942 (7%),ATP binding (10%);DNA binding (8%);4-alpha-D-(1->4)-alpha-D-glucanotrehalose trehalohydrolase activity (7%),GO:0005992 (7%);GO:0006654 (4%);GO:0048017 (4%),trehalose biosynthetic process (7%);phosphatidic acid biosynthetic process (4%);inositol lipid-mediated signaling (4%),IPR013783 (7%);IPR017853 (7%);IPR014756 (6%),Immunoglobulin-like fold (7%);Glycoside hydrolase superfamily (7%);Immunoglobulin E-set (6%),,,,,,,,,,,
WNVMLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.- (50%);1.1.1.91 (25%);3.4.16.- (25%),With NAD(+) or NADP(+) as acceptor (50%);Aryl-alcohol dehydrogenase (NADP(+)) (25%);Serine-type carboxypeptidases (25%),GO:0016021 (17%),integral component of membrane (17%),GO:0016491 (33%);GO:0000287 (17%);GO:0003824 (17%),oxidoreductase activity (33%);magnesium ion binding (17%);catalytic activity (17%),,,IPR023210 (94%);IPR036812 (94%);IPR036188 (3%),NADP-dependent oxidoreductase domain (94%);NADP-dependent oxidoreductase domain superfamily (94%);FAD/NAD(P)-binding domain superfamily (3%),,,,,,,,,,,
TCQMSPGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNPGALEDEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEMLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (42%);GO:0030286 (37%),integral component of membrane (42%);dynein complex (37%),GO:0003777 (42%);GO:0005524 (32%);GO:0005198 (5%),microtubule motor activity (42%);ATP binding (32%);structural molecule activity (5%),GO:0007018 (42%);GO:0006629 (5%);GO:0015031 (5%),microtubule-based movement (42%);lipid metabolic process (5%);protein transport (5%),IPR024743 (47%);IPR035706 (47%);IPR004273 (41%),Dynein heavy chain, coiled coil stalk (47%);Dynein heavy chain, ATP-binding dynein motor region (47%);Dynein heavy chain region D6 P-loop domain (41%),,,,,,,,,
NVLTEAQNYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTNTQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MADDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.12 (16%);2.7.7.7 (6%);3.6.4.12 (5%),Dihydrolipoyllysine-residue acetyltransferase (16%);DNA-directed DNA polymerase (6%);DNA helicase (5%),GO:0016021 (28%);GO:0005737 (8%);GO:0005886 (5%),integral component of membrane (28%);cytoplasm (8%);plasma membrane (5%),GO:0005524 (24%);GO:0016887 (11%);GO:0003677 (7%),ATP binding (24%);ATPase activity (11%);DNA binding (7%),GO:0045900 (9%);GO:0006412 (3%);GO:0071973 (2%),negative regulation of translational elongation (9%);translation (3%);bacterial-type flagellum-dependent cell motility (2%),IPR027417 (15%);IPR022037 (12%);IPR003593 (10%),P-loop containing nucleoside triphosphate hydrolase (15%);Protein of unknown function DUF3606 (12%);AAA+ ATPase domain (10%),,,,,,,,,,,
DDDLTWLMLEHSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFVVVTHLR,Rhizobium rhizosphaerae,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Rhizobiaceae,,,,Rhizobium,,,,Rhizobium rhizosphaerae,,,,,,,,GO:0003824 (100%);GO:0031419 (100%);GO:0046872 (100%),catalytic activity (100%);cobalamin binding (100%);metal ion binding (100%),,,IPR006158 (100%);IPR006638 (100%);IPR007197 (100%),Cobalamin (vitamin B12)-binding domain (100%);Elp3/MiaB/NifB (100%);Radical SAM (100%),,,,,,,,,,,
ENYVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (64%);2.4.1.18 (7%);2.4.99.16 (6%),DNA topoisomerase (64%);1,4-alpha-glucan branching enzyme (7%);Starch synthase (maltosyl-transferring) (6%),GO:0005694 (25%);GO:0016021 (16%);GO:0005737 (2%),chromosome (25%);integral component of membrane (16%);cytoplasm (2%),GO:0003677 (32%);GO:0046872 (28%);GO:0003917 (26%),DNA binding (32%);metal ion binding (28%);DNA topoisomerase type I (single strand cut, ATP-independent) activity (26%),GO:0006265 (26%);GO:0005975 (7%);GO:0006355 (4%),DNA topological change (26%);carbohydrate metabolic process (7%);regulation of transcription, DNA-templated (4%),IPR000380 (21%);IPR006171 (21%);IPR013498 (21%),DNA topoisomerase, type IA (21%);TOPRIM  domain (21%);DNA topoisomerase, type IA, zn finger (21%),,,,,
QSYFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.17 (21%);7.1.1.- (15%);2.7.7.6 (9%),ATP phosphoribosyltransferase (21%);Hydron translocation or charge separation linked to oxidoreductase reactions (15%);DNA-directed RNA polymerase (9%),GO:0016021 (27%);GO:0005737 (11%);GO:0005886 (5%),integral component of membrane (27%);cytoplasm (11%);plasma membrane (5%),GO:0005524 (26%);GO:0016887 (11%);GO:0003824 (8%),ATP binding (26%);ATPase activity (11%);catalytic activity (8%),GO:0055085 (5%);GO:0000105 (5%);GO:0006506 (3%),transmembrane transport (5%);histidine biosynthetic process (5%);GPI anchor biosynthetic process (3%),IPR027417 (15%);IPR003593 (11%);IPR003439 (10%),P-loop containing nucleoside triphosphate hydrolase (15%);AAA+ ATPase domain (11%);ABC transporter-like (10%),,,,,,,,,,,
HVEDWFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (47%);3.2.2.27 (12%);3.2.1.23 (9%),Exoribonuclease II (47%);Uracil-DNA glycosylase (12%);Beta-galactosidase (9%),GO:0016021 (18%);GO:0005737 (16%);GO:0005883 (13%),integral component of membrane (18%);cytoplasm (16%);neurofilament (13%),GO:0003723 (14%);GO:0008859 (12%);GO:0005524 (11%),RNA binding (14%);exoribonuclease II activity (12%);ATP binding (11%),GO:0061564 (13%);GO:0005975 (3%);GO:0006284 (3%),axon development (13%);carbohydrate metabolic process (3%);base-excision repair (3%),IPR016024 (23%);IPR011989 (22%);IPR025283 (18%),Armadillo-type fold (23%);Armadillo-like helical (22%);Domain of unknown function DUF4042 (18%),,,,,,,,,,,
WWMAQPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEFEAACWAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEVNMNLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNQQWMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTEETR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (87%);6.3.5.5 (4%);2.5.1.75 (2%),DNA helicase (87%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (4%);tRNA dimethylallyltransferase (2%),GO:0016021 (9%);GO:0005681 (4%);GO:0016459 (3%),integral component of membrane (9%);spliceosomal complex (4%);myosin complex (3%),GO:0005524 (44%);GO:0003677 (40%);GO:0003678 (37%),ATP binding (44%);DNA binding (40%);DNA helicase activity (37%),GO:0006777 (5%);GO:0000398 (4%);GO:0097500 (2%),Mo-molybdopterin cofactor biosynthetic process (5%);mRNA splicing, via spliceosome (4%);receptor localization to non-motile cilium (2%),IPR027417 (57%);IPR000212 (43%);IPR014017 (42%),P-loop containing nucleoside triphosphate hydrolase (57%);DNA helicase, UvrD/REP type (43%);UvrD-like DNA helicase, C-terminal (42%),,,,,,,,
EWFWFLVNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CAALATVWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVDTFWK,Pseudopedobacter saltans,Bacteria,,,,Bacteroidetes,,,Sphingobacteriia,,,,Sphingobacteriales,,,,,Sphingobacteriaceae,,,,Pseudopedobacter,,,,Pseudopedobacter saltans,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0000155 (100%);GO:0005524 (100%),phosphorelay sensor kinase activity (100%);ATP binding (100%),,,IPR003594 (100%);IPR003660 (100%);IPR003661 (100%),Histidine kinase/HSP90-like ATPase (100%);HAMP domain (100%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (100%),,,,,,,,,,
LTMPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.21 (40%);7.1.1.1 (40%);2.1.2.10 (16%),Nicotinate phosphoribosyltransferase (40%);Proton-translocating NAD(P)(+) transhydrogenase (40%);Aminomethyltransferase (16%),GO:0016021 (45%);GO:0005886 (17%);GO:0005634 (4%),integral component of membrane (45%);plasma membrane (17%);nucleus (4%),GO:0004514 (15%);GO:0004516 (15%);GO:0008750 (15%),nicotinate-nucleotide diphosphorylase (carboxylating) activity (15%);nicotinate phosphoribosyltransferase activity (15%);NAD(P)+ transhydrogenase (AB-specific) activity (15%),GO:0009435 (15%);GO:0042256 (15%);GO:0007165 (7%),NAD biosynthetic process (15%);mature ribosome assembly (15%);signal transduction (7%),IPR002140 (18%);IPR018978 (18%);IPR019783 (18%),Ribosome maturation protein Sdo1/SBDS (18%);Ribosome maturation protein SBDS, C-terminal (18%);Ribosome maturation protein SBDS, N-terminal (18%),,,,,,,,,
TTEHWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (40%);1.4.7.1 (20%);2.7.11.7 (20%),Exoribonuclease II (40%);Glutamate synthase (ferredoxin) (20%);[Myosin heavy-chain] kinase (20%),GO:0005737 (9%);GO:0005634 (3%);GO:0030687 (3%),cytoplasm (9%);nucleus (3%);preribosome, large subunit precursor (3%),GO:0016874 (78%);GO:0003723 (6%);GO:0008859 (6%),ligase activity (78%);RNA binding (6%);exoribonuclease II activity (6%),GO:0000460 (3%);GO:0000470 (3%);GO:0006432 (3%),maturation of 5.8S rRNA (3%);maturation of LSU-rRNA (3%);phenylalanyl-tRNA aminoacylation (3%),IPR021122 (67%);IPR001680 (19%);IPR015943 (19%),RNA ligase domain, REL/Rln2 (67%);WD40 repeat (19%);WD40/YVTN repeat-like-containing domain superfamily (19%),,,,,,,,,
VETVPSGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPLTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.5 (40%);2.3.1.50 (16%);3.1.-.- (16%),Ribonuclease D (40%);Serine C-palmitoyltransferase (16%);Acting on ester bonds (16%),GO:0016021 (55%);GO:0005737 (12%);GO:0000176 (6%),integral component of membrane (55%);cytoplasm (12%);nuclear exosome (RNase complex) (6%),GO:0030170 (30%);GO:0003824 (23%);GO:0008408 (17%),pyridoxal phosphate binding (30%);catalytic activity (23%);3'-5' exonuclease activity (17%),GO:0009058 (30%);GO:0042780 (9%);GO:0006396 (6%),biosynthetic process (30%);tRNA 3'-end processing (9%);RNA processing (6%),IPR004839 (24%);IPR015421 (24%);IPR015422 (24%),Aminotransferase, class I/classII (24%);Pyridoxal phosphate-dependent transferase, major domain (24%);Pyridoxal phosphate-dependent transferase domain 1 (24%),,,,,,,,,
LTTMLAGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEAAGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0046872 (100%),ATP binding (100%);metal ion binding (100%),,,IPR000089 (33%);IPR001882 (33%);IPR003791 (33%),Biotin/lipoyl attachment (33%);Biotin-binding site (33%);Protein of unknown function UPF0178 (33%),,,,,,,,,,,
NSATGQAAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMGLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.1.1 (28%);2.3.1.12 (6%);2.10.1.1 (3%),NADH:ubiquinone reductase (Na(+)-transporting) (28%);Dihydrolipoyllysine-residue acetyltransferase (6%);Molybdopterin molybdotransferase (3%),GO:0016021 (43%);GO:0005737 (21%);GO:0005886 (9%),integral component of membrane (43%);cytoplasm (21%);plasma membrane (9%),GO:0016757 (17%);GO:0005524 (12%);GO:0046872 (6%),transferase activity, transferring glycosyl groups (17%);ATP binding (12%);metal ion binding (6%),GO:0000105 (16%);GO:0055085 (4%);GO:0006814 (3%),histidine biosynthetic process (16%);transmembrane transport (4%);sodium ion transport (3%),IPR027417 (17%);IPR004516 (14%);IPR041715 (14%),P-loop containing nucleoside triphosphate hydrolase (17%);Histidine-tRNA ligase/ATP phosphoribosyltransferase regulatory subunit (14%);Class II Histidinyl-tRNA synthetase (HisRS)-like catalytic core domain (14%),,,,,,,,,,
MPQGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.3 (17%);6.3.5.2 (9%);3.6.1.- (9%),Ribonuclease III (17%);GMP synthase (glutamine-hydrolyzing) (9%);In phosphorus-containing anhydrides (9%),GO:0016021 (26%);GO:0005737 (6%);GO:0048500 (3%),integral component of membrane (26%);cytoplasm (6%);signal recognition particle (3%),GO:0005524 (13%);GO:0005525 (10%);GO:0003677 (9%),ATP binding (13%);GTP binding (10%);DNA binding (9%),GO:0009058 (4%);GO:0008033 (3%);GO:0006353 (3%),biosynthetic process (4%);tRNA processing (3%);DNA-templated transcription, termination (3%),IPR027417 (16%);IPR030378 (5%);IPR006073 (5%),P-loop containing nucleoside triphosphate hydrolase (16%);Circularly permuted (CP)-type guanine nucleotide-binding (G) domain (5%);GTP binding domain (5%),,,,,,,,,,
HMVLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.61 (64%);3.5.1.44 (64%);4.1.1.31 (18%),Protein-glutamate methylesterase (64%);Protein-glutamine glutaminase (64%);Phosphoenolpyruvate carboxylase (18%),GO:0005737 (9%);GO:0016021 (8%);GO:0005634 (1%),cytoplasm (9%);integral component of membrane (8%);nucleus (1%),GO:0046872 (78%);GO:0004222 (77%);GO:0008984 (8%),metal ion binding (78%);metalloendopeptidase activity (77%);protein-glutamate methylesterase activity (8%),GO:0006935 (8%);GO:0006482 (7%);GO:0018277 (7%),chemotaxis (8%);protein demethylation (7%);protein deamination (7%),IPR001567 (77%);IPR024077 (76%);IPR024080 (72%),Peptidase M3A/M3B catalytic domain (77%);Neurolysin/Thimet oligopeptidase, domain 2 (76%);Neurolysin/Thimet oligopeptidase, N-terminal (72%),,,,,,,,,
QTFNN,Maribacter arcticus,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Maribacter,,,,Maribacter arcticus,,,,,,,,,,,,IPR013022 (100%);IPR036237 (100%),Xylose isomerase-like, TIM barrel domain (100%);Xylose isomerase-like superfamily (100%),,,,,,,,,,
WWLANGQMQHGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLFFMEYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYSFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (100%),Serine endopeptidases (100%),GO:0005743 (25%);GO:0016021 (25%);GO:0005737 (6%),mitochondrial inner membrane (25%);integral component of membrane (25%);cytoplasm (6%),GO:0008236 (25%);GO:0016491 (25%);GO:0008270 (13%),serine-type peptidase activity (25%);oxidoreductase activity (25%);zinc ion binding (13%),GO:0006627 (25%);GO:0000160 (6%);GO:0006270 (6%),protein processing involved in protein targeting to mitochondrion (25%);phosphorelay signal transduction system (6%);DNA replication initiation (6%),IPR001680 (23%);IPR015943 (23%);IPR017986 (23%),WD40 repeat (23%);WD40/YVTN repeat-like-containing domain superfamily (23%);WD40-repeat-containing domain (23%),,,,,,,,,,,
MENQAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.4.12 (57%);1.8.1.9 (14%);3.1.-.- (10%),Peptide-methionine (R)-S-oxide reductase (57%);Thioredoxin-disulfide reductase (14%);Acting on ester bonds (10%),GO:0016021 (37%);GO:0009288 (10%);GO:0005737 (6%),integral component of membrane (37%);bacterial-type flagellum (10%);cytoplasm (6%),GO:0005524 (21%);GO:0016887 (16%);GO:0033743 (16%),ATP binding (21%);ATPase activity (16%);peptide-methionine (R)-S-oxide reductase activity (16%),GO:0006979 (16%);GO:0030091 (16%);GO:0071973 (10%),response to oxidative stress (16%);protein repair (16%);bacterial-type flagellum-dependent cell motility (10%),IPR036291 (15%);IPR002347 (14%);IPR027417 (13%),NAD(P)-binding domain superfamily (15%);Short-chain dehydrogenase/reductase SDR (14%);P-loop containing nucleoside triphosphate hydrolase (13%),,,,,,,,,,,
LLMSTDLGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMLAASK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.275 (100%),Acyl phosphate:glycerol-3-phosphate acyltransferase (100%),GO:0016021 (83%);GO:0005886 (50%),integral component of membrane (83%);plasma membrane (50%),GO:0004371 (50%);GO:0008289 (50%);GO:0043772 (50%),glycerone kinase activity (50%);lipid binding (50%);acyl-phosphate glycerol-3-phosphate acyltransferase activity (50%),GO:0006071 (50%);GO:0008654 (50%),glycerol metabolic process (50%);phospholipid biosynthetic process (50%),IPR003797 (50%);IPR003811 (50%);IPR004007 (50%),DegV (50%);Glycerol-3-phosphate acyltransferase, PlsY (50%);DhaL domain (50%),,,,,,,,,,
EVMFMMVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSLPMCVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVWETMLLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVMWALDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTCFFLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (10%);1.3.1.98 (6%);6.2.1.26 (5%),DNA helicase (10%);UDP-N-acetylmuramate dehydrogenase (6%);o-succinylbenzoate--CoA ligase (5%),GO:0016021 (43%);GO:0030288 (13%);GO:0019012 (10%),integral component of membrane (43%);outer membrane-bounded periplasmic space (13%);virion (10%),GO:0005198 (9%);GO:0005524 (7%);GO:0003824 (3%),structural molecule activity (9%);ATP binding (7%);catalytic activity (3%),GO:0071555 (13%);GO:0043711 (13%);GO:0061077 (13%),cell wall organization (13%);pilus organization (13%);chaperone-mediated protein folding (13%),IPR007349 (25%);IPR013783 (19%);IPR001829 (18%),Domain of unknown function DUF418 (25%);Immunoglobulin-like fold (19%);Pili assembly chaperone, bacterial (18%),,,,,,,,,,
AFGAGDDAPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DFNNLFPNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPAYYDVPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WQDWYDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNNMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.225 (50%);3.6.4.12 (50%);3.1.-.- (33%),Protein S-acyltransferase (50%);DNA helicase (50%);Acting on ester bonds (33%),GO:0016021 (30%);GO:0016020 (23%);GO:0005634 (4%),integral component of membrane (30%);membrane (23%);nucleus (4%),GO:0008933 (22%);GO:0008410 (12%);GO:0005524 (10%),lytic transglycosylase activity (22%);CoA-transferase activity (12%);ATP binding (10%),GO:0000270 (22%);GO:0055085 (4%);GO:0000724 (3%),peptidoglycan metabolic process (22%);transmembrane transport (4%);double-strand break repair via homologous recombination (3%),IPR018392 (21%);IPR023346 (21%);IPR036779 (21%),LysM domain (21%);Lysozyme-like domain superfamily (21%);LysM domain superfamily (21%),,,,,,,,,,,
NGALPVMEEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPMFYGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESVTDVLDSHHMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVVVPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045202 (25%),synapse (25%),GO:0005509 (25%);GO:0005543 (25%);GO:0008236 (25%),calcium ion binding (25%);phospholipid binding (25%);serine-type peptidase activity (25%),GO:0007268 (25%);GO:0035556 (25%),chemical synaptic transmission (25%);intracellular signal transduction (25%),IPR000008 (25%);IPR000477 (25%);IPR001375 (25%),C2 domain (25%);Reverse transcriptase domain (25%);Peptidase S9, prolyl oligopeptidase, catalytic domain (25%),,,,,,,,,
LTLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.86 (29%);2.5.1.72 (13%);2.7.7.7 (4%),6-phospho-beta-glucosidase (29%);Quinolinate synthase (13%);DNA-directed DNA polymerase (4%),GO:0016021 (23%);GO:0005737 (7%);GO:0005886 (2%),integral component of membrane (23%);cytoplasm (7%);plasma membrane (2%),GO:0003677 (10%);GO:0005524 (9%);GO:0046872 (7%),DNA binding (10%);ATP binding (9%);metal ion binding (7%),GO:0005975 (9%);GO:0009435 (3%);GO:0008152 (2%),carbohydrate metabolic process (9%);NAD biosynthetic process (3%);metabolic process (2%),IPR017853 (9%);IPR001360 (7%);IPR033132 (7%),Glycoside hydrolase superfamily (9%);Glycoside hydrolase family 1 (7%);Glycosyl hydrolases family 1, N-terminal conserved site (7%),,,,,,,,,,
QASLMHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYFDTLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0055085 (100%),transmembrane transport (100%),IPR000515 (100%);IPR035906 (100%),ABC transporter type 1, transmembrane domain MetI-like (100%);MetI-like superfamily (100%),,,,,,,,,,
SNSSDDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0036459 (33%);GO:0005524 (17%);GO:0016787 (17%),thiol-dependent ubiquitinyl hydrolase activity (33%);ATP binding (17%);hydrolase activity (17%),GO:0016579 (33%);GO:0006360 (17%),protein deubiquitination (33%);transcription by RNA polymerase I (17%),IPR001394 (33%);IPR025305 (33%);IPR028889 (33%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (33%);UCH repeated domain (33%);Ubiquitin specific protease domain (33%),,,,,,,,,,
MNQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.1 (30%);2.4.1.227 (22%);2.7.11.1 (7%),Phosphoribosylformylglycinamidine cyclo-ligase (30%);Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (22%);Non-specific serine/threonine protein kinase (7%),GO:0016021 (23%);GO:0005737 (15%);GO:0005886 (9%),integral component of membrane (23%);cytoplasm (15%);plasma membrane (9%),GO:0005524 (21%);GO:0003677 (20%);GO:0004641 (9%),ATP binding (21%);DNA binding (20%);phosphoribosylformylglycinamidine cyclo-ligase activity (9%),GO:0006189 (9%);GO:0051301 (7%);GO:0008360 (7%),'de novo' IMP biosynthetic process (9%);cell division (7%);regulation of cell shape (7%),IPR009057 (14%);IPR001647 (14%);IPR036271 (13%),Homeobox-like domain superfamily (14%);DNA-binding HTH domain, TetR-type (14%);Tetracyclin repressor-like, C-terminal domain superfamily (13%),,,,,,,,,
TDCHTHEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLYVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (14%);3.6.3.8 (7%);2.7.7.- (5%),Leucine--tRNA ligase (14%);Transferred entry: 7.2.2.10 (7%);Nucleotidyltransferases (5%),GO:0016021 (26%);GO:0005737 (25%);GO:0009380 (19%),integral component of membrane (26%);cytoplasm (25%);excinuclease repair complex (19%),GO:0005524 (35%);GO:0003677 (25%);GO:0046872 (23%),ATP binding (35%);DNA binding (25%);metal ion binding (23%),GO:0006289 (19%);GO:0006281 (3%);GO:0005975 (2%),nucleotide-excision repair (19%);DNA repair (3%);carbohydrate metabolic process (2%),IPR027417 (29%);IPR003593 (21%);IPR017871 (21%),P-loop containing nucleoside triphosphate hydrolase (29%);AAA+ ATPase domain (21%);ABC transporter, conserved site (21%),,,,,,,,,,
FPMPVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMTPEANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDMDGHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEDVMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.225 (67%);1.2.1.70 (33%),Protein S-acyltransferase (67%);Glutamyl-tRNA reductase (33%),GO:0016021 (31%);GO:0005744 (13%);GO:0009898 (6%),integral component of membrane (31%);TIM23 mitochondrial import inner membrane translocase complex (13%);cytoplasmic side of plasma membrane (6%),GO:0008233 (31%);GO:0019706 (13%);GO:0003723 (6%),peptidase activity (31%);protein-cysteine S-palmitoyltransferase activity (13%);RNA binding (6%),GO:0030150 (13%);GO:0000160 (6%);GO:0006782 (6%),protein import into mitochondrial matrix (13%);phosphorelay signal transduction system (6%);protoporphyrinogen IX biosynthetic process (6%),IPR000073 (26%);IPR002410 (26%);IPR029058 (26%),Alpha/beta hydrolase fold-1 (26%);Peptidase S33 (26%);Alpha/Beta hydrolase fold (26%),,,,,,,,,,,
WPETEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.14 (33%);2.1.1.37 (33%);3.1.4.58 (33%),5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (33%);DNA (cytosine-5-)-methyltransferase (33%);RNA 2',3'-cyclic 3'-phosphodiesterase (33%),GO:0015934 (9%),large ribosomal subunit (9%),GO:0016301 (27%);GO:0016829 (27%);GO:0003735 (9%),kinase activity (27%);lyase activity (27%);structural constituent of ribosome (9%),GO:0006412 (9%);GO:0009086 (9%);GO:0032259 (9%),translation (9%);methionine biosynthetic process (9%);methylation (9%),IPR005101 (27%);IPR006050 (27%);IPR014729 (27%),Cryptochrome/DNA photolyase, FAD-binding domain (27%);DNA photolyase, N-terminal (27%);Rossmann-like alpha/beta/alpha sandwich fold (27%),,,,,,,,
WWYFLSHVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLMTSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.3 (100%),Adenosinetriphosphatase (100%),GO:0005737 (20%);GO:0005856 (20%),cytoplasm (20%);cytoskeleton (20%),GO:0016788 (40%);GO:0005086 (20%);GO:0005524 (20%),hydrolase activity, acting on ester bonds (40%);ARF guanyl-nucleotide exchange factor activity (20%);ATP binding (20%),GO:0006397 (40%);GO:0032012 (20%);GO:0110148 (20%),mRNA processing (40%);regulation of ARF protein signal transduction (20%);biomineralization (20%),IPR007708 (40%);IPR000904 (20%);IPR003609 (20%),Lariat debranching enzyme, C-terminal (40%);Sec7 domain (20%);PAN/Apple domain (20%),,,,,,,,,
WYQLMVVSMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFHHGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.132 (55%);1.14.14.17 (27%);1.14.99.7 (9%),Transferred entry: 1.14.14.17 (55%);Squalene monooxygenase (27%);Transferred entry: 1.14.14.17 (9%),GO:0016021 (97%);GO:0005783 (3%);GO:0005811 (1%),integral component of membrane (97%);endoplasmic reticulum (3%);lipid droplet (1%),GO:0004506 (94%);GO:0050660 (90%);GO:0071949 (4%),squalene monooxygenase activity (94%);flavin adenine dinucleotide binding (90%);FAD binding (4%),GO:0016126 (93%);GO:0006696 (2%);GO:0006420 (1%),sterol biosynthetic process (93%);ergosterol biosynthetic process (2%);arginyl-tRNA aminoacylation (1%),IPR036188 (95%);IPR040125 (94%);IPR013698 (94%),FAD/NAD(P)-binding domain superfamily (95%);Squalene monooxygenase (94%);Squalene epoxidase (94%),,,,,,,,,,,
SPATEVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HQTFLLEHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLALMCSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDSYYWAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYTLMPPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SHEASNYSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVVQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (100%),Acting on peptide bonds (peptidases) (100%),,,GO:0016805 (100%),dipeptidase activity (100%),,,IPR005322 (100%),Peptidase C69, dipeptidase A (100%),,,,,,,,,,
MYGLTTSNVGYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLNENWLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (67%);2.5.1.9 (33%),Phenylalanine--tRNA ligase (67%);Riboflavin synthase (33%),GO:0005737 (67%),cytoplasm (67%),GO:0000049 (67%);GO:0000287 (67%);GO:0004826 (67%),tRNA binding (67%);magnesium ion binding (67%);phenylalanine-tRNA ligase activity (67%),GO:0006432 (67%),phenylalanyl-tRNA aminoacylation (67%),IPR002547 (67%);IPR004532 (67%);IPR005121 (67%),tRNA-binding domain (67%);Phenylalanine-tRNA ligase, class IIc, beta subunit (67%);Ferrodoxin-fold anticodon-binding domain (67%),,,,,,,,,
MVAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.2 (33%);1.5.1.43 (17%);5.6.2.2 (6%),Glutamine synthetase (33%);Carboxynorspermidine synthase (17%);DNA topoisomerase (ATP-hydrolyzing) (6%),GO:0016021 (17%);GO:0005737 (7%);GO:0005886 (2%),integral component of membrane (17%);cytoplasm (7%);plasma membrane (2%),GO:0016491 (29%);GO:0005524 (16%);GO:0004356 (12%),oxidoreductase activity (29%);ATP binding (16%);glutamate-ammonia ligase activity (12%),GO:0006542 (10%);GO:0008299 (3%);GO:0006265 (2%),glutamine biosynthetic process (10%);isoprenoid biosynthetic process (3%);DNA topological change (2%),IPR036291 (31%);IPR005097 (26%);IPR032095 (26%),NAD(P)-binding domain superfamily (31%);Saccharopine dehydrogenase, NADP binding domain (26%);Saccharopine dehydrogenase, C-terminal (26%),,,,,,,,,
FNSYDHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YAEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (15%);2.3.2.2 (8%);4.1.99.17 (6%),Hydron translocation or charge separation linked to oxidoreductase reactions (15%);Gamma-glutamyltransferase (8%);Phosphomethylpyrimidine synthase (6%),GO:0016021 (26%);GO:0005737 (12%);GO:0005886 (10%),integral component of membrane (26%);cytoplasm (12%);plasma membrane (10%),GO:0005524 (15%);GO:0046872 (8%);GO:0022857 (8%),ATP binding (15%);metal ion binding (8%);transmembrane transporter activity (8%),GO:0042773 (3%);GO:0006417 (2%);GO:0044238 (2%),ATP synthesis coupled electron transport (3%);regulation of translation (2%);primary metabolic process (2%),IPR027417 (7%);IPR036259 (7%);IPR011701 (7%),P-loop containing nucleoside triphosphate hydrolase (7%);MFS transporter superfamily (7%);Major facilitator superfamily (7%),,,,,,,,,,,
MFDVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.2.2 (75%);2.7.7.8 (8%);1.2.7.1 (3%),H(+)-transporting two-sector ATPase (75%);Polyribonucleotide nucleotidyltransferase (8%);Pyruvate synthase (3%),GO:0005623 (20%);GO:0033178 (20%);GO:0016021 (19%),cell (20%);proton-transporting two-sector ATPase complex, catalytic domain (20%);integral component of membrane (19%),GO:0005524 (53%);GO:0046933 (32%);GO:0046961 (20%),ATP binding (53%);proton-transporting ATP synthase activity, rotational mechanism (32%);proton-transporting ATPase activity, rotational mechanism (20%),GO:0042777 (32%);GO:0045454 (20%);GO:0006260 (14%),plasma membrane ATP synthesis coupled proton transport (32%);cell redox homeostasis (20%);DNA replication (14%),IPR027417 (38%);IPR004100 (33%);IPR022878 (33%),P-loop containing nucleoside triphosphate hydrolase (38%);ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain (33%);V-type ATP synthase catalytic alpha chain (33%),,,,,
CLPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (8%);3.2.2.6 (6%);4.2.1.136 (6%),Acting on ATP; involved in cellular and subcellular movement (8%);ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (6%);ADP-dependent NAD(P)H-hydrate dehydratase (6%),GO:0016021 (42%);GO:0005576 (15%);GO:0005737 (6%),integral component of membrane (42%);extracellular region (15%);cytoplasm (6%),GO:0004888 (26%);GO:0005509 (19%);GO:0046872 (5%),transmembrane signaling receptor activity (26%);calcium ion binding (19%);metal ion binding (5%),GO:0002755 (26%);GO:0006954 (26%);GO:0050707 (23%),MyD88-dependent toll-like receptor signaling pathway (26%);inflammatory response (26%);regulation of cytokine secretion (23%),IPR032675 (39%);IPR001611 (38%);IPR000483 (38%),Leucine-rich repeat domain superfamily (39%);Leucine-rich repeat (38%);Cysteine-rich flanking region, C-terminal (38%),,,,,,,,,,
MTAELVSHDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QYLTMLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.4.2.11 (6%);3.1.26.3 (5%);6.3.4.18 (4%),ABC-type methionine transporter (6%);Ribonuclease III (5%);5-(carboxyamino)imidazole ribonucleotide synthase (4%),GO:0016021 (29%);GO:0005737 (6%);GO:0005874 (5%),integral component of membrane (29%);cytoplasm (6%);microtubule (5%),GO:0005524 (30%);GO:0003777 (10%);GO:0008017 (10%),ATP binding (30%);microtubule motor activity (10%);microtubule binding (10%),GO:0007018 (10%);GO:0007017 (3%);GO:0006355 (2%),microtubule-based movement (10%);microtubule-based process (3%);regulation of transcription, DNA-templated (2%),IPR027417 (24%);IPR001752 (10%);IPR027640 (10%),P-loop containing nucleoside triphosphate hydrolase (24%);Kinesin motor domain (10%);Kinesin-like protein (10%),,,,,,,,,,
RPALANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.-.- (100%),Acting on the CH-CH group of donors (100%),GO:0005634 (50%);GO:0005737 (50%),nucleus (50%);cytoplasm (50%),GO:0004152 (50%);GO:0005524 (50%);GO:0016817 (50%),dihydroorotate dehydrogenase activity (50%);ATP binding (50%);hydrolase activity, acting on acid anhydrides (50%),GO:0006207 (50%);GO:0044205 (50%),'de novo' pyrimidine nucleobase biosynthetic process (50%);'de novo' UMP biosynthetic process (50%),IPR000330 (50%);IPR000953 (50%);IPR001295 (50%),SNF2-related, N-terminal domain (50%);Chromo/chromo shadow domain (50%);Dihydroorotate dehydrogenase, conserved site (50%),,,,,,,,
WQPGHSMQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMFVAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.207 (100%),tRNA (cytidine(34)-2'-O)-methyltransferase (100%),GO:0016021 (75%);GO:0005737 (13%),integral component of membrane (75%);cytoplasm (13%),GO:0005509 (50%);GO:0003723 (13%);GO:0008175 (13%),calcium ion binding (50%);RNA binding (13%);tRNA methyltransferase activity (13%),GO:0000160 (88%),phosphorelay signal transduction system (88%),IPR001789 (78%);IPR011006 (78%);IPR002048 (44%),Signal transduction response regulator, receiver domain (78%);CheY-like superfamily (78%);EF-hand domain (44%),,,,,,,,,,
MVGTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (11%);3.6.4.- (8%);2.8.4.3 (6%),Oxidoreductases (11%);Acting on ATP; involved in cellular and subcellular movement (8%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (6%),GO:0005634 (40%);GO:0016021 (14%);GO:0005886 (4%),nucleus (40%);integral component of membrane (14%);plasma membrane (4%),GO:0003677 (45%);GO:0005524 (5%);GO:0046872 (5%),DNA binding (45%);ATP binding (5%);metal ion binding (5%),GO:0000122 (4%);GO:0045820 (3%);GO:0045922 (3%),negative regulation of transcription by RNA polymerase II (4%);negative regulation of glycolytic process (3%);negative regulation of fatty acid metabolic process (3%),IPR009057 (38%);IPR017884 (34%);IPR001005 (34%),Homeobox-like domain superfamily (38%);SANT domain (34%);SANT/Myb domain (34%),,,,,,,,,,,
DFAETYEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSAPPAQVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TELLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.17 (7%);7.5.2.12 (4%);4.1.1.15 (4%),Transferred entry: 7.5.2.8 (7%);ABC-type L-arabinose transporter (4%);Glutamate decarboxylase (4%),GO:0019013 (46%);GO:0042025 (45%);GO:0019029 (44%),viral nucleocapsid (46%);host cell nucleus (45%);helical viral capsid (44%),GO:0005198 (46%);GO:0003723 (44%);GO:0005524 (19%),structural molecule activity (46%);RNA binding (44%);ATP binding (19%),GO:0075732 (44%);GO:0046718 (44%);GO:0006289 (4%),viral penetration into host nucleus (44%);viral entry into host cell (44%);nucleotide-excision repair (4%),IPR002141 (41%);IPR027417 (17%);IPR003593 (9%),Influenza virus nucleoprotein (NP) (41%);P-loop containing nucleoside triphosphate hydrolase (17%);AAA+ ATPase domain (9%),,,,,,,,,,,
LVTCMEPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVYVMVHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPDDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (45%);2.3.1.- (9%);2.8.1.2 (9%),Isoleucine--tRNA ligase (45%);Transferring groups other than amino-acyl groups (9%);3-mercaptopyruvate sulfurtransferase (9%),GO:0016021 (41%);GO:0005886 (13%);GO:0000176 (12%),integral component of membrane (41%);plasma membrane (13%);nuclear exosome (RNase complex) (12%),GO:0005524 (16%);GO:0000166 (13%);GO:0003676 (13%),ATP binding (16%);nucleotide binding (13%);nucleic acid binding (13%),GO:0006396 (13%);GO:0006428 (6%);GO:0006412 (3%),RNA processing (13%);isoleucyl-tRNA aminoacylation (6%);translation (3%),IPR011990 (18%);IPR002121 (9%);IPR010997 (9%),Tetratricopeptide-like helical domain superfamily (18%);HRDC domain (9%);HRDC-like superfamily (9%),,,,,,,,,,,
FNPSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.3 (43%);2.4.1.- (14%);2.4.1.280 (14%),Adenylate kinase (43%);Hexosyltransferases (14%);N,N'-diacetylchitobiose phosphorylase (14%),GO:0016021 (41%);GO:0009279 (10%);GO:0005737 (8%),integral component of membrane (41%);cell outer membrane (10%);cytoplasm (8%),GO:0005524 (28%);GO:0016787 (15%);GO:0003677 (10%),ATP binding (28%);hydrolase activity (15%);DNA binding (10%),GO:0043165 (8%);GO:0044209 (8%);GO:0005975 (5%),Gram-negative-bacterium-type cell outer membrane assembly (8%);AMP salvage (8%);carbohydrate metabolic process (5%),IPR027417 (20%);IPR003607 (14%);IPR006674 (14%),P-loop containing nucleoside triphosphate hydrolase (20%);HD/PDEase domain (14%);HD domain (14%),,,,,,,,,,
WWSEDNMELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNATGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.74 (35%);3.1.21.3 (17%);1.3.1.98 (13%),1,4-dihydroxy-2-naphthoate polyprenyltransferase (35%);Type I site-specific deoxyribonuclease (17%);UDP-N-acetylmuramate dehydrogenase (13%),GO:0016021 (26%);GO:0005737 (11%);GO:0005887 (11%),integral component of membrane (26%);cytoplasm (11%);integral component of plasma membrane (11%),GO:0005524 (14%);GO:0003677 (11%);GO:0046428 (11%),ATP binding (14%);DNA binding (11%);1,4-dihydroxy-2-naphthoate octaprenyltransferase activity (11%),GO:0009234 (11%);GO:0009307 (6%);GO:0051301 (6%),menaquinone biosynthetic process (11%);DNA restriction-modification system (6%);cell division (6%),IPR036188 (10%);IPR000537 (9%);IPR004657 (9%),FAD/NAD(P)-binding domain superfamily (10%);UbiA prenyltransferase family (9%);1,4-dihydroxy-2-naphthoate octaprenyltransferase (9%),,,,,,,,
MLPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (72%);2.7.2.- (4%);3.4.21.92 (2%),Cytochrome-c oxidase (72%);Phosphotransferases with a carboxy group as acceptor (4%);Endopeptidase Clp (2%),GO:0016021 (47%);GO:0005743 (25%);GO:0045277 (24%),integral component of membrane (47%);mitochondrial inner membrane (25%);respiratory chain complex IV (24%),GO:0046872 (27%);GO:0004129 (25%);GO:0020037 (25%),metal ion binding (27%);cytochrome-c oxidase activity (25%);heme binding (25%),GO:0006119 (25%);GO:0009060 (25%);GO:0006351 (12%),oxidative phosphorylation (25%);aerobic respiration (25%);transcription, DNA-templated (12%),IPR000883 (22%);IPR023616 (22%);IPR036927 (22%),Cytochrome c oxidase subunit I (22%);Cytochrome c oxidase-like, subunit I domain (22%);Cytochrome c oxidase-like, subunit I  superfamily (22%),,,,,,,,
ANGTSEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000785 (33%);GO:0005634 (33%),chromatin (33%);nucleus (33%),GO:0016740 (33%);GO:0008880 (17%),transferase activity (33%);glucuronate isomerase activity (17%),GO:0007064 (50%);GO:0006281 (33%);GO:0006064 (17%),mitotic sister chromatid cohesion (50%);DNA repair (33%);glucuronate catabolic process (17%),IPR011990 (36%);IPR012944 (36%);IPR033985 (36%),Tetratricopeptide-like helical domain superfamily (36%);RagB/SusD domain (36%);SusD-like, N-terminal (36%),,,,,,,,,,
EVSVLMLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLNEEWYDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNQDLYPSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNESFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.22 (10%);1.1.1.267 (5%);2.5.1.19 (5%),UMP kinase (10%);1-deoxy-D-xylulose-5-phosphate reductoisomerase (5%);3-phosphoshikimate 1-carboxyvinyltransferase (5%),GO:0016021 (25%);GO:0005634 (8%);GO:0005737 (7%),integral component of membrane (25%);nucleus (8%);cytoplasm (7%),GO:0003677 (14%);GO:0005524 (10%);GO:0003700 (10%),DNA binding (14%);ATP binding (10%);DNA-binding transcription factor activity (10%),GO:0006355 (5%);GO:0032259 (5%);GO:0055085 (3%),regulation of transcription, DNA-templated (5%);methylation (5%);transmembrane transport (3%),IPR001471 (6%);IPR016177 (6%);IPR036955 (6%),AP2/ERF domain (6%);DNA-binding domain superfamily (6%);AP2/ERF domain superfamily (6%),,,,,,,,,,
ECHPSK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%);GO:0032991 (33%),integral component of membrane (33%);protein-containing complex (33%),GO:0031625 (33%),ubiquitin protein ligase binding (33%),GO:0002218 (67%);GO:0035458 (67%);GO:0031648 (33%),activation of innate immune response (67%);cellular response to interferon-beta (67%);protein destabilization (33%),IPR004020 (100%);IPR004021 (100%);IPR040205 (100%),DAPIN domain (100%);HIN-200/IF120x (100%);HIN-200 family (100%),,,,,,,,,,,
WNVEMMATPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMGNTWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDMLLDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.4 (100%),D-alanine--D-alanine ligase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0005524 (100%);GO:0008716 (100%);GO:0046872 (100%),ATP binding (100%);D-alanine-D-alanine ligase activity (100%);metal ion binding (100%),GO:0008360 (100%);GO:0009252 (100%);GO:0071555 (100%),regulation of cell shape (100%);peptidoglycan biosynthetic process (100%);cell wall organization (100%),IPR000291 (100%);IPR005905 (100%);IPR011095 (100%),D-alanine--D-alanine ligase/VANA/B/C, conserved site (100%);D-alanine--D-alanine ligase (100%);D-alanine--D-alanine ligase, C-terminal (100%),,,,,,,,,
LNEGRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR011429 (50%);IPR011478 (50%);IPR013036 (50%),Cytochrome C, Planctomycete-type (50%);Domain of unknown function DUF1585 (50%);Domain of unknown function DUF1587 (50%),,,,,,,,,,
TVNLMMNPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FWWWMPSLMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYVTAGPEMLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFFMFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.27 (11%);2.4.2.18 (10%);4.3.1.17 (7%),Uracil-DNA glycosylase (11%);Anthranilate phosphoribosyltransferase (10%);L-serine ammonia-lyase (7%),GO:0016021 (18%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (18%);cytoplasm (6%);plasma membrane (3%),GO:0050660 (17%);GO:0009055 (17%);GO:0016787 (14%),flavin adenine dinucleotide binding (17%);electron transfer activity (17%);hydrolase activity (14%),GO:0006284 (4%);GO:0032259 (2%);GO:0006935 (1%),base-excision repair (4%);methylation (2%);chemotaxis (1%),IPR014729 (13%);IPR014730 (13%);IPR001308 (13%),Rossmann-like alpha/beta/alpha sandwich fold (13%);Electron transfer flavoprotein, alpha/beta-subunit, N-terminal (13%);Electron transfer flavoprotein alpha subunit/FixB (13%),,,,,,,,,
EMQQWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.267 (100%),1-deoxy-D-xylulose-5-phosphate reductoisomerase (100%),GO:0016021 (17%),integral component of membrane (17%),GO:0004386 (17%);GO:0016853 (17%);GO:0030604 (17%),helicase activity (17%);isomerase activity (17%);1-deoxy-D-xylulose-5-phosphate reductoisomerase activity (17%),GO:0006323 (50%);GO:0016114 (17%);GO:0019288 (17%),DNA packaging (50%);terpenoid biosynthetic process (17%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (17%),IPR006437 (57%);IPR035412 (57%);IPR035413 (43%),Bacteriophage terminase, large subunit (57%);Phage terminase large subunit, N-terminal (57%);Phage terminase large subunit, C-terminal (43%),,,,,,,
LYVDDEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (100%),Glycogen phosphorylase (100%),,,GO:0008184 (64%);GO:0030170 (64%);GO:0102250 (64%),glycogen phosphorylase activity (64%);pyridoxal phosphate binding (64%);linear malto-oligosaccharide phosphorylase activity (64%),GO:0005975 (64%);GO:0015074 (7%),carbohydrate metabolic process (64%);DNA integration (7%),IPR000811 (64%);IPR011833 (64%);IPR035090 (64%),Glycosyl transferase, family 35 (64%);Glycogen/starch/alpha-glucan phosphorylase (64%);Phosphorylase pyridoxal-phosphate attachment site (64%),,,,,,,,,,
WQDSLETSMLPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMYYGDDEGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFQNYAMFER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DEDLHTDALVGDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.4 (14%);3.6.1.- (14%);3.6.4.12 (14%),Fructokinase (14%);In phosphorus-containing anhydrides (14%);DNA helicase (14%),GO:0016021 (38%);GO:0005886 (3%);GO:0005737 (2%),integral component of membrane (38%);plasma membrane (3%);cytoplasm (2%),GO:0005524 (17%);GO:0003677 (15%);GO:0003678 (6%),ATP binding (17%);DNA binding (15%);DNA helicase activity (6%),GO:0006367 (6%);GO:0006289 (6%);GO:0009085 (4%),transcription initiation from RNA polymerase II promoter (6%);nucleotide-excision repair (6%);lysine biosynthetic process (4%),IPR027417 (12%);IPR014001 (9%);IPR001650 (8%),P-loop containing nucleoside triphosphate hydrolase (12%);Helicase superfamily 1/2, ATP-binding domain (9%);Helicase, C-terminal (8%),,,,,,,,,
TYVMFSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMFWHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEELLFMMLYER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVVTLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (67%);3.5.4.2 (33%),RNA helicase (67%);Adenine deaminase (33%),GO:0016021 (19%);GO:0005737 (4%),integral component of membrane (19%);cytoplasm (4%),GO:0003677 (42%);GO:0005524 (12%);GO:0003676 (8%),DNA binding (42%);ATP binding (12%);nucleic acid binding (8%),GO:0006355 (42%);GO:0000160 (4%);GO:0006146 (4%),regulation of transcription, DNA-templated (42%);phosphorelay signal transduction system (4%);adenine catabolic process (4%),IPR036390 (64%);IPR005471 (55%);IPR014757 (55%),Winged helix DNA-binding domain superfamily (64%);Transcription regulator IclR, N-terminal (55%);Transcription regulator IclR, C-terminal (55%),,,,,,,,
MPVETLDGTVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMSHLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAMLEMTVAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLFSTMSFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTYAEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR000014 (33%);IPR000160 (33%);IPR001387 (33%),PAS domain (33%);GGDEF domain (33%);Cro/C1-type helix-turn-helix domain (33%),,,,,,,,,,,
TYVVCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016787 (67%);GO:0003677 (17%);GO:0016874 (17%),hydrolase activity (67%);DNA binding (17%);ligase activity (17%),GO:0006464 (67%);GO:0006313 (17%);GO:0015074 (17%),cellular protein modification process (67%);transposition, DNA-mediated (17%);DNA integration (17%),IPR002828 (57%);IPR004344 (57%);IPR027746 (57%),Survival protein SurE-like phosphatase/nucleotidase (57%);Tubulin-tyrosine ligase/Tubulin polyglutamylase (57%);Probable tubulin-tyrosine ligase (57%),,,,,,,,,,
EMYNPLLNWNPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNYTNLAALHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEDTVGNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESFMTSDLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAERPTLWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLAPGVPK,Candidatus Desulforudis audaxviator,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Peptococcaceae,,,,Candidatus Desulforudis,,,,Candidatus Desulforudis audaxviator,,,,,,,,,,,,IPR000073 (100%);IPR029058 (100%),Alpha/beta hydrolase fold-1 (100%);Alpha/Beta hydrolase fold (100%),,,,,,,,,,,
QVEEAEEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (11%);1.1.1.23 (6%);2.7.7.0 (6%),DNA helicase (11%);Histidinol dehydrogenase (6%); (6%),GO:0016021 (27%);GO:0005737 (4%);GO:0005654 (3%),integral component of membrane (27%);cytoplasm (4%);nucleoplasm (3%),GO:0003677 (14%);GO:0003676 (12%);GO:0005524 (12%),DNA binding (14%);nucleic acid binding (12%);ATP binding (12%),GO:0034765 (6%);GO:0090307 (2%);GO:0007094 (2%),regulation of ion transmembrane transport (6%);mitotic spindle assembly (2%);mitotic spindle assembly checkpoint (2%),IPR013087 (10%);IPR027417 (8%);IPR005176 (7%),Zinc finger C2H2-type (10%);P-loop containing nucleoside triphosphate hydrolase (8%);Potentiating neddylation domain (7%),,,,,,,,,,,
EMHAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.6 (50%);3.6.1.3 (50%),Catalase (50%);Adenosinetriphosphatase (50%),GO:0016021 (25%);GO:0005737 (13%);GO:0022625 (6%),integral component of membrane (25%);cytoplasm (13%);cytosolic large ribosomal subunit (6%),GO:0005524 (44%);GO:0004672 (38%);GO:0004519 (25%),ATP binding (44%);protein kinase activity (38%);endonuclease activity (25%),GO:0006355 (6%);GO:0006412 (6%);GO:0006779 (6%),regulation of transcription, DNA-templated (6%);translation (6%);porphyrin-containing compound biosynthetic process (6%),IPR001680 (72%);IPR011009 (72%);IPR015943 (72%),WD40 repeat (72%);Protein kinase-like domain superfamily (72%);WD40/YVTN repeat-like-containing domain superfamily (72%),,,,,,,,,,
TYPPWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0016829 (100%),lyase activity (100%),,,IPR008929 (33%);IPR012480 (33%);IPR017853 (33%),Chondroitin AC/alginate lyase (33%);Heparinase II/III-like (33%);Glycoside hydrolase superfamily (33%),,,,,,,,,,,
FEALQPLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLFNWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (50%);1.3.5.1 (13%);2.6.1.52 (13%),Type I site-specific deoxyribonuclease (50%);Succinate dehydrogenase (quinone) (13%);Phosphoserine transaminase (13%),GO:0016021 (41%);GO:0005737 (3%);GO:0005886 (1%),integral component of membrane (41%);cytoplasm (3%);plasma membrane (1%),GO:0003677 (38%);GO:0000150 (33%);GO:0016757 (19%),DNA binding (38%);recombinase activity (33%);transferase activity, transferring glycosyl groups (19%),GO:0006004 (19%);GO:0055085 (15%);GO:0009307 (5%),fucose metabolic process (19%);transmembrane transport (15%);DNA restriction-modification system (5%),IPR011109 (33%);IPR025827 (33%);IPR038109 (33%),DNA-binding recombinase domain (33%);Recombinase zinc beta ribbon domain (33%);DNA-binding recombinase domain superfamily (33%),,,,,,,,,,
MNDVMSYDSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHHEPFFM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AENSPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (20%);GO:0003700 (20%);GO:0004040 (20%),DNA binding (20%);DNA-binding transcription factor activity (20%);amidase activity (20%),GO:0030242 (60%);GO:0006352 (20%),autophagy of peroxisome (60%);DNA-templated transcription, initiation (20%),IPR015412 (38%);IPR026849 (38%);IPR026885 (38%),Autophagy-related, C-terminal (38%);Autophagy-related protein 2 (38%);Autophagy-related protein 2, CAD motif (38%),,,,,,,,
LDLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.14 (16%);6.3.4.19 (15%);3.1.-.- (10%),5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (16%);tRNA(Ile)-lysidine synthetase (15%);Acting on ester bonds (10%),GO:0016021 (14%);GO:0005737 (10%);GO:0005886 (3%),integral component of membrane (14%);cytoplasm (10%);plasma membrane (3%),GO:0005525 (36%);GO:0005524 (10%);GO:0046872 (6%),GTP binding (36%);ATP binding (10%);metal ion binding (6%),GO:0032259 (3%);GO:0006808 (3%);GO:0009086 (3%),methylation (3%);regulation of nitrogen utilization (3%);methionine biosynthetic process (3%),IPR027417 (36%);IPR006073 (31%);IPR030378 (23%),P-loop containing nucleoside triphosphate hydrolase (36%);GTP binding domain (31%);Circularly permuted (CP)-type guanine nucleotide-binding (G) domain (23%),,,,,,,,,,,
TNMAPER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMGVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (44%);2.8.1.8 (17%);6.1.1.7 (17%),Acting on GTP; involved in cellular and subcellular movement (44%);Lipoyl synthase (17%);Alanine--tRNA ligase (17%),GO:0005737 (30%);GO:0016021 (13%);GO:0015934 (4%),cytoplasm (30%);integral component of membrane (13%);large ribosomal subunit (4%),GO:0005525 (28%);GO:0005524 (23%);GO:0046872 (23%),GTP binding (28%);ATP binding (23%);metal ion binding (23%),GO:0042254 (17%);GO:0000917 (11%);GO:0006419 (6%),ribosome biogenesis (17%);division septum assembly (11%);alanyl-tRNA aminoacylation (6%),IPR027417 (32%);IPR006073 (22%);IPR006074 (13%),P-loop containing nucleoside triphosphate hydrolase (32%);GTP binding domain (22%);GTP1/OBG, conserved site (13%),,,,,,,,,,
LLLHFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.148 (67%);3.6.3.43 (33%),Thymidylate synthase (FAD) (67%);Transferred entry: 7.4.2.5 (33%),GO:0016021 (57%);GO:0016020 (7%),integral component of membrane (57%);membrane (7%),GO:0005524 (21%);GO:0004842 (14%);GO:0016887 (14%),ATP binding (21%);ubiquitin-protein transferase activity (14%);ATPase activity (14%),GO:0006231 (14%);GO:0006235 (14%);GO:0032259 (14%),dTMP biosynthetic process (14%);dTTP biosynthetic process (14%);methylation (14%),IPR011990 (19%);IPR013026 (19%);IPR019734 (19%),Tetratricopeptide-like helical domain superfamily (19%);Tetratricopeptide repeat-containing domain (19%);Tetratricopeptide repeat (19%),,,,,,,,,,,
EHLMFSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAHWWYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEQNDQAC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPQLPAPVLAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVAFTHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVPAGPLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPLTLSQLMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYYLNNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (25%);GO:0016021 (25%),cytoplasm (25%);integral component of membrane (25%),GO:0003677 (25%);GO:0005524 (25%);GO:0016787 (25%),DNA binding (25%);ATP binding (25%);hydrolase activity (25%),GO:0042619 (50%);GO:0006260 (25%);GO:0007062 (25%),poly-hydroxybutyrate biosynthetic process (50%);DNA replication (25%);sister chromatid cohesion (25%),IPR010941 (67%);IPR029058 (67%);IPR003395 (33%),Poly-beta-hydroxybutyrate polymerase, N-terminal domain (67%);Alpha/Beta hydrolase fold (67%);RecF/RecN/SMC, N-terminal (33%),,,,,,,,,
MQGYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.9 (30%);1.8.1.4 (22%);6.1.1.4 (14%),Valine--tRNA ligase (30%);Dihydrolipoyl dehydrogenase (22%);Leucine--tRNA ligase (14%),GO:0016021 (13%);GO:0005737 (7%);GO:0005623 (6%),integral component of membrane (13%);cytoplasm (7%);cell (6%),GO:0005524 (25%);GO:0002161 (17%);GO:0004832 (13%),ATP binding (25%);aminoacyl-tRNA editing activity (17%);valine-tRNA ligase activity (13%),GO:0006438 (13%);GO:0006139 (10%);GO:0006355 (7%),valyl-tRNA aminoacylation (13%);nucleobase-containing compound metabolic process (10%);regulation of transcription, DNA-templated (7%),IPR014729 (15%);IPR001412 (15%);IPR009008 (14%),Rossmann-like alpha/beta/alpha sandwich fold (15%);Aminoacyl-tRNA synthetase, class I, conserved site (15%);Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain (14%),,,,,,,
MAANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.- (10%);1.1.1.85 (10%);5.2.1.8 (9%),Aminopeptidases (10%);3-isopropylmalate dehydrogenase (10%);Peptidylprolyl isomerase (9%),GO:0016021 (28%);GO:0005886 (14%);GO:0005737 (7%),integral component of membrane (28%);plasma membrane (14%);cytoplasm (7%),GO:0005524 (12%);GO:0003677 (10%);GO:0005525 (7%),ATP binding (12%);DNA binding (10%);GTP binding (7%),GO:0007265 (5%);GO:0006412 (4%);GO:0051301 (3%),Ras protein signal transduction (5%);translation (4%);cell division (3%),IPR027417 (11%);IPR001806 (5%);IPR020849 (5%),P-loop containing nucleoside triphosphate hydrolase (11%);Small GTPase (5%);Small GTPase superfamily, Ras-type (5%),,,,,,,,,,
MSVQHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.4 (40%);2.2.1.1 (20%);2.7.1.53 (20%),3-dehydroquinate synthase (40%);Transketolase (20%);L-xylulokinase (20%),GO:0005840 (45%);GO:0019867 (13%);GO:0016021 (6%),ribosome (45%);outer membrane (13%);integral component of membrane (6%),GO:0003735 (39%);GO:0043856 (11%);GO:0003995 (6%),structural constituent of ribosome (39%);anti-sigma factor antagonist activity (11%);acyl-CoA dehydrogenase activity (6%),GO:0006412 (39%);GO:0009073 (3%);GO:0009423 (3%),translation (39%);aromatic amino acid family biosynthetic process (3%);chorismate biosynthetic process (3%),IPR000554 (45%);IPR005546 (13%);IPR006315 (13%),Ribosomal protein S7e (45%);Autotransporter beta-domain (13%);Outer membrane autotransporter barrel (13%),,,,,,,,,,,
HDLQNMVTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GHESDPADK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (19%);5.4.99.13 (19%);1.8.4.8 (13%),Acting on GTP; involved in cellular and subcellular movement (19%);Isobutyryl-CoA mutase (19%);Phosphoadenylyl-sulfate reductase (thioredoxin) (13%),GO:0016021 (17%);GO:0005576 (6%);GO:0016020 (5%),integral component of membrane (17%);extracellular region (6%);membrane (5%),GO:0008270 (30%);GO:0003676 (29%);GO:0005524 (9%),zinc ion binding (30%);nucleic acid binding (29%);ATP binding (9%),GO:0006637 (2%);GO:0006935 (2%);GO:0071973 (2%),acyl-CoA metabolic process (2%);chemotaxis (2%);bacterial-type flagellum-dependent cell motility (2%),IPR036236 (22%);IPR003604 (21%);IPR013087 (21%),Zinc finger C2H2 superfamily (22%);Matrin/U1-C-like, C2H2-type zinc finger (21%);Zinc finger C2H2-type (21%),,,,,,,,,,
TPCFETGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AHYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.4.2 (13%);6.3.4.19 (12%);2.7.13.3 (9%),Glycine dehydrogenase (aminomethyl-transferring) (13%);tRNA(Ile)-lysidine synthetase (12%);Histidine kinase (9%),GO:0016021 (23%);GO:0009279 (6%);GO:0005737 (6%),integral component of membrane (23%);cell outer membrane (6%);cytoplasm (6%),GO:0035091 (13%);GO:0005524 (10%);GO:0003677 (5%),phosphatidylinositol binding (13%);ATP binding (10%);DNA binding (5%),GO:0005975 (3%);GO:0009116 (3%);GO:0006400 (2%),carbohydrate metabolic process (3%);nucleoside metabolic process (3%);tRNA modification (2%),IPR024555 (12%);IPR024554 (12%);IPR001683 (12%),PX-associated domain (12%);Domain of unknown function DUF3818, PX-associated (12%);Phox homologous domain (12%),,,,,,,,,,
AWLDSHDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMDPVAHGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVEQGFMTAAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLHHNFLGAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVVTVDPPMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLEPYVMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWVLTCHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVNFLDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFTPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.65 (39%);3.2.1.80 (21%);1.11.1.6 (14%),Levanase (39%);Fructan beta-fructosidase (21%);Catalase (14%),GO:0016021 (4%);GO:0005634 (1%);GO:0000347 (1%),integral component of membrane (4%);nucleus (1%);THO complex (1%),GO:0004553 (45%);GO:0016491 (13%);GO:0005524 (9%),hydrolase activity, hydrolyzing O-glycosyl compounds (45%);oxidoreductase activity (13%);ATP binding (9%),GO:0005975 (54%);GO:0006270 (6%);GO:0006979 (2%),carbohydrate metabolic process (54%);DNA replication initiation (6%);response to oxidative stress (2%),IPR001362 (44%);IPR013148 (44%);IPR013189 (44%),Glycoside hydrolase, family 32 (44%);Glycosyl hydrolase family 32, N-terminal (44%);Glycosyl hydrolase family 32, C-terminal (44%),,,,,,,
ADNSDAVK,Pseudomonas,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Pseudomonadales,,,,,Pseudomonadaceae,,,,Pseudomonas,,,,,,,,,,,,,,,,IPR014147 (100%),Type IV conjugative transfer protein TrbJ (100%),,,,,,,,,,,
LHMDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.11 (100%),Penicillin amidase (100%),GO:0016021 (16%);GO:0009279 (6%);GO:0005634 (3%),integral component of membrane (16%);cell outer membrane (6%);nucleus (3%),GO:0003700 (65%);GO:0005524 (13%);GO:0004386 (6%),DNA-binding transcription factor activity (65%);ATP binding (13%);helicase activity (6%),GO:0043165 (6%);GO:0051205 (6%);GO:0006139 (3%),Gram-negative-bacterium-type cell outer membrane assembly (6%);protein insertion into membrane (6%);nucleobase-containing compound metabolic process (3%),IPR001471 (54%);IPR010106 (11%);IPR027417 (11%),AP2/ERF domain (54%);Recombination-promoting nuclease RpnA (11%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,,,,
VWMLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLCMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.28 (9%);3.1.-.- (7%);3.6.1.57 (7%),Phosphoenolpyruvate transferase (9%);Acting on ester bonds (7%);UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose hydrolase (7%),GO:0016021 (44%);GO:0045211 (31%);GO:0030054 (31%),integral component of membrane (44%);postsynaptic membrane (31%);cell junction (31%),GO:0022848 (30%);GO:0004888 (30%);GO:0036459 (19%),acetylcholine-gated cation-selective channel activity (30%);transmembrane signaling receptor activity (30%);thiol-dependent ubiquitinyl hydrolase activity (19%),GO:0016579 (21%);GO:0006511 (20%);GO:2000300 (4%),protein deubiquitination (21%);ubiquitin-dependent protein catabolic process (20%);regulation of synaptic vesicle exocytosis (4%),IPR006201 (32%);IPR036719 (32%);IPR006029 (32%),Neurotransmitter-gated ion-channel (32%);Neurotransmitter-gated ion-channel transmembrane domain superfamily (32%);Neurotransmitter-gated ion-channel transmembrane domain (32%),,,,,,,,
VDMVDDTYSMSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTRPLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (50%);2.8.1.8 (50%),Ribonucleoside-diphosphate reductase (50%);Lipoyl synthase (50%),GO:0016021 (44%);GO:0005886 (6%);GO:0005737 (3%),integral component of membrane (44%);plasma membrane (6%);cytoplasm (3%),GO:0003684 (21%);GO:0005524 (18%);GO:0016849 (18%),damaged DNA binding (21%);ATP binding (18%);phosphorus-oxygen lyase activity (18%),GO:0006281 (21%);GO:0009190 (18%);GO:0035556 (18%),DNA repair (21%);cyclic nucleotide biosynthetic process (18%);intracellular signal transduction (18%),IPR025997 (28%);IPR028082 (28%);IPR001054 (14%),Periplasmic binding protein (28%);Periplasmic binding protein-like I (28%);Adenylyl cyclase class-3/4/guanylyl cyclase (14%),,,,,,,,,,,
EGGMENLQSAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVSWRPK,Bursaphelenchus xylophilus,Eukaryota,Metazoa,,,Nematoda,,,Chromadorea,,,,Rhabditida,Tylenchina,Tylenchomorpha,,Aphelenchoidea,Aphelenchoididae,,,,Bursaphelenchus,,,,Bursaphelenchus xylophilus,,,,,,,,,,,,,,,,,,,,,,,,
ECFVYR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.- (100%),In phosphorus-containing anhydrides (100%),GO:0005634 (41%);GO:0000775 (38%);GO:0035861 (38%),nucleus (41%);chromosome, centromeric region (38%);site of double-strand break (38%),GO:0005524 (86%);GO:0016817 (46%);GO:0015616 (38%),ATP binding (86%);hydrolase activity, acting on acid anhydrides (46%);DNA translocase activity (38%),GO:0000722 (38%);GO:0006311 (38%);GO:0006338 (38%),telomere maintenance via recombination (38%);meiotic gene conversion (38%);chromatin remodeling (38%),IPR027417 (87%);IPR001650 (87%);IPR000330 (86%),P-loop containing nucleoside triphosphate hydrolase (87%);Helicase, C-terminal (87%);SNF2-related, N-terminal domain (86%),,,,,,,
MDQWAHWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLATLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.2 (55%);1.17.4.1 (10%);2.7.9.3 (8%),Fumarate hydratase (55%);Ribonucleoside-diphosphate reductase (10%);Selenide, water dikinase (8%),GO:0016021 (22%);GO:0045239 (10%);GO:0005634 (6%),integral component of membrane (22%);tricarboxylic acid cycle enzyme complex (10%);nucleus (6%),GO:0003677 (27%);GO:0003700 (19%);GO:0004333 (12%),DNA binding (27%);DNA-binding transcription factor activity (19%);fumarate hydratase activity (12%),GO:0006099 (12%);GO:0006106 (10%);GO:0000160 (9%),tricarboxylic acid cycle (12%);fumarate metabolic process (10%);phosphorelay signal transduction system (9%),IPR036388 (16%);IPR002110 (9%);IPR020683 (9%),Winged helix-like DNA-binding domain superfamily (16%);Ankyrin repeat (9%);Ankyrin repeat-containing domain (9%),,,,,,,,,,
ELCWWMGSANAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWMDHPVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYFLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.- (57%);3.6.4.13 (14%);2.1.1.- (7%),Forming phosphoric ester bonds (57%);RNA helicase (14%);Methyltransferases (7%),GO:0016021 (41%);GO:0005730 (6%);GO:0005635 (3%),integral component of membrane (41%);nucleolus (6%);nuclear envelope (3%),GO:0046872 (28%);GO:0005524 (25%);GO:0008452 (25%),metal ion binding (28%);ATP binding (25%);RNA ligase activity (25%),GO:0006396 (25%);GO:0000463 (6%);GO:0032259 (6%),RNA processing (25%);maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (6%);methylation (6%),IPR001233 (22%);IPR036025 (22%);IPR003594 (14%),tRNA-splicing ligase, RtcB (22%);tRNA-splicing ligase RtcB-like superfamily (22%);Histidine kinase/HSP90-like ATPase (14%),,,,,,,,
DTGFVFM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLMDWLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YGDEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.199 (30%);5.4.99.- (12%);5.4.2.11 (8%),16S rRNA (cytosine(1402)-N(4))-methyltransferase (30%);Transferring other groups (12%);Phosphoglycerate mutase (2,3-diphosphoglycerate-dependent) (8%),GO:0005737 (20%);GO:0016021 (17%);GO:0005886 (4%),cytoplasm (20%);integral component of membrane (17%);plasma membrane (4%),GO:0005524 (15%);GO:0071424 (10%);GO:0046872 (6%),ATP binding (15%);rRNA (cytosine-N4-)-methyltransferase activity (10%);metal ion binding (6%),GO:0070475 (10%);GO:0006420 (5%);GO:0006096 (5%),rRNA base methylation (10%);arginyl-tRNA aminoacylation (5%);glycolytic process (5%),IPR029063 (9%);IPR027417 (9%);IPR002903 (8%),S-adenosyl-L-methionine-dependent methyltransferase (9%);P-loop containing nucleoside triphosphate hydrolase (9%);Ribosomal RNA small subunit methyltransferase H (8%),,,,,,,,,,
MFEMEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (100%),Acting on peptide bonds (peptidases) (100%),GO:0016021 (9%);GO:0005852 (3%);GO:0005886 (3%),integral component of membrane (9%);eukaryotic translation initiation factor 3 complex (3%);plasma membrane (3%),GO:0003677 (53%);GO:0003700 (53%);GO:0030170 (9%),DNA binding (53%);DNA-binding transcription factor activity (53%);pyridoxal phosphate binding (9%),GO:0009058 (9%);GO:0006457 (6%);GO:0000160 (3%),biosynthetic process (9%);protein folding (6%);phosphorelay signal transduction system (3%),IPR036390 (46%);IPR000524 (44%);IPR036388 (44%),Winged helix DNA-binding domain superfamily (46%);Transcription regulator HTH, GntR (44%);Winged helix-like DNA-binding domain superfamily (44%),,,,,,,,,,
MENGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (12%);1.17.99.6 (6%);2.7.7.6 (5%),Molybdopterin molybdotransferase (12%);Epoxyqueuosine reductase (6%);DNA-directed RNA polymerase (5%),GO:0016021 (23%);GO:0005887 (8%);GO:0005737 (4%),integral component of membrane (23%);integral component of plasma membrane (8%);cytoplasm (4%),GO:0005524 (13%);GO:0003677 (11%);GO:0046872 (7%),ATP binding (13%);DNA binding (11%);metal ion binding (7%),GO:0006310 (3%);GO:0031532 (3%);GO:0032259 (2%),DNA recombination (3%);actin cytoskeleton reorganization (3%);methylation (2%),IPR027417 (10%);IPR010445 (6%);IPR036188 (5%),P-loop containing nucleoside triphosphate hydrolase (10%);Lipopolysaccharide assembly protein A domain (6%);FAD/NAD(P)-binding domain superfamily (5%),,,,,,,,,,,
WFMEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEWNHVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYPHQSEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFQPYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0003700 (33%);GO:0008270 (33%);GO:0016772 (33%),DNA-binding transcription factor activity (33%);zinc ion binding (33%);transferase activity, transferring phosphorus-containing groups (33%),GO:0006506 (33%),GPI anchor biosynthetic process (33%),IPR000315 (33%);IPR000835 (33%);IPR001841 (33%),B-box-type zinc finger (33%);MarR-type HTH domain (33%);Zinc finger, RING-type (33%),,,,,,,,,
VNGDTFHNVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HVVENPTYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNSDVER,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%),DNA binding (100%),,,IPR032608 (60%);IPR001387 (20%);IPR002731 (20%),Protein of unknown function DUF4892 (60%);Cro/C1-type helix-turn-helix domain (20%);ATPase, BadF/BadG/BcrA/BcrD type (20%),,,,,,,,,,
VVEVGQNGHMNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.8 (57%);3.4.21.53 (8%);1.1.1.23 (3%),Guanylate kinase (57%);Endopeptidase La (8%);Histidinol dehydrogenase (3%),GO:0005737 (29%);GO:0016021 (18%);GO:0005634 (5%),cytoplasm (29%);integral component of membrane (18%);nucleus (5%),GO:0005524 (43%);GO:0004385 (17%);GO:0003677 (10%),ATP binding (43%);guanylate kinase activity (17%);DNA binding (10%),GO:0001514 (4%);GO:0006289 (2%);GO:0006515 (2%),selenocysteine incorporation (4%);nucleotide-excision repair (2%);protein quality control for misfolded or incompletely synthesized proteins (2%),IPR027417 (45%);IPR008145 (15%);IPR008144 (15%),P-loop containing nucleoside triphosphate hydrolase (45%);Guanylate kinase/L-type calcium channel beta subunit (15%);Guanylate kinase-like domain (15%),,,,,,,,,,,
GGHHDTMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLMTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.9 (71%);1.1.1.205 (7%);2.7.7.7 (4%),Dihydroxy-acid dehydratase (71%);IMP dehydrogenase (7%);DNA-directed DNA polymerase (4%),GO:0005737 (11%);GO:0016021 (9%);GO:0000439 (3%),cytoplasm (11%);integral component of membrane (9%);transcription factor TFIIH core complex (3%),GO:0046872 (40%);GO:0004160 (32%);GO:0051539 (31%),metal ion binding (40%);dihydroxy-acid dehydratase activity (32%);4 iron, 4 sulfur cluster binding (31%),GO:0009097 (30%);GO:0009099 (30%);GO:0006355 (5%),isoleucine biosynthetic process (30%);valine biosynthetic process (30%);regulation of transcription, DNA-templated (5%),IPR000581 (26%);IPR037237 (26%);IPR020558 (25%),Dihydroxy-acid/6-phosphogluconate dehydratase (26%);IlvD/EDD, N-terminal domain (26%);Dihydroxy-acid/6-phosphogluconate dehydratase, conserved site (25%),,,,,,,
ALLLAASK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.99.2 (100%),Pyridoxine 5'-phosphate synthase (100%),GO:0005840 (96%);GO:0009507 (82%);GO:0009536 (13%),ribosome (96%);chloroplast (82%);plastid (13%),GO:0003735 (91%);GO:0019843 (91%);GO:0033856 (1%),structural constituent of ribosome (91%);rRNA binding (91%);pyridoxine 5'-phosphate synthase activity (1%),GO:0006412 (95%);GO:0008615 (1%),translation (95%);pyridoxine biosynthetic process (1%),IPR000114 (94%);IPR016180 (94%);IPR020798 (94%),Ribosomal protein L16 (94%);Ribosomal protein L10e/L16 (94%);Ribosomal protein L16, conserved site (94%),,,,,,,,,,
FCAPMVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SAVHVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNELDQPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),,,IPR006683 (50%);IPR011990 (50%);IPR029069 (50%),Thioesterase domain (50%);Tetratricopeptide-like helical domain superfamily (50%);HotDog domain superfamily (50%),,,,,,,,,,,
WECSSEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMSHQMVAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QEVTNGR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (50%);GO:0016787 (50%),DNA binding (50%);hydrolase activity (50%),GO:0006260 (50%),DNA replication (50%),IPR000989 (50%);IPR006439 (50%);IPR011951 (50%),Replication protein (50%);HAD hydrolase, subfamily IA (50%);HAD-superfamily hydrolase, subfamily IA, YjjG/YfnB (50%),,,,,,,,
NMMEAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPEFVLCLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLVMPNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNMFMMFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADGGYQQQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLTTMVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YWLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.137 (31%);2.7.7.6 (23%);6.3.2.17 (15%),Phosphatidylinositol 3-kinase (31%);DNA-directed RNA polymerase (23%);Tetrahydrofolate synthase (15%),GO:0016021 (25%);GO:0005634 (13%);GO:0005615 (6%),integral component of membrane (25%);nucleus (13%);extracellular space (6%),GO:0008234 (26%);GO:0003677 (14%);GO:0005524 (12%),cysteine-type peptidase activity (26%);DNA binding (14%);ATP binding (12%),GO:0051603 (6%);GO:0048015 (1%);GO:0006351 (1%),proteolysis involved in cellular protein catabolic process (6%);phosphatidylinositol-mediated signaling (1%);transcription, DNA-templated (1%),IPR002740 (79%);IPR015947 (79%);IPR000668 (7%),EVE domain (79%);PUA-like superfamily (79%);Peptidase C1A, papain C-terminal (7%),,,,,,,,,
DMTLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.- (29%);1.2.4.1 (18%);2.7.7.7 (12%),With NAD(+) or NADP(+) as acceptor (29%);Pyruvate dehydrogenase (acetyl-transferring) (18%);DNA-directed DNA polymerase (12%),GO:0016021 (9%);GO:0005634 (3%);GO:0005737 (2%),integral component of membrane (9%);nucleus (3%);cytoplasm (2%),GO:0016624 (29%);GO:0016740 (8%);GO:0005524 (7%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor (29%);transferase activity (8%);ATP binding (7%),GO:0008299 (7%);GO:0030001 (3%);GO:0045493 (3%),isoprenoid biosynthetic process (7%);metal ion transport (3%);xylan catabolic process (3%),IPR001017 (29%);IPR029061 (29%);IPR017596 (28%),Dehydrogenase, E1 component (29%);Thiamin diphosphate-binding fold (29%);Pyruvate dehydrogenase E1 component subunit alpha/BCKADH E1-alpha (28%),,,,,,,,
DNPQWQWPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALHLLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (38%);GO:0009380 (13%);GO:0016021 (13%),cytoplasm (38%);excinuclease repair complex (13%);integral component of membrane (13%),GO:0048037 (50%);GO:0004518 (25%);GO:0003677 (13%),cofactor binding (50%);nuclease activity (25%);DNA binding (13%),GO:0009432 (38%);GO:0006281 (25%);GO:0006289 (13%),SOS response (38%);DNA repair (25%);nucleotide-excision repair (13%),IPR012349 (36%);IPR000305 (27%);IPR001162 (27%),FMN-binding split barrel (36%);GIY-YIG endonuclease (27%);UvrC family homology region (27%),,,,,,,,,,,
VYFNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (98%);1.14.18.1 (0%);2.7.7.72 (0%),Cytochrome-c oxidase (98%);Tyrosinase (0%);CCA tRNA nucleotidyltransferase (0%),GO:0016021 (84%);GO:0005886 (75%);GO:0070469 (75%),integral component of membrane (84%);plasma membrane (75%);respirasome (75%),GO:0004129 (76%);GO:0005507 (69%);GO:0020037 (69%),cytochrome-c oxidase activity (76%);copper ion binding (69%);heme binding (69%),GO:0006817 (2%);GO:0030643 (2%);GO:0045936 (2%),phosphate ion transport (2%);cellular phosphate ion homeostasis (2%);negative regulation of phosphate metabolic process (2%),IPR002429 (64%);IPR008972 (64%);IPR009056 (64%),Cytochrome c oxidase subunit II-like C-terminal (64%);Cupredoxin (64%);Cytochrome c-like domain (64%),,,,,,,,,,,
WMGVPPK,Burkholderiales,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDSHMLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAVVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (23%);2.7.4.1 (18%);2.3.1.- (13%),Transferring other groups (23%);Polyphosphate kinase (18%);Transferring groups other than amino-acyl groups (13%),GO:0016021 (29%);GO:0009358 (4%);GO:0005737 (4%),integral component of membrane (29%);polyphosphate kinase complex (4%);cytoplasm (4%),GO:0005524 (15%);GO:0046872 (8%);GO:0003723 (7%),ATP binding (15%);metal ion binding (8%);RNA binding (7%),GO:0055085 (6%);GO:0001522 (5%);GO:0006799 (4%),transmembrane transport (6%);pseudouridine synthesis (5%);polyphosphate biosynthetic process (4%),IPR027417 (7%);IPR036259 (5%);IPR020103 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);MFS transporter superfamily (5%);Pseudouridine synthase, catalytic domain superfamily (5%),,,,,,,,,,
MDVTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.23 (15%);1.17.4.2 (8%);1.3.5.1 (8%),dUTP diphosphatase (15%);Ribonucleoside-triphosphate reductase (thioredoxin) (8%);Succinate dehydrogenase (quinone) (8%),GO:0016021 (17%);GO:0005634 (2%);GO:0005737 (2%),integral component of membrane (17%);nucleus (2%);cytoplasm (2%),GO:0003677 (22%);GO:0016740 (11%);GO:0003697 (8%),DNA binding (22%);transferase activity (11%);single-stranded DNA binding (8%),GO:0006355 (17%);GO:0006260 (10%);GO:0008299 (10%),regulation of transcription, DNA-templated (17%);DNA replication (10%);isoprenoid biosynthetic process (10%),IPR000551 (12%);IPR009061 (12%);IPR027417 (11%),MerR-type HTH domain (12%);Putative DNA-binding domain superfamily (12%);P-loop containing nucleoside triphosphate hydrolase (11%),,,,,,,,,,
WMLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.17 (13%);1.4.1.13 (7%);1.4.99.- (7%),Transferred entry: 7.5.2.8 (13%);Glutamate synthase (NADPH) (7%);With other acceptors (7%),GO:0016021 (49%);GO:0005886 (7%);GO:0005623 (4%),integral component of membrane (49%);plasma membrane (7%);cell (4%),GO:0005524 (37%);GO:0016887 (28%);GO:0016740 (10%),ATP binding (37%);ATPase activity (28%);transferase activity (10%),GO:0055085 (13%);GO:0006438 (5%);GO:0090286 (4%),transmembrane transport (13%);valyl-tRNA aminoacylation (5%);cytoskeletal anchoring at nuclear membrane (4%),IPR027417 (27%);IPR003439 (25%);IPR017871 (24%),P-loop containing nucleoside triphosphate hydrolase (27%);ABC transporter-like (25%);ABC transporter, conserved site (24%),,,,,,,,,,
DPWVQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005829 (20%);GO:0045111 (20%),cytosol (20%);intermediate filament cytoskeleton (20%),GO:0005509 (60%);GO:0003690 (20%);GO:0003725 (20%),calcium ion binding (60%);double-stranded DNA binding (20%);double-stranded RNA binding (20%),GO:0009231 (20%);GO:0051607 (20%);GO:1900245 (20%),riboflavin biosynthetic process (20%);defense response to virus (20%);positive regulation of MDA-5 signaling pathway (20%),IPR002048 (50%);IPR011992 (50%);IPR018247 (50%),EF-hand domain (50%);EF-hand domain pair (50%);EF-Hand 1, calcium-binding site (50%),,,,,,,,,,
WNDFVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEYVVCSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFLENVSMPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
METPNTNK,Musca domestica,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Diptera,Brachycera,Muscomorpha,,Muscoidea,Muscidae,Muscinae,Muscini,,Musca,Musca,,,Musca domestica,,,,,,,,,,,,IPR042477 (100%),HMG domain-containing protein 4 (100%),,,,,,,,,,,
LPELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (9%);3.5.2.3 (7%);3.6.4.- (7%),Glycogen phosphorylase (9%);Dihydroorotase (7%);Acting on ATP; involved in cellular and subcellular movement (7%),GO:0016021 (23%);GO:0005737 (7%);GO:0005886 (5%),integral component of membrane (23%);cytoplasm (7%);plasma membrane (5%),GO:0005524 (13%);GO:0003677 (7%);GO:0046872 (5%),ATP binding (13%);DNA binding (7%);metal ion binding (5%),GO:0016226 (5%);GO:0005975 (3%);GO:0051604 (3%),iron-sulfur cluster assembly (5%);carbohydrate metabolic process (3%);protein maturation (3%),IPR027417 (10%);IPR003593 (3%);IPR013785 (3%),P-loop containing nucleoside triphosphate hydrolase (10%);AAA+ ATPase domain (3%);Aldolase-type TIM barrel (3%),,,,,,,,,,,
WMNVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005783 (14%);GO:0016021 (14%),endoplasmic reticulum (14%);integral component of membrane (14%),GO:0016787 (57%);GO:0000104 (14%);GO:0003756 (14%),hydrolase activity (57%);succinate dehydrogenase activity (14%);protein disulfide isomerase activity (14%),,,IPR000150 (67%);IPR006379 (67%);IPR023214 (67%),Cof family (67%);HAD-superfamily hydrolase, subfamily IIB (67%);HAD superfamily (67%),,,,,,,,,,
LNLNSLVNK,Cinara cedri,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Hemiptera,Sternorrhyncha,Aphidomorpha,,Aphidoidea,Lachnidae,,,,Cinara,,,,Cinara cedri,,,,,,,,,,,,IPR013087 (67%);IPR006579 (33%),Zinc finger C2H2-type (67%);Pre-C2HC  domain (33%),,,,,,,,,,,
TWSLCAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (32%);2.4.2.14 (13%);6.3.5.1 (13%),Proline--tRNA ligase (32%);Amidophosphoribosyltransferase (13%);NAD(+) synthase (glutamine-hydrolyzing) (13%),GO:0016021 (15%);GO:0005737 (14%);GO:0045202 (9%),integral component of membrane (15%);cytoplasm (14%);synapse (9%),GO:0005524 (18%);GO:0004049 (18%);GO:0005509 (10%),ATP binding (18%);anthranilate synthase activity (18%);calcium ion binding (10%),GO:0000162 (17%);GO:0007268 (9%);GO:0035556 (8%),tryptophan biosynthetic process (17%);chemical synaptic transmission (9%);intracellular signal transduction (8%),IPR005801 (17%);IPR015890 (17%);IPR019999 (17%),ADC synthase (17%);Chorismate-utilising enzyme, C-terminal (17%);Anthranilate synthase component I-like (17%),,,,,,,,,,
MEWMVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLFMAHK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.60 (100%);4.6.1.12 (100%),2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (100%);2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0008685 (50%);GO:0050518 (50%);GO:0004553 (25%),2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity (50%);2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity (50%);hydrolase activity, hydrolyzing O-glycosyl compounds (25%),GO:0016114 (50%);GO:0005975 (25%);GO:0019288 (25%),terpenoid biosynthetic process (50%);carbohydrate metabolic process (25%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (25%),IPR001228 (50%);IPR003526 (50%);IPR018294 (50%),2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (50%);2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (50%);4-diphosphocytidyl-2C-methyl-D-erythritol synthase, conserved site (50%),,,,,
FNVAAYMNVHDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPDGDVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (80%);GO:0000155 (20%),ATP binding (80%);phosphorelay sensor kinase activity (20%),,,IPR000641 (80%);IPR003593 (80%);IPR003959 (80%),CbxX/CfxQ (80%);AAA+ ATPase domain (80%);ATPase, AAA-type, core (80%),,,,,,,,,
YVTNLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (33%);GO:0016021 (33%),cytoplasm (33%);integral component of membrane (33%),GO:0004814 (33%);GO:0005524 (33%);GO:0016740 (33%),arginine-tRNA ligase activity (33%);ATP binding (33%);transferase activity (33%),GO:0006420 (33%),arginyl-tRNA aminoacylation (33%),IPR001296 (40%);IPR028098 (40%);IPR000326 (20%),Glycosyl transferase, family 1 (40%);Glycosyltransferase subfamily 4-like, N-terminal domain (40%);Phosphatidic acid phosphatase type 2/haloperoxidase (20%),,,,,,,,,
GGTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.18 (27%);3.2.1.39 (8%);1.1.1.100 (7%),Anthranilate phosphoribosyltransferase (27%);Glucan endo-1,3-beta-D-glucosidase (8%);3-oxoacyl-[acyl-carrier-protein] reductase (7%),GO:0016021 (18%);GO:0005634 (4%);GO:0005737 (4%),integral component of membrane (18%);nucleus (4%);cytoplasm (4%),GO:0050660 (24%);GO:0016627 (24%);GO:0004497 (15%),flavin adenine dinucleotide binding (24%);oxidoreductase activity, acting on the CH-CH group of donors (24%);monooxygenase activity (15%),GO:0005975 (10%);GO:0000162 (4%);GO:0015074 (2%),carbohydrate metabolic process (10%);tryptophan biosynthetic process (4%);DNA integration (2%),IPR037069 (21%);IPR009100 (21%);IPR013786 (21%),Acyl-CoA dehydrogenase/oxidase, N-terminal domain superfamily (21%);Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily (21%);Acyl-CoA dehydrogenase/oxidase, N-terminal (21%),,,,,,
MFVVDGVDTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDWPDTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDSGNFAYCHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ECMAALVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WAGYQM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CQGVPAR,Paenibacillus pasadenensis,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Paenibacillaceae,,,,Paenibacillus,,,,Paenibacillus pasadenensis,,,,,,,,GO:0008233 (100%),peptidase activity (100%),,,IPR002931 (100%);IPR013589 (100%);IPR038765 (100%),Transglutaminase-like (100%);Bacterial transglutaminase-like, N-terminal (100%);Papain-like cysteine peptidase superfamily (100%),,,,,,,,,,
TDQAPDGHGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDGPNPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (28%);6.5.1.- (7%);3.4.11.18 (5%),DNA-directed DNA polymerase (28%);Forming phosphoric ester bonds (7%);Methionyl aminopeptidase (5%),GO:0005737 (18%);GO:0016021 (18%);GO:0009380 (10%),cytoplasm (18%);integral component of membrane (18%);excinuclease repair complex (10%),GO:0005524 (20%);GO:0003677 (17%);GO:0016887 (11%),ATP binding (20%);DNA binding (17%);ATPase activity (11%),GO:0006289 (11%);GO:0009432 (11%);GO:0032401 (8%),nucleotide-excision repair (11%);SOS response (11%);establishment of melanosome localization (8%),IPR027417 (13%);IPR014001 (10%);IPR001650 (10%),P-loop containing nucleoside triphosphate hydrolase (13%);Helicase superfamily 1/2, ATP-binding domain (10%);Helicase, C-terminal (10%),,,,,,,,,
MMCGEPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.274 (63%);3.1.1.31 (3%);1.1.1.34 (3%),Phosphate acyltransferase (63%);6-phosphogluconolactonase (3%);Hydroxymethylglutaryl-CoA reductase (NADPH) (3%),GO:0005737 (26%);GO:0016021 (15%);GO:0005634 (3%),cytoplasm (26%);integral component of membrane (15%);nucleus (3%),GO:0043811 (22%);GO:0003677 (12%);GO:0005524 (10%),phosphate:acyl-[acyl carrier protein] acyltransferase activity (22%);DNA binding (12%);ATP binding (10%),GO:0006633 (23%);GO:0008654 (23%);GO:0006310 (8%),fatty acid biosynthetic process (23%);phospholipid biosynthetic process (23%);DNA recombination (8%),IPR012281 (17%);IPR003664 (17%);IPR011010 (7%),Phospholipid biosynthesis protein, PlsX-like (17%);Fatty acid synthesis PlsX protein (17%);DNA breaking-rejoining enzyme, catalytic core (7%),,,,,,,,,
MDVEFPK,Saccharomyces,Eukaryota,Fungi,Dikarya,,Ascomycota,Saccharomycotina,,Saccharomycetes,,,,Saccharomycetales,,,,,Saccharomycetaceae,,,,Saccharomyces,,,,,,,,,,GO:0005828 (100%);GO:0032133 (100%);GO:0051233 (100%),kinetochore microtubule (100%);chromosome passenger complex (100%);spindle midzone (100%),GO:0030295 (100%),protein kinase activator activity (100%),GO:0006468 (100%);GO:0007059 (100%);GO:0032465 (100%),protein phosphorylation (100%);chromosome segregation (100%);regulation of cytokinesis (100%),IPR005635 (100%),Inner centromere protein, ARK-binding domain (100%),,,,,,,,,,
HMTFPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGATEMDVDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNTPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.19 (100%),4-aminobutyrate--2-oxoglutarate transaminase (100%),GO:0016021 (40%);GO:0005840 (7%);GO:0005739 (5%),integral component of membrane (40%);ribosome (7%);mitochondrion (5%),GO:0008270 (19%);GO:0009002 (14%);GO:0003735 (7%),zinc ion binding (19%);serine-type D-Ala-D-Ala carboxypeptidase activity (14%);structural constituent of ribosome (7%),GO:0015031 (19%);GO:0006412 (7%);GO:0055085 (5%),protein transport (19%);translation (7%);transmembrane transport (5%),IPR002898 (18%);IPR010666 (16%);IPR001967 (12%),MotA/TolQ/ExbB proton channel (18%);Zinc finger, GRF-type (16%);Peptidase S11, D-alanyl-D-alanine carboxypeptidase A, N-terminal (12%),,,,,,,,
NWCMVGGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLEGDPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.13.11.11 (100%),Tryptophan 2,3-dioxygenase (100%),GO:0005737 (20%);GO:0016021 (20%),cytoplasm (20%);integral component of membrane (20%),GO:0004833 (60%);GO:0020037 (60%);GO:0046872 (60%),tryptophan 2,3-dioxygenase activity (60%);heme binding (60%);metal ion binding (60%),GO:0019441 (60%);GO:0006189 (20%);GO:0018105 (20%),tryptophan catabolic process to kynurenine (60%);'de novo' IMP biosynthetic process (20%);peptidyl-serine phosphorylation (20%),IPR004981 (60%);IPR037217 (60%);IPR000719 (20%),Tryptophan 2,3-dioxygenase (60%);Tryptophan/Indoleamine 2,3-dioxygenase-like (60%);Protein kinase domain (20%),,,,,,,
NAESYSVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPSSDLEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMLNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.6 (22%);1.1.1.100 (11%);2.1.1.- (11%),Methionine adenosyltransferase (22%);3-oxoacyl-[acyl-carrier-protein] reductase (11%);Methyltransferases (11%),GO:0016021 (35%);GO:0005737 (7%);GO:0009279 (7%),integral component of membrane (35%);cytoplasm (7%);cell outer membrane (7%),GO:0005524 (16%);GO:0004553 (9%);GO:0046872 (9%),ATP binding (16%);hydrolase activity, hydrolyzing O-glycosyl compounds (9%);metal ion binding (9%),GO:0005975 (10%);GO:0009291 (4%);GO:0006556 (3%),carbohydrate metabolic process (10%);unidirectional conjugation (4%);S-adenosylmethionine biosynthetic process (3%),IPR027417 (20%);IPR013783 (15%);IPR006102 (9%),P-loop containing nucleoside triphosphate hydrolase (20%);Immunoglobulin-like fold (15%);Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich (9%),,,,,,,,
QPEYLPPR,Rhizobium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Rhizobiaceae,,,,Rhizobium,,,,,,,,,,,,,,,,IPR007407 (100%);IPR036514 (100%),Protein of unknown function DUF459 (100%);SGNH hydrolase superfamily (100%),,,,,,,,,,,
EALPTDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.48 (100%),Indole-3-glycerol-phosphate synthase (100%),GO:0005737 (33%),cytoplasm (33%),GO:0003723 (33%);GO:0003700 (17%);GO:0004425 (17%),RNA binding (33%);DNA-binding transcription factor activity (17%);indole-3-glycerol-phosphate synthase activity (17%),GO:0006353 (33%);GO:0031564 (33%);GO:0000160 (17%),DNA-templated transcription, termination (33%);transcription antitermination (33%);phosphorelay signal transduction system (17%),IPR004919 (22%);IPR009019 (22%);IPR010213 (22%),Domain of unknown function DUF262 (22%);K homology domain superfamily, prokaryotic type (22%);Transcription termination factor NusA (22%),,,,,,,,,
QEEAVYNPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNACAEEDPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QSMDDASSVVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYWLADMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGNHLYK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0003824 (100%),catalytic activity (100%),,,IPR001932 (100%);IPR003018 (100%);IPR011110 (100%),PPM-type phosphatase domain (100%);GAF domain (100%);Two component regulator propeller (100%),,,,,,,,,,,
HMDSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.5 (50%);1.8.4.12 (50%);3.5.4.9 (50%),Methylenetetrahydrofolate dehydrogenase (NADP(+)) (50%);Peptide-methionine (R)-S-oxide reductase (50%);Methenyltetrahydrofolate cyclohydrolase (50%),GO:0016021 (45%);GO:0005634 (18%),integral component of membrane (45%);nucleus (18%),GO:0003677 (18%);GO:0005509 (18%);GO:0003899 (9%),DNA binding (18%);calcium ion binding (18%);DNA-directed 5'-3' RNA polymerase activity (9%),GO:0000105 (9%);GO:0006164 (9%);GO:0006351 (9%),histidine biosynthetic process (9%);purine nucleotide biosynthetic process (9%);transcription, DNA-templated (9%),IPR015943 (36%);IPR001680 (27%);IPR011009 (27%),WD40/YVTN repeat-like-containing domain superfamily (36%);WD40 repeat (27%);Protein kinase-like domain superfamily (27%),,,,,,,,,,
MPGHYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%),DNA binding (100%),GO:0006310 (100%);GO:0015074 (100%),DNA recombination (100%);DNA integration (100%),IPR002104 (67%);IPR011010 (67%);IPR013762 (67%),Integrase, catalytic domain (67%);DNA breaking-rejoining enzyme, catalytic core (67%);Integrase-like, catalytic domain superfamily (67%),,,,,,,,
DLNMYVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHQTMVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVTNPTEPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NCMLGPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MQVLSGMLVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLELMWAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPAVCPAR,Amazona aestiva,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Aves,,Neognathae,,Psittaciformes,,,,,Psittacidae,,,,Amazona,,,,Amazona aestiva,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0008519 (100%),ammonium transmembrane transporter activity (100%),,,IPR002229 (100%);IPR024041 (100%);IPR029020 (100%),Blood group Rhesus C/E/D polypeptide (100%);Ammonium transporter AmtB-like domain (100%);Ammonium/urea transporter (100%),,,,,,,,,,,
VFTTDDAEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLPMLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (14%),cell outer membrane (14%),GO:0003700 (43%);GO:0043565 (43%);GO:0003723 (14%),DNA-binding transcription factor activity (43%);sequence-specific DNA binding (43%);RNA binding (14%),GO:0009190 (14%);GO:0009306 (14%);GO:0035556 (14%),cyclic nucleotide biosynthetic process (14%);protein secretion (14%);intracellular signal transduction (14%),IPR003313 (33%);IPR009057 (33%);IPR018060 (33%),AraC-type arabinose-binding/dimerisation domain (33%);Homeobox-like domain superfamily (33%);DNA binding HTH domain, AraC-type (33%),,,,,,,,,,
FFDFDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (63%);1.-.-.- (20%);6.1.1.1 (10%),Ribonucleoside-diphosphate reductase (63%);Oxidoreductases (20%);Tyrosine--tRNA ligase (10%),GO:0005737 (13%);GO:0016021 (8%);GO:0000329 (6%),cytoplasm (13%);integral component of membrane (8%);fungal-type vacuole membrane (6%),GO:0005524 (44%);GO:0004748 (21%);GO:0005525 (17%),ATP binding (44%);ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor (21%);GTP binding (17%),GO:0006260 (22%);GO:0006281 (8%);GO:0006623 (6%),DNA replication (22%);DNA repair (8%);protein targeting to vacuole (6%),IPR027417 (26%);IPR000788 (21%);IPR013346 (21%),P-loop containing nucleoside triphosphate hydrolase (26%);Ribonucleotide reductase large subunit, C-terminal (21%);Ribonucleotide reductase, class I , alpha subunit (21%),,,,,,,
HNNPVLLWM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSPMPHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFLSYDEVLGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLFCALGTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGFHNPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYWEVHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YTFDLAVGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HVQVNMSLHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLFMVLDVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNMSPGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHYDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.243 (28%);1.6.-.- (6%);2.7.7.6 (6%),Lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase (28%);Acting on NADH or NADPH (6%);DNA-directed RNA polymerase (6%),GO:0016021 (23%);GO:0005737 (15%);GO:0005774 (6%),integral component of membrane (23%);cytoplasm (15%);vacuolar membrane (6%),GO:0008270 (10%);GO:0016491 (7%);GO:0022857 (7%),zinc ion binding (10%);oxidoreductase activity (7%);transmembrane transporter activity (7%),GO:0006886 (14%);GO:0007033 (10%);GO:0000122 (5%),intracellular protein transport (14%);vacuole organization (10%);negative regulation of transcription by RNA polymerase II (5%),IPR006926 (11%);IPR016534 (11%);IPR012337 (9%),Vps16, N-terminal (11%);Vacuolar protein sorting-associated protein 16 (11%);Ribonuclease H-like superfamily (9%),,,,,,,,,,
WNHVHK,Euryarchaeota archaeon,Archaea,,,,Euryarchaeota,,,,,,,,,,,,,,,,,,,,Euryarchaeota archaeon,,,,,,,,GO:0003824 (100%);GO:0050662 (100%),catalytic activity (100%);coenzyme binding (100%),,,IPR001509 (100%);IPR010099 (100%);IPR013549 (100%),NAD-dependent epimerase/dehydratase (100%);Epimerase family protein SDR39U1 (100%);Domain of unknown function DUF1731 (100%),,,,,,,,,,,
NPTWDLMELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLMGHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.193 (50%);3.5.4.26 (50%);2.7.7.24 (25%),5-amino-6-(5-phosphoribosylamino)uracil reductase (50%);Diaminohydroxyphosphoribosylaminopyrimidine deaminase (50%);Glucose-1-phosphate thymidylyltransferase (25%),GO:0016021 (40%);GO:0043231 (8%);GO:0005737 (4%),integral component of membrane (40%);intracellular membrane-bounded organelle (8%);cytoplasm (4%),GO:0005524 (12%);GO:0016740 (12%);GO:0000155 (8%),ATP binding (12%);transferase activity (12%);phosphorelay sensor kinase activity (8%),GO:0006914 (8%);GO:0009231 (8%);GO:0015937 (4%),autophagy (8%);riboflavin biosynthetic process (8%);coenzyme A biosynthetic process (4%),IPR001680 (26%);IPR015943 (26%);IPR017986 (26%),WD40 repeat (26%);WD40/YVTN repeat-like-containing domain superfamily (26%);WD40-repeat-containing domain (26%),,,,,,,,,,,
VVSWVMMALSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LWGQKPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HYTVNGGSQEDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVNPMLLPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLQKPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.22 (11%);6.3.4.14 (11%);6.4.1.2 (11%),GTP 3',8-cyclase (11%);Biotin carboxylase (11%);Acetyl-CoA carboxylase (11%),GO:0016021 (48%);GO:0005737 (4%);GO:0005634 (2%),integral component of membrane (48%);cytoplasm (4%);nucleus (2%),GO:0003677 (10%);GO:0016787 (8%);GO:0005364 (8%),DNA binding (10%);hydrolase activity (8%);maltose:proton symporter activity (8%),GO:0106081 (8%);GO:0106082 (8%);GO:0043709 (7%),maltose import across plasma membrane (8%);sucrose import across plasma membrane (8%);cell adhesion involved in single-species biofilm formation (7%),IPR036259 (18%);IPR001279 (11%);IPR036866 (11%),MFS transporter superfamily (18%);Metallo-beta-lactamase (11%);Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (11%),,,,,,,,,,
LLFHLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FHLYPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (67%);2.5.1.78 (33%),Peptidylprolyl isomerase (67%);6,7-dimethyl-8-ribityllumazine synthase (33%),GO:0005840 (70%);GO:0005737 (5%);GO:0016021 (5%),ribosome (70%);cytoplasm (5%);integral component of membrane (5%),GO:0003735 (68%);GO:0003755 (5%);GO:0030246 (5%),structural constituent of ribosome (68%);peptidyl-prolyl cis-trans isomerase activity (5%);carbohydrate binding (5%),GO:0006412 (68%);GO:0006457 (5%);GO:0007049 (5%),translation (68%);protein folding (5%);cell cycle (5%),IPR036942 (45%);IPR041700 (45%);IPR001857 (37%),TonB-dependent receptor-like, beta-barrel domain superfamily (45%);Outer membrane protein beta-barrel domain 3 (45%);Ribosomal protein L19 (37%),,,,,,,,,
WFQGPDALAAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVFNPSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.24 (100%),Mitogen-activated protein kinase (100%),,,GO:0004707 (80%);GO:0005524 (80%);GO:0016301 (20%),MAP kinase activity (80%);ATP binding (80%);kinase activity (20%),,,IPR000719 (80%);IPR003527 (80%);IPR008271 (80%),Protein kinase domain (80%);Mitogen-activated protein (MAP) kinase, conserved site (80%);Serine/threonine-protein kinase, active site (80%),,,,,,,,,
QAYSFVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLLFMVSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDGVLPPACGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLTYEQMLFLMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMDANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.5 (29%);1.97.1.- (29%);1.97.1.4 (29%),Methylenetetrahydrofolate dehydrogenase (NADP(+)) (29%);Other oxidoreductases (29%);[Formate-C-acetyltransferase]-activating enzyme (29%),GO:0016021 (13%);GO:0005840 (7%),integral component of membrane (13%);ribosome (7%),GO:0051539 (40%);GO:0016491 (33%);GO:0004477 (13%),4 iron, 4 sulfur cluster binding (40%);oxidoreductase activity (33%);methenyltetrahydrofolate cyclohydrolase activity (13%),GO:0000105 (13%);GO:0006164 (13%);GO:0009086 (13%),histidine biosynthetic process (13%);purine nucleotide biosynthetic process (13%);methionine biosynthetic process (13%),IPR007197 (30%);IPR012839 (30%);IPR013785 (30%),Radical SAM (30%);Organic radical enzyme activase (30%);Aldolase-type TIM barrel (30%),,,,,,,,,,
NNMDMVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNLSGHMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.108 (20%);2.7.1.144 (9%);5.6.2.2 (8%),2-(3-amino-3-carboxypropyl)histidine synthase (20%);Tagatose-6-phosphate kinase (9%);DNA topoisomerase (ATP-hydrolyzing) (8%),GO:0016021 (35%);GO:0005840 (7%);GO:0005886 (5%),integral component of membrane (35%);ribosome (7%);plasma membrane (5%),GO:0005524 (8%);GO:0008271 (8%);GO:0003735 (7%),ATP binding (8%);secondary active sulfate transmembrane transporter activity (8%);structural constituent of ribosome (7%),GO:0006412 (7%);GO:0051726 (4%);GO:0006885 (4%),translation (7%);regulation of cell cycle (4%);regulation of pH (4%),IPR001902 (7%);IPR002645 (7%);IPR030285 (7%),SLC26A/SulP transporter (7%);STAS domain (7%);Pendrin (7%),,,,,,,,,,,
QNYQLNMLSEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMMVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (44%);1.2.1.88 (13%);1.5.5.2 (13%),Isoleucine--tRNA ligase (44%);L-glutamate gamma-semialdehyde dehydrogenase (13%);Proline dehydrogenase (13%),GO:0016021 (52%);GO:0005737 (7%);GO:0005886 (3%),integral component of membrane (52%);cytoplasm (7%);plasma membrane (3%),GO:0005524 (11%);GO:0016787 (8%);GO:0008270 (8%),ATP binding (11%);hydrolase activity (8%);zinc ion binding (8%),GO:0006428 (5%);GO:0005975 (2%);GO:0000027 (2%),isoleucyl-tRNA aminoacylation (5%);carbohydrate metabolic process (2%);ribosomal large subunit assembly (2%),IPR036259 (23%);IPR024671 (22%);IPR027417 (8%),MFS transporter superfamily (23%);Autophagy-related protein 22-like (22%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
TTYPWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (29%),integral component of membrane (29%),GO:0003677 (29%);GO:0004930 (14%);GO:0016740 (14%),DNA binding (29%);G protein-coupled receptor activity (14%);transferase activity (14%),GO:0022008 (14%),neurogenesis (14%),IPR001005 (25%);IPR009057 (25%);IPR017877 (25%),SANT/Myb domain (25%);Homeobox-like domain superfamily (25%);Myb-like domain (25%),,,,,,,,,,,
TLMWMPAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWEYMFAQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMYWVQGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNFDYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.3 (50%);5.3.4.1 (25%);5.4.99.12 (25%),Adenosinetriphosphatase (50%);Protein disulfide-isomerase (25%);tRNA pseudouridine(38-40) synthase (25%),GO:0005634 (23%);GO:0009279 (19%);GO:0016020 (15%),nucleus (23%);cell outer membrane (19%);membrane (15%),GO:0005524 (27%);GO:0015288 (23%);GO:0016740 (8%),ATP binding (27%);porin activity (23%);transferase activity (8%),GO:0010033 (8%);GO:0015920 (8%);GO:0034220 (8%),response to organic substance (8%);lipopolysaccharide transport (8%);ion transmembrane transport (8%),IPR000330 (22%);IPR000953 (22%);IPR001650 (22%),SNF2-related, N-terminal domain (22%);Chromo/chromo shadow domain (22%);Helicase, C-terminal (22%),,,,,,,,,
MSANPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.17 (45%);1.1.2.- (5%);1.1.2.7 (5%),Phosphomethylpyrimidine synthase (45%);With a cytochrome as acceptor (5%);Methanol dehydrogenase (cytochrome c) (5%),GO:0016021 (17%);GO:0016020 (6%);GO:0030288 (5%),integral component of membrane (17%);membrane (6%);outer membrane-bounded periplasmic space (5%),GO:0051539 (16%);GO:0005524 (14%);GO:0008270 (14%),4 iron, 4 sulfur cluster binding (16%);ATP binding (14%);zinc ion binding (14%),GO:0009228 (14%);GO:0009229 (13%);GO:0055085 (3%),thiamine biosynthetic process (14%);thiamine diphosphate biosynthetic process (13%);transmembrane transport (3%),IPR027417 (15%);IPR025747 (13%);IPR002817 (12%),P-loop containing nucleoside triphosphate hydrolase (15%);ThiC-associated domain (13%);Phosphomethylpyrimidine synthase ThiC/5-hydroxybenzimidazole synthase BzaA/B (12%),,,,,,,,,,
ADANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (12%);4.1.2.4 (8%);4.2.1.136 (8%),Peptidylprolyl isomerase (12%);Deoxyribose-phosphate aldolase (8%);ADP-dependent NAD(P)H-hydrate dehydratase (8%),GO:0016021 (20%);GO:0005887 (11%);GO:0005737 (6%),integral component of membrane (20%);integral component of plasma membrane (11%);cytoplasm (6%),GO:0005524 (20%);GO:0038062 (11%);GO:0005509 (6%),ATP binding (20%);protein tyrosine kinase collagen receptor activity (11%);calcium ion binding (6%),GO:0006355 (15%);GO:0046777 (3%);GO:0030500 (3%),regulation of transcription, DNA-templated (15%);protein autophosphorylation (3%);regulation of bone mineralization (3%),IPR010985 (12%);IPR013321 (12%);IPR031895 (12%),Ribbon-helix-helix (12%);Arc-type ribbon-helix-helix (12%);RHH transcriptional regulator CopG (12%),,,,,,,,,,
THDEWYCSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLNPLDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.5 (33%);3.2.1.141 (33%);7.1.1.- (22%),Exodeoxyribonuclease V (33%);4-alpha-D-((1->4)-alpha-D-glucano)trehalose trehalohydrolase (33%);Hydron translocation or charge separation linked to oxidoreductase reactions (22%),GO:0016021 (59%);GO:0005886 (32%);GO:0005634 (8%),integral component of membrane (59%);plasma membrane (32%);nucleus (8%),GO:0005509 (39%);GO:0005524 (12%);GO:0003677 (7%),calcium ion binding (39%);ATP binding (12%);DNA binding (7%),GO:0007156 (39%);GO:0003382 (7%);GO:0007015 (7%),homophilic cell adhesion via plasma membrane adhesion molecules (39%);epithelial cell morphogenesis (7%);actin filament organization (7%),IPR042316 (29%);IPR000742 (27%);IPR001791 (27%),IRK-interacting protein-like (29%);EGF-like domain (27%);Laminin G domain (27%),,,,,,,,,,,
QANPTDHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPLNVLSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VDMEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (70%);3.4.14.12 (30%),Acting on peptide bonds (peptidases) (70%);Xaa-Xaa-Pro tripeptidyl-peptidase (30%),GO:0016021 (3%),integral component of membrane (3%),GO:0008236 (96%);GO:0004177 (9%);GO:0003676 (1%),serine-type peptidase activity (96%);aminopeptidase activity (9%);nucleic acid binding (1%),GO:0015074 (1%),DNA integration (1%),IPR001375 (80%);IPR002469 (80%);IPR029058 (80%),Peptidase S9, prolyl oligopeptidase, catalytic domain (80%);Dipeptidylpeptidase IV, N-terminal domain (80%);Alpha/Beta hydrolase fold (80%),,,,,,,,
TDDLEWFMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DFTWYPMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGWLNHQAYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGNLAAHDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYCESQVPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVQHYAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMNEGLTGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QASENPK,Chloroflexi bacterium,Bacteria,,,,Chloroflexi,,,,,,,,,,,,,,,,,,,,Chloroflexi bacterium,,,,,,,,,,,,IPR006396 (100%);IPR014714 (100%);IPR016176 (100%),Glutamate mutase epsilon subunit (100%);Glutamate mutase E subunit, C-terminal domain superfamily (100%);Cobalamin (vitamin B12)-dependent enzyme, catalytic (100%),,,,,,,,,
NMMMEFAWTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WMFFFLYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLVMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (35%);4.2.1.1 (33%);3.4.23.36 (6%),Histidine kinase (35%);Carbonic anhydrase (33%);Signal peptidase II (6%),GO:0016021 (70%);GO:0005887 (5%);GO:0005886 (3%),integral component of membrane (70%);integral component of plasma membrane (5%);plasma membrane (3%),GO:0022857 (44%);GO:0008270 (14%);GO:0004089 (14%),transmembrane transporter activity (44%);zinc ion binding (14%);carbonate dehydratase activity (14%),GO:0046323 (5%);GO:0008643 (5%);GO:0055085 (1%),glucose import (5%);carbohydrate transport (5%);transmembrane transport (1%),IPR036259 (48%);IPR005828 (48%);IPR020846 (47%),MFS transporter superfamily (48%);Major facilitator,  sugar transporter-like (48%);Major facilitator superfamily domain (47%),,,,,,,,,,
TMMDLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGMSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (71%);4.2.2.- (12%);6.6.1.1 (6%),DNA topoisomerase (ATP-hydrolyzing) (71%);Acting on polysaccharides (12%);Magnesium chelatase (6%),GO:0005694 (45%);GO:0005737 (29%);GO:0016021 (14%),chromosome (45%);cytoplasm (29%);integral component of membrane (14%),GO:0005524 (60%);GO:0003677 (56%);GO:0003918 (50%),ATP binding (60%);DNA binding (56%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (50%),GO:0006265 (53%);GO:0006261 (29%);GO:0009252 (8%),DNA topological change (53%);DNA-dependent DNA replication (29%);peptidoglycan biosynthetic process (8%),IPR006691 (40%);IPR035516 (40%);IPR013757 (37%),DNA gyrase/topoisomerase IV, subunit A, C-terminal repeat (40%);DNA gyrase/topoisomerase IV, subunit A, C-terminal (40%);Type IIA DNA topoisomerase subunit A, alpha-helical domain superfamily (37%),,,,,
MDTVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.29 (40%);4.3.3.7 (30%);3.5.4.22 (20%),tRNA-guanine(34) transglycosylase (40%);4-hydroxy-tetrahydrodipicolinate synthase (30%);1-pyrroline-4-hydroxy-2-carboxylate deaminase (20%),GO:0016021 (20%);GO:0005886 (8%);GO:0005737 (6%),integral component of membrane (20%);plasma membrane (8%);cytoplasm (6%),GO:0016829 (55%);GO:0008479 (6%);GO:0046872 (6%),lyase activity (55%);queuine tRNA-ribosyltransferase activity (6%);metal ion binding (6%),GO:0006605 (8%);GO:0043952 (8%);GO:0065002 (8%),protein targeting (8%);protein transport by the Sec complex (8%);intracellular protein transmembrane transport (8%),IPR002220 (58%);IPR013785 (57%);IPR002208 (7%),DapA-like (58%);Aldolase-type TIM barrel (57%);SecY/SEC61-alpha family (7%),,,,,,,,,,,
QEVHDVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLLTETLHANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSLHTPYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGELVAENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SALSTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.13 (16%);4.2.1.- (13%);4.99.1.1 (8%),tRNA-uridine 2-sulfurtransferase (16%);Hydro-lyases (13%);Protoporphyrin ferrochelatase (8%),GO:0016021 (37%);GO:0005737 (7%);GO:0030015 (3%),integral component of membrane (37%);cytoplasm (7%);CCR4-NOT core complex (3%),GO:0003677 (6%);GO:0005524 (6%);GO:0003723 (4%),DNA binding (6%);ATP binding (6%);RNA binding (4%),GO:0005975 (3%);GO:0000746 (3%);GO:0006417 (3%),carbohydrate metabolic process (3%);conjugation (3%);regulation of translation (3%),IPR025128 (15%);IPR007490 (14%);IPR025133 (14%),Poxvirus B22R protein C-terminal domain (15%);Poxvirus B22 (14%);Poxvirus B22R protein N-terminal domain (14%),,,,,,,,,,,
QAALCDVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.181 (27%);6.3.4.15 (25%);2.7.7.7 (19%),Lipoyl(octanoyl) transferase (27%);Biotin--[biotin carboxyl-carrier protein] ligase (25%);DNA-directed DNA polymerase (19%),GO:0005737 (41%);GO:0016021 (7%);GO:0005886 (1%),cytoplasm (41%);integral component of membrane (7%);plasma membrane (1%),GO:0003746 (44%);GO:0005525 (44%);GO:0003924 (39%),translation elongation factor activity (44%);GTP binding (44%);GTPase activity (39%),GO:0006464 (7%);GO:0009107 (6%);GO:0009249 (6%),cellular protein modification process (7%);lipoate biosynthetic process (6%);protein lipoylation (6%),IPR027417 (44%);IPR020568 (42%);IPR035647 (42%),P-loop containing nucleoside triphosphate hydrolase (44%);Ribosomal protein S5 domain 2-type fold (42%);EF-G domain III/V-like (42%),,,,,,,,,,,
NQNAQDLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVEQFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.-.- (30%);2.7.13.3 (10%);2.7.9.1 (10%),Transferring phosphorus-containing groups (30%);Histidine kinase (10%);Pyruvate, phosphate dikinase (10%),GO:0016021 (62%);GO:0005737 (1%);GO:0005840 (1%),integral component of membrane (62%);cytoplasm (1%);ribosome (1%),GO:0005524 (45%);GO:0004888 (29%);GO:0016301 (22%),ATP binding (45%);transmembrane signaling receptor activity (29%);kinase activity (22%),GO:0007165 (36%);GO:0006935 (29%);GO:0006281 (1%),signal transduction (36%);chemotaxis (29%);DNA repair (1%),IPR003660 (35%);IPR033479 (34%);IPR004089 (32%),HAMP domain (35%);Double Cache domain 1 (34%);Methyl-accepting chemotaxis protein (MCP) signalling domain (32%),,,,,,,,,,
HNMLADSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLPLMGGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (28%);2.7.1.26 (11%);2.7.7.2 (11%),Hydron translocation or charge separation linked to oxidoreductase reactions (28%);Riboflavin kinase (11%);FAD synthase (11%),GO:0005840 (50%);GO:0016021 (9%);GO:0019867 (9%),ribosome (50%);integral component of membrane (9%);outer membrane (9%),GO:0003735 (50%);GO:0019843 (49%);GO:0046872 (5%),structural constituent of ribosome (50%);rRNA binding (49%);metal ion binding (5%),GO:0006412 (50%);GO:0035556 (2%);GO:0006304 (2%),translation (50%);intracellular signal transduction (2%);DNA modification (2%),IPR000244 (47%);IPR009027 (47%);IPR020070 (47%),Ribosomal protein L9 (47%);Ribosomal protein L9/RNase H1, N-terminal (47%);Ribosomal protein L9, N-terminal (47%),,,,,,,,,
VNSYTMTGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMMTQFAVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQALYEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.22 (71%);1.1.99.2 (14%);3.4.24.55 (14%),Hydroperoxy fatty acid reductase (71%);L-2-hydroxyglutarate dehydrogenase (14%);Pitrilysin (14%),GO:0016021 (22%);GO:0005739 (8%);GO:0005737 (6%),integral component of membrane (22%);mitochondrion (8%);cytoplasm (6%),GO:0016491 (31%);GO:0004553 (10%);GO:0004601 (10%),oxidoreductase activity (31%);hydrolase activity, hydrolyzing O-glycosyl compounds (10%);peroxidase activity (10%),GO:0000272 (10%);GO:0044267 (6%);GO:0007049 (4%),polysaccharide catabolic process (10%);cellular protein metabolic process (6%);cell cycle (4%),IPR006076 (26%);IPR036188 (26%);IPR000889 (13%),FAD dependent oxidoreductase (26%);FAD/NAD(P)-binding domain superfamily (26%);Glutathione peroxidase (13%),,,,,,,,,,
MMQVYMLLHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.9 (21%);2.7.-.- (9%);1.11.1.15 (8%),Valine--tRNA ligase (21%);Transferring phosphorus-containing groups (9%);Peroxiredoxin (8%),GO:0016021 (20%);GO:0005737 (9%);GO:0000145 (5%),integral component of membrane (20%);cytoplasm (9%);exocyst (5%),GO:0005524 (18%);GO:0046872 (6%);GO:0016491 (6%),ATP binding (18%);metal ion binding (6%);oxidoreductase activity (6%),GO:0006438 (5%);GO:0006893 (5%);GO:0006887 (5%),valyl-tRNA aminoacylation (5%);Golgi to plasma membrane transport (5%);exocytosis (5%),IPR027417 (6%);IPR014729 (6%);IPR001412 (5%),P-loop containing nucleoside triphosphate hydrolase (6%);Rossmann-like alpha/beta/alpha sandwich fold (6%);Aminoacyl-tRNA synthetase, class I, conserved site (5%),,,,,,,,,
QCSMHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0033644 (100%);GO:0044165 (100%),host cell membrane (100%);host cell endoplasmic reticulum (100%),GO:0003723 (100%);GO:0003724 (100%);GO:0003968 (100%),RNA binding (100%);RNA helicase activity (100%);RNA-directed 5'-3' RNA polymerase activity (100%),GO:0006351 (100%);GO:0006370 (100%);GO:0039694 (100%),transcription, DNA-templated (100%);7-methylguanosine mRNA capping (100%);viral RNA genome replication (100%),IPR002068 (50%);IPR008978 (50%);IPR031107 (50%),Alpha crystallin/Hsp20 domain (50%);HSP20-like chaperone (50%);Small heat shock protein HSP20 (50%),,,,,,,,,,
MNGHLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (14%),integral component of membrane (14%),GO:0003913 (57%);GO:0003824 (29%);GO:0008176 (14%),DNA photolyase activity (57%);catalytic activity (29%);tRNA (guanine-N7-)-methyltransferase activity (14%),GO:0006281 (57%);GO:0005975 (29%),DNA repair (57%);carbohydrate metabolic process (29%),IPR002081 (57%);IPR005101 (57%);IPR006050 (57%),Cryptochrome/DNA photolyase class 1 (57%);Cryptochrome/DNA photolyase, FAD-binding domain (57%);DNA photolyase, N-terminal (57%),,,,,,,,,
DGSHAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.3.39 (93%);2.4.2.19 (3%);2.3.1.- (2%),4-hydroxy-2-oxovalerate aldolase (93%);Nicotinate-nucleotide diphosphorylase (carboxylating) (3%);Transferring groups other than amino-acyl groups (2%),GO:0005737 (8%);GO:0016021 (3%),cytoplasm (8%);integral component of membrane (3%),GO:0008701 (72%);GO:0030145 (70%);GO:0003700 (6%),4-hydroxy-2-oxovalerate aldolase activity (72%);manganese ion binding (70%);DNA-binding transcription factor activity (6%),GO:0019439 (71%);GO:0030490 (7%);GO:0009245 (2%),aromatic compound catabolic process (71%);maturation of SSU-rRNA (7%);lipid A biosynthetic process (2%),IPR013785 (56%);IPR000891 (54%);IPR017629 (52%),Aldolase-type TIM barrel (56%);Pyruvate carboxyltransferase (54%);4-hydroxy-2-oxovalerate aldolase (52%),,,,,,,,,,,
HLLENPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (44%);4.1.2.13 (33%);2.3.1.- (11%),DNA topoisomerase (ATP-hydrolyzing) (44%);Fructose-bisphosphate aldolase (33%);Transferring groups other than amino-acyl groups (11%),GO:0016021 (14%);GO:0005739 (12%);GO:0005886 (9%),integral component of membrane (14%);mitochondrion (12%);plasma membrane (9%),GO:0003697 (30%);GO:0003677 (28%);GO:0000150 (16%),single-stranded DNA binding (30%);DNA binding (28%);recombinase activity (16%),GO:0006260 (26%);GO:0006865 (9%);GO:0006096 (7%),DNA replication (26%);amino acid transport (9%);glycolytic process (7%),IPR006441 (50%);IPR000424 (15%);IPR011344 (15%),Bacteriophage P2, GpN, major capsid (50%);Primosome PriB/single-strand DNA-binding (15%);Single-stranded DNA-binding protein (15%),,,,,,,,,
CSVMDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0005524 (100%);GO:0016887 (100%);GO:0042626 (50%),ATP binding (100%);ATPase activity (100%);ATPase-coupled transmembrane transporter activity (50%),,,IPR003439 (60%);IPR003593 (60%);IPR027417 (60%),ABC transporter-like (60%);AAA+ ATPase domain (60%);P-loop containing nucleoside triphosphate hydrolase (60%),,,,,,,,,,,
ALLDTNDSHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EADMNPAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TWLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.34 (55%);3.4.24.- (21%);3.6.4.13 (12%),tRNA (guanosine(18)-2'-O)-methyltransferase (55%);Metalloendopeptidases (21%);RNA helicase (12%),GO:0016021 (20%);GO:0030288 (4%);GO:0005886 (1%),integral component of membrane (20%);outer membrane-bounded periplasmic space (4%);plasma membrane (1%),GO:0003677 (31%);GO:0016987 (27%);GO:0003700 (24%),DNA binding (31%);sigma factor activity (27%);DNA-binding transcription factor activity (24%),GO:0006352 (24%);GO:0002938 (11%);GO:0015074 (2%),DNA-templated transcription, initiation (24%);tRNA guanine ribose methylation (11%);DNA integration (2%),IPR036388 (25%);IPR007627 (24%);IPR013325 (24%),Winged helix-like DNA-binding domain superfamily (25%);RNA polymerase sigma-70 region 2 (24%);RNA polymerase sigma factor, region 2 (24%),,,,,,,,,
AAAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (10%);5.6.2.2 (8%);7.1.2.2 (5%),DNA topoisomerase (10%);DNA topoisomerase (ATP-hydrolyzing) (8%);H(+)-transporting two-sector ATPase (5%),GO:0016021 (13%);GO:0000786 (13%);GO:0005634 (10%),integral component of membrane (13%);nucleosome (13%);nucleus (10%),GO:0003677 (23%);GO:0005524 (10%);GO:0003824 (9%),DNA binding (23%);ATP binding (10%);catalytic activity (9%),GO:0006334 (13%);GO:0006412 (8%);GO:0009250 (5%),nucleosome assembly (13%);translation (8%);glucan biosynthetic process (5%),IPR005819 (11%);IPR036388 (8%);IPR036390 (8%),Histone H5 (11%);Winged helix-like DNA-binding domain superfamily (8%);Winged helix DNA-binding domain superfamily (8%),,,,,,,,,,,
WMFLPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (100%),Hydron translocation or charge separation linked to oxidoreductase reactions (100%),GO:0016021 (33%),integral component of membrane (33%),GO:0003824 (33%);GO:0004252 (33%);GO:0008137 (33%),catalytic activity (33%);serine-type endopeptidase activity (33%);NADH dehydrogenase (ubiquinone) activity (33%),,,IPR000914 (25%);IPR001949 (25%);IPR007197 (25%),Solute-binding protein family 5 domain (25%);NADH:ubiquinone oxidoreductase, 51kDa subunit, conserved site (25%);Radical SAM (25%),,,,,,,,,
NWAMNNSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTSVMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMGGGVPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QEQPEMMAWAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVYSHSAHHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WAPVFCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGQLHM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GAHYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (50%);6.3.4.14 (38%);6.4.1.2 (38%),L-aspartate oxidase (50%);Biotin carboxylase (38%);Acetyl-CoA carboxylase (38%),GO:0016021 (18%);GO:0005737 (11%);GO:0005886 (8%),integral component of membrane (18%);cytoplasm (11%);plasma membrane (8%),GO:0008270 (13%);GO:0003677 (11%);GO:0008237 (11%),zinc ion binding (13%);DNA binding (11%);metallopeptidase activity (11%),GO:0009085 (11%);GO:0009435 (11%);GO:0006633 (8%),lysine biosynthetic process (11%);NAD biosynthetic process (11%);fatty acid biosynthetic process (8%),IPR029058 (19%);IPR013744 (17%);IPR029063 (10%),Alpha/Beta hydrolase fold (19%);Fusarinine C esterase SidJ (17%);S-adenosyl-L-methionine-dependent methyltransferase (10%),,,,,,,,,,,
EEFENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.8 (19%);5.2.1.8 (15%);2.1.2.2 (12%),Guanylate kinase (19%);Peptidylprolyl isomerase (15%);Phosphoribosylglycinamide formyltransferase (12%),GO:0016021 (20%);GO:0005737 (11%);GO:0005815 (7%),integral component of membrane (20%);cytoplasm (11%);microtubule organizing center (7%),GO:0005524 (22%);GO:0004385 (4%);GO:0016787 (4%),ATP binding (22%);guanylate kinase activity (4%);hydrolase activity (4%),GO:0019062 (6%);GO:0039663 (6%);GO:0001522 (2%),virion attachment to host cell (6%);membrane fusion involved in viral entry into host cell (6%);pseudouridine synthesis (2%),IPR027417 (10%);IPR012943 (5%);IPR024545 (5%),P-loop containing nucleoside triphosphate hydrolase (10%);Centrosomin, N-terminal motif 1 (5%);Mto2p-binding domain (5%),,,,,,,,,,
NYSCDHLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVHNAFK,Myomorpha,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Rodentia,Myomorpha,,,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),GO:0004930 (100%);GO:0004984 (100%);GO:0005549 (67%),G protein-coupled receptor activity (100%);olfactory receptor activity (100%);odorant binding (67%),GO:0007186 (67%);GO:0007608 (67%),G protein-coupled receptor signaling pathway (67%);sensory perception of smell (67%),IPR000276 (100%);IPR000725 (100%);IPR017452 (100%),G protein-coupled receptor, rhodopsin-like (100%);Olfactory receptor (100%);GPCR, rhodopsin-like, 7TM (100%),,,,,,,,
EDQPLPPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005525 (100%),GTP binding (100%),,,IPR006073 (100%);IPR021147 (100%);IPR027417 (100%),GTP binding domain (100%);Protein of unknown function DUF697 (100%);P-loop containing nucleoside triphosphate hydrolase (100%),,,,,,,,,,,
VYMMEMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQPNMFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGPHLYK,Massilia sp. SOD,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Oxalobacteraceae,,,,Massilia,,,,Massilia sp. SOD,,,,,,,,GO:0004725 (100%);GO:0008138 (100%),protein tyrosine phosphatase activity (100%);protein tyrosine/serine/threonine phosphatase activity (100%),,,IPR000340 (100%);IPR000387 (100%);IPR016130 (100%),Dual specificity phosphatase, catalytic domain (100%);Tyrosine specific protein phosphatases domain (100%);Protein-tyrosine phosphatase, active site (100%),,,,,,,,,
FTDQLLLPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THMMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.16.3.2 (65%);2.3.3.8 (29%);6.1.1.20 (6%),Bacterial non-heme ferritin (65%);ATP citrate synthase (29%);Phenylalanine--tRNA ligase (6%),GO:0005737 (20%);GO:0005623 (12%);GO:0016021 (9%),cytoplasm (20%);cell (12%);integral component of membrane (9%),GO:0003676 (31%);GO:0005524 (31%);GO:0016887 (18%),nucleic acid binding (31%);ATP binding (31%);ATPase activity (18%),GO:0006826 (12%);GO:0006879 (12%);GO:0006085 (5%),iron ion transport (12%);cellular iron ion homeostasis (12%);acetyl-CoA biosynthetic process (5%),IPR013087 (30%);IPR036236 (27%);IPR027417 (25%),Zinc finger C2H2-type (30%);Zinc finger C2H2 superfamily (27%);P-loop containing nucleoside triphosphate hydrolase (25%),,,,,,,,,,,
VVAELQGRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CDLNGLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.13 (100%),UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (100%),GO:0005737 (50%),cytoplasm (50%),GO:0000287 (50%);GO:0005524 (50%);GO:0008765 (50%),magnesium ion binding (50%);ATP binding (50%);UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase activity (50%),GO:0007049 (50%);GO:0008360 (50%);GO:0009252 (50%),cell cycle (50%);regulation of cell shape (50%);peptidoglycan biosynthetic process (50%),IPR000713 (50%);IPR004101 (50%);IPR005761 (50%),Mur ligase, N-terminal catalytic domain (50%);Mur ligase, C-terminal (50%);UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase (50%),,,,,,
FAMLEAAEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDEWEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (11%);2.8.4.3 (11%);3.1.3.16 (11%),Hexosyltransferases (11%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (11%);Protein-serine/threonine phosphatase (11%),GO:0019013 (49%);GO:0042025 (49%);GO:0030430 (49%),viral nucleocapsid (49%);host cell nucleus (49%);host cell cytoplasm (49%),GO:0005198 (82%);GO:0008270 (50%);GO:0003723 (49%),structural molecule activity (82%);zinc ion binding (50%);RNA binding (49%),GO:0016032 (32%);GO:0039702 (29%);GO:0009405 (6%),viral process (32%);viral budding via host ESCRT complex (29%);pathogenesis (6%),IPR000071 (78%);IPR010999 (78%);IPR012344 (78%),Immunodeficiency lentiviral matrix, N-terminal (78%);Retroviral matrix protein (78%);Matrix protein, lentiviral and alpha-retroviral, N-terminal (78%),,,,,,,,
TLVFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.10 (47%);2.8.4.3 (30%);2.5.1.72 (7%),Formyltetrahydrofolate deformylase (47%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (30%);Quinolinate synthase (7%),GO:0016021 (23%);GO:0005737 (16%);GO:0005886 (5%),integral component of membrane (23%);cytoplasm (16%);plasma membrane (5%),GO:0046872 (13%);GO:0005524 (12%);GO:0008864 (12%),metal ion binding (13%);ATP binding (12%);formyltetrahydrofolate deformylase activity (12%),GO:0006189 (12%);GO:0006730 (12%);GO:0006400 (9%),'de novo' IMP biosynthetic process (12%);one-carbon metabolic process (12%);tRNA modification (9%),IPR010791 (18%);IPR023374 (18%);IPR006311 (15%),AttH domain (18%);AttH-like domain superfamily (18%);Twin-arginine translocation pathway, signal sequence (15%),,,,,,,,,,
MLCFTEK,Euryarchaeota archaeon,Archaea,,,,Euryarchaeota,,,,,,,,,,,,,,,,,,,,Euryarchaeota archaeon,,,,,,,,,,,,IPR000555 (100%);IPR028090 (100%);IPR037518 (100%),JAB1/MPN/MOV34 metalloenzyme domain (100%);JAB domain, prokaryotic (100%);MPN domain (100%),,,,,,,,,,
TAHAVPPPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPFPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.22 (35%);6.1.1.23 (11%);6.1.1.12 (9%),Asparagine--tRNA ligase (35%);Aspartate--tRNA(Asn) ligase (11%);Aspartate--tRNA ligase (9%),GO:0016021 (32%);GO:0005737 (10%);GO:0005669 (5%),integral component of membrane (32%);cytoplasm (10%);transcription factor TFIID complex (5%),GO:0005524 (26%);GO:0003777 (11%);GO:0008017 (10%),ATP binding (26%);microtubule motor activity (11%);microtubule binding (10%),GO:0007018 (11%);GO:0006421 (5%);GO:0006422 (3%),microtubule-based movement (11%);asparaginyl-tRNA aminoacylation (5%);aspartyl-tRNA aminoacylation (3%),IPR027417 (15%);IPR027640 (10%);IPR032405 (10%),P-loop containing nucleoside triphosphate hydrolase (15%);Kinesin-like protein (10%);Kinesin-associated (10%),,,,,,,,,,,
DTLLWSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0016021 (50%),integral component of membrane (50%),GO:0016491 (50%);GO:0003677 (25%);GO:0003887 (25%),oxidoreductase activity (50%);DNA binding (25%);DNA-directed DNA polymerase activity (25%),GO:0006261 (25%);GO:0006281 (25%),DNA-dependent DNA replication (25%);DNA repair (25%),IPR006076 (50%);IPR036188 (50%);IPR000330 (25%),FAD dependent oxidoreductase (50%);FAD/NAD(P)-binding domain superfamily (50%);SNF2-related, N-terminal domain (25%),,,,,,,,,,
FNPEPDEGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGDQEYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNMELMHVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HCMSDETGSVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QSGTEER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.3 (100%),Ornithine carbamoyltransferase (100%),GO:0016021 (27%);GO:0005743 (23%);GO:0005737 (5%),integral component of membrane (27%);mitochondrial inner membrane (23%);cytoplasm (5%),GO:0004725 (64%);GO:0015187 (23%);GO:0016597 (14%),protein tyrosine phosphatase activity (64%);glycine transmembrane transporter activity (23%);amino acid binding (14%),GO:1904983 (23%);GO:0006520 (5%),glycine import into mitochondrion (23%);cellular amino acid metabolic process (5%),IPR000242 (64%);IPR000387 (64%);IPR003595 (64%),PTP type protein phosphatase (64%);Tyrosine specific protein phosphatases domain (64%);Protein-tyrosine phosphatase, catalytic (64%),,,,,,,,,,
ALMNAFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (43%);GO:0005634 (14%);GO:0005669 (14%),integral component of membrane (43%);nucleus (14%);transcription factor TFIID complex (14%),GO:0017025 (43%);GO:0003743 (29%);GO:0046872 (29%),TBP-class protein binding (43%);translation initiation factor activity (29%);metal ion binding (29%),GO:0006355 (29%);GO:0070897 (29%);GO:0001174 (14%),regulation of transcription, DNA-templated (29%);transcription preinitiation complex assembly (29%);transcriptional start site selection at RNA polymerase II promoter (14%),IPR000812 (50%);IPR013150 (50%);IPR013763 (50%),Transcription factor TFIIB (50%);Transcription factor TFIIB, cyclin-like domain (50%);Cyclin-like (50%),,,,,,,,,
QWWQFQDDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNVSVLCRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEKPNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (67%);2.7.7.59 (33%);3.1.4.- (33%),DNA-directed DNA polymerase (67%);[Protein-PII] uridylyltransferase (33%);Phosphoric diester hydrolases (33%),GO:0005634 (24%);GO:0016021 (24%);GO:0005829 (12%),nucleus (24%);integral component of membrane (24%);cytosol (12%),GO:0005524 (24%);GO:0008233 (18%);GO:0000166 (12%),ATP binding (24%);peptidase activity (18%);nucleotide binding (12%),GO:0006260 (12%);GO:0006807 (12%);GO:0019985 (12%),DNA replication (12%);nitrogen compound metabolic process (12%);translesion synthesis (12%),IPR004176 (12%);IPR012461 (12%);IPR027417 (12%),Clp, N-terminal (12%);FAM83, N-terminal (12%);P-loop containing nucleoside triphosphate hydrolase (12%),,,,,,,,,
NTMFLMVYPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCLAGLK,Desulfobacula phenolica,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Desulfobacterales,,,,,Desulfobacteraceae,,,,Desulfobacula,,,,Desulfobacula phenolica,,,,,,,,GO:0003676 (100%);GO:0008409 (100%),nucleic acid binding (100%);5'-3' exonuclease activity (100%),GO:0006281 (100%);GO:0006310 (100%),DNA repair (100%);DNA recombination (100%),IPR001667 (100%);IPR003156 (100%);IPR004610 (100%),DDH domain (100%);DHHA1 domain (100%);Bacterial RecJ exonuclease (100%),,,,,,,,,,,
TLGDSMM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPFVHPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMTHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.2 (25%);2.1.1.107 (15%);1.4.1.3 (5%),CTP synthase (glutamine hydrolyzing) (25%);Uroporphyrinogen-III C-methyltransferase (15%);Glutamate dehydrogenase (NAD(P)(+)) (5%),GO:0016021 (27%);GO:0005737 (7%);GO:0005634 (2%),integral component of membrane (27%);cytoplasm (7%);nucleus (2%),GO:0005524 (14%);GO:0003676 (11%);GO:0016407 (8%),ATP binding (14%);nucleic acid binding (11%);acetyltransferase activity (8%),GO:0006541 (6%);GO:0044210 (6%);GO:0009190 (5%),glutamine metabolic process (6%);'de novo' CTP biosynthetic process (6%);cyclic nucleotide biosynthetic process (5%),IPR027417 (9%);IPR012337 (7%);IPR036397 (7%),P-loop containing nucleoside triphosphate hydrolase (9%);Ribonuclease H-like superfamily (7%);Ribonuclease H superfamily (7%),,,,,,,,,,,
CLSPGVDWDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FQHSM,Selaginella moellendorffii,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Lycopodiopsida,,,,Selaginellales,,,,,Selaginellaceae,,,,Selaginella,,,,Selaginella moellendorffii,,,,,,,,,,,,IPR000648 (100%);IPR001849 (100%);IPR037239 (100%),Oxysterol-binding protein (100%);Pleckstrin homology domain (100%);Oxysterol-binding protein superfamily (100%),,,,,,,,,,,
NQCHFMDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAPSNDGEVC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAFESHMLPNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPPLFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.5.2 (100%),Dihydroorotate dehydrogenase (quinone) (100%),GO:0016021 (25%);GO:0005737 (13%);GO:0005886 (13%),integral component of membrane (25%);cytoplasm (13%);plasma membrane (13%),GO:0003964 (25%);GO:0003824 (13%);GO:0004152 (13%),RNA-directed DNA polymerase activity (25%);catalytic activity (13%);dihydroorotate dehydrogenase activity (13%),GO:0006207 (13%);GO:0044205 (13%);GO:0055114 (13%),'de novo' pyrimidine nucleobase biosynthetic process (13%);'de novo' UMP biosynthetic process (13%);oxidation-reduction process (13%),IPR003737 (30%);IPR024078 (30%);IPR029062 (30%),N-acetylglucosaminyl phosphatidylinositol deacetylase-related (30%);Putative deacetylase LmbE-like domain superfamily (30%);Class I glutamine amidotransferase-like (30%),,,,,,,,,,,
APEEPWPDQWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VWMLSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYGMEQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTQPTHK,Jiangella ureilytica,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Jiangellales,,,,,Jiangellaceae,,,,Jiangella,,,,Jiangella ureilytica,,,,,,,,,,,,,,,,,,,,,,,,
TPLGQAHMSDAGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPMDAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.9 (100%),Methionyl-tRNA formyltransferase (100%),GO:0070449 (20%),elongin complex (20%),GO:0004479 (60%);GO:0004674 (20%);GO:0005524 (20%),methionyl-tRNA formyltransferase activity (60%);protein serine/threonine kinase activity (20%);ATP binding (20%),GO:0000184 (20%);GO:0006357 (20%),nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (20%);regulation of transcription by RNA polymerase II (20%),IPR001555 (38%);IPR002376 (38%);IPR005793 (38%),Phosphoribosylglycinamide formyltransferase, active site (38%);Formyl transferase, N-terminal (38%);Formyl transferase, C-terminal (38%),,,,,,,
QNVAHEK,Fructobacillus fructosus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Lactobacillales,,,,,Leuconostocaceae,,,,Fructobacillus,,,,Fructobacillus fructosus,,,,,,,,,,,,,,,,,,,,,,,,
WFVDCGANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDADTYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%);GO:0005634 (30%),integral component of membrane (60%);nucleus (30%),GO:0008568 (30%);GO:0016887 (30%);GO:0008410 (20%),microtubule-severing ATPase activity (30%);ATPase activity (30%);CoA-transferase activity (20%),GO:0007160 (50%);GO:0010569 (30%);GO:0031122 (30%),cell-matrix adhesion (50%);regulation of double-strand break repair via homologous recombination (30%);cytoplasmic microtubule organization (30%),IPR005533 (55%);IPR003886 (45%);IPR003673 (18%),AMOP domain (55%);NIDO domain (45%);CoA-transferase family III (18%),,,,,,,,,,,
ESDMVPR,Pyronema omphalodes,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Pezizomycetes,,,,Pezizales,,,,,Pyronemataceae,,,,Pyronema,,,,Pyronema omphalodes,,,,,,GO:0031461 (100%),cullin-RING ubiquitin ligase complex (100%),GO:0031625 (100%),ubiquitin protein ligase binding (100%),GO:0006511 (100%),ubiquitin-dependent protein catabolic process (100%),IPR001373 (100%);IPR016157 (100%);IPR016158 (100%),Cullin, N-terminal (100%);Cullin, conserved site (100%);Cullin homology domain (100%),,,,,,,,,
MLEHMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.4 (24%);1.3.99.1 (18%);3.2.1.- (18%),Ribonuclease H (24%);Deleted entry (18%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (18%),GO:0016021 (27%);GO:0005737 (12%);GO:0016020 (5%),integral component of membrane (27%);cytoplasm (12%);membrane (5%),GO:0050660 (20%);GO:0016627 (17%);GO:0000287 (10%),flavin adenine dinucleotide binding (20%);oxidoreductase activity, acting on the CH-CH group of donors (17%);magnesium ion binding (10%),GO:0022900 (19%);GO:0006401 (7%);GO:0008152 (5%),electron transport chain (19%);RNA catabolic process (7%);metabolic process (5%),IPR036188 (24%);IPR003953 (17%);IPR014006 (17%),FAD/NAD(P)-binding domain superfamily (24%);FAD-dependent oxidoreductase 2, FAD binding domain (17%);Succinate dehydrogenase/fumarate reductase, flavoprotein subunit (17%),,,,,,,
WNGNMLVMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPPGFAAAPQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGPAMHSAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETDVAPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNNYELTYSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVTNTFLPCFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GFVDVPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVLPAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.5 (93%);2.3.1.269 (7%),Exodeoxyribonuclease V (93%);Apolipoprotein N-acyltransferase (7%),GO:0016021 (16%);GO:0009338 (10%);GO:0005886 (1%),integral component of membrane (16%);exodeoxyribonuclease V complex (10%);plasma membrane (1%),GO:0003677 (52%);GO:0003824 (15%);GO:0050662 (15%),DNA binding (52%);catalytic activity (15%);coenzyme binding (15%),GO:0006310 (41%);GO:0015074 (37%);GO:0000724 (10%),DNA recombination (41%);DNA integration (37%);double-strand break repair via homologous recombination (10%),IPR002104 (29%);IPR011010 (29%);IPR013762 (29%),Integrase, catalytic domain (29%);DNA breaking-rejoining enzyme, catalytic core (29%);Integrase-like, catalytic domain superfamily (29%),,,,,,,,
MMELLNMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DQWENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0004197 (50%);GO:0003723 (25%);GO:0005042 (25%),cysteine-type endopeptidase activity (50%);RNA binding (25%);netrin receptor activity (25%),GO:0032259 (25%),methylation (25%),IPR001309 (33%);IPR002138 (33%);IPR002398 (33%),Peptidase C14,  p20 domain (33%);Peptidase C14, caspase non-catalytic subunit p10 (33%);Peptidase C14 family (33%),,,,,,,,,
MARPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.37 (65%);2.7.7.41 (4%);6.3.4.2 (3%),Malate dehydrogenase (65%);Phosphatidate cytidylyltransferase (4%);CTP synthase (glutamine hydrolyzing) (3%),GO:0016021 (25%);GO:0005737 (3%);GO:0005634 (3%),integral component of membrane (25%);cytoplasm (3%);nucleus (3%),GO:0003677 (37%);GO:0005242 (13%);GO:0030060 (12%),DNA binding (37%);inward rectifier potassium channel activity (13%);L-malate dehydrogenase activity (12%),GO:0034765 (14%);GO:0006099 (12%);GO:0019752 (11%),regulation of ion transmembrane transport (14%);tricarboxylic acid cycle (12%);carboxylic acid metabolic process (11%),IPR009057 (23%);IPR001647 (21%);IPR023772 (12%),Homeobox-like domain superfamily (23%);DNA-binding HTH domain, TetR-type (21%);DNA-binding HTH domain, TetR-type, conserved site (12%),,,,,,,,
YQVNAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (19%);3.6.1.15 (19%);3.4.22.28 (19%),RNA-directed RNA polymerase (19%);Nucleoside-triphosphate phosphatase (19%);Picornain 3C (19%),GO:0016021 (24%);GO:0042025 (8%);GO:0030430 (8%),integral component of membrane (24%);host cell nucleus (8%);host cell cytoplasm (8%),GO:0005524 (22%);GO:0003723 (19%);GO:0003677 (8%),ATP binding (22%);RNA binding (19%);DNA binding (8%),GO:0039540 (13%);GO:0039502 (8%);GO:0039524 (8%),suppression by virus of host RIG-I activity (13%);suppression by virus of host type I interferon-mediated signaling pathway (8%);suppression by virus of host mRNA processing (8%),IPR027417 (16%);IPR003593 (8%);IPR000256 (7%),P-loop containing nucleoside triphosphate hydrolase (16%);AAA+ ATPase domain (8%);Influenza A virus NS1 protein (7%),,,,,,,,,,,
VDNNWDQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNYSSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.32 (8%);2.8.4.3 (6%);2.6.1.36 (5%),Phosphoenolpyruvate carboxykinase (GTP) (8%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (6%);L-lysine 6-transaminase (5%),GO:0016021 (22%);GO:0005737 (7%);GO:0019028 (3%),integral component of membrane (22%);cytoplasm (7%);viral capsid (3%),GO:0005524 (14%);GO:0003677 (8%);GO:0046872 (8%),ATP binding (14%);DNA binding (8%);metal ion binding (8%),GO:0017000 (3%);GO:0042026 (2%);GO:0006355 (2%),antibiotic biosynthetic process (3%);protein refolding (2%);regulation of transcription, DNA-templated (2%),IPR027417 (9%);IPR001676 (3%);IPR004080 (3%),P-loop containing nucleoside triphosphate hydrolase (9%);Picornavirus capsid (3%);Foot-and-mouth disease virus VP1 coat (3%),,,,,,,,,,
DVCGDPR,Chromera velia,Eukaryota,,,,,,,,,,,,,,,,Chromeraceae,,,,Chromera,,,,Chromera velia,,,,,,,,GO:0003777 (100%);GO:0005524 (100%),microtubule motor activity (100%);ATP binding (100%),GO:0007018 (100%),microtubule-based movement (100%),IPR003593 (100%);IPR013602 (100%);IPR024317 (100%),AAA+ ATPase domain (100%);Dynein heavy chain, domain-2 (100%);Dynein heavy chain, AAA module D4 (100%),,,,,,,,,
EPNGVWEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDWHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.4 (25%);6.3.1.1 (19%);1.8.1.7 (13%),Glucosamine-phosphate N-acetyltransferase (25%);Aspartate--ammonia ligase (19%);Glutathione-disulfide reductase (13%),GO:0016021 (20%);GO:0005737 (11%);GO:0005623 (3%),integral component of membrane (20%);cytoplasm (11%);cell (3%),GO:0003677 (17%);GO:0016987 (11%);GO:0003700 (10%),DNA binding (17%);sigma factor activity (11%);DNA-binding transcription factor activity (10%),GO:0055085 (10%);GO:0001123 (8%);GO:0009253 (6%),transmembrane transport (10%);transcription initiation from bacterial-type RNA polymerase promoter (8%);peptidoglycan catabolic process (6%),IPR023213 (12%);IPR000873 (11%);IPR001242 (11%),Chloramphenicol acetyltransferase-like domain superfamily (12%);AMP-dependent synthetase/ligase (11%);Condensation domain (11%),,,,,,,,,,,
FVVLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.3 (81%);2.7.4.1 (13%);5.2.1.8 (2%),Phosphoribosylformylglycinamidine synthase (81%);Polyphosphate kinase (13%);Peptidylprolyl isomerase (2%),GO:0005737 (43%);GO:0016021 (17%);GO:0009358 (6%),cytoplasm (43%);integral component of membrane (17%);polyphosphate kinase complex (6%),GO:0005524 (55%);GO:0046872 (51%);GO:0004642 (42%),ATP binding (55%);metal ion binding (51%);phosphoribosylformylglycinamidine synthase activity (42%),GO:0006189 (42%);GO:0006541 (42%);GO:0006313 (7%),'de novo' IMP biosynthetic process (42%);glutamine metabolic process (42%);transposition, DNA-mediated (7%),IPR036604 (38%);IPR040707 (38%);IPR010073 (38%),Phosphoribosylformylglycinamidine synthase subunit PurS-like superfamily (38%);Phosphoribosylformylglycinamidine synthase, N-terminal (38%);Phosphoribosylformylglycinamidine synthase PurL (38%),,,,,,,,,
DVVVMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.22 (100%),UDP-glucose 6-dehydrogenase (100%),GO:0016021 (75%),integral component of membrane (75%),GO:0005524 (83%);GO:0004674 (75%);GO:0003824 (8%),ATP binding (83%);protein serine/threonine kinase activity (75%);catalytic activity (8%),GO:0000271 (8%),polysaccharide biosynthetic process (8%),IPR000719 (75%);IPR001611 (75%);IPR008271 (75%),Protein kinase domain (75%);Leucine-rich repeat (75%);Serine/threonine-protein kinase, active site (75%),,,,,,,,,,
MTDLLPECTPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTQTDLTNGNAFFDGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMGGSNGMVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVVMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.20 (20%);3.6.3.- (18%);7.6.2.11 (11%),Transferred entry: 7.6.2.10 (20%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (18%);ABC-type polyamine transporter (11%),GO:0016021 (9%);GO:0043190 (8%);GO:0005886 (3%),integral component of membrane (9%);ATP-binding cassette (ABC) transporter complex (8%);plasma membrane (3%),GO:0005524 (83%);GO:0016887 (76%);GO:0022857 (7%),ATP binding (83%);ATPase activity (76%);transmembrane transporter activity (7%),GO:0008643 (3%);GO:0015833 (2%);GO:0046856 (1%),carbohydrate transport (3%);peptide transport (2%);phosphatidylinositol dephosphorylation (1%),IPR027417 (79%);IPR003439 (77%);IPR003593 (77%),P-loop containing nucleoside triphosphate hydrolase (79%);ABC transporter-like (77%);AAA+ ATPase domain (77%),,,,,,,,,,,
EPTLTVAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNNDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.6 (72%);6.1.1.22 (17%);2.3.2.31 (6%),Exodeoxyribonuclease VII (72%);Asparagine--tRNA ligase (17%);RBR-type E3 ubiquitin transferase (6%),GO:0016021 (33%);GO:0005737 (28%);GO:0009318 (21%),integral component of membrane (33%);cytoplasm (28%);exodeoxyribonuclease VII complex (21%),GO:0003676 (23%);GO:0008855 (21%);GO:0003779 (11%),nucleic acid binding (23%);exodeoxyribonuclease VII activity (21%);actin binding (11%),GO:0006308 (21%);GO:0006355 (5%);GO:0006421 (5%),DNA catabolic process (21%);regulation of transcription, DNA-templated (5%);asparaginyl-tRNA aminoacylation (5%),IPR003753 (21%);IPR020579 (21%);IPR025824 (21%),Exonuclease VII, large subunit (21%);Exonuclease VII, large subunit, C-terminal (21%);OB-fold nucleic acid binding domain (21%),,,,,,,
MVLLQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.25 (19%);4.2.3.3 (15%);1.6.99.- (12%),(d)CMP kinase (19%);Methylglyoxal synthase (15%);With other acceptors (12%),GO:0016021 (23%);GO:0005737 (2%);GO:0016020 (2%),integral component of membrane (23%);cytoplasm (2%);membrane (2%),GO:0003824 (33%);GO:0016829 (10%);GO:0003677 (5%),catalytic activity (33%);lyase activity (10%);DNA binding (5%),GO:0006813 (3%);GO:0006220 (2%);GO:0019242 (1%),potassium ion transport (3%);pyrimidine nucleotide metabolic process (2%);methylglyoxal biosynthetic process (1%),IPR009651 (38%);IPR015421 (38%);IPR015424 (38%),Putative methionine gamma-lyase (38%);Pyridoxal phosphate-dependent transferase, major domain (38%);Pyridoxal phosphate-dependent transferase (38%),,,,,,,,,,
TLYFLLCPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDVENPQPPYEHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYMLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.65 (50%);3.4.11.18 (50%),Diguanylate cyclase (50%);Methionyl aminopeptidase (50%),GO:0016021 (88%),integral component of membrane (88%),GO:0016740 (12%);GO:0003677 (8%);GO:0004497 (4%),transferase activity (12%);DNA binding (8%);monooxygenase activity (4%),GO:0006313 (4%);GO:0007165 (4%);GO:0070084 (4%),transposition, DNA-mediated (4%);signal transduction (4%);protein initiator methionine removal (4%),IPR007360 (57%);IPR003362 (11%);IPR005115 (7%),Invasion gene expression up-regulator, SirB (57%);Bacterial sugar transferase (11%);Uncharacterised domain UPF0126 (7%),,,,,,,,,
DPDSVSMFSTHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VQNPDVER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QWNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.1 (75%);3.1.1.96 (5%);2.7.7.6 (4%),Transketolase (75%);D-aminoacyl-tRNA deacylase (5%);DNA-directed RNA polymerase (4%),GO:0016021 (41%);GO:0005886 (5%);GO:0005737 (4%),integral component of membrane (41%);plasma membrane (5%);cytoplasm (4%),GO:0005524 (32%);GO:0046872 (29%);GO:0004802 (23%),ATP binding (32%);metal ion binding (29%);transketolase activity (23%),GO:0006468 (4%);GO:0015074 (3%);GO:0000462 (2%),protein phosphorylation (4%);DNA integration (3%);maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (2%),IPR000719 (22%);IPR008271 (22%);IPR011009 (22%),Protein kinase domain (22%);Serine/threonine-protein kinase, active site (22%);Protein kinase-like domain superfamily (22%),,,,,,,,
MCYSPENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QFYYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.6.1 (100%),Nitrate reductase (cytochrome) (100%),GO:0005576 (25%);GO:0008622 (25%),extracellular region (25%);epsilon DNA polymerase complex (25%),GO:0003677 (75%);GO:0003887 (25%);GO:0005506 (25%),DNA binding (75%);DNA-directed DNA polymerase activity (25%);iron ion binding (25%),GO:0006261 (25%);GO:0006777 (25%);GO:0042128 (25%),DNA-dependent DNA replication (25%);Mo-molybdopterin cofactor biosynthetic process (25%);nitrate assimilation (25%),IPR000523 (22%);IPR000600 (22%);IPR004482 (22%),Magnesium chelatase ChlI domain (22%);ROK family (22%);Mg chelatase-related protein (22%),,,,,,,,,,,
YYMAVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QWHEESLDDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAGQTM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNYGQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%),integral component of membrane (60%),GO:0016853 (60%);GO:0016740 (20%),isomerase activity (60%);transferase activity (20%),,,IPR011990 (75%);IPR013026 (75%);IPR019734 (75%),Tetratricopeptide-like helical domain superfamily (75%);Tetratricopeptide repeat-containing domain (75%);Tetratricopeptide repeat (75%),,,,,,,,,,,
MNLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.2.2 (15%);5.6.2.2 (8%);3.4.21.92 (6%),H(+)-transporting two-sector ATPase (15%);DNA topoisomerase (ATP-hydrolyzing) (8%);Endopeptidase Clp (6%),GO:0016021 (34%);GO:0005886 (6%);GO:0005737 (6%),integral component of membrane (34%);plasma membrane (6%);cytoplasm (6%),GO:0003677 (21%);GO:0003700 (11%);GO:0005524 (10%),DNA binding (21%);DNA-binding transcription factor activity (11%);ATP binding (10%),GO:0045893 (9%);GO:0006813 (2%);GO:0015986 (2%),positive regulation of transcription, DNA-templated (9%);potassium ion transport (2%);ATP synthesis coupled proton transport (2%),IPR009061 (12%);IPR000551 (12%);IPR015358 (12%),Putative DNA-binding domain superfamily (12%);MerR-type HTH domain (12%);Transcription regulator MerR, DNA binding (12%),,,,,,,,,
NLPSCQAR,Shewanella loihica,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Alteromonadales,,,,,Shewanellaceae,,,,Shewanella,,,,Shewanella loihica,,,,,,GO:0005737 (100%),cytoplasm (100%),GO:0003700 (100%);GO:0043565 (100%),DNA-binding transcription factor activity (100%);sequence-specific DNA binding (100%),,,IPR003313 (100%);IPR009057 (100%);IPR018060 (100%),AraC-type arabinose-binding/dimerisation domain (100%);Homeobox-like domain superfamily (100%);DNA binding HTH domain, AraC-type (100%),,,,,,,,,,
ALLTGPDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLWMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.- (60%);2.1.1.191 (20%);2.7.7.7 (20%),Acting on acid anhydrides; catalyzing transmembrane movement of substances (60%);23S rRNA (cytosine(1962)-C(5))-methyltransferase (20%);DNA-directed DNA polymerase (20%),GO:0005576 (25%);GO:0016021 (11%);GO:0005737 (7%),extracellular region (25%);integral component of membrane (11%);cytoplasm (7%),GO:0005524 (29%);GO:0016887 (29%);GO:0030414 (25%),ATP binding (29%);ATPase activity (29%);peptidase inhibitor activity (25%),GO:0006801 (18%);GO:0006364 (7%);GO:0032259 (7%),superoxide metabolic process (18%);rRNA processing (7%);methylation (7%),IPR003599 (34%);IPR013098 (34%);IPR013783 (34%),Immunoglobulin subtype (34%);Immunoglobulin I-set (34%);Immunoglobulin-like fold (34%),,,,,,,,,,,
DNEEATNSGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVCLLLEVGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGNAKPVVMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.2 (28%);2.7.7.7 (5%);3.6.4.- (4%),Aspartate carbamoyltransferase (28%);DNA-directed DNA polymerase (5%);Acting on ATP; involved in cellular and subcellular movement (4%),GO:0016021 (22%);GO:0005737 (4%);GO:0016607 (3%),integral component of membrane (22%);cytoplasm (4%);nuclear speck (3%),GO:0003677 (12%);GO:0005524 (11%);GO:0003723 (9%),DNA binding (12%);ATP binding (11%);RNA binding (9%),GO:0045892 (6%);GO:0000381 (5%);GO:0044205 (4%),negative regulation of transcription, DNA-templated (6%);regulation of alternative mRNA splicing, via spliceosome (5%);'de novo' UMP biosynthetic process (4%),IPR016024 (10%);IPR008383 (9%);IPR027417 (7%),Armadillo-type fold (10%);Apoptosis inhibitory 5 (9%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,
FLFAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.40 (100%),Pyruvate kinase (100%),GO:0016021 (5%),integral component of membrane (5%),GO:0003677 (19%);GO:0003887 (19%);GO:0004781 (14%),DNA binding (19%);DNA-directed DNA polymerase activity (19%);sulfate adenylyltransferase (ATP) activity (14%),GO:0000493 (33%);GO:0006270 (19%);GO:0006260 (5%),box H/ACA snoRNP assembly (33%);DNA replication initiation (19%);DNA replication (5%),IPR008978 (26%);IPR039742 (26%);IPR007052 (19%),HSP20-like chaperone (26%);Protein Shq1 (26%);CS domain (19%),,,,,,,,,,,
DMLEVEVAPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAPQENDVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQEMWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0003676 (50%);GO:0003779 (25%);GO:0004523 (25%),nucleic acid binding (50%);actin binding (25%);RNA-DNA hybrid ribonuclease activity (25%),,,IPR027417 (36%);IPR029006 (27%);IPR038729 (27%),P-loop containing nucleoside triphosphate hydrolase (36%);ADF-H/Gelsolin-like domain superfamily (27%);Rad50/SbcC-type AAA domain (27%),,,,,,,,,,,
YSAVASPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALPVAMSNLATLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMLHLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.269 (100%),Apolipoprotein N-acyltransferase (100%),GO:0016021 (33%);GO:0005840 (17%);GO:0005886 (17%),integral component of membrane (33%);ribosome (17%);plasma membrane (17%),GO:0003676 (17%);GO:0003735 (17%);GO:0008270 (17%),nucleic acid binding (17%);structural constituent of ribosome (17%);zinc ion binding (17%),GO:0006412 (17%);GO:0042158 (17%),translation (17%);lipoprotein biosynthetic process (17%),IPR000917 (17%);IPR001173 (17%);IPR001878 (17%),Sulfatase, N-terminal (17%);Glycosyltransferase 2-like (17%);Zinc finger, CCHC-type (17%),,,,,,,,,
VEAVMFMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYPTFSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WCYDVFVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMALGTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEGMDYMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QWEEEAAHASTEEAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVVSAMLLTQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPMPVDLLDLYPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YDLELYMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (19%);6.3.3.2 (8%);2.7.7.6 (6%),Acting on ester bonds (19%);5-formyltetrahydrofolate cyclo-ligase (8%);DNA-directed RNA polymerase (6%),GO:0016021 (31%);GO:0005886 (4%);GO:0005737 (4%),integral component of membrane (31%);plasma membrane (4%);cytoplasm (4%),GO:0003677 (13%);GO:0005524 (12%);GO:0046872 (7%),DNA binding (13%);ATP binding (12%);metal ion binding (7%),GO:0006520 (6%);GO:0043571 (3%);GO:0051607 (3%),cellular amino acid metabolic process (6%);maintenance of CRISPR repeat elements (3%);defense response to virus (3%),IPR027417 (8%);IPR036291 (6%);IPR006097 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);NAD(P)-binding domain superfamily (6%);Glutamate/phenylalanine/leucine/valine dehydrogenase, dimerisation domain (5%),,,,,,,,,,
MGNVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (27%);GO:0016020 (7%),integral component of membrane (27%);membrane (7%),GO:0016740 (13%);GO:0000155 (7%);GO:0003677 (7%),transferase activity (13%);phosphorelay sensor kinase activity (7%);DNA binding (7%),GO:0000160 (7%);GO:0006355 (7%);GO:0006487 (7%),phosphorelay signal transduction system (7%);regulation of transcription, DNA-templated (7%);protein N-linked glycosylation (7%),IPR000914 (29%);IPR039424 (29%);IPR023765 (13%),Solute-binding protein family 5 domain (29%);Solute-binding protein family 5 (29%);Solute-binding protein family 5, conserved site (13%),,,,,,,,,
QAESMDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WTEWMGTAAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPHECSANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SAVVFLPPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVEMFVMFNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVVQSMM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYTEVAMGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNVSLQGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNNNYTADK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QDLNMASVQDHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ACVAGDK,Polytolypa hystricis,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Eurotiomycetidae,,,Onygenales,,,,,Ajellomycetaceae,,,,Polytolypa,,,,Polytolypa hystricis,,,,,,,,,,,,IPR021740 (100%);IPR037525 (100%);IPR038491 (100%),Velvet factor (100%);Velvet domain (100%);Velvet domain superfamily (100%),,,,,,,,,,,
QGWFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.- (19%);1.17.7.4 (13%);3.4.-.- (13%),Acting on acid anhydrides; catalyzing transmembrane movement of substances (19%);4-hydroxy-3-methylbut-2-enyl diphosphate reductase (13%);Acting on peptide bonds (peptidases) (13%),GO:0016021 (21%);GO:0005737 (1%);GO:0005886 (1%),integral component of membrane (21%);cytoplasm (1%);plasma membrane (1%),GO:0005524 (32%);GO:0016887 (28%);GO:0003824 (11%),ATP binding (32%);ATPase activity (28%);catalytic activity (11%),GO:0005975 (3%);GO:0015833 (3%);GO:0006355 (1%),carbohydrate metabolic process (3%);peptide transport (3%);regulation of transcription, DNA-templated (1%),IPR027417 (29%);IPR003593 (26%);IPR003439 (26%),P-loop containing nucleoside triphosphate hydrolase (29%);AAA+ ATPase domain (26%);ABC transporter-like (26%),,,,,,,,,,
MEALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (8%);4.2.1.20 (8%);2.4.2.22 (7%),Hydron translocation or charge separation linked to oxidoreductase reactions (8%);Tryptophan synthase (8%);Xanthine phosphoribosyltransferase (7%),GO:0016021 (26%);GO:0005886 (12%);GO:0005737 (10%),integral component of membrane (26%);plasma membrane (12%);cytoplasm (10%),GO:0005524 (17%);GO:0003677 (7%);GO:0046872 (7%),ATP binding (17%);DNA binding (7%);metal ion binding (7%),GO:0071973 (6%);GO:0006935 (6%);GO:0006355 (4%),bacterial-type flagellum-dependent cell motility (6%);chemotaxis (6%);regulation of transcription, DNA-templated (4%),IPR027417 (13%);IPR000533 (6%);IPR002523 (5%),P-loop containing nucleoside triphosphate hydrolase (13%);Tropomyosin (6%);Mg2+ transporter protein, CorA-like/Zinc transport protein ZntB (5%),,,,,,,,,
MLPEMGAGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APGPTGCHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.1 (17%);2.7.7.48 (15%);3.4.22.28 (15%),Glycine hydroxymethyltransferase (17%);RNA-directed RNA polymerase (15%);Picornain 3C (15%),GO:0005737 (15%);GO:0016021 (12%);GO:0016020 (8%),cytoplasm (15%);integral component of membrane (12%);membrane (8%),GO:0005524 (20%);GO:0030170 (11%);GO:0003677 (8%),ATP binding (20%);pyridoxal phosphate binding (11%);DNA binding (8%),GO:0032259 (8%);GO:0035999 (7%);GO:0019264 (7%),methylation (8%);tetrahydrofolate interconversion (7%);glycine biosynthetic process from serine (7%),IPR027417 (15%);IPR015424 (12%);IPR015421 (12%),P-loop containing nucleoside triphosphate hydrolase (15%);Pyridoxal phosphate-dependent transferase (12%);Pyridoxal phosphate-dependent transferase, major domain (12%),,,,,,,,,,
MWVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (19%);3.6.4.12 (11%);1.-.-.- (7%),Acting on polysaccharides (19%);DNA helicase (11%);Oxidoreductases (7%),GO:0016021 (35%);GO:0005887 (5%);GO:0005737 (2%),integral component of membrane (35%);integral component of plasma membrane (5%);cytoplasm (2%),GO:0005524 (12%);GO:0016301 (10%);GO:0016491 (8%),ATP binding (12%);kinase activity (10%);oxidoreductase activity (8%),GO:0005975 (2%);GO:0006351 (2%);GO:0007264 (2%),carbohydrate metabolic process (2%);transcription, DNA-templated (2%);small GTPase mediated signal transduction (2%),IPR036393 (14%);IPR001048 (9%);IPR027417 (8%),Acetylglutamate kinase-like superfamily (14%);Aspartate/glutamate/uridylate kinase (9%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
QNLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.17 (8%);5.6.2.2 (8%);5.1.3.14 (6%),Bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) (8%);DNA topoisomerase (ATP-hydrolyzing) (8%);UDP-N-acetylglucosamine 2-epimerase (non-hydrolyzing) (6%),GO:0016021 (25%);GO:0005737 (8%);GO:0005886 (3%),integral component of membrane (25%);cytoplasm (8%);plasma membrane (3%),GO:0005524 (19%);GO:0003677 (11%);GO:0046872 (7%),ATP binding (19%);DNA binding (11%);metal ion binding (7%),GO:0006355 (4%);GO:0006412 (3%);GO:0043488 (2%),regulation of transcription, DNA-templated (4%);translation (3%);regulation of mRNA stability (2%),IPR027417 (10%);IPR036890 (4%);IPR003594 (4%),P-loop containing nucleoside triphosphate hydrolase (10%);Histidine kinase/HSP90-like ATPase superfamily (4%);Histidine kinase/HSP90-like ATPase (4%),,,,,,,,,,
MPANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (22%);1.1.1.85 (12%);2.7.7.87 (9%),Acting on ester bonds (22%);3-isopropylmalate dehydrogenase (12%);L-threonylcarbamoyladenylate synthase (9%),GO:0016021 (33%);GO:0005737 (14%);GO:0005886 (2%),integral component of membrane (33%);cytoplasm (14%);plasma membrane (2%),GO:0003677 (12%);GO:0005524 (10%);GO:0046872 (9%),DNA binding (12%);ATP binding (10%);metal ion binding (9%),GO:0017000 (5%);GO:0006355 (4%);GO:0006364 (4%),antibiotic biosynthetic process (5%);regulation of transcription, DNA-templated (4%);rRNA processing (4%),IPR011050 (6%);IPR023882 (6%);IPR006311 (5%),Pectin lyase fold/virulence factor (6%);Colanic acid biosynthesis WcaM (6%);Twin-arginine translocation pathway, signal sequence (5%),,,,,,,,,
CNMFQPAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMASPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.-.- (100%),Acting on acid anhydrides (100%),GO:0016021 (29%);GO:0030532 (29%);GO:0000790 (18%),integral component of membrane (29%);small nuclear ribonucleoprotein complex (29%);nuclear chromatin (18%),GO:0046872 (47%);GO:0016817 (35%);GO:0003843 (6%),metal ion binding (47%);hydrolase activity, acting on acid anhydrides (35%);1,3-beta-D-glucan synthase activity (6%),GO:0006351 (41%);GO:0000381 (29%);GO:0006075 (6%),transcription, DNA-templated (41%);regulation of alternative mRNA splicing, via spliceosome (29%);(1->3)-beta-D-glucan biosynthetic process (6%),IPR001965 (44%);IPR011011 (44%);IPR019786 (44%),Zinc finger, PHD-type (44%);Zinc finger, FYVE/PHD-type (44%);Zinc finger, PHD-type, conserved site (44%),,,
MDQQGVLNYSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WDFWMEVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSLLAWMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPDLAHK,Methanobrevibacter arboriphilus,Archaea,,,,Euryarchaeota,,,Methanobacteria,,,,Methanobacteriales,,,,,Methanobacteriaceae,,,,Methanobrevibacter,,,,Methanobrevibacter arboriphilus,,,,,,,,GO:0008233 (100%),peptidase activity (100%),,,IPR001539 (100%);IPR011060 (100%);IPR020988 (100%),Peptidase U32 (100%);Ribulose-phosphate binding barrel (100%);Peptidase U32, collagenase (100%),,,,,,,,,,
LLHSM,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (67%);GO:0003700 (67%);GO:0005524 (17%),DNA binding (67%);DNA-binding transcription factor activity (67%);ATP binding (17%),,,IPR000847 (67%);IPR005119 (67%);IPR036388 (67%),Transcription regulator HTH, LysR (67%);LysR, substrate-binding (67%);Winged helix-like DNA-binding domain superfamily (67%),,,,,,,,,
QSLNLLTAMGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEACGTHGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDAAHHVAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FYEVVNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR007837 (50%);IPR012654 (50%);IPR034660 (50%),DNA damage-inducible protein DinB (50%);Conserved hypothetical protein CHP02391 (50%);DinB/YfiT-like putative metalloenzymes (50%),,,,,,,,,,,
SADSVMLGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLENSAMGPVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNQVLDNK,Entamoeba invadens,Eukaryota,,,,Evosea,,,,,,,Mastigamoebida,,,,,Entamoebidae,,,,Entamoeba,,,,Entamoeba invadens,,,,,,,,,,,,IPR001810 (100%);IPR036047 (100%);IPR036322 (100%),F-box domain (100%);F-box-like domain superfamily (100%);WD40-repeat-containing domain superfamily (100%),,,,,,,,,,,
QVMDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.- (100%),Hydro-lyases (100%),GO:0016021 (24%);GO:0005737 (6%);GO:0009279 (6%),integral component of membrane (24%);cytoplasm (6%);cell outer membrane (6%),GO:0005524 (33%);GO:0003677 (27%);GO:0003700 (18%),ATP binding (33%);DNA binding (27%);DNA-binding transcription factor activity (18%),GO:0009058 (18%);GO:0006457 (9%);GO:0006886 (9%),biosynthetic process (18%);protein folding (9%);intracellular protein transport (9%),IPR018712 (19%);IPR027417 (17%);IPR003439 (15%),Domain of unknown function DUF2235 (19%);P-loop containing nucleoside triphosphate hydrolase (17%);ABC transporter-like (15%),,,,,,,,,,,
ANGLMMSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THVVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.177 (100%),23S rRNA (pseudouridine(1915)-N(3))-methyltransferase (100%),GO:0016021 (11%);GO:0005737 (4%);GO:0042597 (4%),integral component of membrane (11%);cytoplasm (4%);periplasmic space (4%),GO:0008168 (44%);GO:0046872 (41%);GO:0003924 (11%),methyltransferase activity (44%);metal ion binding (41%);GTPase activity (11%),GO:0005975 (7%);GO:0008152 (7%);GO:0006779 (4%),carbohydrate metabolic process (7%);metabolic process (7%);porphyrin-containing compound biosynthetic process (4%),IPR011671 (43%);IPR029063 (43%);IPR000571 (37%),tRNA (uracil-O(2)-)-methyltransferase (43%);S-adenosyl-L-methionine-dependent methyltransferase (43%);Zinc finger, CCCH-type (37%),,,,,,,,,,
FFNMGPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSLDAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (19%);2.3.2.3 (16%);1.3.1.9 (9%),DNA-directed DNA polymerase (19%);Lysyltransferase (16%);Enoyl-[acyl-carrier-protein] reductase (NADH) (9%),GO:0016021 (36%);GO:0005886 (9%);GO:0005737 (7%),integral component of membrane (36%);plasma membrane (9%);cytoplasm (7%),GO:0005524 (17%);GO:0046872 (13%);GO:0003677 (11%),ATP binding (17%);metal ion binding (13%);DNA binding (11%),GO:0006464 (8%);GO:0006260 (6%);GO:0042121 (3%),cellular protein modification process (8%);DNA replication (6%);alginic acid biosynthetic process (3%),IPR013783 (10%);IPR002035 (7%);IPR004666 (7%),Immunoglobulin-like fold (10%);von Willebrand factor, type A (7%);Ribosomal S6 modification enzyme RimK/Lysine biosynthesis enzyme LysX (7%),,,,,,,,,,
MMAENTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (99%);GO:0005744 (25%);GO:0005840 (1%),integral component of membrane (99%);TIM23 mitochondrial import inner membrane translocase complex (25%);ribosome (1%),GO:0015450 (25%);GO:0016787 (2%);GO:0003735 (1%),P-P-bond-hydrolysis-driven protein transmembrane transporter activity (25%);hydrolase activity (2%);structural constituent of ribosome (1%),GO:0006886 (25%);GO:0006412 (1%),intracellular protein transport (25%);translation (1%),IPR005678 (86%);IPR000246 (7%);IPR029055 (7%),Mitochondrial inner membrane translocase complex, subunit Tim17 (86%);Peptidase T2, asparaginase 2 (7%);Nucleophile aminohydrolases, N-terminal (7%),,,,,,,,
LYEEYKPLDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNHASNYSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ATDYNGK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004177 (50%);GO:0004252 (50%);GO:0004553 (50%),aminopeptidase activity (50%);serine-type endopeptidase activity (50%);hydrolase activity, hydrolyzing O-glycosyl compounds (50%),GO:0000272 (50%),polysaccharide catabolic process (50%),IPR006530 (50%);IPR022385 (50%);IPR031325 (50%),YD repeat (50%);Rhs repeat-associated core (50%);RHS repeat (50%),,,,,,,,,,
QLWHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (27%);3.4.25.1 (6%);1.1.2.6 (3%),DNA ligase (NAD(+)) (27%);Proteasome endopeptidase complex (6%);Polyvinyl alcohol dehydrogenase (cytochrome) (3%),GO:0016021 (23%);GO:0043190 (10%);GO:0005886 (3%),integral component of membrane (23%);ATP-binding cassette (ABC) transporter complex (10%);plasma membrane (3%),GO:0003677 (15%);GO:0016846 (11%);GO:0005524 (8%),DNA binding (15%);carbon-sulfur lyase activity (11%);ATP binding (8%),GO:0055085 (9%);GO:0006355 (6%);GO:0006281 (2%),transmembrane transport (9%);regulation of transcription, DNA-templated (6%);DNA repair (2%),IPR011057 (12%);IPR006913 (12%);IPR027417 (10%),Mss4-like superfamily (12%);Glutathione-dependent formaldehyde-activating enzyme/centromere protein V (12%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,,,
HPDTETPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMHMMVWHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVEPMPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0008658 (100%);GO:0016740 (100%),penicillin binding (100%);transferase activity (100%),,,IPR001264 (50%);IPR001460 (50%);IPR006311 (50%),Glycosyl transferase, family 51 (50%);Penicillin-binding protein, transpeptidase (50%);Twin-arginine translocation pathway, signal sequence (50%),,,,,,,,
MMAAEMGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNGNDEK,Scytalidium lignicola,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Leotiomycetes,,,,,,,,,,,,,Scytalidium,,,,Scytalidium lignicola,,,,,,GO:0005634 (100%);GO:0016021 (100%),nucleus (100%);integral component of membrane (100%),GO:0003677 (100%);GO:0008270 (100%),DNA binding (100%);zinc ion binding (100%),GO:0006351 (100%),transcription, DNA-templated (100%),IPR007219 (100%),Transcription factor domain, fungi (100%),,,,,,,,,
LLPVADTVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AATMEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.70 (33%);1.14.17.4 (17%);1.2.1.88 (17%),Glutamyl-tRNA reductase (33%);Aminocyclopropanecarboxylate oxidase (17%);L-glutamate gamma-semialdehyde dehydrogenase (17%),GO:0016021 (14%);GO:0005634 (5%);GO:0005623 (3%),integral component of membrane (14%);nucleus (5%);cell (3%),GO:0046872 (36%);GO:0016491 (29%);GO:0016740 (14%),metal ion binding (36%);oxidoreductase activity (29%);transferase activity (14%),GO:0006782 (3%);GO:0009236 (3%);GO:0019354 (3%),protoporphyrinogen IX biosynthetic process (3%);cobalamin biosynthetic process (3%);siroheme biosynthetic process (3%),IPR005123 (30%);IPR026992 (30%);IPR027443 (30%),Oxoglutarate/iron-dependent dioxygenase (30%);Non-haem dioxygenase N-terminal domain (30%);Isopenicillin N synthase-like (30%),,,,,,,,,,,
DLYHAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.1.20 (77%);1.14.13.2 (8%);2.1.1.207 (8%),Methylenetetrahydrofolate reductase (NAD(P)H) (77%);4-hydroxybenzoate 3-monooxygenase (8%);tRNA (cytidine(34)-2'-O)-methyltransferase (8%),GO:0005764 (18%);GO:0016021 (15%);GO:0005743 (14%),lysosome (18%);integral component of membrane (15%);mitochondrial inner membrane (14%),GO:0016810 (17%);GO:0004489 (15%);GO:0005524 (9%),hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (17%);methylenetetrahydrofolate reductase (NAD(P)H) activity (15%);ATP binding (9%),GO:0006629 (17%);GO:0035999 (15%);GO:0006555 (12%),lipid metabolic process (17%);tetrahydrofolate interconversion (15%);methionine metabolic process (12%),IPR029132 (17%);IPR016699 (16%);IPR029130 (14%),Choloylglycine hydrolase/NAAA C-terminal (17%);Acid ceramidase-like (16%);Acid ceramidase, N-terminal (14%),,,,,,,,,
VENVDYNMPMVDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHAMQEDLDGQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLSYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.1 (53%);4.1.3.40 (21%);1.2.4.2 (5%),Phosphoribosylformylglycinamidine cyclo-ligase (53%);Chorismate lyase (21%);Oxoglutarate dehydrogenase (succinyl-transferring) (5%),GO:0016021 (21%);GO:0005737 (16%);GO:0005886 (6%),integral component of membrane (21%);cytoplasm (16%);plasma membrane (6%),GO:0004553 (17%);GO:0005524 (17%);GO:0003677 (12%),hydrolase activity, hydrolyzing O-glycosyl compounds (17%);ATP binding (17%);DNA binding (12%),GO:0005975 (19%);GO:0006189 (9%);GO:0006744 (4%),carbohydrate metabolic process (19%);'de novo' IMP biosynthetic process (9%);ubiquinone biosynthetic process (4%),IPR017853 (14%);IPR001360 (13%);IPR033132 (12%),Glycoside hydrolase superfamily (14%);Glycoside hydrolase family 1 (13%);Glycosyl hydrolases family 1, N-terminal conserved site (12%),,,,,,,,,
YSLPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.6 (24%);5.6.2.1 (24%);2.3.1.97 (12%),Catalase (24%);DNA topoisomerase (24%);Glycylpeptide N-tetradecanoyltransferase (12%),GO:0016021 (29%);GO:0005694 (4%);GO:0005886 (4%),integral component of membrane (29%);chromosome (4%);plasma membrane (4%),GO:0016491 (11%);GO:0005524 (8%);GO:0016740 (8%),oxidoreductase activity (11%);ATP binding (8%);transferase activity (8%),GO:0006265 (4%);GO:0006281 (3%);GO:0001955 (2%),DNA topological change (4%);DNA repair (3%);blood vessel maturation (2%),IPR009078 (56%);IPR007760 (55%);IPR012347 (54%),Ferritin-like superfamily (56%);Manganese catalase (55%);Ferritin-like (54%),,,,,,,,,,,
NYVMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (17%);GO:0030286 (17%),integral component of membrane (17%);dynein complex (17%),GO:0003723 (33%);GO:0003677 (17%);GO:0003777 (17%),RNA binding (33%);DNA binding (17%);microtubule motor activity (17%),GO:0000160 (17%);GO:0006355 (17%);GO:0007018 (17%),phosphorelay signal transduction system (17%);regulation of transcription, DNA-templated (17%);microtubule-based movement (17%),IPR001890 (40%);IPR027417 (40%);IPR035920 (40%),RNA-binding, CRM domain (40%);P-loop containing nucleoside triphosphate hydrolase (40%);YhbY-like superfamily (40%),,,,,,,,,
FFLLMVHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLTGMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.17 (50%);3.5.2.19 (25%);4.2.1.3 (25%),Glutamate--tRNA ligase (50%);Streptothricin hydrolase (25%);Aconitate hydratase (25%),GO:0016021 (33%);GO:0005737 (25%),integral component of membrane (33%);cytoplasm (25%),GO:0005524 (25%);GO:0000049 (17%);GO:0003676 (17%),ATP binding (25%);tRNA binding (17%);nucleic acid binding (17%),GO:0006424 (17%);GO:0006032 (8%);GO:0006629 (8%),glutamyl-tRNA aminoacylation (17%);chitin catabolic process (8%);lipid metabolic process (8%),IPR000924 (14%);IPR001412 (14%);IPR004527 (14%),Glutamyl/glutaminyl-tRNA synthetase (14%);Aminoacyl-tRNA synthetase, class I, conserved site (14%);Glutamate-tRNA ligase, bacterial/mitochondrial (14%),,,,,,,,
ACVYPK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005576 (33%),extracellular region (33%),GO:0003676 (33%);GO:0016491 (33%);GO:0016740 (33%),nucleic acid binding (33%);oxidoreductase activity (33%);transferase activity (33%),,,IPR000873 (33%);IPR001227 (33%);IPR001242 (33%),AMP-dependent synthetase/ligase (33%);Acyl transferase domain superfamily (33%);Condensation domain (33%),,,,,,,,,,,
MVNNMGYVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (30%);3.1.-.- (21%);2.7.1.23 (6%),DNA-directed DNA polymerase (30%);Acting on ester bonds (21%);NAD(+) kinase (6%),GO:0016021 (19%);GO:0005737 (19%);GO:0030430 (6%),integral component of membrane (19%);cytoplasm (19%);host cell cytoplasm (6%),GO:0005524 (23%);GO:0003684 (9%);GO:0003887 (9%),ATP binding (23%);damaged DNA binding (9%);DNA-directed DNA polymerase activity (9%),GO:0006281 (9%);GO:0006261 (8%);GO:0039502 (6%),DNA repair (9%);DNA-dependent DNA replication (8%);suppression by virus of host type I interferon-mediated signaling pathway (6%),IPR027417 (13%);IPR036775 (8%);IPR017961 (8%),P-loop containing nucleoside triphosphate hydrolase (13%);DNA polymerase, Y-family, little finger domain superfamily (8%);DNA polymerase, Y-family, little finger domain (8%),,,,,,,
SHCLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.14 (67%);2.3.2.31 (33%),Amidophosphoribosyltransferase (67%);RBR-type E3 ubiquitin transferase (33%),GO:0005737 (10%);GO:0005887 (10%);GO:0098794 (10%),cytoplasm (10%);integral component of plasma membrane (10%);postsynapse (10%),GO:0003824 (20%);GO:0016740 (20%);GO:0000287 (10%),catalytic activity (20%);transferase activity (20%);magnesium ion binding (10%),GO:0006189 (10%);GO:0006541 (10%);GO:0009113 (10%),'de novo' IMP biosynthetic process (10%);glutamine metabolic process (10%);purine nucleobase biosynthetic process (10%),IPR000873 (19%);IPR025110 (19%);IPR042099 (19%),AMP-dependent synthetase/ligase (19%);AMP-binding enzyme, C-terminal domain (19%);AMP-dependent synthetase-like superfamily (19%),,,,,,,,,,
HVVVFLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003690 (40%);GO:0003677 (20%);GO:0016491 (20%),double-stranded DNA binding (40%);DNA binding (20%);oxidoreductase activity (20%),GO:0006355 (40%);GO:0006310 (20%);GO:0015074 (20%),regulation of transcription, DNA-templated (40%);DNA recombination (20%);DNA integration (20%),IPR003690 (50%);IPR038538 (50%);IPR002104 (17%),Transcription termination factor, mitochondrial/chloroplastic (50%);MTERF superfamily, mitochondrial/chloroplastic (50%);Integrase, catalytic domain (17%),,,,,,,
FFFPVLDHVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYMMYPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDEASK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.1 (30%);1.17.4.2 (26%);1.1.1.157 (9%),Tyrosine--tRNA ligase (30%);Ribonucleoside-triphosphate reductase (thioredoxin) (26%);3-hydroxybutyryl-CoA dehydrogenase (9%),GO:0016021 (24%);GO:0005737 (10%);GO:0009380 (4%),integral component of membrane (24%);cytoplasm (10%);excinuclease repair complex (4%),GO:0005524 (29%);GO:0003677 (15%);GO:0008998 (10%),ATP binding (29%);DNA binding (15%);ribonucleoside-triphosphate reductase activity (10%),GO:0006260 (10%);GO:0006289 (5%);GO:0006437 (5%),DNA replication (10%);nucleotide-excision repair (5%);tyrosyl-tRNA aminoacylation (5%),IPR027417 (10%);IPR012833 (9%);IPR001650 (8%),P-loop containing nucleoside triphosphate hydrolase (10%);Ribonucleoside-triphosphate reductase, anaerobic (9%);Helicase, C-terminal (8%),,,,,,,,,
DDLFAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004673 (100%);GO:0005524 (100%),protein histidine kinase activity (100%);ATP binding (100%),,,IPR000014 (100%);IPR003594 (100%);IPR003661 (100%),PAS domain (100%);Histidine kinase/HSP90-like ATPase (100%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (100%),,,,,,,,,,
DFYAGYMEGLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DALHVDEEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLKPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.72 (17%);5.2.1.8 (12%);2.7.7.6 (10%),Site-specific DNA-methyltransferase (adenine-specific) (17%);Peptidylprolyl isomerase (12%);DNA-directed RNA polymerase (10%),GO:0016021 (33%);GO:0005737 (8%);GO:0005840 (5%),integral component of membrane (33%);cytoplasm (8%);ribosome (5%),GO:0003677 (28%);GO:0008168 (17%);GO:0005524 (9%),DNA binding (28%);methyltransferase activity (17%);ATP binding (9%),GO:0032259 (17%);GO:0006304 (15%);GO:0006412 (4%),methylation (17%);DNA modification (15%);translation (4%),IPR029063 (20%);IPR011639 (17%);IPR002052 (16%),S-adenosyl-L-methionine-dependent methyltransferase (20%);Restriction modification methylase Eco57I (17%);DNA methylase, N-6 adenine-specific, conserved site (16%),,,,,,,,,
WVVCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.90 (100%),All-trans-octaprenyl-diphosphate synthase (100%),GO:0005634 (70%);GO:0016021 (11%);GO:0000790 (1%),nucleus (70%);integral component of membrane (11%);nuclear chromatin (1%),GO:0003677 (65%);GO:0008270 (6%);GO:0005525 (5%),DNA binding (65%);zinc ion binding (6%);GTP binding (5%),GO:0006355 (54%);GO:0048731 (4%);GO:0010705 (2%),regulation of transcription, DNA-templated (54%);system development (4%);meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (2%),IPR003441 (56%);IPR036093 (56%);IPR027417 (8%),NAC domain (56%);NAC domain superfamily (56%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
TLDQMPR,Sphingobacterium,Bacteria,,,,Bacteroidetes,,,Sphingobacteriia,,,,Sphingobacteriales,,,,,Sphingobacteriaceae,,,,Sphingobacterium,,,,,,,,,,,,,,,,IPR027267 (100%),AH/BAR domain superfamily (100%),,,,,,,,,,,
NHNFGQHACENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MKPPVWANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTYMMMVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPPVFVK,Scyliorhinus torazame,Eukaryota,Metazoa,,,Chordata,Craniata,,Chondrichthyes,Elasmobranchii,Selachii,Galeoidea,Carcharhiniformes,,,,,Scyliorhinidae,,,,Scyliorhinus,,,,Scyliorhinus torazame,,,,,,,,,,,,IPR003598 (100%);IPR003599 (100%);IPR007110 (100%),Immunoglobulin subtype 2 (100%);Immunoglobulin subtype (100%);Immunoglobulin-like domain (100%),,,,,,,,,,,
MGQCDNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNANPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016787 (33%),hydrolase activity (33%),GO:0055085 (67%),transmembrane transport (67%),IPR018389 (50%);IPR038404 (50%);IPR001826 (25%),TRAP transporter solute receptor DctP/TeaA (50%);TRAP transporter solute receptor DctP superfamily (50%);RHS protein (25%),,,,,,,,,,,
WGDRPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (100%),Carboxylic ester hydrolases (100%),,,GO:0016787 (100%),hydrolase activity (100%),,,IPR002018 (100%);IPR019826 (100%);IPR029058 (100%),Carboxylesterase, type B (100%);Carboxylesterase type B, active site (100%);Alpha/Beta hydrolase fold (100%),,,,,,,,,
DLTLVTSVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGQASWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFTLPVVCALTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVAVPM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNDQMTMNVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DFEATGFTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FHEALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (18%);5.4.3.8 (14%);2.7.4.9 (11%),DNA ligase (NAD(+)) (18%);Glutamate-1-semialdehyde 2,1-aminomutase (14%);dTMP kinase (11%),GO:0016021 (15%);GO:0005737 (8%);GO:0000922 (3%),integral component of membrane (15%);cytoplasm (8%);spindle pole (3%),GO:0003677 (24%);GO:0003700 (20%);GO:0005524 (16%),DNA binding (24%);DNA-binding transcription factor activity (20%);ATP binding (16%),GO:0009058 (7%);GO:0006260 (3%);GO:0006281 (3%),biosynthetic process (7%);DNA replication (3%);DNA repair (3%),IPR027417 (13%);IPR036388 (12%);IPR036390 (12%),P-loop containing nucleoside triphosphate hydrolase (13%);Winged helix-like DNA-binding domain superfamily (12%);Winged helix DNA-binding domain superfamily (12%),,,,,,,,,,
AEQNMVPVN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLLDMANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVDLGAAMLELPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WELGFDLLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALPLSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.16 (50%);3.1.26.5 (50%),Thiamine-phosphate kinase (50%);Ribonuclease P (50%),GO:0016021 (23%);GO:0005634 (15%);GO:0005737 (8%),integral component of membrane (23%);nucleus (15%);cytoplasm (8%),GO:0005524 (31%);GO:0003677 (23%);GO:0003682 (12%),ATP binding (31%);DNA binding (23%);chromatin binding (12%),GO:0006260 (15%);GO:0006281 (15%);GO:0006310 (15%),DNA replication (15%);DNA repair (15%);DNA recombination (15%),IPR027417 (16%);IPR003593 (13%);IPR003717 (13%),P-loop containing nucleoside triphosphate hydrolase (16%);AAA+ ATPase domain (13%);Recombination protein O, RecO (13%),,,,,,,,,,
FGGNMPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMVVTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPAVHFCHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLPHTMPPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVWSNMDGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLQFMTVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNYAHFDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVDATVVLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPSWCVMLDVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFFFDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.12 (42%);1.6.2.2 (8%);2.4.2.17 (8%),Transferred entry: 7.2.2.6 (42%);Cytochrome-b5 reductase (8%);ATP phosphoribosyltransferase (8%),GO:0016021 (35%);GO:0009706 (6%);GO:0005886 (3%),integral component of membrane (35%);chloroplast inner membrane (6%);plasma membrane (3%),GO:0005524 (60%);GO:0000166 (12%);GO:0004222 (3%),ATP binding (60%);nucleotide binding (12%);metalloendopeptidase activity (3%),GO:0015031 (6%);GO:0007049 (2%);GO:0051301 (2%),protein transport (6%);cell cycle (2%);cell division (2%),IPR027417 (55%);IPR003593 (51%);IPR018145 (51%),P-loop containing nucleoside triphosphate hydrolase (55%);AAA+ ATPase domain (51%);CagE, TrbE, VirB component of type IV transporter system, central domain (51%),,,,,,,,
DFLTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.- (41%);2.7.13.3 (24%);1.8.1.8 (6%),Phosphoric diester hydrolases (41%);Histidine kinase (24%);Protein-disulfide reductase (6%),GO:0009507 (54%);GO:0015935 (50%);GO:0016021 (11%),chloroplast (54%);small ribosomal subunit (50%);integral component of membrane (11%),GO:0019843 (51%);GO:0003735 (50%);GO:0016829 (14%),rRNA binding (51%);structural constituent of ribosome (50%);lyase activity (14%),GO:0006412 (50%);GO:0071973 (2%);GO:0006281 (2%),translation (50%);bacterial-type flagellum-dependent cell motility (2%);DNA repair (2%),IPR002942 (44%);IPR036986 (44%);IPR022801 (42%),RNA-binding S4 domain (44%);RNA-binding S4 domain superfamily (44%);Ribosomal protein S4/S9 (42%),,,,,,,,,,,
LWDVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.6 (43%);3.1.-.- (11%);3.1.13.- (10%),Phosphoribosylaminoimidazolesuccinocarboxamide synthase (43%);Acting on ester bonds (11%);Exoribonucleases producing 5'-phosphomonoesters (10%),GO:0016021 (16%);GO:0000974 (11%);GO:0005852 (5%),integral component of membrane (16%);Prp19 complex (11%);eukaryotic translation initiation factor 3 complex (5%),GO:0061630 (21%);GO:0005524 (15%);GO:0003677 (11%),ubiquitin protein ligase activity (21%);ATP binding (15%);DNA binding (11%),GO:0006281 (12%);GO:0000398 (10%);GO:0006310 (9%),DNA repair (12%);mRNA splicing, via spliceosome (10%);DNA recombination (9%),IPR001680 (73%);IPR015943 (73%);IPR017986 (72%),WD40 repeat (73%);WD40/YVTN repeat-like-containing domain superfamily (73%);WD40-repeat-containing domain (72%),,,,,,,,,,
DEEDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.144 (38%);2.7.1.40 (14%);5.2.1.8 (11%),Tagatose-6-phosphate kinase (38%);Pyruvate kinase (14%);Peptidylprolyl isomerase (11%),GO:0016021 (22%);GO:0005634 (6%);GO:0005886 (5%),integral component of membrane (22%);nucleus (6%);plasma membrane (5%),GO:0005524 (21%);GO:0005543 (10%);GO:0009024 (9%),ATP binding (21%);phospholipid binding (10%);tagatose-6-phosphate kinase activity (9%),GO:0005988 (9%);GO:2001059 (9%);GO:0051693 (3%),lactose metabolic process (9%);D-tagatose 6-phosphate catabolic process (9%);actin filament capping (3%),IPR002017 (15%);IPR018159 (15%);IPR001849 (14%),Spectrin repeat (15%);Spectrin/alpha-actinin (15%);Pleckstrin homology domain (14%),,,,,,,,,,,
MWPGSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QYFLANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.35 (100%),tRNA (uracil(54)-C(5))-methyltransferase (100%),GO:0016020 (33%),membrane (33%),GO:0016491 (33%);GO:0016787 (33%);GO:0030697 (33%),oxidoreductase activity (33%);hydrolase activity (33%);S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity (33%),GO:0009166 (33%),nucleotide catabolic process (33%),IPR005805 (25%);IPR006076 (25%);IPR008334 (25%),Rieske iron-sulphur protein, C-terminal (25%);FAD dependent oxidoreductase (25%);5'-Nucleotidase, C-terminal (25%),,,,,,,,,
ENQNTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNLPSHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR003169 (96%);IPR035445 (96%);IPR008969 (4%),GYF domain (96%);GYF-like domain superfamily (96%);Carboxypeptidase-like, regulatory domain superfamily (4%),,,,,,,,,,
DYVVPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003743 (100%),translation initiation factor activity (100%),,,IPR003029 (89%);IPR011488 (89%);IPR012340 (89%),S1 domain (89%);Translation initiation factor 2, alpha subunit (89%);Nucleic acid-binding, OB-fold (89%),,,,,,,,,
KPLGPTPR,Mycobacterium,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Corynebacteriales,,,,,Mycobacteriaceae,,,,Mycobacterium,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005524 (100%),ATP binding (100%),,,IPR025565 (100%);IPR036640 (100%),Domain of unknown function DUF4328 (100%);ABC transporter type 1, transmembrane domain superfamily (100%),,,,,,,,,,
HGVAFDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAFNHDDWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNEDALFAQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.1.- (28%);3.4.14.11 (13%);2.7.2.3 (8%),Acid--ammonia (or amine) ligases (amide synthases) (28%);Xaa-Pro dipeptidyl-peptidase (13%);Phosphoglycerate kinase (8%),GO:0016021 (31%);GO:0005737 (3%);GO:0009279 (3%),integral component of membrane (31%);cytoplasm (3%);cell outer membrane (3%),GO:0016874 (14%);GO:0003677 (9%);GO:0005524 (6%),ligase activity (14%);DNA binding (9%);ATP binding (6%),GO:0006355 (7%);GO:0000160 (5%);GO:1990961 (3%),regulation of transcription, DNA-templated (7%);phosphorelay signal transduction system (5%);xenobiotic detoxification by transmembrane export across the plasma membrane (3%),IPR005494 (68%);IPR016185 (68%);IPR036291 (3%),Glutathionylspermidine synthase, pre-ATP-grasp-like domain (68%);Pre-ATP-grasp domain superfamily (68%);NAD(P)-binding domain superfamily (3%),,,,,,,,,
TGCLVGLFWEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVANNTAK,Bradyrhizobium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Rhizobiales,,,,,Bradyrhizobiaceae,,,,Bradyrhizobium,,,,,,,,4.1.1.36 (100%);6.3.2.5 (100%),Phosphopantothenoylcysteine decarboxylase (100%);Phosphopantothenate--cysteine ligase (CTP) (100%),,,GO:0003677 (100%);GO:0004632 (100%);GO:0004633 (100%),DNA binding (100%);phosphopantothenate--cysteine ligase activity (100%);phosphopantothenoylcysteine decarboxylase activity (100%),GO:0006355 (100%);GO:0015937 (100%);GO:0015941 (100%),regulation of transcription, DNA-templated (100%);coenzyme A biosynthetic process (100%);pantothenate catabolic process (100%),IPR003382 (100%);IPR005252 (100%);IPR007085 (100%),Flavoprotein (100%);Coenzyme A biosynthesis bifunctional protein CoaBC (100%);DNA/pantothenate metabolism flavoprotein, C-terminal (100%),,,,,,,,,
DAVPTFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.1 (100%),Transketolase (100%),,,GO:0004802 (50%);GO:0008420 (50%);GO:0043175 (50%),transketolase activity (50%);RNA polymerase II CTD heptapeptide repeat phosphatase activity (50%);RNA polymerase core enzyme binding (50%),GO:0070940 (50%),dephosphorylation of RNA polymerase II C-terminal domain (50%),IPR005474 (33%);IPR005475 (33%);IPR005478 (33%),Transketolase, N-terminal (33%);Transketolase-like, pyrimidine-binding domain (33%);Transketolase, bacterial-like (33%),,,,,,,,
FTMLVHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVPLYWMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSVER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (5%);1.1.1.42 (5%);2.7.4.3 (4%),DNA helicase (5%);Isocitrate dehydrogenase (NADP(+)) (5%);Adenylate kinase (4%),GO:0016021 (23%);GO:0005737 (8%);GO:0005886 (2%),integral component of membrane (23%);cytoplasm (8%);plasma membrane (2%),GO:0005524 (14%);GO:0003677 (11%);GO:0016491 (6%),ATP binding (14%);DNA binding (11%);oxidoreductase activity (6%),GO:0006313 (5%);GO:0000160 (3%);GO:0006351 (2%),transposition, DNA-mediated (5%);phosphorelay signal transduction system (3%);transcription, DNA-templated (2%),IPR027417 (9%);IPR002559 (4%);IPR036188 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);Transposase, IS4-like (4%);FAD/NAD(P)-binding domain superfamily (4%),,,,,,,,
MTQVEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (22%);1.2.4.1 (17%);2.3.1.234 (11%),Metalloendopeptidases (22%);Pyruvate dehydrogenase (acetyl-transferring) (17%);N(6)-L-threonylcarbamoyladenine synthase (11%),GO:0016021 (24%);GO:0005840 (14%);GO:0005737 (6%),integral component of membrane (24%);ribosome (14%);cytoplasm (6%),GO:0004222 (25%);GO:0003735 (15%);GO:0008270 (12%),metalloendopeptidase activity (25%);structural constituent of ribosome (15%);zinc ion binding (12%),GO:0006412 (15%);GO:0006509 (10%);GO:0007219 (10%),translation (15%);membrane protein ectodomain proteolysis (10%);Notch signaling pathway (10%),IPR024079 (23%);IPR012677 (14%);IPR012678 (14%),Metallopeptidase, catalytic domain superfamily (23%);Nucleotide-binding alpha-beta plait domain superfamily (14%);Ribosomal protein L23/L15e core domain superfamily (14%),,,,,,,,,,
TWNVQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.173 (100%);2.1.1.264 (100%),23S rRNA (guanine(2445)-N(2))-methyltransferase (100%);23S rRNA (guanine(2069)-N(7))-methyltransferase (100%),GO:0016021 (77%);GO:0005737 (8%),integral component of membrane (77%);cytoplasm (8%),GO:0005506 (77%);GO:0016705 (77%);GO:0020037 (77%),iron ion binding (77%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (77%);heme binding (77%),GO:0018193 (8%),peptidyl-amino acid modification (8%),IPR001128 (63%);IPR036396 (63%);IPR002403 (56%),Cytochrome P450 (63%);Cytochrome P450 superfamily (63%);Cytochrome P450, E-class, group IV (56%),,,,,,,
CGAGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.136 (24%);5.1.99.6 (23%);2.1.1.- (14%),ADP-dependent NAD(P)H-hydrate dehydratase (24%);NAD(P)H-hydrate epimerase (23%);Methyltransferases (14%),GO:0016021 (19%);GO:0005737 (9%);GO:0005615 (3%),integral component of membrane (19%);cytoplasm (9%);extracellular space (3%),GO:0003677 (14%);GO:0046872 (12%);GO:0005524 (11%),DNA binding (14%);metal ion binding (12%);ATP binding (11%),GO:0046496 (5%);GO:0006265 (3%);GO:0006782 (2%),nicotinamide nucleotide metabolic process (5%);DNA topological change (3%);protoporphyrinogen IX biosynthetic process (2%),IPR002901 (6%);IPR009057 (6%);IPR029056 (5%),Mannosyl-glycoprotein endo-beta-N-acetylglucosamidase-like domain (6%);Homeobox-like domain superfamily (6%);Ribokinase-like (5%),,,,,,,,,,,
AFDVVVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.9 (67%);1.3.3.3 (33%),Nucleotide diphosphatase (67%);Coproporphyrinogen oxidase (33%),GO:0005737 (16%);GO:0016021 (16%);GO:0000110 (5%),cytoplasm (16%);integral component of membrane (16%);nucleotide-excision repair factor 1 complex (5%),GO:0003697 (42%);GO:0004520 (37%);GO:0004519 (11%),single-stranded DNA binding (42%);endodeoxyribonuclease activity (37%);endonuclease activity (11%),GO:0006281 (37%);GO:0009117 (11%);GO:0000712 (5%),DNA repair (37%);nucleotide metabolic process (11%);resolution of meiotic recombination intermediates (5%),IPR006166 (45%);IPR006167 (45%);IPR010994 (45%),ERCC4 domain (45%);DNA repair protein XPF (45%);RuvA domain 2-like (45%),,,,,,,,,,,
MALEPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.23 (50%);4.2.1.33 (17%);2.4.2.14 (8%),S-methyl-5-thioribose-1-phosphate isomerase (50%);3-isopropylmalate dehydratase (17%);Amidophosphoribosyltransferase (8%),GO:0016021 (26%);GO:0005886 (11%);GO:0009316 (5%),integral component of membrane (26%);plasma membrane (11%);3-isopropylmalate dehydratase complex (5%),GO:0046523 (16%);GO:0016491 (8%);GO:0003677 (5%),S-methyl-5-thioribose-1-phosphate isomerase activity (16%);oxidoreductase activity (8%);DNA binding (5%),GO:0019284 (16%);GO:0019509 (16%);GO:0009098 (5%),L-methionine salvage from S-adenosylmethionine (16%);L-methionine salvage from methylthioadenosine (16%);leucine biosynthetic process (5%),IPR005202 (24%);IPR000649 (10%);IPR005251 (10%),Transcription factor GRAS (24%);Initiation factor 2B-related (10%);Methylthioribose-1-phosphate isomerase (10%),,,,,,,,,,,
EGSATTQELDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMKPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (13%);3.2.1.89 (13%);6.3.5.2 (13%),3-methyl-2-oxobutanoate hydroxymethyltransferase (13%);Arabinogalactan endo-beta-1,4-galactanase (13%);GMP synthase (glutamine-hydrolyzing) (13%),GO:0016021 (23%);GO:0005623 (5%);GO:0005737 (5%),integral component of membrane (23%);cell (5%);cytoplasm (5%),GO:0005524 (14%);GO:0016740 (9%);GO:0003677 (8%),ATP binding (14%);transferase activity (9%);DNA binding (8%),GO:0044038 (7%);GO:0045454 (5%);GO:0005975 (4%),cell wall macromolecule biosynthetic process (7%);cell redox homeostasis (5%);carbohydrate metabolic process (4%),IPR005053 (21%);IPR027417 (12%);IPR011990 (6%),MobA/MobL protein (21%);P-loop containing nucleoside triphosphate hydrolase (12%);Tetratricopeptide-like helical domain superfamily (6%),,,,,,,,,,
LMSEVHDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMLETNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.44 (50%);1.16.3.1 (25%);6.3.5.- (25%),Phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (50%);Ferroxidase (25%);Carbon--nitrogen ligases with glutamine as amido-N-donor (25%),GO:0005829 (14%);GO:0005623 (7%);GO:0005886 (7%),cytosol (14%);cell (7%);plasma membrane (7%),GO:0051015 (21%);GO:0003677 (14%);GO:0003723 (14%),actin filament binding (21%);DNA binding (14%);RNA binding (14%),GO:0007010 (21%);GO:0006098 (14%);GO:0019521 (14%),cytoskeleton organization (21%);pentose-phosphate shunt (14%);D-gluconate metabolic process (14%),IPR003128 (20%);IPR007122 (20%);IPR007123 (20%),Villin headpiece (20%);Villin/Gelsolin (20%);Gelsolin-like domain (20%),,,,,,,,,,
LLDWLQWVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YYYLAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSSFVPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.41 (13%);3.1.1.- (10%);3.5.1.10 (9%),Sterol 24-C-methyltransferase (13%);Carboxylic ester hydrolases (10%);Formyltetrahydrofolate deformylase (9%),GO:0005840 (11%);GO:0016021 (11%);GO:0005737 (6%),ribosome (11%);integral component of membrane (11%);cytoplasm (6%),GO:0005524 (32%);GO:0046872 (17%);GO:0004672 (16%),ATP binding (32%);metal ion binding (17%);protein kinase activity (16%),GO:0035556 (14%);GO:0006412 (11%);GO:0032259 (2%),intracellular signal transduction (14%);translation (11%);methylation (2%),IPR011009 (23%);IPR000719 (23%);IPR001245 (16%),Protein kinase-like domain superfamily (23%);Protein kinase domain (23%);Serine-threonine/tyrosine-protein kinase, catalytic domain (16%),,,,,,,,,,
MTEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.46 (4%);2.8.4.3 (4%);2.7.4.22 (3%),Deoxyhypusine synthase (4%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (4%);UMP kinase (3%),GO:0016021 (25%);GO:0005737 (11%);GO:0005886 (8%),integral component of membrane (25%);cytoplasm (11%);plasma membrane (8%),GO:0005524 (14%);GO:0003677 (9%);GO:0046872 (5%),ATP binding (14%);DNA binding (9%);metal ion binding (5%),GO:0006412 (3%);GO:0001682 (2%);GO:0006355 (2%),translation (3%);tRNA 5'-leader removal (2%);regulation of transcription, DNA-templated (2%),IPR027417 (6%);IPR014710 (5%);IPR011051 (5%),P-loop containing nucleoside triphosphate hydrolase (6%);RmlC-like jelly roll fold (5%);RmlC-like cupin domain superfamily (5%),,,,,,,,,,
LVGNAVDAVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLEHCEGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (14%);1.2.1.84 (9%);2.4.-.- (9%),Histidine kinase (14%);Alcohol-forming fatty acyl-CoA reductase (9%);Glycosyltransferases (9%),GO:0016021 (47%);GO:0005886 (37%);GO:0009425 (31%),integral component of membrane (47%);plasma membrane (37%);bacterial-type flagellum basal body (31%),GO:0005524 (12%);GO:0016887 (6%);GO:0000155 (5%),ATP binding (12%);ATPase activity (6%);phosphorelay sensor kinase activity (5%),GO:0009306 (32%);GO:0044781 (31%);GO:0006412 (5%),protein secretion (32%);bacterial-type flagellum organization (31%);translation (5%),IPR005838 (24%);IPR005837 (24%);IPR028103 (14%),Type III secretion system inner membrane P protein (24%);Flagellar transport protein FliP (24%);Spatacsin (14%),,,,,,,,,,,
DYPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.16.4 (15%);6.3.5.4 (9%);7.1.1.- (9%),Serine-type D-Ala-D-Ala carboxypeptidase (15%);Asparagine synthase (glutamine-hydrolyzing) (9%);Hydron translocation or charge separation linked to oxidoreductase reactions (9%),GO:0016021 (17%);GO:0005737 (3%);GO:0005886 (2%),integral component of membrane (17%);cytoplasm (3%);plasma membrane (2%),GO:0004180 (24%);GO:0005524 (15%);GO:0003677 (7%),carboxypeptidase activity (24%);ATP binding (15%);DNA binding (7%),GO:0006541 (4%);GO:0006529 (4%);GO:0005975 (3%),glutamine metabolic process (4%);asparagine biosynthetic process (4%);carbohydrate metabolic process (3%),IPR003709 (24%);IPR009045 (24%);IPR027417 (8%),Peptidase M15B (24%);Hedgehog signalling/DD-peptidase zinc-binding domain superfamily (24%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
AMEALEPK,Halieaceae,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Cellvibrionales,,,,,Halieaceae,,,,,,,,,,,,5.3.1.28 (100%),D-sedoheptulose 7-phosphate isomerase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0008270 (100%);GO:0008968 (100%);GO:0097367 (100%),zinc ion binding (100%);D-sedoheptulose 7-phosphate isomerase activity (100%);carbohydrate derivative binding (100%),GO:0005975 (100%);GO:2001061 (100%),carbohydrate metabolic process (100%);D-glycero-D-manno-heptose 7-phosphate biosynthetic process (100%),IPR001347 (100%);IPR004515 (100%);IPR035461 (100%),Sugar isomerase (SIS) (100%);Phosphoheptose isomerase (100%);GmhA/DiaA (100%),,,,,,,,,,,
EYPALMAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGHAMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (33%);3.1.1.3 (33%);5.1.1.1 (33%),DNA-directed DNA polymerase (33%);Triacylglycerol lipase (33%);Alanine racemase (33%),GO:0016021 (14%);GO:0005737 (7%);GO:0005739 (7%),integral component of membrane (14%);cytoplasm (7%);mitochondrion (7%),GO:0047389 (43%);GO:0000155 (7%);GO:0003676 (7%),glycerophosphocholine phosphodiesterase activity (43%);phosphorelay sensor kinase activity (7%);nucleic acid binding (7%),GO:0046475 (43%);GO:0006260 (7%);GO:0006281 (7%),glycerophospholipid catabolic process (43%);DNA replication (7%);DNA repair (7%),IPR002110 (27%);IPR004331 (27%);IPR020683 (27%),Ankyrin repeat (27%);SPX domain (27%);Ankyrin repeat-containing domain (27%),,,,,,,,,,,
MAPPAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (71%);6.5.1.1 (24%);3.5.1.23 (2%),Peptidylprolyl isomerase (71%);DNA ligase (ATP) (24%);Ceramidase (2%),GO:0019028 (31%);GO:0005634 (24%);GO:0016021 (9%),viral capsid (31%);nucleus (24%);integral component of membrane (9%),GO:0005198 (33%);GO:0003755 (10%);GO:0005524 (7%),structural molecule activity (33%);peptidyl-prolyl cis-trans isomerase activity (10%);ATP binding (7%),GO:0006281 (23%);GO:0006412 (4%);GO:0006260 (4%),DNA repair (23%);translation (4%);DNA replication (4%),IPR013607 (32%);IPR001403 (32%);IPR016184 (32%),Parvovirus coat protein VP1, N-terminal (32%);Parvovirus coat protein VP2 (32%);Capsid/spike protein, ssDNA virus (32%),,,,,,,,,
ALMQPSR,Rothia,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Micrococcales,,,,,Micrococcaceae,,,,Rothia,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMLTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (22%);3.4.24.78 (11%);2.6.1.42 (6%),Acting on ATP; involved in cellular and subcellular movement (22%);GPR endopeptidase (11%);Branched-chain-amino-acid transaminase (6%),GO:0016021 (20%);GO:0005737 (10%);GO:0009380 (5%),integral component of membrane (20%);cytoplasm (10%);excinuclease repair complex (5%),GO:0005524 (13%);GO:0003677 (11%);GO:0008483 (6%),ATP binding (13%);DNA binding (11%);transaminase activity (6%),GO:0006355 (7%);GO:0006289 (5%);GO:0009432 (5%),regulation of transcription, DNA-templated (7%);nucleotide-excision repair (5%);SOS response (5%),IPR027417 (12%);IPR001544 (9%);IPR036038 (9%),P-loop containing nucleoside triphosphate hydrolase (12%);Aminotransferase class IV (9%);Aminotransferase-like, PLP-dependent enzymes (9%),,,,,,,,,
QVTEFPMSLVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSLALAQMTLELLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGVDDVSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNQEAHLNAQHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPNEWDLMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AYPLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.0 (38%);1.-.-.- (8%);1.1.1.100 (8%), (38%);Oxidoreductases (8%);3-oxoacyl-[acyl-carrier-protein] reductase (8%),GO:0016021 (40%);GO:0009279 (23%);GO:0005886 (3%),integral component of membrane (40%);cell outer membrane (23%);plasma membrane (3%),GO:0071949 (15%);GO:0008484 (9%);GO:0046872 (8%),FAD binding (15%);sulfuric ester hydrolase activity (9%);metal ion binding (8%),GO:0045727 (2%);GO:0005975 (1%);GO:0006207 (1%),positive regulation of translation (2%);carbohydrate metabolic process (1%);'de novo' pyrimidine nucleobase biosynthetic process (1%),IPR000531 (17%);IPR012910 (17%);IPR023996 (17%),TonB-dependent receptor-like, beta-barrel (17%);TonB-dependent receptor, plug domain (17%);TonB-dependent outer membrane protein, SusC/RagA (17%),,,,,,,,
TPVAWEFSLPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSPAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.46 (85%);2.3.1.31 (2%);2.7.13.3 (1%),Homoserine O-succinyltransferase (85%);Homoserine O-acetyltransferase (2%);Histidine kinase (1%),GO:0005737 (35%);GO:0016021 (18%);GO:0005886 (1%),cytoplasm (35%);integral component of membrane (18%);plasma membrane (1%),GO:0008899 (34%);GO:0003677 (19%);GO:0005524 (5%),homoserine O-succinyltransferase activity (34%);DNA binding (19%);ATP binding (5%),GO:0009086 (34%);GO:0055085 (6%);GO:0015074 (1%),methionine biosynthetic process (34%);transmembrane transport (6%);DNA integration (1%),IPR029058 (32%);IPR000073 (31%);IPR008220 (30%),Alpha/Beta hydrolase fold (32%);Alpha/beta hydrolase fold-1 (31%);Homoserine/serine acetyltransferase MetX-like (30%),,,,,,,,,,,
MVPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.18 (16%);2.7.1.- (8%);6.3.4.- (7%),Anthranilate phosphoribosyltransferase (16%);Phosphotransferases with an alcohol group as acceptor (8%);Other carbon--nitrogen ligases (7%),GO:0016021 (15%);GO:0005737 (6%);GO:0016020 (5%),integral component of membrane (15%);cytoplasm (6%);membrane (5%),GO:0005524 (24%);GO:0016887 (12%);GO:0046872 (7%),ATP binding (24%);ATPase activity (12%);metal ion binding (7%),GO:0000162 (2%);GO:0006935 (2%);GO:0007165 (2%),tryptophan biosynthetic process (2%);chemotaxis (2%);signal transduction (2%),IPR027417 (15%);IPR003593 (11%);IPR011989 (9%),P-loop containing nucleoside triphosphate hydrolase (15%);AAA+ ATPase domain (11%);Armadillo-like helical (9%),,,,,,,,,,,
EVHHWR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016740 (100%),transferase activity (100%),,,IPR000073 (50%);IPR011990 (50%);IPR013026 (50%),Alpha/beta hydrolase fold-1 (50%);Tetratricopeptide-like helical domain superfamily (50%);Tetratricopeptide repeat-containing domain (50%),,,,,,,,,,,
FVFFLDK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003676 (100%);GO:0008168 (100%),nucleic acid binding (100%);methyltransferase activity (100%),GO:0031167 (100%),rRNA methylation (100%),IPR002052 (100%);IPR004398 (100%);IPR029063 (100%),DNA methylase, N-6 adenine-specific, conserved site (100%);RNA methyltransferase, RsmD (100%);S-adenosyl-L-methionine-dependent methyltransferase (100%),,,,,,,,
FLLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.6.2.11 (54%);2.1.1.170 (4%);2.1.1.- (3%),ABC-type polyamine transporter (54%);16S rRNA (guanine(527)-N(7))-methyltransferase (4%);Methyltransferases (3%),GO:0016021 (32%);GO:0009507 (12%);GO:0043190 (10%),integral component of membrane (32%);chloroplast (12%);ATP-binding cassette (ABC) transporter complex (10%),GO:0005524 (19%);GO:0003723 (13%);GO:0016887 (10%),ATP binding (19%);RNA binding (13%);ATPase activity (10%),GO:0006397 (12%);GO:0008033 (12%);GO:0030042 (4%),mRNA processing (12%);tRNA processing (12%);actin filament depolymerization (4%),IPR027417 (13%);IPR002866 (10%);IPR024942 (10%),P-loop containing nucleoside triphosphate hydrolase (13%);Maturase MatK (10%);Maturase MatK, N-terminal domain (10%),,,,,,,,,,
MMMQWAKPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAPCPSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EENTVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.2 (22%);6.1.1.15 (22%);6.1.1.20 (22%),Non-specific protein-tyrosine kinase (22%);Proline--tRNA ligase (22%);Phenylalanine--tRNA ligase (22%),GO:0016021 (35%);GO:0005737 (9%);GO:0005634 (3%),integral component of membrane (35%);cytoplasm (9%);nucleus (3%),GO:0005524 (26%);GO:0003676 (19%);GO:0046872 (7%),ATP binding (26%);nucleic acid binding (19%);metal ion binding (7%),GO:0006432 (5%);GO:0006433 (5%);GO:0006099 (3%),phenylalanyl-tRNA aminoacylation (5%);prolyl-tRNA aminoacylation (5%);tricarboxylic acid cycle (3%),IPR003864 (16%);IPR026957 (16%);IPR027815 (16%),Calcium-dependent channel, 7TM region, putative phosphate (16%);CSC1-like protein 1 (16%);10TM putative phosphate transporter, cytosolic domain (16%),,,,,,,,
HYTSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (49%);2.4.1.- (4%);2.7.3.9 (4%),DNA topoisomerase (49%);Hexosyltransferases (4%);Phosphoenolpyruvate--protein phosphotransferase (4%),GO:0032300 (65%);GO:0016021 (14%);GO:0005634 (9%),mismatch repair complex (65%);integral component of membrane (14%);nucleus (9%),GO:0005524 (67%);GO:0016887 (67%);GO:0030983 (63%),ATP binding (67%);ATPase activity (67%);mismatched DNA binding (63%),GO:0006298 (66%);GO:0006605 (3%);GO:0043952 (3%),mismatch repair (66%);protein targeting (3%);protein transport by the Sec complex (3%),IPR036890 (64%);IPR038973 (63%);IPR013507 (61%),Histidine kinase/HSP90-like ATPase superfamily (64%);DNA mismatch repair protein MutL/Mlh/Pms (63%);DNA mismatch repair protein,  S5 domain 2-like (61%),,,,,,,,,,
WNGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.- (84%);2.4.1.- (4%);3.4.-.- (4%),Peroxidases (84%);Hexosyltransferases (4%);Acting on peptide bonds (peptidases) (4%),GO:0016021 (24%);GO:0005886 (4%);GO:0031225 (3%),integral component of membrane (24%);plasma membrane (4%);anchored component of membrane (3%),GO:0004601 (62%);GO:0046872 (62%);GO:0020037 (62%),peroxidase activity (62%);metal ion binding (62%);heme binding (62%),GO:0006979 (58%);GO:0005975 (3%);GO:0009058 (3%),response to oxidative stress (58%);carbohydrate metabolic process (3%);biosynthetic process (3%),IPR002016 (53%);IPR010255 (53%);IPR002207 (52%),Haem peroxidase (53%);Haem peroxidase superfamily (53%);Class I peroxidase (52%),,,,,,,,,,,
FTNNHMMYSSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HAQFSNLEM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHLLMSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGLSTSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (17%);GO:0034464 (7%);GO:0005634 (3%),integral component of membrane (17%);BBSome (7%);nucleus (3%),GO:0003677 (62%);GO:0005524 (7%);GO:0003676 (3%),DNA binding (62%);ATP binding (7%);nucleic acid binding (3%),GO:0006355 (52%);GO:1905515 (7%);GO:0006310 (3%),regulation of transcription, DNA-templated (52%);non-motile cilium assembly (7%);DNA recombination (3%),IPR000551 (36%);IPR009061 (36%);IPR006530 (13%),MerR-type HTH domain (36%);Putative DNA-binding domain superfamily (36%);YD repeat (13%),,,,,,,,,,
CEEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.7 (87%);6.3.1.2 (3%);1.2.4.1 (2%),Glutaminyl-tRNA synthase (glutamine-hydrolyzing) (87%);Glutamine synthetase (3%);Pyruvate dehydrogenase (acetyl-transferring) (2%),GO:0016021 (30%);GO:0030956 (30%);GO:0005576 (27%),integral component of membrane (30%);glutamyl-tRNA(Gln) amidotransferase complex (30%);extracellular region (27%),GO:0005524 (38%);GO:0050567 (31%);GO:0004040 (30%),ATP binding (38%);glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity (31%);amidase activity (30%),GO:0006412 (31%);GO:0006030 (3%);GO:0001558 (3%),translation (31%);chitin metabolic process (3%);regulation of cell growth (3%),IPR000120 (27%);IPR023631 (27%);IPR036928 (27%),Amidase (27%);Amidase signature domain (27%);Amidase signature (AS) superfamily (27%),,,,,,,,,,,
VSLVANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (22%);GO:0043190 (11%),integral component of membrane (22%);ATP-binding cassette (ABC) transporter complex (11%),GO:0005524 (33%);GO:0004326 (22%);GO:0003924 (11%),ATP binding (33%);tetrahydrofolylpolyglutamate synthase activity (22%);GTPase activity (11%),GO:0051301 (11%);GO:0055085 (11%),cell division (11%);transmembrane transport (11%),IPR001645 (25%);IPR013221 (25%);IPR018109 (25%),Folylpolyglutamate synthetase (25%);Mur ligase, central (25%);Folylpolyglutamate synthetase, conserved site (25%),,,,,,,,,
GYELNHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (50%);GO:0009507 (25%),cytoplasm (50%);chloroplast (25%),GO:0003676 (25%);GO:0004519 (25%);GO:0004725 (25%),nucleic acid binding (25%);endonuclease activity (25%);protein tyrosine phosphatase activity (25%),GO:0017148 (50%);GO:0042256 (50%);GO:0090071 (50%),negative regulation of translation (50%);mature ribosome assembly (50%);negative regulation of ribosome biogenesis (50%),IPR004394 (33%);IPR000477 (17%);IPR002711 (17%),Protein Iojap/ribosomal silencing factor RsfS (33%);Reverse transcriptase domain (17%);HNH endonuclease (17%),,,,,,,,,,,
LVLMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.3 (31%);3.1.4.- (19%);7.-.-.- (19%),Long-chain-fatty-acid--CoA ligase (31%);Phosphoric diester hydrolases (19%);Translocases (19%),GO:0016021 (23%);GO:0005886 (2%);GO:0032040 (1%),integral component of membrane (23%);plasma membrane (2%);small-subunit processome (1%),GO:0016874 (25%);GO:0003993 (20%);GO:0046872 (14%),ligase activity (25%);acid phosphatase activity (20%);metal ion binding (14%),GO:0000902 (19%);GO:0035556 (4%);GO:0055085 (1%),cell morphogenesis (19%);intracellular signal transduction (4%);transmembrane transport (1%),IPR000873 (31%);IPR020845 (30%);IPR025110 (27%),AMP-dependent synthetase/ligase (31%);AMP-binding, conserved site (30%);AMP-binding enzyme, C-terminal domain (27%),,,,,,,,,
MAPEGSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GEFAVMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (50%);GO:0016021 (50%),cytoplasm (50%);integral component of membrane (50%),,,GO:0006415 (50%),translational termination (50%),IPR002661 (33%);IPR002840 (33%);IPR003114 (33%),Ribosome recycling factor (33%);Aconitase X swivel domain, putative (33%);Phox-associated domain (33%),,,,,,,,,,
QMLLADLFAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLTPMPK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTPAALMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (7%);2.7.7.- (7%);3.1.-.- (4%),DNA helicase (7%);Nucleotidyltransferases (7%);Acting on ester bonds (4%),GO:0016021 (36%);GO:0005737 (3%);GO:0005886 (3%),integral component of membrane (36%);cytoplasm (3%);plasma membrane (3%),GO:0005524 (13%);GO:0003677 (8%);GO:0046872 (4%),ATP binding (13%);DNA binding (8%);metal ion binding (4%),GO:0006355 (3%);GO:0032259 (3%);GO:0006952 (3%),regulation of transcription, DNA-templated (3%);methylation (3%);defense response (3%),IPR027417 (10%);IPR008429 (8%);IPR015943 (3%),P-loop containing nucleoside triphosphate hydrolase (10%);Cleft lip and palate transmembrane 1 (8%);WD40/YVTN repeat-like-containing domain superfamily (3%),,,,,,,,,,
LAQSMVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGVHPHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPTLMMPTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYMFQWLMPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFQHMYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNGLVDNHEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEVPLVVLNHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVASNAQAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPSEQLVPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HVMFSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNGANSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNEHFSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPELMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.170 (56%);1.-.-.- (12%);2.7.7.6 (8%),Anhydro-N-acetylmuramic acid kinase (56%);Oxidoreductases (12%);DNA-directed RNA polymerase (8%),GO:0005829 (34%);GO:0016021 (17%);GO:0005634 (2%),cytosol (34%);integral component of membrane (17%);nucleus (2%),GO:0031593 (34%);GO:0003677 (10%);GO:0005524 (10%),polyubiquitin modification-dependent protein binding (34%);DNA binding (10%);ATP binding (10%),GO:0006511 (34%);GO:0005975 (15%);GO:0006040 (6%),ubiquitin-dependent protein catabolic process (34%);carbohydrate metabolic process (15%);amino sugar metabolic process (6%),IPR015496 (81%);IPR006636 (81%);IPR000626 (74%),Ubiquilin (81%);Heat shock chaperonin-binding (81%);Ubiquitin-like domain (74%),,,,,,,,,,,
SEVFAGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.37 (24%);5.4.99.9 (13%);2.1.1.63 (6%),Malate dehydrogenase (24%);UDP-galactopyranose mutase (13%);Methylated-DNA--[protein]-cysteine S-methyltransferase (6%),GO:0016021 (31%);GO:0005886 (13%);GO:0005737 (3%),integral component of membrane (31%);plasma membrane (13%);cytoplasm (3%),GO:0005524 (12%);GO:0016597 (9%);GO:0016743 (8%),ATP binding (12%);amino acid binding (9%);carboxyl- or carbamoyltransferase activity (8%),GO:0009306 (12%);GO:0006520 (8%);GO:0005975 (6%),protein secretion (12%);cellular amino acid metabolic process (8%);carbohydrate metabolic process (6%),IPR003004 (16%);IPR018076 (16%);IPR042094 (16%),GspF/PilC family (16%);Type II secretion system F domain (16%);Type II secretion system F domain superfamily (16%),,,,,,,,,,,
LLFNMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.102 (40%);1.9.3.1 (20%);2.3.1.286 (20%),C-terminal processing peptidase (40%);Cytochrome-c oxidase (20%);Protein acetyllysine N-acetyltransferase (20%),GO:0016021 (15%);GO:0043190 (5%);GO:0009279 (4%),integral component of membrane (15%);ATP-binding cassette (ABC) transporter complex (5%);cell outer membrane (4%),GO:0003677 (57%);GO:0016987 (56%);GO:0003700 (47%),DNA binding (57%);sigma factor activity (56%);DNA-binding transcription factor activity (47%),GO:0006352 (47%);GO:0055085 (6%);GO:0009306 (5%),DNA-templated transcription, initiation (47%);transmembrane transport (6%);protein secretion (5%),IPR013249 (54%);IPR013324 (54%);IPR014284 (54%),RNA polymerase sigma factor 70, region 4 type 2 (54%);RNA polymerase sigma factor, region 3/4-like (54%);RNA polymerase sigma-70 like domain (54%),,,,,,,,
TLLHWMLEMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DWQCWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYMQEDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEEHQYVQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLMFSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.16 (50%);2.1.1.80 (25%);2.6.1.- (25%),Acetyl-CoA C-acyltransferase (50%);Protein-glutamate O-methyltransferase (25%);Transaminases (25%),GO:0015627 (11%);GO:0016021 (11%),type II protein secretion system complex (11%);integral component of membrane (11%),GO:0004814 (33%);GO:0005524 (33%);GO:0003988 (22%),arginine-tRNA ligase activity (33%);ATP binding (33%);acetyl-CoA C-acyltransferase activity (22%),GO:0006420 (33%);GO:0015628 (11%),arginyl-tRNA aminoacylation (33%);protein secretion by the type II secretion system (11%),IPR001278 (25%);IPR008909 (25%);IPR009080 (25%),Arginine-tRNA ligase (25%);DALR anticodon binding (25%);Aminoacyl-tRNA synthetase, class Ia, anticodon-binding (25%),,,,,,,,,
HLSVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.14.5 (22%);6.3.5.5 (18%);2.3.1.48 (13%),Alkanesulfonate monooxygenase (22%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (18%);Histone acetyltransferase (13%),GO:0016021 (16%);GO:0005634 (6%);GO:0005737 (5%),integral component of membrane (16%);nucleus (6%);cytoplasm (5%),GO:0003677 (25%);GO:0005524 (15%);GO:0046872 (14%),DNA binding (25%);ATP binding (15%);metal ion binding (14%),GO:0006355 (5%);GO:0006281 (3%);GO:0044205 (3%),regulation of transcription, DNA-templated (5%);DNA repair (3%);'de novo' UMP biosynthetic process (3%),IPR027417 (14%);IPR036388 (12%);IPR036390 (12%),P-loop containing nucleoside triphosphate hydrolase (14%);Winged helix-like DNA-binding domain superfamily (12%);Winged helix DNA-binding domain superfamily (12%),,,,,,,,,,
RPDLENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.3 (50%);7.6.2.1 (50%),Ribonuclease III (50%);P-type phospholipid transporter (50%),GO:0005634 (46%);GO:0005737 (8%);GO:0016021 (8%),nucleus (46%);cytoplasm (8%);integral component of membrane (8%),GO:0003677 (54%);GO:0000287 (8%);GO:0003777 (8%),DNA binding (54%);magnesium ion binding (8%);microtubule motor activity (8%),GO:0006260 (8%);GO:0006364 (8%);GO:0006397 (8%),DNA replication (8%);rRNA processing (8%);mRNA processing (8%),IPR009071 (43%);IPR036910 (43%);IPR000425 (7%),High mobility group box domain (43%);High mobility group box domain superfamily (43%);Major intrinsic protein (7%),,,,,,,,,,,
ARPWNVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEEGMAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.2.2 (100%),H(+)-transporting two-sector ATPase (100%),GO:0005886 (33%);GO:0045261 (33%),plasma membrane (33%);proton-transporting ATP synthase complex, catalytic core F(1) (33%),GO:0005524 (50%);GO:0016787 (50%);GO:0046933 (33%),ATP binding (50%);hydrolase activity (50%);proton-transporting ATP synthase activity, rotational mechanism (33%),GO:0015986 (33%);GO:0015937 (17%);GO:0015941 (17%),ATP synthesis coupled proton transport (33%);coenzyme A biosynthetic process (17%);pantothenate catabolic process (17%),IPR000194 (50%);IPR027417 (50%);IPR000073 (33%),ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain (50%);P-loop containing nucleoside triphosphate hydrolase (50%);Alpha/beta hydrolase fold-1 (33%),,,,,,
ESCATNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPLAQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (100%),Glycogen phosphorylase (100%),GO:0016021 (50%),integral component of membrane (50%),GO:0005085 (50%);GO:0005509 (50%);GO:0008184 (50%),guanyl-nucleotide exchange factor activity (50%);calcium ion binding (50%);glycogen phosphorylase activity (50%),GO:0005975 (50%);GO:0007264 (50%),carbohydrate metabolic process (50%);small GTPase mediated signal transduction (50%),IPR000651 (33%);IPR000811 (33%);IPR001478 (33%),Ras-like guanine nucleotide exchange factor, N-terminal (33%);Glycosyl transferase, family 35 (33%);PDZ domain (33%),,,,,,,,,
GPAGPTGAASCSHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EKPESSAAAGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.140 (33%);3.5.2.6 (13%);7.1.1.2 (13%),Sorbitol-6-phosphate 2-dehydrogenase (33%);Beta-lactamase (13%);NADH:ubiquinone reductase (H(+)-translocating) (13%),GO:0016021 (15%);GO:0005634 (3%);GO:0005737 (2%),integral component of membrane (15%);nucleus (3%);cytoplasm (2%),GO:0050661 (48%);GO:0016491 (48%);GO:0005524 (14%),NADP binding (48%);oxidoreductase activity (48%);ATP binding (14%),GO:0006355 (2%);GO:0006633 (2%);GO:0009089 (1%),regulation of transcription, DNA-templated (2%);fatty acid biosynthetic process (2%);lysine biosynthetic process via diaminopimelate (1%),IPR036291 (70%);IPR013974 (61%);IPR005106 (22%),NAD(P)-binding domain superfamily (70%);SAF domain (61%);Aspartate/homoserine dehydrogenase, NAD-binding (22%),,,,,,,,,
FFFAMAYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNYLVDVPVDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGWALMELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDPDSPGTPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLLHLMVVSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNAWVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.149 (63%);4.1.3.40 (38%),Phenylacetyl-CoA 1,2-epoxidase (63%);Chorismate lyase (38%),GO:0005737 (8%);GO:0005886 (3%);GO:0016021 (3%),cytoplasm (8%);plasma membrane (3%);integral component of membrane (3%),GO:0097266 (79%);GO:0005524 (11%);GO:0008813 (8%),phenylacetyl-CoA 1,2-epoxidase activity (79%);ATP binding (11%);chorismate lyase activity (8%),GO:0010124 (76%);GO:0006744 (8%);GO:0042866 (8%),phenylacetate catabolic process (76%);ubiquinone biosynthetic process (8%);pyruvate biosynthetic process (8%),IPR007814 (78%);IPR009078 (78%);IPR012347 (78%),1,2-phenylacetyl-CoA epoxidase, subunit A/C (78%);Ferritin-like superfamily (78%);Ferritin-like (78%),,,,,,,
VTVNMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.13 (100%),tRNA-uridine 2-sulfurtransferase (100%),GO:0016021 (34%);GO:0005737 (11%);GO:0005634 (1%),integral component of membrane (34%);cytoplasm (11%);nucleus (1%),GO:0005524 (51%);GO:0004672 (39%);GO:0000049 (11%),ATP binding (51%);protein kinase activity (39%);tRNA binding (11%),GO:0006400 (11%);GO:0032259 (3%);GO:0006935 (1%),tRNA modification (11%);methylation (3%);chemotaxis (1%),IPR000719 (51%);IPR011009 (51%);IPR001245 (42%),Protein kinase domain (51%);Protein kinase-like domain superfamily (51%);Serine-threonine/tyrosine-protein kinase, catalytic domain (42%),,,,,,,,,,
AVPMGNPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YMPEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.2 (25%);6.1.1.9 (22%);5.6.2.1 (22%),Pectate lyase (25%);Valine--tRNA ligase (22%);DNA topoisomerase (22%),GO:0016021 (26%);GO:0005634 (10%);GO:0005737 (5%),integral component of membrane (26%);nucleus (10%);cytoplasm (5%),GO:0005524 (25%);GO:0046872 (17%);GO:0003677 (13%),ATP binding (25%);metal ion binding (17%);DNA binding (13%),GO:0045490 (4%);GO:0006265 (4%);GO:0006284 (4%),pectin catabolic process (4%);DNA topological change (4%);base-excision repair (4%),IPR009003 (16%);IPR009057 (10%);IPR006447 (8%),Peptidase S1, PA clan (16%);Homeobox-like domain superfamily (10%);Myb domain, plants (8%),,,,,,,,,
NGPLDEN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSLPRPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.21 (100%),Beta-glucosidase (100%),,,GO:0004553 (88%);GO:0016798 (6%);GO:0008422 (3%),hydrolase activity, hydrolyzing O-glycosyl compounds (88%);hydrolase activity, acting on glycosyl bonds (6%);beta-glucosidase activity (3%),GO:0005975 (91%);GO:0008152 (6%);GO:0006434 (2%),carbohydrate metabolic process (91%);metabolic process (6%);seryl-tRNA aminoacylation (2%),IPR013783 (96%);IPR026891 (96%);IPR036881 (95%),Immunoglobulin-like fold (96%);Fibronectin type III-like domain (96%);Glycoside hydrolase family 3 C-terminal domain superfamily (95%),,,,,,,,,
SSANQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.12 (38%);2.4.1.- (38%);3.2.1.- (13%),D-lactate dehydrogenase (quinone) (38%);Hexosyltransferases (38%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (13%),GO:0005730 (17%);GO:0016021 (14%);GO:0016020 (5%),nucleolus (17%);integral component of membrane (14%);membrane (5%),GO:0005524 (47%);GO:0004386 (28%);GO:0003724 (22%),ATP binding (47%);helicase activity (28%);RNA helicase activity (22%),GO:0000462 (17%);GO:0050881 (4%);GO:0006355 (2%),maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (17%);musculoskeletal movement (4%);regulation of transcription, DNA-templated (2%),IPR027417 (49%);IPR001650 (44%);IPR014001 (42%),P-loop containing nucleoside triphosphate hydrolase (49%);Helicase, C-terminal (44%);Helicase superfamily 1/2, ATP-binding domain (42%),,,,,
MDLYYSK,Zostera marina,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Alismatales,,,,,Zosteraceae,,,,Zostera,,,,Zostera marina,,,,,,,,,,,,IPR022801 (100%),Ribosomal protein S4/S9 (100%),,,,,,,,,,,
QTHDGDVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NADLAQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (8%);GO:0016021 (8%),cell (8%);integral component of membrane (8%),GO:0046872 (29%);GO:0003677 (21%);GO:0003700 (21%),metal ion binding (29%);DNA binding (21%);DNA-binding transcription factor activity (21%),GO:0006270 (21%);GO:0006352 (21%);GO:0045454 (8%),DNA replication initiation (21%);DNA-templated transcription, initiation (21%);cell redox homeostasis (8%),IPR002780 (20%);IPR042243 (20%);IPR000792 (17%),Hydrogenase formation HypD protein (20%);HypD, domain 2 (20%);Transcription regulator LuxR, C-terminal (17%),,,,,,,,
TLLNGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (11%);3.5.2.3 (9%);2.7.4.25 (5%),DNA-directed DNA polymerase (11%);Dihydroorotase (9%);(d)CMP kinase (5%),GO:0016021 (23%);GO:0005634 (6%);GO:0009279 (5%),integral component of membrane (23%);nucleus (6%);cell outer membrane (5%),GO:0005524 (14%);GO:0003677 (11%);GO:0004252 (6%),ATP binding (14%);DNA binding (11%);serine-type endopeptidase activity (6%),GO:0000160 (6%);GO:0006355 (5%);GO:0005975 (3%),phosphorelay signal transduction system (6%);regulation of transcription, DNA-templated (5%);carbohydrate metabolic process (3%),IPR027417 (7%);IPR001789 (5%);IPR011006 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Signal transduction response regulator, receiver domain (5%);CheY-like superfamily (5%),,,,,,,,,
MYLDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.48 (86%);5.3.1.1 (14%),Histone acetyltransferase (86%);Triose-phosphate isomerase (14%),GO:0005634 (30%);GO:0016021 (25%);GO:0005737 (5%),nucleus (30%);integral component of membrane (25%);cytoplasm (5%),GO:0004402 (30%);GO:0046872 (30%);GO:0003677 (15%),histone acetyltransferase activity (30%);metal ion binding (30%);DNA binding (15%),GO:0006355 (30%);GO:0006094 (5%);GO:0006096 (5%),regulation of transcription, DNA-templated (30%);gluconeogenesis (5%);glycolytic process (5%),IPR003718 (26%);IPR015946 (26%);IPR036102 (26%),OsmC/Ohr family (26%);K homology domain-like, alpha/beta (26%);OsmC/Ohr superfamily (26%),,,,,,,,,
WNWYFVQEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HVANMHMGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEEYYWMDGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVPLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (98%);4.2.1.24 (2%),Electron-transferring-flavoprotein dehydrogenase (98%);Porphobilinogen synthase (2%),GO:0031305 (18%);GO:0016021 (15%);GO:0005730 (1%),integral component of mitochondrial inner membrane (18%);integral component of membrane (15%);nucleolus (1%),GO:0046872 (79%);GO:0004174 (78%);GO:0051539 (78%),metal ion binding (79%);electron-transferring-flavoprotein dehydrogenase activity (78%);4 iron, 4 sulfur cluster binding (78%),GO:0006979 (18%);GO:0033539 (18%);GO:0022904 (3%),response to oxidative stress (18%);fatty acid beta-oxidation using acyl-CoA dehydrogenase (18%);respiratory electron transport chain (3%),IPR036188 (78%);IPR040156 (78%);IPR017896 (74%),FAD/NAD(P)-binding domain superfamily (78%);Electron transfer flavoprotein-ubiquinone oxidoreductase (78%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (74%),,,,,,,,,
DYDLVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003676 (50%),nucleic acid binding (50%),,,IPR004875 (100%);IPR006600 (100%),DDE superfamily endonuclease domain (100%);HTH CenpB-type DNA-binding domain (100%),,,,,,,,,,,
GNNCAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SHFPTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (50%);1.1.5.3 (25%);2.7.1.167 (25%),Acting on ATP; involved in cellular and subcellular movement (50%);Glycerol-3-phosphate dehydrogenase (25%);D-glycero-beta-D-manno-heptose-7-phosphate kinase (25%),GO:0016021 (48%);GO:0009986 (39%);GO:1990077 (4%),integral component of membrane (48%);cell surface (39%);primosome complex (4%),GO:0008146 (22%);GO:0003677 (9%);GO:0005524 (6%),sulfotransferase activity (22%);DNA binding (9%);ATP binding (6%),GO:0006268 (4%);GO:0006269 (4%);GO:0006072 (2%),DNA unwinding involved in DNA replication (4%);DNA replication, synthesis of RNA primer (4%);glycerol-3-phosphate metabolic process (2%),IPR038877 (39%);IPR000884 (37%);IPR036383 (37%),Thrombospondin type-1 domain-containing protein 1 (39%);Thrombospondin type-1 (TSP1) repeat (37%);Thrombospondin type-1 (TSP1) repeat superfamily (37%),,,,,,,,,,
TLGPVTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AKPPVMFTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPWHNK,Lachancea mirantina,Eukaryota,Fungi,Dikarya,,Ascomycota,Saccharomycotina,,Saccharomycetes,,,,Saccharomycetales,,,,,Saccharomycetaceae,,,,Lachancea,,,,Lachancea mirantina,,,,1.14.19.17 (100%),Sphingolipid 4-desaturase (100%),GO:0016021 (100%),integral component of membrane (100%),GO:0042284 (100%),sphingolipid delta-4 desaturase activity (100%),GO:0030148 (100%),sphingolipid biosynthetic process (100%),IPR005804 (100%);IPR011388 (100%);IPR013866 (100%),Fatty acid desaturase domain (100%);Sphingolipid delta4-desaturase (100%);Sphingolipid delta4-desaturase, N-terminal (100%),,,,,,,,,,
SSHLLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (50%);3.1.-.- (20%);7.1.1.2 (20%),Histidine kinase (50%);Acting on ester bonds (20%);NADH:ubiquinone reductase (H(+)-translocating) (20%),GO:0016021 (31%);GO:1990112 (28%);GO:0005743 (6%),integral component of membrane (31%);RQC complex (28%);mitochondrial inner membrane (6%),GO:0061630 (28%);GO:0008270 (25%);GO:0005524 (22%),ubiquitin protein ligase activity (28%);zinc ion binding (25%);ATP binding (22%),GO:1990116 (28%);GO:0006412 (6%);GO:0042773 (6%),ribosome-associated ubiquitin-dependent protein catabolic process (28%);translation (6%);ATP synthesis coupled electron transport (6%),IPR039795 (25%);IPR013083 (22%);IPR016024 (22%),E3 ubiquitin-protein ligase listerin (25%);Zinc finger, RING/FYVE/PHD-type (22%);Armadillo-type fold (22%),,,,,,,,,,
TAYLDEASR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPALMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (54%);1.1.1.169 (8%);1.4.1.9 (8%),RNA-directed RNA polymerase (54%);2-dehydropantoate 2-reductase (8%);Leucine dehydrogenase (8%),GO:0016021 (21%);GO:0005634 (3%);GO:0015935 (3%),integral component of membrane (21%);nucleus (3%);small ribosomal subunit (3%),GO:0003824 (26%);GO:0003723 (9%);GO:0003968 (9%),catalytic activity (26%);RNA binding (9%);RNA-directed 5'-3' RNA polymerase activity (9%),GO:0031047 (6%);GO:0006520 (5%);GO:0006281 (4%),gene silencing by RNA (6%);cellular amino acid metabolic process (5%);DNA repair (4%),IPR000873 (22%);IPR025110 (21%);IPR042099 (21%),AMP-dependent synthetase/ligase (22%);AMP-binding enzyme, C-terminal domain (21%);AMP-dependent synthetase-like superfamily (21%),,,,,,,,,,
NYCSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.286 (18%);7.3.2.2 (18%);1.8.98.1 (14%),Protein acetyllysine N-acetyltransferase (18%);ABC-type phosphonate transporter (18%);Dihydromethanophenazine:CoB--CoM heterodisulfide reductase (14%),GO:0016021 (28%);GO:0005886 (10%);GO:0005737 (3%),integral component of membrane (28%);plasma membrane (10%);cytoplasm (3%),GO:0016491 (44%);GO:0004984 (10%);GO:0004930 (9%),oxidoreductase activity (44%);olfactory receptor activity (10%);G protein-coupled receptor activity (9%),GO:0000160 (7%);GO:0006637 (2%);GO:0005975 (2%),phosphorelay signal transduction system (7%);acyl-CoA metabolic process (2%);carbohydrate metabolic process (2%),IPR036188 (43%);IPR017896 (41%);IPR023753 (40%),FAD/NAD(P)-binding domain superfamily (43%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (41%);FAD/NAD(P)-binding domain (40%),,,,,,,,,,
YFNWTTEVSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMQHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.18 (50%);3.1.21.3 (22%);1.1.1.3 (11%),5-(carboxyamino)imidazole ribonucleotide synthase (50%);Type I site-specific deoxyribonuclease (22%);Homoserine dehydrogenase (11%),GO:0016021 (16%);GO:0005623 (5%);GO:0005634 (4%),integral component of membrane (16%);cell (5%);nucleus (4%),GO:0003677 (30%);GO:0005524 (28%);GO:0004638 (10%),DNA binding (30%);ATP binding (28%);phosphoribosylaminoimidazole carboxylase activity (10%),GO:0015074 (14%);GO:0006310 (12%);GO:0006189 (10%),DNA integration (14%);DNA recombination (12%);'de novo' IMP biosynthetic process (10%),IPR027417 (15%);IPR010998 (12%);IPR011010 (12%),P-loop containing nucleoside triphosphate hydrolase (15%);Integrase/recombinase, N-terminal (12%);DNA breaking-rejoining enzyme, catalytic core (12%),,,,,,,,,
RPLEMLDYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVMTVWPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMNTGWLNQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQWNMFLANPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHLPLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0090729 (50%),toxin activity (50%),,,IPR036716 (50%);IPR038731 (50%),Pesticidal crystal protein, N-terminal domain superfamily (50%);Glycosyltransferase RgtA/B/C/D-like (50%),,,,,,,,,,
FHVWAENR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.94 (23%);2.7.7.9 (12%);2.3.2.27 (9%),Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (23%);UTP--glucose-1-phosphate uridylyltransferase (12%);RING-type E3 ubiquitin transferase (9%),GO:0005634 (23%);GO:0016021 (22%);GO:0009331 (4%),nucleus (23%);integral component of membrane (22%);glycerol-3-phosphate dehydrogenase complex (4%),GO:0003677 (24%);GO:0005524 (13%);GO:0051287 (5%),DNA binding (24%);ATP binding (13%);NAD binding (5%),GO:0005975 (5%);GO:0006650 (4%);GO:0008654 (4%),carbohydrate metabolic process (5%);glycerophospholipid metabolic process (4%);phospholipid biosynthetic process (4%),IPR009057 (18%);IPR001005 (16%);IPR015495 (16%),Homeobox-like domain superfamily (18%);SANT/Myb domain (16%);Myb-like transcription factor (16%),,,,,,,,,,,
MEFAALVYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THKPLHR,Salmoninae,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,,Salmoniformes,,,,,Salmonidae,Salmoninae,,,,,,,,,,,,,,,,,GO:2001106 (100%),regulation of Rho guanyl-nucleotide exchange factor activity (100%),IPR033588 (100%),Cell cycle progression protein 1 (100%),,,,,,,,,,,
LGLSTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.3 (28%);2.7.7.7 (27%);2.7.1.16 (5%),Phosphoribosylformylglycinamidine synthase (28%);DNA-directed DNA polymerase (27%);Ribulokinase (5%),GO:0016021 (28%);GO:0005737 (7%);GO:0005886 (2%),integral component of membrane (28%);cytoplasm (7%);plasma membrane (2%),GO:0003677 (26%);GO:0005524 (11%);GO:0003887 (8%),DNA binding (26%);ATP binding (11%);DNA-directed DNA polymerase activity (8%),GO:0006281 (8%);GO:0006261 (7%);GO:0006355 (7%),DNA repair (8%);DNA-dependent DNA replication (7%);regulation of transcription, DNA-templated (7%),IPR012337 (8%);IPR036397 (8%);IPR027417 (7%),Ribonuclease H-like superfamily (8%);Ribonuclease H superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,
YNGMAPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTWHSSYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAGQWVRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WSQEMQLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNAGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.20 (28%);4.3.3.7 (10%);2.5.1.145 (5%),Tryptophan synthase (28%);4-hydroxy-tetrahydrodipicolinate synthase (10%);Phosphatidylglycerol--prolipoprotein diacylglyceryl transferase (5%),GO:0016021 (25%);GO:0005634 (4%);GO:0005886 (4%),integral component of membrane (25%);nucleus (4%);plasma membrane (4%),GO:0005524 (9%);GO:0003677 (8%);GO:0008410 (6%),ATP binding (9%);DNA binding (8%);CoA-transferase activity (6%),GO:0006355 (5%);GO:0006310 (2%);GO:0005975 (2%),regulation of transcription, DNA-templated (5%);DNA recombination (2%);carbohydrate metabolic process (2%),IPR027417 (7%);IPR029069 (6%);IPR003673 (6%),P-loop containing nucleoside triphosphate hydrolase (7%);HotDog domain superfamily (6%);CoA-transferase family III (6%),,,,,,,,,,
DDTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (22%);2.2.1.1 (14%);3.1.1.96 (11%),Phenylalanine--tRNA ligase (22%);Transketolase (14%);D-aminoacyl-tRNA deacylase (11%),GO:0016021 (21%);GO:0005737 (13%);GO:0005634 (5%),integral component of membrane (21%);cytoplasm (13%);nucleus (5%),GO:0046872 (15%);GO:0005524 (14%);GO:0003677 (7%),metal ion binding (15%);ATP binding (14%);DNA binding (7%),GO:0006412 (5%);GO:0051131 (3%);GO:0006396 (2%),translation (5%);chaperone-mediated protein complex assembly (3%);RNA processing (2%),IPR009014 (6%);IPR027417 (5%);IPR029061 (5%),Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II (6%);P-loop containing nucleoside triphosphate hydrolase (5%);Thiamin diphosphate-binding fold (5%),,,,,,,,,,,
DTDGDFGVESASPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHCAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.3 (33%);1.-.-.- (7%);1.1.1.195 (7%),Glycerol-3-phosphate dehydrogenase (33%);Oxidoreductases (7%);Cinnamyl-alcohol dehydrogenase (7%),GO:0005847 (51%);GO:0016021 (9%);GO:0005737 (5%),mRNA cleavage and polyadenylation specificity factor complex (51%);integral component of membrane (9%);cytoplasm (5%),GO:0003723 (51%);GO:0003824 (6%);GO:0015562 (6%),RNA binding (51%);catalytic activity (6%);efflux transmembrane transporter activity (6%),GO:0006378 (51%);GO:0006379 (51%);GO:0035194 (4%),mRNA polyadenylation (51%);mRNA cleavage (51%);posttranscriptional gene silencing by RNA (4%),IPR036866 (45%);IPR027075 (44%);IPR011108 (43%),Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (45%);Cleavage and polyadenylation specificity factor subunit 2 (44%);Zn-dependent metallo-hydrolase, RNA specificity domain (43%),,,,,,,,,,
MNRPVMYGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLPNGLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (4%);GO:0016020 (4%);GO:0016021 (4%),cell outer membrane (4%);membrane (4%);integral component of membrane (4%),GO:0016874 (50%);GO:0031177 (42%);GO:0003676 (13%),ligase activity (50%);phosphopantetheine binding (42%);nucleic acid binding (13%),GO:0015074 (13%);GO:0034219 (8%);GO:0005975 (4%),DNA integration (13%);carbohydrate transmembrane transport (8%);carbohydrate metabolic process (4%),IPR000873 (40%);IPR001242 (40%);IPR006162 (40%),AMP-dependent synthetase/ligase (40%);Condensation domain (40%);Phosphopantetheine attachment site (40%),,,,,,,,,,,
VMTVHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (89%);3.1.-.- (9%);3.1.11.5 (2%),DNA helicase (89%);Acting on ester bonds (9%);Exodeoxyribonuclease V (2%),GO:0016021 (1%),integral component of membrane (1%),GO:0005524 (98%);GO:0003677 (97%);GO:0003678 (97%),ATP binding (98%);DNA binding (97%);DNA helicase activity (97%),GO:0006281 (29%);GO:0006302 (3%);GO:0000724 (1%),DNA repair (29%);double-strand break repair (3%);double-strand break repair via homologous recombination (1%),IPR000212 (96%);IPR014017 (96%);IPR027417 (96%),DNA helicase, UvrD/REP type (96%);UvrD-like DNA helicase, C-terminal (96%);P-loop containing nucleoside triphosphate hydrolase (96%),,,,,,,,,
TVDHPLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VQHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.192 (19%);3.1.-.- (15%);3.6.4.12 (13%),23S rRNA (adenine(2503)-C(2))-methyltransferase (19%);Acting on ester bonds (15%);DNA helicase (13%),GO:0016021 (22%);GO:0005737 (7%);GO:0005634 (5%),integral component of membrane (22%);cytoplasm (7%);nucleus (5%),GO:0005524 (12%);GO:0016740 (11%);GO:0016874 (10%),ATP binding (12%);transferase activity (11%);ligase activity (10%),GO:0070475 (3%);GO:0016567 (3%);GO:0006268 (2%),rRNA base methylation (3%);protein ubiquitination (3%);DNA unwinding involved in DNA replication (2%),IPR011762 (11%);IPR029045 (11%);IPR034733 (11%),Acetyl-coenzyme A carboxyltransferase, N-terminal (11%);ClpP/crotonase-like domain superfamily (11%);Acetyl-CoA carboxylase (11%),,,,,,,,,,
TCDDYPLVPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLLLVMEMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNMWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.1 (33%);2.7.1.148 (33%);3.4.11.- (33%),Salicylate 1-monooxygenase (33%);4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase (33%);Aminopeptidases (33%),GO:0016021 (22%);GO:0005730 (10%);GO:0071595 (10%),integral component of membrane (22%);nucleolus (10%);Nem1-Spo7 phosphatase complex (10%),GO:0003723 (12%);GO:0005524 (12%);GO:0003676 (10%),RNA binding (12%);ATP binding (12%);nucleic acid binding (10%),GO:0006529 (10%);GO:0015074 (10%);GO:0035307 (10%),asparagine biosynthetic process (10%);DNA integration (10%);positive regulation of protein dephosphorylation (10%),IPR027417 (19%);IPR000504 (14%);IPR035979 (14%),P-loop containing nucleoside triphosphate hydrolase (19%);RNA recognition motif domain (14%);RNA-binding domain superfamily (14%),,,,,,,,,,,
TVGDSLVAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HCWDMLAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MWWLPDVSQNASHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.1 (25%);6.3.5.5 (16%);6.4.1.7 (7%),Tyrosine--tRNA ligase (25%);Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (16%);2-oxoglutarate carboxylase (7%),GO:0016021 (40%);GO:0005886 (7%);GO:0005737 (5%),integral component of membrane (40%);plasma membrane (7%);cytoplasm (5%),GO:0003824 (18%);GO:0005524 (13%);GO:0003723 (12%),catalytic activity (18%);ATP binding (13%);RNA binding (12%),GO:0055085 (7%);GO:0009401 (3%);GO:0006437 (3%),transmembrane transport (7%);phosphoenolpyruvate-dependent sugar phosphotransferase system (3%);tyrosyl-tRNA aminoacylation (3%),IPR000089 (12%);IPR011053 (12%);IPR013785 (12%),Biotin/lipoyl attachment (12%);Single hybrid motif (12%);Aldolase-type TIM barrel (12%),,,,,,,,,,,
MENNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.99.1.1 (9%);6.5.1.2 (5%);1.11.1.6 (4%),Protoporphyrin ferrochelatase (9%);DNA ligase (NAD(+)) (5%);Catalase (4%),GO:0016021 (37%);GO:0005737 (8%);GO:0005886 (5%),integral component of membrane (37%);cytoplasm (8%);plasma membrane (5%),GO:0003677 (11%);GO:0046872 (9%);GO:0005524 (9%),DNA binding (11%);metal ion binding (9%);ATP binding (9%),GO:0006355 (5%);GO:0055085 (3%);GO:0005975 (3%),regulation of transcription, DNA-templated (5%);transmembrane transport (3%);carbohydrate metabolic process (3%),IPR027417 (6%);IPR036388 (5%);IPR036259 (3%),P-loop containing nucleoside triphosphate hydrolase (6%);Winged helix-like DNA-binding domain superfamily (5%);MFS transporter superfamily (3%),,,,,,,,,,
QNPPNGLYAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLGMPYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLEPNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.20 (100%),Tryptophan synthase (100%),,,GO:0004834 (100%),tryptophan synthase activity (100%),,,IPR001926 (100%);IPR006653 (100%);IPR006654 (100%),Pyridoxal-phosphate dependent enzyme (100%);Tryptophan synthase, beta chain, conserved site (100%);Tryptophan synthase, beta chain (100%),,,,,,,,
AFFFDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003723 (50%);GO:0003857 (50%);GO:0008168 (50%),RNA binding (50%);3-hydroxyacyl-CoA dehydrogenase activity (50%);methyltransferase activity (50%),GO:0006635 (50%);GO:0032259 (50%),fatty acid beta-oxidation (50%);methylation (50%),IPR001678 (50%);IPR001753 (50%);IPR006108 (50%),SAM-dependent methyltransferase RsmB/NOP2-type (50%);Enoyl-CoA hydratase/isomerase (50%);3-hydroxyacyl-CoA dehydrogenase, C-terminal (50%),,,,,,,,,,
NEMYLYLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYLYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.- (27%);5.3.1.14 (27%);2.7.13.3 (18%),Aminopeptidases (27%);L-rhamnose isomerase (27%);Histidine kinase (18%),GO:0016021 (27%);GO:0005737 (17%);GO:0019867 (10%),integral component of membrane (27%);cytoplasm (17%);outer membrane (10%),GO:0005524 (17%);GO:0004177 (10%);GO:0004672 (10%),ATP binding (17%);aminopeptidase activity (10%);protein kinase activity (10%),GO:0019301 (10%);GO:0071709 (10%);GO:0009253 (3%),rhamnose catabolic process (10%);membrane assembly (10%);peptidoglycan catabolic process (3%),IPR000719 (9%);IPR000787 (9%);IPR009308 (9%),Protein kinase domain (9%);Peptidase M29 (9%);Rhamnose isomerase (9%),,,,,,,,,,,
FAAENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.- (23%);2.6.1.52 (20%);7.6.2.1 (13%),In phosphorus-containing anhydrides (23%);Phosphoserine transaminase (20%);P-type phospholipid transporter (13%),GO:0016021 (84%);GO:0005737 (2%);GO:0005840 (1%),integral component of membrane (84%);cytoplasm (2%);ribosome (1%),GO:0005524 (5%);GO:0016787 (3%);GO:0003677 (1%),ATP binding (5%);hydrolase activity (3%);DNA binding (1%),GO:0055085 (1%);GO:0006564 (1%);GO:0006412 (1%),transmembrane transport (1%);L-serine biosynthetic process (1%);translation (1%),IPR018704 (82%);IPR026039 (81%);IPR011990 (81%),Tetratricopeptide repeat-like domain (82%);Uncharacterised protein family UPF0070 (81%);Tetratricopeptide-like helical domain superfamily (81%),,,,,,,,,,,
AAPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.80 (7%);5.2.1.8 (5%);2.5.1.72 (5%),Protein-glutamate O-methyltransferase (7%);Peptidylprolyl isomerase (5%);Quinolinate synthase (5%),GO:0016021 (20%);GO:0005737 (6%);GO:0005634 (2%),integral component of membrane (20%);cytoplasm (6%);nucleus (2%),GO:0005524 (11%);GO:0046872 (8%);GO:0003677 (7%),ATP binding (11%);metal ion binding (8%);DNA binding (7%),GO:0005975 (3%);GO:0007015 (2%);GO:0034765 (2%),carbohydrate metabolic process (3%);actin filament organization (2%);regulation of ion transmembrane transport (2%),IPR005064 (13%);IPR042100 (13%);IPR027417 (8%),Bordetella uptake gene (13%);Bordetella uptake gene, domain 1 (13%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
MEAFHPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MALQAVQWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYESHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.99.1 (50%);2.7.7.7 (50%),Choline dehydrogenase (50%);DNA-directed DNA polymerase (50%),GO:0016021 (25%);GO:0005847 (13%),integral component of membrane (25%);mRNA cleavage and polyadenylation specificity factor complex (13%),GO:0000166 (13%);GO:0003677 (13%);GO:0003887 (13%),nucleotide binding (13%);DNA binding (13%);DNA-directed DNA polymerase activity (13%),GO:0006260 (13%);GO:0006378 (13%);GO:0016042 (13%),DNA replication (13%);mRNA polyadenylation (13%);lipid catabolic process (13%),IPR007854 (25%);IPR039849 (25%);IPR004360 (17%),Pre-mRNA polyadenylation factor Fip1 domain (25%);Pre-mRNA polyadenylation factor Fip1 (25%);Glyoxalase/fosfomycin resistance/dioxygenase domain (17%),,,,,,,,,,,
HELYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (18%);3.6.1.- (14%);6.5.1.2 (11%),DNA-directed DNA polymerase (18%);In phosphorus-containing anhydrides (14%);DNA ligase (NAD(+)) (11%),GO:0016021 (15%);GO:0005737 (5%);GO:0031965 (5%),integral component of membrane (15%);cytoplasm (5%);nuclear membrane (5%),GO:0016805 (20%);GO:0003677 (19%);GO:0005524 (11%),dipeptidase activity (20%);DNA binding (19%);ATP binding (11%),GO:0006281 (5%);GO:0006261 (3%);GO:0006260 (3%),DNA repair (5%);DNA-dependent DNA replication (3%);DNA replication (3%),IPR005322 (16%);IPR027417 (9%);IPR009057 (9%),Peptidase C69, dipeptidase A (16%);P-loop containing nucleoside triphosphate hydrolase (9%);Homeobox-like domain superfamily (9%),,,,,,,,,,
MYFMEYK,Gammaproteobacteria bacterium,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,Gammaproteobacteria bacterium,,,,,,,,GO:0004222 (100%),metalloendopeptidase activity (100%),,,IPR001915 (100%),Peptidase M48 (100%),,,,,,,,,,,
SMVMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (78%);4.1.2.40 (8%);2.4.1.18 (5%),Metalloendopeptidases (78%);Tagatose-bisphosphate aldolase (8%);1,4-alpha-glucan branching enzyme (5%),GO:0016021 (52%);GO:0005886 (36%);GO:0015934 (4%),integral component of membrane (52%);plasma membrane (36%);large ribosomal subunit (4%),GO:0008270 (51%);GO:0005524 (42%);GO:0004222 (37%),zinc ion binding (51%);ATP binding (42%);metalloendopeptidase activity (37%),GO:0030163 (35%);GO:0005975 (17%);GO:0051301 (5%),protein catabolic process (35%);carbohydrate metabolic process (17%);cell division (5%),IPR027417 (36%);IPR003959 (34%);IPR000642 (34%),P-loop containing nucleoside triphosphate hydrolase (36%);ATPase, AAA-type, core (34%);Peptidase M41 (34%),,,,,,,,
SLTFSDTSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTENTNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLNTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.1 (27%);3.4.19.12 (21%);3.4.22.- (21%),Tyrosine--tRNA ligase (27%);Ubiquitinyl hydrolase 1 (21%);Cysteine endopeptidases (21%),GO:0016021 (25%);GO:0005737 (10%);GO:0019033 (4%),integral component of membrane (25%);cytoplasm (10%);viral tegument (4%),GO:0005524 (17%);GO:0003676 (9%);GO:0004519 (9%),ATP binding (17%);nucleic acid binding (9%);endonuclease activity (9%),GO:0006437 (5%);GO:0006281 (5%);GO:0039648 (4%),tyrosyl-tRNA aminoacylation (5%);DNA repair (5%);modulation by virus of host protein ubiquitination (4%),IPR027417 (10%);IPR036188 (6%);IPR003615 (5%),P-loop containing nucleoside triphosphate hydrolase (10%);FAD/NAD(P)-binding domain superfamily (6%);HNH nuclease (5%),,,,,,,,,,,
DYQYAQSRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPDSPATQPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNWAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.30 (50%);4.2.2.2 (15%);7.2.2.6 (8%),Glycerol kinase (50%);Pectate lyase (15%);P-type K(+) transporter (8%),GO:0016021 (26%);GO:0005634 (4%);GO:0005887 (2%),integral component of membrane (26%);nucleus (4%);integral component of plasma membrane (2%),GO:0005524 (27%);GO:0004370 (15%);GO:0003677 (14%),ATP binding (27%);glycerol kinase activity (15%);DNA binding (14%),GO:0006072 (15%);GO:0019563 (14%);GO:0006304 (6%),glycerol-3-phosphate metabolic process (15%);glycerol catabolic process (14%);DNA modification (6%),IPR000577 (14%);IPR005999 (14%);IPR018483 (14%),Carbohydrate kinase, FGGY (14%);Glycerol kinase (14%);Carbohydrate kinase, FGGY, conserved site (14%),,,,,,,,
MAPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.- (8%);6.1.1.19 (5%);3.1.-.- (4%),Endodeoxyribonucleases producing 5'-phosphomonoesters (8%);Arginine--tRNA ligase (5%);Acting on ester bonds (4%),GO:0016021 (29%);GO:0005737 (4%);GO:0005840 (3%),integral component of membrane (29%);cytoplasm (4%);ribosome (3%),GO:0005524 (11%);GO:0003677 (11%);GO:0003676 (7%),ATP binding (11%);DNA binding (11%);nucleic acid binding (7%),GO:0006412 (3%);GO:0006260 (2%);GO:0006364 (2%),translation (3%);DNA replication (2%);rRNA processing (2%),IPR027417 (8%);IPR036291 (6%);IPR008979 (4%),P-loop containing nucleoside triphosphate hydrolase (8%);NAD(P)-binding domain superfamily (6%);Galactose-binding-like domain superfamily (4%),,,,,,,,,,,
GLNTNHGTDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLGLAQHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSDSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.24 (14%);6.1.1.5 (5%);6.3.3.1 (5%),Mitogen-activated protein kinase (14%);Isoleucine--tRNA ligase (5%);Phosphoribosylformylglycinamidine cyclo-ligase (5%),GO:0016021 (33%);GO:0005737 (10%);GO:0005886 (4%),integral component of membrane (33%);cytoplasm (10%);plasma membrane (4%),GO:0005524 (15%);GO:0046872 (6%);GO:0003677 (6%),ATP binding (15%);metal ion binding (6%);DNA binding (6%),GO:0051301 (3%);GO:0055085 (2%);GO:1901135 (1%),cell division (3%);transmembrane transport (2%);carbohydrate derivative metabolic process (1%),IPR027417 (7%);IPR002797 (5%);IPR029303 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Polysaccharide biosynthesis protein (5%);Polysaccharide biosynthesis protein, C-terminal domain (5%),,,,,,,,,,
EFWWVGDEAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.25 (76%);1.6.2.2 (7%);2.1.1.199 (7%),Adenylyl-sulfate kinase (76%);Cytochrome-b5 reductase (7%);16S rRNA (cytosine(1402)-N(4))-methyltransferase (7%),GO:0016021 (13%);GO:0043190 (7%);GO:0005737 (4%),integral component of membrane (13%);ATP-binding cassette (ABC) transporter complex (7%);cytoplasm (4%),GO:0004781 (41%);GO:0005524 (38%);GO:0004020 (36%),sulfate adenylyltransferase (ATP) activity (41%);ATP binding (38%);adenylylsulfate kinase activity (36%),GO:0000103 (43%);GO:0070814 (35%);GO:0009405 (8%),sulfate assimilation (43%);hydrogen sulfide biosynthetic process (35%);pathogenesis (8%),IPR001119 (43%);IPR014729 (24%);IPR015947 (24%),S-layer homology domain (43%);Rossmann-like alpha/beta/alpha sandwich fold (24%);PUA-like superfamily (24%),,,,,,,,,,,
DPSLAWEVYMTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMFVCNK,Bodo saltans,Eukaryota,,,,Euglenozoa,,,Kinetoplastea,Metakinetoplastina,,,Eubodonida,,,,,Bodonidae,,,,Bodo,,,,Bodo saltans,,,,,,,,GO:0004672 (100%);GO:0005524 (100%),protein kinase activity (100%);ATP binding (100%),,,IPR000719 (100%);IPR002110 (100%);IPR011009 (100%),Protein kinase domain (100%);Ankyrin repeat (100%);Protein kinase-like domain superfamily (100%),,,,,,,,,,,
LEWDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.1.1 (20%);2.4.1.1 (11%);6.3.4.13 (8%),NADH:ubiquinone reductase (Na(+)-transporting) (20%);Glycogen phosphorylase (11%);Phosphoribosylamine--glycine ligase (8%),GO:0016021 (17%);GO:0008290 (11%);GO:0005886 (6%),integral component of membrane (17%);F-actin capping protein complex (11%);plasma membrane (6%),GO:0005524 (22%);GO:0046872 (13%);GO:0003779 (9%),ATP binding (22%);metal ion binding (13%);actin binding (9%),GO:0051016 (11%);GO:0019069 (10%);GO:0005975 (8%),barbed-end actin filament capping (11%);viral capsid assembly (10%);carbohydrate metabolic process (8%),IPR035421 (12%);IPR004921 (12%);IPR010332 (12%),Terminase, large subunit gp17-like (12%);Terminase large subunit, T4likevirus-type (12%);ATPase terminase subunit, putative (12%),,,,,,,,
TPLPNHLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLGLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.5 (16%);2.7.7.- (6%);2.3.1.180 (6%),Argininosuccinate synthase (16%);Nucleotidyltransferases (6%);Beta-ketoacyl-[acyl-carrier-protein] synthase III (6%),GO:0016021 (19%);GO:0005737 (13%);GO:0005886 (3%),integral component of membrane (19%);cytoplasm (13%);plasma membrane (3%),GO:0005524 (18%);GO:0004315 (7%);GO:0003677 (7%),ATP binding (18%);3-oxoacyl-[acyl-carrier-protein] synthase activity (7%);DNA binding (7%),GO:0006633 (7%);GO:0006457 (4%);GO:0006526 (3%),fatty acid biosynthetic process (7%);protein folding (4%);arginine biosynthetic process (3%),IPR027417 (9%);IPR029068 (7%);IPR037523 (7%),P-loop containing nucleoside triphosphate hydrolase (9%);Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase (7%);Vicinal oxygen chelate (VOC) domain (7%),,,,,,,,,,,
LVLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (65%);1.1.1.79 (5%);1.1.1.81 (5%),Acting on ATP; involved in cellular and subcellular movement (65%);Glyoxylate reductase (NADP(+)) (5%);Hydroxypyruvate reductase (5%),GO:0016021 (19%);GO:0005737 (16%);GO:0005886 (6%),integral component of membrane (19%);cytoplasm (16%);plasma membrane (6%),GO:0005524 (24%);GO:0003684 (11%);GO:0016740 (11%),ATP binding (24%);damaged DNA binding (11%);transferase activity (11%),GO:0006355 (12%);GO:0000716 (11%);GO:0015031 (4%),regulation of transcription, DNA-templated (12%);transcription-coupled nucleotide-excision repair, DNA damage recognition (11%);protein transport (4%),IPR027417 (21%);IPR001650 (15%);IPR014001 (14%),P-loop containing nucleoside triphosphate hydrolase (21%);Helicase, C-terminal (15%);Helicase superfamily 1/2, ATP-binding domain (14%),,,,,,,
YLMPMDQMEDFLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THLTTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.11.- (57%);2.4.1.129 (14%);3.1.21.3 (14%),With 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (57%);Peptidoglycan glycosyltransferase (14%);Type I site-specific deoxyribonuclease (14%),GO:0016021 (64%);GO:0005886 (8%);GO:0005634 (1%),integral component of membrane (64%);plasma membrane (8%);nucleus (1%),GO:0005524 (44%);GO:0004672 (34%);GO:0004674 (9%),ATP binding (44%);protein kinase activity (34%);protein serine/threonine kinase activity (9%),GO:0046777 (7%);GO:0006352 (2%);GO:0005975 (1%),protein autophosphorylation (7%);DNA-templated transcription, initiation (2%);carbohydrate metabolic process (1%),IPR011009 (64%);IPR000719 (63%);IPR008271 (63%),Protein kinase-like domain superfamily (64%);Protein kinase domain (63%);Serine/threonine-protein kinase, active site (63%),,,,,,,,
EVMPLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.17 (60%);2.3.1.- (40%),ATP phosphoribosyltransferase (60%);Transferring groups other than amino-acyl groups (40%),GO:0005737 (14%);GO:0005694 (7%);GO:0016021 (2%),cytoplasm (14%);chromosome (7%);integral component of membrane (2%),GO:0016740 (51%);GO:0016746 (15%);GO:0003879 (14%),transferase activity (51%);transferase activity, transferring acyl groups (15%);ATP phosphoribosyltransferase activity (14%),GO:0000105 (14%);GO:0000737 (7%);GO:0006355 (3%),histidine biosynthetic process (14%);DNA catabolic process, endonucleolytic (7%);regulation of transcription, DNA-templated (3%),IPR011004 (69%);IPR041561 (69%);IPR020019 (68%),Trimeric LpxA-like superfamily (69%);PglD, N-terminal (69%);Sialic acid O-acyltransferase NeuD-like (68%),,,,,,,
TMLGVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (50%);5.6.2.2 (50%),Methyltransferases (50%);DNA topoisomerase (ATP-hydrolyzing) (50%),GO:0016021 (39%);GO:0016282 (2%);GO:0019867 (2%),integral component of membrane (39%);eukaryotic 43S preinitiation complex (2%);outer membrane (2%),GO:0004180 (12%);GO:0008233 (11%);GO:0022857 (11%),carboxypeptidase activity (12%);peptidase activity (11%);transmembrane transporter activity (11%),GO:0019475 (5%);GO:0016051 (4%);GO:0032259 (4%),L-lysine catabolic process to acetate (5%);carbohydrate biosynthetic process (4%);methylation (4%),IPR009045 (20%);IPR039561 (20%);IPR001036 (13%),Hedgehog signalling/DD-peptidase zinc-binding domain superfamily (20%);Peptidase M15C (20%);Acriflavin resistance protein (13%),,,,,,,,,,,
EVFEAMGMLLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPYMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000781 (17%);GO:0030874 (17%);GO:0031618 (17%),chromosome, telomeric region (17%);nucleolar chromatin (17%);nuclear pericentric heterochromatin (17%),GO:0016491 (33%);GO:0046872 (33%);GO:0050660 (33%),oxidoreductase activity (33%);metal ion binding (33%);flavin adenine dinucleotide binding (33%),GO:0006221 (33%);GO:0000122 (17%);GO:0000183 (17%),pyrimidine nucleotide biosynthetic process (33%);negative regulation of transcription by RNA polymerase II (17%);chromatin silencing at rDNA (17%),IPR001433 (29%);IPR008333 (29%);IPR012165 (29%),Oxidoreductase FAD/NAD(P)-binding (29%);Flavoprotein pyridine nucleotide cytochrome reductase-like, FAD-binding domain (29%);Cytochrome-c3 hydrogenase, gamma subunit (29%),,,,,,,,
HLYPATLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNLGNDENAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVVNVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019867 (50%),outer membrane (50%),GO:0004672 (50%),protein kinase activity (50%),GO:0009405 (50%),pathogenesis (50%),IPR011009 (43%);IPR040976 (43%);IPR004474 (14%),Protein kinase-like domain superfamily (43%);Fungal-type protein kinase (43%);Cell envelope-related transcriptional attenuator domain (14%),,,,,,,,,,,
MMVVAGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEADTAMSLQAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPEFGSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WHAMNK,Pteropus associated gemycircularvirus 3,Viruses,,,,,,,,,,,,,,,,Genomoviridae,,,,Gemycircularvirus,,,,Pteropus associated gemycircularvirus 3,,,,,,,,,,,,,,,,,,,,,,,,
VQTFYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (3%),integral component of membrane (3%),GO:0003677 (93%);GO:0003700 (92%);GO:0004672 (2%),DNA binding (93%);DNA-binding transcription factor activity (92%);protein kinase activity (2%),GO:0006629 (2%),lipid metabolic process (2%),IPR000847 (93%);IPR036388 (93%);IPR036390 (93%),Transcription regulator HTH, LysR (93%);Winged helix-like DNA-binding domain superfamily (93%);Winged helix DNA-binding domain superfamily (93%),,,,,,,,,,
MSLGGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (75%),integral component of membrane (75%),GO:0004601 (13%);GO:0008168 (13%);GO:0016740 (13%),peroxidase activity (13%);methyltransferase activity (13%);transferase activity (13%),GO:0032259 (13%),methylation (13%),IPR005318 (56%);IPR023614 (56%);IPR000028 (11%),Outer membrane porin, bacterial (56%);Porin domain superfamily (56%);Chloroperoxidase (11%),,,,,,,,,,
LVGNALNGTNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDVEPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.15 (20%);2.4.1.- (20%);2.7.7.38 (20%),Peroxiredoxin (20%);Hexosyltransferases (20%);3-deoxy-manno-octulosonate cytidylyltransferase (20%),GO:0016020 (14%);GO:0016021 (14%);GO:0000502 (3%),membrane (14%);integral component of membrane (14%);proteasome complex (3%),GO:0051539 (17%);GO:0009055 (14%);GO:0043531 (10%),4 iron, 4 sulfur cluster binding (17%);electron transfer activity (14%);ADP binding (10%),GO:0005975 (3%);GO:0006270 (3%);GO:0006275 (3%),carbohydrate metabolic process (3%);DNA replication initiation (3%);regulation of DNA replication (3%),IPR027417 (21%);IPR009051 (12%);IPR010208 (12%),P-loop containing nucleoside triphosphate hydrolase (21%);Alpha-helical ferredoxin (12%);Ion-translocating oxidoreductase complex, subunit RnfC/RsxC (12%),,,,,,,,,
FPQPEYVGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEMDVLEGNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CWANQTYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVVVDVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0004930 (100%),G protein-coupled receptor activity (100%),GO:0007166 (100%),cell surface receptor signaling pathway (100%),IPR000203 (50%);IPR000832 (50%);IPR016071 (50%),GPS motif (50%);GPCR, family 2, secretin-like (50%);Staphylococcal nuclease (SNase-like), OB-fold (50%),,,,,,,,
NPQSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.11 (7%);2.7.7.7 (6%);1.3.1.104 (3%),Acetylornithine transaminase (7%);DNA-directed DNA polymerase (6%);Enoyl-[acyl-carrier-protein] reductase (3%),GO:0016021 (17%);GO:0005737 (4%);GO:0005634 (3%),integral component of membrane (17%);cytoplasm (4%);nucleus (3%),GO:0005524 (24%);GO:0008270 (10%);GO:0005525 (10%),ATP binding (24%);zinc ion binding (10%);GTP binding (10%),GO:0006428 (5%);GO:0035556 (3%);GO:0060271 (2%),isoleucyl-tRNA aminoacylation (5%);intracellular signal transduction (3%);cilium assembly (2%),IPR027417 (20%);IPR014001 (9%);IPR001650 (9%),P-loop containing nucleoside triphosphate hydrolase (20%);Helicase superfamily 1/2, ATP-binding domain (9%);Helicase, C-terminal (9%),,,,,,,,,
SMLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.6 (68%);3.6.4.- (7%);7.6.2.1 (7%),Phosphoribosylaminoimidazolesuccinocarboxamide synthase (68%);Acting on ATP; involved in cellular and subcellular movement (7%);P-type phospholipid transporter (7%),GO:0019031 (17%);GO:0016021 (15%);GO:0039626 (10%),viral envelope (17%);integral component of membrane (15%);viral intermediate capsid (10%),GO:0005524 (36%);GO:0004639 (27%);GO:0005198 (17%),ATP binding (36%);phosphoribosylaminoimidazolesuccinocarboxamide synthase activity (27%);structural molecule activity (17%),GO:0006189 (25%);GO:0019064 (17%);GO:0006412 (6%),'de novo' IMP biosynthetic process (25%);fusion of virus membrane with host plasma membrane (17%);translation (6%),IPR028923 (26%);IPR001636 (25%);IPR018236 (24%),SAICAR synthetase/ADE2, N-terminal (26%);Phosphoribosylaminoimidazole-succinocarboxamide synthase (25%);SAICAR synthetase, conserved site (24%),,,,,,,,,
TFTFHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.3 (100%),Aconitate hydratase (100%),GO:0016021 (67%);GO:0005886 (47%);GO:0005871 (7%),integral component of membrane (67%);plasma membrane (47%);kinesin complex (7%),GO:0032977 (53%);GO:0003700 (7%);GO:0003777 (7%),membrane insertase activity (53%);DNA-binding transcription factor activity (7%);microtubule motor activity (7%),GO:0015031 (47%);GO:0005975 (7%);GO:0007018 (7%),protein transport (47%);carbohydrate metabolic process (7%);microtubule-based movement (7%),IPR001708 (33%);IPR028053 (33%);IPR038210 (33%),Membrane  insertase YidC/ALB3/OXA1/COX18 (33%);Membrane insertase YidC, N-terminal (33%);Membrane insertase YidC, periplasmic domain (33%),,,,,,,,,
KPPMMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003723 (100%);GO:0008173 (100%),RNA binding (100%);RNA methyltransferase activity (100%),GO:0006396 (100%),RNA processing (100%),IPR001537 (100%);IPR004384 (100%);IPR029026 (100%),tRNA/rRNA methyltransferase, SpoU type (100%);RNA methyltransferase TrmJ/LasT (100%);tRNA (guanine-N1-)-methyltransferase, N-terminal (100%),,,,,,,,,
LVLPAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.38 (55%);3.6.4.- (7%);2.7.7.6 (6%),3-deoxy-manno-octulosonate cytidylyltransferase (55%);Acting on ATP; involved in cellular and subcellular movement (7%);DNA-directed RNA polymerase (6%),GO:0016021 (28%);GO:0005737 (20%);GO:0009295 (5%),integral component of membrane (28%);cytoplasm (20%);nucleoid (5%),GO:0005524 (20%);GO:0003677 (19%);GO:0004386 (12%),ATP binding (20%);DNA binding (19%);helicase activity (12%),GO:0009103 (10%);GO:0033468 (9%);GO:0006260 (4%),lipopolysaccharide biosynthetic process (10%);CMP-keto-3-deoxy-D-manno-octulosonic acid biosynthetic process (9%);DNA replication (4%),IPR036291 (16%);IPR002347 (15%);IPR027417 (15%),NAD(P)-binding domain superfamily (16%);Short-chain dehydrogenase/reductase SDR (15%);P-loop containing nucleoside triphosphate hydrolase (15%),,,,,,,,,,,
TNSLNCSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNVYPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008484 (100%),sulfuric ester hydrolase activity (100%),,,IPR000917 (50%);IPR012337 (50%);IPR017850 (50%),Sulfatase, N-terminal (50%);Ribonuclease H-like superfamily (50%);Alkaline-phosphatase-like, core domain superfamily (50%),,,,,,,,,
TALNHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.4 (43%);1.1.5.8 (36%);4.2.1.33 (11%),3-dehydroquinate synthase (43%);Quinate dehydrogenase (quinone) (36%);3-isopropylmalate dehydratase (11%),GO:0016021 (65%);GO:0030288 (36%);GO:0009279 (25%),integral component of membrane (65%);outer membrane-bounded periplasmic space (36%);cell outer membrane (25%),GO:0048038 (36%);GO:0016614 (29%);GO:0046872 (13%),quinone binding (36%);oxidoreductase activity, acting on CH-OH group of donors (29%);metal ion binding (13%),GO:0009073 (9%);GO:0009423 (8%);GO:0000272 (3%),aromatic amino acid family biosynthetic process (9%);chorismate biosynthetic process (8%);polysaccharide catabolic process (3%),IPR001479 (31%);IPR002372 (31%);IPR011047 (31%),Quinoprotein dehydrogenase, conserved site (31%);Pyrrolo-quinoline quinone repeat (31%);Quinoprotein alcohol dehydrogenase-like superfamily (31%),,,,,,,,,
HDSAVSHSHVCAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WELASK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.12.1.3 (40%);1.12.1.2 (20%);1.6.99.5 (20%),Hydrogen dehydrogenase (NADP(+)) (40%);Hydrogen dehydrogenase (20%);Transferred entry: 1.6.5.11 (20%),GO:0016021 (13%);GO:0005623 (2%);GO:0005886 (2%),integral component of membrane (13%);cell (2%);plasma membrane (2%),GO:0046872 (70%);GO:0051539 (68%);GO:0008137 (60%),metal ion binding (70%);4 iron, 4 sulfur cluster binding (68%);NADH dehydrogenase (ubiquinone) activity (60%),GO:0006233 (4%);GO:0006310 (2%);GO:0006352 (2%),dTDP biosynthetic process (4%);DNA recombination (2%);DNA-templated transcription, initiation (2%),IPR011538 (59%);IPR037225 (59%);IPR019554 (54%),NADH-ubiquinone oxidoreductase 51kDa subunit, FMN-binding domain (59%);NADH-ubiquinone oxidoreductase 51kDa subunit, FMN-binding domain superfamily (59%);Soluble ligand binding domain (54%),,,,,,,
EASQHFENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADNPVVTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HFWMMWLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYDTVVAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (25%);2.7.7.6 (25%);3.1.11.5 (25%),Nucleotidyltransferases (25%);DNA-directed RNA polymerase (25%);Exodeoxyribonuclease V (25%),GO:0016021 (49%);GO:0005623 (10%);GO:0005765 (10%),integral component of membrane (49%);cell (10%);lysosomal membrane (10%),GO:0005524 (14%);GO:0005245 (10%);GO:0072345 (10%),ATP binding (14%);voltage-gated calcium channel activity (10%);NAADP-sensitive calcium-release channel activity (10%),GO:0015074 (7%);GO:0055085 (6%);GO:0007165 (4%),DNA integration (7%);transmembrane transport (6%);signal transduction (4%),IPR005821 (9%);IPR027359 (8%);IPR027417 (8%),Ion transport domain (9%);Voltage-dependent channel domain superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,,
MELQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (36%);2.7.4.8 (18%);1.15.1.1 (9%),Histidine kinase (36%);Guanylate kinase (18%);Superoxide dismutase (9%),GO:0016021 (37%);GO:0030131 (10%);GO:0005886 (7%),integral component of membrane (37%);clathrin adaptor complex (10%);plasma membrane (7%),GO:0051213 (17%);GO:0003677 (8%);GO:0005524 (7%),dioxygenase activity (17%);DNA binding (8%);ATP binding (7%),GO:0006886 (10%);GO:0016192 (10%);GO:0006355 (6%),intracellular protein transport (10%);vesicle-mediated transport (10%);regulation of transcription, DNA-templated (6%),IPR011051 (28%);IPR013096 (28%);IPR014710 (28%),RmlC-like cupin domain superfamily (28%);Cupin 2, conserved barrel (28%);RmlC-like jelly roll fold (28%),,,,,,,,,
NPVSHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNVNVQFPASPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFSSDFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
STVFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.107 (47%);5.6.2.2 (14%);7.1.2.2 (8%),Diacylglycerol kinase (ATP) (47%);DNA topoisomerase (ATP-hydrolyzing) (14%);H(+)-transporting two-sector ATPase (8%),GO:0016021 (34%);GO:0005737 (4%);GO:0005634 (3%),integral component of membrane (34%);cytoplasm (4%);nucleus (3%),GO:0005524 (37%);GO:0003677 (21%);GO:0016887 (19%),ATP binding (37%);DNA binding (21%);ATPase activity (19%),GO:0006355 (12%);GO:0007205 (7%);GO:0035556 (7%),regulation of transcription, DNA-templated (12%);protein kinase C-activating G protein-coupled receptor signaling pathway (7%);intracellular signal transduction (7%),IPR027417 (21%);IPR003593 (18%);IPR003439 (17%),P-loop containing nucleoside triphosphate hydrolase (21%);AAA+ ATPase domain (18%);ABC transporter-like (17%),,,,,,,,,,
VNDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (18%);3.1.1.3 (9%);6.3.2.2 (9%),Peptidylprolyl isomerase (18%);Triacylglycerol lipase (9%);Glutamate--cysteine ligase (9%),GO:0005634 (44%);GO:0016021 (16%);GO:0005623 (10%),nucleus (44%);integral component of membrane (16%);cell (10%),GO:0008270 (48%);GO:0003707 (47%);GO:0004879 (40%),zinc ion binding (48%);steroid hormone receptor activity (47%);nuclear receptor activity (40%),GO:0000122 (10%);GO:0010988 (10%);GO:0034142 (10%),negative regulation of transcription by RNA polymerase II (10%);regulation of low-density lipoprotein particle clearance (10%);toll-like receptor 4 signaling pathway (10%),IPR000536 (42%);IPR001723 (42%);IPR035500 (42%),Nuclear hormone receptor, ligand-binding domain (42%);Nuclear hormone receptor (42%);Nuclear hormone receptor-like domain superfamily (42%),,,,,,,,,,
CHVAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (96%);GO:0016021 (96%),plasma membrane (96%);integral component of membrane (96%),GO:0005525 (96%);GO:0015093 (88%);GO:0004713 (4%),GTP binding (96%);ferrous iron transmembrane transporter activity (88%);protein tyrosine kinase activity (4%),GO:0055072 (96%),iron ion homeostasis (96%),IPR003373 (83%);IPR006073 (83%);IPR011640 (83%),Ferrous iron transport protein B (83%);GTP binding domain (83%);Ferrous iron transport protein B, C-terminal (83%),,,,,,,,,,
KPTPANAEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FPTAQHNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVYQLER,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016855 (25%);GO:0046872 (25%),racemase and epimerase activity, acting on amino acids and derivatives (25%);metal ion binding (25%),,,IPR000014 (50%);IPR000160 (50%);IPR000700 (50%),PAS domain (50%);GGDEF domain (50%);PAS-associated, C-terminal (50%),,,,,,,,,
TWEVHAAVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLNSNQMSTGGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMGVQMNFDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QSEVENEAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAVVGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0048037 (100%),cofactor binding (100%),,,IPR011576 (98%);IPR012349 (98%);IPR004154 (2%),Pyridoxamine 5'-phosphate oxidase, putative (98%);FMN-binding split barrel (98%);Anticodon-binding (2%),,,,,,,,,,
QPMGMPPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPSWLPTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLHQMDVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPENECPSHEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQRPNMLGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSTENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.6.2.11 (21%);2.1.2.3 (11%);1.3.8.1 (8%),ABC-type polyamine transporter (21%);Phosphoribosylaminoimidazolecarboxamide formyltransferase (11%);Short-chain acyl-CoA dehydrogenase (8%),GO:0016021 (29%);GO:0005886 (10%);GO:0005737 (9%),integral component of membrane (29%);plasma membrane (10%);cytoplasm (9%),GO:0005524 (11%);GO:0003677 (8%);GO:0015079 (7%),ATP binding (11%);DNA binding (8%);potassium ion transmembrane transporter activity (7%),GO:0006164 (3%);GO:0006265 (2%);GO:0006979 (2%),purine nucleotide biosynthetic process (3%);DNA topological change (2%);response to oxidative stress (2%),IPR027417 (10%);IPR036291 (7%);IPR003593 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);NAD(P)-binding domain superfamily (7%);AAA+ ATPase domain (6%),,,,,,,,,,,
NMQDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.66 (30%);2.7.13.3 (9%);3.4.16.- (6%),XTP/dITP diphosphatase (30%);Histidine kinase (9%);Serine-type carboxypeptidases (6%),GO:0016021 (15%);GO:0005634 (15%);GO:0005737 (6%),integral component of membrane (15%);nucleus (15%);cytoplasm (6%),GO:0046983 (14%);GO:0003677 (14%);GO:0000977 (13%),protein dimerization activity (14%);DNA binding (14%);RNA polymerase II regulatory region sequence-specific DNA binding (13%),GO:0045944 (13%);GO:0009117 (4%);GO:0009146 (4%),positive regulation of transcription by RNA polymerase II (13%);nucleotide metabolic process (4%);purine nucleoside triphosphate catabolic process (4%),IPR002100 (12%);IPR022102 (12%);IPR036879 (12%),Transcription factor, MADS-box (12%);Holliday junction regulator protein family C-terminal (12%);Transcription factor, MADS-box superfamily (12%),,,,,,,,,
LPPAMNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMLHEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.104 (90%);4.6.1.2 (10%),Cyanase (90%);Guanylate cyclase (10%),GO:0016021 (15%);GO:0005737 (10%);GO:0015627 (10%),integral component of membrane (15%);cytoplasm (10%);type II protein secretion system complex (10%),GO:0005524 (44%);GO:0016887 (32%);GO:0008824 (24%),ATP binding (44%);ATPase activity (32%);cyanate hydratase activity (24%),GO:0009439 (27%);GO:0015628 (10%);GO:0045944 (2%),cyanate metabolic process (27%);protein secretion by the type II secretion system (10%);positive regulation of transcription by RNA polymerase II (2%),IPR011990 (30%);IPR013026 (30%);IPR019734 (30%),Tetratricopeptide-like helical domain superfamily (30%);Tetratricopeptide repeat-containing domain (30%);Tetratricopeptide repeat (30%),,,,,,,,,,,
WSYLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.85 (43%);4.1.3.27 (29%);1.14.13.9 (14%),Aminodeoxychorismate synthase (43%);Anthranilate synthase (29%);Kynurenine 3-monooxygenase (14%),GO:0016021 (21%);GO:0015934 (6%);GO:0005634 (4%),integral component of membrane (21%);large ribosomal subunit (6%);nucleus (4%),GO:0003676 (10%);GO:0003735 (6%);GO:0019843 (6%),nucleic acid binding (10%);structural constituent of ribosome (6%);rRNA binding (6%),GO:0009058 (40%);GO:0006412 (6%);GO:0015074 (5%),biosynthetic process (40%);translation (6%);DNA integration (5%),IPR005801 (37%);IPR006805 (37%);IPR015890 (36%),ADC synthase (37%);Anthranilate synthase component I, N-terminal (37%);Chorismate-utilising enzyme, C-terminal (36%),,,,,,,,,
QYGLN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (50%);GO:0008134 (50%);GO:0008483 (50%),ATP binding (50%);transcription factor binding (50%);transaminase activity (50%),GO:0006355 (50%),regulation of transcription, DNA-templated (50%),IPR001487 (29%);IPR002078 (29%);IPR002197 (29%),Bromodomain (29%);RNA polymerase sigma factor 54 interaction domain (29%);DNA binding HTH domain,  Fis-type (29%),,,,,,,,,
LLDGTEDMTVGLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNLLEALPSMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SEVDEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.19.12 (100%),Ubiquitinyl hydrolase 1 (100%),GO:0016021 (12%);GO:0030054 (12%);GO:0005856 (7%),integral component of membrane (12%);cell junction (12%);cytoskeleton (7%),GO:0036459 (56%);GO:0003676 (12%);GO:0050839 (12%),thiol-dependent ubiquitinyl hydrolase activity (56%);nucleic acid binding (12%);cell adhesion molecule binding (12%),GO:0016579 (63%);GO:0006511 (61%);GO:0098609 (12%),protein deubiquitination (63%);ubiquitin-dependent protein catabolic process (61%);cell-cell adhesion (12%),IPR038765 (63%);IPR028889 (60%);IPR001394 (58%),Papain-like cysteine peptidase superfamily (63%);Ubiquitin specific protease domain (60%);Peptidase C19, ubiquitin carboxyl-terminal hydrolase (58%),,,,,,,,,,
QGELEANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNAAMALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0005524 (50%);GO:0016887 (50%),ATP binding (50%);ATPase activity (50%),GO:0055085 (50%),transmembrane transport (50%),IPR003439 (50%);IPR003593 (50%);IPR011701 (50%),ABC transporter-like (50%);AAA+ ATPase domain (50%);Major facilitator superfamily (50%),,,,,,,,,,,
QNHVQSDGLAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALLDPTWAER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLQVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (9%);2.5.1.72 (9%);5.6.2.2 (8%),Peptidylprolyl isomerase (9%);Quinolinate synthase (9%);DNA topoisomerase (ATP-hydrolyzing) (8%),GO:0016021 (16%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (16%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (37%);GO:0016887 (26%);GO:0015424 (11%),ATP binding (37%);ATPase activity (26%);ATPase-coupled amino acid transmembrane transporter activity (11%),GO:0005975 (3%);GO:0007165 (2%);GO:0006355 (2%),carbohydrate metabolic process (3%);signal transduction (2%);regulation of transcription, DNA-templated (2%),IPR027417 (31%);IPR003593 (24%);IPR003439 (23%),P-loop containing nucleoside triphosphate hydrolase (31%);AAA+ ATPase domain (24%);ABC transporter-like (23%),,,,,,,,,,
EVTTFSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAMPVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.25 (50%);4.1.99.12 (50%);2.1.1.- (43%),GTP cyclohydrolase II (50%);3,4-dihydroxy-2-butanone-4-phosphate synthase (50%);Methyltransferases (43%),GO:0016021 (27%);GO:0005737 (18%);GO:0009279 (6%),integral component of membrane (27%);cytoplasm (18%);cell outer membrane (6%),GO:0000287 (21%);GO:0003935 (21%);GO:0005525 (21%),magnesium ion binding (21%);GTP cyclohydrolase II activity (21%);GTP binding (21%),GO:0009231 (21%);GO:0005975 (3%);GO:0009067 (3%),riboflavin biosynthetic process (21%);carbohydrate metabolic process (3%);aspartate family amino acid biosynthetic process (3%),IPR000422 (16%);IPR000926 (16%);IPR016299 (16%),3,4-dihydroxy-2-butanone 4-phosphate synthase, RibB (16%);GTP cyclohydrolase II, RibA (16%);Riboflavin biosynthesis protein RibBA (16%),,,,,,,
HPVNDLMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CQVYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (79%);2.7.7.6 (6%);2.7.7.7 (6%),DNA topoisomerase (ATP-hydrolyzing) (79%);DNA-directed RNA polymerase (6%);DNA-directed DNA polymerase (6%),GO:0009360 (6%);GO:0005634 (5%);GO:0016021 (5%),DNA polymerase III complex (6%);nucleus (5%);integral component of membrane (5%),GO:0003677 (66%);GO:0005524 (56%);GO:0003918 (44%),DNA binding (66%);ATP binding (56%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (44%),GO:0006265 (44%);GO:0006260 (18%);GO:0006281 (8%),DNA topological change (44%);DNA replication (18%);DNA repair (8%),IPR035516 (41%);IPR002205 (40%);IPR013757 (40%),DNA gyrase/topoisomerase IV, subunit A, C-terminal (41%);DNA topoisomerase, type IIA, subunit A/C-terminal (40%);Type IIA DNA topoisomerase subunit A, alpha-helical domain superfamily (40%),,,,,
QLFLQHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (100%),Acting on ATP; involved in cellular and subcellular movement (100%),GO:0005737 (20%);GO:0009380 (20%),cytoplasm (20%);excinuclease repair complex (20%),GO:0003677 (40%);GO:0005524 (40%);GO:0016740 (40%),DNA binding (40%);ATP binding (40%);transferase activity (40%),GO:0000716 (20%);GO:0006289 (20%);GO:0006352 (20%),transcription-coupled nucleotide-excision repair, DNA damage recognition (20%);nucleotide-excision repair (20%);DNA-templated transcription, initiation (20%),IPR001296 (40%);IPR027417 (40%);IPR028098 (40%),Glycosyl transferase, family 1 (40%);P-loop containing nucleoside triphosphate hydrolase (40%);Glycosyltransferase subfamily 4-like, N-terminal domain (40%),,,,,,,
FFALHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.54 (78%);3.6.4.- (11%);6.1.1.10 (11%),3-deoxy-7-phosphoheptulonate synthase (78%);Acting on ATP; involved in cellular and subcellular movement (11%);Methionine--tRNA ligase (11%),GO:0016021 (7%);GO:0005737 (4%);GO:0009507 (2%),integral component of membrane (7%);cytoplasm (4%);chloroplast (2%),GO:0003677 (24%);GO:0003700 (24%);GO:0016740 (22%),DNA binding (24%);DNA-binding transcription factor activity (24%);transferase activity (22%),GO:0009073 (13%);GO:0006353 (2%);GO:0006431 (2%),aromatic amino acid family biosynthetic process (13%);DNA-templated transcription, termination (2%);methionyl-tRNA aminoacylation (2%),IPR000847 (21%);IPR005119 (21%);IPR036388 (21%),Transcription regulator HTH, LysR (21%);LysR, substrate-binding (21%);Winged helix-like DNA-binding domain superfamily (21%),,,,,,,,
WPAGDLAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVDMVGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAACAWPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPLHALMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AADHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.33 (36%);1.2.1.84 (12%);2.7.7.87 (11%),Pantothenate kinase (36%);Alcohol-forming fatty acyl-CoA reductase (12%);L-threonylcarbamoyladenylate synthase (11%),GO:0005737 (15%);GO:0016021 (12%);GO:0032040 (3%),cytoplasm (15%);integral component of membrane (12%);small-subunit processome (3%),GO:0005524 (31%);GO:0016887 (10%);GO:0004594 (9%),ATP binding (31%);ATPase activity (10%);pantothenate kinase activity (9%),GO:0015937 (10%);GO:0008033 (3%);GO:0006629 (3%),coenzyme A biosynthetic process (10%);tRNA processing (3%);lipid metabolic process (3%),IPR027417 (22%);IPR003593 (10%);IPR003439 (10%),P-loop containing nucleoside triphosphate hydrolase (22%);AAA+ ATPase domain (10%);ABC transporter-like (10%),,,,,,,,,,,
NQFFLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.15 (100%),Acetyl-CoA carboxytransferase (100%),GO:0009317 (50%);GO:0009570 (50%),acetyl-CoA carboxylase complex (50%);chloroplast stroma (50%),GO:0003676 (50%);GO:0003989 (50%);GO:0005524 (50%),nucleic acid binding (50%);acetyl-CoA carboxylase activity (50%);ATP binding (50%),GO:0006633 (50%);GO:2001295 (50%),fatty acid biosynthetic process (50%);malonyl-CoA biosynthetic process (50%),IPR000438 (50%);IPR002059 (50%);IPR011762 (50%),Acetyl-CoA carboxylase carboxyl transferase, beta subunit (50%);Cold-shock protein, DNA-binding (50%);Acetyl-coenzyme A carboxyltransferase, N-terminal (50%),,,,,,,,
WVYDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.2 (16%);6.2.1.16 (13%);2.1.1.67 (10%),Non-specific protein-tyrosine kinase (16%);Acetoacetate--CoA ligase (13%);Thiopurine S-methyltransferase (10%),GO:0016021 (26%);GO:0009279 (11%);GO:0005737 (2%),integral component of membrane (26%);cell outer membrane (11%);cytoplasm (2%),GO:0016491 (15%);GO:0000155 (8%);GO:0005524 (5%),oxidoreductase activity (15%);phosphorelay sensor kinase activity (8%);ATP binding (5%),GO:0043165 (10%);GO:0051205 (9%);GO:0000724 (5%),Gram-negative-bacterium-type cell outer membrane assembly (10%);protein insertion into membrane (9%);double-strand break repair via homologous recombination (5%),IPR027417 (13%);IPR036291 (13%);IPR015943 (7%),P-loop containing nucleoside triphosphate hydrolase (13%);NAD(P)-binding domain superfamily (13%);WD40/YVTN repeat-like-containing domain superfamily (7%),,,,,,,,,,,
LEEDAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (11%);4.2.1.9 (9%);4.3.2.2 (6%),3-methyl-2-oxobutanoate hydroxymethyltransferase (11%);Dihydroxy-acid dehydratase (9%);Adenylosuccinate lyase (6%),GO:0016021 (18%);GO:0005737 (18%);GO:0005874 (3%),integral component of membrane (18%);cytoplasm (18%);microtubule (3%),GO:0005524 (23%);GO:0005525 (12%);GO:0003924 (11%),ATP binding (23%);GTP binding (12%);GTPase activity (11%),GO:0007018 (3%);GO:0006355 (2%);GO:2000813 (2%),microtubule-based movement (3%);regulation of transcription, DNA-templated (2%);negative regulation of barbed-end actin filament capping (2%),IPR027417 (24%);IPR000178 (9%);IPR000795 (9%),P-loop containing nucleoside triphosphate hydrolase (24%);Translation initiation factor aIF-2, bacterial-like (9%);Transcription factor, GTP-binding domain (9%),,,,,,,,
VSFGHWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALTMDAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.3 (100%),Phosphoribosylformylglycinamidine synthase (100%),GO:0005737 (71%),cytoplasm (71%),GO:0004642 (79%);GO:0005524 (79%);GO:0000287 (71%),phosphoribosylformylglycinamidine synthase activity (79%);ATP binding (79%);magnesium ion binding (71%),GO:0006189 (79%);GO:0006596 (14%),'de novo' IMP biosynthetic process (79%);polyamine biosynthetic process (14%),IPR010074 (73%);IPR010918 (73%);IPR016188 (73%),Phosphoribosylformylglycinamidine subunit PurL (73%);PurM-like, C-terminal domain (73%);PurM-like, N-terminal domain (73%),,,,,,,,,
GFGPDMLMNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMVWQSNLLSGTMHTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.173 (5%);2.1.1.264 (5%);1.1.1.85 (4%),23S rRNA (guanine(2445)-N(2))-methyltransferase (5%);23S rRNA (guanine(2069)-N(7))-methyltransferase (5%);3-isopropylmalate dehydrogenase (4%),GO:0016021 (63%);GO:0005886 (47%);GO:0005737 (3%),integral component of membrane (63%);plasma membrane (47%);cytoplasm (3%),GO:0005524 (5%);GO:0003677 (5%);GO:0046872 (3%),ATP binding (5%);DNA binding (5%);metal ion binding (3%),GO:0006605 (46%);GO:0043952 (46%);GO:0065002 (46%),protein targeting (46%);protein transport by the Sec complex (46%);intracellular protein transmembrane transport (46%),IPR023201 (41%);IPR002208 (41%);IPR026593 (41%),SecY domain superfamily (41%);SecY/SEC61-alpha family (41%);Protein translocase subunit SecY (41%),,,,,,,,,,,
TQMVMMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVYDTNK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042597 (95%);GO:0016021 (3%),periplasmic space (95%);integral component of membrane (3%),GO:0001530 (80%);GO:0016787 (2%);GO:0030246 (2%),lipopolysaccharide binding (80%);hydrolase activity (2%);carbohydrate binding (2%),GO:0015920 (95%);GO:0043165 (95%),lipopolysaccharide transport (95%);Gram-negative-bacterium-type cell outer membrane assembly (95%),IPR005653 (91%);IPR014340 (91%);IPR032812 (4%),Organic solvent tolerance-like, N-terminal (91%);Lipopolysaccharide export system protein LptA (91%);SbsA, Ig-like domain (4%),,,,,,,,,
SFPADVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0019008 (70%);GO:0016021 (20%),molybdopterin synthase complex (70%);integral component of membrane (20%),GO:0005525 (70%);GO:0046872 (70%);GO:0051539 (70%),GTP binding (70%);metal ion binding (70%);4 iron, 4 sulfur cluster binding (70%),GO:0006777 (70%),Mo-molybdopterin cofactor biosynthetic process (70%),IPR000385 (50%);IPR006638 (50%);IPR007197 (50%),MoaA/NifB/PqqE, iron-sulphur binding, conserved site (50%);Elp3/MiaB/NifB (50%);Radical SAM (50%),,,,,,,,
WMMDLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APQHFLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLTYTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (75%);2.5.1.141 (11%);2.7.1.71 (4%),DNA-directed RNA polymerase (75%);Heme o synthase (11%);Shikimate kinase (4%),GO:0016021 (47%);GO:0005634 (19%);GO:0009279 (18%),integral component of membrane (47%);nucleus (19%);cell outer membrane (18%),GO:0003677 (24%);GO:0003899 (19%);GO:0032549 (19%),DNA binding (24%);DNA-directed 5'-3' RNA polymerase activity (19%);ribonucleoside binding (19%),GO:0006351 (19%);GO:0048034 (3%);GO:0006352 (2%),transcription, DNA-templated (19%);heme O biosynthetic process (3%);DNA-templated transcription, initiation (2%),IPR007120 (14%);IPR007121 (14%);IPR007641 (14%),DNA-directed RNA polymerase, subunit 2, hybrid-binding domain (14%);RNA polymerase, beta subunit, conserved site (14%);RNA polymerase Rpb2, domain 7 (14%),,,,
SPTEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (15%);3.6.3.3 (11%);2.1.2.3 (10%),Metalloendopeptidases (15%);Transferred entry: 7.2.2.21 (11%);Phosphoribosylaminoimidazolecarboxamide formyltransferase (10%),GO:0016021 (24%);GO:0005634 (6%);GO:0005886 (4%),integral component of membrane (24%);nucleus (6%);plasma membrane (4%),GO:0005524 (12%);GO:0003677 (9%);GO:0046872 (9%),ATP binding (12%);DNA binding (9%);metal ion binding (9%),GO:0005975 (5%);GO:0000398 (2%);GO:0055085 (2%),carbohydrate metabolic process (5%);mRNA splicing, via spliceosome (2%);transmembrane transport (2%),IPR027417 (12%);IPR034154 (6%);IPR015943 (6%),P-loop containing nucleoside triphosphate hydrolase (12%);Archaeal primase DnaG/twinkle, TOPRIM domain (6%);WD40/YVTN repeat-like-containing domain superfamily (6%),,,,,,,,,
KPTWDPGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAVDAVSNALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPDTYNR,Rikenellaceae bacterium,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Rikenellaceae,,,,,,,,Rikenellaceae bacterium,,,,,,,,,,,,IPR011250 (100%),Outer membrane protein/outer membrane enzyme PagP,  beta-barrel (100%),,,,,,,,,,
ATGSASER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAHMAVEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNHHMLALK,Propionispora hippei,Bacteria,,,,Firmicutes,,,Negativicutes,,,,Selenomonadales,,,,,Sporomusaceae,,,,Propionispora,,,,Propionispora hippei,,,,,,,,GO:0051015 (100%),actin filament binding (100%),GO:0007015 (100%),actin filament organization (100%),IPR008999 (100%);IPR010431 (100%),Actin-crosslinking (100%);Fascin (100%),,,,,,,,,,,
MLSNKPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (60%);GO:0016780 (20%),transmembrane transporter activity (60%);phosphotransferase activity, for other substituted phosphate groups (20%),GO:0008654 (20%),phospholipid biosynthetic process (20%),IPR001036 (27%);IPR027463 (27%);IPR028081 (18%),Acriflavin resistance protein (27%);Multidrug efflux transporter AcrB TolC docking domain, DN/DC subdomains (27%);Leucine-binding protein domain (18%),,,,,,,,,
NAMSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.21 (25%);1.5.1.42 (15%);2.7.7.7 (7%),Starch synthase (25%);FMN reductase (NADH) (15%);DNA-directed DNA polymerase (7%),GO:0016021 (21%);GO:0005737 (4%);GO:0005634 (2%),integral component of membrane (21%);cytoplasm (4%);nucleus (2%),GO:0003677 (12%);GO:0005524 (11%);GO:0016787 (6%),DNA binding (12%);ATP binding (11%);hydrolase activity (6%),GO:0006355 (5%);GO:0005978 (5%);GO:0006807 (4%),regulation of transcription, DNA-templated (5%);glycogen biosynthetic process (5%);nitrogen compound metabolic process (4%),IPR016187 (10%);IPR005532 (10%);IPR019865 (10%),C-type lectin fold (10%);Sulfatase-modifying factor enzyme (10%);Gliding motility-associated lipoprotein GldJ (10%),,,,,,,,,,
MYDLNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (5%),integral component of membrane (5%),GO:0046872 (95%);GO:0003824 (5%),metal ion binding (95%);catalytic activity (5%),,,IPR001781 (95%);IPR017351 (95%);IPR009651 (5%),Zinc finger, LIM-type (95%);LIM and senescent cell antigen-like-containing domain protein 1 (95%);Putative methionine gamma-lyase (5%),,,,,,,,,,
EPQGVHR,Aspergillus brasiliensis,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Eurotiomycetidae,,,Eurotiales,,,,,Aspergillaceae,,,,Aspergillus,,,,Aspergillus brasiliensis,,,,,,,,GO:0008270 (100%);GO:0016491 (100%),zinc ion binding (100%);oxidoreductase activity (100%),,,IPR002328 (100%);IPR011032 (100%);IPR013154 (100%),Alcohol dehydrogenase, zinc-type, conserved site (100%);GroES-like superfamily (100%);Alcohol dehydrogenase, N-terminal (100%),,,,,,,,
HVSVLHWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVQARPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QHYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.26 (18%);3.1.13.4 (12%);3.1.3.16 (12%),N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (18%);Poly(A)-specific ribonuclease (12%);Protein-serine/threonine phosphatase (12%),GO:0016021 (34%);GO:0005886 (6%);GO:0005737 (2%),integral component of membrane (34%);plasma membrane (6%);cytoplasm (2%),GO:0005524 (16%);GO:0003677 (11%);GO:0004930 (7%),ATP binding (16%);DNA binding (11%);G protein-coupled receptor activity (7%),GO:0000160 (4%);GO:0006139 (4%);GO:0006355 (4%),phosphorelay signal transduction system (4%);nucleobase-containing compound metabolic process (4%);regulation of transcription, DNA-templated (4%),IPR024285 (13%);IPR024288 (13%);IPR027417 (10%),Schizont-infected cell agglutination, extracellular beta domain (13%);Schizont-infected cell agglutination, C-terminal domain (13%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,
QYVLQVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.83 (100%),Oligopeptidase B (100%),GO:0016021 (18%),integral component of membrane (18%),GO:0004252 (82%);GO:0070008 (82%);GO:0005524 (9%),serine-type endopeptidase activity (82%);serine-type exopeptidase activity (82%);ATP binding (9%),,,IPR001375 (82%);IPR002470 (82%);IPR023302 (82%),Peptidase S9, prolyl oligopeptidase, catalytic domain (82%);Peptidase S9A, prolyl oligopeptidase (82%);Peptidase S9A, N-terminal domain (82%),,,,,,,
LTFCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.108 (52%);2.1.1.198 (6%);2.8.4.3 (6%),Carnitine 3-dehydrogenase (52%);16S rRNA (cytidine(1402)-2'-O)-methyltransferase (6%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (6%),GO:0016021 (34%);GO:0005886 (30%);GO:0005737 (10%),integral component of membrane (34%);plasma membrane (30%);cytoplasm (10%),GO:0004930 (23%);GO:0004984 (23%);GO:0015485 (7%),G protein-coupled receptor activity (23%);olfactory receptor activity (23%);cholesterol binding (7%),GO:0006869 (17%);GO:0006631 (6%);GO:0042413 (6%),lipid transport (17%);fatty acid metabolic process (6%);carnitine catabolic process (6%),IPR017452 (21%);IPR000276 (21%);IPR000725 (20%),GPCR, rhodopsin-like, 7TM (21%);G protein-coupled receptor, rhodopsin-like (21%);Olfactory receptor (20%),,,,,,,,
QLNHFQTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLSMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (23%);2.7.7.85 (7%);3.5.1.2 (5%),Cytochrome-c oxidase (23%);Diadenylate cyclase (7%);Glutaminase (5%),GO:0016021 (33%);GO:0005743 (5%);GO:0005886 (4%),integral component of membrane (33%);mitochondrial inner membrane (5%);plasma membrane (4%),GO:0005524 (19%);GO:0003677 (10%);GO:0046872 (8%),ATP binding (19%);DNA binding (10%);metal ion binding (8%),GO:0007155 (5%);GO:0030155 (4%);GO:0030334 (4%),cell adhesion (5%);regulation of cell adhesion (4%);regulation of cell migration (4%),IPR027417 (11%);IPR003593 (7%);IPR003439 (6%),P-loop containing nucleoside triphosphate hydrolase (11%);AAA+ ATPase domain (7%);ABC transporter-like (6%),,,,,,,,,,,
FGQNMHCTLVLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDCPDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.- (50%);2.2.1.7 (50%),With oxygen as acceptor (50%);1-deoxy-D-xylulose-5-phosphate synthase (50%),GO:0005737 (31%);GO:0016021 (6%),cytoplasm (31%);integral component of membrane (6%),GO:0035226 (38%);GO:0004177 (31%);GO:0008235 (31%),glutamate-cysteine ligase catalytic subunit binding (38%);aminopeptidase activity (31%);metalloexopeptidase activity (31%),GO:0006750 (38%);GO:0016114 (13%);GO:0009228 (6%),glutathione biosynthetic process (38%);terpenoid biosynthetic process (13%);thiamine biosynthetic process (6%),IPR023210 (30%);IPR032963 (30%);IPR036812 (30%),NADP-dependent oxidoreductase domain (30%);Glutamate--cysteine ligase regulatory subunit (30%);NADP-dependent oxidoreductase domain superfamily (30%),,,,,,,,,,,
FMVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (19%);6.3.5.- (17%);6.2.1.3 (11%),Glycogen phosphorylase (19%);Carbon--nitrogen ligases with glutamine as amido-N-donor (17%);Long-chain-fatty-acid--CoA ligase (11%),GO:0016021 (8%);GO:0015934 (2%);GO:0005737 (1%),integral component of membrane (8%);large ribosomal subunit (2%);cytoplasm (1%),GO:0003824 (58%);GO:0016874 (16%);GO:0005524 (7%),catalytic activity (58%);ligase activity (16%);ATP binding (7%),GO:0006412 (3%);GO:0009908 (1%);GO:0030154 (1%),translation (3%);flower development (1%);cell differentiation (1%),IPR025110 (71%);IPR000873 (70%);IPR042099 (70%),AMP-binding enzyme, C-terminal domain (71%);AMP-dependent synthetase/ligase (70%);AMP-dependent synthetase-like superfamily (70%),,,,,,,,,,
NSLSGMHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CGTGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003723 (100%);GO:0009982 (100%),RNA binding (100%);pseudouridine synthase activity (100%),GO:0031119 (100%),tRNA pseudouridine synthesis (100%),IPR001406 (75%);IPR020095 (75%);IPR020097 (75%),Pseudouridine synthase I, TruA (75%);Pseudouridine synthase I, TruA, C-terminal (75%);Pseudouridine synthase I, TruA, alpha/beta domain (75%),,,,,,
TWMFLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005643 (50%);GO:0005938 (50%);GO:0016021 (50%),nuclear pore (50%);cell cortex (50%);integral component of membrane (50%),GO:1990756 (50%);GO:0004672 (7%);GO:0005524 (7%),ubiquitin ligase-substrate adaptor activity (50%);protein kinase activity (7%);ATP binding (7%),GO:0000209 (50%);GO:0007278 (50%);GO:0007281 (50%),protein polyubiquitination (50%);pole cell fate determination (50%);germ cell development (50%),IPR000210 (73%);IPR011333 (73%);IPR000719 (7%),BTB/POZ domain (73%);SKP1/BTB/POZ domain superfamily (73%);Protein kinase domain (7%),,,,,,,,,,,
WNFESFFGVVLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWDTHSFTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LWSNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.52 (66%);1.14.11.- (31%);2.4.2.43 (3%),Beta-N-acetylhexosaminidase (66%);With 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (31%);Lipid IV(A) 4-amino-4-deoxy-L-arabinosyltransferase (3%),GO:0016021 (30%);GO:0005886 (12%);GO:0005623 (2%),integral component of membrane (30%);plasma membrane (12%);cell (2%),GO:0004563 (37%);GO:0102148 (33%);GO:0005506 (19%),beta-N-acetylhexosaminidase activity (37%);N-acetyl-beta-D-galactosaminidase activity (33%);iron ion binding (19%),GO:0005975 (37%);GO:0055085 (14%);GO:0006352 (2%),carbohydrate metabolic process (37%);transmembrane transport (14%);DNA-templated transcription, initiation (2%),IPR015883 (32%);IPR017853 (32%);IPR025705 (32%),Glycoside hydrolase family 20, catalytic domain (32%);Glycoside hydrolase superfamily (32%);Beta-hexosaminidase (32%),,,,,,,,
DDSGMPK,Motilibacter peucedani,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Frankiales,,,,,Motilibacteraceae,,,,Motilibacter,,,,Motilibacter peucedani,,,,,,,,GO:0003677 (100%);GO:0003678 (100%);GO:0004527 (100%),DNA binding (100%);DNA helicase activity (100%);exonuclease activity (100%),GO:0006281 (100%),DNA repair (100%),IPR000212 (100%);IPR013986 (100%);IPR014016 (100%),DNA helicase, UvrD/REP type (100%);DExx box DNA helicase domain superfamily (100%);UvrD-like helicase, ATP-binding domain (100%),,,,,,,,,
TCTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (27%);2.7.10.1 (20%);2.3.1.225 (10%),Nucleotidyltransferases (27%);Receptor protein-tyrosine kinase (20%);Protein S-acyltransferase (10%),GO:0016021 (47%);GO:0005737 (7%);GO:0009925 (5%),integral component of membrane (47%);cytoplasm (7%);basal plasma membrane (5%),GO:0005524 (23%);GO:0017154 (19%);GO:0004714 (17%),ATP binding (23%);semaphorin receptor activity (19%);transmembrane receptor protein tyrosine kinase activity (17%),GO:0007169 (14%);GO:0050918 (8%);GO:2001028 (8%),transmembrane receptor protein tyrosine kinase signaling pathway (14%);positive chemotaxis (8%);positive regulation of endothelial cell chemotaxis (8%),IPR013783 (21%);IPR014756 (18%);IPR002909 (18%),Immunoglobulin-like fold (21%);Immunoglobulin E-set (18%);IPT domain (18%),,,,,,,,,,,
MPDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.87 (25%);4.2.1.9 (20%);3.6.4.12 (7%),L-threonylcarbamoyladenylate synthase (25%);Dihydroxy-acid dehydratase (20%);DNA helicase (7%),GO:0016021 (46%);GO:0005737 (10%);GO:0005886 (2%),integral component of membrane (46%);cytoplasm (10%);plasma membrane (2%),GO:0022857 (27%);GO:0005524 (15%);GO:0046872 (12%),transmembrane transporter activity (27%);ATP binding (15%);metal ion binding (12%),GO:0008033 (6%);GO:0009097 (5%);GO:0009099 (5%),tRNA processing (6%);isoleucine biosynthetic process (5%);valine biosynthetic process (5%),IPR020846 (32%);IPR036259 (32%);IPR005828 (31%),Major facilitator superfamily domain (32%);MFS transporter superfamily (32%);Major facilitator,  sugar transporter-like (31%),,,,,,,,,,
FNMPANK,Prevotella bergensis,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Prevotellaceae,,,,Prevotella,,,,Prevotella bergensis,,,,,,,,,,,,,,,,,,,,,,,,
VVSLEPVK,Acutalibacter,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Ruminococcaceae,,,,Acutalibacter,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR025436 (100%),Domain of unknown function DUF4179 (100%),,,,,,,,,,,
QQWLM,Cyprinodontoidei,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,Atherinomorphae,Cyprinodontiformes,Cyprinodontoidei,,,,,,,,,,,,,,,,,,,,GO:0016798 (100%),hydrolase activity, acting on glycosyl bonds (100%),,,IPR026071 (100%),Glycosyl hydrolase family 99 (100%),,,,,,,,,,
NMLYLDFVNENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CGWDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (50%);3.1.-.- (50%),Histidine kinase (50%);Acting on ester bonds (50%),GO:0016021 (88%),integral component of membrane (88%),GO:0005267 (50%);GO:0000155 (13%);GO:0005506 (13%),potassium channel activity (50%);phosphorelay sensor kinase activity (13%);iron ion binding (13%),GO:0003085 (25%);GO:0060075 (25%),negative regulation of systemic arterial blood pressure (25%);regulation of resting membrane potential (25%),IPR003280 (36%);IPR005408 (36%);IPR005409 (36%),Two pore domain potassium channel (36%);Two pore domain potassium channel, TWIK family (36%);Two pore domain potassium channel, TWIK-2 (36%),,,,,,,,,
EVELPDLLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGHDLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0005737 (33%),cytoplasm (33%),GO:0003684 (33%);GO:0003887 (33%);GO:0004252 (33%),damaged DNA binding (33%);DNA-directed DNA polymerase activity (33%);serine-type endopeptidase activity (33%),GO:0006281 (33%);GO:0006260 (17%);GO:0006261 (17%),DNA repair (33%);DNA replication (17%);DNA-dependent DNA replication (17%),IPR001126 (29%);IPR001907 (29%);IPR017961 (29%),UmuC domain (29%);ATP-dependent Clp protease proteolytic subunit (29%);DNA polymerase, Y-family, little finger domain (29%),,,,,,,,,
QMLAVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.2 (50%);3.6.4.12 (20%);3.5.1.5 (15%),Non-specific protein-tyrosine kinase (50%);DNA helicase (20%);Urease (15%),GO:0005874 (20%);GO:0016459 (9%);GO:0016021 (5%),microtubule (20%);myosin complex (9%);integral component of membrane (5%),GO:0008270 (67%);GO:0008017 (20%);GO:0019899 (20%),zinc ion binding (67%);microtubule binding (20%);enzyme binding (20%),GO:0010508 (20%);GO:0032897 (20%);GO:0035372 (20%),positive regulation of autophagy (20%);negative regulation of viral transcription (20%);protein localization to microtubule (20%),IPR003649 (71%);IPR017903 (71%);IPR040859 (71%),B-box, C-terminal (71%);COS domain (71%);Midline-1, COS domain (71%),,,,,,,,,
MPTALAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.98.3 (50%);3.5.4.2 (50%),Coproporphyrinogen dehydrogenase (50%);Adenine deaminase (50%),GO:0016021 (30%);GO:0008076 (7%);GO:0005737 (4%),integral component of membrane (30%);voltage-gated potassium channel complex (7%);cytoplasm (4%),GO:0003910 (15%);GO:0005524 (15%);GO:0003677 (11%),DNA ligase (ATP) activity (15%);ATP binding (15%);DNA binding (11%),GO:0006281 (15%);GO:0006310 (15%);GO:0006355 (7%),DNA repair (15%);DNA recombination (15%);regulation of transcription, DNA-templated (7%),IPR012309 (16%);IPR012310 (16%);IPR012340 (16%),DNA ligase, ATP-dependent, C-terminal (16%);DNA ligase, ATP-dependent, central (16%);Nucleic acid-binding, OB-fold (16%),,,,,
CHALVDDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEYDLMMHHDDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DEEVVQVNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDLTHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (33%);3.5.4.19 (33%);3.6.1.31 (33%),Exoribonuclease II (33%);Phosphoribosyl-AMP cyclohydrolase (33%);Phosphoribosyl-ATP diphosphatase (33%),GO:0016021 (13%);GO:0005737 (3%);GO:0005739 (3%),integral component of membrane (13%);cytoplasm (3%);mitochondrion (3%),GO:0005524 (52%);GO:0016887 (45%);GO:0003677 (13%),ATP binding (52%);ATPase activity (45%);DNA binding (13%),GO:0000105 (3%);GO:0006355 (3%);GO:0009058 (3%),histidine biosynthetic process (3%);regulation of transcription, DNA-templated (3%);biosynthetic process (3%),IPR003439 (44%);IPR003593 (44%);IPR017871 (44%),ABC transporter-like (44%);AAA+ ATPase domain (44%);ABC transporter, conserved site (44%),,,,,,,,,
DNLPVAAPNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVTFDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.23 (40%);2.4.1.21 (20%);3.4.11.1 (20%),Aspartate--tRNA(Asn) ligase (40%);Starch synthase (20%);Leucyl aminopeptidase (20%),GO:0016021 (52%);GO:0005737 (6%);GO:0005634 (4%),integral component of membrane (52%);cytoplasm (6%);nucleus (4%),GO:0020037 (43%);GO:0005524 (11%);GO:0003676 (5%),heme binding (43%);ATP binding (11%);nucleic acid binding (5%),GO:0017004 (44%);GO:0009058 (3%);GO:0009166 (3%),cytochrome complex assembly (44%);biosynthetic process (3%);nucleotide catabolic process (3%),IPR002541 (26%);IPR002491 (13%);IPR014756 (13%),Cytochrome c assembly protein (26%);ABC transporter periplasmic binding domain (13%);Immunoglobulin E-set (13%),,,,,,,,,,,
QAVTAENNHEPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGEDGQVMPMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLFC,Photorhabdus temperata,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Enterobacterales,,,,,Morganellaceae,,,,Photorhabdus,,,,Photorhabdus temperata,,,,,,,,,,,,,,,,,,,,,,,,
ALMWFTVEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFTHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (100%),Hydron translocation or charge separation linked to oxidoreductase reactions (100%),GO:0016020 (33%);GO:0016021 (17%),membrane (33%);integral component of membrane (17%),GO:0008137 (33%);GO:0009055 (33%);GO:0046872 (29%),NADH dehydrogenase (ubiquinone) activity (33%);electron transfer activity (33%);metal ion binding (29%),GO:0042773 (33%);GO:0032259 (8%);GO:0000271 (4%),ATP synthesis coupled electron transport (33%);methylation (8%);polysaccharide biosynthetic process (4%),IPR000283 (32%);IPR001041 (32%);IPR006656 (32%),NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site (32%);2Fe-2S ferredoxin-type iron-sulfur binding domain (32%);Molybdopterin oxidoreductase (32%),,,,,,,,,
DMANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.2 (12%);3.6.4.12 (10%);6.3.4.5 (10%),Membrane alanyl aminopeptidase (12%);DNA helicase (10%);Argininosuccinate synthase (10%),GO:0016021 (28%);GO:0016020 (11%);GO:0016459 (3%),integral component of membrane (28%);membrane (11%);myosin complex (3%),GO:0046914 (23%);GO:0005524 (12%);GO:0009055 (11%),transition metal ion binding (23%);ATP binding (12%);electron transfer activity (11%),GO:0042773 (11%);GO:0006355 (3%);GO:0071555 (3%),ATP synthesis coupled electron transport (11%);regulation of transcription, DNA-templated (3%);cell wall organization (3%),IPR007167 (20%);IPR008988 (20%);IPR038157 (20%),Ferrous iron transporter FeoA domain (20%);Transcriptional repressor, C-terminal (20%);Ferrous iron transporter, core domain (20%),,,,,,,,
MPLPSSHLR,Physcomitrella patens,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Bryopsida,Funariidae,,,Funariales,,,,,Funariaceae,,,,Physcomitrella,,,,Physcomitrella patens,,,,,,GO:0005634 (100%),nucleus (100%),GO:0004693 (100%);GO:0005524 (100%),cyclin-dependent protein serine/threonine kinase activity (100%);ATP binding (100%),GO:0006468 (100%);GO:0007346 (100%);GO:0010468 (100%),protein phosphorylation (100%);regulation of mitotic cell cycle (100%);regulation of gene expression (100%),IPR000719 (100%);IPR008271 (100%);IPR011009 (100%),Protein kinase domain (100%);Serine/threonine-protein kinase, active site (100%);Protein kinase-like domain superfamily (100%),,,,,,,,,,
LVLFPTMYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLWGQMMNVMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WSDHNDEMSQEGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPPFVHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYFEGPAPPEVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AWLFPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (14%),integral component of membrane (14%),GO:0005524 (86%);GO:0005525 (71%);GO:0000155 (14%),ATP binding (86%);GTP binding (71%);phosphorelay sensor kinase activity (14%),,,IPR005337 (71%);IPR027417 (71%);IPR001024 (14%),RapZ-like family (71%);P-loop containing nucleoside triphosphate hydrolase (71%);PLAT/LH2 domain (14%),,,,,,,,,,,
LNYLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (22%);1.4.3.1 (7%);2.3.1.- (7%),DNA-directed RNA polymerase (22%);D-aspartate oxidase (7%);Transferring groups other than amino-acyl groups (7%),GO:0016021 (9%);GO:0005737 (6%);GO:0005634 (1%),integral component of membrane (9%);cytoplasm (6%);nucleus (1%),GO:0003676 (57%);GO:0004523 (42%);GO:0003964 (10%),nucleic acid binding (57%);RNA-DNA hybrid ribonuclease activity (42%);RNA-directed DNA polymerase activity (10%),GO:0015074 (30%);GO:0006355 (4%);GO:0055085 (2%),DNA integration (30%);regulation of transcription, DNA-templated (4%);transmembrane transport (2%),IPR036397 (46%);IPR000477 (43%);IPR012337 (43%),Ribonuclease H superfamily (46%);Reverse transcriptase domain (43%);Ribonuclease H-like superfamily (43%),,,,,,,,,,
FGTVVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005730 (50%);GO:0005737 (50%),nucleolus (50%);cytoplasm (50%),GO:0019843 (50%);GO:0120013 (50%),rRNA binding (50%);lipid transfer activity (50%),GO:0000027 (50%);GO:0000470 (50%);GO:0032774 (50%),ribosomal large subunit assembly (50%);maturation of LSU-rRNA (50%);RNA biosynthetic process (50%),IPR009351 (60%);IPR007109 (20%);IPR014830 (20%),Protein of unknown function DUF1006 (60%);Brix domain (20%);Glycolipid transfer protein domain (20%),,,,,,,,,,,
LSSFNCHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPNVAQLNAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FTNMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (98%);6.3.4.2 (1%);1.3.99.- (1%),Ribonucleoside-diphosphate reductase (98%);CTP synthase (glutamine hydrolyzing) (1%);With other acceptors (1%),GO:0016021 (4%);GO:0000790 (0%);GO:0005623 (0%),integral component of membrane (4%);nuclear chromatin (0%);cell (0%),GO:0004748 (82%);GO:0031419 (80%);GO:0000166 (80%),ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor (82%);cobalamin binding (80%);nucleotide binding (80%),GO:0071897 (80%);GO:0006260 (76%);GO:0016539 (3%),DNA biosynthetic process (80%);DNA replication (76%);intein-mediated protein splicing (3%),IPR000788 (78%);IPR013678 (77%);IPR013344 (77%),Ribonucleotide reductase large subunit, C-terminal (78%);Ribonucleotide reductase class II vitamin B12-dependent, N-terminal domain (77%);Ribonucleotide reductase, adenosylcobalamin-dependent (77%),,,,,,,
LWTSHMTDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVFGGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHWQTASATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSEFSYLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMLWWMAMVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DYNMCVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFEDYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (56%);3.6.4.- (21%);6.3.2.8 (5%),DNA-directed DNA polymerase (56%);Acting on ATP; involved in cellular and subcellular movement (21%);UDP-N-acetylmuramate--L-alanine ligase (5%),GO:0042025 (12%);GO:0016021 (10%);GO:0005737 (6%),host cell nucleus (12%);integral component of membrane (10%);cytoplasm (6%),GO:0003677 (31%);GO:0003887 (29%);GO:0005524 (29%),DNA binding (31%);DNA-directed DNA polymerase activity (29%);ATP binding (29%),GO:0006261 (29%);GO:0006281 (29%);GO:0006260 (12%),DNA-dependent DNA replication (29%);DNA repair (29%);DNA replication (12%),IPR012337 (27%);IPR036397 (27%);IPR002421 (26%),Ribonuclease H-like superfamily (27%);Ribonuclease H superfamily (27%);5'-3' exonuclease, N-terminal (26%),,,,,,,,,,
YNGEVLAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNLNHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.3 (100%),Adenylate kinase (100%),GO:0016021 (56%);GO:0005737 (9%);GO:0000808 (3%),integral component of membrane (56%);cytoplasm (9%);origin recognition complex (3%),GO:0016740 (21%);GO:0008658 (18%);GO:0003676 (9%),transferase activity (21%);penicillin binding (18%);nucleic acid binding (9%),GO:0044209 (6%);GO:0000011 (3%);GO:0006166 (3%),AMP salvage (6%);vacuole inheritance (3%);purine ribonucleoside salvage (3%),IPR001264 (20%);IPR001460 (20%);IPR012338 (20%),Glycosyl transferase, family 51 (20%);Penicillin-binding protein, transpeptidase (20%);Beta-lactamase/transpeptidase-like (20%),,,,,,,,,
DLMVNVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.2.2 (28%);2.2.1.7 (19%);2.7.7.7 (6%),Nitrite reductase (cytochrome; ammonia-forming) (28%);1-deoxy-D-xylulose-5-phosphate synthase (19%);DNA-directed DNA polymerase (6%),GO:0016021 (35%);GO:0005634 (4%);GO:0042597 (4%),integral component of membrane (35%);nucleus (4%);periplasmic space (4%),GO:0005524 (9%);GO:0048037 (8%);GO:0016491 (5%),ATP binding (9%);cofactor binding (8%);oxidoreductase activity (5%),GO:0042128 (4%);GO:0016114 (3%);GO:0009228 (3%),nitrate assimilation (4%);terpenoid biosynthetic process (3%);thiamine biosynthetic process (3%),IPR012349 (8%);IPR024747 (8%);IPR027417 (7%),FMN-binding split barrel (8%);Pyridoxamine 5'-phosphate oxidase-related (8%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,,
VAVFHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.85 (19%);3.5.4.2 (19%);7.5.2.7 (19%),Aminodeoxychorismate synthase (19%);Adenine deaminase (19%);ABC-type D-ribose transporter (19%),GO:0016021 (18%);GO:0005886 (8%);GO:0005623 (3%),integral component of membrane (18%);plasma membrane (8%);cell (3%),GO:0005524 (16%);GO:0016887 (13%);GO:0000034 (8%),ATP binding (16%);ATPase activity (13%);adenine deaminase activity (8%),GO:0009396 (26%);GO:0009058 (11%);GO:0006146 (8%),folic acid-containing compound biosynthetic process (26%);biosynthetic process (11%);adenine catabolic process (8%),IPR005801 (26%);IPR005802 (26%);IPR006805 (26%),ADC synthase (26%);Aminodeoxychorismate synthase, component I (26%);Anthranilate synthase component I, N-terminal (26%),,,,,,,,,
WGTHGMMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQQGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.47 (16%);5.1.1.- (5%);2.7.1.90 (4%),Cysteine synthase (16%);Acting on amino acids and derivatives (5%);Diphosphate--fructose-6-phosphate 1-phosphotransferase (4%),GO:0016021 (32%);GO:0009431 (8%);GO:0005737 (6%),integral component of membrane (32%);bacterial-type flagellum basal body, MS ring (8%);cytoplasm (6%),GO:0005524 (10%);GO:0003677 (8%);GO:0003774 (8%),ATP binding (10%);DNA binding (8%);motor activity (8%),GO:0071973 (8%);GO:0032259 (3%);GO:0005975 (2%),bacterial-type flagellum-dependent cell motility (8%);methylation (3%);carbohydrate metabolic process (2%),IPR027417 (8%);IPR000067 (7%);IPR013556 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);Flagellar M-ring protein FliF (7%);Flagellar M-ring C-terminal (7%),,,,,,,,,,
ENGELVDLSYGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WRPAVDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVCTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (60%);1.11.1.7 (7%);3.6.4.12 (4%),DNA topoisomerase (ATP-hydrolyzing) (60%);Peroxidase (7%);DNA helicase (4%),GO:0016021 (26%);GO:0005737 (10%);GO:0005694 (9%),integral component of membrane (26%);cytoplasm (10%);chromosome (9%),GO:0003677 (39%);GO:0005524 (35%);GO:0003918 (30%),DNA binding (39%);ATP binding (35%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (30%),GO:0006265 (30%);GO:0006261 (8%);GO:0006351 (6%),DNA topological change (30%);DNA-dependent DNA replication (8%);transcription, DNA-templated (6%),IPR013506 (28%);IPR014721 (28%);IPR020568 (28%),DNA topoisomerase, type IIA, subunit B, domain 2 (28%);Ribosomal protein S5 domain 2-type fold, subgroup (28%);Ribosomal protein S5 domain 2-type fold (28%),,,,,
QGLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.3.23 (11%);5.6.2.2 (9%);2.7.13.3 (8%),N-succinylarginine dihydrolase (11%);DNA topoisomerase (ATP-hydrolyzing) (9%);Histidine kinase (8%),GO:0016021 (23%);GO:0005737 (8%);GO:0005840 (5%),integral component of membrane (23%);cytoplasm (8%);ribosome (5%),GO:0005524 (14%);GO:0003677 (8%);GO:0005525 (6%),ATP binding (14%);DNA binding (8%);GTP binding (6%),GO:0006412 (5%);GO:0006139 (5%);GO:0006355 (3%),translation (5%);nucleobase-containing compound metabolic process (5%);regulation of transcription, DNA-templated (3%),IPR027417 (11%);IPR020568 (5%);IPR014721 (5%),P-loop containing nucleoside triphosphate hydrolase (11%);Ribosomal protein S5 domain 2-type fold (5%);Ribosomal protein S5 domain 2-type fold, subgroup (5%),,,,,,,,,
VDLTMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.-.- (38%);3.5.1.28 (25%);2.7.4.- (13%),Glycosylases (38%);N-acetylmuramoyl-L-alanine amidase (25%);Phosphotransferases with a phosphate group as acceptor (13%),GO:0016021 (27%);GO:0005634 (21%);GO:0008278 (21%),integral component of membrane (27%);nucleus (21%);cohesin complex (21%),GO:0003682 (21%);GO:0005524 (21%);GO:0046982 (21%),chromatin binding (21%);ATP binding (21%);protein heterodimerization activity (21%),GO:0007064 (21%);GO:0006797 (14%);GO:0005975 (8%),mitotic sister chromatid cohesion (21%);polyphosphate metabolic process (14%);carbohydrate metabolic process (8%),IPR027417 (29%);IPR003395 (16%);IPR010935 (16%),P-loop containing nucleoside triphosphate hydrolase (29%);RecF/RecN/SMC, N-terminal (16%);SMCs flexible hinge (16%),,,,,,,,,,
VLLLQPAAYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSANNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.19 (87%);2.3.1.47 (7%);3.2.1.22 (7%),Arginine--tRNA ligase (87%);8-amino-7-oxononanoate synthase (7%);Alpha-galactosidase (7%),GO:0005737 (29%);GO:0016021 (20%);GO:0005623 (11%),cytoplasm (29%);integral component of membrane (20%);cell (11%),GO:0005524 (27%);GO:0004814 (23%);GO:0052745 (20%),ATP binding (27%);arginine-tRNA ligase activity (23%);inositol phosphate phosphatase activity (20%),GO:0007165 (34%);GO:0046856 (29%);GO:0006420 (23%),signal transduction (34%);phosphatidylinositol dephosphorylation (29%);arginyl-tRNA aminoacylation (23%),IPR000198 (29%);IPR008936 (29%);IPR013783 (29%),Rho GTPase-activating protein domain (29%);Rho GTPase activation protein (29%);Immunoglobulin-like fold (29%),,,,,,,,,,,
FDMVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.9 (100%),UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (100%),GO:0005737 (43%);GO:0016021 (29%),cytoplasm (43%);integral component of membrane (29%),GO:0004326 (43%);GO:0005524 (43%);GO:0008764 (43%),tetrahydrofolylpolyglutamate synthase activity (43%);ATP binding (43%);UDP-N-acetylmuramoylalanine-D-glutamate ligase activity (43%),GO:0007049 (43%);GO:0008360 (43%);GO:0009252 (43%),cell cycle (43%);regulation of cell shape (43%);peptidoglycan biosynthetic process (43%),IPR005762 (43%);IPR013221 (43%);IPR018109 (43%),UDP-N-acetylmuramoylalanine-D-glutamate ligase (43%);Mur ligase, central (43%);Folylpolyglutamate synthetase, conserved site (43%),,,,,,,,,
EAELNSTYPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMWLNLK,Artemisia annua,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Asterales,,,,,Asteraceae,Asteroideae,Anthemideae,Artemisiinae,Artemisia,,,,Artemisia annua,,,,,,,,,,,,IPR032675 (100%),Leucine-rich repeat domain superfamily (100%),,,,,,,,,,,
WNAHSSMCFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGSNHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (100%),Nucleotidyltransferases (100%),GO:0005579 (15%);GO:0005840 (8%);GO:1990077 (8%),membrane attack complex (15%);ribosome (8%);primosome complex (8%),GO:0003677 (23%);GO:0003824 (15%);GO:0003700 (8%),DNA binding (23%);catalytic activity (15%);DNA-binding transcription factor activity (8%),GO:0005975 (15%);GO:0006956 (15%);GO:0000160 (8%),carbohydrate metabolic process (15%);complement activation (15%);phosphorelay signal transduction system (8%),IPR000436 (10%);IPR000884 (10%);IPR001303 (10%),Sushi/SCR/CCP domain (10%);Thrombospondin type-1 (TSP1) repeat (10%);Class II aldolase/adducin N-terminal (10%),,,,,,,,,,,
NMMTPHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WMVLDWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSSCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.170 (20%);3.2.1.24 (20%);2.3.2.27 (7%),Mannosylglycerate hydrolase (20%);Alpha-mannosidase (20%);RING-type E3 ubiquitin transferase (7%),GO:0016021 (26%);GO:0005634 (9%);GO:0005737 (3%),integral component of membrane (26%);nucleus (9%);cytoplasm (3%),GO:0008270 (15%);GO:0005524 (11%);GO:0046872 (9%),zinc ion binding (15%);ATP binding (11%);metal ion binding (9%),GO:0010274 (4%);GO:0007338 (3%);GO:0030317 (3%),hydrotropism (4%);single fertilization (3%);flagellated sperm motility (3%),IPR008913 (10%);IPR037274 (10%);IPR036259 (6%),Zinc finger, CHY-type (10%);Zinc finger, CHY-type superfamily (10%);MFS transporter superfamily (6%),,,,,,,,,
NPEWMMLMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALWMMLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPEPTSFVLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FYNNWFVSLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDSYHAWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPLCMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.74 (75%);4.1.1.- (25%),1,4-dihydroxy-2-naphthoate polyprenyltransferase (75%);Carboxy-lyases (25%),,,GO:0016831 (100%);GO:0016740 (75%),carboxy-lyase activity (100%);transferase activity (75%),,,IPR002830 (83%);IPR022390 (83%);IPR010730 (17%),UbiD decarboxylyase family (83%);4-hydroxybenzoate decarboxylase subunit C (83%);Heterokaryon incompatibility (17%),,,,,,,,,,
NMLANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (20%);3.5.4.30 (20%);5.1.3.2 (20%),Histidine kinase (20%);dCTP deaminase (dUMP-forming) (20%);UDP-glucose 4-epimerase (20%),GO:0016021 (19%);GO:0005737 (4%);GO:0005886 (4%),integral component of membrane (19%);cytoplasm (4%);plasma membrane (4%),GO:0003700 (23%);GO:0003677 (21%);GO:0097367 (21%),DNA-binding transcription factor activity (23%);DNA binding (21%);carbohydrate derivative binding (21%),GO:1901135 (21%);GO:0055085 (4%);GO:0000160 (2%),carbohydrate derivative metabolic process (21%);transmembrane transport (4%);phosphorelay signal transduction system (2%),IPR001638 (20%);IPR036388 (15%);IPR000281 (14%),Solute-binding protein  family 3/N-terminal domain of MltF (20%);Winged helix-like DNA-binding domain superfamily (15%);Helix-turn-helix protein RpiR (14%),,,,,,,,,,,
LTMHGDVMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVQWSQMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NEHMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.- (29%);3.1.3.16 (12%);1.1.1.205 (6%),Transferring alkyl or aryl groups, other than methyl groups (29%);Protein-serine/threonine phosphatase (12%);IMP dehydrogenase (6%),GO:0016021 (42%);GO:0005634 (4%);GO:0005737 (3%),integral component of membrane (42%);nucleus (4%);cytoplasm (3%),GO:0005524 (19%);GO:0046872 (13%);GO:0004722 (12%),ATP binding (19%);metal ion binding (13%);protein serine/threonine phosphatase activity (12%),GO:0055085 (11%);GO:0019346 (4%);GO:0071266 (3%),transmembrane transport (11%);transsulfuration (4%);'de novo' L-methionine biosynthetic process (3%),IPR027417 (19%);IPR003593 (12%);IPR000222 (12%),P-loop containing nucleoside triphosphate hydrolase (19%);AAA+ ATPase domain (12%);PPM-type phosphatase, divalent cation binding (12%),,,,,,,,,
EALHPAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPLLPYWGPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (21%);6.2.1.5 (8%);2.7.7.7 (6%),Acting on ester bonds (21%);Succinate--CoA ligase (ADP-forming) (8%);DNA-directed DNA polymerase (6%),GO:0016021 (26%);GO:0005737 (8%);GO:0005829 (3%),integral component of membrane (26%);cytoplasm (8%);cytosol (3%),GO:0005524 (21%);GO:0003677 (7%);GO:0046872 (7%),ATP binding (21%);DNA binding (7%);metal ion binding (7%),GO:0006298 (4%);GO:0045910 (4%);GO:0006465 (4%),mismatch repair (4%);negative regulation of DNA recombination (4%);signal peptide processing (4%),IPR027417 (12%);IPR029045 (7%);IPR001849 (6%),P-loop containing nucleoside triphosphate hydrolase (12%);ClpP/crotonase-like domain superfamily (7%);Pleckstrin homology domain (6%),,,,,,,,,,,
ADHFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.11 (100%),Aspartate-semialdehyde dehydrogenase (100%),GO:0016021 (20%);GO:0032300 (10%),integral component of membrane (20%);mismatch repair complex (10%),GO:0004073 (30%);GO:0005524 (30%);GO:0016887 (30%),aspartate-semialdehyde dehydrogenase activity (30%);ATP binding (30%);ATPase activity (30%),GO:0009088 (30%);GO:0009089 (30%);GO:0009097 (30%),threonine biosynthetic process (30%);lysine biosynthetic process via diaminopimelate (30%);isoleucine biosynthetic process (30%),IPR000319 (30%);IPR000534 (30%);IPR011534 (30%),Aspartate-semialdehyde dehydrogenase, conserved site (30%);Semialdehyde dehydrogenase, NAD-binding (30%);Aspartate-semialdehyde dehydrogenase, gamma-type (30%),,,,,,,,
ELVPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.2.10 (36%);1.1.1.86 (21%);2.1.1.199 (7%),P-type Ca(2+) transporter (36%);Ketol-acid reductoisomerase (NADP(+)) (21%);16S rRNA (cytosine(1402)-N(4))-methyltransferase (7%),GO:0016021 (46%);GO:0005634 (7%);GO:0005737 (2%),integral component of membrane (46%);nucleus (7%);cytoplasm (2%),GO:0005524 (28%);GO:0003677 (10%);GO:0005388 (5%),ATP binding (28%);DNA binding (10%);calcium transmembrane transporter activity, phosphorylative mechanism (5%),GO:0055085 (4%);GO:0009097 (3%);GO:0009099 (3%),transmembrane transport (4%);isoleucine biosynthetic process (3%);valine biosynthetic process (3%),IPR004014 (13%);IPR008250 (13%);IPR023298 (13%),Cation-transporting P-type ATPase, N-terminal (13%);P-type ATPase, A domain superfamily (13%);P-type ATPase, transmembrane domain superfamily (13%),,,,,,,
TGPGNDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNHQLTVPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPELCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.37 (80%);3.1.3.16 (20%),Uroporphyrinogen decarboxylase (80%);Protein-serine/threonine phosphatase (20%),GO:0005737 (9%);GO:0005634 (2%);GO:0016021 (2%),cytoplasm (9%);nucleus (2%);integral component of membrane (2%),GO:0046872 (31%);GO:0004722 (18%);GO:0003824 (16%),metal ion binding (31%);protein serine/threonine phosphatase activity (18%);catalytic activity (16%),GO:0006782 (9%);GO:0009228 (2%);GO:0046907 (2%),protoporphyrinogen IX biosynthetic process (9%);thiamine biosynthetic process (2%);intracellular transport (2%),IPR001932 (12%);IPR015655 (12%);IPR036457 (12%),PPM-type phosphatase domain (12%);Protein phosphatase 2C family (12%);PPM-type phosphatase domain superfamily (12%),,,,,,,,,,,
QMDSGNK,Legionella pneumophila subsp. pneumophila,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Legionellales,,,,,Legionellaceae,,,,Legionella,,,,Legionella pneumophila,Legionella pneumophila subsp. pneumophila,,,,,,,,,,,,,,,,,,,,,,,
MMNYYPLK,Bacteroidales,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,,,,,,,,,,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (100%);IPR008969 (100%);IPR012910 (100%),TonB-dependent receptor-like, beta-barrel (100%);Carboxypeptidase-like, regulatory domain superfamily (100%);TonB-dependent receptor, plug domain (100%),,,,,,,,
EVLMWMSELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEPVHVMTLAQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANTLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.1 (41%);2.7.11.- (18%);2.7.11.1 (9%),DNA ligase (ATP) (41%);Protein-serine/threonine kinases (18%);Non-specific serine/threonine protein kinase (9%),GO:0016021 (12%);GO:0044291 (6%);GO:0005737 (5%),integral component of membrane (12%);cell-cell contact zone (6%);cytoplasm (5%),GO:0005524 (47%);GO:0003677 (23%);GO:0003910 (21%),ATP binding (47%);DNA binding (23%);DNA ligase (ATP) activity (21%),GO:0006310 (21%);GO:0006281 (11%);GO:0035556 (10%),DNA recombination (21%);DNA repair (11%);intracellular signal transduction (10%),IPR012309 (18%);IPR012310 (18%);IPR012340 (18%),DNA ligase, ATP-dependent, C-terminal (18%);DNA ligase, ATP-dependent, central (18%);Nucleic acid-binding, OB-fold (18%),,,,,,
FGNMFVLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNMAVGHTPQSAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPLVYVSSAPPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQPWSR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (100%),DNA ligase (NAD(+)) (100%),,,GO:0003677 (100%);GO:0003911 (100%);GO:0046872 (99%),DNA binding (100%);DNA ligase (NAD+) activity (100%);metal ion binding (99%),GO:0006260 (100%);GO:0006281 (100%),DNA replication (100%);DNA repair (100%),IPR001357 (95%);IPR003583 (95%);IPR010994 (95%),BRCT domain (95%);Helix-hairpin-helix DNA-binding motif, class 1 (95%);RuvA domain 2-like (95%),,,,,,,,,,
SYHTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (71%);GO:0005886 (14%),integral component of membrane (71%);plasma membrane (14%),GO:0015095 (29%);GO:0046872 (29%);GO:0016301 (14%),magnesium ion transmembrane transporter activity (29%);metal ion binding (29%);kinase activity (14%),GO:0009143 (14%),nucleoside triphosphate catabolic process (14%),IPR000109 (29%);IPR000644 (29%);IPR006667 (29%),Proton-dependent oligopeptide transporter family (29%);CBS domain (29%);SLC41 divalent cation transporters, integral membrane domain (29%),,,,,,,,,,
DYQAM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDDDSGWNDAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLNDPSLK,Marinomonas profundimaris,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Oceanospirillales,,,,,Oceanospirillaceae,,,,Marinomonas,,,,Marinomonas profundimaris,,,,,,,,,,GO:0000271 (100%);GO:0015774 (100%),polysaccharide biosynthetic process (100%);polysaccharide transport (100%),IPR007833 (100%),Capsule polysaccharide biosynthesis (100%),,,,,,,,,,,
HMFAWQMYYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.2 (21%);2.7.13.3 (12%);4.2.1.2 (8%),Glutaminase (21%);Histidine kinase (12%);Fumarate hydratase (8%),GO:0016021 (27%);GO:0005886 (15%);GO:0005739 (6%),integral component of membrane (27%);plasma membrane (15%);mitochondrion (6%),GO:0003723 (20%);GO:0005524 (10%);GO:0003735 (7%),RNA binding (20%);ATP binding (10%);structural constituent of ribosome (7%),GO:0055085 (13%);GO:0006412 (7%);GO:0006541 (3%),transmembrane transport (13%);translation (7%);glutamine metabolic process (3%),IPR004087 (12%);IPR004088 (12%);IPR036612 (12%),K Homology domain (12%);K Homology domain, type 1 (12%);K Homology domain, type 1 superfamily (12%),,,,,,,,,
FFVYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (52%);1.16.3.1 (10%);1.3.5.1 (7%),Oxidoreductases (52%);Ferroxidase (10%);Succinate dehydrogenase (quinone) (7%),GO:0016021 (46%);GO:0005886 (4%);GO:0005634 (1%),integral component of membrane (46%);plasma membrane (4%);nucleus (1%),GO:0003700 (25%);GO:0043565 (25%);GO:0005507 (7%),DNA-binding transcription factor activity (25%);sequence-specific DNA binding (25%);copper ion binding (7%),GO:0000271 (21%);GO:0019064 (5%);GO:0055085 (4%),polysaccharide biosynthetic process (21%);fusion of virus membrane with host plasma membrane (5%);transmembrane transport (4%),IPR009057 (22%);IPR018060 (22%);IPR037923 (22%),Homeobox-like domain superfamily (22%);DNA binding HTH domain, AraC-type (22%);Transcription regulator HTH-like (22%),,,,,,,,,,
NLFYGLLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAGCFALLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVTEGLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.3 (67%);1.2.7.3 (33%),Dethiobiotin synthase (67%);2-oxoglutarate synthase (33%),GO:0016021 (29%);GO:0005737 (4%);GO:0005886 (2%),integral component of membrane (29%);cytoplasm (4%);plasma membrane (2%),GO:0005524 (24%);GO:0016627 (11%);GO:0050660 (11%),ATP binding (24%);oxidoreductase activity, acting on the CH-CH group of donors (11%);flavin adenine dinucleotide binding (11%),GO:0007015 (16%);GO:0009236 (9%);GO:0055085 (7%),actin filament organization (16%);cobalamin biosynthetic process (9%);transmembrane transport (7%),IPR027417 (31%);IPR002611 (16%);IPR001452 (11%),P-loop containing nucleoside triphosphate hydrolase (31%);IstB-like ATP-binding protein (16%);SH3 domain (11%),,,,,,,,,,
VCMAHYAGRPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GEYSCSVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YDLPAPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPWEAHEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HNTSPPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWWMLSNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGEDDLVQLAPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WEMNLPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSEASLNQR,Burkholderiaceae,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Burkholderiaceae,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR005828 (100%);IPR020846 (100%);IPR036259 (100%),Major facilitator,  sugar transporter-like (100%);Major facilitator superfamily domain (100%);MFS transporter superfamily (100%),,,,,,,,,,
GYSLFVMFGANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVLCDMLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASQLDWEYNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHDAAAYNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPDALSENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNHHPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVDVAHK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.5 (100%),Argininosuccinate synthase (100%),GO:0005737 (90%),cytoplasm (90%),GO:0004055 (100%);GO:0005524 (100%),argininosuccinate synthase activity (100%);ATP binding (100%),GO:0006526 (100%),arginine biosynthetic process (100%),IPR001518 (100%);IPR014729 (100%);IPR018223 (100%),Argininosuccinate synthase (100%);Rossmann-like alpha/beta/alpha sandwich fold (100%);Argininosuccinate synthase, conserved site (100%),,,,,,,,,,
FTLWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (47%);5.99.1.2 (22%);3.1.-.- (7%),3-isopropylmalate dehydratase (47%);Transferred entry: 5.6.2.1 (22%);Acting on ester bonds (7%),GO:0016021 (30%);GO:0009316 (12%);GO:0005737 (6%),integral component of membrane (30%);3-isopropylmalate dehydratase complex (12%);cytoplasm (6%),GO:0003677 (25%);GO:0003917 (18%);GO:0003861 (13%),DNA binding (25%);DNA topoisomerase type I (single strand cut, ATP-independent) activity (18%);3-isopropylmalate dehydratase activity (13%),GO:0006265 (18%);GO:0009098 (13%);GO:0007018 (3%),DNA topological change (18%);leucine biosynthetic process (13%);microtubule-based movement (3%),IPR000380 (15%);IPR013497 (15%);IPR013824 (15%),DNA topoisomerase, type IA (15%);DNA topoisomerase, type IA, central (15%);DNA topoisomerase, type IA, central region, subdomain 1 (15%),,,,
NESPNSAANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SCHQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (42%);2.1.1.171 (26%);3.1.3.48 (11%),Metalloendopeptidases (42%);16S rRNA (guanine(966)-N(2))-methyltransferase (26%);Protein-tyrosine-phosphatase (11%),GO:0016021 (15%);GO:0005814 (10%);GO:0034451 (10%),integral component of membrane (15%);centriole (10%);centriolar satellite (10%),GO:0003676 (30%);GO:0008168 (22%);GO:0060090 (17%),nucleic acid binding (30%);methyltransferase activity (22%);molecular adaptor activity (17%),GO:0031167 (22%);GO:0007165 (17%);GO:0007052 (10%),rRNA methylation (22%);signal transduction (17%);mitotic spindle organization (10%),IPR029063 (20%);IPR002052 (19%);IPR004398 (19%),S-adenosyl-L-methionine-dependent methyltransferase (20%);DNA methylase, N-6 adenine-specific, conserved site (19%);RNA methyltransferase, RsmD (19%),,,,,,,,
NLPSVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.9.1.1 (81%);2.7.9.2 (13%);4.1.99.3 (6%),L-seryl-tRNA(Sec) selenium transferase (81%);Pyruvate, water dikinase (13%);Deoxyribodipyrimidine photo-lyase (6%),GO:0005737 (50%);GO:0016021 (4%),cytoplasm (50%);integral component of membrane (4%),GO:0004125 (50%);GO:0016829 (19%);GO:0008986 (12%),L-seryl-tRNASec selenium transferase activity (50%);lyase activity (19%);pyruvate, water dikinase activity (12%),GO:0001514 (50%);GO:0097056 (50%);GO:0018298 (23%),selenocysteine incorporation (50%);selenocysteinyl-tRNA(Sec) biosynthetic process (50%);protein-chromophore linkage (23%),IPR015424 (45%);IPR018319 (45%);IPR004534 (42%),Pyridoxal phosphate-dependent transferase (45%);L-seryl-tRNA selenium transferase-like (45%);L-seryl-tRNA(Sec) selenium transferase (42%),,,,,,,,,
LLMMGSK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.0 (100%), (100%),GO:0016021 (25%);GO:0005886 (13%);GO:0009279 (13%),integral component of membrane (25%);plasma membrane (13%);cell outer membrane (13%),GO:0016491 (50%);GO:0050660 (38%);GO:0003677 (13%),oxidoreductase activity (50%);flavin adenine dinucleotide binding (38%);DNA binding (13%),GO:0006352 (13%);GO:0045727 (13%),DNA-templated transcription, initiation (13%);positive regulation of translation (13%),IPR016156 (38%);IPR023753 (38%);IPR028202 (38%),FAD/NAD-linked reductase, dimerisation domain superfamily (38%);FAD/NAD(P)-binding domain (38%);Reductase, C-terminal (38%),,,,,,,,
TMQNVMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMTHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (33%);2.7.13.3 (31%);2.7.1.24 (11%),DNA helicase (33%);Histidine kinase (31%);Dephospho-CoA kinase (11%),GO:0016021 (6%);GO:1990077 (3%);GO:0005737 (2%),integral component of membrane (6%);primosome complex (3%);cytoplasm (2%),GO:0005524 (82%);GO:0000155 (70%);GO:0004673 (7%),ATP binding (82%);phosphorelay sensor kinase activity (70%);protein histidine kinase activity (7%),GO:0006355 (51%);GO:0006269 (3%);GO:0016539 (3%),regulation of transcription, DNA-templated (51%);DNA replication, synthesis of RNA primer (3%);intein-mediated protein splicing (3%),IPR003661 (73%);IPR036097 (73%);IPR005467 (71%),Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (73%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain superfamily (73%);Histidine kinase domain (71%),,,,,,,
SLFCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (11%);3.4.19.12 (8%);1.1.1.284 (5%),DNA-directed DNA polymerase (11%);Ubiquitinyl hydrolase 1 (8%);S-(hydroxymethyl)glutathione dehydrogenase (5%),GO:0016021 (37%);GO:0005737 (4%);GO:0005886 (1%),integral component of membrane (37%);cytoplasm (4%);plasma membrane (1%),GO:0005524 (20%);GO:0003676 (13%);GO:0004672 (11%),ATP binding (20%);nucleic acid binding (13%);protein kinase activity (11%),GO:0031047 (10%);GO:0006486 (9%);GO:0006260 (5%),gene silencing by RNA (10%);protein glycosylation (9%);DNA replication (5%),IPR011009 (11%);IPR027417 (10%);IPR000719 (10%),Protein kinase-like domain superfamily (11%);P-loop containing nucleoside triphosphate hydrolase (10%);Protein kinase domain (10%),,,,,,,,,,,
TWMSMAR,Paenibacillus sabinae,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Paenibacillaceae,,,,Paenibacillus,,,,Paenibacillus sabinae,,,,2.1.3.3 (100%),Ornithine carbamoyltransferase (100%),,,GO:0004585 (100%);GO:0016597 (100%),ornithine carbamoyltransferase activity (100%);amino acid binding (100%),,,IPR002292 (100%);IPR006130 (100%);IPR006131 (100%),Ornithine/putrescine carbamoyltransferase (100%);Aspartate/ornithine carbamoyltransferase (100%);Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain (100%),,,,,,,,,,
NVYTMDVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLPGCHPFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FALHTTHLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMSPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.8 (100%),Glycerol-3-phosphate dehydrogenase (NAD(+)) (100%),GO:0005789 (50%);GO:0016021 (50%);GO:0009331 (25%),endoplasmic reticulum membrane (50%);integral component of membrane (50%);glycerol-3-phosphate dehydrogenase complex (25%),GO:0004367 (25%);GO:0042803 (25%);GO:0051287 (25%),glycerol-3-phosphate dehydrogenase [NAD+] activity (25%);protein homodimerization activity (25%);NAD binding (25%),GO:0007029 (50%);GO:0005975 (25%);GO:0046168 (25%),endoplasmic reticulum organization (50%);carbohydrate metabolic process (25%);glycerol-3-phosphate catabolic process (25%),IPR009787 (41%);IPR006109 (18%);IPR006168 (18%),Protein jagunal (41%);Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal (18%);Glycerol-3-phosphate dehydrogenase, NAD-dependent (18%),,,,,,,,
DYQGVVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (40%),nucleus (40%),GO:0008270 (100%);GO:0004842 (60%);GO:0003677 (40%),zinc ion binding (100%);ubiquitin-protein transferase activity (60%);DNA binding (40%),GO:0002088 (20%);GO:0007368 (20%);GO:0010216 (20%),lens development in camera-type eye (20%);determination of left/right symmetry (20%);maintenance of DNA methylation (20%),IPR000433 (60%);IPR001199 (60%);IPR004939 (60%),Zinc finger, ZZ-type (60%);Cytochrome b5-like heme/steroid binding domain (60%);APC10/DOC domain (60%),,,,,,,,,,
NFPMTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (89%);GO:0005741 (56%),integral component of membrane (89%);mitochondrial outer membrane (56%),GO:0003924 (56%);GO:0005525 (56%);GO:0005524 (11%),GTPase activity (56%);GTP binding (56%);ATP binding (11%),GO:0008053 (56%),mitochondrial fusion (56%),IPR027417 (56%);IPR006884 (31%);IPR022812 (31%),P-loop containing nucleoside triphosphate hydrolase (56%);Fzo/mitofusin HR2 domain (31%);Dynamin superfamily (31%),,,,,,,,,,,
AHPLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.18 (25%);4.2.2.- (25%);5.3.1.8 (25%),1,4-alpha-glucan branching enzyme (25%);Acting on polysaccharides (25%);Mannose-6-phosphate isomerase (25%),GO:0005819 (17%);GO:0005874 (17%);GO:0015934 (15%),spindle (17%);microtubule (17%);large ribosomal subunit (15%),GO:0004177 (21%);GO:0003735 (15%);GO:0019843 (15%),aminopeptidase activity (21%);structural constituent of ribosome (15%);rRNA binding (15%),GO:0032147 (17%);GO:0060236 (17%);GO:0006412 (15%),activation of protein kinase activity (17%);regulation of mitotic spindle organization (17%);translation (15%),IPR003137 (16%);IPR007484 (16%);IPR009675 (16%),PA domain (16%);Peptidase M28 (16%);TPX2 (16%),,,,,,,,,,
SAMEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.- (6%);2.3.1.234 (4%);3.6.5.0 (4%),Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (6%);N(6)-L-threonylcarbamoyladenine synthase (4%); (4%),GO:0016021 (20%);GO:0005737 (8%);GO:0005634 (5%),integral component of membrane (20%);cytoplasm (8%);nucleus (5%),GO:0005524 (23%);GO:0051082 (11%);GO:0003677 (8%),ATP binding (23%);unfolded protein binding (11%);DNA binding (8%),GO:0006457 (11%);GO:0006412 (4%);GO:0006486 (2%),protein folding (11%);translation (4%);protein glycosylation (2%),IPR027417 (10%);IPR013126 (9%);IPR029048 (8%),P-loop containing nucleoside triphosphate hydrolase (10%);Heat shock protein 70 family (9%);Heat shock protein 70kD, C-terminal domain superfamily (8%),,,,,,,,,
ESLVM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAQPLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.47 (100%),Glucose 1-dehydrogenase (NAD(P)(+)) (100%),GO:0016021 (3%);GO:0005634 (1%);GO:0005694 (1%),integral component of membrane (3%);nucleus (1%);chromosome (1%),GO:0016491 (68%);GO:0047936 (20%);GO:0016829 (4%),oxidoreductase activity (68%);glucose 1-dehydrogenase [NAD(P)] activity (20%);lyase activity (4%),GO:0006313 (1%);GO:0007049 (1%);GO:0007059 (1%),transposition, DNA-mediated (1%);cell cycle (1%);chromosome segregation (1%),IPR002347 (87%);IPR020904 (87%);IPR036291 (87%),Short-chain dehydrogenase/reductase SDR (87%);Short-chain dehydrogenase/reductase, conserved site (87%);NAD(P)-binding domain superfamily (87%),,,,,,,,,
DPWAGGQSLNESK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFETLLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDDQGFPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFWWNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR001734 (100%);IPR038377 (100%),Sodium/solute symporter (100%);Sodium/glucose symporter superfamily (100%),,,,,,,,,,,
QELPCPMHHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVQDWHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVVLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.-.- (28%);2.4.1.212 (10%);3.4.21.107 (10%),Glycosyltransferases (28%);Hyaluronan synthase (10%);Peptidase Do (10%),GO:0016021 (40%);GO:0005737 (4%);GO:0005886 (2%),integral component of membrane (40%);cytoplasm (4%);plasma membrane (2%),GO:0005524 (43%);GO:0016887 (33%);GO:0042626 (19%),ATP binding (43%);ATPase activity (33%);ATPase-coupled transmembrane transporter activity (19%),GO:0005975 (3%);GO:0006355 (2%);GO:0022904 (2%),carbohydrate metabolic process (3%);regulation of transcription, DNA-templated (2%);respiratory electron transport chain (2%),IPR027417 (41%);IPR003439 (35%);IPR003593 (35%),P-loop containing nucleoside triphosphate hydrolase (41%);ABC transporter-like (35%);AAA+ ATPase domain (35%),,,,,,,,,,
DYEFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.267 (14%);3.6.4.12 (14%);1.2.1.5 (5%),1-deoxy-D-xylulose-5-phosphate reductoisomerase (14%);DNA helicase (14%);Aldehyde dehydrogenase (NAD(P)(+)) (5%),GO:0016021 (12%);GO:0005623 (6%);GO:0005840 (2%),integral component of membrane (12%);cell (6%);ribosome (2%),GO:0005524 (18%);GO:0003677 (14%);GO:0004386 (8%),ATP binding (18%);DNA binding (14%);helicase activity (8%),GO:0006310 (8%);GO:0015074 (6%);GO:0045454 (6%),DNA recombination (8%);DNA integration (6%);cell redox homeostasis (6%),IPR027417 (17%);IPR014001 (9%);IPR018035 (9%),P-loop containing nucleoside triphosphate hydrolase (17%);Helicase superfamily 1/2, ATP-binding domain (9%);Flagellar assembly protein FliH/Type III secretion system HrpE (9%),,,,,,,,,,
DLAALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.58 (16%);1.11.1.21 (14%);3.4.14.- (8%),Tagaturonate reductase (16%);Catalase peroxidase (14%);Dipeptidyl-peptidases and tripeptidyl-peptidases (8%),GO:0016021 (13%);GO:0005737 (8%);GO:0005886 (1%),integral component of membrane (13%);cytoplasm (8%);plasma membrane (1%),GO:0005524 (19%);GO:0046872 (9%);GO:0003677 (8%),ATP binding (19%);metal ion binding (9%);DNA binding (8%),GO:0032259 (8%);GO:0042744 (5%);GO:0006979 (4%),methylation (8%);hydrogen peroxide catabolic process (5%);response to oxidative stress (4%),IPR027417 (14%);IPR036291 (7%);IPR029063 (6%),P-loop containing nucleoside triphosphate hydrolase (14%);NAD(P)-binding domain superfamily (7%);S-adenosyl-L-methionine-dependent methyltransferase (6%),,,,,,,,,,,
NDDTALPASGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPDAVAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYSLTADANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHGLVDEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFLDNVHK,Mycoplasma hyopneumoniae,Bacteria,,,,Tenericutes,,,Mollicutes,,,,Mycoplasmatales,,,,,Mycoplasmataceae,,,,Mycoplasma,,,,Mycoplasma hyopneumoniae,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
FLVAANPAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAPHCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (69%);2.1.1.- (22%);1.1.1.49 (6%),L-aspartate oxidase (69%);Methyltransferases (22%);Glucose-6-phosphate dehydrogenase (NADP(+)) (6%),GO:0005737 (56%),cytoplasm (56%),GO:0008734 (57%);GO:0044318 (57%);GO:0008757 (16%),L-aspartate oxidase activity (57%);L-aspartate:fumarate oxidoreductase activity (57%);S-adenosylmethionine-dependent methyltransferase activity (16%),GO:0009435 (56%);GO:0032259 (19%);GO:0009877 (17%),NAD biosynthetic process (56%);methylation (19%);nodulation (17%),IPR003953 (51%);IPR005288 (51%);IPR027477 (51%),FAD-dependent oxidoreductase 2, FAD binding domain (51%);L-aspartate oxidase (51%);Succinate dehydrogenase/fumarate reductase flavoprotein, catalytic domain superfamily (51%),,,,,,,,,
FNYVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.18 (38%);2.7.9.2 (9%);2.4.1.- (6%),Glutamine--tRNA ligase (38%);Pyruvate, water dikinase (9%);Hexosyltransferases (6%),GO:0016021 (45%);GO:0009279 (12%);GO:0005886 (7%),integral component of membrane (45%);cell outer membrane (12%);plasma membrane (7%),GO:0030273 (9%);GO:0005524 (9%);GO:0003677 (8%),melanin-concentrating hormone receptor activity (9%);ATP binding (9%);DNA binding (8%),GO:0007218 (9%);GO:0006310 (4%);GO:0006904 (4%),neuropeptide signaling pathway (9%);DNA recombination (4%);vesicle docking involved in exocytosis (4%),IPR008969 (9%);IPR000531 (9%);IPR023996 (9%),Carboxypeptidase-like, regulatory domain superfamily (9%);TonB-dependent receptor-like, beta-barrel (9%);TonB-dependent outer membrane protein, SusC/RagA (9%),,,,,,,
STWPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (24%);7.1.1.- (22%);2.7.7.7 (18%),Protein-serine/threonine phosphatase (24%);Hydron translocation or charge separation linked to oxidoreductase reactions (22%);DNA-directed DNA polymerase (18%),GO:0016021 (21%);GO:0005634 (10%);GO:0016459 (7%),integral component of membrane (21%);nucleus (10%);myosin complex (7%),GO:0003700 (10%);GO:0005524 (9%);GO:0003824 (9%),DNA-binding transcription factor activity (10%);ATP binding (9%);catalytic activity (9%),GO:0006355 (24%);GO:0006071 (22%);GO:0000122 (9%),regulation of transcription, DNA-templated (24%);glycerol metabolic process (22%);negative regulation of transcription by RNA polymerase II (9%),IPR006994 (22%);IPR006699 (18%);IPR035928 (18%),TCF25/Rqc1 (22%);Glycerol uptake operon antiterminator (18%);GlpP-like superfamily (18%),,,,,,,,,,
HSLLFCMPSSNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMLQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.44 (67%);1.3.1.9 (33%),Trans-2-enoyl-CoA reductase (NAD(+)) (67%);Enoyl-[acyl-carrier-protein] reductase (NADH) (33%),GO:0016021 (8%);GO:0005634 (4%);GO:0005737 (4%),integral component of membrane (8%);nucleus (4%);cytoplasm (4%),GO:0005524 (13%);GO:0051287 (13%);GO:0016788 (8%),ATP binding (13%);NAD binding (13%);hydrolase activity, acting on ester bonds (8%),GO:0006633 (13%);GO:0000160 (8%);GO:0006281 (8%),fatty acid biosynthetic process (13%);phosphorelay signal transduction system (8%);DNA repair (8%),IPR010758 (11%);IPR024906 (11%);IPR024910 (11%),Trans-2-enoyl-CoA reductase (11%);Enoyl reductase FAD binding domain (11%);Trans-2-enoyl-CoA reductase catalytic domain, putative (11%),,,,,,,,,
GELQMMTTVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQEHLHVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMGGQMAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYVPTVHAAGGHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGLLLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.44 (36%);4.1.1.81 (21%);3.6.4.12 (14%),Protein-glutamine glutaminase (36%);Threonine-phosphate decarboxylase (21%);DNA helicase (14%),GO:0016021 (33%);GO:0005680 (14%);GO:0005886 (8%),integral component of membrane (33%);anaphase-promoting complex (14%);plasma membrane (8%),GO:0005524 (11%);GO:0046872 (11%);GO:0003677 (8%),ATP binding (11%);metal ion binding (11%);DNA binding (8%),GO:0071524 (6%);GO:0009236 (6%);GO:0006935 (5%),pyrrolysine biosynthetic process (6%);cobalamin biosynthetic process (6%);chemotaxis (5%),IPR008401 (12%);IPR011761 (7%);IPR003806 (6%),Apc13 (12%);ATP-grasp fold (7%);ATP-grasp fold, PylC-type (6%),,,,,,,,,,
FAFEHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.100 (50%);4.3.1.16 (50%),3-oxoacyl-[acyl-carrier-protein] reductase (50%);Threo-3-hydroxy-L-aspartate ammonia-lyase (50%),,,GO:0030170 (76%);GO:0016829 (24%);GO:0000287 (6%),pyridoxal phosphate binding (76%);lyase activity (24%);magnesium ion binding (6%),GO:0006520 (76%);GO:0006629 (6%);GO:0032259 (6%),cellular amino acid metabolic process (76%);lipid metabolic process (6%);methylation (6%),IPR000634 (72%);IPR001926 (72%);IPR036052 (72%),Serine/threonine dehydratase, pyridoxal-phosphate-binding site (72%);Pyridoxal-phosphate dependent enzyme (72%);Tryptophan synthase beta subunit-like PLP-dependent enzyme (72%),,,,,,,,,,
EEYDCPK,Paenibacillus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Paenibacillaceae,,,,Paenibacillus,,,,,,,,3.2.1.23 (100%),Beta-galactosidase (100%),GO:0009341 (100%),beta-galactosidase complex (100%),GO:0004565 (100%);GO:0030246 (100%),beta-galactosidase activity (100%);carbohydrate binding (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR004199 (100%);IPR006101 (100%);IPR006102 (100%),Beta galactosidase small chain/ domain 5 (100%);Glycoside hydrolase, family 2 (100%);Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich (100%),,,,,,,,
VMCWMHLTLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALAAHCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.47 (100%),Glucose 1-dehydrogenase (NAD(P)(+)) (100%),,,GO:0016491 (71%);GO:0003677 (7%);GO:0004061 (7%),oxidoreductase activity (71%);DNA binding (7%);arylformamidase activity (7%),GO:0006355 (7%);GO:0019441 (7%),regulation of transcription, DNA-templated (7%);tryptophan catabolic process to kynurenine (7%),IPR002347 (69%);IPR020904 (69%);IPR036291 (69%),Short-chain dehydrogenase/reductase SDR (69%);Short-chain dehydrogenase/reductase, conserved site (69%);NAD(P)-binding domain superfamily (69%),,,,,,,,,
NPSAFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003700 (50%);GO:0005524 (50%);GO:0043565 (50%),DNA-binding transcription factor activity (50%);ATP binding (50%);sequence-specific DNA binding (50%),,,IPR000330 (50%);IPR001650 (50%);IPR001841 (50%),SNF2-related, N-terminal domain (50%);Helicase, C-terminal (50%);Zinc finger, RING-type (50%),,,,,,,,
GHEGFDMHMSPGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYDDMTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR007052 (100%);IPR008978 (100%);IPR037898 (100%),CS domain (100%);HSP20-like chaperone (100%);NudC family (100%),,,,,,,,,,,
DVALLEAVDAVSNALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWDMGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGMMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (59%);2.5.1.- (8%);3.1.2.28 (3%),Acting on peptide bonds (peptidases) (59%);Transferring alkyl or aryl groups, other than methyl groups (8%);1,4-dihydroxy-2-naphthoyl-CoA hydrolase (3%),GO:0016021 (6%);GO:0005737 (1%);GO:0005840 (1%),integral component of membrane (6%);cytoplasm (1%);ribosome (1%),GO:0008233 (72%);GO:0008080 (6%);GO:0046872 (5%),peptidase activity (72%);N-acetyltransferase activity (6%);metal ion binding (5%),GO:0045892 (1%);GO:0006355 (1%);GO:0006304 (1%),negative regulation of transcription, DNA-templated (1%);regulation of transcription, DNA-templated (1%);DNA modification (1%),IPR001539 (70%);IPR016181 (6%);IPR000182 (6%),Peptidase U32 (70%);Acyl-CoA N-acyltransferase (6%);GNAT domain (6%),,,,,,,
NLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.27 (11%);5.6.2.2 (5%);2.7.2.3 (5%),Glucose-1-phosphate adenylyltransferase (11%);DNA topoisomerase (ATP-hydrolyzing) (5%);Phosphoglycerate kinase (5%),GO:0016021 (19%);GO:0005634 (9%);GO:0005737 (8%),integral component of membrane (19%);nucleus (9%);cytoplasm (8%),GO:0005524 (14%);GO:0003677 (11%);GO:0003676 (5%),ATP binding (14%);DNA binding (11%);nucleic acid binding (5%),GO:0006355 (6%);GO:0007229 (4%);GO:0007160 (3%),regulation of transcription, DNA-templated (6%);integrin-mediated signaling pathway (4%);cell-matrix adhesion (3%),IPR027417 (7%);IPR035965 (5%);IPR000014 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);PAS domain superfamily (5%);PAS domain (5%),,,,,,,,,,
GFLTYFR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),GO:0004888 (67%);GO:0003951 (33%),transmembrane signaling receptor activity (67%);NAD+ kinase activity (33%),GO:0006935 (67%);GO:0007165 (67%),chemotaxis (67%);signal transduction (67%),IPR003660 (67%);IPR004089 (67%);IPR004090 (67%),HAMP domain (67%);Methyl-accepting chemotaxis protein (MCP) signalling domain (67%);Chemotaxis methyl-accepting receptor (67%),,,,,,,,,,,
NVANNEAVDAAVSNDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHEFAGNK,Zymoseptoria brevis,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Dothideomycetes,Dothideomycetidae,,,Capnodiales,,,,,Mycosphaerellaceae,,,,Zymoseptoria,,,,Zymoseptoria brevis,,,,,,,,,,,,,,,,,,,,,,,,
NYDAC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DYLLVTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (89%),integral component of membrane (89%),GO:0003688 (11%);GO:0004386 (11%);GO:0005524 (11%),DNA replication origin binding (11%);helicase activity (11%);ATP binding (11%),GO:0006260 (11%),DNA replication (11%),IPR002464 (25%);IPR003450 (25%);IPR006442 (25%),DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site (25%);Replication origin-binding protein (25%);Type II toxin-antitoxin system, antitoxin Phd/YefM (25%),,,,,,,
NEMMQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGNVLEGSANHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPGAVMHTQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DYLPNMMTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVVHVAFGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLLMMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.189 (20%);2.3.2.31 (20%);2.7.7.0 (20%),Mycothiol synthase (20%);RBR-type E3 ubiquitin transferase (20%); (20%),GO:0016021 (21%);GO:0000814 (3%);GO:0005886 (3%),integral component of membrane (21%);ESCRT II complex (3%);plasma membrane (3%),GO:0003677 (21%);GO:0005524 (11%);GO:0003700 (10%),DNA binding (21%);ATP binding (11%);DNA-binding transcription factor activity (10%),GO:0006352 (10%);GO:0006306 (8%);GO:0007165 (7%),DNA-templated transcription, initiation (10%);DNA methylation (8%);signal transduction (7%),IPR027417 (15%);IPR036388 (15%);IPR007627 (9%),P-loop containing nucleoside triphosphate hydrolase (15%);Winged helix-like DNA-binding domain superfamily (15%);RNA polymerase sigma-70 region 2 (9%),,,,,,,,,,
TADLFVVPGER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNFMGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLEYYMGPVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QYNGLNM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNTVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.72 (23%);2.7.13.3 (10%);3.1.-.- (8%),Site-specific DNA-methyltransferase (adenine-specific) (23%);Histidine kinase (10%);Acting on ester bonds (8%),GO:0016021 (39%);GO:0005737 (3%);GO:0005886 (3%),integral component of membrane (39%);cytoplasm (3%);plasma membrane (3%),GO:0005524 (14%);GO:0003677 (9%);GO:0016887 (5%),ATP binding (14%);DNA binding (9%);ATPase activity (5%),GO:0055085 (2%);GO:0007165 (2%);GO:0009297 (2%),transmembrane transport (2%);signal transduction (2%);pilus assembly (2%),IPR027417 (8%);IPR029063 (6%);IPR036388 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);S-adenosyl-L-methionine-dependent methyltransferase (6%);Winged helix-like DNA-binding domain superfamily (5%),,,,,,,,,,,
EYSGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.9 (11%);4.2.1.20 (8%);6.1.1.3 (7%),Thioredoxin-disulfide reductase (11%);Tryptophan synthase (8%);Threonine--tRNA ligase (7%),GO:0016021 (34%);GO:0005737 (6%);GO:0005783 (4%),integral component of membrane (34%);cytoplasm (6%);endoplasmic reticulum (4%),GO:0005524 (15%);GO:0004842 (12%);GO:0003677 (8%),ATP binding (15%);ubiquitin-protein transferase activity (12%);DNA binding (8%),GO:0030433 (4%);GO:0006352 (3%);GO:0045454 (2%),ubiquitin-dependent ERAD pathway (4%);DNA-templated transcription, initiation (3%);cell redox homeostasis (2%),IPR042494 (10%);IPR013083 (10%);IPR027417 (10%),E3 ubiquitin-protein ligase RNF103 (10%);Zinc finger, RING/FYVE/PHD-type (10%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,,
VDSEWFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGLMHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (67%);7.1.2.1 (33%),DNA-directed DNA polymerase (67%);P-type H(+)-exporting transporter (33%),GO:0016021 (10%);GO:0005737 (5%);GO:0005576 (2%),integral component of membrane (10%);cytoplasm (5%);extracellular region (2%),GO:0005524 (71%);GO:0004672 (31%);GO:0016887 (31%),ATP binding (71%);protein kinase activity (31%);ATPase activity (31%),GO:0006260 (5%);GO:0006281 (5%);GO:0006772 (2%),DNA replication (5%);DNA repair (5%);thiamine metabolic process (2%),IPR011009 (35%);IPR000719 (33%);IPR003439 (29%),Protein kinase-like domain superfamily (35%);Protein kinase domain (33%);ABC transporter-like (29%),,,,,,,,,,,
SMCWLSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APCESAR,Burkholderia mallei,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,,Burkholderiales,,,,,Burkholderiaceae,,,,Burkholderia,,pseudomallei group,,Burkholderia mallei,,,,,,,,,,,,,,,,,,,,,,,,
MQTLDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.3 (100%),Adenylate kinase (100%),GO:0005737 (40%);GO:0016021 (20%);GO:0030286 (20%),cytoplasm (40%);integral component of membrane (20%);dynein complex (20%),GO:0005524 (100%);GO:0004017 (40%);GO:0003777 (20%),ATP binding (100%);adenylate kinase activity (40%);microtubule motor activity (20%),GO:0007018 (20%),microtubule-based movement (20%),IPR027417 (67%);IPR000850 (33%);IPR003593 (33%),P-loop containing nucleoside triphosphate hydrolase (67%);Adenylate kinase/UMP-CMP kinase (33%);AAA+ ATPase domain (33%),,,,,,,,,,,
HDNLEDHGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYHVMMSPANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMHQMPPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPWALPATGNMM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNWMLEVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLPDGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (33%);2.7.7.6 (11%);1.7.99.4 (6%),Beta-galactosidase (33%);DNA-directed RNA polymerase (11%);Nitrate reductase (6%),GO:0016021 (15%);GO:0009341 (7%);GO:0009325 (6%),integral component of membrane (15%);beta-galactosidase complex (7%);nitrate reductase complex (6%),GO:0003677 (14%);GO:0046872 (11%);GO:0030246 (8%),DNA binding (14%);metal ion binding (11%);carbohydrate binding (8%),GO:0005975 (8%);GO:0006355 (7%);GO:0042126 (6%),carbohydrate metabolic process (8%);regulation of transcription, DNA-templated (7%);nitrate metabolic process (6%),IPR036388 (10%);IPR036390 (10%);IPR013783 (8%),Winged helix-like DNA-binding domain superfamily (10%);Winged helix DNA-binding domain superfamily (10%);Immunoglobulin-like fold (8%),,,,,,,,,,
NVFAMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016491 (50%);GO:0016787 (50%),oxidoreductase activity (50%);hydrolase activity (50%),GO:0016042 (50%),lipid catabolic process (50%),IPR002641 (50%);IPR011032 (50%);IPR013149 (50%),Patatin-like phospholipase domain (50%);GroES-like superfamily (50%);Alcohol dehydrogenase, C-terminal (50%),,,,,,,,,,
TTYQPMTPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLDWTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.31 (22%);6.2.1.1 (22%);2.7.1.24 (11%),6-phosphogluconolactonase (22%);Acetate--CoA ligase (22%);Dephospho-CoA kinase (11%),GO:0016021 (29%);GO:0005634 (22%);GO:0005737 (6%),integral component of membrane (29%);nucleus (22%);cytoplasm (6%),GO:0003677 (25%);GO:0008270 (22%);GO:0000981 (16%),DNA binding (25%);zinc ion binding (22%);DNA-binding transcription factor activity, RNA polymerase II-specific (16%),GO:0006351 (20%);GO:0005975 (14%);GO:0006044 (8%),transcription, DNA-templated (20%);carbohydrate metabolic process (14%);N-acetylglucosamine metabolic process (8%),IPR007219 (18%);IPR001138 (14%);IPR036864 (14%),Transcription factor domain, fungi (18%);Zn(2)-C6 fungal-type DNA-binding domain (14%);Zn(2)-C6 fungal-type DNA-binding domain superfamily (14%),,,,,,,,
MYNPVNQLTNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSVEPSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVDGPYNGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WTMLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.2.- (21%);3.4.21.89 (16%);2.7.7.48 (11%),Linked to the hydrolysis of a nucleoside triphosphate (21%);Signal peptidase I (16%);RNA-directed RNA polymerase (11%),GO:0016021 (52%);GO:0005886 (5%);GO:0005737 (4%),integral component of membrane (52%);plasma membrane (5%);cytoplasm (4%),GO:0008080 (11%);GO:0016846 (9%);GO:0005524 (4%),N-acetyltransferase activity (11%);carbon-sulfur lyase activity (9%);ATP binding (4%),GO:0055085 (7%);GO:0005975 (1%);GO:0005982 (1%),transmembrane transport (7%);carbohydrate metabolic process (1%);starch metabolic process (1%),IPR002823 (23%);IPR016181 (10%);IPR000182 (10%),Protein of unknown function DUF112, transmembrane (23%);Acyl-CoA N-acyltransferase (10%);GNAT domain (10%),,,,,,,,,,
VFFHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.275 (37%);5.4.3.8 (19%);2.7.1.26 (4%),Acyl phosphate:glycerol-3-phosphate acyltransferase (37%);Glutamate-1-semialdehyde 2,1-aminomutase (19%);Riboflavin kinase (4%),GO:0016021 (31%);GO:0005886 (11%);GO:0005737 (5%),integral component of membrane (31%);plasma membrane (11%);cytoplasm (5%),GO:0004252 (18%);GO:0070008 (15%);GO:0043772 (7%),serine-type endopeptidase activity (18%);serine-type exopeptidase activity (15%);acyl-phosphate glycerol-3-phosphate acyltransferase activity (7%),GO:0008654 (7%);GO:0006812 (6%);GO:0005975 (6%),phospholipid biosynthetic process (7%);cation transport (6%);carbohydrate metabolic process (6%),IPR029058 (15%);IPR038951 (15%);IPR023302 (14%),Alpha/Beta hydrolase fold (15%);Outer envelope pore protein 37-like (15%);Peptidase S9A, N-terminal domain (14%),,,,,,,,,
MAVLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (41%);2.1.3.2 (9%);1.11.1.15 (9%),Peptidylprolyl isomerase (41%);Aspartate carbamoyltransferase (9%);Peroxiredoxin (9%),GO:0016021 (34%);GO:0005737 (6%);GO:0005886 (5%),integral component of membrane (34%);cytoplasm (6%);plasma membrane (5%),GO:0003755 (15%);GO:0005524 (9%);GO:0003677 (8%),peptidyl-prolyl cis-trans isomerase activity (15%);ATP binding (9%);DNA binding (8%),GO:0055085 (6%);GO:0006281 (4%);GO:0045454 (4%),transmembrane transport (6%);DNA repair (4%);cell redox homeostasis (4%),IPR000297 (13%);IPR027304 (13%);IPR036259 (9%),Peptidyl-prolyl cis-trans isomerase, PpiC-type (13%);Trigger factor/SurA domain superfamily (13%);MFS transporter superfamily (9%),,,,,,,,,,
GMVTLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0015934 (10%);GO:0016021 (3%),large ribosomal subunit (10%);integral component of membrane (3%),GO:0003677 (79%);GO:0000049 (10%);GO:0003735 (10%),DNA binding (79%);tRNA binding (10%);structural constituent of ribosome (10%),GO:0006412 (10%);GO:0006417 (10%);GO:0006631 (3%),translation (10%);regulation of translation (10%);fatty acid metabolic process (3%),IPR007159 (77%);IPR037914 (77%);IPR002143 (10%),SpoVT-AbrB domain (77%);SpoVT-AbrB domain superfamily (77%);Ribosomal protein L1 (10%),,,,,,,,,,,
MLADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (25%);3.6.4.12 (8%);2.5.1.17 (4%),Hydron translocation or charge separation linked to oxidoreductase reactions (25%);DNA helicase (8%);Corrinoid adenosyltransferase (4%),GO:0016021 (16%);GO:0005737 (14%);GO:0005623 (2%),integral component of membrane (16%);cytoplasm (14%);cell (2%),GO:0005524 (20%);GO:0046872 (12%);GO:0003677 (10%),ATP binding (20%);metal ion binding (12%);DNA binding (10%),GO:0006094 (5%);GO:0051301 (2%);GO:0006886 (2%),gluconeogenesis (5%);cell division (2%);intracellular protein transport (2%),IPR027417 (11%);IPR011537 (7%);IPR037225 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);NADH ubiquinone oxidoreductase, F subunit (7%);NADH-ubiquinone oxidoreductase 51kDa subunit, FMN-binding domain superfamily (7%),,,,,,,,,
DHNLQGDVEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLHVDSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (50%),membrane (50%),GO:0004040 (50%),amidase activity (50%),,,IPR002901 (50%);IPR012854 (50%);IPR036300 (50%),Mannosyl-glycoprotein endo-beta-N-acetylglucosamidase-like domain (50%);Copper amine oxidase-like, N-terminal (50%);Mir domain superfamily (50%),,,,,,,,,,
MHGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.21 (12%);3.2.1.74 (12%);2.4.2.14 (9%),Beta-glucosidase (12%);Glucan 1,4-beta-glucosidase (12%);Amidophosphoribosyltransferase (9%),GO:0005576 (10%);GO:0005829 (10%);GO:0005789 (10%),extracellular region (10%);cytosol (10%);endoplasmic reticulum membrane (10%),GO:0004553 (42%);GO:0004867 (11%);GO:0005524 (9%),hydrolase activity, hydrolyzing O-glycosyl compounds (42%);serine-type endopeptidase inhibitor activity (11%);ATP binding (9%),GO:0005975 (45%);GO:0009913 (10%);GO:0030155 (9%),carbohydrate metabolic process (45%);epidermal cell differentiation (10%);regulation of cell adhesion (9%),IPR017853 (39%);IPR001764 (39%);IPR036962 (39%),Glycoside hydrolase superfamily (39%);Glycoside hydrolase, family 3, N-terminal (39%);Glycoside hydrolase, family 3, N-terminal domain superfamily (39%),,,,,
FWEVLEWNMMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NCMSLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNDEPSSYSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMLHNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (33%);3.6.4.- (17%);4.1.1.36 (17%),DNA helicase (33%);Acting on ATP; involved in cellular and subcellular movement (17%);Phosphopantothenoylcysteine decarboxylase (17%),GO:0016021 (49%);GO:0005634 (29%);GO:0016020 (4%),integral component of membrane (49%);nucleus (29%);membrane (4%),GO:0003779 (9%);GO:0017048 (9%);GO:0005524 (5%),actin binding (9%);Rho GTPase binding (9%);ATP binding (5%),GO:0030036 (9%);GO:0000162 (1%);GO:0000716 (1%),actin cytoskeleton organization (9%);tryptophan biosynthetic process (1%);transcription-coupled nucleotide-excision repair, DNA damage recognition (1%),IPR005045 (44%);IPR000953 (26%);IPR016197 (26%),CDC50/LEM3 family (44%);Chromo/chromo shadow domain (26%);Chromo-like domain superfamily (26%),,,,,,,,,,
ELMMAPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMYETR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%);GO:0005886 (33%),integral component of membrane (67%);plasma membrane (33%),GO:0005509 (33%);GO:0016746 (33%),calcium ion binding (33%);transferase activity, transferring acyl groups (33%),,,IPR002048 (25%);IPR003838 (25%);IPR004960 (25%),EF-hand domain (25%);ABC transporter permease protein domain (25%);Bacterial lipid A biosynthesis acyltransferase (25%),,,,,,,,,,
DPVNPMDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSCAALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (5%),integral component of membrane (5%),GO:0003677 (95%);GO:0003700 (90%),DNA binding (95%);DNA-binding transcription factor activity (90%),,,IPR005119 (91%);IPR000847 (87%);IPR036388 (87%),LysR, substrate-binding (91%);Transcription regulator HTH, LysR (87%);Winged helix-like DNA-binding domain superfamily (87%),,,,,,,,,
LSGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.-.- (31%);2.7.11.1 (14%);3.4.21.- (7%),Acting on acid anhydrides (31%);Non-specific serine/threonine protein kinase (14%);Serine endopeptidases (7%),GO:0016021 (35%);GO:0005737 (13%);GO:0005886 (10%),integral component of membrane (35%);cytoplasm (13%);plasma membrane (10%),GO:0005524 (14%);GO:0046872 (11%);GO:0005525 (10%),ATP binding (14%);metal ion binding (11%);GTP binding (10%),GO:0006400 (9%);GO:0009236 (7%);GO:0005975 (3%),tRNA modification (9%);cobalamin biosynthetic process (7%);carbohydrate metabolic process (3%),IPR027417 (13%);IPR031325 (8%);IPR027266 (8%),P-loop containing nucleoside triphosphate hydrolase (13%);RHS repeat (8%);GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1 (8%),,,,,,,,,,
HMFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.200 (25%);1.13.11.29 (13%);1.3.99.2 (13%),Lipoyl amidotransferase (25%);Stizolobate synthase (13%);Transferred entry: 1.3.8.1 (13%),GO:0016021 (14%);GO:0005737 (3%);GO:0005634 (1%),integral component of membrane (14%);cytoplasm (3%);nucleus (1%),GO:0003676 (54%);GO:0008270 (8%);GO:0003677 (7%),nucleic acid binding (54%);zinc ion binding (8%);DNA binding (7%),GO:0006725 (6%);GO:0006313 (3%);GO:0006004 (1%),cellular aromatic compound metabolic process (6%);transposition, DNA-mediated (3%);fucose metabolic process (1%),IPR013087 (50%);IPR039258 (50%);IPR006674 (7%),Zinc finger C2H2-type (50%);Zinc finger protein 511 (50%);HD domain (7%),,,,,,,,,,
CYYVVNAQTNPLSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPPSSAVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSEVEQHAMFSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQQNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (29%);3.1.1.74 (17%);3.1.26.12 (10%),Acting on ATP; involved in cellular and subcellular movement (29%);Cutinase (17%);Ribonuclease E (10%),GO:0016021 (33%);GO:0005634 (8%);GO:0005576 (4%),integral component of membrane (33%);nucleus (8%);extracellular region (4%),GO:0005524 (12%);GO:0003677 (10%);GO:0003723 (8%),ATP binding (12%);DNA binding (10%);RNA binding (8%),GO:0046856 (7%);GO:0007165 (6%);GO:0006353 (3%),phosphatidylinositol dephosphorylation (7%);signal transduction (6%);DNA-templated transcription, termination (3%),IPR005135 (14%);IPR036691 (14%);IPR027417 (10%),Endonuclease/exonuclease/phosphatase (14%);Endonuclease/exonuclease/phosphatase superfamily (14%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,,,
MMDVTPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNVLWWYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDNLNSNMELQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTSATPQGEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QATAN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.30 (75%);1.11.1.15 (25%),Glycerol kinase (75%);Peroxiredoxin (25%),GO:0016021 (35%);GO:0005623 (4%);GO:0005887 (4%),integral component of membrane (35%);cell (4%);integral component of plasma membrane (4%),GO:0003677 (15%);GO:0003700 (15%);GO:0003824 (15%),DNA binding (15%);DNA-binding transcription factor activity (15%);catalytic activity (15%),GO:0006352 (15%);GO:0006072 (12%);GO:0009267 (12%),DNA-templated transcription, initiation (15%);glycerol-3-phosphate metabolic process (12%);cellular response to starvation (12%),IPR000943 (15%);IPR001509 (15%);IPR007627 (15%),RNA polymerase sigma-70 (15%);NAD-dependent epimerase/dehydratase (15%);RNA polymerase sigma-70 region 2 (15%),,,,,,,,,,
DNDSVGTMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VYSSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (74%);1.1.1.94 (5%);3.4.21.- (2%),DNA topoisomerase (74%);Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (5%);Serine endopeptidases (2%),GO:0005694 (27%);GO:0016021 (20%);GO:0005737 (3%),chromosome (27%);integral component of membrane (20%);cytoplasm (3%),GO:0003677 (40%);GO:0046872 (31%);GO:0003917 (30%),DNA binding (40%);metal ion binding (31%);DNA topoisomerase type I (single strand cut, ATP-independent) activity (30%),GO:0006265 (30%);GO:0005975 (6%);GO:0007018 (2%),DNA topological change (30%);carbohydrate metabolic process (6%);microtubule-based movement (2%),IPR000380 (26%);IPR003602 (26%);IPR013497 (26%),DNA topoisomerase, type IA (26%);DNA topoisomerase, type IA, DNA-binding domain (26%);DNA topoisomerase, type IA, central (26%),,,,,
FWDAGLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WHGFCPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNLENEVEHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLFESNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFVNDSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (84%);GO:0016887 (74%);GO:0016491 (11%),ATP binding (84%);ATPase activity (74%);oxidoreductase activity (11%),GO:0006306 (5%),DNA methylation (5%),IPR003439 (53%);IPR003593 (53%);IPR017871 (53%),ABC transporter-like (53%);AAA+ ATPase domain (53%);ABC transporter, conserved site (53%),,,,,,,,,,
FFPTTEMGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAMVPTGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FALESFGPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDKPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.3.1.1 (19%);7.2.2.10 (19%);5.2.1.8 (15%),Adenosylhomocysteinase (19%);P-type Ca(2+) transporter (19%);Peptidylprolyl isomerase (15%),GO:0016021 (26%);GO:0030018 (5%);GO:0031430 (5%),integral component of membrane (26%);Z disc (5%);M band (5%),GO:0005524 (17%);GO:0003677 (10%);GO:0003723 (7%),ATP binding (17%);DNA binding (10%);RNA binding (7%),GO:0006310 (5%);GO:0042254 (5%);GO:0006298 (5%),DNA recombination (5%);ribosome biogenesis (5%);mismatch repair (5%),IPR013783 (27%);IPR036179 (27%);IPR013098 (26%),Immunoglobulin-like fold (27%);Immunoglobulin-like domain superfamily (27%);Immunoglobulin I-set (26%),,,,,,,,,,,
MLYQQFNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNHSNYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDLMKPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.9 (19%);5.4.99.- (7%);3.6.4.- (5%),Glucose-6-phosphate isomerase (19%);Transferring other groups (7%);Acting on ATP; involved in cellular and subcellular movement (5%),GO:0016021 (29%);GO:0005737 (13%);GO:0019031 (10%),integral component of membrane (29%);cytoplasm (13%);viral envelope (10%),GO:0005524 (20%);GO:0003677 (7%);GO:0016887 (7%),ATP binding (20%);DNA binding (7%);ATPase activity (7%),GO:0019062 (10%);GO:0039663 (8%);GO:0006094 (4%),virion attachment to host cell (10%);membrane fusion involved in viral entry into host cell (8%);gluconeogenesis (4%),IPR027417 (16%);IPR000777 (8%);IPR036377 (8%),P-loop containing nucleoside triphosphate hydrolase (16%);Human immunodeficiency virus 1, envelope glycoprotein Gp120 (8%);Gp120 core superfamily (8%),,,,,,,,,,
YFPEPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.-.- (60%);1.1.1.193 (20%);2.7.11.1 (20%),Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2) (60%);5-amino-6-(5-phosphoribosylamino)uracil reductase (20%);Non-specific serine/threonine protein kinase (20%),GO:0016021 (23%);GO:0005886 (7%);GO:0005789 (3%),integral component of membrane (23%);plasma membrane (7%);endoplasmic reticulum membrane (3%),GO:0004497 (40%);GO:0005506 (40%);GO:0016705 (40%),monooxygenase activity (40%);iron ion binding (40%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (40%),GO:0009231 (20%);GO:0051056 (10%);GO:0006144 (3%),riboflavin biosynthetic process (20%);regulation of small GTPase mediated signal transduction (10%);purine nucleobase metabolic process (3%),IPR001128 (30%);IPR017972 (30%);IPR036396 (30%),Cytochrome P450 (30%);Cytochrome P450, conserved site (30%);Cytochrome P450 superfamily (30%),,,,,,,
VFVMSAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDAALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.16 (26%);7.1.2.2 (17%);1.8.4.8 (8%),GTP cyclohydrolase I (26%);H(+)-transporting two-sector ATPase (17%);Phosphoadenylyl-sulfate reductase (thioredoxin) (8%),GO:0016021 (43%);GO:0005887 (20%);GO:0005902 (5%),integral component of membrane (43%);integral component of plasma membrane (20%);microvillus (5%),GO:1904680 (31%);GO:0005524 (29%);GO:0004714 (23%),peptide transmembrane transporter activity (31%);ATP binding (29%);transmembrane receptor protein tyrosine kinase activity (23%),GO:0006857 (31%);GO:0007169 (16%);GO:0010595 (5%),oligopeptide transport (31%);transmembrane receptor protein tyrosine kinase signaling pathway (16%);positive regulation of endothelial cell migration (5%),IPR036259 (28%);IPR000109 (28%);IPR005279 (28%),MFS transporter superfamily (28%);Proton-dependent oligopeptide transporter family (28%);Dipeptide/tripeptide permease (28%),,,,,,,,,,,
HVLLDSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TENDAARPAEMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVMPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.5 (50%);6.1.1.19 (50%),Urease (50%);Arginine--tRNA ligase (50%),GO:0005737 (40%);GO:0009279 (20%);GO:0015627 (20%),cytoplasm (40%);cell outer membrane (20%);type II protein secretion system complex (20%),GO:0003968 (20%);GO:0004814 (20%);GO:0005524 (20%),RNA-directed 5'-3' RNA polymerase activity (20%);arginine-tRNA ligase activity (20%);ATP binding (20%),GO:0006420 (20%);GO:0015628 (20%);GO:0043419 (20%),arginyl-tRNA aminoacylation (20%);protein secretion by the type II secretion system (20%);urea catabolic process (20%),IPR001278 (25%);IPR001412 (25%);IPR001775 (25%),Arginine-tRNA ligase (25%);Aminoacyl-tRNA synthetase, class I, conserved site (25%);GspD/PilQ family (25%),,,,,,,,,
ENGHAHLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFVHHQR,Pezizomycotina,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR001810 (80%);IPR036047 (60%);IPR032675 (20%),F-box domain (80%);F-box-like domain superfamily (60%);Leucine-rich repeat domain superfamily (20%),,,,,,,,,,,
LLNTGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.31 (35%);7.2.1.1 (4%);2.7.1.19 (3%),Phosphoenolpyruvate carboxylase (35%);NADH:ubiquinone reductase (Na(+)-transporting) (4%);Phosphoribulokinase (3%),GO:0005737 (28%);GO:0016021 (19%);GO:0005874 (5%),cytoplasm (28%);integral component of membrane (19%);microtubule (5%),GO:0050660 (19%);GO:0005524 (9%);GO:0008964 (7%),flavin adenine dinucleotide binding (19%);ATP binding (9%);phosphoenolpyruvate carboxylase activity (7%),GO:0002098 (18%);GO:0015977 (7%);GO:0006107 (7%),tRNA wobble uridine modification (18%);carbon fixation (7%);oxaloacetate metabolic process (7%),IPR036188 (16%);IPR002218 (15%);IPR004416 (15%),FAD/NAD(P)-binding domain superfamily (16%);tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG-related (15%);tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (15%),,,,,,,,,,,
NPDAGVYACELVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLLVC,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (50%);GO:0016021 (50%),cytoplasm (50%);integral component of membrane (50%),GO:0005524 (50%);GO:0008168 (50%);GO:0016887 (50%),ATP binding (50%);methyltransferase activity (50%);ATPase activity (50%),GO:0006364 (50%);GO:0032259 (50%),rRNA processing (50%);methylation (50%),IPR003439 (50%);IPR003593 (50%);IPR013525 (50%),ABC transporter-like (50%);AAA+ ATPase domain (50%);ABC-2 type transporter (50%),,,,,,,,,,,
YGEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.48 (22%);2.5.1.7 (20%);3.1.-.- (4%),Protein-tyrosine-phosphatase (22%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (20%);Acting on ester bonds (4%),GO:0016021 (39%);GO:0005737 (6%);GO:0005886 (1%),integral component of membrane (39%);cytoplasm (6%);plasma membrane (1%),GO:0005524 (38%);GO:0016887 (25%);GO:0042626 (25%),ATP binding (38%);ATPase activity (25%);ATPase-coupled transmembrane transporter activity (25%),GO:0051301 (4%);GO:0007049 (4%);GO:0008360 (4%),cell division (4%);cell cycle (4%);regulation of cell shape (4%),IPR027417 (28%);IPR003593 (23%);IPR003439 (21%),P-loop containing nucleoside triphosphate hydrolase (28%);AAA+ ATPase domain (23%);ABC transporter-like (21%),,,,,,,,,,,
VVWDSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.3 (60%);2.7.7.- (20%);5.1.3.3 (20%),RNA ligase (ATP) (60%);Nucleotidyltransferases (20%);Aldose 1-epimerase (20%),GO:0016021 (17%);GO:0005829 (4%);GO:0005886 (4%),integral component of membrane (17%);cytosol (4%);plasma membrane (4%),GO:0005524 (26%);GO:0008374 (17%);GO:0003972 (13%),ATP binding (26%);O-acyltransferase activity (17%);RNA ligase (ATP) activity (13%),GO:0044255 (17%);GO:0006388 (13%);GO:0000272 (9%),cellular lipid metabolic process (17%);tRNA splicing, via endonucleolytic cleavage and ligation (13%);polysaccharide catabolic process (9%),IPR001680 (41%);IPR017986 (41%);IPR019775 (41%),WD40 repeat (41%);WD40-repeat-containing domain (41%);WD40 repeat, conserved site (41%),,,,,,,,,
DPLVMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (10%),nucleus (10%),GO:0016491 (50%);GO:0004540 (20%);GO:0004674 (20%),oxidoreductase activity (50%);ribonuclease activity (20%);protein serine/threonine kinase activity (20%),GO:0006397 (20%);GO:0006351 (10%),mRNA processing (20%);transcription, DNA-templated (10%),IPR007419 (45%);IPR023753 (45%);IPR036188 (45%),BFD-like [2Fe-2S]-binding domain (45%);FAD/NAD(P)-binding domain (45%);FAD/NAD(P)-binding domain superfamily (45%),,,,,,,,,,
FFLGFANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SRPVYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.19 (100%),3-phosphoshikimate 1-carboxyvinyltransferase (100%),GO:0005737 (23%);GO:0016021 (19%);GO:0005634 (11%),cytoplasm (23%);integral component of membrane (19%);nucleus (11%),GO:0003677 (23%);GO:0003924 (22%);GO:0005525 (22%),DNA binding (23%);GTPase activity (22%);GTP binding (22%),GO:0006281 (17%);GO:0006259 (9%);GO:0000055 (2%),DNA repair (17%);DNA metabolic process (9%);ribosomal large subunit export from nucleus (2%),IPR006073 (17%);IPR016496 (17%);IPR025121 (17%),GTP binding domain (17%);GTPase HflX (17%);GTPase HflX, N-terminal (17%),,,,,,,,,,
SELHHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.18.6.1 (33%);2.3.2.27 (33%);3.2.1.21 (33%),Nitrogenase (33%);RING-type E3 ubiquitin transferase (33%);Beta-glucosidase (33%),GO:0016021 (38%);GO:0043256 (5%),integral component of membrane (38%);laminin complex (5%),GO:0003677 (24%);GO:0005524 (14%);GO:0016491 (14%),DNA binding (24%);ATP binding (14%);oxidoreductase activity (14%),GO:0006355 (19%);GO:0009399 (10%);GO:0005975 (5%),regulation of transcription, DNA-templated (19%);nitrogen fixation (10%);carbohydrate metabolic process (5%),IPR004375 (30%);IPR037012 (30%);IPR013783 (16%),YhcH/YjgK/YiaL family (30%);YhcH/YjgK/YiaL superfamily (30%);Immunoglobulin-like fold (16%),,,,,,,,,,
WASMVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (38%),integral component of membrane (38%),GO:0008324 (13%);GO:0015297 (13%);GO:0042910 (13%),cation transmembrane transporter activity (13%);antiporter activity (13%);xenobiotic transmembrane transporter activity (13%),GO:0006935 (63%);GO:0007165 (63%);GO:0006813 (13%),chemotaxis (63%);signal transduction (63%);potassium ion transport (13%),IPR002545 (50%);IPR036061 (50%);IPR039315 (50%),CheW-like domain (50%);CheW-like domain superfamily (50%);Chemotaxis protein CheW (50%),,,,,,,,,,,
MYLAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.25 (40%);1.2.1.3 (20%);3.1.-.- (20%),Inositol-phosphate phosphatase (40%);Aldehyde dehydrogenase (NAD(+)) (20%);Acting on ester bonds (20%),GO:0016021 (31%);GO:0005739 (3%);GO:0005840 (3%),integral component of membrane (31%);mitochondrion (3%);ribosome (3%),GO:0005524 (17%);GO:0046872 (11%);GO:0016787 (8%),ATP binding (17%);metal ion binding (11%);hydrolase activity (8%),GO:0006396 (6%);GO:0018189 (5%);GO:0006021 (3%),RNA processing (6%);pyrroloquinoline quinone biosynthetic process (5%);inositol biosynthetic process (3%),IPR003778 (15%);IPR029000 (15%);IPR018766 (9%),Carboxyltransferase domain, subdomain A and B (15%);Cyclophilin-like domain superfamily (15%);Zinicin-like metallopeptidase type 2 (9%),,,,,,,,,,
HLVVCNR,Rosellinia necatrix,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Xylariomycetidae,,,Xylariales,,,,,Xylariaceae,,,,Rosellinia,,,,Rosellinia necatrix,,,,,,,,,,,,IPR013968 (100%);IPR020807 (100%);IPR036291 (100%),Polyketide synthase, ketoreductase domain (100%);Polyketide synthase, dehydratase domain (100%);NAD(P)-binding domain superfamily (100%),,,,,,,,,
QNLVNVFHSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWEWMLLSHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMCDNDMVYVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WCHFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (100%),Transaminases (100%),GO:0016021 (50%);GO:0005634 (6%);GO:0005840 (6%),integral component of membrane (50%);nucleus (6%);ribosome (6%),GO:0003700 (19%);GO:0043565 (19%);GO:0016301 (13%),DNA-binding transcription factor activity (19%);sequence-specific DNA binding (19%);kinase activity (13%),GO:0006351 (6%);GO:0006412 (6%);GO:0009058 (6%),transcription, DNA-templated (6%);translation (6%);biosynthetic process (6%),IPR000014 (19%);IPR000700 (19%);IPR001610 (19%),PAS domain (19%);PAS-associated, C-terminal (19%);PAC motif (19%),,,,,,,,,
SYGTNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.129 (50%);2.4.2.10 (50%);3.4.-.- (50%),Peptidoglycan glycosyltransferase (50%);Orotate phosphoribosyltransferase (50%);Acting on peptide bonds (peptidases) (50%),GO:0016021 (37%);GO:0005634 (9%);GO:0005737 (7%),integral component of membrane (37%);nucleus (9%);cytoplasm (7%),GO:0008658 (44%);GO:0016740 (42%);GO:0005524 (18%),penicillin binding (44%);transferase activity (42%);ATP binding (18%),GO:0015074 (9%);GO:0006281 (4%);GO:0007166 (2%),DNA integration (9%);DNA repair (4%);cell surface receptor signaling pathway (2%),IPR001264 (42%);IPR001460 (42%);IPR012338 (42%),Glycosyl transferase, family 51 (42%);Penicillin-binding protein, transpeptidase (42%);Beta-lactamase/transpeptidase-like (42%),,,,,,,,,
FVLTAMNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETPEGMDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.3.27 (36%);6.1.1.2 (7%);6.1.1.4 (5%),Anthranilate synthase (36%);Tryptophan--tRNA ligase (7%);Leucine--tRNA ligase (5%),GO:0016021 (27%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (27%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (17%);GO:0046872 (12%);GO:0004049 (7%),ATP binding (17%);metal ion binding (12%);anthranilate synthase activity (7%),GO:0000162 (7%);GO:0006355 (2%);GO:0000160 (2%),tryptophan biosynthetic process (7%);regulation of transcription, DNA-templated (2%);phosphorelay signal transduction system (2%),IPR027417 (12%);IPR005801 (6%);IPR015890 (6%),P-loop containing nucleoside triphosphate hydrolase (12%);ADC synthase (6%);Chorismate-utilising enzyme, C-terminal (6%),,,,,,,,,
QNLTLNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0003677 (50%);GO:0003700 (25%);GO:0008236 (25%),DNA binding (50%);DNA-binding transcription factor activity (25%);serine-type peptidase activity (25%),,,IPR001387 (33%);IPR010982 (33%);IPR000847 (17%),Cro/C1-type helix-turn-helix domain (33%);Lambda repressor-like, DNA-binding domain superfamily (33%);Transcription regulator HTH, LysR (17%),,,,,,,,,
FVGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.269 (22%);2.7.1.40 (9%);2.7.13.3 (5%),Apolipoprotein N-acyltransferase (22%);Pyruvate kinase (9%);Histidine kinase (5%),GO:0016021 (52%);GO:0009279 (22%);GO:0005886 (6%),integral component of membrane (52%);cell outer membrane (22%);plasma membrane (6%),GO:0005524 (9%);GO:0003677 (7%);GO:0046872 (5%),ATP binding (9%);DNA binding (7%);metal ion binding (5%),GO:0043165 (13%);GO:0051205 (13%);GO:0071709 (8%),Gram-negative-bacterium-type cell outer membrane assembly (13%);protein insertion into membrane (13%);membrane assembly (8%),IPR010827 (17%);IPR039910 (17%);IPR023707 (17%),POTRA domain, BamA/TamA-like (17%);Surface antigen D15-like (17%);Outer membrane protein assembly factor BamA (17%),,,,,,,,,,
HEPTFCVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMQQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.5 (8%);5.2.1.8 (8%);1.8.1.9 (7%),Ribonuclease D (8%);Peptidylprolyl isomerase (8%);Thioredoxin-disulfide reductase (7%),GO:0016021 (20%);GO:0005737 (12%);GO:0005886 (2%),integral component of membrane (20%);cytoplasm (12%);plasma membrane (2%),GO:0003779 (18%);GO:0005524 (16%);GO:0005509 (16%),actin binding (18%);ATP binding (16%);calcium ion binding (16%),GO:0006281 (2%);GO:0007165 (2%);GO:0015628 (2%),DNA repair (2%);signal transduction (2%);protein secretion by the type II secretion system (2%),IPR036872 (16%);IPR002017 (16%);IPR001715 (15%),CH domain superfamily (16%);Spectrin repeat (16%);Calponin homology domain (15%),,,,,,,,,,,
FCQMMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003700 (50%);GO:0016787 (50%);GO:0043565 (50%),DNA-binding transcription factor activity (50%);hydrolase activity (50%);sequence-specific DNA binding (50%),,,IPR001466 (50%);IPR009057 (50%);IPR012338 (50%),Beta-lactamase-related (50%);Homeobox-like domain superfamily (50%);Beta-lactamase/transpeptidase-like (50%),,,,,,,,,,,
NMCGPTLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYNDLVPLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMFFLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFLMQSWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVPAGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.1 (22%);3.4.21.- (9%);3.4.21.53 (9%),DNA ligase (ATP) (22%);Serine endopeptidases (9%);Endopeptidase La (9%),GO:0016021 (57%);GO:0005737 (4%);GO:0005840 (1%),integral component of membrane (57%);cytoplasm (4%);ribosome (1%),GO:0005524 (41%);GO:0004252 (35%);GO:0004176 (35%),ATP binding (41%);serine-type endopeptidase activity (35%);ATP-dependent peptidase activity (35%),GO:0030163 (33%);GO:0006310 (3%);GO:0006637 (3%),protein catabolic process (33%);DNA recombination (3%);acyl-CoA metabolic process (3%),IPR027417 (30%);IPR000523 (28%);IPR027065 (28%),P-loop containing nucleoside triphosphate hydrolase (30%);Magnesium chelatase ChlI domain (28%);Lon protease (28%),,,,,,,,,,,
ELWMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.16.-.- (50%);1.3.1.98 (25%);2.7.7.48 (25%),Oxidizing metal ions (50%);UDP-N-acetylmuramate dehydrogenase (25%);RNA-directed RNA polymerase (25%),GO:0005623 (62%);GO:0016021 (9%);GO:0005634 (2%),cell (62%);integral component of membrane (9%);nucleus (2%),GO:0008199 (62%);GO:0016722 (60%);GO:0003924 (15%),ferric iron binding (62%);oxidoreductase activity, oxidizing metal ions (60%);GTPase activity (15%),GO:0006879 (62%);GO:0007186 (13%);GO:0007049 (2%),cellular iron ion homeostasis (62%);G protein-coupled receptor signaling pathway (13%);cell cycle (2%),IPR002177 (63%);IPR008331 (63%);IPR009078 (63%),DNA-binding protein Dps (63%);Ferritin/DPS protein domain (63%);Ferritin-like superfamily (63%),,,,,,,,,,
LFGQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.6.2.- (36%);2.7.7.6 (15%);2.7.8.- (4%),Linked to the hydrolysis of a nucleoside triphosphate (36%);DNA-directed RNA polymerase (15%);Transferases for other substituted phosphate groups (4%),GO:0016021 (34%);GO:0005887 (9%);GO:0005886 (6%),integral component of membrane (34%);integral component of plasma membrane (9%);plasma membrane (6%),GO:0005524 (22%);GO:0016887 (12%);GO:0003677 (10%),ATP binding (22%);ATPase activity (12%);DNA binding (10%),GO:1990961 (8%);GO:0046677 (8%);GO:0006351 (3%),xenobiotic detoxification by transmembrane export across the plasma membrane (8%);response to antibiotic (8%);transcription, DNA-templated (3%),IPR027417 (17%);IPR003593 (11%);IPR003439 (11%),P-loop containing nucleoside triphosphate hydrolase (17%);AAA+ ATPase domain (11%);ABC transporter-like (11%),,,,,,,,,,
LWMDELEDGNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AELPNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%),integral component of membrane (60%),GO:0003723 (20%);GO:0009982 (20%),RNA binding (20%);pseudouridine synthase activity (20%),GO:0001522 (20%);GO:0036368 (20%),pseudouridine synthesis (20%);cone photoresponse recovery (20%),IPR001680 (62%);IPR005108 (62%);IPR015943 (62%),WD40 repeat (62%);HELP (62%);WD40/YVTN repeat-like-containing domain superfamily (62%),,,,,,,,,,,
LSWGHNDGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APSNTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (40%);3.2.2.31 (20%);3.4.11.- (20%),Type I site-specific deoxyribonuclease (40%);Adenine glycosylase (20%);Aminopeptidases (20%),GO:0005673 (9%);GO:0016021 (7%);GO:0005634 (5%),transcription factor TFIIE complex (9%);integral component of membrane (7%);nucleus (5%),GO:0005524 (19%);GO:0003677 (14%);GO:0003676 (9%),ATP binding (19%);DNA binding (14%);nucleic acid binding (9%),GO:0006367 (9%);GO:0006298 (7%);GO:0015074 (7%),transcription initiation from RNA polymerase II promoter (9%);mismatch repair (7%);DNA integration (7%),IPR027417 (23%);IPR003166 (8%);IPR016656 (8%),P-loop containing nucleoside triphosphate hydrolase (23%);Transcription factor TFIIE beta subunit, DNA-binding domain (8%);Transcription initiation factor TFIIE, beta subunit (8%),,,,,,,,,
EPEVWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.37 (100%),Uroporphyrinogen decarboxylase (100%),GO:0016021 (33%);GO:0005737 (8%),integral component of membrane (33%);cytoplasm (8%),GO:0003677 (17%);GO:0016773 (17%);GO:0003676 (8%),DNA binding (17%);phosphotransferase activity, alcohol group as acceptor (17%);nucleic acid binding (8%),GO:0005975 (17%);GO:0006310 (17%);GO:0015074 (17%),carbohydrate metabolic process (17%);DNA recombination (17%);DNA integration (17%),IPR011990 (32%);IPR013026 (32%);IPR005158 (26%),Tetratricopeptide-like helical domain superfamily (32%);Tetratricopeptide repeat-containing domain (32%);Bacterial transcriptional activator domain (26%),,,,,,,,,,
MLFPQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.207 (22%);2.3.1.274 (22%);3.5.1.88 (22%),tRNA (cytidine(34)-2'-O)-methyltransferase (22%);Phosphate acyltransferase (22%);Peptide deformylase (22%),GO:0016021 (23%);GO:0005886 (12%);GO:0005737 (6%),integral component of membrane (23%);plasma membrane (12%);cytoplasm (6%),GO:0003677 (46%);GO:0000150 (42%);GO:0046872 (6%),DNA binding (46%);recombinase activity (42%);metal ion binding (6%),GO:0005975 (5%);GO:0006412 (5%);GO:0006397 (3%),carbohydrate metabolic process (5%);translation (5%);mRNA processing (3%),IPR038109 (41%);IPR011109 (39%);IPR025827 (34%),DNA-binding recombinase domain superfamily (41%);DNA-binding recombinase domain (39%);Recombinase zinc beta ribbon domain (34%),,,,,,,,,,,
TGNWPSWNGC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELDLEFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.1.17 (87%);1.3.5.6 (4%);2.6.1.85 (4%),L-serine ammonia-lyase (87%);9,9'-di-cis-zeta-carotene desaturase (4%);Aminodeoxychorismate synthase (4%),GO:0016021 (29%);GO:0005737 (6%);GO:0005615 (2%),integral component of membrane (29%);cytoplasm (6%);extracellular space (2%),GO:0051539 (35%);GO:0003941 (33%);GO:0003677 (18%),4 iron, 4 sulfur cluster binding (35%);L-serine ammonia-lyase activity (33%);DNA binding (18%),GO:0006094 (31%);GO:0006260 (8%);GO:0007018 (6%),gluconeogenesis (31%);DNA replication (8%);microtubule-based movement (6%),IPR002912 (31%);IPR004643 (31%);IPR005131 (31%),ACT domain (31%);Iron-sulphur-dependent L-serine dehydratase beta subunit (31%);Serine dehydratase beta chain (31%),,,,,,,,,
EMEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (53%);6.1.1.4 (8%);3.4.25.1 (5%),DNA-directed RNA polymerase (53%);Leucine--tRNA ligase (8%);Proteasome endopeptidase complex (5%),GO:0005634 (17%);GO:0016021 (14%);GO:0019013 (11%),nucleus (17%);integral component of membrane (14%);viral nucleocapsid (11%),GO:0003677 (23%);GO:0008270 (17%);GO:0005524 (17%),DNA binding (23%);zinc ion binding (17%);ATP binding (17%),GO:0006351 (17%);GO:0060271 (7%);GO:0007018 (3%),transcription, DNA-templated (17%);cilium assembly (7%);microtubule-based movement (3%),IPR027417 (10%);IPR007081 (10%);IPR001784 (9%),P-loop containing nucleoside triphosphate hydrolase (10%);RNA polymerase Rpb1, domain 5 (10%);Bunyavirus nucleocapsid (N) protein (9%),,,,,,,,,
TVGLTESCNGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.- (8%);2.7.7.7 (4%);5.2.1.8 (4%),Transferring alkyl or aryl groups, other than methyl groups (8%);DNA-directed DNA polymerase (4%);Peptidylprolyl isomerase (4%),GO:0016021 (33%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (33%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (12%);GO:0003677 (8%);GO:0003723 (5%),ATP binding (12%);DNA binding (8%);RNA binding (5%),GO:0030153 (2%);GO:0019346 (2%);GO:0055085 (2%),bacteriocin immunity (2%);transsulfuration (2%);transmembrane transport (2%),IPR039730 (9%);IPR008532 (8%);IPR027417 (7%),Jlp2/Ccd25 (9%);NFACT, RNA-binding domain (8%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,
LSPFTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (75%),integral component of membrane (75%),GO:0016798 (25%),hydrolase activity, acting on glycosyl bonds (25%),,,IPR008023 (50%);IPR003305 (25%);IPR008979 (25%),Protein of unknown function DUF748 (50%);Carbohydrate-binding, CenC-like (25%);Galactose-binding-like domain superfamily (25%),,,,,,,,,
VYMMGVLYLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAGSCK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.10.1.1 (50%);5.4.99.- (50%),Molybdopterin molybdotransferase (50%);Transferring other groups (50%),GO:0016021 (40%),integral component of membrane (40%),GO:0003676 (10%);GO:0005524 (10%);GO:0008270 (10%),nucleic acid binding (10%);ATP binding (10%);zinc ion binding (10%),GO:0016539 (10%);GO:0001522 (5%);GO:0006777 (5%),intein-mediated protein splicing (10%);pseudouridine synthesis (5%);Mo-molybdopterin cofactor biosynthetic process (5%),IPR000731 (26%);IPR003392 (26%);IPR032190 (26%),Sterol-sensing domain (26%);Protein patched/dispatched (26%);Niemann-Pick C1, N-terminal (26%),,,,,,,,,,
QNGVLAHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QESSYGDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFNPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.3 (40%);1.3.7.11 (20%);3.5.1.18 (20%),Adenylate kinase (40%);2,3-bis-O-geranylgeranyl-sn-glycero-phospholipid reductase (20%);Succinyl-diaminopimelate desuccinylase (20%),GO:0005623 (35%);GO:0005794 (35%);GO:0005628 (30%),cell (35%);Golgi apparatus (35%);prospore membrane (30%),GO:0005524 (15%);GO:0008270 (15%);GO:0004017 (10%),ATP binding (15%);zinc ion binding (15%);adenylate kinase activity (10%),GO:0045053 (35%);GO:0045324 (35%);GO:0006623 (30%),protein retention in Golgi apparatus (35%);late endosome to vacuole transport (35%);protein targeting to vacuole (30%),IPR009543 (27%);IPR017148 (27%);IPR026847 (27%),Vacuolar protein sorting-associated protein 13, SHR-binding domain (27%);Vacuolar protein sorting-associated protein 13, fungi (27%);Vacuolar protein sorting-associated protein 13 (27%),,,,,,,,
TCWAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.- (57%);2.3.-.- (14%);2.4.1.- (14%),Endodeoxyribonucleases producing 5'-phosphomonoesters (57%);Acyltransferases (14%);Hexosyltransferases (14%),GO:0016021 (16%);GO:0042025 (4%);GO:0000139 (1%),integral component of membrane (16%);host cell nucleus (4%);Golgi membrane (1%),GO:0046872 (38%);GO:0003824 (30%);GO:0051539 (30%),metal ion binding (38%);catalytic activity (30%);4 iron, 4 sulfur cluster binding (30%),GO:0006260 (9%);GO:0035556 (2%);GO:0006306 (1%),DNA replication (9%);intracellular signal transduction (2%);DNA methylation (1%),IPR007197 (25%);IPR013785 (25%);IPR023885 (22%),Radical SAM (25%);Aldolase-type TIM barrel (25%);4Fe4S-binding SPASM domain (22%),,,,,,,,,,
TSMNEAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFGFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.10.3.- (29%);3.4.21.88 (22%);2.7.7.7 (8%),With oxygen as acceptor (29%);Repressor LexA (22%);DNA-directed DNA polymerase (8%),GO:0016021 (62%);GO:0070469 (56%);GO:0005737 (6%),integral component of membrane (62%);respirasome (56%);cytoplasm (6%),GO:0020037 (53%);GO:0004129 (52%);GO:0016682 (50%),heme binding (53%);cytochrome-c oxidase activity (52%);oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor (50%),GO:0009060 (52%);GO:0055114 (9%);GO:0006281 (8%),aerobic respiration (52%);oxidation-reduction process (9%);DNA repair (8%),IPR000883 (53%);IPR023616 (53%);IPR036927 (53%),Cytochrome c oxidase subunit I (53%);Cytochrome c oxidase-like, subunit I domain (53%);Cytochrome c oxidase-like, subunit I  superfamily (53%),,,,,,,
DMAVMTSLTANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGHLQHWLLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDHSNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.6 (33%);2.7.1.121 (33%);3.6.4.12 (33%),Lysine/arginine leucyltransferase (33%);Phosphoenolpyruvate--glycerone phosphotransferase (33%);DNA helicase (33%),GO:0016021 (27%);GO:0005737 (8%);GO:0009279 (8%),integral component of membrane (27%);cytoplasm (8%);cell outer membrane (8%),GO:0005524 (19%);GO:0015379 (12%);GO:0003676 (8%),ATP binding (19%);potassium:chloride symporter activity (12%);nucleic acid binding (8%),GO:0006281 (8%);GO:0006310 (8%);GO:0006614 (4%),DNA repair (8%);DNA recombination (8%);SRP-dependent cotranslational protein targeting to membrane (4%),IPR021229 (58%);IPR027417 (9%);IPR027806 (5%),Protein of unknown function DUF2800 (58%);P-loop containing nucleoside triphosphate hydrolase (9%);Harbinger transposase-derived nuclease domain (5%),,,,,,,,,,,
TTSLMPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005576 (100%);GO:0005929 (100%),extracellular region (100%);cilium (100%),GO:0003777 (100%);GO:0005524 (100%);GO:0008017 (100%),microtubule motor activity (100%);ATP binding (100%);microtubule binding (100%),GO:0003351 (100%);GO:0021591 (100%);GO:0060271 (100%),epithelial cilium movement involved in extracellular fluid movement (100%);ventricular system development (100%);cilium assembly (100%),IPR026444 (67%);IPR001752 (33%);IPR013320 (33%),Secretion system C-terminal sorting domain (67%);Kinesin motor domain (33%);Concanavalin A-like lectin/glucanase domain superfamily (33%),,,,,,,,,,,
TLWCGPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPDDDMMWQLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QYEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.115 (19%);5.2.1.8 (12%);2.7.13.3 (11%),UDP-N-acetylglucosamine 4,6-dehydratase (inverting) (19%);Peptidylprolyl isomerase (12%);Histidine kinase (11%),GO:0016021 (22%);GO:0016586 (7%);GO:0005886 (3%),integral component of membrane (22%);RSC-type complex (7%);plasma membrane (3%),GO:0000155 (17%);GO:0003677 (15%);GO:0005524 (9%),phosphorelay sensor kinase activity (17%);DNA binding (15%);ATP binding (9%),GO:0006338 (7%);GO:0006355 (3%);GO:0007018 (3%),chromatin remodeling (7%);regulation of transcription, DNA-templated (3%);microtubule-based movement (3%),IPR036890 (15%);IPR003594 (15%);IPR005467 (15%),Histidine kinase/HSP90-like ATPase superfamily (15%);Histidine kinase/HSP90-like ATPase (15%);Histidine kinase domain (15%),,,,,,,,,
MVGAANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (33%);GO:0005737 (33%);GO:0009279 (33%),cell (33%);cytoplasm (33%);cell outer membrane (33%),GO:0003952 (33%);GO:0004359 (33%);GO:0015035 (33%),NAD+ synthase (glutamine-hydrolyzing) activity (33%);glutaminase activity (33%);protein disulfide oxidoreductase activity (33%),GO:0006662 (33%);GO:0009435 (33%);GO:0010033 (33%),glycerol ether metabolic process (33%);NAD biosynthetic process (33%);response to organic substance (33%),IPR003694 (33%);IPR005653 (33%);IPR005746 (33%),NAD(+) synthetase (33%);Organic solvent tolerance-like, N-terminal (33%);Thioredoxin (33%),,,,,,,,,,
MSLGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.4 (25%);2.1.1.193 (15%);7.1.1.- (10%),D-alanine--D-alanine ligase (25%);16S rRNA (uracil(1498)-N(3))-methyltransferase (15%);Hydron translocation or charge separation linked to oxidoreductase reactions (10%),GO:0016021 (36%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (36%);cytoplasm (6%);plasma membrane (3%),GO:0003677 (14%);GO:0016987 (13%);GO:0001216 (11%),DNA binding (14%);sigma factor activity (13%);DNA-binding transcription activator activity (11%),GO:0006352 (12%);GO:0008360 (3%);GO:0009252 (3%),DNA-templated transcription, initiation (12%);regulation of cell shape (3%);peptidoglycan biosynthetic process (3%),IPR007110 (11%);IPR013783 (11%);IPR000394 (10%),Immunoglobulin-like domain (11%);Immunoglobulin-like fold (11%);RNA polymerase sigma factor 54 (10%),,,,,,,,,,
WWCQMTVDVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MQEVNHDSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNEMPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (77%);GO:0016020 (5%);GO:0005634 (3%),integral component of membrane (77%);membrane (5%);nucleus (3%),GO:0015205 (59%);GO:0015103 (5%);GO:0015297 (5%),nucleobase transmembrane transporter activity (59%);inorganic anion transmembrane transporter activity (5%);antiporter activity (5%),GO:0006629 (5%);GO:0097198 (3%),lipid metabolic process (5%);histone H3-K36 trimethylation (3%),IPR006043 (76%);IPR026033 (71%);IPR002657 (5%),Xanthine/uracil/vitamin C permease (76%);Azaguanine-like transporters (71%);Bile acid:sodium symporter/arsenical resistance protein  Acr3 (5%),,,,,,,,,,,
MLQCSNWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNLTMFLDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYSHGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.- (40%);3.1.22.4 (40%);2.4.1.18 (20%),Pentosyltransferases (40%);Crossover junction endodeoxyribonuclease (40%);1,4-alpha-glucan branching enzyme (20%),GO:0016021 (32%);GO:0005743 (16%);GO:0042597 (11%),integral component of membrane (32%);mitochondrial inner membrane (16%);periplasmic space (11%),GO:0004930 (26%);GO:0004129 (18%);GO:0003676 (11%),G protein-coupled receptor activity (26%);cytochrome-c oxidase activity (18%);nucleic acid binding (11%),GO:0032611 (11%);GO:0002001 (8%);GO:0002281 (8%),interleukin-1 beta production (11%);renin secretion into blood stream (8%);macrophage activation involved in immune response (8%),IPR000276 (21%);IPR017452 (21%);IPR003204 (19%),G protein-coupled receptor, rhodopsin-like (21%);GPCR, rhodopsin-like, 7TM (21%);Cytochrome c oxidase, subunit Va/VI (19%),,,,,,
TWMLTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR008011 (100%),Complex 1 LYR protein (100%),,,,,,,,,,,
SYASMDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLCSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.99.18 (100%),DNA-(apurinic or apyrimidinic site) lyase (100%),GO:0016021 (26%);GO:0031012 (9%);GO:0005739 (3%),integral component of membrane (26%);extracellular matrix (9%);mitochondrion (3%),GO:0016491 (23%);GO:0005524 (14%);GO:0004519 (9%),oxidoreductase activity (23%);ATP binding (14%);endonuclease activity (9%),GO:0006284 (9%);GO:0043124 (6%);GO:0071222 (6%),base-excision repair (9%);negative regulation of I-kappaB kinase/NF-kappaB signaling (6%);cellular response to lipopolysaccharide (6%),IPR000008 (19%);IPR030533 (19%);IPR035892 (19%),C2 domain (19%);C2 calcium-dependent domain-containing protein 4C (19%);C2 domain superfamily (19%),,,,,,,,,,,
DVHNWHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMDTPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.193 (100%),16S rRNA (uracil(1498)-N(3))-methyltransferase (100%),GO:0016021 (19%);GO:0005856 (10%);GO:0005737 (5%),integral component of membrane (19%);cytoskeleton (10%);cytoplasm (5%),GO:0004674 (24%);GO:0005524 (24%);GO:0003723 (19%),protein serine/threonine kinase activity (24%);ATP binding (24%);RNA binding (19%),GO:0007601 (10%);GO:0005975 (5%);GO:0006364 (5%),visual perception (10%);carbohydrate metabolic process (5%);rRNA processing (5%),IPR000719 (22%);IPR003307 (22%);IPR003890 (22%),Protein kinase domain (22%);W2 domain (22%);MIF4G-like, type 3 (22%),,,,,,,,,,
TANGMLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLGPWNSLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMEEGVVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NHQVGHK,Fibrobacter,Bacteria,,,,Fibrobacteres,,,Fibrobacteria,,,,Fibrobacterales,,,,,Fibrobacteraceae,,,,Fibrobacter,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0015209 (100%),cytosine transmembrane transporter activity (100%),,,IPR001248 (100%);IPR030191 (100%);IPR038271 (100%),Purine-cytosine permease (100%);Cytosine permease (100%);Purine-cytosine permease superfamily (100%),,,,,,,,,,,
FMAAEPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%),DNA binding (100%),,,IPR018910 (50%);IPR019606 (50%);IPR004027 (25%),Lipoprotein LpqB, beta-propeller domain, C-terminal (50%);GerMN domain (50%);SEC-C motif (25%),,,,,,,,,
QQTMSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLDAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DETFVVLANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLTTYC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPLFVMPNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVASSELYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVDNSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.169 (94%);2.7.6.3 (6%),2-dehydropantoate 2-reductase (94%);2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase (6%),GO:0016021 (21%);GO:0005634 (18%);GO:0005813 (7%),integral component of membrane (21%);nucleus (18%);centrosome (7%),GO:0008677 (24%);GO:0003677 (19%);GO:0008270 (10%),2-dehydropantoate 2-reductase activity (24%);DNA binding (19%);zinc ion binding (10%),GO:0015940 (22%);GO:0006351 (8%);GO:0022011 (7%),pantothenate biosynthetic process (22%);transcription, DNA-templated (8%);myelination in peripheral nervous system (7%),IPR008927 (19%);IPR013328 (19%);IPR013332 (19%),6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily (19%);6-phosphogluconate dehydrogenase, domain 2 (19%);Ketopantoate reductase, N-terminal domain (19%),,,,,,,
MTLTHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.3 (33%);3.5.4.10 (33%);6.3.2.- (33%),Phosphoribosylaminoimidazolecarboxamide formyltransferase (33%);IMP cyclohydrolase (33%);Acid--amino-acid ligases (peptide synthases) (33%),GO:0016021 (60%);GO:0043190 (4%);GO:0005886 (3%),integral component of membrane (60%);ATP-binding cassette (ABC) transporter complex (4%);plasma membrane (3%),GO:0015297 (47%);GO:0042910 (47%);GO:0003700 (5%),antiporter activity (47%);xenobiotic transmembrane transporter activity (47%);DNA-binding transcription factor activity (5%),GO:0019290 (5%);GO:0005975 (3%);GO:0006355 (3%),siderophore biosynthetic process (5%);carbohydrate metabolic process (3%);regulation of transcription, DNA-templated (3%),IPR002528 (41%);IPR007210 (5%);IPR007310 (5%),Multi antimicrobial extrusion protein (41%);ABC-type glycine betaine transport system, substrate-binding domain (5%);Aerobactin siderophore biosynthesis, IucA/IucC, N-terminal (5%),,,,,,,
VVEAGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (50%);3.6.3.- (50%),L-aspartate oxidase (50%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (50%),GO:0005737 (6%),cytoplasm (6%),GO:0005524 (56%);GO:0016887 (50%);GO:0008270 (28%),ATP binding (56%);ATPase activity (50%);zinc ion binding (28%),GO:0015833 (50%);GO:0009435 (6%),peptide transport (50%);NAD biosynthetic process (6%),IPR003439 (43%);IPR003593 (43%);IPR013563 (43%),ABC transporter-like (43%);AAA+ ATPase domain (43%);Oligopeptide/dipeptide ABC transporter, C-terminal (43%),,,,,,,,,,
MTNELNKPNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMLPWDLTVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVGHDM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEAGWMMELSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTMMLGAGHVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMDNPNTLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLLTMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (10%);GO:0005634 (10%);GO:0005732 (5%),cell (10%);nucleus (10%);small nucleolar ribonucleoprotein complex (5%),GO:0003700 (48%);GO:0008168 (14%);GO:0003677 (10%),DNA-binding transcription factor activity (48%);methyltransferase activity (14%);DNA binding (10%),GO:0032259 (10%);GO:0006364 (5%);GO:0045454 (5%),methylation (10%);rRNA processing (5%);cell redox homeostasis (5%),IPR001034 (34%);IPR011991 (34%);IPR029063 (34%),DeoR-type HTH domain (34%);ArsR-like helix-turn-helix domain (34%);S-adenosyl-L-methionine-dependent methyltransferase (34%),,,,,,,,,,,
QPGPAGPTQGMHQMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DYYHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.31 (24%);2.7.7.59 (11%);3.1.4.- (11%),Adenine glycosylase (24%);[Protein-PII] uridylyltransferase (11%);Phosphoric diester hydrolases (11%),GO:0016021 (32%);GO:0005737 (5%);GO:0016020 (3%),integral component of membrane (32%);cytoplasm (5%);membrane (3%),GO:0071949 (25%);GO:0016491 (23%);GO:0003677 (10%),FAD binding (25%);oxidoreductase activity (23%);DNA binding (10%),GO:0006284 (7%);GO:0005975 (5%);GO:0008202 (3%),base-excision repair (7%);carbohydrate metabolic process (5%);steroid metabolic process (3%),IPR040165 (21%);IPR016166 (20%);IPR036318 (20%),Delta(24)-sterol reductase (21%);FAD-binding domain, PCMH-type (20%);FAD-binding, type PCMH-like superfamily (20%),,,,,,,,,
LEPANNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0035438 (100%),cyclic-di-GMP binding (100%),,,IPR007019 (33%);IPR009875 (33%);IPR009926 (33%),Surfeit locus 6 (33%);PilZ domain (33%);Type III secretion system flagellar brake protein YcgR, N-terminal (33%),,,,,,,,,,
MHNSHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002372 (100%);IPR011047 (100%);IPR015943 (100%),Pyrrolo-quinoline quinone repeat (100%);Quinoprotein alcohol dehydrogenase-like superfamily (100%);WD40/YVTN repeat-like-containing domain superfamily (100%),,,,,,,,,,,
QNMMMLHLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CPVHVNLANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLCLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (20%);2.1.1.37 (10%);2.7.7.49 (10%),Methyltransferases (20%);DNA (cytosine-5-)-methyltransferase (10%);RNA-directed DNA polymerase (10%),GO:0016021 (39%);GO:0005737 (3%);GO:0005634 (2%),integral component of membrane (39%);cytoplasm (3%);nucleus (2%),GO:0003676 (13%);GO:0003677 (6%);GO:0005524 (6%),nucleic acid binding (13%);DNA binding (6%);ATP binding (6%),GO:0015074 (9%);GO:0005975 (5%);GO:0001525 (3%),DNA integration (9%);carbohydrate metabolic process (5%);angiogenesis (3%),IPR012337 (9%);IPR036397 (8%);IPR001584 (7%),Ribonuclease H-like superfamily (9%);Ribonuclease H superfamily (8%);Integrase, catalytic core (7%),,,,,,,,,,
FFNMTWNYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYMEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.-.- (32%);2.4.1.- (27%);2.7.13.3 (9%),Glycosyltransferases (32%);Hexosyltransferases (27%);Histidine kinase (9%),GO:0016021 (72%);GO:0005634 (2%);GO:0005737 (1%),integral component of membrane (72%);nucleus (2%);cytoplasm (1%),GO:0016740 (52%);GO:0016757 (9%);GO:0004144 (4%),transferase activity (52%);transferase activity, transferring glycosyl groups (9%);diacylglycerol O-acyltransferase activity (4%),GO:0045017 (4%);GO:0006351 (1%);GO:0006542 (1%),glycerolipid biosynthetic process (4%);transcription, DNA-templated (1%);glutamine biosynthetic process (1%),IPR029044 (63%);IPR001173 (62%);IPR009721 (4%),Nucleotide-diphospho-sugar transferases (63%);Glycosyltransferase 2-like (62%);O-acyltransferase WSD1, C-terminal (4%),,,,,,,,
MEDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.262 (19%);3.1.3.12 (11%);4.1.2.- (6%),4-hydroxythreonine-4-phosphate dehydrogenase (19%);Trehalose-phosphatase (11%);Aldehyde-lyases (6%),GO:0016021 (29%);GO:0005737 (11%);GO:0005886 (3%),integral component of membrane (29%);cytoplasm (11%);plasma membrane (3%),GO:0005524 (17%);GO:0046872 (11%);GO:0003677 (7%),ATP binding (17%);metal ion binding (11%);DNA binding (7%),GO:0006281 (3%);GO:0006457 (3%);GO:0005992 (3%),DNA repair (3%);protein folding (3%);trehalose biosynthetic process (3%),IPR027417 (11%);IPR003593 (8%);IPR005255 (6%),P-loop containing nucleoside triphosphate hydrolase (11%);AAA+ ATPase domain (8%);PdxA family (6%),,,,,,,,,,,
RPLMPMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YMLTYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.- (100%),Acting on acid anhydrides; catalyzing transmembrane movement of substances (100%),GO:0016021 (10%);GO:0005886 (3%),integral component of membrane (10%);plasma membrane (3%),GO:0003847 (63%);GO:0016787 (13%);GO:0003677 (3%),1-alkyl-2-acetylglycerophosphocholine esterase activity (63%);hydrolase activity (13%);DNA binding (3%),GO:0016042 (63%);GO:0005975 (3%);GO:0006313 (3%),lipid catabolic process (63%);carbohydrate metabolic process (3%);transposition, DNA-mediated (3%),IPR005065 (74%);IPR029058 (74%);IPR005645 (23%),Platelet-activating factor acetylhydrolase-like (74%);Alpha/Beta hydrolase fold (74%);Serine hydrolase FSH (23%),,,,,,,,,,
SQHNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.99.- (22%);2.7.11.1 (15%);3.1.4.4 (15%),Miscellaneous (22%);Non-specific serine/threonine protein kinase (15%);Phospholipase D (15%),GO:0016021 (28%);GO:0016459 (7%);GO:0005737 (4%),integral component of membrane (28%);myosin complex (7%);cytoplasm (4%),GO:0046872 (18%);GO:0003676 (8%);GO:0003774 (7%),metal ion binding (18%);nucleic acid binding (8%);motor activity (7%),GO:0007015 (10%);GO:0015977 (6%);GO:0006629 (4%),actin filament organization (10%);carbon fixation (6%);lipid metabolic process (4%),IPR036855 (9%);IPR000571 (9%);IPR002110 (6%),Zinc finger, CCCH-type superfamily (9%);Zinc finger, CCCH-type (9%);Ankyrin repeat (6%),,,,,,,,,
EEPNPMK,Moelleriella libera,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Hypocreales,,,,,Clavicipitaceae,,,,Moelleriella,,,,Moelleriella libera,,,,,,,,,,,,,,,,,,,,,,,,
APADNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (50%);5.6.2.2 (50%),DNA topoisomerase (50%);DNA topoisomerase (ATP-hydrolyzing) (50%),GO:0016021 (18%);GO:0000124 (11%);GO:0005669 (11%),integral component of membrane (18%);SAGA complex (11%);transcription factor TFIID complex (11%),GO:0003755 (14%);GO:0005506 (11%);GO:0009055 (11%),peptidyl-prolyl cis-trans isomerase activity (14%);iron ion binding (11%);electron transfer activity (11%),GO:0006357 (11%);GO:0055085 (11%);GO:0006367 (7%),regulation of transcription by RNA polymerase II (11%);transmembrane transport (11%);transcription initiation from RNA polymerase II promoter (7%),IPR021326 (16%);IPR002130 (8%);IPR025193 (8%),Protein of unknown function DUF2931 (16%);Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain (8%);Domain of unknown function DUF4114 (8%),,,,,,,,,,,
ANENGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.22.4 (30%);1.11.1.6 (20%);2.7.7.6 (20%),Crossover junction endodeoxyribonuclease (30%);Catalase (20%);DNA-directed RNA polymerase (20%),GO:0016021 (39%);GO:0005737 (8%);GO:0005666 (3%),integral component of membrane (39%);cytoplasm (8%);RNA polymerase III complex (3%),GO:0003677 (13%);GO:0030170 (13%);GO:0046872 (13%),DNA binding (13%);pyridoxal phosphate binding (13%);metal ion binding (13%),GO:0055114 (16%);GO:0019346 (13%);GO:0006281 (8%),oxidation-reduction process (16%);transsulfuration (13%);DNA repair (8%),IPR006593 (19%);IPR000277 (14%);IPR015421 (14%),Cytochrome b561/ferric reductase transmembrane (19%);Cys/Met metabolism, pyridoxal phosphate-dependent enzyme (14%);Pyridoxal phosphate-dependent transferase, major domain (14%),,,,,,,,,
HMGDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.4.1.2 (16%);6.3.4.14 (13%);1.-.-.- (11%),Acetyl-CoA carboxylase (16%);Biotin carboxylase (13%);Oxidoreductases (11%),GO:0016021 (9%);GO:0005840 (4%);GO:0005634 (3%),integral component of membrane (9%);ribosome (4%);nucleus (3%),GO:0005524 (59%);GO:0016887 (44%);GO:0016491 (9%),ATP binding (59%);ATPase activity (44%);oxidoreductase activity (9%),GO:0045900 (44%);GO:0006099 (3%);GO:0006633 (2%),negative regulation of translational elongation (44%);tricarboxylic acid cycle (3%);fatty acid biosynthetic process (2%),IPR027417 (39%);IPR003593 (38%);IPR003439 (37%),P-loop containing nucleoside triphosphate hydrolase (39%);AAA+ ATPase domain (38%);ABC transporter-like (37%),,,,,,,,,,,
FMMNFGMGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDSDDNELGSLVLGVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.199 (14%);4.3.1.3 (10%);6.3.4.21 (9%),16S rRNA (cytosine(1402)-N(4))-methyltransferase (14%);Histidine ammonia-lyase (10%);Nicotinate phosphoribosyltransferase (9%),GO:0016021 (15%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (15%);cytoplasm (5%);nucleus (2%),GO:0046983 (33%);GO:0003824 (10%);GO:0005524 (8%),protein dimerization activity (33%);catalytic activity (10%);ATP binding (8%),GO:0005975 (5%);GO:0006355 (2%);GO:0070475 (2%),carbohydrate metabolic process (5%);regulation of transcription, DNA-templated (2%);rRNA base methylation (2%),IPR036638 (31%);IPR011598 (30%);IPR027417 (5%),Helix-loop-helix DNA-binding domain superfamily (31%);Myc-type, basic helix-loop-helix (bHLH) domain (30%);P-loop containing nucleoside triphosphate hydrolase (5%),,,,,,,,,
CGHEQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (43%);GO:0016021 (14%);GO:0042555 (14%),nucleus (43%);integral component of membrane (14%);MCM complex (14%),GO:0003677 (43%);GO:0003700 (43%);GO:0005524 (43%),DNA binding (43%);DNA-binding transcription factor activity (43%);ATP binding (43%),GO:0006265 (29%);GO:0006270 (14%),DNA topological change (29%);DNA replication initiation (14%),IPR027417 (63%);IPR041677 (50%);IPR000967 (38%),P-loop containing nucleoside triphosphate hydrolase (63%);DNA2/NAM7 helicase, AAA domain (50%);Zinc finger, NF-X1-type (38%),,,,,,,,,
VDLLVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.4 (33%);3.6.4.12 (33%);4.1.1.65 (33%),Phospholipase D (33%);DNA helicase (33%);Phosphatidylserine decarboxylase (33%),GO:0016021 (38%);GO:0005737 (15%);GO:0009380 (15%),integral component of membrane (38%);cytoplasm (15%);excinuclease repair complex (15%),GO:0003677 (15%);GO:0004609 (15%);GO:0009381 (15%),DNA binding (15%);phosphatidylserine decarboxylase activity (15%);excinuclease ABC activity (15%),GO:0006289 (15%);GO:0009432 (15%);GO:0006646 (8%),nucleotide-excision repair (15%);SOS response (15%);phosphatidylethanolamine biosynthetic process (8%),IPR001162 (17%);IPR009445 (17%);IPR010994 (17%),UvrC family homology region (17%);TMEM85/ER membrane protein complex subunit 4 (17%);RuvA domain 2-like (17%),,,,,,,,,,,
EMSWWLDMEEEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHMYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (57%);2.1.1.63 (14%);2.4.1.- (14%),Glycogen phosphorylase (57%);Methylated-DNA--[protein]-cysteine S-methyltransferase (14%);Hexosyltransferases (14%),GO:0016021 (39%);GO:0005737 (8%);GO:0005789 (3%),integral component of membrane (39%);cytoplasm (8%);endoplasmic reticulum membrane (3%),GO:0016787 (13%);GO:0008184 (11%);GO:0008484 (11%),hydrolase activity (13%);glycogen phosphorylase activity (11%);sulfuric ester hydrolase activity (11%),GO:0005975 (11%);GO:0006281 (5%);GO:0051301 (5%),carbohydrate metabolic process (11%);DNA repair (5%);cell division (5%),IPR020126 (35%);IPR006016 (10%);IPR014729 (10%),Protein of unknown function DUF2732 (35%);UspA (10%);Rossmann-like alpha/beta/alpha sandwich fold (10%),,,,,,,,,,,
WWDNHMDASGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLEWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.7.1.3 (33%);5.1.1.7 (23%);3.6.4.- (10%),Kynureninase (33%);Diaminopimelate epimerase (23%);Acting on ATP; involved in cellular and subcellular movement (10%),GO:0016021 (28%);GO:0005737 (27%);GO:0005681 (7%),integral component of membrane (28%);cytoplasm (27%);spliceosomal complex (7%),GO:0008270 (19%);GO:0005524 (12%);GO:0003677 (7%),zinc ion binding (19%);ATP binding (12%);DNA binding (7%),GO:0010468 (14%);GO:0006569 (7%);GO:0097053 (7%),regulation of gene expression (14%);tryptophan catabolic process (7%);L-kynurenine catabolic process (7%),IPR001638 (21%);IPR006311 (13%);IPR027417 (13%),Solute-binding protein  family 3/N-terminal domain of MltF (21%);Twin-arginine translocation pathway, signal sequence (13%);P-loop containing nucleoside triphosphate hydrolase (13%),,,,,,,,,,
DMLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.22 (15%);2.7.11.1 (5%);1.3.5.1 (5%),Xanthine phosphoribosyltransferase (15%);Non-specific serine/threonine protein kinase (5%);Succinate dehydrogenase (quinone) (5%),GO:0016021 (13%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (13%);cytoplasm (5%);plasma membrane (4%),GO:0009055 (15%);GO:0051536 (14%);GO:0005524 (12%),electron transfer activity (15%);iron-sulfur cluster binding (14%);ATP binding (12%),GO:0006099 (14%);GO:0005975 (3%);GO:0006166 (3%),tricarboxylic acid cycle (14%);carbohydrate metabolic process (3%);purine ribonucleoside salvage (3%),IPR017896 (13%);IPR017900 (13%);IPR012675 (13%),4Fe-4S ferredoxin-type, iron-sulphur binding domain (13%);4Fe-4S ferredoxin, iron-sulphur binding, conserved site (13%);Beta-grasp domain superfamily (13%),,,,,,,,
NLLVWVLMNSYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFFEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.205 (12%);6.3.3.1 (7%);2.7.7.7 (7%),tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (12%);Phosphoribosylformylglycinamidine cyclo-ligase (7%);DNA-directed DNA polymerase (7%),GO:0016021 (40%);GO:0005737 (7%);GO:0005886 (2%),integral component of membrane (40%);cytoplasm (7%);plasma membrane (2%),GO:0005524 (13%);GO:0046872 (11%);GO:0003677 (10%),ATP binding (13%);metal ion binding (11%);DNA binding (10%),GO:0015976 (5%);GO:0006066 (5%);GO:0002128 (2%),carbon utilization (5%);alcohol metabolic process (5%);tRNA nucleoside ribose methylation (2%),IPR000731 (8%);IPR003392 (7%);IPR027417 (7%),Sterol-sensing domain (8%);Protein patched/dispatched (7%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,,
NAEFFMELSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHQHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (50%);5.1.3.2 (50%),Acting on ester bonds (50%);UDP-glucose 4-epimerase (50%),GO:0016021 (17%);GO:0019028 (9%);GO:0005680 (4%),integral component of membrane (17%);viral capsid (9%);anaphase-promoting complex (4%),GO:0005096 (39%);GO:0003723 (13%);GO:0004386 (13%),GTPase activator activity (39%);RNA binding (13%);helicase activity (13%),GO:0007165 (35%);GO:0006351 (9%);GO:0018144 (9%),signal transduction (35%);transcription, DNA-templated (9%);RNA-protein covalent cross-linking (9%),IPR001060 (36%);IPR027267 (36%);IPR031160 (36%),FCH domain (36%);AH/BAR domain superfamily (36%);F-BAR domain (36%),,,,,,,,,,
QNNWMVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMFFETPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVTNWMLPQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPYHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (67%);6.1.1.3 (33%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (67%);Threonine--tRNA ligase (33%),GO:0016021 (15%);GO:0005576 (8%);GO:0005737 (8%),integral component of membrane (15%);extracellular region (8%);cytoplasm (8%),GO:0005524 (23%);GO:0004088 (15%);GO:0008270 (15%),ATP binding (23%);carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity (15%);zinc ion binding (15%),GO:0006207 (15%);GO:0006281 (15%);GO:0006310 (15%),'de novo' pyrimidine nucleobase biosynthetic process (15%);DNA repair (15%);DNA recombination (15%),IPR001440 (13%);IPR002474 (13%);IPR003717 (13%),Tetratricopeptide repeat 1 (13%);Carbamoyl-phosphate synthase small subunit, N-terminal domain (13%);Recombination protein O, RecO (13%),,,,,,,,,
FDMLFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0005506 (50%);GO:0005524 (50%);GO:0016491 (50%),iron ion binding (50%);ATP binding (50%);oxidoreductase activity (50%),GO:0008610 (50%),lipid biosynthetic process (50%),IPR003439 (50%);IPR003593 (50%);IPR006694 (50%),ABC transporter-like (50%);AAA+ ATPase domain (50%);Fatty acid hydroxylase (50%),,,,,,,,,,,
FEMTHMVEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPFLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (93%);5.6.2.1 (7%),Proline--tRNA ligase (93%);DNA topoisomerase (7%),GO:0005737 (86%);GO:0005694 (7%),cytoplasm (86%);chromosome (7%),GO:0004827 (86%);GO:0005524 (86%);GO:0002161 (83%),proline-tRNA ligase activity (86%);ATP binding (86%);aminoacyl-tRNA editing activity (83%),GO:0006433 (86%);GO:0006265 (7%),prolyl-tRNA aminoacylation (86%);DNA topological change (7%),IPR002314 (86%);IPR002316 (86%);IPR004154 (86%),Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) (86%);Proline-tRNA ligase, class IIa (86%);Anticodon-binding (86%),,,,,,,,,
HNVVVNR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (100%);GO:0004803 (100%),DNA binding (100%);transposase activity (100%),GO:0006313 (100%),transposition, DNA-mediated (100%),IPR002686 (100%);IPR036515 (100%),Transposase IS200-like (100%);Transposase IS200-like superfamily (100%),,,,,,,,,,
HECPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.11.1.7 (67%);4.99.1.12 (33%),Peroxidase (67%);Pyridinium-3,5-bisthiocarboxylic acid mononucleotide nickel chelatase (33%),GO:0016021 (14%);GO:0005840 (6%);GO:0005634 (2%),integral component of membrane (14%);ribosome (6%);nucleus (2%),GO:0008270 (52%);GO:0003676 (40%);GO:0070180 (6%),zinc ion binding (52%);nucleic acid binding (40%);large ribosomal subunit rRNA binding (6%),GO:0030261 (9%);GO:0006412 (6%);GO:0007275 (5%),chromosome condensation (9%);translation (6%);multicellular organism development (5%),IPR011161 (68%);IPR011162 (68%);IPR037055 (68%),MHC class I-like antigen recognition-like (68%);MHC classes I/II-like antigen recognition protein (68%);MHC class I-like antigen recognition-like superfamily (68%),,,,,,,,,,
MLNYVNWGFTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAQSHVEYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMNLVPEAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPNEMTSLVPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYMHGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WELPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016765 (50%);GO:0003676 (33%);GO:0004386 (33%),transferase activity, transferring alkyl or aryl (other than methyl) groups (50%);nucleic acid binding (33%);helicase activity (33%),GO:0032259 (17%),methylation (17%),IPR000537 (27%);IPR001650 (18%);IPR007502 (18%),UbiA prenyltransferase family (27%);Helicase, C-terminal (18%);Helicase-associated domain (18%),,,,,,,,,
WLQNAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.49 (100%),Urocanate hydratase (100%),GO:0005634 (44%);GO:0016021 (10%);GO:0005737 (6%),nucleus (44%);integral component of membrane (10%);cytoplasm (6%),GO:0000981 (44%);GO:0008270 (44%);GO:0015419 (13%),DNA-binding transcription factor activity, RNA polymerase II-specific (44%);zinc ion binding (44%);ATPase-coupled sulfate transmembrane transporter activity (13%),GO:0019556 (6%);GO:0019557 (6%);GO:0006629 (2%),histidine catabolic process to glutamate and formamide (6%);histidine catabolic process to glutamate and formate (6%);lipid metabolic process (2%),IPR001138 (39%);IPR036864 (39%);IPR005669 (12%),Zn(2)-C6 fungal-type DNA-binding domain (39%);Zn(2)-C6 fungal-type DNA-binding domain superfamily (39%);Thiosulphate/Sulfate-binding protein (12%),,,,,,,,,,
FGLHNTAAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EACTTLGGAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELVAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.11 (11%);2.7.7.6 (4%);1.1.1.3 (3%),Phosphopyruvate hydratase (11%);DNA-directed RNA polymerase (4%);Homoserine dehydrogenase (3%),GO:0016021 (11%);GO:0005737 (8%);GO:0005840 (2%),integral component of membrane (11%);cytoplasm (8%);ribosome (2%),GO:0005524 (31%);GO:0008134 (17%);GO:0003677 (15%),ATP binding (31%);transcription factor binding (17%);DNA binding (15%),GO:0006355 (14%);GO:0000160 (12%);GO:0006412 (3%),regulation of transcription, DNA-templated (14%);phosphorelay signal transduction system (12%);translation (3%),IPR027417 (25%);IPR003593 (18%);IPR002078 (16%),P-loop containing nucleoside triphosphate hydrolase (25%);AAA+ ATPase domain (18%);RNA polymerase sigma factor 54 interaction domain (16%),,,,,,,,,,
MEVNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.16.4 (40%);5.99.1.4 (30%);2.5.1.3 (20%),Serine-type D-Ala-D-Ala carboxypeptidase (40%);2-hydroxychromene-2-carboxylate isomerase (30%);Thiamine phosphate synthase (20%),GO:0016021 (44%);GO:0000139 (2%);GO:0005794 (2%),integral component of membrane (44%);Golgi membrane (2%);Golgi apparatus (2%),GO:0016757 (46%);GO:0009002 (6%);GO:0004519 (5%),transferase activity, transferring glycosyl groups (46%);serine-type D-Ala-D-Ala carboxypeptidase activity (6%);endonuclease activity (5%),GO:0006486 (46%);GO:0010417 (6%);GO:0006260 (5%),protein glycosylation (46%);glucuronoxylan biosynthetic process (6%);DNA replication (5%),IPR004263 (46%);IPR040911 (46%);IPR012338 (7%),Exostosin-like (46%);Exostosin, GT47 domain (46%);Beta-lactamase/transpeptidase-like (7%),,,,,,,,,
MPAEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.15 (18%);2.7.7.60 (14%);3.6.1.66 (14%),Endo-polygalacturonase (18%);2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (14%);XTP/dITP diphosphatase (14%),GO:0016021 (7%);GO:0005634 (4%);GO:0005623 (1%),integral component of membrane (7%);nucleus (4%);cell (1%),GO:0004650 (36%);GO:0003677 (11%);GO:0008270 (5%),polygalacturonase activity (36%);DNA binding (11%);zinc ion binding (5%),GO:0005975 (36%);GO:0006323 (21%);GO:0006351 (5%),carbohydrate metabolic process (36%);DNA packaging (21%);transcription, DNA-templated (5%),IPR000743 (33%);IPR006626 (33%);IPR011050 (33%),Glycoside hydrolase, family 28 (33%);Parallel beta-helix repeat (33%);Pectin lyase fold/virulence factor (33%),,,,,,,,,
FNYVTLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLQQGQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (50%);1.11.1.15 (25%);5.2.1.8 (25%),Acting on ester bonds (50%);Peroxiredoxin (25%);Peptidylprolyl isomerase (25%),GO:0005623 (14%);GO:0016021 (14%),cell (14%);integral component of membrane (14%),GO:0003677 (29%);GO:0003723 (29%);GO:0004519 (29%),DNA binding (29%);RNA binding (29%);endonuclease activity (29%),GO:0043571 (29%);GO:0051607 (29%);GO:0006004 (14%),maintenance of CRISPR repeat elements (29%);defense response to virus (29%);fucose metabolic process (14%),IPR003615 (29%);IPR028629 (29%);IPR033114 (29%),HNH nuclease (29%);CRISPR-associated endonuclease Cas9 (29%);Cas9-type HNH domain (29%),,,,,,,,,,,
WNAMPPR,Kwoniella,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Tremellomycetes,,,,Tremellales,,,,,Cryptococcaceae,,,,Kwoniella,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0004553 (100%),hydrolase activity, hydrolyzing O-glycosyl compounds (100%),GO:0006078 (100%),(1->6)-beta-D-glucan biosynthetic process (100%),IPR000757 (100%);IPR005629 (100%);IPR013320 (100%),Glycoside hydrolase family 16 (100%);Beta-glucan synthesis-associated, Skn1 (100%);Concanavalin A-like lectin/glucanase domain superfamily (100%),,,,,,,,,
FPWMMMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMLSVHYVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYVTM,Firmicutes,Bacteria,,,,Firmicutes,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR001958 (50%);IPR011701 (50%);IPR012547 (50%),Tetracycline resistance protein TetA/multidrug resistance protein MdtG (50%);Major facilitator superfamily (50%);PD-(D/E)XK nuclease superfamily 9 (50%),,,,,,,,,,,
TEFPTGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (50%),ribosome (50%),GO:0005086 (50%),ARF guanyl-nucleotide exchange factor activity (50%),GO:0032012 (50%),regulation of ARF protein signal transduction (50%),IPR000904 (50%);IPR009783 (50%);IPR011993 (50%),Sec7 domain (50%);Protein of unknown function DUF1348 (50%);PH-like domain superfamily (50%),,,,,,,,,,,
QEGYEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.75 (17%);2.7.1.30 (17%);3.1.-.- (17%),tRNA dimethylallyltransferase (17%);Glycerol kinase (17%);Acting on ester bonds (17%),GO:0043190 (3%);GO:0005634 (2%);GO:0005840 (2%),ATP-binding cassette (ABC) transporter complex (3%);nucleus (2%);ribosome (2%),GO:0004197 (26%);GO:0035598 (20%);GO:0051539 (20%),cysteine-type endopeptidase activity (26%);N6-threonylcarbomyladenosine methylthiotransferase activity (20%);4 iron, 4 sulfur cluster binding (20%),GO:0005975 (2%);GO:0005978 (2%);GO:0005980 (2%),carbohydrate metabolic process (2%);glycogen biosynthetic process (2%);glycogen catabolic process (2%),IPR004134 (25%);IPR038765 (25%);IPR000169 (24%),Peptidase C1B, bleomycin hydrolase (25%);Papain-like cysteine peptidase superfamily (25%);Cysteine peptidase, cysteine active site (24%),,,,,,,,
DVNTCNGQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVAADHPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTVLAARPER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVNPPK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,5.3.3.4 (100%),Muconolactone Delta-isomerase (100%),GO:0016021 (75%),integral component of membrane (75%),GO:0016159 (25%),muconolactone delta-isomerase activity (25%),GO:0042952 (25%),beta-ketoadipate pathway (25%),IPR013426 (75%);IPR014263 (75%);IPR017540 (75%),Exosortase, EpsH-like (75%);Methanolan biosynthesis EpsI (75%);Exosortase 1 (75%),,,,,,,,,,
LDNGDDMYNAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDTHFVFGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMWFLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.13.11.25 (50%);2.4.1.17 (50%),3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5dioxygenase (50%);Glucuronosyltransferase (50%),GO:0016021 (25%);GO:0031012 (25%),integral component of membrane (25%);extracellular matrix (25%),GO:0004222 (42%);GO:0008270 (25%);GO:0051213 (17%),metalloendopeptidase activity (42%);zinc ion binding (25%);dioxygenase activity (17%),GO:0009311 (8%),oligosaccharide metabolic process (8%),IPR004360 (44%);IPR029068 (44%);IPR037523 (44%),Glyoxalase/fosfomycin resistance/dioxygenase domain (44%);Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase (44%);Vicinal oxygen chelate (VOC) domain (44%),,,,,
YANFVTK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR023214 (100%);IPR036412 (100%);IPR006379 (50%),HAD superfamily (100%);HAD-like superfamily (100%);HAD-superfamily hydrolase, subfamily IIB (50%),,,,,,,,,,
WGRPQVTMCSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMMPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.- (75%);2.1.1.79 (25%),With NAD(+) or NADP(+) as acceptor (75%);Cyclopropane-fatty-acyl-phospholipid synthase (25%),GO:0016021 (61%);GO:0005886 (16%);GO:0033573 (9%),integral component of membrane (61%);plasma membrane (16%);high-affinity iron permease complex (9%),GO:0015079 (53%);GO:0005381 (9%);GO:0008168 (7%),potassium ion transmembrane transporter activity (53%);iron ion transmembrane transporter activity (9%);methyltransferase activity (7%),GO:0055085 (4%);GO:0008610 (3%);GO:0000160 (1%),transmembrane transport (4%);lipid biosynthetic process (3%);phosphorelay signal transduction system (1%),IPR003855 (53%);IPR023051 (14%);IPR029063 (10%),Potassium transporter (53%);Potassium uptake protein, low affinity, Kup (14%);S-adenosyl-L-methionine-dependent methyltransferase (10%),,,,,,,,,
EHFYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (16%);2.1.1.- (14%);3.1.3.16 (10%),Type I site-specific deoxyribonuclease (16%);Methyltransferases (14%);Protein-serine/threonine phosphatase (10%),GO:0016021 (18%);GO:0005737 (4%);GO:0005623 (2%),integral component of membrane (18%);cytoplasm (4%);cell (2%),GO:0005524 (28%);GO:0003677 (19%);GO:0003700 (8%),ATP binding (28%);DNA binding (19%);DNA-binding transcription factor activity (8%),GO:0005975 (3%);GO:0032259 (2%);GO:0009307 (2%),carbohydrate metabolic process (3%);methylation (2%);DNA restriction-modification system (2%),IPR027417 (22%);IPR003593 (9%);IPR036388 (8%),P-loop containing nucleoside triphosphate hydrolase (22%);AAA+ ATPase domain (9%);Winged helix-like DNA-binding domain superfamily (8%),,,,,,,,,,,
LLPSSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (50%);2.3.1.225 (25%);7.2.2.10 (25%),Acting on ester bonds (50%);Protein S-acyltransferase (25%);P-type Ca(2+) transporter (25%),GO:0005737 (26%);GO:0005634 (21%);GO:0016021 (11%),cytoplasm (26%);nucleus (21%);integral component of membrane (11%),GO:0005524 (21%);GO:0016887 (16%);GO:0046872 (16%),ATP binding (21%);ATPase activity (16%);metal ion binding (16%),GO:0007049 (21%);GO:0007059 (21%);GO:0051301 (21%),cell cycle (21%);chromosome segregation (21%);cell division (21%),IPR003347 (16%);IPR003349 (16%);IPR003768 (16%),JmjC domain (16%);JmjN domain (16%);Segregation and condensation protein A (16%),,,,,,,,,,,
ASGEPNMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AEELSEQEAFNSM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVETECGVDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DDAAESVNNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDPSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (50%);6.1.1.7 (50%),Leucine--tRNA ligase (50%);Alanine--tRNA ligase (50%),GO:0016021 (18%);GO:0005856 (6%);GO:0000932 (2%),integral component of membrane (18%);cytoskeleton (6%);P-body (2%),GO:0004497 (18%);GO:0005506 (18%);GO:0016705 (18%),monooxygenase activity (18%);iron ion binding (18%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (18%),GO:0000290 (18%);GO:0006429 (6%);GO:0006511 (6%),deadenylation-dependent decapping of nuclear-transcribed mRNA (18%);leucyl-tRNA aminoacylation (6%);ubiquitin-dependent protein catabolic process (6%),IPR039900 (20%);IPR019167 (18%);IPR001128 (15%),Pat1-like (20%);mRNA decay factor PAT1 domain (18%);Cytochrome P450 (15%),,,,,,,,,
DHMGPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMNAHYPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPSASPNDENYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APCARPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFEATTSVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQLSHVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYWSLFTDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.223 (23%);4.1.1.65 (23%);2.3.1.- (10%),tRNA(1)(Val) (adenine(37)-N(6))-methyltransferase (23%);Phosphatidylserine decarboxylase (23%);Transferring groups other than amino-acyl groups (10%),GO:0016021 (45%);GO:0005737 (6%);GO:0005886 (6%),integral component of membrane (45%);cytoplasm (6%);plasma membrane (6%),GO:0005524 (22%);GO:0000155 (18%);GO:0003677 (8%),ATP binding (22%);phosphorelay sensor kinase activity (18%);DNA binding (8%),GO:0055085 (6%);GO:0006366 (4%);GO:0006412 (4%),transmembrane transport (6%);transcription by RNA polymerase II (4%);translation (4%),IPR003594 (13%);IPR003661 (13%);IPR004358 (13%),Histidine kinase/HSP90-like ATPase (13%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (13%);Signal transduction histidine kinase-related protein, C-terminal (13%),,,,,,,,,
NSFDCPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEFMLHQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WAMTNLVTNGLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DWHMSNNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YKPVVVYYYVFTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAVVPDVHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CYTQHK,Lachnoclostridium,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Lachnospiraceae,,,,Lachnoclostridium,,,,,,,,,,,,GO:0003677 (100%);GO:0004803 (100%),DNA binding (100%);transposase activity (100%),GO:0006313 (100%),transposition, DNA-mediated (100%),IPR007069 (100%);IPR026889 (100%),Transposase, IS801/IS1294 (100%);Transposase zinc-binding domain (100%),,,,,,,,,
YDEMFDEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGNPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (61%);2.3.1.234 (19%);4.2.1.8 (4%),Electron-transferring-flavoprotein dehydrogenase (61%);N(6)-L-threonylcarbamoyladenine synthase (19%);Mannonate dehydratase (4%),GO:0016021 (10%);GO:0005737 (8%);GO:0015934 (7%),integral component of membrane (10%);cytoplasm (8%);large ribosomal subunit (7%),GO:0046872 (28%);GO:0051539 (25%);GO:0004174 (25%),metal ion binding (28%);4 iron, 4 sulfur cluster binding (25%);electron-transferring-flavoprotein dehydrogenase activity (25%),GO:0002949 (8%);GO:0006412 (7%);GO:0007018 (2%),tRNA threonylcarbamoyladenosine modification (8%);translation (7%);microtubule-based movement (2%),IPR036188 (23%);IPR005669 (23%);IPR040156 (23%),FAD/NAD(P)-binding domain superfamily (23%);Thiosulphate/Sulfate-binding protein (23%);Electron transfer flavoprotein-ubiquinone oxidoreductase (23%),,,,,,,,,,
VSAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.10 (35%);3.1.3.8 (32%);4.2.1.49 (20%),Glucose-1-phosphatase (35%);3-phytase (32%);Urocanate hydratase (20%),GO:0016021 (21%);GO:0005737 (10%);GO:0005886 (3%),integral component of membrane (21%);cytoplasm (10%);plasma membrane (3%),GO:0005524 (19%);GO:0008877 (12%);GO:0016158 (10%),ATP binding (19%);glucose-1-phosphatase activity (12%);3-phytase activity (10%),GO:0019556 (6%);GO:0019557 (6%);GO:0005975 (2%),histidine catabolic process to glutamate and formamide (6%);histidine catabolic process to glutamate and formate (6%);carbohydrate metabolic process (2%),IPR029033 (16%);IPR000560 (16%);IPR033379 (16%),Histidine phosphatase superfamily (16%);Histidine phosphatase superfamily, clade-2 (16%);Histidine acid phosphatase active site (16%),,,,,,,,,,
AEDPSYK,Lactococcus lactis,Bacteria,,,,Firmicutes,,,Bacilli,,,,Lactobacillales,,,,,Streptococcaceae,,,,Lactococcus,,,,Lactococcus lactis,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0055085 (75%),transmembrane transport (75%),IPR011701 (100%);IPR020846 (100%);IPR036259 (100%),Major facilitator superfamily (100%);Major facilitator superfamily domain (100%);MFS transporter superfamily (100%),,,,,,,,,,,
ATAYVWFLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVAGAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.16 (72%);1.4.3.5 (4%);2.1.1.41 (4%),Cysteine--tRNA ligase (72%);Pyridoxal 5'-phosphate synthase (4%);Sterol 24-C-methyltransferase (4%),GO:0016021 (29%);GO:0005886 (24%);GO:0045261 (23%),integral component of membrane (29%);plasma membrane (24%);proton-transporting ATP synthase complex, catalytic core F(1) (23%),GO:0005524 (40%);GO:0046933 (23%);GO:0004817 (15%),ATP binding (40%);proton-transporting ATP synthase activity, rotational mechanism (23%);cysteine-tRNA ligase activity (15%),GO:0042777 (21%);GO:0006423 (14%);GO:0007165 (4%),plasma membrane ATP synthesis coupled proton transport (21%);cysteinyl-tRNA aminoacylation (14%);signal transduction (4%),IPR000131 (20%);IPR035968 (20%);IPR014729 (13%),ATP synthase, F1 complex, gamma subunit (20%);ATP synthase, F1 complex, gamma subunit superfamily (20%);Rossmann-like alpha/beta/alpha sandwich fold (13%),,,,,
MVTHGMMAGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SEPDHQWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPSENVEHPLYER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMMHTLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYVAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (9%);GO:0005576 (5%);GO:0005634 (5%),integral component of membrane (9%);extracellular region (5%);nucleus (5%),GO:0008080 (27%);GO:0016627 (14%);GO:0016787 (14%),N-acetyltransferase activity (27%);oxidoreductase activity, acting on the CH-CH group of donors (14%);hydrolase activity (14%),GO:0006886 (9%);GO:0009253 (9%);GO:0016998 (9%),intracellular protein transport (9%);peptidoglycan catabolic process (9%);cell wall macromolecule catabolic process (9%),IPR000182 (25%);IPR016181 (25%);IPR029058 (17%),GNAT domain (25%);Acyl-CoA N-acyltransferase (25%);Alpha/Beta hydrolase fold (17%),,,,,,,,,,
AAHVVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.2 (100%),5-formyltetrahydrofolate cyclo-ligase (100%),GO:0009341 (50%),beta-galactosidase complex (50%),GO:0004565 (50%);GO:0005524 (50%);GO:0030272 (50%),beta-galactosidase activity (50%);ATP binding (50%);5-formyltetrahydrofolate cyclo-ligase activity (50%),GO:0005975 (50%),carbohydrate metabolic process (50%),IPR002698 (33%);IPR013529 (33%);IPR013584 (33%),5-formyltetrahydrofolate cyclo-ligase (33%);Glycoside hydrolase, family 42, N-terminal (33%);RAP domain (33%),,,,,,,,,
MMLEGVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DWMLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (57%);GO:0005667 (43%);GO:0005737 (43%),nucleus (57%);transcription factor complex (43%);cytoplasm (43%),GO:0003700 (43%);GO:0046983 (43%);GO:0043565 (29%),DNA-binding transcription factor activity (43%);protein dimerization activity (43%);sequence-specific DNA binding (29%),GO:0009410 (29%);GO:0009636 (29%);GO:0045893 (29%),response to xenobiotic stimulus (29%);response to toxic substance (29%);positive regulation of transcription, DNA-templated (29%),IPR000014 (43%);IPR001067 (43%);IPR011598 (43%),PAS domain (43%);Nuclear translocator (43%);Myc-type, basic helix-loop-helix (bHLH) domain (43%),,,,,,,,,
VNTSVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (50%);3.1.4.4 (50%),Pyruvate dehydrogenase (acetyl-transferring) (50%);Phospholipase D (50%),GO:0016021 (43%);GO:0005737 (14%);GO:0005768 (14%),integral component of membrane (43%);cytoplasm (14%);endosome (14%),GO:0003676 (14%);GO:0003755 (14%);GO:0004630 (14%),nucleic acid binding (14%);peptidyl-prolyl cis-trans isomerase activity (14%);phospholipase D activity (14%),GO:0006082 (14%);GO:0006457 (14%);GO:0006654 (14%),organic acid metabolic process (14%);protein folding (14%);phosphatidic acid biosynthetic process (14%),IPR001849 (33%);IPR001127 (17%);IPR001128 (17%),Pleckstrin homology domain (33%);Phosphotransferase system, sugar-specific permease EIIA type 1 (17%);Cytochrome P450 (17%),,,,,,,,,,
EGTSMPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THMLVAVYMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPCTEVEAQGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WDELLYYFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AHSQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.2 (25%);3.6.4.12 (10%);1.17.4.2 (6%),GMP synthase (glutamine-hydrolyzing) (25%);DNA helicase (10%);Ribonucleoside-triphosphate reductase (thioredoxin) (6%),GO:0016021 (15%);GO:0005737 (12%);GO:0005634 (2%),integral component of membrane (15%);cytoplasm (12%);nucleus (2%),GO:0005524 (40%);GO:0051082 (8%);GO:0046872 (7%),ATP binding (40%);unfolded protein binding (8%);metal ion binding (7%),GO:0042026 (8%);GO:0006541 (2%);GO:0006355 (2%),protein refolding (8%);glutamine metabolic process (2%);regulation of transcription, DNA-templated (2%),IPR002423 (23%);IPR027410 (23%);IPR027409 (23%),Chaperonin Cpn60/TCP-1 family (23%);TCP-1-like chaperonin intermediate domain superfamily (23%);GroEL-like apical domain superfamily (23%),,,,,,,,,,
TLLYTENK,Cladophialophora bantiana,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Chaetothyriomycetidae,,,Chaetothyriales,,,,,Herpotrichiellaceae,,,,Cladophialophora,,,,Cladophialophora bantiana,,,,,,,,,,,,,,,,,,,,,,,,
MVVHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.2.2 (37%);2.7.11.1 (16%);1.3.8.2 (3%),H(+)-transporting two-sector ATPase (37%);Non-specific serine/threonine protein kinase (16%);4,4'-diapophytoene desaturase (4,4'-diapolycopene-forming) (3%),GO:0016021 (22%);GO:0005886 (10%);GO:0045261 (7%),integral component of membrane (22%);plasma membrane (10%);proton-transporting ATP synthase complex, catalytic core F(1) (7%),GO:0005524 (21%);GO:1901515 (8%);GO:0046933 (8%),ATP binding (21%);poly-beta-1,6-N-acetyl-D-glucosamine transmembrane transporter activity (8%);proton-transporting ATP synthase activity, rotational mechanism (8%),GO:0015986 (8%);GO:0006355 (2%);GO:0006310 (2%),ATP synthesis coupled proton transport (8%);regulation of transcription, DNA-templated (2%);DNA recombination (2%),IPR027417 (10%);IPR036188 (8%);IPR011990 (7%),P-loop containing nucleoside triphosphate hydrolase (10%);FAD/NAD(P)-binding domain superfamily (8%);Tetratricopeptide-like helical domain superfamily (7%),,,,,
ELGEHAFSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPATAYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMLENDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (50%);GO:0005840 (25%),nucleus (50%);ribosome (25%),GO:0000981 (25%);GO:0003677 (25%);GO:0003682 (25%),DNA-binding transcription factor activity, RNA polymerase II-specific (25%);DNA binding (25%);chromatin binding (25%),GO:0006351 (25%);GO:0006412 (25%);GO:0007049 (25%),transcription, DNA-templated (25%);translation (25%);cell cycle (25%),IPR000266 (17%);IPR001138 (17%);IPR005594 (17%),Ribosomal protein S17/S11 (17%);Zn(2)-C6 fungal-type DNA-binding domain (17%);YadA-like, C-terminal (17%),,,,,,,,
EHWLDGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAFPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.5 (22%);1.2.1.8 (11%);1.2.1.60 (4%),Ribonuclease P (22%);Betaine-aldehyde dehydrogenase (11%);5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase (4%),GO:0016021 (18%);GO:0005737 (4%);GO:0005634 (3%),integral component of membrane (18%);cytoplasm (4%);nucleus (3%),GO:0018480 (9%);GO:0016620 (7%);GO:0005524 (7%),5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase activity (9%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (7%);ATP binding (7%),GO:1901023 (9%);GO:0001682 (4%);GO:0016567 (3%),4-hydroxyphenylacetate catabolic process (9%);tRNA 5'-leader removal (4%);protein ubiquitination (3%),IPR015590 (16%);IPR016161 (16%);IPR016162 (16%),Aldehyde dehydrogenase domain (16%);Aldehyde/histidinol dehydrogenase (16%);Aldehyde dehydrogenase, N-terminal (16%),,,,,,,,
EMHHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.12 (100%),UDP-glucose--hexose-1-phosphate uridylyltransferase (100%),GO:0005737 (94%);GO:0016021 (2%);GO:0000145 (1%),cytoplasm (94%);integral component of membrane (2%);exocyst (1%),GO:0008108 (94%);GO:0004252 (2%);GO:0016779 (1%),UDP-glucose:hexose-1-phosphate uridylyltransferase activity (94%);serine-type endopeptidase activity (2%);nucleotidyltransferase activity (1%),GO:0006012 (94%);GO:0090522 (1%),galactose metabolic process (94%);vesicle tethering involved in exocytosis (1%),IPR000766 (92%);IPR005850 (92%);IPR005849 (91%),Galactose-1-phosphate uridyl transferase, class II (92%);Galactose-1-phosphate uridyl transferase, C-terminal (92%);Galactose-1-phosphate uridyl transferase, N-terminal (91%),,,,,,,,
NLPPVLMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HEDLHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (57%);GO:0005887 (43%);GO:0098794 (14%),integral component of membrane (57%);integral component of plasma membrane (43%);postsynapse (14%),GO:0004888 (43%);GO:0016594 (43%);GO:0022824 (43%),transmembrane signaling receptor activity (43%);glycine binding (43%);transmitter-gated ion channel activity (43%),GO:0007165 (57%),signal transduction (57%),IPR000160 (40%);IPR003660 (40%);IPR029787 (40%),GGDEF domain (40%);HAMP domain (40%);Nucleotide cyclase (40%),,,,,,,,,,,
WQPQVFMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MQPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (26%);2.7.3.- (6%);2.3.1.225 (5%),Histidine kinase (26%);Phosphotransferases with a nitrogenous group as acceptor (6%);Protein S-acyltransferase (5%),GO:0005737 (53%);GO:0016021 (11%);GO:0005886 (1%),cytoplasm (53%);integral component of membrane (11%);plasma membrane (1%),GO:0005524 (56%);GO:0000155 (51%);GO:0046872 (4%),ATP binding (56%);phosphorelay sensor kinase activity (51%);metal ion binding (4%),GO:0006935 (51%);GO:0005975 (1%);GO:0009058 (1%),chemotaxis (51%);carbohydrate metabolic process (1%);biosynthetic process (1%),IPR036890 (50%);IPR003594 (50%);IPR036097 (50%),Histidine kinase/HSP90-like ATPase superfamily (50%);Histidine kinase/HSP90-like ATPase (50%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain superfamily (50%),,,,,,,,,,
EMPMPVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVGSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (18%);2.5.1.108 (10%);2.1.1.37 (9%),DNA ligase (NAD(+)) (18%);2-(3-amino-3-carboxypropyl)histidine synthase (10%);DNA (cytosine-5-)-methyltransferase (9%),GO:0016021 (22%);GO:0005737 (4%);GO:0005886 (3%),integral component of membrane (22%);cytoplasm (4%);plasma membrane (3%),GO:0003677 (12%);GO:0016491 (10%);GO:0005524 (7%),DNA binding (12%);oxidoreductase activity (10%);ATP binding (7%),GO:0006281 (5%);GO:0006260 (5%);GO:0017183 (4%),DNA repair (5%);DNA replication (5%);peptidyl-diphthamide biosynthetic process from peptidyl-histidine (4%),IPR008557 (8%);IPR036291 (8%);IPR006311 (8%),Protein of unknown function DUF839 (8%);NAD(P)-binding domain superfamily (8%);Twin-arginine translocation pathway, signal sequence (8%),,,,,,,,,,
DEENTGHQGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEEEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (33%);1.11.1.15 (8%);2.3.1.225 (8%),DNA-directed DNA polymerase (33%);Peroxiredoxin (8%);Protein S-acyltransferase (8%),GO:0016021 (31%);GO:0005634 (5%);GO:0005737 (4%),integral component of membrane (31%);nucleus (5%);cytoplasm (4%),GO:0005524 (15%);GO:0003723 (6%);GO:0003755 (6%),ATP binding (15%);RNA binding (6%);peptidyl-prolyl cis-trans isomerase activity (6%),GO:0017198 (3%);GO:0018002 (3%);GO:0016573 (2%),N-terminal peptidyl-serine acetylation (3%);N-terminal peptidyl-glutamic acid acetylation (3%);histone acetylation (2%),IPR027417 (14%);IPR003593 (9%);IPR036388 (8%),P-loop containing nucleoside triphosphate hydrolase (14%);AAA+ ATPase domain (9%);Winged helix-like DNA-binding domain superfamily (8%),,,,,,,,,,,
YYTVYMK,Oncopeltus fasciatus,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Hemiptera,Heteroptera,Pentatomomorpha,,Lygaeoidea,Lygaeidae,Lygaeinae,,,Oncopeltus,,,,Oncopeltus fasciatus,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0016747 (100%),transferase activity, transferring acyl groups other than amino-acyl groups (100%),,,IPR002656 (100%),Acyltransferase 3 (100%),,,,,,,,,,
ALEPEGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005654 (8%);GO:0030877 (8%),nucleoplasm (8%);beta-catenin destruction complex (8%),GO:0003676 (33%);GO:0004527 (17%);GO:0005524 (17%),nucleic acid binding (33%);exonuclease activity (17%);ATP binding (17%),GO:0006541 (25%);GO:0000122 (8%);GO:0006529 (8%),glutamine metabolic process (25%);negative regulation of transcription by RNA polymerase II (8%);asparagine biosynthetic process (8%),IPR003156 (25%);IPR038763 (25%);IPR015834 (19%),DHHA1 domain (25%);DHH phosphoesterase superfamily (25%);Uncharacterised conserved protein UCP016642 (19%),,,,,,,,,,,
TGGPVTMLWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPEHLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (100%),Phenylalanine--tRNA ligase (100%),GO:0005737 (50%),cytoplasm (50%),GO:0000049 (50%);GO:0000287 (50%);GO:0003723 (50%),tRNA binding (50%);magnesium ion binding (50%);RNA binding (50%),GO:0006432 (50%);GO:0009443 (50%),phenylalanyl-tRNA aminoacylation (50%);pyridoxal 5'-phosphate salvage (50%),IPR002547 (50%);IPR004087 (50%);IPR004088 (50%),tRNA-binding domain (50%);K Homology domain (50%);K Homology domain, type 1 (50%),,,,,,,,,,
MALPQEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (40%);GO:0005840 (20%),integral component of membrane (40%);ribosome (20%),GO:0000155 (40%);GO:0004519 (40%);GO:0005524 (40%),phosphorelay sensor kinase activity (40%);endonuclease activity (40%);ATP binding (40%),GO:0006412 (20%),translation (20%),IPR008538 (67%);IPR011335 (67%);IPR003594 (17%),Domain of unknown function DUF820 (67%);Restriction endonuclease  type II-like (67%);Histidine kinase/HSP90-like ATPase (17%),,,,,,,,,,,
SFLVVMGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMPDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.24 (39%);2.7.-.- (27%);2.2.1.7 (8%),Dephospho-CoA kinase (39%);Transferring phosphorus-containing groups (27%);1-deoxy-D-xylulose-5-phosphate synthase (8%),GO:0016021 (25%);GO:0005737 (16%);GO:0005634 (1%),integral component of membrane (25%);cytoplasm (16%);nucleus (1%),GO:0005524 (22%);GO:0004140 (13%);GO:0016740 (11%),ATP binding (22%);dephospho-CoA kinase activity (13%);transferase activity (11%),GO:0015937 (13%);GO:0032958 (8%);GO:0009228 (3%),coenzyme A biosynthetic process (13%);inositol phosphate biosynthetic process (8%);thiamine biosynthetic process (3%),IPR027417 (17%);IPR001977 (11%);IPR005522 (8%),P-loop containing nucleoside triphosphate hydrolase (17%);Dephospho-CoA kinase (11%);Inositol polyphosphate kinase (8%),,,,,,,,,,,
MVQHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (15%);4.1.2.13 (12%);2.7.-.- (11%),DNA-directed DNA polymerase (15%);Fructose-bisphosphate aldolase (12%);Transferring phosphorus-containing groups (11%),GO:0016021 (19%);GO:0005737 (3%);GO:0005634 (3%),integral component of membrane (19%);cytoplasm (3%);nucleus (3%),GO:0016787 (23%);GO:0003677 (19%);GO:0005524 (13%),hydrolase activity (23%);DNA binding (19%);ATP binding (13%),GO:0006096 (5%);GO:0030388 (4%);GO:0006281 (4%),glycolytic process (5%);fructose 1,6-bisphosphate metabolic process (4%);DNA repair (4%),IPR002933 (17%);IPR036264 (16%);IPR011650 (9%),Peptidase M20 (17%);Bacterial exopeptidase dimerisation domain (16%);Peptidase M20, dimerisation domain (9%),,,,,,,,,
ENFFTMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TQTLC,Syntrophomonas,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Syntrophomonadaceae,,,,Syntrophomonas,,,,,,,,,,,,,,,,IPR003607 (100%);IPR006674 (100%);IPR037522 (100%),HD/PDEase domain (100%);HD domain (100%);HD-GYP domain (100%),,,,,,,,,,,
NDDLPEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (50%),nucleus (50%),GO:0003677 (50%);GO:0003824 (50%);GO:0004185 (50%),DNA binding (50%);catalytic activity (50%);serine-type carboxypeptidase activity (50%),GO:0006541 (50%);GO:0009396 (50%),glutamine metabolic process (50%);folic acid-containing compound biosynthetic process (50%),IPR001544 (50%);IPR001563 (50%);IPR005801 (50%),Aminotransferase class IV (50%);Peptidase S10, serine carboxypeptidase (50%);ADC synthase (50%),,,,,,,,,,
SLDER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (15%);6.1.1.5 (8%);1.2.1.71 (8%),DNA-directed RNA polymerase (15%);Isoleucine--tRNA ligase (8%);Succinylglutamate-semialdehyde dehydrogenase (8%),GO:0016021 (22%);GO:0043190 (6%);GO:0005886 (6%),integral component of membrane (22%);ATP-binding cassette (ABC) transporter complex (6%);plasma membrane (6%),GO:0005524 (16%);GO:0003677 (15%);GO:0003899 (7%),ATP binding (16%);DNA binding (15%);DNA-directed 5'-3' RNA polymerase activity (7%),GO:0055085 (8%);GO:0006351 (4%);GO:0015031 (4%),transmembrane transport (8%);transcription, DNA-templated (4%);protein transport (4%),IPR027417 (9%);IPR000914 (5%);IPR039424 (5%),P-loop containing nucleoside triphosphate hydrolase (9%);Solute-binding protein family 5 domain (5%);Solute-binding protein family 5 (5%),,,,,,,,,,
LTMAVGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GRPPGMTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSQFTQGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFVFFNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.98 (9%);3.5.1.44 (8%);3.1.1.61 (8%),4-hydroxy-3-polyprenylbenzoate decarboxylase (9%);Protein-glutamine glutaminase (8%);Protein-glutamate methylesterase (8%),GO:0016021 (22%);GO:0005886 (5%);GO:0005737 (4%),integral component of membrane (22%);plasma membrane (5%);cytoplasm (4%),GO:0003677 (14%);GO:0046872 (13%);GO:0005524 (9%),DNA binding (14%);metal ion binding (13%);ATP binding (9%),GO:0006355 (9%);GO:0000160 (9%);GO:0045039 (3%),regulation of transcription, DNA-templated (9%);phosphorelay signal transduction system (9%);protein insertion into mitochondrial inner membrane (3%),IPR027417 (12%);IPR036388 (10%);IPR001789 (8%),P-loop containing nucleoside triphosphate hydrolase (12%);Winged helix-like DNA-binding domain superfamily (10%);Signal transduction response regulator, receiver domain (8%),,,,,,,,,
MPWYHGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMHAPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMCFAVMVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNPNLHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0015969 (100%),guanosine tetraphosphate metabolic process (100%),IPR000836 (100%);IPR001279 (100%);IPR003607 (100%),Phosphoribosyltransferase domain (100%);Metallo-beta-lactamase (100%);HD/PDEase domain (100%),,,,,,,,,,,
GFWMSMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTWPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (33%);6.3.4.13 (33%);2.7.11.1 (17%),Ribonucleoside-diphosphate reductase (33%);Phosphoribosylamine--glycine ligase (33%);Non-specific serine/threonine protein kinase (17%),GO:0016021 (39%);GO:0005886 (11%);GO:0031314 (3%),integral component of membrane (39%);plasma membrane (11%);extrinsic component of mitochondrial inner membrane (3%),GO:0016853 (35%);GO:0030246 (35%);GO:0005524 (8%),isomerase activity (35%);carbohydrate binding (35%);ATP binding (8%),GO:0005975 (35%);GO:0055085 (7%);GO:0006605 (6%),carbohydrate metabolic process (35%);transmembrane transport (7%);protein targeting (6%),IPR008183 (33%);IPR011013 (33%);IPR014718 (33%),Aldose 1-/Glucose-6-phosphate 1-epimerase (33%);Galactose mutarotase-like domain superfamily (33%);Glycoside hydrolase-type carbohydrate-binding (33%),,,,,,,,,,,
WMVNAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.99.1 (100%),Transferred entry: 1.4.99.6 (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0004560 (25%);GO:0008718 (25%);GO:0016757 (25%),alpha-L-fucosidase activity (25%);D-amino-acid dehydrogenase activity (25%);transferase activity, transferring glycosyl groups (25%),GO:0005975 (25%);GO:0006486 (25%),carbohydrate metabolic process (25%);protein glycosylation (25%),IPR000933 (25%);IPR001486 (25%);IPR006076 (25%),Glycoside hydrolase, family 29 (25%);Truncated hemoglobin (25%);FAD dependent oxidoreductase (25%),,,,,,,,,
SLMAAHK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0016301 (100%);GO:0016773 (100%),ATP binding (100%);kinase activity (100%);phosphotransferase activity, alcohol group as acceptor (100%),GO:0005975 (100%);GO:0097171 (100%),carbohydrate metabolic process (100%);ADP-L-glycero-beta-D-manno-heptose biosynthetic process (100%),IPR004821 (100%);IPR011611 (100%);IPR011914 (100%),Cytidyltransferase-like domain (100%);Carbohydrate kinase PfkB (100%);RfaE bifunctional protein, domain II (100%),,,,,,,,,
DHLLMANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYENPLLNFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNAGQFDEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGCLSPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLASSVLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HHATATPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALMWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.16 (50%);3.1.11.6 (8%);3.6.4.12 (8%),L-aspartate oxidase (50%);Exodeoxyribonuclease VII (8%);DNA helicase (8%),GO:0016021 (27%);GO:0005886 (9%);GO:0042825 (9%),integral component of membrane (27%);plasma membrane (9%);TAP complex (9%),GO:0005524 (17%);GO:0016887 (12%);GO:0051213 (12%),ATP binding (17%);ATPase activity (12%);dioxygenase activity (12%),GO:0055085 (10%);GO:0019885 (8%);GO:0009435 (6%),transmembrane transport (10%);antigen processing and presentation of endogenous peptide antigen via MHC class I (8%);NAD biosynthetic process (6%),IPR027417 (18%);IPR029045 (12%);IPR001753 (12%),P-loop containing nucleoside triphosphate hydrolase (18%);ClpP/crotonase-like domain superfamily (12%);Enoyl-CoA hydratase/isomerase (12%),,,,,,,,,,,
MPQTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.306 (41%);2.3.1.274 (15%);7.1.1.- (9%),S-(hydroxymethyl)mycothiol dehydrogenase (41%);Phosphate acyltransferase (15%);Hydron translocation or charge separation linked to oxidoreductase reactions (9%),GO:0016021 (14%);GO:0005737 (9%);GO:0005886 (6%),integral component of membrane (14%);cytoplasm (9%);plasma membrane (6%),GO:0008270 (47%);GO:0016491 (42%);GO:0050607 (10%),zinc ion binding (47%);oxidoreductase activity (42%);mycothiol-dependent formaldehyde dehydrogenase activity (10%),GO:0006633 (4%);GO:0008654 (4%);GO:0006782 (2%),fatty acid biosynthetic process (4%);phospholipid biosynthetic process (4%);protoporphyrinogen IX biosynthetic process (2%),IPR036291 (47%);IPR011032 (47%);IPR013149 (47%),NAD(P)-binding domain superfamily (47%);GroES-like superfamily (47%);Alcohol dehydrogenase, C-terminal (47%),,,,,,,,,,
WDCFLGAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YFNYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (58%);3.4.16.- (8%);3.4.17.- (8%),Acting on ester bonds (58%);Serine-type carboxypeptidases (8%);Metallocarboxypeptidases (8%),GO:0016021 (27%);GO:0005739 (7%);GO:0015935 (3%),integral component of membrane (27%);mitochondrion (7%);small ribosomal subunit (3%),GO:0005524 (20%);GO:0004519 (16%);GO:0016787 (14%),ATP binding (20%);endonuclease activity (16%);hydrolase activity (14%),GO:0006298 (9%);GO:0045910 (8%);GO:0006412 (3%),mismatch repair (9%);negative regulation of DNA recombination (8%);translation (3%),IPR008928 (16%);IPR012341 (16%);IPR010905 (15%),Six-hairpin glycosidase superfamily (16%);Six-hairpin glycosidase-like superfamily (16%);Glycosyl hydrolase, family 88 (15%),,,,,,,,,,
VYQCDHTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPTYGMAAATWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NMDVFEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WHMANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNSSHLPGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCMMDLSHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YWWFLK,Fusarium sambucinum species complex,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Hypocreales,,,,,Nectriaceae,,,,Fusarium,,Fusarium sambucinum species complex,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR003663 (100%);IPR005828 (100%);IPR020846 (100%),Sugar/inositol transporter (100%);Major facilitator,  sugar transporter-like (100%);Major facilitator superfamily domain (100%),,,,,,,,,,
QQHAETQSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QCVPHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLGNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (21%);1.8.1.7 (20%);5.1.1.7 (5%),DNA-directed DNA polymerase (21%);Glutathione-disulfide reductase (20%);Diaminopimelate epimerase (5%),GO:0016021 (23%);GO:0005737 (8%);GO:0019031 (6%),integral component of membrane (23%);cytoplasm (8%);viral envelope (6%),GO:0003677 (14%);GO:0005524 (11%);GO:0046872 (7%),DNA binding (14%);ATP binding (11%);metal ion binding (7%),GO:0019062 (5%);GO:0039663 (5%);GO:0045454 (4%),virion attachment to host cell (5%);membrane fusion involved in viral entry into host cell (5%);cell redox homeostasis (4%),IPR027417 (12%);IPR011990 (6%);IPR019734 (5%),P-loop containing nucleoside triphosphate hydrolase (12%);Tetratricopeptide-like helical domain superfamily (6%);Tetratricopeptide repeat (5%),,,,,,,,,,,
SSEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.99.18 (9%);5.6.2.2 (5%);3.2.1.23 (4%),DNA-(apurinic or apyrimidinic site) lyase (9%);DNA topoisomerase (ATP-hydrolyzing) (5%);Beta-galactosidase (4%),GO:0016021 (28%);GO:0005634 (5%);GO:0005737 (4%),integral component of membrane (28%);nucleus (5%);cytoplasm (4%),GO:0005524 (12%);GO:0046872 (9%);GO:0003677 (8%),ATP binding (12%);metal ion binding (9%);DNA binding (8%),GO:0035556 (3%);GO:0006355 (2%);GO:0006887 (2%),intracellular signal transduction (3%);regulation of transcription, DNA-templated (2%);exocytosis (2%),IPR027417 (9%);IPR013083 (4%);IPR036034 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);Zinc finger, RING/FYVE/PHD-type (4%);PDZ superfamily (4%),,,,,,,,,
DDNDSEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADTVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.2 (57%);3.1.-.- (5%);3.1.1.31 (5%),Adenine deaminase (57%);Acting on ester bonds (5%);6-phosphogluconolactonase (5%),GO:0016021 (15%);GO:0030286 (10%);GO:0036157 (5%),integral component of membrane (15%);dynein complex (10%);outer dynein arm (5%),GO:0003677 (28%);GO:0005524 (20%);GO:0003777 (13%),DNA binding (28%);ATP binding (20%);microtubule motor activity (13%),GO:0000160 (22%);GO:0006355 (22%);GO:0007018 (10%),phosphorelay signal transduction system (22%);regulation of transcription, DNA-templated (22%);microtubule-based movement (10%),IPR001789 (18%);IPR011006 (18%);IPR036388 (17%),Signal transduction response regulator, receiver domain (18%);CheY-like superfamily (18%);Winged helix-like DNA-binding domain superfamily (17%),,,,,,,,,
LGETVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.15 (81%);3.5.1.5 (8%);1.17.7.4 (2%),Glycerol-3-phosphate 1-O-acyltransferase (81%);Urease (8%);4-hydroxy-3-methylbut-2-enyl diphosphate reductase (2%),GO:0005886 (64%);GO:0005737 (7%);GO:0016021 (7%),plasma membrane (64%);cytoplasm (7%);integral component of membrane (7%),GO:0004366 (63%);GO:0102420 (63%);GO:0009039 (6%),glycerol-3-phosphate O-acyltransferase activity (63%);sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity (63%);urease activity (6%),GO:0016024 (63%);GO:0043419 (6%);GO:0019288 (2%),CDP-diacylglycerol biosynthetic process (63%);urea catabolic process (6%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (2%),IPR022284 (63%);IPR002123 (62%);IPR028354 (62%),Glycerol-3-phosphate O-acyltransferase/Dihydroxyacetone phosphate acyltransferase (63%);Phospholipid/glycerol acyltransferase (62%);Glycerol-3-phosphate acyltransferase, PlsB (62%),,,,,,,,,
NGCNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (78%);2.4.1.1 (8%);2.1.1.72 (3%),DNA-directed RNA polymerase (78%);Glycogen phosphorylase (8%);Site-specific DNA-methyltransferase (adenine-specific) (3%),GO:0016021 (37%);GO:0005634 (10%);GO:0000786 (5%),integral component of membrane (37%);nucleus (10%);nucleosome (5%),GO:0003677 (29%);GO:0003899 (17%);GO:0046789 (15%),DNA binding (29%);DNA-directed 5'-3' RNA polymerase activity (17%);host cell surface receptor binding (15%),GO:0006351 (16%);GO:0009405 (15%);GO:0006355 (9%),transcription, DNA-templated (16%);pathogenesis (15%);regulation of transcription, DNA-templated (9%),IPR000722 (13%);IPR006592 (13%);IPR007066 (13%),RNA polymerase, alpha subunit (13%);RNA polymerase, N-terminal (13%);RNA polymerase Rpb1, domain 3 (13%),,,,,,
FGLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (20%);3.1.13.1 (15%);4.1.1.31 (8%),Hexosyltransferases (20%);Exoribonuclease II (15%);Phosphoenolpyruvate carboxylase (8%),GO:0016021 (12%);GO:0005737 (3%);GO:0005886 (1%),integral component of membrane (12%);cytoplasm (3%);plasma membrane (1%),GO:0003677 (31%);GO:0004523 (28%);GO:0008270 (28%),DNA binding (31%);RNA-DNA hybrid ribonuclease activity (28%);zinc ion binding (28%),GO:0015074 (34%);GO:0006310 (26%);GO:0032259 (13%),DNA integration (34%);DNA recombination (26%);methylation (13%),IPR012337 (33%);IPR036397 (33%);IPR001584 (32%),Ribonuclease H-like superfamily (33%);Ribonuclease H superfamily (33%);Integrase, catalytic core (32%),,,,,,,,,,
LTHMPNPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DWSYMAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.42 (19%);2.7.2.1 (11%);5.4.99.12 (4%),Isocitrate dehydrogenase (NADP(+)) (19%);Acetate kinase (11%);tRNA pseudouridine(38-40) synthase (4%),GO:0016021 (28%);GO:0005737 (7%);GO:0005615 (3%),integral component of membrane (28%);cytoplasm (7%);extracellular space (3%),GO:0005524 (17%);GO:0000287 (8%);GO:0003677 (8%),ATP binding (17%);magnesium ion binding (8%);DNA binding (8%),GO:0006102 (5%);GO:0006099 (4%);GO:0006082 (2%),isocitrate metabolic process (5%);tricarboxylic acid cycle (4%);organic acid metabolic process (2%),IPR032675 (13%);IPR001611 (12%);IPR027417 (7%),Leucine-rich repeat domain superfamily (13%);Leucine-rich repeat (12%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,,,
VHVEMGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPDDVDLER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.3 (27%);3.6.4.12 (12%);1.17.4.2 (7%),Ribonuclease III (27%);DNA helicase (12%);Ribonucleoside-triphosphate reductase (thioredoxin) (7%),GO:0016021 (44%);GO:0009279 (7%);GO:0005737 (4%),integral component of membrane (44%);cell outer membrane (7%);cytoplasm (4%),GO:0005524 (16%);GO:0022857 (6%);GO:0016787 (6%),ATP binding (16%);transmembrane transporter activity (6%);hydrolase activity (6%),GO:0006397 (3%);GO:0006364 (3%);GO:0008033 (2%),mRNA processing (3%);rRNA processing (3%);tRNA processing (2%),IPR027417 (10%);IPR003846 (8%);IPR003593 (7%),P-loop containing nucleoside triphosphate hydrolase (10%);Protein adenylyltransferase SelO (8%);AAA+ ATPase domain (7%),,,,,,,,,,,
MADVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.4 (40%);6.3.4.5 (17%);1.1.1.85 (4%),Leucine--tRNA ligase (40%);Argininosuccinate synthase (17%);3-isopropylmalate dehydrogenase (4%),GO:0005737 (30%);GO:0016021 (13%);GO:0005840 (6%),cytoplasm (30%);integral component of membrane (13%);ribosome (6%),GO:0005524 (36%);GO:0004823 (15%);GO:0002161 (14%),ATP binding (36%);leucine-tRNA ligase activity (15%);aminoacyl-tRNA editing activity (14%),GO:0006429 (15%);GO:0006412 (7%);GO:0006526 (6%),leucyl-tRNA aminoacylation (15%);translation (7%);arginine biosynthetic process (6%),IPR014729 (19%);IPR002302 (13%);IPR009008 (13%),Rossmann-like alpha/beta/alpha sandwich fold (19%);Leucine-tRNA ligase (13%);Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain (13%),,,,,,,,,,
QPALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (46%);2.3.2.27 (46%);4.2.1.9 (8%),Acting on ester bonds (46%);RING-type E3 ubiquitin transferase (46%);Dihydroxy-acid dehydratase (8%),GO:0016021 (28%);GO:0005634 (14%);GO:0005737 (4%),integral component of membrane (28%);nucleus (14%);cytoplasm (4%),GO:0008270 (20%);GO:0043565 (13%);GO:0004519 (13%),zinc ion binding (20%);sequence-specific DNA binding (13%);endonuclease activity (13%),GO:0010390 (13%);GO:0030183 (13%);GO:0033077 (13%),histone monoubiquitination (13%);B cell differentiation (13%);T cell differentiation in thymus (13%),IPR024627 (11%);IPR027417 (6%);IPR007527 (4%),V(D)J recombination-activating protein 1 (11%);P-loop containing nucleoside triphosphate hydrolase (6%);Zinc finger, SWIM-type (4%),,,,,,,,,,
MVLVLLYSR,Batrachochytrium dendrobatidis,Eukaryota,Fungi,,,Chytridiomycota,,,Chytridiomycetes,,,,Rhizophydiales,,,,,,,,,Batrachochytrium,,,,Batrachochytrium dendrobatidis,,,,,,,,,,,,,,,,,,,,,,,,
MWTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.8 (19%);1.1.1.38 (16%);3.6.4.12 (16%),Protein-disulfide reductase (19%);Malate dehydrogenase (oxaloacetate-decarboxylating) (16%);DNA helicase (16%),GO:0016021 (38%);GO:0005737 (3%);GO:0005576 (1%),integral component of membrane (38%);cytoplasm (3%);extracellular region (1%),GO:0005524 (13%);GO:0003677 (10%);GO:0046872 (8%),ATP binding (13%);DNA binding (10%);metal ion binding (8%),GO:0009058 (6%);GO:0055085 (4%);GO:0006310 (3%),biosynthetic process (6%);transmembrane transport (4%);DNA recombination (3%),IPR000719 (13%);IPR008271 (13%);IPR011009 (13%),Protein kinase domain (13%);Serine/threonine-protein kinase, active site (13%);Protein kinase-like domain superfamily (13%),,,,,,,,,,
WNLDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (39%);3.1.3.3 (12%);2.5.1.18 (9%),Type I site-specific deoxyribonuclease (39%);Phosphoserine phosphatase (12%);Glutathione transferase (9%),GO:0005737 (10%);GO:0016021 (10%);GO:0009325 (5%),cytoplasm (10%);integral component of membrane (10%);nitrate reductase complex (5%),GO:0005524 (34%);GO:0008081 (17%);GO:0003677 (11%),ATP binding (34%);phosphoric diester hydrolase activity (17%);DNA binding (11%),GO:0006629 (17%);GO:0006353 (9%);GO:0031564 (9%),lipid metabolic process (17%);DNA-templated transcription, termination (9%);transcription antitermination (9%),IPR027417 (30%);IPR014001 (25%);IPR029063 (22%),P-loop containing nucleoside triphosphate hydrolase (30%);Helicase superfamily 1/2, ATP-binding domain (25%);S-adenosyl-L-methionine-dependent methyltransferase (22%),,,,,,,,,
EVLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (58%);5.3.1.17 (8%);2.7.7.6 (2%),Metalloendopeptidases (58%);5-dehydro-4-deoxy-D-glucuronate isomerase (8%);DNA-directed RNA polymerase (2%),GO:0016021 (43%);GO:0005886 (25%);GO:0005737 (5%),integral component of membrane (43%);plasma membrane (25%);cytoplasm (5%),GO:0005524 (33%);GO:0008270 (25%);GO:0016887 (23%),ATP binding (33%);zinc ion binding (25%);ATPase activity (23%),GO:0030163 (21%);GO:0051301 (6%);GO:0006355 (3%),protein catabolic process (21%);cell division (6%);regulation of transcription, DNA-templated (3%),IPR027417 (27%);IPR003593 (21%);IPR037219 (18%),P-loop containing nucleoside triphosphate hydrolase (27%);AAA+ ATPase domain (21%);Peptidase M41-like (18%),,,,,,,,,,
MLGKPNAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSGPMNVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSCEVLEHLSMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFPDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.3 (50%);2.4.1.227 (17%);3.6.1.40 (17%),Phosphoglycerate kinase (50%);Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (17%);Guanosine-5'-triphosphate,3'-diphosphate diphosphatase (17%),GO:0016021 (27%);GO:0005737 (12%);GO:0009279 (12%),integral component of membrane (27%);cytoplasm (12%);cell outer membrane (12%),GO:0005086 (19%);GO:0005524 (15%);GO:0004618 (12%),ARF guanyl-nucleotide exchange factor activity (19%);ATP binding (15%);phosphoglycerate kinase activity (12%),GO:0032012 (19%);GO:0006096 (12%);GO:0005975 (4%),regulation of ARF protein signal transduction (19%);glycolytic process (12%);carbohydrate metabolic process (4%),IPR011993 (15%);IPR027417 (15%);IPR000904 (13%),PH-like domain superfamily (15%);P-loop containing nucleoside triphosphate hydrolase (15%);Sec7 domain (13%),,,,,,,,,,
MNNVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.45 (15%);4.4.1.15 (15%);1.1.1.271 (8%),Thymidylate synthase (15%);D-cysteine desulfhydrase (15%);GDP-L-fucose synthase (8%),GO:0016021 (14%);GO:0005737 (8%);GO:0005886 (3%),integral component of membrane (14%);cytoplasm (8%);plasma membrane (3%),GO:0004519 (18%);GO:0004799 (14%);GO:0016491 (14%),endonuclease activity (18%);thymidylate synthase activity (14%);oxidoreductase activity (14%),GO:0006281 (19%);GO:0006231 (14%);GO:0055085 (4%),DNA repair (19%);dTMP biosynthetic process (14%);transmembrane transport (4%),IPR013882 (18%);IPR000398 (14%);IPR023451 (14%),DNA endonuclease Ctp1, C-terminal (18%);Thymidylate synthase (14%);Thymidylate synthase/dCMP hydroxymethylase domain (14%),,,,,,,,,,
ELSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.0 (22%);2.7.7.7 (8%);1.1.1.205 (7%), (22%);DNA-directed DNA polymerase (8%);IMP dehydrogenase (7%),GO:0005737 (23%);GO:0016021 (19%);GO:0005741 (2%),cytoplasm (23%);integral component of membrane (19%);mitochondrial outer membrane (2%),GO:0003677 (39%);GO:0003700 (30%);GO:0016987 (28%),DNA binding (39%);DNA-binding transcription factor activity (30%);sigma factor activity (28%),GO:0001123 (20%);GO:0006352 (8%);GO:0015074 (5%),transcription initiation from bacterial-type RNA polymerase promoter (20%);DNA-templated transcription, initiation (8%);DNA integration (5%),IPR036388 (32%);IPR013324 (29%);IPR007624 (29%),Winged helix-like DNA-binding domain superfamily (32%);RNA polymerase sigma factor, region 3/4-like (29%);RNA polymerase sigma-70 region 3 (29%),,,,,,,,,
TGTSLCNGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVGANVVMEPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.6 (46%);2.8.2.- (19%);6.1.1.5 (12%),Phosphoribosylaminoimidazolesuccinocarboxamide synthase (46%);Sulfotransferases (19%);Isoleucine--tRNA ligase (12%),GO:0016021 (41%);GO:0005737 (4%);GO:0005634 (4%),integral component of membrane (41%);cytoplasm (4%);nucleus (4%),GO:0005524 (24%);GO:0004639 (10%);GO:0030246 (7%),ATP binding (24%);phosphoribosylaminoimidazolesuccinocarboxamide synthase activity (10%);carbohydrate binding (7%),GO:0006189 (9%);GO:0055085 (7%);GO:0016052 (6%),'de novo' IMP biosynthetic process (9%);transmembrane transport (7%);carbohydrate catabolic process (6%),IPR027417 (11%);IPR028923 (9%);IPR018236 (8%),P-loop containing nucleoside triphosphate hydrolase (11%);SAICAR synthetase/ADE2, N-terminal (9%);SAICAR synthetase, conserved site (8%),,,,,,,,,
EWYYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.- (29%);2.4.1.246 (14%);2.4.1.57 (14%),Transferases for other substituted phosphate groups (29%);Mannosylfructose-phosphate synthase (14%);Transferred entry: 2.4.1.345 (14%),GO:0016021 (61%);GO:0016020 (4%);GO:0019012 (4%),integral component of membrane (61%);membrane (4%);virion (4%),GO:0016740 (23%);GO:0003723 (3%);GO:0016763 (2%),transferase activity (23%);RNA binding (3%);transferase activity, transferring pentosyl groups (2%),GO:0019058 (4%);GO:0097193 (4%);GO:0006400 (2%),viral life cycle (4%);intrinsic apoptotic signaling pathway (4%);tRNA modification (2%),IPR001296 (41%);IPR018796 (8%);IPR000475 (8%),Glycosyl transferase, family 1 (41%);Cytochrome c oxidase assembly factor 8 (8%);Retroviral Vif (Viral infectivity) protein (8%),,,,,,,,,
NDNTEVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFCEPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNMSSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR003599 (67%);IPR013106 (67%);IPR013783 (67%),Immunoglobulin subtype (67%);Immunoglobulin V-set domain (67%);Immunoglobulin-like fold (67%),,,,,,,,,,,
MLANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.3.1 (23%);2.7.7.6 (6%);4.1.1.36 (6%),Isocitrate lyase (23%);DNA-directed RNA polymerase (6%);Phosphopantothenoylcysteine decarboxylase (6%),GO:0016021 (24%);GO:0005737 (9%);GO:0005886 (2%),integral component of membrane (24%);cytoplasm (9%);plasma membrane (2%),GO:0046872 (17%);GO:0004451 (11%);GO:0003677 (11%),metal ion binding (17%);isocitrate lyase activity (11%);DNA binding (11%),GO:0019752 (11%);GO:0006355 (2%);GO:0006310 (2%),carboxylic acid metabolic process (11%);regulation of transcription, DNA-templated (2%);DNA recombination (2%),IPR015813 (10%);IPR006254 (9%);IPR039556 (9%),Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (10%);Isocitrate lyase (9%);ICL/PEPM domain (9%),,,,,,,,,,
LNLNAANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVTEATFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTMLDLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNYTMTFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGHDELR,Luteipulveratus mongoliensis,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Micrococcales,,,,,Dermacoccaceae,,,,Luteipulveratus,,,,Luteipulveratus mongoliensis,,,,,,,,GO:0003676 (100%);GO:0008276 (100%);GO:0102559 (100%),nucleic acid binding (100%);protein methyltransferase activity (100%);protein-(glutamine-N5) methyltransferase activity (100%),,,IPR002052 (100%);IPR004556 (100%);IPR007848 (100%),DNA methylase, N-6 adenine-specific, conserved site (100%);Methyltransferase HemK-like (100%);Methyltransferase small domain (100%),,,,,,,,,
ECLHMDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAWNVAATGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYYDFELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVGEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.-.- (29%);2.7.9.2 (21%);5.1.3.2 (4%),Carbon-oxygen lyases (29%);Pyruvate, water dikinase (21%);UDP-glucose 4-epimerase (4%),GO:0016021 (23%);GO:0005737 (7%);GO:0005886 (4%),integral component of membrane (23%);cytoplasm (7%);plasma membrane (4%),GO:0005524 (17%);GO:0016829 (9%);GO:0003677 (9%),ATP binding (17%);lyase activity (9%);DNA binding (9%),GO:0006412 (9%);GO:0006094 (5%);GO:0006090 (5%),translation (9%);gluconeogenesis (5%);pyruvate metabolic process (5%),IPR002491 (9%);IPR027417 (9%);IPR007214 (7%),ABC transporter periplasmic binding domain (9%);P-loop containing nucleoside triphosphate hydrolase (9%);YbaK/aminoacyl-tRNA synthetase-associated domain (7%),,,,,,,,,,
FVGVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.4 (31%);4.4.1.11 (8%);6.3.4.5 (7%),Adenylosuccinate synthase (31%);Methionine gamma-lyase (8%);Argininosuccinate synthase (7%),GO:0016021 (26%);GO:0005737 (13%);GO:0019867 (3%),integral component of membrane (26%);cytoplasm (13%);outer membrane (3%),GO:0005524 (9%);GO:0005525 (9%);GO:0000287 (8%),ATP binding (9%);GTP binding (9%);magnesium ion binding (8%),GO:0044208 (8%);GO:0015031 (4%);GO:0071709 (4%),'de novo' AMP biosynthetic process (8%);protein transport (4%);membrane assembly (4%),IPR027417 (10%);IPR001114 (7%);IPR042111 (7%),P-loop containing nucleoside triphosphate hydrolase (10%);Adenylosuccinate synthetase (7%);Adenylosuccinate synthetase, domain 3 (7%),,,,,,,,,,
TESSATMGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDVFVTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DTLNMVGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSMLQDPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DEMMVLR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0003677 (67%);GO:0003700 (33%);GO:0016740 (33%),DNA binding (67%);DNA-binding transcription factor activity (33%);transferase activity (33%),GO:0006352 (33%),DNA-templated transcription, initiation (33%),IPR000847 (20%);IPR001173 (20%);IPR005119 (20%),Transcription regulator HTH, LysR (20%);Glycosyltransferase 2-like (20%);LysR, substrate-binding (20%),,,,,,,,
AEEADYQGPGLNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPAQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.7.3 (57%);2.7.7.6 (14%);3.1.11.6 (14%),(E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (57%);DNA-directed RNA polymerase (14%);Exodeoxyribonuclease VII (14%),GO:0016021 (24%);GO:0005737 (21%);GO:0005890 (13%),integral component of membrane (24%);cytoplasm (21%);sodium:potassium-exchanging ATPase complex (13%),GO:0003677 (11%);GO:0005506 (11%);GO:0046429 (11%),DNA binding (11%);iron ion binding (11%);4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase activity (11%),GO:0006813 (11%);GO:0006814 (11%);GO:0016114 (11%),potassium ion transport (11%);sodium ion transport (11%);terpenoid biosynthetic process (11%),IPR000402 (16%);IPR038702 (16%);IPR015565 (14%),Sodium/potassium-transporting ATPase subunit beta (16%);Sodium/potassium-transporting ATPase subunit beta superfamily (16%);Sodium/potassium-transporting ATPase subunit beta, chordates (14%),,,,,,,,,,
DLSVYSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.- (100%),Exoribonucleases producing 5'-phosphomonoesters (100%),GO:0005737 (77%);GO:0016021 (15%);GO:0005887 (8%),cytoplasm (77%);integral component of membrane (15%);integral component of plasma membrane (8%),GO:0003723 (77%);GO:0008409 (77%);GO:0005484 (8%),RNA binding (77%);5'-3' exonuclease activity (77%);SNAP receptor activity (8%),GO:0000956 (77%);GO:0006886 (8%);GO:0009306 (8%),nuclear-transcribed mRNA catabolic process (77%);intracellular protein transport (8%);protein secretion (8%),IPR004859 (77%);IPR016494 (77%);IPR027073 (77%),Putative 5-3 exonuclease (77%);5'-3' exoribonuclease 1 (77%);5'-3' exoribonuclease (77%),,,,,,,,,,,
KPWLDYVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DHVNGMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CFNVMLVMPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMTPTPLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVHMAYDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CTLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (30%);2.4.1.- (9%);6.3.5.11 (7%),Histidine kinase (30%);Hexosyltransferases (9%);Cobyrinate a,c-diamide synthase (glutamine-hydrolyzing) (7%),GO:0016021 (22%);GO:0008622 (5%);GO:0005634 (4%),integral component of membrane (22%);epsilon DNA polymerase complex (5%);nucleus (4%),GO:0005524 (15%);GO:0004553 (10%);GO:0003677 (10%),ATP binding (15%);hydrolase activity, hydrolyzing O-glycosyl compounds (10%);DNA binding (10%),GO:0005975 (11%);GO:0006261 (5%);GO:0007160 (5%),carbohydrate metabolic process (11%);DNA-dependent DNA replication (5%);cell-matrix adhesion (5%),IPR018971 (11%);IPR017853 (10%);IPR000322 (9%),Protein of unknown function DUF1997 (11%);Glycoside hydrolase superfamily (10%);Glycoside hydrolase family 31 (9%),,,,,,,,,
WSDQLPK,Drosophila virilis,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,Neoptera,,Diptera,Brachycera,Muscomorpha,,Ephydroidea,Drosophilidae,Drosophilinae,Drosophilini,,Drosophila,Drosophila,virilis group,,Drosophila virilis,,,,,,,,,,,,IPR008530 (100%),Coiled-coil domain-containing protein 22 (100%),,,,,,,,,,,
VVTHVMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLDWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.4 (33%);7.-.-.- (15%);3.4.21.83 (7%),Poly(A)-specific ribonuclease (33%);Translocases (15%);Oligopeptidase B (7%),GO:0016021 (73%);GO:0005886 (7%);GO:0031251 (4%),integral component of membrane (73%);plasma membrane (7%);PAN complex (4%),GO:0005524 (6%);GO:0005242 (5%);GO:0046872 (5%),ATP binding (6%);inward rectifier potassium channel activity (5%);metal ion binding (5%),GO:0034765 (5%);GO:0000289 (4%);GO:0006397 (4%),regulation of ion transmembrane transport (5%);nuclear-transcribed mRNA poly(A) tail shortening (4%);mRNA processing (4%),IPR002881 (60%);IPR036465 (50%);IPR014756 (4%),Domain of unknown function DUF58 (60%);von Willebrand factor A-like domain superfamily (50%);Immunoglobulin E-set (4%),,,,,,,,,,,
CQSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.44 (12%);3.6.4.- (8%);3.4.11.18 (7%),Phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (12%);Acting on ATP; involved in cellular and subcellular movement (8%);Methionyl aminopeptidase (7%),GO:0016021 (30%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (30%);cytoplasm (5%);nucleus (2%),GO:0005524 (14%);GO:0003676 (10%);GO:0003677 (8%),ATP binding (14%);nucleic acid binding (10%);DNA binding (8%),GO:0007264 (3%);GO:0045892 (2%);GO:0006098 (2%),small GTPase mediated signal transduction (3%);negative regulation of transcription, DNA-templated (2%);pentose-phosphate shunt (2%),IPR032675 (16%);IPR001611 (9%);IPR027417 (8%),Leucine-rich repeat domain superfamily (16%);Leucine-rich repeat (9%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,
HHTMSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EEVMTMVSPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPVNLWGGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVLDLGANPLNPQSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQNEGTMNGVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVFMLLYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLFLLMLGGAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENSQAPK,Botrytis tulipae,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Leotiomycetes,,,,Helotiales,,,,,Sclerotiniaceae,,,,Botrytis,,,,Botrytis tulipae,,,,,,,,GO:0005086 (100%),ARF guanyl-nucleotide exchange factor activity (100%),GO:0032012 (100%),regulation of ARF protein signal transduction (100%),IPR000904 (100%);IPR011993 (100%);IPR023394 (100%),Sec7 domain (100%);PH-like domain superfamily (100%);Sec7, C-terminal domain superfamily (100%),,,,,,,,,,
AMTMLMR,Auriculariopsis ampla,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Agaricomycetes,Agaricomycetidae,,,Agaricales,,,,,Schizophyllaceae,,,,Auriculariopsis,,,,Auriculariopsis ampla,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR001734 (100%);IPR038377 (100%),Sodium/solute symporter (100%);Sodium/glucose symporter superfamily (100%),,,,,,,,,,,
MMPDGDNPTHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMAQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.32 (18%);3.1.1.4 (18%);5.1.1.1 (10%),Phospholipase A(1) (18%);Phospholipase A(2) (18%);Alanine racemase (10%),GO:0016021 (16%);GO:0005856 (16%);GO:0005737 (6%),integral component of membrane (16%);cytoskeleton (16%);cytoplasm (6%),GO:0005524 (18%);GO:0003677 (9%);GO:0046872 (8%),ATP binding (18%);DNA binding (9%);metal ion binding (8%),GO:0016042 (4%);GO:0007018 (3%);GO:0071555 (3%),lipid catabolic process (4%);microtubule-based movement (3%);cell wall organization (3%),IPR001303 (12%);IPR027772 (12%);IPR036409 (12%),Class II aldolase/adducin N-terminal (12%);Gamma-adducin (12%);Class II aldolase/adducin N-terminal domain superfamily (12%),,,,,,,,,,,
YEWTCHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSMVMGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMATGQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042597 (67%),periplasmic space (67%),GO:0005506 (67%);GO:0009055 (67%);GO:0020037 (67%),iron ion binding (67%);electron transfer activity (67%);heme binding (67%),,,IPR009056 (67%);IPR024167 (67%);IPR036909 (67%),Cytochrome c-like domain (67%);Cytochrome c4-like (67%);Cytochrome c-like domain superfamily (67%),,,,,,,,,,,
MADLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.2.- (32%);3.6.4.- (10%);3.6.1.66 (4%),Sulfotransferases (32%);Acting on ATP; involved in cellular and subcellular movement (10%);XTP/dITP diphosphatase (4%),GO:0016021 (26%);GO:0005737 (5%);GO:0005829 (2%),integral component of membrane (26%);cytoplasm (5%);cytosol (2%),GO:0005524 (13%);GO:0046872 (9%);GO:0016301 (6%),ATP binding (13%);metal ion binding (9%);kinase activity (6%),GO:0015074 (3%);GO:0055085 (3%);GO:0000160 (2%),DNA integration (3%);transmembrane transport (3%);phosphorelay signal transduction system (2%),IPR027417 (14%);IPR011009 (7%);IPR004147 (7%),P-loop containing nucleoside triphosphate hydrolase (14%);Protein kinase-like domain superfamily (7%);UbiB domain (7%),,,,,,,,,,,
DLHNDEYLFHGVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLHELYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.5.1 (50%);2.6.1.9 (50%),Succinate dehydrogenase (quinone) (50%);Histidinol-phosphate transaminase (50%),GO:0016021 (30%);GO:0005741 (4%);GO:0005743 (4%),integral component of membrane (30%);mitochondrial outer membrane (4%);mitochondrial inner membrane (4%),GO:0008233 (15%);GO:0003677 (11%);GO:0004843 (11%),peptidase activity (15%);DNA binding (11%);thiol-dependent ubiquitin-specific protease activity (11%),GO:0006511 (11%);GO:0016579 (11%);GO:0000266 (7%),ubiquitin-dependent protein catabolic process (11%);protein deubiquitination (11%);mitochondrial fission (7%),IPR001539 (13%);IPR011990 (13%);IPR020988 (13%),Peptidase U32 (13%);Tetratricopeptide-like helical domain superfamily (13%);Peptidase U32, collagenase (13%),,,,,,,,,,
LYYLMDCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMLLYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.- (50%);3.6.5.0 (50%),Acting on acid anhydrides; catalyzing transmembrane movement of substances (50%); (50%),GO:0016021 (45%);GO:0005886 (23%);GO:0005634 (6%),integral component of membrane (45%);plasma membrane (23%);nucleus (6%),GO:0005524 (19%);GO:0015379 (19%);GO:0046872 (19%),ATP binding (19%);potassium:chloride symporter activity (19%);metal ion binding (19%),GO:0006352 (6%);GO:0015031 (6%);GO:0055085 (6%),DNA-templated transcription, initiation (6%);protein transport (6%);transmembrane transport (6%),IPR027417 (19%);IPR003445 (17%);IPR004772 (17%),P-loop containing nucleoside triphosphate hydrolase (19%);Cation transporter (17%);TrkH potassium transport family (17%),,,,,,,,,,
AASHHDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMAHWMVLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HAAQHDQVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYPATYMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEGNGDR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003677 (50%),DNA binding (50%),GO:0006310 (50%);GO:0007165 (50%);GO:0015074 (50%),DNA recombination (50%);signal transduction (50%);DNA integration (50%),IPR000160 (25%);IPR001633 (25%);IPR002104 (25%),GGDEF domain (25%);EAL domain (25%);Integrase, catalytic domain (25%),,,,,,,,,,
TPVWFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVMLHVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0048037 (50%);GO:0003676 (33%);GO:0005524 (33%),cofactor binding (50%);nucleic acid binding (33%);ATP binding (33%),,,IPR012349 (44%);IPR027417 (44%);IPR014001 (33%),FMN-binding split barrel (44%);P-loop containing nucleoside triphosphate hydrolase (44%);Helicase superfamily 1/2, ATP-binding domain (33%),,,,,,,,,,
NYQNDATPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVFYTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.0 (50%);6.1.1.6 (50%), (50%);Lysine--tRNA ligase (50%),GO:0016021 (68%);GO:0005694 (3%);GO:0005730 (3%),integral component of membrane (68%);chromosome (3%);nucleolus (3%),GO:0008234 (15%);GO:0005524 (13%);GO:0004672 (8%),cysteine-type peptidase activity (15%);ATP binding (13%);protein kinase activity (8%),GO:0007160 (60%);GO:0006004 (3%);GO:0006430 (3%),cell-matrix adhesion (60%);fucose metabolic process (3%);lysyl-tRNA aminoacylation (3%),IPR000436 (51%);IPR001846 (51%);IPR005533 (51%),Sushi/SCR/CCP domain (51%);von Willebrand factor, type D domain (51%);AMOP domain (51%),,,,,,,,,,
EPEWTMLHDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TWMMPR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016620 (75%);GO:0005506 (25%);GO:0016491 (25%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (75%);iron ion binding (25%);oxidoreductase activity (25%),GO:0006081 (75%);GO:0044237 (25%),cellular aldehyde metabolic process (75%);cellular metabolic process (25%),IPR012394 (75%);IPR015590 (75%);IPR016160 (75%),Aldehyde dehydrogenase NAD(P)-dependent (75%);Aldehyde dehydrogenase domain (75%);Aldehyde dehydrogenase, cysteine active site (75%),,,,,,,,
TLYLDDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0004930 (50%);GO:0046872 (50%),G protein-coupled receptor activity (50%);metal ion binding (50%),,,IPR001611 (67%);IPR003591 (67%);IPR032675 (67%),Leucine-rich repeat (67%);Leucine-rich repeat, typical subtype (67%);Leucine-rich repeat domain superfamily (67%),,,,,,,,,,
AYSDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.22 (16%);5.4.99.- (16%);2.7.4.8 (13%),UDP-glucose 6-dehydrogenase (16%);Transferring other groups (16%);Guanylate kinase (13%),GO:0016021 (33%);GO:0005840 (20%);GO:0009279 (5%),integral component of membrane (33%);ribosome (20%);cell outer membrane (5%),GO:0003735 (15%);GO:0022857 (10%);GO:0005524 (9%),structural constituent of ribosome (15%);transmembrane transporter activity (10%);ATP binding (9%),GO:0006412 (20%);GO:0032259 (5%);GO:0005975 (3%),translation (20%);methylation (5%);carbohydrate metabolic process (3%),IPR001854 (16%);IPR036049 (16%);IPR018254 (12%),Ribosomal protein L29/L35 (16%);Ribosomal protein L29/L35 superfamily (16%);Ribosomal protein L29, conserved site (12%),,,,,,,,,,
NQNTHHDLLNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPAANHMNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNLQMMEPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSGQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.- (31%);2.7.7.9 (10%);3.1.-.- (9%),In phosphorus-containing anhydrides (31%);UTP--glucose-1-phosphate uridylyltransferase (10%);Acting on ester bonds (9%),GO:0016021 (42%);GO:0005737 (9%);GO:0005886 (3%),integral component of membrane (42%);cytoplasm (9%);plasma membrane (3%),GO:0005524 (9%);GO:0003824 (5%);GO:0047429 (5%),ATP binding (9%);catalytic activity (5%);nucleoside-triphosphate diphosphatase activity (5%),GO:0009117 (5%);GO:0009058 (4%);GO:0055085 (4%),nucleotide metabolic process (5%);biosynthetic process (4%);transmembrane transport (4%),IPR013783 (14%);IPR003961 (13%);IPR036116 (13%),Immunoglobulin-like fold (14%);Fibronectin type III (13%);Fibronectin type III superfamily (13%),,,,,,,,,,,
CYTTTPVTPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMMGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043531 (100%),ADP binding (100%),,,IPR002182 (100%);IPR027417 (100%);IPR032675 (100%),NB-ARC (100%);P-loop containing nucleoside triphosphate hydrolase (100%);Leucine-rich repeat domain superfamily (100%),,,,,,,,,,,
TTPVMAGTNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSAVTLALLEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MALHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.15 (27%);1.11.1.15 (9%);5.2.1.8 (4%),Glutamate decarboxylase (27%);Peroxiredoxin (9%);Peptidylprolyl isomerase (4%),GO:0016021 (49%);GO:0005737 (2%);GO:0005886 (2%),integral component of membrane (49%);cytoplasm (2%);plasma membrane (2%),GO:0003677 (9%);GO:0005524 (6%);GO:0003700 (4%),DNA binding (9%);ATP binding (6%);DNA-binding transcription factor activity (4%),GO:0055085 (24%);GO:0006536 (3%);GO:0006979 (3%),transmembrane transport (24%);glutamate metabolic process (3%);response to oxidative stress (3%),IPR004695 (23%);IPR038665 (23%);IPR033616 (6%),Voltage-dependent anion channel (23%);Voltage-dependent anion channel superfamily (23%);Protein KIAA1109 (6%),,,,,,,,,,,
VLEPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.1 (84%);3.2.1.23 (6%);6.3.1.2 (2%),Tryptophanase (84%);Beta-galactosidase (6%);Glutamine synthetase (2%),GO:0016021 (7%);GO:0009341 (4%);GO:0005737 (3%),integral component of membrane (7%);beta-galactosidase complex (4%);cytoplasm (3%),GO:0009034 (47%);GO:0005524 (8%);GO:0051213 (4%),tryptophanase activity (47%);ATP binding (8%);dioxygenase activity (4%),GO:0030435 (14%);GO:0000917 (14%);GO:0005975 (6%),sporulation resulting in formation of a cellular spore (14%);division septum assembly (14%);carbohydrate metabolic process (6%),IPR015424 (43%);IPR001597 (43%);IPR015422 (42%),Pyridoxal phosphate-dependent transferase (43%);Aromatic amino acid beta-eliminating lyase/threonine aldolase (43%);Pyridoxal phosphate-dependent transferase domain 1 (42%),,,,,,,,,,,
NSEYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.1 (13%);3.6.4.12 (9%);2.7.13.3 (7%),NAD(+) synthase (glutamine-hydrolyzing) (13%);DNA helicase (9%);Histidine kinase (7%),GO:0016021 (44%);GO:0005737 (5%);GO:0005634 (5%),integral component of membrane (44%);cytoplasm (5%);nucleus (5%),GO:0008484 (10%);GO:0005524 (9%);GO:0003677 (6%),sulfuric ester hydrolase activity (10%);ATP binding (9%);DNA binding (6%),GO:0006334 (3%);GO:0015031 (3%);GO:0006355 (3%),nucleosome assembly (3%);protein transport (3%);regulation of transcription, DNA-templated (3%),IPR017850 (12%);IPR000917 (12%);IPR024607 (10%),Alkaline-phosphatase-like, core domain superfamily (12%);Sulfatase, N-terminal (12%);Sulfatase, conserved site (10%),,,,,,,
RPLVMETNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTNHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.15 (13%);3.1.26.3 (12%);2.1.1.- (7%),Acetyl-CoA carboxytransferase (13%);Ribonuclease III (12%);Methyltransferases (7%),GO:0016021 (28%);GO:0005737 (11%);GO:0005840 (7%),integral component of membrane (28%);cytoplasm (11%);ribosome (7%),GO:0005524 (13%);GO:0046872 (9%);GO:0003677 (7%),ATP binding (13%);metal ion binding (9%);DNA binding (7%),GO:0006412 (7%);GO:0006633 (4%);GO:0009401 (4%),translation (7%);fatty acid biosynthetic process (4%);phosphoenolpyruvate-dependent sugar phosphotransferase system (4%),IPR027417 (6%);IPR001857 (5%);IPR008991 (5%),P-loop containing nucleoside triphosphate hydrolase (6%);Ribosomal protein L19 (5%);Translation protein SH3-like domain superfamily (5%),,,,,,,,,,,
NVHDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (50%);2.7.7.19 (6%);6.1.1.5 (6%),Non-specific serine/threonine protein kinase (50%);Polynucleotide adenylyltransferase (6%);Isoleucine--tRNA ligase (6%),GO:0016021 (21%);GO:0005737 (6%);GO:0005634 (4%),integral component of membrane (21%);cytoplasm (6%);nucleus (4%),GO:0005524 (32%);GO:0046872 (13%);GO:0016887 (12%),ATP binding (32%);metal ion binding (13%);ATPase activity (12%),GO:0035556 (8%);GO:0017148 (3%);GO:0042256 (3%),intracellular signal transduction (8%);negative regulation of translation (3%);mature ribosome assembly (3%),IPR027417 (16%);IPR003593 (10%);IPR003439 (9%),P-loop containing nucleoside triphosphate hydrolase (16%);AAA+ ATPase domain (10%);ABC transporter-like (9%),,,,,,,,,,,
LEQHDSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.- (10%);1.1.1.95 (6%);3.1.26.5 (6%),Endodeoxyribonucleases producing 5'-phosphomonoesters (10%);Phosphoglycerate dehydrogenase (6%);Ribonuclease P (6%),GO:0016021 (22%);GO:0005634 (18%);GO:0009279 (6%),integral component of membrane (22%);nucleus (18%);cell outer membrane (6%),GO:0003713 (15%);GO:0005524 (11%);GO:0003677 (9%),transcription coactivator activity (15%);ATP binding (11%);DNA binding (9%),GO:0071709 (6%);GO:0045944 (3%);GO:0006352 (3%),membrane assembly (6%);positive regulation of transcription by RNA polymerase II (3%);DNA-templated transcription, initiation (3%),IPR026638 (16%);IPR032715 (15%);IPR027417 (7%),Nuclear receptor coactivator 6 (16%);Nuclear receptor coactivator 6, putative nucleic acid-binding region (15%);P-loop containing nucleoside triphosphate hydrolase (7%),,,,,,,,,
LLYDYPLSK,Aequorivita soesokkakensis,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Aequorivita,,,,Aequorivita soesokkakensis,,,,,,,,GO:0003677 (100%);GO:0004519 (100%);GO:0005524 (100%),DNA binding (100%);endonuclease activity (100%);ATP binding (100%),,,IPR001650 (100%);IPR006935 (100%);IPR014001 (100%),Helicase, C-terminal (100%);Helicase/UvrB, N-terminal (100%);Helicase superfamily 1/2, ATP-binding domain (100%),,,,,,,,
HTEYLPVMPLTHEPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DNEWALLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CEEESMPSAELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WDCYQVYVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNGNFNADLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LNYVVEVGNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ACPHSDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPLMWMVAPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFALMANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HTTLEMPGLAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVFCEHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVVGQSNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVDHSMAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFNSMQVMLTYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFVPAAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016888 (50%),endodeoxyribonuclease activity, producing 5'-phosphomonoesters (50%),,,IPR001130 (50%);IPR018228 (50%);IPR032466 (50%),TatD family (50%);Deoxyribonuclease, TatD-related, conserved site (50%);Metal-dependent hydrolase (50%),,,,,,,,
NYQETR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.1.19 (100%),Threonine ammonia-lyase (100%),GO:0016021 (42%);GO:0042597 (8%),integral component of membrane (42%);periplasmic space (8%),GO:0004888 (25%);GO:0005524 (17%);GO:0000155 (8%),transmembrane signaling receptor activity (25%);ATP binding (17%);phosphorelay sensor kinase activity (8%),GO:0006935 (25%);GO:0007165 (25%);GO:0006281 (8%),chemotaxis (25%);signal transduction (25%);DNA repair (8%),IPR000727 (16%);IPR003660 (16%);IPR004089 (16%),Target SNARE coiled-coil homology domain (16%);HAMP domain (16%);Methyl-accepting chemotaxis protein (MCP) signalling domain (16%),,,,,,,,,,,
APAEFVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.- (100%),Transferring alkyl or aryl groups, other than methyl groups (100%),GO:0016021 (50%),integral component of membrane (50%),GO:0015205 (50%);GO:0016765 (50%);GO:0043828 (50%),nucleobase transmembrane transporter activity (50%);transferase activity, transferring alkyl or aryl (other than methyl) groups (50%);tRNA 2-selenouridine synthase activity (50%),GO:0002098 (50%);GO:0070329 (50%),tRNA wobble uridine modification (50%);tRNA seleno-modification (50%),IPR006059 (33%);IPR001763 (17%);IPR005368 (17%),Bacterial extracellular solute-binding protein (33%);Rhodanese-like domain (17%);Uncharacterised protein family UPF0175 (17%),,,,,,,,,
TNQGTSTMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPLSWPAQVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMGHVPDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDMLMQAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QYGAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.77 (71%);1.8.1.4 (11%);6.3.5.3 (11%),Protein-L-isoaspartate(D-aspartate) O-methyltransferase (71%);Dihydrolipoyl dehydrogenase (11%);Phosphoribosylformylglycinamidine synthase (11%),GO:0016021 (12%);GO:0005737 (8%);GO:0009274 (4%),integral component of membrane (12%);cytoplasm (8%);peptidoglycan-based cell wall (4%),GO:0046872 (27%);GO:0005524 (25%);GO:0004719 (23%),metal ion binding (27%);ATP binding (25%);protein-L-isoaspartate (D-aspartate) O-methyltransferase activity (23%),GO:0000281 (23%);GO:0000724 (23%);GO:0007409 (8%),mitotic cytokinesis (23%);double-strand break repair via homologous recombination (23%);axonogenesis (8%),IPR028730 (22%);IPR000682 (21%);IPR029063 (21%),Zinc finger FYVE domain-containing protein 26 (22%);Protein-L-isoaspartate(D-aspartate) O-methyltransferase (21%);S-adenosyl-L-methionine-dependent methyltransferase (21%),,,,,,,,,,,
ANYFALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (100%),Phenylalanine--tRNA ligase (100%),GO:0016021 (20%);GO:0005737 (10%);GO:0005886 (10%),integral component of membrane (20%);cytoplasm (10%);plasma membrane (10%),GO:0003676 (70%);GO:0000049 (10%);GO:0000287 (10%),nucleic acid binding (70%);tRNA binding (10%);magnesium ion binding (10%),GO:0031047 (70%);GO:0006432 (10%),gene silencing by RNA (70%);phenylalanyl-tRNA aminoacylation (10%),IPR003100 (64%);IPR003165 (64%);IPR012337 (64%),PAZ domain (64%);Piwi domain (64%);Ribonuclease H-like superfamily (64%),,,,,,,,,,,
FFYYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.48 (17%);3.1.4.- (11%);3.5.1.98 (11%),Protein-tyrosine-phosphatase (17%);Phosphoric diester hydrolases (11%);Histone deacetylase (11%),GO:0016021 (71%);GO:0009279 (2%);GO:0016020 (1%),integral component of membrane (71%);cell outer membrane (2%);membrane (1%),GO:0016787 (20%);GO:0003677 (15%);GO:0005524 (2%),hydrolase activity (20%);DNA binding (15%);ATP binding (2%),GO:0015031 (2%);GO:0001700 (1%);GO:0007259 (1%),protein transport (2%);embryonic development via the syncytial blastoderm (1%);receptor signaling pathway via JAK-STAT (1%),IPR003607 (35%);IPR006674 (35%);IPR006675 (35%),HD/PDEase domain (35%);HD domain (35%);HDIG domain (35%),,,,,,,,,,,
MVLGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.3.1 (70%);1.8.4.11 (10%);2.7.7.42 (10%),Cytochrome-c oxidase (70%);Peptide-methionine (S)-S-oxide reductase (10%);[Glutamine synthetase] adenylyltransferase (10%),GO:0016021 (48%);GO:0005886 (21%);GO:0070469 (15%),integral component of membrane (48%);plasma membrane (21%);respirasome (15%),GO:0020037 (23%);GO:0004129 (17%);GO:0005507 (17%),heme binding (23%);cytochrome-c oxidase activity (17%);copper ion binding (17%),GO:0032259 (4%);GO:0000820 (2%);GO:0006334 (2%),methylation (4%);regulation of glutamine family amino acid metabolic process (2%);nucleosome assembly (2%),IPR025668 (17%);IPR008972 (10%);IPR036034 (10%),Transposase DDE domain (17%);Cupredoxin (10%);PDZ superfamily (10%),,,,,,,,,,,
EAMTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (53%);4.1.2.13 (9%);4.3.2.2 (2%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (53%);Fructose-bisphosphate aldolase (9%);Adenylosuccinate lyase (2%),GO:0016021 (12%);GO:0005737 (7%);GO:0005886 (2%),integral component of membrane (12%);cytoplasm (7%);plasma membrane (2%),GO:0005524 (29%);GO:0046872 (26%);GO:0004088 (20%),ATP binding (29%);metal ion binding (26%);carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity (20%),GO:0044205 (20%);GO:0006526 (19%);GO:0000184 (4%),'de novo' UMP biosynthetic process (20%);arginine biosynthetic process (19%);nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (4%),IPR016185 (18%);IPR005479 (18%);IPR011761 (18%),Pre-ATP-grasp domain superfamily (18%);Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain (18%);ATP-grasp fold (18%),,,,,,,,,
TAGQLLWTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAEPEPNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.9.1.1 (12%);5.6.2.2 (9%);3.6.4.12 (8%),L-seryl-tRNA(Sec) selenium transferase (12%);DNA topoisomerase (ATP-hydrolyzing) (9%);DNA helicase (8%),GO:0016021 (15%);GO:0005737 (13%);GO:0005886 (2%),integral component of membrane (15%);cytoplasm (13%);plasma membrane (2%),GO:0005524 (29%);GO:0003677 (17%);GO:0008134 (9%),ATP binding (29%);DNA binding (17%);transcription factor binding (9%),GO:0006355 (13%);GO:0000160 (9%);GO:0097056 (4%),regulation of transcription, DNA-templated (13%);phosphorelay signal transduction system (9%);selenocysteinyl-tRNA(Sec) biosynthetic process (4%),IPR027417 (20%);IPR003593 (10%);IPR009057 (9%),P-loop containing nucleoside triphosphate hydrolase (20%);AAA+ ATPase domain (10%);Homeobox-like domain superfamily (9%),,,,,,,,,,
DMVAGNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVTDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (72%);2.1.1.163 (14%);2.1.1.201 (14%),Acting on ATP; involved in cellular and subcellular movement (72%);Demethylmenaquinone methyltransferase (14%);2-methoxy-6-polyprenyl-1,4-benzoquinol methylase (14%),GO:0005737 (34%);GO:0016021 (19%);GO:0000781 (2%),cytoplasm (34%);integral component of membrane (19%);chromosome, telomeric region (2%),GO:0005524 (42%);GO:0016787 (31%);GO:0003684 (26%),ATP binding (42%);hydrolase activity (31%);damaged DNA binding (26%),GO:0006355 (34%);GO:0000716 (30%);GO:0034605 (13%),regulation of transcription, DNA-templated (34%);transcription-coupled nucleotide-excision repair, DNA damage recognition (30%);cellular response to heat (13%),IPR027417 (31%);IPR001650 (22%);IPR003711 (22%),P-loop containing nucleoside triphosphate hydrolase (31%);Helicase, C-terminal (22%);CarD-like/TRCF domain (22%),,,,,,
EPDLPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (100%),Acting on polysaccharides (100%),GO:0005887 (20%);GO:0016021 (13%);GO:0005634 (7%),integral component of plasma membrane (20%);integral component of membrane (13%);nucleus (7%),GO:0010181 (27%);GO:0016491 (27%);GO:0016829 (27%),FMN binding (27%);oxidoreductase activity (27%);lyase activity (27%),GO:0009252 (20%);GO:0071555 (20%);GO:0006281 (7%),peptidoglycan biosynthetic process (20%);cell wall organization (20%);DNA repair (7%),IPR001155 (18%);IPR013783 (18%);IPR003598 (14%),NADH:flavin oxidoreductase/NADH oxidase, N-terminal (18%);Immunoglobulin-like fold (18%);Immunoglobulin subtype 2 (14%),,,,,,,,,,
YFAPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.1 (100%),Acetate--CoA ligase (100%),GO:0016021 (21%);GO:0030286 (11%);GO:0033557 (11%),integral component of membrane (21%);dynein complex (11%);Slx1-Slx4 complex (11%),GO:0005524 (16%);GO:0008483 (16%);GO:0016616 (16%),ATP binding (16%);transaminase activity (16%);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (16%),GO:0006260 (11%);GO:0006281 (11%);GO:0006310 (11%),DNA replication (11%);DNA repair (11%);DNA recombination (11%),IPR036291 (19%);IPR006139 (14%);IPR006140 (14%),NAD(P)-binding domain superfamily (19%);D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (14%);D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain (14%),,,,,,,
WNSWFFMLSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NHELPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0046873 (50%);GO:0070403 (50%),metal ion transmembrane transporter activity (50%);NAD+ binding (50%),,,IPR001810 (33%);IPR002523 (33%);IPR003000 (33%),F-box domain (33%);Mg2+ transporter protein, CorA-like/Zinc transport protein ZntB (33%);Sirtuin family (33%),,,,,,,,,,
DHYWAR,Heterorhabditis bacteriophora,Eukaryota,Metazoa,,,Nematoda,,,Chromadorea,,,,Strongylida,,,,Strongyloidea,Heterorhabditidae,,,,Heterorhabditis,,,,Heterorhabditis bacteriophora,,,,,,,,,,,,IPR001888 (100%);IPR036388 (100%);IPR036390 (100%),Transposase, type 1 (100%);Winged helix-like DNA-binding domain superfamily (100%);Winged helix DNA-binding domain superfamily (100%),,,,,,,,,,
NVACTLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HGCLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (100%),ribosome (100%),GO:0003735 (100%),structural constituent of ribosome (100%),GO:0006412 (100%),translation (100%),IPR000630 (33%);IPR003137 (33%);IPR005175 (33%),Ribosomal protein S8 (33%);PA domain (33%);PPC domain (33%),,,,,,,,,,,
LFTDNNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (60%),integral component of membrane (60%),GO:0003723 (20%);GO:0009982 (20%);GO:0051537 (20%),RNA binding (20%);pseudouridine synthase activity (20%);2 iron, 2 sulfur cluster binding (20%),GO:0001522 (20%),pseudouridine synthesis (20%),IPR000210 (33%);IPR006652 (33%);IPR011333 (33%),BTB/POZ domain (33%);Kelch repeat type 1 (33%);SKP1/BTB/POZ domain superfamily (33%),,,,,,,,,,
SQNSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (67%);3.4.16.4 (33%),DNA-directed DNA polymerase (67%);Serine-type D-Ala-D-Ala carboxypeptidase (33%),GO:0016021 (38%);GO:0015935 (13%);GO:0071339 (8%),integral component of membrane (38%);small ribosomal subunit (13%);MLL1 complex (8%),GO:0003735 (15%);GO:0019843 (15%);GO:0046872 (15%),structural constituent of ribosome (15%);rRNA binding (15%);metal ion binding (15%),GO:0055085 (19%);GO:0006412 (15%);GO:0006351 (13%),transmembrane transport (19%);translation (15%);transcription, DNA-templated (13%),IPR006685 (15%);IPR010920 (15%);IPR011066 (15%),Mechanosensitive ion channel MscS (15%);LSM domain superfamily (15%);Mechanosensitive ion channel MscS, C-terminal (15%),,,,,,,,,
DYDNTMYLEAPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFTYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (22%);2.7.7.7 (11%);3.6.4.- (7%),Non-specific serine/threonine protein kinase (22%);DNA-directed DNA polymerase (11%);Acting on ATP; involved in cellular and subcellular movement (7%),GO:0016021 (43%);GO:0019028 (4%);GO:0005737 (4%),integral component of membrane (43%);viral capsid (4%);cytoplasm (4%),GO:0003677 (11%);GO:0005524 (9%);GO:0003676 (8%),DNA binding (11%);ATP binding (9%);nucleic acid binding (8%),GO:0006261 (6%);GO:0000272 (6%);GO:0051027 (4%),DNA-dependent DNA replication (6%);polysaccharide catabolic process (6%);DNA transport (4%),IPR008429 (26%);IPR030434 (26%);IPR013087 (8%),Cleft lip and palate transmembrane 1 (26%);Cleft lip and palate transmembrane protein 1-like protein (26%);Zinc finger C2H2-type (8%),,,,,,,,,,,
MELFDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008171 (100%),O-methyltransferase activity (100%),GO:0032259 (100%),methylation (100%),IPR002935 (50%);IPR027417 (50%);IPR029063 (50%),Class I-like SAM-dependent O-methyltransferase (50%);P-loop containing nucleoside triphosphate hydrolase (50%);S-adenosyl-L-methionine-dependent methyltransferase (50%),,,,,,,,,,,
LVEYEFMHTDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLQAQMDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFFLYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0005272 (100%),sodium channel activity (100%),,,IPR001873 (50%);IPR016184 (50%),Epithelial sodium channel (50%);Capsid/spike protein, ssDNA virus (50%),,,,,,,,,,
MGWSPLEK,Leptolyngbyaceae,Bacteria,,,,Cyanobacteria,,,,,,,Synechococcales,,,,,Leptolyngbyaceae,,,,,,,,,,,,,,,,GO:0003824 (50%);GO:0016874 (50%),catalytic activity (50%);ligase activity (50%),,,IPR000873 (100%);IPR020845 (100%);IPR025110 (100%),AMP-dependent synthetase/ligase (100%);AMP-binding, conserved site (100%);AMP-binding enzyme, C-terminal domain (100%),,,,,,,,,
LSEDVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (22%),integral component of membrane (22%),GO:0005524 (83%);GO:0004672 (70%);GO:0042393 (9%),ATP binding (83%);protein kinase activity (70%);histone binding (9%),,,IPR011009 (64%);IPR000719 (57%);IPR001245 (57%),Protein kinase-like domain superfamily (64%);Protein kinase domain (57%);Serine-threonine/tyrosine-protein kinase, catalytic domain (57%),,,,,,,,,,
DVVTLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.- (72%);2.7.1.1 (8%);2.7.2.8 (8%),Phosphotransferases with an alcohol group as acceptor (72%);Hexokinase (8%);Acetylglutamate kinase (8%),GO:0005623 (40%);GO:0005840 (31%);GO:0016021 (18%),cell (40%);ribosome (31%);integral component of membrane (18%),GO:0005524 (41%);GO:0005536 (39%);GO:0000049 (31%),ATP binding (41%);glucose binding (39%);tRNA binding (31%),GO:0001678 (39%);GO:0006096 (39%);GO:0006412 (31%),cellular glucose homeostasis (39%);glycolytic process (39%);translation (31%),IPR001312 (43%);IPR022672 (43%);IPR019807 (42%),Hexokinase (43%);Hexokinase, N-terminal (43%);Hexokinase, binding site (42%),,,,,,,,,
AAWAVSWGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFCAGGAGGDGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPLSHSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.3.- (100%),With oxygen as acceptor (100%),GO:0016021 (22%);GO:0005576 (6%);GO:0005886 (6%),integral component of membrane (22%);extracellular region (6%);plasma membrane (6%),GO:0005524 (44%);GO:0000156 (39%);GO:0008134 (39%),ATP binding (44%);phosphorelay response regulator activity (39%);transcription factor binding (39%),GO:0006355 (44%);GO:0009308 (11%);GO:0000160 (6%),regulation of transcription, DNA-templated (44%);amine metabolic process (11%);phosphorelay signal transduction system (6%),IPR027417 (42%);IPR002078 (37%);IPR010524 (37%),P-loop containing nucleoside triphosphate hydrolase (42%);RNA polymerase sigma factor 54 interaction domain (37%);Signal transduction response regulator, propionate catabolism activator, N-terminal (37%),,,,,,,,
EAAWEVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (60%);4.2.1.20 (9%);7.6.2.1 (6%),DNA topoisomerase (ATP-hydrolyzing) (60%);Tryptophan synthase (9%);P-type phospholipid transporter (6%),GO:0016021 (16%);GO:0005694 (14%);GO:0019897 (13%),integral component of membrane (16%);chromosome (14%);extrinsic component of plasma membrane (13%),GO:0005524 (25%);GO:0003677 (19%);GO:0003918 (15%),ATP binding (25%);DNA binding (19%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (15%),GO:0006265 (15%);GO:0007059 (13%);GO:0032543 (3%),DNA topological change (15%);chromosome segregation (13%);mitochondrial translation (3%),IPR013760 (12%);IPR035516 (12%);IPR002205 (12%),DNA topoisomerase, type IIA-like domain superfamily (12%);DNA gyrase/topoisomerase IV, subunit A, C-terminal (12%);DNA topoisomerase, type IIA, subunit A/C-terminal (12%),,,,,
QSDNTLHDGTPAEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMHMMPGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNVLCMELQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTGEEAESALWGTGANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNPVCLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ATPLDYNK,Stanieria cyanosphaera,Bacteria,,,,Cyanobacteria,,,,,,,Pleurocapsales,,,,,Dermocarpellaceae,,,,Stanieria,,,,Stanieria cyanosphaera,,,,,,,,,,,,,,,,,,,,,,,,
MNSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.8 (8%);5.1.3.37 (5%);6.3.3.2 (5%),Guanylate kinase (8%);Mannuronan 5-epimerase (5%);5-formyltetrahydrofolate cyclo-ligase (5%),GO:0016021 (26%);GO:0016020 (6%);GO:0005737 (5%),integral component of membrane (26%);membrane (6%);cytoplasm (5%),GO:0005524 (16%);GO:0003677 (9%);GO:0016887 (8%),ATP binding (16%);DNA binding (9%);ATPase activity (8%),GO:0031460 (5%);GO:0032259 (5%);GO:0006355 (3%),glycine betaine transport (5%);methylation (5%);regulation of transcription, DNA-templated (3%),IPR027417 (12%);IPR003593 (8%);IPR003439 (7%),P-loop containing nucleoside triphosphate hydrolase (12%);AAA+ ATPase domain (8%);ABC transporter-like (7%),,,,,,,,,,
QVTVN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0022857 (33%);GO:0000287 (17%);GO:0004519 (17%),transmembrane transporter activity (33%);magnesium ion binding (17%);endonuclease activity (17%),GO:0019310 (17%);GO:1900034 (17%),inositol catabolic process (17%);regulation of cellular response to heat (17%),IPR013783 (33%);IPR032693 (33%);IPR001036 (22%),Immunoglobulin-like fold (33%);YtkA-like domain (33%);Acriflavin resistance protein (22%),,,,,,,,,,,
TPEFNGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NANEFFMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (10%);3.5.1.98 (7%);2.7.11.1 (6%),Isoleucine--tRNA ligase (10%);Histone deacetylase (7%);Non-specific serine/threonine protein kinase (6%),GO:0016021 (22%);GO:0005634 (6%);GO:0005737 (6%),integral component of membrane (22%);nucleus (6%);cytoplasm (6%),GO:0005524 (20%);GO:0003677 (13%);GO:0046872 (7%),ATP binding (20%);DNA binding (13%);metal ion binding (7%),GO:0051726 (5%);GO:0006397 (3%);GO:0006887 (2%),regulation of cell cycle (5%);mRNA processing (3%);exocytosis (2%),IPR027417 (12%);IPR013783 (4%);IPR036915 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);Immunoglobulin-like fold (4%);Cyclin-like superfamily (4%),,,,,,,,,,,
ANLPVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.182 (67%);2.7.7.42 (33%);2.7.7.89 (33%),16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (67%);[Glutamine synthetase] adenylyltransferase (33%);[Glutamine synthetase]-adenylyl-L-tyrosine phosphorylase (33%),GO:0005737 (29%);GO:0016020 (14%),cytoplasm (29%);membrane (14%),GO:0000179 (29%);GO:0003723 (29%);GO:0005524 (29%),rRNA (adenine-N6,N6-)-dimethyltransferase activity (29%);RNA binding (29%);ATP binding (29%),GO:0000820 (14%);GO:0008152 (14%);GO:0035556 (14%),regulation of glutamine family amino acid metabolic process (14%);metabolic process (14%);intracellular signal transduction (14%),IPR001737 (25%);IPR011530 (25%);IPR020596 (25%),Ribosomal RNA adenine methyltransferase KsgA/Erm (25%);Ribosomal RNA adenine dimethylase (25%);Ribosomal RNA adenine methylase transferase, conserved site (25%),,,,,,,,,
MVEMAPALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WDWWMLGLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVWFLAYSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HWLAAHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSHADDDLMNPDDMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YCQMFEVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSNPLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (33%);4.2.1.22 (33%);6.1.1.20 (33%),Acting on ATP; involved in cellular and subcellular movement (33%);Cystathionine beta-synthase (33%);Phenylalanine--tRNA ligase (33%),GO:0016021 (26%);GO:0005737 (15%);GO:0009380 (4%),integral component of membrane (26%);cytoplasm (15%);excinuclease repair complex (4%),GO:0005524 (26%);GO:0003677 (11%);GO:0003723 (11%),ATP binding (26%);DNA binding (11%);RNA binding (11%),GO:0006396 (11%);GO:0035556 (11%);GO:0007165 (7%),RNA processing (11%);intracellular signal transduction (11%);signal transduction (7%),IPR001810 (24%);IPR005174 (24%);IPR036047 (24%),F-box domain (24%);Domain unknown function DUF295 (24%);F-box-like domain superfamily (24%),,,,,,,,,,,
FSYYWDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNALNDFVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLANPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.54 (100%),D-alanine--[D-alanyl-carrier protein] ligase (100%),GO:0005737 (60%),cytoplasm (60%),GO:0005524 (60%);GO:0047473 (60%);GO:0004497 (20%),ATP binding (60%);D-alanine [D-alanyl carrier protein] ligase activity (60%);monooxygenase activity (20%),GO:0070395 (60%),lipoteichoic acid biosynthetic process (60%),IPR000873 (60%);IPR010071 (60%);IPR010072 (60%),AMP-dependent synthetase/ligase (60%);Amino acid adenylation domain (60%);D-alanine--D-alanyl carrier protein ligase (60%),,,,,,,,,,,
MWYYVLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVEQANAEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMSVPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAATNGPHAQFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLMQAHK,Pezizomycotina,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (100%),nucleus (100%),GO:0003677 (100%);GO:0008270 (100%);GO:0000981 (50%),DNA binding (100%);zinc ion binding (100%);DNA-binding transcription factor activity, RNA polymerase II-specific (50%),GO:0006351 (100%),transcription, DNA-templated (100%),IPR007219 (100%);IPR001138 (50%);IPR001736 (50%),Transcription factor domain, fungi (100%);Zn(2)-C6 fungal-type DNA-binding domain (50%);Phospholipase D/Transphosphatidylase (50%),,,,,,,,
FEGLMPPLEFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNLHEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANECR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (21%);1.12.1.3 (7%);2.3.1.16 (7%),Transferring other groups (21%);Hydrogen dehydrogenase (NADP(+)) (7%);Acetyl-CoA C-acyltransferase (7%),GO:0016021 (30%);GO:0016020 (12%);GO:0005737 (12%),integral component of membrane (30%);membrane (12%);cytoplasm (12%),GO:0005509 (18%);GO:0003677 (12%);GO:0016301 (11%),calcium ion binding (18%);DNA binding (12%);kinase activity (11%),GO:0009966 (11%);GO:0000160 (11%);GO:0006355 (11%),regulation of signal transduction (11%);phosphorelay signal transduction system (11%);regulation of transcription, DNA-templated (11%),IPR004311 (56%);IPR005546 (51%);IPR036709 (51%),Vacuolating cytotoxin, putative (56%);Autotransporter beta-domain (51%);Autotransporter beta-domain superfamily (51%),,,,,,,,,
WMEVLYFFGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGHVFVVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNMFAATAHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LWMLAPK,Penicillium,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Eurotiomycetidae,,,Eurotiales,,,,,Aspergillaceae,,,,Penicillium,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.14 (25%);1.3.1.- (17%);2.4.1.21 (8%),Amidophosphoribosyltransferase (25%);With NAD(+) or NADP(+) as acceptor (17%);Starch synthase (8%),GO:0016021 (22%);GO:0005634 (4%);GO:0005737 (3%),integral component of membrane (22%);nucleus (4%);cytoplasm (3%),GO:0003677 (17%);GO:0005509 (12%);GO:0005544 (12%),DNA binding (17%);calcium ion binding (12%);calcium-dependent phospholipid binding (12%),GO:0006355 (11%);GO:0000160 (6%);GO:0009058 (6%),regulation of transcription, DNA-templated (11%);phosphorelay signal transduction system (6%);biosynthetic process (6%),IPR018502 (11%);IPR036388 (11%);IPR037104 (11%),Annexin repeat (11%);Winged helix-like DNA-binding domain superfamily (11%);Annexin superfamily (11%),,,,,,,,,,
EGSLVPSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDMLADNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNDCPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APLLGEELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPTWNPGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ADMLLSQDWNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPWYSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.7.7 (82%);1.14.19.6 (6%);1.11.1.5 (3%),Ferredoxin:protochlorophyllide reductase (ATP-dependent) (82%);Acyl-CoA (9+3)-desaturase (6%);Cytochrome-c peroxidase (3%),GO:0016021 (35%);GO:0000307 (2%);GO:0000790 (2%),integral component of membrane (35%);cyclin-dependent protein kinase holoenzyme complex (2%);nuclear chromatin (2%),GO:0005524 (57%);GO:0016636 (43%);GO:0016730 (43%),ATP binding (57%);oxidoreductase activity, acting on the CH-CH group of donors, iron-sulfur protein as acceptor (43%);oxidoreductase activity, acting on iron-sulfur proteins as donors (43%),GO:0019685 (43%);GO:0036068 (33%);GO:0006629 (11%),photosynthesis, dark reaction (43%);light-independent chlorophyll biosynthetic process (33%);lipid metabolic process (11%),IPR000510 (40%);IPR005969 (40%);IPR013580 (40%),Nitrogenase/oxidoreductase, component 1 (40%);Light-independent protochlorophyllide reductase, B subunit (40%);Proto-chlorophyllide/chlorophyllide reductase, C-terminal (40%),,,,
MMTAVLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTQNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (23%);6.1.1.11 (20%);4.1.1.31 (9%),Type I site-specific deoxyribonuclease (23%);Serine--tRNA ligase (20%);Phosphoenolpyruvate carboxylase (9%),GO:0016021 (37%);GO:0005891 (5%);GO:0005634 (2%),integral component of membrane (37%);voltage-gated calcium channel complex (5%);nucleus (2%),GO:0003677 (16%);GO:0000155 (15%);GO:0005524 (10%),DNA binding (16%);phosphorelay sensor kinase activity (15%);ATP binding (10%),GO:0006310 (7%);GO:0006303 (7%);GO:0034765 (6%),DNA recombination (7%);double-strand break repair via nonhomologous end joining (7%);regulation of ion transmembrane transport (6%),IPR036890 (15%);IPR003594 (15%);IPR005467 (15%),Histidine kinase/HSP90-like ATPase superfamily (15%);Histidine kinase/HSP90-like ATPase (15%);Histidine kinase domain (15%),,,,,,,,,,,
DELHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (45%);2.7.1.40 (4%);2.7.7.7 (2%),Acting on ester bonds (45%);Pyruvate kinase (4%);DNA-directed DNA polymerase (2%),GO:0016021 (22%);GO:0005886 (12%);GO:0005737 (11%),integral component of membrane (22%);plasma membrane (12%);cytoplasm (11%),GO:0005524 (15%);GO:0003723 (12%);GO:0004521 (11%),ATP binding (15%);RNA binding (12%);endoribonuclease activity (11%),GO:0006402 (11%);GO:0006099 (4%);GO:0006289 (3%),mRNA catabolic process (11%);tricarboxylic acid cycle (4%);nucleotide-excision repair (3%),IPR027417 (10%);IPR003607 (9%);IPR006674 (9%),P-loop containing nucleoside triphosphate hydrolase (10%);HD/PDEase domain (9%);HD domain (9%),,,,,,,,,,,
NALYDMPGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYSCVAPFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ATLGFGLLMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAHAMSR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004672 (100%);GO:0005524 (100%),protein kinase activity (100%);ATP binding (100%),,,IPR000719 (50%);IPR003423 (50%);IPR008266 (50%),Protein kinase domain (50%);Outer membrane efflux protein (50%);Tyrosine-protein kinase, active site (50%),,,,,,,,,,
LGTNHGR,Pelagibacterales bacterium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Pelagibacterales,,,,,,,,,,,,,Pelagibacterales bacterium,,,,,,,,,,,,IPR005565 (100%),Haemolysin activator HlyB, C-terminal (100%),,,,,,,,,,
DTLWTGPSADWNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LESDGAGVR,Aspergillus ellipticus,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Eurotiomycetidae,,,Eurotiales,,,,,Aspergillaceae,,,,Aspergillus,,,,Aspergillus ellipticus,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0055085 (100%),transmembrane transport (100%),IPR011701 (100%);IPR020846 (100%);IPR036259 (100%),Major facilitator superfamily (100%);Major facilitator superfamily domain (100%);MFS transporter superfamily (100%),,,,,,,,,,,
ELWPSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.3 (78%);2.1.1.72 (11%);3.1.3.2 (11%),Aconitate hydratase (78%);Site-specific DNA-methyltransferase (adenine-specific) (11%);Acid phosphatase (11%),GO:0032040 (15%);GO:0005623 (7%);GO:0016021 (6%),small-subunit processome (15%);cell (7%);integral component of membrane (6%),GO:0003677 (45%);GO:0008270 (13%);GO:0003994 (12%),DNA binding (45%);zinc ion binding (13%);aconitate hydratase activity (12%),GO:0006364 (15%);GO:0009086 (9%);GO:0006879 (7%),rRNA processing (15%);methionine biosynthetic process (9%);cellular iron ion homeostasis (7%),IPR010982 (39%);IPR038722 (38%);IPR001387 (25%),Lambda repressor-like, DNA-binding domain superfamily (39%);Ner, winged helix-turn-helix DNA-binding domain (38%);Cro/C1-type helix-turn-helix domain (25%),,,,,,,,,
FGVYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.220 (22%);2.7.1.26 (20%);2.7.7.2 (20%),tRNA (adenine(58)-N(1))-methyltransferase (22%);Riboflavin kinase (20%);FAD synthase (20%),GO:0016021 (29%);GO:0005852 (4%);GO:0016282 (4%),integral component of membrane (29%);eukaryotic translation initiation factor 3 complex (4%);eukaryotic 43S preinitiation complex (4%),GO:0005524 (10%);GO:0016740 (6%);GO:0003723 (6%),ATP binding (10%);transferase activity (6%);RNA binding (6%),GO:0001522 (5%);GO:0001732 (4%);GO:0009231 (3%),pseudouridine synthesis (5%);formation of cytoplasmic translation initiation complex (4%);riboflavin biosynthetic process (3%),IPR027805 (15%);IPR027806 (11%);IPR027417 (6%),Transposase, Helix-turn-helix domain (15%);Harbinger transposase-derived nuclease domain (11%);P-loop containing nucleoside triphosphate hydrolase (6%),,,,,,,,,,
FNHLLESK,Geobacter,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Desulfuromonadales,,,,,Geobacteraceae,,,,Geobacter,,,,,,,,,,,,,,,,IPR017896 (100%);IPR017900 (100%);IPR036188 (100%),4Fe-4S ferredoxin-type, iron-sulphur binding domain (100%);4Fe-4S ferredoxin, iron-sulphur binding, conserved site (100%);FAD/NAD(P)-binding domain superfamily (100%),,,,,,,,
TDDLWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.62 (100%),Chlorophyll synthase (100%),GO:0016021 (60%);GO:0005581 (8%);GO:0019867 (8%),integral component of membrane (60%);collagen trimer (8%);outer membrane (8%),GO:0042302 (38%);GO:0005524 (5%);GO:0009055 (5%),structural constituent of cuticle (38%);ATP binding (5%);electron transfer activity (5%),GO:0000160 (3%);GO:0006298 (3%);GO:0006364 (3%),phosphorelay signal transduction system (3%);mismatch repair (3%);rRNA processing (3%),IPR002486 (31%);IPR008160 (23%);IPR027417 (10%),Nematode cuticle collagen, N-terminal (31%);Collagen triple helix repeat (23%);P-loop containing nucleoside triphosphate hydrolase (10%),,,,,,,,,,
ALDTHMLFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPLNDYK,Flavobacterium,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Flavobacterium,,,,,,,,5.6.2.2 (100%),DNA topoisomerase (ATP-hydrolyzing) (100%),GO:0005694 (50%);GO:0005737 (50%),chromosome (50%);cytoplasm (50%),GO:0003677 (50%);GO:0003918 (50%);GO:0004866 (50%),DNA binding (50%);DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (50%);endopeptidase inhibitor activity (50%),GO:0006261 (50%);GO:0006265 (50%),DNA-dependent DNA replication (50%);DNA topological change (50%),IPR001599 (50%);IPR002205 (50%);IPR002890 (50%),Alpha-2-macroglobulin (50%);DNA topoisomerase, type IIA, subunit A/C-terminal (50%);Macroglobulin domain (50%),,,,,,,,
NMLVTAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.31 (100%),Adenine glycosylase (100%),GO:0015934 (25%),large ribosomal subunit (25%),GO:0003677 (25%);GO:0003735 (25%);GO:0008233 (25%),DNA binding (25%);structural constituent of ribosome (25%);peptidase activity (25%),GO:0006284 (25%);GO:0006412 (25%),base-excision repair (25%);translation (25%),IPR013491 (43%);IPR006431 (29%);IPR000445 (14%),Caudovirus, tape measure, N-terminal (43%);Bacteriophage lambda, GpH, tail tape measure, C-terminal (29%);Helix-hairpin-helix motif (14%),,,,,,
TPWVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.32 (100%),Maleylacetate reductase (100%),GO:0016021 (7%);GO:0005829 (2%);GO:0009279 (2%),integral component of membrane (7%);cytosol (2%);cell outer membrane (2%),GO:0046872 (88%);GO:0016491 (81%);GO:0018506 (7%),metal ion binding (88%);oxidoreductase activity (81%);maleylacetate reductase activity (7%),GO:0005975 (2%),carbohydrate metabolic process (2%),IPR001670 (82%);IPR018211 (82%);IPR039697 (82%),Alcohol dehydrogenase, iron-type/glycerol dehydrogenase GldA (82%);Alcohol dehydrogenase, iron-type, conserved site (82%);Iron-type alcohol dehydrogenase-like (82%),,,,,,,,
EASLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (19%);5.3.1.13 (6%);1.2.1.11 (5%),Acting on ester bonds (19%);Arabinose-5-phosphate isomerase (6%);Aspartate-semialdehyde dehydrogenase (5%),GO:0016021 (29%);GO:0005737 (7%);GO:0005886 (7%),integral component of membrane (29%);cytoplasm (7%);plasma membrane (7%),GO:0005524 (19%);GO:0046872 (7%);GO:0003677 (7%),ATP binding (19%);metal ion binding (7%);DNA binding (7%),GO:0009847 (3%);GO:0006298 (3%);GO:0045910 (3%),spore germination (3%);mismatch repair (3%);negative regulation of DNA recombination (3%),IPR027417 (12%);IPR025165 (5%);IPR013783 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);Protein of unknown function DUF4100 (5%);Immunoglobulin-like fold (4%),,,,,,,,,,,
MVGTPLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNTMHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.63 (100%),Methylated-DNA--[protein]-cysteine S-methyltransferase (100%),GO:0016021 (60%);GO:0005737 (20%),integral component of membrane (60%);cytoplasm (20%),GO:0004888 (40%);GO:0003824 (20%);GO:0003908 (20%),transmembrane signaling receptor activity (40%);catalytic activity (20%);methylated-DNA-[protein]-cysteine S-methyltransferase activity (20%),GO:0006935 (40%);GO:0007165 (40%);GO:0006307 (20%),chemotaxis (40%);signal transduction (40%);DNA dealkylation involved in DNA repair (20%),IPR005017 (78%);IPR042117 (78%);IPR004089 (6%),Outer membrane protein transport protein (OMPP1/FadL/TodX) (78%);OMPP1/FadL/TodX superfamily (78%);Methyl-accepting chemotaxis protein (MCP) signalling domain (6%),,,,,,,,,,,
FFNLGDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NALQTNDFEWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DYEMNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.- (100%),Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (100%),GO:0016021 (83%);GO:0009279 (33%);GO:0016020 (17%),integral component of membrane (83%);cell outer membrane (33%);membrane (17%),GO:0000155 (17%);GO:0004571 (17%);GO:0005509 (17%),phosphorelay sensor kinase activity (17%);mannosyl-oligosaccharide 1,2-alpha-mannosidase activity (17%);calcium ion binding (17%),GO:0006355 (17%);GO:0008152 (17%),regulation of transcription, DNA-templated (17%);metabolic process (17%),IPR006664 (25%);IPR006665 (25%);IPR011659 (25%),Outer membrane protein, bacterial (25%);OmpA-like domain (25%);WD40-like Beta Propeller (25%),,,,,,,
DPDLMYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMGLLSSAVAVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MGMEPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000178 (100%);GO:0005737 (100%),exosome (RNase complex) (100%);cytoplasm (100%),GO:0003676 (100%);GO:0008270 (100%),nucleic acid binding (100%);zinc ion binding (100%),GO:0006396 (100%);GO:0006401 (100%),RNA processing (100%);RNA catabolic process (100%),IPR003029 (50%);IPR007837 (50%);IPR012340 (50%),S1 domain (50%);DNA damage-inducible protein DinB (50%);Nucleic acid-binding, OB-fold (50%),,,,,,,,,,
MDGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.1 (68%);1.9.3.1 (3%);1.11.1.21 (2%),Acetate kinase (68%);Cytochrome-c oxidase (3%);Catalase peroxidase (2%),GO:0016021 (36%);GO:0005737 (20%);GO:0005794 (10%),integral component of membrane (36%);cytoplasm (20%);Golgi apparatus (10%),GO:0005524 (28%);GO:0008776 (18%);GO:0000287 (18%),ATP binding (28%);acetate kinase activity (18%);magnesium ion binding (18%),GO:0006085 (17%);GO:0006082 (16%);GO:0006486 (11%),acetyl-CoA biosynthetic process (17%);organic acid metabolic process (16%);protein glycosylation (11%),IPR001623 (17%);IPR036869 (17%);IPR015399 (16%),DnaJ domain (17%);Chaperone J-domain superfamily (17%);Domain of unknown function DUF1977, DnaJ-like (16%),,,,,,,,,,
EAVNQQQGQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WELNENR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005887 (50%),integral component of plasma membrane (50%),GO:0004673 (50%);GO:0015221 (50%),protein histidine kinase activity (50%);lipopolysaccharide transmembrane transporter activity (50%),GO:0000160 (50%);GO:0006355 (50%);GO:0009584 (50%),phosphorelay signal transduction system (50%);regulation of transcription, DNA-templated (50%);detection of visible light (50%),IPR010664 (78%);IPR001294 (22%);IPR001789 (22%),Lipopolysaccharide assembly, LptC-related (78%);Phytochrome (22%);Signal transduction response regulator, receiver domain (22%),,,,,,,,
ALEMHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.2 (60%);1.1.1.169 (20%);1.11.1.6 (20%),Fumarate hydratase (60%);2-dehydropantoate 2-reductase (20%);Catalase (20%),GO:0016021 (24%);GO:0045239 (3%);GO:0005886 (2%),integral component of membrane (24%);tricarboxylic acid cycle enzyme complex (3%);plasma membrane (2%),GO:0003677 (25%);GO:0003700 (14%);GO:0016987 (13%),DNA binding (25%);DNA-binding transcription factor activity (14%);sigma factor activity (13%),GO:0006352 (12%);GO:0000160 (6%);GO:0006355 (6%),DNA-templated transcription, initiation (12%);phosphorelay signal transduction system (6%);regulation of transcription, DNA-templated (6%),IPR011990 (20%);IPR013026 (17%);IPR019734 (17%),Tetratricopeptide-like helical domain superfamily (20%);Tetratricopeptide repeat-containing domain (17%);Tetratricopeptide repeat (17%),,,,,,,,,
WYVNCR,Embleya scabrispora,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Streptomycetales,,,,,Streptomycetaceae,,,,Embleya,,,,Embleya scabrispora,,,,,,,,,,,,IPR035418 (100%),Transcription regulator HTH, AraC- type, ligand binding domain-like (100%),,,,,,,,,
MLLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.7 (9%);2.7.1.40 (6%);7.6.2.1 (6%),Diaminopimelate epimerase (9%);Pyruvate kinase (6%);P-type phospholipid transporter (6%),GO:0016021 (25%);GO:0005737 (8%);GO:0009295 (4%),integral component of membrane (25%);cytoplasm (8%);nucleoid (4%),GO:0005524 (10%);GO:0003677 (9%);GO:0016787 (6%),ATP binding (10%);DNA binding (9%);hydrolase activity (6%),GO:0006355 (4%);GO:0005975 (2%);GO:0009089 (2%),regulation of transcription, DNA-templated (4%);carbohydrate metabolic process (2%);lysine biosynthetic process via diaminopimelate (2%),IPR000595 (12%);IPR018490 (12%);IPR036390 (11%),Cyclic nucleotide-binding domain (12%);Cyclic nucleotide-binding-like (12%);Winged helix DNA-binding domain superfamily (11%),,,,,,,,,,
TQLCANPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPGVTHAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMSPPQK,Pseudarcicella hirudinis,Bacteria,,,,Bacteroidetes,,,Cytophagia,,,,Cytophagales,,,,,Cytophagaceae,,,,Pseudarcicella,,,,Pseudarcicella hirudinis,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0042834 (100%),peptidoglycan binding (100%),,,IPR007730 (100%);IPR036680 (100%);IPR040495 (100%),Sporulation-like domain (100%);Sporulation-like domain superfamily (100%);CCDC81-like prokaryotic HU domain 1 (100%),,,,,,,,,,,
MNSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (15%);4.2.1.33 (7%);5.4.99.- (4%),DNA-directed DNA polymerase (15%);3-isopropylmalate dehydratase (7%);Transferring other groups (4%),GO:0016021 (30%);GO:0005737 (8%);GO:0005886 (6%),integral component of membrane (30%);cytoplasm (8%);plasma membrane (6%),GO:0005524 (9%);GO:0003677 (9%);GO:0046872 (6%),ATP binding (9%);DNA binding (9%);metal ion binding (6%),GO:0006260 (3%);GO:0055085 (3%);GO:0015031 (2%),DNA replication (3%);transmembrane transport (3%);protein transport (2%),IPR027417 (6%);IPR014710 (4%);IPR007168 (4%),P-loop containing nucleoside triphosphate hydrolase (6%);RmlC-like jelly roll fold (4%);Phage shock protein, PspC, N-terminal (4%),,,,,,,,,
SYMGEEK,Noccaea caerulescens,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Brassicales,,,,,Brassicaceae,,Coluteocarpeae,,Noccaea,,,,Noccaea caerulescens,,,,,,,,GO:0016788 (100%),hydrolase activity, acting on ester bonds (100%),,,IPR001087 (100%);IPR035669 (100%);IPR036514 (100%),GDSL lipase/esterase (100%);GDSL lipase/esterase-like, plant (100%);SGNH hydrolase superfamily (100%),,,,,,,,,
AAHER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.- (16%);5.3.1.28 (11%);3.7.1.3 (7%),Ligases forming aminoacyl-tRNA and related compounds (16%);D-sedoheptulose 7-phosphate isomerase (11%);Kynureninase (7%),GO:0016021 (16%);GO:0005737 (12%);GO:0005886 (4%),integral component of membrane (16%);cytoplasm (12%);plasma membrane (4%),GO:0005524 (22%);GO:0003677 (11%);GO:0008270 (7%),ATP binding (22%);DNA binding (11%);zinc ion binding (7%),GO:0005975 (4%);GO:0043039 (3%);GO:0006400 (3%),carbohydrate metabolic process (4%);tRNA aminoacylation (3%);tRNA modification (3%),IPR027417 (15%);IPR036291 (6%);IPR011032 (4%),P-loop containing nucleoside triphosphate hydrolase (15%);NAD(P)-binding domain superfamily (6%);GroES-like superfamily (4%),,,,,,,,,,,
AAPAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (13%);7.1.2.2 (6%);4.2.99.18 (6%),DNA topoisomerase (13%);H(+)-transporting two-sector ATPase (6%);DNA-(apurinic or apyrimidinic site) lyase (6%),GO:0000786 (18%);GO:0016021 (11%);GO:0005737 (8%),nucleosome (18%);integral component of membrane (11%);cytoplasm (8%),GO:0003677 (44%);GO:0005524 (8%);GO:0008270 (5%),DNA binding (44%);ATP binding (8%);zinc ion binding (5%),GO:0030261 (18%);GO:0006334 (18%);GO:0006412 (4%),chromosome condensation (18%);nucleosome assembly (18%);translation (4%),IPR005819 (16%);IPR009970 (10%);IPR000119 (8%),Histone H5 (16%);Histone H1-like nucleoprotein HC2 (10%);Histone-like DNA-binding protein (8%),,,,,,,,,,,
WMTHGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004360 (100%);GO:0097367 (100%),glutamine-fructose-6-phosphate transaminase (isomerizing) activity (100%);carbohydrate derivative binding (100%),GO:1901137 (100%),carbohydrate derivative biosynthetic process (100%),IPR001347 (33%);IPR005855 (33%);IPR013211 (33%),Sugar isomerase (SIS) (33%);Glucosamine-fructose-6-phosphate aminotransferase, isomerising (33%);LVIVD (33%),,,,,,,,,,
LMYFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (19%);3.4.21.107 (14%);3.5.1.49 (14%),DNA (cytosine-5-)-methyltransferase (19%);Peptidase Do (14%);Formamidase (14%),GO:0005634 (10%);GO:0005886 (9%);GO:0016021 (9%),nucleus (10%);plasma membrane (9%);integral component of membrane (9%),GO:0005096 (74%);GO:1902936 (73%);GO:0046872 (51%),GTPase activator activity (74%);phosphatidylinositol bisphosphate binding (73%);metal ion binding (51%),GO:0006357 (3%);GO:0000082 (2%);GO:0006351 (2%),regulation of transcription by RNA polymerase II (3%);G1/S transition of mitotic cell cycle (2%);transcription, DNA-templated (2%),IPR011993 (73%);IPR001849 (72%);IPR037851 (71%),PH-like domain superfamily (73%);Pleckstrin homology domain (72%);ADAP, PH domain 2 (71%),,,,,,,,,
MVMPLTNEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.54 (27%);2.7.8.26 (3%);3.6.3.- (3%),D-alanine--[D-alanyl-carrier protein] ligase (27%);Adenosylcobinamide-GDP ribazoletransferase (3%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (3%),GO:0016021 (30%);GO:0005737 (11%);GO:0005634 (3%),integral component of membrane (30%);cytoplasm (11%);nucleus (3%),GO:0005524 (25%);GO:0016887 (12%);GO:0003677 (5%),ATP binding (25%);ATPase activity (12%);DNA binding (5%),GO:0070395 (5%);GO:0055085 (3%);GO:0006396 (3%),lipoteichoic acid biosynthetic process (5%);transmembrane transport (3%);RNA processing (3%),IPR027417 (15%);IPR003593 (11%);IPR003439 (10%),P-loop containing nucleoside triphosphate hydrolase (15%);AAA+ ATPase domain (11%);ABC transporter-like (10%),,,,,,,,,,,
MTHMHPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNWAVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MWVTFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016758 (100%),transferase activity, transferring hexosyl groups (100%),,,IPR012808 (50%);IPR015996 (50%);IPR000095 (25%),Conserved hypothetical protein CHP02453 (50%);Uncharacterised conserved protein UCP028451 (50%);CRIB domain (25%),,,,,,,,,,
TNWTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.234 (100%),dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucopyranosN,N-dimethyltransferase (100%),GO:0016021 (47%),integral component of membrane (47%),GO:0008237 (13%);GO:0003676 (7%);GO:0008168 (7%),metallopeptidase activity (13%);nucleic acid binding (7%);methyltransferase activity (7%),GO:0000160 (13%);GO:0015074 (7%);GO:0032259 (7%),phosphorelay signal transduction system (13%);DNA integration (7%);methylation (7%),IPR018070 (32%);IPR001584 (14%);IPR012337 (14%),Neuromedin U, amidation site (32%);Integrase, catalytic core (14%);Ribonuclease H-like superfamily (14%),,,,,,
MFHVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.3 (20%);1.5.5.2 (10%);2.3.1.184 (10%),Adenylate kinase (20%);Proline dehydrogenase (10%);Acyl-homoserine-lactone synthase (10%),GO:0030289 (58%);GO:0016021 (15%);GO:0008287 (4%),protein phosphatase 4 complex (58%);integral component of membrane (15%);protein serine/threonine phosphatase complex (4%),GO:0019888 (58%);GO:0008270 (5%);GO:0005524 (4%),protein phosphatase regulator activity (58%);zinc ion binding (5%);ATP binding (4%),GO:0007165 (58%);GO:0006470 (4%);GO:0055114 (2%),signal transduction (58%);protein dephosphorylation (4%);oxidation-reduction process (2%),IPR011989 (52%);IPR016024 (52%);IPR031087 (52%),Armadillo-like helical (52%);Armadillo-type fold (52%);Serine/threonine-protein phosphatase 4 regulatory subunit 1 (52%),,,,,,,,,,,
WYPGCSVSALALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVWHDFDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLHQFEFLPTEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPSAPVYEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HVSVLHEAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLYLDNDK,Myxococcales bacterium,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Myxococcales,,,,,,,,,,,,,Myxococcales bacterium,,,,,,,,,,,,IPR011047 (100%);IPR013783 (100%);IPR015943 (100%),Quinoprotein alcohol dehydrogenase-like superfamily (100%);Immunoglobulin-like fold (100%);WD40/YVTN repeat-like-containing domain superfamily (100%),,,,,,,,,,,
FHMAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.98.3 (28%);1.3.99.22 (28%);3.6.4.- (11%),Coproporphyrinogen dehydrogenase (28%);Transferred entry: 1.3.98.3 (28%);Acting on ATP; involved in cellular and subcellular movement (11%),GO:0016021 (22%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (22%);cytoplasm (5%);nucleus (2%),GO:0003677 (23%);GO:0051536 (20%);GO:0003824 (16%),DNA binding (23%);iron-sulfur cluster binding (20%);catalytic activity (16%),GO:0005975 (4%);GO:0006310 (4%);GO:0015074 (4%),carbohydrate metabolic process (4%);DNA recombination (4%);DNA integration (4%),IPR006638 (18%);IPR007197 (18%);IPR023404 (18%),Elp3/MiaB/NifB (18%);Radical SAM (18%);Radical SAM, alpha/beta horseshoe (18%),,,,,,,,,,
AENADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (26%);6.1.1.7 (22%);2.5.1.47 (13%),Endopeptidase La (26%);Alanine--tRNA ligase (22%);Cysteine synthase (13%),GO:0016021 (28%);GO:0005737 (27%);GO:0005623 (5%),integral component of membrane (28%);cytoplasm (27%);cell (5%),GO:0005524 (18%);GO:0046872 (17%);GO:0000049 (7%),ATP binding (18%);metal ion binding (17%);tRNA binding (7%),GO:0006515 (6%);GO:0034605 (6%);GO:0006419 (4%),protein quality control for misfolded or incompletely synthesized proteins (6%);cellular response to heat (6%);alanyl-tRNA aminoacylation (4%),IPR001667 (8%);IPR004097 (8%);IPR038222 (8%),DDH domain (8%);DHHA2 domain (8%);DHHA2 domain superfamily (8%),,,,,,,,,,,
VPVAWGK,Planctomycetes bacterium,Bacteria,,,,Planctomycetes,,,,,,,,,,,,,,,,,,,,Planctomycetes bacterium,,,,,,,,,,,,IPR025592 (100%),Domain of unknown function DUF4347 (100%),,,,,,,,,,,
METLPNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLLPNAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.0 (46%);6.1.1.17 (7%);2.3.1.31 (4%), (46%);Glutamate--tRNA ligase (7%);Homoserine O-acetyltransferase (4%),GO:0005886 (17%);GO:0016021 (17%);GO:0005737 (8%),plasma membrane (17%);integral component of membrane (17%);cytoplasm (8%),GO:0005524 (23%);GO:0003677 (21%);GO:0003746 (18%),ATP binding (23%);DNA binding (21%);translation elongation factor activity (18%),GO:0045727 (15%);GO:0006281 (11%);GO:0032968 (6%),positive regulation of translation (15%);DNA repair (11%);positive regulation of transcription elongation from RNA polymerase II promoter (6%),IPR027417 (27%);IPR035647 (13%);IPR000640 (13%),P-loop containing nucleoside triphosphate hydrolase (27%);EF-G domain III/V-like (13%);Elongation factor EFG, domain V-like (13%),,,,,,,,,,
WMFPMMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CYYYAALLSGWWNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGNGYFNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPWFLAELR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGFMLAYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESSVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.14 (33%);1.17.4.1 (10%);3.4.-.- (4%),Amidophosphoribosyltransferase (33%);Ribonucleoside-diphosphate reductase (10%);Acting on peptide bonds (peptidases) (4%),GO:0016021 (23%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (23%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (13%);GO:0003677 (9%);GO:0046872 (8%),ATP binding (13%);DNA binding (9%);metal ion binding (8%),GO:0006189 (5%);GO:0006541 (5%);GO:0009116 (5%),'de novo' IMP biosynthetic process (5%);glutamine metabolic process (5%);nucleoside metabolic process (5%),IPR027417 (7%);IPR029055 (5%);IPR013083 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Nucleophile aminohydrolases, N-terminal (5%);Zinc finger, RING/FYVE/PHD-type (5%),,,,,,,,,
QGNTENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.0 (33%);2.3.1.274 (16%);2.1.1.296 (11%), (33%);Phosphate acyltransferase (16%);Methyltransferase cap2 (11%),GO:0016021 (18%);GO:0005737 (18%);GO:0009279 (12%),integral component of membrane (18%);cytoplasm (18%);cell outer membrane (12%),GO:0005524 (27%);GO:0008933 (12%);GO:0016837 (11%),ATP binding (27%);lytic transglycosylase activity (12%);carbon-oxygen lyase activity, acting on polysaccharides (11%),GO:0071555 (12%);GO:0016998 (12%);GO:0000270 (11%),cell wall organization (12%);cell wall macromolecule catabolic process (12%);peptidoglycan metabolic process (11%),IPR001638 (11%);IPR023346 (11%);IPR008258 (11%),Solute-binding protein  family 3/N-terminal domain of MltF (11%);Lysozyme-like domain superfamily (11%);Transglycosylase SLT domain 1 (11%),,,,,,,,,,
AEWGMESR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETFNENPFDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SEPLPSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (39%),integral component of membrane (39%),GO:0003677 (17%);GO:0016829 (17%);GO:0005524 (13%),DNA binding (17%);lyase activity (17%);ATP binding (13%),GO:0018298 (17%);GO:0000160 (4%);GO:0006310 (4%),protein-chromophore linkage (17%);phosphorelay signal transduction system (4%);DNA recombination (4%),IPR000160 (21%);IPR029787 (21%);IPR002081 (17%),GGDEF domain (21%);Nucleotide cyclase (21%);Cryptochrome/DNA photolyase class 1 (17%),,,,,,,,,,,
MDVEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.99.5 (50%);2.7.1.23 (50%),Transferred entry: 1.2.7.12 (50%);NAD(+) kinase (50%),GO:0016021 (35%);GO:0005634 (12%);GO:0005886 (12%),integral component of membrane (35%);nucleus (12%);plasma membrane (12%),GO:0003677 (18%);GO:0005524 (18%);GO:0003676 (12%),DNA binding (18%);ATP binding (18%);nucleic acid binding (12%),GO:0006351 (12%);GO:0007049 (12%);GO:0007059 (12%),transcription, DNA-templated (12%);cell cycle (12%);chromosome segregation (12%),IPR011256 (16%);IPR019587 (16%);IPR023393 (16%),Regulatory factor, effector binding domain superfamily (16%);Polyketide cyclase/dehydrase (16%);START-like domain superfamily (16%),,,,,,,,,
FVLFTMLAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYHTEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.31 (25%);2.3.1.225 (13%);2.5.1.141 (13%),RBR-type E3 ubiquitin transferase (25%);Protein S-acyltransferase (13%);Heme o synthase (13%),GO:0016021 (40%);GO:0005886 (5%);GO:0005737 (3%),integral component of membrane (40%);plasma membrane (5%);cytoplasm (3%),GO:0005524 (25%);GO:0016491 (13%);GO:0000155 (10%),ATP binding (25%);oxidoreductase activity (13%);phosphorelay sensor kinase activity (10%),GO:0005975 (5%);GO:0007264 (3%);GO:0016052 (3%),carbohydrate metabolic process (5%);small GTPase mediated signal transduction (3%);carbohydrate catabolic process (3%),IPR027417 (18%);IPR000719 (9%);IPR001155 (9%),P-loop containing nucleoside triphosphate hydrolase (18%);Protein kinase domain (9%);NADH:flavin oxidoreductase/NADH oxidase, N-terminal (9%),,,,,,,,,,
NENNMFVPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DPSGQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.14.4 (52%);3.4.11.- (24%);2.7.13.3 (10%),Dipeptidyl-peptidase III (52%);Aminopeptidases (24%);Histidine kinase (10%),GO:0005634 (28%);GO:0005737 (15%);GO:0016021 (13%),nucleus (28%);cytoplasm (15%);integral component of membrane (13%),GO:0008270 (35%);GO:0003712 (27%);GO:0004402 (27%),zinc ion binding (35%);transcription coregulator activity (27%);histone acetyltransferase activity (27%),GO:0006355 (29%);GO:0009058 (7%);GO:0061959 (5%),regulation of transcription, DNA-templated (29%);biosynthetic process (7%);response to (R)-carnitine (5%),IPR000197 (23%);IPR001487 (23%);IPR003101 (23%),Zinc finger, TAZ-type (23%);Bromodomain (23%);Coactivator CBP, KIX domain (23%),,,,,,,,
MFVDPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.4.11 (50%);2.3.2.29 (50%),Peptide-methionine (S)-S-oxide reductase (50%);Aspartate/glutamate leucyltransferase (50%),GO:0005634 (50%);GO:0016020 (7%);GO:0016021 (5%),nucleus (50%);membrane (7%);integral component of membrane (5%),GO:0003677 (52%);GO:0008270 (50%);GO:0000981 (48%),DNA binding (52%);zinc ion binding (50%);DNA-binding transcription factor activity, RNA polymerase II-specific (48%),GO:0006351 (50%);GO:0007165 (12%);GO:0006935 (7%),transcription, DNA-templated (50%);signal transduction (12%);chemotaxis (7%),IPR007219 (38%);IPR001138 (36%);IPR036864 (36%),Transcription factor domain, fungi (38%);Zn(2)-C6 fungal-type DNA-binding domain (36%);Zn(2)-C6 fungal-type DNA-binding domain superfamily (36%),,,,,,,,
QGVANENEAHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDYAYLR,Prevotella,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,Prevotellaceae,,,,Prevotella,,,,,,,,,,GO:0005623 (100%),cell (100%),GO:0016209 (100%);GO:0016491 (100%),antioxidant activity (100%);oxidoreductase activity (100%),GO:0045454 (100%),cell redox homeostasis (100%),IPR000866 (100%);IPR013766 (100%);IPR036249 (100%),Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant (100%);Thioredoxin domain (100%);Thioredoxin-like superfamily (100%),,,,,,,,,,,
ALLLPPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (33%);4.6.1.1 (33%);6.1.1.5 (33%),Serine endopeptidases (33%);Adenylate cyclase (33%);Isoleucine--tRNA ligase (33%),GO:0016021 (77%);GO:0009507 (11%);GO:0005737 (2%),integral component of membrane (77%);chloroplast (11%);cytoplasm (2%),GO:0015297 (32%);GO:0042910 (32%);GO:0005524 (13%),antiporter activity (32%);xenobiotic transmembrane transporter activity (32%);ATP binding (13%),GO:0055085 (8%);GO:0006428 (4%);GO:0000160 (2%),transmembrane transport (8%);isoleucyl-tRNA aminoacylation (4%);phosphorelay signal transduction system (2%),IPR002528 (36%);IPR011993 (11%);IPR009057 (7%),Multi antimicrobial extrusion protein (36%);PH-like domain superfamily (11%);Homeobox-like domain superfamily (7%),,,,,,,,,,,
TDNPTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.9.2 (40%);2.1.3.3 (20%);3.2.1.- (20%),Pyruvate, water dikinase (40%);Ornithine carbamoyltransferase (20%);Glycosidases, i.e. enzymes hydrolyzing O- and S-glycosyl compounds (20%),GO:0016021 (31%);GO:0000221 (7%);GO:0005681 (5%),integral component of membrane (31%);vacuolar proton-transporting V-type ATPase, V1 domain (7%);spliceosomal complex (5%),GO:0003677 (10%);GO:0005524 (7%);GO:0016787 (7%),DNA binding (10%);ATP binding (7%);hydrolase activity (7%),GO:0006310 (10%);GO:0015074 (10%);GO:0000398 (5%),DNA recombination (10%);DNA integration (10%);mRNA splicing, via spliceosome (5%),IPR029063 (12%);IPR008258 (11%);IPR021459 (11%),S-adenosyl-L-methionine-dependent methyltransferase (12%);Transglycosylase SLT domain 1 (11%);Glycosyl hydrolases related to GH101 family, GHL1-GHL3 (11%),,,,,,
YMDHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (38%);1.9.3.1 (25%);3.1.-.- (13%),Carboxylic ester hydrolases (38%);Cytochrome-c oxidase (25%);Acting on ester bonds (13%),GO:0016021 (31%);GO:0005634 (16%);GO:0005576 (11%),integral component of membrane (31%);nucleus (16%);extracellular region (11%),GO:0003677 (16%);GO:0046872 (13%);GO:0016491 (10%),DNA binding (16%);metal ion binding (13%);oxidoreductase activity (10%),GO:0006310 (15%);GO:0015074 (13%);GO:0071555 (11%),DNA recombination (15%);DNA integration (13%);cell wall organization (11%),IPR011010 (13%);IPR013762 (13%);IPR004367 (11%),DNA breaking-rejoining enzyme, catalytic core (13%);Integrase-like, catalytic domain superfamily (13%);Cyclin, C-terminal domain (11%),,,,,,,,
QVMYTSPDVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPAATSNGPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGVWQSNLTNVCFYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGEGTPATTAGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYLWHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.22 (100%),GTP 3',8-cyclase (100%),GO:0016021 (67%);GO:0019008 (17%),integral component of membrane (67%);molybdopterin synthase complex (17%),GO:0003964 (17%);GO:0005525 (17%);GO:0046872 (17%),RNA-directed DNA polymerase activity (17%);GTP binding (17%);metal ion binding (17%),GO:0006777 (17%),Mo-molybdopterin cofactor biosynthetic process (17%),IPR000477 (50%);IPR006638 (50%);IPR007197 (50%),Reverse transcriptase domain (50%);Elp3/MiaB/NifB (50%);Radical SAM (50%),,,,,,,,,,
VQTMTEK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003777 (100%);GO:0005524 (100%),microtubule motor activity (100%);ATP binding (100%),GO:0007018 (100%),microtubule-based movement (100%),IPR013594 (50%);IPR013602 (50%);IPR021942 (50%),Dynein heavy chain, domain-1 (50%);Dynein heavy chain, domain-2 (50%);Protein of unknown function DUF3557 (50%),,,,,,,,,
QVMVTLENANPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WMFAEGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WSHLQPMC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGNDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (11%);3.6.4.13 (10%);2.5.1.6 (7%),Acting on ATP; involved in cellular and subcellular movement (11%);RNA helicase (10%);Methionine adenosyltransferase (7%),GO:0016021 (14%);GO:0005737 (10%);GO:0005840 (5%),integral component of membrane (14%);cytoplasm (10%);ribosome (5%),GO:0003676 (17%);GO:0005524 (16%);GO:0003723 (15%),nucleic acid binding (17%);ATP binding (16%);RNA binding (15%),GO:0006412 (10%);GO:0006308 (4%);GO:0009405 (2%),translation (10%);DNA catabolic process (4%);pathogenesis (2%),IPR027417 (16%);IPR011049 (11%);IPR001343 (11%),P-loop containing nucleoside triphosphate hydrolase (16%);Serralysin-like metalloprotease, C-terminal (11%);RTX calcium-binding nonapeptide repeat (11%),,,,,,,,,,
AFLDMEGPHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FQLANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.133 (40%);2.3.1.193 (20%);4.1.1.36 (20%),dTDP-4-dehydrorhamnose reductase (40%);tRNA(Met) cytidine acetyltransferase (20%);Phosphopantothenoylcysteine decarboxylase (20%),GO:0016021 (40%);GO:0005886 (5%);GO:0000799 (2%),integral component of membrane (40%);plasma membrane (5%);nuclear condensin complex (2%),GO:0005524 (30%);GO:0043565 (19%);GO:0008134 (18%),ATP binding (30%);sequence-specific DNA binding (19%);transcription factor binding (18%),GO:0055085 (25%);GO:0006355 (18%);GO:0000160 (7%),transmembrane transport (25%);regulation of transcription, DNA-templated (18%);phosphorelay signal transduction system (7%),IPR009057 (24%);IPR027417 (24%);IPR032688 (20%),Homeobox-like domain superfamily (24%);P-loop containing nucleoside triphosphate hydrolase (24%);ABC-2 family transporter protein (20%),,,,,,,,,,
HDEHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.108 (21%);2.5.1.10 (14%);2.5.1.29 (14%),Ectoine synthase (21%);(2E,6E)-farnesyl diphosphate synthase (14%);Geranylgeranyl diphosphate synthase (14%),GO:0016021 (40%);GO:0005737 (2%);GO:0005886 (2%),integral component of membrane (40%);cytoplasm (2%);plasma membrane (2%),GO:0005524 (10%);GO:0016740 (7%);GO:0003676 (6%),ATP binding (10%);transferase activity (7%);nucleic acid binding (6%),GO:0008360 (12%);GO:0006541 (7%);GO:0008299 (6%),regulation of cell shape (12%);glutamine metabolic process (7%);isoprenoid biosynthetic process (6%),IPR007221 (10%);IPR042175 (10%);IPR042177 (10%),Rod shape-determining protein MreC (10%);Cell/Rod shape-determining protein MreC, domain 2 (10%);Cell/Rod shape-determining protein MreC, domain 1 (10%),,,,,,,,
MEVGHVGMHMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APLANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (79%);2.3.2.31 (9%);4.2.1.17 (6%),Signal peptidase I (79%);RBR-type E3 ubiquitin transferase (9%);Enoyl-CoA hydratase (6%),GO:0016021 (35%);GO:0000786 (1%);GO:0005634 (1%),integral component of membrane (35%);nucleosome (1%);nucleus (1%),GO:0008236 (22%);GO:0046872 (20%);GO:0016740 (17%),serine-type peptidase activity (22%);metal ion binding (20%);transferase activity (17%),GO:0005978 (10%);GO:0005980 (10%);GO:0000398 (1%),glycogen biosynthetic process (10%);glycogen catabolic process (10%);mRNA splicing, via spliceosome (1%),IPR038763 (24%);IPR000223 (18%);IPR015927 (18%),DHH phosphoesterase superfamily (24%);Peptidase S26A, signal peptidase I (18%);Peptidase S24/S26A/S26B/S26C (18%),,,,,,,,,
HMYQMVDPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAWEAVEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WFQGMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPYPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.62 (33%);2.7.1.23 (33%);3.6.1.15 (33%),Adenosylmethionine--8-amino-7-oxononanoate transaminase (33%);NAD(+) kinase (33%);Nucleoside-triphosphate phosphatase (33%),GO:0016021 (30%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (30%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (35%);GO:0003723 (23%);GO:0004672 (23%),ATP binding (35%);RNA binding (23%);protein kinase activity (23%),GO:0043048 (20%);GO:0005975 (3%);GO:0006741 (3%),dolichyl monophosphate biosynthetic process (20%);carbohydrate metabolic process (3%);NADP biosynthetic process (3%),IPR011009 (30%);IPR000719 (28%);IPR008271 (28%),Protein kinase-like domain superfamily (30%);Protein kinase domain (28%);Serine/threonine-protein kinase, active site (28%),,,,,,,,,,
MTDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.198 (17%);4.2.1.49 (5%);3.1.11.6 (3%),16S rRNA (cytidine(1402)-2'-O)-methyltransferase (17%);Urocanate hydratase (5%);Exodeoxyribonuclease VII (3%),GO:0016021 (26%);GO:0005737 (17%);GO:0005886 (4%),integral component of membrane (26%);cytoplasm (17%);plasma membrane (4%),GO:0005524 (11%);GO:0003677 (7%);GO:0046872 (7%),ATP binding (11%);DNA binding (7%);metal ion binding (7%),GO:0055085 (4%);GO:0000453 (4%);GO:0006412 (3%),transmembrane transport (4%);enzyme-directed rRNA 2'-O-methylation (4%);translation (3%),IPR027417 (10%);IPR009000 (5%);IPR036291 (4%),P-loop containing nucleoside triphosphate hydrolase (10%);Translation protein, beta-barrel domain superfamily (5%);NAD(P)-binding domain superfamily (4%),,,,,,,,,,
WLAEGLVLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAQEWN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYEMFELVDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGTLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.3.2 (69%);3.1.4.4 (9%);2.7.1.107 (6%),Transferred entry: 7.2.2.14 (69%);Phospholipase D (9%);Diacylglycerol kinase (ATP) (6%),GO:0016021 (12%);GO:0005886 (7%);GO:0005634 (1%),integral component of membrane (12%);plasma membrane (7%);nucleus (1%),GO:0046872 (75%);GO:0005085 (73%);GO:0000166 (10%),metal ion binding (75%);guanyl-nucleotide exchange factor activity (73%);nucleotide binding (10%),GO:0043087 (14%);GO:0000184 (3%);GO:0035556 (1%),regulation of GTPase activity (14%);nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (3%);intracellular signal transduction (1%),IPR011993 (80%);IPR001849 (79%);IPR035899 (75%),PH-like domain superfamily (80%);Pleckstrin homology domain (79%);Dbl homology (DH) domain superfamily (75%),,,,,,,,,,
QNNHVALEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGGQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.2 (57%);1.3.1.89 (29%);2.7.11.- (14%),CTP synthase (glutamine hydrolyzing) (57%);tRNA-dihydrouridine(47) synthase (NAD(P)(+)) (29%);Protein-serine/threonine kinases (14%),GO:0016021 (26%);GO:0005634 (13%);GO:0005886 (6%),integral component of membrane (26%);nucleus (13%);plasma membrane (6%),GO:0005524 (26%);GO:0046872 (19%);GO:0003677 (13%),ATP binding (26%);metal ion binding (19%);DNA binding (13%),GO:0006351 (13%);GO:0006541 (13%);GO:0044210 (13%),transcription, DNA-templated (13%);glutamine metabolic process (13%);'de novo' CTP biosynthetic process (13%),IPR004993 (60%);IPR027417 (9%);IPR004468 (5%),GH3 family (60%);P-loop containing nucleoside triphosphate hydrolase (9%);CTP synthase (5%),,,,,,,,,,
QAWDTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.43 (40%);2.7.7.7 (27%);4.1.2.48 (27%),Lipid IV(A) 4-amino-4-deoxy-L-arabinosyltransferase (40%);DNA-directed DNA polymerase (27%);Low-specificity L-threonine aldolase (27%),GO:0016021 (34%);GO:0005886 (21%);GO:0005737 (14%),integral component of membrane (34%);plasma membrane (21%);cytoplasm (14%),GO:0003824 (24%);GO:0103015 (21%);GO:0000030 (17%),catalytic activity (24%);4-amino-4-deoxy-L-arabinose transferase activity (21%);mannosyltransferase activity (17%),GO:0009103 (21%);GO:0009245 (21%);GO:0006493 (17%),lipopolysaccharide biosynthetic process (21%);lipid A biosynthetic process (21%);protein O-linked glycosylation (17%),IPR036249 (21%);IPR004879 (18%);IPR008928 (18%),Thioredoxin-like superfamily (21%);Domain of unknown function DUF255 (18%);Six-hairpin glycosidase superfamily (18%),,,,,,,,,,,
QVLLSLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR007110 (50%);IPR013098 (50%);IPR013783 (50%),Immunoglobulin-like domain (50%);Immunoglobulin I-set (50%);Immunoglobulin-like fold (50%),,,,,,,,,,,
LMHPEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.130 (33%);3.1.3.16 (33%);7.-.-.- (33%),Tetraacyldisaccharide 4'-kinase (33%);Protein-serine/threonine phosphatase (33%);Translocases (33%),GO:0016021 (50%);GO:0005840 (3%);GO:0005886 (3%),integral component of membrane (50%);ribosome (3%);plasma membrane (3%),GO:0046872 (41%);GO:0003824 (38%);GO:0003676 (6%),metal ion binding (41%);catalytic activity (38%);nucleic acid binding (6%),GO:0005975 (6%);GO:0017004 (6%);GO:0055085 (6%),carbohydrate metabolic process (6%);cytochrome complex assembly (6%);transmembrane transport (6%),IPR007863 (35%);IPR011249 (35%);IPR011765 (35%),Peptidase M16, C-terminal (35%);Metalloenzyme, LuxS/M16 peptidase-like (35%);Peptidase M16, N-terminal (35%),,,,,,,,
WNNGNMLGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGTQQSDVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDDNAPLETVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDFNNMAQALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLASLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.46 (35%);3.6.3.- (10%);4.2.1.2 (10%),6-aminohexanoate-oligomer exohydrolase (35%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (10%);Fumarate hydratase (10%),GO:0016021 (24%);GO:0005737 (2%);GO:0009507 (1%),integral component of membrane (24%);cytoplasm (2%);chloroplast (1%),GO:0005524 (26%);GO:0016887 (18%);GO:0003677 (9%),ATP binding (26%);ATPase activity (18%);DNA binding (9%),GO:0015833 (14%);GO:0006915 (10%);GO:0009253 (7%),peptide transport (14%);apoptotic process (10%);peptidoglycan catabolic process (7%),IPR027417 (21%);IPR003593 (15%);IPR003439 (15%),P-loop containing nucleoside triphosphate hydrolase (21%);AAA+ ATPase domain (15%);ABC transporter-like (15%),,,,,,,,,,,
AKPYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.5.2 (16%);2.8.1.7 (14%);1.2.1.44 (9%),L-cysteine S-thiosulfotransferase (16%);Cysteine desulfurase (14%);Cinnamoyl-CoA reductase (9%),GO:0016021 (14%);GO:0005886 (4%);GO:0015934 (2%),integral component of membrane (14%);plasma membrane (4%);large ribosomal subunit (2%),GO:0003677 (13%);GO:0046872 (11%);GO:0050662 (11%),DNA binding (13%);metal ion binding (11%);coenzyme binding (11%),GO:0015074 (11%);GO:0006310 (10%);GO:0006596 (10%),DNA integration (11%);DNA recombination (10%);polyamine biosynthetic process (10%),IPR036291 (14%);IPR036526 (12%);IPR003010 (12%),NAD(P)-binding domain superfamily (14%);Carbon-nitrogen hydrolase superfamily (12%);Carbon-nitrogen hydrolase (12%),,,,,,,,,,,
VMLDMMDNPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVHMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.9 (33%);2.7.13.3 (27%);3.4.11.- (11%),Glucose-6-phosphate isomerase (33%);Histidine kinase (27%);Aminopeptidases (11%),GO:0000151 (13%);GO:0016021 (13%);GO:0005737 (4%),ubiquitin ligase complex (13%);integral component of membrane (13%);cytoplasm (4%),GO:0003676 (35%);GO:0005524 (34%);GO:0030983 (30%),nucleic acid binding (35%);ATP binding (34%);mismatched DNA binding (30%),GO:0006298 (30%);GO:0006511 (13%);GO:0007286 (3%),mismatch repair (30%);ubiquitin-dependent protein catabolic process (13%);spermatid development (3%),IPR013087 (36%);IPR036236 (35%);IPR027417 (30%),Zinc finger C2H2-type (36%);Zinc finger C2H2 superfamily (35%);P-loop containing nucleoside triphosphate hydrolase (30%),,,,,,,,,,,
TEGLMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.7 (47%);2.6.1.52 (13%);6.1.1.3 (13%),1-deoxy-D-xylulose-5-phosphate synthase (47%);Phosphoserine transaminase (13%);Threonine--tRNA ligase (13%),GO:0016021 (34%);GO:0005737 (8%);GO:0005886 (4%),integral component of membrane (34%);cytoplasm (8%);plasma membrane (4%),GO:0000287 (13%);GO:0008661 (13%);GO:0030976 (13%),magnesium ion binding (13%);1-deoxy-D-xylulose-5-phosphate synthase activity (13%);thiamine pyrophosphate binding (13%),GO:0009228 (13%);GO:0016114 (13%);GO:0052865 (13%),thiamine biosynthetic process (13%);terpenoid biosynthetic process (13%);1-deoxy-D-xylulose 5-phosphate biosynthetic process (13%),IPR007296 (13%);IPR025841 (13%);IPR005122 (8%),Domain of unknown function DUF403 (13%);Circularly permuted ATP-grasp type 2 (13%);Uracil-DNA glycosylase-like (8%),,,,,,,,,,,
MACVHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.57 (100%),Aromatic-amino-acid transaminase (100%),GO:0005576 (11%);GO:0005887 (11%),extracellular region (11%);integral component of plasma membrane (11%),GO:0048037 (33%);GO:0003779 (11%);GO:0004713 (11%),cofactor binding (33%);actin binding (11%);protein tyrosine kinase activity (11%),GO:0007155 (11%);GO:0031532 (11%),cell adhesion (11%);actin cytoskeleton reorganization (11%),IPR007386 (27%);IPR012349 (27%);IPR001007 (18%),Protein of unknown function DUF447 (27%);FMN-binding split barrel (27%);VWFC domain (18%),,,,,,,,,,,
TSSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.- (57%);2.6.1.42 (3%);2.7.4.1 (3%),Exoribonucleases producing 5'-phosphomonoesters (57%);Branched-chain-amino-acid transaminase (3%);Polyphosphate kinase (3%),GO:0016021 (21%);GO:0019013 (14%);GO:0030430 (13%),integral component of membrane (21%);viral nucleocapsid (14%);host cell cytoplasm (13%),GO:0046872 (18%);GO:0005524 (15%);GO:0003723 (14%),metal ion binding (18%);ATP binding (15%);RNA binding (14%),GO:0039689 (12%);GO:0039696 (12%);GO:0039724 (12%),negative stranded viral RNA replication (12%);RNA-templated viral transcription (12%);suppression by virus of host IKBKE activity (12%),IPR010393 (17%);IPR029068 (17%);IPR035083 (9%),Protein of unknown function DUF991 (17%);Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase (17%);Nucleocapsid, N-terminal, Arenaviridae (9%),,,,,,,,,
VVLHLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWEVAQLK,Haemonchus placei,Eukaryota,Metazoa,,,Nematoda,,,Chromadorea,,,,Strongylida,,,,Trichostrongyloidea,Haemonchidae,,,,Haemonchus,,,,Haemonchus placei,,,,,,,,,,,,IPR019311 (100%),Protein of unknown function DUF2362 (100%),,,,,,,,,,,
MYMFNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009366 (30%);GO:0016021 (30%);GO:0005739 (10%),enterobactin synthetase complex (30%);integral component of membrane (30%);mitochondrion (10%),GO:0000287 (30%);GO:0008897 (30%);GO:0003700 (20%),magnesium ion binding (30%);holo-[acyl-carrier-protein] synthase activity (30%);DNA-binding transcription factor activity (20%),GO:0009239 (30%);GO:0005975 (10%),enterobactin biosynthetic process (30%);carbohydrate metabolic process (10%),IPR003542 (30%);IPR008278 (30%);IPR037143 (30%),Enterobactin synthetase-like, component D (30%);4'-phosphopantetheinyl transferase domain (30%);4'-phosphopantetheinyl transferase domain superfamily (30%),,,,,,,,,,
MPWMDFLLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.3 (9%);2.8.2.- (3%);3.1.-.- (3%),Threonine--tRNA ligase (9%);Sulfotransferases (3%);Acting on ester bonds (3%),GO:0016021 (23%);GO:0005737 (7%);GO:0005886 (4%),integral component of membrane (23%);cytoplasm (7%);plasma membrane (4%),GO:0005524 (18%);GO:0003677 (14%);GO:0046872 (7%),ATP binding (18%);DNA binding (14%);metal ion binding (7%),GO:0033567 (5%);GO:0006281 (4%);GO:0005975 (3%),DNA replication, Okazaki fragment processing (5%);DNA repair (4%);carbohydrate metabolic process (3%),IPR027417 (13%);IPR029060 (4%);IPR002421 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);PIN-like domain superfamily (4%);5'-3' exonuclease, N-terminal (4%),,,,,,,,,
ACGDAAAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.9.6.1 (20%);3.4.21.- (7%);2.7.-.- (3%),Nitrate reductase (cytochrome) (20%);Serine endopeptidases (7%);Transferring phosphorus-containing groups (3%),GO:0016021 (42%);GO:0005886 (4%);GO:0005737 (3%),integral component of membrane (42%);plasma membrane (4%);cytoplasm (3%),GO:0016772 (13%);GO:0008484 (13%);GO:0005524 (9%),transferase activity, transferring phosphorus-containing groups (13%);sulfuric ester hydrolase activity (13%);ATP binding (9%),GO:0042128 (3%);GO:0006777 (3%);GO:0015031 (3%),nitrate assimilation (3%);Mo-molybdopterin cofactor biosynthetic process (3%);protein transport (3%),IPR017850 (11%);IPR040423 (11%);IPR000917 (11%),Alkaline-phosphatase-like, core domain superfamily (11%);Phosphoethanolamine transferase (11%);Sulfatase, N-terminal (11%),,,,,,,,
NVSCYMMLPPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DFLDLTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLMYAGLMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAHHMFPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSWLKPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.2 (100%),5-formyltetrahydrofolate cyclo-ligase (100%),GO:0016021 (40%),integral component of membrane (40%),GO:0005524 (60%);GO:0000155 (40%);GO:0030170 (40%),ATP binding (60%);phosphorelay sensor kinase activity (40%);pyridoxal phosphate binding (40%),GO:0009058 (40%),biosynthetic process (40%),IPR003594 (40%);IPR003661 (40%);IPR004358 (40%),Histidine kinase/HSP90-like ATPase (40%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (40%);Signal transduction histidine kinase-related protein, C-terminal (40%),,,,,,,,,
NVVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.- (41%);2.1.1.193 (6%);4.1.1.33 (5%),Acting on amino acids and derivatives (41%);16S rRNA (uracil(1498)-N(3))-methyltransferase (6%);Diphosphomevalonate decarboxylase (5%),GO:0016021 (22%);GO:0005737 (10%);GO:0005886 (5%),integral component of membrane (22%);cytoplasm (10%);plasma membrane (5%),GO:0046872 (13%);GO:0016855 (9%);GO:0016491 (8%),metal ion binding (13%);racemase and epimerase activity, acting on amino acids and derivatives (9%);oxidoreductase activity (8%),GO:0032259 (3%);GO:0055085 (3%);GO:0006355 (2%),methylation (3%);transmembrane transport (3%);regulation of transcription, DNA-templated (2%),IPR036291 (9%);IPR027417 (7%);IPR013341 (7%),NAD(P)-binding domain superfamily (9%);P-loop containing nucleoside triphosphate hydrolase (7%);Mandelate racemase/muconate lactonizing enzyme, N-terminal domain (7%),,,,,,,,
MESLGPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%);GO:0030015 (33%),integral component of membrane (33%);CCR4-NOT core complex (33%),GO:0003677 (33%);GO:0004674 (33%);GO:0005524 (33%),DNA binding (33%);protein serine/threonine kinase activity (33%);ATP binding (33%),GO:0006417 (33%),regulation of translation (33%),IPR001387 (50%);IPR010982 (50%);IPR000719 (25%),Cro/C1-type helix-turn-helix domain (50%);Lambda repressor-like, DNA-binding domain superfamily (50%);Protein kinase domain (25%),,,,,,,,,,
WCELPK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0016740 (50%);GO:0016846 (50%),transferase activity (50%);carbon-sulfur lyase activity (50%),,,IPR004681 (33%);IPR006913 (33%);IPR010656 (33%),TRAP transporter large membrane protein DctM (33%);Glutathione-dependent formaldehyde-activating enzyme/centromere protein V (33%);TRAP C4-dicarboxylate transport system permease DctM subunit (33%),,,,,,,,,,,
TESLGPHHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFEVPLLGEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEEDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.3 (65%);3.6.4.12 (4%);3.1.-.- (4%),Phosphoglycerate kinase (65%);DNA helicase (4%);Acting on ester bonds (4%),GO:0005737 (28%);GO:0016021 (21%);GO:0005634 (6%),cytoplasm (28%);integral component of membrane (21%);nucleus (6%),GO:0005524 (40%);GO:0004618 (23%);GO:0003677 (10%),ATP binding (40%);phosphoglycerate kinase activity (23%);DNA binding (10%),GO:0006096 (23%);GO:0006355 (4%);GO:0006605 (2%),glycolytic process (23%);regulation of transcription, DNA-templated (4%);protein targeting (2%),IPR001576 (19%);IPR015824 (19%);IPR036043 (19%),Phosphoglycerate kinase (19%);Phosphoglycerate kinase, N-terminal (19%);Phosphoglycerate kinase superfamily (19%),,,,,,,,,
MLFDYSPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMLTHTK,Pseudocrenilabrinae,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,Cichlomorphae,Cichliformes,,,,,Cichlidae,Pseudocrenilabrinae,,,,,,,,,,,,,GO:0016021 (60%);GO:0016020 (40%),integral component of membrane (60%);membrane (40%),GO:0004896 (100%),cytokine receptor activity (100%),,,IPR003531 (100%);IPR003961 (100%);IPR013783 (100%),Short hematopoietin receptor, family 1, conserved site (100%);Fibronectin type III (100%);Immunoglobulin-like fold (100%),,,,,,,,,
WGQGYCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAHLVM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HFAANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.27 (46%);2.7.4.22 (31%);2.6.1.- (15%),tRNA pseudouridine(13) synthase (46%);UMP kinase (31%);Transaminases (15%),GO:0016021 (14%);GO:0005737 (11%);GO:0005886 (6%),integral component of membrane (14%);cytoplasm (11%);plasma membrane (6%),GO:0003723 (25%);GO:0106029 (17%);GO:0004144 (11%),RNA binding (25%);tRNA pseudouridine synthase activity (17%);diacylglycerol O-acyltransferase activity (11%),GO:0031119 (17%);GO:0044210 (11%);GO:0045017 (11%),tRNA pseudouridine synthesis (17%);'de novo' CTP biosynthetic process (11%);glycerolipid biosynthetic process (11%),IPR001656 (16%);IPR011760 (16%);IPR020103 (16%),Pseudouridine synthase, TruD (16%);Pseudouridine synthase, TruD, insertion domain (16%);Pseudouridine synthase, catalytic domain superfamily (16%),,,,,,,
TLMLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.55 (25%);2.3.1.1 (13%);2.3.1.35 (13%),3-deoxy-8-phosphooctulonate synthase (25%);Amino-acid N-acetyltransferase (13%);Glutamate N-acetyltransferase (13%),GO:0016021 (56%);GO:0005886 (37%);GO:0008540 (3%),integral component of membrane (56%);plasma membrane (37%);proteasome regulatory particle, base subcomplex (3%),GO:0003677 (21%);GO:0003700 (14%);GO:0005524 (6%),DNA binding (21%);DNA-binding transcription factor activity (14%);ATP binding (6%),GO:0055085 (36%);GO:0042176 (4%);GO:0006310 (2%),transmembrane transport (36%);regulation of protein catabolic process (4%);DNA recombination (2%),IPR000515 (25%);IPR035906 (25%);IPR000477 (21%),ABC transporter type 1, transmembrane domain MetI-like (25%);MetI-like superfamily (25%);Reverse transcriptase domain (21%),,,,,,,,,
WAELMYYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DELMLVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WWMHMTLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLDSPQGR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,2.3.1.47 (100%),8-amino-7-oxononanoate synthase (100%),,,GO:0008710 (100%);GO:0030170 (100%),8-amino-7-oxononanoate synthase activity (100%);pyridoxal phosphate binding (100%),GO:0009102 (100%),biotin biosynthetic process (100%),IPR001917 (100%);IPR004723 (100%);IPR004839 (100%),Aminotransferase, class-II, pyridoxal-phosphate binding site (100%);8-amino-7-oxononanoate synthase,  Archaea/Proteobacteria type (100%);Aminotransferase, class I/classII (100%),,,,,,,
SPLSHLVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WELWMMSLLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTWDNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.17 (8%);2.1.1.182 (7%);3.5.4.- (5%),Glutamate--tRNA ligase (8%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (7%);In cyclic amidines (5%),GO:0016021 (35%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (35%);cytoplasm (5%);plasma membrane (3%),GO:0003677 (9%);GO:0005524 (9%);GO:0003700 (4%),DNA binding (9%);ATP binding (9%);DNA-binding transcription factor activity (4%),GO:0006289 (3%);GO:0009411 (2%);GO:0055085 (2%),nucleotide-excision repair (3%);response to UV (2%);transmembrane transport (2%),IPR003695 (8%);IPR036465 (7%);IPR006175 (5%),Ppx/GppA phosphatase (8%);von Willebrand factor A-like domain superfamily (7%);YjgF/YER057c/UK114 family (5%),,,,,,,,,,,
MGMLLGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWMVSHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVSQGSHFEVGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLHQWMK,Talaromyces stipitatus,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Eurotiomycetes,Eurotiomycetidae,,,Eurotiales,,,,,Trichocomaceae,,,,Talaromyces,,,,Talaromyces stipitatus,,,,,,,,,,,,,,,,,,,,,,,,
SPPSAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.19.12 (77%);2.7.7.7 (16%);6.1.1.7 (2%),Ubiquitinyl hydrolase 1 (77%);DNA-directed DNA polymerase (16%);Alanine--tRNA ligase (2%),GO:0016021 (58%);GO:0005741 (14%);GO:0000784 (8%),integral component of membrane (58%);mitochondrial outer membrane (14%);nuclear chromosome, telomeric region (8%),GO:0036459 (42%);GO:0004197 (16%);GO:0004843 (16%),thiol-dependent ubiquitinyl hydrolase activity (42%);cysteine-type endopeptidase activity (16%);thiol-dependent ubiquitin-specific protease activity (16%),GO:0006511 (55%);GO:0016579 (45%);GO:0000422 (14%),ubiquitin-dependent protein catabolic process (55%);protein deubiquitination (45%);autophagy of mitochondrion (14%),IPR001394 (51%);IPR018200 (51%);IPR028889 (51%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (51%);Ubiquitin specific protease, conserved site (51%);Ubiquitin specific protease domain (51%),,,,,,,,
MVATENQMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HDDPGNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMQQSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CWGPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.1 (92%);3.6.4.12 (8%),Receptor protein-tyrosine kinase (92%);DNA helicase (8%),GO:0016021 (78%);GO:0005887 (4%);GO:0009925 (4%),integral component of membrane (78%);integral component of plasma membrane (4%);basal plasma membrane (4%),GO:0005524 (90%);GO:0004714 (82%);GO:0003677 (8%),ATP binding (90%);transmembrane receptor protein tyrosine kinase activity (82%);DNA binding (8%),GO:0007169 (82%);GO:0007275 (4%);GO:0008284 (4%),transmembrane receptor protein tyrosine kinase signaling pathway (82%);multicellular organism development (4%);positive regulation of cell population proliferation (4%),IPR006211 (76%);IPR009030 (76%);IPR036941 (76%),Furin-like cysteine-rich domain (76%);Growth factor receptor cysteine-rich domain superfamily (76%);Receptor L-domain superfamily (76%),,,,,,,,,,,
HTSSCMVELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNNDVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (67%);3.2.1.31 (33%),Beta-galactosidase (67%);Beta-glucuronidase (33%),GO:0030130 (6%);GO:0030132 (6%);GO:0071439 (6%),clathrin coat of trans-Golgi network vesicle (6%);clathrin coat of coated pit (6%);clathrin complex (6%),GO:0004553 (69%);GO:0004565 (13%);GO:0003839 (6%),hydrolase activity, hydrolyzing O-glycosyl compounds (69%);beta-galactosidase activity (13%);gamma-glutamylcyclotransferase activity (6%),GO:0005975 (88%);GO:0006886 (6%);GO:0016192 (6%),carbohydrate metabolic process (88%);intracellular protein transport (6%);vesicle-mediated transport (6%),IPR006102 (78%);IPR006103 (78%);IPR013783 (78%),Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich (78%);Glycoside hydrolase family 2, catalytic domain (78%);Immunoglobulin-like fold (78%),,,,,,,
NSLLMMLSGPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTHLFADM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WSQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (40%);1.17.1.4 (20%);2.1.1.37 (20%),Signal peptidase I (40%);Xanthine dehydrogenase (20%);DNA (cytosine-5-)-methyltransferase (20%),GO:0016021 (61%);GO:0005634 (2%);GO:0005737 (1%),integral component of membrane (61%);nucleus (2%);cytoplasm (1%),GO:0022857 (30%);GO:0016491 (8%);GO:0003723 (4%),transmembrane transporter activity (30%);oxidoreductase activity (8%);RNA binding (4%),GO:0008643 (6%);GO:0006081 (4%);GO:0000398 (4%),carbohydrate transport (6%);cellular aldehyde metabolic process (4%);mRNA splicing, via spliceosome (4%),IPR036259 (30%);IPR005828 (28%);IPR003663 (28%),MFS transporter superfamily (30%);Major facilitator,  sugar transporter-like (28%);Sugar/inositol transporter (28%),,,,,,,,,
MEEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.21 (9%);2.7.4.24 (9%);5.4.99.- (7%),Inositol-hexakisphosphate kinase (9%);Diphosphoinositol-pentakisphosphate kinase (9%);Transferring other groups (7%),GO:0016021 (28%);GO:0005737 (8%);GO:0005634 (5%),integral component of membrane (28%);cytoplasm (8%);nucleus (5%),GO:0005524 (14%);GO:0003677 (11%);GO:0046872 (9%),ATP binding (14%);DNA binding (11%);metal ion binding (9%),GO:0006355 (7%);GO:0000160 (4%);GO:0016226 (3%),regulation of transcription, DNA-templated (7%);phosphorelay signal transduction system (4%);iron-sulfur cluster assembly (3%),IPR027417 (7%);IPR036388 (6%);IPR001789 (3%),P-loop containing nucleoside triphosphate hydrolase (7%);Winged helix-like DNA-binding domain superfamily (6%);Signal transduction response regulator, receiver domain (3%),,,,,,,,,
NYYFAAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVTALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.5.5 (17%);2.10.1.1 (17%);3.4.16.- (17%),NADPH:quinone reductase (17%);Molybdopterin molybdotransferase (17%);Serine-type carboxypeptidases (17%),GO:0016021 (27%);GO:0005887 (6%);GO:0005737 (3%),integral component of membrane (27%);integral component of plasma membrane (6%);cytoplasm (3%),GO:0003824 (18%);GO:0016874 (9%);GO:0015604 (6%),catalytic activity (18%);ligase activity (9%);organic phosphonate transmembrane transporter activity (6%),GO:0008610 (4%);GO:0009190 (4%);GO:0035556 (4%),lipid biosynthetic process (4%);cyclic nucleotide biosynthetic process (4%);intracellular signal transduction (4%),IPR000873 (19%);IPR042099 (19%);IPR025110 (15%),AMP-dependent synthetase/ligase (19%);AMP-dependent synthetase-like superfamily (19%);AMP-binding enzyme, C-terminal domain (15%),,,,,,,,,,
CNPWYSDGPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.69 (29%);1.4.3.16 (10%);5.4.4.2 (10%),Gluconate 5-dehydrogenase (29%);L-aspartate oxidase (10%);Isochorismate synthase (10%),GO:0016021 (19%);GO:0005737 (5%);GO:0009295 (4%),integral component of membrane (19%);cytoplasm (5%);nucleoid (4%),GO:0003824 (13%);GO:0003677 (10%);GO:0003700 (8%),catalytic activity (13%);DNA binding (10%);DNA-binding transcription factor activity (8%),GO:0055085 (2%);GO:0009058 (2%);GO:0006306 (1%),transmembrane transport (2%);biosynthetic process (2%);DNA methylation (1%),IPR000873 (15%);IPR042099 (15%);IPR025110 (15%),AMP-dependent synthetase/ligase (15%);AMP-dependent synthetase-like superfamily (15%);AMP-binding enzyme, C-terminal domain (15%),,,,,,,,,,
NVTMWLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMWWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (82%);GO:0005886 (36%),integral component of membrane (82%);plasma membrane (36%),GO:0005525 (36%);GO:0015093 (36%);GO:0046914 (36%),GTP binding (36%);ferrous iron transmembrane transporter activity (36%);transition metal ion binding (36%),GO:0016192 (36%);GO:0055072 (36%);GO:0006281 (9%),vesicle-mediated transport (36%);iron ion homeostasis (36%);DNA repair (9%),IPR001388 (36%);IPR010908 (36%);IPR011012 (36%),Synaptobrevin (36%);Longin domain (36%);Longin-like domain superfamily (36%),,,,,,,,,,,
QNWATMDLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QEEPPDPER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LECTFAETASHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLPNPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (72%);1.10.9.1 (6%);1.4.4.2 (6%),Acting on ATP; involved in cellular and subcellular movement (72%);Transferred entry: 7.1.1.6 (6%);Glycine dehydrogenase (aminomethyl-transferring) (6%),GO:0005737 (26%);GO:0016021 (12%);GO:0005739 (4%),cytoplasm (26%);integral component of membrane (12%);mitochondrion (4%),GO:0005524 (46%);GO:0016787 (16%);GO:0003684 (15%),ATP binding (46%);hydrolase activity (16%);damaged DNA binding (15%),GO:0000716 (15%);GO:0006355 (15%);GO:0006099 (4%),transcription-coupled nucleotide-excision repair, DNA damage recognition (15%);regulation of transcription, DNA-templated (15%);tricarboxylic acid cycle (4%),IPR027417 (27%);IPR005479 (22%);IPR005481 (22%),P-loop containing nucleoside triphosphate hydrolase (27%);Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain (22%);Biotin carboxylase-like, N-terminal domain (22%),,,,,,,
NHHNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.18 (53%);3.6.4.- (13%);3.2.1.35 (5%),1,4-alpha-glucan branching enzyme (53%);Acting on ATP; involved in cellular and subcellular movement (13%);Hyaluronoglucosaminidase (5%),GO:0016021 (33%);GO:0005634 (3%);GO:0005886 (3%),integral component of membrane (33%);nucleus (3%);plasma membrane (3%),GO:0005524 (13%);GO:0003844 (12%);GO:0004553 (12%),ATP binding (13%);1,4-alpha-glucan branching enzyme activity (12%);hydrolase activity, hydrolyzing O-glycosyl compounds (12%),GO:0005978 (12%);GO:0007291 (4%);GO:0007591 (4%),glycogen biosynthetic process (12%);sperm individualization (4%);molting cycle, chitin-based cuticle (4%),IPR017853 (13%);IPR004193 (11%);IPR006047 (11%),Glycoside hydrolase superfamily (13%);Glycoside hydrolase, family 13, N-terminal (11%);Glycosyl hydrolase, family 13, catalytic domain (11%),,,
AHALFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.1 (81%);3.1.13.1 (4%);6.3.4.2 (3%),Triose-phosphate isomerase (81%);Exoribonuclease II (4%);CTP synthase (glutamine hydrolyzing) (3%),GO:0005737 (59%);GO:0005886 (15%);GO:0016021 (8%),cytoplasm (59%);plasma membrane (15%);integral component of membrane (8%),GO:0004807 (41%);GO:0005524 (24%);GO:0046872 (14%),triose-phosphate isomerase activity (41%);ATP binding (24%);metal ion binding (14%),GO:0006094 (41%);GO:0006096 (41%);GO:0006605 (17%),gluconeogenesis (41%);glycolytic process (41%);protein targeting (17%),IPR013785 (36%);IPR000652 (36%);IPR020861 (36%),Aldolase-type TIM barrel (36%);Triosephosphate isomerase (36%);Triosephosphate isomerase, active site (36%),,,,,,,,,,
QLEGYADHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFETER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (29%);5.6.2.2 (29%);2.1.1.228 (14%),3-isopropylmalate dehydratase (29%);DNA topoisomerase (ATP-hydrolyzing) (29%);tRNA (guanine(37)-N(1))-methyltransferase (14%),GO:0005858 (47%);GO:0016021 (28%);GO:0005930 (5%),axonemal dynein complex (47%);integral component of membrane (28%);axoneme (5%),GO:0004888 (7%);GO:0005524 (5%);GO:0003824 (4%),transmembrane signaling receptor activity (7%);ATP binding (5%);catalytic activity (4%),GO:0070286 (47%);GO:0003352 (20%);GO:0007165 (11%),axonemal dynein complex assembly (47%);regulation of cilium movement (20%);signal transduction (11%),IPR039750 (43%);IPR039505 (43%);IPR002881 (15%),Dynein regulatory complex protein (43%);Dynein regulatory complex protein 1/2, N-terminal (43%);Domain of unknown function DUF58 (15%),,,,,,,,,,
EVPLVVC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYNECNLLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLSHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.5.3 (21%);2.7.7.7 (9%);4.1.1.15 (6%),Glycerol-3-phosphate dehydrogenase (21%);DNA-directed DNA polymerase (9%);Glutamate decarboxylase (6%),GO:0016589 (32%);GO:0016021 (15%);GO:0005634 (7%),NURF complex (32%);integral component of membrane (15%);nucleus (7%),GO:0046872 (33%);GO:0003677 (22%);GO:0005524 (17%),metal ion binding (33%);DNA binding (22%);ATP binding (17%),GO:0006357 (31%);GO:0006355 (4%);GO:0015833 (3%),regulation of transcription by RNA polymerase II (31%);regulation of transcription, DNA-templated (4%);peptide transport (3%),IPR011011 (30%);IPR038028 (30%);IPR001965 (28%),Zinc finger, FYVE/PHD-type (30%);Nucleosome-remodeling factor subunit BPTF (30%);Zinc finger, PHD-type (28%),,,,,,,,
MGLSTPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016491 (100%);GO:0016740 (100%);GO:0031177 (100%),oxidoreductase activity (100%);transferase activity (100%);phosphopantetheine binding (100%),,,IPR001227 (100%);IPR006162 (100%);IPR009081 (100%),Acyl transferase domain superfamily (100%);Phosphopantetheine attachment site (100%);Phosphopantetheine binding ACP domain (100%),,,,,,,,,,,
DNGYNLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.169 (100%),2-dehydropantoate 2-reductase (100%),GO:0016021 (33%);GO:0005886 (17%),integral component of membrane (33%);plasma membrane (17%),GO:0008677 (58%);GO:0003824 (8%);GO:0004930 (8%),2-dehydropantoate 2-reductase activity (58%);catalytic activity (8%);G protein-coupled receptor activity (8%),GO:0015940 (58%);GO:0009291 (8%),pantothenate biosynthetic process (58%);unidirectional conjugation (8%),IPR003710 (64%);IPR008927 (64%);IPR013328 (64%),Ketopantoate reductase ApbA/PanE (64%);6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily (64%);6-phosphogluconate dehydrogenase, domain 2 (64%),,,,,,,,,
WMLMMVYVSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLLGVEGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.9 (28%);2.7.11.- (7%);3.1.4.1 (3%),Valine--tRNA ligase (28%);Protein-serine/threonine kinases (7%);Phosphodiesterase I (3%),GO:0016021 (25%);GO:0005737 (9%);GO:0005576 (4%),integral component of membrane (25%);cytoplasm (9%);extracellular region (4%),GO:0005524 (21%);GO:0003677 (7%);GO:0002161 (7%),ATP binding (21%);DNA binding (7%);aminoacyl-tRNA editing activity (7%),GO:0006438 (6%);GO:0071973 (4%);GO:0007155 (4%),valyl-tRNA aminoacylation (6%);bacterial-type flagellum-dependent cell motility (4%);cell adhesion (4%),IPR027417 (9%);IPR014729 (7%);IPR002300 (5%),P-loop containing nucleoside triphosphate hydrolase (9%);Rossmann-like alpha/beta/alpha sandwich fold (7%);Aminoacyl-tRNA synthetase, class Ia (5%),,,,,,,,,,
ALFTHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (20%);1.2.1.41 (10%);1.2.1.88 (10%),Methyltransferases (20%);Glutamate-5-semialdehyde dehydrogenase (10%);L-glutamate gamma-semialdehyde dehydrogenase (10%),GO:0016021 (32%);GO:0005737 (2%);GO:0005840 (1%),integral component of membrane (32%);cytoplasm (2%);ribosome (1%),GO:0004061 (32%);GO:0005524 (13%);GO:0046872 (9%),arylformamidase activity (32%);ATP binding (13%);metal ion binding (9%),GO:0019441 (32%);GO:0008202 (5%);GO:0009058 (2%),tryptophan catabolic process to kynurenine (32%);steroid metabolic process (5%);biosynthetic process (2%),IPR037175 (31%);IPR007325 (31%);IPR012427 (10%),Kynurenine formamidase superfamily (31%);Kynurenine formamidase/cyclase-like (31%);Protein of unknown function DUF1622 (10%),,,,,,,,,,,
VNESTVFHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLSVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.3 (21%);2.7.13.3 (11%);1.1.1.108 (5%),Thiamine phosphate synthase (21%);Histidine kinase (11%);Carnitine 3-dehydrogenase (5%),GO:0016021 (31%);GO:0005737 (3%);GO:0005886 (2%),integral component of membrane (31%);cytoplasm (3%);plasma membrane (2%),GO:0003677 (27%);GO:0003700 (21%);GO:0030170 (19%),DNA binding (27%);DNA-binding transcription factor activity (21%);pyridoxal phosphate binding (19%),GO:0009058 (19%);GO:0009228 (2%);GO:0009229 (2%),biosynthetic process (19%);thiamine biosynthetic process (2%);thiamine diphosphate biosynthetic process (2%),IPR036388 (23%);IPR036390 (21%);IPR000524 (19%),Winged helix-like DNA-binding domain superfamily (23%);Winged helix DNA-binding domain superfamily (21%);Transcription regulator HTH, GntR (19%),,,,,,,,,,
WSFFNGMHLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EVMVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.- (87%);2.7.13.3 (6%);3.1.26.3 (3%),Phosphotransferases with a carboxy group as acceptor (87%);Histidine kinase (6%);Ribonuclease III (3%),GO:0005887 (56%);GO:0016021 (4%);GO:0005737 (1%),integral component of plasma membrane (56%);integral component of membrane (4%);cytoplasm (1%),GO:0005524 (87%);GO:0016774 (56%);GO:0009927 (49%),ATP binding (87%);phosphotransferase activity, carboxyl group as acceptor (56%);histidine phosphotransfer kinase activity (49%),GO:0000160 (25%);GO:0006396 (23%);GO:0006351 (12%),phosphorelay signal transduction system (25%);RNA processing (23%);transcription, DNA-templated (12%),IPR036890 (58%);IPR003594 (57%);IPR005467 (57%),Histidine kinase/HSP90-like ATPase superfamily (58%);Histidine kinase/HSP90-like ATPase (57%);Histidine kinase domain (57%),,,,,,,,,
QNQWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.11.6 (40%);2.1.1.182 (15%);5.1.1.- (15%),Exodeoxyribonuclease VII (40%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (15%);Acting on amino acids and derivatives (15%),GO:0016021 (37%);GO:0005737 (7%);GO:0009318 (6%),integral component of membrane (37%);cytoplasm (7%);exodeoxyribonuclease VII complex (6%),GO:0016747 (23%);GO:0015562 (11%);GO:0005524 (10%),transferase activity, transferring acyl groups other than amino-acyl groups (23%);efflux transmembrane transporter activity (11%);ATP binding (10%),GO:0006308 (6%);GO:0006139 (3%);GO:0007018 (2%),DNA catabolic process (6%);nucleobase-containing compound metabolic process (3%);microtubule-based movement (2%),IPR002656 (20%);IPR003423 (9%);IPR027417 (8%),Acyltransferase 3 (20%);Outer membrane efflux protein (9%);P-loop containing nucleoside triphosphate hydrolase (8%),,,,,,,,,,
QTSLTMR,Bacillus,Bacteria,,,,Firmicutes,,,Bacilli,,,,Bacillales,,,,,Bacillaceae,,,,Bacillus,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),,,GO:0003677 (92%);GO:0005524 (92%);GO:0043139 (88%),DNA binding (92%);ATP binding (92%);5'-3' DNA helicase activity (88%),,,IPR006345 (100%);IPR027417 (100%);IPR027785 (100%),RecD-like DNA helicase (100%);P-loop containing nucleoside triphosphate hydrolase (100%);UvrD-like helicase C-terminal domain (100%),,,,,,,,,,,
MAAGAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.8 (40%);2.1.1.193 (20%);3.2.2.1 (20%),Betaine-aldehyde dehydrogenase (40%);16S rRNA (uracil(1498)-N(3))-methyltransferase (20%);Purine nucleosidase (20%),GO:0016020 (94%);GO:0016021 (2%);GO:0005737 (0%),membrane (94%);integral component of membrane (2%);cytoplasm (0%),GO:0015095 (94%);GO:0005524 (2%);GO:0008134 (2%),magnesium ion transmembrane transporter activity (94%);ATP binding (2%);transcription factor binding (2%),GO:0006355 (2%);GO:0008152 (1%);GO:0006313 (0%),regulation of transcription, DNA-templated (2%);metabolic process (1%);transposition, DNA-mediated (0%),IPR000644 (92%);IPR006668 (92%);IPR006669 (92%),CBS domain (92%);Magnesium transporter, MgtE intracellular domain (92%);Magnesium transporter MgtE (92%),,,,,,,,
WNAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.1 (56%);2.7.7.38 (6%);3.1.1.29 (6%),Receptor protein-tyrosine kinase (56%);3-deoxy-manno-octulosonate cytidylyltransferase (6%);Aminoacyl-tRNA hydrolase (6%),GO:0016021 (52%);GO:0005886 (3%);GO:0005737 (2%),integral component of membrane (52%);plasma membrane (3%);cytoplasm (2%),GO:0005524 (19%);GO:0003824 (11%);GO:0000155 (9%),ATP binding (19%);catalytic activity (11%);phosphorelay sensor kinase activity (9%),GO:0007169 (8%);GO:0006355 (8%);GO:0006508 (6%),transmembrane receptor protein tyrosine kinase signaling pathway (8%);regulation of transcription, DNA-templated (8%);proteolysis (6%),IPR013783 (9%);IPR036034 (9%);IPR000719 (7%),Immunoglobulin-like fold (9%);PDZ superfamily (9%);Protein kinase domain (7%),,,,,,,,,,
EPDQTMETLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVALAHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.84 (100%),Alcohol-forming fatty acyl-CoA reductase (100%),GO:0000325 (14%);GO:0005774 (14%);GO:0016020 (14%),plant-type vacuole (14%);vacuolar membrane (14%);membrane (14%),GO:0000287 (29%);GO:0008801 (29%);GO:0016787 (29%),magnesium ion binding (29%);beta-phosphoglucomutase activity (29%);hydrolase activity (29%),GO:0005975 (29%);GO:0006629 (29%);GO:0000160 (14%),carbohydrate metabolic process (29%);lipid metabolic process (29%);phosphorelay signal transduction system (14%),IPR005194 (25%);IPR005195 (25%);IPR005196 (25%),Glycoside hydrolase family 65, C-terminal (25%);Glycoside hydrolase, family 65, central catalytic (25%);Glycoside hydrolase, family 65, N-terminal (25%),,,,,,
TLSTDMVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFCDDVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDDTGPASYQEHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSLPVQSLHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVEHLDHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDGVDMVDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLDVAEGTNWLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLFLNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.4 (32%);5.4.99.12 (23%);2.7.13.3 (14%),tRNA uracil 4-sulfurtransferase (32%);tRNA pseudouridine(38-40) synthase (23%);Histidine kinase (14%),GO:0016021 (58%);GO:0005737 (10%);GO:0005891 (3%),integral component of membrane (58%);cytoplasm (10%);voltage-gated calcium channel complex (3%),GO:0005524 (17%);GO:0003677 (8%);GO:0000155 (7%),ATP binding (17%);DNA binding (8%);phosphorelay sensor kinase activity (7%),GO:0006310 (6%);GO:0006281 (4%);GO:0009228 (4%),DNA recombination (6%);DNA repair (4%);thiamine biosynthetic process (4%),IPR036259 (11%);IPR039309 (8%);IPR003594 (7%),MFS transporter superfamily (11%);Biopterin transporter family (8%);Histidine kinase/HSP90-like ATPase (7%),,,,,,,,,,,
SYDSSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPLLSPGR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004190 (33%);GO:0004553 (33%);GO:0005524 (33%),aspartic-type endopeptidase activity (33%);hydrolase activity, hydrolyzing O-glycosyl compounds (33%);ATP binding (33%),GO:0005975 (33%);GO:0006298 (33%),carbohydrate metabolic process (33%);mismatch repair (33%),IPR000432 (33%);IPR001764 (33%);IPR001969 (33%),DNA mismatch repair protein MutS, C-terminal (33%);Glycoside hydrolase, family 3, N-terminal (33%);Aspartic peptidase, active site (33%),,,,,,
DLVWDLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AATTGGASHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNPAANK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (100%),Nucleotidyltransferases (100%),GO:0005840 (10%);GO:0016021 (10%),ribosome (10%);integral component of membrane (10%),GO:0003677 (40%);GO:0003896 (40%);GO:0008270 (40%),DNA binding (40%);DNA primase activity (40%);zinc ion binding (40%),GO:0006412 (10%);GO:0006606 (10%),translation (10%);protein import into nucleus (10%),IPR002694 (44%);IPR006171 (44%);IPR013264 (44%),Zinc finger, CHC2-type (44%);TOPRIM  domain (44%);DNA primase, catalytic core, N-terminal (44%),,,,,,,,
HMEDNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0005509 (33%);GO:0008270 (33%),calcium ion binding (33%);zinc ion binding (33%),,,IPR000315 (33%);IPR001611 (33%);IPR002048 (33%),B-box-type zinc finger (33%);Leucine-rich repeat (33%);EF-hand domain (33%),,,,,,,,,,,
AEHFVENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVMMPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HNMAAQQCTFEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPVYLVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVEQPDVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVWTGMDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMMHNK,Metazoa,Eukaryota,Metazoa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0004674 (67%);GO:0005524 (67%);GO:0038023 (33%),protein serine/threonine kinase activity (67%);ATP binding (67%);signaling receptor activity (33%),GO:0003140 (67%);GO:0008630 (67%);GO:0035469 (67%),determination of left/right asymmetry in lateral mesoderm (67%);intrinsic apoptotic signaling pathway in response to DNA damage (67%);determination of pancreatic left/right asymmetry (67%),IPR000403 (50%);IPR001304 (50%);IPR003151 (50%),Phosphatidylinositol 3-/4-kinase, catalytic domain (50%);C-type lectin-like (50%);PIK-related kinase, FAT (50%),,,,,,,,,
SLALTMHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYVANDNGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MWDPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.144 (71%);1.1.1.42 (5%);2.7.10.2 (5%),Trans-aconitate 2-methyltransferase (71%);Isocitrate dehydrogenase (NADP(+)) (5%);Non-specific protein-tyrosine kinase (5%),GO:0016021 (20%);GO:0005737 (18%);GO:0005730 (10%),integral component of membrane (20%);cytoplasm (18%);nucleolus (10%),GO:0030798 (13%);GO:0004497 (6%);GO:0005506 (6%),trans-aconitate 2-methyltransferase activity (13%);monooxygenase activity (6%);iron ion binding (6%),GO:0032259 (13%);GO:0000027 (6%);GO:0110136 (6%),methylation (13%);ribosomal large subunit assembly (6%);protein-RNA complex remodeling (6%),IPR001680 (19%);IPR015943 (19%);IPR017986 (17%),WD40 repeat (19%);WD40/YVTN repeat-like-containing domain superfamily (19%);WD40-repeat-containing domain (17%),,,,,,,,,,,
EPCDMVLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSCTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (15%);3.2.1.67 (10%);3.2.2.20 (10%),DNA topoisomerase (ATP-hydrolyzing) (15%);Galacturonan 1,4-alpha-galacturonidase (10%);DNA-3-methyladenine glycosylase I (10%),GO:0016021 (18%);GO:0005576 (8%);GO:0005634 (6%),integral component of membrane (18%);extracellular region (8%);nucleus (6%),GO:0003824 (13%);GO:0003677 (11%);GO:0005524 (11%),catalytic activity (13%);DNA binding (11%);ATP binding (11%),GO:0006284 (14%);GO:0005975 (9%);GO:0071555 (7%),base-excision repair (14%);carbohydrate metabolic process (9%);cell wall organization (7%),IPR003265 (10%);IPR011257 (10%);IPR023170 (10%),HhH-GPD domain (10%);DNA glycosylase (10%);Helix-turn-helix, base-excision DNA repair, C-terminal (10%),,,,,,,,
TAACHSK,Nematocida parisii,Eukaryota,Fungi,,,Microsporidia,,,,,,,,,,,,,,,,Nematocida,,,,Nematocida parisii,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,,,,,,,,,,,,
AALNEELSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLWHGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (74%);GO:0005737 (3%);GO:0005886 (3%),integral component of membrane (74%);cytoplasm (3%);plasma membrane (3%),GO:0009055 (17%);GO:0051536 (17%);GO:0016620 (6%),electron transfer activity (17%);iron-sulfur cluster binding (17%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (6%),GO:0009306 (57%);GO:0006099 (17%);GO:0006171 (3%),protein secretion (57%);tricarboxylic acid cycle (17%);cAMP biosynthetic process (3%),IPR006144 (61%);IPR004489 (17%);IPR009051 (17%),Secretion protein HlyD, conserved site (61%);Succinate dehydrogenase/fumarate reductase iron-sulphur protein (17%);Alpha-helical ferredoxin (17%),,,,,,,,
AGALFASDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LHVVLM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPLFPSQK,Flavobacterium,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Flavobacteriaceae,,,,Flavobacterium,,,,,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (100%);IPR008969 (100%);IPR012910 (100%),TonB-dependent receptor-like, beta-barrel (100%);Carboxypeptidase-like, regulatory domain superfamily (100%);TonB-dependent receptor, plug domain (100%),,,,,,,,
QEENESLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YEVAGNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019867 (100%),outer membrane (100%),,,,,IPR003991 (50%);IPR004899 (50%);IPR005546 (50%),Pertactin virulence factor family (50%);Pertactin, central region (50%);Autotransporter beta-domain (50%),,,,,,,,,,
MLRPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.51 (14%);2.7.13.3 (10%);2.7.7.6 (8%),1-acylglycerol-3-phosphate O-acyltransferase (14%);Histidine kinase (10%);DNA-directed RNA polymerase (8%),GO:0016021 (36%);GO:0005737 (3%);GO:0005634 (2%),integral component of membrane (36%);cytoplasm (3%);nucleus (2%),GO:0003677 (16%);GO:0005524 (11%);GO:0000155 (5%),DNA binding (16%);ATP binding (11%);phosphorelay sensor kinase activity (5%),GO:0006310 (6%);GO:0015074 (6%);GO:0006355 (5%),DNA recombination (6%);DNA integration (6%);regulation of transcription, DNA-templated (5%),IPR015943 (7%);IPR001680 (7%);IPR017986 (7%),WD40/YVTN repeat-like-containing domain superfamily (7%);WD40 repeat (7%);WD40-repeat-containing domain (7%),,,,,,,,,,
NFNAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (23%);5.4.99.12 (8%);1.11.1.7 (6%),DNA-directed DNA polymerase (23%);tRNA pseudouridine(38-40) synthase (8%);Peroxidase (6%),GO:0016021 (17%);GO:0005737 (2%);GO:0005886 (2%),integral component of membrane (17%);cytoplasm (2%);plasma membrane (2%),GO:0005524 (48%);GO:0004674 (37%);GO:0003677 (6%),ATP binding (48%);protein serine/threonine kinase activity (37%);DNA binding (6%),GO:0008612 (4%);GO:0006281 (2%);GO:0006261 (2%),peptidyl-lysine modification to peptidyl-hypusine (4%);DNA repair (2%);DNA-dependent DNA replication (2%),IPR011009 (43%);IPR000719 (43%);IPR008271 (42%),Protein kinase-like domain superfamily (43%);Protein kinase domain (43%);Serine/threonine-protein kinase, active site (42%),,,,,,,,,,
ANTHFENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPMVPGR,Haloactinopolyspora alba,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Jiangellales,,,,,Jiangellaceae,,,,Haloactinopolyspora,,,,Haloactinopolyspora alba,,,,,,,,GO:0005507 (100%),copper ion binding (100%),GO:0055070 (100%),copper ion homeostasis (100%),IPR005627 (100%);IPR023648 (100%);IPR036822 (100%),Copper homeostasis protein CutC (100%);Copper homeostasis CutC domain (100%);Copper homeostasis (CutC) domain superfamily (100%),,,,,,,,,,,
WLEHFFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEGLLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.4 (96%);3.1.-.- (2%);3.6.4.12 (2%),Amidase (96%);Acting on ester bonds (2%);DNA helicase (2%),GO:0016021 (3%);GO:0005737 (3%);GO:0005886 (1%),integral component of membrane (3%);cytoplasm (3%);plasma membrane (1%),GO:0004040 (73%);GO:0043864 (25%);GO:0005524 (8%),amidase activity (73%);indoleacetamide hydrolase activity (25%);ATP binding (8%),GO:0006281 (11%);GO:0006310 (11%);GO:0006353 (3%),DNA repair (11%);DNA recombination (11%);DNA-templated transcription, termination (3%),IPR036928 (74%);IPR023631 (72%);IPR000120 (71%),Amidase signature (AS) superfamily (74%);Amidase signature domain (72%);Amidase (71%),,,,,,,,,,
WWPTYMFAVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LHWCEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.166 (50%);3.4.24.- (50%),3-deoxy-D-manno-octulosonic acid kinase (50%);Metalloendopeptidases (50%),GO:0005743 (33%);GO:0005886 (33%),mitochondrial inner membrane (33%);plasma membrane (33%),GO:0004672 (33%);GO:0004673 (33%);GO:0005524 (33%),protein kinase activity (33%);protein histidine kinase activity (33%);ATP binding (33%),GO:0009244 (33%),lipopolysaccharide core region biosynthetic process (33%),IPR001810 (40%);IPR036047 (40%);IPR000014 (20%),F-box domain (40%);F-box-like domain superfamily (40%);PAS domain (20%),,,,,,,,,,,
TLMVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.88 (17%);1.5.5.2 (17%);2.1.1.- (12%),L-glutamate gamma-semialdehyde dehydrogenase (17%);Proline dehydrogenase (17%);Methyltransferases (12%),GO:0016021 (20%);GO:0005737 (6%);GO:0005886 (1%),integral component of membrane (20%);cytoplasm (6%);plasma membrane (1%),GO:0008173 (22%);GO:0005524 (22%);GO:0016887 (13%),RNA methyltransferase activity (22%);ATP binding (22%);ATPase activity (13%),GO:0006396 (22%);GO:0006561 (4%);GO:0010133 (4%),RNA processing (22%);proline biosynthetic process (4%);proline catabolic process to glutamate (4%),IPR029063 (22%);IPR012340 (21%);IPR010280 (21%),S-adenosyl-L-methionine-dependent methyltransferase (22%);Nucleic acid-binding, OB-fold (21%);(Uracil-5)-methyltransferase family (21%),,,,,,,,,,
MQLTSHAVMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLWHNLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (33%);GO:0005886 (33%);GO:0016021 (33%),cytoplasm (33%);plasma membrane (33%);integral component of membrane (33%),GO:0005524 (67%);GO:0003677 (33%);GO:0003678 (33%),ATP binding (67%);DNA binding (33%);DNA helicase activity (33%),GO:0006270 (33%);GO:0006275 (33%);GO:0006281 (33%),DNA replication initiation (33%);regulation of DNA replication (33%);DNA repair (33%),IPR027417 (50%);IPR001957 (25%);IPR003593 (25%),P-loop containing nucleoside triphosphate hydrolase (50%);Chromosomal replication control, initiator DnaA (25%);AAA+ ATPase domain (25%),,,,,,,,,,
AEVGDMPPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDAPSNPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLSVYMFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AWYCHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQNPWMLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFAAEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.9 (13%);5.1.3.2 (13%);2.1.3.15 (8%),Methionyl-tRNA formyltransferase (13%);UDP-glucose 4-epimerase (13%);Acetyl-CoA carboxytransferase (8%),GO:0016021 (15%);GO:0005737 (2%);GO:0005886 (2%),integral component of membrane (15%);cytoplasm (2%);plasma membrane (2%),GO:0016740 (20%);GO:0005524 (16%);GO:0050660 (10%),transferase activity (20%);ATP binding (16%);flavin adenine dinucleotide binding (10%),GO:0005975 (4%);GO:0006355 (2%);GO:0006012 (1%),carbohydrate metabolic process (4%);regulation of transcription, DNA-templated (2%);galactose metabolic process (1%),IPR004045 (18%);IPR036249 (18%);IPR010987 (18%),Glutathione S-transferase, N-terminal (18%);Thioredoxin-like superfamily (18%);Glutathione S-transferase, C-terminal-like (18%),,,,,,,,
QGMQDQNPNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLPPMDK,Labeo rohita,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,Cypriniphysae,Cypriniformes,Cyprinoidei,,,,Cyprinidae,,,,Labeo,,,,Labeo rohita,,,,,,,,GO:0003777 (100%);GO:0005524 (100%);GO:0008017 (100%),microtubule motor activity (100%);ATP binding (100%);microtubule binding (100%),GO:0007018 (100%),microtubule-based movement (100%),IPR000340 (100%);IPR000387 (100%);IPR001752 (100%),Dual specificity phosphatase, catalytic domain (100%);Tyrosine specific protein phosphatases domain (100%);Kinesin motor domain (100%),,,,,,,,,,
